PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Stoof, SP; van der Klis, FRM; van Rooijen, DM; Knol, MJ; Sanders, EAM; Berbers, GAM				Stoof, Susanne P.; van der Klis, Fiona R. M.; van Rooijen, Debbie M.; Knol, Mirjam J.; Sanders, Elisabeth A. M.; Berbers, Guy A. M.			Timing of an Adolescent Booster after Single Primary Meningococcal Serogroup C Conjugate Immunization at Young Age; An Intervention Study among Dutch Teenagers	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; UNITED-KINGDOM; GLYCOCONJUGATE VACCINE; IMMUNOLOGICAL MEMORY; POLYSACCHARIDE VACCINE; MULTIPLEX IMMUNOASSAY; SERUM ANTIBODIES; PRIMARY SCHEDULE; IMMUNE-RESPONSE; CLINICAL-TRIAL	Background: Meningococcal serogroup C (MenC) specific antibody levels decline rapidly after a single primary MenC conjugate (MenCC) vaccination in preschool children. A second MenCC vaccination during (pre) adolescence might attain longer lasting individual and herd protection. We aimed to establish an appropriate age for a (pre) adolescent MenCC booster vaccination. Methods: A phase-IV trial with healthy 10-year-olds (n = 91), 12-year-olds (n = 91) and 15-year-olds (n = 86) who were primed with a MenCC vaccine nine years earlier. All participants received a booster vaccination with the same vaccine. Serum bactericidal antibody assay titers (SBA, using baby rabbit complement), MenC-polysaccharide (MenC-PS) specific IgG, IgG subclass and avidity and tetanus-specific IgG levels were measured prior to (T0) and 1 month (T1) and 1 year (T2) after the booster. An SBA titer >= 8 was the correlate of protection. Results: 258 (96.3%) participants completed all three study visits. At T0, 19% of the 10-year-olds still had an SBA titer >= 8, compared to 34% of the 12-year-olds (P = 0.057) and 45% of the 15-year-olds (P<0.001). All participants developed high SBA titers (GMTs>30,000 in all age groups) and MenC-PS specific IgG levels at T1. IgG levels mainly consisted of IgG1, but the contribution of IgG2 increased with age. At T2, 100% of participants still had an SBA titer >= 8, but the 15-year-olds showed the highest protective antibody levels and the lowest decay. Conclusion: Nine years after primary MenCC vaccination adolescents develop high protective antibody levels in response to a booster and are still sufficiently protected one year later. Our results suggest that persistence of individual - and herd - protection increases with the age at which an adolescent booster is administered.	[Stoof, Susanne P.; van der Klis, Fiona R. M.; van Rooijen, Debbie M.; Knol, Mirjam J.; Berbers, Guy A. M.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Stoof, Susanne P.; Sanders, Elisabeth A. M.] Univ Med Ctr, Wilhelmina Childrens Hosp, Dept Immunol & Infect Dis, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Stoof, SP (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.	susanne.stoof@rivm.nl; guy.berbers@rivm.nl			Dutch Ministry of Health	Dutch Ministry of Health	This study was funded by the Dutch Ministry of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Baxter kindly provided the vaccines.	Andrews N, 2003, CLIN DIAGN LAB IMMUN, V10, P780, DOI 10.1128/CDLI.10.5.780-786.2003; [Anonymous], VACC SCHED; Borrow R, 2005, VACCINE, V23, P2222, DOI 10.1016/j.vaccine.2005.01.051; Borrow R, 2003, INFECT IMMUN, V71, P5549, DOI 10.1128/IAI.71.10.5549-5555.2003; Borrow R, 2010, CLIN VACCINE IMMUNOL, V17, P154, DOI 10.1128/CVI.00384-09; Christensen H, 2010, LANCET INFECT DIS, V10, P853, DOI 10.1016/S1473-3099(10)70251-6; de Voer RM, 2008, CLIN VACCINE IMMUNOL, V15, P1188, DOI 10.1128/CVI.00478-07; de Voer RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023497; de Voer RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012144; de Voer RM, 2009, VACCINE, V27, P6974, DOI 10.1016/j.vaccine.2009.09.082; de Whalley PCS, 2013, ARCH DIS CHILD, V98, P686, DOI 10.1136/archdischild-2013-303893; de Whalley PCS, 2011, PEDIATR INFECT DIS J, V30, pE203, DOI 10.1097/INF.0b013e318224fb14; Diez-Domingo J, 2010, PEDIATR INFECT DIS J, V29, P148, DOI 10.1097/INF.0b013e3181b9a831; Findlow H, 2012, PEDIATR INFECT DIS J, V31, P616, DOI 10.1097/INF.0b013e31824f34e6; Goldblatt D, 2002, J INFECT DIS, V185, P397, DOI 10.1086/338474; Harris SL, 2007, CLIN VACCINE IMMUNOL, V14, P397, DOI 10.1128/CVI.00241-06; Jafri RZ, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-17; Kelly DF, 2009, IMMUNOLOGY, V127, P134, DOI 10.1111/j.1365-2567.2008.02934.x; Khatami A, 2011, CLIN VACCINE IMMUNOL, V18, P2038, DOI 10.1128/CVI.05354-11; Khatami A, 2011, PEDIATR INFECT DIS J, V30, P197, DOI 10.1097/INF.0b013e3181f728fd; Lal G, 2004, CLIN DIAGN LAB IMMUN, V11, P272, DOI 10.1128/CDLI.11.2.272-279.2004; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; Maslanka SE, 1997, CLIN DIAGN LAB IMMUN, V4, P156, DOI 10.1128/CDLI.4.2.156-167.1997; Neppelenbroek SE, 2003, DAS GOED GEDAAN REPO; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Perrett KP, 2010, CLIN INFECT DIS, V50, P1601, DOI 10.1086/652765; Richmond P, 2001, J INFECT DIS, V183, P160, DOI 10.1086/317646; Rohner GB, 2008, J IMMUNOL, V180, P2165, DOI 10.4049/jimmunol.180.4.2165; Snape MD, 2008, BRIT MED J, V336, P1487, DOI 10.1136/bmj.39563.545255.AE; Snape MD, 2006, CLIN INFECT DIS, V43, P1387, DOI 10.1086/508776; Snape MD, 2005, PEDIATR INFECT DIS J, V24, P128, DOI 10.1097/01.inf.0000151029.58752.27; Trotter CL, 2009, EXPERT REV VACCINES, V8, P851, DOI [10.1586/erv.09.48, 10.1586/ERV.09.48]; Trotter CL, 2005, AM J EPIDEMIOL, V162, P89, DOI 10.1093/aje/kwi160; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; van der Klis FRM, 2009, NETH J MED, V67, P301; van Gageldonk PGM, 2008, J IMMUNOL METHODS, V335, P79, DOI 10.1016/j.jim.2008.02.018; van Lier EA, 2013, VACCINATIEGRAAD RIJK; van't Klooster T, 2013, NATL IMMUNISATION PR, V201001002; Vickers DM, 2013, VACCINE	40	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100651	10.1371/journal.pone.0100651	http://dx.doi.org/10.1371/journal.pone.0100651			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963638	gold, Green Published, Green Submitted			2022-12-25	WOS:000338709500072
J	Machado, AMD; Sommer, MOA				Machado, Ana Manuel Dantas; Sommer, Morten O. A.			Human Intestinal Cells Modulate Conjugational Transfer of Multidrug Resistance Plasmids between Clinical Escherichia coli Isolates	PLOS ONE			English	Article							GENE-TRANSFER; GUT INFLAMMATION; MICROFLORA; MICROBIOTA; DIVERSITY; HEALTH	Bacterial conjugation in the human gut microbiota is believed to play a major role in the dissemination of antibiotic resistance genes and virulence plasmids. However, the modulation of bacterial conjugation by the human host remains poorly understood and there is a need for controlled systems to study this process. We established an in vitro co-culture system to study the interaction between human intestinal cells and bacteria. We show that the conjugation efficiency of a plasmid encoding an extended spectrum beta-lactamase is reduced when clinical isolates of Escherichia coli are co-cultured with human intestinal cells. We show that filtered media from co-cultures contain a factor that reduces conjugation efficiency. Protease treatment of the filtered media eliminates this inhibition of conjugation. This data suggests that a peptide or protein based factor is secreted on the apical side of the intestinal cells exposed to bacteria leading to a two-fold reduction in conjugation efficiency. These results show that human gut epithelial cells can modulate bacterial conjugation and may have relevance to gene exchange in the gut.	[Machado, Ana Manuel Dantas; Sommer, Morten O. A.] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Sommer, Morten O. A.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark	Technical University of Denmark; Technical University of Denmark	Sommer, MOA (corresponding author), Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark.	msom@bio.dtu.dk		Sommer, Morten Otto Alexander/0000-0003-4005-5674	EU FP7-Health Program Evotar [282004]; Lundbeck Foundation; Novo Nordisk Foundation; Danish Free Research Councils; Lundbeck Foundation [R140-2013-13496, R77-2010-6772] Funding Source: researchfish; Novo Nordisk Fonden [NNF10CC1016517, NNF14OC0011335, NNF13SA0009311, NNF13SA0006019] Funding Source: researchfish	EU FP7-Health Program Evotar; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Free Research Councils; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This research was funded by the EU FP7-Health Program Evotar (282004) and the Lundbeck Foundation. MOAS acknowledges additional funding from the Novo Nordisk Foundation and The Danish Free Research Councils. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baquero F, 2011, ANTIMICROB AGENTS CH, V55, P3649, DOI 10.1128/AAC.00013-11; Bates S, 1998, J BACTERIOL, V180, P6538, DOI 10.1128/JB.180.24.6538-6543.1998; Burrus V, 2002, MOL MICROBIOL, V46, P601, DOI 10.1046/j.1365-2958.2002.03191.x; Chiller K, 2001, J INVEST DERM SYMP P, V6, P170, DOI 10.1046/j.0022-202x.2001.00043.x; Daniels JB, 2007, APPL ENVIRON MICROB, V73, P8005, DOI 10.1128/AEM.01325-07; Dantas G, 2013, ANNU REV MICROBIOL, V67, P459, DOI 10.1146/annurev-micro-092412-155642; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Eisenhofer G, 1997, J CLIN ENDOCR METAB, V82, P3864, DOI 10.1210/jc.82.11.3864; Faure S, 2010, ANTIMICROB AGENTS CH, V54, P164, DOI 10.1128/AAC.00310-09; FRANKE AE, 1981, J BACTERIOL, V145, P494, DOI 10.1128/JB.145.1.494-502.1981; Halary S, 2010, P NATL ACAD SCI USA, V107, P127, DOI 10.1073/pnas.0908978107; HEINEMANN JA, 1991, TRENDS GENET, V7, P181, DOI 10.1016/0168-9525(91)90122-7; Hull MW, 2007, INFECT DIS CLIN N AM, V21, P265, DOI 10.1016/j.idc.2007.03.015; Karra E, 2010, MOL CELL ENDOCRINOL, V316, P120, DOI 10.1016/j.mce.2009.06.010; KASUYA M, 1964, J BACTERIOL, V88, P322, DOI 10.1128/JB.88.2.322-328.1964; Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02; Kunz C, 2009, ADV EXP MED BIOL, V639, P67, DOI 10.1007/978-1-4020-8749-3_6; Lester CH, 2006, ANTIMICROB AGENTS CH, V50, P596, DOI 10.1128/AAC.50.2.596-599.2006; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Licht TR, 1999, MICROBIOL-SGM, V145, P2615, DOI 10.1099/00221287-145-9-2615; Licht TR, 1999, ENVIRON MICROBIOL, V1, P23, DOI 10.1046/j.1462-2920.1999.00001.x; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; MCCONNELL M A, 1991, Microbial Ecology in Health and Disease, V4, P343; Morelli L, 2008, J NUTR, V138, p1791S, DOI 10.1093/jn/138.9.1791S; Moubareck C, 2003, ANTIMICROB AGENTS CH, V47, P2993, DOI 10.1128/AAC.47.9.2993-2996.2003; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Pedron T, 2008, CELL HOST MICROBE, V3, P344, DOI 10.1016/j.chom.2008.05.010; POULSEN LK, 1995, J BACTERIOL, V177, P5840, DOI 10.1128/jb.177.20.5840-5845.1995; ROBERTS M, 1979, INFECT IMMUN, V24, P982, DOI 10.1128/IAI.24.3.982-984.1979; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Smet A, 2011, J APPL MICROBIOL, V110, P541, DOI 10.1111/j.1365-2672.2010.04907.x; Sommer MOA, 2011, CURR OPIN MICROBIOL, V14, P556, DOI 10.1016/j.mib.2011.07.005; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Stecher B, 2012, P NATL ACAD SCI USA, V109, P1269, DOI 10.1073/pnas.1113246109; TATUM EL, 1947, J BACTERIOL, V53, P673, DOI 10.1128/JB.53.6.673-684.1947; Trobos M, 2009, J ANTIMICROB CHEMOTH, V63, P80, DOI 10.1093/jac/dkn437; WADOLKOWSKI EA, 1988, INFECT IMMUN, V56, P1030, DOI 10.1128/IAI.56.5.1030-1035.1988; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415	41	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100739	10.1371/journal.pone.0100739	http://dx.doi.org/10.1371/journal.pone.0100739			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955767	Green Submitted, Green Published, gold			2022-12-25	WOS:000338917900092
J	Lyonnet, BB; Diacovich, L; Cabruja, M; Bardou, F; Quemard, A; Gago, G; Gramajo, H				Bazet Lyonnet, Bernardo; Diacovich, Lautaro; Cabruja, Matias; Bardou, Fabienne; Quemard, Annaik; Gago, Gabriela; Gramajo, Hugo			Pleiotropic Effect of AccD5 and AccE5 Depletion in Acyl-Coenzyme A Carboxylase Activity and in Lipid Biosynthesis in Mycobacteria	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; MYCOLIC ACID BIOSYNTHESIS; COA CARBOXYLASE; A CARBOXYLASE; FATTY-ACID; STREPTOMYCES-COELICOLOR; CONDENSING ENZYMES; ESCHERICHIA-COLI; TUBERCULOSIS; TRANSFORMATION	Mycobacteria contain a large variety of fatty acids which are used for the biosynthesis of several complex cell wall lipids that have been implicated in the ability of the organism to resist host defenses. The building blocks for the biosynthesis of all these lipids are provided by a fairly complex set of acyl-CoA carboxylases (ACCases) whose subunit composition and roles within these organisms have not yet been clearly established. Previous biochemical and structural studies provided strong evidences that ACCase 5 from Mycobacterium tuberculosis is formed by the AccA3, AccD5 and AccE5 subunits and that this enzyme complex carboxylates acetyl-CoA and propionyl-CoA with a clear substrate preference for the latest. In this work we used a genetic approach to unambiguously demonstrate that the products of both accD5 and accE5 genes are essential for the viability of Mycobacterium smegmatis. By obtaining a conditional mutant on the accD5-accE5 operon, we also demonstrated that the main physiological role of this enzyme complex was to provide the substrates for fatty acid and mycolic acid biosynthesis. Furthermore, enzymatic and biochemical analysis of the conditional mutant provided strong evidences supporting the notion that AccD5 and/or AccE5 have an additional role in the carboxylation of long chain acyl-CoA prior to mycolic acid condensation. These studies represent a significant step towards a better understanding of the roles of ACCases in mycobacteria and confirm ACCase 5 as an interesting target for the development of new antimycobacterial drugs.	[Bazet Lyonnet, Bernardo; Diacovich, Lautaro; Cabruja, Matias; Gago, Gabriela; Gramajo, Hugo] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Inst Biol Mol & Celular Rosario IBR CONICET, Lab Physiol & Genet Actinomycetes, RA-2000 Rosario, Argentina; [Bardou, Fabienne; Quemard, Annaik] CNRS, IPBS, Dept TB & Biol Infect, Toulouse, France; [Bardou, Fabienne; Quemard, Annaik] Univ Toulouse, UPS, IPBS, Toulouse, France	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Gago, G (corresponding author), Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Inst Biol Mol & Celular Rosario IBR CONICET, Lab Physiol & Genet Actinomycetes, RA-2000 Rosario, Argentina.	gago@ibr-conicet.gov.ar; gramajo@ibr-conicet.gov.ar		Diacovich, Lautaro/0000-0002-3339-0100; Cabruja, Matias/0000-0001-7691-6494; Gago, Gabriela/0000-0001-7668-0119; Quemard, Annaik/0000-0002-5545-3424	NIH [1R01AI095183-01]; Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Republica Argentina (MINCYT)/ECOS-Sud France [A11B04]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2008-1640, PICTO 2011-0047, PICT 2011-0245]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095183] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Republica Argentina (MINCYT)/ECOS-Sud France; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH (1R01AI095183-01 to HG), Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Republica Argentina (MINCYT)/ECOS-Sud France (A11B04 to HG and AQ), Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2008-1640 and PICTO 2011-0047 to HG, PICT 2011-0245 to GG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabolaza A, 2010, MOL MICROBIOL, V78, P47, DOI 10.1111/j.1365-2958.2010.07274.x; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Boldrin F, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq235; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Cegielski JP, 2010, CLIN INFECT DIS, V50, pS195, DOI 10.1086/651491; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; CONNELL ND, 1994, METHOD CELL BIOL, V45, P107; Consaul SA, 2004, FEMS MICROBIOL LETT, V234, P297, DOI 10.1016/j.femsle.2004.03.041; Cronan JE, 2002, PROG LIPID RES, V41, P407, DOI 10.1016/S0163-7827(02)00007-3; Daffe M, 2008, MYCOBACTERIAL CELL ENVELOPE, P3; Daniel J, 2007, J BACTERIOL, V189, P911, DOI 10.1128/JB.01019-06; Diacovich L, 2002, J BIOL CHEM, V277, P31228, DOI 10.1074/jbc.M203263200; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Forti F, 2009, J BIOTECHNOL, V140, P270, DOI 10.1016/j.jbiotec.2009.02.001; Gago G, 2006, J BACTERIOL, V188, P477, DOI 10.1128/JB.188.2.477-486.2006; Gago G, 2011, FEMS MICROBIOL REV, V35, P475, DOI 10.1111/j.1574-6976.2010.00259.x; Gande R, 2007, J BACTERIOL, V189, P5257, DOI 10.1128/JB.00254-07; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harrington M, 2010, CLIN INFECT DIS, V50, pS260, DOI 10.1086/651500; Kremer L, 2000, J BIOL CHEM, V275, P16857, DOI 10.1074/jbc.M000569200; Kurth DG, 2009, MICROBIOLOGY; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin TW, 2006, P NATL ACAD SCI USA, V103, P3072, DOI 10.1073/pnas.0510580103; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; Oh TJ, 2006, J BIOL CHEM, V281, P3899, DOI 10.1074/jbc.M511761200; Pawelczyk J, 2011, J BACTERIOL, V193, P6960, DOI 10.1128/JB.05638-11; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Portevin D, 2005, J BIOL CHEM, V280, P8862, DOI 10.1074/jbc.M408578200; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Rao V, 2006, J CLIN INVEST, V116, P1660, DOI 10.1172/JCI27335; Sambrook J., 2002, MOL CLONING LAB MANU; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Sun D, 2006, ANAL BIOCHEM, V349, P87, DOI 10.1016/j.ab.2005.10.006; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Veyron-Churlet R, 2005, J MOL BIOL, V353, P847, DOI 10.1016/j.jmb.2005.09.016; Veyron-Churlet R, 2004, MOL MICROBIOL, V54, P1161, DOI 10.1111/j.1365-2958.2004.04334.x; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	41	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99853	10.1371/journal.pone.0099853	http://dx.doi.org/10.1371/journal.pone.0099853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950047	gold, Green Published, Green Submitted			2022-12-25	WOS:000338276300020
J	Dobson, NC; De Grave, S; Johnson, ML				Dobson, Nicola C.; De Grave, Sammy; Johnson, Magnus L.			Linking Eye Design with Host Symbiont Relationships in Pontoniine Shrimps (Crustacea, Decapoda, Palaemonidae)	PLOS ONE			English	Article							INDO-PACIFIC PONTONIINAE; DEEP-SEA CRUSTACEANS; HABITAT DEPTH; PHYLOGENETIC ANALYSIS; SPECTRAL SENSITIVITY; PERICLIMENES COSTA; OPTICAL-PARAMETERS; REFLECTS HABITAT; ACCESSORY EYE; MATING SYSTEM	Symbiosis is prevalent in the marine environment with many studies examining the effects of such interactions between host and symbiont. Pontoniine shrimps are a group whose ecology is characterised by symbiotic interactions. This investigation examines the gross morphology of Pontoniinae compound eyes and superficial optical parameters with reference to their symbiotic relationship or lifestyle category; free-living, ectosymbiont, endosymbiont (bivalves) or endosymbiont (non-bivalves). The eye morphologies of free-living and ectosymbiotic species are very similar, yet differ from both forms of endosymbiotic species. Endosymbionts have significantly smaller and simpler eyes with larger facets and bigger interommatidial angles and eye parameters for increased sensitivity levels. However bivalve endosymbionts form an intermediary group between non-bivalve endosymbionts and ectosymbionts as a result of their more active lifestyle. The accessory eye or "nebenauge", although of uncertain function, commonly occurs in free-living Pontoniinae species but rarely in endosymbionts apart from in more primitive species. The variation in morphology reflects tensions between functional requirements and ecological pressures that have strongly influenced eye design in Pontoniinae.	[Dobson, Nicola C.; Johnson, Magnus L.] Univ Hull, Fac Sci & Engn, Ctr Environm & Marine Sci, Scarborough, N Yorkshire, England; [De Grave, Sammy] Univ Oxford, Museum Nat Hist, Oxford, England	University of Hull; University of Oxford	Dobson, NC (corresponding author), Univ Hull, Fac Sci & Engn, Ctr Environm & Marine Sci, Scarborough Campus, Scarborough, N Yorkshire, England.	n.dobson@biosci.hull.ac.uk		Dobson, Nicola/0000-0002-7061-1646; De Grave, Sammy/0000-0002-2437-2445				Baeza JA, 2011, INVERTEBR BIOL, V130, P351, DOI 10.1111/j.1744-7410.2011.00244.x; Baeza JA, 2011, J EXP MAR BIOL ECOL, V407, P41, DOI 10.1016/j.jembe.2011.07.011; Baeza JA, 2013, J ZOOL, V289, P172, DOI 10.1111/j.1469-7998.2012.00974.x; Baeza JA, 2008, MAR BIOL, V153, P387, DOI 10.1007/s00227-007-0815-9; Baeza JA, 2007, REV BIOL MAR OCEANOG, V42, P7; Baker RH, 2001, EVOLUTION, V55, P1373; Baker RH, 2003, EVOLUTION, V57, P87; Bauer RT., 2004, REMARKABLE SHRIMPS A; Bauer T, 1998, J ZOOL, V245, P467, DOI 10.1111/j.1469-7998.1998.tb00121.x; BOWMAN TE, 1984, J CRUSTACEAN BIOL, V4, P7, DOI 10.2307/1547891; Brooke MD, 1999, P ROY SOC B-BIOL SCI, V266, P405, DOI 10.1098/rspb.1999.0652; BRUCE A J, 1972, Crustaceana (Leiden), V23, P243, DOI 10.1163/156854072X00147; Bruce A.J., 1994, Theses Zoologicae, V25, P1; BRUCE A J, 1976, Micronesica, V12, P83; Bruce A. J., 1977, Atoll Res Bull, VNo. 205, P1; BRUCE AJ, 1966, B MAR SCI, V16, P584; Bruce AJ, 2003, CAH BIOL MAR, V44, P299; Bruce AJ, 2002, CRUSTACEANA, V75, P277, DOI 10.1163/156854002760095390; BRUCE AJ, 1981, CRUSTACEANA, V40, P113, DOI 10.1163/156854081X00516; BRUCE AJ, 1981, ATOLL RES B, V245, P1; Bruce AJ, 2007, CAH BIOL MAR, V48, P403; Bruce AJ, 2011, CAH BIOL MAR, V52, P119; Chace F.A., 1993, SMITHSONIAN CONTRIBU, V543, P1, DOI [10.5479/si.00810282.543, DOI 10.5479/SI.00810282.543]; CHACE F A JR, 1969, Crustaceana (Leiden), V16, P251, DOI 10.1163/156854069X00295; Chiussi R, 2002, J CHEM ECOL, V28, P1787, DOI 10.1023/A:1020561101616; Cronin Thomas W., 2008, Evolution Education and Outreach, V1, P463, DOI 10.1007/s12052-008-0085-0; De Grave S., 2011, Zoologische Mededelingen (Leiden), V85, P195; De Grave S, 2001, J BIOGEOGR, V28, P1239, DOI 10.1046/j.1365-2699.2001.00633.x; De Grave S., 2009, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V110, P139; De Grave S, 2009, CRUSTACEANA, V82, P829, DOI 10.1163/156854009X427379; Duris Z, 2010, ZOOTAXA, P106; Duris Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021987; Ellers J, 2012, ECOL LETT, V15, P1071, DOI 10.1111/j.1461-0248.2012.01830.x; Fautin DG, 1995, MAR ECOL PROG SER, V129, P77, DOI 10.3354/meps129077; Field A., 2012, DISCOVERING STAT USI; FORDYCE D, 1993, PALEOBIOLOGY, V19, P288, DOI 10.1017/S0094837300000282; Frank TM, 2012, J EXP BIOL, V215, P3344, DOI 10.1242/jeb.072033; Fransen CHJM, 2012, ZOOTAXA, P43; Fransen Charles H. J. M., 2007, V29, P103; Fransen CHJM, 1995, VITA MARINA, V42, P105; Fransen CHJM, 2002, ZOOLOGISCHE VERHANDE, V336, P1, DOI DOI 10.1163/156854008784513483; Frederiksen R, 2008, J EXP BIOL, V211, P844, DOI 10.1242/jeb.012179; Gaten E, 1998, CONTRIB ZOOL, V67, P223, DOI 10.1163/18759866-06704001; GATEN E, 1992, J MAR BIOL ASSOC UK, V72, P61, DOI 10.1017/S0025315400048785; Goffredi SK, 2010, ENV MICROBIOL REP, V2, P479, DOI 10.1111/j.1758-2229.2010.00136.x; Guo CC, 1996, J EXP MAR BIOL ECOL, V202, P165, DOI 10.1016/0022-0981(96)00020-2; Hemmi JM, 2003, J EXP BIOL, V206, P3951, DOI 10.1242/jeb.00636; HILLERADAMS P, 1984, J COMP PHYSIOL, V154, P307, DOI 10.1007/BF00605230; HILLERADAMS P, 1985, ZOOMORPHOLOGY, V105, P108, DOI 10.1007/BF00312145; HILLERADAMS P, 1988, VISION RES, V28, P667, DOI 10.1016/0042-6989(88)90047-8; Huang HD, 2005, J EXP MAR BIOL ECOL, V326, P56, DOI 10.1016/j.jembe.2005.05.008; ITAYA SK, 1976, TISSUE CELL, V8, P583, DOI 10.1016/0040-8166(76)90032-X; Johnson ML, 2002, J MAR BIOL ASSOC UK, V82, P835, DOI 10.1017/S0025315402006203; Johnson ML, 2000, MAR BIOL, V136, P243, DOI 10.1007/s002270050682; Johnson ML, 2000, BIOL BULL, V199, P6, DOI 10.2307/1542701; Kawada H, 2006, J INSECT PHYSIOL, V52, P67, DOI 10.1016/j.jinsphys.2005.09.004; Kou Q, 2013, MOL PHYLOGENET EVOL, V68, P14, DOI 10.1016/j.ympev.2013.03.010; Land MF, 2002, ANIMAL EYES; LANGDON JW, 1985, MAR BEHAV PHYSIOL, V11, P315, DOI 10.1080/10236248509387056; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Li H, 2002, J CRUSTACEAN BIOL, V22, P449, DOI 10.1651/0278-0372(2002)022[0449:TEOALO]2.0.CO;2; Li XZ, 2004, RAFFLES B ZOOL, P67; Liu Y, 2012, J MORPHOL, V273, P883, DOI 10.1002/jmor.20028; Martinelli JE, 2008, VIE MILIEU, V58, P133; Mascaro M, 2012, J EXP MAR BIOL ECOL, V413, P87, DOI 10.1016/j.jembe.2011.11.026; McCammon A, 2010, CORAL REEFS, V29, P419, DOI 10.1007/s00338-009-0583-8; McCormick T, 1998, PALEOBIOLOGY, V24, P235; MILLAR RH, 1971, ADV MAR BIOL, V9, P1, DOI 10.1016/S0065-2881(08)60341-7; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; Okuno J, 2010, ZOOTAXA, P85; Pachelle Paulo P. G., 2012, Marine Biodiversity Records, V5, pe83, DOI 10.1017/S1755267212000486; Paracer S, 2000, SYMBIOSIS INTRO BIOL, V2nd; PATTON WK, 1994, B MAR SCI, V55, P193; R Core Team R, 2022, R LANG ENV STAT COMP; Ross D.M., 1983, P163; Rutowski RL, 2009, ARTHROPOD STRUCT DEV, V38, P91, DOI 10.1016/j.asd.2008.08.003; Rutowski RL, 2000, J ZOOL, V252, P187, DOI 10.1111/j.1469-7998.2000.tb00614.x; SAFFO MB, 1992, AM ZOOL, V32, P557; SNYDER AW, 1979, VISION INVERTEBRATES, P225; Spotte S, 1998, HELGOLANDER MEERESUN, V52, P59, DOI 10.1007/BF02908736; SPOTTE S, 1994, B MAR SCI, V55, P212; Stavenga D.G., 1989, FACETS VISION; Stavenga DG, 2003, J COMP PHYSIOL A, V189, P189, DOI 10.1007/s00359-003-0390-6; Thiel M, 2001, SYMBIOSIS, V30, P163; UGOLINI A, 1993, CRUSTACEANA, V65, P112, DOI 10.1163/156854093X00441; Van Damme K, 2011, ZOOL J LINN SOC-LOND, V161, P31, DOI 10.1111/j.1096-3642.2010.00639.x; VandenSpiegel D, 1998, J EXP MAR BIOL ECOL, V225, P185, DOI 10.1016/S0022-0981(97)00222-0; Waloszek D, 2005, ARTHROPOD STRUCT DEV, V34, P189, DOI 10.1016/j.asd.2005.01.005; WARRANT EJ, 1993, PROG NEUROBIOL, V40, P413, DOI 10.1016/0301-0082(93)90017-M; Warrant EJ, 2004, BIOL REV, V79, P671, DOI 10.1017/S1464793103006420; Welsh JH, 1937, BIOL BULL-US, V72, P57, DOI 10.2307/1537540; Welsh JH, 1938, BIOL BULL-US, V74, P364, DOI 10.2307/1537810; Williamson JE, 2012, J EXP MAR BIOL ECOL, V414, P38, DOI 10.1016/j.jembe.2012.01.009; Yamamura N, 1996, RES POPUL ECOL, V38, P211, DOI 10.1007/BF02515729	94	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99505	10.1371/journal.pone.0099505	http://dx.doi.org/10.1371/journal.pone.0099505			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950292	Green Published, gold			2022-12-25	WOS:000338276300015
J	Duval, C; de Tayrac, M; Sanschagrin, F; Michaud, K; Gould, PV; Saikali, S				Duval, Celine; de Tayrac, Marie; Sanschagrin, Francois; Michaud, Karine; Gould, Peter Vincent; Saikali, Stephan			ImmunoFISH Is a Reliable Technique for the Assessment of 1p and 19q Status in Oligodendrogliomas	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; COMPARATIVE GENOMIC HYBRIDIZATION; PROGNOSTIC VALUE; 1P/19Q LOSS; MOLECULAR DIAGNOSTICS; EUROPEAN ORGANIZATION; GENETIC SIGNATURE; INTERPHASE FISH; TUMOR LOCATION; CHROMOSOMES 1P	Objective: To develop a new ImmunoFISH technique for the study of oligodendrogliomas by combining a standard immunohistochemical stain using MIB-1 antibody with a standard FISH technique using commercial 1p36 and 19q13 chromosomal probes. Methods: Validation was performed by two observers on a series of 36 pre-selected oligodendrogliomas and compared to the results previously determined by FISH alone. Results: The ImFISH technique is easy to perform and to analyze and is no more time-consuming than the usual FISH technique. Our results show that the inter-observer reliability of ImFISH is high (kappa = 0.86 and 0.95 respectively for 1p and 19q). Compared to FISH, the ImFISH exhibits a very high sensitivity (similar to 100%) and specificity (similar to 90%) for 1p and/or 19q deleted cases. The sensitivity is high for normal cases (similar to 85%) and imbalanced cases (similar to 90%) with a specificity ranging between 50 and 85%. Finally, there were no significant differences between FISH and ImFISH results calculated on 60, 40 or 20 cells. Conclusion: Our study demonstrates the reliability of the ImFISH technique in oligodendrogliomas and emphasizes its advantage in poorly cellular tumoral specimen.	[Duval, Celine; Sanschagrin, Francois; Gould, Peter Vincent; Saikali, Stephan] Ctr Hosp Univ Quebec, Dept Pathol, Quebec City, PQ, Canada; [de Tayrac, Marie] Ctr Hosp Univ Rennes, Dept Genom & Mol Genet, Rennes, France; [Michaud, Karine] Ctr Hosp Univ Quebec, Dept Neurosurg, Quebec City, PQ, Canada	Laval University; CHU Rennes; Universite de Rennes; Laval University	Saikali, S (corresponding author), Ctr Hosp Univ Quebec, Dept Pathol, Quebec City, PQ, Canada.	stephan.saikali.cha@ssss.gouv.qc.ca	Michaud, Karine/AAM-3026-2020; de Tayrac, Marie/AAG-7800-2020		Fondation des hopitaux Enfant-Jesus-Saint Sacrement (Quebec city Quebec) [682/8317]	Fondation des hopitaux Enfant-Jesus-Saint Sacrement (Quebec city Quebec)	This study was supported by the Fondation des hopitaux Enfant-Jesus-Saint Sacrement (Quebec city Quebec): grant number 682/8317. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldape K, 2007, ARCH PATHOL LAB MED, V131, P242; Ambros PF, 2001, MED PEDIATR ONCOL, V37, P492, DOI 10.1002/mpo.1242; Belaud-Rotureau MA, 2006, ACTA NEUROPATHOL, V111, P255, DOI 10.1007/s00401-005-0001-4; Bigner S H, 1999, Neuro Oncol, V1, P52, DOI 10.1093/neuonc/1.1.52; Bigner SH, 1999, AM J PATHOL, V155, P375, DOI 10.1016/S0002-9440(10)65134-6; Bouvier C, 2004, J NEURO-ONCOL, V68, P141, DOI 10.1023/B:NEON.0000027758.10286.c1; Broholm H, 2008, CLIN NEUROPATHOL, V27, P378; Burger PC, 2001, MODERN PATHOL, V14, P842, DOI 10.1038/modpathol.3880400; Cairncross G, 2008, CANCER J, V14, P352, DOI 10.1097/PPO.0b013e31818d8178; Calattini S, 2010, BLOOD, V116, P4546, DOI 10.1182/blood-2010-05-285452; Campos M, 2013, HISTOL HISTOPATHOL, V28, P1439, DOI 10.14670/HH-28.1439; Coons SW, 1997, NEUROSURGERY, V41, P878, DOI 10.1097/00006123-199710000-00021; Ducray F, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-41; Fallon KB, 2004, J NEUROPATH EXP NEUR, V63, P314, DOI 10.1093/jnen/63.4.314; Franco-Hernandez C, 2009, CANCER GENET CYTOGEN, V190, P93, DOI 10.1016/j.cancergencyto.2008.09.017; Fuller CE, 2005, ADV ANAT PATHOL, V12, P180, DOI 10.1097/01.pap.0000175117.47918.f7; Fuller CE, 2002, BRAIN PATHOL, V12, P67; Gadji M, 2009, CANCER GENET CYTOGEN, V194, P12, DOI 10.1016/j.cancergencyto.2009.05.004; Gatta LB, 2012, APPL IMMUNOHISTO M M, V20, P413, DOI 10.1097/PAI.0b013e31823fb322; Gelpi E, 2003, MODERN PATHOL, V16, P708, DOI 10.1097/01.MP.0000076981.90281.BF; Giannini C, 2008, BRAIN PATHOL, V18, P360, DOI 10.1111/j.1750-3639.2008.00129.x; Gonzales M, 2006, J CLIN NEUROSCI, V13, P96, DOI 10.1016/j.jocn.2005.06.004; Hartmann C, 2005, J NEUROPATH EXP NEUR, V64, P10, DOI 10.1093/jnen/64.1.10; Hartmann C, 2011, CLIN CANCER RES, V17, P4588, DOI 10.1158/1078-0432.CCR-10-3194; Hirose T, 2010, NEUROPATHOLOGY, V30, P586, DOI 10.1111/j.1440-1789.2010.01116.x; Horbinski C, 2012, J NEUROPATH EXP NEUR, V71, P73, DOI 10.1097/NEN.0b013e318240fa65; Horbinski C, 2011, BRAIN PATHOL, V21, P57, DOI 10.1111/j.1750-3639.2010.00453.x; Horbinski C, 2010, ACTA NEUROPATHOL, V119, P641, DOI 10.1007/s00401-009-0634-9; Huang L, 2009, NEUROPATH APPL NEURO, V35, P367, DOI 10.1111/j.1365-2990.2008.01002.x; Jenkins RB, 2006, CANCER RES, V66, P9852, DOI 10.1158/0008-5472.CAN-06-1796; Jeon YK, 2007, NEUROPATHOLOGY, V27, P10, DOI 10.1111/j.1440-1789.2006.00735.x; Jha P, 2011, DIAGN MOL PATHOL, V20, P40, DOI 10.1097/PDM.0b013e3181e961e9; Kanamori M, 2009, J NEURO-ONCOL, V93, P219, DOI 10.1007/s11060-008-9762-7; Kanner AA, 2006, J NEUROSURG, V104, P542, DOI 10.3171/jns.2006.104.4.542; Kitange G, 2005, GENE CHROMOSOME CANC, V42, P68, DOI 10.1002/gcc.20108; Koschny R, 2006, PATHOL RES PRACT, V202, P23, DOI 10.1016/j.prp.2005.10.010; Koschny R, 2002, CANCER GENET CYTOGEN, V135, P147, DOI 10.1016/S0165-4608(01)00650-1; Kouwenhoven MCM, 2006, EUR J CANCER, V42, P2499, DOI 10.1016/j.ejca.2006.05.021; Kros JM, 2007, J NEUROPATH EXP NEUR, V66, P545, DOI 10.1097/01.jnen.0000263869.84188.72; Lass U, 2013, BRAIN PATHOL, V23, P311, DOI 10.1111/bpa.12003; Law ME, 2005, CANCER GENET CYTOGEN, V160, P1, DOI 10.1016/j.cancergencyto.2004.11.012; Mahajan D, 2009, AM J CLIN PATHOL, V132, P118, DOI 10.1309/AJCP5Y7BNXBWCCNX; Martinez-Ramirez A, 2004, LEUKEMIA, V18, P348, DOI 10.1038/sj.leu.2403230; McDonald JM, 2005, CANCER-AM CANCER SOC, V104, P1468, DOI 10.1002/cncr.21338; Mohapatra G, 2006, J MOL DIAGN, V8, P268, DOI 10.2353/jmoldx.2006.050109; Mueller W, 2002, AM J PATHOL, V161, P313, DOI 10.1016/S0002-9440(10)64183-1; Nigro JM, 2001, AM J PATHOL, V158, P1253, DOI 10.1016/S0002-9440(10)64076-X; Perry A, 2001, AM J PATHOL, V159, P57, DOI 10.1016/S0002-9440(10)61673-2; Preusser M, 2012, HISTOPATHOLOGY, V60, P885, DOI 10.1111/j.1365-2559.2011.04134.x; Ramirez C, 2010, NEURO-ONCOLOGY, V12, P490, DOI 10.1093/neuonc/nop071; Reddy KS, 2008, CANCER GENET CYTOGEN, V184, P77, DOI 10.1016/j.cancergencyto.2008.03.009; Reifenberger G, 2003, J NEUROPATH EXP NEUR, V62, P111, DOI 10.1093/jnen/62.2.111; Sasaki H, 2002, J NEUROPATH EXP NEUR, V61, P58, DOI 10.1093/jnen/61.1.58; Scheie D, 2006, AM J SURG PATHOL, V30, P828, DOI 10.1097/01.pas.0000213250.44822.2e; Scheie D, 2011, NEURO-ONCOLOGY, V13, P1225, DOI 10.1093/neuonc/nor114; Senetta R, 2013, J NEUROPATH EXP NEUR, V72, P432, DOI 10.1097/NEN.0b013e3182901f41; Shukla B, 2009, NEUROL INDIA, V57, P559, DOI 10.4103/0028-3886.57795; Smith J.D.H., 1999, PUR AP M-WI; Smith JS, 2000, J CLIN ONCOL, V18, P636, DOI 10.1200/JCO.2000.18.3.636; Snuderl M, 2009, CLIN CANCER RES, V15, P6430, DOI 10.1158/1078-0432.CCR-09-0867; The WHO, 2020, CLASSIFICATION TUMOU; Trost D, 2007, INT J CANCER, V120, P2368, DOI 10.1002/ijc.22574; Trudel D, 2013, J HISTOCHEM CYTOCHEM, V61, P500, DOI 10.1369/0022155413490946; van den Bent MJ, 2003, CANCER-AM CANCER SOC, V97, P1276, DOI 10.1002/cncr.11187; WEBERMATTHIESEN K, 1992, J HISTOCHEM CYTOCHEM, V40, P171, DOI 10.1177/40.2.1552161; Wiens AL, 2012, J NEUROPATH EXP NEUR, V71, P618, DOI 10.1097/NEN.0b013e31825b5f7a; Woehrer A, 2011, CLIN NEUROPATHOL, V30, P47, DOI 10.5414/NPP30047; Zlatescu MC, 2001, CANCER RES, V61, P6713	68	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100342	10.1371/journal.pone.0100342	http://dx.doi.org/10.1371/journal.pone.0100342			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949947	gold, Green Published, Green Submitted			2022-12-25	WOS:000338276300067
J	Katsanou, ES; Kyriakopoulou, K; Emmanouil, C; Fokialakis, N; Skaltsounis, AL; Machera, K				Katsanou, Efrosini S.; Kyriakopoulou, Katerina; Emmanouil, Christina; Fokialakis, Nikolas; Skaltsounis, Alexios-Leandros; Machera, Kyriaki			Modulation of CYP1A1 and CYP1A2 Hepatic Enzymes after Oral Administration of Chios Mastic Gum to Male Wistar Rats	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; PROSTATE-CANCER CELLS; IN-VITRO; HELICOBACTER-PYLORI; DRUG-METABOLISM; RISK-ASSESSMENT; OLEANOLIC ACID; VAR. CHIA; INDUCTION; EXPRESSION	Chios mastic gum (CMG), a resin derived from Pistacia lentiscus var. chia, is known since ancient times for its pharmacological activities. CYP1A1 and CYP1A2 enzymes are among the most involved in the biotransformation of chemicals and the metabolic activation of pro-carcinogens. Previous studies referring to the modulation of these enzymes by CMG have revealed findings of unclear biological and toxicological significance. For hi purpose, the modulation of CYP1A1 and CYP1A2 enzymes in the liver of male Wistar rats following oral administration of CMG extract (CMGE), at the levels of mRNA and CYP1A1 enzyme activity, was compared to respective enzyme modulation following oral administration known bioactive natural product, caffeine, as control compound known to involve hepatic enzymes in its metabolism mRNA levels of Cyp1a1 and Cyp1a2 were measured by reverse transcription real-time polymerase chain reaction and the relative quantification was calculated. CYP1A1 enzyme induction was measured through the activity of ethoxyresorufin-O-deethylase (EROD). The results indicated that administration of CMGE at the recommended pharmaceutical dose does not induce significant transcriptional modulation of Cyp1a1/2 and subsequent enzyme activity induction of CYP1A1 while effects of he same order of magnitude were observed in the same test system following the administration of caffeine at the mean daily consumed levels. The outcome of this study further confirms the lack of any toxicological or biological significance of the specific findings on liver following the administration of CMGE.	[Katsanou, Efrosini S.; Kyriakopoulou, Katerina; Emmanouil, Christina; Machera, Kyriaki] Benaki Phytopathol Inst, Dept Pesticides Control & Phytopharm, Lab Toxicol Control Pesticides, Athens, Greece; [Fokialakis, Nikolas; Skaltsounis, Alexios-Leandros] Univ Athens, Fac Pharm, Dept Pharmacognosy & Nat Prod Chem, Athens, Greece	National & Kapodistrian University of Athens	Machera, K (corresponding author), Benaki Phytopathol Inst, Dept Pesticides Control & Phytopharm, Lab Toxicol Control Pesticides, Athens, Greece.	k.machera@bpi.gr	Katsanou, Efrosini/AAU-1502-2020; Fokialakis, Nikolas/AAD-1498-2020; skaltsounis, alexios leandros/AAE-9617-2019	Katsanou, Efrosini/0000-0002-6381-1332; Fokialakis, Nikolas/0000-0001-7028-1870; Emmanouil, Christina/0000-0003-0101-9531	Benaki Phytopathological Institute; INSPIRE project of the European Commission [FP7-REGPOT-2011-1/284460]	Benaki Phytopathological Institute; INSPIRE project of the European Commission	This work was funded by Benaki Phytopathological Institute in the frames of the wider project "Reaseach on bioactive natural compounds". Part of this work has been financially supported by INSPIRE project (FP7-REGPOT-2011-1/284460) of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHABBAL MJ, 1984, CLIN EXP PHARMACOL P, V11, P541, DOI 10.1111/j.1440-1681.1984.tb00864.x; Andreadou I, 2008, REV CLIN PHARM PHARM, V22, P107; AUSTIN CA, 1988, BIOCHEM PHARMACOL, V37, P2223, DOI 10.1016/0006-2952(88)90585-0; Balan KV, 2007, PHYTOMEDICINE, V14, P263, DOI 10.1016/j.phymed.2006.03.009; BERTHOU F, 1995, LIFE SCI, V57, P541, DOI 10.1016/0024-3205(95)00304-O; BURKE MD, 1985, BIOCHEM PHARMACOL, V34, P3337, DOI 10.1016/0006-2952(85)90355-7; Cheung C, 2008, J PHARMACOL EXP THER, V327, P288, DOI 10.1124/jpet.108.141242; Corcos L, 1998, FEBS LETT, V425, P293, DOI 10.1016/S0014-5793(98)00246-4; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; DeOliveira ACAX, 1997, TOXICOL LETT, V92, P39, DOI 10.1016/S0378-4274(97)00034-9; Doi K, 2009, TOXICOL APPL PHARM, V234, P135, DOI 10.1016/j.taap.2008.10.001; Giaginis C, 2011, NUTR CANCER, V63, P1174, DOI 10.1080/01635581.2011.607546; Goasduff T, 1996, BIOCHEM PHARMACOL, V52, P1915, DOI 10.1016/S0006-2952(96)00522-9; He ML, 2007, ACTA PHARMACOL SIN, V28, P567, DOI 10.1111/j.1745-7254.2007.00535.x; He ML, 2007, ACTA PHARMACOL SIN, V28, P446, DOI 10.1111/j.1745-7254.2007.00536.x; He ML, 2006, CANCER-AM CANCER SOC, V106, P2547, DOI 10.1002/cncr.21935; Huang XY, 2010, ACTA PHARMACOL SIN, V31, P741, DOI 10.1038/aps.2010.54; Kang JS, 2007, FOOD CHEM TOXICOL, V45, P494, DOI 10.1016/j.fct.2006.09.013; Kim KA, 2004, LIFE SCI, V74, P2769, DOI 10.1016/j.lfs.2003.10.020; Kottakis F, 2009, EUR J GASTROEN HEPAT, V21, P143, DOI 10.1097/MEG.0b013e32831c50c9; Kuriyama S, 2003, TOXICOLOGY, V186, P11, DOI 10.1016/S0300-483X(02)00602-9; LIU J, 1995, J PHARMACOL EXP THER, V275, P768; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loizou S, 2009, EXP BIOL MED, V234, P553, DOI 10.3181/0811-RM-338; Magkouta S, 2009, NUTR CANCER, V61, P640, DOI 10.1080/01635580902825647; Marone P, 2001, J CHEMOTHERAPY, V13, P611, DOI 10.1179/joc.2001.13.6.611; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; Moulos P, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-68; Paraschos S, 2007, ANTIMICROB AGENTS CH, V51, P551, DOI 10.1128/AAC.00642-06; QUATTROCHI LC, 1994, J BIOL CHEM, V269, P6949; REICKS MM, 1993, XENOBIOTICA, V23, P809, DOI 10.3109/00498259309166786; Sidorova YA, 2005, TOXICOL LETT, V155, P253, DOI 10.1016/j.toxlet.2004.10.001; SILVER G, 1988, J BIOL CHEM, V263, P11802; Sterer N, 2008, J DENT, V36, P535, DOI 10.1016/j.jdent.2008.04.001; Takahashi K, 2003, J PERIODONTOL, V74, P501, DOI 10.1902/jop.2003.74.4.501; Tassou CC, 1995, INT BIODETER BIODEGR, V36, P411, DOI 10.1016/0964-8305(95)00103-4; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103; Wu RQ, 2006, INT J MOL MED, V18, P339	38	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100190	10.1371/journal.pone.0100190	http://dx.doi.org/10.1371/journal.pone.0100190			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950217	Green Published, Green Submitted, gold			2022-12-25	WOS:000338276300046
J	Petzold, S; Averbeck, M; Simon, JC; Lehmann, I; Polte, T				Petzold, Susanne; Averbeck, Marco; Simon, Jan C.; Lehmann, Irina; Polte, Tobias			Lifetime-Dependent Effects of Bisphenol A on Asthma Development in an Experimental Mouse Model	PLOS ONE			English	Article							ALLERGIC-ASTHMA; FETAL EXPOSURE; T-CELLS; GLUCOCORTICOID-RECEPTOR; ENDOCRINE DISRUPTORS; CYTOKINE PRODUCTION; PRENATAL EXPOSURE; RHESUS-MONKEYS; IN-VITRO; MICE	Background: Environmental factors are thought to contribute significantly to the increase of asthma prevalence in the last two decades. Bisphenol A (BPA) is a xenoestrogen commonly used in consumer products and the plastic industry. There is evidence and an ongoing discussion that endocrine disruptors like BPA may affect human health and also exert alterations on in the immune system. The aim of this study was to investigate age-dependent effects of BPA on the asthma risk using a murine model to explain the controversial results reported till date. Methods: BALB/c mice were exposed to BPA via the drinking water for different time periods including pregnancy and breastfeeding. To induce an asthma phenotype, mice were sensitized to ovalbumin (OVA), followed by an intrapulmonary allergen challenge. Results: BPA exposure during pregnancy and breastfeeding had no significant effect on asthma development in the offspring. In contrast, lifelong exposure from birth until the last antigen challenge clearly increased eosinophilic inflammation in the lung, airway hyperreactivity and antigen-specific serum IgE levels in OVA-sensitized adult mice compared to mice without BPA exposure. Surprisingly, BPA intake during the sensitization period significantly reduced the development of allergic asthma. This effect was reversed in the presence of a glucocorticoid receptor antagonist. Conclusions: Our results demonstrate that the impact of BPA on asthma risk is strongly age-dependent and ranges from asthma-promoting to asthma-reducing effects. This could explain the diversity of results from previous studies regarding the observed health impact of BPA.	[Petzold, Susanne; Lehmann, Irina; Polte, Tobias] UFZ Helmholtz Ctr Environm Res Leipzig Halle, Dept Environm Immunol, Leipzig, Germany; [Petzold, Susanne; Averbeck, Marco; Simon, Jan C.; Polte, Tobias] Univ Leipzig, Med Ctr, Dept Dermatol Venerol & Allergol, D-04109 Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University	Polte, T (corresponding author), UFZ Helmholtz Ctr Environm Res Leipzig Halle, Dept Environm Immunol, Leipzig, Germany.	tobias.polte@ufz.de	Jahreis, Susanne/AAA-9826-2020	Lehmann, Irina/0000-0001-8875-5587	Helmholtz Association [VG-NG-337]	Helmholtz Association(Helmholtz Association)	This work was supported by the Helmholtz Association grant VG-NG-337. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh M, 2006, J MED INVESTIG, V53, P70, DOI 10.2152/jmi.53.70; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Bauer SM, 2012, TOXICOL SCI, V130, P82, DOI 10.1093/toxsci/kfs227; Bickert T, 2009, INT ARCH ALLERGY IMM, V149, P219, DOI 10.1159/000199717; Biedermann S, 2010, ANAL BIOANAL CHEM, V398, P571, DOI 10.1007/s00216-010-3936-9; Bonisch U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039817; Cai YP, 2012, INT ARCH ALLERGY IMM, V158, P252, DOI 10.1159/000331437; DeBie JJ, 1996, BRIT J PHARMACOL, V119, P1484; Doerge DR, 2011, TOXICOL LETT, V207, P298, DOI 10.1016/j.toxlet.2011.09.020; Donohue KM, 2013, J ALLERGY CLIN IMMUN, V131, P736, DOI 10.1016/j.jaci.2012.12.1573; Ege MJ, 2006, J ALLERGY CLIN IMMUN, V117, P817, DOI 10.1016/j.jaci.2005.12.1307; Epstein MM, 2004, INT ARCH ALLERGY IMM, V133, P84, DOI 10.1159/000076131; Fund TBC, 2010, SAF ALT BISPH A BPA, P1; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2136, DOI 10.1271/bbb.70004; Guo HC, 2010, CELL MOL IMMUNOL, V7, P227, DOI 10.1038/cmi.2010.14; Inadera H, 2000, ENDOCRINOLOGY, V141, P50, DOI 10.1210/en.141.1.50; Jeffery PK, 1998, AM J RESP CRIT CARE, V157, pS174, DOI 10.1164/ajrccm.157.5.rsaa-1; Lack G, 1996, J IMMUNOL, V157, P1432; Lee MH, 2003, IMMUNOLOGY, V109, P76, DOI 10.1046/j.1365-2567.2003.01631.x; Li XM, 1996, J IMMUNOL, V157, P3216; Midoro-Horiuti T, 2010, ENVIRON HEALTH PERSP, V118, P273, DOI 10.1289/ehp.0901259; Nagel SC, 1997, ENVIRON HEALTH PERSP, V105, P70, DOI 10.1289/ehp.9710570; Nakajima Y, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-8; O'Brien E, 2013, J IMMUNOTOXICOL; Pearce N, 2006, INT J TUBERC LUNG D, V10, P125; Polte T, 2006, J CLIN INVEST, V116, P1025, DOI 10.1172/JCI23792; Polte T, 2008, CLIN EXP ALLERGY, V38, P1950, DOI 10.1111/j.1365-2222.2008.03096.x; Polte T, 2007, CLIN EXP ALLERGY, V37, P1374, DOI 10.1111/j.1365-2222.2007.02785.x; Polte T, 2008, J ALLERGY CLIN IMMUN, V122, P1022, DOI 10.1016/j.jaci.2008.09.014; Polte T, 2006, J ALLERGY CLIN IMMUN, V118, P942, DOI 10.1016/j.jaci.2006.07.014; Polte T, 2009, EUR J IMMUNOL, V39, P1736, DOI 10.1002/eji.200839004; Pottenger LH, 2000, TOXICOL SCI, V54, P3, DOI 10.1093/toxsci/54.1.3; Prasanth GK, 2010, J APPL TOXICOL, V30, P769, DOI 10.1002/jat.1570; Regal JF, 2000, P SOC EXP BIOL MED, V223, P372, DOI 10.1046/j.1525-1373.2000.22353.x; Reiprich M, 2013, ALLERGY, V68, P481, DOI 10.1111/all.12121; Rochester JR, 2013, REPROD TOXICOL, V42, P132, DOI 10.1016/j.reprotox.2013.08.008; Sargis RM, 2010, OBESITY, V18, P1283, DOI 10.1038/oby.2009.419; Schonfelder G, 2002, ENVIRON HEALTH PERSP, V110, pA703, DOI 10.1289/ehp.021100703; Schutze N, 2010, AM J RESP CRIT CARE, V181, P1188, DOI 10.1164/rccm.200909-1350OC; Spanier AJ, 2012, ENVIRON HEALTH PERSP, V120, P916, DOI 10.1289/ehp.1104175; Taylor JA, 2011, ENVIRON HEALTH PERSP, V119, P422, DOI 10.1289/ehp.1002514; Tian XL, 2003, INT ARCH ALLERGY IMM, V132, P240, DOI 10.1159/000074305; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Vaidya SV, 2012, J ASTHMA, V49, P800, DOI 10.3109/02770903.2012.721041; Van Winkle LS, 2013, ENVIRON HEALTH PERSP, V121, P912, DOI 10.1289/ehp.1206064; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg Laura N., 2013, Reviews on Environmental Health, V28, P37, DOI 10.1515/reveh-2012-0034; Welshons WV, 1999, TOXICOL IND HEALTH, V15, P12, DOI 10.1191/074823399678846745; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Yan HM, 2008, ENVIRON HEALTH PERSP, V116, P514, DOI 10.1289/ehp.10829; Yoshino S, 2004, IMMUNOLOGY, V112, P489, DOI 10.1111/j.1365-2567.2004.01900.x	51	30	33	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100468	10.1371/journal.pone.0100468	http://dx.doi.org/10.1371/journal.pone.0100468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950052	Green Submitted, Green Published, gold			2022-12-25	WOS:000338276300076
J	Pijnenburg, M; Caeyenberghs, K; Janssens, L; Goossens, N; Swinnen, SP; Sunaert, S; Brumagne, S				Pijnenburg, Madelon; Caeyenberghs, Karen; Janssens, Lotte; Goossens, Nina; Swinnen, Stephan P.; Sunaert, Stefan; Brumagne, Simon			Microstructural Integrity of the Superior Cerebellar Peduncle Is Associated with an Impaired Proprioceptive Weighting Capacity in Individuals with Non-Specific Low Back Pain	PLOS ONE			English	Article							POSTURAL CONTROL; DISABILITY INDEX; MOVEMENT; BALANCE; REORGANIZATION; ORIENTATION; VIBRATION; PEOPLE; CORTEX; STANCE	Introduction: Postural control is a complex sensorimotor task that requires an intact network of white matter connections. The ability to weight proprioceptive signals is crucial for postural control. However, research into central processing of proprioceptive signals for postural control is lacking. This is specifically of interest in individuals with non-specific low back pain (NSLBP), because impairments in postural control have been observed as possible underlying mechanisms of NSLBP. Therefore, the objective was to investigate potential differences in sensorimotor white matter microstructure between individuals with NSLBP and healthy controls, and to determine whether the alterations in individuals with NSLBP are associated with the capacity to weight proprioceptive signals for postural control. Methods: The contribution of proprioceptive signals from the ankle and back muscles to postural control was evaluated by local muscle vibration in 18 individuals with NSLBP and 18 healthy controls. Center of pressure displacement in response to muscle vibration was determined during upright standing on a stable and unstable support surface. Diffusion magnetic resonance imaging was applied to examine whether this proprioceptive contribution was associated with sensorimotor white matter microstructure. Results: Individuals with NSLBP showed a trend towards a reduced fractional anisotropy along the left superior cerebellar peduncle compared to healthy controls (p = 0.039). The impaired microstructural integrity of the superior cerebellar peduncle in individuals with NSLBP was significantly correlated with the response to ankle muscle vibration (p < 0.003). Conclusions: In individuals with NSLBP, a decreased integrity of the superior cerebellar peduncle was associated with an increased reliance on ankle muscle proprioception, even on unstable support surface, which implies an impaired proprioceptive weighting capacity. Our findings emphasize the importance of the superior cerebellar peduncle in proprioceptive weighting for postural control in individuals with NSLBP.	[Pijnenburg, Madelon; Janssens, Lotte; Goossens, Nina; Brumagne, Simon] Univ Leuven, KU Leuven Dept Rehabil Sci, Leuven, Belgium; [Caeyenberghs, Karen] Univ Ghent, Dept Phys Therapy & Motor Rehabil, B-9000 Ghent, Belgium; [Caeyenberghs, Karen] Univ Ghent, Dept Movement & Sports Sci, B-9000 Ghent, Belgium; [Swinnen, Stephan P.] Univ Leuven, KU Leuven Dept Kinesiol, Leuven, Belgium; [Sunaert, Stefan] Univ Leuven, KU Leuven Dept Imaging & Pathol, Leuven, Belgium	KU Leuven; Ghent University; Ghent University; KU Leuven; KU Leuven	Pijnenburg, M (corresponding author), Univ Leuven, KU Leuven Dept Rehabil Sci, Leuven, Belgium.	Madelon.Pijnenburg@faber.kuleuven.be	Goossens, Nina/AAH-9865-2021; Janssens, Lotte/T-1845-2017; Sunaert, Stefan/E-8031-2011	Janssens, Lotte/0000-0002-6133-4915; Caeyenberghs, Karen/0000-0001-7009-6843; Sunaert, Stefan/0000-0002-1177-4680; Goossens, Nina/0000-0002-9458-3125; Brumagne, Simon/0000-0002-0251-9338	Agency for Innovation by Science and Technology - Flanders (IWT); Research Foundation - Flanders (FWO)	Agency for Innovation by Science and Technology - Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation - Flanders (FWO)(FWO)	This work was supported by the Agency for Innovation by Science and Technology - Flanders (IWT) (PhD fellowship Madelon Pijnenburg) (http://www.iwt.be/) and by The Research Foundation - Flanders (FWO) (PhD fellowship Lotte Janssens) (http://www.fwo.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; [Anonymous], 2005, AM HERITAGE STEDMANS; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Brumagne S, 2004, NEUROSCI LETT, V366, P63, DOI 10.1016/j.neulet.2004.05.013; Brumagne S, 2000, SPINE, V25, P989, DOI 10.1097/00007632-200004150-00015; Brumagne S, 2013, SPINAL CONTROL REHAB, P219; Brumagne S, 2008, EUR SPINE J, V17, P1177, DOI 10.1007/s00586-008-0709-7; Buckalew N, 2010, PAIN MED, V11, P1183, DOI 10.1111/j.1526-4637.2010.00899.x; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Carver S, 2006, BIOL CYBERN, V95, P123, DOI 10.1007/s00422-006-0069-5; Claeys K, 2013, THESIS; Claeys K, 2011, EUR J APPL PHYSIOL, V111, P115, DOI 10.1007/s00421-010-1637-x; Cordo PJ, 2005, EXP BRAIN RES, V167, P324, DOI 10.1007/s00221-005-0034-x; della Volpe R, 2006, GAIT POSTURE, V24, P349, DOI 10.1016/j.gaitpost.2005.10.009; Deprez S, 2013, BRAIN IMAGING BEHAV, V7, P409, DOI 10.1007/s11682-012-9220-1; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Flor H, 1997, NEUROSCI LETT, V224, P5, DOI 10.1016/S0304-3940(97)13441-3; GANDEVIA SC, 1992, TRENDS NEUROSCI, V15, P62, DOI 10.1016/0166-2236(92)90028-7; Gill KP, 1998, SPINE, V23, P371, DOI 10.1097/00007632-199802010-00017; Hanaie R, 2013, CEREBELLUM, V12, P645, DOI 10.1007/s12311-013-0475-x; Hancock MJ, 2011, EUR SPINE J, V20, P2105, DOI 10.1007/s00586-011-1886-3; HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.1080/01621459.1987.10478551; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; HORAK FB, 1994, J NEUROPHYSIOL, V72, P479, DOI 10.1152/jn.1994.72.2.479; Janssens L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057949; Janssens L, 2010, SPINE, V35, P1088, DOI 10.1097/BRS.0b013e3181bee5c3; Kiers H, 2014, GAIT POSTURE, VS0966-6362; Kiers H, 2012, EUR J APPL PHYSIOL, V112, P1577, DOI 10.1007/s00421-011-2124-8; Kong J, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-43; Lackner JR, 2005, ANNU REV PSYCHOL, V56, P115, DOI 10.1146/annurev.psych.55.090902.142023; Leemans A., 2009, P INT SOC MAG RESON, P3537, DOI DOI 10.1093/OCCMED/KQR069; Mansour AR, 2013, PAIN, V154, P2160, DOI 10.1016/j.pain.2013.06.044; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; Costa LDM, 2013, SPINE, V38, P148, DOI 10.1097/BRS.0b013e318267a92f; Mok NW, 2011, SPINE, V36, pE45, DOI 10.1097/BRS.0b013e3181dfce83; Newcomer KL, 2000, SPINE, V25, P2488, DOI 10.1097/00007632-200010010-00011; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Prosperini L, 2013, RADIOLOGY, V268, P181, DOI 10.1148/radiol.13121695; ROLL JP, 1982, EXP BRAIN RES, V47, P177; Roussel NA, 2013, CLIN J PAIN, V29, P625, DOI 10.1097/AJP.0b013e31826f9a71; Ruhe A, 2011, EUR SPINE J, V20, P358, DOI 10.1007/s00586-010-1543-2; Tsao H, 2008, BRAIN, V131, P2161, DOI 10.1093/brain/awn154; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409	44	22	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100666	10.1371/journal.pone.0100666	http://dx.doi.org/10.1371/journal.pone.0100666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949796	Green Published, Green Submitted, gold			2022-12-25	WOS:000338276300105
J	Sherwood, JM; Holmes, D; Kaliviotis, E; Balabani, S				Sherwood, Joseph M.; Holmes, David; Kaliviotis, Efstathios; Balabani, Stavroula			Spatial Distributions of Red Blood Cells Significantly Alter Local Haemodynamics	PLOS ONE			English	Article							FREE LAYER FORMATION; SKELETAL-MUSCLE VENULES; ERYTHROCYTE AGGREGATION; MICROVASCULAR BIFURCATIONS; IN-VIVO; APPARENT VISCOSITY; VELOCITY PROFILES; FLOWING BLOOD; SHEAR RATE; TUBE FLOW	Although bulk changes in red blood cell concentration between vessels have been well characterised, local distributions are generally overlooked. Red blood cells aggregate, deform and migrate within vessels, forming heterogeneous distributions which have considerable effect on local haemodynamics. The present study reports data on the local distribution of human red blood cells in a sequentially bifurcating microchannel, representing the branching geometry of the microvasculature. Imaging methodologies with simple extrapolations are used to infer three dimensional, time-averaged velocity and haematocrit distributions under a range of flow conditions. Strong correlation between the bluntness of the velocity and haematocrit profiles in the parent branch of the geometry is observed and red blood cell aggregation has a notable effect on the observed trends. The two branches of the first bifurcation show similar characteristics in terms of the shapes of the profiles and the extent of plasma skimming, despite the difference in geometric configuration. In the second bifurcation, considerable asymmetry between the branches in the plasma skimming relationship is observed, and elucidated by considering individual haematocrit profiles. The results of the study highlight the importance of considering local haematocrit distributions in the analysis of blood flow and could lead to more accurate computational models of blood flow in microvascular networks. The experimental approaches developed in this work provide a foundation for further examining the characteristics of microhaemodynamics.	[Sherwood, Joseph M.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Sherwood, Joseph M.; Kaliviotis, Efstathios; Balabani, Stavroula] UCL, Dept Mech Engn, London, England; [Holmes, David] UCL, London Ctr Nanotechnol, London, England; [Holmes, David] Sphere Fluid Ltd, Cambridge, England	Imperial College London; University of London; University College London; University of London; University College London	Balabani, S (corresponding author), UCL, Dept Mech Engn, London, England.	s.balabani@ucl.ac.uk	Sherwood, Joseph M. M/I-7984-2014; Kaliviotis, Efstathios/A-7721-2016; Sherwood, Joseph M/P-9619-2018	Sherwood, Joseph M. M/0000-0002-4402-9767; Kaliviotis, Efstathios/0000-0003-4149-4396; Sherwood, Joseph M/0000-0002-4402-9767; balabani, stavroula/0000-0002-6287-1106	King's College London; UCL EPSRC Strategic Enterprise Award [GR/T11364/01]	King's College London; UCL EPSRC Strategic Enterprise Award(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Joseph Sherwood was partly funded by a King's College London Studentship David Holmes was funded via UCL EPSRC Strategic Enterprise Award (GR/T11364/01) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARTS PAMM, 1988, ARTERIOSCLEROSIS, V8, P819, DOI 10.1161/01.ATV.8.6.819; ALONSO C, 1995, AM J PHYSIOL-HEART C, V268, pH25, DOI 10.1152/ajpheart.1995.268.1.H25; Baskurt OK, 1999, BIORHEOLOGY, V36, P447; Bishop JJ, 2001, AM J PHYSIOL-HEART C, V281, pH939, DOI 10.1152/ajpheart.2001.281.2.H939; Bishop JJ, 2001, AM J PHYSIOL-HEART C, V280, pH222, DOI 10.1152/ajpheart.2001.280.1.H222; Bishop JJ, 2003, AM J PHYSIOL-HEART C, V286, p113H; Bruus H., 2008, THEORETICAL MICROFLU, V18; Cabel M, 1997, AM J PHYSIOL-HEART C, V272, pH1020; CARR RT, 1990, MICROVASC RES, V40, P179, DOI 10.1016/0026-2862(90)90017-L; CARR RT, 1991, MICROVASC RES, V41, P184, DOI 10.1016/0026-2862(91)90020-C; Carr Russell T., 1995, Microcirculation (New York), V2, P345, DOI 10.3109/10739689509148278; Chesnutt JKW, 2009, MICROVASC RES, V78, P301, DOI 10.1016/j.mvr.2009.09.003; CHIEN S, 1985, AM J PHYSIOL, V248, pH568, DOI 10.1152/ajpheart.1985.248.4.H568; Cokelet G., 2011, HEMORHEOLOGY HEMODYN; Cokelet GR, 2005, BIORHEOLOGY, V42, P385; Cokelet GR, 1999, BIORHEOLOGY, V36, P343; DELLIMORE JW, 1983, AM J PHYSIOL, V244, pH635, DOI 10.1152/ajpheart.1983.244.5.H635; Fedosov DA, 2011, P NATL ACAD SCI USA, V108, P11772, DOI 10.1073/pnas.1101210108; FENTON BM, 1985, MICROVASC RES, V29, P103, DOI 10.1016/0026-2862(85)90010-X; Freund JB, 2014, ANNU REV FLUID MECH, V46, P67, DOI 10.1146/annurev-fluid-010313-141349; Freund JB, 2011, J FLUID MECH, V671, P466, DOI 10.1017/S0022112010005835; Fry BC, 2012, MICROCIRCULATION, V19, P530, DOI 10.1111/j.1549-8719.2012.00184.x; GAEHTGENS P, 1979, PFLUG ARCH EUR J PHY, V380, P115, DOI 10.1007/BF00582145; GOLDSMIT.HL, 1972, PROC R SOC SER B-BIO, V182, P351, DOI 10.1098/rspb.1972.0084; GOLDSMITH HL, 1968, J GEN PHYSIOL, V52, pS5; GUSTAFSSON L, 1981, AM J PHYSIOL, V241, pH513, DOI 10.1152/ajpheart.1981.241.4.H513; HOUSE SD, 1986, AM J PHYSIOL, V250, pH828, DOI 10.1152/ajpheart.1986.250.5.H828; Imai Y, 2010, J BIOMECH, V43, P1386, DOI 10.1016/j.jbiomech.2010.01.011; Kaliviotis E, 2008, BIORHEOLOGY, V45, P639, DOI 10.3233/BIR-2008-0514; Kim S, 2006, AM J PHYSIOL-HEART C, V290, pH941, DOI 10.1152/ajpheart.00645.2005; Kline SJ, 1953, MECH ENG, V75, P3, DOI DOI 10.1016/J.CHAOS.2005.11.046; Lee J, 2008, MICROCIRCULATION, V15, P699, DOI 10.1080/10739680802229589; LIPOWSKY HH, 1974, MICROVASC RES, V7, P73, DOI 10.1016/0026-2862(74)90038-7; Manjunatha M, 2002, CLIN HEMORHEOL MICRO, V27, P91; Meiselman HJ, 2009, BIORHEOLOGY, V46, P1, DOI 10.3233/BIR-2009-0522; Moger J, 2004, J BIOMED OPT, V9, P982, DOI 10.1117/1.1781163; Olsen MG, 2000, EXP FLUIDS, V29, pS166, DOI 10.1007/s003480070018; Ong PK, 2013, MICROCIRCULATION, V20, P440, DOI 10.1111/micc.12045; Ong PK, 2011, MICROCIRCULATION, V18, P541, DOI 10.1111/j.1549-8719.2011.00114.x; Ong PK, 2010, AM J PHYSIOL-HEART C, V298, pH1870, DOI 10.1152/ajpheart.01182.2009; Pan Q, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4025879; PERKKIO J, 1987, THROMB RES, V45, P517, DOI 10.1016/0049-3848(87)90314-8; Poelma C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045247; POPEL AS, 1994, J APPL PHYSIOL, V77, P1790, DOI 10.1152/jappl.1994.77.4.1790; PRIES AR, 1990, CIRC RES, V67, P826, DOI 10.1161/01.RES.67.4.826; PRIES AR, 1989, MICROVASC RES, V38, P81, DOI 10.1016/0026-2862(89)90018-6; PRIES AR, 1992, AM J PHYSIOL, V263, pH1770, DOI 10.1152/ajpheart.1992.263.6.H1770; PRIES AR, 1994, CIRC RES, V75, P904, DOI 10.1161/01.RES.75.5.904; REINKE W, 1987, AM J PHYSIOL, V253, pH540, DOI 10.1152/ajpheart.1987.253.3.H540; REINKE W, 1986, CIRC RES, V59, P124, DOI 10.1161/01.RES.59.2.124; Reneman RS, 2006, J VASC RES, V43, P251, DOI 10.1159/000091648; Rossi M, 2012, EXP FLUIDS, V52, P1063, DOI 10.1007/s00348-011-1194-z; Secomb T, 2008, MICROCIRCULATION, V15, P765, DOI 10.1080/10739680802350112; Sherwood JM, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.4717755; Sherwood JM, 2014, BIOMECH MODEL MECHAN, V13, P259, DOI 10.1007/s10237-012-0449-9; SOUTANI M, 1995, AM J PHYSIOL-HEART C, V268, pH1959, DOI 10.1152/ajpheart.1995.268.5.H1959; Westerweel J, 2005, EXP FLUIDS, V39, P1096, DOI 10.1007/s00348-005-0016-6; Yalcin O, 2011, BIORHEOLOGY, V48; Zhang JF, 2009, MICROVASC RES, V77, P265, DOI 10.1016/j.mvr.2009.01.010	59	50	50	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100473	10.1371/journal.pone.0100473	http://dx.doi.org/10.1371/journal.pone.0100473			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950214	gold, Green Published, Green Submitted			2022-12-25	WOS:000338276300078
J	Yoshizaki, K; Hu, LZ; Nguyen, T; Sakai, K; He, B; Fong, C; Yamada, Y; Bikle, DD; Oda, Y				Yoshizaki, Keigo; Hu, Lizhi; Thai Nguyen; Sakai, Kiyoshi; He, Bing; Fong, Chak; Yamada, Yoshihiko; Bikle, Daniel D.; Oda, Yuko			Ablation of Coactivator Med1 Switches the Cell Fate of Dental Epithelia to That Generating Hair	PLOS ONE			English	Article							FOLLICLE STEM-CELLS; AMELOBLAST-LINEAGE; GENE-EXPRESSION; MEDIATOR; DIFFERENTIATION; NOTCH; TRANSCRIPTION; PROTEIN; TOOTH; REGULATOR	Cell fates are determined by specific transcriptional programs. Here we provide evidence that the transcriptional coactivator, Mediator 1 (Med1), is essential for the cell fate determination of ectodermal epithelia. Conditional deletion of Med1 in vivo converted dental epithelia into epidermal epithelia, causing defects in enamel organ development while promoting hair formation in the incisors. We identified multiple processes by which hairs are generated in Med1 deficient incisors: 1) dental epithelial stem cells lacking Med 1 fail to commit to the dental lineage, 2) Sox2-expressing stem cells extend into the differentiation zone and remain multi-potent due to reduced Notch1 signaling, and 3) epidermal fate is induced by calcium as demonstrated in dental epithelial cell cultures. These results demonstrate that Med1 is a master regulator in adult stem cells to govern epithelial cell fate.	[Hu, Lizhi; Thai Nguyen; Fong, Chak; Bikle, Daniel D.; Oda, Yuko] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Hu, Lizhi; Thai Nguyen; Fong, Chak; Bikle, Daniel D.; Oda, Yuko] Univ Calif San Francisco, Dept Endocrinol, San Francisco, CA 94143 USA; [Hu, Lizhi; Thai Nguyen; Fong, Chak; Bikle, Daniel D.; Oda, Yuko] Vet Affairs Med Ctr San Francisco, San Francisco, CA USA; [Yoshizaki, Keigo; Sakai, Kiyoshi; He, Bing; Yamada, Yoshihiko] Natl Inst Dent & Craniofacial Res, Lab Cell & Dev Biol, NIH, Bethesda, MD USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Oda, Y (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	yuko.oda@ucsf.edu	He, Bing/V-5552-2019	Yoshizaki, Keigo/0000-0002-0598-5879	National Institutes of Health [R01 AR050023]; DOD [CA110338]; VA Merit Review; Intramural Research Program of the National Institutes of Dental and Craniofacial Research, NIH; Japanese Research Fellowship of Japan Society for the Promotion of Science; Chinese Research grant NSFC [81301360]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE025357, ZIADE000720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); VA Merit Review(US Department of Veterans Affairs); Intramural Research Program of the National Institutes of Dental and Craniofacial Research, NIH; Japanese Research Fellowship of Japan Society for the Promotion of Science; Chinese Research grant NSFC; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health grant R01 AR050023 (DDB), DOD grant CA110338 (DDB), a VA Merit Review (DDB), the Intramural Research Program of the National Institutes of Dental and Craniofacial Research, NIH (YY), and Chinese Research grant NSFC 81301360 (LH). KY was supported in part by the Japanese Research Fellowship of Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biehs B, 2013, NAT CELL BIOL, V15, P846, DOI 10.1038/ncb2766; Bikle D, 2007, J STEROID BIOCHEM, V103, P396, DOI 10.1016/j.jsbmb.2006.12.063; Bikle DD, 2012, EXPERT REV ENDOCRINO, V7, P461, DOI 10.1586/EEM.12.34; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Castro B, 2005, DEVELOPMENT, V132, P3333, DOI 10.1242/dev.01920; Felszeghy S, 2010, DIFFERENTIATION, V80, P241, DOI 10.1016/j.diff.2010.06.004; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gebauer JM, 2009, MATRIX BIOL, V28, P456, DOI 10.1016/j.matbio.2009.07.006; Harada H, 2006, BIOCHEM BIOPH RES CO, V340, P611, DOI 10.1016/j.bbrc.2005.12.053; Jia YZ, 2005, J BIOL CHEM, V280, P10766, DOI 10.1074/jbc.M413331200; Jia YZ, 2004, J BIOL CHEM, V279, P24427, DOI 10.1074/jbc.M402391200; Jiang PP, 2010, P NATL ACAD SCI USA, V107, P6765, DOI 10.1073/pnas.1001814107; Josephsen K, 2010, AM J PHYSIOL-CELL PH, V299, pC1299, DOI 10.1152/ajpcell.00218.2010; Juuri E, 2013, DEVELOPMENT, V140, P1424, DOI 10.1242/dev.089599; Juuri E, 2012, DEV CELL, V23, P317, DOI 10.1016/j.devcel.2012.05.012; Kadaja M, 2014, GENE DEV, V28, P328, DOI 10.1101/gad.233247.113; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Katsube K, 2009, DEV GROWTH DIFFER, V51, P55, DOI 10.1111/j.1440-169X.2009.01077.x; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Klein OD, 2008, DEVELOPMENT, V135, P377, DOI 10.1242/dev.015081; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; Mitsiadis TA, 2010, DEVELOPMENT, V137, P3025, DOI 10.1242/dev.049528; Mitsiadis TA, 2009, BIRTH DEFECTS RES C, V87, P199, DOI 10.1002/bdrc.20160; Mosher DF, 2012, MATRIX BIOL, V31, P155, DOI 10.1016/j.matbio.2012.01.003; Nakajima T, 2013, J INVEST DERMATOL, V133, P354, DOI 10.1038/jid.2012.293; Oda Y, 2012, J INVEST DERMATOL, V132, P1075, DOI 10.1038/jid.2011.430; Oda Y, 2010, J INVEST DERMATOL, V130, P2377, DOI 10.1038/jid.2010.148; Perdigoto CN, 2013, BBA-GEN SUBJECTS, V1830, P2307, DOI 10.1016/j.bbagen.2012.08.009; Poche RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030357; Seidel K, 2010, DEVELOPMENT, V137, P3753, DOI 10.1242/dev.056358; Sharabi AB, 2009, CLONING STEM CELLS, V11, P523, DOI 10.1089/clo.2009.0020; Simmer JP, 2009, J BIOL CHEM, V284, P19110, DOI 10.1074/jbc.M109.013623; Stumpf M, 2010, P NATL ACAD SCI USA, V107, P21541, DOI 10.1073/pnas.1005794107; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Tanimura S, 2011, CELL STEM CELL, V8, P177, DOI 10.1016/j.stem.2010.11.029; Wang XP, 2007, PLOS BIOL, V5, P1324, DOI 10.1371/journal.pbio.0050159; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yue XJ, 2011, P NATL ACAD SCI USA, V108, P17105, DOI 10.1073/pnas.1109095108; Zheng LW, 2013, INT J ORAL SCI, V5, P1, DOI 10.1038/ijos.2013.14; Zuo GW, 2010, HISTOL HISTOPATHOL, V25, P795, DOI 10.14670/HH-25.795	44	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99991	10.1371/journal.pone.0099991	http://dx.doi.org/10.1371/journal.pone.0099991			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949995	Green Published, gold, Green Submitted			2022-12-25	WOS:000338276300027
J	George, J; Matucci-Cerinic, M; Bar, I; Shimoni, S				George, Jacob; Matucci-Cerinic, Marco; Bar, Iris; Shimoni, Sara			Circulating Autoantibodies to Endothelial Progenitor Cells: Binding Characteristics and Association with Risk Factors for Atherosclerosis	PLOS ONE			English	Article							SYSTEMIC-SCLEROSIS; ANTIBODY-LEVELS; LIVER-DISEASES; HEART; HYPERTENSION; CORRELATE	Objective: Endothelial progenitor cells (EPC) are committed to transform into EC promoting vasculogenic ischemic repair. Anti-endothelial cells (AECA) have been described in various disorders with an associated vascular damage. Herein, we explored a novel circulating population of IgG reactive with EPC, in patients with differential risk profile for atherosclerotic vascular disease. Approach and Results: A novel cyto-ELISA system was established where the coated cells were late outgrowth EPC. Levels of anti-EPC antibodies were determined in 100 subjects and differential risk score for atherosclerosis, as well as to circulating EPC levels and the inflammatory markers IL-6 and C-reactive protein. To study endothelial cell (EC) activating properties, sera were tested for their ability to induce VCAM-1 expression in a cell ELISA system. Detectable levels of anti-EPC antibodies, that correlated with age, Framingham risk score and CRP concentrations but did not associate with levels of LDL, HDL, hypertension or diabetes, were detected. Anti-EPC antibodies were distinct from EC binding antibodies as shown by competitive inhibition studies, and have been positively correlated with the extent of EC activation manifested by in vitro VCAM-1 expression. Conclusion: This is the first study showing a newly defined subgroup of self-antibodies binding EPC and associating positively with the Framingham risk score. Further studies are required to characterize and test this interesting subset of EPC binding autoantibodies and their potential significance.	[George, Jacob; Bar, Iris; Shimoni, Sara] Hebrew Univ Jerusalem, Kaplan Med Ctr, Ctr Heart, Jerusalem, Israel; [Matucci-Cerinic, Marco] Univ Florence, Div Rheumatol AOUC, Dept Expt & Clin Med, Florence, Italy	Hebrew University of Jerusalem; Kaplan Medical Center; University of Florence	George, J (corresponding author), Hebrew Univ Jerusalem, Kaplan Med Ctr, Ctr Heart, Jerusalem, Israel.	jgeorge@bezeqint.net	CERINIC, marco MATUCCI/AAO-2769-2020					Alessandri C, 2006, ADV CLIN CHEM, V42, P297, DOI 10.1016/S0065-2423(06)42008-4; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Avouac J, 2008, ANN RHEUM DIS, V67, P1455, DOI 10.1136/ard.2007.082131; Belizna C, 2006, ANN RHEUM DIS, V65, P1545, DOI 10.1136/ard.2005.035295; Ben-Shoshan J, 2007, PHARMACOL THERAPEUT, V115, P25, DOI 10.1016/j.pharmthera.2007.03.012; Caforio ALP, 2010, HEART, V96, P779, DOI 10.1136/hrt.2009.187138; Del Papa N, 2010, J RHEUMATOL, V37, P2053, DOI 10.3899/jrheum.091346; Elsheikh E, 2010, SCAND CARDIOVASC J, V44, P255, DOI 10.3109/14017431003797168; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Geft D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003238; George J, 1998, CIRCULATION, V97, P900, DOI 10.1161/01.CIR.97.9.900; George J, 2006, TISSUE ENG, V12, P331, DOI 10.1089/ten.2006.12.331; George J, 2000, IMMUNOL LETT, V73, P23, DOI 10.1016/S0165-2478(00)00192-9; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Kawamoto A, 2008, TRENDS CARDIOVAS MED, V18, P33, DOI 10.1016/j.tcm.2007.11.004; Negi VS, 1998, J RHEUMATOL, V25, P462; NICHOLSON GC, 1977, CLIN IMMUNOL IMMUNOP, V7, P349, DOI 10.1016/0090-1229(77)90069-1; OYA H, 1995, ADV EXP MED BIOL, V371, P1087; Papadopoulos DP, 2008, INT J CARDIOL, V130, P405, DOI 10.1016/j.ijcard.2007.08.122; Papadopoulos DP, 2006, CLIN EXP HYPERTENS, V28, P663, DOI 10.1080/10641960601013567; Schwartzenberg S, 2007, ARTERIOSCL THROM VAS, V27, pE27, DOI 10.1161/ATVBAHA.107.139626; TANNENBAUM SH, 1986, J IMMUNOL, V137, P1532; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Zamanou A, 2002, J CLIN LAB ANAL, V16, P194, DOI 10.1002/jcla.10040	25	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e97836	10.1371/journal.pone.0097836	http://dx.doi.org/10.1371/journal.pone.0097836			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945945	Green Published, gold			2022-12-25	WOS:000340721500004
J	Broselid, S; Berg, KA; Chavera, TA; Kahn, R; Clarke, WP; Olde, B; Leeb-Lundberg, LMF				Broselid, Stefan; Berg, Kelly A.; Chavera, Teresa A.; Kahn, Robin; Clarke, William P.; Olde, Bjoern; Leeb-Lundberg, L. M. Fredrik			G protein-coupled Receptor 30 (GPR30) Forms a Plasma Membrane Complex with Membrane-associated Guanylate Kinases (MAGUKs) and Protein Kinase A-anchoring Protein 5 (AKAP5) That Constitutively Inhibits cAMP Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; ESTROGEN-RECEPTOR; ADENYLYL-CYCLASE; PDZ PROTEINS; AMPA RECEPTORS; TRAFFICKING; PSD-95; ENDOCYTOSIS; OCCURS; PKA	GPR30, or G protein-coupled estrogen receptor, is a G protein-coupled receptor reported to bind 17 beta-estradiol (E-2), couple to the G proteins G(s) and G(i/o), and mediate non-genomic estrogenic responses. However, controversies exist regarding the receptor pharmacological profile, effector coupling, and subcellular localization. We addressed the role of the type I PDZ motif at the receptor C terminus in receptor trafficking and coupling to cAMP production in HEK293 cells and CHO cells ectopically expressing the receptor and in Madin-Darby canine kidney cells expressing the native receptor. GPR30 was localized both intracellularly and in the plasma membrane and subject to limited basal endocytosis. E-2 and G-1, reported GPR30 agonists, neither stimulated nor inhibited cAMP production through GPR30, nor did they influence receptor localization. Instead, GPR30 constitutively inhibited cAMP production stimulated by a heterologous agonist independently of G(i/o). Moreover, siRNA knockdown of native GPR30 increased cAMP production. Deletion of the receptor PDZ motif interfered with inhibition of cAMP production and increased basal receptor endocytosis. GPR30 interacted with membrane-associated guanylate kinases, including SAP97 and PSD-95, and protein kinase A-anchoring protein (AKAP) 5 in the plasma membrane in a PDZ-dependent manner. Knockdown of AKAP5 or St-Ht31 treatment, to disrupt AKAP interaction with the PKA RII beta regulatory subunit, decreased inhibition of cAMP production, and St-Ht31 increased basal receptor endocytosis. Therefore, GPR30 forms a plasma membrane complex with a membrane-associated guanylate kinase and AKAP5, which constitutively attenuates cAMP production in response to heterologous agonists independently of G(i/o) and retains receptors in the plasma membrane.	[Broselid, Stefan; Leeb-Lundberg, L. M. Fredrik] Lund Univ, Dept Expt Med Sci, S-22184 Lund, Sweden; [Kahn, Robin] Lund Univ, Dept Nephrol, S-22184 Lund, Sweden; [Olde, Bjoern] Lund Univ, Dept Cardiol, S-22184 Lund, Sweden; [Berg, Kelly A.; Chavera, Teresa A.; Clarke, William P.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA	Lund University; Lund University; Lund University; University of Texas System; University of Texas Health San Antonio	Leeb-Lundberg, LMF (corresponding author), Lund Univ, Dept Expt Med Sci, BMC A12, S-22184 Lund, Sweden.	fredrik.leeb-lundberg@med.lu.se	Clarke, William/L-3999-2019	Clarke, William/0000-0002-8861-8256; Broselid, Stefan/0000-0001-5489-460X	Swedish Cancer Foundation; Swedish Research Council; NovoNordisk Foundation; Alfred Osterlund Foundation; Gunnar Nilsson Cancer Foundation	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); NovoNordisk Foundation(Novo Nordisk Foundation); Alfred Osterlund Foundation; Gunnar Nilsson Cancer Foundation	This work was supported by the Swedish Cancer Foundation, the Swedish Research Council, the NovoNordisk Foundation, the Alfred Osterlund Foundation, and the Gunnar Nilsson Cancer Foundation (to L. M. F. L. L.).	Akama KT, 2013, J BIOL CHEM, V288, P6438, DOI 10.1074/jbc.M112.412478; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; BERG KA, 1994, MOL PHARMACOL, V46, P477; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Cai C, 2008, NEUROSCIENCE, V157, P833, DOI 10.1016/j.neuroscience.2008.09.048; CARR DW, 1991, J BIOL CHEM, V266, P14188; Cheng SB, 2011, J BIOL CHEM, V286, P22441, DOI 10.1074/jbc.M111.224071; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; Dunn HA, 2013, J BIOL CHEM, V288, P15023, DOI 10.1074/jbc.M113.473660; Efendiev R, 2010, J BIOL CHEM, V285, P14450, DOI 10.1074/jbc.M110.109769; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Enquist J, 2007, MOL PHARMACOL, V71, P494, DOI 10.1124/mol.106.030858; Filardo E, 2007, ENDOCRINOLOGY, V148, P3236, DOI 10.1210/en.2006-1605; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Funakoshi T, 2006, BIOCHEM BIOPH RES CO, V346, P904, DOI 10.1016/j.bbrc.2006.05.191; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Gardner LA, 2007, J BIOL CHEM, V282, P5085, DOI 10.1074/jbc.M608871200; Gardner LA, 2006, J BIOL CHEM, V281, P33537, DOI 10.1074/jbc.M601809200; Gavarini S, 2006, MOL BIOL CELL, V17, P4619, DOI 10.1091/mbc.E06-03-0218; Gros R, 2011, HYPERTENSION, V57, P442, DOI 10.1161/HYPERTENSIONAHA.110.161653; He JQ, 2006, J BIOL CHEM, V281, P2820, DOI 10.1074/jbc.M509503200; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Joiner MLA, 2010, EMBO J, V29, P482, DOI 10.1038/emboj.2009.344; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Langer G, 2010, STEROIDS, V75, P603, DOI 10.1016/j.steroids.2009.12.006; Lenhart PM, 2013, J MOL ENDOCRINOL, V51, P191, DOI 10.1530/JME-13-0021; Li X, 2013, J BIOL CHEM, V288, P33797, DOI 10.1074/jbc.M113.470559; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Nikandrova YA, 2010, J BIOL CHEM, V285, P923, DOI 10.1074/jbc.M109.033985; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Otto C, 2008, ENDOCRINOLOGY, V149, P4846, DOI 10.1210/en.2008-0269; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Piggott LA, 2008, P NATL ACAD SCI USA, V105, P13835, DOI 10.1073/pnas.0712100105; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Romero G, 2011, ADV PHARMACOL, V62, P279, DOI 10.1016/B978-0-12-385952-5.00003-8; Sanden C, 2011, MOL PHARMACOL, V79, P400, DOI 10.1124/mol.110.069500; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Scott JD, 2013, ANNU REV PHARMACOL, V53, P187, DOI 10.1146/annurev-pharmtox-011112-140204; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Vijayaraghavan S, 1997, J BIOL CHEM, V272, P4747, DOI 10.1074/jbc.272.8.4747; Xia ZQ, 2003, J BIOL CHEM, V278, P21901, DOI 10.1074/jbc.M301905200; Zhong HN, 2009, NEURON, V62, P363, DOI 10.1016/j.neuron.2009.03.013	47	43	44	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22117	22127		10.1074/jbc.M114.566893	http://dx.doi.org/10.1074/jbc.M114.566893			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24962572	Green Published, hybrid			2022-12-25	WOS:000340593500027
J	Ishino, S; Yamagami, T; Kitamura, M; Kodera, N; Mori, T; Sugiyama, S; Ando, T; Goda, N; Tenno, T; Hiroaki, H; Ishino, Y				Ishino, Sonoko; Yamagami, Takeshi; Kitamura, Makoto; Kodera, Noriyuki; Mori, Tetsuya; Sugiyama, Shyogo; Ando, Toshio; Goda, Natsuko; Tenno, Takeshi; Hiroaki, Hidekazu; Ishino, Yoshizumi			Multiple Interactions of the Intrinsically Disordered Region between the Helicase and Nuclease Domains of the Archaeal Hef Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FANCONI-ANEMIA PATHWAY; CROSS-LINK REPAIR; HYPERTHERMOPHILIC ARCHAEON; PYROCOCCUS-FURIOSUS; UNSTRUCTURED REGIONS; DNA-REPAIR; ENDONUCLEASE; DYNAMICS; COMPLEX; SYSTEM	Hef is an archaeal protein that probably functions mainly in stalled replication fork repair. The presence of an unstructured region was predicted between the two distinct domains of the Hef protein. We analyzed the interdomain region of Thermococcus kodakarensis Hef and demonstrated its disordered structure by CD, NMR, and high speed atomic force microscopy (AFM). To investigate the functions of this intrinsically disordered region (IDR), we screened for proteins interacting with the IDR of Hef by a yeast two-hybrid method, and 10 candidate proteins were obtained. We found that PCNA1 and a RecJ-like protein specifically bind to the IDR in vitro. These results suggested that the Hef protein interacts with several different proteins that work together in the pathways downstream from stalled replication fork repair by converting the IDR structure depending on the partner protein.	[Ishino, Sonoko; Yamagami, Takeshi; Kitamura, Makoto; Ishino, Yoshizumi] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Fukuoka 8128581, Japan; [Ishino, Sonoko; Yamagami, Takeshi; Kitamura, Makoto; Ishino, Yoshizumi] Kyushu Univ, Fac Agr, Fukuoka 8128581, Japan; [Kodera, Noriyuki; Mori, Tetsuya; Sugiyama, Shyogo; Ando, Toshio] Kanazawa Univ, Coll Sci & Engn, Bio AFM Frontier Res Ctr, Kanazawa, Ishikawa 9201192, Japan; [Kodera, Noriyuki; Mori, Tetsuya; Sugiyama, Shyogo; Ando, Toshio] Kanazawa Univ, Coll Sci & Engn, Dept Phys, Kanazawa, Ishikawa 9201192, Japan; [Goda, Natsuko; Tenno, Takeshi; Hiroaki, Hidekazu] Nagoya Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4648601, Japan	Kyushu University; Kyushu University; Kanazawa University; Kanazawa University; Nagoya University	Ishino, Y (corresponding author), 6-10-1 Hakozaki,Higashi Ku, Fukuoka 8128581, Japan.	ishino@agr.kyushu-u.ac.jp	Hiroaki, Hidekazu/G-9564-2012; ANDO, Toshio/E-7054-2015; HIROAKI, HIDEKAZU/N-1658-2019; Kodera, Noriyuki/AAJ-1797-2020; Kodera, Noriyuki/E-6569-2015	ANDO, Toshio/0000-0001-8819-154X; HIROAKI, HIDEKAZU/0000-0003-1621-5893; Kodera, Noriyuki/0000-0003-4880-8423; Ishino, Yoshizumi/0000-0001-9419-0826; Ishino, Sonoko/0000-0002-1833-1735	Ministry of Education, Culture, Sports, Science and Technology of Japan [21113005, 23310152, 26242075, 21113002]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Ministry of Education, Culture, Sports, Science and Technology of Japan Grants 21113005, 23310152, and 26242075 (to Y. I.) and 21113002 (to T. A.).	Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Ando T, 2008, PROG SURF SCI, V83, P337, DOI 10.1016/j.progsurf.2008.09.001; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Constantinou A, 2012, CHROMOSOMA, V121, P21, DOI 10.1007/s00412-011-0349-2; Crossan GP, 2012, J PATHOL, V226, P326, DOI 10.1002/path.3002; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Deans AJ, 2009, MOL CELL, V36, P943, DOI 10.1016/j.molcel.2009.12.006; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Errico A, 2012, CRIT REV BIOCHEM MOL, V47, P222, DOI 10.3109/10409238.2012.655374; FORMANKAY JD, 1992, BIOCHEMISTRY-US, V31, P3442, DOI 10.1021/bi00128a019; Franchitto A, 2011, CELL CYCLE, V10, P4039, DOI 10.4161/cc.10.23.18409; Fujikane R, 2010, GENES GENET SYST, V85, P243, DOI 10.1266/ggs.85.243; Fukuchi S, 2009, NUCLEIC ACIDS RES, V37, pD333, DOI 10.1093/nar/gkn855; Fukuchi S, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-26; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hashimoto M, 2013, BIOPHYS J, V104, P2222, DOI 10.1016/j.bpj.2013.04.007; Jones RM, 2012, BIOCHEM J, V443, P13, DOI 10.1042/BJ20112100; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Kiyonari S, 2008, J BIOL CHEM, V283, P24185, DOI 10.1074/jbc.M802837200; Kiyonari S, 2006, J BIOL CHEM, V281, P28023, DOI 10.1074/jbc.M603403200; Komori K, 2004, J BIOL CHEM, V279, P53175, DOI 10.1074/jbc.M409243200; Komori K, 2002, GENES GENET SYST, V77, P227, DOI 10.1266/ggs.77.227; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Kuba Y, 2012, GENES CELLS, V17, P923, DOI 10.1111/gtc.12007; Lestini R, 2013, NUCLEIC ACIDS RES, V41, P10358, DOI 10.1093/nar/gkt816; Lestini R, 2010, DNA REPAIR, V9, P994, DOI 10.1016/j.dnarep.2010.06.012; Li Z, 2011, NUCLEIC ACIDS RES, V39, P6114, DOI 10.1093/nar/gkr181; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; MORRISET.JD, 1973, BIOCHEMISTRY-US, V12, P1290, DOI 10.1021/bi00731a008; Mosedale G, 2005, NAT STRUCT MOL BIOL, V12, P763, DOI 10.1038/nsmb981; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Newman M, 2005, EMBO J, V24, P895, DOI 10.1038/sj.emboj.7600581; Nishino T, 2006, CURR OPIN STRUC BIOL, V16, P60, DOI 10.1016/j.sbi.2006.01.009; Nishino T, 2005, STRUCTURE, V13, P143, DOI 10.1016/j.str.2004.11.008; Nishino T, 2003, STRUCTURE, V11, P445, DOI 10.1016/S0969-2126(03)00046-7; Orengo CA, 2005, ANNU REV BIOCHEM, V74, P867, DOI 10.1146/annurev.biochem.74.082803.133029; Pluchon PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079707; Rezaei-Ghaleh N, 2012, CHEMBIOCHEM, V13, P930, DOI 10.1002/cbic.201200093; Roberts JA, 2003, MOL MICROBIOL, V48, P361, DOI 10.1046/j.1365-2958.2003.03444.x; Sato T, 2005, APPL ENVIRON MICROB, V71, P3889, DOI 10.1128/AEM.71.7.3889-3899.2005; Sengerova B, 2011, CELL CYCLE, V10, P3999, DOI 10.4161/cc.10.23.18385; Singh TR, 2010, MOL CELL, V37, P879, DOI 10.1016/j.molcel.2010.01.036; Tao YY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1779; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Tori K, 2007, J BACTERIOL, V189, P5652, DOI 10.1128/JB.00073-07; Ulrich HD, 2013, CHROMOSOMA, V122, P259, DOI 10.1007/s00412-013-0410-4; Uversky VN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S7; Vogel C, 2004, J MOL BIOL, V336, P809, DOI 10.1016/j.jmb.2003.12.026; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Weathers EA, 2004, FEBS LETT, V576, P348, DOI 10.1016/j.febslet.2004.09.036; Yan ZJ, 2010, MOL CELL, V37, P865, DOI 10.1016/j.molcel.2010.01.039; Yuan H, 2013, NUCLEIC ACIDS RES, V41, P5817, DOI 10.1093/nar/gkt275	53	27	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21627	21639		10.1074/jbc.M114.554998	http://dx.doi.org/10.1074/jbc.M114.554998			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24947516	Green Published, hybrid			2022-12-25	WOS:000340558300037
J	Lind, KR; Sizmur, T; Benomar, S; Miller, A; Cademartiri, L				Lind, Kara R.; Sizmur, Tom; Benomar, Saida; Miller, Anthony; Cademartiri, Ludovico			LEGO (R) Bricks as Building Blocks for Centimeter-Scale Biological Environments: The Case of Plants	PLOS ONE			English	Article							ROOT-SYSTEM ARCHITECTURE; CELL-CULTURE; SOIL; GROWTH	LEGO bricks are commercially available interlocking pieces of plastic that are conventionally used as toys. We describe their use to build engineered environments for cm-scale biological systems, in particular plant roots. Specifically, we take advantage of the unique modularity of these building blocks to create inexpensive, transparent, reconfigurable, and highly scalable environments for plant growth in which structural obstacles and chemical gradients can be precisely engineered to mimic soil.	[Lind, Kara R.; Sizmur, Tom; Benomar, Saida; Miller, Anthony; Cademartiri, Ludovico] Iowa State Univ, Dept Mat Sci & Engn, Ames, IA 50011 USA; [Sizmur, Tom; Benomar, Saida; Cademartiri, Ludovico] Iowa State Univ, US Dept Energy, Ames Lab, Ames, IA USA; [Miller, Anthony] Iowa State Univ, Dept Agron, Ames, IA USA; [Cademartiri, Ludovico] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA USA	Iowa State University; Iowa State University; United States Department of Energy (DOE); Ames National Laboratory; Iowa State University; Iowa State University	Cademartiri, L (corresponding author), Iowa State Univ, Dept Mat Sci & Engn, Ames, IA 50011 USA.	lcademar@iastate.edu	Cademartiri, Ludovico/A-4142-2008; Sizmur, Tom/F-4532-2018	Cademartiri, Ludovico/0000-0001-8805-9434; Sizmur, Tom/0000-0001-9835-7195	Iowa State University	Iowa State University	The work was funded by Iowa State University through a startup grant to LC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen M, 2011, EXP MATH, V20, P145, DOI 10.1080/10586458.2011.564539; Balvin M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.078301; Bengough AG, 2010, MICROSC RES TECHNIQ, V73, P27, DOI 10.1002/jemt.20749; Clark KA, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-8; de Dorlodot S, 2007, TRENDS PLANT SCI, V12, P474, DOI 10.1016/j.tplants.2007.08.012; Derda R, 2009, P NATL ACAD SCI USA, V106, P18457, DOI 10.1073/pnas.0910666106; Downie H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044276; EMMERICH WE, 1991, CROP SCI, V31, P454, DOI 10.2135/cropsci1991.0011183X003100020046x; FAO, 2009, FOOD BAL SHEETS; Fiorani F, 2013, ANNU REV PLANT BIOL, V64, P267, DOI 10.1146/annurev-arplant-050312-120137; Gilroy S, 2008, PLANT TROPISMS; Grossmann G, 2011, PLANT CELL, V23, P4234, DOI 10.1105/tpc.111.092577; Hargreaves CE, 2009, PLANT SOIL, V316, P285, DOI 10.1007/s11104-008-9780-4; Hulme SE, 2007, LAB CHIP, V7, P1515, DOI 10.1039/b707861g; Ingram PA, 2012, PHILOS T R SOC B, V367, P1559, DOI 10.1098/rstb.2011.0241; Krysan P, 2004, PLANT PHYSIOL, V135, P1162, DOI 10.1104/pp.104.040774; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; LYNCH J, 1995, PLANT PHYSIOL, V109, P7, DOI 10.1104/pp.109.1.7; Massa GD, 2003, PLANT J, V33, P435, DOI 10.1046/j.1365-313X.2003.01637.x; McNamara S, 1999, ASEE ANN C; Meier M, 2010, LAB CHIP, V10, P2147, DOI 10.1039/c004629a; Nunan N, 2002, MICROBIAL ECOL, V44, P296, DOI 10.1007/s00248-002-2021-0; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; PARASHAR A, 2011, APPL PHYS LETT, V98; Poorter H, 2012, FUNCTIONAL PLANT BIO; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Sizmur T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096730; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; The LEGO Group, 2013, LEG GROUP CO PROF; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Tracy SR, 2010, J EXP BOT, V61, P311, DOI 10.1093/jxb/erp386; Whalley WR, 2013, PLANT SOIL, V364, P171, DOI 10.1007/s11104-012-1342-0; Whitesides G, 2012, FRUGAL WAY PROMISE C; Whitesides GM, 2013, LAB CHIP, V13, P11, DOI 10.1039/c2lc90109a; Young IM, 2004, SCIENCE, V304, P1634, DOI 10.1126/science.1097394; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407	37	12	12	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100867	10.1371/journal.pone.0100867	http://dx.doi.org/10.1371/journal.pone.0100867			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963716	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000338709500092
J	Moller, AP; Bonisoli-Alquati, A; Mousseau, TA; Rudolfsen, G				Moller, Anders Pape; Bonisoli-Alquati, Andrea; Mousseau, Timothy A.; Rudolfsen, Geir			Aspermy, Sperm Quality and Radiation in Chernobyl Birds	PLOS ONE			English	Article							SWALLOWS HIRUNDO-RUSTICA; REACTIVE OXYGEN; BARN SWALLOWS; DNA-DAMAGE; OXIDATIVE STRESS; MICROSATELLITE MUTATIONS; IONIZING-RADIATION; SOCIAL-STATUS; COMET ASSAY; COMPETITION	Background: Following the Chernobyl nuclear power plant accident, large amounts of radionuclides were emitted and spread in the environment. Animals living in such contaminated areas are predicted to suffer fitness costs including reductions in the quality and quantity of gametes. Methodology/Principal Findings: We studied whether aspermy and sperm quality were affected by radioactive contamination by examining ejaculates from wild caught birds breeding in areas varying in background radiation level by more than three orders of magnitude around Chernobyl, Ukraine. The frequency of males with aspermy increased logarithmically with radiation level. While 18.4% of males from contaminated areas had no sperm that was only the case for 3.0% of males from uncontaminated control areas. Furthermore, there were negative relationships between sperm quality as reflected by reduced sperm velocity and motility, respectively, and radiation. Conclusions/Significance: Our results suggest that radioactive contamination around Chernobyl affects sperm production and quality. We are the first to report an interspecific difference in sperm quality in relation to radioactive contamination.	[Moller, Anders Pape] Univ Paris 11, CNRS, UMR 8079, Lab Ecol Systemat & Evolut, F-91405 Orsay, France; [Bonisoli-Alquati, Andrea; Mousseau, Timothy A.] Univ S Carolina, Dept Biol Sci, Columbia, SC USA; [Rudolfsen, Geir] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; UiT The Arctic University of Tromso	Moller, AP (corresponding author), Univ Paris 11, CNRS, UMR 8079, Lab Ecol Systemat & Evolut, Batiment 362, F-91405 Orsay, France.	anders.moller@u-psud.fr	Mousseau, Timothy A/A-1253-2011; Alquati, Andrea Bonisoli/S-2082-2017; Rudolfsen, Geir/ABD-7777-2020; Moller, Anders/O-6665-2016	Alquati, Andrea Bonisoli/0000-0002-9255-7556; Moller, Anders/0000-0003-3739-4675; Rudolfsen, Geir/0000-0001-7984-8458; Mousseau, Timothy/0000-0002-2235-4868	CNRS (France); University of South Carolina College of Arts Sciences; NATO; Fulbright Program; Samuel Freeman Charitable Trust; National Geographic Society; Norwegian Radiation Protection Authority	CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); University of South Carolina College of Arts Sciences; NATO(NATO (North Atlantic Treaty Organisation)); Fulbright Program; Samuel Freeman Charitable Trust; National Geographic Society(National Geographic Society); Norwegian Radiation Protection Authority	We are grateful for logistic help during our visit to Ukraine from G. Milinevsky, L. Milinevski, I. Chizchevsky, A. Peklo, A. Rozhok, I. Kozeretska, S. Taykova, W. Mardal and E. Flensted-Jensen. We received funding from the CNRS (France), University of South Carolina College of Arts & Sciences, NATO, the Fulbright Program, the Samuel Freeman Charitable Trust, the National Geographic Society and Norwegian Radiation Protection Authority in support of this research. Support and sperm tracking equipment was kindly provided by Ivar Folstad, University of Tromso.	Agarwal A, 2006, FERTIL STERIL, V86, P878, DOI 10.1016/j.fertnstert.2006.02.111; Aitken RJ, 1998, J CELL SCI, V111, P645; Aitken RJ, 1998, BIOL REPROD, V59, P1037, DOI 10.1095/biolreprod59.5.1037; AITKEN RJ, 1987, J REPROD FERTIL, V81, P459; ASH P, 1980, BRIT J RADIOL, V53, P271, DOI 10.1259/0007-1285-53-628-271; BIRIOUKOV A, 1993, ARCH ANDROLOGY, V30, P99, DOI 10.3109/01485019308987741; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; Birkhead TR, 1998, SPERM COMPETITION SE; Bonisoli-Alquati A, 2010, COMP BIOCHEM PHYS C, V151, P271, DOI 10.1016/j.cbpc.2009.11.006; Bonisoli-Alquati A, 2010, COMP BIOCHEM PHYS A, V155, P205, DOI 10.1016/j.cbpa.2009.10.041; CHEKHOVICH AV, 1993, GENETIKA+, V29, P312; CLIFTON DK, 1983, J ANDROL, V4, P387; Cornwallis CK, 2007, AM NAT, V170, P758, DOI 10.1086/521955; Cornwallis CK, 2006, EVOLUTION, V60, P1486, DOI 10.1111/j.0014-3820.2006.tb01227.x; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; European Union, 1998, EU PUBL EUR; Fischbein A, 1997, ENVIRON HEALTH PERSP, V105, P1445, DOI 10.2307/3433648; Folstad I, 1997, BEHAV ECOL, V8, P109, DOI 10.1093/beheco/8.1.109; Frenzilli G, 2001, MUTAT RES-GEN TOX EN, V491, P139, DOI 10.1016/S1383-5718(01)00136-X; Frenzilli G, 1998, MUTAT RES-GEN TOX EN, V415, P151, DOI 10.1016/S1383-5718(98)00060-6; Furitsu K, 2005, MUTAT RES-GEN TOX EN, V581, P69, DOI 10.1016/j.mrgentox.2004.11.002; Gage MJG, 2004, CURR BIOL, V14, P44, DOI 10.1016/j.cub.2003.12.028; Garcia O, 2005, MUTAT RES-GEN TOX EN, V565, P191, DOI 10.1016/j.mrgentox.2004.10.001; Gaschak S. P., 2008, Radiatsionnaya Biologiya Radioekologiya, V48, P28; Gelman A., 2007, DATA ANAL USING REGR; Gemignani F, 1999, MUTAT RES-GEN TOX EN, V446, P245, DOI 10.1016/S1383-5718(99)00194-1; Goncharov NP, 1998, INT J ANDROL, V21, P271; Helfenstein F, 2010, ECOL LETT, V13, P213, DOI 10.1111/j.1461-0248.2009.01419.x; Hermosell IG, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0530; Hinton TG, 2007, HEALTH PHYS, V93, P427, DOI 10.1097/01.HP.0000281179.03443.2e; Hunter FM, 2002, CURR BIOL, V12, P121, DOI 10.1016/S0960-9822(01)00647-9; International Atomic Energy Agency, 1992, EFF ION RAD PLANTS A; JONES R, 1973, PROC R SOC SER B-BIO, V184, P103, DOI 10.1098/rspb.1973.0035; Kleven O, 2009, EVOLUTION, V63, P2466, DOI 10.1111/j.1558-5646.2009.00725.x; Lanzafame FM, 2009, REPROD BIOMED ONLINE, V19, P638, DOI 10.1016/j.rbmo.2009.09.014; Laskemoen T, 2008, J AVIAN BIOL, V39, P322, DOI 10.1111/j.0908-8857.2008.04178.x; Laskemoen T, 2010, BEHAV ECOL SOCIOBIOL, V64, P1473, DOI 10.1007/s00265-010-0962-8; Levitan DR, 2000, P ROY SOC B-BIOL SCI, V267, P531, DOI 10.1098/rspb.2000.1032; Lifjeld JT, 2007, J AVIAN BIOL, V38, P267, DOI 10.1111/j.2007.0908-8857.04126.x; Mahfouz R, 2010, FERTIL STERIL, V94, P2141, DOI 10.1016/j.fertnstert.2009.12.030; Malo AF, 2005, BIOL REPROD, V72, P822, DOI 10.1095/biolreprod.104.036368; Meeks HN, 2007, ENVIRON TOXICOL CHEM, V26, P361, DOI 10.1897/06-346R.1; MEISTRICH ML, 1982, J ANDROL, V3, P58; MEISTRICH ML, 1985, RADIAT RES, V102, P138, DOI 10.2307/3576437; Mikkelsen RB, 2003, ONCOGENE, V22, P5734, DOI 10.1038/sj.onc.1206663; Moller AP, 2008, MUTAT RES-GEN TOX EN, V650, P210, DOI 10.1016/j.mrgentox.2007.12.006; Moller AP, 2007, BIOLOGY LETT, V3, P483, DOI 10.1098/rsbl.2007.0226; Moller AP, 2007, BIOL LETTERS, V3, P414, DOI 10.1098/rsbl.2007.0136; Moller AP, 2009, J EVOLUTION BIOL, V22, P334, DOI 10.1111/j.1420-9101.2008.01650.x; Moller AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035223; Moller AP, 2005, P ROY SOC B-BIOL SCI, V272, P247, DOI 10.1098/rspb.2004.2914; Moller AP, 2003, EVOLUTION, V57, P2139, DOI 10.1554/03-051; Moller AP, 2001, EVOLUTION, V55, P2097; Parker GA, 2010, BIOL REV, V85, P897, DOI 10.1111/j.1469-185X.2010.00140.x; Pizzari T, 2007, P ROY SOC B-BIOL SCI, V274, P853, DOI 10.1098/rspb.2006.0080; Pomerantseva MD, 1997, MUTAT RES-FUND MOL M, V381, P97, DOI 10.1016/S0027-5107(97)00155-3; Prise KM, 2006, OCCUP MED-OXFORD, V56, P156, DOI 10.1093/occmed/kql010; Rowe M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015720; ROWLEY MJ, 1974, RADIAT RES, V59, P665, DOI 10.2307/3574084; Rudolfsen G, 2006, P ROY SOC B-BIOL SCI, V273, P325, DOI 10.1098/rspb.2005.3305; Rudolfsen G, 2008, AQUAC RES, V39, P212, DOI 10.1111/j.1365-2109.2007.01863.x; Ryabokon NI, 2006, RADIAT ENVIRON BIOPH, V45, P167, DOI 10.1007/s00411-006-0054-3; Sakharov IY, 1996, ANDROLOGIA, V28, P259; SAS, 2012, JMP VERS 10 0; Sawyer DE, 2003, MUTAT RES-FUND MOL M, V529, P21, DOI 10.1016/S0027-5107(03)00101-5; Sawyer DE, 2001, REDOX REP, V6, P182, DOI 10.1179/135100001101536157; Svensson L.A., 2006, IDENTIFICATION GUIDE; Tremellen K, 2008, HUM REPROD UPDATE, V14, P243, DOI 10.1093/humupd/dmn004; Tunc O, 2009, REPROD BIOMED ONLINE, V18, P761, DOI 10.1016/S1472-6483(10)60024-7; UNSCEAR, 2008, EFF ATOM RAD SOUR EF, V1, P1; WARD JF, 1994, RADIAT RES, V138, pS85, DOI 10.2307/3578769; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Wickliffe JK, 2003, ENVIRON MOL MUTAGEN, V42, P11, DOI 10.1002/em.10170; Yumura Y, 2009, INT J UROL, V16, P202, DOI 10.1111/j.1442-2042.2008.02213.x; ZALATA A, 1995, HUM REPROD, V10, P1444, DOI 10.1093/HUMREP/10.6.1444	76	17	18	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100296	10.1371/journal.pone.0100296	http://dx.doi.org/10.1371/journal.pone.0100296			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963711	Green Submitted, Green Published, gold			2022-12-25	WOS:000338709500038
J	Shimoni, R; Pham, K; Yassin, M; Ludford-Menting, MJ; Gu, M; Russell, SM				Shimoni, Raz; Pham, Kim; Yassin, Mohammed; Ludford-Menting, Mandy J.; Gu, Min; Russell, Sarah M.			Normalized Polarization Ratios for the Analysis of Cell Polarity	PLOS ONE			English	Article							T-LYMPHOCYTE DIVISION; ASYMMETRIC DIVISION; MICROSCOPY; TIME; STEM; SEGREGATION; IMMUNITY; SYSTEM	The quantification and analysis of molecular localization in living cells is increasingly important for elucidating biological pathways, and new methods are rapidly emerging. The quantification of cell polarity has generated much interest recently, and ratiometric analysis of fluorescence microscopy images provides one means to quantify cell polarity. However, detection of fluorescence, and the ratiometric measurement, is likely to be sensitive to acquisition settings and image processing parameters. Using imaging of EGFP-expressing cells and computer simulations of variations in fluorescence ratios, we characterized the dependence of ratiometric measurements on processing parameters. This analysis showed that image settings alter polarization measurements; and that clustered localization is more susceptible to artifacts than homogeneous localization. To correct for such inconsistencies, we developed and validated a method for choosing the most appropriate analysis settings, and for incorporating internal controls to ensure fidelity of polarity measurements. This approach is applicable to testing polarity in all cells where the axis of polarity is known.	[Shimoni, Raz; Pham, Kim; Gu, Min; Russell, Sarah M.] Swinburne Univ Technol, Fac Sci Engn & Technol, Ctr Microphoton, Hawthorn, Vic 3122, Australia; [Yassin, Mohammed; Ludford-Menting, Mandy J.; Russell, Sarah M.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Shimoni, Raz; Pham, Kim; Yassin, Mohammed; Ludford-Menting, Mandy J.; Russell, Sarah M.] Peter MacCallum Canc Ctr, Immune Signalling Lab, East Melbourne, Vic, Australia	Swinburne University of Technology; Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center	Russell, SM (corresponding author), Swinburne Univ Technol, Fac Sci Engn & Technol, Ctr Microphoton, Hawthorn, Vic 3122, Australia.	sarah.russell@petermac.org	Gu, Min/B-6627-2008; Russell, Sarah M/B-9341-2009	Russell, Sarah M/0000-0001-5826-9641	National Health and Medical Research Foundation [1020234, 620500]; Australian Research Council [FT0990405]; Human Frontiers Science Program [RGP0049/2007]	National Health and Medical Research Foundation; Australian Research Council(Australian Research Council); Human Frontiers Science Program(Human Frontier Science Program)	This work was supported by the National Health and Medical Research Foundation, https://www.nhmrc.gov.au/, 1020234, 620500; the Australian Research Council, http://www.arc.gov.au/, FT0990405; and the Human Frontiers Science Program, http://www.hfsp.org/, RGP0049/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRESENHAM JE, 1965, IBM SYST J, V4, P25, DOI 10.1147/sj.41.0025; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chang JT, 2011, IMMUNITY, V34, P492, DOI 10.1016/j.immuni.2011.03.017; Couturier L, 2013, CURR BIOL, V23, P588, DOI 10.1016/j.cub.2013.03.002; Dalton CM, 2013, J CELL SCI, V126, P2955, DOI 10.1242/jcs.128744; Day D, 2009, IMMUNOL CELL BIOL, V87, P154, DOI 10.1038/icb.2008.79; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Filby A, 2011, CYTOM PART A, V79A, P496, DOI 10.1002/cyto.a.21091; Frigault MM, 2009, J CELL SCI, V122, P753, DOI 10.1242/jcs.033837; Guberman JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000233; Habib SJ, 2013, SCIENCE, V339, P1445, DOI 10.1126/science.1231077; Hawkins ED, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2796; Huh D, 2011, P NATL ACAD SCI USA, V108, P15004, DOI 10.1073/pnas.1013171108; Villalta JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019031; King CG, 2012, IMMUNITY, V37, P709, DOI 10.1016/j.immuni.2012.06.021; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Lehmussola A, 2007, IEEE T MED IMAGING, V26, P1010, DOI 10.1109/TMI.2007.896925; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Melichar HJ, 2011, IMMUNOL CELL BIOL, V89, P549, DOI 10.1038/icb.2010.122; Moreau HD, 2012, IMMUNITY; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Oliaro J, 2010, J IMMUNOL, V185, P367, DOI 10.4049/jimmunol.0903627; Pang Z, 2012, J MICROSC-OXFORD, V246, P1, DOI [10.1111/j.1365-2818.2011.03581.x, 10.1111/j.1365-2818.201.1.03581.x]; Pawley JB, 2006, HDB BIOL CONFOCAL MI, p[xxviii, 985]; Pham K, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00026; Pham K, 2013, IMMUNOL CELL BIOL, V91, P70, DOI 10.1038/icb.2012.49; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Ramsbottom KM, 2014, J IMMUNOL, V192, P553, DOI 10.4049/jimmunol.1302197; Restifo NP, 2013, CURR OPIN IMMUNOL; Roybal KT, 2013, IMMUNOL REV, V256, P133, DOI 10.1111/imr.12103; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Russell S, 2008, J CELL SCI, V121, P131, DOI 10.1242/jcs.021253; Shimoni R, 2013, BIOINFORMATICS, V29, P817, DOI 10.1093/bioinformatics/btt035; Skamagki M, 2013, CELL REP, V3, P442, DOI 10.1016/j.celrep.2013.01.006; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Summers HD, 2011, NAT NANOTECHNOL, V6, P170, DOI [10.1038/nnano.2010.277, 10.1038/NNANO.2010.277]; Ting SB, 2012, BLOOD, V119, P2510, DOI 10.1182/blood-2011-11-393272; Waters JC, 2009, J CELL BIOL, V185, P1135, DOI 10.1083/jcb.200903097; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Yan Y, 2013, ACS NANO, V7, P5558, DOI 10.1021/nn401800u; Yang Y H, 2001, Brief Bioinform, V2, P341, DOI 10.1093/bib/2.4.341	41	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99885	10.1371/journal.pone.0099885	http://dx.doi.org/10.1371/journal.pone.0099885			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963926	gold, Green Published			2022-12-25	WOS:000338709500022
J	Aho, J; Hakim, A; Vuylsteke, B; Semde, G; Gbais, HG; Diarrassouba, M; Thiam, M; Laga, M				Aho, Josephine; Hakim, Avi; Vuylsteke, Bea; Semde, Gisele; Gbais, Honorat G.; Diarrassouba, Mamadou; Thiam, Marguerite; Laga, Marie			Exploring Risk Behaviors and Vulnerability for HIV among Men Who Have Sex with Men in Abidjan, Cote d'Ivoire: Poor Knowledge, Homophobia and Sexual Violence	PLOS ONE			English	Article							INTERNALIZED HOMOPHOBIA; HUMAN-RIGHTS; INFECTION; DEPRESSION; PREVALENCE; TRANSMISSION; METAANALYSIS; PREVENTION; HIV/AIDS; AFRICA	Men who have sex with men (MSM) are at high risk of HIV. Few data are available on MSM and HIV-related risk behaviors in West Africa. We aimed to describe risk behaviors and vulnerability among MSM in Abidjan, Cote d'Ivoire. We conducted a cross-sectional respondent-driven sampling survey with 601 MSM in 2011-2012. Sociodemographic and behavioural data as well as data related to emotional state and stigma were collected. Population estimates with 95% confidence intervals were produced. Survey weighted logistic regression was used to assess factors associated with inconsistent condom use in the prior 12 months. Most MSM were 24 years of age or younger (63.9%) and had attained at least primary education (84.4%). HIV risk behaviors such as low condom and water-based lubricant use, high numbers of male and female sex partners, and sex work were frequently reported as well as verbal, physical and sexual abuse. Inconsistent condom use during anal sex with a male partner in the prior 12 months was reported by 66.0% of the MSM and was positively associated with history of forced sex, alcohol consumption, having a regular partner and a casual partner, having bought sex, and self-perception of low HIV risk. MSM in Abidjan exhibit multiple and frequent HIV-related risk behaviors. To address those behaviours, a combination of individual but also structural interventions will be needed given the context of stigma, homophobia and violence.	[Aho, Josephine; Vuylsteke, Bea; Laga, Marie] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Hakim, Avi] Ctr Dis Control & Prevent, Atlanta, GA USA; [Semde, Gisele] Family Hlth Int 360, Kinshasa, DEM REP CONGO; [Gbais, Honorat G.] Family Hlth Int 360, Abidjan, Cote Ivoire; [Diarrassouba, Mamadou] Ctr Dis Control & Prevent, Abidjan, Cote Ivoire; [Thiam, Marguerite] Minist Hlth & Fight AIDS, Program Highly Vulnerable Populat, Abidjan, Cote Ivoire	Institute of Tropical Medicine (ITM); Centers for Disease Control & Prevention - USA	Aho, J (corresponding author), Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.	joseaho@yahoo.ca			US President's Emergency Plan for AIDS Relief; US Centers for Disease Control and Prevention (CDC); Canadian Institutes for Health Research	US President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); US Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	The survey was funded by the US President's Emergency Plan for AIDS Relief and the US Centers for Disease Control and Prevention (CDC). CDC was involved in the study design but not directly with the study participants. JA is a recipient of a postdoctoral fellowship by the Canadian Institutes for Health Research.	Alvy LM, 2011, AIDS BEHAV, V15, P1171, DOI 10.1007/s10461-010-9678-z; Arnold MP, 2013, AIDS BEHAV, V17, pS4, DOI 10.1007/s10461-012-0324-9; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-36; Baral S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004997; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Calzavara LM, 2012, AIDS BEHAV, V16, P633, DOI 10.1007/s10461-010-9879-5; Chapman J, 2011, AIDS CARE, V23, P449, DOI 10.1080/09540121.2010.507758; Creswell J.W., 2007, DESIGNING CONDUCTING; Diaz Rafael M, 2004, Cultur Divers Ethnic Minor Psychol, V10, P255, DOI 10.1037/1099-9809.10.3.255; Hakim A, 2013, HIV PREVALENCE ASS R; Heckathorn DD, 2007, SOCIOL METHODOL, V37, P151, DOI 10.1111/j.1467-9531.2007.00188.x; Heckathorn DD, 2011, SOCIOL METHODOL, V41, P355, DOI 10.1111/j.1467-9531.2011.01244.x; Huebner DM, 2002, AM J COMMUN PSYCHOL, V30, P327, DOI 10.1023/A:1015325303002; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Lane T, 2011, AIDS BEHAV, V15, P626, DOI 10.1007/s10461-009-9598-y; Merrigan M, 2011, SEX TRANSM INFECT, V87, P65, DOI 10.1136/sti.2008.034991; Ministere de la Sante A et de la Lutte contre le Sida [Co A te d'Ivoire] & Institut National de la Statistique (INS) MEASURE DHS, 2013, ENQ DEM SANT IND MUL; Ministere de la Santeet de la Lutte contre le Sida de Cote d'Ivoire INdlS Measure DHS ICF International, 2012, ENQ DEM SANT IND MUL; Monahan PO, 2009, J GEN INTERN MED, V24, P189, DOI 10.1007/s11606-008-0846-z; Rebe KB, 2011, SAMJ S AFR MED J, V101, P708; Salganik MJ, 2006, J URBAN HEALTH, V83, pI98, DOI 10.1007/s11524-006-9106-x; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Tucker A, 2013, AIDS CARE; van Griensven F, 2009, CURR OPIN HIV AIDS, V4, P300, DOI 10.1097/COH.0b013e32832c3bb3; Voisin D. R., 2012, J ADOLESCENCE; Vu L, 2012, AIDS BEHAV, V16, P717, DOI 10.1007/s10461-011-9948-4; Vuylsteke B, 2012, SEX TRANSM INFECT, V88, P288, DOI 10.1136/sextrans-2011-050276	30	43	43	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99591	10.1371/journal.pone.0099591	http://dx.doi.org/10.1371/journal.pone.0099591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7UT	24959923	gold, Green Published, Green Submitted			2022-12-25	WOS:000338633900010
J	Ghamrawi, S; Renier, G; Saulnier, P; Cuenot, S; Zykwinska, A; Dutilh, BE; Thornton, C; Faure, S; Bouchara, JP				Ghamrawi, Sarah; Renier, Gilles; Saulnier, Patrick; Cuenot, Stephane; Zykwinska, Agata; Dutilh, Bas E.; Thornton, Christopher; Faure, Sebastien; Bouchara, Jean-Philippe			Cell Wall Modifications during Conidial Maturation of the Human Pathogenic Fungus Pseudallescheria boydii	PLOS ONE			English	Article							CRYPTOCOCCUS-NEOFORMANS; FILAMENTOUS FUNGI; MELANIN SYNTHESIS; ADHERENCE; VIRULENCE; COMPLEX; DIFFERENTIATION; HYDROPHOBICITY; COLONIZATION; SCEDOSPORIUM	Progress in extending the life expectancy of cystic fibrosis (CF) patients remains jeopardized by the increasing incidence of fungal respiratory infections. Pseudallescheria boydii (P. boydii), an emerging pathogen of humans, is a filamentous fungus frequently isolated from the respiratory secretions of CF patients. It is commonly believed that infection by this fungus occurs through inhalation of airborne conidia, but the mechanisms allowing the adherence of Pseudallescheria to the host epithelial cells and its escape from the host immune defenses remain largely unknown. Given that the cell wall orchestrates all these processes, we were interested in studying its dynamic changes in conidia as function of the age of cultures. We found that the surface hydrophobicity and electronegative charge of conidia increased with the age of culture. Melanin that can influence the cell surface properties, was extracted from conidia and estimated using UV-visible spectrophotometry. Cells were also directly examined and compared using electron paramagnetic resonance (EPR) that determines the production of free radicals. Consistent with the increased amount of melanin, the EPR signal intensity decreased suggesting polymerization of melanin. These results were confirmed by flow cytometry after studying the effect of melanin polymerization on the surface accessibility of mannose-containing glycoconjugates to fluorescent concanavalin A. In the absence of melanin, conidia showed a marked increase in fluorescence intensity as the age of culture increased. Using atomic force microscopy, we were unable to find rodlet-forming hydrophobins, molecules that can also affect conidial surface properties. In conclusion, the changes in surface properties and biochemical composition of the conidial wall with the age of culture highlight the process of conidial maturation. Mannose-containing glycoconjugates that are involved in immune recognition, are progressively masked by polymerization of melanin, an antioxidant that is commonly thought to allow fungal escape from the host immune defenses.	[Ghamrawi, Sarah; Renier, Gilles; Bouchara, Jean-Philippe] Univ Angers, LUNAM Univ, Grp Etud Interact Hote Pathogene EA 3142, Angers, France; [Renier, Gilles; Bouchara, Jean-Philippe] CHU Angers, Lab Parasitol Mycol, Angers, France; [Saulnier, Patrick] Univ Angers, LUNAM Univ, INSERM, U646, Angers, France; [Cuenot, Stephane; Zykwinska, Agata] Univ Nantes, LUNAM Univ, Inst Mat Jean Rouxel, Nantes, France; [Dutilh, Bas E.] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Dutilh, Bas E.] Univ Fed Rio de Janeiro, Inst Biol, Dept Marine Biol, Rio De Janeiro, Brazil; [Thornton, Christopher] Univ Exeter, Dept Biosci, Exeter, Devon, England; [Faure, Sebastien] LUNAM Univ, INSERM, U1063, Angers, France	Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Nantes Universite; Radboud University Nijmegen; Universidade Federal do Rio de Janeiro; University of Exeter; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers	Ghamrawi, S (corresponding author), Univ Angers, LUNAM Univ, Grp Etud Interact Hote Pathogene EA 3142, Angers, France.	sarah.ghamrawi@gmail.com	Dutilh, Bas E./B-9719-2011; SAULNIER, Patrick/K-4271-2015; Clere, Nicolas/K-4414-2015	Dutilh, Bas E./0000-0003-2329-7890; Saulnier, Patrick/0000-0002-6408-3533; Faure, Sebastien/0000-0001-7524-8295; Cuenot, Stephane/0000-0003-1883-3847	"Region Pays de la Loire" in the frame of "Myco-AFM" research program; Dutch Virgo Consortium [FES0908, NGI 050-060-452]; CAPES/BRASIL	"Region Pays de la Loire" in the frame of "Myco-AFM" research program(Region Pays de la Loire); Dutch Virgo Consortium; CAPES/BRASIL(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The study was funded by "Region Pays de la Loire" in the frame of "Myco-AFM" research program). BED was supported by the Dutch Virgo Consortium (FES0908, NGI 050-060-452) and CAPES/BRASIL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bittencourt VCB, 2006, J BIOL CHEM, V281, P22614, DOI 10.1074/jbc.M511417200; Carrion SD, 2013, J IMMUNOL, V191, P2581, DOI 10.4049/jimmunol.1300748; Cortez KJ, 2008, CLIN MICROBIOL REV, V21, P157, DOI 10.1128/CMR.00039-07; Cunha MML, 2005, MICROSC RES TECHNIQ, V68, P377, DOI 10.1002/jemt.20260; Dalle F, 2003, INFECT IMMUN, V71, P7061, DOI 10.1128/IAI.71.12.7061-7068.2003; Desai C, 2011, FEMS YEAST RES, V11, P595, DOI 10.1111/j.1567-1364.2011.00743.x; Dubey MK, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-18; ENOCHS WS, 1993, PIGM CELL RES, V6, P91, DOI 10.1111/j.1600-0749.1993.tb00587.x; Fang WG, 2006, MYCOL RES, V110, P1165, DOI 10.1016/j.mycres.2006.04.014; Figueiredo RT, 2010, J BIOL CHEM, V285, P40714, DOI 10.1074/jbc.M110.181255; Frases S, 2007, APPL ENVIRON MICROB, V73, P615, DOI 10.1128/AEM.01947-06; GADD GM, 1982, T BRIT MYCOL SOC, V78, P115, DOI 10.1016/S0007-1536(82)80083-1; Gilgado F, 2005, J CLIN MICROBIOL, V43, P4930, DOI 10.1128/JCM.43.10.4930-4942.2005; Gilgado F, 2008, J CLIN MICROBIOL, V46, P766, DOI 10.1128/JCM.01122-07; Gilgado F, 2006, ANTIMICROB AGENTS CH, V50, P4211, DOI 10.1128/AAC.00981-06; Gravelat FN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003575; Gravelat FN, 2010, CELL MICROBIOL, V12, P473, DOI 10.1111/j.1462-5822.2009.01408.x; Khajo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025092; Kiffer-Moreira T, 2007, ARCH MICROBIOL, V188, P159, DOI 10.1007/s00203-007-0232-y; Kim S, 2005, MOL MICROBIOL, V57, P1224, DOI 10.1111/j.1365-2958.2005.04750.x; Kriznik A, 2005, CR BIOL, V328, P928, DOI 10.1016/j.crvi.2005.05.011; Linder MB, 2005, FEMS MICROBIOL REV, V29, P877, DOI 10.1016/j.femsre.2005.01.004; Masuoka J, 1997, MICROBIOL-UK, V143, P3015, DOI 10.1099/00221287-143-9-3015; Masuoka J, 1999, FEMS IMMUNOL MED MIC, V24, P421, DOI 10.1111/j.1574-695X.1999.tb01314.x; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; Nosanchuk JD, 1997, INFECT IMMUN, V65, P1836, DOI 10.1128/IAI.65.5.1836-1841.1997; Nosanchuk JD, 2006, ANTIMICROB AGENTS CH, V50, P3519, DOI 10.1128/AAC.00545-06; O'Bryan Thomas A, 2005, Expert Rev Anti Infect Ther, V3, P765, DOI 10.1586/14787210.3.5.765; Pihet M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-177; Pinto MR, 2004, MICROBES INFECT, V6, P1259, DOI 10.1016/j.micinf.2004.07.006; Pinto MR, 2002, GLYCOBIOLOGY, V12, P251, DOI 10.1093/glycob/12.4.251; Pokorny R, 2005, J BASIC MICROB, V45, P219, DOI 10.1002/jobm.200410354; Raggam RB, 2011, MYCOSES, V54, pE394, DOI 10.1111/j.1439-0507.2010.01933.x; Santos ALS, 2009, MED MYCOL, V47, P375, DOI 10.1080/13693780802610305; Sarangarajan R, 2006, MELANOMA RES, V16, P3, DOI 10.1097/01.cmr.0000195699.35143.df; Stringer JR, 2007, J EUKARYOT MICROBIOL, V54, P8, DOI 10.1111/j.1550-7408.2006.00225.x; Tronchin G, 2008, MED MYCOL, V46, P749, DOI 10.1080/13693780802206435; Voelz K, 2010, EUKARYOT CELL, V9, P835, DOI 10.1128/EC.00039-10; Wakamatsu K, 2002, PIGM CELL RES, V15, P174, DOI 10.1034/j.1600-0749.2002.02017.x; Wang YL, 1996, INFECT IMMUN, V64, P2420, DOI 10.1128/IAI.64.7.2420-2424.1996; Wargenau A, 2011, RES MICROBIOL, V162, P1011, DOI 10.1016/j.resmic.2011.07.006; Zouhair R, 2013, MED MYCOL, V51, P603, DOI 10.3109/13693786.2013.770606	42	19	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100290	10.1371/journal.pone.0100290	http://dx.doi.org/10.1371/journal.pone.0100290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950099	Green Published, gold			2022-12-25	WOS:000338276300060
J	Kuppusamy, H; Ogmundsdottir, HM; Baigorri, E; Warkentin, A; Steingrimsdottir, H; Haraldsdottir, V; Mant, MJ; Mackey, J; Johnston, JB; Adamia, S; Belch, AR; Pilarski, LM				Kuppusamy, Hemalatha; Ogmundsdottir, Helga M.; Baigorri, Eva; Warkentin, Amanda; Steingrimsdottir, Hlif; Haraldsdottir, Vilhelmina; Mant, Michael J.; Mackey, John; Johnston, James B.; Adamia, Sophia; Belch, Andrew R.; Pilarski, Linda M.			Inherited Polymorphisms in Hyaluronan Synthase 1 Predict Risk of Systemic B-Cell Malignancies but Not of Breast Cancer	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; GENOME-WIDE ASSOCIATION; MULTIPLE-MYELOMA; GENE; RECEPTOR; HAS1; MACROGLOBULINEMIA; EXPRESSION; VARIANTS; SNPS	Genetic variations in the hyaluronan synthase 1 gene (HAS1) influence HAS1 aberrant splicing. HAS1 is aberrantly spliced in malignant cells from multiple myeloma (MM) and Waldenstrom macroglobulinemia (WM), but not in their counterparts from healthy donors. The presence of aberrant HAS1 splice variants predicts for poor survival in multiple myeloma (MM). We evaluated the influence of inherited HAS1 single nucleotide polymorphisms (SNP) on the risk of having a systemic B cell malignancy in 1414 individuals compromising 832 patients and 582 healthy controls, including familial analysis of an Icelandic kindred. We sequenced HAS1 gene segments from 181 patients with MM, 98 with monoclonal gammopathy of undetermined significance (MGUS), 72 with Waldenstrom macroglobulinemia (WM), 169 with chronic lymphocytic leukemia (CLL), as well as 34 members of a monoclonal gammopathy-prone Icelandic family, 212 age-matched healthy donors and a case-control cohort of 295 breast cancer patients with 353 healthy controls. Three linked single nucleotide polymorphisms (SNP) in HAS1 intron3 are significantly associated with B-cell malignancies (range p = 0.007 to p = 10(-5)), but not MGUS or breast cancer, and predict risk in a 34 member Icelandic family (p = 0.005, Odds Ratio = 5.8 (OR)), a relatively homogeneous cohort. In contrast, exon3 SNPs were not significantly different among the study groups. Pooled analyses showed a strong association between the linked HAS1 intron3 SNPs and B-cell malignancies (OR = 1.78), but not for sporadic MGUS or for breast cancer (OR, 1.0). The minor allele genotypes of HAS1 SNPs are significantly more frequent in MM, WM, CLL and in affected members of a monoclonal gammopathy-prone family than they are in breast cancer, sporadic MGUS or healthy donors. These inherited changes may increase the risk for systemic B-cell malignancies but not for solid tumors.	[Kuppusamy, Hemalatha; Baigorri, Eva; Warkentin, Amanda; Mant, Michael J.; Mackey, John; Belch, Andrew R.; Pilarski, Linda M.] Univ Alberta, Edmonton, AB, Canada; [Kuppusamy, Hemalatha; Baigorri, Eva; Warkentin, Amanda; Mant, Michael J.; Mackey, John; Belch, Andrew R.; Pilarski, Linda M.] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Ogmundsdottir, Helga M.] Univ Iceland, Reykjavik, Iceland; [Steingrimsdottir, Hlif; Haraldsdottir, Vilhelmina] Landspitali Univ Hosp, Reykjavik, Iceland; [Johnston, James B.] Canc Care Manitoba, Dept Hematol, Winnipeg, MB, Canada; [Johnston, James B.] Univ Manitoba, Winnipeg, MB, Canada; [Adamia, Sophia] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	University of Alberta; University of Alberta; University of Iceland; Landspitali National University Hospital; University of Manitoba; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Pilarski, LM (corresponding author), Univ Alberta, Edmonton, AB, Canada.	lpilarsk@ualberta.ca	Adamia, Sophia/AAG-7502-2020; Ögmundsdóttir, Helga M/L-6970-2015		Myeloma Alberta; Alberta Cancer Foundation; Canadian Institutes of Health Research	Myeloma Alberta; Alberta Cancer Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by grants to LMP and ARB from Myeloma Alberta, the Alberta Cancer Foundation and the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamia S, 2005, CLIN LYMPHOMA, V5, P253, DOI 10.3816/CLM.2005.n.010; Adamia S, 2005, BLOOD, V105, P4836, DOI 10.1182/blood-2004-10-3825; Adamia S, 2013, CURR CANCER DRUG TAR, V13, P347, DOI 10.2174/1568009611313040001; Adamia S, 2008, BLOOD, V112, P5111, DOI 10.1182/blood-2008-02-141770; Altieri A, 2006, EUR J CANCER, V42, P1661, DOI 10.1016/j.ejca.2005.11.033; Berndt SI, 2013, NAT GENET, V45, P868, DOI 10.1038/ng.2652; Berulava T, 2010, EUR J HUM GENET, V18, P1054, DOI 10.1038/ejhg.2010.71; Coombs CC, 2012, BLOOD, V120, P1687, DOI 10.1182/blood-2012-02-408799; Ghosh A, 2009, J BIOL CHEM, V284, P18840, DOI 10.1074/jbc.M109.013813; Goldin LR, 2009, HAEMATOL-HEMATOL J, V94, P647, DOI 10.3324/haematol.2008.003632; Hiratani H, 2005, J CLIN ENDOCR METAB, V90, P2898, DOI 10.1210/jc.2004-2148; Kang SH, 2008, ACTA HAEMATOL-BASEL, V119, P60, DOI 10.1159/000117572; Kriangkum J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053469; Lachance J, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-57; Landgren O, 2009, BLOOD, V114, P791, DOI 10.1182/blood-2008-12-191676; Liang XY, 2009, BRIT J HAEMATOL, V146, P418, DOI 10.1111/j.1365-2141.2009.07790.x; Maggini V, 2008, LEUKEMIA RES, V32, P988, DOI 10.1016/j.leukres.2007.10.008; MasellisSmith A, 1996, BLOOD, V87, P1891; Mauro FR, 2006, HAEMATOLOGICA, V91, P1117; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Ogmundsdottir HM, 2005, HAEMATOLOGICA, V90, P66; OGSMUNDSDOTTIR HM, 1994, SCAND J IMMUNOL, V40, P195, DOI 10.1111/j.1365-3083.1994.tb03450.x; Owen RG, 2003, SEMIN ONCOL, V30, P110, DOI 10.1053/sonc.2003.50082; Royer RH, 2010, BLOOD, V115, P4464, DOI 10.1182/blood-2009-10-247973; Sava GP, 2014, LEUKEMIA LYMPHOMA, V55, P160, DOI 10.3109/10428194.2013.800197; Simpson MA, 2001, J BIOL CHEM, V276, P17949, DOI 10.1074/jbc.M010064200; Smith A, 2006, BRIT J HAEMATOL, V132, P410, DOI 10.1111/j.1365-2141.2005.05867.x; Speedy HE, 2013, ADV EXP MED BIOL, V792, P293, DOI 10.1007/978-1-4614-8051-8_13; Treon SP, 2012, NEW ENGL J MED, V367, P826, DOI 10.1056/NEJMoa1200710; Wilkins K, 2011, HUM MOL GENET, V20, P4831, DOI 10.1093/hmg/ddr422; Yabushita H, 2005, ONCOL REP, V13, P1101; Yabushita H, 2004, ONCOL REP, V12, P739; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P20552, DOI 10.1073/pnas.0707106104	34	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100691	10.1371/journal.pone.0100691	http://dx.doi.org/10.1371/journal.pone.0100691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950197	gold, Green Published, Green Submitted			2022-12-25	WOS:000338276300109
J	Hernandez-Brito, D; Carrete, M; Popa-Lisseanu, AG; Ibanez, C; Tella, JL				Hernandez-Brito, Dailos; Carrete, Martina; Popa-Lisseanu, Ana G.; Ibanez, Carlos; Tella, Jose L.			Crowding in the City: Losing and Winning Competitors of an Invasive Bird	PLOS ONE			English	Article							PARAKEETS PSITTACULA-KRAMERI; SPARROW PASSER-DOMESTICUS; KESTREL FALCO-NAUMANNI; SPECIES INVASIONS; INTERSPECIFIC COMPETITION; BIOTIC HOMOGENIZATION; RISK-ASSESSMENT; NOCTULE BATS; HABITAT USE; IMPACT	Invasive species can take advantage of resources unexploited by natives (opportunism hypothesis) or they can exploit the same resources but more aggressively or efficiently (competition hypothesis), thus impacting native species. However, invasive species tend to exploit anthropogenic habitats that are inefficiently used by natives such as urban environments. Focusing on the ring-necked parakeet (Psittacula krameri), one of the most invasive birds worldwide, we combined observations of interspecific aggressions, species-specific cavity-nest preferences and the spatial distribution of the native cavity-nesting vertebrate community to determine the invasion process as well as its potential impacts on native species in a Mediterranean city. Our results support the competition hypothesis, suggesting that ring-necked parakeets are outcompeting native species sharing nest-site preferences. Parakeets initiated and won most interspecific aggressions, which were directed towards competitors but also towards predators. This behaviour could explain the spatial arrangement of natives, with most bird species breeding close to parakeets possibly to take advantage of their effective antipredatory behaviour. However, temporal and spatial patterns of segregation suggest that a threatened bat species is negatively affected by parakeets. This demonstrates that common species gain benefits and threatened ones (in this study, a bat and possibly a falcon) lose nest sites due to invaders. Therefore, the conservation status of the native species that pay the costs of competition with invaders should be considered. This scenario of winners and losers may, however, shift towards more losers if the ring-necked parakeet population continues to grow, thus requiring close monitoring and control/eradication programs to avoid further impacts.	[Hernandez-Brito, Dailos; Carrete, Martina; Tella, Jose L.] CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain; [Carrete, Martina] Univ Pablo Olavide, Dept Phys Chem & Nat Syst, Seville, Spain; [Popa-Lisseanu, Ana G.] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Ibanez, Carlos] CSIC, Dept Evolutionary Ecol, Estn Biol Donana, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidad Pablo de Olavide; Leibniz Institut fur Zoo und Wildtierforschung; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Carrete, M (corresponding author), CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain.	mcarrete@upo.es	Carrete, Martina/A-6376-2009; Carrete, Martina/D-2618-2017; Tella, José L/I-3707-2015; Hernández-Brito, Dailos/AAR-3234-2021; Ibanez, Carlos/H-7577-2015	Carrete, Martina/0000-0002-0491-2950; Tella, José L/0000-0002-3038-7424; Hernández-Brito, Dailos/0000-0002-5203-3512; Ibanez, Carlos/0000-0003-1181-7641; Chiaradia, Andre/0000-0002-6178-4211	Fundacion Repsol and Project of Excellence from the Junta de Andalucia [P08-RNM-4014]; COST (European Cooperation in Science and Technology) action ParrotNet; project EBD-Severo Ochoa [SEV-2012-0262];  [RYC-2009-04860]	Fundacion Repsol and Project of Excellence from the Junta de Andalucia; COST (European Cooperation in Science and Technology) action ParrotNet; project EBD-Severo Ochoa; 	MC (RYC-2009-04860) and JLT were supported by Fundacion Repsol and Project of Excellence from the Junta de Andalucia P08-RNM-4014. The authors would like to acknowledge the support provided by COST (European Cooperation in Science and Technology) action ParrotNet and the project EBD-Severo Ochoa (SEV-2012-0262) for the realization of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer HG, 2011, IBIS, V153, P204, DOI 10.1111/j.1474-919X.2010.01085.x; Blackburn TM, 2010, ANIM CONSERV, V13, P227, DOI 10.1111/j.1469-1795.2010.00372.x; Blackburn TM, 2009, OXFORD AVIAN BIOL, P1; Blanco G, 1997, ANIM BEHAV, V54, P335, DOI 10.1006/anbe.1996.0465; Bremner A, 2007, BIOL CONSERV, V139, P306, DOI 10.1016/j.biocon.2007.07.005; Brown CR, 2001, CURR ORNITHOL, V16, P1; Butler CJ, 2003, THESIS U OXFORD OXFO; Carrete M, 2010, ANIM CONSERV, V13, P390, DOI 10.1111/j.1469-1795.2010.00352.x; Carrete M, 2008, FRONT ECOL ENVIRON, V6, P466, DOI 10.1890/1540-9295-6.9.466.b; Carrete M, 2008, FRONT ECOL ENVIRON, V6, P207, DOI 10.1890/070075; Carrete M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018859; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Catry I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058320; Clavero M, 2009, BIOL CONSERV, V142, P2043, DOI 10.1016/j.biocon.2009.03.034; Clergeau P, 2009, PERRUCHE COLLIER PSI; Czajka Christina, 2011, Open Ornithology Journal, V4, P17, DOI 10.2174/1874453201104010017; Davis A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059332; Davis AY, 2014, BIOL INVASIONS, V16, P415, DOI 10.1007/s10530-013-0530-z; Diamond J.M., 1975, P342; Dunning J.B., 2007, CRC HDB AVIAN BODY M; Edelaar P, 2012, IBIS, V154, P635, DOI 10.1111/j.1474-919X.2012.01250.x; Fletcher M., 2007, REV STATUS ECOLOGY L; Forero MG, 1996, BIOL CONSERV, V78, P289, DOI 10.1016/S0006-3207(96)00011-0; Freed LA, 2009, CURR BIOL, V19, P1736, DOI 10.1016/j.cub.2009.08.044; Gebhardt H, 1996, WILDLIFE BIOL, V2, P205, DOI 10.2981/wlb.1996.020; Haarsma A-J, 2009, LEVENDE NATUUR, V114, P10; Halfwerk W, 2011, J APPL ECOL, V48, P210, DOI 10.1111/j.1365-2664.2010.01914.x; Hierro JL, 2005, J ECOL, V93, P5, DOI 10.1111/j.0022-0477.2004.00953.x; Ibanez C, 2001, P NATL ACAD SCI USA, V98, P9700, DOI 10.1073/pnas.171140598; Ibanez C., 2004, HDB SAUGETIERE EUROP, VII, P695, DOI DOI 10.1080/0964704X.2013.774246; Ibanez C, 2009, J MAMMAL, V90, P235, DOI 10.1644/08-MAMM-A-037.1; Japiot X., 2005, PSITTACIDES VILLES E; Krause J, 2002, LIVING GROUPS; Kumschick S, 2010, BIOL CONSERV, V143, P2757, DOI 10.1016/j.biocon.2010.07.023; Lever C., 2005, NATURALIZED BIRDS WO; MACARTHUR R, 1970, Theoretical Population Biology, V1, P1, DOI 10.1016/0040-5809(70)90039-0; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Martui R., 2003, ATLAS AVES REPRODUCT; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Moilanen A, 1998, ECOLOGY, V79, P2503, DOI 10.1890/0012-9658(1998)079[2503:MDEOHQ]2.0.CO;2; Mori E, 2013, HYSTRIX, V24, P195, DOI 10.4404/hystrix-24.2-8689; Munoz AR, 2006, DIVERS DISTRIB, V12, P656, DOI 10.1111/j.1472-4642.2006.00272.x; NEGRO JJ, 1993, BIRD STUDY, V40, P115, DOI 10.1080/00063659309477136; Newson SE, 2011, IBIS, V153, P509, DOI 10.1111/j.1474-919X.2011.01121.x; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; Newton I., 1998, POPULATION LIMITATIO; Orchan Y, 2013, BIOL INVASIONS, V15, P429, DOI 10.1007/s10530-012-0298-6; Palomo LJ., 2007, ATLAS LIBRO ROJO MAM; Popa-Lisseanu AG, 2009, J ZOOL, V278, P126, DOI 10.1111/j.1469-7998.2009.00556.x; Popa-Lisseanu AG, 2008, ANIM BEHAV, V75, P471, DOI 10.1016/j.anbehav.2007.05.011; Robinson RA, 2005, IBIS, V147, P552, DOI 10.1111/j.1474-919x.2005.00427.x; Rosenzweig ML, 2001, EVOL ECOL RES, V3, P361; Sax DF, 2000, GLOBAL ECOL BIOGEOGR, V9, P363, DOI 10.1046/j.1365-2699.2000.00217.x; Sax DF, 2002, AM NAT, V160, P766, DOI 10.1086/343877; Sax DF, 2008, P NATL ACAD SCI USA, V105, P11490, DOI 10.1073/pnas.0802290105; Sebastian-Gonzalez E, 2010, P ROY SOC B-BIOL SCI, V277, P2983, DOI 10.1098/rspb.2010.0244; Serrano D, 2005, AM NAT, V166, pE22, DOI 10.1086/431255; Serrano D, 2004, ECOLOGY, V85, P3438, DOI 10.1890/04-0463; Shaw LM, 2008, J ORNITHOL, V149, P293, DOI 10.1007/s10336-008-0285-y; Simberloff D., 1981, P53; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Sol D, 2012, OECOLOGIA, V169, P553, DOI 10.1007/s00442-011-2203-x; STAMPS JA, 1988, AM NAT, V131, P329, DOI 10.1086/284793; Start A. N., 1998, Western Australian Naturalist, V22, P123; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Strubbe D, 2007, ECOGRAPHY, V30, P578, DOI 10.1111/j.0906-7590.2007.05096.x; Strubbe D, 2011, BIOL CONSERV, V144, P2112, DOI 10.1016/j.biocon.2011.05.001; Strubbe D, 2011, IBIS, V153, P180, DOI 10.1111/j.1474-919X.2010.01074.x; Strubbe D, 2010, J APPL ECOL, V47, P549, DOI 10.1111/j.1365-2664.2010.01808.x; Strubbe D, 2009, BIOL CONSERV, V142, P1588, DOI 10.1016/j.biocon.2009.02.026; Tablado Z, 2010, CONSERV BIOL, V24, P1230, DOI 10.1111/j.1523-1739.2010.01483.x; Tayleur J., 2010, BOU P IMP NONN SPEC; Tella J.L., 1996, P53, DOI 10.1016/B978-012100130-8/50009-2; Tella JL, 1998, CONSERV BIOL, V12, P593, DOI 10.1046/j.1523-1739.1998.96288.x; van Wilgenburg E, 2010, EVOL APPL, V3, P136, DOI 10.1111/j.1752-4571.2009.00114.x	78	66	71	3	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100593	10.1371/journal.pone.0100593	http://dx.doi.org/10.1371/journal.pone.0100593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945439	Green Published, Green Submitted, gold			2022-12-25	WOS:000340721500095
J	Condello, S; Morgan, CA; Nagdas, S; Cao, L; Turek, J; Hurley, TD; Matei, D				Condello, S.; Morgan, C. A.; Nagdas, S.; Cao, L.; Turek, J.; Hurley, T. D.; Matei, D.			beta-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids	ONCOGENE			English	Article							STEM-CELL PHENOTYPE; PROTEIN EXPRESSION; WNT/BETA-CATENIN; GENE-EXPRESSION; IN-VITRO; ALDEHYDE DEHYDROGENASE; SIGNALING PATHWAYS; EPITHELIAL-CELLS; RESISTANCE; MONOLAYER	Cancer cells form three-dimensional (3D) multicellular aggregates (or spheroids) under non-adherent culture conditions. In ovarian cancer (OC), spheroids serve as a vehicle for cancer cell dissemination in the peritoneal cavity, protecting cells from environmental stress-induced anoikis. To identify new targetable molecules in OC spheroids, we investigated gene expression profiles and networks upregulated in 3D vs traditional monolayer culture conditions. We identified ALDH1A1, a cancer stem cell marker as being overexpressed in OC spheroids and directly connected to key elements of the beta-catenin pathway. beta-Catenin function and ALDH1A1 expression were increased in OC spheroids vs monolayers and in successive spheroid generations, suggesting that 3D aggregates are enriched in cells with stem cell characteristics. beta-Catenin knockdown decreased ALDH1A1 expression levels and beta-catenin co-immunoprecipitated with the ALDH1A1 promoter, suggesting that ALDH1A1 is a direct beta-catenin target. Both short interfering RNA-mediated beta-catenin knockdown and A37 ((ethyl-2-((4-oxo-3-(3-(pryrrolidin-1-yl) propyl)-3,4-dihydrobenzo [4,5]thioeno [3,2-d] pyrimidin-2-yl) thio) acetate)), a novel ALDH1A1 small-molecule enzymatic inhibitor described here for the first time, disrupted OC spheroid formation and cell viability (P<0.001). beta-Catenin knockdown blocked tumor growth and peritoneal metastasis in an OC xenograft model. These data strongly support the role of beta-catenin-regulated ALDH1A1 in the maintenance of OC spheroids and propose new ALDH1A1 inhibitors targeting this cell population.	[Condello, S.; Cao, L.; Matei, D.] Indiana Univ, Dept Med, Indianapolis, IN USA; [Morgan, C. A.; Hurley, T. D.; Matei, D.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Nagdas, S.] Univ Virginia, Sch Med, Indianapolis, IN USA; [Turek, J.] Purdue Univ, Coll Vet Med, Indianapolis, IN USA; [Hurley, T. D.; Matei, D.] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46202 USA; [Matei, D.] Indiana Univ Sch Med, VA Roudebush Hosp, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Virginia; Purdue University System; Purdue University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Hurley, TD (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, MS-4019, Indianapolis, IN 46202 USA.	thurley@iu.edu; dmatei@iu.edu	Condello, Salvatore/ABB-6743-2021	Condello, Salvatore/0000-0003-4979-3681; Matei, Daniela/0000-0003-2169-5035; HURLEY, THOMAS/0000-0002-5942-1163	US Department of Veterans Affairs; NIH [R01-AA018123, R01EB016582]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB016582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018123] Funding Source: NIH RePORTER	US Department of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank Dr Jeanette McClintick from the Indiana University Center for Medical Genomics, Dr Malgorzata Kamocha from IBCM and Dr Chirayu Goswami from the Bioinformatics Core for technical assistance. This work was made possible by funding from the US Department of Veterans Affairs to DM and from NIH to TDH (R01-AA018123), DM and JT (R01EB016582).	Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Barbone D, 2008, J BIOL CHEM, V283, P13021, DOI 10.1074/jbc.M709698200; Burleson KM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-6; Burleson KM, 2004, CLIN EXP METASTAS, V21, P685, DOI 10.1007/s10585-004-5768-5; Cai C, 2012, MOL MED REP, V5, P1191, DOI 10.3892/mmr.2012.802; Camper SA, 2011, P NATL ACAD SCI USA, V108, P11303, DOI 10.1073/pnas.1108275108; Cao L, 2012, ONCOGENE, V31, P2521, DOI 10.1038/onc.2011.429; Chang TT, 2009, TISSUE ENG PT A, V15, P559, DOI 10.1089/ten.tea.2007.0434; Chau WK, 2013, ONCOGENE, V32, P2767, DOI 10.1038/onc.2012.290; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Cody NAL, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-34; Condello S, 2013, FASEB J, V27, P3100, DOI 10.1096/fj.12-222620; David L, 2008, ACTA BIOMATER, V4, P256, DOI 10.1016/j.actbio.2007.08.012; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Frankel A, 2000, CLIN CANCER RES, V6, P3719; Frankel A, 1997, CANCER RES, V57, P2388; Gaedtke L, 2007, J PROTEOME RES, V6, P4111, DOI 10.1021/pr0700596; Hazlehurst LA, 2003, ONCOGENE, V22, P7396, DOI 10.1038/sj.onc.1206943; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Howes AL, 2007, MOL CANCER THER, V6, P2505, DOI 10.1158/1535-7163.MCT-06-0698; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Jackson Brian, 2011, Human Genomics, V5, P283; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; L'Esperance S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-99; Lawrenson K, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-43; Lee JM, 2013, LAB INVEST, V93, P528, DOI 10.1038/labinvest.2013.41; Lengyel E, 2014, ONCOGENE, V33, P3619, DOI 10.1038/onc.2013.321; Levanon K, 2008, J CLIN ONCOL, V26, P5284, DOI 10.1200/JCO.2008.18.1107; Li JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-49; Liu H, 2004, J CELL BIOL, V164, P603, DOI 10.1083/jcb.200306090; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Moss NM, 2009, CANCER RES, V69, P7121, DOI 10.1158/0008-5472.CAN-08-4151; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Parajuli B, 2011, CHEM-BIOL INTERACT, V191, P153, DOI 10.1016/j.cbi.2011.02.018; Park SH, 2008, MOL ENDOCRINOL, V22, P2085, DOI 10.1210/me.2007-0512; Pierre-Louis O, 2009, STEM CELLS, V27, P2552, DOI 10.1002/stem.186; Poland J, 2002, ELECTROPHORESIS, V23, P1174, DOI 10.1002/1522-2683(200204)23:7/8<1174::AID-ELPS1174>3.0.CO;2-O; Puiffe ML, 2007, NEOPLASIA, V9, P820, DOI 10.1593/neo.07472; Ray A, 2011, INT J ONCOL, V39, P797, DOI 10.3892/ijo.2011.1093; Reuben JM, 2011, EUR J CANCER, V47, P1527, DOI 10.1016/j.ejca.2011.01.011; Serebriiskii I, 2008, MATRIX BIOL, V27, P573, DOI 10.1016/j.matbio.2008.02.008; Shank JJ, 2012, GYNECOL ONCOL, V127, P390, DOI 10.1016/j.ygyno.2012.07.115; Silva IA, 2011, CANCER RES, V71, P3991, DOI 10.1158/0008-5472.CAN-10-3175; Sodek KL, 2009, INT J CANCER, V124, P2060, DOI 10.1002/ijc.24188; Song XQ, 2003, DEVELOPMENT, V130, P3259, DOI 10.1242/dev.00524; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Vidi Pierre-Alexandre, 2013, Methods Mol Biol, V945, P193, DOI 10.1007/978-1-62703-125-7_13; Wang F, 2002, JNCI-J NATL CANCER I, V94, P1494, DOI 10.1093/jnci/94.19.1494; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Weiswald LB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-106; Yasuda K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068187; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	54	117	119	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 30	2015	34	18					2297	2308		10.1038/onc.2014.178	http://dx.doi.org/10.1038/onc.2014.178			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CH2AH	24954508	Green Accepted, Green Submitted			2022-12-25	WOS:000353824800003
J	Liang, W; Miao, S; Zhang, B; He, S; Shou, C; Manivel, P; Krishna, R; Chen, Y; Shi, YE				Liang, W.; Miao, S.; Zhang, B.; He, S.; Shou, C.; Manivel, P.; Krishna, R.; Chen, Y.; Shi, Y. E.			Synuclein gamma protects Akt and mTOR and renders tumor resistance to Hsp90 disruption	ONCOGENE			English	Article							BREAST-CANCER CELLS; ENDOPLASMIC-RETICULUM STRESS; ESTROGEN-RECEPTOR; INDUCED APOPTOSIS; ALPHA-SYNUCLEIN; TYROSINE KINASE; UP-REGULATION; CHAPERONE; GENE; METASTASIS	Heat shock protein (Hsp)90 regulates many key pathways in oncogenesis, including Akt and mammalian target of rapamycin (mTOR). The strengths of disruption of Hsp90 in cancer therapy include their versatility in inhibiting a wide range of oncogenic pathways. The present study demonstrated that synuclein. (SNCG) protects the functions of Akt and mTOR in the condition when the function of Hsp90 is blocked. Disruption of Hsp90 abolished Akt activity and mTOR signaling. However, expression of SNCG restored Akt activity and mTOR signaling. SNCG bound to Akt and mTOR in the presence and absence of Hsp90. Specifically, the C-terminal (Gln106-Asp127) of SNCG bound to the loop connecting alpha C helix and beta 4 sheet of the kinase domain of Akt. SNCG renders resistance to 17-AAG-induced apoptosis both in vitro and in tumor xenograft. A clinical follow-up study indicates that patients with an SNCG-positive breast cancer have a significantly shorter disease-free survival and overall survival than patients with SNCG-negative tumors. The present study indicates that SNCG protects Hsp90 client proteins of Akt and mTOR, and renders drug resistance to Hsp90 disruption.	[Liang, W.; Miao, S.; Zhang, B.; He, S.; Shi, Y. E.] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing 210029, Jiangsu, Peoples R China; [Shou, C.] Peking Univ, Beijing Canc Hosp & Inst, Sch Oncol, Beijing 100871, Peoples R China; [Manivel, P.; Krishna, R.] Pondicherry Univ, Sch Life Sci, Ctr Bioinformat, Pondicherry, India; [Chen, Y.] Zhejiang Univ, Sch Med, Womens Hosp, Dept Surg, Hangzhou 310006, Zhejiang, Peoples R China; [Shi, Y. E.] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University; Peking University; Pondicherry University; Zhejiang University; Nanjing Medical University	Shi, YE (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Guangzhou Rd 300, Nanjing 210029, Jiangsu, Peoples R China.	chenyiding@gmail.com; daweieric@gmail.com	Panneerselvam, Manivel/M-5453-2013	Panneerselvam, Manivel/0000-0002-5831-8404	State Key Program of National Natural Science Foundation of China [81230054, 91029739]; National Key Technology R&D Program for the 12th Five-year Plan of China [2013BAI01B06]; State Key Laboratory of Reproductive Medicine; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program for the 12th Five-year Plan of China(National Key Technology R&D Program); State Key Laboratory of Reproductive Medicine; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported in part by grants 81230054 and 91029739 from the State Key Program of National Natural Science Foundation of China; a grant from the National Key Technology R&D Program for the 12th Five-year Plan of China (2013BAI01B06); and a grant from the State Key Laboratory of Reproductive Medicine, and a Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Bonvini P, 2002, CANCER RES, V62, P1559; Bruening W, 2000, CANCER-AM CANCER SOC, V88, P2154, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2154::AID-CNCR23>3.0.CO;2-9; Caldas-Lopes E, 2009, P NATL ACAD SCI USA, V106, P8368, DOI 10.1073/pnas.0903392106; Chiosis G, 2001, CHEM BIOL, V8, P289, DOI 10.1016/S1074-5521(01)00015-1; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Czekierdowski A, 2006, NEUROENDOCRINOL LETT, V27, P381; Davenport EL, 2007, BLOOD, V110, P2641, DOI 10.1182/blood-2006-11-053728; Fung KM, 2003, ACTA NEUROPATHOL, V106, P167, DOI 10.1007/s00401-003-0718-x; Gaspar N, 2009, CANCER RES, V69, P1966, DOI 10.1158/0008-5472.CAN-08-3131; Guo J, 2007, INT J CANCER, V121, P1296, DOI 10.1002/ijc.22763; Gupta A, 2003, ONCOGENE, V22, P7593, DOI 10.1038/sj.onc.1206880; Hibi T, 2009, CLIN CANCER RES, V15, P2864, DOI 10.1158/1078-0432.CCR-08-2946; Hu H, 2009, CLIN CANCER RES, V15, P5485, DOI 10.1158/1078-0432.CCR-08-2491; Hua H, 2009, J PATHOL, V217, P507, DOI 10.1002/path.2465; Inaba S, 2005, BREAST CANCER RES TR, V94, P25, DOI 10.1007/s10549-005-6938-0; Iwaki H, 2004, CANCER SCI, V95, P955, DOI 10.1111/j.1349-7006.2004.tb03183.x; Ji HJ, 1997, CANCER RES, V57, P759; Jia TL, 1999, CANCER RES, V59, P742; Jiang YF, 2003, CANCER RES, V63, P3899; Jiang YF, 2004, CANCER RES, V64, P4539, DOI 10.1158/0008-5472.CAN-03-3650; Li ZK, 2004, CANCER-AM CANCER SOC, V101, P58, DOI 10.1002/cncr.20321; Liu CY, 2008, CANCER LETT, V269, P148, DOI 10.1016/j.canlet.2008.04.037; Liu CY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-359; Liu HY, 2005, CANCER RES, V65, P7635, DOI 10.1158/0008-5472.CAN-05-1089; Liu YE, 2007, ONCOGENE, V26, P2115, DOI 10.1038/sj.onc.1210000; Manivel P, 2011, J MOL MODEL, V17, P251, DOI 10.1007/s00894-010-0718-4; McCollum AK, 2006, CANCER RES, V66, P10967, DOI 10.1158/0008-5472.CAN-06-1629; Neckers L, 2007, J BIOSCIENCES, V32, P517, DOI 10.1007/s12038-007-0051-y; Nimmanapalli R, 2001, CANCER RES, V61, P1799; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Okawa Y, 2009, BLOOD, V113, P846, DOI 10.1182/blood-2008-04-151928; Pan ZZ, 2006, INT J ONCOL, V29, P1201; Pan ZZ, 2002, J BIOL CHEM, V277, P35050, DOI 10.1074/jbc.M201650200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Shi YE, 2010, AM J PATHOL, V177, P964, DOI 10.2353/ajpath.2010.100061; Singh VK, 2007, CANCER RES, V67, P626, DOI 10.1158/0008-5472.CAN-06-1820; Solit DB, 2003, CANCER RES, V63, P2139; Souza JM, 2000, FEBS LETT, V474, P116, DOI 10.1016/S0014-5793(00)01563-5; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Taiyab A, 2009, BIOCHEM PHARMACOL, V78, P142, DOI 10.1016/j.bcp.2009.04.001; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Wu KJ, 2003, CANCER EPIDEM BIOMAR, V12, P920; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Zhao W, 2006, INT J ONCOL, V28, P1081	48	19	21	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 30	2015	34	18					2398	2405		10.1038/onc.2014.126	http://dx.doi.org/10.1038/onc.2014.126			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CH2AH	24954510				2022-12-25	WOS:000353824800012
J	Gu, HM; Mickler, EA; Cummings, OW; Sandusky, GE; Weber, DJ; Gracon, A; Woodruff, T; Wilkes, DS; Vittal, R				Gu, Hongmei; Mickler, Elizabeth A.; Cummings, Oscar W.; Sandusky, George E.; Weber, Daniel J.; Gracon, Adam; Woodruff, Trent; Wilkes, David S.; Vittal, Ragini			Crosstalk between TGF-beta 1 and complement activation augments epithelial injury in pulmonary fibrosis	FASEB JOURNAL			English	Article						C3a; C5a; CD46; CD55; IPF	TGF-BETA RECEPTOR; MESENCHYMAL TRANSITION; PROTEIN-KINASE; ANAPHYLATOXIN C3A; IMMUNE-COMPLEXES; EXPRESSION; INHIBITION; CELLS; C5A; TRANSDIFFERENTIATION	The epithelial complement inhibitory proteins (CIPs) cluster of differentiation 46 and 55 (CD46 and CD55) regulate circulating immune complex-mediated complement activation in idiopathic pulmonary fibrosis (IPF). Our previous studies demonstrated that IL-17A mediates epithelial injury via transforming growth factor beta 1 (TGF-beta 1) and down-regulates CIPs. In the current study, we examined the mechanistic role of TGF-beta 1 in complement activation-mediated airway epithelial injury in IPF pathogenesis. We observed lower epithelial CIP expression in IPF lungs compared to normal lungs, associated with elevated levels of complement component 3a and 5a (C3a and C5a), locally and systemically. In normal primary human small airway epithelial cells (SAECs) treated with TGF-beta 1 (10 ng/ml), C3a, or C5a (100 nM), we observed loss of CIPs and increased poly(ADP-ribose) polymerase (PARP) activation [also observed with RNA interference (RNAi) of CD46/CD55]. TGF-beta 1-mediated loss of CIPs and Snail induction [SNAI1; a transcriptional repressor of E-cadherin (E-CAD)] was blocked by inhibiting mitogen-activated protein kinase (p38MAPK; SB203580) and RNAi silencing of SNAI1. C3a- and C5a-mediated loss of CIPs was also blocked by p38MAPK inhibition. While C3a upregulated TGFb transcripts, both C3a and C5a down-regulated SMAD7 (negative regulator of TGF-beta), and whereas TGF-beta 1 induced C3a/C5a receptor (C3aR/C5aR) expression, pharmacologic C3aR/C5aR inhibition protected against C3a- /C5a-mediated loss of CIPs. Taken together, our results suggest that epithelial injury in IPF can be collectively amplified as a result of TGF-beta 1-induced loss of CIPs leading to complement activation that down-regulates CIPs and induces TGF-beta 1 expression.	[Gu, Hongmei; Mickler, Elizabeth A.; Wilkes, David S.; Vittal, Ragini] Indiana Univ Sch Med, Ctr Immunobiol, Indianapolis, IN 46202 USA; [Gu, Hongmei; Mickler, Elizabeth A.; Wilkes, David S.; Vittal, Ragini] Indiana Univ Sch Med, Div Pulm, Dept Med, Indianapolis, IN 46202 USA; [Cummings, Oscar W.; Sandusky, George E.] Indiana Univ Sch Med, Dept Pathol, Indianapolis, IN 46202 USA; [Weber, Daniel J.; Gracon, Adam] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA; [Wilkes, David S.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Woodruff, Trent] Univ Queensland, Sch Biomed Sci, Therapeut Dev & Translat Program, St Lucia, Qld, Australia	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Queensland	Vittal, R (corresponding author), Indiana Univ Sch Med, 980 W Walnut St,Walther Hall C406, Indianapolis, IN 46202 USA.	rvittal@iu.edu	Woodruff, Trent M/B-4861-2009; VITTAL, RAGINI/AAE-9052-2020; Woodruff, Trent/AAS-4629-2020	Woodruff, Trent M/0000-0003-1382-911X; Woodruff, Trent/0000-0003-1382-911X	U.S. National Institutes of Health [NIH-NHLBI-LTRG CS11-99-0002, NIH-NHLBI R01 HL109288, NIH-NHLBI R01 HL096845]; ImmuneWorks, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109288, R01HL096845] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ImmuneWorks, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank K. P. Lipking for analyzing the immunostaining intensity in the clinical tissues. The study was funded in part by U.S. National Institutes of Health grants NIH-NHLBI-LTRG CS11-99-0002 and NIH-NHLBI R01 HL109288 to R. V. and NIH-NHLBI R01 HL096845 to D.S.W. D.S.W. is a cofounder of ImmuneWorks, Inc., a biotechnology company involved in developing therapeutics for various forms of lung diseases. The other authors declare no conflicts of interests.	Addis-Lieser E, 2005, J IMMUNOL, V175, P1894, DOI 10.4049/jimmunol.175.3.1894; Akram KM, 2013, EUR RESPIR J, V41, P683, DOI 10.1183/09031936.00213411; Bakin AV, 2002, J CELL SCI, V115, P3193; Boor P, 2007, J AM SOC NEPHROL, V18, P1508, DOI 10.1681/ASN.2006121343; Bosmann M, 2013, FASEB J, V27, P5010, DOI 10.1096/fj.13-236380; Boulares AH, 2003, AM J RESP CELL MOL, V28, P322, DOI 10.1165/rcmb.2001-0015OC; Braun MC, 2004, J IMMUNOL, V173, P4190, DOI 10.4049/jimmunol.173.6.4190; Carrozzino F, 2005, AM J PHYSIOL-CELL PH, V289, pC1002, DOI 10.1152/ajpcell.00175.2005; DREISIN RB, 1978, NEW ENGL J MED, V298, P353, DOI 10.1056/NEJM197802162980701; Drouin SM, 2001, J IMMUNOL, V166, P2025, DOI 10.4049/jimmunol.166.3.2025; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Fregonese L, 2005, J ALLERGY CLIN IMMUN, V115, P1148, DOI 10.1016/j.jaci.2005.01.068; Fujita T, 2002, AM J RESP CELL MOL, V27, P542, DOI 10.1165/rcmb.4775; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; JANSEN HM, 1984, CLIN EXP IMMUNOL, V56, P311; Jayachandran A, 2009, THORAX, V64, P1053, DOI 10.1136/thx.2009.121798; KAPANCI Y, 1995, AM J RESP CRIT CARE, V152, P2163, DOI 10.1164/ajrccm.152.6.8520791; Katzenstein ALA, 1998, AM J RESP CRIT CARE, V157, P1301, DOI 10.1164/ajrccm.157.4.9707039; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kohl J, 1999, MOL IMMUNOL, V36, P893, DOI 10.1016/S0161-5890(99)00111-X; Li M, 2011, J CLIN INVEST, V121, P277, DOI 10.1172/JCI42090; Li QJ, 2010, J AM SOC NEPHROL, V21, P1344, DOI 10.1681/ASN.2009090977; Liszewski MK, 1996, ADV IMMUNOL, V61, P201; Liu F, 2011, CHINESE MED J-PEKING, V124, P4039, DOI 10.3760/cma.j.issn.0366-6999.2011.23.036; Loverre A, 2011, AM J TRANSPLANT, V11, P1248, DOI 10.1111/j.1600-6143.2011.03529.x; MELICONI R, 1990, CLIN IMMUNOL IMMUNOP, V57, P64, DOI 10.1016/0090-1229(90)90022-I; MOLINA H, 1992, J EXP MED, V175, P121, DOI 10.1084/jem.175.1.121; Nishiura H, 2010, APOPTOSIS, V15, P966, DOI 10.1007/s10495-010-0511-y; PHAN SH, 1982, AM J PATHOL, V107, P25; Pittet JF, 2001, J CLIN INVEST, V107, P1537, DOI 10.1172/JCI11963; Polosukhin VV, 2012, EXP LUNG RES, V38, P135, DOI 10.3109/01902148.2012.658595; QUIGG RJ, 1989, J IMMUNOL, V142, P877; Sacks SH, 2010, EUR J IMMUNOL, V40, P668, DOI 10.1002/eji.201040355; Singhera GK, 2008, EXP LUNG RES, V34, P579, DOI 10.1080/01902140802369372; Sun L, 2009, FASEB J, V23, P3808, DOI 10.1096/fj.09-133694; Suzuki H, 2013, J IMMUNOL, V191, P4431, DOI 10.4049/jimmunol.1202242; Tang ZY, 2009, J AM SOC NEPHROL, V20, P593, DOI 10.1681/ASN.2008040434; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Varsano S, 1996, AM J RESP CELL MOL, V15, P731, DOI 10.1165/ajrcmb.15.6.8969267; VARSANO S, 1995, AM J RESP CRIT CARE, V152, P1087, DOI 10.1164/ajrccm.152.3.7545058; Vidyasagar A, 2008, AM J PHYSIOL-RENAL, V295, pF707, DOI 10.1152/ajprenal.90240.2008; Vittal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076451; Vittal R, 2013, AM J RESP CELL MOL, V49, P47, DOI 10.1165/rcmb.2012-0389OC; Vittal R, 2013, AM J PHYSIOL-LUNG C, V304, pL401, DOI 10.1152/ajplung.00080.2012; Wettstein G, 2013, FASEB J, V27, P1549, DOI 10.1096/fj.12-220053; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Yadav UCS, 2013, FREE RADICAL BIO MED, V65, P15, DOI 10.1016/j.freeradbiomed.2013.06.008; Zhou BY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038827, 10.1371/journal.pone.0038241]	52	53	59	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4223	4234		10.1096/fj.13-247650	http://dx.doi.org/10.1096/fj.13-247650			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	24958208	Green Submitted, Green Published			2022-12-25	WOS:000342222700004
J	Munoz, S; Manjon, E; Sanchez, Y				Munoz, Sofia; Manjon, Elvira; Sanchez, Yolanda			The Putative Exchange Factor Gef3p Interacts with Rho3p GTPase and the Septin Ring during Cytokinesis in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL; DIVISION-SITE; EXOCYST COMPLEX; FORMIN FOR3P; MEMBRANE; INTEGRITY; BINDING; CDC42P; ROLES; SEPARATION	The small GTP-binding proteins of the Rho family and its regulatory proteins play a central role in cytokinetic actomyosin ring assembly and cytokinesis. Here we show that the fission yeast guanine nucleotide exchange factor Gef3p interacts with Rho3p at the division site. Gef3p contains a putative DH homology domain and a BAR/IMD-like domain. The protein localized to the division site late in mitosis, where it formed a ring that did not constrict with actomyosin ring (cytokinetic actomyosin ring) invagination; instead, it split into a double ring that resembled the septin ring. Gef3p co-localized with septins and Mid2p and required septins and Mid2p for its localization. Gef3p interacts physically with the GTP-bound form of Rho3p. Although Gef3p is not essential for cell separation, the simultaneous disruption of gef3(+) and Rho3p-interacting proteins, such as Sec8p, an exocyst component, Apm1p, a subunit of the clathrin adaptor complex or For3p, an actin-polymerizing protein, yielded cells with strong defects in septation and polarity respectively. Our results suggest that interactions between septins and Rho-GEFs provide a new targeting mechanism for GTPases in cytokinesis, in this case probably contributing to Rho3p function in vesicle tethering and vesicle trafficking in the later steps of cell separation.	Univ Salamanca, Inst Biol Func & Genom IBFG, Consejo Super Invest Cient, Salamanca 37007, Spain; Univ Salamanca, Dept Microbiol & Genet, Salamanca 37007, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; University of Salamanca	Sanchez, Y (corresponding author), Univ Salamanca, Inst Biol Func & Genom, CSIC, C Zacarias Gonzalez S-N, Salamanca 37007, Spain.	ysm@usal.es	Manjón, Elvira/B-7357-2017; Muñoz, Sofía/T-6030-2019; Muñoz, Sofía/GQI-2567-2022; Sanchez, Yolanda/L-2847-2014	Manjón, Elvira/0000-0001-5682-3143; Muñoz, Sofía/0000-0001-5512-2468; Sanchez, Yolanda/0000-0002-7650-9319	Ramon Areces Foundation	Ramon Areces Foundation	We thank P. Perez, P. M. Coll, H. Valdivieso, J. C. Ribas, and C. Rodriguez-Vazquez de Aldana from the IBFG, Spain, F. Chang from Columbia University, M. Balasubramanian from the Mechanobiology Institute, Singapore, and J. Bahler from Wellcome Trust UK for providing plasmids and strains. We recognize P. Bolanos for initiating this work. Text was revised by N. Skinner. Instituto de Biologia Funcional y Genomica acknowledges the institutional support granted by the Ramon Areces Foundation during 2011 and 2012.	An HB, 2004, MOL BIOL CELL, V15, P5551, DOI 10.1091/mbc.E04-07-0640; Aspenstrom P, 2009, INT REV CEL MOL BIO, V272, P1, DOI 10.1016/S1937-6448(08)01601-8; Balasubramanian MK, 2012, CYTOSKELETON, V69, P942, DOI 10.1002/cm.21082; Barral Y., 2008, SEPTINS, P101; Bathe M, 2010, TRENDS MICROBIOL, V18, P38, DOI 10.1016/j.tim.2009.10.002; Bendezu FO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040248; Bendezu FO, 2011, MOL BIOL CELL, V22, P44, DOI 10.1091/mbc.E10-08-0720; Berlin A, 2003, J CELL BIOL, V160, P1083, DOI 10.1083/jcb.200212016; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Buchsbaum RJ, 2007, J CELL SCI, V120, P1149, DOI 10.1242/jcs.03428; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Coll PM, 2007, EMBO J, V26, P1865, DOI 10.1038/sj.emboj.7601641; Coll PM, 2003, MOL BIOL CELL, V14, P313, DOI 10.1091/mbc.E02-07-0400; Cortes JCG, 2007, MOL MICROBIOL, V65, P201, DOI 10.1111/j.1365-2958.2007.05784.x; de Kreuk Bart-Jan, 2012, Small GTPases, V3, P45, DOI 10.4161/sgtp.18960; Estravis M, 2011, TRAFFIC, V12, P1744, DOI 10.1111/j.1600-0854.2011.01275.x; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Garcia P, 2006, MOL BIOL CELL, V17, P1620, DOI 10.1091/mbc.E05-10-0933; Garcia P, 2006, YEAST, V23, P1031, DOI 10.1002/yea.1409; Garcia P, 2009, GENETICS, V181, P1321, DOI 10.1534/genetics.108.094839; Garcia P, 2009, MOL BIOL CELL, V20, P721, DOI 10.1091/mbc.E08-07-0673; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; Goya A, 2011, CYTOSKELETON, V68, P69, DOI 10.1002/cm.20500; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Heider MR, 2012, TRAFFIC, V13, P898, DOI 10.1111/j.1600-0854.2012.01353.x; Hirata D, 1998, J CELL SCI, V111, P149; Hirota K, 2003, MOL BIOL CELL, V14, P3617, DOI 10.1091/mbc.E02-10-0665; Iwaki N, 2003, BIOCHEM BIOPH RES CO, V312, P414, DOI 10.1016/j.bbrc.2003.10.140; Joo E, 2005, TRAFFIC, V6, P626, DOI 10.1111/j.1600-0854.2005.00305.x; Kita A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016842; Krapp A, 2008, BIOCHEM SOC T, V36, P411, DOI 10.1042/BST0360411; Laporte D, 2011, J CELL BIOL, V192, P1005, DOI 10.1083/jcb.201008171; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; Martin SG, 2007, MOL BIOL CELL, V18, P4155, DOI 10.1091/mbc.E07-02-0094; Martin-Cuadrado AB, 2005, MOL BIOL CELL, V16, P4867, DOI 10.1091/mbc.E04-12-1114; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morrell-Falvey JL, 2005, J CELL SCI, V118, P5563, DOI 10.1242/jcs.02664; Mutoh T, 2005, GENES CELLS, V10, P1189, DOI 10.1111/j.1365-2443.2005.00908.x; Nakamura T, 2001, MOL BIOL CELL, V12, P3955, DOI 10.1091/mbc.12.12.3955; Nakano K, 2002, J CELL SCI, V115, P4629, DOI 10.1242/jcs.00150; Nakano K, 2011, TRAFFIC, V12, P726, DOI 10.1111/j.1600-0854.2011.01190.x; Perez P, 2010, BIOCHEM J, V426, P243, DOI 10.1042/BJ20091823; Pollard TD, 2010, CURR OPIN CELL BIOL, V22, P50, DOI 10.1016/j.ceb.2009.11.010; Pollard TD, 2010, NAT REV MOL CELL BIO, V11, P149, DOI 10.1038/nrm2834; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rincon SA, 2009, MOL BIOL CELL, V20, P4390, DOI 10.1091/mbc.E09-03-0207; Roncero C, 2010, YEAST, V27, P521, DOI 10.1002/yea.1779; Rossman KL, 2005, TRENDS BIOCHEM SCI, V30, P163, DOI 10.1016/j.tibs.2005.02.002; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sipiczki M, 2007, FEMS YEAST RES, V7, P761, DOI 10.1111/j.1567-1364.2007.00266.x; Spiliotis ET, 2012, TRAFFIC, V13, P195, DOI 10.1111/j.1600-0854.2011.01268.x; Suetsugu S, 2010, SEMIN CELL DEV BIOL, V21, P340, DOI 10.1016/j.semcdb.2009.12.002; Tajadura V, 2004, J CELL SCI, V117, P6163, DOI 10.1242/jcs.01530; Tasto JJ, 2003, J CELL BIOL, V160, P1093, DOI 10.1083/jcb.200211126; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Wang HY, 2003, GENETICS, V164, P1323; Wang HY, 2002, MOL BIOL CELL, V13, P515, DOI 10.1091/mbc.01-11-0542; Wolfe BA, 2009, GENE DEV, V23, P896, DOI 10.1101/gad.1801209; Wu JQ, 2010, GENETICS, V186, P897, DOI 10.1534/genetics.110.119842; Ye YF, 2012, MOL BIOL CELL, V23, P1181, DOI 10.1091/mbc.E11-09-0800; Yoshida S, 2006, SCIENCE, V313, P108, DOI 10.1126/science.1126747; Yoshida S, 2009, GENE DEV, V23, P810, DOI 10.1101/gad.1785209; Yu YF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01866; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3	69	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21995	22007		10.1074/jbc.M114.548792	http://dx.doi.org/10.1074/jbc.M114.548792			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24947517	Green Published, hybrid			2022-12-25	WOS:000340593500016
J	Wiener, M; Thompson, JC; Coslett, HB				Wiener, Martin; Thompson, James C.; Coslett, H. Branch			Continuous Carryover of Temporal Context Dissociates Response Bias from Perceptual Influence for Duration	PLOS ONE			English	Article							PSYCHOMETRIC FUNCTION; INTRINSIC MODELS; TIME PERCEPTION; INTERVAL; BISECTION; IDENTIFICATION; DISTORTIONS; INFORMATION; INTEGRATION; JUDGMENT	Recent experimental evidence suggests that the perception of temporal intervals is influenced by the temporal context in which they are presented. A longstanding example is the time-order-error, wherein the perception of two intervals relative to one another is influenced by the order in which they are presented. Here, we test whether the perception of temporal intervals in an absolute judgment task is influenced by the preceding temporal context. Human subjects participated in a temporal bisection task with no anchor durations (partition method). Intervals were demarcated by a Gaussian blob (visual condition) or burst of white noise (auditory condition) that persisted for one of seven logarithmically spaced sub-second intervals. Crucially, the order in which stimuli were presented was first-order counterbalanced, allowing us to measure the carryover effect of every successive combination of intervals. The results demonstrated a number of distinct findings. First, the perception of each interval was biased by the prior response, such that each interval was judged similarly to the preceding trial. Second, the perception of each interval was also influenced by the prior interval, such that perceived duration shifted away from the preceding interval. Additionally, the effect of decision bias was larger for visual intervals, whereas auditory intervals engendered greater perceptual carryover. We quantified these effects by designing a biologically-inspired computational model that measures noisy representations of time against an adaptive memory prior while simultaneously accounting for uncertainty, consistent with a Bayesian heuristic. We found that our model could account for all of the effects observed in human data. Additionally, our model could only accommodate both carryover effects when uncertainty and memory were calculated separately, suggesting separate neural representations for each. These findings demonstrate that time is susceptible to similar carryover effects as other basic stimulus attributes, and that the brain rapidly adapts to temporal context.	[Wiener, Martin; Coslett, H. Branch] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Wiener, Martin; Thompson, James C.] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA	University of Pennsylvania; George Mason University	Wiener, M (corresponding author), Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA.	mwiener@gmu.edu			George Mason University Libraries Open Access publishing Fund	George Mason University Libraries Open Access publishing Fund	Publication of this article was funded in part by the George Mason University Libraries Open Access publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerbi L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002771; Aguirre GK, 2011, NEUROIMAGE, V56, P1293, DOI 10.1016/j.neuroimage.2011.02.005; Agus TR, 2010, NEURON, V66, P610, DOI 10.1016/j.neuron.2010.04.014; Allman MJ, 2012, BRAIN, V135, P656, DOI 10.1093/brain/awr210; Bao M, 2012, P NATL ACAD SCI USA, V109, P5898, DOI 10.1073/pnas.1113503109; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Brown GDA, 2005, J EXP PSYCHOL HUMAN, V31, P919, DOI 10.1037/0096-1523.31.5.919; Burr D, 2007, NAT NEUROSCI, V10, P423, DOI 10.1038/nn1874; Cicchini GM, 2012, J NEUROSCI, V32, P1056, DOI 10.1523/JNEUROSCI.3411-11.2012; Cravo AM, 2013, J NEUROSCI, V33, P4002, DOI 10.1523/JNEUROSCI.4675-12.2013; Droit-Volet S, 2013, NEUROPSYCHOLOGIA, V51, P220, DOI 10.1016/j.neuropsychologia.2012.09.023; Dyjas O, 2012, ATTEN PERCEPT PSYCHO, V74, P1819, DOI 10.3758/s13414-012-0362-4; Ferris SJ, 2001, PERCEPTION, V30, P1363, DOI 10.1068/p2917; Fruend I, 2011, J VISION, V11, DOI 10.1167/11.6.16; GESCHEIDER GA, 1988, ANNU REV PSYCHOL, V39, P169, DOI 10.1146/annurev.psych.39.1.169; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; Gilden DL, 2001, PSYCHOL REV, V108, P33, DOI 10.1037/0033-295X.108.1.33; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; He JF, 1997, J NEUROSCI, V17, P2615; HELLSTROM A, 1985, PSYCHOL BULL, V97, P35, DOI 10.1037/0033-2909.97.1.35; Heron J, 2012, P ROY SOC B-BIOL SCI, V279, P690, DOI 10.1098/rspb.2011.1131; Hollingworth H. L., 1910, J PHILOS PSYCHOL SCI, V7, P461, DOI [10.2307/2012819, DOI 10.2307/2012819]; IVRY RB, 1995, J EXP PSYCHOL HUMAN, V21, P3, DOI 10.1037/0096-1523.21.1.3; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Jazayeri M, 2010, NAT NEUROSCI, V13, P1020, DOI 10.1038/nn.2590; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Jones M, 2006, J EXP PSYCHOL LEARN, V32, P316, DOI 10.1037/0278-7393.32.3.316; Jones MR, 2005, PERCEPT PSYCHOPHYS, V67, P398, DOI 10.3758/BF03193320; Kahn DA, 2010, J VISION, V10, DOI 10.1167/10.10.12; Kelly A, 2001, Q J EXP PSYCHOL-A, V54, P805, DOI 10.1080/02724980042000327; Klampfl S, 2012, J NEUROPHYSIOL, V108, P1366, DOI 10.1152/jn.00935.2011; Kopec CD, 2010, BRAIN COGNITION, V74, P262, DOI 10.1016/j.bandc.2010.08.006; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Kwon OS, 2013, P NATL ACAD SCI USA, V110, pE1064, DOI 10.1073/pnas.1214869110; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Li Y, 2013, P NATL ACAD SCI USA, V110, P17154, DOI 10.1073/pnas.1310666110; Los S.A., 2010, ATTENTION TIME, P289, DOI [10.1093/acprof:oso/9780199563456.003.0021, DOI 10.1093/ACPROF:OSO/9780199563456.001.0001]; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; Matthews WJ, 2013, COGNITIVE PSYCHOL, V66, P259, DOI 10.1016/j.cogpsych.2013.01.001; Matthews WJ, 2009, Q J EXP PSYCHOL, V62, P2014, DOI 10.1080/17470210802649285; Matthews WJ, 2009, JUDGM DECIS MAK, V4, P64; Merchant H, 2013, ANNU REV NEUROSCI, V36, P313, DOI 10.1146/annurev-neuro-062012-170349; MORI S, 1995, PERCEPT PSYCHOPHYS, V57, P1065, DOI 10.3758/BF03205465; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Pariyadath V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049362; Peirce JW, 2009, FRONT NEUROINFORM, V2, DOI 10.3389/neuro.11.010.2008; Pestilli F, 2011, NEURON, V72, P832, DOI 10.1016/j.neuron.2011.09.025; Petzschner FH, 2011, J NEUROSCI, V31, P17220, DOI 10.1523/JNEUROSCI.2028-11.2011; Raviv O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002731; Rohenkohl G, 2012, J NEUROSCI, V32, P8424, DOI 10.1523/JNEUROSCI.0804-12.2012; Shi ZH, 2013, TRENDS COGN SCI, V17, P556, DOI 10.1016/j.tics.2013.09.009; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Simen P, 2011, J NEUROSCI, V31, P9238, DOI 10.1523/JNEUROSCI.3121-10.2011; Spencer RMC, 2009, PHILOS T R SOC B, V364, P1853, DOI 10.1098/rstb.2009.0024; Stewart N, 2005, PSYCHOL REV, V112, P881, DOI 10.1037/0033-295X.112.4.881; Summerfield C, 2011, NEURON, V71, P725, DOI 10.1016/j.neuron.2011.06.022; Taatgen N, 2011, MEM COGNITION, V39, P1546, DOI 10.3758/s13421-011-0113-0; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P579, DOI 10.3758/BF03196615; WEARDEN JH, 1995, Q J EXP PSYCHOL-B, V48, P289; WEARDEN JH, 1991, Q J EXP PSYCHOL-B, V43, P59; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wiener M, 2012, J NEUROSCI, V32, P12258, DOI 10.1523/JNEUROSCI.2511-12.2012; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064; Wilson RC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003150	66	31	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100803	10.1371/journal.pone.0100803	http://dx.doi.org/10.1371/journal.pone.0100803			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8WO	24963624	gold, Green Published, Green Submitted			2022-12-25	WOS:000338709500081
J	Fujimaki, T; Saiki, S; Tashiro, E; Yamada, D; Kitagawa, M; Hattori, N; Imoto, M				Fujimaki, Takahiro; Saiki, Shinji; Tashiro, Etsu; Yamada, Daisuke; Kitagawa, Mitsuhiro; Hattori, Nobutaka; Imoto, Masaya			Identification of Licopyranocoumarin and Glycyrurol from Herbal Medicines as Neuroprotective Compounds for Parkinson's Disease	PLOS ONE			English	Article							COMPLEX-I DEFICIENCY; SUBSTANTIA-NIGRA; DOPAMINERGIC-NEURONS; MITOCHONDRIAL DYSFUNCTION; ANTIOXIDANT ACTIVITY; OXIDATIVE STRESS; PARS COMPACTA; SH-SY5Y CELLS; MOUSE MODEL; MPTP MODEL	In the course of screening for the anti-Parkinsonian drugs from a library of traditional herbal medicines, we found that the extracts of choi-joki-to and daio-kanzo-to protected cells from MPP+-induced cell death. Because choi-joki-to and daio-kanzo-to commonly contain the genus Glycyrrhiza, we isolated licopyranocoumarin (LPC) and glycyrurol (GCR) as potent neuroprotective principals from Glycyrrhiza. LPC and GCR markedly blocked MPP+-induced neuronal PC12D cell death and disappearance of mitochondrial membrane potential, which were mediated by JNK. LPC and GCR inhibited MPP+-induced JNK activation through the suppression of reactive oxygen species (ROS) generation, thereby inhibiting MPP+-induced neuronal PC12D cell death. These results indicated that LPC and GCR derived from choi-joki-to and daio-kanzo-to would be promising drug leads for PD treatment in the future.	[Fujimaki, Takahiro; Tashiro, Etsu; Kitagawa, Mitsuhiro; Imoto, Masaya] Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan; [Saiki, Shinji; Yamada, Daisuke; Hattori, Nobutaka] Juntendo Univ, Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 113, Japan	Keio University; Juntendo University	Hattori, N (corresponding author), Juntendo Univ, Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 113, Japan.	nhattori@juntendo.ac.jp; imoto@bio.keio.ac.jp	Saiki, Shinji/ABC-8214-2021; Hattori, Nobutaka/ACR-0069-2022	Saiki, Shinji/0000-0002-9732-8488; Tashiro, Etsu/0000-0003-4533-623X	Health Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan; Grants-in-Aid for Scientific Research [23102006, 26350974] Funding Source: KAKEN	Health Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Health Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan. The extract powder of 128 traditional herbal (kampo) medicines (The Kampo, TJ-1 similar to 3, TJ-5 similar to 12, TJ-14 similar to 41, TJ-43, TJ-45 similar to 48, TJ-50 similar to 93, TJ-95 similar to 128, TJ-133 similar to 138) and powder of Glycyrrhiza were kindly donated from Tsumura Corporation (Tokyo, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam ZI, 1997, J NEUROCHEM, V69, P1196, DOI 10.1046/j.1471-4159.1997.69031196.x; Asl MN, 2008, PHYTOTHER RES, V22, P709, DOI 10.1002/ptr.2362; Bae N, 2011, J ETHNOPHARMACOL, V134, P313, DOI 10.1016/j.jep.2010.12.016; Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BINDOFF LA, 1989, LANCET, V2, P49, DOI 10.1016/S0140-6736(89)90291-2; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Cao BY, 2010, J ETHNOPHARMACOL, V131, P122, DOI 10.1016/j.jep.2010.06.009; Chung V, 2006, MOVEMENT DISORD, V21, P1709, DOI 10.1002/mds.21008; COHEN G, 1984, EUR J PHARMACOL, V106, P209, DOI 10.1016/0014-2999(84)90700-3; DAVIS GC, 1979, PSYCHIAT RES, V1, P249, DOI 10.1016/0165-1781(79)90006-4; Dawson TM, 2002, NAT NEUROSCI, V5, P1058, DOI 10.1038/nn941; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; Doo AR, 2010, J ETHNOPHARMACOL, V131, P433, DOI 10.1016/j.jep.2010.07.008; Eberhardt O, 2003, TOXICOL LETT, V139, P135, DOI 10.1016/S0378-4274(02)00428-9; Esteves ARF, 2008, MITOCHONDRION, V8, P219, DOI 10.1016/j.mito.2008.03.004; Fernandez-Puntero B, 2001, BIOL PHARM BULL, V24, P777, DOI 10.1248/bpb.24.777; Floor E, 1998, J NEUROCHEM, V70, P268; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; Hasegawa A, 2002, JPN J PHARMACOL, V89, P164, DOI 10.1254/jjp.89.164; Hashimoto R., 2012, EVID-BASED COMPL ALT, V2012, DOI DOI 10.1155/2012/693717; HATANO T, 1989, CHEM PHARM BULL, V37, P3005, DOI 10.1248/cpb.37.3005; HEIKKILA RE, 1984, SCIENCE, V224, P1451, DOI 10.1126/science.6610213; HEIKKILA RE, 1984, NATURE, V311, P467, DOI 10.1038/311467a0; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; Iizuka A, 2000, J Atheroscler Thromb, V6, P49; Infanger DW, 2006, ANTIOXID REDOX SIGN, V8, P1583, DOI 10.1089/ars.2006.8.1583; Jin H, 2013, BIOCH BIOPHYSICA ACT; Kasai A, 2008, BIOL PHARM BULL, V31, P838, DOI 10.1248/bpb.31.838; KATOHSEMBA R, 1987, J NEUROSCI RES, V17, P36, DOI 10.1002/jnr.490170106; Kawatani M, 2003, EXP CELL RES, V286, P57, DOI 10.1016/S0014-4827(03)00098-3; Kim SY, 2007, NEUROSCI LETT, V413, P132, DOI 10.1016/j.neulet.2006.11.074; Klintworth H, 2007, TOXICOL SCI, V97, P149, DOI 10.1093/toxsci/kfm029; Kobayashi K, 2002, BIOL PHARM BULL, V25, P1108, DOI 10.1248/bpb.25.1108; Kong XC, 2011, BRAIN RES, V1383, P99, DOI 10.1016/j.brainres.2011.01.093; Kumazawa S, 2002, J AGR FOOD CHEM, V50, P373, DOI 10.1021/jf010938r; Li XF, 2011, BRAIN RES, V1382, P9, DOI 10.1016/j.brainres.2011.01.015; Lin X, 2009, FEBS J, V276, P2022, DOI 10.1111/j.1742-4658.2009.06938.x; Manyam B V, 1999, Adv Neurol, V80, P565; Martinez TN, 2012, ANTIOXID REDOX SIGN, V16, P920, DOI 10.1089/ars.2011.4033; Mielke K, 2000, PROG NEUROBIOL, V61, P45, DOI 10.1016/S0301-0082(99)00042-8; Newhouse K, 2004, TOXICOL SCI, V79, P137, DOI 10.1093/toxsci/kfh089; Ng TB, 2000, LIFE SCI, V66, P709, DOI 10.1016/S0024-3205(99)00642-6; Nishimura K, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nen082; Oi H, 2002, P NATL ACAD SCI USA, V99, P3042, DOI 10.1073/pnas.052709499; Park SW, 2011, NEUROSCI RES, V69, P283, DOI 10.1016/j.neures.2011.01.004; Park SW, 2004, NEUROSCI LETT, V363, P243, DOI 10.1016/j.neulet.2004.03.072; Parker WD, 2008, BRAIN RES, V1189, P215, DOI 10.1016/j.brainres.2007.10.061; Parker WD, 1998, AM J HUM GENET, V62, P758, DOI 10.1086/301812; Saporito MS, 1999, J PHARMACOL EXP THER, V288, P421; Sawada M, 2006, J NEURAL TRANSM-SUPP, P373; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Seaton TA, 1997, BRAIN RES, V777, P110; Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020; Song JX, 2012, J ETHNOPHARMACOL, V139, P698, DOI 10.1016/j.jep.2011.12.030; Swerdlow RH, 1999, BIOCHEM BIOPH RES CO, V261, P701, DOI 10.1006/bbrc.1999.1095; Tao WW, 2012, FITOTERAPIA, V83, P422, DOI 10.1016/j.fitote.2011.12.010; Tatton WG, 2003, ANN NEUROL, V53, pS61, DOI 10.1002/ana.10489; Testa CM, 2005, MOL BRAIN RES, V134, P109, DOI 10.1016/j.molbrainres.2004.11.007; Trimmer PA, 2004, J NEUROCHEM, V88, P800, DOI 10.1046/j.1471-4159.2003.02168.x; Tsukamoto S, 2005, BIOL PHARM BULL, V28, P2000, DOI 10.1248/bpb.28.2000; Vladimirov Iu A, 1991, Biull Eksp Biol Med, V112, P472; Voss T, 2008, CURR NEUROL NEUROSCI, V8, P304, DOI 10.1007/s11910-008-0047-5; Xia XG, 2001, P NATL ACAD SCI USA, V98, P10433, DOI 10.1073/pnas.181182298; Yang LC, 2009, J NEUROCHEM, V109, P1427, DOI 10.1111/j.1471-4159.2009.06074.x; Yao S, 2006, J CHROMATOGR A, V1115, P64, DOI 10.1016/j.chroma.2006.02.071; Yurekli VA, 2013, CELL MOL NEUROBIOL, V33, P205, DOI 10.1007/s10571-012-9886-3; Zhou JJ, 2013, BRAIN RES, V1508, P53, DOI 10.1016/j.brainres.2013.02.049	68	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100395	10.1371/journal.pone.0100395	http://dx.doi.org/10.1371/journal.pone.0100395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960051	Green Submitted, gold, Green Published			2022-12-25	WOS:000338633900044
J	Pinzon, NE; Stroo, E; 't Hart, BA; Bol, JGJM; Drukarch, B; Bauer, J; van Dam, AM				Pinzon, Nathaly Espitia; Stroo, Esther; 't Hart, Bert A.; Bol, John G. J. M.; Drukarch, Benjamin; Bauer, Jan; van Dam, Anne-Marie			Tissue Transglutaminase in Marmoset Experimental Multiple Sclerosis: Discrepancy between White and Grey Matter	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CELL-ADHESION; CROSS-LINKING; DIFFERENTIAL EXPRESSION; CORTICAL-LESIONS; MATRIX PROTEINS; FIBRONECTIN; INTEGRIN; PATHOLOGY; DISEASE	Infiltration of leukocytes is a major pathological event in white matter lesion formation in the brain of multiple sclerosis (MS) patients. In grey matter lesions, less infiltration of these cells occur, but microglial activation is present. Thus far, the interaction of beta-integrins with extracellular matrix proteins, e.g. fibronectin, is considered to be of importance for the influx of immune cells. Recent in vitro studies indicate a possible role for the enzyme tissue Transglutaminase (TG2) in mediating cell adhesion and migration. In the present study we questioned whether TG2 is present in white and grey matter lesions observed in the marmoset model for MS. To this end, immunohistochemical studies were performed. We observed that TG2, expressed by infiltrating monocytes in white matter lesions co-expressed beta(1)-integrin and is located in close apposition to deposited fibronectin. These data suggest an important role for TG2 in the adhesion and migration of infiltrating monocytes during white matter lesion formation. Moreover, in grey matter lesions, TG2 is mainly present in microglial cells together with some beta(1)-integrin, whereas fibronectin is absent in these lesions. These data imply an alternative role for microglial-derived TG2 in grey matter lesions, e.g. cell proliferation. Further research should clarify the functional role of TG2 in monocytes or microglial cells in MS lesion formation.	[Pinzon, Nathaly Espitia; Stroo, Esther; Bol, John G. J. M.; Drukarch, Benjamin; van Dam, Anne-Marie] Vrije Univ Amsterdam Med Ctr, Neurosci Campus Amsterdam, Dept Anat & Neurosci, Amsterdam, Netherlands; ['t Hart, Bert A.] Biomed Primate Res Ctr, Dept Immunobiol, Rijswijk, Netherlands; ['t Hart, Bert A.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; [Bauer, Jan] Ctr Brain Res, Dept Neuroimmunol, Vienna, Austria	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Groningen	van Dam, AM (corresponding author), Vrije Univ Amsterdam Med Ctr, Neurosci Campus Amsterdam, Dept Anat & Neurosci, Amsterdam, Netherlands.	amw.vandam@vumc.nl	; Bauer, Jan/F-5429-2011	Drukarch, Benjamin/0000-0002-2417-8888; Bauer, Jan/0000-0001-5802-8047	Dutch Stichting MS Research [09-693MS]	Dutch Stichting MS Research	The present study was supported by the Dutch Stichting MS Research (project 09-693MS, received by: NEP & AMD). http://msresearch.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Akimov SS, 2001, J CELL SCI, V114, P2989; Akimov SS, 2001, BLOOD, V98, P1567, DOI 10.1182/blood.V98.5.1567; Bauer M, 2009, P NATL ACAD SCI USA, V106, P1920, DOI 10.1073/pnas.0808909106; Belkin AM, 2011, FEBS J, V278, P4704, DOI 10.1111/j.1742-4658.2011.08346.x; Bo L, 2003, MULT SCLER, V9, P323, DOI 10.1191/1352458503ms917oa; Bo L, 2009, ACTA NEUROL SCAND, V120, P51, DOI 10.1111/j.1600-0404.2009.01216.x; Bo L, 1996, J NEUROPATH EXP NEUR, V55, P1060, DOI 10.1097/00005072-199655100-00006; BO L, 1994, J NEUROIMMUNOL, V51, P135, DOI 10.1016/0165-5728(94)90075-2; Brosnan CF, 2013, GLIA, V61, P453, DOI 10.1002/glia.22443; BRUCK W, 1995, ANN NEUROL, V38, P788, DOI 10.1002/ana.410380514; Caccamo D, 2010, AMINO ACIDS, V38, P653, DOI 10.1007/s00726-009-0428-3; Calabrese M, 2010, NEUROLOGY, V75, P1234, DOI 10.1212/WNL.0b013e3181f5d4da; Colak G, 2012, NEUROBIOL DIS, V45, P1042, DOI 10.1016/j.nbd.2011.12.023; Collighan RJ, 2009, AMINO ACIDS, V36, P659, DOI 10.1007/s00726-008-0190-y; Dal Bianco A, 2008, ANN NEUROL, V63, P174, DOI 10.1002/ana.21240; de Graaf WL, 2013, EUR RADIOL, V23, P528, DOI 10.1007/s00330-012-2619-7; de Jager M, 2013, NEUROBIOL AGING, V34, P1159, DOI 10.1016/j.neurobiolaging.2012.10.005; DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; Engel C, 2007, J NEUROL, V254, P30, DOI 10.1007/s00415-007-2009-2; Falasca L, 2005, J IMMUNOL, V174, P7330, DOI 10.4049/jimmunol.174.11.7330; Falasca L, 2008, J IMMUNOL, V180, P2616, DOI 10.4049/jimmunol.180.4.2616; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Gaudry CA, 1999, EXP CELL RES, V252, P104, DOI 10.1006/excr.1999.4633; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Gray E, 2008, BRAIN PATHOL, V18, P86, DOI 10.1111/j.1750-3639.2007.00110.x; Haanstra KG, 2013, J IMMUNOL, V190, P1961, DOI 10.4049/jimmunol.1202490; Hafler DA, 2004, J CLIN INVEST, V113, P788, DOI 10.1172/JCI200421357; Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0; Hodrea J, 2010, IMMUNOL LETT, V130, P74, DOI 10.1016/j.imlet.2009.12.010; Hwang IK, 2009, BRAIN RES, V1263, P134, DOI 10.1016/j.brainres.2009.01.038; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Johnson GVW, 1997, BRAIN RES, V751, P323, DOI 10.1016/S0006-8993(96)01431-X; Junn E, 2003, P NATL ACAD SCI USA, V100, P2047, DOI 10.1073/pnas.0438021100; Kap YS, 2008, J IMMUNOL, V180, P1326, DOI 10.4049/jimmunol.180.3.1326; Kim SY, 1999, J BIOL CHEM, V274, P30715, DOI 10.1074/jbc.274.43.30715; Kooi EJ, 2012, NEUROLOGY, V79, P1369, DOI 10.1212/WNL.0b013e31826c1b1c; Korn T, 2008, J NEUROL, V255, P2, DOI 10.1007/s00415-008-6001-2; Lassmann H, 2014, GLIA, P1; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Lesort M, 1999, J NEUROCHEM, V73, P2018; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; LORAND L, 1988, P NATL ACAD SCI USA, V85, P1057, DOI 10.1073/pnas.85.4.1057; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Lucchinetti CF, 1996, BRAIN PATHOL, V6, P259, DOI 10.1111/j.1750-3639.1996.tb00854.x; MEHTA K, 1986, CANCER RES, V46, P1388; Mix E, 2010, PROG NEUROBIOL, V92, P386, DOI 10.1016/j.pneurobio.2010.06.005; Nasu-Tada K, 2005, GLIA, V52, P98, DOI 10.1002/glia.20224; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Oh K, 2012, CLIN IMMUNOL, V145, P122, DOI 10.1016/j.clim.2012.08.009; Papadopoulos D, 2009, BRAIN PATHOL, V19, P238, DOI 10.1111/j.1750-3639.2008.00177.x; Park KC, 2004, BIOCHEM BIOPH RES CO, V323, P1055, DOI 10.1016/j.bbrc.2004.08.204; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Petzold A, 2002, BRAIN, V125, P1462, DOI 10.1093/brain/awf165; PIERSCHBACHER M, 1983, P NATL ACAD SCI-BIOL, V80, P1224, DOI 10.1073/pnas.80.5.1224; Politis M, 2012, NEUROLOGY, V79, P523, DOI 10.1212/WNL.0b013e3182635645; Popescu BFG, 2012, ANNU REV PATHOL-MECH, V7, P185, DOI 10.1146/annurev-pathol-011811-132443; Rawji KS, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/948976; Reynolds R, 2011, ACTA NEUROPATHOL, V122, P155, DOI 10.1007/s00401-011-0840-0; Ruan QM, 2007, FRONT BIOSCI-LANDMRK, V12, P891, DOI 10.2741/2111; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Schonrock LM, 1998, NEUROPATH APPL NEURO, V24, P320; SEIVING B, 1991, EUR J HAEMATOL, V46, P263; Seta N, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/820827; SOBEL RA, 1989, AM J PATHOL, V135, P161; Sriram S, 2011, J NEUROIMMUNOL, V239, P13, DOI 10.1016/j.jneuroim.2011.08.012; Stadelmann C, 2008, J NEUROL, V255, P12, DOI 10.1007/s00415-008-1003-7; Stadelmann C, 2011, CURR OPIN NEUROL, V24, P224, DOI 10.1097/WCO.0b013e328346056f; Stys PK, 2012, NAT REV NEUROSCI, V13, P507, DOI 10.1038/nrn3275; Szondy Z, 2003, P NATL ACAD SCI USA, V100, P7812, DOI 10.1073/pnas.0832466100; 't Hart BA, 1998, AM J PATHOL, V153, P649, DOI 10.1016/S0002-9440(10)65606-4; 't Hart BA, 2011, TRENDS MOL MED, V17, P119, DOI 10.1016/j.molmed.2010.11.006; 't Hart BA, 2009, J NEUROPATH EXP NEUR, V68, P341, DOI 10.1097/NEN.0b013e31819f1d24; THOMAZY V, 1989, CELL TISSUE RES, V255, P215; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; van der Valk P, 2000, NEUROPATH APPL NEURO, V26, P2, DOI 10.1046/j.1365-2990.2000.00217.x; van Horssen J, 2005, J NEUROPATH EXP NEUR, V64, P722, DOI 10.1097/01.jnen.0000173894.09553.13; Horssen J, 2007, J NEUROCHEM, V103, P1293, DOI 10.1111/j.1471-4159.2007.04897.x; van Strien ME, 2011, BRAIN PATHOL, V21, P44, DOI 10.1111/j.1750-3639.2010.00428.x; Vercellino M, 2007, J NEUROPATH EXP NEUR, V66, P732, DOI 10.1097/nen.0b013e31812571b0; Vercellino M, 2009, J NEUROPATH EXP NEUR, V68, P489, DOI 10.1097/NEN.0b013e3181a19a5a; Wang Z, 2010, J BIOL CHEM, V285, P40212, DOI 10.1074/jbc.M110.123703; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133; Wilhelmus MMM, 2008, EUR J PHARMACOL, V585, P464, DOI 10.1016/j.ejphar.2008.01.059; Zemskov EA, 2006, FRONT BIOSCI-LANDMRK, V11, P1057, DOI 10.2741/1863	88	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100574	10.1371/journal.pone.0100574	http://dx.doi.org/10.1371/journal.pone.0100574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959868	Green Submitted, Green Published, gold			2022-12-25	WOS:000338633900058
J	Zhang, N; Shu, HY; Huang, TT; Zhang, QL; Li, D; Zhang, GQ; Peng, XY; Liu, CF; Luo, WF; Hu, LF				Zhang, Ning; Shu, Hai-Yang; Huang, Tingting; Zhang, Qi-Lin; Li, Da; Zhang, Guan-Qun; Peng, Xiao-Yan; Liu, Chun-Feng; Luo, Wei-Feng; Hu, Li-Fang			Nrf2 Signaling Contributes to the Neuroprotective Effects of Urate against 6-OHDA Toxicity	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; URIC-ACID; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; PATHWAY; KEAP1; DEGRADATION; PROTECTION; LIGASE; CELLS	Background: Mounting evidence shows that urate may become a biomarker of Parkinson's disease (PD) diagnosis and prognosis and a neuroprotectant candidate for PD therapy. However, the cellular and molecular mechanisms underlying its neuroprotective actions remain poorly understood. Results: In this study, we showed that urate pretreatment protected dopaminergic cell line (SH-SY5Y and MES23.5) against 6-hydroxydopamine (6-OHDA)- and hydrogen peroxide-induced cell damage. Urate was found to be accumulated into SH-SY5Y cells after 30 min treatment. Moreover, urate induced NF-E2-related factor 2 (Nrf2) accumulation by inhibiting its ubiquitinationa and degradation, and also promoted its nuclear translocation; however, it did not modulate Nrf2 mRNA level or Kelch-like ECH-associated protein 1 (Keap1) expression. In addition, urate markedly up-regulated the transcription and protein expression of gamma-glutamate-cysteine ligase catalytic subunit (gamma-GCLC) and heme oxygenase-1 (HO-1), both of which are controlled by Nrf2 activity. Furthermore, Nrf2 knockdown by siRNA abolished the intracellular glutathione augmentation and the protection exerted by urate pretreatment. Conclusion: Our findings demonstrated that urate treatment may result in Nrf2-targeted anti-oxidant genes transcription and expression by reducing Nrf2 ubiquitination and degradation and promoting its nuclear translocation, and thus offer neuroprotection on dopaminergic cells against oxidative stresses.	[Zhang, Ning; Shu, Hai-Yang; Huang, Tingting; Zhang, Qi-Lin; Li, Da; Zhang, Guan-Qun; Peng, Xiao-Yan; Liu, Chun-Feng; Luo, Wei-Feng; Hu, Li-Fang] Soochow Univ, Affiliated Hosp 2, Jiangsu Key Lab Translat Res & Therapy Neuropsych, Dept Neurol, Suzhou, Jiangsu, Peoples R China; [Zhang, Ning; Huang, Tingting; Liu, Chun-Feng; Luo, Wei-Feng; Hu, Li-Fang] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China; [Hu, Li-Fang] Soochow Univ, Dept Pharmacol, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Luo, WF (corresponding author), Soochow Univ, Affiliated Hosp 2, Jiangsu Key Lab Translat Res & Therapy Neuropsych, Dept Neurol, Suzhou, Jiangsu, Peoples R China.	lwfwxx@126.com; hulifang@suda.edu.cn	Hu, Li-Fang/S-3153-2019; Hu, Li-Fang/ABD-9621-2021	Hu, Li-Fang/0000-0001-8326-7779; Hu, Li-Fang/0000-0001-8326-7779; Liu, Chun-Feng/0000-0002-8364-0219	National Natural Science Foundation of China [81171212]; Natural Science Foundation of Jiangsu Province, China [BK2010229, BK2010228]; Suzhou Technology Support Program [SS201112]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Suzhou Technology Support Program	This work was supported by grants from National Natural Science Foundation of China (81171212), Natural Science Foundation of Jiangsu Province, China (BK2010229, BK2010228) and also Suzhou Technology Support Program (SS201112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annanmaki T, 2008, PARKINSONISM RELAT D, V14, P576, DOI 10.1016/j.parkreldis.2007.11.001; Ansari N, 2011, EUR J PHARMACOL, V658, P84, DOI 10.1016/j.ejphar.2011.02.028; Aoyama K, 2011, NEUROSCIENCE, V181, P206, DOI 10.1016/j.neuroscience.2011.02.047; Tobon-Velasco JC, 2012, FREE RADICAL BIO MED, V53, P1024, DOI 10.1016/j.freeradbiomed.2012.06.040; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; CHURCH WH, 1994, BRAIN RES BULL, V33, P419, DOI 10.1016/0361-9230(94)90285-2; Cipriani S, 2012, J NEUROCHEM, V123, P172, DOI 10.1111/j.1471-4159.2012.07820.x; CRAWFORD GD, 1992, J NEUROSCI, V12, P3392; Dimitroula HV, 2008, NEUROLOGIST, V14, P238, DOI 10.1097/NRL.0b013e31815c666b; Du YZ, 2007, GLIA, V55, P463, DOI 10.1002/glia.20472; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Gong L, 2012, J NEUROCHEM, V123, P876, DOI 10.1111/jnc.12038; Guerreiro S, 2009, J NEUROCHEM, V109, P1118, DOI 10.1111/j.1471-4159.2009.06040.x; Gunjima K, 2014, J CELL BIOCHEM, V115, P151, DOI 10.1002/jcb.24643; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Jakel RJ, 2007, BRAIN RES, V1144, P192, DOI 10.1016/j.brainres.2007.01.131; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Li Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035122; Mahajan M, 2009, INDIAN J CLIN BIOCHE, V24, P205, DOI 10.1007/s12291-009-0038-6; PROCTOR P, 1970, NATURE, V228, P868, DOI 10.1038/228868a0; Ramsey CP, 2007, J NEUROPATH EXP NEUR, V66, P75, DOI 10.1097/nen.0b013e31802d6da9; Sautin YY, 2008, NUCLEOS NUCLEOT NUCL, V27, P608, DOI 10.1080/15257770802138558; Schwarzschild MA, 2008, ARCH NEUROL-CHICAGO, V65, P716, DOI 10.1001/archneur.2008.65.6.nct70003; Spector R, 2006, PHARM RES-DORDR, V23, P2515, DOI 10.1007/s11095-006-9091-5; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; Tobon-Velasco JC, 2013, TOXICOLOGY, V304, P109, DOI 10.1016/j.tox.2012.12.011; Yeum KJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P97, DOI 10.1016/j.abb.2004.03.006; Yu JJ, 2012, J BIOCHEM MOL TOXIC, V26, P264, DOI 10.1002/jbt.21417; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; Zhu TG, 2012, NEUROSCI LETT, V506, P175, DOI 10.1016/j.neulet.2011.10.075	32	38	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100286	10.1371/journal.pone.0100286	http://dx.doi.org/10.1371/journal.pone.0100286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959672	Green Submitted, Green Published, gold			2022-12-25	WOS:000338633900037
J	Chiang, N; Hsiao, YT; Yang, HJ; Lin, YC; Lu, JC; Wang, CT				Chiang, Ning; Hsiao, Yu-Tien; Yang, Hui-Ju; Lin, Yu-Chun; Lu, Juu-Chin; Wang, Chih-Tien			Phosphomimetic Mutation of Cysteine String Protein-alpha Increases the Rate of Regulated Exocytosis by Modulating Fusion Pore Dynamics in PC12 Cells	PLOS ONE			English	Article							ADRENAL CHROMAFFIN CELLS; DENSE-CORE VESICLES; KISS-AND-RUN; CSP-ALPHA; CA2+-TRIGGERED EXOCYTOSIS; TRANSMITTER RELEASE; SYNAPTOTAGMIN-I; KINASE-A; SYNAPTIC VESICLES; SNARE-COMPLEX	Background: Cysteine string protein-alpha (CSP alpha) is a chaperone to ensure protein folding. Loss of CSP alpha function associates with many neurological diseases. However, its function in modulating regulated exocytosis remains elusive. Although csp alpha-knockouts exhibit impaired synaptic transmission, overexpression of CSP alpha in neuroendocrine cells inhibits secretion. These seemingly conflicting results lead to a hypothesis that CSP alpha may undergo a modification that switches its function in regulating neurotransmitter and hormone secretion. Previous studies implied that CSP alpha undergoes phosphorylation at Ser(10) that may influence exocytosis by altering fusion pore dynamics. However, direct evidence is missing up to date. Methodology/Principal Findings: Using amperometry, we investigated how phosphorylation at Ser(10) of CSP alpha (CSP alpha-Ser(10)) modulates regulated exocytosis and if this modulation involves regulating a specific kinetic step of fusion pore dynamics. The real-time exocytosis of single vesicles was detected in PC12 cells overexpressing control vector, wild-type CSP alpha (WT), the CSP alpha phosphodeficient mutant (S10A), or the CSP alpha phosphomimetic mutants (S10D and S10E). The shapes of amperometric signals were used to distinguish the full-fusion events (i.e., prespike feet followed by spikes) and the kiss-and-run events (i.e., square-shaped flickers). We found that the secretion rate was significantly increased in cells overexpressing S10D or S10E compared to WT or S10A. Further analysis showed that overexpression of S10D or S10E prolonged fusion pore lifetime compared to WT or S10A. The fraction of kiss-alpha nd-run events was significantly lower but the frequency of full-fusion events was higher in cells overexpressing S10D or S10E compared to WT or S10A. Advanced kinetic analysis suggests that overexpression of S10D or S10E may stabilize open fusion pores mainly by inhibiting them from closing. Conclusions/Significance: CSP alpha may modulate fusion pore dynamics in a phosphorylation-dependent manner. Therefore, through changing its phosphorylated state influenced by diverse cellular signalings, CSP alpha may have a great capacity to modulate the rate of regulated exocytosis.	[Chiang, Ning; Hsiao, Yu-Tien; Yang, Hui-Ju; Wang, Chih-Tien] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan; [Chiang, Ning; Wang, Chih-Tien] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Chiang, Ning; Wang, Chih-Tien] Natl Taiwan Univ, Neurobiol & Cognit Sci Ctr, Taipei 10764, Taiwan; [Wang, Chih-Tien] Natl Taiwan Univ, Genome & Syst Biol Degree Program, Taipei 10764, Taiwan; [Lin, Yu-Chun; Lu, Juu-Chin] Chang Gung Univ, Dept Physiol & Pharmacol, Coll Med, Taoyuan, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; Chang Gung University	Lu, JC (corresponding author), Chang Gung Univ, Dept Physiol & Pharmacol, Coll Med, Taoyuan, Taiwan.	juuchin@mail.cgu.edu.tw; chihtienwang@ntu.edu.tw	Lu, Juu-Chin/ABB-3198-2020; Wang, Chih-Tien/GRE-8232-2022	Lu, Juu-Chin/0000-0001-8523-6992; Wang, Chih-Tien/0000-0001-7639-7508	Chang Gung Medical Research Project [CMRPD1C0591]; National Science Council [NSC-101-2320-B-182-007, NSC-102-2320-B-182-022-MY3, NSC-97-2311-B-002-001-MY2, NSC-100-2321-B-002-001, NSC-100-2311-B-002-010]; National Taiwan University; National Health Research Institutes [NHRI-EX100-9718NC]	Chang Gung Medical Research Project; National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); National Health Research Institutes(National Health Research Institutes, Japan)	Funding was provided by Chang Gung Medical Research Project (CMRPD1C0591) and National Science Council (NSC-101-2320-B-182-007; NSC-102-2320-B-182-022-MY3) to JCL; National Taiwan University, National Science Council (NSC-97-2311-B-002-001-MY2; NSC-100-2321-B-002-001; NSC-100-2311-B-002-010) and National Health Research Institutes (NHRI-EX100-9718NC) to CTW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; Alvarez de Toledo G, 1993, NATURE, V363, P554; Bai JH, 2004, NEURON, V41, P929, DOI 10.1016/S0896-6273(04)00117-5; Boal F, 2011, FASEB J, V25, P132, DOI 10.1096/fj.09-152033; Brown H, 1998, EMBO J, V17, P5048, DOI 10.1093/emboj/17.17.5048; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Chamberlain LH, 1998, MOL BIOL CELL, V9, P2259, DOI 10.1091/mbc.9.8.2259; Chamberlain LH, 1996, J BIOL CHEM, V271, P19514, DOI 10.1074/jbc.271.32.19514; Chamberlain LH, 2000, J NEUROCHEM, V74, P1781, DOI 10.1046/j.1471-4159.2000.0741781.x; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chiang CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047465; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Chow Robert H., 1995, P245; Colliver TL, 2000, J NEUROCHEM, V74, P1086; COLQUHOUN D, 1982, PHILOS T ROY SOC B, V300, P1, DOI 10.1098/rstb.1982.0156; Colquhoun David, 1995, P397; Cormack B, 1994, CURRENT PROTOCOLS MO; Dernick G, 2003, NAT CELL BIOL, V5, P358, DOI 10.1038/ncb956; Dunn TA, 2008, DEV NEUROBIOL, V68, P835, DOI 10.1002/dneu.20619; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; Evans GJO, 2005, EUR J NEUROSCI, V21, P2671, DOI 10.1111/j.1460-9568.2005.04118.x; Evans GJO, 2006, J BIOL CHEM, V281, P1564, DOI 10.1074/jbc.M503628200; Evans GJO, 2002, BIOCHEM J, V364, P343, DOI 10.1042/BJ20020123; Evans GJO, 2001, J BIOL CHEM, V276, P47877, DOI 10.1074/jbc.M108186200; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Fulop T, 2007, J NEUROSCI METH, V166, P195, DOI 10.1016/j.jneumeth.2007.07.004; Graham ME, 2000, J NEUROSCI, V20, P1281; Haller M, 1998, BIOPHYSICAL J, V74; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; Han X, 2006, J CELL BIOL, V172, P281, DOI 10.1083/jcb.200510012; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; JACKSON MB, 1992, METHOD ENZYMOL, V207, P729; Jackson MB, 2008, NAT STRUCT MOL BIOL, V15, P684, DOI 10.1038/nsmb.1449; Kochubey O, 2011, TRENDS NEUROSCI, V34, P237, DOI 10.1016/j.tins.2011.02.006; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Lynch KL, 2008, MOL BIOL CELL, V19, P5093, DOI 10.1091/mbc.E08-03-0235; MASTROGIACOMO A, 1994, SCIENCE, V263, P981, DOI 10.1126/science.7906056; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Prescott GR, 2008, BIOCHEM BIOPH RES CO, V377, P809, DOI 10.1016/j.bbrc.2008.10.069; Schmitz F, 2006, P NATL ACAD SCI USA, V103, P2926, DOI 10.1073/pnas.0510060103; Segovia M, 2010, P NATL ACAD SCI USA, V107, P19032, DOI 10.1073/pnas.1014070107; Sharma M, 2012, EMBO J, V31, P829, DOI 10.1038/emboj.2011.467; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Sorensen JB, 2003, J GEN PHYSIOL, V122, P265, DOI 10.1085/jgp.200308855; UMBACH JA, 1994, NEURON, V13, P899, DOI 10.1016/0896-6273(94)90255-0; Wang CT, 2006, J PHYSIOL-LONDON, V570, P295, DOI 10.1113/jphysiol.2005.097378; Wang CT, 2003, NATURE, V424, P943, DOI 10.1038/nature01857; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Wang P, 2003, J BIOL CHEM, V278, P47030, DOI 10.1074/jbc.M306728200; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; Zhang H, 1998, FEBS LETT, V437, P267, DOI 10.1016/S0014-5793(98)01233-2; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140; Zhang YQ, 2012, NEURON, V74, P136, DOI 10.1016/j.neuron.2012.01.029; Zhang Z, 2008, J GEN PHYSIOL, V131, P117, DOI 10.1085/jgp.200709891; Zhang Z, 2011, MOL BIOL CELL, V22, P2324, DOI 10.1091/mbc.E11-02-0159; Zhang Z, 2010, MOL BIOL CELL, V21, P2821, DOI 10.1091/mbc.E10-04-0285; Zhang Z, 2009, MOL BIOL CELL, V20, P5086, DOI 10.1091/mbc.E09-08-0691; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7; Zhu D, 2007, BIOCHEM BIOPH RES CO, V361, P922, DOI 10.1016/j.bbrc.2007.07.083; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	64	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99180	10.1371/journal.pone.0099180	http://dx.doi.org/10.1371/journal.pone.0099180			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956274	Green Published, Green Submitted, gold			2022-12-25	WOS:000338917900007
J	Forberg, H; Hauge, AG; Valheim, M; Garcon, F; Nunez, A; Gerner, W; Mair, KH; Graham, SP; Brookes, SM; Storset, AK				Forberg, Hilde; Hauge, Anna G.; Valheim, Mette; Garcon, Fanny; Nunez, Alejandro; Gerner, Wilhelm; Mair, Kerstin H.; Graham, Simon P.; Brookes, Sharon M.; Storset, Anne K.			Early Responses of Natural Killer Cells in Pigs Experimentally Infected with 2009 Pandemic H1N1 Influenza A Virus	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NK CELLS; CYTOKINE RESPONSES; IMMUNE-RESPONSES; PORCINE NK; SWINE; ACTIVATION; NKP46; TRANSMISSION; PATHOGENESIS	Natural killer (NK) cells are important players in the innate immune response against influenza A virus and the activating receptor NKp46, which binds hemagglutinin on the surface of infected cells, has been assigned a role in this context. As pigs are natural hosts for influenza A viruses and pigs possess both NKp46 2 and NKp46(+) NK cells, they represent a good animal model for studying the role of the NKp46 receptor during influenza. We explored the role of NK cells in piglets experimentally infected with 2009 pandemic H1N1 influenza virus by flow cytometric analyses of cells isolated from blood and lung tissue and by immunostaining of lung tissue sections. The number of NKp46(+) NK cells was reduced while NKp46 2 NK cells remained unaltered in the blood 1-3 days after infection. In the lungs, the intensity of NKp46 expression on NK cells was increased during the first 3 days, and areas where influenza virus nucleoprotein was detected were associated with increased numbers of NKp46(+) NK cells when compared to uninfected areas. NKp46(+) NK cells in the lung were neither found to be infected with influenza virus nor to be undergoing apoptosis. The binding of porcine NKp46 to influenza virus infected cells was verified in an in vitro assay. These data support the involvement of porcine NKp46(+) NK cells in the local immune response against influenza virus.	[Forberg, Hilde; Hauge, Anna G.; Valheim, Mette] Norwegian Vet Inst, Dept Lab Serv, Oslo, Norway; [Garcon, Fanny; Graham, Simon P.; Brookes, Sharon M.] Anim Hlth & Vet Labs Agcy, Dept Virol, Addlestone, Surrey, England; [Nunez, Alejandro] Anim Hlth & Vet Labs Agcy, Dept Pathol, Addlestone, Surrey, England; [Gerner, Wilhelm; Mair, Kerstin H.] Univ Vet Med Vienna, Dept Pathobiol, Vienna, Austria; [Storset, Anne K.] Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, Oslo, Norway	Norwegian Veterinary Institute; Veterinary Laboratories Agency; Veterinary Laboratories Agency; University of Veterinary Medicine Vienna; Norwegian University of Life Sciences	Forberg, H (corresponding author), Norwegian Vet Inst, Dept Lab Serv, Oslo, Norway.	hilde.forberg@vetinst.no	Gerner, Wilhelm/GOH-2654-2022; Castel, Alejandro Núñez/C-2560-2011; Brookes, Sharon M/C-8016-2011; Brookes, Sharon M/W-2128-2019; Mair, Kerstin/GVS-3351-2022; Graham, Simon P/C-8337-2011	Brookes, Sharon M/0000-0001-9207-6659; Brookes, Sharon M/0000-0001-9207-6659; Graham, Simon P/0000-0003-4852-405X; Nunez, Alejandro/0000-0001-5926-7541; Gerner, Wilhelm/0000-0002-2431-5889	European Commission [GA-258084]; Norwegian Research Council [207836]	European Commission(European CommissionEuropean Commission Joint Research Centre); Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the European Commission FP7 Flupig project GA-258084 and the Norwegian Research Council 207836. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achdout H, 2010, J VIROL, V84, P3993, DOI 10.1128/JVI.02289-09; Arnon TI, 2004, BLOOD, V103, P664, DOI 10.1182/blood-2003-05-1716; Barbe F, 2011, VET J, V187, P48, DOI 10.1016/j.tvjl.2009.12.012; Bean AGD, 2013, NAT REV IMMUNOL, V13, P851, DOI 10.1038/nri3551; Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530; Brookes SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009068; Crisci E, 2013, MOL IMMUNOL, V55, P200, DOI 10.1016/j.molimm.2013.02.008; Denney L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010675; Draghi M, 2007, J IMMUNOL, V178, P2688, DOI 10.4049/jimmunol.178.5.2688; Du N, 2010, J VIROL, V84, P7822, DOI 10.1128/JVI.00069-10; Ferlazzo G, 2004, J IMMUNOL, V172, P1455, DOI 10.4049/jimmunol.172.3.1455; Fox A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031535; French AR, 2003, CURR OPIN IMMUNOL, V15, P45, DOI 10.1016/S095279150200002X; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Gerner W, 2009, DEV COMP IMMUNOL, V33, P310, DOI 10.1016/j.dci.2008.06.003; Gregoire C, 2007, IMMUNOL REV, V220, P169, DOI 10.1111/j.1600-065X.2007.00563.x; HALBUR PG, 1995, VET PATHOL, V32, P648, DOI 10.1177/030098589503200606; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Heinen PP, 2001, J GEN VIROL, V82, P2697, DOI 10.1099/0022-1317-82-11-2697; Hofshagen M, 2009, EUROSURVEILLANCE, V14, P15; Jost S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025060; Jost S, 2011, IMMUNOLOGY, V132, P516, DOI 10.1111/j.1365-2567.2010.03394.x; Kaiser L, 2001, J MED VIROL, V64, P262, DOI 10.1002/jmv.1045; Khatri M, 2010, J VIROL, V84, P11210, DOI 10.1128/JVI.01211-10; Kilander A, 2010, EUROSURVEILLANCE, V15, P1, DOI DOI 10.1128/JVI.01136-10; Kim B, 2009, J VET MED SCI, V71, P611, DOI 10.1292/jvms.71.611; Kuiken T, 2008, VACCINE, V26, pD59, DOI 10.1016/j.vaccine.2008.07.025; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Mair KH, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-13; Mair KH, 2012, EUR J IMMUNOL, V42, P1261, DOI 10.1002/eji.201141989; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Mao HW, 2009, J VIROL, V83, P9215, DOI 10.1128/JVI.00805-09; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Nelson MI, 2012, J GEN VIROL, V93, P2195, DOI 10.1099/vir.0.044974-0; OIE (World Organisation for Animal Health), 2010, SWIN INFL MAN DIAGN; Owen RE, 2007, J VIROL, V81, P11170, DOI 10.1128/JVI.01217-07; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Punpanich W, 2012, INT J INFECT DIS, V16, pE714, DOI 10.1016/j.ijid.2012.05.1025; Seo SH, 2002, J VIROL, V76, P1071, DOI 10.1128/JVI.76.3.1071-1076.2002; Slomka MJ, 2010, INFLUENZA OTHER RESP, V4, P277, DOI 10.1111/j.1750-2659.2010.00149.x; Talker SC, 2013, DEV COMP IMMUNOL, V40, P51, DOI 10.1016/j.dci.2013.01.003; Valheim M, 2002, RES VET SCI, V73, P77, DOI 10.1016/S0034-5288(02)00071-1; van Helden MJG, 2012, J IMMUNOL, V189, P2333, DOI 10.4049/jimmunol.1200008; Van Reeth K, 1999, RES VET SCI, V67, P47, DOI 10.1053/rvsc.1998.0277; Weiss ID, 2010, J INTERF CYTOK RES, V30, P439, DOI 10.1089/jir.2009.0084; Welliver TP, 2007, J INFECT DIS, V195, P1126, DOI 10.1086/512615; WHO, 2009, CDC PROT REALT RT PC; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279	48	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100619	10.1371/journal.pone.0100619	http://dx.doi.org/10.1371/journal.pone.0100619			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955764	gold, Green Published, Green Submitted			2022-12-25	WOS:000338917900074
J	Martin-Ramirez, J; Kok, MGM; Hofman, M; Bierings, R; Creemers, EE; Meijers, JCM; Voorberg, J; Pinto-Sietsma, SJ				Martin-Ramirez, Javier; Kok, Maayke G. M.; Hofman, Menno; Bierings, Ruben; Creemers, Esther E.; Meijers, Joost C. M.; Voorberg, Jan; Pinto-Sietsma, Sara-Joan			Individual with Subclinical Atherosclerosis Have Impaired Proliferation of Blood Outgrowth Endothelial Cells, Which Can Be Restored by Statin Therapy	PLOS ONE			English	Article							PROGENITOR CELLS; CORONARY-ARTERY; IDENTITY; INCREASE; NUMBER; MEN	Background: To study the regenerative capacity of the endothelium in patients with coronary artery disease (CAD), we cultured blood outgrowth endothelial cells (BOECs) of patients with premature CAD and their first degree relatives (FDR). Additionally we evaluated the influence of statin treatment on circulating BOEC precursors in subjects with subclinical atherosclerosis. Methods and Results: Patients with premature CAD (men <51 yr, women <56 yr) and their FDRs were included. Based on coronary calcification (CAC) scores FDRs were divided in a group of healthy subjects (CAC = 0) and subjects with subclinical atherosclerosis (CAC>0). We did not observe differences in the number of BOEC colonies and proliferation between premature CAD patients and FDRs. FDRs with subclinical atherosclerosis had lower colony numbers compared with healthy FDRs, however this was not statistically significant, and BOEC proliferation was significantly impaired (OR = 0.45, 95% CI 0.21-0.96). Unexpectedly, the number of BOEC colonies and BOEC proliferation were similar for premature CAD patients and healthy FDRs. Since a considerable number of premature CAD patients used statins, we studied the number of BOEC precursors as well as their proliferative capacity in ten individuals with subclinical atherosclerosis, before and after statin therapy. Interestingly, FDRs with subclinical atherosclerosis showed a significant increase in the number of BOEC colonies after statin therapy. Conclusion: BOEC proliferation of subjects with subclinical atherosclerosis is impaired compared with healthy controls. In these subjects, statin therapy significantly increased the number of circulating BOEC precursors as well as their proliferative capacity, revealing a beneficial effect of statins on endothelial regeneration.	[Martin-Ramirez, Javier; Hofman, Menno; Bierings, Ruben; Voorberg, Jan] Sanquin AMC Landsteiner Lab, Dept Plasma Prot, Amsterdam, Netherlands; [Kok, Maayke G. M.; Meijers, Joost C. M.; Pinto-Sietsma, Sara-Joan] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Creemers, Esther E.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Kok, Maayke G. M.; Meijers, Joost C. M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Pinto-Sietsma, Sara-Joan] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Pinto-Sietsma, SJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	S.J.Pinto@amc.uva.nl	Meijers, J.C.M./S-5981-2019; SJ, Pinto-Sietsma/AAI-3207-2021; Bierings, Ruben/AAQ-8854-2020	Meijers, J.C.M./0000-0002-4198-6780; Bierings, Ruben/0000-0002-1205-9689; Voorberg, Jan/0000-0003-4585-2621; Creemers, Esther/0000-0002-9001-3854	CTMM, the Center for Translational Molecular Medicine, project INCOAG [01C-201]; Dutch Heart Foundation	CTMM, the Center for Translational Molecular Medicine, project INCOAG; Dutch Heart Foundation(Netherlands Heart Foundation)	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project INCOAG (grant 01C-201), and supported by the Dutch Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bielak LF, 2009, CLIN MED INSIGHTS-CA, V3, P53; Campioni D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056377; Cheng S, 2010, CIRCULATION, V122, P1176, DOI 10.1161/CIRCULATIONAHA.109.931279; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hauser ER, 2003, AM HEART J, V145, P602, DOI 10.1067/mhj.2003.13; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Hughes AD, 2007, EUR J CLIN INVEST, V37, P35, DOI 10.1111/j.1365-2362.2007.01743.x; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Landmesser U, 2004, CIRCULATION, V110, P1933, DOI 10.1161/01.CIR.0000143232.67642.7A; Laslett LJ, 2012, J AM COLL CARDIOL, V60, pS1, DOI 10.1016/j.jacc.2012.11.002; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Martin-Ramirez J, 2012, NAT PROTOC, V7, P1709, DOI 10.1038/nprot.2012.093; Massa M, 2009, EXP HEMATOL, V37, P8, DOI 10.1016/j.exphem.2008.09.007; Medina RJ, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-18; Meneveau N, 2011, BASIC RES CARDIOL, V106, P1397, DOI 10.1007/s00395-011-0220-x; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Schmidt-Lucke C, 2010, ATHEROSCLEROSIS, V211, P249, DOI 10.1016/j.atherosclerosis.2010.02.007; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; van Agtmaal EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038399; Van Breevoort D, 2014, BLOOD, DOI 10.1182; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Werner N, 2002, ARTERIOSCL THROM VAS, V22, P1567, DOI 10.1161/01.ATV.0000036417.43987.D8; Yoder MC, 2010, ARTERIOSCL THROM VAS, V30, P1094, DOI 10.1161/ATVBAHA.109.191635	29	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99890	10.1371/journal.pone.0099890	http://dx.doi.org/10.1371/journal.pone.0099890			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955753	Green Submitted, gold, Green Published			2022-12-25	WOS:000338917900020
J	Sun, W; Li, ZR; Gao, FQ; Shi, ZC; Zhang, QD; Guo, WS				Sun, Wei; Li, Zirong; Gao, Fuqiang; Shi, Zhencai; Zhang, Qidong; Guo, Wanshou			Recombinant Human Bone Morphogenetic Protein-2 in Debridement and Impacted Bone Graft for the Treatment of Femoral Head Osteonecrosis	PLOS ONE			English	Article							CORE DECOMPRESSION; AVASCULAR NECROSIS; ROTATIONAL OSTEOTOMY; FOLLOW-UP; IMPLANTATION; PRESERVATION	The purpose of this study was to compare the clinical outcomes of impacted bone graft with or without recombinant human bone morphogenetic protein-2 (rhBMP-2) for osteonecrosis of the femoral head (ONFH). We examined the effect of bone-grafting through a window at the femoral head-neck junction, known as the "light bulb" approach, for the treatment of ONFH with a combination of artificial bone (Novobone) mixed with or without rhBMP-2. A total of 42 patients (72 hips) were followed-up from 5 to 7.67 years (average of 6.1 years). The patients with and without BMP were the first group (IBG+ rhBMP-2) and the second group (IBG), respectively. The clinical effectiveness was evaluated by Harris hip score (HHS). The radiographic follow-up was evaluated by pre- and postoperative X-ray and CT scan. Excellent, good, and fair functions were obtained in 36, 12, and 7 hips, respectively. The survival rate was 81.8% and 71.8% in the first and second group, respectively. However, the survival rate was 90.3% in ARCO stage IIb, c, and only 34.6% in ARCO stage IIIa(P<0.05). It was concluded that good and excellent mid-term follow-up could be achieved in selected patients with ONFH treated with impacted bone graft operation. The rhBMP-2 might improve the clinical efficacy and quality of bone repair.	[Sun, Wei; Li, Zirong; Gao, Fuqiang; Shi, Zhencai; Zhang, Qidong; Guo, Wanshou] China Japan Friendship Hosp, Ctr Osteonecrosis & Joint Preserving & Reconstruc, Beijing, Peoples R China	China-Japan Friendship Hospital	Sun, W (corresponding author), China Japan Friendship Hosp, Ctr Osteonecrosis & Joint Preserving & Reconstruc, Beijing, Peoples R China.	sun887@163.com; 13366656822@163.com			National Natural Science Foundation of China [81372013]; Research Fund of China-Japan Friendship Hospital [2013-MS-27]; China-Japan Friendship Hospital Youth Science and technology excellence project [2014-QNYC-A-06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund of China-Japan Friendship Hospital; China-Japan Friendship Hospital Youth Science and technology excellence project	This study was supported by the National Natural Science Foundation of China (81372013) and the Research Fund of China-Japan Friendship Hospital (2013-MS-27). China-Japan Friendship Hospital Youth Science and technology excellence project (2014-QNYC-A-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, ARCO NEWS; Carragee EJ, 2013, J BONE JOINT SURG AM, V95A, P1537, DOI 10.2106/JBJS.L.01483; Chen Ying, 2010, Zhonghua Yi Xue Za Zhi, V90, P2652; Gangji V, 2011, BONE, V49, P1005, DOI 10.1016/j.bone.2011.07.032; Hamanishi M, 2014, ARCH ORTHOP TRAUM SU, V134, P305, DOI 10.1007/s00402-013-1919-y; Hasegawa Y, 2003, J BONE JOINT SURG BR, V85B, P191, DOI 10.1302/0301-620X.85B2.13190; Hernigou P, 2005, J BONE JOINT SURG BR, V87B, P896, DOI 10.1302/0301-620X.87B7.16289; Hitt KD, 2004, SEMIN ARTHROPLAST, V15, P145; Hungerford DS, 2008, TECH ORTHOP, V23, P26, DOI 10.1097/BTO.0b013e3181690840; Israelite C, 2005, CLIN ORTHOP RELAT R, P285, DOI 10.1097/01.blo.0000192365.58958.84; Kim HKW, 2012, J BONE JOINT SURG AM, V94A, P659, DOI 10.2106/JBJS.J.01834; Leung PC, 1996, CLIN ORTHOP RELAT R, P139, DOI 10.1097/00003086-199602000-00019; [李子荣 Li Zirong], 2012, [中华骨科杂志, Chinese Journal of Orthopedics], V32, P515; Lieberman JR, 2012, CLIN ORTHOP RELAT R, V470, P525, DOI 10.1007/s11999-011-2050-4; Lieberman JR, 2004, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000150312.53937.6f; Lieberman JR, 2004, CLIN ORTHOP RELAT R, P29; Marciniak D, 2005, J BONE JOINT SURG AM, V87A, P742, DOI 10.2106/JBJS.D.02004; Mesfin A, 2013, J BONE JOINT SURG AM, V95A, P1546, DOI 10.2106/JBJS.L.01730; Mont MA, 2003, CLIN ORTHOP RELAT R, P84, DOI 10.1097/01.blo.0000096826.67494.38; Mont MA, 2004, J BONE JOINT SURG AM, V86A, P41, DOI 10.2106/00004623-200412002-00008; Mont MA, 2001, J BONE JOINT SURG AM, V83A, P1013, DOI 10.2106/00004623-200107000-00006; Mont MA, 2010, J BONE JOINT SURG AM, V92A, P2165, DOI 10.2106/JBJS.I.00575; ROSENWASSER MP, 1994, CLIN ORTHOP RELAT R, P17; Sugioka Y, 2008, CLIN ORTHOP RELAT R, V466, P1104, DOI 10.1007/s11999-008-0192-9; Sun W, 2014, ORTHOPEDICS, V37, pE24, DOI 10.3928/01477447-20131219-12; Sun Wei, 2011, Orthop Surg, V3, P131, DOI 10.1111/j.1757-7861.2011.00127.x; Vandermeer JS, 2011, J BONE JOINT SURG AM, V93A, P905, DOI 10.2106/JBJS.J.00716; Wang BL, 2010, ARCH ORTHOP TRAUM SU, V130, P859, DOI 10.1007/s00402-009-0939-0; Wang BL, 2010, INT ORTHOP, V34, P635, DOI 10.1007/s00264-009-0822-1; Wang W, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-142; [杨强 Yang Qiang], 2011, [中华骨科杂志, Chinese Journal of Orthopedics], V31, P549; Zhao DW, 2012, BONE, V50, P325, DOI 10.1016/j.bone.2011.11.002	32	44	56	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100424	10.1371/journal.pone.0100424	http://dx.doi.org/10.1371/journal.pone.0100424			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956102	Green Published, Green Submitted, gold			2022-12-25	WOS:000338917900050
J	Annamanedi, M; Kalle, AM				Annamanedi, Madhavi; Kalle, Arunasree M.			Celecoxib Sensitizes Staphylococcus aureus to Antibiotics in Macrophages by Modulating SIRT1	PLOS ONE			English	Article							CHONDROCYTES IN-VITRO; RESVERATROL; INFLAMMATION; INHIBITION; APOPTOSIS; COX-2; PHAGOCYTOSIS; EXPRESSION; RESISTANCE; ACTIVATORS	We have previously shown that celecoxib in combination with an antibiotic, increase the bacterial sensitivity to antibiotics. However, the underlying molecular mechanism remained elusive. Efficacy of the combinatorial treatment of celecoxib and ampicillin in vitro was evaluated on macrophage-phagocytosed S aureus. To elucidate the mechanism, signaling pathway of infection and inflammation involving TLR2, JNK, SIRT1 and NF-kappa B was studied by FACS, Western blot, ELISA and activity assays. Combinatorial treatment of ampicillin and celecoxib reduced the bacterial load in the macrophages. Further studies clearly suggested the activation of the master regulator of oxidative stress and inflammation SIRT1,, by celecoxib when used alone and/or in combination with ampicillin. Also, the results indicated that celecoxib inhibited JNK phosphorylation thereby stabilizing and activating SIRT1 protein that inhibited the COX-2 gene transcription with a significant decrease in the levels of protein inflammatory cytokines like IL-6, MIP-1 alpha and IL-1 beta via inhibition of NF-kappa B. SIRT1 activation by celecoxib also resulted in increase of catalase and peroxidase activity with a decrease in Nitric oxide levels. In conclusion, we demonstrate a novel role of celecoxib in controlling inflammation as an enhancer of antibiotic activity against bacteria by modulating SIRT1.	[Annamanedi, Madhavi; Kalle, Arunasree M.] Univ Hyderabad, Sch Life Sci, Dept Anim Sci, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Kalle, AM (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Anim Sci, Hyderabad 500134, Andhra Pradesh, India.	arunasreemk@uohyd.ac.in	Kalle, Arunasree M./AAI-9819-2020	Kalle, Arunasree M./0000-0002-5948-2337; Annamanedi, Madhavi/0000-0001-5460-6532	Indian Council of Medical Research (ICMR), India [AMR-19-2011-ECD-I]; Department of Biotechnology-Innovative Young Biotechnologist Award (DBT-IYBA), India [BT/03/IYBA/2010]; National Institute of Animal Biotechnology (NIAB), India [NIAB/CP/108/2012]	Indian Council of Medical Research (ICMR), India(Indian Council of Medical Research (ICMR)); Department of Biotechnology-Innovative Young Biotechnologist Award (DBT-IYBA), India; National Institute of Animal Biotechnology (NIAB), India	This study was partially funded by Indian Council of Medical Research (ICMR), India (Grant# AMR-19-2011-ECD-I). Financial assistance from Department of Biotechnology-Innovative Young Biotechnologist Award (DBT-IYBA), India (Grant# BT/03/IYBA/2010) and National Institute of Animal Biotechnology (NIAB), India(Grant# NIAB/CP/108/2012) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arunasree KM, 2008, LEUKEMIA RES, V32, P855, DOI 10.1016/j.leukres.2007.11.007; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Chen CJ, 2009, BIOCHEM BIOPH RES CO, V378, P389, DOI 10.1016/j.bbrc.2008.11.110; Csaki C, 2008, BIOCHEM PHARMACOL, V75, P677, DOI 10.1016/j.bcp.2007.09.014; Csaki C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2850; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Ejim L, 2010, NAT CHEM BIOL; Gajraj NM, 2007, CURR TOP MED CHEM, V7, P235, DOI 10.2174/156802607779941323; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hojgard S., 2012, INFECT ECOL EPIDEMIO, V2, P18165; Howes Laurence Guy, 2007, Ther Clin Risk Manag, V3, P831; Iyori M, 2008, ANTIMICROB AGENTS CH, V52, P121, DOI 10.1128/AAC.00210-07; Kalle AM, 2011, ANTIMICROB AGENTS CH, V55, P439, DOI 10.1128/AAC.00735-10; Knutson MD, 2008, NUTR REV, V66, P591, DOI 10.1111/j.1753-4887.2008.00109.x; Koziel J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005210; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Lee JH, 2009, DIABETES, V58, P344, DOI 10.2337/db07-1795; Lefebre MD, 2001, MICROBIOL-SGM, V147, P97, DOI 10.1099/00221287-147-1-97; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Palladino MA, 2007, BIOL REPROD, V76, P958, DOI 10.1095/biolreprod.106.059410; Pietrocola G, 2011, INT J ARTIF ORGANS, V34, P799, DOI 10.5301/ijao.5000030; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rahman I, 2012, PREV MED, V54, pS20, DOI 10.1016/j.ypmed.2011.11.014; Ruof J, 2000, Z RHEUMATOL, V59, P124, DOI 10.1007/s003930050217; Schug TT, 2010, MOL CELL BIOL, V30, P4712, DOI 10.1128/MCB.00657-10; Shakibaei M, 2009, MOL NUTR FOOD RES, V53, P115, DOI 10.1002/mnfr.200800148; Shakibaei M, 2008, BIOCHEM PHARMACOL, V76, P1426, DOI 10.1016/j.bcp.2008.05.029; Shakibaei M, 2007, ANN NY ACAD SCI, V1095, P554, DOI 10.1196/annals.1397.060; Shakibaei M, 2011, J BIOL CHEM, V286, P11492, DOI 10.1074/jbc.M110.198713; Stables MJ, 2010, BLOOD, V116, P2950, DOI 10.1182/blood-2010-05-284844; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Verdin E, 2007, MOL CELL, V28, P354, DOI 10.1016/j.molcel.2007.10.013; Wang GL, 2009, BIOCHEM BIOPH RES CO, V380, P644, DOI 10.1016/j.bbrc.2009.01.163; Wu JT, 2005, J SURG RES, V123, P158, DOI 10.1016/j.jss.2004.06.006; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Zhang R, 2010, J BIOL CHEM, V285, P7097, DOI 10.1074/jbc.M109.038604; Zhang ZY, 2010, J BIOL CHEM, V285, P41391, DOI 10.1074/jbc.M110.174482	37	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99285	10.1371/journal.pone.0099285	http://dx.doi.org/10.1371/journal.pone.0099285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950067	Green Submitted, Green Published, gold			2022-12-25	WOS:000338276300012
J	Farah, BL; Sinha, RA; Wu, YJ; Singh, BK; Zhou, J; Bay, BH; Yen, PM				Farah, Benjamin L.; Sinha, Rohit A.; Wu, Yajun; Singh, Brijesh K.; Zhou, Jin; Bay, Boon-Huat; Yen, Paul M.			beta-Adrenergic Agonist and Antagonist Regulation of Autophagy in HepG2 Cells, Primary Mouse Hepatocytes, and Mouse Liver	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; PROTEIN-KINASE-A; GLYCOGEN AUTOPHAGY; MICE; DEGRADATION; ACTIVATION; INHIBITION; GLUCOSE; MAINTENANCE; CLENBUTEROL	Autophagy recently has been shown to be involved in normal hepatic function and in pathological conditions such as nonalcoholic fatty liver disease. Adrenergic signalling also is an important regulator of hepatic metabolism and function. However, currently little is known about the potential role of adrenergic signaling on hepatic autophagy, and whether the beta-adrenergic receptor itself may be a key regulator of autophagy. To address these issues, we investigated the actions of the beta(2)-adrenergic receptor agonist, clenbuterol on hepatic autophagy. Surprisingly, we found that clenbuterol stimulated autophagy and autophagic flux in hepatoma cells, primary hepatocytes and in vivo. Similar effects also were observed with epinephrine treatment. Interestingly, propranolol caused a late block in autophagy in the absence and presence of clenbuterol, both in cell culture and in vivo. Thus, our results demonstrate that the beta(2)-adrenergic receptor is a key regulator of hepatic autophagy, and that the beta-blocker propranolol can independently induce a late block in autophagy.	[Farah, Benjamin L.; Sinha, Rohit A.; Singh, Brijesh K.; Zhou, Jin; Yen, Paul M.] Duke NUS Grad Med Sch Singapore, Cardiovasc & Metab Disorders Program, Singapore, Singapore; [Wu, Yajun; Bay, Boon-Huat] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117595, Singapore; [Yen, Paul M.] Duke Univ, Med Ctr, Dept Med & Pharmacol, Sarah W Stedman Nutr & Metab Ctr, Durham, NC USA; [Yen, Paul M.] Duke Univ, Med Ctr, Dept Canc Biol, Sarah W Stedman Nutr & Metab Ctr, Durham, NC USA	National University of Singapore; National University of Singapore; Duke University; Duke University	Yen, PM (corresponding author), Duke NUS Grad Med Sch Singapore, Cardiovasc & Metab Disorders Program, Singapore, Singapore.	paul.yen@duke-nus.edu.sg	Sinha, Rohit/GXV-2427-2022; Yen, Paul M/V-9857-2019; Singh, Brijesh K/C-1093-2009	Singh, Brijesh K/0000-0003-4615-3988; Wu, Yajun/0000-0001-9598-4433; Yen, Paul/0000-0002-3790-8114	Singapore National Medical Research Council Grant [NMRC/CIRG/1340/2012]; Duke-NUS Graduate Medical School Faculty Funds; Singapore Ministry of Health; Singapore Ministry of Education; Singapore Ministry of Trade; A*STAR	Singapore National Medical Research Council Grant(National Medical Research Council, Singapore); Duke-NUS Graduate Medical School Faculty Funds; Singapore Ministry of Health(Ministry of Health-Singapore); Singapore Ministry of Education(Ministry of Education, Singapore); Singapore Ministry of Trade; A*STAR(Agency for Science Technology & Research (A*STAR))	This study was carried out with funds supplied by Singapore National Medical Research Council Grant [NMRC/CIRG/1340/2012] provided to Dr. Paul M. Yen, as well as by Duke-NUS Graduate Medical School Faculty Funds also to Dr. Paul M. Yen, sponsored by the Singapore Ministries of Health, Education, and Trade, as well as A*STAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Aranguiz-Urroz P, 2011, BBA-MOL BASIS DIS, V1812, P23, DOI 10.1016/j.bbadis.2010.07.003; Ashoor R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082481; Baker JG, 2010, BRIT J PHARMACOL, V160, P1048, DOI 10.1111/j.1476-5381.2010.00754.x; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; BONER AL, 1988, PEDIATR PULM, V4, P197, DOI 10.1002/ppul.1950040402; BRODDE OE, 1990, AM HEART J, V120, P1565, DOI 10.1016/0002-8703(90)90060-B; Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041; Ezaki J, 2011, AUTOPHAGY, V7, P727, DOI 10.4161/auto.7.7.15371; Goncalves DAP, 2012, AM J PHYSIOL-ENDOC M, V302, pE123, DOI 10.1152/ajpendo.00188.2011; GORDON PB, 1991, BIOMED BIOCHIM ACTA, V50, P383; Hernandez-Gea V, 2013, J HEPATOL, V59, P98, DOI 10.1016/j.jhep.2013.02.016; Hernandez-Gea V, 2012, GASTROENTEROLOGY, V142, P938, DOI 10.1053/j.gastro.2011.12.044; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; HOLEN I, 1991, BIOMED BIOCHIM ACTA, V50, P389; Inoue H, 2013, EUR J PHARMACOL, V714, P170, DOI 10.1016/j.ejphar.2013.06.018; Ishizaki J, 2000, J PHARMACOL EXP THER, V294, P1088; JAVITT NB, 1990, FASEB J, V4, P161, DOI 10.1096/fasebj.4.2.2153592; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Kazmi F, 2013, DRUG METAB DISPOS, V41, P897, DOI 10.1124/dmd.112.050054; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kondomerkos DJ, 2005, HISTOL HISTOPATHOL, V20, P689, DOI 10.14670/HH-20.689; Kotoulas OB, 2006, PATHOL RES PRACT, V202, P631, DOI 10.1016/j.prp.2006.04.001; Kotsafti A, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-118; Lampidonis AD, 2011, GENE, V477, P1, DOI 10.1016/j.gene.2011.01.007; Lin CW, 2013, J HEPATOL, V58, P993, DOI 10.1016/j.jhep.2013.01.011; Lizaso A, 2013, AUTOPHAGY, V9, P1228, DOI 10.4161/auto.24893; Loomba R, 2010, GASTROENTEROLOGY, V139, P836, DOI 10.1053/j.gastro.2010.06.009; McKee C, 2013, BIOCHEM BIOPH RES CO, V437, P597, DOI 10.1016/j.bbrc.2013.07.005; Meschini S, 2011, CURR CANCER DRUG TAR, V11, P357, DOI 10.2174/156800911794519707; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Omar B, 2009, CELL SIGNAL, V21, P760, DOI 10.1016/j.cellsig.2009.01.015; Pereira C, 2005, INT J BIOCHEM CELL B, V37, P1948, DOI 10.1016/j.biocel.2005.05.009; Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300; Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004; Serste T, 2010, HEPATOLOGY, V52, P1017, DOI 10.1002/hep.23775; Sharara-Chami RI, 2012, INT J BIOCHEM CELL B, V44, P905, DOI 10.1016/j.biocel.2012.02.016; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sinha RA, 2013, HEPATOLOGY; Sinha RA, 2012, J CLIN INVEST, V122, P2428, DOI 10.1172/JCI60580; Stankov MV, 2012, AIDS, V26, P1995, DOI 10.1097/QAD.0b013e32835804f9; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Thoen LFR, 2011, J HEPATOL, V55, P1353, DOI 10.1016/j.jhep.2011.07.010; TRAGANOS F, 1994, METHOD CELL BIOL, V41, P185; Ugland H, 2011, AUTOPHAGY, V7, P1199, DOI 10.4161/auto.7.10.16649; Wachter SB, 2012, CARDIOLOGY, V122, P104, DOI 10.1159/000339271; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851	51	37	38	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e98155	10.1371/journal.pone.0098155	http://dx.doi.org/10.1371/journal.pone.0098155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950230	gold, Green Published, Green Submitted			2022-12-25	WOS:000338276300006
J	Haimerl, M; Wachtler, M; Zeman, F; Verloh, N; Platzek, I; Schreyer, AG; Stroszczynski, C; Wiggermann, P				Haimerl, Michael; Waechtler, Max; Zeman, Florian; Verloh, Niklas; Platzek, Ivan; Schreyer, Andreas Georg; Stroszczynski, Christian; Wiggermann, Philipp			Quantitative Evaluation of Enhancement Patterns in Focal Solid Liver Lesions with Gd-EOB-DTPA-Enhanced MRI	PLOS ONE			English	Article							EARLY HEPATOCELLULAR-CARCINOMA; MULTICENTER PHASE-III; GADOXETIC-ACID; NODULAR HYPERPLASIA; HISTOPATHOLOGIC FINDINGS; CONTRAST AGENT; SPIRAL CT; GADOBENATE DIMEGLUMINE; INITIAL OBSERVATIONS; HEPATIC ADENOMA	Purpose: The objective was to investigate the dynamic enhancement patterns in focal solid liver lesions after the administration of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) by means of dynamic magnetic resonance imaging (MRI) including hepatobiliary phase (HP) images 20 min after Gd-EOB-DTPA administration. Materials and Methods: Non-enhanced T1/T2-weighted as well as dynamic magnetic resonance (MR) images during the arterial phase (AP), the portal venous phase (PVP), the late phase (LP), and the HP (20 min) were obtained from 83 patients (54 male, 29 female, mean age 62.01 years) with focal solid liver lesions. MRI was conducted by means of a 1.5-T system for 63 patients with malignant liver lesions (HCCs: n = 34, metastases: n = 29) and for 20 patients with benign liver lesions (FNH lesions: n = 14, hemangiomas: n = 3, adenomas: n = 3). For quantitative analysis, signal-to-noise ratios (SNR), contrast enhancement ratios (CER), lesion-to-liver contrast ratios (LLC), and signal intensity (SI) ratios were measured. Results: The SNR of liver parenchyma significantly increased in each dynamic phase after Gd-EOB-DTPA administration compared to the SNR of non-enhanced images (p<0.001). The CER of HCCs and metastases significantly decreased between LP and HP images (p = 0.0011, p<0.0001). However, FNH lesions did not show any significant difference, whereas an increased CER was found in hemangiomas. The mean LLCs of FNH lesions were significantly higher than those of HCCs and metastases. The LLC values of hemangiomas remained negative during the entire time course, whereas the LLC of adenomas indicated hyperintensity from the AP to the LP. Furthermore, adenomas showed hypointensity in HP images. Conclusion: Gd-EOB-DTPA-enhanced MRI may help diagnose focal solid liver lesions by evaluating their enhancement patterns.	[Haimerl, Michael; Waechtler, Max; Verloh, Niklas; Schreyer, Andreas Georg; Stroszczynski, Christian; Wiggermann, Philipp] Univ Med Ctr Regensburg, Dept Radiol, Regensburg, Germany; [Zeman, Florian] Univ Med Ctr Regensburg, Ctr Clin Trials, Regensburg, Germany; [Platzek, Ivan] Univ Hosp Carl Gustav Carus Dresden, Dept Radiol, Dresden, Germany	University of Regensburg; University of Regensburg; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Haimerl, M (corresponding author), Univ Med Ctr Regensburg, Dept Radiol, Regensburg, Germany.	michael.haimerl@ukr.de	Platzek, Ivan/AAZ-8124-2020; Wiggermann, Philipp/AAY-6759-2021; Verloh, Niklas/AAS-5386-2021; Schreye, Andreas/ABC-3197-2020; Zeman, Florian/GNH-3239-2022; WIGGERMANN, Philipp/AAX-6721-2021	Platzek, Ivan/0000-0002-5933-8108; Verloh, Niklas/0000-0002-8424-5827; Schreyer, Andreas/0000-0002-2539-059X				Bartolozzi C, 2007, EUR RADIOL, V17, P2519, DOI 10.1007/s00330-007-0602-5; Bluemke DA, 2005, RADIOLOGY, V237, P89, DOI 10.1148/radiol.2371031842; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Farges O, 2010, DIGEST SURG, V27, P32, DOI 10.1159/000268405; Frericks BB, 2009, AM J ROENTGENOL, V193, P1053, DOI 10.2214/AJR.08.1946; Giovanoli O, 2008, AM J ROENTGENOL, V190, pW290, DOI 10.2214/AJR.07.3198; Grazioli L, 2005, RADIOLOGY, V236, P166, DOI 10.1148/radiol.2361040338; Grazioli L, 2012, RADIOLOGY, V262, P520, DOI 10.1148/radiol.11101742; HAMM B, 1994, RADIOLOGY, V190, P417, DOI 10.1148/radiology.190.2.8284392; HAMM B, 1995, RADIOLOGY, V195, P785, DOI 10.1148/radiology.195.3.7754011; Hammerstingl R, 2008, EUR RADIOL, V18, P457, DOI 10.1007/s00330-007-0716-9; Huppertz A, 2005, RADIOLOGY, V234, P468, DOI 10.1148/radiol.2342040278; Ichikawa T, 2000, RADIOLOGY, V214, P861, DOI 10.1148/radiology.214.3.r00mr28861; Ichikawa T, 2010, INVEST RADIOL, V45, P133, DOI 10.1097/RLI.0b013e3181caea5b; Kim YK, 2006, RADIOLOGY, V238, P531, DOI 10.1148/radiol.2381042193; Kojiro M, 2009, HEPATOLOGY, V49, P658, DOI 10.1002/hep.22709; Lee SA, 2011, MAGN RESON IMAGING, V29, P83, DOI 10.1016/j.mri.2010.07.019; Mohajer K, 2012, J MAGN RESON IMAGING, V36, P686, DOI 10.1002/jmri.23701; Morana G, 2002, ACAD RADIOL, V9, pS476, DOI 10.1016/S1076-6332(03)80268-4; Morana G, 2011, INVEST RADIOL, V46, P225, DOI 10.1097/RLI.0b013e3181feee3a; Motosugi U, 2011, INVEST RADIOL, V46, P141, DOI 10.1097/RLI.0b013e3181f9c487; Motosugi U, 2010, RADIOLOGY, V256, P151, DOI 10.1148/radiol.10091885; Oudkerk M, 2002, RADIOLOGY, V223, P517, DOI 10.1148/radiol.2232010318; Petersein J, 2000, RADIOLOGY, V215, P727, DOI 10.1148/radiology.215.3.r00jn14727; PUECH A, 1964, Montp Med, V65, P114; Raman SS, 2010, J COMPUT ASSIST TOMO, V34, P163, DOI 10.1097/RCT.0b013e3181c89d87; Reimer P, 1997, EUR RADIOL, V7, P275, DOI 10.1007/s003300050150; Saito Kazuhiro, 2005, Magn Reson Med Sci, V4, P1, DOI 10.2463/mrms.4.1; Sano K, 2011, RADIOLOGY, V261, P834, DOI 10.1148/radiol.11101840; Semelka RC, 2001, J MAGN RESON IMAGING, V13, P397, DOI 10.1002/jmri.1057; Tanimoto A, 2009, EUR RADIOL, V19, pS975, DOI 10.1007/s00330-009-1624-y; Tsuda N, 2010, RADIOLOGY, V256, P767, DOI 10.1148/radiol.10092065; Vogl TJ, 1996, RADIOLOGY, V200, P59, DOI 10.1148/radiology.200.1.8657946; WANLESS IR, 1985, HEPATOLOGY, V5, P1194, DOI 10.1002/hep.1840050622; Weinmann HJ, 1996, ACAD RADIOL, V3, pS232, DOI 10.1016/S1076-6332(96)80544-7; Zech CJ, 2008, INVEST RADIOL, V43, P504, DOI 10.1097/RLI.0b013e3181705cd1	36	11	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100315	10.1371/journal.pone.0100315	http://dx.doi.org/10.1371/journal.pone.0100315			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950259	Green Published, gold, Green Submitted			2022-12-25	WOS:000338276300063
J	Wong, L; Hutson, PR; Bushman, W				Wong, Letitia; Hutson, Paul R.; Bushman, Wade			Prostatic Inflammation Induces Fibrosis in a Mouse Model of Chronic Bacterial Infection	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; URINARY-TRACT SYMPTOMS; FATTY LIVER-DISEASE; CIRCULATING FIBROCYTES; EXTRACELLULAR-MATRIX; MYOCARDIAL FIBROSIS; COLLAGEN-SYNTHESIS; TISSUE FIBROSIS; LUNG-DISEASE; PATHOGENESIS	Inflammation of the prostate is strongly correlated with development of lower urinary tract symptoms and several studies have implicated prostatic fibrosis in the pathogenesis of bladder outlet obstruction. It has been postulated that inflammation induces prostatic fibrosis but this relationship has never been tested. Here, we characterized the fibrotic response to inflammation in a mouse model of chronic bacterial-induced prostatic inflammation. Transurethral instillation of the uropathogenic E. coli into C3H/HeOuJ male mice induced persistent prostatic inflammation followed by a significant increase in collagen deposition and hydroxyproline content. This fibrotic response to inflammation was accompanied with an increase in collagen synthesis determined by the incorporation of H-3-hydroxyproline and mRNA expression of several collagen remodeling-associated genes, including Col1a1, Col1a2, Col3a1, Mmp2, Mmp9, and Lox. Correlation analysis revealed a positive correlation of inflammation severity with collagen deposition and immunohistochemical staining revealed that CD45+VIM+ fibrocytes were abundant in inflamed prostates at the time point coinciding with increased collagen synthesis. Furthermore, flow cytometric analysis demonstrated an increased percentage of these CD45+VIM+ fibrocytes among collagen type I expressing cells. These data show-for the first time-that chronic prostatic inflammation induces collagen deposition and implicates fibrocytes in the fibrotic process.	[Wong, Letitia; Bushman, Wade] Univ Wisconsin, Dept Urol, Madison, WI 53706 USA; [Wong, Letitia] Univ Wisconsin, Mol & Environm Toxicol Ctr, Madison, WI USA; [Hutson, Paul R.] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bushman, W (corresponding author), Univ Wisconsin, Dept Urol, Madison, WI 53706 USA.	bushman@urology.wisc.edu			National Institutes of Health [R01DK0757]; National Institute of Environmental Health Sciences [T32 ES007015]; UW-Madison School of Medicine and Public Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); UW-Madison School of Medicine and Public Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by R01DK0757 (to WB) from the National Institutes of Health (http://www.nih.gov), T32 ES007015 (to LW) from the National Institute of Environmental Health Sciences (https://www.niehs.nih.gov), and Herman I. Shapiro Distinguished Graduate Fellowship (to LW) from UW-Madison School of Medicine and Public Health (http://www.med.wisc.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Andersson-Sjoland A, 2008, INT J BIOCHEM CELL B, V40, P2129, DOI 10.1016/j.biocel.2008.02.012; Armstrong L, 1999, AM J RESP CRIT CARE, V160, P1910, DOI 10.1164/ajrccm.160.6.9811084; Atamas SP, 2002, LIFE SCI, V72, P631, DOI 10.1016/S0024-3205(02)02299-3; Barron DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013751; Bercovich E, 1999, Arch Ital Urol Androl, V71, P287; Besnard AG, 2013, J LEUKOCYTE BIOL, V94, P1317, DOI 10.1189/jlb.0313140; Boehm BJ, 2012, PROSTATE, V72, P307, DOI 10.1002/pros.21433; Borthwick LA, 2013, BBA-MOL BASIS DIS, V1832, P1049, DOI 10.1016/j.bbadis.2012.09.014; Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Cantiello F, 2013, UROLOGY, V81, P1018, DOI 10.1016/j.urology.2013.01.053; CUNHA GR, 1983, DIFFERENTIATION, V24, P174, DOI 10.1111/j.1432-0436.1983.tb01317.x; De Marzo AM, 1999, AM J PATHOL, V155, P1985, DOI 10.1016/S0002-9440(10)65517-4; Degryse AL, 2011, AM J PHYSIOL-LUNG C, V300, pL887, DOI 10.1152/ajplung.00397.2010; Elkahwaji JE, 2007, PROSTATE, V67, P14, DOI 10.1002/pros.20445; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Galligan CL, 2012, ARTHRITIS RHEUM-US, V64, P3583, DOI 10.1002/art.34589; Galligan CL, 2010, RHEUMATOLOGY, V49, P640, DOI 10.1093/rheumatology/kep265; Garcia-Bolao I, 2008, EUR HEART J, V29, P898, DOI 10.1093/eurheartj/ehn098; Gharaee-Kermani M, 1998, J LEUKOCYTE BIOL, V64, P657, DOI 10.1002/jlb.64.5.657; Gharaee-Kermani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049278; Gordon MK, 2010, CELL TISSUE RES, V339, P247, DOI 10.1007/s00441-009-0844-4; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hutson PR, 2003, J CHROMATOGR B, V791, P427, DOI 10.1016/S1570-0232(03)00248-4; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Kang HR, 2007, J BIOL CHEM, V282, P7723, DOI 10.1074/jbc.M610764200; Kramer G, 2007, EUR UROL, V51, P1202, DOI 10.1016/j.eururo.2006.12.011; Lagente V, 2005, BRAZ J MED BIOL RES, V38, P1521, DOI 10.1590/S0100-879X2005001000009; Lv XX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068631; Ma JJ, 2012, J UROLOGY, V188, P1375, DOI 10.1016/j.juro.2012.06.007; Marker PC, 2003, DEV BIOL, V253, P165, DOI 10.1016/S0012-1606(02)00031-3; McAnulty RJ, 2005, METH MOLEC MED, V117, P189; MCLENACHAN JM, 1990, AM J HYPERTENS, V3, P735, DOI 10.1093/ajh/3.10.735; Mehrad B, 2007, BIOCHEM BIOPH RES CO, V353, P104, DOI 10.1016/j.bbrc.2006.11.149; Morrison C, 2000, UROL RES, V28, P304, DOI 10.1007/s002400000123; Nickel JC, 2008, EUR UROL, V54, P1379, DOI 10.1016/j.eururo.2007.11.026; Pardo A, 2002, INT J BIOCHEM CELL B, V34, P1534, DOI 10.1016/S1357-2725(02)00091-2; Peng XY, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-12; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Querejeta R, 2004, CIRCULATION, V110, P1263, DOI 10.1161/01.CIR.0000140973.60992.9A; Rieder F, 2009, NAT REV GASTRO HEPAT, V6, P228, DOI 10.1038/nrgastro.2009.31; Robert G, 2009, PROSTATE, V69, P1774, DOI 10.1002/pros.21027; Rodes J, 2007, TXB HEPATOLOGY BASIC; Roehrborn CG, 2006, BJU INT, V97, P7, DOI 10.1111/j.1464-410X.2006.06098.x; Rydell-Tormanen K, 2012, LAB INVEST, V92, P917, DOI 10.1038/labinvest.2012.57; Saito F, 2008, AM J RESP CELL MOL, V38, P566, DOI 10.1165/rcmb.2007-0299OC; Sakai N, 2006, P NATL ACAD SCI USA, V103, P14098, DOI 10.1073/pnas.0511200103; Sakai N, 2010, HUM PATHOL, V41, P672, DOI 10.1016/j.humpath.2009.10.008; Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380; SELMAN M, 1986, THORAX, V41, P355, DOI 10.1136/thx.41.5.355; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Shinohara DB, 2013, PROSTATE, V73, P1007, DOI 10.1002/pros.22648; Steiner GE, 2003, LAB INVEST, V83, P1131, DOI 10.1097/01.LAB.0000081388.40145.65; Thickett DR, 2001, SARCOIDOSIS VASC DIF, V18, P27; Ueha S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00071; VATER CA, 1979, BIOCHEM J, V181, P639, DOI 10.1042/bj1810639; Wang CH, 2008, AM J RESP CRIT CARE, V178, P583, DOI 10.1164/rccm.200710-1557OC; Wight TN, 2011, AM J PHYSIOL-GASTR L, V301, pG950, DOI 10.1152/ajpgi.00132.2011; Wilson M, 2010, J PETROL, V51, P1, DOI 10.1093/petrology/egp099	66	34	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100770	10.1371/journal.pone.0100770	http://dx.doi.org/10.1371/journal.pone.0100770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950301	Green Published, Green Submitted, gold			2022-12-25	WOS:000338276300111
J	Fang, YW; Liu, LY; Zhang, HL; Jiang, DF; Chu, D				Fang, Yi-Wei; Liu, Ling-Yun; Zhang, Hua-Li; Jiang, De-Feng; Chu, Dong			Competitive Ability and Fitness Differences between Two Introduced Populations of the Invasive Whitefly Bemisia tabaci Q in China	PLOS ONE			English	Article							CYTOPLASMIC INCOMPATIBILITY; BACTERIAL SYMBIONT; PARASITOID WASP; BIOTYPE-Q; ENCARSIA-PERGANDIELLA; RAPID SPREAD; WOLBACHIA; CARDINIUM; HEMIPTERA; MITOCHONDRIAL	Background: Our long-term field survey revealed that the Cardinium infection rate in Bemisia tabaci Q (also known as biotype Q) population was low in Shandong, China over the past few years. We hypothesize that (1) the Cardinium-infected (C+) B. tabaci Q population cannot efficiently compete with the Cardinium-uninfected (C-) B. tabaci Q population; (2) no reproductive isolation may have occurred between C+ and C-; and (3) the C-population has higher fitness than the C+ population. Methodology and Results: To reveal the differences in competitive ability and fitness between the two introduced populations (C+ and C-), competition between C+ and C- was examined over several generations. Subsequently, the reproductive isolation between C+ and C- was studied by crossing C+ with C- individuals, and the fitnesses of C+ and C- populations were compared using a two-sex life table method. Our results demonstrate that the competitive ability of the C+ whiteflies was weaker than that of C-. There is that no reproductive isolation occurred between the two populations and the C- population had higher fitness than the C+ population. Conclusion: The competitive ability and fitness differences of two populations may explain why C- whitefly populations have been dominant during the past few years in Shandong, China. However, the potential role Cardinium plays in whitefly should be further explored.	[Fang, Yi-Wei; Liu, Ling-Yun; Zhang, Hua-Li; Jiang, De-Feng; Chu, Dong] Qingdao Agr Univ, Coll Agron & Plant Protect, Key Lab Integrated Crop Pest Management Shandong, Qingdao, Peoples R China	Qingdao Agricultural University	Chu, D (corresponding author), Qingdao Agr Univ, Coll Agron & Plant Protect, Key Lab Integrated Crop Pest Management Shandong, Qingdao, Peoples R China.	chinachudong@qau.edu.cn	CHU, DONG/AAI-1892-2020; Chu, Dong/AAS-3914-2020	Chu, Dong/0000-0001-5716-4979	High-Level Talents Fund of Qingdao Agricultural University [631212]; National Natural Science Foundation of China [31272105]; Science and Technology Development Planning Program of Qingdao [13-1-3-108-nsh]; Taishan Mountain Scholar Constructive Engineering Foundation of Shandong	High-Level Talents Fund of Qingdao Agricultural University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Planning Program of Qingdao; Taishan Mountain Scholar Constructive Engineering Foundation of Shandong	This research was supported by the High-Level Talents Fund of Qingdao Agricultural University (631212), the National Natural Science Foundation of China (31272105), the Science and Technology Development Planning Program of Qingdao (13-1-3-108-nsh), and the Taishan Mountain Scholar Constructive Engineering Foundation of Shandong to D. Chu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackman RL, 1998, B ENTOMOL RES, V88, P213, DOI 10.1017/S0007485300025785; Breeuwer J.A.J., 1992, Insect Molecular Biology, V1, P25, DOI 10.1111/j.1365-2583.1993.tb00074.x; Brownstin JS, 2003, J INVERTEBR PATHOL, V84, P24, DOI 10.1016/S0022-2011(03)00082-X; Bull J. J., 1983, EVOLUTION SEX DETERM; Chi H, 2006, ENVIRON ENTOMOL, V35, P10, DOI 10.1603/0046-225X-35.1.10; CHI H, 1988, ENVIRON ENTOMOL, V17, P26, DOI 10.1093/ee/17.1.26; Chi H, 2019, TWOSEX MSCHART COMPU; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Chu D, 2011, B ENTOMOL RES, V101, P467, DOI 10.1017/S0007485311000022; Chu D, 2011, B ENTOMOL RES, V101, P477, DOI 10.1017/S0007485311000083; Chu D, 2006, FLA ENTOMOL, V89, P168, DOI 10.1653/0015-4040(2006)89[168:TIOTEQ]2.0.CO;2; Chu D, 2012, J ECON ENTOMOL, V105, P242, DOI 10.1603/EC11039; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; Czosnek H, 2011, WHITEFLY, BEMISIA TABACI (HOMOPTERA: ALEYRODIDAE) INTERACTION WITH GEMINIVIRUS-INFECTED HOST PLANTS: BEMISIA TABACI, HOST PLANTS AND GEMINIVIRUSES, P51, DOI 10.1007/978-94-007-1524-0_3; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Efron B., 1994, INTRO BOOTSTRAP; Fisher R.A., 1930, GENETICAL THEORY NAT; Giorgini M, 2009, HEREDITY, V102, P365, DOI 10.1038/hdy.2008.135; GOODMAN D, 1982, AM NAT, V119, P803, DOI 10.1086/283956; Gotoh T, 2007, HEREDITY, V98, P13, DOI 10.1038/sj.hdy.6800881; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hagimori T, 2006, CURR MICROBIOL, V52, P97, DOI 10.1007/s00284-005-0092-0; Haine ER, 2008, P ROY SOC B-BIOL SCI, V275, P353, DOI 10.1098/rspb.2007.1211; Harris LR, 2010, HEREDITY, V104, P239, DOI 10.1038/hdy.2009.130; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Hunter MS, 2003, P ROY SOC B-BIOL SCI, V270, P2185, DOI 10.1098/rspb.2003.2475; Hurst GDD, 1999, P ROY SOC B-BIOL SCI, V266, P735, DOI 10.1098/rspb.1999.0698; Jaenike J, 2010, SCIENCE, V329, P212, DOI 10.1126/science.1188235; Kenyon SG, 2007, J EVOLUTION BIOL, V20, P707, DOI 10.1111/j.1420-9101.2006.01238.x; Khasdan V, 2005, B ENTOMOL RES, V95, P605, DOI 10.1079/BER2005390; Kurtti TJ, 1996, J INVERTEBR PATHOL, V67, P318, DOI 10.1006/jipa.1996.0050; Li XC, 2012, PEST MANAG SCI, V68, P83, DOI 10.1002/ps.2227; Luan JB, 2008, ENTOMOL EXP APPL, V129, P316, DOI 10.1111/j.1570-7458.2008.00777.x; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Nakamura Y, 2009, APPL ENVIRON MICROB, V75, P6757, DOI 10.1128/AEM.01583-09; Nirgianaki A, 2003, CURR MICROBIOL, V47, P93, DOI 10.1007/s00284-002-3969-1; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030760; Pan HP, 2011, J ECON ENTOMOL, V104, P978, DOI 10.1603/EC11009; Provencher LM, 2005, ANN ENTOMOL SOC AM, V98, P629, DOI 10.1603/0013-8746(2005)098[0629:PITANC]2.0.CO;2; Ros VID, 2009, HEREDITY, V102, P413, DOI 10.1038/hdy.2009.4; ROUSSET F, 1992, P ROY SOC B-BIOL SCI, V250, P91, DOI 10.1098/rspb.1992.0135; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stefanini A, 2012, J EVOLUTION BIOL, V25, P1521, DOI 10.1111/j.1420-9101.2012.02535.x; STOUTHAMER R, 1993, NATURE, V361, P66, DOI 10.1038/361066a0; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Teng X, 2010, FLA ENTOMOL, V93, P363, DOI 10.1653/024.093.0307; Vanthournout B, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-15; Wang HL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-401; Wang JJ, 2008, J ECON ENTOMOL, V101, P1711, DOI 10.1603/0022-0493(2008)101[1711:EOROCI]2.0.CO;2; Wang XW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-458; Weeks AR, 2001, SCIENCE, V292, P2479, DOI 10.1126/science.1060411; Weeks AR, 2004, P ROY SOC B-BIOL SCI, V271, pS193, DOI 10.1098/rsbl.2003.0137; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; White JA, 2011, HEREDITY, V106, P585, DOI 10.1038/hdy.2010.89; White JA, 2009, HEREDITY, V102, P483, DOI 10.1038/hdy.2009.5; Zchori-Fein E, 2004, INT J SYST EVOL MICR, V54, P961, DOI 10.1099/ijs.0.02957-0; Zchori-Fein E, 2001, P NATL ACAD SCI USA, V98, P12555, DOI 10.1073/pnas.221467498; Zchori-Fein E, 2002, ANN ENTOMOL SOC AM, V95, P711, DOI 10.1603/0013-8746(2002)095[0711:DOPAWB]2.0.CO;2; Zhang XF, 2012, ENVIRON ENTOMOL, V41, P833, DOI 10.1603/EN12078	61	29	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100423	10.1371/journal.pone.0100423	http://dx.doi.org/10.1371/journal.pone.0100423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945699	Green Published, gold, Green Submitted			2022-12-25	WOS:000340721500073
J	Eckey, K; Wrobel, E; Strutz-Seebohm, N; Pott, L; Schmitt, N; Seebohm, G				Eckey, Karina; Wrobel, Eva; Strutz-Seebohm, Nathalie; Pott, Lutz; Schmitt, Nicole; Seebohm, Guiscard			Novel K(v)7.1-Phosphatidylinositol 4,5-Bisphosphate Interaction Sites Uncovered by Charge Neutralization Scanning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; POTASSIUM CHANNELS; K+ CHANNEL; BIOPHYSICAL PROPERTIES; UNRELATED PATIENTS; MISSENSE MUTATION; STRUCTURAL BASIS; KCNQ1; PIP2; ACTIVATION	K(v)7.1 to K(v)7.5 alpha-subunits belong to the family of voltage-gated potassium channels (K-v). Assembled with the beta-subunit KCNE1, K(v)7.1 conducts the slowly activating potassium current I-Ks, which is one of the major currents underlying repolarization of the cardiac action potential. A known regulator of K(v)7 channels is the lipid phosphatidylinositol 4,5-bisphosphate (PIP2). PIP2 increases the macroscopic current amplitude by stabilizing the open conformation of 7.1/KCNE1 channels. However, knowledge about the exact nature of the interaction is incomplete. The aim of this study was the identification of the amino acids responsible for the interaction between K(v)7.1 and PIP2. We generated 13 charge neutralizing point mutations at the intracellular membrane border and characterized them electro-physiologically in complex with KCNE1 under the influence of diC(8)-PIP2. Electrophysiological analysis of corresponding long QT syndrome mutants suggested impaired PIP2 regulation as the cause for channel dysfunction. To clarify the underlying structural mechanism of PIP2 binding, molecular dynamics simulations of K(v)7.1/KCNE1 complexes containing two PIP2 molecules in each subunit at specific sites were performed. Here, we identified a subset of nine residues participating in the interaction of PIP2 and K(v)7.1/KCNE1. These residues may form at least two binding pockets per subunit, leading to the stabilization of channel conformations upon PIP2 binding.	[Eckey, Karina] Ruhr Univ Bochum, Dept Biochem, I Cat Channel Grp, D-44801 Bochum, Germany; [Eckey, Karina; Seebohm, Guiscard] Ruhr Univ Bochum, Int Grad Sch Neurosci, D-44801 Bochum, Germany; [Eckey, Karina; Seebohm, Guiscard] Ruhr Univ Bochum, Res Sch, D-44801 Bochum, Germany; [Pott, Lutz] Ruhr Univ Bochum, Inst Physiol, D-44801 Bochum, Germany; [Wrobel, Eva; Strutz-Seebohm, Nathalie; Seebohm, Guiscard] Univ Hosp Munster, Dept Cardiovasc Med, IfGH Myocellular Electrophysiol, D-48149 Munster, Germany; [Schmitt, Nicole] Univ Copenhagen, Danish Natl Res Fdn, Ctr Cardiac Arrhythmia, DK-1165 Copenhagen, Denmark	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; University of Munster; Danmarks Grundforskningsfond; University of Copenhagen	Seebohm, G (corresponding author), Univ Hosp Munster, Dept Cardiovasc Med, IfGH Myocellular Electrophysiol, D-48149 Munster, Germany.	guiscard.seebohm@ukmuenster.de	Schmitt, Nicole/B-8725-2012	Schmitt, Nicole/0000-0001-9482-9749; Pott, Lutz/0000-0002-4000-4132	Deutsche Forschungsgemeinschaft [1077/3-1]; International Graduate School of Neuroscience (Ruhr University Bochum); Ruhr University Bochum Research School	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Graduate School of Neuroscience (Ruhr University Bochum); Ruhr University Bochum Research School	This work was supported by Deutsche Forschungsgemeinschaft Grant 1077/3-1 and by student grants of the International Graduate School of Neuroscience (Ruhr University Bochum) and the Ruhr University Bochum Research School (to K. E.).	Angelo K, 2002, BIOPHYS J, V83, P1997, DOI 10.1016/S0006-3495(02)73961-1; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; BERRIDGE MJ, 1984, BIOCHEM J, V220, P345, DOI 10.1042/bj2200345; Chouabe C, 2000, CARDIOVASC RES, V45, P971, DOI 10.1016/S0008-6363(99)00411-3; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Demolombe S, 2001, AM J PHYSIOL-CELL PH, V280, pC359, DOI 10.1152/ajpcell.2001.280.2.C359; Donger C, 1997, CIRCULATION, V96, P2778, DOI 10.1161/01.CIR.96.9.2778; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; FRASER GR, 1964, ANN HUM GENET, V28, P133, DOI 10.1111/j.1469-1809.1964.tb00469.x; Grunnet M, 2002, J PHYSIOL-LONDON, V542, P119, DOI 10.1113/jphysiol.2002.017301; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hernandez CC, 2008, J GEN PHYSIOL, V132, P361, DOI 10.1085/jgp.200810007; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Huijbregts RPH, 2000, TRAFFIC, V1, P195, DOI 10.1034/j.1600-0854.2000.010301.x; JERVELL A, 1957, AM HEART J, V54, P59, DOI 10.1016/0002-8703(57)90079-0; Jespersen T, 2005, PHYSIOLOGY, V20, P408, DOI 10.1152/physiol.00031.2005; Kang CB, 2008, BIOCHEMISTRY-US, V47, P7999, DOI 10.1021/bi800875q; Kanovsky J, 2010, HEART RHYTHM, V7, P531, DOI 10.1016/j.hrthm.2009.11.034; Kapplinger JD, 2009, HEART RHYTHM, V6, P1297, DOI 10.1016/j.hrthm.2009.05.021; Kubota T, 2000, J CARDIOVASC ELECTR, V11, P1048, DOI 10.1111/j.1540-8167.2000.tb00178.x; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; LOPEZ HS, 1989, EUR J NEUROSCI, V1, P529, DOI 10.1111/j.1460-9568.1989.tb00360.x; Loussouarn G, 2003, EMBO J, V22, P5412, DOI 10.1093/emboj/cdg526; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; Millat G, 2006, CLIN GENET, V70, P214, DOI 10.1111/j.1399-0004.2006.00671.x; MOSS AJ, 1991, CIRCULATION, V84, P1136, DOI 10.1161/01.CIR.84.3.1136; MOSS AJ, 1985, CIRCULATION, V71, P17, DOI 10.1161/01.CIR.71.1.17; Napolitano C, 2005, JAMA-J AM MED ASSOC, V294, P2975, DOI 10.1001/jama.294.23.2975; Nebl T, 2000, CURR BIOL, V10, pR351, DOI 10.1016/S0960-9822(00)00465-6; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Park KH, 2005, CIRC RES, V96, P730, DOI 10.1161/01.RES.0000161451.04649.a8; PFAFFINGER P, 1988, J NEUROSCI, V8, P3343; Pusch M, 1998, PFLUG ARCH EUR J PHY, V437, P172, DOI 10.1007/s004240050765; ROMANO C, 1963, Minerva Pediatr, V15, P1155; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Sechi AS, 2000, J CELL SCI, V113, P3685; Seebohm G, 2005, CELL PHYSIOL BIOCHEM, V16, P255, DOI 10.1159/000089851; Seebohm G, 2001, PFLUG ARCH EUR J PHY, V442, P891; Seebohm G., 2014, PFLUGERS AR IN PRESS; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Strutz-Seebohm N, 2011, CELL PHYSIOL BIOCHEM, V27, P443, DOI 10.1159/000329965; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Tamargo J, 2004, CARDIOVASC RES, V62, P9, DOI 10.1016/j.cardiores.2003.12.026; Thomas AM, 2006, J MEMBRANE BIOL, V211, P43, DOI 10.1007/s00232-006-0014-5; Thomas AM, 2011, J BIOL CHEM, V286, P2088, DOI 10.1074/jbc.M110.153551; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Tristani-Firouzi M, 1998, J PHYSIOL-LONDON, V510, P37, DOI 10.1111/j.1469-7793.1998.037bz.x; WARD O C, 1964, J Ir Med Assoc, V54, P103; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Wrobel E, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00142; Xu XL, 2008, J GEN PHYSIOL, V131, P589, DOI 10.1085/jgp.200809976; Yang T, 2009, CIRC-ARRHYTHMIA ELEC, V2, P417, DOI 10.1161/CIRCEP.109.850149; Zaydman MA, 2013, P NATL ACAD SCI USA, V110, P13180, DOI 10.1073/pnas.1305167110; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	59	22	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22749	22758		10.1074/jbc.M114.589796	http://dx.doi.org/10.1074/jbc.M114.589796			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24947509	Green Published, hybrid			2022-12-25	WOS:000341017200020
J	Gerhold, JM; Sedman, T; Visacka, K; Slezakova, J; Tomaska, L; Nosek, J; Sedman, J				Gerhold, Joachim M.; Sedman, Tiina; Visacka, Katarina; Slezakova, Judita; Tomaska, Lubomir; Nosek, Jozef; Sedman, Juhan			Replication Intermediates of the Linear Mitochondrial DNA of Candida parapsilosis Suggest a Common Recombination Based Mechanism for Yeast Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROLLING-CIRCLE REPLICATION; CHENOPODIUM-ALBUM L.; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION INITIATION; LAGGING-STRAND; PLASMID MP1; GENOME; MAINTENANCE; SEQUENCES; PROTEIN	Variation in the topology of mitochondrial DNA (mtDNA) in eukaryotes evokes the question if differently structured DNAs are replicated by a common mechanism. RNA-primed DNA synthesis has been established as a mechanism for replicating the circular animal/mammalian mtDNA. In yeasts, circular mtDNA molecules were assumed to be templates for rolling circle DNA-replication. We recently showed that in Candida albicans, which has circular mapping mtDNA, recombination driven replication is a major mechanism for replicating a complex branched mtDNA network. Careful analyses of C. albicans-mtDNA did not reveal detectable amounts of circular DNA molecules. In the present study we addressed the question of how the unit sized linear mtDNA of Candida parapsilosis terminating at both ends with arrays of tandem repeats (mitochondrial telomeres) is replicated. Originally, we expected to find replication intermediates diagnostic of canonical bi-directional replication initiation at the centrally located bi-directional promoter region. However, we found that the linear mtDNA of Candida parapsilosis also employs recombination for replication initiation. The most striking findings were that the mitochondrial telomeres appear to be hot spots for recombination driven replication, and that stable RNA: DNA hybrids, with a potential role in mtDNA replication, are also present in the mtDNA preparations.	[Gerhold, Joachim M.; Sedman, Tiina; Sedman, Juhan] Univ Tartu, Inst Mol & Cell Biol, Dept Biochem, EE-51014 Tartu, Estonia; [Visacka, Katarina; Slezakova, Judita; Tomaska, Lubomir] Comenius Univ, Fac Nat Sci, Dept Genet, Bratislava 84215, Slovakia; [Nosek, Jozef] Comenius Univ, Fac Nat Sci, Dept Biochem, Bratislava 84215, Slovakia	University of Tartu; Comenius University Bratislava; Comenius University Bratislava	Gerhold, JM (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Dept Biochem, Riia 23c, EE-51014 Tartu, Estonia.	gerhold@ut.ee	Tomaska, Lubomir/I-3071-2014; Gerhold, Joachim M/B-7276-2012; Nosek, Jozef/A-7581-2008; Prochazkova, Katarina/ABE-1222-2021; Gerhold, Joachim/N-3033-2019; Sedman, Juhan/H-1820-2011	Tomaska, Lubomir/0000-0003-4886-1910; Gerhold, Joachim M/0000-0002-4972-1947; Nosek, Jozef/0000-0002-1020-5451; Prochazkova, Katarina/0000-0003-4147-6577; Gerhold, Joachim/0000-0002-4972-1947; Sedman, Juhan/0000-0003-2081-1452	Estonian Science Foundation [ETF 8449, 8845]; Estonian Institutional Funding Grant [IUT14021]; Slovak Research and Development Agency [APVV 0123-10, 0035-11]; Slovak Grant Agency [VEGA 1/0405/11, 1/0311/12]	Estonian Science Foundation; Estonian Institutional Funding Grant; Slovak Research and Development Agency(Slovak Research and Development Agency); Slovak Grant Agency(Vedecka grantova agentura MSVVaS SR a SAV (VEGA))	This work was supported by Estonian Science Foundation Grants ETF 8449 and 8845, the Estonian Institutional Funding Grant IUT14021, Slovak Research and Development Agency Grants APVV 0123-10 and 0035-11, and Slovak Grant Agency Grants VEGA 1/0405/11 and 1/0311/12.	Backert S, 1997, NUCLEIC ACIDS RES, V25, P582, DOI 10.1093/nar/25.3.582; Backert S, 1996, CURR GENET, V29, P427, DOI 10.1007/BF02221510; Backert S, 2002, EMBO J, V21, P3128, DOI 10.1093/emboj/cdf311; Backert S, 1996, MOL CELL BIOL, V16, P6285; Backert S, 2000, PLASMID, V43, P166, DOI 10.1006/plas.1999.1437; Backert S, 2000, CURR GENET, V37, P304, DOI 10.1007/s002940050532; BALDACCI G, 1982, EMBO J, V1, P987, DOI 10.1002/j.1460-2075.1982.tb01282.x; BALDACCI G, 1984, EMBO J, V3, P2115, DOI 10.1002/j.1460-2075.1984.tb02099.x; Bendich AJ, 2004, PLANT CELL, V16, P1661, DOI 10.1105/tpc.160771; Bendich AJ, 2010, MOL CELL, V39, P831, DOI 10.1016/j.molcel.2010.09.005; Bullerwell CE, 2003, NUCLEIC ACIDS RES, V31, P759, DOI 10.1093/nar/gkg134; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; DEZAMAROCZY M, 1984, GENE, V32, P439, DOI 10.1016/0378-1119(84)90019-2; DEZAMAROCZY M, 1981, NATURE, V292, P75, DOI 10.1038/292075a0; DEZAMAROCZY M, 1979, FEBS LETT, V108, P429, DOI 10.1016/0014-5793(79)80580-3; DIECKMANN CL, 1987, EMBO J, V6, P4197, DOI 10.1002/j.1460-2075.1987.tb02767.x; FANGMAN WL, 1989, MOL CELL BIOL, V9, P1917, DOI 10.1128/MCB.9.5.1917; FANGMAN WL, 1990, MOL CELL BIOL, V10, P10, DOI 10.1128/MCB.10.1.10; Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7; Fricova D, 2010, MICROBIOL-SGM, V156, P2153, DOI 10.1099/mic.0.038646-0; FUKUHARA H, 1993, MOL CELL BIOL, V13, P2309, DOI 10.1128/MCB.13.4.2309; Gerhold JM, 2010, MOL CELL, V39, P851, DOI 10.1016/j.molcel.2010.09.002; Graves T, 1998, NUCLEIC ACIDS RES, V26, P1309, DOI 10.1093/nar/26.5.1309; Grigoriev A, 1998, NUCLEIC ACIDS RES, V26, P2286, DOI 10.1093/nar/26.10.2286; HAN ZY, 1994, CHROMOSOMA, V103, P162, DOI 10.1007/BF00368008; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; Joers P, 2007, FEMS YEAST RES, V7, P118, DOI 10.1111/j.1567-1364.2006.00132.x; Kosa P, 2006, NUCLEIC ACIDS RES, V34, P2472, DOI 10.1093/nar/gkl327; Lecrenier N, 2000, GENE, V246, P37, DOI 10.1016/S0378-1119(00)00107-4; Ling F, 2007, MOL CELL BIOL, V27, P1133, DOI 10.1128/MCB.00770-06; LOCKSHON D, 1995, CELL, V81, P947, DOI 10.1016/0092-8674(95)90014-4; MacAlpine DM, 1998, P NATL ACAD SCI USA, V95, P6739, DOI 10.1073/pnas.95.12.6739; MALESZKA R, 1992, CURR GENET, V22, P341, DOI 10.1007/BF00317933; MALESZKA R, 1992, BIOCHEM BIOPH RES CO, V186, P1669, DOI 10.1016/S0006-291X(05)81600-6; MALESZKA R, 1991, EMBO J, V10, P3923, DOI 10.1002/j.1460-2075.1991.tb04962.x; NOSEK J, 1995, MOL GEN GENET, V247, P61, DOI 10.1007/BF00425822; Nosek J, 2005, J BIOL CHEM, V280, P10840, DOI 10.1074/jbc.M409295200; Nosek J, 2004, MOL GENET GENOMICS, V272, P173, DOI 10.1007/s00438-004-1046-0; Nosek J, 2003, CURR GENET, V44, P73, DOI 10.1007/s00294-003-0426-z; Nosek J, 1998, TRENDS GENET, V14, P184, DOI 10.1016/S0168-9525(98)01443-7; Oldenburg DJ, 2004, J MOL BIOL, V344, P1311, DOI 10.1016/j.jmb.2004.10.001; Oldenburg DJ, 2004, J MOL BIOL, V335, P953, DOI 10.1016/j.jmb.2003.11.020; Oldenburg DJ, 2001, J MOL BIOL, V310, P549, DOI 10.1006/jmbi.2001.4783; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Paquin B, 2000, MOL BIOL EVOL, V17, P1760, DOI 10.1093/oxfordjournals.molbev.a026274; Petersen RF, 2002, J MOL BIOL, V318, P627, DOI 10.1016/S0022-2836(02)00037-2; PISKUR J, 1989, MOL GEN GENET, V218, P161, DOI 10.1007/BF00330579; Pohjoismaki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029; Pohjoismaki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600; Preiser PR, 1996, EMBO J, V15, P684, DOI 10.1002/j.1460-2075.1996.tb00401.x; Sedman T, 2000, MOL CELL BIOL, V20, P1816, DOI 10.1128/MCB.20.5.1816-1824.2000; Shibata T, 2007, MITOCHONDRION, V7, P17, DOI 10.1016/j.mito.2006.11.024; Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282; Tomaska L, 2000, NUCLEIC ACIDS RES, V28, P4479, DOI 10.1093/nar/28.22.4479; Tomaska L, 2002, MITOCHONDRION, V1, P455, DOI 10.1016/S1567-7249(02)00009-0; Valach M, 2011, NUCLEIC ACIDS RES, V39, P4202, DOI 10.1093/nar/gkq1345; Visacka K, 2009, MICROBIOL-SGM, V155, P1226, DOI 10.1099/mic.0.025759-0; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Williamson D, 2002, NAT REV GENET, V3, P475, DOI 10.1038/nrg814; XU BJ, 1992, NUCLEIC ACIDS RES, V20, P1053, DOI 10.1093/nar/20.5.1053; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9; Yasukawa T, 2005, MOL CELL, V18, P651, DOI 10.1016/j.molcel.2005.05.002; Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392; ZINN AR, 1988, P NATL ACAD SCI USA, V85, P2686, DOI 10.1073/pnas.85.8.2686; Zuo XM, 2002, GENETICS, V160, P1389	65	20	20	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22659	22670		10.1074/jbc.M114.552828	http://dx.doi.org/10.1074/jbc.M114.552828			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24951592	Green Published, hybrid			2022-12-25	WOS:000341017200012
J	Arcovito, A; Chiarella, S; Della Longa, S; Di Matteo, A; Lo Sterzo, C; Scaglione, GL; Federici, L				Arcovito, Alessandro; Chiarella, Sara; Della Longa, Stefano; Di Matteo, Adele; Lo Sterzo, Carlo; Scaglione, Giovanni Luca; Federici, Luca			Synergic Role of Nucleophosmin Three-helix Bundle and a Flanking Unstructured Tail in the Interaction with G-quadruplex DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; DENATURED STATE; MOLECULAR-DYNAMICS; NUCLEOLAR PROTEIN; RIBOSOMAL-RNA; LEUKEMIA; COMPLEX; BINDING; RECOGNITION; MUTATIONS	Nucleophosmin (NPM1) is a nucleocytoplasmic shuttling protein, mainly localized at nucleoli, that plays a number of functions in ribosome biogenesis and export, cell cycle control, and response to stress stimuli. NPM1 is the most frequently mutated gene in acute myeloid leukemia; mutations map to the C-terminal domain of the protein and cause its denaturation and aberrant cytoplasmic translocation. NPM1 C-terminal domain binds G-quadruplex regions at ribosomal DNA and at gene promoters, including the well characterized sequence from the nuclease-hypersensitive element III region of the c-MYC promoter. These activities are lost by the leukemic variant. Here we analyze the NPM1/G-quadruplex interaction, focusing on residues belonging to both the NPM1 terminal three-helix bundle and a lysine-rich unstructured tail, which has been shown to be necessary for high affinity recognition. We performed extended site-directed mutagenesis and measured binding rate constants through surface plasmon resonance analysis. These data, supported by molecular dynamics simulations, suggest that the unstructured tail plays a double role in the reaction mechanism. On the one hand, it facilitates the formation of an encounter complex through long range electrostatic interactions; on the other hand, it directly contacts the G-quadruplex scaffold through multiple and transient electrostatic interactions, significantly enlarging the contact surface.	[Arcovito, Alessandro; Scaglione, Giovanni Luca] Univ Cattolica Sacro Cuore, Ist Biochim & Biochim Clin, I-00168 Rome, Italy; [Chiarella, Sara; Federici, Luca] Fdn Univ DAnnunzio, CeSI Ctr Sci Invecchiamento, I-66013 Chieti, Italy; [Chiarella, Sara; Lo Sterzo, Carlo] Univ Roma La Sapienza, Dipartimento Sci Biochim, I-00185 Rome, Italy; [Della Longa, Stefano] Univ Aquila, Dipartimento Med Clin Sanita Pubbl Sci Vita & Amb, I-67100 Laquila, Italy; [Di Matteo, Adele] CNR, Ist Biol Med Mol & NanoBiotecnol, I-00185 Rome, Italy; [Federici, Luca] Univ G dAnnunzio, Dipartimento Sci Sperimentali & Clin, I-66013 Chieti, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; G d'Annunzio University of Chieti-Pescara; Sapienza University Rome; University of L'Aquila; Consiglio Nazionale delle Ricerche (CNR); G d'Annunzio University of Chieti-Pescara	Federici, L (corresponding author), Univ G dAnnunzio, Dipartimento Sci Sperimentali & Clin, CeSI Ctr Sci Invecchiamento, Via Vestini 31, I-66013 Chieti, Italy.	lfederici@unich.it	Arcovito, Alessandro/I-5552-2012; Di Matteo, Adele/AAC-8338-2019; Scaglione, Giovanni Luca/ABD-6776-2020	Arcovito, Alessandro/0000-0002-8384-4844; Di Matteo, Adele/0000-0002-5921-7365; Scaglione, Giovanni Luca/0000-0001-5622-7843; della longa, stefano/0000-0002-8157-9530	Associazione Italiana Ricerca sul Cancro Grant [AIRC IG2011-11712]; Italian Ministry of University and Research (Universita Cattolica Sacro Cuore, Rome) [Linea D.1]	Associazione Italiana Ricerca sul Cancro Grant(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of University and Research (Universita Cattolica Sacro Cuore, Rome)	This work was supported by Associazione Italiana Ricerca sul Cancro Grant AIRC IG2011-11712 (to L. F.). and the Italian Ministry of University and Research (Linea D.1, 2012 Universita Cattolica Sacro Cuore, Rome) (to A. A.).	Banuelos S, 2013, FEBS LETT, V587, P2254, DOI 10.1016/j.febslet.2013.05.055; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chiarella S, 2013, BIOCHEM BIOPH RES CO, V435, P64, DOI 10.1016/j.bbrc.2013.04.038; Chiarella S, 2013, NUCLEIC ACIDS RES, V41, P3228, DOI 10.1093/nar/gkt001; Colombo E, 2011, ONCOGENE, V30, P2595, DOI 10.1038/onc.2010.646; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2011, BLOOD REV, V25, P247, DOI 10.1016/j.blre.2011.06.001; Federici L, 2013, PROTEIN SCI, V22, P545, DOI 10.1002/pro.2240; Federici L, 2010, J BIOL CHEM, V285, P37138, DOI 10.1074/jbc.M110.166736; Gallo A, 2012, J BIOL CHEM, V287, P26539, DOI 10.1074/jbc.M112.371013; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Grummitt Charles G, 2008, J Biol Chem, V283, P23326, DOI 10.1074/jbc.M801706200; Guo X, 2012, BIOCOMPUT-PAC SYM, P104; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; Hisaoka M, 2014, NUCLEIC ACIDS RES, V42, P1180, DOI 10.1093/nar/gkt897; KANG YJ, 1975, CANCER RES, V35, P1470; Maggi LB, 2008, MOL CELL BIOL, V28, P7050, DOI 10.1128/MCB.01548-07; Marasco D, 2013, BIOCHEM BIOPH RES CO, V430, P523, DOI 10.1016/j.bbrc.2012.12.002; Murano K, 2008, MOL CELL BIOL, V28, P3114, DOI 10.1128/MCB.02078-07; Okuwaki M, 2001, FEBS LETT, V506, P272, DOI 10.1016/S0014-5793(01)02939-8; Phan AT, 2005, NAT CHEM BIOL, V1, P167, DOI 10.1038/nchembio723; Savkur RS, 1998, NUCLEIC ACIDS RES, V26, P4508, DOI 10.1093/nar/26.19.4508; Scaloni F, 2010, P NATL ACAD SCI USA, V107, P5447, DOI 10.1073/pnas.0910516107; Scaloni F, 2009, FASEB J, V23, P2360, DOI 10.1096/fj.08-128306; Schilder J, 2013, CURR OPIN STRUC BIOL, V23, P911, DOI 10.1016/j.sbi.2013.07.009; Scognamiglio PL, 2014, BBA-GEN SUBJECTS, V1840, P2050, DOI 10.1016/j.bbagen.2014.02.017; Shandilya J, 2009, MOL CELL BIOL, V29, P5115, DOI 10.1128/MCB.01969-08; SWINT L, 1993, PROTEIN SCI, V2, P2037, DOI 10.1002/pro.5560021205; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Ubbink M, 2009, FEBS LETT, V583, P1060, DOI 10.1016/j.febslet.2009.02.046; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Wulff JE, 2007, J AM CHEM SOC, V129, P14444, DOI 10.1021/ja075327f	36	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21230	21241		10.1074/jbc.M114.565010	http://dx.doi.org/10.1074/jbc.M114.565010			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24952945	Green Published, hybrid			2022-12-25	WOS:000340558300003
J	Abdulmawjood, A; Grabowski, N; Fohler, S; Kittler, S; Nagengast, H; Klein, G				Abdulmawjood, Amir; Grabowski, Nils; Fohler, Svenja; Kittler, Sophie; Nagengast, Helga; Klein, Guenter			Development of Loop-Mediated Isothermal Amplification (LAMP) Assay for Rapid and Sensitive Identification of Ostrich Meat	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; SALMON SALMO-SALAR; LINKED-IMMUNOSORBENT-ASSAY; CYTOCHROME-B GENE; MITOCHONDRIAL-DNA; RFLP ANALYSIS; PCR; PRODUCTS	Animal species identification is one of the primary duties of official food control. Since ostrich meat is difficult to be differentiated macroscopically from beef, therefore new analytical methods are needed. To enforce labeling regulations for the authentication of ostrich meat, it might be of importance to develop and evaluate a rapid and reliable assay. In the present study, a loop-mediated isothermal amplification (LAMP) assay based on the cytochrome b gene of the mitochondrial DNA of the species Struthio camelus was developed. The LAMP assay was used in combination with a real-time fluorometer. The developed system allowed the detection of 0.01% ostrich meat products. In parallel, a direct swab method without nucleic acid extraction using the HYPLEX LPTV buffer was also evaluated. This rapid processing method allowed detection of ostrich meat without major incubation steps. In summary, the LAMP assay had excellent sensitivity and specificity for detecting ostrich meat and could provide a sampling-to-result identification-time of 15 to 20 minutes.	[Abdulmawjood, Amir; Grabowski, Nils; Fohler, Svenja; Kittler, Sophie; Nagengast, Helga; Klein, Guenter] Univ Vet Med, Inst Food Qual & Food Safety, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Abdulmawjood, A (corresponding author), Univ Vet Med, Inst Food Qual & Food Safety, Hannover, Germany.	amir.abdulmawjood@tiho-hannover.de	Klein, Günter/G-5321-2013; Abdulmawjood, Amir/C-6083-2015; Grabowski, Nils Th. T/D-8542-2015; Abdulmawjood, Amir/AAL-5523-2020	Klein, Günter/0000-0003-1931-2701; Abdulmawjood, Amir/0000-0001-5189-8381; Grabowski, Nils Th. T/0000-0003-0440-9594; Woudstra, Svenja/0000-0003-4668-1799				Abdulmawjood A, 2012, MEAT SCI, V91, P272, DOI 10.1016/j.meatsci.2012.02.001; Abdulmawjood A, 2003, J FOOD SCI, V68, P1757, DOI 10.1111/j.1365-2621.2003.tb12324.x; Abdulmawjood A, 2002, J FOOD SCI, V67, P1688, DOI 10.1111/j.1365-2621.2002.tb08706.x; Abdulmawjood A, 2001, J FOOD SCI, V66, P1287, DOI 10.1111/j.1365-2621.2001.tb15203.x; Carney BL, 1997, CAN J FISH AQUAT SCI, V54, P940, DOI 10.1139/cjfas-54-4-940; Carrera E, 1996, J FOOD PROTECT, V59, P521, DOI 10.4315/0362-028X-59.5.521; Carrera E, 1998, J FOOD PROTECT, V61, P482, DOI 10.4315/0362-028X-61.4.482; Carrera E, 1999, ARCH LEBENSMITTELHYG, V50, P76; Cespedes A, 1999, J FOOD PROTECT, V62, P1178, DOI 10.4315/0362-028X-62.10.1178; Curtis KA, 2008, J VIROL METHODS, V151, P264, DOI 10.1016/j.jviromet.2008.04.011; D'Amato Maria Eugenia, 2013, Investig Genet, V4, P6, DOI 10.1186/2041-2223-4-6; Kiddle G, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-15; Kistner C, 2004, STRAUSSE ZUCHT HALTU; Niessen L, 2013, FOOD MICROBIOL, V36, P191, DOI 10.1016/j.fm.2013.04.017; Njiru ZK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001572; Ram JL, 1996, J AGR FOOD CHEM, V44, P2460, DOI 10.1021/jf950822t; Rigaa A, 1997, HEREDITY, V79, P380, DOI 10.1038/sj.hdy.6882370; Tartaglia M, 1998, J FOOD PROTECT, V61, P513, DOI 10.4315/0362-028X-61.5.513; WILSON AC, 1985, BIOL J LINN SOC, V26, P375, DOI 10.1111/j.1095-8312.1985.tb02048.x; Yoshizaki G, 1997, J FISH BIOL, V51, P193, DOI 10.1006/jfbi.1997.0428	20	61	65	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100717	10.1371/journal.pone.0100717	http://dx.doi.org/10.1371/journal.pone.0100717			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963709	gold, Green Published, Green Submitted			2022-12-25	WOS:000338709500074
J	Leite, RN; Kolokotronis, SO; Almeida, FC; Werneck, FP; Rogers, DS; Weksler, M				Leite, Rafael N.; Kolokotronis, Sergios-Orestis; Almeida, Francisca C.; Werneck, Fernanda P.; Rogers, Duke S.; Weksler, Marcelo			In the Wake of Invasion: Tracing the Historical Biogeography of the South American Cricetid Radiation (Rodentia, Sigmodontinae)	PLOS ONE			English	Article							LOWER MIOCENE COMMUNITIES; DISPERSAL-VICARIANCE ANALYSIS; BIOTIC INTERCHANGE; NEOTROPICAL PALEOBOTANY; MIDDLE MIOCENE; PHYLOGENETIC ESTIMATION; DIVERSIFICATION RATES; CENTRAL ARGENTINA; FAUNAL TURNOVER; MUROID RODENTS	The Great American Biotic Interchange (GABI) was greatly influenced by the completion of the Isthmus of Panama and impacted the composition of modern faunal assemblages in the Americas. However, the contribution of preceding events has been comparatively less explored, even though early immigrants in the fossil records are evidence for waif dispersals. The cricetid rodents of the subfamily Sigmodontinae are a classic example of a species-rich South American radiation resulting from an early episode of North American invasion. Here, we provide a temporal and spatial framework to address key aspects of the historical biogeography and diversification of this diverse mammal group by using mitochondrial and nuclear DNA datasets coupled with methods of divergence time estimation, ancestral area reconstruction and comparative phylogenetics. Relaxed-clock time estimates indicate that divergence of the Sigmodontinae began in the middle-late Miocene (ca. 12-9 Ma). Dispersal-vicariance analyses point to the arrival of a single lineage of northern invaders with a widespread ancestral distribution and imply that the initial differentiation between Central and South America gave rise to the most basal groups within the subfamily. These two major clades diversified in the late Miocene followed by the radiation of main tribes until the early Pliocene. Within the Oryzomyalia, tribes diverged initially in eastern South America whereas multiple dispersals into the Andes promoted further diversification of the majority of modern genera. A comparatively uniform background tempo of diversification explains the species richness of sigmodontines across most nodes, except for two akodontine genera with recent increases in diversification rates. The bridging of the Central American seaway and episodes of low sea levels likely facilitated the invasion of South America long before the onset of the post-Isthmian phase of the GABI.	[Leite, Rafael N.; Rogers, Duke S.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Leite, Rafael N.; Werneck, Fernanda P.] Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil; [Kolokotronis, Sergios-Orestis] Fordham Univ, Dept Biol Sci, Bronx, NY 10458 USA; [Almeida, Francisca C.] Univ Barcelona, Dept Genet, Barcelona, Spain; [Rogers, Duke S.] Brigham Young Univ, Monte L Bean Life Sci Museum, Provo, UT 84602 USA; [Weksler, Marcelo] Univ Fed Estado Rio de Janeiro, Dept Zool, Rio De Janeiro, Brazil	Brigham Young University; Institute Nacional de Pesquisas da Amazonia; Fordham University; University of Barcelona; Brigham Young University; Universidade Federal do Estado do Rio de Janeiro	Leite, RN (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	rnleite@gmail.com	Almeida, Francisca Cunha/E-5849-2016; Leite, Rafael N./O-1216-2013; Kolokotronis, Sergios-Orestis/GWM-5773-2022; Kolokotronis, Sergios-Orestis/A-1910-2009; Weksler, Marcelo/A-7420-2010; Werneck, Fernanda P./J-9629-2013	Almeida, Francisca Cunha/0000-0001-6003-4657; Leite, Rafael N./0000-0002-3945-1007; Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Weksler, Marcelo/0000-0001-8111-4779; Werneck, Fernanda P./0000-0002-8779-2607	CAPES [BEX 1861/07-7]; BYU Graduate Student Society; Julia Greenwell scholarship from the College of Life Sciences; Monte L. Bean Life Science Museum; American Society of Mammalogists; Idea Wild; CNPq [BJT-374307/2012-1, 481286/2011-0]; FCA to the Juan de la Cierva Fellowship, Ministry of Science and Innovation; FAPERJ [E-26/110.505/2012, E-26/101.950/2012]; National Science Foundation (NSF) [DDIG/DEB1115208]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); BYU Graduate Student Society; Julia Greenwell scholarship from the College of Life Sciences; Monte L. Bean Life Science Museum; American Society of Mammalogists; Idea Wild; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FCA to the Juan de la Cierva Fellowship, Ministry of Science and Innovation; FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National Science Foundation (NSF)(National Science Foundation (NSF))	RNL was supported by CAPES (BEX 1861/07-7), BYU Graduate Student Society, Julia Greenwell scholarship from the College of Life Sciences, Monte L. Bean Life Science Museum, American Society of Mammalogists Grants-in-Aid, and Idea Wild. FPW is thankful to CNPq's Science Without Borders Program (BJT-374307/2012-1) and FCA to the Juan de la Cierva Fellowship, Ministry of Science and Innovation. MW was supported by FAPERJ (E-26/110.505/2012 and E-26/101.950/2012) and CNPq (481286/2011-0). Additional support was provided to RNL and DSR from the National Science Foundation (NSF) (DDIG/DEB1115208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Ali JR, 2012, J BIOGEOGR, V39, P431, DOI 10.1111/j.1365-2699.2011.02674.x; Almeida FC, 2007, MOL PHYLOGENET EVOL, V42, P449, DOI 10.1016/j.ympev.2006.07.005; Almendra Ana Laura, 2012, P203; Bacon CD, 2013, BOT J LINN SOC, V171, P287, DOI 10.1111/j.1095-8339.2012.01281.x; BASKIN JA, 1978, J MAMMAL, V59, P125, DOI 10.2307/1379882; Battistuzzi FU, 2010, MOL BIOL EVOL, V27, P1289, DOI 10.1093/molbev/msq014; Bermingham E, 1998, MOL ECOL, V7, P499, DOI 10.1046/j.1365-294x.1998.00358.x; Burnham RJ, 1999, ANN MO BOT GARD, V86, P546, DOI 10.2307/2666185; Campbell KE, 2010, J S AM EARTH SCI, V29, P619, DOI 10.1016/j.jsames.2009.11.007; Carleton Michael D., 1999, American Museum Novitates, V3256, P1; Cione Alberto L., 2007, Asociacion Paleontologica Argentina Publicacion Especial, V11, P257; Coates AG, 2004, GEOL SOC AM BULL, V116, P1327, DOI 10.1130/B25275.1; COATES AG, 1992, GEOL SOC AM BULL, V104, P814, DOI 10.1130/0016-7606(1992)104<0814:COTIOP>2.3.CO;2; Cody S, 2010, ECOGRAPHY, V33, P326, DOI 10.1111/j.1600-0587.2010.06327.x; Cole M., 1986, SAVANNAS BIOGEOGRAPH; COLINVAUX P, 1997, CENTRAL AM NATURAL C, P123; Collins LS, 1996, GEOLOGY, V24, P687, DOI 10.1130/0091-7613(1996)024<0687:TLMPIS>2.3.CO;2; Cusimano N, 2010, SYST BIOL, V59, P458, DOI 10.1093/sysbio/syq032; D'Elia G, 2003, CLADISTICS, V19, P307, DOI 10.1016/S0748-3007(03)00071-9; D'Elía Guillermo, 2007, Gayana (Concepc.), V71, P187; Da Silva JMC, 2002, BIOSCIENCE, V52, P225, DOI 10.1641/0006-3568(2002)052[0225:BPACIT]2.0.CO;2; DEBRUIJN H, 1970, PROC K NED AKAD B-PH, V73, P535; deGamero MLD, 1996, PALAEOGEOGR PALAEOCL, V123, P385, DOI 10.1016/0031-0182(96)00115-0; Dowler RC, 2000, ORYX, V34, P109, DOI 10.1046/j.1365-3008.2000.00104.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; DUQUECARO H, 1990, PALAEOGEOGR PALAEOCL, V77, P203, DOI 10.1016/0031-0182(90)90178-A; Engel SR, 1998, MOL BIOL EVOL, V15, P35, DOI 10.1093/oxfordjournals.molbev.a025845; Fabre PH, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-88; Farris DW, 2011, GEOLOGY; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Freudenthal Matthijs, 1998, Treballs del Museu de Geologia de Barcelona, V7, P11; GRAHAM A, 1988, ANN MO BOT GARD, V75, P1467, DOI 10.2307/2399296; GRAHAM A, 1988, ANN MO BOT GARD, V75, P1440, DOI 10.2307/2399295; GRAHAM A, 1989, ANN MO BOT GARD, V76, P50, DOI 10.2307/2399342; GRAHAM A, 1987, AM J BOT, V74, P1519, DOI 10.2307/2444046; Graham A, 1997, SYST BOT, V22, P139, DOI 10.2307/2419682; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; HERSHKOVITZ P, 1969, Q REV BIOL, V44, P1, DOI 10.1086/405975; Hershkovitz P, 1966, PARASITES PANAMA, P725; HIRSCHFELD SE, 1976, J PALEONTOL, V50, P433; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; HOORN C, 1995, GEOLOGY, V23, P237, DOI 10.1130/0091-7613(1995)023<0237:ATAACF>2.3.CO;2; Iturralde-Vinent MA, 1999, B AM MUS NAT HIST, P1; Jacobs LL, 1984, J VERTEBR PALEONTOL, V55, P265; Jansa SA, 2004, MOL PHYLOGENET EVOL, V31, P256, DOI 10.1016/j.ympev.2003.07.002; Janssen T, 2004, BOT J LINN SOC, V146, P385, DOI 10.1111/j.1095-8339.2004.00345.x; John CM, 2011, EARTH PLANET SC LETT, V304, P455, DOI 10.1016/j.epsl.2011.02.013; John CM, 2004, GEOLOGY, V32, P829, DOI 10.1130/G20580.1; Jombart T, 2010, BIOINFORMATICS, V26, P1907, DOI 10.1093/bioinformatics/btq292; Kelt DA, 2010, J MAMMAL, V91, P1524, DOI 10.1644/10-MAMM-A-306.1; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kirby MX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002791; Kirby MX, 2005, PALAEOGEOGR PALAEOCL, V228, P193, DOI 10.1016/j.palaeo.2005.06.002; Korth W.W., 1994, TERTIARY RECORD RODE; MARSHALL LG, 1982, SCIENCE, V215, P1351, DOI 10.1126/science.215.4538.1351; MARSHALL LG, 1979, PALEOBIOLOGY, V5, P126, DOI 10.1017/S0094837300006412; MARSHALL LG, 1988, AM SCI, V76, P380; Martinez JJ, 2012, ACTA THERIOL, V57, P277, DOI 10.1007/s13364-011-0070-9; Maslin MA, 1998, QUATERNARY SCI REV, V17, P411, DOI 10.1016/S0277-3791(97)00047-4; McCafferty WP, 1998, J N AM BENTHOL SOC, V17, P1, DOI 10.2307/1468048; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Montes C, 2012, GEOL SOC AM BULL, V124, P780, DOI 10.1130/B30528.1; Montes C, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008959; Morgan G, 2005, IDEA OF A EUROPEAN SUPERSTATE: PUBLIC JUSTIFICATION AND EUROPEAN INTEGRATION, P45; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; Nasif Norma L., 2009, Ser. correl. geol., V25, P105; Pacheco V, 2003, PHYLOGENETIC ANAL TH; Parada A, 2013, MOL PHYLOGENETICS EV; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2006, ANAL PHYLOGENETICS E; PATTERSON B, 1968, Q REV BIOL, V43, P409, DOI 10.1086/405916; Porter ML, 2005, MOL PHYLOGENET EVOL, V37, P355, DOI 10.1016/j.ympev.2005.06.021; Poux C, 2006, SYST BIOL, V55, P228, DOI 10.1080/10635150500481390; Prevosti FJ, 2009, PALAEOGEOGR PALAEOCL, V280, P543, DOI 10.1016/j.palaeo.2009.05.021; R Development Core Team, 2012, R LANG ENV STAT COMP; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; Rambaut A., 2007, TRACE V1 4; Reig O.A., 1981, Monographiae Naturae, P1; Reig O.A., 1978, Publicaciones del Museo Municipal de Ciencias Naturales "Lorenzo Scaglia", V2, P164; REIG OA, 1980, J ZOOL, V192, P257; REIG OA, 1984, REV BRAS GENET, V7, P333; Reig OA, 1975, ACTA CIENT VENEZ, V26, P7; Retallack GJ, 2007, PALAIOS, V22, P667, DOI 10.2110/palo.2006.p06-130r; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Pinto-Sanchez NR, 2012, MOL PHYLOGENET EVOL, V62, P954, DOI 10.1016/j.ympev.2011.11.022; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Rowe DL, 2010, J BIOGEOGR, V37, P305, DOI 10.1111/j.1365-2699.2009.02190.x; Sarmiento G., 1975, J BIOGEOGR, V2, P233, DOI DOI 10.2307/3037998; SARMIENTO G., 1976, EVOLUTION DESERT BIO, P65; Savage J.M., 1974, Contributions Sci, VNo. 260, P1; Schenk JJ, 2013, SYST BIOL, V62, P837, DOI 10.1093/sysbio/syt050; Simpson G. G., 1969, BIOGEOGRAPHY ECOLOGY, V19, P879; SIMPSON GEORGE GAYLORD, 1950, AMER SCIENTIST, V38, P361; Smith BT, 2010, ECOGRAPHY, V33, P333, DOI 10.1111/j.1600-0587.2009.06335.x; Smith MF, 1999, BIOL J LINN SOC, V50, P149; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stehli F. G, 1985, GREAT AM BIOTIC INTE; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Tomassini RL, 2013, J S AM EARTH SCI, V48, P31, DOI 10.1016/j.jsames.2013.08.002; Turvey ST, 2012, MAMM BIOL, V77, P404, DOI 10.1016/j.mambio.2012.03.005; Upham NS, 2012, MOL PHYLOGENET EVOL, V63, P417, DOI 10.1016/j.ympev.2012.01.020; Vanzolini P.E., 1985, Topics in Geobiology, V4, P475; Verzi DH, 2008, PALAEOGEOGR PALAEOCL, V267, P284, DOI 10.1016/j.palaeo.2008.07.003; Vilela JF, 2013, J ZOOLOGICAL SYSTEMA; Voss Robert S., 1993, American Museum Novitates, V3073, P1; VRBA ES, 1992, J MAMMAL, V73, P1, DOI 10.2307/1381862; WEBB S D, 1976, Paleobiology, V2, P220; Webb SD, 2006, ANN MO BOT GARD, V93, P245; WEBB SD, 1991, PALEOBIOLOGY, V17, P266, DOI 10.1017/S0094837300010605; WEBB SD, 1978, ANNU REV ECOL SYST, V9, P393, DOI 10.1146/annurev.es.09.110178.002141; Weir JT, 2009, P NATL ACAD SCI USA, V106, P21737, DOI 10.1073/pnas.0903811106; Weksler M, 2003, MOL PHYLOGENET EVOL, V29, P331, DOI 10.1016/S1055-7903(03)00132-5; WHITMORE FC, 1965, SCIENCE, V148, P180, DOI 10.1126/science.148.3667.180; Woodburne M.O., 2006, ADV LATE TERTIARY VE, V4, P73; Woodburne MO, 2010, J MAMM EVOL, V17, P245, DOI 10.1007/s10914-010-9144-8; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yu Y., 2013, RASP RECONSTRUCT ANC; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zeh JA, 2003, MOL ECOL, V12, P2759, DOI 10.1046/j.1365-294X.2003.01914.x	129	57	64	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100687	10.1371/journal.pone.0100687	http://dx.doi.org/10.1371/journal.pone.0100687			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963664	Green Submitted, Green Published, gold			2022-12-25	WOS:000338709500073
J	Utter, B; Deutsch, DR; Schuch, R; Winer, BY; Verratti, K; Bishop-Lilly, K; Sozhamannan, S; Fischetti, VA				Utter, Bryan; Deutsch, Douglas R.; Schuch, Raymond; Winer, Benjamin Y.; Verratti, Kathleen; Bishop-Lilly, Kim; Sozhamannan, Shanmuga; Fischetti, Vincent A.			Beyond the Chromosome: The Prevalence of Unique Extra-Chromosomal Bacteriophages with Integrated Virulence Genes in Pathogenic Staphylococcus aureus	PLOS ONE			English	Article							CHEMOTAXIS INHIBITORY PROTEIN; BACILLUS-ANTHRACIS; MOLECULAR CHARACTERIZATION; COMPLEMENT INHIBITOR; GENOMIC ANALYSIS; IMMUNE EVASION; PHAGE; EXPRESSION; EVOLUTION; TRANSDUCTION	In Staphylococcus aureus, the disease impact of chromosomally integrated prophages on virulence is well described. However, the existence of extra-chromosomal prophages, both plasmidial and episomal, remains obscure. Despite the recent explosion in bacterial and bacteriophage genomic sequencing, studies have failed to specifically focus on extra-chromosomal elements. We selectively enriched and sequenced extra-chromosomal DNA from S. aureus isolates using Roche-454 technology and uncovered evidence for the widespread distribution of multiple extra-chromosomal prophages (ExP Phi s) throughout both antibiotic-sensitive and -resistant strains. We completely sequenced one such element comprised of a 43.8 kbp, circular ExP Phi (designated Phi BU01) from a vancomycin-intermediate S. aureus (VISA) strain. Assembly and annotation of Phi BU01 revealed a number of putative virulence determinants encoded within a bacteriophage immune evasion cluster (IEC). Our identification of several potential ExP Phi s and mobile genetic elements (MGEs) also revealed numerous putative virulence factors and antibiotic resistance genes. We describe here a previously unidentified level of genetic diversity of stealth extra-chromosomal elements in S. aureus, including phages with a larger presence outside the chromosome that likely play a prominent role in pathogenesis and strain diversity driven by horizontal gene transfer (HGT).	[Utter, Bryan; Deutsch, Douglas R.; Schuch, Raymond; Winer, Benjamin Y.; Fischetti, Vincent A.] Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, New York, NY 10021 USA; [Verratti, Kathleen; Bishop-Lilly, Kim; Sozhamannan, Shanmuga] Henry M Jackson Fdn, Bethesda, MD USA; [Verratti, Kathleen; Bishop-Lilly, Kim; Sozhamannan, Shanmuga] Naval Med Res Ctr Frederick, Ft Detrick, MD USA	Rockefeller University; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Naval Medical Research Center (NMRC)	Utter, B (corresponding author), Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, 1230 York Ave, New York, NY 10021 USA.	butter@rockefeller.edu	Sozhamannan, Shanmuga/AGF-2410-2022; Sozhamannan, Shanmuga/AAN-7809-2020	Sozhamannan, Shanmuga/0000-0002-6762-7874; Winer, Benjamin/0000-0001-7895-2544	USPHS [AI-057472]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI070084, R01AI057472] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by USPHS grant AI-057472 to VAF from the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; BETLEY MJ, 1985, SCIENCE, V229, P185, DOI 10.1126/science.3160112; Bokarewa MI, 2006, INT J BIOCHEM CELL B, V38, P504, DOI 10.1016/j.biocel.2005.07.005; Bonilla CY, 2012, J BACTERIOL, V194, P5110, DOI 10.1128/JB.00958-12; Cao R, 2012, APPL ENVIRON MICROB, V78, P4942, DOI 10.1128/AEM.00803-12; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; CHINAULT AC, 1979, GENE, V5, P111; Chung M, 2000, MICROB DRUG RESIST, V6, P189, DOI 10.1089/mdr.2000.6.189; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; Euler CW, REVERSAL MUTAT UNPUB; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Gilmer DB, 2013, ANTIMICROB AGENTS CH, V57, P2743, DOI 10.1128/AAC.02526-12; Goerke C, 2004, J INFECT DIS, V189, P724, DOI 10.1086/381502; Goerke C, 2006, MOL MICROBIOL, V61, P1673, DOI 10.1111/j.1365-2958.2006.05354.x; Han CS, 2006, J BACTERIOL, V188, P3382, DOI 10.1128/JB.188.9.3382-3390.2006; Haraldsen JD, 2003, MOL MICROBIOL, V48, P811, DOI 10.1046/j.1365-2958.2003.03471.x; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; IKEDA H, 1968, COLD SPRING HARB SYM, V33, P791, DOI 10.1101/SQB.1968.033.01.091; Kahankova J, 2010, ENVIRON MICROBIOL, V12, P2527, DOI 10.1111/j.1462-2920.2010.02226.x; Kaneko J, 1998, GENE, V215, P57, DOI 10.1016/S0378-1119(98)00278-9; Kiel JL, 2008, FOLIA MICROBIOL, V53, P472, DOI 10.1007/s12223-008-0074-2; KIRBY JE, 1994, J BACTERIOL, V176, P2068, DOI 10.1128/jb.176.7.2068-2081.1994; Klumpp Jochen, 2012, Bacteriophage, V2, P190; Kos VN, 2012, MBIO, V3, DOI 10.1128/mBio.00112-12; KUNKEL B, 1990, GENE DEV, V4, P525, DOI 10.1101/gad.4.4.525; Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102; Lawrence JG, 2001, TRENDS MICROBIOL, V9, P535, DOI 10.1016/S0966-842X(01)02198-9; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Lindsay JA, 2004, TRENDS MICROBIOL, V12, P378, DOI 10.1016/j.tim.2004.06.004; Lindsay Jodi A., 2006, Functional & Integrative Genomics, V6, P186, DOI 10.1007/s10142-005-0019-7; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; LOCHHEAD AG, 1952, J BACTERIOL, V63, P219, DOI 10.1128/JB.63.2.219-226.1952; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matos RC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003539; McCarthy AJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00006; McCarthy AJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-104; Mobberley JM, 2008, J VIROL, V82, P6618, DOI 10.1128/JVI.00140-08; Moore PCL, 2001, J CLIN MICROBIOL, V39, P2760, DOI 10.1128/JCM.39.8.2760-2767.2001; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Rokop ME, 2004, MOL MICROBIOL, V52, P1757, DOI 10.1111/j.1365-2958.2004.04091.x; Romero P, 2009, J BACTERIOL, V191, P4854, DOI 10.1128/JB.01272-08; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Rooijakkers SHM, 2006, CELL MICROBIOL, V8, P1282, DOI 10.1111/j.1462-5822.2006.00709.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Scharn CR, 2013, ANTIMICROB AGENTS CH, V57, P5233, DOI 10.1128/AAC.01058-13; Schuch R, 2006, J BACTERIOL, V188, P3037, DOI 10.1128/JB.188.8.3037-3051.2006; Schuch R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006532; Shambrook J, 2001, MOL CLONING LAB MANU; Shearer JES, 2011, G3-GENES GENOM GENET, V1, P581, DOI 10.1534/g3.111.000760; Sozhamannan S, 2008, APPL ENVIRON MICROB, V74, P6792, DOI 10.1128/AEM.01124-08; Tao LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000888; THORNE CB, 1968, BACTERIOL REV, V32, P358, DOI 10.1128/MMBR.32.4_Pt_1.358-361.1968; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; VERA T, 1968, AM J VET RES, V29, P1059; WALKER DH, 1976, J VIROL, V19, P271, DOI 10.1128/JVI.19.1.271-274.1976; Xia GQ, 2014, INFECT GENET EVOL, V21, P593, DOI 10.1016/j.meegid.2013.04.022; Zabala B, 2009, APPL ENVIRON MICROB, V75, P1697, DOI 10.1128/AEM.01995-08	61	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100502	10.1371/journal.pone.0100502	http://dx.doi.org/10.1371/journal.pone.0100502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963913	gold, Green Published, Green Submitted			2022-12-25	WOS:000338709500058
J	Yang, JH; Liu, JW; Liu, J; Li, WY; Li, XY; He, Y; Ye, L				Yang, Jinghui; Liu, Jianwei; Liu, Jing; Li, Wenyuan; Li, Xiaoying; He, Yao; Ye, Ling			Genetic Association Study with Metabolic Syndrome and Metabolic-Related Traits in a Cross-Sectional Sample and a 10-Year Longitudinal Sample of Chinese Elderly Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PANCREATIC BETA-CELLS; INSULIN-RESISTANCE; SUSCEPTIBILITY LOCI; MESSENGER-RNA; INSIG2 GENE; RISK LOCI; TYPE-2; OBESITY; POLYMORPHISM	Background: The metabolic syndrome (MetS) has been known as partly heritable, while the number of genetic studies on MetS and metabolic-related traits among Chinese elderly was limited. Methods: A cross-sectional analysis was performed among 2 014 aged participants from September 2009 to June 2010 in Beijing, China. An additional longitudinal study was carried out among the same study population from 2001 to 2010. Biochemical profile and anthropometric parameters of all the participants were measured. The associations of 23 SNPs located within 17 candidate genes (MTHFR, PPAR gamma, LPL, INSIG, TCF7L2, FTO, KCNJ11, JAZF1, CDKN2A/B, ADIPOQ, WFS1, CDKAL1, IGF2BP2, KCNQ1, MTNR1B, IRS1, ACE) with overweight and obesity, diabetes, metabolic phenotypes, and MetS were examined in both studies. Results: In this Chinese elderly population, prevalence of overweight, central obesity, diabetes, dyslipidemia, hypertension, and MetS were 48.3%, 71.0%, 32.4%, 75.7%, 68.3% and 54.5%, respectively. In the cross-sectional analyses, no SNP was found to be associated with MetS. Genotype TT of SNP rs4402960 within the gene IGF2BP2 was associated with overweight (odds ratio (OR) = 0.479, 95% confidence interval (CI): 0.316-0.724, p = 0.001) and genotype CA of SNP rs1801131 within the gene MTHFR was associated with hypertension (OR = 1.560, 95% CI: 1.194-2.240, p = 0.001). However, these associations were not observed in the longitudinal analyses. Conclusions: The associations of SNP rs4402960 with overweight as well as the association of SNP rs1801131 with hypertension were found to be statistically significant. No SNP was identified to be associated with MetS in our study with statistical significance.	[Yang, Jinghui; Liu, Jianwei; Liu, Jing; Li, Xiaoying; He, Yao; Ye, Ling] Gen Hosp Peoples Liberat Army, Inst Geriatr, Beijing, Peoples R China; [Yang, Jinghui; Liu, Jianwei; Liu, Jing; He, Yao; Ye, Ling] Gen Hosp Peoples Liberat Army, Beijing Key Lab Aging & Geriatr, Beijing, Peoples R China; [Li, Wenyuan] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Li, Xiaoying] Gen Hosp Peoples Liberat Army, Dept Geriatr Cardiol, Beijing, Peoples R China	Harvard University; Harvard T.H. Chan School of Public Health	He, Y (corresponding author), Gen Hosp Peoples Liberat Army, Inst Geriatr, Beijing, Peoples R China.	yhe301@x263.net; lye301@gmail.com	Li, Wenyuan/AAD-4648-2019; Li, Wenyuan/GOG-9505-2022	Li, Wenyuan/0000-0001-6196-9964; He, Yao/0000-0001-6205-7895	Beijing Municipal Science and Technology Commission [D121100004912003]; Special Research Fund of the Ministry of Health of China [201002011]; National Natural Science Foundation of China [21071150, 81072355]	Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Special Research Fund of the Ministry of Health of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Beijing Municipal Science and Technology Commission (No. D121100004912003), Special Research Fund of the Ministry of Health of China (No. 201002011), the National Natural Science Foundation of China (No. 21071150 and No. 81072355). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; [Anonymous], IDF CONS WORLDW DEF; Bellia A, 2009, NUTR METAB CARDIOVAS, V19, P455, DOI 10.1016/j.numecd.2008.11.002; Boes E, 2008, OBESITY, V16, P827, DOI 10.1038/oby.2007.132; Bosy-Westphal A, 2007, INT J OBESITY, V31, P784, DOI 10.1038/sj.ijo.0803481; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Ciullo M, 2008, DIABETES, V57, P783, DOI 10.2337/db07-0970; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gavin JR, 1997, DIABETES CARE, V20, P1183; Groenewoud MJ, 2008, DIABETOLOGIA, V51, P1659, DOI 10.1007/s00125-008-1083-z; HAFFNER SM, 1992, DIABETES, V41, P715, DOI 10.2337/diabetes.41.6.715; He Y, 2006, J VASC SURG, V44, P333, DOI 10.1016/j.jvs.2006.03.032; Henneman P, 2008, J MED GENET, V45, P572, DOI 10.1136/jmg.2008.058388; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hu C, 2009, DIABETOLOGIA, V52, P1322, DOI 10.1007/s00125-009-1335-6; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Kumar J, 2007, CLIN GENET, V71, P415, DOI 10.1111/j.1399-0004.2007.00795.x; Li X, 2009, OBESITY, V17, P729, DOI 10.1038/oby.2008.593; Liu Y, 2009, DIABETOLOGIA, V52, P1315, DOI 10.1007/s00125-009-1375-y; MacDonald PE, 2002, J BIOL CHEM, V277, P44938, DOI 10.1074/jbc.M205532200; MacDonald PE, 2001, MOL ENDOCRINOL, V15, P1423, DOI 10.1210/me.15.8.1423; Markan S, 2007, MOL CELL BIOCHEM, V302, P125, DOI 10.1007/s11010-007-9434-5; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Oki K, 2009, BRIT J NUTR, V101, P322, DOI 10.1017/S0007114508006557; Palmer ND, 2008, DIABETES, V57, P1093, DOI 10.2337/db07-1169; Pollex RL, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-80; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Rong R, 2009, DIABETES, V58, P478, DOI 10.2337/db08-0877; Rosskopf D, 2007, SCIENCE, V315, P187, DOI DOI 10.1126/science.1130571; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Salonen JT, 2007, AM J HUM GENET, V81, P338, DOI 10.1086/520599; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Smith AJP, 2007, INT J OBESITY, V31, P1753, DOI 10.1038/sj.ijo.0803645; Steinthorsdottir V, NET GENET, V39, P770; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Timpson NJ, 2009, DIABETES, V58, P505, DOI 10.2337/db08-0906; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; World Health Organization, 2000, ASIA PACIFIC PERSPEC; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yang WS, 2007, AM J CLIN NUTR, V86, P509, DOI 10.1093/ajcn/86.2.509; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Yu W, 2012, DIABETOLOGIA, V55, P2655, DOI 10.1007/s00125-012-2636-8; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang M, 2005, J GEN PHYSIOL, V126, P353, DOI 10.1085/jgp.200509312	54	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100548	10.1371/journal.pone.0100548	http://dx.doi.org/10.1371/journal.pone.0100548			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959828	Green Submitted, Green Published, gold			2022-12-25	WOS:000338633900056
J	Yi, W; Tian, Q; Dai, ZP; Liu, XH				Yi, Wei; Tian, Qing; Dai, Zhipeng; Liu, Xiaohu			Mechanical Behaviour of Umbrella-Shaped, Ni-Ti Memory Alloy Femoral Head Support Device during Implant Operation: A Finite Element Analysis Study	PLOS ONE			English	Article							EARLY OSTEONECROSIS; OSTEOTOMY; MODEL	A new instrument used for treating femoral head osteonecrosis was recently proposed: the umbrella-shaped, Ni-Ti memory femoral head support device. The device has an efficacy rate of 82.35%. Traditional radiographic study provides limited information about the mechanical behaviour of the support device during an implant operation. Thus, this study proposes a finite element analysis method, which includes a 3-step formal head model construction scheme and a unique material assignment strategy for evaluating mechanical behaviour during an implant operation. Four different scenarios with different constraints, initial positions and bone qualities are analyzed using the simulation method. The max radium of the implanted device was consistent with observation data, which confirms the accuracy of the proposed method. To ensure that the device does not unexpectedly open and puncture the femoral head, the constraint on the impact device should be strong. The initial position of sleeve should be in the middle to reduce the damage to the decompression channel. The operation may fail because of poor bone quality caused by severe osteoporosis. The proposed finite element analysis method has proven to be an accurate tool for studying the mechanical behaviour of umbrella-shaped, Ni-Ti memory alloy femoral head support device during an implant operation. The 3-step construct scheme can be implemented with any kind of bone structure meshed with multiple element types.	[Yi, Wei; Liu, Xiaohu] Huazhong Univ Sci & Technol, Dept Mech, Wuhan 430074, Hubei, Peoples R China; [Tian, Qing; Dai, Zhipeng] Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Liu, XH (corresponding author), Huazhong Univ Sci & Technol, Dept Mech, Wuhan 430074, Hubei, Peoples R China.	xhliu@mail.hust.edu.cn		Liu, Xiaohu/0000-0002-8973-438X	National Natural Science Foundation of China [11172110]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China through the project No. 11172110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge JM, 2004, J BONE JOINT SURG AM, V86A, P1955, DOI 10.2106/00004623-200409000-00014; Auricchio F, 1997, COMPUT METHOD APPL M, V143, P175, DOI 10.1016/S0045-7825(96)01147-4; Brinson L.C., 1993, J INTEL MAT SYST STR, V4, P229, DOI [10.1177/1045389X9300400213, DOI 10.1177/1045389X9300400213]; Burgers TA, 2008, J BIOMECH, V41, P1077, DOI 10.1016/j.jbiomech.2007.11.018; Christ D, 2009, INT J SOLIDS STRUCT, V46, P3694, DOI 10.1016/j.ijsolstr.2009.06.017; Gao XJ, 2000, INT J PLASTICITY, V16, P1345, DOI 10.1016/S0749-6419(00)00013-9; Gibson Lorna J, 1999, CELLULAR SOLIDS STRU, DOI DOI 10.1017/CBO9781139878326; Kainuma R, 1986, MECH ALL ROUND SHAPE, P717; KOO KH, 1995, J BONE JOINT SURG BR, V77B, P870, DOI 10.1302/0301-620X.77B6.7593097; Lutz A, 2011, BIOMECH MODEL MECHAN, V10, P627, DOI 10.1007/s10237-010-0261-3; Marker DR, 2008, J BONE JOINT SURG AM, V90A, P175, DOI 10.2106/JBJS.H.00671; MULLER I, 1979, ARCH RATION MECH AN, V70, P61, DOI 10.1007/BF00276382; Necchi S, 2008, INT ENDOD J, V41, P939, DOI 10.1111/j.1365-2591.2008.01454.x; Plakseychuk AY, 2003, J BONE JOINT SURG AM, V85A, P589, DOI 10.2106/00004623-200304000-00001; Shuler MS, 2007, J ARTHROPLASTY, V22, P26, DOI 10.1016/j.arth.2006.03.007; SUGIOKA Y, 1992, CLIN ORTHOP RELAT R, P111; SUN QP, 1993, J MECH PHYS SOLIDS, V41, P1, DOI 10.1016/0022-5096(93)90060-S; TANAKA K, 1986, RES MECH, V18, P251; Wang Y, 2009, J ARTHROPLASTY, V24, P1006, DOI 10.1016/j.arth.2008.07.010; Yu X., 2013, 2013 S DESIGN TEST I, P1; Zhao G, 2010, J BONE JOINT SURG BR, V92B, P781, DOI 10.1302/0301-620X.92B6.23621	21	0	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100765	10.1371/journal.pone.0100765	http://dx.doi.org/10.1371/journal.pone.0100765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960038	Green Published, gold, Green Submitted			2022-12-25	WOS:000338633900083
J	Ao, Y; Mich-Basso, JD; Lin, B; Yang, L				Ao, Ying; Mich-Basso, Jocelyn Danielle; Lin, Bo; Yang, Lei			High Efficient Differentiation of Functional Hepatocytes from Porcine Induced Pluripotent Stem Cells	PLOS ONE			English	Article							HEPATIC DIFFERENTIATION; DEFINITIVE ENDODERM; EPITHELIAL-CELLS; GROWTH-FACTOR; LIVER; EXPRESSION; TRANSPLANTATION; COMBINATION; GENERATION; PATHWAYS	Hepatocyte transplantation is considered to be a promising therapy for patients with liver diseases. Induced pluripotent stem cells (iPSCs) provide an unlimited source for the generation of functional hepatocytes. In this study, we generated iPSCs from porcine ear fibroblasts (PEFs) by overexpressing Sox2, Klf4, Oct4, and c-Myc (SKOM), and developed a novel strategy for the efficient differentiation of hepatocyte-like cells from porcine iPSCs by following the processes of early liver development. The differentiated cells displayed the phenotypes of hepatocytes, exhibited classic hepatocyte-associated bio-functions, such as LDL uptake, glycogen storage and urea secretion, as well as possessed the metabolic activities of cytochrome P-450 (CYP) 3A and 2C. Furthermore, we compared the hepatocyte differentiation efficacy of our protocol with another published method, and the results demonstrated that our differentiation strategy could significantly improve the generation of morphological and functional hepatocyte-like cells from porcine iPSCs. In conclusion, this study establishes an efficient method for in vitro generation of functional hepatocytes from porcine iPSCs, which could represent a promising cell source for preclinical testing of cell-based therapeutics for liver failure and for pharmacological applications.	[Ao, Ying] Wuhan Univ, Dept Pharmacol, Basic Med Sch, Wuhan 430072, Hubei, Peoples R China; [Ao, Ying; Mich-Basso, Jocelyn Danielle; Lin, Bo; Yang, Lei] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA 15260 USA	Wuhan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yang, L (corresponding author), Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA 15260 USA.	lyang@pitt.edu	Yang, Lei/D-7462-2015		National Institutes of Health Grants through the University of Pittsburgh Clinical and Translational Science Institute [UL1 RR024153, UL1TR000005]; National Natural Science Foundation of China [81001466]; State Scholarship Fund of China [201208420547]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	National Institutes of Health Grants through the University of Pittsburgh Clinical and Translational Science Institute; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Scholarship Fund of China; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by the National Institutes of Health Grants UL1 RR024153 and UL1TR000005 through the University of Pittsburgh Clinical and Translational Science Institute to Stem Cell Core at of University of Pittsburgh under direction by L.Y., and by National Natural Science Foundation of China (No. 81001466) and State Scholarship Fund of China (No. 201208420547) to Y.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2008, STEM CELLS, V26, P1117, DOI 10.1634/stemcells.2007-1102; Aravalli RN, 2012, VET J, V194, P369, DOI 10.1016/j.tvjl.2012.05.013; Balasiddaiah A, 2013, J PHYSIOL BIOCHEM, V69, P835, DOI 10.1007/s13105-013-0260-9; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; BELANGER L, 1981, BIOCHEMISTRY-US, V20, P6665, DOI 10.1021/bi00526a022; Caperna TJ, 2011, IN VITRO CELL DEV-AN, V47, P218, DOI 10.1007/s11626-010-9382-3; Chen YF, 2012, HEPATOLOGY, V55, P1193, DOI 10.1002/hep.24790; Cheng X, 2012, CELL STEM CELL, V10, P371, DOI 10.1016/j.stem.2012.02.024; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; DEJUAN C, 1992, J CELL PHYSIOL, V152, P95, DOI 10.1002/jcp.1041520113; Fitzpatrick E, 2009, J INTERN MED, V266, P339, DOI 10.1111/j.1365-2796.2009.02152.x; Fondevila C, 2011, J SURG RES, V167, pE39, DOI 10.1016/j.jss.2011.01.012; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Ma XC, 2013, STEM CELL TRANSL MED, V2, P409, DOI 10.5966/sctm.2012-0160; NAWA K, 1986, J BIOL CHEM, V261, P6883; Nieuwoudt M, 2006, BIOMATERIALS, V27, P3836, DOI 10.1016/j.biomaterials.2006.02.013; Qian LC, 2012, BIOTECHNOL J, V7, P440, DOI 10.1002/biot.201100184; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; Sanchez A, 2010, WORLD J GASTROENTERO, V16, P5148, DOI 10.3748/wjg.v16.i41.5148; Sancho-Bru P, 2011, J HEPATOL, V54, P98, DOI 10.1016/j.jhep.2010.06.014; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Snykers S, 2009, STEM CELLS, V27, P577, DOI 10.1634/stemcells.2008-0963; Sui L, 2013, INT J DEV BIOL, V57, P1, DOI [10.1387/ijdb.1201151s, 10.1387/ijdb.120115ls]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tanimizu N, 2004, J CELL SCI, V117, P3165, DOI 10.1242/jcs.01169; Watt AJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-37; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu Y, 2012, STEM CELL RES, V9, P196, DOI 10.1016/j.scr.2012.06.004; Zhang Q, 2011, CHINESE MED J-PEKING, V124, P3786, DOI 10.3760/cma.j.issn.0366-6999.2011.22.033; Zhang WX, 2010, ADV DRUG DELIVER REV, V62, P814, DOI 10.1016/j.addr.2010.02.005	31	16	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100417	10.1371/journal.pone.0100417	http://dx.doi.org/10.1371/journal.pone.0100417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949734	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000338276300073
J	Hansell, AL; Rose, N; Cowie, CT; Belousova, EG; Bakolis, I; Ng, K; Toelle, BG; Marks, GB				Hansell, Anna L.; Rose, Nectarios; Cowie, Christine T.; Belousova, Elena G.; Bakolis, Ioannis; Ng, Kitty; Toelle, Brett G.; Marks, Guy B.		Childhood Asthma Prevention Study	Weighted Road Density and Allergic Disease in Children at High Risk of Developing Asthma	PLOS ONE			English	Article							AIR-POLLUTION EXPOSURE; RESPIRATORY SYMPTOMS; LUNG-FUNCTION; NITROGEN-DIOXIDE; BRONCHIAL HYPERRESPONSIVENESS; CHILDHOOD ASTHMA; SCHOOLCHILDREN; SENSITIZATION; PREVALENCE; ATOPY	Background: Evidence for an association between traffic-related air pollution and allergic disease is inconsistent, possibly because the adverse effects may be limited to susceptible subgroups and these have not been identified. This study examined children in the Childhood Asthma Prevention Study (CAPS), potentially susceptible to air pollution effects because of a family history of asthma. Methods: We examined cross-sectional associations at age eight years between road density within 75 m and 50 m of home address weighted by road type (traffic density), as a proxy for traffic-related air pollution, on the following allergic and respiratory outcomes: skin prick tests (SPTs), total and specific serum IgE, pre- and post-bronchodilator lung function, airway hyperresponsiveness, exhaled NO, and reported asthma and rhinitis. Results: Weighted road density was positively associated with allergic sensitisation and allergic rhinitis. Adjusted relative risk (RR) for house dust mite (HDM) positive SPT was 1.25 (95% CI: 1.06-1.48), for detectable house dust mite-specific IgE was 1.19 (95% CI: 1.01-1.41) and for allergic rhinitis was 1.30 (95% CI: 1.03-1.63) per 100 m local road or 33.3 m motorway within 50 m of home. Associations were also seen with small decrements of peak and mid-expiratory flows and increased risk of asthma, current wheeze and rhinitis in atopic children. Conclusion: Associations between road density and allergic disease were found in a potentially susceptible subgroup of children at high risk of developing atopy and asthma.	[Hansell, Anna L.; Bakolis, Ioannis] Univ London Imperial Coll Sci Technol & Med, MRC PHE Ctr Environm & Hlth, London, England; [Hansell, Anna L.] Imperial Coll Healthcare NHS Trust, Publ Hlth & Primary Care Directorate, London, England; [Rose, Nectarios; Cowie, Christine T.; Belousova, Elena G.; Ng, Kitty; Toelle, Brett G.; Marks, Guy B.] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia; [Rose, Nectarios] New South Wales Hlth Minist, Sydney, NSW, Australia; [Cowie, Christine T.; Marks, Guy B.] Univ New S Wales, South West Sydney Clin Sch, Liverpool, NSW, Australia; [Toelle, Brett G.] Sydney Local Hlth Dist, Sydney, NSW, Australia; [Marks, Guy B.] Liverpool Hosp, Dept Resp Med, Liverpool, NSW, Australia	Imperial College London; Imperial College London; University of Sydney; Woolcock Institute of Medical Research; University of New South Wales Sydney; Liverpool Hospital	Hansell, AL (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC PHE Ctr Environm & Hlth, London, England.	a.hansell@imperial.ac.uk	Toelle, Brett G/B-1531-2008; Cowie, Christine T/M-2864-2017; Cowie, Christine/X-5945-2019; Marks, Guy B./F-5058-2013	Toelle, Brett G/0000-0002-7375-0019; Cowie, Christine T/0000-0003-1177-4733; Cowie, Christine/0000-0003-1177-4733; Marks, Guy B./0000-0002-8976-8053; Bakolis, Ioannis/0000-0002-4800-1630; Garden, Frances/0000-0003-1653-3031; Hansell, Anna/0000-0001-9904-7447; Rose, Nectarios/0000-0002-7384-9967	National Health and Medical Research Council of Australia; Cooperative Research Centre for Asthma; New South Wales Department of Health; Children's Hospital Westmead; University of Sydney, Faculty of Medicine; Wellcome Trust [075833]; University of Sydney International Visiting Research Fellowship; New South Wales Department of Health Biostatistical Training Program; Medical Research Council [G0801056] Funding Source: researchfish; MRC [G0801056] Funding Source: UKRI	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cooperative Research Centre for Asthma(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); New South Wales Department of Health; Children's Hospital Westmead; University of Sydney, Faculty of Medicine(University of Sydney); Wellcome Trust(Wellcome TrustEuropean Commission); University of Sydney International Visiting Research Fellowship(University of Sydney); New South Wales Department of Health Biostatistical Training Program; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Sources of funding and support for this work include: National Health and Medical Research Council of Australia, Cooperative Research Centre for Asthma, New South Wales Department of Health, Children's Hospital Westmead, University of Sydney, Faculty of Medicine, University of Sydney, Faculty of Medicine, Strategic Research Grant 2008. Contributions of goods and services were made by Allergopharma Joachim Ganzer KG Germany, John Sands Australia, Hasbro, Toll refrigerated, AstraZeneca Australia, and Nu-Mega Ingredients Pty Ltd. Goods were provided at reduced cost by Auspharm, Allersearch and Goodman Fielder Foods. AH was funded by Wellcome Trust grant number 075833 and a University of Sydney International Visiting Research Fellowship. NR was supported by the New South Wales Department of Health Biostatistical Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Institute of Health and Welfare website. Australian Centre for Asthma Monitoring (ACAM), 2011, AIHW ASTHM SER, V6; Baumann LM, 2011, J ALLERGY CLIN IMMUN, V127, P875, DOI 10.1016/j.jaci.2010.11.031; Bel EH, 2004, CURR OPIN PULM MED, V10, P44, DOI 10.1097/00063198-200401000-00008; Braback L, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-17; Brauer M, 2002, AM J RESP CRIT CARE, V166, P1092, DOI 10.1164/rccm.200108-007OC; Dales R, 2008, ENVIRON HEALTH PERSP, V116, P1423, DOI 10.1289/ehp.10943; Department of Environment CCaWN, 2010, CURR AIR QUAL NEW S; Diaz-Sanchez D, 1999, J ALLERGY CLIN IMMUN, V104, P1183, DOI 10.1016/S0091-6749(99)70011-4; Gauderman WJ, 2005, EPIDEMIOLOGY, V16, P737, DOI 10.1097/01.ede.0000181308.51440.75; Gehring U, 2013, ENVIRON HEALTH PERSP, V121, P1357, DOI 10.1289/ehp.1306770; Gehring U, 2010, AM J RESP CRIT CARE, V181, P596, DOI 10.1164/rccm.200906-0858OC; Gilbert NL, 2003, SCI TOTAL ENVIRON, V312, P43, DOI 10.1016/S0048-9697(03)00228-6; Gruzieva O, 2014, J ALLERGY CLIN IMMUN, V133, P767, DOI 10.1016/j.jaci.2013.07.048; Gruzieva O, 2012, J ALLERGY CLIN IMMUN, V129, P240, DOI 10.1016/j.jaci.2011.11.001; HEI publications website, 2010, TRAFFIC RELATED AIR; Hirsch T, 1999, EUR RESPIR J, V14, P669, DOI 10.1034/j.1399-3003.1999.14c29.x; Janssen NAH, 2003, ENVIRON HEALTH PERSP, V111, P1512, DOI 10.1289/ehp.6243; Karner AA, 2010, ENVIRON SCI TECHNOL, V44, P5334, DOI 10.1021/es100008x; Kim JJ, 2004, AM J RESP CRIT CARE, V170, P520, DOI 10.1164/rccm.200403-281OC; Lee YL, 2011, INT J HYG ENVIR HEAL, V214, P369, DOI 10.1016/j.ijheh.2011.05.004; Mihrshahi S, 2001, CONTROL CLIN TRIALS, V22, P333, DOI 10.1016/S0197-2456(01)00112-X; Morgenstern V, 2008, AM J RESP CRIT CARE, V177, P1331, DOI 10.1164/rccm.200701-036OC; Nicolai T, 2003, EUR RESPIR J, V21, P956, DOI 10.1183/09031936.03.00041103a; Nordling E, 2008, EPIDEMIOLOGY, V19, P401, DOI 10.1097/EDE.0b013e31816a1ce3; Osman Mustafa, 2007, Prim Care Respir J, V16, P28, DOI 10.3132/pcrj.2007.00006; Pearce N, 1999, THORAX, V54, P268, DOI 10.1136/thx.54.3.268; PEAT JK, 1990, J ALLERGY CLIN IMMUN, V85, P65, DOI 10.1016/0091-6749(90)90223-Q; Peters JM, 1999, AM J RESP CRIT CARE, V159, P760, DOI 10.1164/ajrccm.159.3.9804143; Pujades-Rodriguez M, 2009, OCCUP ENVIRON MED, V66, P679, DOI 10.1136/oem.2008.043885; Rose N, 2009, ATMOS ENVIRON, V43, P5009, DOI 10.1016/j.atmosenv.2009.06.049; Rosenlund M, 2009, THORAX, V64, P573, DOI 10.1136/thx.2007.094953; Schultz ES, 2012, AM J RESP CRIT CARE, V186, P1286, DOI 10.1164/rccm.201206-1045OC; Shima M, 2000, INT J EPIDEMIOL, V29, P862, DOI 10.1093/ije/29.5.862; Studnicka M, 1997, EUR RESPIR J, V10, P2275, DOI 10.1183/09031936.97.10102275; Toelle BG, 2004, BRIT MED J, V328, P386, DOI 10.1136/bmj.328.7436.386; Toelle BG, 2010, J ALLERGY CLIN IMMUN, V126, P388, DOI 10.1016/j.jaci.2010.04.031; vanVliet P, 1997, ENVIRON RES, V74, P122, DOI 10.1006/enrs.1997.3757; Venn A, 2000, OCCUP ENVIRON MED, V57, P152, DOI 10.1136/oem.57.3.152; WJST M, 1993, BRIT MED J, V307, P596, DOI 10.1136/bmj.307.6904.596; Zhou Y, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-89; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	41	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e98978	10.1371/journal.pone.0098978	http://dx.doi.org/10.1371/journal.pone.0098978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949625	gold, Green Published, Green Submitted			2022-12-25	WOS:000338276300008
J	Luo, R; Jeong, SJ; Yang, AN; Wen, MY; Saslowsky, DE; Lencer, WI; Arac, D; Piao, XH				Luo, Rong; Jeong, Sung-Jin; Yang, Annie; Wen, Miaoyun; Saslowsky, David E.; Lencer, Wayne I.; Arac, Demet; Piao, Xianhua			Mechanism for Adhesion G Protein-Coupled Receptor GPR56-Mediated RhoA Activation Induced By Collagen III Stimulation	PLOS ONE			English	Article							LIPID RAFTS; CELL-ADHESION; FRONTOPARIETAL POLYMICROGYRIA; GPR56; GPCR; LAMINATION; EXPRESSION; SUBUNITS; DOMAIN; ROLES	GPR56 is a member of the adhesion G protein-coupled receptor (GPCR) family. Despite the importance of GPR56 in brain development, where mutations cause a devastating human brain malformation called bilateral frontoparietal polymicrogyria (BFPP), the signaling mechanism(s) remain largely unknown. Like many other adhesion GPCRs, GPR56 is cleaved via a GPCR autoproteolysis-inducing (GAIN) domain into N- and C-terminal fragments (GPR56(N) and GPR56(C)); however, the biological significance of this cleavage is elusive. Taking advantage of the recent identification of a GPR56 ligand and the presence of BFPP-associated mutations, we investigated the molecular mechanism of GPR56 signaling. We demonstrate that ligand binding releases GPR56(N) from the membrane-bound GPR56(C) and triggers the association of GPR56(C) with lipid rafts and RhoA activation. Furthermore, one of the BFPP-associated mutations, L640R, does not affect collagen III-induced lipid raft association of GPR56. Instead, it specifically abolishes collagen III-mediated RhoA activation. Together, these findings reveal a novel signaling mechanism that may apply to other members of the adhesion GPCR family.	[Luo, Rong; Jeong, Sung-Jin; Yang, Annie; Wen, Miaoyun; Piao, Xianhua] Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA; [Luo, Rong; Jeong, Sung-Jin; Yang, Annie; Wen, Miaoyun; Piao, Xianhua] Harvard Univ, Sch Med, Boston, MA USA; [Saslowsky, David E.; Lencer, Wayne I.] Boston Childrens Hosp, Div Gastroenterol, Boston, MA USA; [Arac, Demet] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Chicago	Piao, XH (corresponding author), Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA.	xianhua.piao@childrens.harvard.edu		Lencer, Wayne/0000-0001-7346-2730; Piao, Xianhua/0000-0001-7540-6767	National Institute of Neurological Disorders and Stroke (NINDS) [R01 NS057536]; William Randolph Hearst Fund Award; Leonard and Isabelle Goldenson Research Fellowship; Cerebral Palsy International Research Foundation Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048106, R37DK048106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057536] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); William Randolph Hearst Fund Award; Leonard and Isabelle Goldenson Research Fellowship; Cerebral Palsy International Research Foundation Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported in part by National Institute of Neurological Disorders and Stroke (NINDS) grant R01 NS057536 (X. P.); William Randolph Hearst Fund Award (S.J. & R. L); Leonard and Isabelle Goldenson Research Fellowship (R. L.); and Cerebral Palsy International Research Foundation Award (S.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Bjarnadottir TK, 2004, GENOMICS, V84, P23, DOI 10.1016/j.ygeno.2003.12.004; Chiang NY, 2011, J BIOL CHEM, V286, P14215, DOI 10.1074/jbc.M110.183830; Guirland C, 2007, ADV EXP MED BIOL, V621, P144, DOI 10.1007/978-0-387-76715-4_11; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Huang YS, 2012, MOL CELL BIOL, V32, P1408, DOI 10.1128/MCB.06557-11; Jeong SJ, 2012, J COMP NEUROL, V520, P2930, DOI 10.1002/cne.23076; Jeong SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029767; Jin ZH, 2007, HUM MOL GENET, V16, P1972, DOI 10.1093/hmg/ddm144; Koirala S, 2009, J NEUROSCI, V29, P7439, DOI 10.1523/JNEUROSCI.1182-09.2009; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; LENCER WI, 1995, P NATL ACAD SCI USA, V92, P10094, DOI 10.1073/pnas.92.22.10094; Li SH, 2008, J NEUROSCI, V28, P5817, DOI 10.1523/JNEUROSCI.0853-08.2008; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Luo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029818; Luo R, 2011, P NATL ACAD SCI USA, V108, P12925, DOI 10.1073/pnas.1104821108; Luo R, 2011, PEDIATR NEUROL, V45, P49, DOI 10.1016/j.pediatrneurol.2011.02.004; Paavola KJ, 2011, J BIOL CHEM, V286, P28914, DOI 10.1074/jbc.M111.247973; Parrini E, 2008, EPILEPSIA; Piao XH, 2005, ANN NEUROL, V58, P680, DOI 10.1002/ana.20616; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Promel S, 2013, TRENDS PHARMACOL SCI, V34, P470, DOI 10.1016/j.tips.2013.06.002; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Shashidhar S, 2005, ONCOGENE, V24, P1673, DOI 10.1038/sj.onc.1208395; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Staubach S, 2011, EXPERT REV PROTEOMIC, V8, P263, DOI [10.1586/EPR.11.2, 10.1586/epr.11.2]; Xu L, 2006, P NATL ACAD SCI USA, V103, P9023, DOI 10.1073/pnas.0602681103; Yang L, 2011, CANC RES; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005	32	47	49	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100043	10.1371/journal.pone.0100043	http://dx.doi.org/10.1371/journal.pone.0100043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949629	Green Published, gold, Green Submitted			2022-12-25	WOS:000338276300032
J	Wang, WH; Zhang, XA; Xu, YJ; Weinstock, GM; Di Bisceglie, AM; Fan, XF				Wang, Weihua; Zhang, Xiaoan; Xu, Yanjuan; Weinstock, George M.; Di Bisceglie, Adrian M.; Fan, Xiaofeng			High-Resolution Quantification of Hepatitis C Virus Genome-Wide Mutation Load and Its Correlation with the Outcome of Peginterferon-Alpha2a and Ribavirin Combination Therapy	PLOS ONE			English	Article							RESISTANCE; AMPLIFICATION; INTERFERON; SEPARATION; DIVERSITY; DISCOVERY; DYNAMICS; CLONING	Hepatitis C virus (HCV) is a highly mutable RNA virus and circulates as a heterogeneous population in individual patients. The magnitude of such population heterogeneity has long been proposed to be linked with diverse clinical phenotypes, including antiviral therapy. Yet data accumulated thus far are fairly inconclusive. By the integration of long RT-PCR with 454 sequencing, we have built a pipeline optimized for the quantification of HCV genome-wide mutation load at 1% resolution of mutation frequency, followed by a retrospective study to examine the role of HCV mutation load in peginterferon-alpha2a and ribavirin combination antiviral therapy. Genome-wide HCV mutation load varied widely with a range from 92 to 1639 mutations and presented a Poisson distribution among 56 patients (Kolmogorov-Smirnov statistic = 0.078, p = 0.25). Patients achieving sustained virological response (n = 26) had significantly lower mutation loads than that in null responders (n = 30) (mean and standard derivation: 524 +/- 279 vs. 805 +/- 271, p = 0.00035). All 36,818 mutations detected in 56 patients displayed a power-law distribution in terms of mutation frequency in viral population. The low-frequency mutation load, but not the high-frequency load, was proportional firmly to the total mutation load. In-depth analyses revealed that intra-patient HCV population structure was shaped by multiple factors, including immune pressure, strain difference and genetic drift. These findings explain previous conflicting reports using low-resolution methods and highlight a dominant role of natural selection in response to therapeutic intervention. By attaining its signatures from complex interaction between host and virus, the high-resolution quantification of HCV mutation load predicts outcomes from interferon-based antiviral therapy and could also be a potential biomarker in other clinical settings.	[Wang, Weihua; Zhang, Xiaoan; Xu, Yanjuan; Di Bisceglie, Adrian M.; Fan, Xiaofeng] St Louis Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, St Louis, MO 63103 USA; [Di Bisceglie, Adrian M.; Fan, Xiaofeng] St Louis Univ, Sch Med, Ctr Liver, St Louis, MO USA; [Weinstock, George M.] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA; [Wang, Weihua] Wuhan Ctr TB Control, Wuhan, Hubei, Peoples R China	Saint Louis University; Saint Louis University; Washington University (WUSTL)	Di Bisceglie, AM (corresponding author), St Louis Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, St Louis, MO 63103 USA.	dibiscam@slu.edu; fanx@slu.edu	Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592	US National Institutes of Health (NIH) [DK80711]; National Institute of Diabetes & Digestive & Kidney Diseases [N01-DK9-2326, N01-DK-9-2324, N01-DK-9-2319, N01-DK-9-2327, N01-DK-9-2320, N01-DK-9-2321, N01-DK-9-2325, N01-DK-9-2323, N01-DK-9-2322, N01-DK-9-2318, N01-DK-9-2328]; Hoffmann-La Roche, through a Cooperative Research and Development Agreement (CRADA); National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [N01DK092319, N01DK092321, N01DK092327, N01DK092318, N01DK092320, N01DK092326, N01DK092328, R01DK080711, N01DK092324, N01DK092325, N01DK092322, N01DK092323] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes & Digestive & Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Hoffmann-La Roche, through a Cooperative Research and Development Agreement (CRADA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the US National Institutes of Health (NIH) (grant DK80711 to XF). The HALT-C clinical trial was supported by National Institute of Diabetes & Digestive & Kidney Diseases contracts N01-DK9-2326, N01-DK-9-2324, Contract N01-DK-9-2319, N01-DK-9-2327, N01-DK-9-2320, N01-DK-9-2321, N01-DK-9-2325, N01-DK-9-2323, N01-DK-9-2322, N01-DK-9-2318, and N01-DK-9-2328. Additional financial support for the HALT-C clinical trial was provided by Hoffmann-La Roche, through a Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias A, 2013, J GEN VIROL, V94, P817, DOI 10.1099/vir.0.049171-0; Balagopal A, 2010, GASTROENTEROLOGY, V139, P1865, DOI 10.1053/j.gastro.2010.10.004; Belshaw R, 2011, CURR OPIN VIROL, V1, P430, DOI 10.1016/j.coviro.2011.08.004; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fan XF, 2006, BIOCHEM BIOPH RES CO, V346, P1163, DOI 10.1016/j.bbrc.2006.06.039; Fan XF, 2010, METHODS MOL BIOL, V630, P139, DOI 10.1007/978-1-60761-629-0_10; Fan XF, 2009, HEPATOLOGY, V50, P1765, DOI 10.1002/hep.23290; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Gillespie C. S., 2013, FITTING HEAVY TAILED; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Lancaster KZ, 2012, CURR OPIN MICROBIOL, V15, P525, DOI 10.1016/j.mib.2012.05.007; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; LARDER BA, 1993, NATURE, V365, P671, DOI 10.1038/365671a0; Larsen BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076502; Lee WM, 2004, CONTROL CLIN TRIALS, V25, P472, DOI 10.1016/j.cct.2004.08.003; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Perales C, 2013, J VIROL, V87, P7593, DOI 10.1128/JVI.02824-12; Pickett BE, 2011, J VIRAL HEPATITIS, V18, P608, DOI 10.1111/j.1365-2893.2010.01342.x; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ray SC, 1999, J VIROL, V73, P2938, DOI 10.1128/JVI.73.4.2938-2946.1999; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Van Belleghem SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042605; Van Laethem K, 1999, J ACQ IMMUN DEF SYND, V22, P107; Wohnsland A, 2007, CLIN MICROBIOL REV, V20, P23, DOI 10.1128/CMR.00010-06; Wright CF, 2011, J VIROL, V85, P2266, DOI 10.1128/JVI.01396-10; Zagordi O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-119; Zehender G, 2005, J VIROL, V79, P9145, DOI 10.1128/JVI.79.14.9145-9156.2005; Zhang XA, 2011, J CLIN VIROL, V52, P333, DOI 10.1016/j.jcv.2011.08.022; Zhou DH, 2007, J VIROL METHODS, V141, P220, DOI 10.1016/j.jviromet.2006.12.002	41	10	10	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100131	10.1371/journal.pone.0100131	http://dx.doi.org/10.1371/journal.pone.0100131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950220	Green Published, Green Submitted, gold			2022-12-25	WOS:000338276300038
J	Zhou, MJ; Zhou, L; Zheng, L; Guo, LH; Wang, YH; Liu, HX; Ou, CS; Ding, ZH				Zhou, Meijuan; Zhou, Liang; Zheng, Li; Guo, Ling; Wang, Yinghui; Liu, Hongxia; Ou, Chengshan; Ding, Zhenhua			miR-365 Promotes Cutaneous Squamous Cell Carcinoma (CSCC) through Targeting Nuclear Factor I/B (NFIB)	PLOS ONE			English	Article							CANCER-CELLS; LUNG-CANCER; SKELETAL MYOGENESIS; MICRORNA TARGETS; TRANSCRIPTION; BREAST; PREDICTION; FAMILY; ROLES; BCL-2	Aberrant expression of microRNAs plays vital roles in tumor development and progression. As transcription factors (TFs) are the critical components of signaling cascades, specific targeting effects of microRNAs to specific TFs may determine the role of microRNAs in different cancers. In this study, we identified Nuclear Factor I/B (NFIB) as one of the targets of miR-365 which was previously verified as an onco-miR in cutaneous squamous cell carcinoma (CSCC). Down-regulation of NFIB was a general feature in both CSCC cell lines and tumors from patients which show drastically up-regulated miR-365 expression levels. The siRNA-based knockdown of NFIB mimic the carcinogenic transformation of normal cells by ectopically expression of miR-365 which indicates depletion of NFIB is necessary for miR-365 to exert its pro-carcinogenic function. NFIB may represent a functional barrier targeted by miR-365 to the development of CSCC. Further studies also discovered a conserved feedback regulatory circuitry formed by NFIB and miR-365 in CSCC development which may be potentially utilized as therapeutic target to improve the clinical CSCC treatment.	[Zhou, Meijuan; Zhou, Liang; Zheng, Li; Guo, Ling; Wang, Yinghui; Liu, Hongxia; Ou, Chengshan; Ding, Zhenhua] Southern Med Univ, Dept Radiat Med, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Ding, ZH (corresponding author), Southern Med Univ, Dept Radiat Med, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China.	dingzh@smu.edu.cn	Zhou, Liang/P-4174-2015; wang, yinghui/GWV-7334-2022	Zhou, Liang/0000-0001-5973-7873; 	National Natural Science Foundation of China [81172634, 81202152]; School of Public Health and Tropical Medicine of southern Medical University, China [GW201314]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); School of Public Health and Tropical Medicine of southern Medical University, China	This work was supported by grants from the National Natural Science Foundation of China (81172634 and 81202152, http://www.nsfc.gov.cn/) and Grant from School of Public Health and Tropical Medicine of southern Medical University, China (GW201314, http://web2.fimmu.com/phatm/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cooper SJ, 2007, CURR CANCER DRUG TAR, V7, P325, DOI 10.2174/156800907780809714; Dooley AL, 2011, GENE DEV, V25, P1470, DOI 10.1101/gad.2046711; Enright AJ, 2004, GENOME BIOL, V5; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Giglia-Mari G, 2003, HUM MUTAT, V21, P217, DOI 10.1002/humu.10179; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Guo L, 2009, PHOTOCHEM PHOTOBIOL, V85, P765, DOI 10.1111/j.1751-1097.2008.00482.x; Guo S-L, 2013, NATURE COMMUNICATION, V4, P2554; Hamada S, 2014, CELL SIGNAL, V26, P179, DOI 10.1016/j.cellsig.2013.11.003; Hsu YC, 2011, DEV BIOL, V354, P242, DOI 10.1016/j.ydbio.2011.04.002; Juin P, 2013, NAT REV CANCER, V13, P455, DOI 10.1038/nrc3538; Kang SM, 2013, CANCER LETT, V335, P487, DOI 10.1016/j.canlet.2013.03.006; Kollmann K, 2013, CANCER CELL, V24, P167, DOI 10.1016/j.ccr.2013.07.012; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Moon HG, 2011, MOL ONCOL, V5, P538, DOI 10.1016/j.molonc.2011.08.002; Nie J, 2012, CARCINOGENESIS, V33, P220, DOI 10.1093/carcin/bgr245; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Pjanic M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-181; Qi J, 2012, CELL CYCLE, V11, P177, DOI 10.4161/cc.11.1.18576; Sidransky D, 2002, NAT REV CANCER, V2, P210, DOI 10.1038/nrc755; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Xia HP, 2005, INT J MOL MED, V16, P943; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Zhou L, 2012, J BIOL CHEM, V287, P25255, DOI 10.1074/jbc.M112.357053; Zhou L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033766; Zhou MJ, 2013, CARCINOGENESIS, V34, P1653, DOI 10.1093/carcin/bgt097; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	29	57	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100620	10.1371/journal.pone.0100620	http://dx.doi.org/10.1371/journal.pone.0100620			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949940	Green Published, gold, Green Submitted			2022-12-25	WOS:000338276300099
J	Dempsey, AF; Fuhrel-Forbis, A; Konrath, S				Dempsey, Amanda F.; Fuhrel-Forbis, Andrea; Konrath, Sara			Use of the Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS) in Young Adult Women	PLOS ONE			English	Article							NONINFLUENZA VACCINATION COVERAGE; AGED 13-17 YEARS; UNITED-STATES	Background: Validated measures that can accurate describe young adults' HPV vaccination attitudes and how these relate to vaccination intention and receipt are needed for developing interventions to improve low HPV vaccination levels. The Carolina HPV Immunization Attitudes Scale (CHIAS) is a validated measure of these outcomes that was originally designed for parents. Objective: To assess the performance of the CHIAS among young adult women using an exploratory factor analysis. Methods: A convenience sample of 139 young adult women (age 18-26 years) were given the CHIAS measure at baseline. Factor analysis was used to determine attitudinal factor groupings and the association of these factors with HPV vaccination intention. A 6-month follow up assessment examined the stability of the CHIAS over time and the association of baseline vaccine factors with vaccine receipt. Results: Five factors loaded on to the CHIAS in young adults - "Barriers,'' "Harms,'' "Effectiveness,'' "Risk Denial'' and "Uncertainty,'' - which was similar to the factor loadings of CHIAS for parents. "Harms'' was the factor most consistently associated with vaccination intention at all time points assessed. Only 5 women had received or made an appointment to receive the vaccine at the 6-month follow-up. Conclusions: In terms of categorizing HPV vaccination attitudes, the CHIAS appears to have similar performance among young adults as in parents. However, additional studies are needed to assess the utility of the CHIAS for predicting HPV vaccine receipt among the young adult population.	Univ Colorado Denver, Childrens Outcomes Res Program, Aurora, CO 80204 USA; [Fuhrel-Forbis, Andrea; Konrath, Sara] Univ Michigan, Inst Social Res, Ann Arbor, MI USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Michigan System; University of Michigan	Dempsey, AF (corresponding author), Univ Colorado Denver, Childrens Outcomes Res Program, Aurora, CO 80204 USA.	Amanda.dempsey@ucdenver.edu		Konrath, Sara/0000-0001-9182-0095	Office of the Vice President for Research at the University of Michigan	Office of the Vice President for Research at the University of Michigan(University of Michigan System)	This work was funded by the Office of the Vice President for Research at the University of Michigan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, MMWR MORB MORTAL WKL, V61, P671; [Anonymous], 2013, MMWR MORB MORTAL WKL, V62, P685; [Anonymous], 2013, MMWR MORB MORTAL WKL, V62, P66; Brewer NT, 2007, PREV MED, V45, P107, DOI 10.1016/j.ypmed.2007.05.013; Dempsey AF, 2006, PEDIATRICS, V117, P1486, DOI 10.1542/peds.2005-1381; Gowda C, 2012, HUM VACCIN IMMUNO, V9, P1; Gowda C, 2012, SYSTEMATIC EVALUATIO; Gowda C, 2012, SEX TRANSM DIS, V39, P475, DOI 10.1097/OLQ.0b013e318248a6d5; Jemal A, 2013, J NATL CANC I; Kessels SJM, 2012, VACCINE, V30, P3546, DOI 10.1016/j.vaccine.2012.03.063; McRee AL, 2010, SEX TRANSM DIS, V37, P234, DOI 10.1097/OLQ.0b013e3181c37e15; Ratanasiripong NT, 2012, J AM COLL HEALTH, V60, P461, DOI 10.1080/07448481.2012.684365; U.S. Department of Health and Human Services, 2010, HLTH PEOPL 2020; Williams WW, 2014, MMWR-MORBID MORTAL W, V63, P95	14	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100193	10.1371/journal.pone.0100193	http://dx.doi.org/10.1371/journal.pone.0100193			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945630	Green Published, gold, Green Submitted			2022-12-25	WOS:000340721500048
J	Faust, JE; Manisundaram, A; Ivanova, PT; Milne, SB; Summerville, JB; Brown, HA; Wangler, M; Stern, M; McNew, JA				Faust, Joseph E.; Manisundaram, Arvind; Ivanova, Pavlina T.; Milne, Stephen B.; Summerville, James B.; Brown, H. Alex; Wangler, Michael; Stern, Michael; McNew, James A.			Peroxisomes Are Required for Lipid Metabolism and Muscle Function in Drosophila melanogaster	PLOS ONE			English	Article							GENE DISRUPTION PROJECT; ZELLWEGER-SYNDROME; MEMBRANE-PROTEINS; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; TARGETING SIGNAL; MITOCHONDRIAL MYOPATHY; BIOGENESIS DISORDERS; OXIDATIVE STRESS; KNOCKOUT MOUSE	Peroxisomes are ubiquitous organelles that perform lipid and reactive oxygen species metabolism. Defects in peroxisome biogenesis cause peroxisome biogenesis disorders (PBDs). The most severe PBD, Zellweger syndrome, is characterized in part by neuronal dysfunction, craniofacial malformations, and low muscle tone (hypotonia). These devastating diseases lack effective therapies and the development of animal models may reveal new drug targets. We have generated Drosophila mutants with impaired peroxisome biogenesis by disrupting the early peroxin gene pex3, which participates in budding of pre-peroxisomes from the ER and peroxisomal membrane protein localization. pex3 deletion mutants lack detectible peroxisomes and die before or during pupariation. At earlier stages of development, larvae lacking Pex3 display reduced size and impaired lipid metabolism. Selective loss of peroxisomes in muscles impairs muscle function and results in flightless animals. Although, hypotonia in PBD patients is thought to be a secondary effect of neuronal dysfunction, our results suggest that peroxisome loss directly affects muscle physiology, possibly by disrupting energy metabolism. Understanding the role of peroxisomes in Drosophila physiology, specifically in muscle cells may reveal novel aspects of PBD etiology.	[Faust, Joseph E.; Manisundaram, Arvind; Summerville, James B.; Stern, Michael; McNew, James A.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Ivanova, Pavlina T.; Milne, Stephen B.; Brown, H. Alex] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Ivanova, Pavlina T.; Milne, Stephen B.; Brown, H. Alex] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Nashville, TN 37212 USA; [Wangler, Michael] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Rice University; Vanderbilt University; Vanderbilt University; Baylor College of Medicine	McNew, JA (corresponding author), Rice Univ, Dept Biochem & Cell Biol, POB 1892, Houston, TX 77251 USA.	mcnew@rice.edu	McNew, James/ABD-8081-2020; McNew, James/AAV-4911-2020; Wangler, Michael/H-6368-2019	McNew, James/0000-0001-8459-3664; Wangler, Michael/0000-0001-5245-5910; Faust, Joseph/0000-0002-2183-8529	National Institutes of Health; Virginia; L.E. Simmons Family Foundation Collaborative Research Fund; Bixler-Johnson-Mayes Endowed Chair; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101377] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS076547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia; L.E. Simmons Family Foundation Collaborative Research Fund; Bixler-Johnson-Mayes Endowed Chair; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work in the McNew lab is funded by the National Institutes of Health and The Virginia and L.E. Simmons Family Foundation Collaborative Research Fund. Partial support was also provided by the Bixler-Johnson-Mayes Endowed Chair (H.A.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Acosta Ivan F, 2010, Arabidopsis Book, V8, pe0129, DOI 10.1199/tab.0129; Baes M, 2012, BBA-MOL BASIS DIS, V1822, P1489, DOI 10.1016/j.bbadis.2012.03.003; Baumgart E, 2001, AM J PATHOL, V159, P1477, DOI 10.1016/S0002-9440(10)62534-5; BEARD ME, 1987, P NATL ACAD SCI USA, V84, P7433, DOI 10.1073/pnas.84.21.7433; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bellen HJ, 2011, GENETICS, V188, P731, DOI 10.1534/genetics.111.126995; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; Chen HY, 2010, HUM MOL GENET, V19, P494, DOI 10.1093/hmg/ddp518; Cook RK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r21; Cutler RG, 2001, MECH AGEING DEV, V122, P895, DOI 10.1016/S0047-6374(01)00246-9; Dammai V, 2001, CELL, V105, P187, DOI 10.1016/S0092-8674(01)00310-5; Dirkx R, 2005, HEPATOLOGY, V41, P868, DOI 10.1002/hep.20628; Distel B, 1996, J CELL BIOL, V135, P1, DOI 10.1083/jcb.135.1.1; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; Faust JE, 2012, TRAFFIC, V13, P1378, DOI 10.1111/j.1600-0854.2012.01393.x; Faust PL, 1997, J CELL BIOL, V139, P1293, DOI 10.1083/jcb.139.5.1293; Feng YF, 2004, J NEUROGENET, V18, P377, DOI 10.1080/01677060490894522; Ferdinandusse S, 2009, MOL GENET METAB, V96, P121, DOI 10.1016/j.ymgme.2008.11.165; Ghosh A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003980; GOLDFISCHER S, 1973, SCIENCE, V182, P62, DOI 10.1126/science.182.4107.62; GOULD SJ, 1987, J CELL BIOL, V105, P2923, DOI 10.1083/jcb.105.6.2923; Gresham D, 2011, GENETICS, V187, P299, DOI 10.1534/genetics.110.120766; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Haghighi AP, 2003, NEURON, V39, P255, DOI 10.1016/S0896-6273(03)00427-6; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Hettema EH, 2000, EMBO J, V19, P223, DOI 10.1093/emboj/19.2.223; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Komen JC, 2007, CELL MOL LIFE SCI, V64, P3271, DOI 10.1007/s00018-007-7357-7; Kovacs WJ, 2004, MOL CELL BIOL, V24, P1, DOI 10.1128/MCB.24.1.1-13.2004; Kragt A, 2005, J BIOL CHEM, V280, P34350, DOI 10.1074/jbc.M505432200; Ma CL, 2011, J CELL BIOL, V193, P7, DOI 10.1083/jcb.201010022; Mast FD, 2011, DIS MODEL MECH, V4, P659, DOI 10.1242/dmm.007419; Matsuzono Y, 2006, J BIOL CHEM, V281, P36, DOI 10.1074/jbc.M509819200; Maxwell M, 2003, MOL CELL BIOL, V23, P5947, DOI 10.1128/MCB.23.16.5947-5957.2003; Motley AM, 2007, J CELL BIOL, V178, P399, DOI 10.1083/jcb.200702167; Motley AM, 2012, EMBO J, V31, P2852, DOI 10.1038/emboj.2012.151; Motley AM, 2000, EMBO REP, V1, P40, DOI 10.1093/embo-reports/kvd010; Muller CC, 2011, DIS MODEL MECH, V4, P104, DOI 10.1242/dmm.004622; MULLERHOCKER J, 1984, VIRCHOWS ARCH B, V45, P125, DOI 10.1007/BF02889859; Munck JM, 2009, J CELL BIOL, V187, P463, DOI 10.1083/jcb.200906161; Nakayama M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022984; Ranganayakulu G, 1996, DEV BIOL, V176, P143, DOI 10.1006/dbio.1996.9987; Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049; SARNAT HB, 1983, CAN J NEUROL SCI, V10, P170, DOI 10.1017/S0317167100044863; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Sepp KJ, 1999, GENETICS, V151, P1093; Shibata H, 2004, J BIOL CHEM, V279, P38486, DOI 10.1074/jbc.M402204200; South ST, 2000, J CELL BIOL, V149, P1345, DOI 10.1083/jcb.149.7.1345; Southall TD, 2006, PHYSIOL GENOMICS, V26, P35, DOI 10.1152/physiolgenomics.00038.2006; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; STJULES R, 1990, EXP EYE RES, V51, P607; STJULES R, 1989, TISSUE CELL, V21, P661, DOI 10.1016/0040-8166(89)90077-3; Suster ML, 2003, J NEUROBIOL, V55, P233, DOI 10.1002/neu.10202; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; Tam YYC, 2005, J BIOL CHEM, V280, P34933, DOI 10.1074/jbc.M506208200; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Vacaru AM, 2013, J BIOL CHEM, V288, P11520, DOI 10.1074/jbc.M113.460972; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; van der Zand A, 2010, MOL BIOL CELL, V21, P2057, DOI 10.1091/mbc.E10-02-0082; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wang SX, 2013, BIOCHEM BIOPH RES CO, V438, P452, DOI 10.1016/j.bbrc.2013.07.100; Wolff J, 1986, Pediatr Neurol, V2, P141, DOI 10.1016/0887-8994(86)90004-4; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600; Zolman BR, 2008, GENETICS, V180, P237, DOI 10.1534/genetics.108.090399	72	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100213	10.1371/journal.pone.0100213	http://dx.doi.org/10.1371/journal.pone.0100213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945818	Green Published, gold, Green Submitted			2022-12-25	WOS:000340721500050
J	Kobayashi-Ishihara, M; Takahashi, H; Ohnishi, K; Nishimura, K; Terahara, K; Ato, M; Itamura, S; Kageyama, T; Tsunetsugu-Yokota, Y				Kobayashi-Ishihara, Mie; Takahashi, Hitoshi; Ohnishi, Kazuo; Nishimura, Kengo; Terahara, Kazutaka; Ato, Manabu; Itamura, Shigeyuki; Kageyama, Tsutomu; Tsunetsugu-Yokota, Yasuko			Broad Cross-Reactive Epitopes of the H5N1 Influenza Virus Identified by Murine Antibodies against the A/Vietnam/1194/2004 Hemagglutinin	PLOS ONE			English	Article							RECEPTOR-BINDING; MONOCLONAL-ANTIBODIES; HUMANS METAANALYSIS; ANTIGENIC DRIFT; INFECTIONS; SEROEVIDENCE; BIRDS	There is an urgent need for a rapid diagnostic system to detect the H5 subtype of the influenza A virus. We previously developed monoclonal antibodies (mAbs) against the H5 hemagglutinin (HA) for use in a rapid diagnostic kit. In this study, we determined the epitopes of the anti-H5 HA murine mAbs OM-b, AY-2C2, and YH-1A1. Binding assays of the mAbs to different strains of H5 HAs indicated that OM-b and AY-2C2 cross-reacted with HAs from clades 1, 2.1.3.2, 2.2, and 2.3.4, whereas YH-1A1 failed to bind to those of clades 2.1.3.2 and 2.3.4. HA chimeras revealed that the epitopes for each of the mAbs were in the HA1 region. Analysis of escape mutants revealed that OM-b and AY-2C2 mAbs interacted mainly with amino acid residues D43 and G46, and the YH-1A1 mAb interacted with G139 and K or R140 of H5 HA. Multiple alignments of H5 HA protein sequences showed that D43 and G46 were very conserved among H5N1 HAs, except those in clade 2.2.1 and clade 7 (88.7%). The epitope for YH-1A1 mAb was highly variable in the HAs of H5N1, although it was well conserved in those of H5N2-N9. The OM-b and AY-2C2 mAbs could bind to the HAs of clades 1.1 and 2.3.2.1 that are currently epidemic in Asia, and we conclude that these would be effective for the detection of H5N1 infections in this region.	[Kobayashi-Ishihara, Mie; Ohnishi, Kazuo; Terahara, Kazutaka; Ato, Manabu; Tsunetsugu-Yokota, Yasuko] Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, Tokyo 1628640, Japan; [Takahashi, Hitoshi; Itamura, Shigeyuki; Kageyama, Tsutomu] Natl Inst Infect Dis, Influenza Virus Res Ctr, Tokyo 1628640, Japan; [Nishimura, Kengo] Toyobo Co, Tsuruga Inst Biotechnol, Tsuruga, Fukui, Japan; [Tsunetsugu-Yokota, Yasuko] Tokyo Univ Technol, Sch Human Sci, Dept Med Technol, Ohta Ku, Tokyo, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Toyobo Co., Ltd; Tokyo University of Technology	Tsunetsugu-Yokota, Y (corresponding author), Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, Tokyo 1628640, Japan.	yokotaysk@stf.teu.ac.jp	Ato, Manabu/K-6452-2019	Ato, Manabu/0000-0002-3178-2645; Terahara, Kazutaka/0000-0001-9876-4356	Human Science Foundation in the Ministry of Health, Labor and Welfare, Japan; Japanese government (Ministry of Health, Labor and Welfare); Grants-in-Aid for Scientific Research [26860311] Funding Source: KAKEN	Human Science Foundation in the Ministry of Health, Labor and Welfare, Japan; Japanese government (Ministry of Health, Labor and Welfare); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant from the Human Science Foundation in the Ministry of Health, Labor and Welfare, Japan, and carried out in collaboration with KN of Toyobo, Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work was completely funded by a grant from the Japanese government (Ministry of Health, Labor and Welfare), and all materials and results are owned by the institute, NIID (government research institute).	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Barik S, 1993, Methods Mol Biol, V15, P277, DOI 10.1385/0-89603-244-2:277; Cai ZP, 2012, J MOL BIOL, V422, P145, DOI 10.1016/j.jmb.2012.05.011; Chen YX, 2009, J INFECT DIS, V199, P49, DOI 10.1086/594374; Crusat M, 2013, VIROLOGY, V447, P326, DOI 10.1016/j.virol.2013.08.010; Das SR, 2013, CELL HOST MICROBE, V13, P314, DOI 10.1016/j.chom.2013.02.008; Dreyfus C, 2013, J VIROL, V87, P7149, DOI 10.1128/JVI.02975-12; Du A, 2009, BIOCHEM BIOPH RES CO, V378, P197, DOI 10.1016/j.bbrc.2008.11.022; Hensley SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015190; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Kandun IN, 2008, LANCET, V372, P744, DOI 10.1016/S0140-6736(08)61125-3; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; KOO GC, 1986, J IMMUNOL, V137, P3742; KOO GC, 1984, HYBRIDOMA, V3, P301, DOI 10.1089/hyb.1984.3.301; Li YB, 2011, EMERG INFECT DIS, V17, P265, DOI 10.3201/eid1702.100732; Mahy BWJ, 1996, VIROLOGY METHODS MAN; MAIOROV VN, 1994, J MOL BIOL, V235, P625, DOI 10.1006/jmbi.1994.1017; Miyagawa E, 2011, J VIROL METHODS, V173, P213, DOI 10.1016/j.jviromet.2011.02.007; Ohkura T, 2012, BIOCHEM BIOPH RES CO, V418, P38, DOI 10.1016/j.bbrc.2011.12.108; Ohnishi K, 2012, JPN J INFECT DIS, V65, P19; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Prabakaran M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004566; Reece PA, 2010, POSTGRAD MED, V122, P134, DOI 10.3810/pgm.2010.09.2210; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Sakoda Y, 2012, J GEN VIROL, V93, P541, DOI 10.1099/vir.0.037572-0; Sakurai A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076753; Tang DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043596; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Van Kerkhove MD, 2012, SCIENCE, V336, DOI 10.1126/science.1221434; Velkov T, 2013, MOL IMMUNOL, V56, P705, DOI 10.1016/j.molimm.2013.07.010; Wang TT, 2012, SCIENCE, V335, P1463, DOI 10.1126/science.1218888; Watanabe Y, 2012, J GEN VIROL, V93, P2215, DOI 10.1099/vir.0.044032-0; Watanabe Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002068; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Zhu XY, 2013, J VIROL, V87, P12619, DOI 10.1128/JVI.01577-13	38	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99201	10.1371/journal.pone.0099201	http://dx.doi.org/10.1371/journal.pone.0099201			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945805	Green Submitted, gold, Green Published			2022-12-25	WOS:000340721500014
J	Stokes, AN; Ducey, PK; Neuman-Lee, L; Hanifin, CT; French, SS; Pfrender, ME; Brodie, ED; Brodie, ED				Stokes, Amber N.; Ducey, Peter K.; Neuman-Lee, Lorin; Hanifin, Charles T.; French, Susannah S.; Pfrender, Michael E.; Brodie, Edmund D., III; Brodie, Edmund D., Jr.			Confirmation and Distribution of Tetrodotoxin for the First Time in Terrestrial Invertebrates: Two Terrestrial Flatworm Species (Bipalium adventitium and Bipalium kewense)	PLOS ONE			English	Article							ROUGH-SKIN NEWT; TARICHA-GRANULOSA; EGGS; TRICLADIDA; PREDATION; BLOCKAGE; INCREASE; BEHAVIOR; ECOLOGY	The potent neurotoxin tetrodotoxin (TTX) is known from a diverse array of taxa, but is unknown in terrestrial invertebrates. Tetrodotoxin is a low molecular weight compound that acts by blocking voltage-gated sodium channels, inducing paralysis. However, the origins and ecological functions of TTX in most taxa remain mysterious. Here, we show that TTX is present in two species of terrestrial flatworm (Bipalium adventitium and Bipalium kewense) using a competitive inhibition enzymatic immunoassay to quantify the toxin and high phase liquid chromatography to confirm the presence. We also investigated the distribution of TTX throughout the bodies of the flatworms and provide evidence suggesting that TTX is used during predation to subdue large prey items. We also show that the egg capsules of B. adventitium have TTX, indicating a further role in defense. These data suggest a potential route for TTX bioaccumulation in terrestrial systems.	[Stokes, Amber N.] Calif State Univ, Dept Biol, Bakersfield, CA 93311 USA; [Ducey, Peter K.] SUNY Coll Cortland, Dept Biol Sci, Cortland, NY 13045 USA; [Neuman-Lee, Lorin; French, Susannah S.; Brodie, Edmund D., Jr.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Hanifin, Charles T.] Utah State Univ Uintah Basin, Dept Biol, Vernal, UT USA; [Pfrender, Michael E.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Brodie, Edmund D., III] Univ Virginia, Mt Lake Biol Stn, Charlottesville, VA USA; [Brodie, Edmund D., III] Univ Virginia, Dept Biol, Charlottesville, VA USA	California State University System; California State University Bakersfield; State University of New York (SUNY) System; SUNY Cortland; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; University of Notre Dame; University of Virginia; University of Virginia	Stokes, AN (corresponding author), Calif State Univ, Dept Biol, Bakersfield, CA 93311 USA.	astokes2@csub.edu	Pfrender, Micheal E./C-5065-2019	Neuman-Lee, Lorin/0000-0002-0225-5686	Utah State University, SUNY Cortland, NSF [DEB-0922251]; Division Of Environmental Biology [0922216] Funding Source: National Science Foundation	Utah State University, SUNY Cortland, NSF; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Utah State University, SUNY Cortland, NSF: DEB-0922251 to ME Pfrender, ED Brodie, Jr, and ED Brodie III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRODIE ED, 1968, COPEIA, P307; Cardall BL, 2004, TOXICON, V44, P933, DOI 10.1016/j.toxicon.2004.09.006; DINDAL DL, 1970, AM MIDL NAT, V83, P635, DOI 10.2307/2423970; Ducey PK, 2005, PEDOBIOLOGIA, V49, P367, DOI 10.1016/j.pedobi.2005.04.002; Ducey PK, 1999, AM MIDL NAT, V141, P305, DOI 10.1674/0003-0031(1999)141[0305:LPAPHP]2.0.CO;2; Fernandes MC, 2001, BELG J ZOOL, V131, P173; Fiore C, 2004, BEHAV PROCESS, V67, P327, DOI 10.1016/j.beproc.2004.06.001; FUHRMAN FA, 1969, J AGR FOOD CHEM, V17, P417, DOI 10.1021/jf60163a043; Gall BG, 2012, TOXICON, V60, P1057, DOI 10.1016/j.toxicon.2012.07.017; Hanifin CT, 2008, PLOS BIOL, V6, P471, DOI 10.1371/journal.pbio.0060060; Hanifin CT, 2003, J CHEM ECOL, V29, P1729, DOI 10.1023/A:1024885824823; Hanifin CT, 2002, TOXICON, V40, P1149, DOI 10.1016/S0041-0101(02)00115-0; KAO CY, 1966, PHARMACOL REV, V18, P997; MATSUMURA K, 1995, APPL ENVIRON MICROB, V61, P3468, DOI 10.1128/AEM.61.9.3468-3470.1995; MIYAZAWA K, 1987, TOXICON, V25, P975, DOI 10.1016/0041-0101(87)90160-7; Miyazawa K, 2001, J TOXICOL-TOXIN REV, V20, P11, DOI 10.1081/TXR-100103081; NARAHASH.T, 1967, SCIENCE, V156, P976, DOI 10.1126/science.156.3777.976; NARAHASHI T, 1964, J GEN PHYSIOL, V47, P965, DOI 10.1085/jgp.47.5.965; OGREN RE, 1995, HYDROBIOLOGIA, V305, P105, DOI 10.1007/BF00036370; Ritson-Williams R, 2005, PNAS, P3176; SHEUMACK DD, 1984, TOXICON, V22, P811, DOI 10.1016/0041-0101(84)90164-8; Shimizu C, 1982, MAR SCI MON, V16, P560; Stokes AN, 2012, BIOL PROCED ONLINE, V14, DOI 10.1186/1480-9222-14-3; Stokes AN, 2011, AM MIDL NAT, V165, P389, DOI 10.1674/0003-0031-165.2.389; Williams BL, 2010, MAR DRUGS, V8, P381, DOI 10.3390/md8030381; Zaborski ER, 2002, AM MIDL NAT, V148, P401, DOI 10.1674/0003-0031(2002)148[0401:OOFBBT]2.0.CO;2	26	38	39	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100718	10.1371/journal.pone.0100718	http://dx.doi.org/10.1371/journal.pone.0100718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963791	Green Submitted, Green Published, gold			2022-12-25	WOS:000338709500075
J	Abu Sadat, M; Jeon, J; Mir, AA; Choi, J; Choi, J; Lee, YH				Abu Sadat, Md.; Jeon, Junhyun; Mir, Albely Afifa; Choi, Jaeyoung; Choi, Jaehyuk; Lee, Yong-Hwan			Regulation of Cellular Diacylglycerol through Lipid Phosphate Phosphatases Is Required for Pathogenesis of the Rice Blast Fungus, Magnaporthe oryzae	PLOS ONE			English	Article							PROTEIN-KINASE-C; SIGNAL-TRANSDUCTION; APPRESSORIUM FORMATION; MEMBRANE-PROTEIN; GENETIC-ANALYSIS; GRISEA; SEQUENCE; IDENTIFICATION; PATHOGENICITY; ACID	Considering implication of diacylglycerol in both metabolism and signaling pathways, maintaining proper levels of diacylglycerol (DAG) is critical to cellular homeostasis and development. Except the PIP2-PLC mediated pathway, metabolic pathways leading to generation of DAG converge on dephosphorylation of phosphatidic acid catalyzed by lipid phosphate phosphatases. Here we report the role of such enzymes in a model plant pathogenic fungus, Magnaporthe oryzae. We identified five genes encoding putative lipid phosphate phosphatases (MoLPP1 to MoLPP5). Targeted disruption of four genes (except MoLPP4) showed that MoLPP3 and MoLPP5 are required for normal progression of infection-specific development and proliferation within host plants, whereas MoLPP1 and MoLPP2 are indispensable for fungal pathogenicity. Reintroduction of MoLPP3 and MoLPP5 into individual deletion mutants restored all the defects. Furthermore, exogenous addition of saturated DAG not only restored defect in appressorium formation but also complemented reduced virulence in both mutants. Taken together, our data indicate differential roles of lipid phosphate phosphatase genes and requirement of proper regulation of cellular DAGs for fungal development and pathogenesis.	[Abu Sadat, Md.; Jeon, Junhyun; Mir, Albely Afifa; Choi, Jaeyoung; Lee, Yong-Hwan] Seoul Natl Univ, Plant Genom & Breeding Inst, Dept Agr Biotechnol, Seoul, South Korea; [Abu Sadat, Md.; Jeon, Junhyun; Mir, Albely Afifa; Choi, Jaeyoung; Choi, Jaehyuk; Lee, Yong-Hwan] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Choi, Jaehyuk; Lee, Yong-Hwan] Seoul Natl Univ, Ctr Fungal Pathogenesis, Plant Genom & Breeding Inst, Seoul, South Korea; [Lee, Yong-Hwan] Seoul Natl Univ, Ctr Fungal Genet Resources, Plant Genom & Breeding Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lee, YH (corresponding author), Seoul Natl Univ, Plant Genom & Breeding Inst, Dept Agr Biotechnol, Seoul, South Korea.	yonglee@snu.ac.kr	Choi, Jaeyoung/H-8665-2013; Choi, Jaeyoung/T-5932-2019	Choi, Jaeyoung/0000-0003-2206-4593; Choi, Jaeyoung/0000-0003-2206-4593	National Research Foundation of Korea - Korea government [2008-0061897, 2013-003196]; Next-Generation BioGreen 21 Program of Rural Development Administration in Korea [PJ00821201]; Brain Korea 21 Program	National Research Foundation of Korea - Korea government(National Research Foundation of KoreaKorean Government); Next-Generation BioGreen 21 Program of Rural Development Administration in Korea; Brain Korea 21 Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by the National Research Foundation of Korea grant funded by the Korea government (2008-0061897 and 2013-003196), and the Next-Generation BioGreen 21 Program of Rural Development Administration in Korea (PJ00821201). Sadat is grateful for a graduate fellowship through the Brain Korea 21 Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez FJ, 2007, EUKARYOT CELL, V6, P755, DOI 10.1128/EC.00008-07; Athenstaedt K, 1999, EUR J BIOCHEM, V266, P1, DOI 10.1046/j.1432-1327.1999.00822.x; Baker B, 1997, SCIENCE, V276, P726, DOI 10.1126/science.276.5313.726; Balhadere PV, 1999, MOL PLANT MICROBE IN, V12, P129, DOI 10.1094/MPMI.1999.12.2.129; BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; BOURETT TM, 1990, CAN J BOT, V68, P329, DOI 10.1139/b90-044; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chi MH, 2009, PLANT PATHOLOGY J, V25, P108, DOI 10.5423/PPJ.2009.25.1.108; Choi J, 2007, MOL MICROBIOL, V66, P826, DOI 10.1111/j.1365-2958.2007.05971.x; Choi J, 2013, NUCLEIC ACIDS RES, V41, pD714, DOI 10.1093/nar/gks1163; Choi J, 2011, FUNGAL GENET BIOL, V48, P445, DOI 10.1016/j.fgb.2011.01.001; D'Souza CA, 2001, FEMS MICROBIOL REV, V25, P349, DOI 10.1111/j.1574-6976.2001.tb00582.x; Deacon EM, 2002, J CELL SCI, V115, P983; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; DeZwaan TM, 1999, PLANT CELL, V11, P2013, DOI 10.1105/tpc.11.10.2013; Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000; Goff SA, 2005, SCIENCE, V309, P879; Goldston AM, 2012, TRENDS PARASITOL, V28, P417, DOI 10.1016/j.pt.2012.07.002; Gomez-Fernandez JC, 2007, CHEM PHYS LIPIDS, V148, P1, DOI 10.1016/j.chemphyslip.2007.04.003; Goni FM, 1999, PROG LIPID RES, V38, P1, DOI 10.1016/S0163-7827(98)00021-6; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Ile KE, 2012, DEVELOPMENT, V139, P2535, DOI 10.1242/dev.077289; Jenkins GM, 1997, J BIOL CHEM, V272, P32566, DOI 10.1074/jbc.272.51.32566; Jeon J, 2008, MOL PLANT MICROBE IN, V21, P525, DOI 10.1094/MPMI-21-5-0525; Jia YJ, 2003, FEBS LETT, V552, P240, DOI 10.1016/S0014-5793(03)00931-1; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Kim S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-104; Klose J, 2004, MOL MICROBIOL, V52, P823, DOI 10.1111/j.1365-2958.2004.04019.x; Koga H, 2004, PHYSIOL MOL PLANT P, V64, P67, DOI 10.1016/j.pmpp.2004.07.002; LEE YH, 1993, PLANT CELL, V5, P693, DOI 10.1105/tpc.5.6.693; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Nanjundan M, 2003, AM J PHYSIOL-LUNG C, V284, pL1, DOI 10.1152/ajplung.00029.2002; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; Paradis S, 2011, PLANT PHYSIOL BIOCH, V49, P357, DOI 10.1016/j.plaphy.2011.01.010; Park G, 2002, MOL PLANT MICROBE IN, V15, P183, DOI 10.1094/MPMI.2002.15.3.183; Park SY, 2010, PLANT PATHOLOGY J, V26, P313, DOI 10.5423/PPJ.2010.26.4.313; PATTON JL, 1992, J BACTERIOL, V174, P7180, DOI 10.1128/jb.174.22.7180-7184.1992; PESSIN MS, 1989, J BIOL CHEM, V264, P8729; Pettitt TR, 1997, J BIOL CHEM, V272, P17354, DOI 10.1074/jbc.272.28.17354; Pierrugues O, 2001, J BIOL CHEM, V276, P20300, DOI 10.1074/jbc.M009726200; Rho HS, 2009, MOL PLANT PATHOL, V10, P337, DOI [10.1111/J.1364-3703.2009.00536.X, 10.1111/j.1364-3703.2009.00536.x]; Rhome R, 2009, ANNU REV MICROBIOL, V63, P119, DOI 10.1146/annurev.micro.091208.073431; Sambrook J, 2001, MOL CLONING LAB MANU; Sciorra VA, 1999, BIOCHIM BIOPHYS ACTA, V1582, P45; Shea JM, 2006, CURR OPIN MICROBIOL, V9, P352, DOI 10.1016/j.mib.2006.06.003; Siafakas AR, 2006, EUKARYOT CELL, V5, P488, DOI 10.1128/EC.5.3.488-498.2006; Spiegel S, 1996, CURR OPIN CELL BIOL, V8, P159, DOI 10.1016/S0955-0674(96)80061-5; Stukey J, 1997, PROTEIN SCI, V6, P469; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; Talbot NJ, 2001, ADV BOT RES, V34, P263, DOI 10.1016/S0065-2296(01)34011-9; Thines E, 1997, FEMS MICROBIOL LETT, V156, P91, DOI 10.1016/S0378-1097(97)00407-2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Urban M, 1999, EMBO J, V18, P512, DOI 10.1093/emboj/18.3.512; VALENT B, 1991, ANNU REV PHYTOPATHOL, V29, P443, DOI 10.1146/annurev.py.29.090191.002303; Villalba F, 2008, FUNGAL GENET BIOL, V45, P68, DOI 10.1016/j.fgb.2007.06.006; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Wakelam MJO, 1998, BBA-MOL CELL BIOL L, V1436, P117, DOI 10.1016/S0005-2760(98)00123-4; Wang ZY, 2007, MOL PLANT MICROBE IN, V20, P475, DOI 10.1094/MPMI-20-5-0475; Wang ZY, 2003, MOL MICROBIOL, V47, P1601, DOI 10.1046/j.1365-2958.2003.03412.x; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhang N, 1996, GENETICS, V143, P1231	69	9	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100726	10.1371/journal.pone.0100726	http://dx.doi.org/10.1371/journal.pone.0100726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959955	Green Submitted, Green Published, gold			2022-12-25	WOS:000338633900076
J	Chiu, CL; Aguilar, JS; Tsai, CY; Wu, GK; Gratton, E; Digman, MA				Chiu, Chi-Li; Aguilar, Jose S.; Tsai, Connie Y.; Wu, GuiKai; Gratton, Enrico; Digman, Michelle A.			Nanoimaging of Focal Adhesion Dynamics in 3D	PLOS ONE			English	Article							IMAGE CORRELATION SPECTROSCOPY; CELL-MIGRATION; PAXILLIN; ACTIN; TURNOVER; TRACKING; INVASION; REVEALS	Organization and dynamics of focal adhesion proteins have been well characterized in cells grown on two-dimensional (2D) cell culture surfaces. However, much less is known about the dynamic association of these proteins in the 3D microenvironment. Limited imaging technologies capable of measuring protein interactions in real time and space for cells grown in 3D is a major impediment in understanding how proteins function under different environmental cues. In this study, we applied the nano-scale precise imaging by rapid beam oscillation (nSPIRO) technique and combined the scaning-fluorescence correlation spectroscopy (sFCS) and the number and molecular brightness (N&B) methods to investigate paxillin and actin dynamics at focal adhesions in 3D. Both MDA-MB-231 cells and U2OS cells produce elongated protrusions with high intensity regions of paxillin in cell grown in 3D collagen matrices. Using sFCS we found higher percentage of slow diffusing proteins at these focal spots, suggesting assembling/disassembling processes. In addition, the N&B analysis shows paxillin aggregated predominantly at these focal contacts which are next to collagen fibers. At those sites, actin showed slower apparent diffusion rate, which indicated that actin is either polymerizing or binding to the scaffolds in these locals. Our findings demonstrate that by multiplexing these techniques we have the ability to spatially and temporally quantify focal adhesion assembly and disassembly in 3D space and allow the understanding tumor cell invasion in a more complex relevant environment.	[Chiu, Chi-Li; Gratton, Enrico; Digman, Michelle A.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Tsai, Connie Y.; Wu, GuiKai] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Aguilar, Jose S.; Gratton, Enrico; Digman, Michelle A.] Univ Calif Irvine, Fluorescence Dynam Lab, Dept Biomed Engn, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Digman, MA (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA.	mdigman@uci.edu		, Michelle/0000-0003-4611-7100	W.M. Keck Foundation [50242]; W.M. Keck Nanoimaging Lab at UCI; National Institutes of Health [P50 GM076516]; National Institute of General Medical Sciences [8 P41 GM103540-27]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516] Funding Source: NIH RePORTER	W.M. Keck Foundation(W.M. Keck Foundation); W.M. Keck Nanoimaging Lab at UCI; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the W.M. Keck Foundation (Award 50242), The W.M. Keck Nanoimaging Lab at UCI, The National Institutes of Health P50 GM076516, and National Institute of General Medical Sciences (8 P41 GM103540-27). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Deakin NO, 2011, MOL BIOL CELL, V22, P327, DOI 10.1091/mbc.E10-09-0790; Digman MA, 2005, BIOPHYS J, V89, P1317, DOI 10.1529/biophysj.105.062836; Digman MA, 2008, BIOPHYS J, V94, P2819, DOI 10.1529/biophysj.107.104984; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Digman MA, 2009, P NATL ACAD SCI USA, V106, P2170, DOI 10.1073/pnas.0806036106; Fraley SI, 2011, NAT CELL BIOL, V13, P5, DOI 10.1038/ncb0111-5; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Harunaga JS, 2011, MATRIX BIOL; Hayakawa K, 2008, J CELL SCI, V121, P496, DOI 10.1242/jcs.022053; Hebert B, 2005, BIOPHYS J, V88, P3601, DOI 10.1529/biophysj.104.054874; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kis-Petikova K, 2004, MICROSC RES TECHNIQ, V63, P34, DOI 10.1002/jemt.10417; Kraning-Rush CM, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015009; Kubow Kristopher E, 2011, Nat Cell Biol, V13, P3, DOI 10.1038/ncb0111-3; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Lanzano L, 2011, J BIOPHOTONICS, V4, P415, DOI 10.1002/jbio.201100002; Levi V, 2005, BIOPHYS J, V88, P2919, DOI 10.1529/biophysj.104.044230; Maskarinec SA, 2009, P NATL ACAD SCI USA, V106, P22108, DOI 10.1073/pnas.0904565106; McGrath JL, 1998, BIOPHYS J, V75, P2070, DOI 10.1016/S0006-3495(98)77649-0; Meyer AS, 2012, J CELL BIOL, V197, P721, DOI 10.1083/jcb.201201003; Miron-Mendoza M, 2010, BIOMATERIALS, V31, P6425, DOI 10.1016/j.biomaterials.2010.04.064; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pathak A, 2011, INTEGR BIOL CAMB; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Rhee S, 2009, EXP MOL MED, V41, P858, DOI 10.3858/emm.2009.41.12.096; Rossow M, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3088203; Rossow MJ, 2010, NAT PROTOC, V5, P1761, DOI 10.1038/nprot.2010.122; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Tanner K, 2009, BIOPHYS J, V97, P2098, DOI 10.1016/j.bpj.2009.06.052; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Yu XZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030605	38	20	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99896	10.1371/journal.pone.0099896	http://dx.doi.org/10.1371/journal.pone.0099896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959851	Green Published, gold			2022-12-25	WOS:000338633900016
J	Erb, A; Althaus, M				Erb, Alexandra; Althaus, Mike			Actions of Hydrogen Sulfide on Sodium Transport Processes across Native Distal Lung Epithelia (Xenopus laevis)	PLOS ONE			English	Article							CL-SECRETION; CHANNELS; PROTECTS; INJURY; EXPRESSION; CLEARANCE; NYSTATIN; EDEMA; CELLS; H2S	Hydrogen sulfide (H2S) is well known as a highly toxic environmental chemical threat. Prolonged exposure to H2S can lead to the formation of pulmonary edema. However, the mechanisms of how H2S facilitates edema formation are poorly understood. Since edema formation can be enhanced by an impaired clearance of electrolytes and, consequently, fluid across the alveolar epithelium, it was questioned whether H2S may interfere with transepithelial electrolyte absorption. Electrolyte absorption was electrophysiologically measured across native distal lung preparations (Xenopus laevis) in Ussing chambers. The exposure of lung epithelia to H2S decreased net transepithelial electrolyte absorption. This was due to an impairment of amiloride-sensitive sodium transport. H2S inhibited the activity of the Na+/K+-ATPase as well as lidocaine-sensitive potassium channels located in the basolateral membrane of the epithelium. Inhibition of these transport molecules diminishes the electrochemical gradient which is necessary for transepithelial sodium absorption. Since sodium absorption osmotically facilitates alveolar fluid clearance, interference of H2S with the epithelial transport machinery provides a mechanism which enhances edema formation in H2S-exposed lungs.	[Erb, Alexandra; Althaus, Mike] Univ Giessen, Inst Anim Physiol, D-35390 Giessen, Germany	Justus Liebig University Giessen	Althaus, M (corresponding author), Univ Giessen, Inst Anim Physiol, D-35390 Giessen, Germany.	mike.althaus@bio.uni-giessen.de		Althaus, Mike/0000-0002-3554-7538	German Research Foundation (DFG) [AL1453/1-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work has been funded by a grant from the German Research Foundation (DFG) No. AL1453/1-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus M, 2012, BRIT J PHARMACOL, V166, P1946, DOI 10.1111/j.1476-5381.2012.01909.x; Althaus M, 2011, PULM MED, V2011, DOI 10.1155/2011/830320; Althaus M, 2011, AM J RESP CELL MOL, V44, P53, DOI 10.1165/2009-0335OC; Berger J, 2011, AM J PHYSIOL-REG I, V300, pR616, DOI 10.1152/ajpregu.00464.2010; Cao H, 2014, TOXICOL LETT, V224, P387, DOI 10.1016/j.toxlet.2013.11.008; Egli M, 2004, J PHYSIOL-LONDON, V560, P857, DOI 10.1113/jphysiol.2004.066704; Esechie A, 2009, BRIT J PHARMACOL, V158, P1442, DOI 10.1111/j.1476-5381.2009.00411.x; Faller S, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-26; Faller S, 2010, ANESTHESIOLOGY, V113, P104, DOI 10.1097/ALN.0b013e3181de7107; FISCHER H, 1989, AM J PHYSIOL, V256, pC764, DOI 10.1152/ajpcell.1989.256.4.C764; FISCHER H, 1990, PFLUG ARCH EUR J PHY, V416, P62, DOI 10.1007/BF00370222; Francis RC, 2011, ANESTHESIOLOGY, V115, P1012, DOI 10.1097/ALN.0b013e31823306cf; Fronius M, 2003, J MEMBRANE BIOL, V195, P43, DOI 10.1007/s00232-003-2043-7; Fronius Martin, 2013, Curr Mol Pharmacol, V6, P13; Guidotti TL, 2010, INT J TOXICOL, V29, P569, DOI 10.1177/1091581810384882; Guidotti TL, 1996, OCCUP MED-OXFORD, V46, P367, DOI 10.1093/occmed/46.5.367; Jain L, 2001, AM J PHYSIOL-LUNG C, V280, pL646, DOI 10.1152/ajplung.2001.280.4.L646; KOEFOEDJOHNSEN V, 1958, ACTA PHYSIOL SCAND, V42, P298, DOI 10.1111/j.1748-1716.1958.tb01563.x; Kolluru GK, 2013, REDOX BIOL, V1, P313, DOI 10.1016/j.redox.2013.05.001; LEWIS SA, 1977, J GEN PHYSIOL, V70, P427, DOI 10.1085/jgp.70.4.427; Madurga A, 2014, AM J PHYSL LUNG CELL; MEBAN C, 1973, J ANAT, V114, P235; Mimoun S, 2012, ANTIOXID REDOX SIGN, V17, P1, DOI 10.1089/ars.2011.4186; OLVER RE, 1986, J PHYSIOL-LONDON, V376, P321, DOI 10.1113/jphysiol.1986.sp016156; Otulakowski G, 2010, ANESTHESIOLOGY, V113, P4, DOI 10.1097/ALN.0b013e3181dec00e; Rashid S, 2013, BRIT J PHARMACOL, V168, P1902, DOI 10.1111/bph.12084; REIFFENSTEIN RJ, 1992, ANNU REV PHARMACOL, V32, P109, DOI 10.1146/annurev.pa.32.040192.000545; RUSSELL JM, 1977, J MEMBRANE BIOL, V37, P137, DOI 10.1007/BF01940929; Sommer D, 2007, RESP PHYSIOL NEUROBI, V158, P97, DOI 10.1016/j.resp.2007.03.016; Sznajder JI, 2002, J APPL PHYSIOL, V93, P1860, DOI 10.1152/japplphysiol.00022.2002; Vadivel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090965; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035	33	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100971	10.1371/journal.pone.0100971	http://dx.doi.org/10.1371/journal.pone.0100971			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960042	Green Published, Green Submitted, gold			2022-12-25	WOS:000338633900108
J	Obermeyer, AC; Capehart, SL; Jarman, JB; Francis, MB				Obermeyer, Allie C.; Capehart, Stacy L.; Jarman, John B.; Francis, Matthew B.			Multivalent Viral Capsids with Internal Cargo for Fibrin Imaging	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; COMBINATORIAL LIBRARIES; CONTRAST AGENT; PEPTIDE; NANOPARTICLES; PROTEIN; POLYMERIZATION; BINDING; SURFACE; BACTERIOPHAGE-MS2	Thrombosis is the cause of many cardiovascular syndromes and is a significant contributor to life-threatening diseases, such as myocardial infarction and stroke. Thrombus targeted imaging agents have the capability to provide molecular information about pathological clots, potentially improving detection, risk stratification, and therapy of thrombosis-related diseases. Nanocarriers are a promising platform for the development of molecular imaging agents as they can be modified to have external targeting ligands and internal functional cargo. In this work, we report the synthesis and use of chemically functionalized bacteriophage MS2 capsids as biomolecule-based nanoparticles for fibrin imaging. The capsids were modified using an oxidative coupling reaction, conjugating similar to 90 copies of a fibrin targeting peptide to the exterior of each protein shell. The ability of the multivalent, targeted capsids to bind fibrin was first demonstrated by determining the impact on thrombin-mediated clot formation. The modified capsids out-performed the free peptides and were shown to inhibit clot formation at effective concentrations over ten-fold lower than the monomeric peptide alone. The installation of near-infrared fluorophores on the interior surface of the capsids enabled optical detection of binding to fibrin clots. The targeted capsids bound to fibrin, exhibiting higher signal-to-background than control, non-targeted MS2-based nanoagents. The in vitro assessment of the capsids suggests that fibrin-targeted MS2 capsids could be used as delivery agents to thrombi for diagnostic or therapeutic applications.	[Obermeyer, Allie C.; Capehart, Stacy L.; Jarman, John B.; Francis, Matthew B.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Francis, Matthew B.] Lawrence Berkeley Natl Labs, Div Mat Sci, Berkeley, CA USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Francis, MB (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	mbfrancis@berkeley.edu	Obermeyer, Allie/P-9227-2016	Obermeyer, Allie/0000-0003-2412-2021	DOD Breast Cancer Research Program [BC061995]; NSF; UC Berkeley Chemical Biology Graduate Program [1 T32 GMO66698]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066698] Funding Source: NIH RePORTER	DOD Breast Cancer Research Program(United States Department of Defense); NSF(National Science Foundation (NSF)); UC Berkeley Chemical Biology Graduate Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were generously supported by the DOD Breast Cancer Research Program (BC061995). ACO and SLC were supported by graduate research fellowships from the NSF. The UC Berkeley Chemical Biology Graduate Program (Training Grant 1 T32 GMO66698) is acknowledged for their support of ACO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aruva MR, 2006, J NUCL MED, V47, P155; Ashley CE, 2011, ACS NANO, V5, P5729, DOI 10.1021/nn201397z; Behrens CR, 2011, J AM CHEM SOC, V133, P16398, DOI 10.1021/ja2033298; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Carrico ZM, 2008, CHEM COMMUN, P1205, DOI 10.1039/b717826c; Chacko AM, 2011, CURR OPIN COLLOID IN, V16, P215, DOI 10.1016/j.cocis.2011.01.008; Choudhury RP, 2009, ARTERIOSCL THROM VAS, V29, P983, DOI 10.1161/ATVBAHA.108.165498; Choudhury RP, 2004, NAT REV DRUG DISCOV, V3, P913, DOI 10.1038/nrd1548; Comellas-Aragones M, 2011, SOFT MATTER, V7, P11380, DOI 10.1039/c1sm06123b; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Farkas ME, 2013, MOL PHARMACEUT, V10, P69, DOI 10.1021/mp3003754; Garimella PD, 2011, J AM CHEM SOC, V133, P14704, DOI 10.1021/ja204516p; Gestwicki JE, 2002, J AM CHEM SOC, V124, P14922, DOI 10.1021/ja027184x; Hood CA, 2008, J PEPT SCI, V14, P97, DOI 10.1002/psc.921; Hooker JM, 2004, J AM CHEM SOC, V126, P3718, DOI 10.1021/ja031790q; HUI KY, 1983, SCIENCE, V222, P1129, DOI 10.1126/science.6648524; Jayagopal A, 2007, BIOCONJUGATE CHEM, V18, P1424, DOI 10.1021/bc070020r; JOHNSON P, 1965, BIOCHIM BIOPHYS ACTA, V102, P467, DOI 10.1016/0926-6585(65)90137-8; Kamaly N, 2010, INT J MOL SCI, V11, P1759, DOI 10.3390/ijms11041759; Kickhoefer VA, 2005, P NATL ACAD SCI USA, V102, P4348, DOI 10.1073/pnas.0500929102; Kitagawa T, 2012, MOL IMAGING BIOL, V14, P315, DOI 10.1007/s11307-011-0495-1; KNIGHT LC, 1988, J NUCL MED, V29, P494; Kodadek T, 2006, MOL BIOSYST, V2, P25, DOI 10.1039/b514349g; Kolodziej AF, 2012, BIOCONJUGATE CHEM, V23, P548, DOI 10.1021/bc200613e; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LATALLO ZS, 1962, AM J PHYSIOL, V202, P681, DOI 10.1152/ajplegacy.1962.202.4.681; LAUDANO AP, 1978, P NATL ACAD SCI USA, V75, P3085, DOI 10.1073/pnas.75.7.3085; Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171; Lee LA, 2006, NANOMED-NANOTECHNOL, V2, P137, DOI 10.1016/j.nano.2006.07.009; Li D, 2010, CIRC-CARDIOVASC IMAG, V3, P464, DOI 10.1161/CIRCIMAGING.109.896654; Li F, 2009, SMALL, V5, P718, DOI 10.1002/smll.200801303; Manchester M, 2006, ADV DRUG DELIVER REV, V58, P1505, DOI 10.1016/j.addr.2006.09.014; MASTICO RA, 1993, J GEN VIROL, V74, P541, DOI 10.1099/0022-1317-74-4-541; McCarthy JR, 2008, ADV DRUG DELIVER REV, V60, P1241, DOI 10.1016/j.addr.2008.03.014; McCarthy JR, 2010, CURR CARDIOVASC IMAG, V3, P42, DOI 10.1007/s12410-009-9002-3; McCarthy JR, 2011, NANOMEDICINE-UK, V6, P1291, DOI [10.2217/NNM.11.128, 10.2217/nnm.11.128]; McCarthy JR, 2009, BIOCONJUGATE CHEM, V20, P1251, DOI 10.1021/bc9001163; Meldrum T, 2010, J AM CHEM SOC, V132, P5936, DOI 10.1021/ja100319f; Nahrendorf M, 2009, JACC-CARDIOVASC IMAG, V2, P1213, DOI 10.1016/j.jcmg.2009.04.016; Overoye-Chan K, 2008, J AM CHEM SOC, V130, P6025, DOI 10.1021/ja800834y; Parrott MC, 2009, J AM CHEM SOC, V131, P2906, DOI 10.1021/ja8078175; Peter K, 2000, CIRCULATION, V101, P1158, DOI 10.1161/01.CIR.101.10.1158; Plummer EM, 2012, NANOMEDICINE-UK, V7, P877, DOI [10.2217/nnm.11.185, 10.2217/NNM.11.185]; Pokorski JK, 2011, CHEMBIOCHEM, V12, P2441, DOI 10.1002/cbic.201100469; Pratt KP, 1997, P NATL ACAD SCI USA, V94, P7176, DOI 10.1073/pnas.94.14.7176; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Santoro SW, 2002, NAT BIOTECHNOL, V20, P1044, DOI 10.1038/nbt742; Sanz J, 2008, NATURE, V451, P953, DOI 10.1038/nature06803; Sigal GB, 1996, J AM CHEM SOC, V118, P3789, DOI 10.1021/ja953729u; Soon ASC, 2011, BIOMATERIALS, V32, P4406, DOI 10.1016/j.biomaterials.2011.02.050; Terashima M, 2011, BIOMATERIALS, V32, P1430, DOI 10.1016/j.biomaterials.2010.09.029; Thakur ML, 2000, J NUCL MED, V41, P161; Tong GJ, 2009, J AM CHEM SOC, V131, P11174, DOI 10.1021/ja903857f; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Uchida M, 2006, J AM CHEM SOC, V128, P16626, DOI 10.1021/ja0655690; Uchida M, 2011, ACS NANO, V5, P2493, DOI 10.1021/nn102863y; Udugamasooriya DG, 2008, J AM CHEM SOC, V130, P5744, DOI 10.1021/ja711193x; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Watson JW, 2011, BIOCHEMISTRY-US, V50, P9923, DOI 10.1021/bi201406c; Wei B, 2009, BIOMED PHARMACOTHER, V63, P313, DOI 10.1016/j.biopha.2008.07.086; Woller EK, 2003, J AM CHEM SOC, V125, P8820, DOI 10.1021/ja0352496; Yang Z, 2000, P NATL ACAD SCI USA, V97, P14156, DOI 10.1073/pnas.97.26.14156; Yildiz I, 2011, CURR OPIN BIOTECH, V22, P901, DOI 10.1016/j.copbio.2011.04.020; Yu X, 2000, MAGNET RESON MED, V44, P867, DOI 10.1002/1522-2594(200012)44:6<867::AID-MRM7>3.0.CO;2-P	65	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100678	10.1371/journal.pone.0100678	http://dx.doi.org/10.1371/journal.pone.0100678			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960118	gold, Green Published, Green Submitted			2022-12-25	WOS:000338633900068
J	Parkunan, SM; Astley, R; Callegan, MC				Parkunan, Salai Madhumathi; Astley, Roger; Callegan, Michelle C.			Role of TLR5 and Flagella in Bacillus Intraocular Infection	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; STAPHYLOCOCCUS-AUREUS VIRULENCE; TOLL-LIKE RECEPTORS; BACTERIAL ENDOPHTHALMITIS; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; INFLAMMATORY RESPONSES; CEREUS INFECTION; BARRIER FUNCTION; HEMOLYSIN BL	B. cereus possesses flagella which allow the organism to migrate within the eye during a blinding form of intraocular infection called endophthalmitis. Because flagella is a ligand for Toll-like receptor 5 (TLR5), we hypothesized that TLR5 contributed to endophthalmitis pathogenesis. Endophthalmitis was induced in C57BL/6J and TLR5-/- mice by injecting 100 CFU of B. cereus into the mid-vitreous. Eyes were analyzed for intraocular bacterial growth, retinal function, and inflammation by published methods. Purified B. cereus flagellin was also injected into the mid-vitreous of wild type C57BL/6J mice and inflammation was analyzed. TLR5 activation by B. cereus flagellin was also analyzed in vitro. B. cereus grew rapidly and at similar rates in infected eyes of C57BL/6J and TLR5-/- mice. A significant loss in retinal function in both groups of mice was observed at 8 and 12 hours postinfection. Retinal architecture disruption and acute inflammation (neutrophil infiltration and proinflammatory cytokine concentrations) increased and were significant at 8 and 12 hours postinfection. Acute inflammation was comparable in TLR5-/- and C57BL/6J mice. Physiological concentrations of purified B. cereus flagellin caused significant inflammation in C57BL/6J mouse eyes, but not to the extent of that observed during active infection. Purified B. cereus flagellin was a weak agonist for TLR5 in vitro. These results demonstrated that the absence of TLR5 did not have a significant effect on the evolution of B. cereus endophthalmitis. This disparity may be due to sequence differences in important TLR5 binding domains in B. cereus flagellin or the lack of flagellin monomers in the eye to activate TLR5 during infection. Taken together, these results suggest a limited role for flagellin/TLR5 interactions in B. cereus endophthalmitis. Based on this and previous data, the importance of flagella in this disease lies in its contribution to the motility of the organism within the eye during infection.	[Parkunan, Salai Madhumathi; Callegan, Michelle C.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Astley, Roger; Callegan, Michelle C.] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73190 USA; [Callegan, Michelle C.] Dean A McGee Eye Inst, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Callegan, MC (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA.	michelle-callegan@ouhsc.edu		Astley, Roger/0000-0002-2243-119X	National Institutes of Health (NIH) [R01EY012985]; NIH CORE Grant [P30EY012191]; National Center for Research Resources COBRE Grant [P20RR017703]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY021725, R01EY012985] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH CORE Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources COBRE Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by National Institutes of Health (NIH) Grant R01EY012985 (to MCC, http://www.nih.gov). The authors' research is also supported in part by NIH CORE Grant P30EY012191 (Robert E. Anderson, OUHSC), National Center for Research Resources COBRE Grant P20RR017703 (Robert E. Anderson, OUHSC), and an unrestricted grant to the Dean A. McGee Eye Institute from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Andersen-Nissen E, 2007, J IMMUNOL, V178, P4717, DOI 10.4049/jimmunol.178.8.4717; Beecher DJ, 2000, INFECT IMMUN, V68, P5269, DOI 10.1128/IAI.68.9.5269-5276.2000; BERGER SA, 1983, J CLIN MICROBIOL, V18, P974, DOI 10.1128/JCM.18.4.974-975.1983; BOOTH MC, 1995, INVEST OPHTH VIS SCI, V36, P1828; Booth MC, 1997, INFECT IMMUN, V65, P1550, DOI 10.1128/IAI.65.4.1550-1556.1997; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; BRYCE EA, 1993, INFECT CONT HOSP EP, V14, P459, DOI 10.1086/646779; Callegan MC, 1999, INFECT IMMUN, V67, P3348, DOI 10.1128/IAI.67.7.3348-3356.1999; Callegan MC, 2005, INVEST OPHTH VIS SCI, V46, P3233, DOI 10.1167/iovs.05-0410; Callegan MC, 1999, INFECT IMMUN, V67, P3357, DOI 10.1128/IAI.67.7.3357-3366.1999; Callegan MC, 2003, INFECT IMMUN, V71, P3116, DOI 10.1128/IAI.71.6.3116-3124.2003; Callegan MC, 2002, INFECT IMMUN, V70, P5381, DOI 10.1128/IAI.70.10.5381-5389.2002; Callegan MC, 2002, CLIN MICROBIOL REV, V15, P111, DOI 10.1128/CMR.15.1.111-124.2002; Callegan MC, 2002, DNA CELL BIOL, V21, P367, DOI 10.1089/10445490260099647; Callegan MC, 2007, PROG RETIN EYE RES, V26, P189, DOI 10.1016/j.preteyeres.2006.12.001; Callegan MC, 2006, INVEST OPHTH VIS SCI, V47, P4461, DOI 10.1167/iovs.06-0301; Campodonico VL, 2010, INFECT IMMUN, V78, P746, DOI 10.1128/IAI.00806-09; Chang JH, 2006, BRIT J OPHTHALMOL, V90, P103, DOI 10.1136/bjo.2005.072686; Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009; Das T, 1999, BRIT J OPHTHALMOL, V83, P1050, DOI 10.1136/bjo.83.9.1050; de Vos AF, 2009, J IMMUNOL, V183, P533, DOI 10.4049/jimmunol.0802189; DEPAMPHI.ML, 1971, J BACTERIOL, V105, P376, DOI 10.1128/JB.105.1.376-383.1971; Dolan SA, 2012, INFECT CONT HOSP EP, V33, P666, DOI 10.1086/666334; Donnelly MA, 2002, J BIOL CHEM, V277, P40456, DOI 10.1074/jbc.M206851200; Fournier B, 2009, INFECT IMMUN, V77, P4121, DOI 10.1128/IAI.00656-09; Gao N, 2011, INVEST OPHTH VIS SCI, V52, P3074, DOI 10.1167/iovs.10-5928; Ghelardi E, 2002, J BACTERIOL, V184, P6424, DOI 10.1128/JB.184.23.6424-6433.2002; Guttenplan SB, 2013, MOL MICROBIOL, V87, P211, DOI 10.1111/mmi.12103; Hawn TR, 2007, J IMMUNOL, V179, P6981, DOI 10.4049/jimmunol.179.10.6981; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hernaiz C, 2003, CLIN MICROBIOL INFEC, V9, P973, DOI 10.1046/j.1469-0691.2003.00682.x; Hozono Y, 2006, BIOCHEM BIOPH RES CO, V347, P238, DOI 10.1016/j.bbrc.2006.06.088; Hsueh PR, 1999, J CLIN MICROBIOL, V37, P2280, DOI 10.1128/JCM.37.7.2280-2284.1999; Im J, 2009, MOL IMMUNOL, V47, P614, DOI 10.1016/j.molimm.2009.09.004; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Jarchum I, 2011, INFECT IMMUN, V79, P1498, DOI 10.1128/IAI.01196-10; JETT BD, 1995, INVEST OPHTH VIS SCI, V36, P9; JETT BD, 1992, INFECT IMMUN, V60, P2445, DOI 10.1128/IAI.60.6.2445-2452.1992; Kalpoe JS, 2008, J HOSP INFECT, V68, P341, DOI 10.1016/j.jhin.2008.01.017; Kojima K, 2008, BRIT J OPHTHALMOL, V92, P411, DOI 10.1136/bjo.2007.128322; Kumar A, 2007, INVEST OPHTH VIS SCI, V48, P4664, DOI 10.1167/iovs.07-0473; Kumar A, 2010, J INFECT DIS, V201, P255, DOI 10.1086/649589; Kumar MV, 2004, J NEUROIMMUNOL, V153, P7, DOI 10.1016/j.jneuroim.2004.04.018; Lai MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072047; Lambiase A, 2011, CLIN SCI, V120, P441, DOI 10.1042/CS20100425; Lin X, 2012, NEUROL SCI, P1; McCole DF, 2003, CURR OPIN GASTROEN, V19, P578, DOI 10.1097/00001574-200311000-00011; Meredith T A, 1996, Trans Am Ophthalmol Soc, V94, P241; Morris AE, 2009, AM J PHYSIOL-LUNG C, V297, pL1112, DOI 10.1152/ajplung.00155.2009; MOTZEL SL, 1991, J CLIN MICROBIOL, V29, P2566, DOI 10.1128/JCM.29.11.2566-2570.1991; Moyer AL, 2009, INVEST OPHTH VIS SCI, V50, P3783, DOI 10.1167/iovs.08-3051; Novosad BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028619; Ramadan RT, 2008, INVEST OPHTH VIS SCI, V49, P4482, DOI 10.1167/iovs.08-2085; Ramadan RT, 2006, CURR EYE RES, V31, P955, DOI 10.1080/02713680600976925; Redfern RL, 2011, EXP EYE RES, V92, P209, DOI 10.1016/j.exer.2010.12.005; Sadaka A, 2012, PROG RETIN EYE RES, V31, P316, DOI 10.1016/j.preteyeres.2012.03.004; Salvetti S, 2007, MICROBIOL-SGM, V153, P2541, DOI 10.1099/mic.0.2006/005553-0; Sanders DSA, 2005, J CLIN PATHOL, V58, P568, DOI 10.1136/jcp.2004.021840; Sanders ME, 2011, INVEST OPHTH VIS SCI, V52, P865, DOI 10.1167/iovs.10-5513; Sanders ME, 2008, CLIN OPHTHALMOL, V2, P793; Senesi S, 2002, MICROBIOL-SGM, V148, P1785, DOI 10.1099/00221287-148-6-1785; Senesi S, 2010, RES MICROBIOL, V161, P743, DOI 10.1016/j.resmic.2010.10.007; Shah GK, 2000, OPHTHALMOLOGY, V107, P486, DOI 10.1016/S0161-6420(99)00139-6; Smith K, 2003, POETRY REV, V93, P5; Sun Y, 2010, J IMMUNOL, V185, P4272, DOI 10.4049/jimmunol.1000874; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wiskur BJ, 2008, INVEST OPHTH VIS SCI, V49, P1480, DOI 10.1167/iovs.07-1303; Yang JY, 2014, J INNATE IMMUN, V6, P47, DOI 10.1159/000351476; Yoshino Y, 2013, LIFE SCI, V92, P211, DOI 10.1016/j.lfs.2012.11.017; Yoshizumi MO, 1998, RETINA-J RET VIT DIS, V18, P130, DOI 10.1097/00006982-199818020-00006; Zhang F., 2013, DEP SYST NETW WORKSH, P1; Zhang J, 2003, INVEST OPHTH VIS SCI, V44, P4247, DOI 10.1167/iovs.03-0219	73	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100543	10.1371/journal.pone.0100543	http://dx.doi.org/10.1371/journal.pone.0100543			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959742	gold, Green Published, Green Submitted			2022-12-25	WOS:000338633900055
J	Pletnev, S; Shcherbakova, DM; Subach, OM; Pletneva, NV; Malashkevich, VN; Almo, SC; Dauter, Z; Verkhusha, VV				Pletnev, Sergei; Shcherbakova, Daria M.; Subach, Oksana M.; Pletneva, Nadya V.; Malashkevich, Vladimir N.; Almo, Steven C.; Dauter, Zbigniew; Verkhusha, Vladislav V.			Orange Fluorescent Proteins: Structural Studies of LSSmOrange, PSmOrange and PSmOrange2	PLOS ONE			English	Article							LARGE STOKES SHIFT; MONOMERIC RED; ZOANTHUS SP; FRET; VARIANT; PHOTOCONVERSION; CHROMOPHORE; REFINEMENT; PATHWAYS; DYNAMICS	A structural analysis of the recently developed orange fluorescent proteins with novel phenotypes, LSSmOrange (lambda(ex)/lambda(em) at 437/572 nm), PSmOrange (lambda(ex)/lambda(em) at 548/565 nm and for photoconverted form at 636/662 nm) and PSmOrange2 (lambda(ex)/lambda(em) at 546/561 nm and for photoconverted form at 619/651 nm), is presented. The obtained crystallographic structures provide an understanding of how the ensemble of a few key mutations enabled special properties of the orange FPs. While only a single Ile161Asp mutation, enabling excited state proton transfer, is critical for LSSmOrange, other substitutions provide refinement of its special properties and an exceptional 120 nm large Stokes shift. Similarly, a single Gln64Leu mutation was sufficient to cause structural changes resulting in photoswitchability of PSmOrange, and only one additional substitution (Phe65Ile), yielding PSmOrange2, was enough to greatly decrease the energy of photoconversion and increase its efficiency of photoswitching. Fluorescence of photoconverted PSmOrange and PSmOrange2 demonstrated an unexpected bathochromic shift relative to the fluorescence of classic red FPs, such as DsRed, eqFP578 and zFP574. The structural changes associated with this fluorescence shift are of considerable value for the design of advanced far-red FPs. For this reason the chromophore transformations accompanying photoconversion of the orange FPs are discussed.	[Pletnev, Sergei] Leidos Biomed Res Inc, Basic Res Program, Argonne, IL 60439 USA; [Pletnev, Sergei; Dauter, Zbigniew] NCI, Macromol Crystallog Lab, Argonne, IL USA; [Shcherbakova, Daria M.; Subach, Oksana M.; Verkhusha, Vladislav V.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA; [Malashkevich, Vladimir N.; Almo, Steven C.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA; [Pletneva, Nadya V.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Subach, Oksana M.] Moscow Inst Phys & Technol, Dept Nano Bio Informat & Cognit Technol, Moscow, Russia	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Moscow Institute of Physics & Technology	Pletnev, S (corresponding author), Leidos Biomed Res Inc, Basic Res Program, Argonne, IL 60439 USA.	pletnevs@mail.nih.gov; vladislav.verkhusha@einstein.yu.edu	Verkhusha, Vladislav/AAU-7784-2020; Subach, Oksana (Gritsenko)/K-7086-2014; Pletneva, Nadya/F-7839-2014	Verkhusha, Vladislav/0000-0002-2083-8121; Zucker-Scharff, Thomas/0000-0002-1790-7405; Pletneva, Nadya/0000-0001-9681-4022	US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; National Cancer Institute, NIH [HHSN261200800001E]; NIH [GM073913, CA164468]; Albert Einstein Cancer Center [CA013330]; New York Structural Genomics Research Center; Russian Science Foundation [14-14-00281]; NATIONAL CANCER INSTITUTE [P30CA013330, R01CA164468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244, R01GM073913] Funding Source: NIH RePORTER	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein Cancer Center; New York Structural Genomics Research Center; Russian Science Foundation(Russian Science Foundation (RSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. W-31-109-Eng-38. The authors thank Rafael Toro for help with the crystallization screening and X29 beamline staff at NSLS for help with data collection. This work was supported in part with Federal funds from the National Cancer Institute, NIH, under contract HHSN261200800001E, the Intramural Research Program of the NIH, the NIH grants GM073913 and CA164468 (to VVV), the Albert Einstein Cancer Center grant CA013330, the New York Structural Genomics Research Center (to SCA), and by a grant from the Russian Science Foundation 14-14-00281. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products or organizations imply endorsement by the US Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon N, 2005, BIOPHYS J, V88, P2452, DOI 10.1529/biophysj.104.055541; Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chattoraj M, 1996, P NATL ACAD SCI USA, V93, P8362, DOI 10.1073/pnas.93.16.8362; Chudakov DM, 2007, NAT PROTOC, V2, P2024, DOI 10.1038/nprot.2007.291; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Habuchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003944; Henderson JN, 2009, J AM CHEM SOC, V131, P13212, DOI 10.1021/ja904665x; Hoi H, 2013, CHEM BIOL, V20, P1296, DOI 10.1016/j.chembiol.2013.08.008; Hoi HF, 2010, J MOL BIOL, V401, P776, DOI 10.1016/j.jmb.2010.06.056; Karasawa S, 2004, BIOCHEM J, V381, P307, DOI 10.1042/BJ20040321; Kikuchi A, 2008, BIOCHEMISTRY-US, V47, P11573, DOI 10.1021/bi800727v; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lippincott-Schwartz J, 2009, TRENDS CELL BIOL, V19, P555, DOI 10.1016/j.tcb.2009.09.003; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Piatkevich KD, 2010, J AM CHEM SOC, V132, P10762, DOI 10.1021/ja101974k; Piatkevich KD, 2010, P NATL ACAD SCI USA, V107, P5369, DOI 10.1073/pnas.0914365107; Pletnev S, 2012, J MOL BIOL, V417, P144, DOI 10.1016/j.jmb.2012.01.044; Pletneva N, 2006, ACTA CRYSTALLOGR D, V62, P527, DOI 10.1107/S0907444906007852; Pletneva NV, 2007, RUSS J BIOORG CHEM+, V33, P390, DOI 10.1134/S1068162007040048; Pletneva NV, 2013, ACTA CRYSTALLOGR D, V69, P1005, DOI 10.1107/S0907444913004034; Pletneva NV, 2011, PROTEIN SCI, V20, P1265, DOI 10.1002/pro.654; Remington SJ, 2005, BIOCHEMISTRY-US, V44, P202, DOI 10.1021/bi048383r; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shcherbakova DM, 2012, ANGEW CHEM INT EDIT, V51, P10724, DOI 10.1002/anie.201200408; Shcherbakova DM, 2012, J AM CHEM SOC, V134, P7913, DOI 10.1021/ja3018972; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Strack RL, 2008, NAT METHODS, V5, P955, DOI 10.1038/nmeth.1264; Strack RL, 2009, BIOCHEMISTRY-US, V48, P8279, DOI 10.1021/bi900870u; Strack RL, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-32; Subach OM, 2012, J AM CHEM SOC, V134, P14789, DOI 10.1021/ja3034137; Subach OM, 2011, NAT METHODS, V8, P771, DOI 10.1038/nmeth.1664; Tsutsui H, 2008, NAT METHODS, V5, P683, DOI 10.1038/nmeth.1235; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Violot S, 2009, J AM CHEM SOC, V131, P10356, DOI 10.1021/ja903695n; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu B, 2011, CURR OPIN CELL BIOL, V23, P310, DOI 10.1016/j.ceb.2010.12.004; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462; Zapata-Hommer O, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-5	52	15	17	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99136	10.1371/journal.pone.0099136	http://dx.doi.org/10.1371/journal.pone.0099136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960050	Green Published, gold, Green Submitted			2022-12-25	WOS:000338633900003
J	Tossavainen, H; Kukkurainen, S; Maatta, JAE; Kahkonen, N; Pihlajamaa, T; Hytonen, VP; Kulomaa, MS; Permi, P				Tossavainen, Helena; Kukkurainen, Sampo; Maatta, Juha A. E.; Kahkonen, Niklas; Pihlajamaa, Tero; Hytonen, Vesa P.; Kulomaa, Markku S.; Permi, Perttu			Chimeric Avidin - NMR Structure and Dynamics of a 56 kDa Homotetrameric Thermostable Protein	PLOS ONE			English	Article							MAGNETIC-RESONANCE RELAXATION; GROUP HYDROGEN-EXCHANGE; MODEL-FREE APPROACH; BIOTIN-BINDING; TEMPERATURE-DEPENDENCE; BACKBONE DYNAMICS; ROTATIONAL DIFFUSION; MOLECULAR-DYNAMICS; THERMAL-STABILITY; ORDER PARAMETERS	Chimeric avidin (ChiAVD) is a product of rational protein engineering remarkably resistant to heat and harsh conditions. In quest of the fundamentals behind factors affecting stability we have elucidated the solution NMR spectroscopic structure of the biotin-bound form of ChiAVD and characterized the protein dynamics through N-15 relaxation and hydrogen/deuterium (H/D) exchange of this and the biotin-free form. To surmount the challenges arising from the very large size of the protein for NMR spectroscopy, we took advantage of its high thermostability. Conventional triple resonance experiments for fully protonated proteins combined with methyl-detection optimized experiments acquired at 58 degrees C were adequate for the structure determination of this 56 kDa protein. The model-free parameters derived from the N-15 relaxation data reveal a remarkably rigid protein at 58 degrees C in both the biotin-bound and the free forms. The H/D exchange experiments indicate a notable increase in hydrogen protection upon biotin binding.	[Tossavainen, Helena; Pihlajamaa, Tero; Permi, Perttu] Univ Helsinki, Inst Biotechnol, Program Struct Biol & Biophys, Helsinki, Finland; [Kukkurainen, Sampo; Maatta, Juha A. E.; Kahkonen, Niklas; Hytonen, Vesa P.; Kulomaa, Markku S.] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Kukkurainen, Sampo; Maatta, Juha A. E.; Kahkonen, Niklas; Hytonen, Vesa P.; Kulomaa, Markku S.] Tampere Univ Hosp, Tampere, Finland; [Maatta, Juha A. E.; Kahkonen, Niklas; Hytonen, Vesa P.; Kulomaa, Markku S.] BioMediTech, Tampere, Finland; [Kukkurainen, Sampo; Maatta, Juha A. E.; Hytonen, Vesa P.] Fimlab Labs, Tampere, Finland	University of Helsinki; Tampere University; Tampere University; Tampere University Hospital	Permi, P (corresponding author), Univ Helsinki, Inst Biotechnol, Program Struct Biol & Biophys, Helsinki, Finland.	Perttu.Permi@helsinki.fi	Määttä, Juha/A-6629-2016; Hytonen, Vesa P./E-8855-2013	Määttä, Juha/0000-0003-3885-6149; Hytonen, Vesa P./0000-0002-9357-1480; Kukkurainen, Sampo/0000-0002-0635-784X	Academy of Finland [259447, 136288, 140978]; Sigrid Juselius Foundation; Tampere Graduate Program in Biomedicine and Biotechnology	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere Graduate Program in Biomedicine and Biotechnology	Funding provided by Academy of Finland (www.aka.fi) grants 259447 (PP), 136288, 140978 (VPH), Sigrid Juselius Foundation (www.sigridjuselius.fi): PP & VPH and Tampere Graduate Program in Biomedicine and Biotechnology (www.uta.fi/bmt/tgpbb: SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKKE M, 1993, J AM CHEM SOC, V115, P9832, DOI 10.1021/ja00074a073; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Celej MS, 2004, BIOCHEM BIOPH RES CO, V325, P922, DOI 10.1016/j.bbrc.2004.10.118; Chang SL, 2005, J MAGN RESON, V174, P43, DOI 10.1016/j.jmr.2005.01.008; Chivers CE, 2010, NAT METHODS, V7, P391, DOI [10.1038/nmeth.1450, 10.1038/NMETH.1450]; CONNELLY GP, 1993, PROTEINS, V17, P87, DOI 10.1002/prot.340170111; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DIAMANDIS EP, 1991, CLIN CHEM, V37, P625; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Eisenberg-Domovich Y, 2005, ACTA CRYSTALLOGR D, V61, P528, DOI 10.1107/S0907444905003914; Gonzalez M, 1999, BIOMOL ENG, V16, P67, DOI 10.1016/S1050-3862(99)00041-8; Goto NK, 1999, J BIOMOL NMR, V13, P369, DOI 10.1023/A:1008393201236; Heikkinen JJ, 2011, ACS APPL MATER INTER, V3, P2240, DOI 10.1021/am200272u; Heikkinen JJ, 2011, COLLOID SURFACE B, V87, P409, DOI 10.1016/j.colsurfb.2011.05.052; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hytonen VP, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-28; Hytonen VP, 2005, PROTEINS, V61, P597, DOI 10.1002/prot.20604; Hytonen VP, 2005, J BIOL CHEM, V280, P10228, DOI 10.1074/jbc.M414196200; Hytonen VP, 2004, J BIOL CHEM, V279, P9337, DOI 10.1074/jbc.M310989200; Hytonen VR, 2004, BIOCHEM J, V384, P385, DOI 10.1042/BJ20041114; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Laitinen OH, 2006, CELL MOL LIFE SCI, V63, P2992, DOI 10.1007/s00018-006-6288-z; Laitinen OH, 2002, BIOCHEM J, V363, P609, DOI 10.1042/0264-6021:3630609; Laitinen OH, 2001, J BIOL CHEM, V276, P8219, DOI 10.1074/jbc.M007930200; Laitinen OH, 2007, TRENDS BIOTECHNOL, V25, P269, DOI 10.1016/j.tibtech.2007.04.001; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; LIVNAH O, 1993, P NATL ACAD SCI USA, V90, P5076, DOI 10.1073/pnas.90.11.5076; Lopez-Mendez B, 2006, J AM CHEM SOC, V128, P13112, DOI 10.1021/ja061136l; Maatta JAE, 2011, BIOTECHNOL BIOENG, V108, P481, DOI 10.1002/bit.22962; Mantylahti S, 2010, J BIOMOL NMR, V47, P183, DOI 10.1007/s10858-010-9422-z; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; MCCOY MA, 1992, J AM CHEM SOC, V114, P2108, DOI 10.1021/ja00032a026; Morin S, 2009, BIOPHYS J, V96, P4681, DOI 10.1016/j.bpj.2009.02.068; Pawley NH, 2002, J MOL BIOL, V324, P991, DOI 10.1016/S0022-2836(02)01146-4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SANO T, 1995, P NATL ACAD SCI USA, V92, P3180, DOI 10.1073/pnas.92.8.3180; Savard PY, 2006, BIOCHEMISTRY-US, V45, P11414, DOI 10.1021/bi060414q; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Seewald MJ, 2000, PROTEIN SCI, V9, P1177, DOI 10.1110/ps.9.6.1177; SKELTON NJ, 1992, J MOL BIOL, V227, P1100, DOI 10.1016/0022-2836(92)90524-N; Spyracopoulos L, 2001, BIOCHEMISTRY-US, V40, P12541, DOI 10.1021/bi010903k; Tjandra N, 1996, J BIOMOL NMR, V8, P273, DOI 10.1007/BF00410326; Torchia DA, 2011, J MAGN RESON, V212, P1, DOI 10.1016/j.jmr.2011.07.010; Tossavainen H, 2013, BIOMOL NMR ASSIGN, V7, P35, DOI 10.1007/s12104-012-9371-4; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Wang TZ, 2003, J AM CHEM SOC, V125, P8639, DOI 10.1021/ja034077+; Wilchek M, 1999, BIOMOL ENG, V16, P1; Williams DH, 2006, J MOL BIOL, V355, P760, DOI 10.1016/j.jmb.2005.11.015; Wurtz P, 2006, J BIOMOL NMR, V36, P12, DOI 10.1007/s10858-006-9056-3; Yang DW, 1996, J MOL BIOL, V263, P369, DOI 10.1006/jmbi.1996.0581	57	1	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100564	10.1371/journal.pone.0100564	http://dx.doi.org/10.1371/journal.pone.0100564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959850	Green Submitted, Green Published, gold			2022-12-25	WOS:000338633900057
J	Zhou, Y; Ni, HP; Balint, K; Sanzari, JK; Dentchev, T; Diffenderfer, ES; Wilson, JM; Cengel, KA; Weissman, D				Zhou, Yu; Ni, Houping; Balint, Klara; Sanzari, Jenine K.; Dentchev, Tzvete; Diffenderfer, Eric S.; Wilson, Jolaine M.; Cengel, Keith A.; Weissman, Drew			Ionizing Radiation Selectively Reduces Skin Regulatory T Cells and Alters Immune Function	PLOS ONE			English	Article							DNA-PKCS; IN-VIVO; DOSE DISTRIBUTION; UV-RADIATION; IRRADIATION; THERAPY; PROTON; SYSTEM; RESISTANCE; TOLERANCE	The skin serves multiple functions that are critical for life. The protection from pathogens is achieved by a complicated interaction between aggressive effectors and controlling functions that limit damage. Inhomogeneous radiation with limited penetration is used in certain types of therapeutics and is experienced with exposure to solar particle events outside the protection of the Earth's magnetic field. This study explores the effect of ionizing radiation on skin immune function. We demonstrate that radiation, both homogeneous and inhomogeneous, induces inflammation with resultant specific loss of regulatory T cells from the skin. This results in a hyper-responsive state with increased delayed type hypersensitivity in vivo and CD4(+) T cell proliferation in vitro. The effects of inhomogeneous radiation to the skin of astronauts or as part of a therapeutic approach could result in an unexpected enhancement in skin immune function. The effects of this need to be considered in the design of radiation therapy protocols and in the development of countermeasures for extended space travel.	[Zhou, Yu; Ni, Houping; Balint, Klara; Weissman, Drew] Univ Penn, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA; [Sanzari, Jenine K.; Diffenderfer, Eric S.; Wilson, Jolaine M.; Cengel, Keith A.] Univ Penn, Dept Radiat Oncol, Philadelphia, PA USA; [Dentchev, Tzvete] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Weissman, D (corresponding author), Univ Penn, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA.	dreww@mail.med.upenn.edu	Balint, Klara/ABB-8816-2021	Balint, Klara/0000-0002-1540-1988	National Space Biomedical Research Institute through National Aeronautics and Space Administration [NCC 9-58]	National Space Biomedical Research Institute through National Aeronautics and Space Administration	This work was supported by a grant from the National Space Biomedical Research Institute through National Aeronautics and Space Administration NCC 9-58. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Ariotti N, 2012, MOL BIOL CELL, V23, P1826, DOI 10.1091/mbc.E11-10-0847; Ariotti S, 2012, P NATL ACAD SCI USA, V109, P19739, DOI 10.1073/pnas.1208927109; Ariotti S, 2012, ADV IMMUNOL, V114, P203, DOI 10.1016/B978-0-12-396548-6.00008-1; AWWAD M, 1988, CANCER IMMUNOL IMMUN, V26, P55; Balogh A, 2013, INFLAMM RES, V62, P201, DOI 10.1007/s00011-012-0567-y; Balter S, 2010, RADIOLOGY, V254, P326, DOI 10.1148/radiol.2542082312; Burzyn D, 2013, NAT IMMUNOL, V14, P1007, DOI 10.1038/ni.2683; Cao MD, 2011, INT J RADIAT BIOL, V87, P71, DOI 10.3109/09553002.2010.518208; Cengel KA, 2010, RADIAT ENVIRON BIOPH, V49, P715, DOI 10.1007/s00411-010-0315-z; Chen KL, 2010, POULTRY SCI, V89, P887, DOI 10.3382/ps.2009-00524; DUNN PL, 1991, J LEUKOCYTE BIOL, V49, P388, DOI 10.1002/jlb.49.4.388; EKKEL ED, 1995, J ANIM SCI, V73, P1544; EKKEL ED, 1995, VET QUART, V17, P143, DOI 10.1080/01652176.1995.9694554; Franco D, 2009, DNA REPAIR, V8, P813, DOI 10.1016/j.dnarep.2009.03.007; Geherin SA, 2012, J IMMUNOL, V188, P6027, DOI 10.4049/jimmunol.1102639; Gleason NR, 1999, SURG ENDOSC-ULTRAS, V13, P1032, DOI 10.1007/s004649901163; Gridley DS, 2011, IN VIVO, V25, P871; Gridley DS, 2010, TECHNOL CANCER RES T, V9, P637, DOI 10.1177/153303461000900612; Hagelstrom RT, 2008, ONCOGENE, V27, P6761, DOI 10.1038/onc.2008.276; Halliday GM, 2012, J DERMATOL SCI, V66, P176, DOI 10.1016/j.jdermsci.2011.12.009; Hart PH, 2011, NAT REV IMMUNOL, V11, P584, DOI 10.1038/nri3045; Hauswald H, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-118; Hernandez A, 2005, VET IMMUNOL IMMUNOP, V104, P45, DOI 10.1016/j.vetimm.2004.10.006; Hong A, 2012, CANCER J, V18, P203, DOI 10.1097/PPO.0b013e31824b241a; Hu SW, 2009, HEALTH PHYS, V96, P465, DOI 10.1097/01.HP.0000339020.92837.61; Ikushima H, 2011, INT J RADIAT ONCOL, V79, P473, DOI 10.1016/j.ijrobp.2009.11.009; Juzeniene A, 2009, J PHOTOCH PHOTOBIO B, V96, P93, DOI 10.1016/j.jphotobiol.2009.04.009; Kachikwu EL, 2011, INT J RADIAT ONCOL, V81, P1128, DOI 10.1016/j.ijrobp.2010.09.034; Kim MHY, 2009, HEALTH PHYS, V97, P68, DOI 10.1097/01.HP.0000346799.65001.9c; Kohnke M, 2012, CHEM BIOL, V19, P866, DOI 10.1016/j.chembiol.2012.05.019; Komatsu N, 2007, P NATL ACAD SCI USA, V104, P8959, DOI 10.1073/pnas.0702004104; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Li MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085665; Liston A, 2014, NAT REV IMMUNOL, V14, P154, DOI 10.1038/nri3605; Loser K, 2012, J INVEST DERMATOL, V132, P864, DOI 10.1038/jid.2011.375; Massimino S, 2003, J VET INTERN MED, V17, P835, DOI 10.1892/0891-6640(2003)017&lt;0835:EOAADO&gt;2.3.CO;2; McFarland HI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039092; Nelson C, 2010, INT J RADIAT ONCOL, V76, P1578, DOI 10.1016/j.ijrobp.2009.08.002; NISCO SJ, 1995, TRANSPLANTATION, V59, P1444, DOI 10.1097/00007890-199505270-00015; Norval M, 2011, PHOTOCHEM PHOTOBIOL, V87, P965, DOI 10.1111/j.1751-1097.2011.00969.x; Pathania S, 2011, VACCINE, V29, P7296, DOI 10.1016/j.vaccine.2011.07.065; Pustisek N, 2011, COLLEGIUM ANTROPOL, V35, P339; Qu YY, 2010, CELL MOL IMMUNOL, V7, P419, DOI 10.1038/cmi.2010.45; Qu YY, 2010, RADIAT RES, V173, P148, DOI 10.1667/RR0978.1; Romero-Weaver AL, 2013, RADIAT RES, V180, P177, DOI 10.1667/RR3055.1; Romero-Weaver AL, 2013, ASTROBIOLOGY, V13, P570, DOI 10.1089/ast.2012.0916; Sanzari JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071757; Seo HW, 2012, BMC VET RES, V8, P1, DOI 10.1186/1746-6148-8-194; Sklar LR, 2013, PHOTOCH PHOTOBIO SCI, V12, P54, DOI 10.1039/c2pp25152c; Suchin EJ, 2001, J IMMUNOL, V166, P973, DOI 10.4049/jimmunol.166.2.973; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Ullrich SE, 2012, J INVEST DERMATOL, V132, P896, DOI 10.1038/jid.2011.405; Walser PJ, 2012, CELL, V150, P752, DOI 10.1016/j.cell.2012.06.042; Williams ES, 2009, CANCER RES, V69, P2100, DOI 10.1158/0008-5472.CAN-08-2854; Wilson JM, 2011, RADIAT RES, V176, P649, DOI 10.1667/RR2541.1; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016	58	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100800	10.1371/journal.pone.0100800	http://dx.doi.org/10.1371/journal.pone.0100800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959865	Green Submitted, Green Published, gold			2022-12-25	WOS:000338633900088
J	Hancock, KJ; Lawrence, D; Zubrick, SR				Hancock, Kirsten J.; Lawrence, David; Zubrick, Stephen R.			Higher Maternal Protectiveness Is Associated with Higher Odds of Child Overweight and Obesity: A Longitudinal Australian Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SOCIOECONOMIC-STATUS; WEIGHT STATUS; TRENDS; PARENTS; PERCEPTIONS; SAFETY; RISK; PLAY; FEAR	In recent years there has been an increasing interest in overprotective parenting and the potential role it plays in child development. While some have argued that a trend towards increased parental fear and reduced opportunity for independent mobility may be linked to increasing rates of child overweight and obesity, there is limited empirical information available to support this claim. Using data from the Longitudinal Study of Australian Children, this study aimed to examine the longitudinal relationships between maternal protectiveness and child overweight and obesity. A cohort of 4-5 year old children was followed up at 6-7, 8-9 and 10-11 years of age (n = 2596). Measures included a protective parenting scale administered when children were 6-7 and 8-9 years of age, child body mass index (BMI), family characteristics including household income, neighbourhood disadvantage, child's position amongst siblings, and maternal BMI, education, employment, mental health and age at first birth. International Obesity Taskforce age-and sex-specific BMI cut points were used to determine if children were in the normal, overweight or obese BMI range. There was no association between maternal protectiveness and the odds of children being overweight or obese at age 4-5, 6-7 or 8-9 years. However at age 10-11 years, a 1 standard deviation increase in maternal protectiveness was associated with a 13% increase in the odds of children being overweight or obese. The results provide evidence of a relationship between maternal protectiveness and child overweight and obesity, however further research is required to understand the mechanism(s) that links the two concepts.	[Hancock, Kirsten J.; Lawrence, David; Zubrick, Stephen R.] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia	Telethon Kids Institute; University of Western Australia	Hancock, KJ (corresponding author), Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia.	kirsten.hancock@telethonkids.org.au	Lawrence, David/C-8292-2009; Zubrick, Stephen R/CAI-1970-2022; Hancock, Kirsten/T-1836-2019	Lawrence, David/0000-0003-4700-1425; Zubrick, Stephen R/0000-0002-6369-1713; Hancock, Kirsten/0000-0001-6213-2488	National Health and Medical Research Council program grant [572742]	National Health and Medical Research Council program grant(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by a National Health and Medical Research Council program grant (#572742) (http://www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHW, 2012, PICT AUSTR CHILD 201; AIHW National Injury Surveillance Unit, 2012, INJ RES STAT SER, V75; Barton M, 2010, PEDIATRICS, V125, P361, DOI 10.1542/peds.2009-2037; Bayer JK, 2006, J APPL DEV PSYCHOL, V27, P542, DOI 10.1016/j.appdev.2006.08.002; Branche C., 2008, WORLD REPORT CHILD I; Brussoni M, 2013, QUAL HEALTH RES, V23, P1388, DOI 10.1177/1049732313505916; Carver A, 2008, HEALTH PLACE, V14, P217, DOI 10.1016/j.healthplace.2007.06.004; Carver A, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-57; Clements R., 2004, CONTEMP ISS EARLY CH, V5, P68; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cooklin AR, 2014, J FAM ISSUES, V35, P1497, DOI 10.1177/0192513X13481776; Cooklin AR, 2013, J FAM PSYCHOL, V27, P618, DOI 10.1037/a0033332; Cooklin AR, 2012, AUST NZ J PUBL HEAL, V36, P249, DOI 10.1111/j.1753-6405.2012.00846.x; Craig L, 2014, BRIT J SOCIOL, V65, P555, DOI 10.1111/1468-4446.12035; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; Department of Social Services, 2014, ACC DSS LONG DAT; Ding D, 2012, AM J HEALTH PROMOT, V26, P189, DOI 10.4278/ajhp.100701-QUAN-224; Doukas G, 2010, ACCIDENT ANAL PREV, V42, P1705, DOI 10.1016/j.aap.2010.04.010; Eager D., 2011, P IPWEA INT PUBL WOR; Gabriel T., 2010, NY TIMES; Givertz M, 2014, COMMUN RES, V41, P1111, DOI 10.1177/0093650212456392; Gray P, 2011, AM J PLAY, V3, P443; Hafekost K, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-41; Hancock KJ, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-299; Harten N, 2004, AUST NZ J PUBL HEAL, V28, P167; Hedeker D., 2006, LONGITUDINAL DATA AN; Jones RA, 2010, INT J PEDIATR OBES, V5, P256, DOI 10.3109/17477160903271971; Karsten L., 2005, CHILDRENS GEOGRAPHIE, V3, P275, DOI 10.1080/14733280500352912; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Mitchell R, 2009, J PAEDIATR CHILD H, V45, P754, DOI 10.1111/j.1440-1754.2007.01157.x; Olds TS, 2010, INT J OBESITY, V34, P57, DOI 10.1038/ijo.2009.211; Page AS, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-2; Paton G, 2012, TELEGRAPH; Pleck J.H., 2010, ROLE FATHER CHILD DE, P58; Salmon J, 2005, AUST NZ J PUBL HEAL, V29, P337, DOI 10.1111/j.1467-842X.2005.tb00204.x; Schiffrin HH, 2014, J CHILD FAM STUD, V23, P548, DOI 10.1007/s10826-013-9716-3; SHUTT JE, 2004, CRIMINAL JUSTICE STU, V0017; Sipthorp M, 2009, 6 LSAC AUSTR I FAM S; Snyder Howard N., 2000, SEXUAL ASSAULT YOUNG; Soloff C., 2006, 3 LSAC AUSTR I FAM S; Thomasgard M, 1997, AM J ORTHOPSYCHIAT, V67, P330, DOI 10.1037/h0080237; Tomkinson Grant R, 2007, Med Sport Sci, V50, P168, DOI 10.1159/000101361; Tomkinson Grant R, 2007, Med Sport Sci, V50, P46, DOI 10.1159/000101075; Tulloch MI, 2004, J SOCIOL, V40, P362, DOI 10.1177/1440783304048380; Ungar M, 2009, AM J FAM THER, V37, P258, DOI 10.1080/01926180802534247; Valentine G., 2004, PUBLIC SPACE CULTURE, V1; Vaus D., 2002, ANAL SOCIAL SCI DATA; Veitch J, 2006, HEALTH PLACE, V12, P383, DOI 10.1016/j.healthplace.2005.02.009; Wilson DK, 2004, ANN BEHAV MED, V28, P20, DOI 10.1207/s15324796abm2801_4; Zubrick S., 2010, NOTHING FEAR ITSELF	50	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100686	10.1371/journal.pone.0100686	http://dx.doi.org/10.1371/journal.pone.0100686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL1WV	24955586	Green Submitted, gold, Green Published			2022-12-25	WOS:000338917900082
J	Lim, YF; Lentle, RG; Janssen, PWM; Williams, MAK; de Loubens, C; Mansel, BW; Chambers, P				Lim, Yuen Feung; Lentle, Roger G.; Janssen, Patrick W. M.; Williams, Martin A. K.; de Loubens, Clement; Mansel, Bradley W.; Chambers, Paul			Determination of Villous Rigidity in the Distal Ileum of the Possum (Trichosurus vulpecula)	PLOS ONE			English	Article							SMALL-INTESTINE; ABSORPTION; DIGESTA; MOTILITY; MARKER; SYSTEM; MUCINS; LAYERS; FLOW; DOG	We investigated the passive mechanical properties of villi in ex vivo preparations of sections of the wall of the distal ileum from the brushtail possum (Trichosurus vulpecula) by using a flow cell to impose physiological and supra-physiological levels of shear stress on the tips of villi. We directly determined the stress applied from the magnitude of the local velocities in the stress inducing flow and additionally mapped the patterns of flow around isolated villi by tracking the trajectories of introduced 3 mu m microbeads with bright field micro particle image velocimetry (mPIV). Ileal villi were relatively rigid along their entire length (mean 550 mu m), and exhibited no noticeable bending even at flow rates that exceeded calculated normal physiological shear stress (>0.5 mPa). However, movement of villus tips indicated that the whole rigid structure of a villus could pivot about the base, likely from laxity at the point of union of the villous shaft with the underlying mucosa. Flow moved upward toward the tip on the upper portions of isolated villi on the surface facing the flow and downward toward the base on the downstream surface. The fluid in sites at distances greater than 150 mu m below the villous tips was virtually stagnant indicating that significant convective mixing in the lower intervillous spaces was unlikely. Together the findings indicate that mixing and absorption is likely to be confined to the tips of villi under conditions where the villi and intestinal wall are immobile and is unlikely to be greatly augmented by passive bending of the shafts of villi.	[Lim, Yuen Feung; Lentle, Roger G.; Janssen, Patrick W. M.; de Loubens, Clement] Massey Univ, Inst Food Nutr & Human Hlth, Palmerston North, New Zealand; [Williams, Martin A. K.; Mansel, Bradley W.] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand; [Lentle, Roger G.; Williams, Martin A. K.] Massey Univ, Riddet Inst, Palmerston North, New Zealand; [Williams, Martin A. K.; Mansel, Bradley W.] MacDiarmid Inst Adv Mat & Nanotechnol, Wellington, New Zealand; [Chambers, Paul] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand	Massey University; Massey University; Massey University; Victoria University Wellington; Massey University	Lentle, RG (corresponding author), Massey Univ, Inst Food Nutr & Human Hlth, Palmerston North, New Zealand.	r.g.lentle@massey.ac.nz	de Loubens, Clement/N-2116-2015	de Loubens, Clement/0000-0002-4988-9168; Mansel, Bradley/0000-0003-4484-2093	Dick & Mary Earle PhD Food Research Fund	Dick & Mary Earle PhD Food Research Fund	This study was funded by the Dick & Mary Earle PhD Food Research Fund administered by the Riddet Institute, New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN A, 1993, PHYSIOL REV, V73, P823, DOI 10.1152/physrev.1993.73.4.823; BUENO L, 1975, J PHYSIOL-LONDON, V249, P69, DOI 10.1113/jphysiol.1975.sp011003; Corfield AP, 2001, FRONT BIOSCI-LANDMRK, V6, pD1321, DOI 10.2741/Corfield; DANIEL H, 1989, AM J PHYSIOL, V257, pG489, DOI 10.1152/ajpgi.1989.257.4.G489; DANIELSEN EM, 1982, BIOCHEM J, V202, P647, DOI 10.1042/bj2020647; DAVIDSON GP, 1977, J CLIN INVEST, V60, P1402, DOI 10.1172/JCI108901; GROVUM WL, 1973, BRIT J NUTR, V29, P13, DOI 10.1079/BJN19730072; Gruzdkov AA, 1989, MEMBRANE DIGESTION N, P228; GULDNER FH, 1972, Z ZELLFORSCH MIK ANA, V135, P349, DOI 10.1007/BF00307181; Ham AW, 1969, HISTOLOGY; HOLZHEIMER G, 1989, AM J PHYSIOL, V256, pG188, DOI 10.1152/ajpgi.1989.256.1.G188; Hosoyamada Y, 2005, ANAT EMBRYOL, V210, P1, DOI 10.1007/s00429-005-0011-y; Hosoyamada Y, 2007, ARCH HISTOL CYTOL, V70, P107, DOI 10.1679/aohc.70.107; Hulls C, 2012, J COMP PHYSIOL B, V182, P287, DOI 10.1007/s00360-011-0610-2; Janssen P. W. M., 2013, NEW ADV GASTROINTEST, V10, P219, DOI DOI 10.1007/978-94-007-6561-0_12; KARARLI TT, 1995, BIOPHARM DRUG DISPOS, V16, P351, DOI 10.1002/bdd.2510160502; KEANE RD, 1990, MEAS SCI TECHNOL, V1, P1202, DOI 10.1088/0957-0233/1/11/013; KING CE, 1945, AM J PHYSIOL, V143, P325, DOI 10.1152/ajplegacy.1945.143.3.325; Kuzmuk KN, 2005, J NUTR, V135, P1940, DOI 10.1093/jn/135.8.1940; Lentle RG, 2005, J COMP PHYSIOL B, V175, P337, DOI 10.1007/s00360-005-0490-4; Lentle RG, 2013, NEUROGASTROENTEROLOG, V25, P881; LEVITT MD, 1990, J CLIN INVEST, V86, P1540, DOI 10.1172/JCI114873; Lim YF, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1008; MAILMAN D, 1990, AM J PHYSIOL, V258, pG238, DOI 10.1152/ajpgi.1990.258.2.G238; MAURY J, 1995, EUR J BIOCHEM, V228, P323; Pappenheimer JR, 2001, J MEMBRANE BIOL, V184, P233, DOI 10.1007/s00232-001-0094-1; Pappenheimer JR, 2001, J MEMBRANE BIOL, V179, P185, DOI 10.1007/s002320010047; Prasad AK, 2000, CURR SCI INDIA, V79, P51; Raffel M., 1998, EXP FLUID MECH; Robbe C, 2003, J BIOL CHEM, V278, P46337, DOI 10.1074/jbc.M302529200; RYU KH, 1982, AM J PHYSIOL, V242, pG364, DOI 10.1152/ajpgi.1982.242.4.G364; Santiago JG, 1998, EXP FLUIDS, V25, P316, DOI 10.1007/s003480050235; Thielicke W, 2013, COMMUNICATION; Thielicke W, 2013, PIVLAB TIME RESOLVED; Tietjens O, 1935, B AM MATH SOC, V41, P173; Wang YX, 2010, PHILOS T R SOC A, V368, P2863, DOI 10.1098/rsta.2010.0090; WEINSTEIN LD, 1969, ARCH SURG-CHICAGO, V99, P560; WESTERGAARD H, 1974, J CLIN INVEST, V54, P718, DOI 10.1172/JCI107810; WOMACK WA, 1988, GASTROENTEROLOGY, V94, P977, DOI 10.1016/0016-5085(88)90556-2	39	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100140	10.1371/journal.pone.0100140	http://dx.doi.org/10.1371/journal.pone.0100140			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956476	Green Published, gold, Green Submitted			2022-12-25	WOS:000338917900027
J	Peng, HS; Liao, MB; Zhang, MY; Xie, Y; Xu, L; Zhang, YJ; Zheng, XFS; Wang, HY; Chen, YF				Peng, Hai-Shan; Liao, Ming-Bin; Zhang, Mei-Yin; Xie, Yin; Xu, Li; Zhang, Yao-Jun; Zheng, X. F. Steven; Wang, Hui-Yun; Chen, Yi-Fei			Synergistic Inhibitory Effect of Hyperbaric Oxygen Combined with Sorafenib on Hepatoma Cells	PLOS ONE			English	Article							ADVANCED HEPATOCELLULAR-CARCINOMA; CANCER-CELLS; IN-VITRO; THERAPY; APOPTOSIS; PATHWAYS; SURVIVAL; HYPOXIA; CHEMOTHERAPY; MOBILIZATION	Objectives: Hypoxia is a common phenomenon in solid tumors, associated with chemotherapy and radiotherapy resistance, recurrence and metastasis. Hyperbaric oxygen (HBO) therapy can increase tissue oxygen pressure and content to prevent the resistance, recurrence and metastasis of cancer. Presently, Sorafenib is a first-line drug, targeted for hepatocellular carcinoma (HCC) but effective in only a small portion of patients and can induce hypoxia. The purpose of this study is to investigate the effect of HBO in combination with sorafenib on hepatoma cells. Methods: Hepatoma cell lines (BEL-7402 and SK-Hep1) were treated with HBO at 2 atmosphere absolute pressure for 80 min per day or combined with sorafenib or cisplatin. At different time points, cells were tested for cell growth, colony formation, apoptosis, cell cycle and migration. Finally, miRNA from the hepatoma cells was detected by microRNA array and validated by qRT-PCR. Results: Although HBO, sorafenib or cisplatin alone could inhibit growth of hepatoma cells, HBO combined with sorafenib or cisplatin resulted in much greater synergistic growth inhibition (cell proliferation and colony formation) in hepatoma cells. Similarly, the synergistic effect of HBO and sorafenib on induction of apoptosis was also observed in hepatoma cells. HBO induced G1 arrest in SK-Hep1 not in BEL-7402 cells, but enhanced cell cycle arrest induced by sorafenib in BEL-7402 treated cells. However, HBO had no obvious effect on the migration of hepatoma cells, and microRNA array analysis showed that hepatoma cells with HBO treatment had significantly different microRNA expression profiles from those with blank control. Conclusions: We show for the first time that HBO combined with sorafenib results in synergistic growth inhibition and apoptosis in hepatoma cells, suggesting a potential application of HBO combined with sorafenib in HCC patients. Additionally, we also show that HBO significantly altered microRNA expression in hepatoma cells.	[Peng, Hai-Shan; Zhang, Mei-Yin; Xie, Yin; Wang, Hui-Yun] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Peng, Hai-Shan; Zhang, Mei-Yin; Xie, Yin; Wang, Hui-Yun] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Liao, Ming-Bin; Chen, Yi-Fei] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Hyperbar Oxygen Therapy Ctr, Guangzhou, Guangdong, Peoples R China; [Xu, Li; Zhang, Yao-Jun] Sun Yat Sen Univ, Ctr Canc, Dept Hepatobiliary Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Zheng, X. F. Steven] Rutgers State Univ, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA	State Key Lab Oncology South China; Sun Yat Sen University; Guangzhou Medical University; Sun Yat Sen University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Wang, HY (corresponding author), State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	wanghyun@mail.sysu.edu.cn; xwcyfmm2001@aliyun.com	YANG, YANG/U-3889-2017; Zhang, Yaojun/U-2965-2019	Zhang, Yaojun/0000-0002-9752-4729	Guangdong Natural Science Foundation [S2012010008627]; State Key Laboratory of Oncology in South China	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); State Key Laboratory of Oncology in South China	The project is supported by Guangdong Natural Science Foundation (grant No: S2012010008627 for YFC) and partially supported by Research Fund of State Key Laboratory of Oncology in South China (to HYW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JF, 1963, BMJ-BRIT MED J, P314, DOI 10.1136/bmj.1.5326.314; Agnello F, 2013, WORLD J HEPATOL, V5, P417, DOI 10.4254/wjh.v5.i8.417; Chai H, 2010, INT J CLIN EXP PATHO, V3, P408; Chang AY, 2013, ANTI-CANCER DRUG, V24, P251, DOI 10.1097/CAD.0b013e32835ba289; Chen YC, 2007, LEUKEMIA RES, V31, P805, DOI 10.1016/j.leukres.2006.09.016; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Danesh-Sani SA, 2012, J CRANIOFAC SURG, V23, pE483, DOI 10.1097/SCS.0b013e3182668777; Daruwalla J, 2007, J DRUG TARGET, V15, P487, DOI 10.1080/10611860701499839; Di Costanzo GG, 2012, DIGEST LIVER DIS, V44, P788, DOI 10.1016/j.dld.2012.04.001; Di Marco V, 2013, ANN ONCOL, V24, pii30, DOI 10.1093/annonc/mdt055; Durmaz E, 1999, Br J Nurs, V8, P1067; Edwards ML, 2010, J VET EMERG CRIT CAR, V20, P289, DOI 10.1111/j.1476-4431.2010.00535_1.x; FELDMEIER JJ, 1994, UNDERSEA HYPERBAR M, V21, P467; Galmiche A, 2013, CANC LETT; Gedaly R, 2010, ANTICANCER RES, V30, P4951; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Hsu CH, 2010, J HEPATOL, V53, P126, DOI 10.1016/j.jhep.2010.01.035; Hsu Chiun, 2009, Expert Rev Clin Pharmacol, V2, P129, DOI 10.1586/17512433.2.2.129; Huang SB, 2010, MOL CANCER THER, V9, P742, DOI 10.1158/1535-7163.MCT-09-1004; Kalns JE, 1999, IN VITRO CELL DEV-AN, V35, P98; Kane RC, 2009, ONCOLOGIST, V14, P95, DOI 10.1634/theoncologist.2008-0185; Lee CH, 2012, UNDERSEA HYPERBAR M, V39, P1089; Liang YJ, 2013, HEPATOLOGY, V57, P1847, DOI 10.1002/hep.26224; Liu LP, 2012, CLIN CANCER RES, V18, P5662, DOI 10.1158/1078-0432.CCR-12-0552; Liu WW, 2013, TARGET ONCOL, V8, P79, DOI 10.1007/s11523-013-0259-8; Moen I, 2012, TARGET ONCOL, V7, P233, DOI 10.1007/s11523-012-0233-x; Mori S, 2009, ONCOGENE, V28, P2796, DOI 10.1038/onc.2009.139; Nakada T, 2012, UROL INT, V89, P208, DOI 10.1159/000338910; Nakano M, 2013, ONCOLOGY-BASEL, V84, P108, DOI 10.1159/000342650; Ohguri T, 2009, INT J HYPERTHER, V25, P160, DOI 10.1080/02656730802610357; Ranieri G, 2012, CURR MED CHEM, V19, P938, DOI 10.2174/092986712799320736; Thom SR, 2006, AM J PHYSIOL-HEART C, V290, pH1378, DOI 10.1152/ajpheart.00888.2005; Thom SR, 2011, WOUND REPAIR REGEN, V19, P149, DOI 10.1111/j.1524-475X.2010.00660.x; Wei RR, 2013, CLIN CANCER RES, V19, P4780, DOI 10.1158/1078-0432.CCR-12-2728; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Xu Li, 2009, Zhonghua Zhongliu Zazhi, V31, P58, DOI 10.3760/cma.j.issn.0253-3766.2009.01.015; Yeh YT, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/290575; Yu CR, 2006, MOL CANCER THER, V5, P2378, DOI 10.1158/1535-7163.MCT-06-0235; Zavaglia C, 2013, EUR J GASTROEN HEPAT, V25, P180, DOI 10.1097/MEG.0b013e328359e550; Zhai B, 2013, WORLD J HEPATOL, V5, P345, DOI 10.4254/wjh.v5.i7.345; Zhang T, 2010, ANTI-CANCER DRUG, V21, P326, DOI 10.1097/CAD.0b013e3283350e26	41	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100814	10.1371/journal.pone.0100814	http://dx.doi.org/10.1371/journal.pone.0100814			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956259	Green Submitted, Green Published, gold			2022-12-25	WOS:000338917900097
J	Siggers, P; Carre, GA; Bogani, D; Warr, N; Wells, S; Hilton, H; Esapa, C; Hajihosseini, MK; Greenfield, A				Siggers, Pam; Carre, Gwenn-Ael; Bogani, Debora; Warr, Nick; Wells, Sara; Hilton, Helen; Esapa, Chris; Hajihosseini, Mohammad K.; Greenfield, Andy			A Novel Mouse Fgfr2 Mutant, Hobbyhorse (hob), Exhibits Complete XY Gonadal Sex Reversal	PLOS ONE			English	Article							FIBROBLAST GROWTH-FACTORS; SRY; EXPRESSION; SOX9; DIFFERENTIATION; PROLIFERATION; GENE	The secreted molecule fibroblast growth factor 9 (FGF9) plays a critical role in testis determination in the mouse. In embryonic gonadal somatic cells it is required for maintenance of SOX9 expression, a key determinant of Sertoli cell fate. Conditional gene targeting studies have identified FGFR2 as the main gonadal receptor for FGF9 during sex determination. However, such studies can be complicated by inefficient and variable deletion of floxed alleles, depending on the choice of Cre deleter strain. Here, we report a novel, constitutive allele of Fgfr2, hobbyhorse (hob), which was identified in an ENU-based forward genetic screen for novel testis-determining loci. Fgr2(hob) is caused by a C to T mutation in the invariant exon 7, resulting in a polypeptide with a mis-sense mutation at position 263 (Pro263Ser) in the third extracellular immunoglobulin-like domain of FGFR2. Mutant homozygous embryos show severe limb and lung defects and, when on the sensitised C57BL/6J (B6) genetic background, undergo complete XY gonadal sex reversal associated with failure to maintain expression of Sox9. Genetic crosses employing a null mutant of Fgfr2 suggest that Fgr2(hob) is a hypomorphic allele, affecting both the FGFR2b and FGFR2c splice isoforms of the receptor. We exploited the consistent phenotype of this constitutive mutant by analysing MAPK signalling at the sex-determining stage of gonad development, but no significant abnormalities in mutant embryos were detected.	[Siggers, Pam; Carre, Gwenn-Ael; Bogani, Debora; Warr, Nick; Hilton, Helen; Esapa, Chris; Greenfield, Andy] MRC, Mammalian Genet Unit, Harwell, Oxon, England; [Bogani, Debora; Wells, Sara] MRC, Mary Lyon Ctr, Harwell, Oxon, England; [Hajihosseini, Mohammad K.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Greenfield, A (corresponding author), MRC, Mammalian Genet Unit, Harwell, Oxon, England.	a.greenfield@har.mrc.ac.uk	Greenfield, Andy/F-5099-2017	Greenfield, Andy/0000-0002-1477-1776; Warr, Nick/0000-0003-0767-1360	UK Medical Research Council [MC_A390_5RX50]; Medical Research Council [MC_U142684167, MC_UP_1502/1] Funding Source: researchfish; MRC [MC_UP_1502/1, MC_U142684167] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the UK Medical Research Council through Core funding to AG at its Mammalian Genetics Unit, Harwell (MC_A390_5RX50). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagheri-Fam S, 2008, DEV BIOL, V314, P71, DOI 10.1016/j.ydbio.2007.11.010; Bogani D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000196; Bullejos M, 2001, DEV DYNAM, V221, P201, DOI 10.1002/dvdy.1134; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Field S, 2011, DEVELOPMENT, V138, P1131, DOI 10.1242/dev.058149; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; Grimmond S, 2000, HUM MOL GENET, V9, P1553, DOI 10.1093/hmg/9.10.1553; Harada M, 2009, NAT GENET, V41, P289, DOI 10.1038/ng.316; Hiramatsu R, 2010, DEVELOPMENT, V137, P303, DOI 10.1242/dev.040519; Hiramatsu R, 2009, DEVELOPMENT, V136, P129, DOI 10.1242/dev.029587; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Jameson SA, 2012, DEV BIOL, V370, P24, DOI 10.1016/j.ydbio.2012.06.009; Keren-Politansky A, 2009, DEV BIOL, V335, P374, DOI 10.1016/j.ydbio.2009.09.012; Kim Y, 2007, P NATL ACAD SCI USA, V104, P16558, DOI 10.1073/pnas.0702581104; Kim Y, 2006, PLOS BIOL, V4, P1000, DOI 10.1371/journal.pbio.0040187; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Murakami S, 2000, P NATL ACAD SCI USA, V97, P1113, DOI 10.1073/pnas.97.3.1113; Patterson VL, 2009, HUM MOL GENET, V18, P1719, DOI 10.1093/hmg/ddp075; Schmahl J, 2004, DEVELOPMENT, V131, P3627, DOI 10.1242/dev.01239; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Suzuki-Hirano A, 2010, DEV BIOL, V337, P284, DOI 10.1016/j.ydbio.2009.10.044; Warr N, 2014, HUM MOL GENET, V23, P3035, DOI 10.1093/hmg/ddu020; Warr N, 2012, DEV CELL, V23, P1020, DOI 10.1016/j.devcel.2012.09.016; Warr N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019572; Warr N, 2009, DEV BIOL, V326, P273, DOI 10.1016/j.ydbio.2008.11.023; Wilhelm D, 2009, MECH DEVELOP, V126, P324, DOI 10.1016/j.mod.2009.02.006; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Xu XL, 1998, DEVELOPMENT, V125, P753	29	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100447	10.1371/journal.pone.0100447	http://dx.doi.org/10.1371/journal.pone.0100447			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956260	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000338917900052
J	Xue, XD; Huang, JH; Wang, HS				Xue, Xiaodong; Huang, Jianhua; Wang, Huishan			The Study of the Intercellular Trafficking of the Fusion Proteins of Herpes Simplex Virus Protein VP22	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SKELETAL MYOBLAST TRANSPLANTATION; IMPROVES CARDIAC-FUNCTION; IMPROVED HEART FUNCTION; MARROW STROMAL CELLS; GENE-TRANSFER; MYOCARDIAL-INFARCTION; IN-VITRO; BONE; REGENERATION	Background: Genetic modifications can improve the therapeutic efficacy of mesenchymal stem cell (MSC) transplantation in myocardial infarction. However, so far, the efficiency of MSC modification is very low. Seeking for a more efficient way of MSC modification, we investigated the possibility of employing the intercellular trafficking capacity of the herpes simplex virus type-1 tegument protein VP22 on the enhancement of MSC modification. Methods: Plasmids pVP22-myc, pVP22-EGFP, pEGFP-VP22, pVP22-hBcl-xL and phBcl-xL-VP22 were constructed for the expressions of the myc-tagged VP22 and the fusion proteins VP22-EGFP, EGFP-VP22, VP22-hBcl-xL and hBcl-xL-VP22. MSCs were isolated from rat bone marrow and the surface markers were identified by Flowcytometry. COS-1 cells were transfected with the above plasmids and co-cultured with untransfected MSCs, the intercellular transportations of the constructed proteins were studied by immunofluorescence. The solubility of VP22-hBcl-xL and hBcl-xL-VP22 was analyzed by Western blot. Results: VP22-myc could be expressed in and spread between COS-1 cells, which indicates the validity of our VP22 expression construct. Flowcytometry analysis revealed that the isolated MSCs were CD29, CD44, and CD90 positive and were negative for the hematopoietic markers, CD34 and CD45. The co-culturing and immunofluorescence assay showed that VP22-myc, VP22-EGFP and EGFP-VP22 could traffic between COS-1 cells and MSCs, while the evidence of intercellular transportation of VP22-hBcl-xL and hBcl-xL-VP22 was not detected. Western blot analysis showed that VP22-hBcl-xL and hBcl-xL-VP22 were both insoluble in the cell lysate suggesting interactions of the fusion proteins with other cellular components. Conclusions: The intercellular trafficking of VP22-myc, VP22-EGFP and EGFP-VP22 between COS-1 cells and MSCs presents an intriguing prospect in the therapeutic application of VP22 as a delivery vehicle which enhances genetic modifications of MSCs. However, VP22-hBcl-xL and hBcl-xL-VP22 failed to spread between cells, which are due to the insolubility of the fusion protein incurred by interactions with other cellular components.	[Xue, Xiaodong; Wang, Huishan] Gen Hosp Shenyang Mil Area Command, Dept Cardiovasc Surg, Shenyang, Liaoning, Peoples R China; [Huang, Jianhua] Ningxia Peoples Hosp, Dept Cardiothorac Surg, Yinchuan, Ningxia, Peoples R China		Wang, HS (corresponding author), Gen Hosp Shenyang Mil Area Command, Dept Cardiovasc Surg, Shenyang, Liaoning, Peoples R China.	wanghuishanCA@126.com	Wang, Huishan/V-5258-2017	Wang, Huishan/0000-0001-6523-7488	National Natural Science Foundation of China [81071267]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (No. 81071267). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslan H, 2006, TISSUE ENG, V12, P877, DOI 10.1089/ten.2006.12.877; Boura JS, 2013, HUM GENE THER METHOD, V24, P38, DOI 10.1089/hgtb.2012.185; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Edelstein ML, 2007, J GENE MED, V9, P833, DOI 10.1002/jgm.1100; Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7; Fan L, 2009, EUR J HEART FAIL, V11, P1023, DOI 10.1093/eurjhf/hfp135; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Griffin M, 2010, DISCOV MED, V9, P219; Helledie T, 2008, STEM CELLS DEV, V17, P837, DOI 10.1089/scd.2007.0209; Huang JH, 2005, CIRCULATION, V112, P76, DOI 10.1161/CIRCULATIONAHA.105.535740; Huang JH, 2003, BIOCHEM BIOPH RES CO, V311, P64, DOI 10.1016/j.bbrc.2003.09.160; Jo JI, 2007, TISSUE ENG, V13, P313, DOI 10.1089/ten.2006.0133; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kumar S, 2008, GENE THER, V15, P711, DOI 10.1038/gt.2008.35; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Lemken ML, 2007, MOL THER, V15, P310, DOI 10.1038/sj.mt.6300013; Lennon DP, 2006, EXP HEMATOL, V34, P1606, DOI 10.1016/j.exphem.2006.07.015; Leri A, 2005, PHYSIOL REV, V85, P1373, DOI 10.1152/physrev.00013.2005; Li RK, 1999, J MOL CELL CARDIOL, V31, P513, DOI 10.1006/jmcc.1998.0882; Li WZ, 2007, STEM CELLS, V25, P2118, DOI 10.1634/stemcells.2006-0771; Liang XP, 1997, VACCINE, V15, P1057, DOI 10.1016/S0264-410X(97)00008-X; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; McMahon JM, 2006, STEM CELLS DEV, V15, P87, DOI 10.1089/scd.2006.15.87; Menasche P, 2003, J AM COLL CARDIOL, V41, P1078, DOI 10.1016/S0735-1097(03)00092-5; Min JY, 2003, J THORAC CARDIOV SUR, V125, P361, DOI 10.1067/mtc.2003.101; Murry CE, 1996, J CLIN INVEST, V98, P2512, DOI 10.1172/JCI119070; Nienhuis AW, 2006, MOL THER, V13, P1031, DOI 10.1016/j.ymthe.2006.03.001; Nishi K, 2007, J BIOL CHEM, V282, P27503, DOI 10.1074/jbc.M703810200; Nishikawa M, 2010, MOL THER, V18, P421, DOI 10.1038/mt.2009.203; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; Phelan A, 1998, NAT BIOTECHNOL, V16, P440, DOI 10.1038/nbt0598-440; Piao WH, 2010, ANGIOGENESIS, V13, P203, DOI 10.1007/s10456-010-9169-x; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pontikoglou C, 2011, STEM CELL REV REP, V7, P569, DOI 10.1007/s12015-011-9228-8; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; Rutjes SA, 2003, J MOL MED, V81, P558, DOI 10.1007/s00109-003-0457-4; Sorrell JM, 2009, TISSUE ENG PT A, V15, P1751, DOI 10.1089/ten.tea.2008.0254; Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1; Tang T, 2007, CIRC RES, V100, P1540, DOI 10.1161/CIRCRESAHA.107.101102; Tang YL, 2005, J AM COLL CARDIOL, V46, P1339, DOI 10.1016/j.jacc.2005.05.079; Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Tomita S, 1999, CIRCULATION, V100, P247, DOI 10.1161/01.cir.100.suppl_2.ii-247; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Yoo KJ, 2000, ANN THORAC SURG, V70, P859, DOI 10.1016/S0003-4975(00)01630-1; Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367	49	5	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100840	10.1371/journal.pone.0100840	http://dx.doi.org/10.1371/journal.pone.0100840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955582	gold, Green Published, Green Submitted			2022-12-25	WOS:000338917900100
J	Gong, WP; Xiong, XL; Qi, Y; Jiao, J; Duan, CS; Wen, BH				Gong, Wenping; Xiong, Xiaolu; Qi, Yong; Jiao, Jun; Duan, Changsong; Wen, Bohai			Identification of Novel Surface-Exposed Proteins of Rickettsia rickettsii by Affinity Purification and Proteomics	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; ACTIN-BASED MOTILITY; SPOTTED-FEVER; COXIELLA-BURNETII; DENDRITIC CELLS; AUTOTRANSPORTER; ADHERENCE; OMPA; EXPRESSION; PROTECTION	Rickettsia rickettsii, the causative agent of Rocky Mountain spotted fever, is the most pathogenic member among Rickettsia spp. Surface-exposed proteins (SEPs) of R. rickettsii may play important roles in its pathogenesis or immunity. In this study, R. rickettsii organisms were surface-labeled with sulfo-NHS-SS-biotin and the labeled proteins were affinity-purified with streptavidin. The isolated proteins were separated by two-dimensional electrophoresis, and 10 proteins were identified among 23 protein spots by electrospray ionization tandem mass spectrometry. Five (OmpA, OmpB, GroEL, GroES, and a DNA-binding protein) of the 10 proteins were previously characterized as surface proteins of R. rickettsii. Another 5 proteins (Adr1, Adr2, OmpW, Porin_4, and TolC) were first recognized as SEPs of R. rickettsii herein. The genes encoding the 5 novel SEPs were expressed in Escherichia coli cells, resulting in 5 recombinant SEPs (rSEPs), which were used to immunize mice. After challenge with viable R. rickettsii cells, the rickettsial load in the spleen, liver, or lung of mice immunized with rAdr2 and in the lungs of mice immunized with other rSEPs excluding rTolC was significantly lower than in mice that were mock-immunized with PBS. The in vitro neutralization test revealed that sera from mice immunized with rAdr1, rAdr2, or rOmpW reduced R. rickettsii adherence to and invasion of vascular endothelial cells. The immuno-electron microscopic assay clearly showed that the novel SEPs were located in the outer and/or inner membrane of R. rickettsii. Altogether, the 5 novel SEPs identified herein might be involved in the interaction of R. rickettsii with vascular endothelial cells, and all of them except TolC were protective antigens.	[Gong, Wenping; Xiong, Xiaolu; Qi, Yong; Jiao, Jun; Duan, Changsong; Wen, Bohai] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Xiong, XL (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	xiongxiaolu624@sohu.com; wenbohai@yahoo.com	Gong, Wenping/B-8183-2018; Qi, Yong/AAK-8798-2021; Jiao, Jun/ABE-7519-2021	Gong, Wenping/0000-0002-0333-890X; Qi, Yong/0000-0001-6186-9023; 	National Basic Research Program of China [2010CB530200/2010CB530205]; National Natural Science Foundation of China [81371767, 31170161]; Natural Science and Technology Major Project of China [2013ZX10004803]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science and Technology Major Project of China	This work was supported by the National Basic Research Program of China [grant 2010CB530200/2010CB530205], the National Natural Science Foundation of China grants 81371767 and 31170161, and the Natural Science and Technology Major Project of China [grant 2013ZX10004803]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerman Nicole C, 2008, Curr Protoc Microbiol, VChapter 3, DOI 10.1002/9780471729259.mc03a05s11; Balraj P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002582; Balraj P, 2009, ANN NY ACAD SCI, V1166, P94, DOI 10.1111/j.1749-6632.2009.04517.x; BENZ R, 1988, EUR J BIOCHEM, V176, P1, DOI 10.1111/j.1432-1033.1988.tb14245.x; Blanc G, 2005, MOL BIOL EVOL, V22, P2073, DOI 10.1093/molbev/msi199; Chan YGY, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00139; Clifton DR, 1998, P NATL ACAD SCI USA, V95, P4646, DOI 10.1073/pnas.95.8.4646; Croquet-Valdes PA, 2001, VACCINE, V20, P979; Diaz-Montero CM, 2001, AM J TROP MED HYG, V65, P371, DOI 10.4269/ajtmh.2001.65.371; Duan CS, 2011, AM J TROP MED HYG, V85, P504, DOI 10.4269/ajtmh.2011.10-0660; *EE M, 1899, MED SENTINEL, V7, P433; Ellison DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005612; Feng HM, 2004, INFECT IMMUN, V72, P3524, DOI 10.1128/IAI.72.6.3524-3530.2004; HANSON BA, 1983, INFECT IMMUN, V42, P341, DOI 10.1128/IAI.42.1.341-349.1983; HARRELL GT, 1949, ARCH INTERN MED, V83, P331, DOI 10.1001/archinte.1949.00220320085007; Heinzen RA, 2003, ANN NY ACAD SCI, V990, P535, DOI 10.1111/j.1749-6632.2003.tb07424.x; Hong HD, 2006, J BIOL CHEM, V281, P7568, DOI 10.1074/jbc.M512365200; HORNEY LF, 1988, SOUTHERN MED J, V81, P915, DOI 10.1097/00007611-198807000-00028; Jacob-Dubuisson F, 2004, BBA-MOL CELL RES, V1694, P235, DOI 10.1016/j.bbamcr.2004.03.008; Jeng RL, 2004, CELL MICROBIOL, V6, P761, DOI 10.1111/j.1462-5822.2004.00402.x; Jiao YM, 2005, ANN NY ACAD SCI, V1063, P261, DOI 10.1196/annals.1355.042; Johnson JM, 1999, J MOL BIOL, V287, P695, DOI 10.1006/jmbi.1999.2630; Jordan JM, 2009, J INFECT DIS, V199, P236, DOI 10.1086/595833; Kaur SJ, 2012, J BACTERIOL, V194, P4920, DOI 10.1128/JB.00793-12; Kleba B, 2010, INFECT IMMUN, V78, P2240, DOI 10.1128/IAI.00100-10; Koronakis V, 1997, MOL MICROBIOL, V23, P617, DOI 10.1046/j.1365-2958.1997.d01-1880.x; Li H, 1998, MICROB PATHOGENESIS, V24, P289, DOI 10.1006/mpat.1997.0197; Lin J, 2002, MICROBES INFECT, V4, P325, DOI 10.1016/S1286-4579(02)01545-9; Mansueto P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/967852; Marandi MV, 1997, INFECT IMMUN, V65, P4502, DOI 10.1128/IAI.65.11.4502-4508.1997; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Niu Dong-sheng, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P526; Ogawa M, 2007, PROTEOMICS, V7, P1232, DOI 10.1002/pmic.200600721; PANTELIS G, 2004, NUCL ACIDS RES, V32; Park H, 2011, J BIOL CHEM, V286, P35096, DOI 10.1074/jbc.M111.263855; Pinne M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006071; POLICASTRO PF, 1994, MICROBIOL-SGM, V140, P2941, DOI 10.1099/13500872-140-11-2941; Pornwiroon W, 2009, INFECT IMMUN, V77, P5262, DOI 10.1128/IAI.00911-09; Qi Y, 2013, VACCINE, V31, P5643, DOI 10.1016/j.vaccine.2013.09.064; Qi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070440; Renesto P, 2005, FEMS MICROBIOL LETT, V245, P231, DOI 10.1016/j.femsle.2005.03.004; Renesto P, 2006, RES MICROBIOL, V157, P605, DOI 10.1016/j.resmic.2006.02.002; Riley SP, 2010, INFECT IMMUN, V78, P1895, DOI 10.1128/IAI.01165-09; Sears KT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002856; SILVERMAN DJ, 1986, J INFECT DIS, V153, P694, DOI 10.1093/infdis/153.4.694; Uchiyama T, 2006, MICROBES INFECT, V8, P801, DOI 10.1016/j.micinf.2005.10.003; Vellaiswamy M, 2011, NEW MICROBIOL, V34, P209; Vellaiswamy M, 2011, MICROB PATHOGENESIS, V50, P233, DOI 10.1016/j.micpath.2011.01.009; WALKER DH, 1989, CLIN MICROBIOL REV, V2, P227, DOI 10.1128/CMR.2.3.227-240.1989; WALKER DH, 1980, HUM PATHOL, V11, P263, DOI 10.1016/S0046-8177(80)80008-6; Wei Y, 2011, J INFECT DIS, V203, P283, DOI 10.1093/infdis/jiq037; WEINBERG EH, 1969, J BACTERIOL, V98, P398, DOI 10.1128/JB.98.2.398-402.1969; XIONG X, 2012, VACCINE; Xiong XL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-35	54	21	22	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100253	10.1371/journal.pone.0100253	http://dx.doi.org/10.1371/journal.pone.0100253			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950252	Green Submitted, Green Published, gold			2022-12-25	WOS:000338276300055
J	Rinde, E; Christie, H; Fagerli, CW; Bekkby, T; Gundersen, H; Norderhaug, KM; Hjermann, DO				Rinde, Eli; Christie, Hartvig; Fagerli, Camilla W.; Bekkby, Trine; Gundersen, Hege; Norderhaug, Kjell Magnus; Hjermann, Dag O.			The Influence of Physical Factors on Kelp and Sea Urchin Distribution in Previously and Still Grazed Areas in the NE Atlantic	PLOS ONE			English	Article							STRONGYLOCENTROTUS-DROEBACHIENSIS; LAMINARIA-HYPERBOREA; SPECIES DISTRIBUTION; MODEL SELECTION; FOREST RECOVERY; BARREN GROUNDS; ECOLOGY; GROWTH; STABILITY; COMMUNITY	The spatial distribution of kelp (Laminaria hyperborea) and sea urchins (Strongylocentrotus droebachiensis) in the NE Atlantic are highly related to physical factors and to temporal changes in temperature. On a large scale, we identified borders for kelp recovery and sea urchin persistence along the north-south gradient. Sea urchin persistence was also related to the coast-ocean gradient. The southern border corresponds to summer temperatures exceeding about 10 degrees C, a threshold value known to be critical for sea urchin recruitment and development. The outer border along the coast-ocean gradient is related to temperature, wave exposure and salinity. On a finer scale, kelp recovery occurs mainly at ridges in outer, wave exposed, saline and warm areas whereas sea urchins still dominate in inner, shallow and cold areas, particularly in areas with optimal current speed for sea urchin foraging. In contrast to other studies in Europe, we here show a positive influence of climate change to presence of a long-lived climax canopy-forming kelp. The extent of the coast-ocean gradient varies within the study area, and is especially wide in the southern part where the presence of islands and skerries increases the area of the shallow coastal zone. This creates a large area with intermediate physical conditions for the two species and a mosaic of kelp and sea urchin dominated patches. The statistical models (GAM and BRT) show high performance and indicate recovery of kelp in 45-60% of the study area. The study shows the value of combining a traditional (GAM) and a more complex (BRT) modeling approach to gain insight into complex spatial patterns of species or habitats. The results, methods and approaches are of general ecological relevance regardless of ecosystems and species, although they are particularly relevant for understanding and exploring the corresponding changes between algae and grazers in different coastal areas.	[Rinde, Eli; Christie, Hartvig; Fagerli, Camilla W.; Bekkby, Trine; Gundersen, Hege; Norderhaug, Kjell Magnus; Hjermann, Dag O.] Norwegian Inst Water Res, Sect Marine Biol, Oslo, Norway; [Fagerli, Camilla W.; Gundersen, Hege; Norderhaug, Kjell Magnus] Univ Oslo, Dept Biosci, Oslo, Norway; [Bekkby, Trine] Univ Oslo, Nat Hist Museum, Oslo, Norway	Norwegian Institute for Water Research (NIVA); University of Oslo; University of Oslo	Rinde, E (corresponding author), Norwegian Inst Water Res, Sect Marine Biol, Oslo, Norway.	eli.rinde@niva.no	Gundersen, Hege/F-1494-2013; Bekkby, Trine/GRY-2922-2022	Gundersen, Hege/0000-0001-9706-1325; Bekkby, Trine/0000-0001-8188-8264; Rinde, Eli/0000-0002-5960-3725; Fagerli, Camilla With/0000-0003-2855-7524	Directorate for Nature management and data from a national program on mapping of marine biodiversity; Ministry of the Environment and Ministry of Fisheries and Coastal Affairs; Research council of Norway [Vega2045]; Norwegian Institute for Water Research	Directorate for Nature management and data from a national program on mapping of marine biodiversity; Ministry of the Environment and Ministry of Fisheries and Coastal Affairs; Research council of Norway(Research Council of Norway); Norwegian Institute for Water Research	The study is based on field data sampled in projects financed by the Directorate for Nature management and data from a national program on mapping of marine biodiversity (financed by Ministry of the Environment and Ministry of Fisheries and Coastal Affairs). Part of the analysis is funded by the Research council of Norway trough the research project Vega2045. Time to write the paper is funded by Norwegian Institute for Water Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch T, 2001, ECHINOD ST, V6, P1; Barton K., 2012, MUMIN MULTIMODEL INF; Bekkby T, 2009, ICES J MAR SCI, V66, P2106, DOI 10.1093/icesjms/fsp195; BOLTON JJ, 1982, MAR BIOL, V66, P89, DOI 10.1007/BF00397259; Brattegard T, 2011, 82011 NORW DIR NAT; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Cameron A, 2011, EUSEAMAP PREPARATORY; CHAPMAN ARO, 1981, MAR BIOL, V62, P307, DOI 10.1007/BF00397697; Christie H, 2003, J MAR BIOL ASSOC UK, V83, P687, DOI 10.1017/S0025315403007653h; Clemente S, 2013, MAR BIOL, V160, P579, DOI 10.1007/s00227-012-2114-3; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; Downie AL, 2013, ESTUAR COAST SHELF S, V121, P8, DOI 10.1016/j.ecss.2012.12.020; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; ESTES JA, 1995, ECOL MONOGR, V65, P75, DOI 10.2307/2937159; Estes JA, 2013, B MAR SCI, V89, P11, DOI 10.5343/bms.2011.1122; Fagerli CW, 2014, MAR ECOL PROG SER, V502, P207, DOI 10.3354/meps10701; Fagerli CW, 2013, MAR ECOL PROG SER, V488, P119, DOI 10.3354/meps10413; Falk W, 2011, J VEG SCI, V22, P621, DOI 10.1111/j.1654-1103.2011.01294.x; Falk-Petersen I-B, 1983, SARSIA, V68, P7; Freeman EA, 2008, J STAT SOFTW, V23, P1; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Gorman D, 2013, MAR BIOL, V160, P309, DOI 10.1007/s00227-012-2089-0; Guisan A, 2007, ECOL MONOGR, V77, P615, DOI 10.1890/06-1060.1; HAGEN NT, 1987, SARSIA, V72, P213, DOI 10.1080/00364827.1987.10419719; HAGEN NT, 1983, SARSIA, V68, P177, DOI 10.1080/00364827.1983.10420570; Hijmans R.J., 2011, DISMO SPECIES DISTRI; HIMMELMAN JH, 1983, OECOLOGIA, V59, P27, DOI 10.1007/BF00388068; JACKSON GA, 1977, J PHYCOL, V13, P32; KAIN J M, 1971, FAO (Food and Agriculture Organization of the United Nations) Fisheries Synopsis, V87, P1; KAIN JM, 1971, J MAR BIOL ASSOC UK, V51, P387, DOI 10.1017/S0025315400031866; Kawamata S, 1998, J EXP MAR BIOL ECOL, V224, P31, DOI 10.1016/S0022-0981(97)00165-2; KEATS DW, 1990, MAR ECOL PROG SER, V68, P181, DOI 10.3354/meps068181; Konar B, 2003, ECOLOGY, V84, P174, DOI 10.1890/0012-9658(2003)084[0174:TSOBRB]2.0.CO;2; Krumhansl KA, 2012, MAR ECOL PROG SER, V467, P281, DOI 10.3354/meps09940; LANGE R, 1964, COMP BIOCHEM PHYSIOL, V13, P205, DOI 10.1016/0010-406X(64)90117-3; Lauzon-Guay JS, 2010, MAR ECOL PROG SER, V403, P29, DOI 10.3354/meps08494; Lauzon-Guay JS, 2009, MAR ECOL PROG SER, V375, P25, DOI 10.3354/meps07758; Lee CT, 2008, NAT HAZARD EARTH SYS, V8, P941, DOI 10.5194/nhess-8-941-2008; Leinaas HP, 1996, OECOLOGIA, V105, P524, DOI 10.1007/BF00330016; Lindley JA, 2002, J MAR BIOL ASSOC UK, V82, P31, DOI 10.1017/S0025315402005155; Lobban C.S., 1994, SEAWEED ECOLOGY PHYS; LUNING K, 1986, BRIT PHYCOL J, V21, P269; Martinez-Rincon RO, 2012, ECOL MODEL, V233, P20, DOI 10.1016/j.ecolmodel.2012.03.006; Mass T, 2010, P NATL ACAD SCI USA, V107, P2527, DOI 10.1073/pnas.0912348107; Miller SM, 2011, J PHYCOL, V47, P505, DOI 10.1111/j.1529-8817.2011.00966.x; Nilsen JEO, 2006, PROG OCEANOGR, V70, P58, DOI 10.1016/j.pocean.2006.03.014; Norderhaug KM, 2011, ESTUAR COAST SHELF S, V95, P135, DOI 10.1016/j.ecss.2011.08.028; Norderhaug KM, 2009, MAR BIOL RES, V5, P515, DOI 10.1080/17451000902932985; Norderhaug KN, 2005, J MAR BIOL ASSOC UK, V85, P1279, DOI 10.1017/S0025315405012439; Ottersen G, 2010, ICES J MAR SCI, V67, P1525, DOI 10.1093/icesjms/fsq099; Pedersen MF, 2012, MAR ECOL PROG SER, V451, P45, DOI 10.3354/meps09594; R Core Team, 2021, R LANG ENV STAT COMP; Raybaud V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066044; Rinde E, 2005, MAR BIOL, V146, P1051, DOI 10.1007/s00227-004-1513-5; Rinde E, 2007, THESIS U OSLO NORWAY; ROLLER RA, 1994, CAN J ZOOL, V72, P1931, DOI 10.1139/z94-262; SCHEIBLING R, 1986, OECOLOGIA, V68, P186, DOI 10.1007/BF00384786; SCHEIBLING RE, 1991, MAR BIOL, V110, P105, DOI 10.1007/BF01313097; Siikavuopio SI, 2006, AQUACULTURE, V255, P389, DOI 10.1016/j.aquaculture.2005.12.021; Siikavuopio SI, 2012, AQUACULTURE, V354, P27, DOI 10.1016/j.aquaculture.2012.04.036; Sivertsen K, 1997, CAN J FISH AQUAT SCI, V54, P2872, DOI 10.1139/cjfas-54-12-2872; Sivertsen K, 1982, 782 NORDL; Sjotun K, 2006, MAR BIOL RES, V2, P24, DOI 10.1080/17451000500537418; SJOTUN K, 1995, MAR ECOL PROG SER, V126, P213, DOI 10.3354/meps126213; SKADSHEIM A, 1995, MAR ECOL PROG SER, V119, P199, DOI 10.3354/meps119199; Smale DA, 2013, ECOL EVOL, V3, P4016, DOI 10.1002/ece3.774; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Steneck RS, 2004, ECOSYSTEMS, V7, P323, DOI 10.1007/s10021-004-0240-6; STEPHENS RE, 1972, BIOL BULL, V142, P132, DOI 10.2307/1540251; Stewart Nathan L., 2012, Journal of Marine Biology, P1; Tegner MJ, 1997, MAR ECOL PROG SER, V146, P117, DOI 10.3354/meps146117; Woll AK, 2006, ICES J MAR SCI, V63, P421, DOI 10.1016/j.icesjms.2005.10.004; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	75	41	42	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100222	10.1371/journal.pone.0100222	http://dx.doi.org/10.1371/journal.pone.0100222			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949954	Green Published, gold			2022-12-25	WOS:000338276300051
J	Zhao, G; Dai, CL; Zhao, MW				Zhao, Guang; Dai, Caili; Zhao, Mingwei			Investigation of the Profile Control Mechanisms of Dispersed Particle Gel	PLOS ONE			English	Article							WATER SHUTOFF; POLYMER	Dispersed particle gel (DPG) particles of nano-to micron-to mm-size have been prepared successfully and will be used for profile control treatment in mature oilfields. The profile control and enhanced oil recovery mechanisms of DPG particles have been investigated using core flow tests and visual simulation experiments. Core flow test results show that DPG particles can easily be injected into deep formations and can effectively plug the high permeability zones. The high profile improvement rate improves reservoir heterogeneity and diverts fluid into the low permeability zone. Both water and oil permeability were reduced when DPG particles were injected, but the disproportionate permeability reduction effect was significant. Water permeability decreases more than the oil permeability to ensure that oil flows in its own pathways and can easily be driven out. Visual simulation experiments demonstrate that DPG particles can pass directly or by deformation through porous media and enter deep formations. By retention, adsorption, trapping and bridging, DPG particles can effectively reduce the permeability of porous media in high permeability zones and divert fluid into a low permeability zone, thus improving formation profiles and enhancing oil recovery.	[Zhao, Guang; Dai, Caili; Zhao, Mingwei] China Univ Petr, State Key Lab Heavy Oil Proc, Qingdao, Shandong, Peoples R China	China University of Petroleum	Zhao, G (corresponding author), China Univ Petr, State Key Lab Heavy Oil Proc, Qingdao, Shandong, Peoples R China.	zhaoguang.sdau@163.com; daicl306@163.com		Dai, Cai li/0000-0002-7477-8865; Zhao, Guang/0000-0002-2254-3511	National Natural Science Foundation of China [51174221]; Science Funds for Distinguished Young Scholar of Shandong Province [JQ201013]; Program for New Century Excellent Talents in University [20110226]; Program for Changjiang Scholars and Innovative Reserch Team in University [IRT1294]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Funds for Distinguished Young Scholar of Shandong Province; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Program for Changjiang Scholars and Innovative Reserch Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was sponsored by Supported by National Natural Science Foundation of China (No. 51174221), Science Funds for Distinguished Young Scholar of Shandong Province (No. JQ201013), Program for New Century Excellent Talents in University (No. 20110226), Program for Changjiang Scholars and Innovative Reserch Team in University(IRT1294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Muntasheri GA, 2007, J PETROL SCI ENG, V59, P73, DOI 10.1016/j.petrol.2007.02.010; Bai B., 2008, 2008 SPE DOE IMPR OI; Bai BJ, 2007, SPE RESERV EVAL ENG, V10, P415, DOI 10.2118/89389-PA; Beverte L, 2013, J APPL POLYM SCI, DOI [10.1002/app.39477, DOI 10.1002/APP.39477]; Bryant SL, 1996, SPE PROD FACIL, V11, P209, DOI 10.2118/35446-PA; Chauveteau G, 2001, 2001 SPE INT S OILF; Chauveteau G, 1999, INT S OILF CHEM C HO; Dai CL, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.39462; Dai CL, 2012, MOLECULES, V17, P14484, DOI 10.3390/molecules171214484; Liang TJ, 1995, SPE RESERV EVAL ENG, V10, P282; Liu Y, 2006, 2006 SPE DOE S IMPR; Liu Y.Z., 2013, SPE PROD OP S HELD O; Moradi-Araghi A, 2000, J PETROL SCI ENG, V26, P1, DOI 10.1016/S0920-4105(00)00015-2; Nimmo J. R., 2004, ENCY SOILS ENV, V3, P295, DOI DOI 10.1016/B978-0-12-409548-9.05265-9; Perez D, 2001, SPE DRILL COMPLETION, V16, P182, DOI 10.2118/73196-PA; Qin J.S., 2003, RESERVOIR PHYS, P265; Stavland A, 2001, ANN TECHN C EXH 30 S; You Q., 2013, J ENERGY RESOUR TECH, V135, P1; Zhao F.L., 2001, OILFIELD CHEM, P95; Zhao FL, 1999, J CHINA U PETROL, V23, P49; Zhao G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082651; Zhao G, 2013, J SOL-GEL SCI TECHN, V65, P392, DOI 10.1007/s10971-012-2951-z	22	19	21	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100471	10.1371/journal.pone.0100471	http://dx.doi.org/10.1371/journal.pone.0100471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950174	Green Published, gold, Green Submitted			2022-12-25	WOS:000338276300077
J	Zhou, Y; Wang, DY; Gao, XF; Lew, K; Richards, AM; Wang, PP				Zhou, Yue; Wang, Daying; Gao, Xiufang; Lew, Karsheng; Richards, Arthur Mark; Wang, Peipei			mTORC2 Phosphorylation of Akt1: A Possible Mechanism for Hydrogen Sulfide-Induced Cardioprotection	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; PERMEABILITY TRANSITION PORE; HEART; KINASE; BAX; INHIBITOR; PROTECTS; SURVIVAL; GROWTH; MITOCHONDRIAL	Hydrogen sulfide (H2S) is known to have cardiac protective effects through Akt activation. Akt acts as a 'central sensor' for myocyte survival or death; its activity is regulated by multiple kinases including PI3K, mTORC2, PDK1 and phosphatases including PTEN, PP2A and PHLPPL. Based on the previous finding that PI3K inhibitor LY294002 abolishes H2S-induced Akt phosphorylation and cardioprotection, it is accepted that PI3K is the mediator of H2S-induced Akt phosphorylation. However, LY294002 inhibits both PI3K and mTOR, and PI3K only recruits Akt to the membrane where Akt is phosphorylated by Akt kinases. We undertook a series of experiments to further evaluate the role of mTORC2, PDK1, PTEN, PP2A and PHLPPL in H2S-induced Akt phosphorylation and cardioprotection, which, we believe, has not been investigated before. Hearts from adult Sprague-Dawley rats were isolated and subjected to (i) normoxia, (ii) global ischemia and (iii) ischemia/reperfusion in the presence or absence of 50 mu M of H2S donor NaHS. Cardiac mechanical function and lactate dehydrogenase (LDH) release were assessed. All hearts also were Western analyzed at the end of perfusion for Akt and a panel of appropriate Akt regulators and targets. Hearts pretreated with 50 mM NaHS had improved function at the end of reperfusion (Rate pressure product; 19 +/- 4x10(3) vs. 10 +/- 3x10(3) mmHg/min, p < 0.05) and reduced cell injury (LDH release 19 +/- 10 vs. 170 +/- 87 mU/ml p<0.05) compared to untreated hearts. NaHS significantly increased phospho-Akt, phospho-mTOR, phospho-Bim and Bcl-2 in reperfused hearts (P<0.05). Furthermore using H9c2 cells we demonstrate that NaHS pretreatment reduces apoptosis following hypoxia/re-oxygenation. Importantly, PP242, a specific mTOR inhibitor, abolished both cardioprotection and protein phosphorylation in isolated heart and reduced apoptotic effects in H9c2 cells. Treating hearts with NaHS only during reperfusion produced less cardioprotection through a similar mechanism. These data suggest mTORC2 phosphorylation of Akt is a key mediator of H2S-induced cardioprotection in I/R.	[Zhou, Yue; Lew, Karsheng; Richards, Arthur Mark; Wang, Peipei] Natl Univ Singapore, Cardiovasc Res Inst, Singapore 117548, Singapore; [Wang, Daying] Putuo Hosp, Dept Cardiol, Shanghai, Peoples R China; [Gao, Xiufang] Fudan Univ, Huashan Hosp, Dept Cardiol, Shanghai 200433, Peoples R China	National University of Singapore; Fudan University	Wang, PP (corresponding author), Natl Univ Singapore, Cardiovasc Res Inst, Singapore 117548, Singapore.	mdcwp@nus.edu.sg		Lew, Jason/0000-0002-6838-9900; Wang, Peipei/0000-0002-3768-7833; Zhou, Yue/0000-0002-7184-9920	Cardiovascular Research Institute Start-up Fund (National University of Singapore, Singapore); NMRC Centre Grant (National Medical Research Council, Ministry of Health, Singapore)	Cardiovascular Research Institute Start-up Fund (National University of Singapore, Singapore); NMRC Centre Grant (National Medical Research Council, Ministry of Health, Singapore)	The present work was supported by Cardiovascular Research Institute Start-up Fund (National University of Singapore, Singapore) and NMRC Centre Grant (National Medical Research Council, Ministry of Health, Singapore). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; Aoyagi T, 2012, AM J PHYSIOL-HEART C, V303, pH75, DOI 10.1152/ajpheart.00241.2012; Ballou LM, 2007, J BIOL CHEM, V282, P24463, DOI 10.1074/jbc.M704741200; Bar N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010859; Bian JS, 2006, J PHARMACOL EXP THER, V316, P670, DOI 10.1124/jpet.105.092023; Bliksoen M, 2008, EUR J CARDIO-THORAC, V34, P344, DOI 10.1016/j.ejcts.2008.03.017; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Chen L, 2007, CHINESE MED J-PEKING, V120, P389, DOI 10.1097/00029330-200703010-00008; Chung EJ, 2010, INVEST OPHTH VIS SCI, V51, P6232, DOI 10.1167/iovs.10-5747; Das S, 2005, AM J PHYSIOL-HEART C, V288, pH328, DOI 10.1152/ajpheart.00453.2004; Degrande ST, 2012, J BIOL CHEM; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Eden M, 2013, CIRCULATION, V128; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Geng B, 2004, BIOCHEM BIOPH RES CO, V318, P756, DOI 10.1016/j.bbrc.2004.04.094; Gharbi SI, 2007, BIOCHEM J, V404, P15, DOI 10.1042/BJ20061489; Gurusamy N, 2010, CARDIOVASC RES, V86, P103, DOI 10.1093/cvr/cvp384; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024; Hochhauser E, 2003, AM J PHYSIOL-HEART C, V284, pH2351, DOI 10.1152/ajpheart.00783.2002; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hu Y, 2008, PFLUG ARCH EUR J PHY, V455, P607, DOI 10.1007/s00424-007-0321-4; Hwang SK, 2011, BMB REP, V44, P506, DOI 10.5483/BMBRep.2011.44.8.506; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Matsui T, 1999, CIRCULATION, V100, P2373, DOI 10.1161/01.CIR.100.23.2373; Meller R, 2009, NEUROSCIENTIST, V15, P243, DOI 10.1177/1073858408327809; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Osipov RM, 2009, J CARDIOVASC PHARM, V54, P287, DOI 10.1097/FJC.0b013e3181b2b72b; Pan LL, 2011, AMINO ACIDS, V41, P205, DOI 10.1007/s00726-011-0834-1; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Salloum FN, 2009, CIRCULATION, V120, pS31, DOI 10.1161/CIRCULATIONAHA.108.843979; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sen U, 2008, PHARMACOLOGY, V82, P201, DOI 10.1159/000156486; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; Walsh K, 2006, CIRCULATION, V113, P2032, DOI 10.1161/CIRCULATIONAHA.106.615138; Wang PP, 2007, J PHARMACOL EXP THER, V321, P213, DOI 10.1124/jpet.106.115519; Wang PP, 2008, LIFE SCI, V83, P836, DOI 10.1016/j.lfs.2008.09.024; Wang PP, 2005, CIRCULATION, V111, P2066, DOI 10.1161/01.CIR.0000162466.06150.D4; Whiteman M, 2009, J CELL MOL MED, V13, P488, DOI 10.1111/j.1582-4934.2009.00645.x; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yong QC, 2008, AM J PHYSIOL-HEART C, V295, pH1330, DOI 10.1152/ajpheart.00244.2008	46	90	96	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99665	10.1371/journal.pone.0099665	http://dx.doi.org/10.1371/journal.pone.0099665			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949720	gold, Green Published, Green Submitted			2022-12-25	WOS:000338276300017
J	Chung, HK; Cho, Y; Choi, S; Shin, MJ				Chung, Hye-Kyung; Cho, Yoonsu; Choi, Sumi; Shin, Min-Jeong			The Association between Serum 25-Hydroxyvitamin D Concentrations and Depressive Symptoms in Korean Adults: Findings from the Fifth Korea National Health and Nutrition Examination Survey 2010	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; PARATHYROID-HORMONE; MAJOR DEPRESSION; GLOBAL BURDEN; OLDER-ADULTS; DISEASE; POPULATION; SMOKING; LEVEL	The aims of this study were to examine the association between circulating vitamin D (25(OH) D) levels and depressive symptoms and to evaluate the associations between depressive symptoms and various sociodemographic factors. Data on serum 25(OH) D levels, sociodemographic factors, and information on depressive symptoms were obtained from the Korea National Health and Nutrition Examination Survey V-1 2010. A total of 3,570 Koreans aged >= 20 years were included in the statistical analysis. Subjects with depressive symptoms had lower serum levels of 25(OH) D (41.6 +/- 16.2 nmol/L) than those without (44.3 +/- 16.2 nmol/L; P-value<0.05; effect size = 0.17). In a logistic regression analysis, the 25(OH) D sufficiency group (>= 50 nmol/L) revealed fewer depressive symptoms (OR, 0.72; 95% CI, 0.53-0.97; P-value = 0.032) after adjusting for multiple factors. In addition, females (OR, 3.61; 95% CI, 2.55-5.11; P-value, 0.001), problematic alcohol users (OR, 2.33; 95% CI, 1.63-3.34; P-value, 0.001), current smokers (OR, 1.43; 95% CI, 1.02-1.99; P-value = 0.036), and subjects who experienced weight loss (OR, 1.78; 95% CI, 1.30-2.44; P-value, 0.001) were more likely to answer "yes" on question for depressive symptoms. In conclusion, low serum levels of 25(OH) D were associated with an increased risk for depression symptoms in Korean adults. In addition, several sociodemographic factors were related to the depressive symptoms. Our results provide insight into the relationships among vitamin D status, sociodemographic factors, and depression in the Korean population.	[Chung, Hye-Kyung] Yonsei Univ, Coll Med, Severance Inst Vasc & Metab Res, Seoul, South Korea; [Cho, Yoonsu; Shin, Min-Jeong] Korea Univ, Dept Food & Nutr, Seoul, South Korea; [Cho, Yoonsu; Shin, Min-Jeong] Korea Univ, Grad Sch, Dept Publ Hlth Sci, Seoul, South Korea; [Choi, Sumi] Pusan Natl Univ, Dept Child Dev & Family Studies, Pusan 609735, South Korea; [Shin, Min-Jeong] Korea Univ, Guro Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System; Korea University; Korea University; Pusan National University; Korea University; Korea University Medicine (KU Medicine)	Shin, MJ (corresponding author), Korea Univ, Dept Food & Nutr, Seoul, South Korea.	mjshin@korea.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2013R1A1A2A10006101]; Creative Allied Project (CAP) grant - Korea Research Council of Fundamental Science and Technology (KRCF)	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Creative Allied Project (CAP) grant - Korea Research Council of Fundamental Science and Technology (KRCF)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A2A10006101) and the Creative Allied Project (CAP) grant funded by the Korea Research Council of Fundamental Science and Technology (KRCF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvisa-Negrin J, 2009, ALCOHOL ALCOHOLISM, V44, P468, DOI 10.1093/alcalc/agp038; Bjelland I, 2008, SOC SCI MED, V66, P1334, DOI 10.1016/j.socscimed.2007.12.019; Brehm JM, 2012, AM J RESP CRIT CARE, V186, P140, DOI 10.1164/rccm.201203-0431OC; Chung HK, 2013, ANN NUTR METAB, V62, P129, DOI 10.1159/000345587; Cutillas-Marco E, 2012, PHOTODERMATOL PHOTO, V28, P159, DOI 10.1111/j.1600-0781.2012.00649.x; Daly RM, 2012, CLIN ENDOCRINOL, V77, P26, DOI 10.1111/j.1365-2265.2011.04320.x; Ernst CR, 2012, CRIT CARE NURS CLIN, V24, P509, DOI 10.1016/j.ccell.2012.07.006; Eskandari F, 2007, ARCH INTERN MED, V167, P2329, DOI 10.1001/archinte.167.21.2329; Fergusson DM, 2003, PSYCHOL MED, V33, P1357, DOI 10.1017/S0033291703008596; Foss YJ, 2009, MED HYPOTHESES, V72, P314, DOI 10.1016/j.mehy.2008.10.005; Gracious BL, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-38; Grant WB, 2005, ALTERN MED REV, V10, P94; Hendin Herbert., 2008, SUICIDE SUICIDE PREV; Herran A, 2000, PSYCHOSOM MED, V62, P779, DOI 10.1097/00006842-200011000-00006; Hoang MT, 2011, MAYO CLIN PROC, V86, P1050, DOI 10.4065/mcp.2011.0208; HOLICK MF, 1994, AM J CLIN NUTR, V60, P619, DOI 10.1093/ajcn/60.4.619; Holick MF, 2008, NUTR REV, V66, pS182, DOI 10.1111/j.1753-4887.2008.00104.x; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hoogendijk WJG, 2008, ARCH GEN PSYCHIAT, V65, P508, DOI 10.1001/archpsyc.65.5.508; Hurskainen AR, 2012, DIABETES-METAB RES, V28, P418, DOI 10.1002/dmrr.2286; Jang MS, 2005, KOR J DEV PSYCHOL, V18, P87; Jorde R, 2008, J INTERN MED, V264, P599, DOI 10.1111/j.1365-2796.2008.02008.x; Jorde R, 2006, J NEUROL, V253, P464, DOI 10.1007/s00415-005-0027-5; Kesby JP, 2011, MOL CELL ENDOCRINOL, V347, P121, DOI 10.1016/j.mce.2011.05.014; Korea Ministry of Health and Welfare, 2011, KOR HLTH STAT 2010 K; Langman CB, 2000, CURR OPIN PEDIATR, V12, P135, DOI 10.1097/00008480-200004000-00009; Le Strat Y, 2013, COMPR PSYCHIAT, V54, P831, DOI 10.1016/j.comppsych.2013.02.009; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Molina MAL, 2014, PSYCHOL HEALTH MED, V19, P136, DOI 10.1080/13548506.2013.793369; Matud MP, 2004, PERS INDIV DIFFER, V37, P1401, DOI 10.1016/j.paid.2004.01.010; McGreevy C, 2011, ANN INTERN MED, V155, P820, DOI 10.7326/0003-4819-155-12-201112200-00004; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Oertel-Knochel V, 2014, EUR ARCH PSYCHIAT CL; *ORG EC COOP DEV, 2007, OECD HLTH DAT 2007; Palmer MT, 2013, INFLAMM BOWEL DIS, V19, P2245, DOI 10.1097/MIB.0b013e31828a3b6f; PARDRIDGE WM, 1985, J NEUROCHEM, V44, P1138, DOI 10.1111/j.1471-4159.1985.tb08735.x; Parker G, 2011, ACTA PSYCHIAT SCAND, V124, P243, DOI 10.1111/j.1600-0447.2011.01705.x; Pearce SHS, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5664; Picotto G, 2012, CANCER INVEST, V30, P604, DOI 10.3109/07357907.2012.721039; Rhee SY, 2012, DIABETIC MED, V29, P1003, DOI 10.1111/j.1464-5491.2012.03575.x; Saliba W, 2013, OSTEOPOROSIS INT, V24, P1447, DOI 10.1007/s00198-012-2129-0; Saraceno Benedetto, 2002, Epidemiol Psichiatr Soc, V11, P83; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schneider B, 2000, J NEURAL TRANSM, V107, P839, DOI 10.1007/s007020070063; Scragg R, 2007, AM J HYPERTENS, V20, P713, DOI 10.1016/j.amjhyper.2007.01.017; Stewart R, 2010, PSYCHOSOM MED, V72, P608, DOI 10.1097/PSY.0b013e3181e9bf15; Thuesen B, 2012, BONE, V50, P605, DOI 10.1016/j.bone.2011.12.016; Vieth R, 2011, BEST PRACT RES CL EN, V25, P681, DOI 10.1016/j.beem.2011.06.009; Wacker M, 2013, DERM-ENDOCRINOL, V5, DOI [10.4161/derm.24476, 10.4161/derm.24494]; Watkins C, 2001, BRIT MED J, V323, P1159, DOI 10.1136/bmj.323.7322.1159; WHO (World Health Organization), 2013, SCHIST PROGR REP 200; Wilkins CH, 2006, AM J GERIAT PSYCHIAT, V14, P1032, DOI 10.1097/01.JGP.0000240986.74642.7c	52	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99185	10.1371/journal.pone.0099185	http://dx.doi.org/10.1371/journal.pone.0099185			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945632	Green Submitted, gold, Green Published			2022-12-25	WOS:000340721500012
J	Erdelyi, M; Simon, J; Barnard, EA; Kaminski, CF				Erdelyi, Miklos; Simon, Joseph; Barnard, Eric A.; Kaminski, Clemens F.			Analyzing Receptor Assemblies in the Cell Membrane Using Fluorescence Anisotropy Imaging with TIRF Microscopy	PLOS ONE			English	Article							P2Y(1) RECEPTOR; QUANTITATIVE PROTOCOL; INTERNATIONAL UNION; SIGNALING COMPLEXES; HOMO-FRET; PROTEIN; PHARMACOLOGY; DIMERIZATION; ACTIVATION; CHANNEL	Signaling within and between animal cells is controlled by the many receptor proteins in their membrane. They variously operate as trans-membrane monomers and homo-or hetero-dimers, and may assemble with ion-channels: analyses thereof are needed in studies of receptor actions in tissue physiology and pathology. Interactions between membrane proteins are detectable when pre-labeled with fluorophores, but a much fuller analysis is achievable via advanced optical techniques on living cells. In this context, the measurement of polarization anisotropy in the emitted fluorescence has been the least exploited. Here we demonstrate its methodology and particular advantages in the study of receptor protein assembly. Through excitation in both TIRF and EPI fluorescence illumination modes we are able to quantify and suppress contributions to the signal from extraneous intra-cellular fluorescence, and we show that the loss of fluorescence-polarization measured in membrane proteins reports on receptor protein assembly in real time. Receptor monomers and homo-dimers in the cell membrane can be analyzed quantitatively and for homo-dimers only a single fluorescent marker is needed, thus suppressing ambiguities that arise in alternative assays, which require multiple label moieties and which are thus subject to stoichiometric uncertainty.	[Erdelyi, Miklos; Kaminski, Clemens F.] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England; [Erdelyi, Miklos] Natl Phys Lab, Analyt Sci Div, Teddington TW11 0LW, Middx, England; [Simon, Joseph; Barnard, Eric A.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England; [Erdelyi, Miklos] Univ Szeged, Dept Opt & Quantum Elect, Szeged, Hungary	University of Cambridge; National Physical Laboratory - UK; University of Cambridge; Szeged University	Kaminski, CF (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England.	cfk23@cam.ac.uk	Kaminski, Clemens/G-7488-2016	Kaminski, Clemens/0000-0002-5194-0962	Wellcome Trust [089703/Z/09/Z]; Medical Research Council [MR/K015850/1, MR/K02292X/1]; Alzheimer Research UK Trust [ARUK-EG2012A-1]; Engineering and Physical Science Research Council [EP/H018301/1]; Marie-Curie [PCIG13-GA-2013-618273]; NMS (National Measurement Systems); Bolyai Janos fellowship; Alzheimers Research UK [ARUK-EG2012A-1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H018301/1] Funding Source: researchfish; EPSRC [EP/H018301/1] Funding Source: UKRI; MRC [MR/K02292X/1, MR/K015850/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer Research UK Trust(Alzheimer's Research UK (ARUK)); Engineering and Physical Science Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Marie-Curie(European Commission); NMS (National Measurement Systems); Bolyai Janos fellowship(Hungarian Academy of Sciences); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Wellcome Trust (089703/Z/09/Z), the Medical Research Council (MR/K015850/1 and MR/K02292X/1), the Alzheimer Research UK Trust (ARUK-EG2012A-1), the Engineering and Physical Science Research Council (EP/H018301/1), Marie-Curie (PCIG13-GA-2013-618273), NMS (National Measurement Systems), and the Bolyai Janos fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Altier C, 2008, J RECEPT SIG TRANSD, V28, P71, DOI 10.1080/10799890801941947 ; AXELROD D, 1979, BIOPHYS J, V26, P557, DOI 10.1016/S0006-3495(79)85271-6; Axelrod D., 2007, SPRINGER SERIES OPTI, V87; Bockaert J, 2003, FEBS LETT, V546, P65, DOI 10.1016/S0014-5793(03)00453-8; Chan FTS, 2011, CHEMPHYSCHEM, V12, P500, DOI 10.1002/cphc.201000833; Choi RCY, 2008, J BIOL CHEM, V283, P11050, DOI 10.1074/jbc.M709266200; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Dietz MS, 2013, BMC BIOPHYS, V6, DOI 10.1186/2046-1682-6-6; Digman MA, 2008, BIOPHYS J, V94, P2819, DOI 10.1529/biophysj.107.104984; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; DIX JA, 1990, BIOPHYS J, V57, P231, DOI 10.1016/S0006-3495(90)82526-1; Doupnik CA, 2008, J RECEPT SIG TRANSD, V28, P83, DOI [10.1080/10799890801941970, 10.1080/10799890801941970 ]; Elder AD, 2009, J R SOC INTERFACE, V6, pS59, DOI 10.1098/rsif.2008.0381.focus; Elder A, 2008, J OPT SOC AM A, V25, P452, DOI 10.1364/JOSAA.25.000452; Esposito A, 2011, OPT EXPRESS, V19, P2546, DOI 10.1364/OE.19.002546; Filippov AK, 2000, BRIT J PHARMACOL, V129, P1063, DOI 10.1038/sj.bjp.0703185; Fujimoto Y., 2007, US patent, Patent No. [US 7,199,938 B2, 7199938]; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; Hastie P, 2013, P NATL ACAD SCI USA, V110, P5163, DOI 10.1073/pnas.1218765110; Kaminski CF, 2014, METHODS MOL BIOL, V1076, P445, DOI 10.1007/978-1-62703-649-8_19; Kim HS, 2003, J MED CHEM, V46, P4974, DOI 10.1021/jm030127+; Lakowicz R. J., 2006, PRINCIPLES FLUORESCE, V3rd; Lidke DS, 2003, BIOCHEM SOC T, V31, P1020; Lin H, 2013, NAT METHODS, V10, P140, DOI [10.1038/NMETH.2324, 10.1038/nmeth.2324]; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Optics Reference, 2001, OSLO OPT SOFTW VERS; Padilla-Parra S, 2009, BIOPHYS J, V97, P2368, DOI 10.1016/j.bpj.2009.07.044; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Squire A, 2004, J STRUCT BIOL, V147, P62, DOI 10.1016/j.jsb.2003.10.013; Teramura Y, 2006, EMBO J, V25, P4215, DOI 10.1038/sj.emboj.7601308; van Ham TJ, 2010, J MOL BIOL, V395, P627, DOI 10.1016/j.jmb.2009.10.066; WEBB TE, 1993, FEBS LETT, V324, P219, DOI 10.1016/0014-5793(93)81397-I	35	11	11	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100526	10.1371/journal.pone.0100526	http://dx.doi.org/10.1371/journal.pone.0100526			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945870	Green Submitted, Green Published, gold			2022-12-25	WOS:000340721500086
J	Ghoshal, P; Rajendran, M; Odo, N; Ikuta, T				Ghoshal, Pushpankur; Rajendran, Mythilypriya; Odo, Nadine; Ikuta, Tohru			Glycosylation Inhibitors Efficiently Inhibit P-Selectin-Mediated Cell Adhesion to Endothelial Cells	PLOS ONE			English	Article							INHALED NITRIC-OXIDE; FETAL-HEMOGLOBIN PRODUCTION; GRANULE MEMBRANE-PROTEIN; ACUTE CHEST SYNDROME; RED-BLOOD-CELLS; SICKLE ERYTHROCYTES; IN-VIVO; HYPOXIA-REOXYGENATION; ADHERENT LEUKOCYTES; POTENTIAL ROLE	Adhesion molecules play a critical role in the adhesive interactions of multiple cell types in sickle cell disease (SCD). We previously showed that anti-P-selectin aptamer efficiently inhibits cell adhesion to endothelial cells (ECs) and permits SCD mice to survive hypoxic stress. In an effort to discover new mechanisms with which to inhibit P-selectin, we examined the role of glycosylation. P-selectin is a 90 kDa protein but was found to migrate as 90 and 140 kDa bands on gel electrophoresis. When P-selectin isolated from ECs was digested with peptide N-glycosidase F, but not O-glycosidase, the 140 kDa band was lost and the 90 kDa band was enhanced. Treatment of ECs with tunicamycin, an N-glycosylation inhibitor, suppressed CD62P (P-selectin) expression on the cell surface as well as the 140 kDa form in the cytoplasm. These results indicate that the 140 kDa band is N-glycosylated and glycosylation is critical for cell surface expression of P-selectin in ECs. Thrombin, which stimulates P-selectin expression on ECs, induced AKT phosphorylation, whereas tunicamycin inhibited AKT phosphorylation, suggesting that AKT signaling is involved in the tunicamycin-mediated inhibition of P-selectin expression. Importantly, the adhesion of sickle red blood cells (sRBCs) and leukocytes to ECs induced by thrombin or hypoxia was markedly inhibited by two structurally distinct glycosylation inhibitors; the levels of which were comparable to that of a P-selectin monoclonal antibody which most strongly inhibited cell adhesion in vivo. Knockdown studies of P-selectin using short-hairpin RNAs in ECs suppressed sRBC adhesion, indicating a legitimate role for P-selectin in sRBC adhesion. Together, these results demonstrate that P-selectin expression on ECs is regulated in part by glycosylation mechanisms and that glycosylation inhibitors efficiently reduce the adhesion of sRBCs and leukocytes to ECs. Glycosylation inhibitors may lead to a novel therapy which inhibits cell adhesion in SCD.	[Ghoshal, Pushpankur; Rajendran, Mythilypriya; Odo, Nadine; Ikuta, Tohru] Georgia Regents Univ, Med Coll Georgia, Dept Anesthesiol & Perioperat Med, Augusta, GA 30901 USA	University System of Georgia; Augusta University	Ghoshal, P (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Anesthesiol & Perioperat Med, Augusta, GA 30901 USA.	pghoshal@gru.edu; tikuta@gru.edu	Odo, Nadine/AAV-5466-2021	Odo, Nadine/0000-0003-4103-1404	National Institute on Minority Health and Health Disparity [P20 MD003383]; National Institute on Minority Health and Health Disparities [P20MD003383] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparity; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by a grant from the National Institute on Minority Health and Health Disparity (P20 MD003383 to Tohru Ikuta). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinsheye I, 2011, BLOOD, V118, P19, DOI 10.1182/blood-2011-03-325258; Ataga KI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029786; Atz AM, 1997, ANESTHESIOLOGY, V87, P988, DOI 10.1097/00000542-199710000-00037; Ballas SK, 2005, HEMATOL ONCOL CLIN N, V19, P785, DOI 10.1016/j.hoc.2005.07.008; BIRCH KA, 1994, J CELL PHYSIOL, V160, P545, DOI 10.1002/jcp.1041600318; Brittain JE, 2001, J CLIN INVEST, V107, P1555, DOI 10.1172/JCI10817; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; Chang JS, 2010, BLOOD, V116, P1779, DOI 10.1182/blood-2009-12-260513; Closse C, 1997, THROMB RES, V85, P159, DOI 10.1016/S0049-3848(96)00233-2; Closse C, 1996, HAEMOSTASIS, V26, P177; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Dwek RA, 2002, NAT REV DRUG DISCOV, V1, P65, DOI 10.1038/nrd708; Embury SH, 2004, BLOOD, V104, P3378, DOI 10.1182/blood-2004-02-0713; Embury SH, 2004, MICROCIRCULATION, V11, P101, DOI 10.1080/10739680490278277; Emoto T, 2012, AM J CARDIOL, V109, P42, DOI 10.1016/j.amjcard.2011.08.005; Ferrone FA, 2004, MICROCIRCULATION, V11, P115, DOI 10.1080/10739680490278312; Fuhler GM, 2003, BLOOD, V101, P1172, DOI 10.1182/blood.V101.3.1172; Ghoshal P, 2009, CANCER RES, V69, P4380, DOI 10.1158/0008-5472.CAN-08-3467; Gratton RJ, 2004, PLACENTA, V25, P62, DOI 10.1016/S0143-4004(03)00216-9; Gries A, 1998, CIRCULATION, V97, P1481; Gutsaeva DR, 2014, BLOOD, V123, P1917, DOI 10.1182/blood-2013-06-510180; Gutsaeva DR, 2011, BLOOD, V117, P727, DOI 10.1182/blood-2010-05-285718; Head CA, 2010, AM J HEMATOL, V85, P800, DOI 10.1002/ajh.21832; Hebbel RP, 1997, J CLIN INVEST, V99, P2561, DOI 10.1172/JCI119442; HEBBEL RP, 1980, NEW ENGL J MED, V302, P992, DOI 10.1056/NEJM198005013021803; HEIFETZ A, 1979, BIOCHEMISTRY-US, V18, P2186, DOI 10.1021/bi00578a008; Imai C, 2014, METABOLISM, V63, P746, DOI 10.1016/j.metabol.2013.12.014; JACOB GS, 1995, CURR OPIN STRUC BIOL, V5, P605, DOI 10.1016/0959-440X(95)80051-4; Jang WG, 2011, BMB REP, V44, P735, DOI 10.5483/BMBRep.2011.44.11.735; JOHNSTON GI, 1989, J BIOL CHEM, V264, P1816; Kasschau MR, 1996, BLOOD, V87, P771, DOI 10.1182/blood.V87.2.771.bloodjournal872771; Kaul DK, 2000, BLOOD, V95, P368, DOI 10.1182/blood.V95.2.368; Koutsioulis D, 2008, GLYCOBIOLOGY, V18, P799, DOI 10.1093/glycob/cwn069; KURANTSINMILLS J, 1992, BRIT J HAEMATOL, V81, P539, DOI 10.1111/j.1365-2141.1992.tb02989.x; Kutlar A, 2012, AM J HEMATOL, V87, P536, DOI 10.1002/ajh.23147; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee SP, 1998, BLOOD, V92, P2951, DOI 10.1182/blood.V92.8.2951.420k30_2951_2958; Levasseur DN, 2004, J BIOL CHEM, V279, P27518, DOI 10.1074/jbc.M402578200; Liao W, 2001, BIOCHEM J, V353, P493, DOI 10.1042/0264-6021:3530493; Matsui NM, 2002, BLOOD, V100, P3790, DOI 10.1182/blood-2002-02-0626; Matsui NM, 2001, BLOOD, V98, P1955, DOI 10.1182/blood.V98.6.1955; MCEVER RP, 1994, CURR OPIN IMMUNOL, V6, P75, DOI 10.1016/0952-7915(94)90037-X; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; MILLER BA, 1986, BLOOD, V67, P1404; NELSON RM, 1993, BLOOD, V82, P3253; Oppert M, 2004, SWISS MED WKLY, V134, P165; Orbach H, 2004, SEMIN ARTHRITIS RHEU, V34, P593, DOI 10.1016/j.semarthrit.2004.06.003; PAHLSSON P, 1995, EUR J IMMUNOL, V25, P2452, DOI 10.1002/eji.1830250907; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; PLATT OS, 1984, J CLIN INVEST, V74, P652, DOI 10.1172/JCI111464; Rodgers G P, 1989, Prog Clin Biol Res, V316B, P281; ROSSAINT R, 1993, NEW ENGL J MED, V328, P399, DOI 10.1056/NEJM199302113280605; Ryan TM, 1997, SCIENCE, V278, P873, DOI 10.1126/science.278.5339.873; SAUL R, 1985, P NATL ACAD SCI USA, V82, P93, DOI 10.1073/pnas.82.1.93; Setty BNY, 1996, BLOOD, V88, P2311, DOI 10.1182/blood.V88.6.2311.bloodjournal8862311; Stegelmeier BL, 2008, TOXICOL PATHOL, V36, P651, DOI 10.1177/0192623308317420; SUGAMA Y, 1992, J CELL BIOL, V119, P935, DOI 10.1083/jcb.119.4.935; SUGIHARA K, 1992, BLOOD, V80, P2634; Sullivan KJ, 1999, CRIT CARE MED, V27, P2563, DOI 10.1097/00003246-199911000-00039; Trottein F, 2009, GLYCOCONJUGATE J, V26, P1259, DOI 10.1007/s10719-009-9244-y; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Turhan A, 2002, P NATL ACAD SCI USA, V99, P3047, DOI 10.1073/pnas.052522799; Turhan A, 2004, BLOOD, V103, P2397, DOI 10.1182/blood-2003-07-2209; van den Tweel XW, 2010, AM J HEMATOL, V85, P746, DOI 10.1002/ajh.21846; VANHOEK AN, 1995, BIOCHEMISTRY-US, V34, P2212, DOI 10.1021/bi00007a015; Varki A., 1999, ESSENTIALS GLYCOBIOL; Vichinsky E, 2002, LANCET, V360, P629, DOI 10.1016/S0140-6736(02)09776-3; Weiner DL, 2003, JAMA-J AM MED ASSOC, V289, P1136, DOI 10.1001/jama.289.9.1136; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Whitby K, 2005, J VIROL, V79, P8698, DOI 10.1128/JVI.79.14.8698-8706.2005; Wood KC, 2004, AM J PHYSIOL-HEART C, V286, pH1608, DOI 10.1152/ajpheart.01056.2003; YARBRO JW, 1965, P NATL ACAD SCI USA, V53, P1033, DOI 10.1073/pnas.53.5.1033	72	9	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99363	10.1371/journal.pone.0099363	http://dx.doi.org/10.1371/journal.pone.0099363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945938	Green Published, Green Submitted, gold			2022-12-25	WOS:000340721500016
J	Jamin, A; Thunuguntla, P; Wicklund, A; Jones, C; Wiebe, MS				Jamin, Augusta; Thunuguntla, Prasanth; Wicklund, April; Jones, Clinton; Wiebe, Matthew S.			Barrier to Autointegration Factor Becomes Dephosphorylated during HSV-1 Infection and Can Act as a Host Defense by Impairing Viral DNA Replication and Gene Expression	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; CELL-CYCLE PROGRESSION; TEMPERATURE-SENSITIVE MUTANTS; REGULATORY PROTEIN ICP27; VACCINIA-RELATED KINASES; FACTOR BAF; NUCLEAR-ENVELOPE; TYPE-1 ICP27; DELETION MUTANTS; STRUCTURAL BASIS	BAF (Barrier to Autointegration Factor) is a highly conserved DNA binding protein that senses poxviral DNA in the cytoplasm and tightly binds to the viral genome to interfere with DNA replication and transcription. To counteract BAF, a poxviral-encoded protein kinase phosphorylates BAF, which renders BAF unable to bind DNA and allows efficient viral replication to occur. Herein, we examined how BAF phosphorylation is affected by herpes simplex virus type 1 (HSV-1) infection and tested the ability of BAF to interfere with HSV-1 productive infection. Interestingly, we found that BAF phosphorylation decreases markedly following HSV-1 infection. To determine whether dephosphorylated BAF impacts HSV-1 productive infection, we employed cell lines stably expressing a constitutively unphosphorylated form of BAF (BAF-MAAAQ) and cells overexpressing wild type (wt) BAF for comparison. Although HSV-1 production in cells overexpressing wtBAF was similar to that in cells expressing no additional BAF, viral growth was reduced approximately 80% in the presence of BAF-MAAAQ. Experiments were also performed to determine the mechanism of the antiviral activity of BAF with the following results. BAF-MAAAQ was localized to the nucleus, whereas wtBAF was dispersed throughout cells prior to infection. Following infection, wtBAF becomes dephosphorylated and relocalized to the nucleus. Additionally, BAF was associated with the HSV-1 genome during infection, with BAF-MAAAQ associated to a greater extent than wtBAF. Importantly, unphosphorylated BAF inhibited both viral DNA replication and gene expression. For example, expression of two regulatory proteins, ICP0 and VP16, were substantially reduced in cells expressing BAF-MAAAQ. However, other viral genes were not dramatically affected suggesting that expression of certain viral genes can be differentially regulated by unphosphorylated BAF. Collectively, these results suggest that BAF can act in a phosphorylation-regulated manner to impair HSV-1 transcription and/or DNA replication, which is similar to the antiviral activity of BAF during vaccinia infection.	[Jamin, Augusta; Thunuguntla, Prasanth; Wicklund, April; Jones, Clinton; Wiebe, Matthew S.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68588 USA; [Jamin, Augusta; Thunuguntla, Prasanth; Wicklund, April; Jones, Clinton; Wiebe, Matthew S.] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Wiebe, MS (corresponding author), Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68588 USA.	mwiebe2@unl.edu	Wiebe, Matthew/X-5007-2019; Wiebe, Matt/AAC-4642-2021	Wiebe, Matthew/0000-0001-6337-6556; 	National Institutes of Health [K22AI080941, R56AI099062, P30GM10359, T32 AI060547]; US Department of Agriculture [2013-01041]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI099062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding came from K22AI080941-grant from the National Institutes of Health (www.nih.gov) to MW; R56AI099062 - grant from the National Institutes of Health (www.nih.gov) to MSW; P30GM10359-grant from the National Institutes of Health (www.nih.gov) supported MSW; T32 AI060547-grant from the National Institutes of Health (www.nih.gov) supported AJ; 2013-01041 - grant from the US Department of Agriculture (www.usda.gov) to CJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asencio C, 2012, CELL, V150, P122, DOI 10.1016/j.cell.2012.04.043; Bar DZ, 2014, MOL BIOL CELL, V25, P1127, DOI 10.1091/mbc.E13-08-0477; Bengtsson L, 2006, MOL BIOL CELL, V17, P1154, DOI 10.1091/mbc.E05-04-0356; Brachner A, 2012, J CELL SCI, V125, P1048, DOI 10.1242/jcs.098392; Bradley CM, 2005, NAT STRUCT MOL BIOL, V12, P935, DOI 10.1038/nsmb989; Cai M, 1998, NAT STRUCT BIOL, V5, P903, DOI 10.1038/2345; CAMPBELL MEM, 1984, J MOL BIOL, V180, P1, DOI 10.1016/0022-2836(84)90427-3; Cliffe AR, 2008, J VIROL, V82, P12030, DOI 10.1128/JVI.01575-08; de Oca RM, 2011, NUCLEUS-PHILA, V2, P580, DOI 10.4161/nucl.2.6.17960; de Oca RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007050; de Oca ROM, 2005, J BIOL CHEM, V280, P42252, DOI 10.1074/jbc.M509917200; Dechat T, 2004, J CELL SCI, V117, P6117, DOI 10.1242/jcs.01529; DELUCA NA, 1985, J VIROL, V56, P558, DOI 10.1128/JVI.56.2.558-570.1985; DELUCA NA, 1985, MOL CELL BIOL, V5, P1997, DOI 10.1128/MCB.5.8.1997; Devireddy LR, 2000, J BIOL CHEM, V275, P77, DOI 10.1074/jbc.275.1.77; Dittrich CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024555; DIXON RAF, 1980, J VIROL, V36, P189, DOI 10.1128/JVI.36.1.189-203.1980; EVERETT R, 1995, J VIROL, V69, P7339, DOI 10.1128/JVI.69.11.7339-7344.1995; Everett RD, 1999, J CELL SCI, V112, P4581; Everett RD, 1997, EMBO J, V16, P1519, DOI 10.1093/emboj/16.7.1519; FRAME MC, 1987, J GEN VIROL, V68, P2699, DOI 10.1099/0022-1317-68-10-2699; Furukawa K, 2003, J CELL SCI, V116, P3811, DOI 10.1242/jcs.00682; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; GU BH, 1994, J VIROL, V68, P7953, DOI 10.1128/JVI.68.12.7953-7965.1994; GU BH, 1993, P NATL ACAD SCI USA, V90, P9528, DOI 10.1073/pnas.90.20.9528; Gu HD, 2005, P NATL ACAD SCI USA, V102, P7571, DOI 10.1073/pnas.0502658102; Haraguchi T, 2001, J CELL SCI, V114, P4575; Haraguchi T, 2008, J CELL SCI, V121, P2540, DOI 10.1242/jcs.033597; Haraguchi T, 2007, J CELL SCI, V120, P1967, DOI 10.1242/jcs.03461; HARDY WR, 1994, J VIROL, V68, P7790, DOI 10.1128/JVI.68.12.7790-7799.1994; Hobbs WE, 1999, J VIROL, V73, P8245, DOI 10.1128/JVI.73.10.8245-8255.1999; HOLLAND LE, 1980, VIROLOGY, V101, P10, DOI 10.1016/0042-6822(80)90479-1; HONESS RW, 1974, J VIROL, V14, P8, DOI 10.1128/JVI.14.1.8-19.1974; Ibrahim N, 2013, VIROLOGY, V444, P363, DOI 10.1016/j.virol.2013.07.002; Ibrahim N, 2011, J VIROL, V85, P11588, DOI 10.1128/JVI.00641-11; Jamin A, 2014, J VIROL, V88, P5342, DOI 10.1128/JVI.00427-14; Johnson KE, 2013, J VIROL, V87, P5005, DOI 10.1128/JVI.00082-13; Jordan Robert, 1997, Journal of Virology, V71, P6850; Kawaguchi Y, 1997, J VIROL, V71, P1019, DOI 10.1128/JVI.71.2.1019-1024.1997; Kawaguchi Y, 1997, J VIROL, V71, P7328, DOI 10.1128/JVI.71.10.7328-7336.1997; Kushnir AS, 2010, J VIROL, V84, P188, DOI 10.1128/JVI.01377-09; Lancaster OM, 2007, J CELL BIOL, V179, P817, DOI 10.1083/jcb.200706067; LIESEGANG TJ, 1989, ARCH OPHTHALMOL-CHIC, V107, P1155, DOI 10.1001/archopht.1989.01070020221029; Margalit A, 2007, J CELL BIOL, V178, P661, DOI 10.1083/jcb.200704049; Margalit Ayelet, 2005, V264, P231, DOI 10.1002/0470093765.ch16; MCCARTHY AM, 1989, J VIROL, V63, P18, DOI 10.1128/JVI.63.1.18-27.1989; MCMAHAN L, 1990, J VIROL, V64, P3471, DOI 10.1128/JVI.64.7.3471-3485.1990; Melroe GT, 2004, J VIROL, V78, P8411, DOI 10.1128/JVI.78.16.8411-8420.2004; MEREDITH M, 1995, VIROLOGY, V209, P174, DOI 10.1006/viro.1995.1241; MEREDITH M, 1994, VIROLOGY, V200, P457, DOI 10.1006/viro.1994.1209; MICHAEL N, 1993, P NATL ACAD SCI USA, V90, P2286, DOI 10.1073/pnas.90.6.2286; Molitor TP, 2014, MOL BIOL CELL; Nahmias A J, 1990, Scand J Infect Dis Suppl, V69, P19; NESBURN AB, 1983, REPORT CORNEAL DIS P; Nezu J, 1997, GENOMICS, V45, P327, DOI 10.1006/geno.1997.4938; Nichols RJ, 2006, MOL BIOL CELL, V17, P2451, DOI 10.1091/mbc.E05-12-1179; OHARE P, 1985, J VIROL, V56, P723, DOI 10.1128/JVI.56.3.723-733.1985; Orzalli MH, 2012, P NATL ACAD SCI USA, V109, pE3008, DOI 10.1073/pnas.1211302109; Poon APW, 2006, P NATL ACAD SCI USA, V103, P9993, DOI 10.1073/pnas.0604142103; Poon APW, 2003, J VIROL, V77, P12671, DOI 10.1128/JVI.77.23.12671-12678.2003; PURVES FC, 1987, J VIROL, V61, P2896, DOI 10.1128/JVI.61.9.2896-2901.1987; Remeijer L, 2004, OCUL IMMUNOL INFLAMM, V12, P255, DOI 10.1080/092739490500363; REMPEL RE, 1990, J VIROL, V64, P574, DOI 10.1128/JVI.64.2.574-583.1990; REMPEL RE, 1992, J VIROL, V66, P4413, DOI 10.1128/JVI.66.7.4413-4426.1992; ROBERTS MS, 1988, J VIROL, V62, P4307, DOI 10.1128/JVI.62.11.4307-4320.1988; ROIZMAN B, 2007, FIELDS VIROLOGY, P2502; SACKS WR, 1985, J VIROL, V55, P796, DOI 10.1128/JVI.55.3.796-805.1985; SANDRIGOLDIN RM, 1995, J VIROL, V69, P6063, DOI 10.1128/JVI.69.10.6063-6076.1995; Segura-Totten M, 2002, J CELL BIOL, V158, P475, DOI 10.1083/jcb.200202019; Shimi T, 2004, J STRUCT BIOL, V147, P31, DOI 10.1016/j.jsb.2003.11.013; Sinani D, 2013, J VIROL, V87, P13042, DOI 10.1128/JVI.02476-13; Skoko D, 2009, P NATL ACAD SCI USA, V106, P16610, DOI 10.1073/pnas.0909077106; SMITH CA, 1993, J VIROL, V67, P4676, DOI 10.1128/JVI.67.8.4676-4687.1993; SMITH RF, 1989, J VIROL, V63, P450, DOI 10.1128/JVI.63.1.450-455.1989; Suzuki Y, 2002, J VIROL, V76, P12376, DOI 10.1128/JVI.76.23.12376-12380.2002; Suzuki Y, 2010, J BIOL CHEM, V285, P24032, DOI 10.1074/jbc.M110.116640; Towbin BD, 2010, COLD SH Q B, V75, P555, DOI 10.1101/sqb.2010.75.041; Tyler Kenneth L, 2004, Herpes, V11 Suppl 2, p57A; Umland TC, 2000, BIOCHEMISTRY-US, V39, P9130, DOI 10.1021/bi000572w; Wang XJ, 2002, J BIOL CHEM, V277, P43288, DOI 10.1074/jbc.M207952200; Wang YM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004103; WASSLER M, 1987, BIOCHEM J, V247, P407, DOI 10.1042/bj2470407; WHITLEY RJ, 1991, DRUGS, V42, P406, DOI 10.2165/00003495-199142030-00005; Wiebe MS, 2007, CELL HOST MICROBE, V1, P187, DOI 10.1016/j.chom.2007.03.007; Xu FJ, 2002, J INFECT DIS, V185, P1019, DOI 10.1086/340041; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964; Zheng RL, 2000, P NATL ACAD SCI USA, V97, P8997, DOI 10.1073/pnas.150240197; Zhuang X, 2013, J BIOL CHEM	88	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100511	10.1371/journal.pone.0100511	http://dx.doi.org/10.1371/journal.pone.0100511			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945635	Green Published, gold			2022-12-25	WOS:000340721500083
J	Wong, MM; Byun, JS; Sacta, M; Jin, QH; Baek, S; Gardner, K				Wong, Madeline M.; Byun, Jung S.; Sacta, Maria; Jin, Qihuang; Baek, SongJoon; Gardner, Kevin			Promoter-Bound p300 Complexes Facilitate Post-Mitotic Transmission of Transcriptional Memory	PLOS ONE			English	Article							RNA-POLYMERASE-II; BROMODOMAIN PROTEIN BRD4; LONG-TERM-MEMORY; MITOTIC BOOKMARKING; GENE-EXPRESSION; HISTONE ACETYLTRANSFERASES; DEPENDENT TRANSCRIPTION; EPIGENETIC CONTROL; COACTIVATOR P300; BINDING PROTEIN	A central hallmark of epigenetic inheritance is the parental transmission of changes in patterns of gene expression to progeny without modification of DNA sequence. Although, the trans-generational conveyance of this molecular memory has been traditionally linked to covalent modification of histone and/or DNA, recent studies suggest a role for proteins that persist or remain bound within chromatin to "bookmark" specific loci for enhanced or potentiated responses in daughter cells immediately following cell division. In this report we describe a role for p300 in enabling gene bookmarking by pre-initiation complexes (PICs) containing RNA polymerase II (pol II), Mediator and TBP. Once formed these complexes require p300 to facilitate reacquisition of protein complex assemblies, chromatin modifications and long range chromatin interactions that enable post-mitotic transmission of transcriptional memory of prior environmental stimuli.	[Wong, Madeline M.; Byun, Jung S.; Sacta, Maria; Gardner, Kevin] NCI, Genet Branch, Bethesda, MD 20892 USA; [Jin, Qihuang] Natl Inst Diabet & Digest & Kidney Dis, Lab Endocrinol & Receptor Biol, Bethesda, MD USA; [Baek, SongJoon] NCI, Lab Receptor Biol & Gene Express, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gardner, K (corresponding author), NCI, Genet Branch, Bethesda, MD 20892 USA.	gardnerk@mail.nih.gov		Byun, Jung Shin/0000-0001-9049-9594	Intramural Research Program of the US National Institutes of Health; US National Cancer Institute; US National Institute on Minority Health and Health Disparities; NATIONAL CANCER INSTITUTE [ZIABC010846] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institute on Minority Health and Health Disparities; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the US National Institutes of Health, the US National Cancer Institute, and the US National Institute on Minority Health and Health Disparities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM SE, 1993, ONCOGENE, V8, P1639; Acevedo ML, 2003, MOL CELL BIOL, V23, P335, DOI 10.1128/MCB.23.1.335-348.2003; Ali SA, 2008, P NATL ACAD SCI USA, V105, P6632, DOI 10.1073/pnas.0800970105; Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; Barrett RM, 2011, NEUROPSYCHOPHARMACOL, V36, P1545, DOI 10.1038/npp.2011.61; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Blobel GA, 2009, MOL CELL, V36, P970, DOI 10.1016/j.molcel.2009.12.001; Butscher WG, 1998, J BIOL CHEM, V273, P552, DOI 10.1074/jbc.273.1.552; Byun JS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1652; Byun JS, 2009, P NATL ACAD SCI USA, V106, P19292, DOI 10.1073/pnas.0905469106; Caravaca JM, 2013, GENE DEV, V27, P251, DOI 10.1101/gad.206458.112; Chen DY, 2005, J CELL BIOL, V168, P41, DOI 10.1083/jcb.200407182; Chopra VS, 2009, GENE DEV, V23, P1505, DOI 10.1101/gad.1807309; Christova R, 2002, NAT CELL BIOL, V4, P79, DOI 10.1038/ncb733; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; COSENZA SC, 1994, J CELL BIOCHEM, V55, P503, DOI 10.1002/jcb.240550410; Crump NT, 2011, P NATL ACAD SCI USA, V108, P7814, DOI 10.1073/pnas.1100099108; Cuylen S, 2010, CELL STEM CELL, V7, P424, DOI 10.1016/j.stem.2010.09.006; Dallas PB, 1997, J VIROL, V71, P1726, DOI 10.1128/JVI.71.2.1726-1731.1997; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Delcuve GP, 2009, J CELL PHYSIOL, V219, P243, DOI 10.1002/jcp.21678; Dey A, 2009, MOL BIOL CELL; Di LJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2438; FERRERI K, 1994, P NATL ACAD SCI USA, V91, P1210, DOI 10.1073/pnas.91.4.1210; Ganusov VV, 2005, J IMMUNOL METHODS, V298, P183, DOI 10.1016/j.jim.2005.01.011; Ge Y, 2006, BLOOD, V108, P4126, DOI 10.1182/blood-2006-04-017046; Giralt A, 2012, HUM MOL GENET, V21, P1203, DOI 10.1093/hmg/ddr552; Goodman RH, 2000, GENE DEV, V14, P1553; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; GROUDINE M, 1982, CELL, V30, P131, DOI 10.1016/0092-8674(82)90019-8; Hakim O, 2009, J BIOL CHEM, V284, P6048, DOI 10.1074/jbc.C800212200; Hasan S, 2001, NATURE, V410, P387, DOI 10.1038/35066610; Huang ZQ, 2003, EMBO J, V22, P2146, DOI 10.1093/emboj/cdg219; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; John S, 1998, BIOESSAYS, V20, P275, DOI 10.1002/(SICI)1521-1878(199804)20:4<275::AID-BIES1>3.3.CO;2-6; Kadauke S, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-6; Kadauke S, 2012, CELL, V150, P725, DOI 10.1016/j.cell.2012.06.038; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kininis M, 2009, MOL CELL BIOL, V29, P1123, DOI 10.1128/MCB.00841-08; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Krubasik D, 2006, BRIT J CANCER, V94, P1326, DOI 10.1038/sj.bjc.6603101; Kruhlak MJ, 2001, J BIOL CHEM, V276, P38307; Lanzuolo C, 2012, ANNU REV GENET, V46, P561, DOI 10.1146/annurev-genet-110711-155603; Li QJ, 2003, EMBO J, V22, P281, DOI 10.1093/emboj/cdg028; Liu X, 2013, BBA-GENE REGUL MECH, V1829, P2, DOI 10.1016/j.bbagrm.2012.09.003; Maddox SA, 2013, LEARN MEMORY, V20, P109, DOI 10.1101/lm.029157.112; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Ng RK, 2008, NAT CELL BIOL, V10, P102, DOI 10.1038/ncb1674; O'Donnell A, 2012, BIOCHEM SOC T, V40, P58, DOI 10.1042/BST20110636; Parker D, 1996, MOL CELL BIOL, V16, P694; Parsons GG, 1997, MOL CELL BIOL, V17, P5791, DOI 10.1128/MCB.17.10.5791; Prasanth KV, 2003, MOL BIOL CELL, V14, P1043, DOI 10.1091/mbc.E02-10-0669; PRESCOTT DM, 1962, EXP CELL RES, V26, P260, DOI 10.1016/0014-4827(62)90176-3; Remeseiro S, 2013, CURR OPIN CELL BIOL, V25, P63, DOI 10.1016/j.ceb.2012.10.013; Sarge KD, 2009, CELL CYCLE, V8, P818, DOI 10.4161/cc.8.6.7849; Schaaf CA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003382; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Sekinger EA, 2001, CELL, V105, P403, DOI 10.1016/S0092-8674(01)00329-4; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Smallwood A, 2013, CURR OPIN CELL BIOL, V25, P387, DOI 10.1016/j.ceb.2013.02.005; Sunagawa Y, 2010, J BIOL CHEM, V285, P9556, DOI 10.1074/jbc.M109.070458; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; von MA, 2000, J CELL BIOL, V150, P265; Wang F, 2013, CELL MOL LIFE SCI, V70, P3989, DOI 10.1007/s00018-012-1254-4; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Xing HY, 2008, NAT CELL BIOL, V10, P1318, DOI 10.1038/ncb1790; Xing HY, 2005, SCIENCE, V307, P421, DOI 10.1126/science.1106478; Yang ML, 2012, DIABETES, V61, P1959, DOI 10.2337/db11-1755; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Young DW, 2007, P NATL ACAD SCI USA, V104, P3189, DOI 10.1073/pnas.0611419104; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Zaidi SK, 2011, J BIOL CHEM, V286, P18355, DOI 10.1074/jbc.R110.197061; Zaidi SK, 2010, NAT REV GENET, V11, P583, DOI 10.1038/nrg2827; Zaidi SK, 2003, P NATL ACAD SCI USA, V100, P14852, DOI 10.1073/pnas.2533076100; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhao R, 2011, NAT CELL BIOL, V13, P1295, DOI 10.1038/ncb2341	83	19	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99989	10.1371/journal.pone.0099989	http://dx.doi.org/10.1371/journal.pone.0099989			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945803	gold, Green Published, Green Submitted			2022-12-25	WOS:000340721500038
J	Chen, LP; Ma, L; Bai, Q; Zhu, XN; Zhang, JM; Wei, Q; Li, DC; Gao, C; Li, J; Zhang, ZB; Liu, CX; He, ZN; Zeng, XW; Zhang, AH; Qu, WD; Zhuang, ZX; Chen, W; Xiao, YM				Chen, Liping; Ma, Lu; Bai, Qing; Zhu, Xiaonian; Zhang, Jinmiao; Wei, Qing; Li, Daochuan; Gao, Chen; Li, Jie; Zhang, Zhengbao; Liu, Caixia; He, Zhini; Zeng, Xiaowen; Zhang, Aihua; Qu, Weidong; Zhuang, Zhixiong; Chen, Wen; Xiao, Yongmei			Heavy Metal-induced Metallothionein Expression Is Regulated by Specific Protein Phosphatase 2A Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-I; HUMAN HEPATOCELLULAR CARCINOMAS; SIGNAL-TRANSDUCTION CASCADES; GENE-EXPRESSION; OXIDATIVE STRESS; FACTOR MTF-1; RESPONSIVE TRANSCRIPTION; GUANGDONG PROVINCE; CADMIUM TOXICITY; ZINC HOMEOSTASIS	Induction of metallothionein (MT) expression is involved in metal homeostasis and detoxification. To identify the key pathways that regulate metal-induced cytotoxicity, we investigate how phosphorylated metal-responsive transcription factor-1 (MTF-1) contributed to induction of MT expression. Immortal human embryonic kidney cells (HEK cells) were treated with seven kinds of metals including cadmium chloride (CdCl2), zinc sulfate (ZnSO4), copper sulfate(CuSO4), lead acetate (PbAc), nickel sulfate (NiSO4), sodium arsenite (NaAsO2), and potassium bichromate (K2Cr2O7). The MT expression was induced in a dose-response and time-dependent manner upon various metal treatments. A cycle of phosphorylation and dephosphorylation was required for translocation of MTF-1 from cytoplasm to nucleus, leading to the up-regulation of MTs expression. Protein phosphatase 2A (PP2A) participated in regulating MT expression through dephosphorylation of MTF-1. A loss-of-function screen revealed that the specific PP2A complexes containing PR110 were involved in metal-induced MT expression. Suppression of PP2A PR110 in HEK cells resulted in the persistent MTF-1 phosphorylation and the disturbance of MTF-1 nuclear translocation, which was concomitant with a significant decrease of MT expression and enhanced cytotoxicity in HEK cells. Notably, MTF-1 was found in complex with specific PP2A complexes containing the PR110 subunit upon metal exposure. Furthermore, we identify that the dephosphorylation of MTF-1 at residue Thr-254 is directly regulated by PP2A PR110 complexes and responsible for MTF-1 activation. Taken together, these findings delineate a novel pathway that determines cytotoxicity in response to metal treatments and provide new insight into the role of PP2A in cellular stress response.	[Chen, Liping; Ma, Lu; Bai, Qing; Zhu, Xiaonian; Zhang, Jinmiao; Wei, Qing; Li, Daochuan; Gao, Chen; Li, Jie; Zhang, Zhengbao; Liu, Caixia; He, Zhini; Zeng, Xiaowen; Chen, Wen; Xiao, Yongmei] Sun Yat Sen Univ, Sch Publ Hlth, Dept Toxicol, Guangzhou 510080, Guangdong, Peoples R China; [Zhang, Aihua] Guiyang Med Univ, Sch Publ Hlth, Dept Toxicol, Guiyang 550004, Peoples R China; [Qu, Weidong] Fudan Univ, Sch Publ Hlth, Dept Environm Hlth, Shanghai 200032, Peoples R China; [Zhuang, Zhixiong] Shenzhen Ctr Dis Control & Prevent, Dept Toxicol, Shenzhen 518001, Peoples R China	Sun Yat Sen University; Guizhou Medical University; Fudan University; Shenzhen Center for Disease Control & Prevention (SZCDC)	Chen, W (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Fac Prevent Med, Guangzhou 510080, Guangdong, Peoples R China.	chenwen@mail.sysu.edu.cn; xiaoym@mail.sysu.edu.cn		He, Zhini/0000-0002-9185-5500	National Key Basic Research and Development Program [2010CB912803, 2012CB525003]; National Nature Science Foundation of China (NSFC) [81325017, 81072284, 30901211, 81172603, 81273127]; National "Twelfth Five-Year" Plan for Science and Technology [2014BAI12B02]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme GDUPS; Natural Science Foundation of Guangdong Province [S2012040007713]	National Key Basic Research and Development Program(National Basic Research Program of China); National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National "Twelfth Five-Year" Plan for Science and Technology; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme GDUPS; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Key Basic Research and Development Program (2010CB912803 and 2012CB525003), the National Nature Science Foundation of China (NSFC) (81325017, 81072284, 30901211, 81172603, and 81273127), the National "Twelfth Five-Year" Plan for Science and Technology (2014BAI12B02), the Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme GDUPS (2010), and the Natural Science Foundation of Guangdong Province (S2012040007713).	AbdelMageed AB, 1997, CANCER GENE THER, V4, P199; Alissa EM, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/870125; Anderson RS, 1999, DEV COMP IMMUNOL, V23, P443, DOI 10.1016/S0145-305X(99)00029-4; Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; Arroyo JD, 2005, ONCOGENE, V24, P7746, DOI 10.1038/sj.onc.1209038; Baillat G, 2001, MOL BIOL CELL, V12, P663, DOI 10.1091/mbc.12.3.663; Bao QS, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-217; Brandao R, 2006, CELL BIOL TOXICOL, V22, P429, DOI 10.1007/s10565-006-0119-8; Castets F, 1996, J CELL BIOL, V134, P1051, DOI 10.1083/jcb.134.4.1051; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Conrad CC, 1997, J TOXICOL ENV HEALTH, V52, P527; Datta J, 2007, CANCER RES, V67, P2736, DOI 10.1158/0008-5472.CAN-06-4433; DeLisle RC, 1996, AM J PHYSIOL-CELL PH, V271, pC1103, DOI 10.1152/ajpcell.1996.271.4.C1103; DURNAM DM, 1981, J BIOL CHEM, V256, P5712; ECKER DJ, 1986, J BIOL CHEM, V261, P6895; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Ghoshal K, 2001, PROG NUCLEIC ACID RE, V66, P357; Giedroc DP, 2001, ANTIOXID REDOX SIGN, V3, P577, DOI 10.1089/15230860152542943; GOERING PL, 1983, TOXICOL APPL PHARM, V70, P195, DOI 10.1016/0041-008X(83)90095-9; Haq F, 2003, MUTAT RES-FUND MOL M, V533, P211, DOI 10.1016/j.mrfmmm.2003.07.014; HART BA, 1993, CANCER LETT, V75, P121, DOI 10.1016/0304-3835(93)90196-G; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; Huang P C, 1987, Experientia Suppl, V52, P439; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032; Jiang HM, 2004, BIOCHEM J, V382, P33, DOI 10.1042/BJ20040504; Jin RX, 2002, CARCINOGENESIS, V23, P81, DOI 10.1093/carcin/23.1.81; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Klaassen CD, 1999, ANNU REV PHARMACOL, V39, P267, DOI 10.1146/annurev.pharmtox.39.1.267; Knapen D, 2007, AQUAT TOXICOL, V82, P163, DOI 10.1016/j.aquatox.2007.02.008; LaRochelle O, 2001, J BIOL CHEM, V276, P41879, DOI 10.1074/jbc.M108313200; Li XY, 2004, J BIOL CHEM, V279, P765, DOI 10.1074/jbc.M307907200; Lin CF, 2007, J CELL SCI, V120, P2935, DOI 10.1242/jcs.03473; Lu Q, 2003, J BIOL CHEM, V278, P4639, DOI 10.1074/jbc.M210949200; Ma T, 2004, WORLD J GASTROENTERO, V10, P172, DOI 10.3748/wjg.v10.i2.172; Mao J, 2012, CARCINOGENESIS, V33, P2568, DOI 10.1093/carcin/bgs287; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Miura N, 2007, YAKUGAKU ZASSHI, V127, P665, DOI 10.1248/yakushi.127.665; Moreno CS, 2001, J BIOL CHEM, V276, P24253, DOI 10.1074/jbc.M102398200; Murphy BJ, 1999, CANCER RES, V59, P1315; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; PALMITER RD, 1994, P NATL ACAD SCI USA, V91, P1219, DOI 10.1073/pnas.91.4.1219; Papetti P, 2009, ENVIRON MONIT ASSESS, V159, P589, DOI 10.1007/s10661-008-0725-4; Park JD, 2001, TOXICOLOGY, V163, P93, DOI 10.1016/S0300-483X(01)00375-4; Pearce LL, 2000, J NUTR, V130, p1467S, DOI 10.1093/jn/130.5.1467S; Qing L, 2004, P NATL ACAD SCI USA, V101, P17126, DOI 10.1073/pnas.0407492101; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; Rodgers JT, 2011, MOL CELL, V41, P471, DOI 10.1016/j.molcel.2011.02.007; Saydam N, 2002, J BIOL CHEM, V277, P20438, DOI 10.1074/jbc.M110631200; Saydam N, 2001, J BIOL CHEM, V276, P25487, DOI 10.1074/jbc.M009154200; Shariati F, 2011, BIOL TRACE ELEM RES, V143, P281, DOI 10.1007/s12011-010-8877-9; Smirnova IV, 2000, J BIOL CHEM, V275, P9377, DOI 10.1074/jbc.275.13.9377; Song MO, 2014, EXP CELL RES, V322, P39, DOI 10.1016/j.yexcr.2014.01.013; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Wang GL, 2004, GENE DEV, V18, P912, DOI 10.1101/gad.1183304; Wang M, 2011, BIOL TRACE ELEM RES, V142, P362, DOI 10.1007/s12011-010-8802-2; Wang M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-319; YAMADA H, 1991, CHEM-BIOL INTERACT, V78, P347, DOI 10.1016/0009-2797(91)90064-E; Yorimitsu T, 2009, AUTOPHAGY, V5, P616, DOI 10.4161/auto.5.5.8091	60	44	51	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22413	22426		10.1074/jbc.M114.548677	http://dx.doi.org/10.1074/jbc.M114.548677			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24962574	hybrid, Green Published			2022-12-25	WOS:000340593500051
J	Roy, A; Tesauro, C; Frohlich, R; Hede, MS; Nielsen, MJ; Kjeldsen, E; Bonven, B; Stougaard, M; Gromova, I; Knudsen, BR				Roy, Amit; Tesauro, Cinzia; Frohlich, Rikke; Hede, Marianne S.; Nielsen, Maria J.; Kjeldsen, Eigil; Bonven, Bjarne; Stougaard, Magnus; Gromova, Irina; Knudsen, Birgitta R.			Decreased Camptothecin Sensitivity of the Stem-Cell-Like Fraction of Caco2 Cells Correlates with an Altered Phosphorylation Pattern of Topoisomerase I	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; PROTEIN-KINASE-C; TUMOR-INITIATING CELLS; SODIUM-BUTYRATE; LYMPHOMA-CELLS; LUNG-CANCER; DNA; RESISTANCE; LINE; IDENTIFICATION	The CD44+ and CD44- subpopulations of the colorectal cancer cell line Caco2 were analyzed separately for their sensitivities to the antitumor drug camptothecin. CD44+ cells were less sensitive to camptothecin than CD44- cells. The relative resistance of CD44+ cells was correlated with (i) reduced activity of the nuclear enzyme topoisomerase I and (ii) insensitivity of this enzyme to camptothecin when analyzed in extracts. In contrast, topoisomerase I activity was higher in extracts from CD44- cells and the enzyme was camptothecin sensitive. Topoisomerase I from the two subpopulations were differentially phosphorylated in a manner that appeared to determine the drug sensitivity and activity of the enzyme. This finding was further supported by the fact that phosphorylation of topoisomerase I in CD44+ cell extract by protein kinase CK2 converted the enzyme to a camptothecin sensitive, more active form mimicking topoisomerase I in extracts from CD44- cells. Conversely, dephosphorylation of topoisomerase I in extracts from CD44- cells rendered the enzyme less active and camptothecin resistant. These findings add to our understanding of chemotherapy resistance in the Caco2 CD44+ cancer stem cell model.	[Roy, Amit; Tesauro, Cinzia; Frohlich, Rikke; Nielsen, Maria J.; Bonven, Bjarne; Knudsen, Birgitta R.] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Hede, Marianne S.] Zymonostics ApS, Aarhus, Denmark; [Kjeldsen, Eigil] Aarhus Univ Hosp, Cancercytogenet Sect, Hemodiagnost Lab, DK-8000 Aarhus, Denmark; [Stougaard, Magnus] Aarhus Univ Hosp, Dept Pathol, DK-8000 Aarhus, Denmark; [Gromova, Irina] Danish Canc Soc, Danish Canc Res Ctr, Genome Integr Unit, Copenhagen, Denmark	Aarhus University; Aarhus University; Aarhus University; Danish Cancer Society	Knudsen, BR (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark.	brk@mb.au.dk		Stougaard, Magnus/0000-0001-7456-902X; Knudsen, Birgitta Ruth/0000-0002-3484-3802; Tesauro, Cinzia/0000-0003-2986-9618; Gromova, Irina/0000-0003-4357-5958	Carlsberg Foundation; Danish Cancer Society; Aase og Ejnar Danielsens Foundation; Fabrikant Einar Willumsens Mindelegat; Friedrich Wilhelm Frank & Hustru Angelina Franks Mindelegat; Arvid Nilssons Foundation; Minister Erna Hamiltons Legat for Videnskab og Kunst; Familien Erichsens Mindefond; Karen Elise Jensen's Foundation; Dagmar Marshall's Foundation; Einar Hansen & Vera Hansen's Foundation; Harboe Foundation; Louis Hansen's Foundation; Horslev Foundation; Kobmand Sven Hansen & hustru Ina Hansen's Foundation; Emil Hertz & hustru Inger Hertz' Foundation; Civilingenior Frode Nygaard's Foundation; Kong Christian den Tiende's Foundation; Gangsted Foundation; KU's Foundation for Cancer research; Ludvig og Franciska Andersen's Foundation; Frimodt-Heineke's Foundation; Familien Hede Nielsens Foundation; Marie & M. B. Richters Foundation; Lykfeldts legat; Fhv. Dir. Leo Nielsen og Hustru Karen Margrethe Nielsens Legat for Laegevidenskabelig Grundforskning	Carlsberg Foundation(Carlsberg Foundation); Danish Cancer Society(Danish Cancer Society); Aase og Ejnar Danielsens Foundation; Fabrikant Einar Willumsens Mindelegat; Friedrich Wilhelm Frank & Hustru Angelina Franks Mindelegat; Arvid Nilssons Foundation; Minister Erna Hamiltons Legat for Videnskab og Kunst; Familien Erichsens Mindefond; Karen Elise Jensen's Foundation; Dagmar Marshall's Foundation; Einar Hansen & Vera Hansen's Foundation; Harboe Foundation; Louis Hansen's Foundation; Horslev Foundation; Kobmand Sven Hansen & hustru Ina Hansen's Foundation; Emil Hertz & hustru Inger Hertz' Foundation; Civilingenior Frode Nygaard's Foundation; Kong Christian den Tiende's Foundation; Gangsted Foundation; KU's Foundation for Cancer research; Ludvig og Franciska Andersen's Foundation; Frimodt-Heineke's Foundation; Familien Hede Nielsens Foundation; Marie & M. B. Richters Foundation; Lykfeldts legat; Fhv. Dir. Leo Nielsen og Hustru Karen Margrethe Nielsens Legat for Laegevidenskabelig Grundforskning	This research was supported by the Carlsberg Foundation (post doc grant for AR), the Danish Cancer Society, Aase og Ejnar Danielsens Foundation, the Fabrikant Einar Willumsens Mindelegat, the Friedrich Wilhelm Frank & Hustru Angelina Franks Mindelegat, the Arvid Nilssons Foundation, the Minister Erna Hamiltons Legat for Videnskab og Kunst, the Familien Erichsens Mindefond, Karen Elise Jensen's Foundation, Dagmar Marshall's Foundation, Dir. Einar Hansen & Vera Hansen's Foundation, The Harboe Foundation, Louis Hansen's Foundation, The Horslev Foundation, Kobmand Sven Hansen & hustru Ina Hansen's Foundation, Dir. Emil Hertz & hustru Inger Hertz' Foundation, Civilingenior Frode Nygaard's Foundation, Kong Christian den Tiende's Foundation, The Gangsted Foundation, KU's Foundation for Cancer research, Ludvig og Franciska Andersen's Foundation, Frimodt-Heineke's Foundation, the Familien Hede Nielsens Foundation, the Marie & M. B. Richters Foundation, the Lykfeldts legat, the Fhv. Dir. Leo Nielsen og Hustru Karen Margrethe Nielsens Legat for Laegevidenskabelig Grundforskning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah LN, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-3; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alison MR, 2011, J PATHOL, V223, P147, DOI 10.1002/path.2793; Andersen FF, 2009, ACS NANO, V3, P4043, DOI 10.1021/nn9012912; [Anonymous], ANN SURG ONCOL, V15, P2027; AUGERON C, 1984, CANCER RES, V44, P3961; Bandyopadhyay K, 2007, BIOCHEMISTRY-US, V46, P14325, DOI 10.1021/bi7013618; Bandyopadhyay K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050427; Bandyopadhyay K, 2011, BIOCHEMISTRY-US, V50, P704, DOI 10.1021/bi101110e; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Beretta GL, 2006, CURR MED CHEM, V13, P3291, DOI 10.2174/092986706778773121; Beretta GL, 2013, CURR MED CHEM, V20, P1541; Burgess DJ, 2008, P NATL ACAD SCI USA, V105, P9053, DOI 10.1073/pnas.0803513105; CARDELLINI E, 1993, BIOCHEM J, V291, P303, DOI 10.1042/bj2910303; CELIS JE, 2006, CELL BIOL LAB HDB, P165; Christiansen K, 1996, ANN NY ACAD SCI, V803, P50, DOI 10.1111/j.1749-6632.1996.tb26376.x; CODERONI S, 1990, INT J BIOCHEM, V22, P737, DOI 10.1016/0020-711X(90)90009-R; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Emmink BL, 2011, GASTROENTEROLOGY, V141, P269, DOI 10.1053/j.gastro.2011.03.052; ENG WK, 1988, MOL PHARMACOL, V34, P755; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Gerrits CJH, 1997, BRIT J CANCER, V76, P952, DOI 10.1038/bjc.1997.491; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Gongora C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-64; Grivicich I, 2001, BRAZ J MED BIOL RES, V34, P1087, DOI 10.1590/S0100-879X2001000900001; Gromov P, 2006, CELL BIOL, P527; Gromov P, 2008, MOL ONCOL, V2, P368, DOI 10.1016/j.molonc.2008.09.003; Hann CL, 1998, J BIOL CHEM, V273, P31519, DOI 10.1074/jbc.273.47.31519; HERTZBERG RP, 1990, J BIOL CHEM, V265, P19287; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Jansen WJM, 1997, INT J CANCER, V70, P335, DOI 10.1002/(SICI)1097-0215(19970127)70:3<335::AID-IJC15>3.0.CO;2-E; Juul S, 2011, ACS NANO, V5, P8305, DOI 10.1021/nn203012q; KAISERMAN HB, 1988, BIOCHEMISTRY-US, V27, P3216, DOI 10.1021/bi00409a014; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; KJELDSEN E, 1988, J BIOL CHEM, V263, P3912; Knudsen BR, 1996, J CHROMATOGR B, V684, P307, DOI 10.1016/0378-4347(96)00152-1; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Kowalska-Loth B, 2003, MOL BIOL REP, V30, P107, DOI 10.1023/A:1023942226954; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Leppard JB, 2005, CHROMOSOMA, V114, P75, DOI 10.1007/s00412-005-0345-5; Li XG, 1997, BIOCHEM PHARMACOL, V53, P1019, DOI 10.1016/S0006-2952(96)00899-4; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; MADELAINE I, 1993, BIOCHEM PHARMACOL, V45, P339, DOI 10.1016/0006-2952(93)90069-9; Moisan F, 2006, BRIT J CANCER, V95, P906, DOI 10.1038/sj.bjc.6603361; Moreau LC, 2013, ANTICANCER RES, V33, P1765; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Pommier Y, 1999, DRUG RESIST UPDATE, V2, P307, DOI 10.1054/drup.1999.0102; POMMIER Y, 1990, J BIOL CHEM, V265, P9418; POMMIER Y, 1993, CANCER CHEMOTH PHARM, V32, P103, DOI 10.1007/BF00685611; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Proszek J, 2014, SENSORS-BASEL, V14, P1195, DOI 10.3390/s140101195; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; SAMUELS DS, 1989, FEBS LETT, V259, P57, DOI 10.1016/0014-5793(89)81493-0; Sell S, 2010, AM J PATHOL, V176, P2584, DOI 10.2353/ajpath.2010.091064; Setoguchi T, 2004, CELL CYCLE, V3, P414; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; SORENSEN M, 1995, BRIT J CANCER, V72, P399, DOI 10.1038/bjc.1995.345; Soret J, 2003, CANCER RES, V63, P8203; SOULEIMANI A, 1993, FEBS LETT, V326, P45, DOI 10.1016/0014-5793(93)81758-R; St-Amant C, 2006, BIOCHEM CELL BIOL, V84, P55, DOI 10.1139/O05-157; STARON K, 1994, CARCINOGENESIS, V15, P2953, DOI 10.1093/carcin/15.12.2953; STARON K, 1995, BBA-GENE STRUCT EXPR, V1260, P35, DOI 10.1016/0167-4781(94)00175-3; Staron K, 1996, ANN NY ACAD SCI, V803, P321, DOI 10.1111/j.1749-6632.1996.tb26406.x; Stougaard M, 2009, ACS NANO, V3, P223, DOI 10.1021/nn800509b; Strumberg D, 2000, MOL CELL BIOL, V20, P3977, DOI 10.1128/MCB.20.11.3977-3987.2000; SUGIMOTO Y, 1990, CANCER RES, V50, P6925; Tesauro C, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-100; TSAO YP, 1993, CANCER RES, V53, P5908; TURMAN MA, 1993, BIOCHEM MED METAB B, V50, P210, DOI 10.1006/bmmb.1993.1063; Wolpin BM, 2008, GASTROENTEROLOGY, V134, P1296, DOI 10.1053/j.gastro.2008.02.098; Yu DH, 2004, J BIOL CHEM, V279, P51851, DOI 10.1074/jbc.M404396200	73	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99628	10.1371/journal.pone.0099628	http://dx.doi.org/10.1371/journal.pone.0099628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960044	Green Published, Green Submitted, gold			2022-12-25	WOS:000338633900011
J	Terami, N; Ogawa, D; Tachibana, H; Hatanaka, T; Wada, J; Nakatsuka, A; Eguchi, J; Horiguchi, CS; Nishii, N; Yamada, H; Takei, K; Makino, H				Terami, Naoto; Ogawa, Daisuke; Tachibana, Hiromi; Hatanaka, Takashi; Wada, Jun; Nakatsuka, Atsuko; Eguchi, Jun; Horiguchi, Chikage Sato; Nishii, Naoko; Yamada, Hiroshi; Takei, Kohji; Makino, Hirofumi			Long-Term Treatment with the Sodium Glucose Cotransporter 2 Inhibitor, Dapagliflozin, Ameliorates Glucose Homeostasis and Diabetic Nephropathy in db/db Mice	PLOS ONE			English	Article							SGLT2 INHIBITOR; PANCREATIC-FUNCTION; OXIDATIVE STRESS; RENAL INJURY; MELLITUS; RATS; INFLAMMATION; COMPLICATIONS; HYPERGLYCEMIA; ACTIVATION	Inhibition of sodium glucose cotransporter 2 (SGLT2) has been reported as a new therapeutic strategy for treating diabetes. However, the effect of SGLT2 inhibitors on the kidney is unknown. In addition, whether SGLT2 inhibitors have an anti-inflammatory or antioxidative stress effect is still unclear. In this study, to resolve these issues, we evaluated the effects of the SGLT2 inhibitor, dapagliflozin, using a mouse model of type 2 diabetes and cultured proximal tubular epithelial (mProx24) cells. Male db/db mice were administered 0.1 or 1.0 mg/kg of dapagliflozin for 12 weeks. Body weight, blood pressure, blood glucose, hemoglobin A1c, albuminuria and creatinine clearance were measured. Mesangial matrix accumulation and interstitial fibrosis in the kidney and pancreatic beta-cell mass were evaluated by histological analysis. Furthermore, gene expression of inflammatory mediators, such as osteopontin, monocyte chemoattractant protein-1 and transforming growth factor-beta, was evaluated by quantitative reverse transcriptase-PCR. In addition, oxidative stress was evaluated by dihydroethidium and NADPH oxidase 4 staining. Administration of 0.1 or 1.0 mg/kg of dapagliflozin ameliorated hyperglycemia, beta-cell damage and albuminuria in db/db mice. Serum creatinine, creatinine clearance and blood pressure were not affected by administration of dapagliflozin, but glomerular mesangial expansion and interstitial fibrosis were suppressed in a dose-dependent manner. Dapagliflozin treatment markedly decreased macrophage infiltration and the gene expression of inflammation and oxidative stress in the kidney of db/db mice. Moreover, dapagliflozin suppressed the high-glucose-induced gene expression of inflammatory cytokines and oxidative stress in cultured mProx24 cells. These data suggest that dapagliflozin ameliorates diabetic nephropathy by improving hyperglycemia along with inhibiting inflammation and oxidative stress.	[Terami, Naoto; Ogawa, Daisuke; Tachibana, Hiromi; Hatanaka, Takashi; Wada, Jun; Nakatsuka, Atsuko; Eguchi, Jun; Horiguchi, Chikage Sato; Nishii, Naoko; Makino, Hirofumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama, Japan; [Ogawa, Daisuke] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Diabet Nephropathy, Okayama, Japan; [Yamada, Hiroshi; Takei, Kohji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurochem, Okayama, Japan	Okayama University; Okayama University; Okayama University	Ogawa, D (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama, Japan.	daiogawa@md.okayama-u.ac.jp	WADA, Jun/B-2023-2011; Yamada, Hiroshi/AGZ-4497-2022; Nakatsuka, Atsuko/L-2765-2017; YAMADA, Hiroshi/B-2251-2011	WADA, Jun/0000-0003-1468-5170; Yamada, Hiroshi/0000-0002-9328-3446; YAMADA, Hiroshi/0000-0002-9328-3446; Takei, Kohji/0000-0002-6555-9425	Ministry of Education, Culture, Sports, Science and Technology [25461223, 24790927]; Ministry of Health, Labour and Welfare of Japan; Naito Foundation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF))	This study was supported in part by Grant-in-Aid for Scientific Research (C) to D. Ogawa (25461223) and Grant-in-Aid for Young Scientists (B) to C. Sato Horiguchi (24790927) from the Ministry of Education, Culture, Sports, Science and Technology, and by Grant-in-Aid for Diabetic Nephropathy and Nephrosclerosis Research from the Ministry of Health, Labour and Welfare of Japan. This work was also supported by the Naito Foundation and the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchie A, 2013, NAT BIOTECHNOL, V31, P469, DOI 10.1038/nbt0613-469; Chao EC, 2010, NAT REV DRUG DISCOV, V9, P551, DOI 10.1038/nrd3180; Chen L, 2012, CURR MOL MED, V12, P995, DOI 10.2174/156652412802480970; Chen LH, 2013, DIABETES OBES METAB, V15, P392, DOI 10.1111/dom.12064; Cherney DZI, 2014, CIRCULATION, V129, P587, DOI 10.1161/CIRCULATIONAHA.113.005081; DeFronzo RA, 2013, DIABETES CARE; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Fujimori Y, 2008, J PHARMACOL EXP THER, V327, P268, DOI 10.1124/jpet.108.140210; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gilbertson DT, 2005, J AM SOC NEPHROL, V16, P3736, DOI 10.1681/ASN.2005010112; Han SP, 2008, DIABETES, V57, P1723, DOI 10.2337/db07-1472; HEDIGER MA, 1994, PHYSIOL REV, V74, P993, DOI 10.1152/physrev.1994.74.4.993; Jurczak MJ, 2011, DIABETES, V60, P890, DOI 10.2337/db10-1328; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Kodera R, 2011, DIABETOLOGIA, V54, P965, DOI 10.1007/s00125-010-2028-x; Kojima N, 2013, J PHARMACOL EXP THER, V345, P464, DOI 10.1124/jpet.113.203869; Macdonald FR, 2010, DIABETES OBES METAB, V12, P1004, DOI 10.1111/j.1463-1326.2010.01291.x; Matsushita Y, 2011, DIABETES, V60, P960, DOI 10.2337/db10-1361; Nagata T, 2013, BRIT J PHARMACOL, V170, P519, DOI 10.1111/bph.12269; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Ogawa D, 2011, EXP DIABETES RES, DOI 10.1155/2011/534872; Ohga S, 2007, AM J PHYSIOL-RENAL, V292, pF1141, DOI 10.1152/ajprenal.00288.2005; Okada S, 2003, DIABETES, V52, P2586, DOI 10.2337/diabetes.52.10.2586; Plosker GL, 2012, DRUGS, V72, P2289, DOI 10.2165/11209910-000000000-00000; Tachibana H, 2012, J AM SOC NEPHROL, V23, P1835, DOI 10.1681/ASN.2012010022; Tahara A, 2013, EUR J PHARMACOL, V715, P246, DOI 10.1016/j.ejphar.2013.05.014; Vallon V, 2013, AM J PHYSIOL-RENAL, V304, pF156, DOI 10.1152/ajprenal.00409.2012; Vlassara H, 2012, J GERONTOL A-BIOL, V67, P1410, DOI 10.1093/gerona/gls195; Whaley JM, 2012, DIABET METAB SYND OB, V5, P135, DOI 10.2147/DMSO.S22503; Wright EM, 2001, AM J PHYSIOL-RENAL, V280, pF10, DOI 10.1152/ajprenal.2001.280.1.F10	30	210	229	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100777	10.1371/journal.pone.0100777	http://dx.doi.org/10.1371/journal.pone.0100777			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960177	Green Submitted, gold, Green Published			2022-12-25	WOS:000338633900084
J	Xiao, GH; Xia, CL; Yang, J; Liu, JQ; Du, HZ; Kang, XJ; Lin, YY; Guan, RH; Yan, PK; Tang, SS				Xiao, Guohong; Xia, Chenglai; Yang, Jie; Liu, Jianqiao; Du, Hongzi; Kang, Xiangjin; Lin, Yuyi; Guan, Ronghua; Yan, Pengke; Tang, Shengsong			MiR-133b Regulates the Expression of the Actin Protein TAGLN2 during Oocyte Growth and Maturation: A Potential Target for Infertility Therapy	PLOS ONE			English	Article							GENE-EXPRESSION; MICRORNAS; PROLIFERATION; CELLS	Infertility is an area of increasing in life science research. Although follicular maturation disorders and anovulation are the primary causations of infertility, its molecular mechanism is not well understood. Recent research has shown that microRNAs (miRNAs) might play an important role in the regulation of ovarian follicle development and maturation. In this study, the expression of miRNAs in metaphase I (MI) oocytes treated with or without insulin-like growth factor 1 (IGF-1) was observed by microRNA microarray analysis. Results show that 145 miRNAs were up-regulated and 200 miRNAs were down-regulated in MI oocytes after IGF-1 treatment. MiR-133b, which was up-regulated more than 30-fold, was chosen for further research. As a potential target of miR133b, transgelin 2 (TAGLN2) gene was down-regulated, at both transcription and translation levels, in miR-133b- over-expressed 293T cells, but TAGLN2 was up-regulated when the expression of miR-133b was inhibited. Furthermore, the expression level of TAGLN2 in the ovaries of 8-week-old mice was higher than that observed in 4-week-old mice. Immunofluorescence experiments showed that TAGLN2 was located in the cytoplasm. In general, our results indicate that miR-133b may play important roles in the growth and maturation of oocytes by regulating its potential target, TAGLN2, at both transcription and translation levels. Therefore, our research provides a potential new target for infertility therapy.	[Xiao, Guohong; Tang, Shengsong] Univ South China, Dept Pathol, Hengyang, Peoples R China; [Xiao, Guohong; Xia, Chenglai; Yang, Jie; Liu, Jianqiao; Du, Hongzi; Kang, Xiangjin; Lin, Yuyi; Guan, Ronghua; Yan, Pengke] Guangzhou Med Univ, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Xiao, Guohong; Yang, Jie; Liu, Jianqiao; Du, Hongzi; Kang, Xiangjin; Lin, Yuyi; Guan, Ronghua] Guangdong Prov Key Lab Reprod Med, Guangzhou, Guangdong, Peoples R China; [Tang, Shengsong] Hunan Univ Arts & Sci, Ctr Life Sci, Changde, Peoples R China	University of South China; Guangzhou Medical University; Hunan University of Arts & Science	Tang, SS (corresponding author), Univ South China, Dept Pathol, Hengyang, Peoples R China.	tangss111@163.com			Technology Innovation Platform in Hunan [09K072, 12K120]	Technology Innovation Platform in Hunan	This study was supported by Open Fund of Technology Innovation Platform in Hunan (No. 09K072, 12K120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assou S, 2013, HUM REPROD, V28, P3038, DOI 10.1093/humrep/det321; Bachelot A, 2002, ENDOCRINOLOGY, V143, P4104, DOI 10.1210/en.2002-220087; Carletti MZ, 2010, BIOL REPROD, V83, P286, DOI 10.1095/biolreprod.109.081448; Chang RJ, 2013, MOL CELL ENDOCRINOL, V373, P51, DOI 10.1016/j.mce.2012.07.011; Coyral-Castel S, 2012, THERIOGENOLOGY, V77, P1822, DOI 10.1016/j.theriogenology.2011.12.028; da Silveira Juliano C, 2012, Biol Reprod, V86, P71, DOI 10.1095/biolreprod.111.093252; Dai AY, 2013, FEBS LETT, V587, P2474, DOI 10.1016/j.febslet.2013.06.023; Hennebold JD, 2004, HUM REPROD UPDATE, V10, P227, DOI 10.1093/humupd/dmh017; Hidalgo GD, 2011, FERTIL STERIL, V96, P700, DOI 10.1016/j.fertnstert.2011.06.052; HWANG HW, 2007, BRIT J CANCER, V94, P776; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Kim YJ, 2013, HUM REPROD, V28, P3050, DOI 10.1093/humrep/det338; Lehrbach NJ, 2012, RNA, V18, P2220, DOI 10.1261/rna.035402.112; Lei L, 2010, MOL CELL ENDOCRINOL, V315, P63, DOI 10.1016/j.mce.2009.09.021; Li XJ, 2010, J REPROD CONTRACEPTI, V21, P27; Liang M, 2013, MOL CELL ENDOCRINOL, V370, P119, DOI 10.1016/j.mce.2013.02.014; Luense LJ, 2009, TRENDS ENDOCRIN MET, V20, P265, DOI 10.1016/j.tem.2009.05.001; Ma XH, 2006, J BIOL CHEM, V281, P9351, DOI 10.1074/jbc.M511512200; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Nogueira D, 2012, SEMIN REPROD MED, V30, P199, DOI 10.1055/s-0032-1311522; Nohata N, 2011, ONCOTARGET, V2, P29; Otsuka M, 2008, J CLIN INVEST, V118, P1944, DOI 10.1172/JCI33680; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Panguluri SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008760; Sohel MMH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078505; Sucharov C, 2008, J MOL CELL CARDIOL, V45, P185, DOI 10.1016/j.yjmcc.2008.04.014; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Velazquez MA, 2012, THERIOGENOLOGY, V78, P517, DOI 10.1016/j.theriogenology.2012.02.034; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Xu YW, 2011, J ASSIST REPROD GEN, V28, P559, DOI 10.1007/s10815-011-9590-0; Yang SH, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.107730; Yao GD, 2010, MOL ENDOCRINOL, V24, P540, DOI 10.1210/me.2009-0432; Zhang Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054250, 10.1371/journal.pone.0059667]	34	29	34	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100751	10.1371/journal.pone.0100751	http://dx.doi.org/10.1371/journal.pone.0100751			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959893	gold, Green Published, Green Submitted			2022-12-25	WOS:000338633900081
J	Gopalan, TK; Gururaj, P; Gupta, R; Gopal, DR; Rajesh, P; Chidambaram, B; Kalyanasundaram, A; Angamuthu, R				Gopalan, Tirumurugaan Krishnaswamy; Gururaj, Pradheepa; Gupta, Ravi; Gopal, Dhinakar Raj; Rajesh, Preeti; Chidambaram, Balachandran; Kalyanasundaram, Aravindan; Angamuthu, Raja			Transcriptome Profiling Reveals Higher Vertebrate Orthologous of Intra-Cytoplasmic Pattern Recognition Receptors in Grey Bamboo Shark	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; SEQUENCING TECHNOLOGIES; RNA; ULTRAFAST; EVOLUTION; GENOME	From an immunologist perspective, sharks are an important group of jawed cartilaginous fishes and survey of the public database revealed a great gap in availability of large-scale sequence data for the group of Chondrichthyans the elasmobranchs. In an attempt to bridge this deficit we generated the transcriptome from the spleen and kidney tissues (a total of 1,606,172 transcripts) of the shark, Chiloscyllium griseum using the Illumina HiSeq2000 platform. With a cut off of > = 300 bp and an expression value of >1RPKM we used 43,385 transcripts for BLASTX analysis which revealed 17,548 transcripts matching to the NCBI nr database with an E-value of <=10(-5) and similarity score of 40%. The longest transcript was 16,974 bases with matched to HECT domain containing E3 ubiqutin protein ligase. MEGAN4 annotation pipeline revealed immune and signalling pathways including cell adhesion molecules, cytokine-cytokine receptor interaction, T-cell receptor signalling pathway and chemokine signaling pathway to be highly expressed in spleen, while different metabolism pathways such as amino acid metabolism, carbohydrate metabolism, lipid metabolism and xenobiotic biodegradation were highly expressed in kidney. Few of the candidate genes were selected to analyze their expression levels in various tissues by real-time PCR and also localization of a receptor by in-situ PCR to validate the prediction. We also predicted the domains structures of some of the identified pattern recognition receptors, their phylogenetic relationship with lower and higher vertebrates and the complete downstream signaling mediators of classical dsRNA signaling pathway. The generated transcriptome will be a valuable resource to further genetic and genomic research in elasmobranchs.	[Gopalan, Tirumurugaan Krishnaswamy; Gururaj, Pradheepa; Gopal, Dhinakar Raj; Kalyanasundaram, Aravindan; Angamuthu, Raja] Tamil Nadu Vet & Anim Sci Univ, Dept Anim Biotechnol, Madras, Tamil Nadu, India; [Gopalan, Tirumurugaan Krishnaswamy; Gopal, Dhinakar Raj] Tamil Nadu Vet & Anim Sci Univ, Madras, Tamil Nadu, India; [Gupta, Ravi; Rajesh, Preeti] SciGenom Labs Pvt Ltd, Cochin, Kerala, India; [Chidambaram, Balachandran] Tamil Nadu Vet & Anim Sci Univ, Dept Vet Pathol, Madras, Tamil Nadu, India	Tamil Nadu Veterinary & Animal Sciences University; Tamil Nadu Veterinary & Animal Sciences University; Tamil Nadu Veterinary & Animal Sciences University	Gopal, DR (corresponding author), Tamil Nadu Vet & Anim Sci Univ, Dept Anim Biotechnol, Madras, Tamil Nadu, India.	dhinakarrajg@tanvuas.org.in	Angamuthu, Raja/AAG-6357-2020; Gopal, DHinakar Raj/AAE-4411-2020; Kalyanasundaram, Aravindan/AAC-3500-2021	Gopal, Dhinakar Raj/0000-0003-0254-926X; Kalyanasundaram, Aravindan/0000-0001-6301-4328	ICAR-NAIP [C30018]	ICAR-NAIP(Indian Council of Agricultural Research (ICAR))	The authors thank ICAR-NAIP for funding this study (C30018) and TANUVAS for all facilities to carry out his work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandhakumar C, 2012, FISH SHELLFISH IMMUN, V33, P1174, DOI 10.1016/j.fsi.2012.09.007; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baoprasertkul P, 2006, IMMUNOGENETICS, V58, P817, DOI 10.1007/s00251-006-0144-z; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CARROLL RL, 1988, VERTEBRATE PALEONTOL; Chen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036256; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Feldmeyer B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-317; Flajnik MF, 2000, CURR TOP MICROBIOL, V248, P249; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Hao DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021220; Hazon N, 2003, COMP BIOCHEM PHYS B, V136, P685, DOI 10.1016/S1096-4959(03)00280-X; Hertzano R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002309; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Inoue J, 2010, SYST BIOL, V59, P74, DOI 10.1093/sysbio/syp078; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Litman GW, 2010, NAT REV IMMUNOL, V10, P543, DOI 10.1038/nri2807; Litman GF, 1999, ANNU REV IMMUNOL, V17, P109, DOI 10.1146/annurev.immunol.17.1.109; Mattingly C, 2004, ZEBRAFISH, V1, P111, DOI 10.1089/zeb.2004.1.111; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Phelan PE, 2005, MOL IMMUNOL, V42, P1057, DOI 10.1016/j.molimm.2004.11.005; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Rodriguez MF, 2005, IMMUNOGENETICS, V57, P510, DOI 10.1007/s00251-005-0013-1; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Swathi A, 2013, J MOL MODEL, V19, P3863, DOI 10.1007/s00894-013-1871-3; Takechi M, 2011, J EXP ZOOL PART B, V316B, P526, DOI 10.1002/jez.b.21427; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tirumurugaan KG, 2010, VET IMMUNOL IMMUNOP, V133, P296, DOI 10.1016/j.vetimm.2009.08.015; Tsuboi N, 2002, J IMMUNOL, V169, P2026, DOI 10.4049/jimmunol.169.4.2026; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang W, 2013, J ZHEJIANG UNIV-SC B, V14, P58, DOI 10.1631/jzus.B1200219; Wheat CW, 2011, METHODS MOL BIOL, V772, P129, DOI 10.1007/978-1-61779-228-1_7; Zhang J., 2012, FUNCTIONAL GENOMICS	41	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100018	10.1371/journal.pone.0100018	http://dx.doi.org/10.1371/journal.pone.0100018			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956167	gold, Green Published, Green Submitted			2022-12-25	WOS:000338917900024
J	Sanford, JL; Barski, SA; Seen, CM; Dickens, JC; Shields, VDC				Sanford, Jillian L.; Barski, Sharon A.; Seen, Christina M.; Dickens, Joseph C.; Shields, Vonnie D. C.			Neurophysiological and Behavioral Responses of Gypsy Moth Larvae to Insect Repellents: DEET, IR3535, and Picaridin	PLOS ONE			English	Article							LYMANTRIA-DISPAR L.; AEDES-AEGYPTI; MOSQUITO REPELLENTS; LEPIDOPTERA LYMANTRIIDAE; SPECIALIST HERBIVORES; CELLULAR BASIS; BITTER TASTE; DETERRENT; RECEPTOR; GENERALIST	The interactions between insect repellents and the olfactory system have been widely studied, however relatively little is known about the effects of repellents on the gustatory system of insects. In this study, we show that the gustatory receptor neuron (GRN) located in the medial styloconic sensilla on the maxillary palps of gypsy moth larvae, and known to be sensitive to feeding deterrents, also responds to the insect repellents DEET, IR3535, and picaridin. These repellents did not elicit responses in the lateral styloconic sensilla. Moreover, behavioral studies demonstrated that each repellent deterred feeding. This is the first study to show perception of insect repellents by the gustatory system of a lepidopteran larva and suggests that detection of a range of bitter or aversive compounds may be a broadly conserved feature among insects.	[Sanford, Jillian L.; Barski, Sharon A.; Seen, Christina M.; Shields, Vonnie D. C.] Towson Univ, Dept Biol Sci, Insect Morphol & Physiol Lab, Towson, MD 21252 USA; [Dickens, Joseph C.] ARS, USDA, Henry A Wallace Beltsville Agr Res Ctr, Invas Insect Biocontrol & Behav Lab, Beltsville, MD USA	University System of Maryland; Towson University; United States Department of Agriculture (USDA)	Shields, VDC (corresponding author), Towson Univ, Dept Biol Sci, Insect Morphol & Physiol Lab, Towson, MD 21252 USA.	vshields@towson.edu	Dickens, Dick/AGY-7295-2022		Towson University Graduate Student Association; NIH [1R15DC007609-01, 2R25GM058264-05A1]; Deployed War Fighter Protection (DWFP) Program - Department of Defense through the Armed Forces Pest Management Board (AFPMB); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R15DC007609] Funding Source: NIH RePORTER	Towson University Graduate Student Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deployed War Fighter Protection (DWFP) Program - Department of Defense through the Armed Forces Pest Management Board (AFPMB); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants to J.L.S. (Towson University Graduate Student Association), and V. D. C. S. (NIH 1R15DC007609-01). S. B. and C. S. were supported by NIH grant 2R25GM058264-05A1. J.C.D. was supported partly by a grant from the Deployed War Fighter Protection (DWFP) Program funded by the Department of Defense through the Armed Forces Pest Management Board (AFPMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard DR, 2004, J MED ENTOMOL, V41, P726, DOI 10.1603/0022-2585-41.4.726; BARZEEV M, 1959, J ECON ENTOMOL, V52, P268, DOI 10.1093/jee/52.2.268; Bernays EA, 2000, J COMP PHYSIOL A, V186, P13, DOI 10.1007/s003590050002; Bohbot JD, 2011, MED VET ENTOMOL, V25, P436, DOI 10.1111/j.1365-2915.2011.00949.x; Brown M, 1997, J AM ACAD DERMATOL, V36, P243, DOI 10.1016/S0190-9622(97)70289-5; Descoins C, 1999, J INSECT PHYSIOL, V45, P871, DOI 10.1016/S0022-1910(99)00057-8; Dickens JC, 2013, PESTIC BIOCHEM PHYS, V106, P149, DOI 10.1016/j.pestbp.2013.02.006; Dyer LA, 2003, J CHEM ECOL, V29, P2499, DOI 10.1023/A:1026310001958; Glendinning JI, 1997, J NEUROPHYSIOL, V78, P734, DOI 10.1152/jn.1997.78.2.734; Glendinning JI, 2006, J NEUROSCI, V26, P8900, DOI 10.1523/JNEUROSCI.2351-06.2006; HODGSON ES, 1955, SCIENCE, V122, P417, DOI 10.1126/science.122.3166.417-a; Katz TM, 2008, J AM ACAD DERMATOL, V58, P865, DOI 10.1016/j.jaad.2007.10.005; Klun JA, 2006, J MED ENTOMOL, V43, P34, DOI 10.1603/0022-2585(2006)043[0034:RADEOS]2.0.CO;2; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Licciardi S, 2006, MED VET ENTOMOL, V20, P288, DOI 10.1111/j.1365-2915.2006.00630.x; LIEBHOLD AM, 1995, FOREST SCI, V41, P1; Martin TL, 2012, ARTHROPOD-PLANT INTE, V6, P519, DOI 10.1007/s11829-012-9209-0; Martin TL, 2012, ARTHROPOD-PLANT INTE, V6, P259, DOI 10.1007/s11829-012-9183-6; Natarajan R, 2005, PEST MANAG SCI, V61, P1193, DOI 10.1002/ps.1116; Park BS, 2002, CROP PROT, V21, P249, DOI 10.1016/S0261-2194(01)00079-5; Rharrabe K, 2011, ENTOMOL EXP APPL, V138, P33, DOI 10.1111/j.1570-7458.2010.01068.x; Richards LA, 2010, J CHEM ECOL, V36, P1105, DOI 10.1007/s10886-010-9852-9; Sanford JL, 2013, NATURWISSENSCHAFTEN, V100, P269, DOI 10.1007/s00114-013-1021-x; SCHOONHOVEN L. M., 1966, ARCH NEER ZOOL, V16, P497; SCHOONHOVEN LM, 1994, J COMP PHYSIOL A, V175, P519; Shields VDC, 2006, NATURWISSENSCHAFTEN, V93, P127, DOI 10.1007/s00114-005-0070-1; SHIELDS VDC, 1995, PHILOS T R SOC B, V347, P447, DOI 10.1098/rstb.1995.0036; Shields VDC, 2003, ANN ENTOMOL SOC AM, V96, P920, DOI 10.1603/0013-8746(2003)096[0920:HSAAOS]2.0.CO;2; Shields VDC, 2008, ARTHROPOD-PLANT INTE, V2, P101, DOI 10.1007/s11829-008-9035-6; Shields VDC, 2009, ANN ENTOMOL SOC AM, V102, P1116, DOI 10.1603/008.102.0621; Sokal R.R., 2012, BIOMETRY PRINCIPLES; Sparks JT, 2013, INSECT BIOCHEM MOLEC, V43, P1161, DOI 10.1016/j.ibmb.2013.10.005; Tavares WS, 2011, J MED PLANTS RES, V5, P5301; van Loon JJA, 1999, ENTOMOL EXP APPL, V91, P29, DOI 10.1046/j.1570-7458.1999.00463.x; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105; Zhou DS, 2010, J COMP PHYSIOL A, V196, P791, DOI 10.1007/s00359-010-0558-9	38	5	5	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99924	10.1371/journal.pone.0099924	http://dx.doi.org/10.1371/journal.pone.0099924			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955823	Green Submitted, Green Published, gold			2022-12-25	WOS:000338917900021
J	Yoo, JY; Shin, H; Kim, TH; Choi, WS; Ferguson, SD; Fazleabas, AT; Young, SL; Lessey, BA; Ha, UH; Jeong, JW				Yoo, Jung-Yoon; Shin, Heesung; Kim, Tae Hoon; Choi, Won-Seok; Ferguson, Susan D.; Fazleabas, Asgerally T.; Young, Steven L.; Lessey, Bruce A.; Ha, Un-Hwan; Jeong, Jae-Wook			CRISPLD2 Is a Target of Progesterone Receptor and Its Expression Is Decreased in Women with Endometriosis	PLOS ONE			English	Article							MOUSE UTERUS; GENE-EXPRESSION; BRANCHING MORPHOGENESIS; REPRODUCTIVE FUNCTIONS; SIGNAL TRANSDUCER; PERITONEAL-FLUID; EPITHELIAL-CELLS; PAPIO-ANUBIS; IMPLANTATION; INFLAMMATION	Endometriosis, defined as the presence of endometrial cells outside of the uterine cavity, is a major cause of infertility and pelvic pain, afflicting more than 10% of reproductive age women. Endometriosis is a chronic inflammatory disease and lipopolysaccharide promotes the proliferation and invasion of endometriotic stromal cells. Cysteine-rich secretory protein LCCL domain-containing 2 (CRISPLD2) has high affinity for lipopolysaccharide and plays a critical role in defense against endotoxin shock. However, the function of CRISPLD2 has not been studied in endometriosis and uterine biology. Herein, we examined the expression of CRISPLD2 in endometrium from patients with and without endometriosis using immunohistochemistry. The expression of CRISPLD2 was higher in the secretory phase in human menstrual cycle compared to proliferative phase. The expression of CRISPLD2 was significantly decreased in the endometrium of women with endometriosis in the early secretory phase compared to women without endometriosis. The increase of CRISPLD2 expression at the early secretory and dysregulation of its expression in endometriosis suggest progesterone (P4) regulation of CRISPLD2. To investigate whether CRISPLD2 is regulated by P4, we examined the expression of the CRISPLD2 in the uteri of wild-type and progesterone receptor knock out (PRKO) mice. The expression of CRISPLD2 was significantly increased after P4 treatment in the wild-type mice. However, CRISPLD2 expression was significantly decreased in the (PRKO) mice treated with P4. During early pregnancy, the expression of CRISPLD2 was increased in decidua of implantation and postimplantation stages. CRISPLD2 levels were also increased in cultured human endometrial stromal cells during in vitro decidualization. These results suggest that the CRISPLD2 is a target of the progesterone receptor and may play an important role in pathogenesis of endometriosis.	[Yoo, Jung-Yoon; Shin, Heesung; Kim, Tae Hoon; Ferguson, Susan D.; Fazleabas, Asgerally T.; Jeong, Jae-Wook] Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, Coll Human Med, Grand Rapids, MI USA; [Shin, Heesung; Ha, Un-Hwan] Korea Univ, Dept Biotechnol & Bioinformat, Sejong, South Korea; [Choi, Won-Seok] Korea Natl Univ Transportat, Dept Food Sci & Technol, Chungbuk, South Korea; [Young, Steven L.] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC USA; [Lessey, Bruce A.] Greenville Hosp Syst, Univ Med Grp, Dept Obstet & Gynecol, Greenville, SC USA	Michigan State University; Michigan State University College of Human Medicine; Korea University; Korea National University of Transportation; University of North Carolina; University of North Carolina Chapel Hill; Greenville Health System	Ha, UH (corresponding author), Korea Univ, Dept Biotechnol & Bioinformat, Sejong, South Korea.	haunhwan@korea.ac.kr; JaeWook.Jeong@hc.msu.edu	Ha, Un-Hwan/ABH-8017-2020; Young, Steven L/G-2304-2014	Young, Steven L/0000-0002-5205-4495; Ha, Un-Hwan/0000-0001-9182-7000; Yoo, Jung-Yoon/0000-0001-9366-3863	NIH [R01 HD067721, R01 HD057873]; American Cancer Society [RSG-12-084-01-TBG]; Converging Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2013K000249]; BK21 plus program of the Ministry of Education, Korea; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067721] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Converging Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; BK21 plus program of the Ministry of Education, Korea; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NIH R01 HD067721 (to SLY and BAL), NIH R01 HD057873 and American Cancer Society Research Grant RSG-12-084-01-TBG (to JWJ), and the Converging Research Center Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (No. 2013K000249), and the BK21 plus program of the Ministry of Education, Korea (to UHH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar Y, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104497; Aisemberg J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056161; Al-Sabbagh M, 2012, MOL CELL ENDOCRINOL, V358, P208, DOI 10.1016/j.mce.2011.10.035; Attia GR, 2000, J CLIN ENDOCR METAB, V85, P2897, DOI 10.1210/jc.85.8.2897; BOUTTEN A, 1992, CLIN CHIM ACTA, V210, P187, DOI 10.1016/0009-8981(92)90204-4; Bruner-Tran K L, 2013, Minerva Ginecol, V65, P199; Bulun SE, 2006, MOL CELL ENDOCRINOL, V248, P94, DOI 10.1016/j.mce.2005.11.041; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Burney RO, 2007, ENDOCRINOLOGY, V148, P3814, DOI 10.1210/en.2006-1692; Burney RO, 2007, ENDOCRINOLOGY; BUYALOS RP, 1992, FERTIL STERIL, V58, P302; Chiquet BT, 2007, HUM MOL GENET, V16, P2241, DOI 10.1093/hmg/ddm176; CLARKE CL, 1990, ENDOCR REV, V11, P266, DOI 10.1210/edrv-11-2-266; Conneely OM, 2002, RECENT PROG HORM RES, V57, P339, DOI 10.1210/rp.57.1.339; Conneely OM, 2001, MOL CELL ENDOCRINOL, V179, P97, DOI 10.1016/S0303-7207(01)00465-8; Conneely Orla M, 2002, Rev Endocr Metab Disord, V3, P201, DOI 10.1023/A:1020020308980; Daftary GS, 2004, J CLIN ENDOCR METAB, V89, P2390, DOI 10.1210/jc.2003-031389; Dekel N, 2010, AM J REPROD IMMUNOL, V63, P17, DOI 10.1111/j.1600-0897.2009.00792.x; Dimitriadis E, 2006, J REPROD IMMUNOL, V69, P53, DOI 10.1016/j.jri.2005.07.004; Eskenazi B, 1997, OBSTET GYN CLIN N AM, V24, P235, DOI 10.1016/S0889-8545(05)70302-8; Evans J, 2013, BIOL REPROD; Evans J, 2012, REV ENDOCR METAB DIS, V13, P277, DOI 10.1007/s11154-012-9223-7; Filant J, 2014, FASEB J, V28, P230, DOI 10.1096/fj.13-237446; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Greer S, 2013, J PHARMACOL EXP THER, V346, P473, DOI 10.1124/jpet.113.206284; GROSSKINSKY CM, 1993, BAILLIERE CLIN OB GY, V7, P701, DOI 10.1016/S0950-3552(05)80459-6; HALME J, 1984, OBSTET GYNECOL, V64, P151; Hardy DB, 2006, MOL ENDOCRINOL, V20, P2724, DOI 10.1210/me.2006-0112; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; HUETHUDSON YM, 1989, ENDOCRINOLOGY, V125, P1683, DOI 10.1210/endo-125-3-1683; Kao LC, 2003, ENDOCRINOLOGY, V144, P2870, DOI 10.1210/en.2003-0043; Kaplan F, 1999, AM J PHYSIOL-LUNG C, V276, pL1027, DOI 10.1152/ajplung.1999.276.6.L1027; Kaunitz AM, 1998, INT J FERTIL WOMEN M, V43, P73; Kim JJ, 2007, MOL HUM REPROD, V13, P323, DOI 10.1093/molehr/gam005; Kim JJ, 1998, BIOL REPROD, V59, P160, DOI 10.1095/biolreprod59.1.160; Kim TH, 2010, BIOL REPROD, V82, P706, DOI 10.1095/biolreprod.109.081307; KISTNER RW, 1958, AM J OBSTET GYNECOL, V75, P264, DOI 10.1016/0002-9378(58)90384-3; Kobayashi H, 2014, MOL MED REP, V9, P9, DOI 10.3892/mmr.2013.1755; Kundu JK, 2008, MUTAT RES-REV MUTAT, V659, P15, DOI 10.1016/j.mrrev.2008.03.002; Kurihara I, 2007, PLOS GENET, V3, P1053, DOI 10.1371/journal.pgen.0030102; Lan J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-83; Lee CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075282; Lee JH, 2013, FASEB J, V27, P2553, DOI 10.1096/fj.12-225664; Lee K, 2006, NAT GENET, V38, P1204, DOI 10.1038/ng1874; Lee KY, 2004, REPRODUCTION, V128, P679, DOI 10.1530/rep.1.00340; Liu TY, 2002, BIOL REPROD, V67, P114, DOI 10.1095/biolreprod67.1.114; Lydon JP, 1996, J STEROID BIOCHEM, V56, P67, DOI 10.1016/0960-0760(95)00254-5; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MARTIN L, 1973, J ENDOCRINOL, V56, P133, DOI 10.1677/joe.0.0560133; MARTIN L, 1973, J ENDOCRINOL, V57, P549, DOI 10.1677/joe.0.0570549; Minici F, 2008, HUM REPROD, V23, P530, DOI 10.1093/humrep/dem399; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; OLIVE DL, 1993, NEW ENGL J MED, V328, P1759, DOI 10.1056/NEJM199306173282407; Olive DL, 2004, BEST PRACT RES CL OB, V18, P319, DOI 10.1016/j.bpobgyn.2004.03.005; Oyewumi L, 2003, BIOCHEM J, V376, P61, DOI 10.1042/BJ20030591; Oyewumi L, 2003, AM J RESP CELL MOL, V28, P232, DOI 10.1165/rcmb.4877; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; Pellicer A, 1998, FERTIL STERIL, V70, P425, DOI 10.1016/S0015-0282(98)00204-0; Rubel CA, 2012, MOL ENDOCRINOL, V26, P1428, DOI 10.1210/me.2011-1355; Rubel CA, 2010, SEMIN REPROD MED, V28, P27, DOI 10.1055/s-0029-1242990; Sinaii N, 2002, HUM REPROD, V17, P2715, DOI 10.1093/humrep/17.10.2715; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Tabibzadeh S, 2000, J CLIN ENDOCR METAB, V85, P2526, DOI 10.1210/jc.85.7.2526; Vasarhelyi V, 2013, BIOCHIMIE; von Wolff M, 2000, MOL HUM REPROD, V6, P627; Wang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065743; Wang YX, 2013, P NATL ACAD SCI USA, V110, P16975, DOI 10.1073/pnas.1315862110; Wang ZQ, 2009, J IMMUNOL, V183, P6646, DOI 10.4049/jimmunol.0802348; Wetendorf M, 2012, MOL CELL ENDOCRINOL, V357, P108, DOI 10.1016/j.mce.2011.10.028; Yang SJ, 2002, J CLIN ENDOCR METAB, V87, P2336, DOI 10.1210/jc.87.5.2336; Yuan QP, 2012, GENESIS, V50, P871, DOI 10.1002/dvg.22051	72	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100481	10.1371/journal.pone.0100481	http://dx.doi.org/10.1371/journal.pone.0100481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955763	gold, Green Published, Green Submitted			2022-12-25	WOS:000338917900056
J	Cianci, F; Sweeney, S; Konate, I; Nagot, N; Low, A; Mayaud, P; Vickerman, P				Cianci, Fiona; Sweeney, Sedona; Konate, Issouf; Nagot, Nicolas; Low, Andrea; Mayaud, Philippe; Vickerman, Peter			The Cost of Providing Combined Prevention and Treatment Services, Including ART, to Female Sex Workers in Burkina Faso	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV PREVENTION; COMMERCIAL SEX; HIGH-RISK; CARE; HEALTH; INTERVENTIONS; TRANSMISSION; EQUIVALENCE; POPULATIONS	Background: Female Sex workers (FSW) are important in driving HIV transmission in West Africa. The Yerelon clinic in Burkina Faso has provided combined preventative and therapeutic services, including anti-retroviral therapy (ART), for FSWs since 1998, with evidence suggesting it has decreased HIV prevalence and incidence in this group. No data exists on the costs of such a combined prevention and treatment intervention for FSW. This study aims to determine the mean cost of service provision per patient year for FSWs attending the Yerelon clinic, and identifies differences in costs between patient groups. Methods: Field-based retrospective cost analyses were undertaken using top-down and bottom-up costing approaches for 2010. Expenditure and service utilisation data was collated from primary sources. Patients were divided into groups according to full-time or occasional sex-work, HIV status and ART duration. Patient specific service use data was extracted. Costs were converted to 2012 US$. Sensitivity analyses considered removal of all research costs, different discount rates and use of different ART treatment regimens and follow-up schedules. Results: Using the top-down costing approach, the mean annual cost of service provision for FSWs on or off ART was US$1098 and US$882, respectively. The cost for FSWs on ART reduced by 29%, to US$781, if all research-related costs were removed and national ART monitoring guidelines were followed. The bottom-up patient-level costing showed the cost of the service varied greatly across patient groups (US$505-US$1117), primarily due to large differences in the costs of different ART regimens. HIV-negative women had the lowest annual cost at US$505. Conclusion: Whilst FSWs may require specialised services to optimise their care and hence, the public health benefits, our study shows that the cost of ART provision within a combined prevention and treatment intervention setting is comparable to providing ART to other population groups in Africa.	[Cianci, Fiona; Sweeney, Sedona; Vickerman, Peter] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, Social & Math Epidemiol Grp, London WC1, England; [Konate, Issouf] UR VIH MA, Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Nagot, Nicolas; Low, Andrea] INSERM, U1058, Montpellier, France; [Nagot, Nicolas; Low, Andrea] Univ Montpellier I, Montpellier, France; [Mayaud, Philippe] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Vickerman, Peter] Univ Bristol, Dept Social & Community Med, Bristol, Avon, England	University of London; London School of Hygiene & Tropical Medicine; Centre Muraz; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; University of London; London School of Hygiene & Tropical Medicine; University of Bristol	Cianci, F (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, Social & Math Epidemiol Grp, London WC1, England.	fionacianci@yahoo.com	Nagot, Nicolas/I-9467-2014	Vickerman, Peter/0000-0002-8291-5890; Low, Andrea/0000-0002-7088-4556; MAYAUD, Philippe/0000-0001-5730-947X; Nagot, Nicolas/0000-0002-3493-2821				Alary M, 2004, AIDS, V18, P945, DOI 10.1097/00002030-200404090-00013; Alary M, 2002, AIDS, V16, P463, DOI 10.1097/00002030-200202150-00019; [Anonymous], UNAIDS COUNTR REP; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; BCEAO, 2012, TAUX INT BCEAO; Bikilla Asfaw Demissie, 2009, Cost Eff Resour Alloc, V7, P6, DOI 10.1186/1478-7547-7-6; Burgos Jose L, 2010, PLoS One, V5, pe11413, DOI 10.1371/journal.pone.0011413; Chakrapani V, 2009, AIDS PATIENT CARE ST, V23, P973, DOI 10.1089/apc.2009.0035; Chandrashekar S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S7; Chapko MK, 2009, HEALTH ECON, V18, P1188, DOI 10.1002/hec.1422; CNLS, 2011, ENQ SURV COMP AUPR G; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cote AM, 2004, AIDS, V18, P917, DOI [10.1097/01.aids.0000111475.61782.98, 10.1097/00002030-200404090-00009]; Creese A, 1994, COST ANAL PRIMARY HL; Deghaye N, 2006, SAMJ S AFR MED J, V96, P140; Drummond M.F., 2015, METHODS EC EVALUATIO; Fung ICH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-195; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Granich R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030216; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Halbwachs H, 2000, Health Estate, V54, P26; Harling G, 2007, SAMJ S AFR MED J, V97, P593; HOGAN DR, 2005, BRIT MED J, V331, P1431, DOI DOI 10.1136/BMJ.38643.368692.68; Hounton SH, 2008, AIDS CARE, V20, P582, DOI 10.1080/09540120701868303; Huet Charlotte, 2011, BMC Public Health, V11, P700, DOI 10.1186/1471-2458-11-700; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Jia ZW, 2013, LANCET, V382, P1195, DOI 10.1016/S0140-6736(12)61898-4; Jouquet G, 2011, JAIDS-J ACQ IMM DEF, V58, pE68, DOI 10.1097/QAI.0b013e31822a9f8d; Konate I, 2011, JAIDS-J ACQ IMM DEF, V57, pS50, DOI 10.1097/QAI.0b013e3182207a3f; Loubiere S, 2010, CURR OPIN HIV AIDS, V5, P225, DOI 10.1097/COH.0b013e3283384a9d; Low AJ, 2014, JAIDS-J ACQ IMM DEF, V65, P237, DOI 10.1097/QAI.0000000000000049; Lowndes CM, 2000, AIDS, V14, P2523, DOI 10.1097/00002030-200011100-00015; Martinson N, 2009, JAIDS-J ACQ IMM DEF, V50, P327, DOI 10.1097/QAI.0b013e3181958546; Menzies NA, 2011, AIDS, V25, P1753, DOI 10.1097/QAD.0b013e3283463eec; Modjarrad K, 2008, AIDS, V22, P2179, DOI 10.1097/QAD.0b013e328312c756; Montague BT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-701; National Institute of Drug Abuse, 2012, 2012 MTF SURV; Prinja S, 2011, SEX TRANSM INFECT, V87, P354, DOI 10.1136/sti.2010.047829; Rosen S, 2008, TROP MED INT HEALTH, V13, P1005, DOI 10.1111/j.1365-3156.2008.02114.x; Rosen S, 2008, JAIDS-J ACQ IMM DEF, V48, P334, DOI 10.1097/QAI.0b013e31817ae5ef; Tagar E SM, 2012, MULTICOUNTRY ANAL TR; Terris-Prestholt F, 2011, GUIDELINES COST EFFE; UNAIDS, 2011, WORLD AIDS DAY REP 2; UNICEF, 2011, BURK FAS STAT; Vickerman P, 2010, AIDS, V24, P2554, DOI 10.1097/QAD.0b013e32833e8663; WHO, 2010, ANT THER HIV INF AD; WHO UNICEF & UNAIDS., 2011, UN ACC, P1; Yaya Bocum F KS, 2009, CARACTERISTIQUES REV	48	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100107	10.1371/journal.pone.0100107	http://dx.doi.org/10.1371/journal.pone.0100107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2UZ	24950185	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000338276300037
J	Gul, T; Islam, S; Shah, RA; Khan, I; Shafie, S				Gul, Taza; Islam, Saed; Shah, Rehan Ali; Khan, Ilyas; Shafie, Sharidan			Thin Film Flow in MHD Third Grade Fluid on a Vertical Belt with Temperature Dependent Viscosity	PLOS ONE			English	Article							HOMOTOPY ASYMPTOTIC METHOD; ADOMIAN DECOMPOSITION METHOD; PERTURBATION METHOD; RELIABLE TREATMENT; STARTING SOLUTIONS; CONVECTION FLOW; 2ND-GRADE FLUID; 3RD-GRADE FLUID; HEAT-TRANSFER; POROUS-MEDIUM	In this work, we have carried out the influence of temperature dependent viscosity on thin film flow of a magnetohydrodynamic (MHD) third grade fluid past a vertical belt. The governing coupled non-linear differential equations with appropriate boundary conditions are solved analytically by using Adomian Decomposition Method (ADM). In order to make comparison, the governing problem has also been solved by using Optimal Homotopy Asymptotic Method (OHAM). The physical characteristics of the problem have been well discussed in graphs for several parameter of interest.	[Gul, Taza; Islam, Saed] Abdul Wali Khan Univ Mardan, Dept Math, Mardan, Kpk, Pakistan; [Shah, Rehan Ali] UET Peshawar, Dept Math, Peshawar, Kpk, Pakistan; [Shafie, Sharidan] Majmaah Univ, Coll Engn, Majmaah, Saudi Arabia; [Khan, Ilyas] Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Utm Johor Bahru, Johor, Malaysia	Majmaah University; Universiti Teknologi Malaysia	Shafie, S (corresponding author), Majmaah Univ, Coll Engn, Majmaah, Saudi Arabia.	sharidan@utm.my	Gul, Taza/R-7774-2019; SHAFIE, SHARIDAN/A-2210-2013; Khan, Ilyas/C-8770-2019; Saeed, Islam/AAD-6067-2020	Gul, Taza/0000-0003-1376-8345; SHAFIE, SHARIDAN/0000-0001-7795-2278; Khan, Ilyas/0000-0002-2056-9371; Saeed, Islam/0000-0001-5263-4871	research Management center - UTM; MOE (Ministry of Education) [4F109, 04H27]; UTM	research Management center - UTM; MOE (Ministry of Education); UTM(University of Toronto)	The authors would like to acknowledge the research Management center - UTM and MOE (Ministry of Education) for the financial support through vote 4F109 & 04H27 for this research. Prof. S. Islam gratefully acknowledges the financial support of his visit provided by UTM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adomian G., 1994, SOLVING FRONTIER PRO; Adomian G, 1992, MATH COMPUT MODEL, V13, P287; Ali F, 2012, INT J NONLIN MECH, V47, P521, DOI 10.1016/j.ijnonlinmec.2011.09.027; Costa A, 2003, NONLINEAR PROC GEOPH, V10, P545, DOI 10.5194/npg-10-545-2003; Ellahi R, 2010, MATH COMPUT MODEL, V52, P1783, DOI 10.1016/j.mcm.2010.07.005; Fakhar K, 2008, APPL MATH COMPUT, V202, P376, DOI 10.1016/j.amc.2008.02.029; Fetecau C, 2006, INT J ENG SCI, V44, P788, DOI 10.1016/j.ijengsci.2006.04.010; Fetecau C, 2005, INT J ENG SCI, V43, P781, DOI 10.1016/j.ijengsci.2004.12.009; Fetecau C, 2013, Z NATURFORSCH A, V68, P659, DOI 10.5560/ZNA.2013-0041; Fetecau C, 2011, Z NATURFORSCH A, V66, P753, DOI 10.5560/ZNA.2011-0044; Gul T, 2013, J APPL MATH, DOI 10.1155/2013/707286; Hayat T, 2014, J THERMOPHYS HEAT TR, V28, P155, DOI 10.2514/1.T4113; Joneidi AA, 2009, INT COMMUN HEAT MASS, V36, P1082, DOI 10.1016/j.icheatmasstransfer.2009.06.021; Khaled ARA, 2004, INT J ENG SCI, V42, P509, DOI 10.1016/j.ijengsci.2003.08.005; Khan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090280; Liao S., 2003, PERTURBATION INTRO H, DOI 10.1201/9780203491164; Marinca V, 2008, CENT EUR J PHYS, V6, P648, DOI [10.2478/s11534-008-0061-x, 10.2478/S11534-008-0061-x]; Marinca V, 2008, INT COMMUN HEAT MASS, V35, P710, DOI 10.1016/j.icheatmasstransfer.2008.02.010; Marinca V, 2009, APPL MATH LETT, V22, P245, DOI 10.1016/j.aml.2008.03.019; Miladinova S, 2004, J NON-NEWTON FLUID, V122, P69, DOI 10.1016/j.jnnfm.2004.01.021; Nadeem S, 2008, PHYS LETT A, V372, P4965, DOI 10.1016/j.physleta.2008.05.048; Nazar M, 2010, NONLINEAR ANAL-REAL, V11, P584, DOI 10.1016/j.nonrwa.2008.10.055; Qasim M, 2013, ALEX ENG J, V52, P571, DOI 10.1016/j.aej.2013.08.004; Qasim M, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14007-5; Qasim M, 2012, Z NATURFORSCH A, V67, P195, DOI 10.5560/ZNA.2012-0006; Rubbab Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078352; Siddiqui AM, 2008, CHAOS SOLITON FRACT, V35, P140, DOI 10.1016/j.chaos.2006.05.026; Siddiqui AM, 2007, CHAOS SOLITON FRACT, V33, P1006, DOI 10.1016/j.chaos.2006.01.101; Siddiqui AM, 2006, PHYS LETT A, V352, P404, DOI 10.1016/j.physleta.2005.12.033; Tan WC, 2007, PHYS LETT A, V360, P454, DOI 10.1016/j.physleta.2006.08.054; Turkyilmazoglu M, 2011, INT J THERM SCI, V50, P831, DOI 10.1016/j.ijthermalsci.2010.12.014; Turkyilmazoglu M, 2010, INT J MECH SCI, V52, P1735, DOI 10.1016/j.ijmecsci.2010.09.007; Turkyilmazoglu M, 2010, APPL MATH LETT, V23, P1226, DOI 10.1016/j.aml.2010.06.003; Turkyilmazoglu M, 2010, COMPUT FLUIDS, V39, P793, DOI 10.1016/j.compfluid.2009.12.007; Wazwaz AM, 2005, APPL MATH COMPUT, V166, P652, DOI 10.1016/j.amc.2004.06.059; Wazwaz AM, 2005, APPL MATH COMPUT, V161, P543, DOI 10.1016/j.amc.2003.12.048; Yao YD, 2010, NONLINEAR ANAL-REAL, V11, P4442, DOI 10.1016/j.nonrwa.2010.05.027	37	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e97552	10.1371/journal.pone.0097552	http://dx.doi.org/10.1371/journal.pone.0097552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949988	Green Published, gold			2022-12-25	WOS:000338276300003
J	Han, YS; Zhang, FF; Tian, YH; Hu, PP; Li, B; Wang, K				Han, Yongsheng; Zhang, Fangfang; Tian, Yanghua; Hu, Panpan; Li, Bo; Wang, Kai			Selective Impairment of Attentional Networks of Alerting in Wilson's Disease	PLOS ONE			English	Article							PARKINSONS-DISEASE; EXECUTIVE CONTROL; VERBAL FLUENCY; RATING-SCALE; DEFICITS; RELIABILITY; INVOLVEMENT; DYSFUNCTION	Wilson's disease (WD) is typically affected by attention, which is one of the cognitive domains. The Attention Network Test (ANT) was developed to measure the functioning of the following three individual attentional networks: orienting, alerting, and executive control. The ANT has been used in a variety of neuropsychiatric conditions; however, it has not been used in WD. The aim of this study was to investigate the attentional function of WD patients, and 35 patients with early and moderate neurological WD, as well as 35 gender-, age-, and education-matched healthy controls performed the ANT. Remarkable differences between the patients and healthy controls were observed in the alerting network (p = 0.007) in contrast the differences in the orienting (p = 0.729) and executive control (p = 0.888) networks of visual attention. The mean reaction time in the ANT was significantly longer in the WD patients than in the controls (p<0.001, 0.001). In the WD patients, there was an effect specifically on the alerting domain of the attention network, whereas the orienting and executive control domains were not affected.	[Han, Yongsheng; Zhang, Fangfang; Tian, Yanghua; Hu, Panpan; Wang, Kai] Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei, Anhui, Peoples R China; [Han, Yongsheng; Li, Bo] Anhui Univ Chinese Med, Inst Neurol, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui University of Chinese Medicine	Wang, K (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei, Anhui, Peoples R China.	wangkai1964@126.com	Zhang, Fang/HHN-2153-2022; hu, panpan/ABD-5695-2021	Tian, Yanghua/0000-0001-5038-0599				Ala A, 2007, LANCET, V369, P397, DOI 10.1016/S0140-6736(07)60196-2; Allcock LM, 2009, PARKINSONISM RELAT D, V15, P110, DOI 10.1016/j.parkreldis.2008.03.010; Audet T, 2000, BRAIN COGNITION, V43, P17; Beane M, 2004, PROG NEUROBIOL, V74, P167, DOI 10.1016/j.pneurobio.2004.09.001; BLACKBURN HL, 1957, J CONSULT PSYCHOL, V21, P139, DOI 10.1037/h0047235; Booth JE, 2007, ARCH CLIN NEUROPSYCH, V22, P423, DOI 10.1016/j.acn.2007.01.017; Couette M, 2008, NEUROPSYCHOLOGIA, V46, P1391, DOI 10.1016/j.neuropsychologia.2007.12.017; Cristinzio C, 2013, BEHAV NEUROL, V27, P495, DOI [10.1155/2013/312426, 10.3233/BEN-129020]; Crivelli L, 2012, J INT NEUROPSYCH SOC, V18, P757, DOI 10.1017/S1355617712000410; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fan J, 2007, J NEUROSCI, V27, P6197, DOI 10.1523/JNEUROSCI.1833-07.2007; Farrin L, 2003, J NEUROPSYCH CLIN N, V15, P98, DOI 10.1176/appi.neuropsych.15.1.98; Frota Norberto Anizio Ferreira, 2009, Dement. neuropsychol., V3, P16, DOI 10.1590/S1980-57642009DN30100004; Fuentes LJ, 2010, DEMENT GERIATR COGN, V29, P139, DOI 10.1159/000275672; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Gajda J, 1994, J NEUROL S, V1, P161; GJERRIS A, 1983, J AFFECT DISORDERS, V5, P163, DOI 10.1016/0165-0327(83)90009-5; Gong, 1992, WECHSLER ADULT INTEL; Green AE, 2008, NAT REV NEUROSCI, V9, P710, DOI 10.1038/nrn2461; HANLEY JR, 1990, NEUROPSYCHOLOGIA, V28, P737, DOI 10.1016/0028-3932(90)90129-C; HAWKINS RA, 1987, NEUROLOGY, V37, P1707, DOI 10.1212/WNL.37.11.1707; Hegde S, 2010, NEUROL INDIA, V58, P708, DOI 10.4103/0028-3886.72172; Henry JD, 2004, J INT NEUROPSYCH SOC, V10, P608, DOI 10.1017/S1355617704104141; Kubler A, 2003, NEUROIMAGE, V20, P1298, DOI 10.1016/S1053-8119(03)00400-2; LANG C, 1989, J CLIN EXP NEUROPSYC, V11, P569, DOI 10.1080/01688638908400914; Leinweber B, 2008, MOVEMENT DISORD, V23, P54, DOI 10.1002/mds.21761; Leskin LP, 2007, NEUROPSYCHOLOGY, V21, P275, DOI 10.1037/0894-4105.21.3.275; Lin JJ, 2006, PEDIATR NEUROL, V35, P284, DOI 10.1016/j.pediatrneurol.2006.04.004; Litwin T, 2013, J NEUROL SCI, V329, P55, DOI 10.1016/j.jns.2013.03.021; Lundervold AJ, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-27; Middleton F. A., 1995, Society for Neuroscience Abstracts, V21, P676; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; MILLER IW, 1985, PSYCHIAT RES, V14, P131, DOI 10.1016/0165-1781(85)90057-5; Pacheco-Unguetti AP, 2011, J ANXIETY DISORD, V25, P888, DOI 10.1016/j.janxdis.2011.04.010; Portala K, 2000, ACTA PSYCHIAT SCAND, V101, P104, DOI 10.1034/j.1600-0447.2000.90085.x; Portala K, 2001, EUR ARCH PSY CLIN N, V251, P262, DOI 10.1007/PL00007543; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Rathbun JK, 1996, INT J NEUROSCI, V85, P221, DOI 10.3109/00207459608986684; Roberts EA, 2008, HEPATOLOGY, V47, P2089, DOI 10.1002/hep.22261; Schiff ND, 2008, ANN NY ACAD SCI, V1129, P105, DOI 10.1196/annals.1417.029; Seniow J, 2002, MOVEMENT DISORD, V17, P1077, DOI 10.1002/mds.10195; SNOW BJ, 1991, J NEUROL NEUROSUR PS, V54, P12, DOI 10.1136/jnnp.54.1.12; STAROSTARUBINSTEIN S, 1987, ARCH NEUROL-CHICAGO, V44, P365, DOI 10.1001/archneur.1987.00520160007005; Strum W, 1997, NEUROLOGICAL REHABIL, V7, P81; Svetel M, 2009, PARKINSONISM RELAT D, V15, P772, DOI 10.1016/j.parkreldis.2009.01.010; Swainson R, 2000, NEUROPSYCHOLOGIA, V38, P596, DOI 10.1016/S0028-3932(99)00103-7; Urbanek C, 2010, MULT SCLER J, V16, P93, DOI 10.1177/1352458509350308; Wang K, 2005, SCHIZOPHR RES, V78, P235, DOI 10.1016/j.schres.2005.01.019; Zhou SS, 2012, NEUROSCI LETT, V509, P50, DOI 10.1016/j.neulet.2011.12.049	50	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100454	10.1371/journal.pone.0100454	http://dx.doi.org/10.1371/journal.pone.0100454			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2UZ	24949936	Green Published, Green Submitted, gold			2022-12-25	WOS:000338276300075
J	Hancock, DG; Shklovskaya, E; Guy, TV; Falsafi, R; Fjell, CD; Ritchie, W; Hancock, REW; Fazekas de St Groth, B				Hancock, David G.; Shklovskaya, Elena; Guy, Thomas V.; Falsafi, Reza; Fjell, Chris D.; Ritchie, William; Hancock, Robert E. W.; Fazekas de St Groth, Barbara			A Systems Biology Approach to the Analysis of Subset-Specific Responses to Lipopolysaccharide in Dendritic Cells	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; IN-VIVO; T-CELLS; TRANSCRIPTIONAL NETWORK; NEGATIVE REGULATION; INNATE IMMUNITY; MARGINAL ZONE; CUTTING EDGE; STEADY-STATE; INTEGRATION	Dendritic cells (DCs) are critical for regulating CD4 and CD8 T cell immunity, controlling Th1, Th2, and Th17 commitment, generating inducible Tregs, and mediating tolerance. It is believed that distinct DC subsets have evolved to control these different immune outcomes. However, how DC subsets mount different responses to inflammatory and/or tolerogenic signals in order to accomplish their divergent functions remains unclear. Lipopolysaccharide (LPS) provides an excellent model for investigating responses in closely related splenic DC subsets, as all subsets express the LPS receptor TLR4 and respond to LPS in vitro. However, previous studies of the LPS-induced DC transcriptome have been performed only on mixed DC populations. Moreover, comparisons of the in vivo response of two closely related DC subsets to LPS stimulation have not been reported in the literature to date. We compared the transcriptomes of murine splenic CD8 and CD11b DC subsets after in vivo LPS stimulation, using RNA-Seq and systems biology approaches. We identified subset-specific gene signatures, which included multiple functional immune mediators unique to each subset. To explain the observed subset-specific differences, we used a network analysis approach. While both DC subsets used a conserved set of transcription factors and major signalling pathways, the subsets showed differential regulation of sets of genes that 'fine-tune' the network Hubs expressed in common. We propose a model in which signalling through common pathway components is 'fine-tuned' by transcriptional control of subset-specific modulators, thus allowing for distinct functional outcomes in closely related DC subsets. We extend this analysis to comparable datasets from the literature and confirm that our model can account for cell subset-specific responses to LPS stimulation in multiple subpopulations in mouse and man.	[Hancock, David G.; Shklovskaya, Elena; Guy, Thomas V.; Ritchie, William; Fazekas de St Groth, Barbara] Centenary Inst Canc Med & Cell Biol, Sydney, NSW, Australia; [Hancock, David G.; Shklovskaya, Elena; Guy, Thomas V.; Fazekas de St Groth, Barbara] Univ Sydney, Discipline Dermatol, Sydney, NSW 2006, Australia; [Falsafi, Reza; Fjell, Chris D.; Hancock, Robert E. W.] Univ British Columbia, Ctr Microbial Dis & Immun Res, Vancouver, BC V5Z 1M9, Canada; [Fjell, Chris D.] Univ British Columbia, James Hogg Res Ctr, St Pauls Hosp, Vancouver, BC V5Z 1M9, Canada	University of Sydney; Centenary Institute; University of Sydney; University of British Columbia; St. Paul's Hospital; University of British Columbia; University of Saskatchewan	Fazekas de St Groth, B (corresponding author), Centenary Inst Canc Med & Cell Biol, Sydney, NSW, Australia.	b.fazekas@centenary.org.au	Hancock, Robert E. W./E-1145-2013; Hancock, David/CAF-2615-2022; de St Groth, Barbara Fazekas/O-3017-2017	Hancock, Robert E. W./0000-0001-5989-8503; Hancock, David/0000-0003-4782-2661; de St Groth, Barbara Fazekas/0000-0001-6817-9690; Fjell, Christopher/0000-0001-6304-2628; Shklovskaya, Elena/0000-0002-6155-1020	Australian National Health and Medical Research Council (NHMRC) [1012930, 571156]; Canadian Institutes of Health Research (CIHR) [MOP-74493]; CIHR; Cancer Institute NSW Research Scholar Awards; NHMRC	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Cancer Institute NSW Research Scholar Awards; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian National Health and Medical Research Council (NHMRC; http://www.nhmrc.gov.au/; ES and BFdSG: #1012930, WR: #571156). Funding to REWH from the Canadian Institutes of Health Research (CIHR; http://www.cihr-irsc.gc.ca/e/193.html; MOP-74493) is gratefully acknowledged. REWH holds a Canada Research Chair. CF was supported by a fellowship from CIHR. DGH and TVG were supported by Cancer Institute NSW Research Scholar Awards (http://www.cancerinstitute.org.au/). BFdSG is supported by an NHMRC Principal Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Anandasabapathy N, 2011, J EXP MED, V208, P1695, DOI 10.1084/jem.20102657; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Azuma M, 2012, ONCOIMMUNOLOGY, V1, P581, DOI 10.4161/onci.19893; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990; Barsky A, 2007, BIOINFORMATICS, V23, P1040, DOI 10.1093/bioinformatics/btm057; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Chaussabel D, 2003, BLOOD, V102, P672, DOI 10.1182/blood-2002-10-3232; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Coquerelle C, 2010, IMMUNOL REV, V234, P317, DOI 10.1111/j.0105-2896.2009.00887.x; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Crozat K, 2011, J IMMUNOL, V187, P4411, DOI 10.4049/jimmunol.1101717; Davidson D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053641; Delgado-Martin C, 2011, J BIOL CHEM, V286, P37222, DOI 10.1074/jbc.M111.294116; DeSmedt T, 1996, J EXP MED, V184, P1413, DOI 10.1084/jem.184.4.1413; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Edwards AD, 2003, J IMMUNOL, V171, P47, DOI 10.4049/jimmunol.171.1.47; Eisenbarth SC, 2012, NATURE, V484, P510, DOI 10.1038/nature11012; Elpek KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023921; Ermolaeva MA, 2008, NAT IMMUNOL, V9, P1037, DOI 10.1038/ni.1638; Gantier MP, 2012, NUCLEIC ACIDS RES, V40, P8048, DOI 10.1093/nar/gks521; Gardy JL, 2009, TRENDS IMMUNOL, V30, P249, DOI 10.1016/j.it.2009.03.009; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Guimond M, 2009, NAT IMMUNOL, V10, P149, DOI 10.1038/ni.1695; Hamasaki T, 2010, CLIN VACCINE IMMUNOL, V17, P748, DOI 10.1128/CVI.00505-09; Hancock DG, 2013, CLIN EXP IMMUNOL, V171, P147, DOI 10.1111/cei.12027; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hsing M, 2009, BIOINFORMATION, V4, P164, DOI 10.6026/97320630004164; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Idoyaga J, 2009, P NATL ACAD SCI USA, V106, P1524, DOI 10.1073/pnas.0812247106; Kabashima K, 2007, BIOCHEM BIOPH RES CO, V361, P1012, DOI 10.1016/j.bbrc.2007.07.128; Kasahara S, 2012, J LEUKOCYTE BIOL, V91, P437, DOI 10.1189/jlb.0711384; Kress E, 2006, MOL IMMUNOL, V43, P2002, DOI 10.1016/j.molimm.2005.11.011; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Li LQ, 2000, SCAND J IMMUNOL, V51, P361; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Lind EF, 2008, J IMMUNOL, V181, P354, DOI 10.4049/jimmunol.181.1.354; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Mayer ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016246; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ostuni R, 2010, CELL MOL LIFE SCI, V67, P4109, DOI 10.1007/s00018-010-0464-x; Pandey G, 2013, J IMMUNOL METHODS, V387, P71, DOI 10.1016/j.jim.2012.09.012; Patenaude J, 2010, CELL MOL LIFE SCI, V67, P1315, DOI 10.1007/s00018-009-0251-8; Patil S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-137; Pena OM, 2011, J IMMUNOL, V186, P7243, DOI 10.4049/jimmunol.1001952; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Pulendran B, 2001, J IMMUNOL, V167, P5067, DOI 10.4049/jimmunol.167.9.5067; Qiu CH, 2009, J IMMUNOL, V182, P4127, DOI 10.4049/jimmunol.0803364; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Scatizzi JC, 2009, EUR J IMMUNOL, V39, P820, DOI 10.1002/eji.200838683; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Seok J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-78; Sheng KC, 2008, J IMMUNOL, V181, P2455, DOI 10.4049/jimmunol.181.4.2455; Shklovskaya E, 2011, P NATL ACAD SCI USA, V108, P18049, DOI 10.1073/pnas.1110076108; Smith JR, 2007, INVEST OPHTH VIS SCI, V48, P2676, DOI 10.1167/iovs.06-0598; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Steinman RM, 2010, IMMUNOL REV, V234, P5, DOI 10.1111/j.0105-2896.2009.00888.x; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; Sun YP, 2011, BLOOD, V117, P6172, DOI 10.1182/blood-2010-12-325647; Tegner J, 2006, CELL IMMUNOL, V244, P105, DOI 10.1016/j.cellimm.2007.01.010; Torri A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009404; Trakala M, 2009, EUR J IMMUNOL, V39, P810, DOI 10.1002/eji.200838676; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923; Zhu N, 2009, MOL BIOL REP, V36, P2075, DOI 10.1007/s11033-008-9419-9; Zhu YN, 2012, MOL CELL, V46, P408, DOI 10.1016/j.molcel.2012.05.011; Zietara N, 2009, J IMMUNOL, V183, P1099, DOI 10.4049/jimmunol.0803214	80	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100613	10.1371/journal.pone.0100613	http://dx.doi.org/10.1371/journal.pone.0100613			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949855	Green Published, Green Submitted, gold			2022-12-25	WOS:000338276300098
J	Xi, L; Wang, T; Zhao, F; Zheng, QJ; Li, XN; Luo, J; Liu, J; Quan, DP; Ge, J				Xi, Lei; Wang, Tao; Zhao, Feng; Zheng, Qiongjuan; Li, Xiaoning; Luo, Jing; Liu, Ji; Quan, Daping; Ge, Jian			Evaluation of an Injectable Thermosensitive Hydrogel As Drug Delivery Implant for Ocular Glaucoma Surgery	PLOS ONE			English	Article							BLOCK-COPOLYMER HYDROGELS; POLOXAMER 407 GELS; FILTRATION SURGERY; MITOMYCIN-C; IN-VITRO; PLURONIC(R) F127; THERMOREVERSIBLE HYDROGELS; INTRAPERITONEAL INJECTION; SUSTAINED DELIVERY; CONTROLLED-RELEASE	In this study, a biodegradable thermo-sensitive hydrogel from poly(trimethylene carbonate)(15)-F127-poly(trimethylene carbonate)(15)(PTMC15-F127-PTMC15) was designed and evaluated as an injectable implant during ocular glaucoma filtration surgery in vivo and in vitro. Mitomycin C (MMC) was loaded into this hydrogel for controlled released to prolong the efficacy and to reduce the long-term toxicity. The properties of the hydrogel were confirmed using H-1 NMR and gel permeation chromatography (GPC). Compared to the Pluronic F127 hydrogel, the PTMC15-F127-PTMC15 hydrogel showed a good solution-gel transition temperature at 37 degrees C, a lower work concentration of 5% w/v and a longer mass loss time of more than 2 weeks. The in vitro study showed that the drug could be released from PTMC15-F127-PTMC15 (5% w/v) hydrogel for up to 16 days with only 57% of drug released in the first day. Moreover, the cell toxicity, which was tested via LDH and ANNEXIN V/PI, decreased within 72 h in human tenon's fibroblast cells (HTFs). The in vivo behavior in a rabbit glaucoma filtration surgery model indicated that this hydrogel loaded with 0.1 mg/ml MMC led to a better functional bleb with a prolonged mean bleb survival time (25.5 +/- 2.9 days). The scar tissue formation, new collagen deposition and myofibroblast generation appeared to be reduced upon histological and immunohistochemistry examinations, with no obvious side effects and inflammatory reactions. The in vitro and in vivo results demonstrated that this novel hydrogel is a safe and effective drug delivery candidate in ocular glaucoma surgery.	[Xi, Lei; Zhao, Feng; Li, Xiaoning; Ge, Jian] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Tao; Zheng, Qiongjuan; Quan, Daping] Sun Yat Sen Univ, Sch Chem & Chem Engn, DSAPM & PCFM Lab, Guangzhou 510275, Guangdong, Peoples R China; [Li, Xiaoning] Aier Eye Hosp Grp, Changsha, Hunan, Peoples R China; [Luo, Jing] Cent S Univ, Dept Ophthalmol, Xiang Ya Hosp 2, Changsha, Hunan, Peoples R China; [Liu, Ji] Yale Univ, Yale Eye Ctr, New Haven, CT USA	Sun Yat Sen University; Sun Yat Sen University; Central South University; Yale University	Quan, DP (corresponding author), Sun Yat Sen Univ, Sch Chem & Chem Engn, DSAPM & PCFM Lab, Guangzhou 510275, Guangdong, Peoples R China.	cesqdp@mail.sysu.edu.cn; gejian@mail.sysu.edu.cn		Luo, Jing/0000-0002-8905-9388	China National Natural Science Foundation [81170846, U1134007]; Fundamental Research Funds of State Key Laboratory of Ophthalmology of China [2012PI02]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds of State Key Laboratory of Ophthalmology of China	This work was supported by the China National Natural Science Foundation (NO. 81170846 and U1134007), the Fundamental Research Funds of State Key Laboratory of Ophthalmology of China (N0. 2012PI02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake DA, 2006, J GLAUCOMA, V15, P291, DOI 10.1097/01.ijg.0000212236.96039.9c; Branco MC, 2009, BIOMATERIALS, V30, P1339, DOI 10.1016/j.biomaterials.2008.11.019; Buwalda SJ, 2010, BIOMACROMOLECULES, V11, P224, DOI 10.1021/bm901080d; Chen HSL, 2006, INVEST OPHTH VIS SCI, V47, P5310, DOI 10.1167/iovs.06-0378; Chetoni P, 2007, J DRUG DELIV SCI TEC, V17, P43, DOI 10.1016/S1773-2247(07)50006-7; Congdon NG, 2012, OPHTHAL EPIDEMIOL, V19, P149, DOI 10.3109/09286586.2012.667493; Cordeiro MF, 1997, INVEST OPHTH VIS SCI, V38, P1639; DeBry PW, 2002, ARCH OPHTHALMOL-CHIC, V120, P297; Derakhshandeh K, 2010, DRUG DES DEV THER, V4, P255; Duan LH, 2012, EUR J PHARM SCI, V46, P357, DOI 10.1016/j.ejps.2012.02.023; Dumortier G, 2006, PHARM RES-DORDR, V23, P2709, DOI 10.1007/s11095-006-9104-4; Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055; Gao YA, 2010, DRUG DEV IND PHARM, V36, P1131, DOI 10.3109/03639041003680826; Grover DS, 2012, CURR OPIN OPHTHALMOL, V23, P127, DOI 10.1097/ICU.0b013e32834ff2b7; Gupta R, 2011, VET OPHTHALMOL, V14, P304, DOI 10.1111/j.1463-5224.2011.00877.x; He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005; He Y, 2008, INVEST OPHTH VIS SCI, V49, P1447, DOI 10.1167/iovs.07-1361; Hiemstra C, 2007, J AM CHEM SOC, V129, P9918, DOI 10.1021/ja072113p; Hsu WC, 2000, INVEST OPHTH VIS SCI, V41, P2404; JOHNSTON T P, 1985, Journal of Parenteral Science and Technology, V39, P83; JOHNSTON TP, 1992, PHARM RES-DORDR, V9, P425, DOI 10.1023/A:1015815624334; Joo MK, 2009, J MATER CHEM, V19, P5891, DOI 10.1039/b902208b; Joshi AB, 2005, J GLAUCOMA, V14, P172, DOI 10.1097/01.ijg.0000151684.12033.4d; Kang HZ, 2011, LANGMUIR, V27, P399, DOI 10.1021/la1037553; Karlgard CCS, 2003, INT J PHARM, V257, P141, DOI 10.1016/S0378-5173(03)00124-8; KATAKAM M, 1995, J PHARM SCI-US, V84, P713, DOI 10.1002/jps.2600840609; KHAW PT, 1993, OPHTHALMOLOGY, V100, P367; Kirkland SE, 2008, BIOMACROMOLECULES, V9, P481, DOI 10.1021/bm700968t; Kirwan JF, 2013, OPHTHALMOLOGY, V120, P2532, DOI 10.1016/j.ophtha.2013.07.049; Koz OG, 2007, J GLAUCOMA, V16, P610, DOI 10.1097/IJG.0b013e31815c89b9; Kozobolis VP, 2002, J GLAUCOMA, V11, P287, DOI 10.1097/00061198-200208000-00003; Lama PJ, 2003, SURV OPHTHALMOL, V48, P314, DOI 10.1016/S0039-6257(03)00038-9; Lattanzio FA, 2005, J GLAUCOMA, V14, P441, DOI 10.1097/01.ijg.0000185432.63408.1e; Lee DS, 2010, BIOMEDICAL APPLICATIONS OF HYDROGELS HANDBOOK, P123, DOI 10.1007/978-1-4419-5919-5_7; Li EY, 2013, INVEST OPHTH VIS SCI, V54, P3394, DOI 10.1167/iovs.12-11549; Li MY, 2011, J MATER SCI-MATER M, V22, P2745, DOI 10.1007/s10856-011-4455-8; Li Z, 2009, BIOMACROMOLECULES, V10, P3306, DOI 10.1021/bm900900e; Li ZQ, 2009, INVEST OPHTH VIS SCI, V50, P5217, DOI 10.1167/iovs.08-2662; Liu WG, 2008, J MATER SCI-MATER M, V19, P3365, DOI 10.1007/s10856-008-3486-2; Liu Y, 2007, J CONTROL RELEASE, V117, P387, DOI 10.1016/j.jconrel.2006.11.024; Mead AL, 2003, INVEST OPHTH VIS SCI, V44, P3394, DOI 10.1167/iovs.02-0978; Memarzadeh F, 2009, INVEST OPHTH VIS SCI, V50, P3233, DOI 10.1167/iovs.08-2441; Meyer-Ter-Vehn T, 2008, INVEST OPHTH VIS SCI, V49, P3955, DOI 10.1167/iovs.07-1610; Nagarwal RC, 2011, COLLOID SURFACE B, V86, P28, DOI 10.1016/j.colsurfb.2011.03.023; Ness PJ, 2010, AM J OPHTHALMOL, V150, P498, DOI 10.1016/j.ajo.2010.05.006; Paavola A, 1998, J CONTROL RELEASE, V52, P169, DOI 10.1016/S0168-3659(97)00206-X; Palma SD, 2009, J CONTROL RELEASE, V138, P24, DOI 10.1016/j.jconrel.2009.04.035; Pandit NK, 1998, INT J PHARM, V167, P183, DOI 10.1016/S0378-5173(98)00074-X; Park H, 2013, BIOMATERIALS, V34, P6992, DOI 10.1016/j.biomaterials.2013.05.070; PEC EA, 1992, J PHARM SCI-US, V81, P626, DOI 10.1002/jps.2600810707; Pego AP, 2003, J BIOMED MATER RES A, V67A, P1044, DOI 10.1002/jbm.a.10121; Peng D, 1999, Yan Ke Xue Bao, V15, P51; Rhodes NP, 2007, BIOMATERIALS, V28, P5131, DOI 10.1016/j.biomaterials.2007.08.004; Sahiner N, 2009, ARCH OPHTHALMOL-CHIC, V127, P448, DOI 10.1001/archophthalmol.2009.19; SCHMOLKA IR, 1972, J BIOMED MATER RES, V6, P571, DOI 10.1002/jbm.820060609; Sen E, 2010, J OCUL PHARMACOL TH, V26, P399, DOI 10.1089/jop.2010.0064; Sharma PK, 2004, INT J PHARMACEUT, V278, P361, DOI 10.1016/j.ijpharm.2004.03.029; Sidoti PA, 2000, OPHTHALMOLOGY, V107, P422, DOI 10.1016/S0161-6420(99)00130-X; Stratton LP, 1997, J PHARM SCI, V86, P1006, DOI 10.1021/js970034d; Tang S, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/015008; Veyries ML, 1999, INT J PHARMACEUT, V192, P183, DOI 10.1016/S0378-5173(99)00307-5; Wang Wenhua, 2011, Eye Sci, V26, P197, DOI 10.3969/j.issn.1000-4432.2011.04.003; Wenzel JGW, 2002, J CONTROL RELEASE, V85, P51, DOI 10.1016/S0168-3659(02)00271-7; Wimmer I, 2002, OPHTHALMOLOGE, V99, P678, DOI 10.1007/s00347-002-0698-6; Wong TT, 2009, OPHTHALMOLOGY, V116, P175, DOI 10.1016/j.ophtha.2008.09.049; Xiao YQ, 2009, INVEST OPHTH VIS SCI, V50, P1698, DOI 10.1167/iovs.08-1675; Xiong XY, 2007, J CONTROL RELEASE, V120, P11, DOI 10.1016/j.jconrel.2007.04.004; Yan MF, 2012, POLYM INT, V61, P1525, DOI 10.1002/pi.4240; Yan ZC, 2011, MOL VIS, V17, P2495; Ye HH, 2010, MOL VIS, V16, P2502; Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k; Yu L, 2010, BIOMACROMOLECULES, V11, P2169, DOI 10.1021/bm100549q; Yueling Z, 2005, J HEBEI MED COLL CON, V22, P6; Zhang L, 2002, J CONTROL RELEASE, V85, P73, DOI 10.1016/S0168-3659(02)00273-0; Zhong H, 2011, INVEST OPHTH VIS SCI, V52, P3136, DOI 10.1167/iovs.10-6240; Zhou Q, 2011, COLLOID SURFACE B, V86, P45, DOI 10.1016/j.colsurfb.2011.03.013	76	42	42	7	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100632	10.1371/journal.pone.0100632	http://dx.doi.org/10.1371/journal.pone.0100632			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950176	Green Published, Green Submitted, gold			2022-12-25	WOS:000338276300101
J	Yoshida, Y; Hayashi, Y; Suda, M; Tateno, K; Okada, S; Moriya, J; Yokoyama, M; Nojima, A; Yamashita, M; Kobayashi, Y; Shimizu, I; Minamino, T				Yoshida, Yohko; Hayashi, Yuka; Suda, Masayoshi; Tateno, Kaoru; Okada, Sho; Moriya, Junji; Yokoyama, Masataka; Nojima, Aika; Yamashita, Masakatsu; Kobayashi, Yoshio; Shimizu, Ippei; Minamino, Tohru			Notch Signaling Regulates the Lifespan of Vascular Endothelial Cells via a p16-Dependent Pathway	PLOS ONE			English	Article							SENESCENCE; TELOMERE; ANGIOGENESIS; EXPRESSION; STRESS; DLL4	Evolutionarily conserved Notch signaling controls cell fate determination and differentiation during development, and is also essential for neovascularization in adults. Although recent studies suggest that the Notch pathway is associated with age-related conditions, it remains unclear whether Notch signaling is involved in vascular aging. Here we show that Notch signaling has a crucial role in endothelial cell senescence. Inhibition of Notch signaling in human endothelial cells induced premature senescence via a p16-dependent pathway. Conversely, over-expression of Notch1 or Jagged1 prolonged the replicative lifespan of endothelial cells. Notch1 positively regulated the expression of inhibitor of DNA binding 1 (Id1) and MAP kinase phosphatase 1 (MKP1), while MKP1 further up-regulated Id1 expression by inhibiting p38MAPK-induced protein degradation. Over-expression of Id1 down-regulated p16 expression, thereby inhibiting premature senescence of Notch1-deleted endothelial cells. These findings indicate that Notch1 signaling has a role in the regulation of endothelial cell senescence via a p16-dependent pathway and suggest that activation of Notch1 could be a new therapeutic target for treating age-associated vascular diseases.	[Yoshida, Yohko; Hayashi, Yuka; Suda, Masayoshi; Shimizu, Ippei; Minamino, Tohru] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan; [Tateno, Kaoru; Okada, Sho; Moriya, Junji; Yokoyama, Masataka; Nojima, Aika; Kobayashi, Yoshio] Chiba Univ, Grad Sch Med, Dept Cardiovasc Med, Chiba, Japan; [Yamashita, Masakatsu] Kazusa DNA Res Inst, Chiba, Japan; [Minamino, Tohru] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	Niigata University; Chiba University; Kazusa DNA Research Institute; Japan Science & Technology Agency (JST)	Minamino, T (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan.	t_minamino@yahoo.co.jp	Minamino, Tohru/P-8145-2018	Minamino, Tohru/0000-0003-1627-6151; Shimizu, Ippei/0000-0003-3333-8131	Ministry of Education, Culture, Sports, Science and Technology of Japan [2430195, 25126706, 25670382]; Ono Medical Research Foundation; Uehara Memorial Foundation; NOVARTIS Foundation for the Promotion Science; Japan Diabetes Foundation; SENSHIN Medical Research Foundation; Takeda Science Foundation; Mitsubishi Pharma Research Foundation; Takeda Medical Research Foundation; SUZUKEN Memorial Foundation; Japan Heart Foundation & Astellas/Pfizer Grant for Research on Atherosclerosis Update; Japan Heart Foundation Dr. Hiroshi Irisawa & Dr. Aya Irisawa Memorial Research Grant; Grants-in-Aid for Scientific Research [24390195] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ono Medical Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); NOVARTIS Foundation for the Promotion Science; Japan Diabetes Foundation; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Pharma Research Foundation; Takeda Medical Research Foundation; SUZUKEN Memorial Foundation; Japan Heart Foundation & Astellas/Pfizer Grant for Research on Atherosclerosis Update; Japan Heart Foundation Dr. Hiroshi Irisawa & Dr. Aya Irisawa Memorial Research Grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant numbers 2430195, 25126706, 25670382), and the grants from the Ono Medical Research Foundation, the Uehara Memorial Foundation, the NOVARTIS Foundation for the Promotion Science, the Japan Diabetes Foundation, the SENSHIN Medical Research Foundation, the Takeda Science Foundation, and the Mitsubishi Pharma Research Foundation, the Takeda Medical Research Foundation, the SUZUKEN Memorial Foundation (to TM), and the Japan Heart Foundation & Astellas/Pfizer Grant for Research on Atherosclerosis Update and the Japan Heart Foundation Dr. Hiroshi Irisawa & Dr. Aya Irisawa Memorial Research Grant (to YY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ables JL, 2011, NAT REV NEUROSCI, V12, P269, DOI 10.1038/nrn3024; Alani RM, 2001, P NATL ACAD SCI USA, V98, P7812, DOI 10.1073/pnas.141235398; Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Carey KA, 2007, J GERONTOL A-BIOL, V62, P9, DOI 10.1093/gerona/62.1.9; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Eilken HM, 2010, NAT MED, V16, P853, DOI 10.1038/nm0810-853; Ethell DW, 2010, NEUROSCIENTIST, V16, P614, DOI 10.1177/1073858410366162; Faragher RGA, 1998, BIOESSAYS, V20, P985, DOI 10.1002/(SICI)1521-1878(199812)20:12<985::AID-BIES4>3.3.CO;2-1; Garcia A, 2012, HISTOL HISTOPATHOL, V27, P151, DOI 10.14670/HH-27.151; Gil ME, 2004, MOL BIOTECHNOL, V27, P169, DOI 10.1385/MB:27:2:169; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Guo SC, 2011, BBA-REV CANCER, V1815, P197, DOI 10.1016/j.bbcan.2010.12.002; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Hirsch DD, 1997, J BIOL CHEM, V272, P4568, DOI 10.1074/jbc.272.7.4568; Kikuchi R, 2011, LAB INVEST, V91, P691, DOI 10.1038/labinvest.2011.5; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Limbourg FP, 2005, CIRCULATION, V111, P1826, DOI 10.1161/01.CIR.0000160870.93058.DD; Liu ZJ, 2012, ATHEROSCLEROSIS, V225, P296, DOI 10.1016/j.atherosclerosis.2012.04.010; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; Mancini SJC, 2005, BLOOD, V105, P2340, DOI 10.1182/blood-2004-08-3207; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045; Niessen K, 2007, AM J PHYSIOL-CELL PH, V293, pC1, DOI 10.1152/ajpcell.00415.2006; Nobta M, 2005, J BIOL CHEM, V280, P15842, DOI 10.1074/jbc.M412891200; Noseda M, 2004, MOL CELL BIOL, V24, P8813, DOI 10.1128/MCB.24.20.8813-8822.2004; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7; South AP, 2012, SEMIN CELL DEV BIOL, V23, P458, DOI 10.1016/j.semcdb.2012.01.017; Takeshita K, 2007, CIRC RES, V100, P70, DOI 10.1161/01.RES.0000254788.47304.6e; Thomas JL, 2013, CELL MOL LIFE SCI, V70, P1779, DOI 10.1007/s00018-013-1312-6; Vandevyver S, 2012, J CLIN INVEST, V122, P2130, DOI 10.1172/JCI60006; Venkatesh D, 2011, ARTERIOSCL THROM VAS, V31, P876, DOI 10.1161/ATVBAHA.110.221945	41	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100359	10.1371/journal.pone.0100359	http://dx.doi.org/10.1371/journal.pone.0100359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950189	Green Published, gold, Green Submitted			2022-12-25	WOS:000338276300069
J	Dong, YJ; Silva, KAS; Dong, YL; Zhang, LP				Dong, Yanjun; Santos Silva, Kleiton Augusto; Dong, Yanlan; Zhang, Liping			Glucocorticoids increase adipocytes in muscle by affecting IL-4 regulated FAP activity	FASEB JOURNAL			English	Article						progenitors; dexamethasone	SKELETAL-MUSCLE; STEM-CELLS; INSULIN-RESISTANCE; SATELLITE CELLS; FIBRO/ADIPOGENIC PROGENITORS; ADIPOGENIC DIFFERENTIATION; CUSHINGS-SYNDROME; METABOLISM; MYOGENESIS; OBESITY	An increase in intramuscular adipocyte tissue (IMAT) is associated with glucose dysregulation, decreased muscle strength, and increased risk of disability. Unfortunately, the mechanisms stimulating intramuscular adipogenesis remain unclear. We found that dexamethasone (Dex) administration to mice with injured muscles stimulates the accumulation of IMAT. To identify precursors of these adipocytes, we isolated satellite cells and fibro/adipogenic progenitors (FAPs) from muscle; satellite cells did not differentiate into adipocytes even following Dex treatment. In contrast, Dex stimulated FAP differentiation into adipocytes. In vivo, we transplanted purified FAPs from transgenic, EGFP mice into the injured muscles of C57/BL6 mice and found that Dex administration stimulated adipogenesis from FAP-EGFP. The increase in adipogenesis depended on Dex-induced inhibition of interleukin-4 (IL-4). In the injured muscle of IL-4-knockout mice, the levels of adipocytes were increased, while in the injured muscles of Dex-treated mice with IL-4 injections, adipogenesis was suppressed. In cultured FAPs, IL-4 inhibited Dex-induced conversion of FAPs into adipocytes; this did not occur in FAPs expressing knockdown of the IL-4 receptor. Thus, we concluded that glucocorticoids stimulate FAPs to differentiate into adipocytes in injured muscles. This process is blocked by IL-4, suggesting that interfering with IL-4 signaling could prevent adipogenesis in muscle.	[Dong, Yanjun; Santos Silva, Kleiton Augusto; Dong, Yanlan; Zhang, Liping] Baylor Coll Med, Div Nephrol, Houston, TX 77030 USA; [Dong, Yanjun] Capital Med Univ, Beijing Zhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [Santos Silva, Kleiton Augusto] Univ Fed Sao Paulo, Dept Med, Div Nephrol, Sao Paulo, Brazil	Baylor College of Medicine; Capital Medical University; Universidade Federal de Sao Paulo (UNIFESP)	Zhang, LP (corresponding author), Baylor Coll Med, Div Nephrol, M-S BCM 395,One Baylor Plaza,ABBR R705, Houston, TX 77030 USA.	lipingz@bcm.edu		Silva, Kleiton/0000-0001-8230-0012; Dong, Yanjun/0000-0001-6396-8949	Satellite Health; American Diabetic Association [1-11-BS-194]; U.S. National Institutes of Health (NIH) [R37 DK37175]; Cytometry and Cell Sorting Core at Baylor College of Medicine; NIH [AI036211, CA125123, RR024574, P30 DK079638]; Pilot/Feasibility Program of the Diabetes Research Center at Baylor College of Medicine; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638, R37DK037175] Funding Source: NIH RePORTER	Satellite Health; American Diabetic Association(American Diabetes Association); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cytometry and Cell Sorting Core at Baylor College of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pilot/Feasibility Program of the Diabetes Research Center at Baylor College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. William E. Mitch for his critical review. This work was supported by the generous support of Dr. and Mrs. Harold Selzman, the Norman S. Coplon extramural research grants from Satellite Health and the American Diabetic Association (1-11-BS-194) to L.Z., U.S. National Institutes of Health (NIH) grant R37 DK37175, and the Cytometry and Cell Sorting Core at Baylor College of Medicine, with funding from the NIH (AI036211, CA125123, and RR024574), and the expert assistance of Joel M. Sederstrom. The work was supported in part by the Pilot/Feasibility Program of the Diabetes Research Center at Baylor College of Medicine, with funding from the NIH (P30 DK079638).	Aguiari P, 2008, P NATL ACAD SCI USA, V105, P1226, DOI 10.1073/pnas.0711402105; Andrew R, 2002, EXP CLIN ENDOCR DIAB, V110, P284, DOI 10.1055/s-2002-34591; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Asensio C, 2004, INT J OBESITY, V28, pS45, DOI 10.1038/sj.ijo.0802856; Carcamo-Orive I, 2010, J BONE MINER RES, V25, P2115, DOI 10.1002/jbmr.120; Chang YH, 2012, INT J OBESITY, V36, P993, DOI 10.1038/ijo.2011.168; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; DASILVA ML, 2006, J CELL SCI, V119, P2204, DOI DOI 10.1242/JCS.02932; Delmonico MJ, 2009, AM J CLIN NUTR, V90, P1579, DOI 10.3945/ajcn.2009.28047; Dong YJ, 2013, AM J PHYSIOL-ENDOC M, V305, pE367, DOI 10.1152/ajpendo.00644.2012; Dong YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058554; Duclos M, 2001, CLIN ENDOCRINOL, V55, P447, DOI 10.1046/j.1365-2265.2001.01384.x; FANG CH, 1995, J AM COLL SURGEONS, V180, P33; Feldman BJ, 2006, P NATL ACAD SCI USA, V103, P15675, DOI 10.1073/pnas.0607501103; GOLDSPINK G, 1994, NEUROMUSCULAR DISORD, V4, P183, DOI 10.1016/0960-8966(94)90019-1; Goodpaster BH, 2004, PEDIATR DIABETES, V5, P219, DOI 10.1111/j.1399-543X.2004.00071.x; Gounarides JS, 2008, ENDOCRINOLOGY, V149, P758, DOI 10.1210/en.2007-1214; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Hilton TN, 2008, PHYS THER, V88, P1336, DOI 10.2522/ptj.20080079; Hu Zhaoyong, 2009, J Clin Invest, V119, P3059, DOI 10.1172/JCI38770; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Korach-Andre M, 2005, AM J PHYSIOL-ENDOC M, V288, pE106, DOI 10.1152/ajpendo.00089.2004; LAMAS AM, 1991, J IMMUNOL, V147, P254; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; MAY RC, 1986, J CLIN INVEST, V77, P614, DOI 10.1172/JCI112344; Mito N, 2000, METABOLISM, V49, P1295, DOI 10.1053/meta.2000.9523; Nakamura K, 2012, AGING-US, V4, P40; PASTORET C, 1995, J NEUROL SCI, V129, P97, DOI 10.1016/0022-510X(94)00276-T; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; Ricardo-Gonzalez RR, 2010, P NATL ACAD SCI USA, V107, P22617, DOI 10.1073/pnas.1009152108; ROSS EJ, 1982, LANCET, V2, P646; SCHLEIMER RP, 1994, J ALLERGY CLIN IMMUN, V94, P1202, DOI 10.1016/0091-6749(94)90333-6; Seale P, 2001, DEV CELL, V1, P333, DOI 10.1016/S1534-5807(01)00049-1; Smas CM, 1999, J BIOL CHEM, V274, P12632, DOI 10.1074/jbc.274.18.12632; Starkey JD, 2011, J HISTOCHEM CYTOCHEM, V59, P33, DOI 10.1369/jhc.2010.956995; Tauchmanova L, 2002, J CLIN ENDOCR METAB, V87, P4872, DOI 10.1210/jc.2001-011766; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Tuttle Lori J, 2012, J Aging Res, V2012, P172957, DOI 10.1155/2012/172957; Uezumi A, 2011, J CELL SCI, V124, P3654, DOI 10.1242/jcs.086629; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Young HE, 2001, ANAT RECORD, V264, P51, DOI 10.1002/ar.1128; Zhang LP, 2012, J BIOL CHEM, V287, P6177, DOI 10.1074/jbc.M111.292649; Zhang LP, 2010, J AM SOC NEPHROL, V21, P419, DOI 10.1681/ASN.2009060571; Zhang LP, 2009, AM J PATHOL, V175, P2518, DOI 10.2353/ajpath.2009.090275; Zhang LP, 2009, J AM SOC NEPHROL, V20, P604, DOI 10.1681/ASN.2008060628	48	40	41	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2014	28	9					4123	4132		10.1096/fj.14-254011	http://dx.doi.org/10.1096/fj.14-254011			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN8HU	24948596	Green Published			2022-12-25	WOS:000340845900029
J	Sol, A; Skvirsky, Y; Nashef, R; Zelentsova, K; Burstyn-Cohen, T; Blotnick, E; Muhlrad, A; Bachrach, G				Sol, Asaf; Skvirsky, Yaniv; Nashef, Rizan; Zelentsova, Katya; Burstyn-Cohen, Tal; Blotnick, Edna; Muhlrad, Andras; Bachrach, Gilad			Actin Enables the Antimicrobial Action of LL-37 Peptide in the Presence of Microbial Proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVASIVE BACTERIAL-INFECTION; HUMAN CATHELICIDIN LL-37; INNATE IMMUNE-RESPONSE; F-ACTIN; HOST-DEFENSE; PORPHYROMONAS-GINGIVALIS; ANTIBACTERIAL PEPTIDES; CONFORMATIONAL-CHANGES; CYSTIC-FIBROSIS; IN-VITRO	Host defense peptides play an important host-protective role by their microcidal action, immunomodulatory functions, and tissue repair activities. Proteolysis is a common strategy of pathogens used to neutralize host defense peptides. Here, we show that actin, the most abundant structural protein in eukaryotes, binds the LL-37 host defense peptide, protects it from degradation by the proteases of Pseudomonas aeruginosa and Porphyromonas gingivalis, and enables its antimicrobial activity despite the presence of the proteases. Co-localization of LL-37 with extracellular actin was observed in necrotized regions of samples from oral lesions. Competition assays, cross-linking experiments, limited proteolysis, and mass spectrometry revealed that LL-37 binds by specific hydrophobic interactions to the His-40-Lys-50 segment of actin, located in the DNase I binding loop. The integrity of the binding site of both LL-37 and actin is a prerequisite to the binding. Our results demonstrate that actin, presumably released by dead cells and abundant in infected sites, might be utilized by the immune system to enhance spatio-temporal immunity in an attempt to arrest infection and control inflammation.	[Sol, Asaf; Skvirsky, Yaniv; Zelentsova, Katya; Burstyn-Cohen, Tal; Muhlrad, Andras; Bachrach, Gilad] Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Inst Dent Sci, IL-91120 Jerusalem, Israel; [Nashef, Rizan] Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Dept Oral & Maxillofacial Surg, IL-91120 Jerusalem, Israel; [Blotnick, Edna] Hebrew Univ Jerusalem, Dept Med Neurobiol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Bachrach, G (corresponding author), Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Inst Dent Sci, IL-91120 Jerusalem, Israel.	giladba@ekmd.huji.ac.il	Burstyn-Cohen, Tal/K-8846-2012	Burstyn-Cohen, Tal/0000-0002-2324-2921; Bachrach, Gilad/0000-0003-1350-2280; Sol, Asaf/0000-0002-8731-2490	Israel Science Foundation [208/10]	Israel Science Foundation(Israel Science Foundation)	This work was supported by Israel Science Foundation Grant 208/10.	Altman H, 2006, J ANTIMICROB CHEMOTH, V58, P198, DOI 10.1093/jac/dkl181; Bachrach G, 2008, ANTIMICROB AGENTS CH, V52, P638, DOI 10.1128/AAC.01271-07; Bals R, 1998, P NATL ACAD SCI USA, V95, P9541, DOI 10.1073/pnas.95.16.9541; Baron AC, 1999, J PERIODONTAL RES, V34, P437, DOI 10.1111/j.1600-0765.1999.tb02279.x; Benchaar SA, 2007, BIOCHEMISTRY-US, V46, P225, DOI 10.1021/bi0610754; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bucki R, 2007, EUR RESPIR J, V29, P624, DOI 10.1183/09031936.00080806; Carretero M, 2008, J INVEST DERMATOL, V128, P223, DOI 10.1038/sj.jid.5701043; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; COWLAND JB, 1995, FEBS LETT, V368, P173, DOI 10.1016/0014-5793(95)00634-L; de Haar SF, 2006, INFECT IMMUN, V74, P5284, DOI 10.1128/IAI.02016-05; Devine DA, 2002, CURR PHARM DESIGN, V8, P703, DOI 10.2174/1381612023395501; Devine DA, 1999, MICROBIOL-UK, V145, P965, DOI 10.1099/13500872-145-4-965; Eli-Berchoer L, 2000, J MUSCLE RES CELL M, V21, P405, DOI 10.1023/A:1005649604515; FOLK JE, 1985, METHOD ENZYMOL, V113, P358; Gutner M, 2009, INFECT IMMUN, V77, P5558, DOI 10.1128/IAI.00648-09; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hegyi G, 1998, BIOCHEMISTRY-US, V37, P17784, DOI 10.1021/bi981285j; Hilpert K, 2005, NAT BIOTECHNOL, V23, P1008, DOI 10.1038/nbt1113; Hirsch T, 2009, J GENE MED, V11, P220, DOI 10.1002/jgm.1287; Hollands A, 2012, J BIOL CHEM, V287, P40891, DOI 10.1074/jbc.M112.404582; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kim E, 1995, BIOPHYS J, V69, P2024, DOI 10.1016/S0006-3495(95)80072-X; Koziel J, 2010, J INNATE IMMUN, V2, P288, DOI 10.1159/000281881; Lehrer RI, 2002, CURR OPIN HEMATOL, V9, P18, DOI 10.1097/00062752-200201000-00004; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Mookherjee N, 2009, J IMMUNOL, V183, P2688, DOI 10.4049/jimmunol.0802586; Morioka Y, 2008, J IMMUNOL, V181, P3915, DOI 10.4049/jimmunol.181.6.3915; Muhlrad A, 2004, J MOL BIOL, V342, P1559, DOI 10.1016/j.jmb.2004.08.010; Muhlrad A, 2011, BIOPHYS CHEM, V155, P45, DOI 10.1016/j.bpc.2011.02.008; MUSZBEK L, 1975, ARCH BIOCHEM BIOPHYS, V167, P99, DOI 10.1016/0003-9861(75)90445-2; MUSZBEK L, 1974, P NATL ACAD SCI USA, V71, P2208, DOI 10.1073/pnas.71.6.2208; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Puius YA, 1998, CURR OPIN CELL BIOL, V10, P23, DOI 10.1016/S0955-0674(98)80083-5; Puklo M, 2008, ORAL MICROBIOL IMMUN, V23, P328, DOI 10.1111/j.1399-302X.2008.00433.x; Putsep K, 2002, LANCET, V360, P1144, DOI 10.1016/S0140-6736(02)11201-3; Radzishevsky IS, 2007, NAT BIOTECHNOL, V25, P657, DOI 10.1038/nbt1309; Rosen G, 2012, INFECT IMMUN, V80, P1107, DOI 10.1128/IAI.05903-11; Rottner K, 2011, CURR OPIN CELL BIOL, V23, P569, DOI 10.1016/j.ceb.2011.07.003; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; SCHWYTER D, 1989, BIOCHEMISTRY-US, V28, P5889, DOI 10.1021/bi00440a027; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Sieprawska-Lupa M, 2004, ANTIMICROB AGENTS CH, V48, P4673, DOI 10.1128/AAC.48.12.4673-4679.2004; Sochacki KA, 2011, P NATL ACAD SCI USA, V108, pE77, DOI 10.1073/pnas.1101130108; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Sol A, 2013, INFECT IMMUN, V81, P3577, DOI 10.1128/IAI.01288-12; Sol A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050078; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; Thomassin JL, 2012, INFECT IMMUN, V80, P483, DOI 10.1128/IAI.05674-11; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Wang GS, 2012, ANTIMICROB AGENTS CH, V56, P845, DOI 10.1128/AAC.05637-11; Weiner DJ, 2003, AM J RESP CELL MOL, V28, P738, DOI 10.1165/rcmb.2002-0191OC; WELSH MJ, 1995, SCI AM, V273, P52, DOI 10.1038/scientificamerican1295-52; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Zaiou M, 2003, J INVEST DERMATOL, V120, P810, DOI 10.1046/j.1523-1747.2003.12132.x; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	60	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22926	22941		10.1074/jbc.M114.579672	http://dx.doi.org/10.1074/jbc.M114.579672			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24947511	Green Published, hybrid			2022-12-25	WOS:000341017200033
J	Zhang, YX; Shimizu, H; Siu, KL; Mahajan, A; Chen, JN; Cai, H				Zhang, Yixuan; Shimizu, Hirohito; Siu, Kin Lung; Mahajan, Aman; Chen, Jau-Nian; Cai, Hua			NADPH Oxidase 4 Induces Cardiac Arrhythmic Phenotype in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATRIAL-FIBRILLATION; OXIDATIVE STRESS; CARDIOVASCULAR-SYSTEM; MODEL; NOX4; DYSFUNCTION; SUPEROXIDE; ACTIVATION; EXPRESSION; INCREASES	Oxidative stress has been implicated in cardiac arrhythmia, although a causal relationship remains undefined. We have recently demonstrated a marked up-regulation of NADPH oxidase isoform 4 (NOX4) in patients with atrial fibrillation, which is accompanied by overproduction of reactive oxygen species (ROS). In this study, we investigated the impact on the cardiac phenotype of NOX4 overexpression in zebrafish. One-cell stage embryos were injected with NOX4 RNA prior to video recording of a GFP-labeled (myl7:GFP zebrafish line) beating heart in real time at 24-31 h post-fertilization. Intriguingly, NOX4 embryos developed cardiac arrhythmia that is characterized by irregular heartbeats. When quantitatively analyzed by an established LQ-1 program, the NOX4 embryos displayed much more variable beat-to-beat intervals (mean S. D. of beat-to-beat intervals was 0.027 s/beat in control embryos versus 0.038 s/beat in NOX4 embryos). Both the phenotype and the increased ROS in NOX4 embryos were attenuated by NOX4 morpholino co-injection, treatments of the embryos with polyethylene glycol-conjugated superoxide dismutase, or NOX4 inhibitors fulvene-5, 6-dimethylaminofulvene, and proton sponge blue. Injection of NOX4-P437H mutant RNA had no effect on the cardiac phenotype or ROS production. In addition, phosphorylation of calcium/calmodulin- dependent protein kinase II was increased in NOX4 embryos but diminished by polyethylene glycol-conjugated superoxide dismutase, whereas its inhibitor KN93 or AIP abolished the arrhythmic phenotype. Taken together, our data for the first time uncover a novel pathway that underlies the development of cardiac arrhythmia, namely NOX4 activation, subsequent NOX4-specific NADPH-driven ROS production, and redox-sensitive CaMKII activation. These find-ings may ultimately lead to novel therapeutics targeting cardiac arrhythmia.	[Zhang, Yixuan; Siu, Kin Lung; Mahajan, Aman; Cai, Hua] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Div Mol Med,Dept Anesthesiol, Los Angeles, CA 90095 USA; [Zhang, Yixuan; Siu, Kin Lung; Mahajan, Aman; Cai, Hua] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Div Mol Med,Dept Med, Los Angeles, CA 90095 USA; [Zhang, Yixuan; Siu, Kin Lung; Mahajan, Aman; Cai, Hua] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Div Cardiol,Dept Anesthesiol, Los Angeles, CA 90095 USA; [Zhang, Yixuan; Siu, Kin Lung; Mahajan, Aman; Cai, Hua] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Div Cardiol,Dept Med, Los Angeles, CA 90095 USA; [Shimizu, Hirohito; Chen, Jau-Nian] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Cai, H (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Div Mol Med,Dept Anesthesiol & Med, 650 Charles E Young Dr, Los Angeles, CA 90095 USA.	hcai@mednet.ucla.edu	Zhang, Yixuan/I-8007-2014; Chen, Jau-Nian/AAM-7808-2020	Zhang, Yixuan/0000-0001-7317-7235; Chen, Jau-Nian/0000-0001-8807-3607	National Institutes of Health from NHLBI [HL077440, HL088975, HL108701, HL119968, HL096980]; American Heart Association [12EIA8990025]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108701, R01HL096980, R01HL077440, R01HL119968, R01HL088975] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL077440 and HL088975 (to H. C.), HL108701 (to H. C. and D. G. H.), HL119968 (to H. C.), and HL096980 (to J. N. C.) from NHLBI. This work was also supported by American Heart Association Established Investigator Award 12EIA8990025 (to H. C.).	Ago T, 2010, CIRC RES, V106, P1253, DOI 10.1161/CIRCRESAHA.109.213116; Bakkers J, 2011, CARDIOVASC RES, V91, P279, DOI 10.1093/cvr/cvr098; Bhandarkar SS, 2009, J CLIN INVEST, V119, P2359, DOI 10.1172/JCI33877; Burns CG, 2005, NAT CHEM BIOL, V1, P263, DOI 10.1038/nchembio732; Cai H, 2002, CIRCULATION, V106, P2854, DOI 10.1161/01.CIR.0000039327.11661.16; Chalupsky K, 2005, P NATL ACAD SCI USA, V102, P9056, DOI 10.1073/pnas.0409594102; Chan PK, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-11; Chang JP, 2011, CARDIOVASC PATHOL, V20, P99, DOI 10.1016/j.carpath.2009.12.005; Chen JN, 1996, DEVELOPMENT, V123, P293; Chen JN, 1996, DEVELOPMENT, V122, P3809; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Craige SM, 2011, CIRCULATION, V124, P731, DOI 10.1161/CIRCULATIONAHA.111.030775; DINAUER MC, 1989, J CLIN INVEST, V84, P2012, DOI 10.1172/JCI114393; Dudley SC, 2005, CIRCULATION, V112, P1266, DOI 10.1161/CIRCULATIONAHA.105.538108; Elahi MM, 2008, EUR J CARDIOV PREV R, V15, P735, DOI 10.1097/HJR.0b013e328317f38a; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Gao L, 2009, J MOL CELL CARDIOL, V47, P752, DOI 10.1016/j.yjmcc.2009.07.025; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Incardona JP, 2009, ENVIRON SCI TECHNOL, V43, P201, DOI 10.1021/es802270t; Kang KA, 2006, J RADIAT RES, V47, P61, DOI 10.1269/jrr.47.61; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Kim YM, 2005, CIRC RES, V97, P629, DOI 10.1161/01.RES.0000183735.09871.61; Kim YM, 2008, J AM COLL CARDIOL, V51, P68, DOI 10.1016/j.jacc.2007.07.085; Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152; Kuroda J, 2010, P NATL ACAD SCI USA, V107, P15565, DOI 10.1073/pnas.1002178107; Langenbacher AD, 2005, P NATL ACAD SCI USA, V102, P17699, DOI 10.1073/pnas.0502679102; Li JY, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0271-7; Lu G, 2007, GENE DEV, V21, P784, DOI 10.1101/gad.1499107; Munson JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003016; Nguyen Catherine T, 2008, Drug Discov Today Dis Models, V5, P135; Perry BN, 2006, J INVEST DERMATOL, V126, P2316, DOI 10.1038/sj.jid.5700413; Ray R, 2011, ARTERIOSCL THROM VAS, V31, P1368, DOI 10.1161/ATVBAHA.110.219238; Rothschild SC, 2007, DEV DYNAM, V236, P295, DOI 10.1002/dvdy.21005; Rothschild SC, 2009, DEV BIOL, V330, P175, DOI 10.1016/j.ydbio.2009.03.024; Schwerte T, 2006, J EXP BIOL, V209, P1093, DOI 10.1242/jeb.02117; Ueno N, 2005, J BIOL CHEM, V280, P23328, DOI 10.1074/jbc.M414548200; Youn JY, 2012, DIABETOLOGIA, V55, P2069, DOI 10.1007/s00125-012-2557-6; Youn JY, 2013, J MOL CELL CARDIOL, V62, P72, DOI 10.1016/j.yjmcc.2013.04.019; Zhang J, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00140; Zhang J, 2010, J MOL CELL CARDIOL, V48, P1060, DOI 10.1016/j.yjmcc.2009.11.020; Zhang YY, 2013, AQUAT TOXICOL, V142, P26, DOI 10.1016/j.aquatox.2013.07.014	41	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23200	23208		10.1074/jbc.M114.587196	http://dx.doi.org/10.1074/jbc.M114.587196			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24962575	Green Published, hybrid			2022-12-25	WOS:000341017200056
J	Qiao, H; Liu, Y; Veach, RA; Wylezinski, L; Hawiger, J				Qiao, Huan; Liu, Yan; Veach, Ruth A.; Wylezinski, Lukasz; Hawiger, Jacek			The Adaptor CRADD/RAIDD Controls Activation of Endothelial Cells by Proinflammatory Stimuli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; LUNG MICROVASCULAR ENDOTHELIA; FAMILY KINASE ACTIVATION; PARACELLULAR PATHWAY; IMMUNE-RESPONSES; BARRIER FUNCTION; GROWTH-FACTOR; PROTEIN; BCL10; RECEPTOR	A hallmark of inflammation, increased vascular permeability, is induced in endothelial cells by multiple agonists through stimulus-coupled assembly of the CARMA3 signalosome, which contains the adaptor protein BCL10. Previously, we reported that BCL10 in immune cells is targeted by the "death" adaptor CRADD/RAIDD (CRADD), which negatively regulates nuclear factor kappa B (NF kappa B)-dependent cytokine and chemokine expression in T cells (Lin, Q., Liu, Y., Moore, D. J., Elizer, S. K., Veach, R. A., Hawiger, J., and Ruley, H. E. (2012) J. Immunol. 188, 2493-2497). This novel anti-inflammatory CRADD-BCL10 axis prompted us to analyze CRADD expression and its potential anti-inflammatory action in non-immune cells. We focused our study on microvascular endothelial cells because they play a key role in inflammation. We found that CRADD-deficient murine endothelial cells display heightened BCL10-mediated expression of the pleotropic proinflammatory cytokine IL-6 and chemokine monocyte chemoattractant protein-1 (MCP-1/CCL2) in response to LPS and thrombin. Moreover, these agonists also induce significantly increased permeability in cradd(-/-), as compared with cradd(+/+), primary murine endothelial cells. CRADD-deficient cells displayed more F-actin polymerization with concomitant disruption of adherens junctions. In turn, increasing intracellular CRADD by delivery of a novel recombinant cell-penetrating CRADD protein (CP-CRADD) restored endothelial barrier function and suppressed the induction of IL-6 and MCP-1 evoked by LPS and thrombin. Likewise, CP-CRADD enhanced barrier function in CRADD-sufficient endothelial cells. These results indicate that depletion of endogenous CRADD compromises endothelial barrier function in response to inflammatory signals. Thus, we define a novel function for CRADD in endothelial cells as an inducible suppressor of BCL10, a key mediator of responses to proinflammatory agonists.	[Qiao, Huan; Liu, Yan; Veach, Ruth A.; Hawiger, Jacek] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med,Sch Med, Nashville, TN 37232 USA; [Wylezinski, Lukasz; Hawiger, Jacek] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Hawiger, J (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med,Sch Med, 1161 21st Ave S, Nashville, TN 37232 USA.	jacek.hawiger@vanderbilt.edu		Wylezinski, Lukasz/0000-0001-6481-8379; Veach, Ruth Ann/0000-0003-0038-8802	Vanderbilt University Medical Center's Digestive Disease Research Center - National Institutes of Health [P30DK058404]; Vanderbilt Ingram Cancer Center by National Institutes of Health [P30CA068485]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085833, T32HL069765, R01HL069452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015752] Funding Source: NIH RePORTER	Vanderbilt University Medical Center's Digestive Disease Research Center - National Institutes of Health; Vanderbilt Ingram Cancer Center by National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Fluorescence microscopy and analysis was performed in part through the use of the VUMC Cell Imaging Shared Resource. Cell Imaging and other Core Services were funded in part through Vanderbilt University Medical Center's Digestive Disease Research Center supported by National Institutes of Health Grant P30DK058404 and the Vanderbilt Ingram Cancer Center supported by National Institutes of Health Grant P30CA068485.	Aghajanian A, 2008, J THROMB HAEMOST, V6, P1453, DOI 10.1111/j.1538-7836.2008.03087.x; Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Bannerman DD, 1999, LAB INVEST, V79, P1181; Bhattacharyya S, 2007, AM J PHYSIOL-GASTR L, V293, pG429, DOI 10.1152/ajpgi.00149.2007; Bhattacharyya S, 2010, EXP CELL RES, V316, P3317, DOI 10.1016/j.yexcr.2010.05.004; Blonska M, 2009, IMMUNOL REV, V228, P199, DOI 10.1111/j.1600-065X.2008.00749.x; Bogatcheva NV, 2009, J CELL PHYSIOL, V221, P750, DOI 10.1002/jcp.21913; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Colgan OC, 2007, AM J PHYSIOL-HEART C, V292, pH3190, DOI 10.1152/ajpheart.01177.2006; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Delekta PC, 2010, J BIOL CHEM, V285, P41432, DOI 10.1074/jbc.M110.158949; Desai TR, 2002, J SURG RES, V104, P118, DOI 10.1006/jsre.2002.6415; DiGiandomenico A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.1162191; Dong W, 2006, J BIOL CHEM, V281, P26029, DOI 10.1074/jbc.M513057200; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Fletcher TC, 2010, J BIOL CHEM, V285, P18727, DOI 10.1074/jbc.M109.095216; Fraser CC, 2008, INT REV IMMUNOL, V27, P320, DOI 10.1080/08830180802262765; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Garcia Joe G. N., 1996, Seminars in Thrombosis and Hemostasis, V22, P309, DOI 10.1055/s-2007-999025; Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011; Gong P, 2008, J BIOL CHEM, V283, P13437, DOI 10.1074/jbc.M707986200; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hawiger J, 2011, CRIT CARE, V15, DOI 10.1186/cc10482; He F, 2011, NEUROSCIENCE, V188, P35, DOI 10.1016/j.neuroscience.2011.04.025; Herwig MC, 2013, PATHOBIOLOGY, V80, P245, DOI 10.1159/000347062; Hirano K, 2007, ARTERIOSCL THROM VAS, V27, P27, DOI 10.1161/01.ATV.0000251995.73307.2d; Jiang CY, 2012, IMMUNOL REV, V246, P141, DOI 10.1111/j.1600-065X.2012.01110.x; Jo D, 2005, NAT MED, V11, P892, DOI 10.1038/nm1269; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Kenne E, 2011, THROMB HAEMOSTASIS, V105, P783, DOI 10.1160/TH10-10-0635; Klemm S, 2007, P NATL ACAD SCI USA, V104, P134, DOI 10.1073/pnas.0608388103; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lin Q, 2012, J IMMUNOL, V188, P2493, DOI 10.4049/jimmunol.1101502; Liu AG, 2012, J BIOL CHEM, V287, P16132, DOI 10.1074/jbc.M111.310102; Londono D, 2011, J IMMUNOL, V186, P7176, DOI 10.4049/jimmunol.1100060; Major CD, 2003, ARTERIOSCL THROM VAS, V23, P931, DOI 10.1161/01.ATV.0000070100.47907.26; Marion S, 2012, DEV CELL, V23, P954, DOI 10.1016/j.devcel.2012.09.021; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; Martorell L, 2008, THROMB HAEMOSTASIS, V99, P305, DOI 10.1160/TH07-08-0481; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; McAllister-Lucas LM, 2010, J BIOL CHEM, V285, P25880, DOI 10.1074/jbc.C110.109421; Minami T, 2004, ARTERIOSCL THROM VAS, V24, P41, DOI 10.1161/01.ATV.0000099880.09014.7D; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Paul S, 2013, TRENDS IMMUNOL, V34, P269, DOI 10.1016/j.it.2013.02.002; Qiao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035746; Rakesh K, 2005, BIOCHEM PHARMACOL, V70, P649, DOI 10.1016/j.bcp.2005.04.042; Rueda D, 2007, J IMMUNOL, V178, P4373, DOI 10.4049/jimmunol.178.7.4373; SCHREIBER AB, 1985, P NATL ACAD SCI USA, V82, P6138, DOI 10.1073/pnas.82.18.6138; Stamatovic SM, 2003, J CELL SCI, V116, P4615, DOI 10.1242/jcs.00755; Sun Jiyuan, 2010, World J Biol Chem, V1, P353, DOI 10.4331/wjbc.v1.i12.353; Unger RE, 2002, MICROVASC RES, V64, P384, DOI 10.1006/mvre.2002.2434; van der Heijden M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023448; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Wang DH, 2007, P NATL ACAD SCI USA, V104, P145, DOI 10.1073/pnas.0601894104; Wang YX, 2013, INT J MOL MED, V32, P568, DOI 10.3892/ijmm.2013.1420; Wegener Elmar, 2007, Sci STKE, V2007, ppe21, DOI 10.1126/stke.3842007pe21; Yuan D, 2012, J APPL PHYSIOL, V113, P1110, DOI 10.1152/japplphysiol.00102.2012; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	60	8	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21973	21983		10.1074/jbc.M114.588723	http://dx.doi.org/10.1074/jbc.M114.588723			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24958727	hybrid, Green Published			2022-12-25	WOS:000340593500014
J	Chiang, EPI; Tsai, SY; Kuo, YH; Pai, MH; Chiu, HL; Rodriguez, RL; Tang, FY				Chiang, En-Pei Isabel; Tsai, Shu-Yao; Kuo, Yueh-Hsiung; Pai, Man-Hui; Chiu, Hsi-Lin; Rodriguez, Raymond L.; Tang, Feng-Yao			Caffeic Acid Derivatives Inhibit the Growth of Colon Cancer: Involvement of the PI3-K/Akt and AMPK Signaling Pathways	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PHENETHYL ESTER CAPE; COLORECTAL-CANCER; TUMOR-GROWTH; CYCLIN D1; EXPRESSION; CELLS; ENERGY; CONSUMPTION; PROGRESSION	Background: The aberrant regulation of phosphatidylinositide 3-kinases (PI3-K)/Akt, AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (m-TOR) signaling pathways in cancer has prompted significant interest in the suppression of these pathways to treat cancer. Caffeic acid (CA) has been reported to possess important anti-inflammatory actions. However, the molecular mechanisms by which CA derivatives including caffeic acid phenethyl ester (CAPE) and caffeic acid phenylpropyl ester (CAPPE), exert inhibitory effects on the proliferation of human colorectal cancer (CRC) cells have yet to be elucidated. Methodology/Principal Findings: CAPE and CAPPE were evaluated for their ability to modulate these signaling pathways and suppress the proliferation of CRC cells both in vitro and in vivo. Anti-cancer effects of these CA derivatives were measured by using proliferation assays, cell cycle analysis, western blotting assay, reporter gene assay and immunohistochemical (IHC) staining assays both in vitro and in vivo. This study demonstrates that CAPE and CAPPE exhibit a dose-dependent inhibition of proliferation and survival of CRC cells through the induction of G(0)/G(1) cell cycle arrest and augmentation of apoptotic pathways. Consumption of CAPE and CAPPE significantly inhibited the growth of colorectal tumors in a mouse xenograft model. The mechanisms of action included a modulation of PI3-K/Akt, AMPK and m-TOR signaling cascades both in vitro and in vivo. In conclusion, the results demonstrate novel anti-cancer mechanisms of CA derivatives against the growth of human CRC cells. Conclusions: CA derivatives are potent anti-cancer agents that augment AMPK activation and promote apoptosis in human CRC cells. The structure of CA derivatives can be used for the rational design of novel inhibitors that target human CRC cells.	[Chiang, En-Pei Isabel] Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, Taichung 40227, Taiwan; [Chiang, En-Pei Isabel] Natl Chung Hsing Univ, NCHU UCD Plant & Food Biotechnol Program, Taichung 40227, Taiwan; [Chiang, En-Pei Isabel] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Tsai, Shu-Yao] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan; [Kuo, Yueh-Hsiung; Chiu, Hsi-Lin] China Med Univ, Dept Chinese Pharmaceut Sci & Chinese Med Resourc, Taichung, Taiwan; [Kuo, Yueh-Hsiung; Chiu, Hsi-Lin] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Pai, Man-Hui] Taipei Med Univ, Dept Anat, Taipei, Taiwan; [Rodriguez, Raymond L.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Tang, Feng-Yao] China Med Univ, Dept Nutr, Biomed Sci Lab, Taichung, Taiwan	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; Asia University Taiwan; China Medical University Taiwan; Asia University Taiwan; Taipei Medical University; University of California System; University of California Davis; China Medical University Taiwan	Tang, FY (corresponding author), China Med Univ, Dept Nutr, Biomed Sci Lab, Taichung, Taiwan.	vincenttang@mail.cmu.edu.tw	Chiang, EnPei/K-1694-2013	Chiang, EnPei/0000-0002-0158-0962	National Science Council [NSC-100-2320-B-039-003, 100-2628-B005-002-MY4, 101-2320-B-039-054-MY3, 101-2320-B-005-006-MY3, 102-2911-I-005 -301, 101-2811-B-039-024]; Department of Health [DOH 102-TD-B-111-004, DOH-102-TD-C-111-005]; China Medical University (CMU) [CMU101- Award -10, CMU100-ASIA-11, CMU101-ASIA-3, CMU101-S-25]; Ministry of Education, Taiwan, R.O.C.	National Science Council(Ministry of Science and Technology, Taiwan); Department of Health; China Medical University (CMU)(China Medical University); Ministry of Education, Taiwan, R.O.C.(Ministry of Education, Taiwan)	This material is based upon work supported, in part, by the Ministry of Education, Taiwan, R.O.C. under the ATU plan, National Science Council grant, under Agreements NSC-100-2320-B-039-003, 100-2628-B005-002-MY4, 101-2320-B-039-054-MY3, 101-2320-B-005-006-MY3, 102-2911-I-005 -301, 101-2811-B-039-024, the Department of Health Grant under Agreements DOH 102-TD-B-111-004 and DOH-102-TD-C-111-005 and China Medical University (CMU) grant under Agreements CMU101- Award -10, CMU100-ASIA-11, CMU101-ASIA-3, and CMU101-S-25. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the Ministry of Education, National Science Council, Department of Health, National Chung Hsing University, Taipei Medical University, Asia University, University of California Davis and China Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algire C, 2010, ENDOCR-RELAT CANCER, V17, P351, DOI 10.1677/ERC-09-0252; Aparicio T, 1999, GASTROEN CLIN BIOL, V23, P330; Baba Y, 2010, BRIT J CANCER, V103, P1025, DOI 10.1038/sj.bjc.6605846; Bates RC, 2001, CANCER RES, V61, P5275; Chen MF, 2004, J RADIAT RES, V45, P253, DOI 10.1269/jrr.45.253; Chuu CP, 2012, CANCER PREV RES, V5, P788, DOI 10.1158/1940-6207.CAPR-12-0004-T; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; Gocer H, 2011, INT J FOOD SCI NUTR, V62, P821, DOI 10.3109/09637486.2011.585963; Gulhati P, 2012, CARCINOGENESIS, V33, P1782, DOI 10.1093/carcin/bgs203; Gustin JP, 2009, P NATL ACAD SCI USA, V106, P2835, DOI 10.1073/pnas.0813351106; Halilovic E, 2010, CANCER RES, V70, P6804, DOI 10.1158/0008-5472.CAN-10-0409; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Kuchiba A, 2012, JNCI-J NATL CANCER I, V104, P415, DOI 10.1093/jnci/djr542; Kuo YY, 2013, INT J MOL SCI, V14, P8801, DOI 10.3390/ijms14058801; Liao HF, 2003, J AGR FOOD CHEM, V51, P7907, DOI 10.1021/jf034729d; Lin HP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031286, 10.1371/journal.pone.0035240]; Liu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047049; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Mohan S, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-40; Nardini M, 1998, FREE RADICAL BIO MED, V25, P1098, DOI 10.1016/S0891-5849(98)00180-4; Nardini M, 2001, FREE RADICAL BIO MED, V30, P722, DOI 10.1016/S0891-5849(00)00515-3; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Philp AJ, 2001, CANCER RES, V61, P7426; Piazzon A, 2012, J AGR FOOD CHEM, V60, P12312, DOI 10.1021/jf304076z; Ponnurangam S, 2013, MOL CANCER THER, V12, P598, DOI 10.1158/1535-7163.MCT-12-0907; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Pramanik KC, 2013, CARCINOGENESIS, V34, P2061, DOI 10.1093/carcin/bgt154; Ramana KV, 2010, MOL CANCER THER, V9, P813, DOI 10.1158/1535-7163.MCT-09-0795; Ribeiro U, 2007, J CLIN GASTROENTEROL, V41, P871, DOI 10.1097/MCG.0b013e31806b5938; SATO R, 1993, P NATL ACAD SCI USA, V90, P9261, DOI 10.1073/pnas.90.20.9261; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Slattery ML, 2010, CARCINOGENESIS, V31, P1604, DOI 10.1093/carcin/bgq142; Stacey DW, 2003, CURR OPIN CELL BIOL, V15, P158, DOI 10.1016/S0955-0674(03)00008-5; Tang FY, 2008, MOL NUTR FOOD RES, V52, P646, DOI 10.1002/mnfr.200700272; Tang FY, 2008, J NUTR BIOCHEM, V19, P287, DOI 10.1016/j.jnutbio.2007.03.003; Tang FY, 2012, MOL NUTR FOOD RES, V56, P1520, DOI 10.1002/mnfr.201200098; Tang FY, 2012, J NUTR BIOCHEM, V23, P1302, DOI 10.1016/j.jnutbio.2011.07.011; Tang FY, 2011, J AGR FOOD CHEM, V59, P9011, DOI 10.1021/jf2017644; Tolba MF, 2013, IUBMB LIFE, V65, P716, DOI 10.1002/iub.1188; Uwai K, 2008, BIOORGAN MED CHEM, V16, P7795, DOI 10.1016/j.bmc.2008.07.006; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vogt PK, 2007, TRENDS BIOCHEM SCI, V32, P342, DOI 10.1016/j.tibs.2007.05.005; Wang QS, 1998, CARCINOGENESIS, V19, P2001, DOI 10.1093/carcin/19.11.2001; Wang W, 2009, ACTA PHYSIOL, V196, P55, DOI 10.1111/j.1748-1716.2009.01980.x; Wee S, 2009, CANCER RES, V69, P4286, DOI 10.1158/0008-5472.CAN-08-4765; Weyant MJ, 2000, CLIN CANCER RES, V6, P949; Wolter F, 2001, J NUTR, V131, P2197, DOI 10.1093/jn/131.8.2197; Xiang DB, 2006, ANTI-CANCER DRUG, V17, P753, DOI 10.1097/01.cad.0000224441.01082.bb; Yilmaz HR, 2004, J BIOCHEM MOL TOXIC, V18, P234, DOI 10.1002/jbt.20028; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zakikhani M, 2008, CANCER PREV RES, V1, P369, DOI 10.1158/1940-6207.CAPR-08-0081	57	74	74	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99631	10.1371/journal.pone.0099631	http://dx.doi.org/10.1371/journal.pone.0099631			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960186	Green Published, gold			2022-12-25	WOS:000338633900012
J	Shiloach, T; Berens, C; Danke, C; Waiskopf, O; Perlman, R; Ben-Yehuda, D				Shiloach, Tamar; Berens, Christian; Danke, Christina; Waiskopf, Ortal; Perlman, Riki; Ben-Yehuda, Dina			tLivin Displays Flexibility by Promoting Alternative Cell Death Mechanisms	PLOS ONE			English	Article							APOPTOSIS PROTEIN FAMILY; LUNG-CANCER; POLY(ADP-RIBOSE) POLYMERASE-1; SIGNAL-TRANSDUCTION; IAP PROTEINS; KINASE RIP; ML-IAP; INHIBITOR; LIVIN; EXPRESSION	Livin is a member of the Inhibitor of Apoptosis (IAP) protein family that inhibits apoptosis triggered by a variety of stimuli. We previously demonstrated that while Livin inhibits caspase activity, caspases can cleave Livin to produce a truncated protein, tLivin and that this newly formed tLivin paradoxically induces cell death. However to date, the mechanism of tLivin-induced cell death is not fully understood. In this study, we set out to characterize the form of cell death mediated by tLivin. Here we demonstrate that, unlike most death-promoting proteins, tLivin is a flexible inducer of cell death capable of promoting necrosis or apoptosis in different cell lines. The unusual flexibility of tLivin is displayed by its ability to activate an alternative form of cell death when apoptosis is inhibited. Thus, tLivin can promote more than one form of cell death in the same cell type. Interestingly, in cells where tLivin induces necrosis, deletion of the caspase binding BIR domain results in tLivin-induced apoptosis, suggesting the BIR domain can potentially hamper the ability of tLivin to induce apoptosis. We further elucidate that tLivin activates the JNK pathway and both tLivin-induced apoptosis and necrosis are partially mediated by JNK activity. Acquired resistance to apoptosis, common in many tumors, impinges on the efficiency of conventional anti-cancer agents that function primarily by inducing apoptosis. The ability of tLivin to induce death of apoptosis-compromised cells makes it an attractive candidate for targeted cancer therapy.	[Shiloach, Tamar; Waiskopf, Ortal; Perlman, Riki; Ben-Yehuda, Dina] Hadassah Hebrew Univ Med Ctr, Div Hematol, Jerusalem, Israel; [Berens, Christian; Danke, Christina] Univ Erlangen Nurnberg, Dept Biol Microbiol, D-91054 Erlangen, Germany	Hebrew University of Jerusalem; University of Erlangen Nuremberg	Ben-Yehuda, D (corresponding author), Hadassah Hebrew Univ Med Ctr, Div Hematol, Jerusalem, Israel.	dbyehuda@hadassah.org.il			Israel Science Foundation [524/06]; Public Committee for the Allocation of Estate Funds [3000003130]; Israel Ministry of Justice [3130]; Gabrielle Rich Leukemia Foundation	Israel Science Foundation(Israel Science Foundation); Public Committee for the Allocation of Estate Funds; Israel Ministry of Justice; Gabrielle Rich Leukemia Foundation	This work was supported by the Israel Science Foundation (grant 524/06), the Public Committee for the Allocation of Estate Funds (grant 3000003130), Israel Ministry of Justice (grant 3130) and the Gabrielle Rich Leukemia Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Elrahman I, 2009, CANCER RES, V69, P5475, DOI 10.1158/0008-5472.CAN-09-0424; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Ashhab Y, 2001, FEBS LETT, V495, P56, DOI 10.1016/S0014-5793(01)02366-3; Basu A, 2003, FEBS LETT, V538, P41, DOI 10.1016/S0014-5793(03)00131-5; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; CAMPOS L, 1993, BLOOD, V81, P3091; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Chen YS, 2010, MOL BIOL REP, V37, P2241, DOI 10.1007/s11033-009-9711-3; Clem RJ, 2001, J BIOL CHEM, V276, P7602, DOI 10.1074/jbc.M010259200; Crnkovic-Mertens I, 2006, LUNG CANCER, V54, P135, DOI 10.1016/j.lungcan.2006.07.018; Danke C, 2010, J GENE MED, V12, P501, DOI 10.1002/jgm.1461; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Dunai ZA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041945; Engstrom W, 2010, CELL PROLIFERAT, V43, P56, DOI 10.1111/j.1365-2184.2009.00654.x; Fan MY, 2000, J BIOL CHEM, V275, P29980, DOI 10.1074/jbc.M003776200; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Gong J, 2005, J CLIN PATHOL, V58, P1081, DOI 10.1136/jcp.2005.025817; Guimaraes CA, 2004, EUR J BIOCHEM, V271, P1638, DOI 10.1111/j.1432-1033.2004.04084.x; Hariu H, 2005, CLIN CANCER RES, V11, P1000; Herr R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-17; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Kasof GM, 2001, J BIOL CHEM, V276, P3238, DOI 10.1074/jbc.M003670200; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Kim DK, 2005, PEDIATR DEVEL PATHOL, V8, P621, DOI 10.1007/s10024-005-4108-3; Kim JY, 2011, APOPTOSIS, V16, P114, DOI 10.1007/s10495-010-0550-4; Kreuzaler P, 2012, NAT REV CANCER, V12, P411, DOI 10.1038/nrc3264; Lazar I, 2012, ONCOLOGY-BASEL, V82, P197, DOI 10.1159/000334234; LEHMANN F, 1995, EUR J IMMUNOL, V25, P340, DOI 10.1002/eji.1830250206; Levy DS, 2009, BLOOD, V113, P1723, DOI 10.1182/blood-2008-02-137737; Lin JH, 2000, BIOCHEM BIOPH RES CO, V279, P820, DOI 10.1006/bbrc.2000.4027; Liu GH, 2013, INT J ONCOL, V42, P2037, DOI 10.3892/ijo.2013.1883; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; Ma L, 2006, CELL DEATH DIFFER, V13, P2079, DOI 10.1038/sj.cdd.4401959; Mace PD, 2010, CELL DEATH DIFFER, V17, P46, DOI 10.1038/cdd.2009.45; Maueroder C, 2013, AUTOIMMUNITY, V46, P329, DOI 10.3109/08916934.2012.752463; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Nachmias B, 2003, CANCER RES, V63, P6340; Okada M, 2004, BLOOD, V103, P2299, DOI 10.1182/blood-2003-05-1605; Ondrouskova E, 2008, LEUKEMIA RES, V32, P599, DOI 10.1016/j.leukres.2007.05.012; Ronen D, 2009, J BIOL CHEM, V284, P24948, DOI 10.1074/jbc.M109.023754; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Sanna MG, 2002, MOL CELL BIOL, V22, P1754, DOI 10.1128/MCB.22.6.1754-1766.2002; Shi Y, 2011, HERZ, V36, P296, DOI 10.1007/s00059-011-3470-3; Sugimoto K, 2002, BRIT J HAEMATOL, V118, P229, DOI 10.1046/j.1365-2141.2002.03577.x; Tanabe H, 2004, LUNG CANCER, V46, P299, DOI 10.1016/j.lungcan.2004.05.002; Tang FM, 2002, MOL CELL BIOL, V22, P8571, DOI 10.1128/MCB.22.24.8571-8579.2002; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Ventura JJ, 2004, GENE DEV, V18, P2905, DOI 10.1101/gad.1223004; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Vucic D, 2000, CURR BIOL, V10, P1359, DOI 10.1016/S0960-9822(00)00781-8; Wagener N, 2007, BRIT J CANCER, V97, P1271, DOI 10.1038/sj.bjc.6604028; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; Wang TS, 2010, BIOMED PHARMACOTHER, V64, P333, DOI 10.1016/j.biopha.2009.06.002; Xu Y, 2006, J BIOL CHEM, V281, P8788, DOI 10.1074/jbc.M508135200; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	65	3	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e101075	10.1371/journal.pone.0101075	http://dx.doi.org/10.1371/journal.pone.0101075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960127	gold, Green Submitted, Green Published			2022-12-25	WOS:000338633900116
J	Briney, BS; Willis, JR; Finn, JA; McKinney, BA; Crowe, JE				Briney, Bryan S.; Willis, Jordan R.; Finn, Jessica A.; McKinney, Brett A.; Crowe, James E., Jr.			Tissue-Specific Expressed Antibody Variable Gene Repertoires	PLOS ONE			English	Article							MEMORY B-CELLS; MONOCLONAL-ANTIBODIES; IMMUNOGLOBULIN HEAVY; SOMATIC MUTATION; IMMUNE-RESPONSE; HIV-1; INSERTIONS; DELETIONS; SEGMENT; REGION	Recent developments in genetic technologies allow deep analysis of the sequence diversity of immune repertoires, but little work has been reported on the architecture of immune repertoires in mucosal tissues. Antibodies are the key to prevention of infections at the mucosal surface, but it is currently unclear whether the B cell repertoire at mucosal surfaces reflects the dominant antibodies found in the systemic compartment or whether mucosal tissues harbor unique repertoires. We examined the expressed antibody variable gene repertoires from 10 different human tissues using RNA samples derived from a large number of individuals. The results revealed that mucosal tissues such as stomach, intestine and lung possess unique antibody gene repertoires that differed substantially from those found in lymphoid tissues or peripheral blood. Mutation frequency analysis of mucosal tissue repertoires revealed that they were highly mutated, with little evidence for the presence of naive B cells, in contrast to blood. Mucosal tissue repertoires possessed longer heavy chain complementarity determining region 3 loops than lymphoid tissue repertoires. We also noted a large increase in frequency of both insertions and deletions in the small intestine antibody repertoire. These data suggest that mucosal immune repertoires are distinct in many ways from the systemic compartment.	[Briney, Bryan S.; Finn, Jessica A.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Willis, Jordan R.] Vanderbilt Univ, Chem & Phys Biol Program, Nashville, TN 37235 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN USA; [McKinney, Brett A.] Univ Tulsa, Tandy Sch Comp Sci, Tulsa, OK 74104 USA; [McKinney, Brett A.] Univ Tulsa, Dept Math, Tulsa, OK 74104 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Tulsa; University of Tulsa	Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA.	james.crowe@vanderbilt.edu	Crowe, James/B-5549-2009	Crowe, James/0000-0002-0049-1079	NIH Contract [HHSN272200900047C]; NIH grant [R01 AI106002]; DoD grant [HDTRA1-10-1-0067]; NIH [T32 HL069765]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106002] Funding Source: NIH RePORTER	NIH Contract(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by NIH Contract HHSN272200900047C, NIH grant R01 AI106002, and DoD grant HDTRA1-10-1-0067. BSB was supported by NIH T32 HL069765. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDERSON EE, 1991, J IMMUNOL, V147, P1667; Aguilera I, 2001, IMMUNOLOGY, V102, P273, DOI 10.1046/j.1365-2567.2001.01159.x; Alamyar E., 2012, IMMUNOME RES, V8, P26, DOI [DOI 10.1007/978-1-61779-842-9_32, 10.4172/1745-7580.1000056, DOI 10.4172/1745-7580.1000056]; ALT FW, 1992, IMMUNOL TODAY, V13, P306, DOI 10.1016/0167-5699(92)90043-7; Arnaout R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022365; Benckert J, 2011, J CLIN INVEST, V121, P1946, DOI 10.1172/JCI44447; Boyd SD, 2010, J IMMUNOL, V184, P6986, DOI 10.4049/jimmunol.1000445; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Briney BS, 2012, GENES IMMUN, V13, P523, DOI 10.1038/gene.2012.28; Briney BS, 2012, GENES IMMUN, V13, P469, DOI 10.1038/gene.2012.20; Briney BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036750; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; CROUZIER R, 1995, J IMMUNOL, V154, P4526; DeKosky BJ, 2013, NAT BIOTECHNOL, V31, P166, DOI 10.1038/nbt.2492; Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; Gorny MK, 2009, MOL IMMUNOL, V46, P917, DOI 10.1016/j.molimm.2008.09.005; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Holtmeier W, 2000, GASTROENTEROLOGY, V119, P1253, DOI 10.1053/gast.2000.20219; Krause JC, 2011, MBIO, V2, DOI 10.1128/mBio.00345-10; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Milstein C, 1996, ADV PROTEIN CHEM, V49, P451, DOI 10.1016/S0065-3233(08)60494-5; Neuberger MS, 2008, IMMUNOL CELL BIOL, V86, P124, DOI 10.1038/sj.icb.7100160; Neuberger MS, 1995, CURR OPIN IMMUNOL; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schatz DG, 2004, IMMUNOL REV, V200, P5, DOI 10.1111/j.0105-2896.2004.00173.x; Suzuki K, 2010, IMMUNITY, V33, P71, DOI 10.1016/j.immuni.2010.07.003; Tian CX, 2008, J IMMUNOL, V180, P3279, DOI 10.4049/jimmunol.180.5.3279; Tian CX, 2007, MOL IMMUNOL, V44, P2173, DOI 10.1016/j.molimm.2006.11.020; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Weitkamp JH, 2005, J IMMUNOL, V174, P3454, DOI 10.4049/jimmunol.174.6.3454; Wilson P, 1998, IMMUNOL REV, V162, P143, DOI 10.1111/j.1600-065X.1998.tb01437.x; Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59; Wine Y, 2013, P NATL ACAD SCI USA, V110, P2993, DOI 10.1073/pnas.1213737110; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wu YC, 2010, BLOOD, V116, P1070, DOI 10.1182/blood-2010-03-275859; Zemlin M, 2008, J IMMUNOL, V181, P8416, DOI 10.4049/jimmunol.181.12.8416; Zouali M, 1996, APPL BIOCHEM BIOTECH, V61, P149, DOI 10.1007/BF02785697	41	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100839	10.1371/journal.pone.0100839	http://dx.doi.org/10.1371/journal.pone.0100839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956460	Green Published, gold, Green Submitted			2022-12-25	WOS:000338917900099
J	Mokhtar, SS; Marshall, CR; Phipps, ME; Thiruvahindrapuram, B; Lionel, AC; Scherer, SW; Peng, HB				Mokhtar, Siti Shuhada; Marshall, Christian R.; Phipps, Maude E.; Thiruvahindrapuram, Bhooma; Lionel, Anath C.; Scherer, Stephen W.; Peng, Hoh Boon			Novel Population Specific Autosomal Copy Number Variation and Its Functional Analysis amongst Negritos from Peninsular Malaysia	PLOS ONE			English	Article							SOUTHEAST-ASIA; GENE CHRNA7; VARIANTS; DUPLICATIONS; SELECTION; SPECTRUM; IMPACT	Copy number variation (CNV) has been recognized as a major contributor to human genome diversity. It plays an important role in determining phenotypes and has been associated with a number of common and complex diseases. However CNV data from diverse populations is still limited. Here we report the first investigation of CNV in the indigenous populations from Peninsular Malaysia. We genotyped 34 Negrito genomes from Peninsular Malaysia using the Affymetrix SNP 6.0 microarray and identified 48 putative novel CNVs, consisting of 24 gains and 24 losses, of which 5 were identified in at least 2 unrelated samples. These CNVs appear unique to the Negrito population and were absent in the DGV, HapMap3 and Singapore Genome Variation Project (SGVP) datasets. Analysis of gene ontology revealed that genes within these CNVs were enriched in the immune system (GO:0002376), response to stimulus mechanisms (GO:0050896), the metabolic pathways (GO:0001852), as well as regulation of transcription (GO:0006355). Copy number gains in CNV regions (CNVRs) enriched with genes were significantly higher than the losses (P value <0.001). In view of the small population size, relative isolation and semi-nomadic lifestyles of this community, we speculate that these CNVs may be attributed to recent local adaptation of Negritos from Peninsular Malaysia.	[Mokhtar, Siti Shuhada; Peng, Hoh Boon] Univ Teknol MARA, Fac Med, Inst Med Mol Biotechnol, Selangor, Malaysia; [Marshall, Christian R.; Thiruvahindrapuram, Bhooma; Lionel, Anath C.; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1X8, Canada; [Phipps, Maude E.] Monash Univ Sunway Campus, Jeffrey Cheah Sch Med & Hlth Sci, Selangor, Malaysia; [Marshall, Christian R.; Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON, Canada; [Marshall, Christian R.; Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	Universiti Teknologi MARA; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Monash University; Monash University Sunway; University of Toronto; University of Toronto	Peng, HB (corresponding author), Univ Teknol MARA, Fac Med, Inst Med Mol Biotechnol, Sungai Buloh Campus, Selangor, Malaysia.	hbpeng@salam.uitm.edu.my	Scherer, Stephen W./B-3785-2013; Phipps, Maude/F-7590-2012; Hoh, Boon-Peng/H-8682-2016	Scherer, Stephen W./0000-0002-8326-1999; Phipps, Maude/0000-0001-8314-068X; Hoh, Boon-Peng/0000-0001-9249-4965	Ministry of Science, Technology and Innovation (MOSTI) [100-RM/BIOTEK 16/6/2 B, 100-RMI/GOV 16/6/2]; Dr. Ranjeet Bhagwan Singh International Fellowship (Academy of Science Malaysia); University of Toronto McLaughlin Centre; Hospital for Sick Children Foundation; NeuroDevNet doctoral fellowship	Ministry of Science, Technology and Innovation (MOSTI)(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Dr. Ranjeet Bhagwan Singh International Fellowship (Academy of Science Malaysia); University of Toronto McLaughlin Centre; Hospital for Sick Children Foundation; NeuroDevNet doctoral fellowship	This study is supported by Ministry of Science, Technology and Innovation (MOSTI) grant erBiotek Grant # 100-RM/BIOTEK 16/6/2 B (1/2011) and [100-RMI/GOV 16/6/2 (19/2011] awarded to HB Peng & ME Phipps, Dr. Ranjeet Bhagwan Singh International Fellowship (Academy of Science Malaysia) awarded to HB Peng and support from the University of Toronto McLaughlin Centre and The Hospital for Sick Children Foundation. ACL holds a NeuroDevNet doctoral fellowship. SWS holds the GlaxoSmithKline-CIHR Chair in Genome Sciences at the University of Toronto and The Hospital for Sick Children. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Ali O, 1995, Asia Pac J Clin Nutr, V4, P319; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Baer A., 1999, HLTH DIS SURVIVAL BI; Barker G, 2007, J HUM EVOL, V52, P243, DOI 10.1016/j.jhevol.2006.08.011; Bellwood P, 1993, ASIAN PERSPECT, V32, P37; Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a; Chen WT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023087; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Estivill X, 2007, PLOS GENET, V3, P1787, DOI 10.1371/journal.pgen.0030190; Gautam P, 2012, HUM GENET, V131, P131, DOI 10.1007/s00439-011-1050-5; Girirajan S, 2011, ANNU REV GENET, V45, P203, DOI 10.1146/annurev-genet-102209-163544; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; Hill C, 2006, MOL BIOL EVOL, V23, P2480, DOI 10.1093/molbev/msl124; Hoh B. P., 2011, Malaysian Applied Biology, V40, P61; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Jinam TA, 2008, ETHNIC HEALTH, V13, P277, DOI 10.1080/13557850801930478; Korbel JO, 2008, CURR OPIN STRUC BIOL, V18, P366, DOI 10.1016/j.sbi.2008.02.005; Kristiansson K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-109; Ku CS, 2010, HUM MUTAT, V31, P851, DOI 10.1002/humu.21287; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; Li J, 2001, GENETIC LINGUISTIC A; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lionel AC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002464; Lou HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027341; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; McElroy JP, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-15; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Nozawa M, 2007, P NATL ACAD SCI USA, V104, P20421, DOI 10.1073/pnas.0709956104; Otto SP, 2002, ADV GENET, V46, P451; Peng MS, 2010, MOL BIOL EVOL, V27, P2417, DOI 10.1093/molbev/msq131; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Stephens SH, 2009, SCHIZOPHR RES, V109, P102, DOI 10.1016/j.schres.2008.12.017; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; Taske NL, 2002, EPILEPSY RES, V49, P157, DOI 10.1016/S0920-1211(02)00027-X; Yim SH, 2010, HUM MOL GENET, V19, P1001, DOI 10.1093/hmg/ddp564; Zhang YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041768	42	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100371	10.1371/journal.pone.0100371	http://dx.doi.org/10.1371/journal.pone.0100371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956385	Green Published, Green Submitted, gold			2022-12-25	WOS:000338917900044
J	Pacurar, DI; Pacurar, ML; Pacurar, AM; Gutierrez, L; Bellini, C				Pacurar, Daniel I.; Pacurar, Monica L.; Pacurar, Andrea M.; Gutierrez, Laurent; Bellini, Catherine			Novel Viable Allele of Arabidopsis CULLIN1 Identified in a Screen for Superroot2 Suppressors by Next Generation Sequencing-Assisted Mapping	PLOS ONE			English	Article							MAP-BASED CLONING; UBIQUITIN-PROTEIN LIGASES; AUXIN RESPONSE; MUTATION IDENTIFICATION; JASMONATE RESPONSE; THALIANA DEFINE; GENOME; COMPLEX; MUTANT; HOMEOSTASIS	Map-based cloning (MBC) is the conventional approach for linking phenotypes to genotypes, and has been successfully used to identify causal mutations in diverse organisms. Next-generation sequencing (NGS) technologies offer unprecedented possibilities to sequence the entire genomes of organisms, thereby in principle enabling direct identification of causal mutations without mapping. However, although mapping-by-sequencing has proven to be a cost effective alternative to classical MBC in particular situations, methods based solely on NGS still have limitations and need to be refined. Aiming to identify the causal mutations in suppressors of Arabidopsis thaliana superroot2 phenotype, generated by ethyl methane sulfonate (EMS) treatment, we combined NGS and classical mapping, to rapidly identify the point mutations and restrict the number of testable candidates by defining the chromosomal intervals containing the causal mutations, respectively. The NGS-assisted mapping approach we describe here facilitates unbiased identification of virtually any causal EMS-generated mutation by overlapping the identification (deep sequencing) and validation (mapping) steps. To exemplify the useful marriage of the two approaches we discuss the strategy used to identify a new viable recessive allele of the Arabidopsis CULLIN1 gene in the non-reference Wassilewskija (Ws-4) accession.	[Pacurar, Daniel I.; Pacurar, Monica L.; Bellini, Catherine] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; [Pacurar, Monica L.; Pacurar, Andrea M.] Univ Agr Sci & Vet Med, Fac Hort, Cluj Napoca, Romania; [Gutierrez, Laurent] Univ Picardie Jules Verne, Mol Biol Platform CRRBM, Amiens, France; [Bellini, Catherine] INRA, AgroParisTech, UMR1318, Inst Jean Pierre Bourgin, Versailles, France	Umea University; University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; Picardie Universites; Universite de Picardie Jules Verne (UPJV); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Pacurar, DI (corresponding author), Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden.	Daniel.Pacurar@umu.se	Pacurar, Andrea/R-4603-2017; Bellini, Catherine/E-7189-2013	Pacurar, Andrea/0000-0001-8818-2889; Bellini, Catherine/0000-0003-2985-6649; PACURAR, DANIEL IOAN/0000-0002-1888-5228; gutierrez, laurent/0000-0003-4829-8531	Swedish Foundation for Strategic Research (SSF); Swedish Research Council for Research and Innovation for Sustainable Growth (VINNOVA); Swedish Research Council (VR) [VR 621-2010-4359]; K. AMP; A. WallenbergFoundation; Carl Trygger Foundation [CTS08: 298]; Erasmus Programme	Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Swedish Research Council for Research and Innovation for Sustainable Growth (VINNOVA); Swedish Research Council (VR)(Swedish Research Council); K. AMP; A. WallenbergFoundation; Carl Trygger Foundation; Erasmus Programme	This work was supported by the Swedish Foundation for Strategic Research (SSF), the Swedish Research Council for Research and Innovation for Sustainable Growth (VINNOVA), the Swedish Research Council (VR) [VR 621-2010-4359], the K. & A. WallenbergFoundation, the Carl Trygger Foundation [CTS08: 298] to CB, and the Erasmus Programme to AMP. The specific roles of the authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Ashelford K, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r28; Austin RS, 2011, PLANT J, V67, P715, DOI 10.1111/j.1365-313X.2011.04619.x; Barlier I, 2000, P NATL ACAD SCI USA, V97, P14819, DOI 10.1073/pnas.260502697; Bellini C, 2014, ANNU REV PLANT BIOL, V65, P639, DOI 10.1146/annurev-arplant-050213-035645; BOERJAN W, 1995, PLANT CELL, V7, P1405, DOI 10.1105/tpc.7.9.1405; Cuperus JT, 2010, P NATL ACAD SCI USA, V107, P466, DOI 10.1073/pnas.0913203107; da Costa CT, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00133; Delarue M, 1998, PLANT J, V14, P603, DOI 10.1046/j.1365-313X.1998.00163.x; Esteve-Bruna D, 2013, PLANT PHYSIOL, V161, P1303, DOI 10.1104/pp.112.207779; Geiss G, 2009, ROOT DEV ANN PLANT R, P127; Gilkerson J, 2009, GENETICS, V181, P945, DOI 10.1534/genetics.108.097675; Gingerich DJ, 2005, J BIOL CHEM, V280, P18810, DOI 10.1074/jbc.M413247200; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Gutierrez L, 2012, PLANT CELL, V24, P2515, DOI 10.1105/tpc.112.099119; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; Hanania U, 2004, PLANT MOL BIOL REP, V22, P173, DOI 10.1007/BF02772724; Hartwig B, 2012, PLANT PHYSIOL, V160, P591, DOI 10.1104/pp.112.200311; Hobbie L, 2000, DEVELOPMENT, V127, P23; Hua ZH, 2011, ANNU REV PLANT BIOL, V62, P299, DOI 10.1146/annurev-arplant-042809-112256; Jander G, 2002, PLANT PHYSIOL, V129, P440, DOI 10.1104/pp.003533; Laitinen RAE, 2010, PLANT PHYSIOL, V153, P652, DOI 10.1104/pp.110.156448; Lindner H, 2012, GENETICS, V191, P1381, DOI 10.1534/genetics.112.141341; Lister R, 2009, CURR OPIN PLANT BIOL, V12, P107, DOI 10.1016/j.pbi.2008.11.004; Liu KH, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-12; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Mokry M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-256; Moon J, 2007, PLANT PHYSIOL, V143, P684, DOI 10.1104/pp.106.091439; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Nordstrom KJV, 2013, NAT BIOTECHNOL, V31, P325, DOI 10.1038/nbt.2515; Pacurar DI, 2014, PHYSIOL PLANTARUM, V151, P83, DOI 10.1111/ppl.12171; Pacurar DI, 2014, J EXP BOT, V65, P1605, DOI 10.1093/jxb/eru026; Pacurar DI, 2012, J EXP BOT, V63, P2491, DOI 10.1093/jxb/err422; Peters JL, 2003, TRENDS PLANT SCI, V8, P484, DOI 10.1016/j.tplants.2003.09.002; Pollock DD, 2004, GENETICS, V168, P489, DOI 10.1534/genetics.103.024430; Quint M, 2005, PLANT J, V43, P371, DOI 10.1111/j.1365-313X.2005.02449.x; Reeves PH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002506; Ren CM, 2005, PLANT J, V42, P514, DOI 10.1111/j.1365-313X.2005.02394.x; Schneeberger K, 2011, TRENDS PLANT SCI, V16, P282, DOI 10.1016/j.tplants.2011.02.006; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Shen WH, 2002, MOL BIOL CELL, V13, P1916, DOI 10.1091/mbc.E02-02-0077; Smolen G, 2002, GENETICS, V160, P323; Sorin C, 2005, PLANT CELL, V17, P1343, DOI 10.1105/tpc.105.031625; Sukumar P, 2013, PLANT PHYSIOL, V162, P1392, DOI 10.1104/pp.113.217174; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Zhu Y, 2012, GENETICS, V192, P139, DOI 10.1534/genetics.112.141986	50	5	5	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100846	10.1371/journal.pone.0100846	http://dx.doi.org/10.1371/journal.pone.0100846			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955772	gold, Green Published, Green Submitted			2022-12-25	WOS:000338917900101
J	Sugiyama, A; Ueda, Y; Zushi, T; Takase, H; Yazaki, K				Sugiyama, Akifumi; Ueda, Yoshikatsu; Zushi, Takahiro; Takase, Hisabumi; Yazaki, Kazufumi			Changes in the Bacterial Community of Soybean Rhizospheres during Growth in the Field	PLOS ONE			English	Article							SOIL MICROBIAL COMMUNITY; PROMOTING RHIZOBACTERIA; PYROSEQUENCING REVEALS; BIOCONTROL; PLANTS; DIVERSITY; PATHOGEN; PGPR	Highly diverse communities of bacteria inhabiting soybean rhizospheres play pivotal roles in plant growth and crop production; however, little is known about the changes that occur in these communities during growth. We used both culture-dependent physiological profiling and culture independent DNA-based approaches to characterize the bacterial communities of the soybean rhizosphere during growth in the field. The physiological properties of the bacterial communities were analyzed by a community-level substrate utilization assay with BioLog Eco plates, and the composition of the communities was assessed by gene pyrosequencing. Higher metabolic capabilities were found in rhizosphere soil than in bulk soil during all stages of the BioLog assay. Pyrosequencing analysis revealed that differences between the bacterial communities of rhizosphere and bulk soils at the phylum level; i.e., Proteobacteria were increased, while Acidobacteria and Firmicutes were decreased in rhizosphere soil during growth. Analysis of operational taxonomic units showed that the bacterial communities of the rhizosphere changed significantly during growth, with a higher abundance of potential plant growth promoting rhizobacteria, including Bacillus, Bradyrhizobium, and Rhizobium, in a stage-specific manner. These findings demonstrated that rhizosphere bacterial communities were changed during soybean growth in the field.	[Sugiyama, Akifumi; Ueda, Yoshikatsu; Zushi, Takahiro; Yazaki, Kazufumi] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto, Japan; [Takase, Hisabumi] Kyoto Gakuen Univ, Fac Bioenvironm Sci, Kameoka, Kyoto, Japan	Kyoto University	Sugiyama, A (corresponding author), Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto, Japan.	akifumi_sugiyama@rish.kyoto-u.ac.jp	Ueda, Yoshikatsu/AAY-6944-2020	Ueda, Yoshikatsu/0000-0001-5896-9859; Sugiyama, Akifumi/0000-0002-9643-6639	Kyoto University Step-Up Grant for Young Scientists; Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement) [SFC2001]	Kyoto University Step-Up Grant for Young Scientists; Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement)	This study was partly supported by a Kyoto University Step-Up Grant for Young Scientists (AS) and a grant from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement, SFC2001) (AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badri DV, 2009, PLANT PHYSIOL, V151, P2006, DOI 10.1104/pp.109.147462; Badri DV, 2009, PLANT CELL ENVIRON, V32, P666, DOI [10.1111/j.1365-3040.2009.01926.x, 10.1111/j.1365-3040.2008.01926.x]; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bakker MG, 2012, PLANT SOIL, V360, P1, DOI 10.1007/s11104-012-1361-x; BARBOUR WM, 1991, APPL ENVIRON MICROB, V57, P2635, DOI 10.1128/AEM.57.9.2635-2639.1991; Batten KM, 2006, BIOL INVASIONS, V8, P217, DOI 10.1007/s10530-004-3856-8; Beneduzi A, 2012, GENET MOL BIOL, V35, P1044, DOI 10.1590/S1415-47572012000600020; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Bloemberg GV, 2001, CURR OPIN PLANT BIOL, V4, P343, DOI 10.1016/S1369-5266(00)00183-7; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Buonaurio R, 2002, INT J SYST EVOL MICR, V52, P2081, DOI [10.1099/ijs.0.02063-0, 10.1099/00207713-52-6-2081]; Chaparro JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055731; Chaparro JM, 2013, ISME J IN PRESS; DARRAH PR, 1993, PLANT SOIL, V155, P1, DOI 10.1007/BF00024980; de Souza R, 2013, PLANT SOIL, V366, P585, DOI 10.1007/s11104-012-1430-1; DeAngelis KM, 2009, ISME J, V3, P168, DOI 10.1038/ismej.2008.103; Denison RF, 2011, CURR BIOL, V21, pR775, DOI 10.1016/j.cub.2011.06.018; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; de Vasconcellos RLF, 2009, BIOCONTROL, V54, P807, DOI 10.1007/s10526-009-9226-9; Frac M, 2012, SENSORS-BASEL, V12, P3253, DOI 10.3390/s120303253; Garbeva P, 2008, PLANT SOIL, V302, P19, DOI 10.1007/s11104-007-9432-0; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Girvan MS, 2003, APPL ENVIRON MICROB, V69, P1800, DOI 10.1128/AEM.69.3.1800-1809.2003; Govindasamy V, 2010, MICROBIOL MONOGR, V18, P333, DOI 10.1007/978-3-642-13612-2_15; Haichar FE, 2008, ISME J, V2, P1221, DOI 10.1038/ismej.2008.80; Hartmann A, 2008, PLANT SOIL, V312, P7, DOI 10.1007/s11104-007-9514-z; Houlden A, 2008, FEMS MICROBIOL ECOL, V65, P193, DOI 10.1111/j.1574-6941.2008.00535.x; Ikeda S, 2010, ISME J, V4, P315, DOI 10.1038/ismej.2009.119; Inceoglu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023321; Inceoglu O, 2010, APPL ENVIRON MICROB, V76, P3675, DOI 10.1128/AEM.00040-10; Innes L, 2004, BIOL FERT SOILS, V40, P7, DOI 10.1007/s00374-004-0748-0; Insunza V, 2002, PLANT SOIL, V241, P271, DOI 10.1023/A:1016159902759; Jie WG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072898; Johnson EG, 2008, CHEM BIOL, V15, P43, DOI 10.1016/j.chembiol.2007.11.014; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; Kumar A, 2011, BACTERIA IN AGROBIOLOGY: CROP ECOSYSTEMS, P37, DOI 10.1007/978-3-642-18357-7_2; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Manter DK, 2010, MICROB ECOL, V60, P157, DOI 10.1007/s00248-010-9658-x; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; McKenzie VJ, 2012, ISME J, V6, P588, DOI 10.1038/ismej.2011.129; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Micallef SA, 2009, J EXP BOT, V60, P1729, DOI 10.1093/jxb/erp053; Mougel C, 2006, NEW PHYTOL, V170, P165, DOI 10.1111/j.1469-8137.2006.01650.x; Ofek M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040117; Oger PM, 2004, MICROB ECOL, V47, P96, DOI 10.1007/s00248-003-2012-9; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Richardson AE, 2009, PLANT SOIL, V321, P305, DOI 10.1007/s11104-009-9895-2; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seipke RF, 2011, MICROBIOL-SGM, V157, P2681, DOI 10.1099/mic.0.047977-0; Shentu JL, 2008, J ZHEJIANG UNIV-SC B, V9, P250, DOI 10.1631/jzus.B0710630; Sugiyama A, 2012, SECRETIONS EXUDATES, P27, DOI DOI 10.1007/978-3-642-23047-9_; Sugiyama A, 2013, BOTANY, V91, P123, DOI 10.1139/cjb-2012-0217; Sugiyama A, 2010, PLANT DIS, V94, P1329, DOI 10.1094/PDIS-02-10-0090; Tsavkelova EA, 2007, ARCH MICROBIOL, V188, P655, DOI 10.1007/s00203-007-0286-x; Uroz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055929; Uroz S, 2010, ENV MICROBIOL REP, V2, P281, DOI 10.1111/j.1758-2229.2009.00117.x; Xu YX, 2009, SOIL BIOL BIOCHEM, V41, P919, DOI 10.1016/j.soilbio.2008.10.027; Yokota K, 2011, CELL MOL LIFE SCI, V68, P1341, DOI 10.1007/s00018-011-0651-4	61	107	111	6	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100709	10.1371/journal.pone.0100709	http://dx.doi.org/10.1371/journal.pone.0100709			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955843	Green Published, gold, Green Submitted			2022-12-25	WOS:000338917900084
J	bin Yusof, MT; Kershaw, MJ; Soanes, DM; Talbot, NJ				bin Yusof, Mohammad Termizi; Kershaw, Michael J.; Soanes, Darren M.; Talbot, Nicholas J.			FAR1 and FAR2 Regulate the Expression of Genes Associated with Lipid Metabolism in the Rice Blast Fungus Magnaporthe oryzae	PLOS ONE			English	Article							MITOCHONDRIAL BETA-OXIDATION; COENZYME-A SYNTHETASE; PLANT INFECTION; TRANSCRIPTION FACTORS; FUNCTIONAL-ANALYSIS; GLYOXYLATE CYCLE; IN-VIVO; REQUIRES; FACB; MOBILIZATION	The rice blast fungus Magnaporthe oryzae causes plant disease via specialised infection structures called appressoria. These dome-shaped cells are able to generate enormous internal pressure, which enables penetration of rice tissue by invasive hyphae. Previous studies have shown that mobilisation of lipid bodies and subsequent lipid metabolism are essential prerequisites for successful appressorium-mediated plant infection, which requires autophagic recycling of the contents of germinated spores and germ tubes to the developing appressorium. Here, we set out to identify putative regulators of lipid metabolism in the rice blast fungus. We report the identification of FAR1 and FAR2, which encode highly conserved members of the Zn2-Cys6 family of transcriptional regulators. We generated Delta far1, Delta far2 and Delta far1 Delta far2 double mutants in M. oryzae and show that these deletion mutants are deficient in growth on long chain fatty acids. In addition, Dfar2 mutants are also unable to grow on acetate and short chain fatty acids. FAR1 and FAR2 are necessary for differential expression of genes involved in fatty acid beta-oxidation, acetyl-CoA translocation, peroxisomal biogenesis, and the glyoxylate cycle in response to the presence of lipids. Furthermore, FAR2 is necessary for expression of genes associated with acetyl-CoA synthesis. Interestingly, Delta far1, Delta far2 and Delta far1Dfar2 mutants show no observable delay or reduction in lipid body mobilisation during plant infection, suggesting that these transcriptional regulators control lipid substrate utilization by the fungus but not the mobilisation of intracellular lipid reserves during infection-related morphogenesis.	[bin Yusof, Mohammad Termizi; Kershaw, Michael J.; Soanes, Darren M.; Talbot, Nicholas J.] Univ Exeter, Sch Biosci, Exeter, Devon, England; [bin Yusof, Mohammad Termizi] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Microbiol, Serdang 43400, Selangor, Malaysia	University of Exeter; Universiti Putra Malaysia	Talbot, NJ (corresponding author), Univ Exeter, Sch Biosci, Exeter, Devon, England.	n.j.talbot@exeter.ac.uk	Talbot, Nicholas J/I-5618-2019; Talbot, Nicholas J/I-9584-2014	Talbot, Nicholas J/0000-0001-6434-7757; Talbot, Nicholas J/0000-0001-6434-7757; Yusof, Mohd Termizi/0000-0002-5241-3443	Malaysia Ministry of Higher Education; Universiti Putra Malaysia; European Research Council Advanced Investigator Award [294702 GENBLAST]; BBSRC [BB/G013896/1, BB/H018727/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H018727/1, BB/G013896/1] Funding Source: researchfish	Malaysia Ministry of Higher Education(Ministry of Education, Malaysia); Universiti Putra Malaysia; European Research Council Advanced Investigator Award(European Research Council (ERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Malaysia Ministry of Higher Education and Universiti Putra Malaysia and a European Research Council Advanced Investigator Award 294702 GENBLAST to NJT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianopoulos A, 2006, MOLECULAR PRINCIPLES OF FUNGAL PATHOGENESIS, P441; Badaruddin M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003604; Bhadauria V, 2012, PLANT SIGNAL BEHAV, V7, P1206, DOI 10.4161/psb.21368; Bhambra GK, 2006, MOL MICROBIOL, V61, P46, DOI 10.1111/j.1365-2958.2006.05209.x; BOURETT TM, 1990, CAN J BOT, V68, P329, DOI 10.1139/b90-044; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Catlett N.L., 2003, FUNGAL GENET NEWSL, V50, P9, DOI DOI 10.4148/1941-4765.1150; deJong JC, 1997, NATURE, V389, P244, DOI 10.1038/38418; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Foster AJ, 2003, EMBO J, V22, P225, DOI 10.1093/emboj/cdg018; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Gilbert MJ, 2006, NATURE, V440, P535, DOI 10.1038/nature04567; Gomez D, 2002, MOL MICROBIOL, V44, P585, DOI 10.1046/j.1365-2958.2002.02939.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hynes MJ, 2006, EUKARYOT CELL, V5, P794, DOI 10.1128/EC.5.5.794-805.2006; KATZ ME, 1989, MOL CELL BIOL, V9, P5696, DOI 10.1128/MCB.9.12.5696; Kershaw MJ, 2009, P NATL ACAD SCI USA, V106, P15967, DOI 10.1073/pnas.0901477106; KRATZER S, 1995, GENE, V161, P75, DOI 10.1016/0378-1119(95)00289-I; Li DX, 2002, J BIOL CHEM, V277, P7905, DOI 10.1074/jbc.M108799200; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Lu JP, 2009, CURR GENET, V55, P461, DOI 10.1007/s00294-009-0259-5; Maggio-Hall LA, 2004, MOL MICROBIOL, V54, P1173, DOI 10.1111/j.1365-2958.2004.04340.x; Martinez-Rocha AL, 2008, CELL MICROBIOL, V10, P1339, DOI 10.1111/j.1462-5822.2008.01130.x; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Patkar RN, 2012, MOL MICROBIOL, V86, P1345, DOI 10.1111/mmi.12060; Ramirez MA, 2009, EUKARYOT CELL, V8, P1604, DOI 10.1128/EC.00206-09; Ramos-Pamplona M, 2006, MOL MICROBIOL, V61, P61, DOI 10.1111/j.1365-2958.2006.05194.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SANDEMAN RA, 1989, MOL GEN GENET, V218, P87, DOI 10.1007/BF00330569; Soanes DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002514; Sweigard JA, 1997, FUNGAL GENET NEWSL, V44, P52, DOI DOI 10.4148/1941-4765.1287; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Todd RB, 1998, EMBO J, V17, P2042, DOI 10.1093/emboj/17.7.2042; Todd RB, 1997, FUNGAL GENET BIOL, V21, P388, DOI 10.1006/fgbi.1997.0993; Todd RB, 1997, FUNGAL GENET BIOL, V22, P92, DOI 10.1006/fgbi.1997.1007; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; Wang ZY, 2007, MOL PLANT MICROBE IN, V20, P475, DOI 10.1094/MPMI-20-5-0475; Wang ZY, 2003, MOL MICROBIOL, V47, P1601, DOI 10.1046/j.1365-2958.2003.03412.x; Weber RWS, 2001, PROTOPLASMA, V216, P101, DOI 10.1007/BF02680137; Wilson RA, 2010, P NATL ACAD SCI USA, V107, P21902, DOI 10.1073/pnas.1006839107; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200	45	15	15	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99760	10.1371/journal.pone.0099760	http://dx.doi.org/10.1371/journal.pone.0099760			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949933	Green Submitted, gold, Green Published			2022-12-25	WOS:000338276300019
J	Castro, EF; Campos, RH; Cavallaro, LV				Castro, Eliana F.; Campos, Rodolfo H.; Cavallaro, Lucia V.			Stability of the Resistance to the Thiosemicarbazone Derived from 5,6-Dimethoxy-1-Indanone, a Non-Nucleoside Polymerase Inhibitor of Bovine Viral Diarrhea Virus	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASE; INTERFERON REGULATORY FACTOR-3; NONSTRUCTURAL PROTEIN; PROTEASOMAL DEGRADATION; SERINE-PROTEASE; CLEAVAGE SITES; NS5A PROTEIN; MDBK CELLS; PESTIVIRUS; APOPTOSIS	Bovine viral diarrhea virus (BVDV) is the prototype Pestivirus. BVDV infection is distributed worldwide and causes serious problems for the livestock industry. The thiosemicarbazone of 5,6-dimethoxy-1-indanone (TSC) is a non-nucleoside polymerase inhibitor (NNI) of BVDV. All TSC-resistant BVDV variants (BVDV-TSCr T1-5) present an N264D mutation in the NS5B gene (RdRp) whereas the variant BVDV-TSCr T-1 also presents an NS5B A392E mutation. In the present study, we carried out twenty passages of BVDV-TSCr T1-5 in MDBK cells in the absence of TSC to evaluate the stability of the resistance. The viral populations obtained (BVDV R1-5) remained resistant to the antiviral compound and conserved the mutations in NS5B associated with this phenotype. Along the passages, BVDV R-2, R-3 and R-5 presented a delay in the production of cytopathic effect that correlated with a decrease in cell apoptosis and intracellular accumulation of viral RNA. The complete genome sequences that encode for NS2 to NS5B, Npro and Erns were analyzed. Additional mutations were detected in the NS5B of BVDV R-1, R-3 and R-4. In both BVDV R2 and R3, most of the mutations found were localized in NS5A, whereas in BVDV R-5, the only mutation fixed was NS5A V177A. These results suggest that mutations in NS5A could alter BVDV cytopathogenicity. In conclusion, the stability of the resistance to TSC may be due to the fixation of different compensatory mutations in each BVDV-TSCr. During their replication in a TSC-free medium, some virus populations presented a kind of interaction with the host cell that resembled a persistent infection: decreased cytopathogenicity and viral genome synthesis. This is the first report on the stability of antiviral resistance and on the evolution of NNI-resistant BVDV variants. The results obtained for BVDV-TSCr could also be applied for other NNIs.	[Castro, Eliana F.; Campos, Rodolfo H.; Cavallaro, Lucia V.] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, RA-1113 Buenos Aires, DF, Argentina	University of Buenos Aires	Cavallaro, LV (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, RA-1113 Buenos Aires, DF, Argentina.	lcavalla@ffyb.uba.ar		Castro, Eliana F./0000-0003-1153-1176	Agencia Nacional para la Promocion Cientifica y Tecnologica [PICT 2012-2867]; Universidad de Buenos Aires (UBACYT) from Argentina [20020100100612]	Agencia Nacional para la Promocion Cientifica y Tecnologica(ANPCyT); Universidad de Buenos Aires (UBACYT) from Argentina	This research was supported by grants from Agencia Nacional para la Promocion Cientifica y Tecnologica (PICT 2012-2867) (http://www.agencia.mincyt.gob.ar/) and Universidad de Buenos Aires (UBACYT 2011-2014, No 20020100100612) (http://www.uba.ar/secyt/) from Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applied Biosystems, 2004, 7900HT FAST REAL TIM; BAKER JC, 1995, VET CLIN N AM-FOOD A, V11, P425, DOI 10.1016/S0749-0720(15)30460-6; Baroth M, 2000, VIROLOGY, V278, P456, DOI 10.1006/viro.2000.0644; Becher P, 2001, J VIROL, V75, P6256, DOI 10.1128/JVI.75.14.6256-6264.2001; Castro EF, 2011, J VIROL, V85, P5436, DOI 10.1128/JVI.00859-10; Chen ZH, 2007, VIROLOGY, V366, P277, DOI 10.1016/j.virol.2007.04.023; Choi KH, 2004, P NATL ACAD SCI USA, V101, P4425, DOI 10.1073/pnas.0400660101; COLLETT MS, 1988, J GEN VIROL, V69, P2637, DOI 10.1099/0022-1317-69-10-2637; Di Rienzo J.A., 2011, INFOSTAT VERSION 201; Finkielsztein LM, 2010, CURR MED CHEM, V17, P2933, DOI 10.2174/092986710792065036; Finkielsztein LM, 2008, EUR J MED CHEM, V43, P1767, DOI 10.1016/j.ejmech.2007.10.023; Gallei A, 2005, J VIROL, V79, P14261, DOI 10.1128/JVI.79.22.14261-14270.2005; Gil LHVG, 2006, J VIROL, V80, P900, DOI 10.1128/JVI.80.2.900-911.2006; Giliberti G, 2010, BIOORGAN MED CHEM, V18, P6055, DOI 10.1016/j.bmc.2010.06.065; Govorkova EA, 2010, J VIROL, V84, P8042, DOI 10.1128/JVI.00689-10; Grummer B, 2002, VIRUS RES, V90, P143, DOI 10.1016/S0168-1702(02)00150-8; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hatada EN, 2000, CURR OPIN IMMUNOL, V12, P52, DOI 10.1016/S0952-7915(99)00050-3; Hilton L, 2006, J VIROL, V80, P11723, DOI 10.1128/JVI.01145-06; Hoff HS, 1997, VIRUS RES, V49, P101, DOI 10.1016/S0168-1702(97)01460-3; Hu ZX, 2010, JAIDS-J ACQ IMM DEF, V55, P148, DOI 10.1097/QAI.0b013e3181e9a87a; Isken O, 2014, J VIROL, V88, P82, DOI 10.1128/JVI.01957-13; Johnson CM, 2001, J GEN VIROL, V82, P2935, DOI 10.1099/0022-1317-82-12-2935; Jordan R, 2002, J VIROL, V76, P9588, DOI 10.1128/JVI.76.19.9588-9599.2002; Kummerer BM, 2000, J VIROL, V74, P390, DOI 10.1128/JVI.74.1.390-400.2000; Lackner T, 2004, J VIROL, V78, P10765, DOI 10.1128/JVI.78.19.10765-10775.2004; Lai VCH, 1999, J VIROL, V73, P10129, DOI 10.1128/JVI.73.12.10129-10136.1999; Lindenbach BD, 2007, FIELDS VIROLOGY, V1, P1126; Maeda K, 2009, J VET MED SCI, V71, P801, DOI 10.1292/jvms.71.801; Magkouras I, 2008, J GEN VIROL, V89, P2501, DOI 10.1099/vir.0.2008/003749-0; Matzener P, 2009, VIRUS RES, V140, P15, DOI 10.1016/j.virusres.2008.10.015; Mendez E, 1998, J VIROL, V72, P4737, DOI 10.1128/JVI.72.6.4737-4745.1998; Meyers G, 2007, J VIROL, V81, P3327, DOI 10.1128/JVI.02372-06; MOENNIG V, 1992, ADV VIRUS RES, V41, P53, DOI 10.1016/S0065-3527(08)60035-4; Newcomer BW, 2013, VIRUS RES, V174, P95, DOI 10.1016/j.virusres.2013.03.007; Pacheco J. M., 2003, Revista Argentina de Microbiologia, V35, P19; Pankraz A, 2009, J VIROL, V83, P12415, DOI 10.1128/JVI.01487-09; Peterhans E, 2010, VET RES, V41, DOI 10.1051/vetres/2010016; Qu L, 2001, J VIROL, V75, P10651, DOI 10.1128/JVI.75.22.10651-10662.2001; RUMENAPF T, 1993, J VIROL, V67, P3288; Rweyemamu M M, 1990, Rev Sci Tech, V9, P207; Sapay N, 2006, BIOCHEMISTRY-US, V45, P2221, DOI 10.1021/bi0517685; Schweizer M, 1999, J GEN VIROL, V80, P1147, DOI 10.1099/0022-1317-80-5-1147; Steffens S, 1999, J GEN VIROL, V80, P2583, DOI 10.1099/0022-1317-80-10-2583; Tautz N, 1999, J VIROL, V73, P9422, DOI 10.1128/JVI.73.11.9422-9432.1999; Tautz N, 1997, J VIROL, V71, P5415, DOI 10.1128/JVI.71.7.5415-5422.1997; Tautz N, 2000, VIROLOGY, V273, P351, DOI 10.1006/viro.2000.0425; Tellinghuisen TL, 2006, J VIROL, V80, P7450, DOI 10.1128/JVI.00358-06; Thompson JD, 1997, NUCELIC ACIDS RES, V25, P7876; Tonelli M, 2010, BIOORGAN MED CHEM, V18, P2304, DOI 10.1016/j.bmc.2010.01.058; Trotter J, 2011, WINMDI 2 9 WINDOWS M; Vassilev VB, 2000, VIRUS RES, V69, P95, DOI 10.1016/S0168-1702(00)00176-3; WARRENER P, 1995, J VIROL, V69, P1720, DOI 10.1128/JVI.69.3.1720-1726.1995; Weiskircher E, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-185; Wu WW, 2011, J VIROL, V85, P10421, DOI 10.1128/JVI.05349-11; Xu JA, 1997, J VIROL, V71, P5312, DOI 10.1128/JVI.71.7.5312-5322.1997; Yamane D, 2006, J GEN VIROL, V87, P2961, DOI 10.1099/vir.0.81820-0; Zahoor MA, 2010, J GEN VIROL, V91, P1939, DOI 10.1099/vir.0.020990-0; Zahoor MA, 2009, ARCH VIROL, V154, P1745, DOI 10.1007/s00705-009-0505-7; Zhang G, 1996, J GEN VIROL, V77, P1677, DOI 10.1099/0022-1317-77-8-1677; Zhong WD, 1998, J VIROL, V72, P9365, DOI 10.1128/JVI.72.11.9365-9369.1998; Zoth SC, 2006, J VIROL METHODS, V138, P99, DOI 10.1016/j.jviromet.2006.07.025	63	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100528	10.1371/journal.pone.0100528	http://dx.doi.org/10.1371/journal.pone.0100528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950191	Green Published, gold, Green Submitted			2022-12-25	WOS:000338276300085
J	Molenda, N; Urbanova, K; Weiser, N; Kusche-Vihrog, K; Gunzel, D; Schillers, H				Molenda, Natalia; Urbanova, Katarina; Weiser, Nelly; Kusche-Vihrog, Kristina; Guenzel, Dorothee; Schillers, Hermann			Paracellular Transport through Healthy and Cystic Fibrosis Bronchial Epithelial Cell Lines - Do We Have a Proper Model?	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; IN-VITRO MODEL; BARRIER FUNCTION; AIRWAY EPITHELIUM; FLUID TRANSPORT; TIGHT JUNCTIONS; CFTR; PERMEABILITY; EXPRESSION; FLUORESCEIN	It has been reported recently that the cystic fibrosis transmembrane conductance regulator (CFTR) besides transcellular chloride transport, also controls the paracellular permeability of bronchial epithelium. The aim of this study was to test whether overexpressing wtCFTR solely regulates paracellular permeability of cell monolayers. To answer this question we used a CFBE41o(-) cell line transfected with wtCFTR or mutant F508del-CFTR and compered them with parental line and healthy 16HBE14o(-) cells. Transepithelial electrical resistance (TER) and paracellular fluorescein flux were measured under control and CFTR-stimulating conditions. CFTR stimulation significant decreased TER in 16HBE14o(-) and also in CFBE41o(-) cells transfected with wtCFTR. In contrast, TER increased upon stimulation in CFBE41o(-) cells and CFBE41o(-) cells transfected with F508del-CFTR. Under non-stimulated conditions, all four cell lines had similar paracellular fluorescein flux. Stimulation increased only the paracellular permeability of the 16HBE14o(-) cell monolayers. We observed that 16HBE14o(-) cells were significantly smaller and showed a different structure of cell-cell contacts than CFBE41o(-) and its overexpressing clones. Consequently, 16HBE14o(-) cells have about 80% more cell-cell contacts through which electrical current and solutes can leak. Also tight junction protein composition is different in 'healthy' 16HBE14o(-) cells compared to 'cystic fibrosis' CFBE41o(-) cells. We found that claudin-3 expression was considerably stronger in 16HBE14o- cells than in the three CFBE41o(-) cell clones and thus independent of the presence of functional CFTR. Together, CFBE41o(-) cell line transfection with wtCFTR modifies transcellular conductance, but not the paracellular permeability. We conclude that CFTR overexpression is not sufficient to fully reconstitute transport in CF bronchial epithelium. Hence, it is not recommended to use those cell lines to study CFTR-dependent epithelial transport.	[Molenda, Natalia; Urbanova, Katarina; Weiser, Nelly; Kusche-Vihrog, Kristina; Schillers, Hermann] Univ Munster, Inst Physiol 2, D-48149 Munster, Germany; [Guenzel, Dorothee] Charite Campus Benjamin Franklin, Inst Clin Physiol, Berlin, Germany	University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schillers, H (corresponding author), Univ Munster, Inst Physiol 2, D-48149 Munster, Germany.	Hermann.Schillers@uni-muenster.de		Gunzel, Dorothee/0000-0002-7998-7164; Schillers, Hermann/0000-0001-6090-4771	Deutsche Forschungsgemeinschaft [SFB 629 (A6)]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Work was supported by the Deutsche Forschungsgemeinschaft SFB 629 (A6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Barnes LM, 2003, BIOTECHNOL BIOENG, V81, P631, DOI 10.1002/bit.10517; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Coyne CB, 2003, AM J PHYSIOL-LUNG C, V285, pL1166, DOI 10.1152/ajplung.00182.2003; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Ehrhardt C, 2006, CELL TISSUE RES, V323, P405, DOI 10.1007/s00441-005-0062-7; Ehrhardt C, 2002, CELL TISSUE RES, V308, P391, DOI 10.1007/s00441-002-0548-5; Flynn AN, 2009, P NATL ACAD SCI USA, V106, P3591, DOI 10.1073/pnas.0813393106; GONZALEZMARISCAL L, 1989, J MEMBRANE BIOL, V107, P43, DOI 10.1007/BF01871082; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Illek B, 2008, CELL PHYSIOL BIOCHEM, V22, P57, DOI 10.1159/000149783; Jiang C, 1997, J PHYSIOL-LONDON, V501, P637, DOI 10.1111/j.1469-7793.1997.637bm.x; JIANG CW, 1993, SCIENCE, V262, P424, DOI 10.1126/science.8211164; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Kapus A, 2006, BIOCHEM CELL BIOL, V84, P870, DOI 10.1139/O06-202; Koljonen M, 2006, EUR J PHARM BIOPHARM, V64, P379, DOI 10.1016/j.ejpb.2006.06.006; Konishi Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2449, DOI 10.1271/bbb.66.2449; Kunzelmann K, 1997, FEBS LETT, V400, P341, DOI 10.1016/S0014-5793(96)01414-7; Kuwayama K, 2002, BIOCHEM PHARMACOL, V63, P81, DOI 10.1016/S0006-2952(01)00853-X; LeSimple P, 2010, J PHYSIOL-LONDON, V588, P1195, DOI 10.1113/jphysiol.2009.182246; LEWIS SA, 1995, PHYSIOL REV, V75, P561, DOI 10.1152/physrev.1995.75.3.561; Lin XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067496; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Milatz S, 2010, BBA-BIOMEMBRANES, V1798, P2048, DOI 10.1016/j.bbamem.2010.07.014; Nilsson HE, 2010, EXP MOL PATHOL, V88, P118, DOI 10.1016/j.yexmp.2009.09.018; Overgaard CE, 2012, ANN NY ACAD SCI, V1257, P167, DOI 10.1111/j.1749-6632.2012.06545.x; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; POWELL DW, 1981, AM J PHYSIOL, V241, pG275, DOI 10.1152/ajpgi.1981.241.4.G275; Schwiebert Erik M., 1999, Physiological Reviews, V79, pS145; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Soini Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-70; Treharne KJ, 2009, CELL PHYSIOL BIOCHEM, V24, P347, DOI 10.1159/000257427; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Wan H, 2000, EUR RESPIR J, V15, P1058, DOI 10.1034/j.1399-3003.2000.01514.x; Weiser N, 2011, CELL PHYSIOL BIOCHEM, V28, P289, DOI 10.1159/000331742; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R	37	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100621	10.1371/journal.pone.0100621	http://dx.doi.org/10.1371/journal.pone.0100621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945658	Green Submitted, gold, Green Published			2022-12-25	WOS:000340721500097
J	Saha, K; Sambo, D; Richardson, BD; Lin, LM; Butler, B; Villarroel, L; Khoshbouei, H				Saha, Kaustuv; Sambo, Danielle; Richardson, Ben D.; Lin, Landon M.; Butler, Brittany; Villarroel, Laura; Khoshbouei, Habibeh			Intracellular Methamphetamine Prevents the Dopamine-induced Enhancement of Neuronal Firing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR DOPAMINE; TRANSMEMBRANE SEGMENT; TRANSPORTER FUNCTION; DEPENDENT MECHANISM; AMPHETAMINE ACTION; IMPULSE ACTIVITY; PLASMA-MEMBRANE; CROSS-LINKING; MICE LACKING; IN-VIVO	The dysregulation of the dopaminergic system is implicated in multiple neurological and neuropsychiatric disorders such as Parkinson disease and drug addiction. The primary target of psychostimulants such as amphetamine and methamphetamine is the dopamine transporter (DAT), the major regulator of extracellular dopamine levels in the brain. However, the behavioral and neurophysiological correlates of methamphetamine and amphetamine administration are unique from one another, thereby suggesting these two compounds impact dopaminergic neurotransmission differentially. We further examined the unique mechanisms by which amphetamine and methamphetamine regulate DAT function and dopamine neurotransmission; in the present study we examined the impact of extracellular and intracellular amphetamine and methamphetamine on the spontaneous firing of cultured midbrain dopaminergic neurons and isolated DAT-mediated current. In dopaminergic neurons the spontaneous firing rate was enhanced by extracellular application of amphetamine > dopamine > methamphetamine and was DAT-dependent. Amphetamine > methamphetamine similarly enhanced DAT-mediated inward current, which was sensitive to isosmotic substitution of Na+ or Cl- ion. Although isosmotic substitution of extracellular Na+ ions blocked amphetamine and methamphetamine-induced DAT-mediated inward current similarly, the removal of extracellular Cl- ions preferentially blocked amphetamine-induced inward current. The intracellular application of methamphetamine, but not amphetamine, prevented the dopamine-induced increase in the spontaneous firing of dopaminergic neurons and the corresponding DAT-mediated inward current. The results reveal a new mechanism for methamphetamine-induced dysregulation of dopaminergic neurons.	Univ Florida, McKnight Brain Inst, Coll Med, Dept Neurosci, Gainesville, FL 32611 USA; Univ Florida, McKnight Brain Inst, Coll Med, Dept Psychiat, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Khoshbouei, H (corresponding author), Univ Florida, McKnight Brain Inst, Dept Neurosci, Dept Psychiat, 1149 Newell Dr,POB 100244, Gainesville, FL 32611 USA.	habibeh@ufl.edu	Richardson, Ben/GNP-5689-2022	Richardson, Ben/0000-0003-0403-4956; Khoshbouei, Habibeh/0000-0002-1533-8771; SAHA, KAUSTUV/0000-0002-2931-1422	National Institutes of Health [DA026947, NS071122]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026947] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA026947 and NS071122.	[Anonymous], 2006, NAT I DRUG AB NIDA R; Baucum AJ, 2004, J NEUROSCI, V24, P3436, DOI 10.1523/JNEUROSCI.0387-04.2004; Beckstead MJ, 2004, NEURON, V42, P939, DOI 10.1016/j.neuron.2004.05.019; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; BERTORELLO AM, 1990, NATURE, V347, P386, DOI 10.1038/347386a0; BUKAUSKAS FF, 1992, EXP PHYSIOL, V77, P903, DOI 10.1113/expphysiol.1992.sp003657; Carvelli L, 2004, P NATL ACAD SCI USA, V101, P16046, DOI 10.1073/pnas.0403299101; Chen NH, 2008, J NEUROCHEM, V105, P910, DOI 10.1111/j.1471-4159.2007.05195.x; Dawson TM, 2002, NAT NEUROSCI, V5, P1058, DOI 10.1038/nn941; Erreger K, 2008, J NEUROSCI, V28, P976, DOI 10.1523/JNEUROSCI.2796-07.2008; ESHLEMAN AJ, 1994, MOL PHARMACOL, V45, P312; FISCHER JF, 1976, P W PHARMACOL SOC, V19, P179; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Fon EA, 1997, NEURON, V19, P1271, DOI 10.1016/S0896-6273(00)80418-3; Garcia BG, 2005, MOL PHARMACOL, V68, P102, DOI 10.1124/mol.104.009092; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Goodwin JS, 2009, J BIOL CHEM, V284, P2978, DOI 10.1074/jbc.M805298200; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; GU H, 1994, J BIOL CHEM, V269, P7124; Hastrup H, 2003, J BIOL CHEM, V278, P45045, DOI 10.1074/jbc.C300349200; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; HORNYKIEWICZ O, 1986, NEW ENGL J MED, V315, P347, DOI 10.1056/NEJM198608073150602; Ingram SL, 2002, NAT NEUROSCI, V5, P971, DOI 10.1038/nn920; Iversen SD, 2007, TRENDS NEUROSCI, V30, P188, DOI 10.1016/j.tins.2007.03.002; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Jones SR, 1998, J NEUROSCI, V18, P1979; Kahlig KM, 2003, EUR J PHARMACOL, V479, P153, DOI 10.1016/j.ejphar.2003.08.065; Kahlig KM, 2005, P NATL ACAD SCI USA, V102, P3495, DOI 10.1073/pnas.0407737102; KEEFE KA, 1992, NEUROSCIENCE, V47, P325, DOI 10.1016/0306-4522(92)90248-Z; KEEFE KA, 1993, J NEURAL TRANSM-GEN, V91, P223, DOI 10.1007/BF01245233; Khoshbouei H, 2003, J BIOL CHEM, V278, P12070, DOI 10.1074/jbc.M212815200; KRUEGER BK, 1990, J NEUROCHEM, V55, P260, DOI 10.1111/j.1471-4159.1990.tb08847.x; Leviel V, 2011, J NEUROCHEM, V118, P475, DOI 10.1111/j.1471-4159.2011.07335.x; McCutcheon JE, 2012, J NEUROPHYSIOL, V108, P1620, DOI 10.1152/jn.00077.2012; MCELVAIN JS, 1992, BIOCHEM PHARMACOL, V43, P2189, DOI 10.1016/0006-2952(92)90178-L; NIEOULLON A, 1977, NATURE, V266, P375, DOI 10.1038/266375a0; OBIANWU HO, 1968, J PHARM PHARMACOL, V20, P585, DOI 10.1111/j.2042-7158.1968.tb09818.x; Paladini CA, 2003, P NATL ACAD SCI USA, V100, P2866, DOI 10.1073/pnas.0138018100; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Pierce RC, 1997, J NEUROSCI, V17, P3254; Rau TF, 2011, NEUROPHARMACOLOGY, V61, P677, DOI 10.1016/j.neuropharm.2011.05.010; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rodriguez-Menchaca AA, 2012, BRIT J PHARMACOL, V165, P2749, DOI 10.1111/j.1476-5381.2011.01728.x; Salahpour A, 2008, P NATL ACAD SCI USA, V105, P4405, DOI 10.1073/pnas.0707646105; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Sitte HH, 1998, J NEUROCHEM, V71, P1289; SNYDER SH, 1973, ANN NY ACAD SCI, V205, P310, DOI 10.1111/j.1749-6632.1973.tb43188.x; Sonders MS, 1997, J NEUROSCI, V17, P960; Swant J, 2011, J BIOL CHEM, V286, P43933, DOI 10.1074/jbc.M111.241232; WALL SC, 1995, MOL PHARMACOL, V47, P544; Wei Y, 2007, MOL PHARMACOL, V71, P835, DOI 10.1124/mol.106.026351; WISE CD, 1973, SCIENCE, V181, P344, DOI 10.1126/science.181.4097.344; WONG DT, 1972, J PHARM PHARMACOL, V24, P171, DOI 10.1111/j.2042-7158.1972.tb08958.x; ZHOU Z, 1995, J BIOL CHEM, V270, P3498, DOI 10.1074/jbc.270.8.3498; Zhu J, 2008, CNS NEUROL DISORD-DR, V7, P393, DOI 10.2174/187152708786927877	55	29	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22246	22257		10.1074/jbc.M114.563056	http://dx.doi.org/10.1074/jbc.M114.563056			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24962577	Green Published, hybrid			2022-12-25	WOS:000340593500038
J	Tian, T; Zhu, YL; Zhou, YY; Liang, GF; Wang, YY; Hu, FH; Xiao, ZD				Tian, Tian; Zhu, Yan-Liang; Zhou, Yue-Yuan; Liang, Gao-Feng; Wang, Yuan-Yuan; Hu, Fei-Hu; Xiao, Zhong-Dang			Exosome Uptake through Clathrin-mediated Endocytosis and Macropinocytosis and Mediating miR-21 Delivery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR TRAFFICKING; TGF-BETA; MICRORNAS; PATHWAYS; CELLS; INTERNALIZATION; IDENTIFICATION; ART	Exosomes are nanoscale membrane vesicles secreted from many types of cells. Carrying functional molecules, exosomes transfer information between cells and mediate many physiological and pathological processes. In this report, utilizing selective inhibitors, molecular tools, and specific endocytosis markers, the cellular uptake of PC12 cell-derived exosomes was imaged by high-throughput microscopy and statistically analyzed. It was found that the uptake was through clathrin-mediated endocytosis and macropinocytosis. Furthermore, PC12 cell-derived exosomes can enter and deliver microRNAs (miRNAs) into bone marrow-derived mesenchymal stromal cells (BMSCs), and decrease the expression level of transforming growth factor beta receptor II (TGF beta RII) and tropomyosin-1 (TPM1) through miR-21. These results show the pathway of exosome internalization and demonstrate that tumor cell-derived exosomes regulate target gene expression in normal cells.	[Tian, Tian; Zhu, Yan-Liang; Zhou, Yue-Yuan; Liang, Gao-Feng; Wang, Yuan-Yuan; Hu, Fei-Hu; Xiao, Zhong-Dang] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China; [Tian, Tian] Nanjing Med Univ, Dept Neurobiol, Nanjing 210029, Jiangsu, Peoples R China	Southeast University - China; Nanjing Medical University	Xiao, ZD (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.	zdxiao@seu.edu.cn	Lv, Yuanjie/AER-0767-2022		National Basic Research Program of China (973 Program) [2013CB932902]; NSFC [61071047, 31371003]; Natural Science Foundation of Jiangsu Province [BK2012122, BK20130886]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20130092110030]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Basic Research Program of China (973 Program: 2013CB932902), NSFC (No. 61071047, 31371003), the Natural Science Foundation of Jiangsu Province (No. BK2012122, BK20130886), and the Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20130092110030).	Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Cai ZJ, 2012, CELL RES, V22, P607, DOI 10.1038/cr.2011.196; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Chen X, 2012, PROTEIN CELL, V3, P28, DOI 10.1007/s13238-012-2003-z; Chen X, 2010, CELL RES, V20, P1128, DOI 10.1038/cr.2010.80; Chiba M, 2012, ONCOL REP, V28, P1551, DOI 10.3892/or.2012.1967; Christianson HC, 2013, P NATL ACAD SCI USA, V110, P17380, DOI 10.1073/pnas.1304266110; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; de Gassart A, 2004, TRAFFIC, V5, P896, DOI 10.1111/j.1600-0854.2004.00223.x; Feng D, 2010, TRAFFIC, V11, P675, DOI 10.1111/j.1600-0854.2010.01041.x; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Gaus K, 2006, J CELL BIOL, V174, P725, DOI 10.1083/jcb.200603034; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Iero M, 2008, CELL DEATH DIFFER, V15, P80, DOI 10.1038/sj.cdd.4402237; Karagiannis GS, 2010, MOL ONCOL, V4, P496, DOI 10.1016/j.molonc.2010.09.001; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8; Li LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046957; Lu LX, 2013, ACS APPL MATER INTER, V5, P319, DOI 10.1021/am302146w; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Rappoport J, 2004, TRAFFIC, V5, P327, DOI 10.1111/j.1600-0854.2004.00187.x; Ribas J, 2010, CELL CYCLE, V9, P923, DOI 10.4161/cc.9.5.10930; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Shabo I, 2011, ADV EXP MED BIOL, V714, P141, DOI 10.1007/978-94-007-0782-5_7; Staals RHJ, 2010, ADV EXP MED BIOL, V702, P132, DOI 10.1007/978-1-4419-7841-7_11; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Svensson KJ, 2013, J BIOL CHEM, V288, P17713, DOI 10.1074/jbc.M112.445403; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tian T, 2013, J CELL PHYSIOL, V228, P1487, DOI 10.1002/jcp.24304; Tian TA, 2010, J CELL BIOCHEM, V111, P488, DOI 10.1002/jcb.22733; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Yuyama K, 2009, J NEUROCHEM, V109, P1250, DOI 10.1111/j.1471-4159.2009.06046.x; Zhang F, 2009, TRAFFIC, V10, P411, DOI 10.1111/j.1600-0854.2009.00879.x; Zhang WS, 2009, CELL SIGNAL, V21, P237, DOI 10.1016/j.cellsig.2008.10.008; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	41	384	396	10	124	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22258	22267		10.1074/jbc.M114.588046	http://dx.doi.org/10.1074/jbc.M114.588046			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24951588	Green Published, hybrid			2022-12-25	WOS:000340593500039
J	Tsukahara, T; Emori, M; Murata, K; Hirano, T; Muroi, N; Kyono, M; Toji, S; Watanabe, K; Torigoe, T; Kochin, V; Asanuma, H; Matsumiya, H; Yamashita, K; Himi, T; Ichimiya, S; Wada, T; Yamashita, T; Hasegawa, T; Sato, N				Tsukahara, Tomohide; Emori, Makoto; Murata, Kenji; Hirano, Takahisa; Muroi, Norihiro; Kyono, Masanori; Toji, Shingo; Watanabe, Kazue; Torigoe, Toshihiko; Kochin, Vitaly; Asanuma, Hiroko; Matsumiya, Hiroshi; Yamashita, Keiji; Himi, Tetsuo; Ichimiya, Shingo; Wada, Takuro; Yamashita, Toshihiko; Hasegawa, Tadashi; Sato, Noriyuki			Specific Targeting of a Naturally Presented Osteosarcoma Antigen, Papillomavirus Binding Factor Peptide, Using an Artificial Monoclonal Antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-IMMUNOTHERAPY TARGET; ABERRANT EXPRESSION; PROTEIN; IDENTIFICATION; INDUCTION; EPITOPES; POTENCY	Osteosarcoma is a rare but highly malignant tumor occurring most frequently in adolescents. The prognosis of non-responders to chemotherapy is still poor, and new treatment modalities are needed. To develop peptide-based immunotherapy, we previously identified autologous cytotoxic T lymphocyte-defined osteosarcoma antigen papillomavirus binding factor (PBF) in the context of HLA-B55 and the cytotoxic T lymphocyte epitope (PBF A2.2) presented by HLA-A2. PBF and HLA class I are expressed in similar to 90 and 70% of various sarcomas, respectively. However, the expression status of peptide PBF A2.2 presented by HLA-A2 on osteosarcoma cells has remained unknown because it is difficult to generate a specific probe that reacts with the HLA.peptide complex. For detection and qualification of the HLA-A*02:01.PBF A2.2 peptide complex on osteosarcoma cells, we tried to isolate a single chain variable fragment (scFv) antibody directed to the HLA-*A0201.PBF A2.2 complex using a naive scFv phage display library. As a result, scFv clone D12 with high affinity (K-D = 1.53 x 10(-9) M) was isolated. D12 could react with PBF A2.2 peptide-pulsed T2 cells and HLA-A2+PBF+ osteosarcoma cell lines and simultaneously demonstrated that the HLA.peptide complex was expressed on osteosarcoma cells. In conclusion, scFv clone D12 might be useful to select candidate patients for PBF A2.2 peptide-based immunotherapy and develop antibody-based immunotherapy.	[Tsukahara, Tomohide; Murata, Kenji; Torigoe, Toshihiko; Kochin, Vitaly; Sato, Noriyuki] Sapporo Med Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido 0608556, Japan; [Hirano, Takahisa; Muroi, Norihiro; Kyono, Masanori] Sapporo Med Univ, Sch Med, MD PhD Program, Sapporo, Hokkaido 0608556, Japan; [Ichimiya, Shingo] Sapporo Med Univ, Sch Med, Dept Immunol, Frontier Med Res Ctr, Sapporo, Hokkaido 0608556, Japan; [Emori, Makoto; Murata, Kenji; Wada, Takuro; Yamashita, Toshihiko] Sapporo Med Univ, Sch Med, Dept Orthopaed Surg, Sapporo, Hokkaido 0608543, Japan; [Toji, Shingo; Watanabe, Kazue] Med & Biol Labs Co Ltd, Ina Lab, Ina, Saitama 3960002, Japan; [Asanuma, Hiroko; Hasegawa, Tadashi] Sapporo Med Univ Hosp, Div Surg Pathol, Sapporo, Hokkaido 0608543, Japan; [Matsumiya, Hiroshi; Yamashita, Keiji; Himi, Tetsuo] Sapporo Med Univ, Sch Med, Dept Otolaryngol, Sapporo, Hokkaido 0608543, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Tsukahara, T (corresponding author), Sapporo Med Univ, Sch Med, Dept Pathol, Chuo Ku, West 17,South 1, Sapporo, Hokkaido 0608556, Japan.	tukahara@sapmed.ac.jp			Japan Society for the Promotion of Science (KAKENHI) [21249025, 20390403, 22689041, 25462344]; Management Expenses Grants from Government [23-A-10, 23-A-44]; Northern Advancement Center for Science and Technology [H24-S-5]; Takeda Science Foundation [2010-Kenkyu-Shorei]; Suhara Memorial Foundation [H24-12]	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Management Expenses Grants from Government; Northern Advancement Center for Science and Technology; Takeda Science Foundation(Takeda Science Foundation (TSF)); Suhara Memorial Foundation	This work was supported by grants from Japan Society for the Promotion of Science Grants-in-aid for Scientific Research (KAKENHI) 21249025 (to N. S.), 20390403 (to T. W.), and 22689041 and 25462344 (to T. Tsukahara); Management Expenses Grants 23-A-10 (to T. W.) and 23-A-44 (to N. S.) from the Government to the National Cancer Center; and Northern Advancement Center for Science and Technology Grant H24-S-5, Takeda Science Foundation Grant 2010-Kenkyu-Shorei, and Suhara Memorial Foundation Grant H24-12 (to T. Tsukahara).	Boeckle S, 2002, VIROLOGY, V293, P103, DOI 10.1006/viro.2001.1231; Bossi G, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26840; CAMPBELL CJ, 1975, J BONE JOINT SURG AM, VA 57, P143, DOI 10.2106/00004623-197557020-00001; Dahan R, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/erm.2012.2; Ferrari S, 2007, CURR OPIN ONCOL, V19, P341, DOI 10.1097/CCO.0b013e328122d73f; Fletcher C.D., 2002, WHO CLASSIFICATION T, P120; Hariu H, 2005, CLIN CANCER RES, V11, P1000; Hasegawa R, 2013, EXP CELL RES, V319, P68, DOI 10.1016/j.yexcr.2012.11.003; Hirohashi Y, 2002, CLIN CANCER RES, V8, P1731; Honma I, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-103; Ida K, 2004, J IMMUNOL, V173, P1436, DOI 10.4049/jimmunol.173.2.1436; Inoda S, 2011, EXP MOL PATHOL, V90, P55, DOI 10.1016/j.yexmp.2010.10.001; Jordanovski D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074911; Kawaguchi S, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-31; Lefranc MP, 2003, NUCLEIC ACIDS RES, V31, P307, DOI 10.1093/nar/gkg085; Lewis VO, 2007, J BONE JOINT SURG AM, V89A, P1399, DOI 10.2106/JBJS.G.00075; Maki RG, 2006, CURR OPIN ONCOL, V18, P363, DOI 10.1097/01.cco.0000228743.72165.86; Meyers PA, 2005, J CLIN ONCOL, V23, P2004, DOI 10.1200/JCO.2005.06.031; Michaeli Y, 2009, J IMMUNOL, V182, P6328, DOI 10.4049/jimmunol.0801898; Morita R, 2014, CANCER SCI, V105, P389, DOI 10.1111/cas.12362; Nabeta Yuki, 2003, J Orthop Sci, V8, P554, DOI 10.1007/s00776-003-0663-5; Nahshol O, 2008, ANAL BIOCHEM, V383, P52, DOI 10.1016/j.ab.2008.08.017; Pansri P, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-6; PARKER KC, 1994, J IMMUNOL, V152, P163; Purbhoo MA, 2006, J IMMUNOL, V176, P7308, DOI 10.4049/jimmunol.176.12.7308; Sato N, 2009, PATHOL INT, V59, P205, DOI 10.1111/j.1440-1827.2009.02353.x; Sato Y, 2002, J IMMUNOL, V169, P1611, DOI 10.4049/jimmunol.169.3.1611; Schofield DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r254; Sichtig N, 2007, ARCH BIOCHEM BIOPHYS, V464, P90, DOI 10.1016/j.abb.2007.04.017; Southam C M, 1972, Proc Natl Cancer Conf, V7, P91; The Japanese Orthopaedic Association (JOA) Musculoskeletal Tumor Committee, 2000, GEN RUL CLIN PATH ST, P52; Tsukahara T, 2006, J ORTHOP RES, V24, P94, DOI 10.1002/jor.20019; Tsukahara T, 2004, CANCER RES, V64, P5442, DOI 10.1158/0008-5472.CAN-04-0522; Tsukahara T, 2008, CANCER SCI, V99, P368, DOI 10.1111/j.1349-7006.2008.00695.x; Tsukahara T, 2006, CANCER SCI, V97, P1374, DOI 10.1111/j.1349-7006.2006.00317.x; Tsukahara T, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-44; Tsukahara T, 2009, CANCER SCI, V100, P47, DOI 10.1111/j.1349-7006.2008.00991.x; Tsukahara Tomohide, 2008, Current Immunology Reviews, V4, P235, DOI 10.2174/157339508786447959; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; WADA T, 1988, CANCER RES, V48, P2273	40	6	7	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22035	22047		10.1074/jbc.M114.568725	http://dx.doi.org/10.1074/jbc.M114.568725			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24962571	Green Published, hybrid			2022-12-25	WOS:000340593500021
J	Bail, M; Meister, LMB; Campagnoli, EB; Jorge, JH; Ban, MDI; Sanchez-Ayala, A; Campanha, NH				Bail, Michele; Brol Meister, Lissandra Matos; Campagnoli, Eduardo Bauml; Jorge, Janaina Habib; Iglesias Ban, Manuella de Cassia; Sanchez-Ayala, Alfonso; Campanha, Nara Hellen			Histopathological Changes by the Use of Soft Reline Materials: A Rat Model Study	PLOS ONE			English	Article							DENTURE BASE; METHYL-METHACRYLATE; RESIDUAL MONOMER; LINING MATERIALS; RESILIENT LINER; ACRYLIC RESINS; L929 CELLS; WATER-BATH; CYTOTOXICITY; OVERDENTURE	Aim: To assess the histopathological changes of rat palatal mucosa exposed to soft reline materials. Methods: Forty-five adult female Wistar rats with controlled living conditions and fed ad libitum were employed. Palatal appliances of heat-polymerized acrylic resin Lucitone 550 were manufactured and worn by forty animals during 14 days. Five animals did not use the appliances (G1) and were used to control the appliance influence. One experimental group (n = 10) used the appliances without any relining material (G2) to control the material effect. Three experimental groups (n = 10) received the following soft reline materials below appliances: Dentusoft (G3), Dentuflex (G4), and Trusoft (G5). Appliances from half of each experimental group(n = 5) was immersed in water bath at 55 degrees C for 10 min before use. Animals were slaughtered and the palates were fixed in 10% buffered formalin. Hematoxylin and eosin stained sections of 5 mu m were analyzed by computerized planimetry. Cellular compartment, keratin and total epithelial thickness, and basement membrane length were measured to histopathological description. Analysis of variance and Tukey post-hoc test were used to data examination(alpha = 0.05). Results: For heat-treatment groups, G4 showed less elongated ridges at the basal layer interface (p = 0.037) than G2. When comparing the conditions with and without heat-treatment, only G2 showed a significant decrease in the cellular compartment, keratin layer and total epithelium thickness (p<0.05). Conclusion: The post-polymerization for Lucitone 550 was an effective method to reduce the changes in the rat palatal mucosa. The soft reline materials tested did not cause significant histopathological changes in the rat palatal mucosa.	[Bail, Michele; Brol Meister, Lissandra Matos; Campagnoli, Eduardo Bauml; Iglesias Ban, Manuella de Cassia; Sanchez-Ayala, Alfonso; Campanha, Nara Hellen] Univ Estadual Ponta Grossa, Dept Dent, Ponta Grossa, Parana, Brazil; [Jorge, Janaina Habib] Univ Estadual Paulista, UNESP, Araraquara Dent Sch, Dept Dent Mat & Prosthodont, Sao Paulo, Brazil	Universidade Estadual de Ponta Grossa; Universidade Estadual Paulista	Jorge, JH (corresponding author), Univ Estadual Paulista, UNESP, Araraquara Dent Sch, Dept Dent Mat & Prosthodont, Sao Paulo, Brazil.	janainahj@bol.com.br	Jorge, Janaina Habib/H-7896-2013; Bombarda, Nara H.C./C-7956-2013; Jorge, Janaina Habib/Q-2197-2019; Sánchez-Ayala, Alfonso/A-9049-2015	Jorge, Janaina Habib/0000-0002-9135-3455; Bombarda, Nara H.C./0000-0002-9915-1591; Jorge, Janaina Habib/0000-0002-9135-3455; Sánchez-Ayala, Alfonso/0000-0003-3426-0997	CAPES, Brazil; Araucaria Foundation, Parana, Brazil [11386]	CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Araucaria Foundation, Parana, Brazil(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA)	This study was performed by MB as partial fulfillment of her PhD degree at the Ponta Grossa State University. This investigation was supported in part by Grants from the CAPES, Brazil (P.I. MB); Araucaria Foundation, Parana, Brazil, 11386 (P.I. JHJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akal U K, 1997, J Marmara Univ Dent Fac, V2, P665; ALI A, 1986, BRIT DENT J, V161, P444, DOI 10.1038/sj.bdj.4806008; ANDERSEN L, 1986, HUMAN ORAL EMBRYOLOG; [Anonymous], 1992, 10993 ISO; [Anonymous], 1996, 7405 ISO; Atay A, 2012, DENT MATER J, V31, P1082, DOI 10.4012/dmj.2012-209; BAKER S, 1988, J DENT RES, V67, P1295, DOI 10.1177/00220345880670101001; Barclay SC, 1997, J DENT, V25, P251, DOI 10.1016/S0300-5712(96)00005-X; BROWNE RM, 1994, J DENT, V22, pS21, DOI 10.1016/0300-5712(94)90035-3; Brozek R, 2011, DENT MATER, V27, P281, DOI 10.1016/j.dental.2010.11.003; BRUNETTE DM, 1984, J CELL SCI, V69, P35; Cain JR, 1998, INT J ORAL MAX IMPL, V13, P857; Campanha NH, 2006, INT J PROSTHODONT, V19, P195; Chatterjee S, 2003, BIOCHEM BIOPH RES CO, V309, P36, DOI 10.1016/S0006-291X(03)01513-4; COOK RJ, 1991, J DENT, V19, P135, DOI 10.1016/0300-5712(91)90001-F; ELsyad MA, 2012, INT J PROSTHODONT, V25, P148; Elsyad MA, 2010, CLIN ORAL IMPLAN RES, V21, P473, DOI 10.1111/j.1600-0501.2009.01879.x; GOLLAMUDI R, 1985, J APPL TOXICOL, V5, P368, DOI 10.1002/jat.2550050606; Goncalves TS, 2006, AM J ORTHOD DENTOFAC, V129, P431, DOI 10.1016/j.ajodo.2005.10.017; GRAHAM BS, 1991, J DENT RES, V70, P870, DOI 10.1177/00220345910700050101; Hara T, 2000, J ORAL PATHOL MED, V29, P33, DOI 10.1034/j.1600-0714.2000.290106.x; Hashimoto Y, 2007, DENT MATER J, V26, P785, DOI 10.4012/dmj.26.785; HENSTENPETTERSEN A, 1991, J PROSTHET DENT, V65, P138, DOI 10.1016/0022-3913(91)90066-6; Hilborn J, 2007, J TISSUE ENG REGEN M, V1, P110, DOI 10.1002/term.4; Inoue T, 2001, Adv Dent Res, V15, P101; ISO, 2020, 800022020 ISO; Jiang JT, 2011, TOXICOLOGY, V290, P322, DOI 10.1016/j.tox.2011.10.008; Jorge JH, 2007, GERODONTOLOGY, V24, P52, DOI 10.1111/j.1741-2358.2007.00146.x; Jorge Janaina Habib, 2009, Quintessence Int, V40, pe93; Jorge Janaina Habib, 2006, J. Appl. Oral Sci., V14, P203, DOI 10.1590/S1678-77572006000300011; Kedjarune U, 1999, AUST DENT J, V44, P25, DOI 10.1111/j.1834-7819.1999.tb00532.x; Kiat-Amnuay S, 1999, J PROSTHET DENT, V81, P568, DOI 10.1016/S0022-3913(99)70211-8; Lai YL, 2004, J ORAL REHABIL, V31, P1165, DOI 10.1111/j.1365-2842.2004.01355.x; LAMB DJ, 1983, J DENT, V11, P80, DOI 10.1016/0300-5712(83)90051-9; LANDBERG G, 1990, EXP CELL RES, V187, P111, DOI 10.1016/0014-4827(90)90124-S; Lee SY, 2002, EUR J ORAL SCI, V110, P179, DOI 10.1034/j.1600-0722.2002.11232.x; Lefebvre Carol A., 1992, International Journal of Prosthodontics, V5, P558; Lunder T, 2000, CONTACT DERMATITIS, V43, P232; MACK PJ, 1989, AUST DENT J, V34, P454, DOI 10.1111/j.1834-7819.1989.tb00704.x; Munksgaard EC, 2005, EUR J ORAL SCI, V113, P166, DOI 10.1111/j.1600-0722.2005.00204.x; Munksgaard EC, 2004, EUR J ORAL SCI, V112, P101, DOI 10.1111/j.0909-8836.2004.00091.x; Murata H, 1996, DENT MATER, V12, P19, DOI 10.1016/S0109-5641(96)80059-5; Murata H, 2010, DENT MATER J, V29, P446, DOI 10.4012/dmj.2009-135; Nakai M, 1999, BIOCHEM BIOPH RES CO, V254, P311, DOI 10.1006/bbrc.1998.9928; Niedermeier W, 1990, Dtsch Zahnarztl Z, V45, P443; Oki K, 2002, J ORAL REHABIL, V29, P594, DOI 10.1046/j.1365-2842.2002.00863.x; Ostlund S, 1958, ACTA ODONTOL SCAND, V16; Ozdemir KG, 2009, J BIOMED MATER RES B, V90B, P82, DOI 10.1002/jbm.b.31256; Pant N, 2011, HUM EXP TOXICOL, V30, P507, DOI 10.1177/0960327110374205; RAZEK MKA, 1978, J PROSTHET DENT, V39, P29; SCHMALZ G, 1994, J DENT, V22, pS6, DOI 10.1016/0300-5712(94)90032-9; Sjogren G, 2000, J PROSTHET DENT, V84, P229, DOI 10.1067/mpr.2000.107227; Sofou A, 2005, ANAL BIOANAL CHEM, V381, P1336, DOI 10.1007/s00216-005-3059-x; Tay LY, 2012, GERODONTOLOGY, V29, pE275, DOI 10.1111/j.1741-2358.2011.00463.x; TSUCHIYA H, 1994, J PROSTHET DENT, V71, P618, DOI 10.1016/0022-3913(94)90448-0; Tsuruoka M, 2008, J ORAL REHABIL, V35, P889, DOI 10.1111/j.1365-2842.2008.01883.x; Urban VM, 2007, DENT MATER, V23, P363, DOI 10.1016/j.dental.2006.01.021; Vallittu PK, 1998, EUR J ORAL SCI, V106, P588, DOI 10.1046/j.0909-8836.1998.eos106109.x; VERHEIJEN R, 1989, J CELL SCI, V92, P531; Yoshii E, 1997, J BIOMED MATER RES, V37, P517, DOI 10.1002/(SICI)1097-4636(19971215)37:4<517::AID-JBM10>3.0.CO;2-5; Zentner A, 2000, EUR J ORTHODONT, V22, P639, DOI 10.1093/ejo/22.6.639	61	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100293	10.1371/journal.pone.0100293	http://dx.doi.org/10.1371/journal.pone.0100293			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963657	Green Published, gold, Green Submitted			2022-12-25	WOS:000338709500037
J	Cordeiro, EMG; Correa, AS; Guedes, RNC				Cordeiro, Erick Mauricio G.; Correa, Alberto S.; Guedes, Raul Narciso C.			Insecticide-Mediated Shift in Ecological Dominance between Two Competing Species of Grain Beetles	PLOS ONE			English	Article							INTERMEDIATE DISTURBANCE HYPOTHESIS; LARVAL COMPETITION; PESTICIDES; POPULATIONS; PREDATION; HORMESIS; HISTORY; SUSCEPTIBILITY; DISPLACEMENT; COEXISTENCE	Competition is a driving force regulating communities often considered an intermittent phenomenon, difficult to verify and potentially driven by environmental disturbances. Insecticides are agents of environmental disturbance that can potentially change ecological relationships and competitive outcomes, but this subject has seldom been examined. As the co-existing cereal grain beetle species Sitophilus zeamais Motschulsky and Rhyzopertha dominica F. share a common realized niche, directly competing for the same resources, they were used as models in our study. Intraspecific competition experiments were performed with increasing insect densities and insecticide doses in additive and replacement series using various density combinations of both beetle species maintained on insecticide-free or -sprayed grains. Insecticide-mediated release from competitive stress was not observed in our study of intraspecific competition in grain beetles. The insecticide enhanced the effect of insect density, particularly for the maize weevil S. zeamais, further impairing population growth at high densities. Therefore, insecticide susceptibility increased with intraspecific competition favoring insecticide efficacy. However, the effect of insecticide exposure on competitive interaction extends beyond intraspecific competition, affecting interspecific competition as well. Sitophilus zeamais was the dominant species when in interspecific competition prevailing in natural conditions (without insecticide exposure), but the dominance and species prevalence shifted from S. zeamais to R. dominica under insecticide exposure. Therefore, high conspecific densities favored insecticide efficacy, but the strength of the relationship differs with the species. In addition, the insecticide mediated a shift in species dominance and competition outcome indicating that insecticides are relevant mediators of species interaction, potentially influencing community composition and raising management concerns as potential cause of secondary pest outbreaks.	[Cordeiro, Erick Mauricio G.; Correa, Alberto S.; Guedes, Raul Narciso C.] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [Correa, Alberto S.] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Entomol & Acarol Agr, Sao Paulo, Brazil	Universidade Federal de Vicosa; Universidade de Sao Paulo	Guedes, RNC (corresponding author), Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil.	guedes@ufv.br	Guedes, Raul Narciso Carvalho/L-3924-2013; Correa, Alberto S/C-4683-2014; Cordeiro, Erick MG/P-7042-2015	Guedes, Raul Narciso Carvalho/0000-0001-6229-7549; Correa, Alberto S/0000-0002-3788-7480; 	Minas Gerais State Foundation of Research Aid (FAPEMIG); CAPES Foundation (Brazilian Ministry of Education); National Council for Scientific and Technological Development (CNPq); Brazilian Ministry of Science and Technology	Minas Gerais State Foundation of Research Aid (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES Foundation (Brazilian Ministry of Education)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Ministry of Science and Technology	Funding was provided by the following Brazilian agencies: Minas Gerais State Foundation of Research Aid (FAPEMIG; www.fapemig.br), the CAPES Foundation (Brazilian Ministry of Education; www.capes.gov.br), and the National Council for Scientific and Technological Development (CNPq; Brazilian Ministry of Science and Technology; www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYALA FJ, 1969, NATURE, V224, P1076, DOI 10.1038/2241076a0; Beketov MA, 2006, J APPL ECOL, V43, P1069, DOI 10.1111/j.1365-2664.2006.01226.x; BIRCH LC, 1957, AM NAT, V91, P5, DOI 10.1086/281957; BIRCH LC, 1953, EVOLUTION, V7, P136, DOI 10.2307/2405749; Boone MD, 2002, ECOL APPL, V12, P307, DOI 10.1890/1051-0761(2002)012[0307:IOAIWC]2.0.CO;2; COLEGRAVE N, 1994, OIKOS, V71, P499, DOI 10.2307/3545838; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cordeiro EMG, 2013, CHEMOSPHERE, V93, P1111, DOI 10.1016/j.chemosphere.2013.06.030; Crombie A. C., 1947, Journal of Animal Ecology, V16, P44; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Foit K, 2012, AQUAT TOXICOL, V106, P25, DOI 10.1016/j.aquatox.2011.09.012; Forbes VE, 1999, ENVIRON TOXICOL CHEM, V18, P1544, DOI 10.1002/etc.5620180729; Fox JW, 2013, TRENDS ECOL EVOL, V28, P86, DOI 10.1016/j.tree.2012.08.014; Gao YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092625; Gause GF, 1935, AM NAT, V69, P596, DOI 10.1086/280628; Guedes, 2011, STEWART POSTHARV REV, V5, P1, DOI DOI 10.2212/SPR.2011.3.5; Guedes NMP, 2010, ANIM BEHAV, V79, P281, DOI 10.1016/j.anbehav.2009.10.022; Guedes RNC, 2009, J ECON ENTOMOL, V102, P170, DOI 10.1603/029.102.0124; Guedes RNC, 2007, AUSTRAL ECOL, V32, P697, DOI 10.1111/j.1442-9993.2007.01769.x; Guedes RNC, 2014, PEST MANAG SCI, V70, P690, DOI 10.1002/ps.3669; HARDIN MR, 1995, CROP PROT, V14, P3, DOI 10.1016/0261-2194(95)91106-P; HAYNES KF, 1988, ANNU REV ENTOMOL, V33, P149, DOI 10.1146/annurev.en.33.010188.001053; Kesavaraju B, 2012, J MED ENTOMOL, V49, P988, DOI 10.1603/ME11245; Knillmann S, 2012, ECOTOXICOLOGY, V21, P1857, DOI 10.1007/s10646-012-0919-y; Liess M, 2005, ENVIRON TOXICOL CHEM, V24, P954, DOI 10.1897/03-652.1; Liess M, 2010, AQUAT TOXICOL, V97, P15, DOI 10.1016/j.aquatox.2009.11.018; Linke-Gamenick I, 1999, MAR ECOL PROG SER, V184, P139, DOI 10.3354/meps184139; Lotka A. J., 1925, ELEMENTS PHYS BIOL, DOI 10.1038/116461b0; LOTKA ALFRED J., 1932, JOUR WASHINGTON ACAD SCI, V22, P461; MAPA, 2014, MAN GAR QUAL AN; Mills NE, 2004, ECOL APPL, V14, P1041, DOI 10.1890/02-5134; Muturi EJ, 2011, J MED ENTOMOL, V48, P429, DOI 10.1603/ME10213; Oliveira EE, 2007, CHEMOSPHERE, V69, P17, DOI 10.1016/j.chemosphere.2007.04.077; PARK T, 1948, ECOL MONOGR, V18, P265, DOI 10.2307/1948641; Pestana JLT, 2009, AQUAT TOXICOL, V93, P138, DOI 10.1016/j.aquatox.2009.04.008; Rees David P., 1996, P1; Reitz SR, 2002, ANNU REV ENTOMOL, V47, P435, DOI 10.1146/annurev.ento.47.091201.145227; RIPPER WE, 1956, ANNU REV ENTOMOL, V1, P403, DOI 10.1146/annurev.en.01.010156.002155; SAS Institute, 2008, SAS STAT US GUID; SCHOENER TW, 1982, AM SCI, V70, P586; Shea K, 2004, ECOL LETT, V7, P491, DOI 10.1111/j.1461-0248.2004.00600.x; Sheil D, 2013, TRENDS ECOL EVOL, V28, P571, DOI 10.1016/j.tree.2013.07.006; Smith R.H., 1985, P423; SMITH RH, 1991, ADV ECOL RES, V21, P63, DOI 10.1016/S0065-2504(08)60097-5; Stark JD, 1997, ECOTOX ENVIRON SAFE, V37, P273, DOI 10.1006/eesa.1997.1552; Stark JD, 2003, ANNU REV ENTOMOL, V48, P505, DOI 10.1146/annurev.ento.48.091801.112621; Sun DB, 2013, B ENTOMOL RES, V103, P344, DOI 10.1017/S0007485312000788; Mallqui KSV, 2013, J STORED PROD RES, V55, P32, DOI 10.1016/j.jspr.2013.07.004; Vonesh JR, 2009, OECOLOGIA, V160, P379, DOI 10.1007/s00442-009-1301-5; Walthall WK, 1997, ENVIRON TOXICOL CHEM, V16, P1068, DOI 10.1002/etc.5620160529; White P.S., 1985, ECOLOGY NATURAL DIST, P3, DOI 10.1016/B978-0-12-554520-4.50006-X; WIENS JA, 1977, AM SCI, V65, P590; WIENS JA, 1986, COMMUNITY ECOLOGY, P154; Wilkinson DM, 1999, OIKOS, V84, P145, DOI 10.2307/3546874; WISSINGER SA, 1989, ECOLOGY, V70, P1017, DOI 10.2307/1941370; WITMAN JD, 1987, ECOL MONOGR, V57, P167, DOI 10.2307/1942623	56	29	30	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100990	10.1371/journal.pone.0100990	http://dx.doi.org/10.1371/journal.pone.0100990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959673	Green Published, Green Submitted, gold			2022-12-25	WOS:000338633900109
J	Das, I; Basantray, I; Mamidi, P; Nayak, TK; Pratheek, BM; Chattopadhyay, S; Chattopadhyay, S				Das, Indrani; Basantray, Itishree; Mamidi, Prabhudutta; Nayak, Tapas K.; Pratheek, B. M.; Chattopadhyay, Subhasis; Chattopadhyay, Soma			Heat Shock Protein 90 Positively Regulates Chikungunya Virus Replication by Stabilizing Viral Non-Structural Protein nsP2 during Infection	PLOS ONE			English	Article							HSP90 MOLECULAR CHAPERONE; ORIGIN-BINDING PROTEIN; REVERSE-TRANSCRIPTASE; RNA REPLICATION; CROSS-TALK; EXPRESSION; CELLS; INHIBITION; APOPTOSIS; IDENTIFICATION	Background: The high morbidity and socio-economic loss associated with the recent massive global outbreak of Chikungunya virus (CHIKV) emphasize the need to understand the biology of the virus for developing effective antiviral therapies. Methods and Findings: In this study, an attempt was made to understand the molecular mechanism involved in Heat shock protein 90 (Hsp90) mediated regulation of CHIKV infection in mammalian cells using CHIKV prototype strain (S 27) and Indian outbreak strain of 2006 (DRDE-06). Our results showed that Hsp90 is required at a very early stage of viral replication and Hsp90 inhibitor Geldanamycin (GA) can abrogate new virus particle formation more effectively in the case of S 27 than that of DRDE-06. Further analysis revealed that CHIKV nsP2 protein level is specifically reduced by GA treatment as well as HSP90-siRNA transfection; however, viral RNA remains unaltered. Immunoprecipitation analysis showed that nsP2 interacts with Hsp90 during infection; however this interaction is reduced in the presence of GA. In addition, our analysis on Hsp90 associated PI3K/Akt/mTOR signaling pathway demonstrated that CHIKV infection stabilizes Raf1 and activates Hsp90 client protein Akt, which in turn phosphorylates mTOR. Subsequently, this phosphorylation leads to the activation of two important downstream effectors, S6K and 4EBP1, which may facilitate translation of viral as well as cellular mRNAs. Hence, the data suggests that CHIKV infection is regulated by Hsp90 associated Akt phosphorylation and DRDE-06 is more efficient than S 27 in enhancing the activation of host signaling molecules for its efficient replication and virus production. Conclusion: Hsp90 positively regulates Chikungunya virus replication by stabilizing CHIKV-nsP2 through its interaction during infection. The study highlights the possible molecular mechanism of GA mediated inhibition of CHIKV replication and differential effect of this drug on S 27 and DRDE-06, which will be informative for developing effective anti-CHIKV therapies in future.	[Das, Indrani; Basantray, Itishree; Mamidi, Prabhudutta; Chattopadhyay, Soma] Inst Life Sci, Bhubaneswar, Odisha, India; [Nayak, Tapas K.; Pratheek, B. M.; Chattopadhyay, Subhasis] Natl Inst Sci Educ & Res, Sch Biol Sci, Bhubaneswar, Odisha, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); National Institute of Science Education & Research (NISER)	Chattopadhyay, S (corresponding author), Inst Life Sci, Bhubaneswar, Odisha, India.	sochat.ils@gmail.com	Mamidi, Prabhudutta/GNM-5436-2022		Department of Biotechnology, Ministry of Science and Technology, Govt. of India [BT/PR13118/GBD/27/186/2009]; Council of Scientific and Industrial Research (CSIR) [37(1542)/12/EMR-II]; Ministry of Science and Technology, Govt. of India [BT/PR15173/GBD/27/356/2011]; Ministry of Science and Technology, Govt. of India	Department of Biotechnology, Ministry of Science and Technology, Govt. of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Ministry of Science and Technology, Govt. of India; Ministry of Science and Technology, Govt. of India	This work was supported by Department of Biotechnology, Ministry of Science and Technology, Govt. of India vide grant no. BT/PR13118/GBD/27/186/2009 and BT/PR15173/GBD/27/356/2011 Ministry of Science and Technology, Govt. of India and by Council of Scientific and Industrial Research (CSIR) ( Project No. 37(1542)/12/EMR-II), Ministry of Science and Technology, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt V, 2007, CELL MOL LIFE SCI, V64, P2525, DOI 10.1007/s00018-007-7188-6; Basha Walid, 2005, Antiviral Chemistry & Chemotherapy, V16, P135; Basso AD, 2002, ONCOGENE, V21, P1159, DOI 10.1038/sj.onc.1205184; Blagosklonny MV, 2002, LEUKEMIA, V16, P455, DOI 10.1038/sj.leu.2402415; Bourai M, 2012, J VIROL, V86, P3121, DOI 10.1128/JVI.06390-11; Brenner BG, 2001, EXPERT OPIN BIOL TH, V1, P67, DOI 10.1517/14712598.1.1.67; Burch AD, 2005, J VIROL, V79, P10740, DOI 10.1128/JVI.79.16.10740-10749.2005; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Chattopadhyay S, 2006, J VIROL, V80, P4491, DOI 10.1128/JVI.80.9.4491-4500.2006; Chattopadhyay S, J VIROL METHODS C, V199C, P86; Chattopadhyay S, 2007, J VIROL, V81, P13659, DOI 10.1128/JVI.01204-07; Clippinger AJ, 2011, J VIROL, V85, P3930, DOI 10.1128/JVI.01913-10; Creagh EM, 2000, LEUKEMIA, V14, P1161, DOI 10.1038/sj.leu.2401841; Das PK, 2014, J BIOL CHEM, V289, P5635, DOI 10.1074/jbc.M113.503433; Dittmar KD, 1998, J BIOL CHEM, V273, P7358, DOI 10.1074/jbc.273.13.7358; Dutta D, 2011, J BIOL CHEM, V286, P20065, DOI 10.1074/jbc.M111.231878; Dutta D, 2009, VIROLOGY, V391, P325, DOI 10.1016/j.virol.2009.06.044; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Enserink M, 2007, SCIENCE, V318, P1860, DOI 10.1126/science.318.5858.1860; Fros JJ, 2013, J VIROL, V87, P10394, DOI 10.1128/JVI.00884-13; Fujita N, 2002, J BIOL CHEM, V277, P10346, DOI 10.1074/jbc.M106736200; Garmashova N, 2006, J VIROL, V80, P5686, DOI 10.1128/JVI.02739-05; Geller R, 2007, GENE DEV, V21, P195, DOI 10.1101/gad.1505307; GRIFFIN DE, 2007, FIELDS VIROLOGY; Hu JM, 2004, J VIROL, V78, P13122, DOI 10.1128/JVI.78.23.13122-13131.2004; Hu JM, 1996, P NATL ACAD SCI USA, V93, P1060, DOI 10.1073/pnas.93.3.1060; Hu JM, 2000, J VIROL, V74, P11447, DOI 10.1128/JVI.74.24.11447-11455.2000; Hung JJ, 2002, J VIROL, V76, P1379, DOI 10.1128/JVI.76.3.1379-1390.2002; Karpe YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022336; Khan M, 2011, ANTIVIR RES, V89, P1, DOI 10.1016/j.antiviral.2010.10.009; Kumar A, 2006, PLOS ONE, V9; LAAKKONEN P, 1994, J VIROL, V68, P7418, DOI 10.1128/JVI.68.11.7418-7425.1994; Lewthwaite J, 1998, TRENDS MICROBIOL, V6, P426, DOI 10.1016/S0966-842X(98)01362-6; Li L, 2010, NATURE, V468, P705, DOI 10.1038/nature09546; Ludwig S, 2006, CELL MICROBIOL, V8, P375, DOI 10.1111/j.1462-5822.2005.00678.x; Ma YJ, 2004, J CHEM NEUROANAT, V28, P51, DOI 10.1016/j.jchemneu.2003.08.007; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Momose F, 2002, J BIOL CHEM, V277, P45306, DOI 10.1074/jbc.M206822200; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Naito T, 2007, J VIROL, V81, P1339, DOI 10.1128/JVI.01917-06; Neckers L, 2008, CELL HOST MICROBE, V4, P519, DOI 10.1016/j.chom.2008.10.011; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Parida MM, 2007, J CLIN MICROBIOL, V45, P351, DOI 10.1128/JCM.01734-06; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pastorino BAM, 2008, VIRUS RES, V131, P293, DOI 10.1016/j.virusres.2007.09.009; PERANEN J, 1990, J VIROL, V64, P1888; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Rathore AP, 2013, ANTIVIRAL RES C, V103C, P7; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schulte TW, 1997, BIOCHEM BIOPH RES CO, V239, P655, DOI 10.1006/bbrc.1997.7527; SEDGER L, 1994, J VIROL, V68, P4685, DOI 10.1128/JVI.68.7.4685-4689.1994; Sharp S, 2006, ADV CANCER RES, V95, P323, DOI 10.1016/S0065-230X(06)95009-X; Stewart S, 1999, MOL CELL BIOL, V19, P5523; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Sullivan CS, 2001, VIROLOGY, V287, P1, DOI 10.1006/viro.2001.1038; Sullivan W, 1997, J BIOL CHEM, V272, P8007, DOI 10.1074/jbc.272.12.8007; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; Waxman L, 2001, P NATL ACAD SCI USA, V98, P13931, DOI 10.1073/pnas.241510898; WELCH WJ, 1993, SCI AM, V268, P56, DOI 10.1038/scientificamerican0593-56; WELCH WJ, 1982, J BIOL CHEM, V257, P4949; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; XU Y, 1993, P NATL ACAD SCI USA, V90, P7074, DOI 10.1073/pnas.90.15.7074; Yao JQ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-30; Zheng ZZ, 2010, J GEN VIROL, V91, P1728, DOI 10.1099/vir.0.019323-0	69	50	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100531	10.1371/journal.pone.0100531	http://dx.doi.org/10.1371/journal.pone.0100531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959709	Green Published, gold, Green Submitted			2022-12-25	WOS:000338633900054
J	Forde, N; Simintiras, CA; Sturmey, R; Mamo, S; Kelly, AK; Spencer, TE; Bazer, FW; Lonergan, P				Forde, Niamh; Simintiras, Constantine A.; Sturmey, Roger; Mamo, Solomon; Kelly, Alan K.; Spencer, Thomas E.; Bazer, Fuller W.; Lonergan, Pat			Amino Acids in the Uterine Luminal Fluid Reflects the Temporal Changes in Transporter Expression in the Endometrium and Conceptus during Early Pregnancy in Cattle	PLOS ONE			English	Article							SELECT NUTRIENTS; SYSTEMIC PROGESTERONE; BOVINE ENDOMETRIUM; ESTROUS-CYCLE; EMBRYO; LUMEN; ELONGATION; METABOLISM; SECRETIONS; SURVIVAL	In cattle, conceptus-maternal interactions are critical for the establishment and maintenance of pregnancy. A major component of this early interaction involves the transport of nutrients and secretion of key molecules by uterine epithelial cells to help support conceptus development during the peri-implantation period of pregnancy. Objectives were to: 1) analyze temporal changes in the amino acid (AA) content of uterine luminal fluid (ULF) during the bovine estrous cycle; 2) understand conceptus-induced alterations in AA content; 3) determine expression of AA transporters in the endometrium and conceptus; and 4) determine how these transporters are modulated by (Progesterone) P4. Concentrations of aspartic acid, arginine, glutamine, histidine, lysine, isoleucine, leucine, phenylalanine and tyrosine decreased on Day 16 of the estrous cycle but increased on Day 19 in pregnant heifers (P, 0.05). Glutamic acid only increased in pregnant heifers on Day 19 (P, 0.001). Asparagine concentrations were greater in ULF of cyclic compared to pregnant heifers on Day 7 (P, 0.05) while valine concentrations were higher in pregnant heifers on Day 16 (P, 0.05). Temporal changes in expression of the cationic AA transporters SLC7A1 SLC7A4 and SLC7A6 occurred in the endometrium during the estrous cycle/early pregnancy coordinate with changes in conceptus expression of SLC7A4, SLC7A2 and SLC7A1 (P < 0.05). Only one acidic AA transporter (SLC1A5) increased in the endometrium while conceptus expression of SLC1A4 increased (P < 0.05). The neutral AA transporters SLC38A2 and SLC7A5 increased in the endometrium in a temporal manner while conceptus expression of SLC38A7, SLC43A2, SLC38A11 and SLC7A8 also increased (P < 0.05). P4 modified the expression of SLC1A1, -1A4, -1A5, -38A2, 38A4, -38A7, -43A2, -6A14, -7A1, -7A5 and -7A7 in the endometrium. Results demonstrate that temporal changes in AA in the ULF reflect changes in transporter expression in the endometrium and conceptus during early pregnancy in cattle, some of which are modified by P4.	[Forde, Niamh; Mamo, Solomon; Lonergan, Pat] Univ Coll Dublin, Sch Agr & Food Sci, Dublin 2, Ireland; [Simintiras, Constantine A.; Sturmey, Roger; Kelly, Alan K.] Univ Hull, Ctr Cardiovasc & Metab Res, Kingston Upon Hull HU6 7RX, N Humberside, England; [Spencer, Thomas E.] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA; [Bazer, Fuller W.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA	University College Dublin; University of Hull; Washington State University; Texas A&M University System; Texas A&M University College Station	Forde, N (corresponding author), Univ Coll Dublin, Sch Agr & Food Sci, Dublin 2, Ireland.	niamh.forde@ucd.ie	Simintiras, Constantine A./AAW-7287-2021; Spencer, Thomas/AAD-6434-2020; Bazer, Fuller/AAF-4317-2021	Simintiras, Constantine A./0000-0001-5123-258X; Bazer, Fuller/0000-0002-5823-5086; Sturmey, Roger/0000-0003-4423-5058; Forde, Niamh/0000-0002-3539-9643; Spencer, Thomas/0000-0003-2815-766X	Science Foundation Ireland [10/IN.1/B3011]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Science Foundation Ireland under grant number 10/IN.1/B3011 to PL. (www.sfi.ie.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos NI, 2005, REPROD FERT DEVELOP, V17, P799, DOI 10.1071/RD04104; Bauersachs S, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094771; Bazer FW, 2012, J REPROD DEVELOP, V58, P180, DOI 10.1262/jrd.2011-019; Bazer FW, 2010, BIOL REPROD, P75; BAZER FW, 1975, J ANIM SCI, V41, P1376, DOI 10.2527/jas1975.4151376x; Berendt FJ, 2005, PROTEOMICS, V5, P2551, DOI 10.1002/pmic.200401242; BETTERIDGE KJ, 1980, J REPROD FERTIL, V59, P205, DOI 10.1530/jrf.0.0590205; Brandao DO, 2004, BIOL REPROD, V71, P2048, DOI 10.1095/biolreprod.103.025916; Carter F, 2008, REPROD FERT DEVELOP, V20, P368, DOI 10.1071/RD07204; Clemente M, 2009, REPRODUCTION, V138, P507, DOI 10.1530/REP-09-0152; Diskin MG, 2008, REPROD DOMEST ANIM, V43, P260, DOI 10.1111/j.1439-0531.2008.01171.x; Dorniak P, 2012, J ANIM SCI; Dorniak P, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100487; Dorniak P, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097063; Dorniak P, 2011, BIOL REPROD, V84, P1119, DOI 10.1095/biolreprod.110.089979; Forde N, 2011, BIOL REPROD, V85, P144, DOI 10.1095/biolreprod.110.090019; Forde N, 2011, BIOL REPROD, V84, P266, DOI 10.1095/biolreprod.110.085910; Forde N, 2009, BIOL REPROD, V81, P784, DOI 10.1095/biolreprod.108.074336; Forde N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-321; Forde N, 2012, J REPROD DEVELOP, V58, P189, DOI 10.1262/jrd.2011-021; Gao HJ, 2009, BIOL REPROD, V80, P1196, DOI 10.1095/biolreprod.108.075440; Gao HJ, 2009, BIOL REPROD, V80, P602, DOI 10.1095/biolreprod.108.073890; Gao HJ, 2009, BIOL REPROD, V80, P86, DOI 10.1095/biolreprod.108.071597; Gray CA, 2002, REPRODUCTION, V124, P289, DOI 10.1530/rep.0.1240289; Groebner AE, 2011, CELL REPROGRAM, V13, P403, DOI 10.1089/cell.2011.0006; Groebner AE, 2011, REPRODUCTION, V141, P685, DOI 10.1530/REP-10-0533; Houghton FD, 2002, HUM REPROD, V17, P999, DOI 10.1093/humrep/17.4.999; Hugentobler SA, 2010, REPROD FERT DEVELOP, V22, P684, DOI 10.1071/RD09129; Hugentobler SA, 2007, MOL REPROD DEV, V74, P445, DOI 10.1002/mrd.20607; Kim J, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105080; Ledgard AM, 2011, REPROD FERT DEVELOP, V23, P737, DOI 10.1071/RD10183; Leese HJ, 2012, REPRODUCTION, V143, P417, DOI 10.1530/REP-11-0484; Mamo S, 2011, BIOL REPROD, V85, P1143, DOI 10.1095/biolreprod.111.092643; Meier S, 2014, J DAIRY SCI, V97, P1364, DOI 10.3168/jds.2013-6954; Meier S, 2011, J DAIRY RES, V78, P263, DOI 10.1017/S0022029911000173; Mullen MP, 2014, REPROD FERT DEVELOP, V26, P282, DOI 10.1071/RD12319; NORTHEY DL, 1980, J ANIM SCI, V50, P298, DOI 10.2527/jas1980.502298x; Satterfield MC, 2010, BIOL REPROD, V82, P224, DOI 10.1095/biolreprod.109.076729; Sturmey RG, 2010, MOL REPROD DEV, V77, P285, DOI 10.1002/mrd.21145; Wale PL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100552	40	81	83	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100010	10.1371/journal.pone.0100010	http://dx.doi.org/10.1371/journal.pone.0100010			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960174	Green Published, gold, Green Submitted			2022-12-25	WOS:000338633900020
J	Leymarie, O; Embury-Hyatt, C; Chevalier, C; Jouneau, L; Moroldo, M; Da Costa, B; Berhane, Y; Delmas, B; Weingartl, HM; Le Goffic, R				Leymarie, Olivier; Embury-Hyatt, Carissa; Chevalier, Christophe; Jouneau, Luc; Moroldo, Marco; Da Costa, Bruno; Berhane, Yohannes; Delmas, Bernard; Weingartl, Hana M.; Le Goffic, Ronan			PB1-F2 Attenuates Virulence of Highly Pathogenic Avian H5N1 Influenza Virus in Chickens	PLOS ONE			English	Article							MITOCHONDRIAL-MEMBRANE; PANDEMIC INFLUENZA; PROTEIN; TRANSMISSION; CELLS; EXPRESSION; DEATH; DUCKS; GENE; HA	Highly pathogenic avian influenza virus (HPAIV) is a permanent threat due to its capacity to cross species barriers and generate severe infections and high mortality in humans. Recent findings have highlighted the potential role of PB1-F2, a small accessory influenza protein, in the pathogenesis process mediated by HPAIV in mammals. In this study, using a recombinant H5N1 HPAIV (wt) and its PB1-F2-deleted mutant (Delta F2), we studied the effects of PB1-F2 in a chicken model. Unexpectedly, when using low inoculation dose we observed that the wt-infected chickens had a higher survival rate than the Delta F2-infected chickens, a feature that contrasts with what is usually observed in mammals. High inoculation dose had similar mortality rate for both viruses, and comparison of the bio-distribution of the two viruses indicated that the expression of PB1-F2 allows a better spreading of the virus within chicken embryos. Transcriptomic profiles of lungs and blood cells were characterized at two days post-infection in chickens inoculated with the wild type (wt) or the Delta F2 mutant viruses. In lungs, the expression of PB1-F2 during the infection induced pathways related to calcium signaling and repressed a large panel of immunological functions. In blood cells, PB1-F2 was associated with a gene signature specific for mitochondrial dysfunction and down-modulated leucocytes activation. Finally we compared the effect of PB1-F2 in lungs of chickens and mice. We identified that gene signature associated to tissue damages is a PB1-F2 feature shared by the two species; by contrast, the early inhibition of immune response mediated by PB1-F2 observed in chickens is not seen in mice. In summary, our data suggest that PB1-F2 expression deeply affect the immune response in chickens in a way that may attenuate pathogenicity at low infection dose, a feature differing from what was previously observed in mammal species.	[Leymarie, Olivier; Chevalier, Christophe; Jouneau, Luc; Da Costa, Bruno; Delmas, Bernard; Le Goffic, Ronan] INRA, Unite Rech UR892, Unite Virol & Immunol Mol, Jouy En Josas, France; [Embury-Hyatt, Carissa; Berhane, Yohannes; Weingartl, Hana M.] Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada; [Moroldo, Marco] INRA, Ctr Ressources Biol Genom Anim Domest & Interet E, Jouy En Josas, France; [Weingartl, Hana M.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Canadian Food Inspection Agency; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Manitoba	Weingartl, HM (corresponding author), Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada.	Hana.Weingartl@inspection.gc.ca; ronan.legoffic@jouy.inra.fr	Chevalier, Christophe/AAW-5560-2020; Jouneau, Luc/AAC-4711-2020; LE GOFFIC, Ronan/M-3099-2019; Chevalier, Christophe/AAK-4461-2020; LE GOFFIC, Ronan/B-7649-2008; Chevalier, Christophe/C-2575-2009	LE GOFFIC, Ronan/0000-0002-2012-0064; LE GOFFIC, Ronan/0000-0002-2012-0064; Chevalier, Christophe/0000-0003-3231-9027; Leymarie, Olivier/0000-0001-8670-3089	Conseil regional d'Ile-de-France through DIM Malinf ("Domaine d'Interet Majeur Maladies Infectieuses, parasitaires et nosocomiales emergentes'') [dim100157]; OECD Co-operative Research Programme [TAD/PROG 67049]; "DIM Malinf'' doctoral fellowships - "Conseil regional d'Ile-de-France''	Conseil regional d'Ile-de-France through DIM Malinf ("Domaine d'Interet Majeur Maladies Infectieuses, parasitaires et nosocomiales emergentes'')(Region Ile-de-France); OECD Co-operative Research Programme; "DIM Malinf'' doctoral fellowships - "Conseil regional d'Ile-de-France''	This work was partially funded by the Conseil regional d'Ile-de-France through DIM Malinf ("Domaine d'Interet Majeur Maladies Infectieuses, parasitaires et nosocomiales emergentes'', Grant#: dim100157) and by the OECD Co-operative Research Programme (Contract No.: TAD/PROG 67049). OL was supported by "DIM Malinf'' doctoral fellowships awarded by the "Conseil regional d'Ile-de-France''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alymova IV, 2011, J VIROL, V85, P12324, DOI 10.1128/JVI.05872-11; Audas TE, 2008, MOL CELL BIOL, V28, P3952, DOI 10.1128/MCB.01439-07; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Brown IH, 2010, AVIAN DIS, V54, P187, DOI 10.1637/8949-053109-Reg.1; Cardona CJ, 2009, COMP IMMUNOL MICROB, V32, P255, DOI 10.1016/j.cimid.2008.01.001; Chakrabarti AK, 2013, VIROLOGY; Chanturiya AN, 2004, J VIROL, V78, P6304, DOI 10.1128/JVI.78.12.6304-6312.2004; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chevalier C, 2010, J BIOL CHEM, V285, P13233, DOI 10.1074/jbc.M109.067710; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Conenello GM, 2011, J VIROL, V85, P652, DOI 10.1128/JVI.01987-10; DeLuca DS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S13-S6; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Dundon WG, 2012, VIRUS GENES, V44, P363, DOI 10.1007/s11262-012-0714-0; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gibbs JS, 2003, J VIROL, V77, P7214, DOI 10.1128/JVI.77.13.7214-7224.2003; Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; Hassan IH, 2012, J BIOL CHEM, V287, P4679, DOI 10.1074/jbc.M111.284695; Henkel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011112; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Iverson AR, 2011, J INFECT DIS, V203, P880, DOI 10.1093/infdis/jiq113; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Kim JK, 2009, INFLUENZA OTHER RESP, V3, P121, DOI 10.1111/j.1750-2659.2009.00084.x; Kuchipudi SV, 2012, IMMUNOL CELL BIOL, V90, P116, DOI 10.1038/icb.2011.17; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Le Goffic R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002202; Le Goffic R, 2010, J IMMUNOL, V185, P4812, DOI 10.4049/jimmunol.0903952; Leymarie O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057894; Mazur I, 2008, CELL MICROBIOL; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; McAuley JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001014; McAuley JL, 2010, J VIROL, V84, P558, DOI 10.1128/JVI.01785-09; OIE-WAHID, 2012, INF VIR NOT AV INFL; Pappas C, 2008, P NATL ACAD SCI USA, V105, P3064, DOI 10.1073/pnas.0711815105; Pasricha G, 2012, INFLUENZA OTHER RESP; Schmolke M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002186; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Srikanth S, 2012, P NATL ACAD SCI USA, V109, P8682, DOI 10.1073/pnas.1200667109; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Ueda M, 2010, J VIROL, V84, P3068, DOI 10.1128/JVI.01923-09; Varga ZT, 2012, J VIROL, V86, P8359, DOI 10.1128/JVI.01122-12; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wang TT, 2012, SCIENCE, V335, P1463, DOI 10.1126/science.1218888; Wise HM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002998; Wise HM, 2009, J VIROL, V83, P8021, DOI 10.1128/JVI.00826-09; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu H, 2014, ELIFE, V3, DOI 10.7554/eLife.01489; Yamada H, 2004, FEBS LETT, V578, P331, DOI 10.1016/j.febslet.2004.11.017; Yen HL, 2009, CURR TOP MICROBIOL, V333, P3, DOI 10.1007/978-3-540-92165-3_1; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40; Zell R, 2007, J GEN VIROL, V88, P536, DOI 10.1099/vir.0.82378-0	58	23	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100679	10.1371/journal.pone.0100679	http://dx.doi.org/10.1371/journal.pone.0100679			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959667	Green Submitted, Green Published, gold			2022-12-25	WOS:000338633900069
J	Liu, H; Wang, DX; Li, Y; Li, Z; Zhang, Y; Lei, F; Du, LN; Tang, XD				Liu, Hong; Wang, Dexi; Li, Yun; Li, Zhe; Zhang, Ying; Lei, Fei; Du, Lina; Tang, Xiangdong			Examination of Daytime Sleepiness and Cognitive Performance Testing in Patients with Primary Insomnia	PLOS ONE			English	Article							ATTENTION NETWORK TEST; LATENCY TEST; NEUROPSYCHOLOGICAL PERFORMANCE; IMPAIRMENT; DEPRESSION; VIGILANCE; CHILDREN; RECOVERY; DEFICITS	Objective: While individuals with insomnia consistently complain of cognitive impairment, previous studies on the effect of insomnia on objective measures of cognitive function have obtained ambiguous results. The relationship between daytime sleepiness and cognitive manifestations in insomnia patients is not clear. Methods: Thirty-six primary insomnia patients (PIPs) and 26 good sleep controls (GSCs) with age and gender matched manner were included in the study. Participants underwent an overnight polysomnography followed by a multiple sleep latency test (MSLT) and an examination of the attention network test (ANT). ANT reflected three attentional networks including alerting, orienting and executive control. According to whether accompanied with excessive daytime sleepiness (EDS), the insomnia group were subdivided into PIPs with EDS (n = 12, score on MSLT<10 min) and PIPs without EDS (n = 24, score on MSLT >= 10 min). Results: PIPs only performed worse on executive control function than GSCs in ANT. PIPs with EDS had longer overall reaction time (RT) related to PIPs without EDS. Further analyses with Pearson correlation analysis showed a significant negative correlation between the overall RT and MSLT latency in insomniacs (r = 20.444, p<0.01), whereas no such correlation was found in controls. Conclusions: Results suggest that PIPs do show executive control function deficits compared with GSCs. Daytime sleepiness in terms of MSLT latency was associated with poor cognitive manifestations in patients with insomnia.	[Liu, Hong; Wang, Dexi; Li, Yun; Li, Zhe; Lei, Fei; Du, Lina; Tang, Xiangdong] Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Sleep Med Ctr,Mental Hlth Ctr, Chengdu 610064, Sichuan Provinc, Peoples R China; [Liu, Hong] First Peoples Hosp Yibin, Dept Internal Med, Yibin, Sichuan Provinc, Peoples R China; [Wang, Dexi] First Peoples Hosp Yibin, Dept Neurosurg, Yibin, Sichuan Provinc, Peoples R China; [Zhang, Ying] Dalhousie Univ, Dept Psychol, Halifax, NS, Canada	Sichuan University; Dalhousie University	Tang, XD (corresponding author), Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Sleep Med Ctr,Mental Hlth Ctr, Chengdu 610064, Sichuan Provinc, Peoples R China.	xiangdong.tang@gmail.com		Tang, Xiangdong/0000-0001-6876-3328; Li, Yun/0000-0001-6276-9104; Zhang, Ying/0000-0003-4363-5666	National Natural Science Foundation of China [81170072]; Sino-German Joint Center for Sleep Medicine [GZ538]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sino-German Joint Center for Sleep Medicine	This work was supported by the National Natural Science Foundation of China (81170072) and by the Sino-German Joint Center for Sleep Medicine (GZ538). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsdottir S, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-9; Altena E, 2008, SLEEP, V31, P1271; Altena E, 2008, J SLEEP RES, V17, P335, DOI 10.1111/j.1365-2869.2008.00671.x; American Psychiatric Association A, 1994, DIAGN STAT MAN MENT; Bayard S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033525; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Brocki K, 2009, NEUROSCIENCE, V164, P241, DOI 10.1016/j.neuroscience.2009.01.029; BUYSSE DJ, 1991, SLEEP, V14, P331; CARSKADON MA, 1986, SLEEP, V9, P519, DOI 10.1093/sleep/9.4.519; Carter CS, 1999, REV NEUROSCIENCE, V10, P49; Covassin N, 2011, INT J PSYCHOPHYSIOL, V80, P79, DOI 10.1016/j.ijpsycho.2011.02.005; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Drummond SPA, 2005, SLEEP, V28, P1059; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Edinger JD, 2003, J SLEEP RES, V12, P43, DOI 10.1046/j.1365-2869.2003.00335.x; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fernandez-Mendoza J, 2010, SLEEP, V33, P459, DOI 10.1093/sleep/33.4.459; Finan PH, 2013, SLEEP MED REV, V17, P173, DOI 10.1016/j.smrv.2012.03.003; Fortier-Brochu E, 2012, SLEEP MED REV, V16, P83, DOI 10.1016/j.smrv.2011.03.008; Fossella J, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-14; Fulda S, 2001, SLEEP MED REV, V5, P423, DOI 10.1053/smrv.2001.0157; Gradisar M, 2007, J CLIN SLEEP MED, V3, P722; Huang LL, 2012, J SLEEP RES, V21, P684, DOI 10.1111/j.1365-2869.2012.01028.x; Iber C., 2007, AASM MANUAL SCORING; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Lamond N, 2007, J SLEEP RES, V16, P33, DOI 10.1111/j.1365-2869.2007.00574.x; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067928, 10.1371/journal.pone.0057604, 10.1371/journal.pone.0083037]; Littner MR, 2005, SLEEP, V28, P113, DOI 10.1093/sleep/28.1.113; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; MENDELSON WB, 1984, PSYCHIAT RES, V12, P235, DOI 10.1016/0165-1781(84)90029-5; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Neuhaus AH, 2010, INT J PSYCHOPHYSIOL, V76, P72, DOI 10.1016/j.ijpsycho.2010.02.005; O'Brien LM, 2009, CHILD ADOL PSYCH CL, V18, P813, DOI 10.1016/j.chc.2009.04.008; Orff HJ, 2007, SLEEP, V30, P1205, DOI 10.1093/sleep/30.9.1205; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Riedel BW, 2000, SLEEP MED REV, V4, P277, DOI 10.1053/smrv.1999.0074; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Sateia MJ, 2004, LANCET, V364, P1959, DOI 10.1016/S0140-6736(04)17480-1; SCHNEIDERHELMERT D, 1987, SLEEP, V10, P452; Shekleton JA, 2010, SLEEP MED REV, V14, P47, DOI 10.1016/j.smrv.2009.06.001; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Van Dam NT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054035; Van Dongen HPA, 2004, SLEEP, V27, P423; Vignola A, 2000, J GERONTOL B-PSYCHOL, V55, pP54; Wang K, 2005, SCHIZOPHR RES, V78, P235, DOI 10.1016/j.schres.2005.01.019; Weaver B, 2009, ACCIDENT ANAL PREV, V41, P76, DOI 10.1016/j.aap.2008.09.006; Westlye LT, 2011, CEREB CORTEX, V21, P345, DOI 10.1093/cercor/bhq101; Yin XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050590; ZAMMIT GK, 1988, J CLIN PSYCHOL, V44, P123, DOI 10.1002/1097-4679(198803)44:2<123::AID-JCLP2270440206>3.0.CO;2-D	50	24	25	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100965	10.1371/journal.pone.0100965	http://dx.doi.org/10.1371/journal.pone.0100965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7UT	24959897	Green Published, Green Submitted, gold			2022-12-25	WOS:000338633900106
J	Odaka, H; Arai, S; Inoue, T; Kitaguchi, T				Odaka, Haruki; Arai, Satoshi; Inoue, Takafumi; Kitaguchi, Tetsuya			Genetically-Encoded Yellow Fluorescent cAMP Indicator with an Expanded Dynamic Range for Dual-Color Imaging	PLOS ONE			English	Article							ADENYLYL-CYCLASE DEFINES; EPAC ACTIVATION; PROTEIN; CA2+; MICRODOMAINS; SECRETION; RECEPTOR; CELLS; PROBE	Cyclic AMP is a ubiquitous second messenger, which mediates many cellular responses mainly initiated by activation of cell surface receptors. Various Forster resonance energy transfer-based ratiometric cAMP indicators have been created for monitoring the spatial and temporal dynamics of cAMP at the single-cell level. However, single fluorescent protein-based cAMP indicators have been poorly developed, with improvement required for dynamic range and brightness. Based on our previous yellow fluorescent protein-based cAMP indicator, Flamindo, we developed an improved yellow fluorescent cAMP indicator named Flamindo2. Flamindo2 has a 2-fold expanded dynamic range and 8-fold increased brightness compared with Flamindo by optimization of linker peptides in the vicinity of the chromophore. We found that fluorescence intensity of Flamindo2 was decreased to 25% in response to cAMP. Live-cell cAMP imaging of the cytosol and nucleus in COS7 cells using Flamindo2 and nlsFlamindo2, respectively, showed that forskolin elevated cAMP levels in each compartment with different kinetics. Furthermore, dual-color imaging of cAMP and Ca2+ with Flamindo2 and a red fluorescent Ca2+ indicator, R-GECO, showed that cAMP and Ca2+ elevation were induced by noradrenaline in single HeLa cells. Our study shows that Flamindo2, which is feasible for multi-color imaging with other intracellular signaling molecules, is useful and is an alternative tool for live-cell imaging of intracellular cAMP dynamics.	[Odaka, Haruki; Arai, Satoshi; Kitaguchi, Tetsuya] Waseda Univ, Waseda Biosci Res Inst Singapore WABIOS, Cell Signaling Grp, Singapore, Singapore; [Odaka, Haruki; Inoue, Takafumi] Waseda Univ, Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Tokyo, Japan	Waseda University	Kitaguchi, T (corresponding author), Waseda Univ, Waseda Biosci Res Inst Singapore WABIOS, Cell Signaling Grp, Singapore, Singapore.	kitaguct@aoni.waseda.jp	KITAGUCHI, TETSUYA/AAR-1895-2021; Inoue, Takafumi/AAM-9533-2020; Kitaguchi, Tetsuya/F-5260-2017; Odaka, Haruki/AAQ-4448-2020; ARAI, SATOSHI/L-6709-2018	KITAGUCHI, TETSUYA/0000-0001-6701-1933; Inoue, Takafumi/0000-0002-2728-0060; Kitaguchi, Tetsuya/0000-0001-6701-1933; Odaka, Haruki/0000-0001-5632-2680; ARAI, SATOSHI/0000-0003-4807-8248	Waseda University Organization for University Research Initiatives; Ministry of Education, Culture, Sports, Science and Technology of Japan;  [25350970]	Waseda University Organization for University Research Initiatives; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This research was supported by the Waseda University Organization for University Research Initiatives, a Grant-in aid for Scientific Research to T.K. (grant number 25350970) and the Supporting Project to Form the Strategic Research Platforms for a Private University from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS SR, 1991, NATURE, V349, P694, DOI 10.1038/349694a0; Baillie GS, 2009, FEBS J, V276, P1790, DOI 10.1111/j.1742-4658.2009.06926.x; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; KASAI H, 1994, TRENDS NEUROSCI, V17, P95, DOI 10.1016/0166-2236(94)90112-0; Kawai Y, 2004, ANAL CHEM, V76, P6144, DOI 10.1021/ac040037s; Kitaguchi T, 2013, BIOCHEM J, V450, P365, DOI 10.1042/BJ20121022; Li BY, 1999, ACTA PHARMACOL SIN, V20, P1011; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/NMETH.2333, 10.1038/nmeth.2333]; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Nausch LWM, 2008, P NATL ACAD SCI USA, V105, P365, DOI 10.1073/pnas.0710387105; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Ohkura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051286; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; SCHWINN DA, 1991, MOL PHARMACOL, V40, P619; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; TALLMAN JF, 1977, P NATL ACAD SCI USA, V74, P873, DOI 10.1073/pnas.74.3.873; Tantama M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3550; Willoughby D, 2008, NAT METHODS, V5, P29, DOI 10.1038/NMETH1135; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje	30	51	54	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100252	10.1371/journal.pone.0100252	http://dx.doi.org/10.1371/journal.pone.0100252			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959857	Green Submitted, Green Published, gold			2022-12-25	WOS:000338633900032
J	Shao, HJ; Xue, QS; Zhang, FJ; Luo, Y; Zhu, H; Zhang, XQ; Zhang, HH; Ding, WL; Yu, BW				Shao, Haijun; Xue, Qingsheng; Zhang, Fujun; Luo, Yan; Zhu, Hao; Zhang, Xiaoqing; Zhang, Honghai; Ding, Wenlong; Yu, Buwei			Spinal SIRT1 Activation Attenuates Neuropathic Pain in Mice	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PERIPHERAL-NERVE INJURY; DEACETYLASE SIRT1; IN-VIVO; CIRCADIAN CONTROL; SENSITIVE METHOD; SENSORY NEURONS; RESVERATROL; NICOTINAMIDE; INHIBITORS	Abnormal histone acetylation occurs during neuropathic pain through an epigenetic mechanism. Silent information regulator 1 (sir2 or SIRT1), a NAD-dependent deacetylase, plays complex systemic roles in a variety of processes through deacetylating acetylated histone and other specific substrates. But the role of SIRT1 in neuropathic pain is not well established yet. The present study was intended to detect SIRT1 content and activity, nicotinamide (NAM) and nicotinamide adenine dinucleotide (NAD) in the spinal cord using immunoblotting or mass spectroscopy over time in mice following chronic constriction injury (CCI) or sham surgery. In addition, the effect of intrathecal injection of NAD or resveratrol on thermal hyperalgesia and mechanical allodynia was evaluated in CCI mice. Finally, we investigated whether SIRT1 inhibitor EX-527 could reverse the anti-nociceptive effect of NAD or resveratrol. It was found that spinal SIRT1 expression, deacetylase activity and NAD/NAM decreased significantly 1, 3, 7, 14 and 21 days after CCI surgery as compared with sham group. In addition, daily intrathecal injection of 5 mu l 800 mM NAD 1 h before and 1 day after CCI surgery or single intrathecal injection of 5 mu l 90 mM resveratrol 1 h before CCI surgery produced a transient inhibitory effect on thermal hyperalgesia and mechanical allodynia in CCI mice. Finally, an intrathecal injection of 5 mu l 1.2 mM EX-527 1 h before NAD or resveratrol administration reversed the anti-nociceptive effect of NAD or resveratrol. These data indicate that the reduction in SIRT1 deacetylase activity may be a factor contributing to the development of neuropathic pain in CCI mice. Our findings suggest that the enhancement of spinal NAD/NAM and/or SIRT1 activity may be a potentially promising strategy for the prevention or treatment of neuropathic pain.	[Shao, Haijun; Xue, Qingsheng; Zhang, Fujun; Luo, Yan; Zhang, Xiaoqing; Yu, Buwei] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Anesthesiol, Shanghai 200030, Peoples R China; [Zhu, Hao; Ding, Wenlong] Shanghai Jiao Tong Univ, Sch Med, Dept Anat, Shanghai 200030, Peoples R China; [Zhang, Honghai] Nanjing Med Univ, Hangzhou Peoples Hosp 1, Dept Anesthesiol, Hangzhou, Zhejiang, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Nanjing Medical University	Yu, BW (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Anesthesiol, Shanghai 200030, Peoples R China.	yubuwei_1958@163.com			Natural Sciences Foundation of China [30400421]	Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Sciences Foundation of China (grant number 30400421). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adilakshmi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039674; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Baron R, 2006, NAT CLIN PRACT NEURO, V2, P95, DOI 10.1038/ncpneuro0113; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bellamacina CR, 1996, FASEB J, V10, P1257, DOI 10.1096/fasebj.10.11.8836039; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bermudez-Ocana DY, 2006, PHARMACOL BIOCHEM BE, V84, P535, DOI 10.1016/j.pbb.2006.06.019; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruzzone S, 2001, FASEB J, V15, P10; Chiechio S, 2009, MOL PHARMACOL, V75, P1014, DOI 10.1124/mol.108.054346; Denk F, 2013, PAIN, V154, P1668, DOI 10.1016/j.pain.2013.05.021; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hoane MR, 2008, NEUROSCIENCE, V154, P861, DOI 10.1016/j.neuroscience.2008.04.044; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Imai S, 2011, J NEUROSCI, V31, P15294, DOI 10.1523/JNEUROSCI.0921-11.2011; Imai S, 2009, BBA-GEN SUBJECTS, V1790, P997, DOI 10.1016/j.bbagen.2009.03.005; Kiguchi N, 2012, J PHARMACOL EXP THER, V340, P577, DOI 10.1124/jpet.111.187724; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Klaidman LK, 1996, NEUROSCI LETT, V206, P5, DOI 10.1016/0304-3940(96)12446-0; Larrosa M, 2011, EUR J NUTR, V50, P673, DOI 10.1007/s00394-011-0178-3; Lee JC, 2012, BRAIN RES, V1433, P20, DOI 10.1016/j.brainres.2011.11.019; Milne JC, 2008, CURR OPIN CHEM BIOL, V12, P11, DOI 10.1016/j.cbpa.2008.01.019; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Perez-Severiano F, 2008, PHARMACOL BIOCHEM BE, V90, P742, DOI 10.1016/j.pbb.2008.05.024; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Renthal W, 2009, NEURON, V62, P335, DOI 10.1016/j.neuron.2009.03.026; Tang BL, 2010, BRAIN RES BULL, V81, P359, DOI 10.1016/j.brainresbull.2009.12.007; Tillu DV, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-5; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tsai RY, 2012, ANESTH ANALG, V115, P944, DOI 10.1213/ANE.0b013e31825da0fb; Uchida H, 2013, NEUROSCIENCE, V240, P147, DOI 10.1016/j.neuroscience.2013.02.053; Uchida H, 2010, NEUROSCIENCE, V166, P1, DOI 10.1016/j.neuroscience.2009.12.021; Uchida H, 2010, J NEUROSCI, V30, P4806, DOI 10.1523/JNEUROSCI.5541-09.2010; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Wang Y, 2012, GENE THER; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Wuertz K, 2011, SPINE, V36, pE1373, DOI 10.1097/BRS.0b013e318221e655; Yin Q, 2013, REG ANESTH PAIN MED; Zakhary SM, 2010, ANAT REC, V293, P1024, DOI 10.1002/ar.21116	47	58	60	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100938	10.1371/journal.pone.0100938	http://dx.doi.org/10.1371/journal.pone.0100938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959710	Green Published, Green Submitted, gold			2022-12-25	WOS:000338633900102
J	Suplatov, D; Panin, N; Kirilin, E; Shcherbakova, T; Kudryavtsev, P; Svedas, V				Suplatov, Dmitry; Panin, Nikolay; Kirilin, Evgeny; Shcherbakova, Tatyana; Kudryavtsev, Pavel; Svedas, Vytas			Computational Design of a pH Stable Enzyme: Understanding Molecular Mechanism of Penicillin Acylase's Adaptation to Alkaline Conditions	PLOS ONE			English	Article							PROTEIN STABILITY; DIRECTED EVOLUTION; CATALYTIC EFFICIENCY; TRICHODERMA-REESEI; CRYSTAL-STRUCTURE; GENETIC-ANALYSIS; ALPHA-AMYLASE; DYNAMICS; RESOLUTION; ACYLATION	Protein stability provides advantageous development of novel properties and can be crucial in affording tolerance to mutations that introduce functionally preferential phenotypes. Consequently, understanding the determining factors for protein stability is important for the study of structure-function relationship and design of novel protein functions. Thermal stability has been extensively studied in connection with practical application of biocatalysts. However, little work has been done to explore the mechanism of pH-dependent inactivation. In this study, bioinformatic analysis of the Ntn-hydrolase superfamily was performed to identify functionally important subfamily-specific positions in protein structures. Furthermore, the involvement of these positions in pH-induced inactivation was studied. The conformational mobility of penicillin acylase in Escherichia coli was analyzed through molecular modeling in neutral and alkaline conditions. Two functionally important subfamily-specific residues, Glu beta 482 and Asp beta 484, were found. Ionization of these residues at alkaline pH promoted the collapse of a buried network of stabilizing interactions that consequently disrupted the functional protein conformation. The subfamily-specific position Asp beta 484 was selected as a hotspot for mutation to engineer enzyme variant tolerant to alkaline medium. The corresponding D beta 484N mutant was produced and showed 9-fold increase in stability at alkaline conditions. Bioinformatic analysis of subfamily-specific positions can be further explored to study mechanisms of protein inactivation and to design more stable variants for the engineering of homologous Ntn-hydrolases with improved catalytic properties.	[Svedas, Vytas] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow, Russia	Lomonosov Moscow State University; Lomonosov Moscow State University	Svedas, V (corresponding author), Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia.	vytas@belozersky.msu.ru	panin, nikolay/AAO-1045-2020; Svedas, Vytas/J-6594-2012; Evgeny, Kirilin/AAG-3522-2019; Suplatov, Dmitry/A-4878-2015	Svedas, Vytas/0000-0002-1664-0307; Evgeny, Kirilin/0000-0003-4960-8925; Suplatov, Dmitry/0000-0002-7054-3487	Skolkovo Institute of Science and Technology [182-MRA]; Russian Foundation for Basic Research [14-08-00987]	Skolkovo Institute of Science and Technology; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	Financial support from Skolkovo Institute of Science and Technology (grant 182-MRA) and Russian Foundation for Basic Research (grant 14-08-00987) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; AKKE M, 1990, PROTEINS, V8, P23, DOI 10.1002/prot.340080106; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arroyo M, 2003, APPL MICROBIOL BIOT, V60, P507, DOI 10.1007/s00253-002-1113-6; Azevedo AM, 1999, J CHEM TECHNOL BIOT, V74, P1110, DOI 10.1002/(SICI)1097-4660(199911)74:11<1110::AID-JCTB149>3.0.CO;2-B; Basso A, 2001, J MOL CATAL B-ENZYM, V11, P851, DOI 10.1016/S1381-1177(00)00070-9; Basso A, 2007, ADV SYNTH CATAL, V349, P877, DOI 10.1002/adsc.200600337; Beadle BM, 2002, J MOL BIOL, V321, P285, DOI 10.1016/S0022-2836(02)00599-5; Belien T, 2009, PROTEIN ENG DES SEL, V22, P587, DOI 10.1093/protein/gzp024; Bessler C, 2003, PROTEIN SCI, V12, P2141, DOI 10.1110/ps.0384403; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; Bruggink A, 1998, ORG PROCESS RES DEV, V2, P128, DOI 10.1021/op9700643; Chen L, 2005, THESIS U WATERLOO; Chilov GG, 2003, TETRAHEDRON-ASYMMETR, V14, P2613, DOI 10.1016/S0957-4166(03)00523-8; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; CUNNINGHAM BC, 1987, PROTEIN ENG, V1, P319, DOI 10.1093/protein/1.4.319; Day R, 2002, J MOL BIOL, V322, P189, DOI 10.1016/S0022-2836(02)00672-1; Deaguero AL, 2012, PROTEIN ENG DES SEL, V25, P135, DOI 10.1093/protein/gzr065; DELRIO G, 1995, BIOTECHNOL BIOENG, V48, P141, DOI 10.1002/bit.260480208; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; DUGGLEBY HJ, 1995, NATURE, V373, P264, DOI 10.1038/373264a0; Eijsink VGH, 2004, J BIOTECHNOL, V113, P105, DOI 10.1016/j.jbiotec.2004.03.026; Eijsink VGH, 2005, BIOMOL ENG, V22, P21, DOI 10.1016/j.bioeng.2004.12.003; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; Finkelstein A. V, 2002, PROTEIN PHYS, P207; Fischer JD, 2008, BIOINFORMATICS, V24, P613, DOI 10.1093/bioinformatics/btm626; Fushinobu S, 1998, PROTEIN ENG, V11, P1121, DOI 10.1093/protein/11.12.1121; Gardossi L, 2010, TRENDS BIOTECHNOL, V28, P171, DOI 10.1016/j.tibtech.2010.01.001; Giorgino T, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i07; Grinberg VY, 2008, BBA-PROTEINS PROTEOM, V1784, P736, DOI 10.1016/j.bbapap.2008.01.016; Groger H., 2012, ENZYME CATALYSIS ORG, P1; Gulich S, 2002, PROTEIN ENG, V15, P835, DOI 10.1093/protein/15.10.835; Guranda DT, 2010, ACTA NATURAE, V2, P94, DOI 10.32607/20758251-2010-2-1-94-96; Guranda DT, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1386, DOI 10.1007/s10541-005-0085-4; Guranda DT, 2004, TETRAHEDRON-ASYMMETR, V15, P2901, DOI 10.1016/j.tetasy.2004.06.051; Guranda DT, 2001, TETRAHEDRON-ASYMMETR, V12, P1645, DOI 10.1016/S0957-4166(01)00263-4; Hanefeld U, 2009, CHEM SOC REV, V38, P453, DOI 10.1039/b711564b; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ismail H, 2008, GREEN CHEM, V10, P415, DOI 10.1039/b714088f; Iyer PV, 2008, PROCESS BIOCHEM, V43, P1019, DOI 10.1016/j.procbio.2008.06.004; Jasnaya AS, 2008, MOSCOW U CHEM BULL, V49, P127; Kallenberg AI, 2005, ADV SYNTH CATAL, V347, P905, DOI 10.1002/adsc.200505042; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Katchalski-Katzir E, 2000, J MOL CATAL B-ENZYM, V10, P157, DOI 10.1016/S1381-1177(00)00124-7; Khan S, 2010, HUM MUTAT, V31, P675, DOI 10.1002/humu.21242; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LESK AM, 1980, J MOL BIOL, V136, P225, DOI 10.1016/0022-2836(80)90373-3; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liu LW, 2009, PROCESS BIOCHEM, V44, P912, DOI 10.1016/j.procbio.2009.02.013; Liu YH, 2012, J APPL MICROBIOL, V113, P541, DOI 10.1111/j.1365-2672.2012.05359.x; Margolin AL, 1996, TRENDS BIOTECHNOL, V14, P223, DOI 10.1016/0167-7799(96)10031-7; MARGOLIN AL, 1982, BIOTECHNOL BIOENG, V24, P237, DOI 10.1002/bit.260240119; Mateo C, 2002, BIOTECHNOL PROGR, V18, P629, DOI 10.1021/bp010171n; MATTHEWS BW, 1993, ANNU REV BIOCHEM, V62, P139, DOI 10.1146/annurev.bi.62.070193.001035; McVey CE, 2001, J MOL BIOL, V313, P139, DOI 10.1006/jmbi.2001.5043; Menke M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040010; Mongan J, 2005, CURR OPIN STRUC BIOL, V15, P157, DOI 10.1016/j.sbi.2005.02.002; Mongan J, 2004, J COMPUT CHEM, V25, P2038, DOI 10.1002/jcc.20139; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Novikov FN, 2013, FEBS J, V280, P115, DOI 10.1111/febs.12054; O'Fagain C, 2011, METHODS MOL BIOL, V681, P103, DOI 10.1007/978-1-60761-913-0_7; Oinonen C, 2000, PROTEIN SCI, V9, P2329, DOI 10.1110/ps.9.12.2329; PAKULA AA, 1989, ANNU REV GENET, V23, P289, DOI 10.1146/annurev.ge.23.120189.001445; Palmer B, 2008, J BIOTECHNOL, V134, P222, DOI 10.1016/j.jbiotec.2007.12.009; Park S, 2005, PROTEINS, V60, P450, DOI 10.1002/prot.20511; Pchelintsev NA, 2009, J MOL CATAL B-ENZYM, V56, P202, DOI 10.1016/j.molcatb.2008.05.006; Phadtare S, 2002, BIOTECHNOL PROGR, V18, P483, DOI 10.1021/bp015504v; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pleiss J, 2012, ENZYME CATALYSIS ORG, P89; Polizzi Karen M., 2006, Biotechnology Journal, V1, P531, DOI 10.1002/biot.200600029; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; Qin YQ, 2008, J BIOTECHNOL, V135, P190, DOI 10.1016/j.jbiotec.2008.03.016; Rehm S, 2010, PROTEIN SCI, V19, P2122, DOI 10.1002/pro.493; Robinson NE, 2002, P NATL ACAD SCI USA, V99, P5283, DOI 10.1073/pnas.082102799; SALI A, 1994, NATURE, V369, P248, DOI 10.1038/369248a0; SAWYER L, 1982, NATURE, V295, P79, DOI 10.1038/295079a0; Scheraga HA, 2007, ANNU REV PHYS CHEM, V58, P57, DOI 10.1146/annurev.physchem.58.032806.104614; SERRANO L, 1993, J MOL BIOL, V233, P305, DOI 10.1006/jmbi.1993.1508; Shaw A, 1996, CURR OPIN STRUC BIOL, V6, P546, DOI 10.1016/S0959-440X(96)80122-9; Shirai T, 1997, PROTEIN ENG, V10, P627, DOI 10.1093/protein/10.6.627; Shirai T, 2001, J MOL BIOL, V310, P1079, DOI 10.1006/jmbi.2001.4835; Shumway R. H., 2010, TIME SERIES ANAL ITS; Sillitoe I, 2013, NUCLEIC ACIDS RES, V41, pD490, DOI 10.1093/nar/gks1211; SOLODENKO VA, 1993, TETRAHEDRON-ASYMMETR, V4, P1965, DOI 10.1016/S0957-4166(00)82240-5; Soloshonok VA, 1998, J ORG CHEM, V63, P1878, DOI 10.1021/jo971777m; Stephens DE, 2009, FEMS MICROBIOL LETT, V293, P42, DOI 10.1111/j.1574-6968.2009.01519.x; Suplatov DA, 2012, PROTEIN ENG DES SEL, V25, P689, DOI 10.1093/protein/gzs068; Suplatov D, 2014, J BIOMOL STRUCT DYN, V32, P1752, DOI 10.1080/07391102.2013.834514; Suplatov D, 2014, J BIOMOL STRUCT DYN, V32, P75, DOI 10.1080/07391102.2012.750249; Svedas V, 1997, FEBS LETT, V417, P414, DOI 10.1016/S0014-5793(97)01289-1; Svedas VK, 1998, ANN NY ACAD SCI, V864, P524, DOI 10.1111/j.1749-6632.1998.tb10373.x; Svedas VK, 1977, BIOORG KHIM, V3, P546; Taly JF, 2011, NAT PROTOC, V6, P1669, DOI 10.1038/nprot.2011.393; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Trodler P, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-9; Uversky VN, 2013, BIOPOLYMERS, V99, P870, DOI 10.1002/bip.22298; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; van Rantwijk F, 2004, TETRAHEDRON, V60, P501, DOI 10.1016/j.tet.2003.10.018; Voevodin V.l., 2012, OTKRYTYE SISTEMY, V7, P36; Wagner GP., 2005, ROBUSTNESS EVOLVABIL; Wang T, 2005, BIOMOL ENG, V22, P89, DOI 10.1016/j.bioeng.2004.10.003; Wohlfahrt G, 2003, BIOCHEMISTRY-US, V42, P10095, DOI 10.1021/bi034954o; Xu H, 2013, J BIOSCI BIOENG, V115, P618, DOI 10.1016/j.jbiosc.2012.12.006; YANG AS, 1993, J MOL BIOL, V231, P459, DOI 10.1006/jmbi.1993.1294; Yang HQ, 2013, J BIOTECHNOL, V164, P59, DOI 10.1016/j.jbiotec.2012.12.007; Zeldovich KB, 2007, P NATL ACAD SCI USA, V104, P16152, DOI 10.1073/pnas.0705366104	108	40	43	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100643	10.1371/journal.pone.0100643	http://dx.doi.org/10.1371/journal.pone.0100643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959852	Green Submitted, Green Published, gold			2022-12-25	WOS:000338633900065
J	Narahara, M; Higasa, K; Nakamura, S; Tabara, Y; Kawaguchi, T; Ishii, M; Matsubara, K; Matsuda, F; Yamada, R				Narahara, Maiko; Higasa, Koichiro; Nakamura, Seiji; Tabara, Yasuharu; Kawaguchi, Takahisa; Ishii, Miho; Matsubara, Kenichi; Matsuda, Fumihiko; Yamada, Ryo			Large-Scale East-Asian eQTL Mapping Reveals Novel Candidate Genes for LD Mapping and the Genomic Landscape of Transcriptional Effects of Sequence Variants	PLOS ONE			English	Article							CROHNS-DISEASE SUSCEPTIBILITY; LONG NONCODING RNAS; WIDE ASSOCIATION; EXPRESSION; LOCI; IMPACT; IDENTIFICATION; POLYMORPHISMS; POPULATIONS; ANNOTATION	Profiles of sequence variants that influence gene transcription are very important for understanding mechanisms that affect phenotypic variation and disease susceptibility. Using genotypes at 1.4 million SNPs and a comprehensive transcriptional profile of 15,454 coding genes and 6,113 lincRNA genes obtained from peripheral blood cells of 298 Japanese individuals, we mapped expression quantitative trait loci (eQTLs). We identified 3,804 cis-eQTLs (within 500 kb from target genes) and 165 trans-eQTLs (>500 kb away or on different chromosomes). Cis-eQTLs were often located in transcribed or adjacent regions of genes; among these regions, 59 untranslated regions and 59 flanking regions had the largest effects. Epigenetic evidence for regulatory potential accumulated in public databases explained the magnitude of the effects of our eQTLs. Cis-eQTLs were often located near the respective target genes, if not within genes. Large effect sizes were observed with eQTLs near target genes, and effect sizes were obviously attenuated as the eQTL distance from the gene increased. Using a very stringent significance threshold, we identified 165 large-effect trans-eQTLs. We used our eQTL map to assess 8,069 disease-associated SNPs identified in 1,436 genome-wide association studies (GWAS). We identified genes that might be truly causative, but GWAS might have failed to identify for 148 out of the GWAS-identified SNPs; for example, TUFM (P = 3.3E-48) was identified for inflammatory bowel disease (early onset); ZFP90 (P = 4.4E-34) for ulcerative colitis; and IDUA (P = 2.2E-11) for Parkinson's disease. We identified four genes (P<2.0E-14) that might be related to three diseases and two hematological traits; each expression is regulated by trans-eQTLs on a different chromosome than the gene.	[Narahara, Maiko; Higasa, Koichiro; Tabara, Yasuharu; Kawaguchi, Takahisa; Matsuda, Fumihiko; Yamada, Ryo] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Nakamura, Seiji; Ishii, Miho; Matsubara, Kenichi] DNA Chip Res Inc, Yokohama, Kanagawa, Japan	Kyoto University; DNA Chip Research Inc.	Yamada, R (corresponding author), Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan.	ryamada@genome.med.kyoto-u.ac.jp		Yamada, Ryo/0000-0002-1587-630X	Ministry of Health, Labour and Welfare, Japan; Kyoto University; Ministry of Health, Labour and Welfare of Japan [201238002A]; DNA Chip Research Inc.	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Kyoto University; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); DNA Chip Research Inc.	This work was supported by Ministry of Health, Labour and Welfare, Japan (2009-2013), Kyoto University (2006), and the Research Grant for Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan (201238002A). Co-authors Seiji Nakamura, Miho Ishii and Kenichi Matsubara are employed by DNA Chip Research Inc. DNA Chip Research Inc. provided support in the form of salaries for authors Seiji Nakamura, Miho Ishii and Kenichi Matsubara, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Alberts R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000622; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Benovoy D, 2008, NUCLEIC ACIDS RES, V36, P4417, DOI 10.1093/nar/gkn409; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Brown CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003649; Bushel PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034286; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cheung VG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000480; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Duan S, 2008, AM J HUM GENET, V82, P1101, DOI 10.1016/j.ajhg.2008.03.006; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li J, 2013, HUM MOL GENET, V22, P1457, DOI 10.1093/hmg/dds534; Ma HQ, 2009, WORLD J GASTROENTERO, V15, P4844, DOI 10.3748/wjg.15.4844; Mehta D, 2013, EUR J HUM GENET, V21, P48, DOI 10.1038/ejhg.2012.106; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Plagnol V, 2009, BIOSTATISTICS, V10, P327, DOI 10.1093/biostatistics/kxn039; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sasayama D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054967; Sliwerska E, 2007, BIOL PSYCHIAT, V61, P13, DOI 10.1016/j.biopsych.2006.01.023; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Spizzo R, 2012, ONCOGENE, V31, P4577, DOI 10.1038/onc.2011.621; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tse KP, 2009, AM J HUM GENET, V85, P194, DOI 10.1016/j.ajhg.2009.07.007; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Walter NAR, 2007, NAT METHODS, V4, P679, DOI 10.1038/nmeth0907-679; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Yang SK, 2014, GUT, V63, P80, DOI 10.1136/gutjnl-2013-305193; Zhang W, 2008, AM J HUM GENET, V82, P631, DOI 10.1016/j.ajhg.2007.12.015	46	100	100	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100924	10.1371/journal.pone.0100924	http://dx.doi.org/10.1371/journal.pone.0100924			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956270	Green Published, Green Submitted, gold			2022-12-25	WOS:000338917900106
J	Wang, CS; Wang, SG; Li, K; Ju, YP; Li, JP; Zhang, YX; Li, JH; Liu, XY; Shi, XY; Zhao, QH				Wang, Chuanshun; Wang, Shige; Li, Kai; Ju, Yaping; Li, Jipeng; Zhang, Yongxing; Li, Jinhua; Liu, Xuanyong; Shi, Xiangyang; Zhao, Qinghua			Preparation of Laponite Bioceramics for Potential Bone Tissue Engineering Applications	PLOS ONE			English	Article							POLY(LACTIC-CO-GLYCOLIC ACID) NANOFIBERS; IN-VITRO; CANCER-CELLS; HYDROXYAPATITE; REGENERATION; COMPOSITE; DIFFERENTIATION; FABRICATION; DOXORUBICIN; SCAFFOLDS	We report a facile approach to preparing laponite (LAP) bioceramics via sintering LAP powder compacts for bone tissue engineering applications. The sintering behavior and mechanical properties of LAP compacts under different temperatures, heating rates, and soaking times were investigated. We show that LAP bioceramic with a smooth and porous surface can be formed at 800 degrees C with a heating rate of 5 degrees C/h for 6 h under air. The formed LAP bioceramic was systematically characterized via different methods. Our results reveal that the LAP bioceramic possesses an excellent surface hydrophilicity and serum absorption capacity, and good cytocompatibility and hemocompatibility as demonstrated by resazurin reduction assay of rat mesenchymal stem cells (rMSCs) and hemolytic assay of pig red blood cells, respectively. The potential bone tissue engineering applicability of LAP bioceramic was explored by studying the surface mineralization behavior via soaking in simulated body fluid (SBF), as well as the surface cellular response of rMSCs. Our results suggest that LAP bioceramic is able to induce hydroxyapatite deposition on its surface when soaked in SBF and rMSCs can proliferate well on the LAP bioceramic surface. Most strikingly, alkaline phosphatase activity together with alizarin red staining results reveal that the produced LAP bioceramic is able to induce osteoblast differentiation of rMSCs in growth medium without any inducing factors. Finally, in vivo animal implantation, acute systemic toxicity test and hematoxylin and eosin (H&E)-staining data demonstrate that the prepared LAP bioceramic displays an excellent biosafety and is able to heal the bone defect. Findings from this study suggest that the developed LAP bioceramic holds a great promise for treating bone defects in bone tissue engineering.	[Wang, Chuanshun; Li, Kai; Ju, Yaping; Li, Jipeng; Zhang, Yongxing; Zhao, Qinghua] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Orthopaed, Shanghai 200030, Peoples R China; [Wang, Shige; Shi, Xiangyang] Donghua Univ, Coll Mat Sci & Engn, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai, Peoples R China; [Li, Jinhua; Liu, Xuanyong] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China; [Shi, Xiangyang] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Donghua University; Chinese Academy of Sciences; Shanghai Institute of Ceramics, CAS; Donghua University	Shi, XY (corresponding author), Donghua Univ, Coll Mat Sci & Engn, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai, Peoples R China.	xshi@dhu.edu.cn; sawboneszhao@163.com	LI, Jinhua/AAI-3716-2021; Shi, Xiangyang/A-1289-2007; Liu, Xuanyong/J-2609-2018; Wang, Shige/H-7436-2012	LI, Jinhua/0000-0003-1110-7471; Shi, Xiangyang/0000-0001-6785-6645; Wang, Shige/0000-0002-7639-6035	Medicine and Engineering Joint Foundation of Shanghai Jiao Tong University [YG2011MS28]; High-Tech Research and Development Program of China [2012AA030309]; program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning	Medicine and Engineering Joint Foundation of Shanghai Jiao Tong University; High-Tech Research and Development Program of China; program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning	This work was financially supported by the Medicine and Engineering Joint Foundation of Shanghai Jiao Tong University (No. YG2011MS28), the High-Tech Research and Development Program of China (2012AA030309), and the program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri D, 2013, ACTA BIOMATER, V9, P9401, DOI 10.1016/j.actbio.2013.07.026; Cao ZB, 2013, MAT SCI ENG C-MATER, V33, P3522, DOI 10.1016/j.msec.2013.04.045; Chung CJ, 2011, ACTA BIOMATER, V7, P4081, DOI 10.1016/j.actbio.2011.07.004; Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050; Fernandes LF, 2009, CONNECT TISSUE RES, V50, P336, DOI 10.3109/03008200902855909; Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121; Hench L. L., 1971, J BIOMED MATER RES, V5, P117, DOI DOI 10.1002/JBM.820050611; Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004; Huang J, 2010, ACTA BIOMATER, V6, P241, DOI 10.1016/j.actbio.2009.06.032; Huang Y, 2009, BIOMATERIALS, V30, P5041, DOI 10.1016/j.biomaterials.2009.05.077; Jabbari-Farouji S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061405; Jung H, 2008, APPL CLAY SCI, V40, P99, DOI 10.1016/j.clay.2007.09.002; Kumar A, 2013, J BIOMED MATER RES A, V101, P2925, DOI 10.1002/jbm.a.34603; Liao HH, 2011, COLLOID SURFACE B, V84, P528, DOI 10.1016/j.colsurfb.2011.02.010; Loty C, 2001, J BONE MINER RES, V16, P231, DOI 10.1359/jbmr.2001.16.2.231; Magallanes-Perdomo M, 2013, ACTA BIOMATER, V6, P2254; Marcacci M, 1999, CALCIFIED TISSUE INT, V64, P83, DOI 10.1007/s002239900583; da Silva HM, 2010, COLLOID SURFACE B, V80, P138, DOI 10.1016/j.colsurfb.2010.05.040; Meng ZX, 2010, MAT SCI ENG C-MATER, V30, P1014, DOI 10.1016/j.msec.2010.05.003; Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016; Qi RL, 2012, J BIOMAT SCI-POLYM E, V23, P299, DOI 10.1163/092050610X550340; Qi RL, 2010, J MATER CHEM, V20, P10622, DOI 10.1039/c0jm01328e; Rossi AL, 2012, BONE, V50, P301, DOI 10.1016/j.bone.2011.10.022; SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299, DOI 10.1097/00003086-198604000-00036; Sowmya S, 2013, PROG POLYM SCI, V38, P1748, DOI 10.1016/j.progpolymsci.2013.05.005; Swetha M, 2010, INT J BIOL MACROMOL, V47, P1, DOI 10.1016/j.ijbiomac.2010.03.015; Tas AC, 2004, J MATER RES, V19, P2742, DOI 10.1557/JMR.2004.0349; Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m; Viseras C, 2010, APPL CLAY SCI, V48, P291, DOI 10.1016/j.clay.2010.01.007; Wang QZ, 2008, J MATER SCI-MATER M, V19, P1371, DOI 10.1007/s10856-007-3243-y; Wang SG, 2013, LANGMUIR, V29, P5030, DOI 10.1021/la4001363; Wang SG, 2012, J MATER CHEM, V22, P23357, DOI 10.1039/c2jm34249a; Wang SG, 2012, ACS APPL MATER INTER, V4, P6393, DOI 10.1021/am302130b; Wu CT, 2013, J INORG MATER, V28, P29, DOI 10.3724/SP.J.1077.2013.12241; Wu CT, 2006, J BIOMATER APPL, V21, P119, DOI 10.1177/0885328206057953; Wu CT, 2013, J MATER CHEM B, V1, P2710, DOI 10.1039/c3tb20275e; Wu CT, 2013, J MATER CHEM B, V1, P876, DOI 10.1039/c2tb00391k; Wu CT, 2005, BIOMATERIALS, V26, P2925, DOI 10.1016/j.biomaterials.2004.09.019; Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134; Yoon E, 2007, TISSUE ENG, V13, P619, DOI 10.1089/ten.2006.0102; Zaidman N., 2012, RECENT PATENTS REGEN, V2, P65	41	47	51	3	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99585	10.1371/journal.pone.0099585	http://dx.doi.org/10.1371/journal.pone.0099585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955961	Green Published, gold, Green Submitted			2022-12-25	WOS:000338917900013
J	Yang, F; Zhou, XC; Du, SK; Zhao, YJ; Ren, W; Deng, Q; Wang, FL; Yuan, JL				Yang, Fan; Zhou, Xingchun; Du, Shuangkuan; Zhao, Yongjun; Ren, Wei; Deng, Qian; Wang, Fuli; Yuan, Jianlin			LIM and SH3 Domain Protein 1 (LASP-1) Overexpression Was Associated with Aggressive Phenotype and Poor Prognosis in Clear Cell Renal Cell Cancer	PLOS ONE			English	Article							INFLUENCES ZYXIN LOCALIZATION; BREAST-CANCER; ACTIN-BINDING; MIGRATION; PHOSPHORYLATION; PROLIFERATION; CARCINOMA; SURVIVAL; KINASE	Background: LIM and SH3 protein 1 (LASP-1) is a specific focal adhesion protein that is known to be involved in numerous biological and pathological processes. LASP-1 overexpression has been described in several types of cancers, but its expression and role in clear cell renal cell cancer (ccRCC) remains unknown. Methods: Using immunohistochemistry, we analyzed LASP-1 protein expression in 216 clinicopathologically characterized ccRCC cases. We also examined LASP-1 expression in 20 paired ccRCC tissues and in 2 cell lines by real-time PCR and Western blot. Using RNA interference, we investigated the effects of LASP-1 depletion on tumor cell behavior in vitro. Statistical analyses were used to determine the associations between LASP-1 levels, tumor features and patient outcomes. Results: LASP-1 overexpression was observed in ccRCC tissues (P<0.0001) compared to adjuvant nontumorous tissues, and its expression levels were closely correlated with overall survival and recurrence-free survival (P = 0.044 and 0.006, respectively) in patients with ccRCC. RNA interference-mediated silencing of the LASP-1 gene in 786-0 ccRCC cells significantly inhibited cell migration. Conclusions: The results of the present study indicate that LASP-1 may serve as a prognostic biomarker for ccRCC patients and may be a promising target for the treatment of ccRCC.	[Yang, Fan; Wang, Fuli; Yuan, Jianlin] Fourth Mil Med Univ, Xijing Hosp, Dept Urol Surg, Xian 710032, Shaanxi, Peoples R China; [Zhou, Xingchun] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Zhou, Xingchun] Fourth Mil Med Univ, Expt Teaching Ctr Basic Med, Xian 710032, Shaanxi, Peoples R China; [Du, Shuangkuan; Zhao, Yongjun; Ren, Wei; Deng, Qian] Peoples Hosp Shaanxi Prov, Dept Urol Surg, Xian, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Xi'an Medical University	Wang, FL (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Urol Surg, Xian 710032, Shaanxi, Peoples R China.	fuli_wang@yeah.net; Yuanjianlin1122@163.com						Bex A, 2012, BJU INT, V110, P1289, DOI 10.1111/j.1464-410X.2012.11100.x; Butt E, 2003, J BIOL CHEM, V278, P15601, DOI 10.1074/jbc.M209009200; Chew CS, 2000, J CELL SCI, V113, P2035; Chew CS, 2002, J CELL SCI, V115, P4787, DOI 10.1242/jcs.00174; Chiyomaru T, 2012, UROL ONCOL-SEMIN ORI, V30, P434, DOI 10.1016/j.urolonc.2010.05.008; Frietsch JJ, 2010, BRIT J CANCER, V102, P1645, DOI 10.1038/sj.bjc.6605685; Grunewald TGP, 2007, BRIT J CANCER, V96, P296, DOI 10.1038/sj.bjc.6603545; Grunewald TGP, 2006, EXP CELL RES, V312, P974, DOI 10.1016/j.yexcr.2005.12.016; Keicher C, 2004, BIOCHEM BIOPH RES CO, V324, P308, DOI 10.1016/j.bbrc.2004.08.235; Leibovich BC, 2010, J UROLOGY, V183, P1309, DOI 10.1016/j.juro.2009.12.035; Li B, 2004, J BIOL CHEM, V279, P20401, DOI 10.1074/jbc.M310304200; Lin YH, 2004, J CELL BIOL, V165, P421, DOI 10.1083/jcb.200311045; Mihlan S, 2013, ONCOGENE, V32, P2107, DOI 10.1038/onc.2012.216; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Rachlin AS, 2006, J CELL SCI, V119, P995, DOI 10.1242/jcs.02825; Schreiber VR, 1998, MOL MED, V4, P675, DOI 10.1007/BF03401929; TOMASETTO C, 1995, FEBS LETT, V373, P245, DOI 10.1016/0014-5793(95)01040-L; Traenka C, 2010, CANCER RES, V70, P8003, DOI 10.1158/0008-5472.CAN-10-0592; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Wang B, 2009, J HEPATOL, V50, P528, DOI 10.1016/j.jhep.2008.10.025; Wang H, 2013, EUR J CANCER, V49, P974, DOI 10.1016/j.ejca.2012.09.032; Zhao LA, 2010, GUT, V59, P1226, DOI 10.1136/gut.2009.202739	22	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100557	10.1371/journal.pone.0100557	http://dx.doi.org/10.1371/journal.pone.0100557			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955835	Green Submitted, gold, Green Published			2022-12-25	WOS:000338917900066
J	Zitnik, S; Subelj, L; Bajec, M				Zitnik, Slavko; Subelj, Lovro; Bajec, Marko			SkipCor: Skip-Mention Coreference Resolution Using Linear-Chain Conditional Random Fields	PLOS ONE			English	Article								Coreference resolution tries to identify all expressions (called mentions) in observed text that refer to the same entity. Beside entity extraction and relation extraction, it represents one of the three complementary tasks in Information Extraction. In this paper we describe a novel coreference resolution system SkipCor that reformulates the problem as a sequence labeling task. None of the existing supervised, unsupervised, pairwise or sequence-based models are similar to our approach, which only uses linear-chain conditional random fields and supports high scalability with fast model training and inference, and a straightforward parallelization. We evaluate the proposed system against the ACE 2004, CoNLL 2012 and SemEval 2010 benchmark datasets. SkipCor clearly outperforms two baseline systems that detect coreferentiality using the same features as SkipCor. The obtained results are at least comparable to the current state-of-the-art in coreference resolution.	[Zitnik, Slavko; Subelj, Lovro; Bajec, Marko] Univ Ljubljana, Lab Data Technol, Ljubljana, Slovenia; [Zitnik, Slavko] Optilab Doo, Ljubljana, Slovenia	University of Ljubljana	Zitnik, S (corresponding author), Univ Ljubljana, Lab Data Technol, Ljubljana, Slovenia.	slavko.zitnik@fri.uni-lj.si	Šubelj, Lovro/V-9106-2018	Šubelj, Lovro/0000-0002-4161-2260	Slovene Research Agency ARRS [P2-0359]; European Union, European Social Fund	Slovene Research Agency ARRS(Slovenian Research Agency - Slovenia); European Union, European Social Fund(European Social Fund (ESF))	The work has been supported by the Slovene Research Agency ARRS within the research program P2-0359 and partly financed by the European Union, European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN PM, 1992, THIRD CONFERENCE ON APPLIED NATURAL LANGUAGE PROCESSING, P170; Attardi Giuseppe, 2010, P 5 INT WORKSH SEM E, P108; Bagga Amit, 1998, INT C LANG RES EV W, P563, DOI DOI 10.3115/980845.980859; Bansal M, 2012, P 50 ANN M ASS COMP, V1; Bejan CA, 2010, ACL 2010: 48TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, P1412; Bejan Cosmin Adrian, 2009, ADV NEURAL INFORM PR, V22, P73; Bergsma S, 2006, COLING/ACL 2006, VOLS 1 AND 2, PROCEEDINGS OF THE CONFERENCE, P33; Bernardi R, 2010, P INT C LANG RES EV, P1; Bjorkelund Anders, 2012, JOINT C EMNLP CONLL, P49; Broscheit S., 2010, P 5 INT WORKSH SEM E, P104; Cai J., 2010, P 23 INT C COMP LING, P143; Charniak Eugene, 2001, P 2 M N AM CHAPT ASS, P1; Chen C., 2012, JOINT C EMNLP CONLL, P56; Chinchor N, 1993, P 5 C MESS UND, P6978; Chincor Nancy, 1991, P 3 C MESSAGE UNDERS, P17; Clark JH, 2008, LANGUAGE STAT 2 LIT, P1; Cohn T, 2006, LECT NOTES COMPUT SC, V4212, P606; Culotta Aron, 2007, HUM LANG TECHN C N A, P81; Doddington G. R., 2004, P LREC, V2, P1; Fernandes Eraldo, 2012, JOINT C EMNLP CONLL, P41; Finkel J. R., 2005, P 43 ANN M ASS COMP, P363, DOI 10.3115/1219840.1219885; Finkel Jenny Rose, 2008, P 46 ANN M ASS COMP, P45; Fosler-Lussier E, 2013, P IEEE, V101, P1054, DOI 10.1109/JPROC.2013.2248112; Gilbert N, 2013, DOMAIN SPECIFIC CORE, P1; Haghighi Aria, 2009, P 2009 C EMP METH NA, P1152; Hirschman Lynette, 1997, P 7 MESSAGE UNDERSTA, P1; Huang S., 2009, ADV COMPUTATIONAL LI, P157; Kobdani Hamidreza, 2010, P 5 INT WORKSH SEM E, P92; Lafferty J, 2001, P 18 INT C MACH LEAR, P282, DOI DOI 10.1038/NPROT.2006.61; Lee H., 2011, P 15 C COMPUTATIONAL, P28; Li X, 2012, P JOINT C EMNLP CONL, P83; Luo X, 2004, P 42 ANN M ASS COMP, P136; Luo Xiaoqiang, 2007, HLT NAACL, P73; Luo Xiaoqiang, 2005, P C HUM LANG TECHN E, P25, DOI [DOI 10.3115/1220575.1220579, 10.3115/1220575.1220579]; McCallum A, 2004, NEURAL INFORM PROCES, P1; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Ng V, 2002, 40TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P104; Ng Vincent, 2008, P C EMP METH NAT LAN, P640; Nguyen N, 2012, BMC BIOINFORMATICS, V13, P1; Okazaki Naoaki, 2007, CRFSUITE FAST IMPLEM; Orasan C, 2007, J ARTIF INTELL RES, V29, P79, DOI 10.1613/jair.2179; Pradhan Sameer, 2012, P 16 C COMP NAT LANG, P1; Pradipta S, 2011, P 15 C COMP NAT LANG, P1; Raghunathan Karthik, 2010, P 2010 C EMP METH NA, P492; Rahman A, 2009, P 2009 C EMP METH NA, P968, DOI DOI 10.3115/1699571.1699639; Ram RVS, 2012, P C INT TEXT PROC CO, P285; Recasens M., 2009, P 5 INT WORKSH SEM E, P1; Sapena E., 2010, P ACL WORKSH SEM EV, P88; Sarawagi S, 2007, FOUND TRENDS DATABAS, V1, P261, DOI 10.1561/1500000003; Soon WM, 2001, COMPUT LINGUIST, V27, P521, DOI 10.1162/089120101753342653; Stamborg M., 2012, JOINT C EMNLP CONLL, P64; Stoyanov V., 2010, P 48 ANN M ASS COMP, P156; Vilain Marc, 1995, 6 MESS UND C MUC 6 P, P45, DOI [10.3115/1072399.1072405, DOI 10.3115/1072399.1072405]; Wellner B., 2004, P 20 C UNC ART INT, P593; Wimalasuriya DC, 2010, J INF SCI, V36, P306, DOI 10.1177/0165551509360123; Winkler W.E, 1990, P SECT SURV RES ISS; Zhekova D, 2010, P 5 INT WORKSH SEM E, P96; Zhekova D, 2012, JOINT C EMNLP CONLL, P88	58	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100101	10.1371/journal.pone.0100101	http://dx.doi.org/10.1371/journal.pone.0100101			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956272	gold, Green Published, Green Submitted			2022-12-25	WOS:000338917900025
J	Winterbach, HEK; Winterbach, CW; Somers, MJ				Winterbach, Hanlie E. K.; Winterbach, Christiaan W.; Somers, Michael J.			Landscape Suitability in Botswana for the Conservation of Its Six Large African Carnivores	PLOS ONE			English	Article							LIONS PANTHERA-LEO; HUMAN-WILDLIFE CONFLICT; LIVESTOCK PREDATION; PREY PREFERENCES; MIGRATION; ECOSYSTEM; LEOPARDS; SAVANNA; COUNTS; AREA	Wide-ranging large carnivores often range beyond the boundaries of protected areas into human-dominated areas. Mapping out potentially suitable habitats on a country-wide scale and identifying areas with potentially high levels of threats to large carnivore survival is necessary to develop national conservation action plans. We used a novel approach to map and identify these areas in Botswana for its large carnivore guild consisting of lion (Panthera leo), leopard (Panthera pardus), spotted hyaena (Crocuta crocuta), brown hyaena (Hyaena brunnea), cheetah (Acinonyx jubatus) and African wild dog (Lycaon pictus). The habitat suitability for large carnivores depends primarily on prey availability, interspecific competition, and conflict with humans. Prey availability is most likely the strongest natural determinant. We used the distribution of biomass of typical wild ungulate species occurring in Botswana which is preyed upon by the six large carnivores to evaluate the potential suitability of the different management zones in the country to sustain large carnivore populations. In areas where a high biomass of large prey species occurred, we assumed interspecific competition between dominant and subordinated competitors to be high. This reduced the suitability of these areas for conservation of subordinate competitors, and vice versa. We used the percentage of prey biomass of the total prey and livestock biomass to identify areas with potentially high levels of conflict in agricultural areas. High to medium biomass of large prey was mostly confined to conservation zones, while small prey biomass was more evenly spread across large parts of the country. This necessitates different conservation strategies for carnivores with a preference for large prey, and those that can persist in the agricultural areas. To ensure connectivity between populations inside Botswana and also with its neighbours, a number of critical areas for priority management actions exist in the agricultural zones.	[Winterbach, Hanlie E. K.; Winterbach, Christiaan W.] Tau Consultants Pty Ltd, Maun, Botswana; [Winterbach, Hanlie E. K.; Winterbach, Christiaan W.; Somers, Michael J.] Univ Pretoria, Ctr Wildlife Management, ZA-0002 Pretoria, South Africa; [Somers, Michael J.] Univ Pretoria, Ctr Invas Biol, ZA-0002 Pretoria, South Africa	University of Pretoria; University of Pretoria	Winterbach, HEK (corresponding author), Tau Consultants Pty Ltd, Maun, Botswana.	tauconsultants@gmail.com	/A-1523-2008	/0000-0002-5836-8823	Botswana Wildlife Management Association; Tau Consultants; Tau Consultants (Pty) Ltd	Botswana Wildlife Management Association; Tau Consultants; Tau Consultants (Pty) Ltd	This work was supported by Botswana Wildlife Management Association and Tau Consultants. Co-authors H.E.K. Winterbach and C.W. Winterbach are employed by Tau Consultants (Pty) Ltd. Tau Consultants (Pty) Ltd provided support in the form of salaries for authors H.E.K. Winterbach and C.W. Winterbach, but did not have any additional role in the study design, data collection and analysis. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2011, 2011 POPULATION HOUS; [Anonymous], 2010, CONSULTANCY IDENTIFY; [Anonymous], 2000, BOTSWANA AERIAL SURV; [Anonymous], 2011, STATS BRIEF 2007 200; [Anonymous], 2009, BOTSWANA WATER STAT; [Anonymous], 2001, BOTSWANA NATL ATLAS; [Anonymous], 2012, STATS BRIEF BOTSWANA; Bartlam-Brooks HLA, 2011, ORYX, V45, P210, DOI 10.1017/S0030605310000414; Bauer D, 2014, CAN J ZOOL, V92, P97, DOI 10.1139/cjz-2013-0176; Bauer H, 2004, ORYX, V38, P26, DOI 10.1017/S0030605304000055; BEDIA, 2012, BEEF SECT; Bergstrom R, 1999, AFR J ECOL, V37, P12, DOI 10.1046/j.1365-2028.1999.00165.x; Boast LK, 2008, LARGE PREDATOR UNPUB; BROOKS CJ, 2005, THESIS U BRISTOL UK; Campbell A., 1981, Botswana Notes and Records, V13, P111; Chanda R, 2003, J ARID ENVIRON, V54, P425, DOI 10.1006/jare.2002.1100; Creel S, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P337; Darkoh M.B.K, 1999, CASE STUDIES RANGELA, P61; Frank LG, 2006, JOH E SO AFR LION CO; Fuller TK, 2001, CONSERV BIOL SER, V5, P163; Funston PJ, 2001, GT87; Gusset M, 2009, ORYX, V43, P67, DOI 10.1017/S0030605308990475; Hayward MW, 2007, BIOL CONSERV, V139, P219, DOI 10.1016/j.biocon.2007.06.018; Hayward MW, 2008, S AFR J WILDL RES, V38, P93, DOI 10.3957/0379-4369-38.2.93; Hemson G, 2003, THESIS U OXFORD UK; Hibert F, 2010, BIODIVERS CONSERV, V19, P2003, DOI 10.1007/s10531-010-9822-0; Houser A, 2009, S AFR J WILDL RES, V39, P11, DOI 10.3957/056.039.0102; IUCN Species Survival Commission, 2007, REG CONS ST IN PRESS; Jachmann H, 2002, J APPL ECOL, V39, P841, DOI 10.1046/j.1365-2664.2002.00752.x; Jefferis K, 2005, TRADE LIBERALIZATION, P32; Kent VT, 2010, THESIS DURHAM U UK; Kerth G, 2013, CONSERV GENET RESOUR, V5, P1101, DOI 10.1007/s12686-013-9979-4; Kissui BM, 2008, ANIM CONSERV, V11, P422, DOI 10.1111/j.1469-1795.2008.00199.x; Klein Rebecca, 2007, Cat News, P14; Lindsey PA, 2004, S AFR J WILDL RES, V34, P77; Marker LL, 2005, RANGELAND ECOL MANAG, V58, P329, DOI 10.2111/1551-5028(2005)058[0329:PEOLDP]2.0.CO;2; Marker LL, 2003, CONSERV BIOL, V17, P1290, DOI 10.1046/j.1523-1739.2003.02077.x; Marker LL, 2003, S AFR J WILDL RES, V33, P43; Mbaiwa J.E., 2006, INT J WILDERNESS, V12, P41; MBAIWA JE, 2006, INT J WILDERNESS, V12, P41; Mbaiwa JE, 2010, J SUSTAIN TOUR, V18, P635, DOI 10.1080/09669581003653500; McNutt JW, 2012, BIOL J LINN SOC, V105, P8, DOI 10.1111/j.1095-8312.2011.01785.x; Moleele NM, 2003, J ARID ENVIRON, V54, P405, DOI 10.1006/jare.2002.1099; Moleele NM, 2002, J ENVIRON MANAGE, V64, P3, DOI 10.1006/jema.2001.0486; Ogada MO, 2003, CONSERV BIOL, V17, P1521, DOI 10.1111/j.1523-1739.2003.00061.x; Ogara W. O., 2010, African Journal of Environmental Science and Technology, V4, P540; Ogutu JO, 2005, J ZOOL, V265, P281, DOI 10.1017/S0952836904006302; Patterson BD, 2004, BIOL CONSERV, V119, P507, DOI 10.1016/j.biocon.2004.01.013; Purchase G, 2007, CAT NEWS SI, VSI3, P44; Quinn GP, 2003, EXPT DESIGN DATA ANA; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Riginos C, 2012, PASTORALISM, V2, DOI 10.1186/2041-7136-2-10; Schiess-Meier M, 2007, J WILDLIFE MANAGE, V71, P1267, DOI 10.2193/2006-177; Valeix M, 2012, J APPL ECOL, V49, P73, DOI 10.1111/j.1365-2664.2011.02099.x; Van Bommel L, 2007, AFR J ECOL, V45, P490, DOI 10.1111/j.1365-2028.2007.00759.x; Verlinden A, 1998, AFR J ECOL, V36, P117; Wallgren M, 2009, AFR J ECOL, V47, P20, DOI 10.1111/j.1365-2028.2007.00904.x; Weilenmann M, 2010, WILDLIFE RES, V37, P702, DOI 10.1071/WR10013; WILLIAMSON D, 1988, AFR J ECOL, V26, P269, DOI 10.1111/j.1365-2028.1988.tb00979.x; WINT W, 2000, BOTSWANA AERIAL SURV; Winterbach CW, 2003, PREDATOR MA IN PRESS; Winterbach HEK, 2013, MAMMAL REV, V43, P89, DOI 10.1111/j.1365-2907.2011.00209.x; Woodroffe R, 2005, CONSERV BIOL SER, V9, P1; Woodroffe R, 2001, CONSERV BIOL SER, V5, P61; Woodroffe Rosie, 2005, P154	65	18	18	1	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100202	10.1371/journal.pone.0100202	http://dx.doi.org/10.1371/journal.pone.0100202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949735	Green Published, gold, Green Submitted			2022-12-25	WOS:000338276300049
J	Slenn, TJ; Morris, B; Havens, CG; Freeman, RM; Takahashi, TS; Walter, JC				Slenn, Tamara J.; Morris, Benjamin; Havens, Courtney G.; Freeman, Robert M., Jr.; Takahashi, Tatsuro S.; Walter, Johannes C.			Thymine DNA Glycosylase Is a CRL4(Cdt2) Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE REGULATION; E3 UBIQUITIN LIGASE; PIP BOX; RIBONUCLEOTIDE REDUCTASE; CDT1 PROTEOLYSIS; GENE-EXPRESSION; NUCLEAR ANTIGEN; REPLICATION; XENOPUS; PCNA	The E3 ubiquitin ligase CRL4(Cdt2) targets proteins for destruction in S phase and after DNA damage by coupling ubiquitylation to DNA-bound proliferating cell nuclear antigen (PCNA). Coupling to PCNA involves a PCNA-interacting peptide (PIP) degron motif in the substrate that recruits CRL4(Cdt2) while binding to PCNA. In vertebrates, CRL4(Cdt2) promotes degradation of proteins whose presence in S phase is deleterious, including Cdt1, Set8, and p21. Here, we show that CRL4(Cdt2) targets thymine DNA glycosylase (TDG), a base excision repair enzyme that is involved in DNA demethylation. TDG contains a conserved and nearly perfect match to the PIP degron consensus. TDG is ubiquitylated and destroyed in a PCNA-, Cdt2-, and PIP degron-dependent manner during DNA repair in Xenopus egg extract. The protein can also be destroyed during DNA replication in this system. During Xenopus development, TDG first accumulates during gastrulation, and its expression is down-regulated by CRL4(Cdt2). Our results expand the group of vertebrate CRL4(Cdt2) substrates to include a bona fide DNA repair enzyme.	[Slenn, Tamara J.; Morris, Benjamin; Havens, Courtney G.; Walter, Johannes C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Freeman, Robert M., Jr.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Takahashi, Tatsuro S.] Osaka Univ, Grad Sch Sci, Osaka, Japan; [Walter, Johannes C.] Harvard Univ, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Osaka University; Harvard University; Howard Hughes Medical Institute	Walter, JC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	johannes_walter@hms.harvard.edu	Takahashi, Tatsuro/F-4669-2016; Takahashi, Tatsuro/AAD-9936-2020	Takahashi, Tatsuro/0000-0002-1947-7680; Takahashi, Tatsuro/0000-0002-1947-7680; Freeman, Robert/0000-0003-1463-9748; Walter, Johannes/0000-0002-4186-7570	National Institutes of Health [GM80676]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080676, R01GM026875, T32GM007598, R37GM026875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM80676 (to J. C. W.).	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2011, CELL CYCLE, V10, P241, DOI 10.4161/cc.10.2.14530; Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Blitz IL, 2006, SEMIN CELL DEV BIOL, V17, P133, DOI 10.1016/j.semcdb.2005.11.002; Bowes JB, 2008, NUCLEIC ACIDS RES, V36, pD761, DOI 10.1093/nar/gkm826; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; DASSO M, 1990, CELL, V61, P811, DOI 10.1016/0092-8674(90)90191-G; Faber J, 1994, NORMAL TABLE XENOPUS; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hardeland U, 2000, J BIOL CHEM, V275, P33449, DOI 10.1074/jbc.M005095200; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hardeland U, 2007, NUCLEIC ACIDS RES, V35, P3859, DOI 10.1093/nar/gkm337; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; Havens CG, 2012, J BIOL CHEM, V287, P11410, DOI 10.1074/jbc.M111.337683; Havens CG, 2011, GENE DEV, V25, P1568, DOI 10.1101/gad.2068611; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Joseph RE, 2008, PROTEIN EXPRES PURIF, V60, P194, DOI 10.1016/j.pep.2008.04.001; Kim DH, 2010, MOL CELL BIOL, V30, P4120, DOI 10.1128/MCB.01135-09; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Lebofsky Ronald, 2009, V521, P229, DOI [10.1007/978-1-60327-817-5_13, 10.1007/978-1-60327-815-7_13]; Liu C, 2003, GENE DEV, V17, P1130, DOI 10.1101/gad.1090803; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Mansilla SF, 2013, NUCLEIC ACIDS RES, V41, P6942, DOI 10.1093/nar/gkt475; Michishita M, 2011, GENES CELLS, V16, P12, DOI 10.1111/j.1365-2443.2010.01464.x; Mohan RD, 2010, NUCLEIC ACIDS RES, V38, P1135, DOI 10.1093/nar/gkp1097; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Raddatz G, 2013, P NATL ACAD SCI USA, V110, P8627, DOI 10.1073/pnas.1306723110; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Ralph E, 2006, EMBO REP, V7, P1134, DOI 10.1038/sj.embor.7400827; Salguero I, 2012, CURR BIOL, V22, P720, DOI 10.1016/j.cub.2012.02.070; Sansam CL, 2006, GENE DEV, V20, P3117, DOI 10.1101/gad.1482106; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Shibata E, 2014, J BIOL CHEM, V289, P23056, DOI 10.1074/jbc.M114.574210; Shibutani ST, 2008, DEV CELL, V15, P890, DOI 10.1016/j.devcel.2008.10.003; Sive H. L., 2010, EARLY DEV XENOPUS LA, P99; Smet-Nocca C, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-4; Stancheva I, 2002, DEV BIOL, V243, P155, DOI 10.1006/dbio.2001.0560; Stokes MP, 2003, J CELL BIOL, V163, P245, DOI 10.1083/jcb.200306006; Terai K, 2013, J BIOL CHEM, V288, P30509, DOI 10.1074/jbc.C113.505586; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Tsanov N, 2014, NUCLEIC ACIDS RES, V42, P3692, DOI 10.1093/nar/gkt1400; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Xu YF, 2012, CELL, V151, P1200, DOI 10.1016/j.cell.2012.11.014; Yanai I, 2011, DEV CELL, V20, P483, DOI 10.1016/j.devcel.2011.03.015; Zhang L, 2012, NAT CHEM BIOL, V8, P328, DOI [10.1038/NCHEMBIO.914, 10.1038/nchembio.914]; Zhang SF, 2013, J BIOL CHEM, V288, P29550, DOI 10.1074/jbc.M113.490466	67	32	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23043	23055		10.1074/jbc.M114.574194	http://dx.doi.org/10.1074/jbc.M114.574194			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24947512	hybrid, Green Published			2022-12-25	WOS:000341017200042
J	Aggarwal, C; Jimenez, JC; Nanavati, D; Federle, MJ				Aggarwal, Chaitanya; Jimenez, Juan Cristobal; Nanavati, Dhaval; Federle, Michael J.			Multiple Length Peptide-Pheromone Variants Produced by Streptococcus pyogenes Directly Bind Rgg Proteins to Confer Transcriptional Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDENTIFICATION; COMPETENCE; MECHANISM; MUTANT	Streptococcus pyogenes, a human-restricted pathogen, accounts for substantial mortality related to infections worldwide. Recent studies indicate that streptococci produce and respond to several secreted peptide signaling molecules (pheromones), including those known as short hydrophobic peptides (SHPs), to regulate gene expression by a quorum-sensing mechanism. Upon transport into the bacterial cell, pheromones bind to and modulate activity of receptor proteins belonging to the Rgg family of transcription factors. Previously, we reported biofilm regulation by the Rgg2/3 quorum-sensing circuit in S. pyogenes. The aim of this study was to identify the composition of mature pheromones from cell-free culture supernatants that facilitate biofilm formation. Bioluminescent reporters were employed to detect active pheromones in culture supernatants fractionated by reverse-phase chromatography, and mass spectrometry was used to characterize their properties. Surprisingly, multiple SHPs that varied by length were detected. Synthetic peptides of each variant were tested individually using bioluminescence reporters and biofilm growth assays, and although activities differed widely among the group, peptides comprising the C-terminal eight amino acids of the full-length native peptide were most active. Direct Rgg/SHP interactions were determined using a fluorescence polarization assay that utilized FITC-labeled peptide ligands. Peptide receptor affinities were seen to be as low as 500 nM and their binding affinities directly correlated with observed bioactivity. Revelation of naturally produced pheromones along with determination of their affinity for cognate receptors are important steps forward in designing com-pounds whose purpose is positioned for future therapeutics aimed at treating infections through the interference of bacterial communication.	[Aggarwal, Chaitanya; Federle, Michael J.] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Ctr Pharmaceut Biotechnol, Chicago, IL 60607 USA; [Jimenez, Juan Cristobal] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60607 USA; [Nanavati, Dhaval] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University	Federle, MJ (corresponding author), Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Ctr Pharmaceut Biotechnol, 3152 MBRB,M-C 870,900 S Ashland Ave, Chicago, IL 60607 USA.	mfederle@uic.edu	Federle, Michael J./E-5522-2017		National Institutes of Health from NIAID [RO1-AI091779]; Burroughs Wellcome Fund Investigators in Pathogenesis of Infectious Diseases; Chicago Biomedical Consortium; Searle Funds at the Chicago Community Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091779] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund Investigators in Pathogenesis of Infectious Diseases(Burroughs Wellcome Fund); Chicago Biomedical Consortium; Searle Funds at the Chicago Community Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-AI091779 from NIAID. This work was also supported by Burroughs Wellcome Fund Investigators in Pathogenesis of Infectious Diseases.; Supported in part by the Chicago Biomedical Consortium with support from the Searle Funds at the Chicago Community Trust.	Antunes LCM, 2010, MICROBIOL-SGM, V156, P2271, DOI 10.1099/mic.0.038794-0; Bachmann H, 2008, APPL ENVIRON MICROB, V74, P4727, DOI 10.1128/AEM.00297-08; Chang JC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002190; Cook LC, 2013, MBIO, V4, DOI 10.1128/mBio.00382-13; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Degnan BA, 2000, INFECT IMMUN, V68, P2441, DOI 10.1128/IAI.68.5.2441-2448.2000; DeMuri GP, 2014, J PEDIAT INF DIS SOC, V3, P336, DOI 10.1093/jpids/piu030; Federle MJ, 2012, VIRULENCE, V3, P92, DOI 10.4161/viru.3.1.18652; Fleuchot B, 2011, MOL MICROBIOL, V80, P1102, DOI 10.1111/j.1365-2958.2011.07633.x; Fleuchot B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066042; Fontaine L, 2010, J BACTERIOL, V192, P1444, DOI 10.1128/JB.01251-09; Gardan R, 2013, J BACTERIOL, V195, P1845, DOI 10.1128/JB.02196-12; Howell-Adams B, 2000, MOL MICROBIOL, V37, P1146, DOI 10.1046/j.1365-2958.2000.02067.x; HUSMANN LK, 1995, INFECT IMMUN, V63, P345, DOI 10.1128/IAI.63.1.345-348.1995; Ibrahim M, 2007, J BACTERIOL, V189, P8844, DOI 10.1128/JB.01057-07; Ibrahim M, 2007, MICROBIOL-SGM, V153, P3631, DOI 10.1099/mic.0.2007/006205-0; Khan R, 2012, J BACTERIOL, V194, P3781, DOI 10.1128/JB.00624-12; LaSarre B, 2013, J BACTERIOL, V195, P4310, DOI 10.1128/JB.00684-13; LaSarre B, 2012, MBIO, V3, DOI 10.1128/mBio.00333-12; MAGUIN E, 1992, J BACTERIOL, V174, P5633, DOI 10.1128/JB.174.17.5633-5638.1992; Mashburn-Warren L, 2010, MOL MICROBIOL, V78, P589, DOI 10.1111/j.1365-2958.2010.07361.x; McShan WM, 2008, J BACTERIOL, V190, P7773, DOI 10.1128/JB.00672-08; McShan W. Michael, 1998, Methods in Cell Science, V20, P51, DOI 10.1023/A:1009773309163; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; Romero Manuel, 2012, Recent Pat Biotechnol, V6, P2; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Sanders JW, 1998, MOL MICROBIOL, V27, P299, DOI 10.1046/j.1365-2958.1998.00676.x; Thoendel M, 2010, ADV APPL MICROBIOL, V71, P91, DOI 10.1016/S0065-2164(10)71004-2; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001	31	34	34	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22427	22436		10.1074/jbc.M114.583989	http://dx.doi.org/10.1074/jbc.M114.583989			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24958729	hybrid, Green Published			2022-12-25	WOS:000340593500052
J	Pereyra-Bonnet, F; Gimeno, ML; Argumedo, NR; Ielpi, M; Cardozo, JA; Gimenez, CA; Hyon, SH; Balzaretti, M; Loresi, M; Fainstein-Day, P; Litwak, LE; Argibay, PF				Pereyra-Bonnet, Federico; Gimeno, Maria L.; Argumedo, Nelson R.; Ielpi, Marcelo; Cardozo, Johana A.; Gimenez, Carla A.; Hyon, Sung-Ho; Balzaretti, Marta; Loresi, Monica; Fainstein-Day, Patricia; Litwak, Leon E.; Argibay, Pablo F.			Skin Fibroblasts from Patients with Type 1 Diabetes (T1D) Can Be Chemically Transdifferentiated into Insulin-Expressing Clusters: A Transgene-Free Approach	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; DNA METHYLATION; SMALL-MOLECULE; BISULFITE-PCR; DIFFERENTIATION; BONE; TRANSPLANTATION; INDUCTION; CONVERT; ISLETS	The conversion of differentiated cells into insulin-producing cells is a promising approach for the autologous replacement of pancreatic cells in patients with type 1 diabetes (T1D). At present, cellular reprogramming strategies encompass ethical problems, epigenetic failure or teratoma formation, which has prompted the development of new approaches. Here, we report a novel technique for the conversion of skin fibroblasts from T1D patients into insulin-expressing clusters using only drug-based induction. Our results demonstrate that skin fibroblasts from diabetic patients have pancreatic differentiation capacities and avoid the necessity of using transgenic strategies, stem cell sources or global demethylation steps. These findings open new possibilities for studying diabetes mechanisms, drug screenings and ultimately autologous transgenic-free regenerative medicine therapies in patients with T1D.	[Pereyra-Bonnet, Federico; Gimeno, Maria L.; Argumedo, Nelson R.; Ielpi, Marcelo; Cardozo, Johana A.; Gimenez, Carla A.; Loresi, Monica; Argibay, Pablo F.] HIBA, ICBME, Buenos Aires, DF, Argentina; [Hyon, Sung-Ho] HIBA, Gen Surg Serv, Buenos Aires, DF, Argentina; [Balzaretti, Marta; Fainstein-Day, Patricia; Litwak, Leon E.] HIBA, Endocrinol & Nucl Med Serv, Buenos Aires, DF, Argentina		Pereyra-Bonnet, F (corresponding author), HIBA, ICBME, Buenos Aires, DF, Argentina.	federico.pereyra@hospitalitaliano.org.ar	Hyon, Sung Ho/AAM-6884-2020	Fainstein-Day, Patricia/0000-0002-6402-1690	Hospital Italiano de Buenos Aires; FUCIBA; Fundacion Florencio Fiorini	Hospital Italiano de Buenos Aires; FUCIBA; Fundacion Florencio Fiorini	This work was financially supported by Hospital Italiano de Buenos Aires, FUCIBA and Fundacion Florencio Fiorini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Cappellesso-Fleury S, 2010, J CLIN IMMUNOL, V30, P607, DOI 10.1007/s10875-010-9415-4; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Daley GQ, 2012, CELL STEM CELL, V10, P740, DOI 10.1016/j.stem.2012.05.010; Drucker DJ, 1998, DIABETES, V47, P159, DOI 10.2337/diabetes.47.2.159; Feldon SE, 2006, AM J PATHOL, V169, P1183, DOI 10.2353/ajpath.2006.060434; Fomina-Yadlin D, 2010, P NATL ACAD SCI USA, V107, P15099, DOI 10.1073/pnas.1010018107; Gregoire FM, 2001, EXP BIOL MED, V226, P997, DOI 10.1177/153537020122601106; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Guo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022387; Habeck M, 2003, NAT MED, V9, P1228, DOI 10.1038/nm1003-1228a; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hee CK, 2006, BIOMATERIALS, V27, P875, DOI 10.1016/j.biomaterials.2005.07.004; Hirata K, 2003, BONE, V32, P502, DOI 10.1016/S8756-3282(03)00054-1; Hosokawa M, 2001, BIOCHEM BIOPH RES CO, V289, P1114, DOI 10.1006/bbrc.2001.6145; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Hyon SH, 2004, CELL TRANSPLANT, V13, P61, DOI 10.3727/000000004772664905; Jiang MH, 2010, LAB INVEST, V90, P282, DOI 10.1038/labinvest.2009.132; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kass SU, 1997, TRENDS GENET, V13, P444, DOI 10.1016/S0168-9525(97)01268-7; Krebsbach PH, 2000, HUM GENE THER, V11, P1201, DOI 10.1089/10430340050015248; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kubo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024058; Kuroda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006953; Lau J, 2009, CELL TRANSPLANT, V18, P23, DOI 10.3727/096368909788237131; Lee CS, 2006, DIABETES, V55, P269; Lei T, 2007, CELL RES, V17, P682, DOI 10.1038/cr.2007.61; Li K, 2014, CELL STEM CELL, V14, P228, DOI 10.1016/j.stem.2014.01.006; Li Z, 2000, J ENDOCRINOL, V165, P93, DOI 10.1677/joe.0.1650093; Lisanti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079044; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lysy PA, 2007, HEPATOLOGY, V46, P1574, DOI 10.1002/hep.21839; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; Masuda S, 2013, J MOL CELL BIOL, V5, P354, DOI 10.1093/jmcb/mjt034; Mizuno S, 1996, EXP CELL RES, V227, P89, DOI 10.1006/excr.1996.0253; Palm F, 2004, DIABETES-METAB RES, V20, P452, DOI 10.1002/dmrr.472; Pennarossa G, 2013, P NATL ACAD SCI USA, V110, P8948, DOI 10.1073/pnas.1220637110; Pinney SE, 2011, DIABETOLOGIA, V54, P2606, DOI 10.1007/s00125-011-2250-1; REDDI AH, 1972, P NATL ACAD SCI USA, V69, P1601, DOI 10.1073/pnas.69.6.1601; Rutherford RB, 2003, CONNECT TISSUE RES, V44, P117, DOI 10.1080/03008200390152197; Rutherford RB, 2002, TISSUE ENG, V8, P441, DOI 10.1089/107632702760184709; Ryan EA, 2002, DIABETES, V51, P2148, DOI 10.2337/diabetes.51.7.2148; Shui CX, 2002, J CELL PHYSIOL, V193, P164, DOI 10.1002/jcp.10157; Siegfried Z, 1997, CURR BIOL, V7, pR305, DOI 10.1016/S0960-9822(06)00144-8; Sumi S, 2004, PANCREAS, V29, pE85, DOI 10.1097/00006676-200410000-00017; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Wakao S, 2011, P NATL ACAD SCI USA, V108, P9875, DOI 10.1073/pnas.1100816108; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28; Zhou J, 1999, DIABETES, V48, P2358, DOI 10.2337/diabetes.48.12.2358; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015	57	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100369	10.1371/journal.pone.0100369	http://dx.doi.org/10.1371/journal.pone.0100369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963634	Green Published, gold, Green Submitted			2022-12-25	WOS:000338709500045
J	Zong, JF; Lin, SJ; Chen, YB; Wang, BY; Xiao, YP; Lin, J; Li, R; Pan, JJ				Zong, Jingfeng; Lin, Shaojun; Chen, Yunbin; Wang, Bingyi; Xiao, Youping; Lin, Jin; Li, Rui; Pan, Jianji			Does MRI-Detected Cranial Nerve Involvement Affect the Prognosis of Locally Advanced Nasopharyngeal Carcinoma Treated with Intensity Modulated Radiotherapy?	PLOS ONE			English	Article							CONVENTIONAL 2-DIMENSIONAL RADIOTHERAPY; TRIGEMINAL NERVE; CANCER; CHEMOTHERAPY; EXPERIENCE; OUTCOMES; SPREAD; TRIAL; PALSY; HEAD	Nasopharyngeal carcinoma (NPC) is one of the common cancers in South China. It can easily invade into cranial nerves, especially in patients with local advanced disease. Despite the fact that the magnetic resonance imaging (MRI) findings are not always consistent with the symptoms of CN palsy, MRI is recommended for the detection of CN involvement (CNI). However, the prognostic impact of MRI-detected CNI in NPC patients is still controversial. To investigate the prognostic value of MRI detected CNI, we performed a retrospective analysis on the clinical data of 375 patients with NPC who were initially diagnosed by MRI. All patients had T3-4 disease and received radical intensity modulated radiation therapy (IMRT) as their primary treatment. The incidence of MRI-detected CNI was 60.8%. A higher incidence of MRI-detected CNI was observed in T4 disease compared with T3 disease (96.8% vs. 42.8%, P<0.001), and a higher incidence was also found in patients with Stage IV disease compared with those with Stage III disease (91.5% vs. 42.3%; P<0.001). The local relapse-free survival (LRFS), distant metastasis-free survival (DMFS), and overall survival (OS) of patients with T3 disease, with or without MRI-detected CNI, was superior to that of patients with T4 disease (P<0.05). No significant differences in LRFS, DMFS or OS were observed between T3 patients with or without MRI-detected CNI. The survival of Stage III patients with or without MRI-detected CNI was significantly superior to that of Stage IV patients (P<0.01), but there was no significant difference between Stage III patients with or without MRI-detected CNI for all endpoints. Therefore, when treated with IMRT, MRI-detected CNI in patients with NPC does not appear to affect the prognosis. In patients with clinical T3 disease, the presence of MRI-detected CNI is not sufficient evidence for defining T4 disease.	[Zong, Jingfeng; Lin, Shaojun; Chen, Yunbin; Wang, Bingyi; Xiao, Youping; Lin, Jin; Li, Rui; Pan, Jianji] Fujian Med Univ, Prov Clin Coll, Fuzhou, Fujian Province, Peoples R China; [Zong, Jingfeng; Lin, Shaojun; Wang, Bingyi; Lin, Jin; Li, Rui; Pan, Jianji] Fujian Prov Canc Hosp, Dept Radiat Oncol, Fuzhou, Fujian Province, Peoples R China; [Zong, Jingfeng; Lin, Shaojun; Wang, Bingyi; Lin, Jin; Li, Rui; Pan, Jianji] Fujian Prov Canc Hosp, Fujian Prov Key Lab Translat Canc Med, Fuzhou, Fujian Province, Peoples R China; [Chen, Yunbin; Xiao, Youping] Fujian Prov Canc Hosp, Dept Radiol, Fuzhou, Fujian Province, Peoples R China	Fujian Medical University	Pan, JJ (corresponding author), Fujian Med Univ, Prov Clin Coll, Fuzhou, Fujian Province, Peoples R China.	panjianji@126.com	, 宗井凤/AAH-1938-2020	Pan, Jianji/0000-0002-3211-7874	Clinical Specialty Discipline Construction Program of Fujian, P.R.C	Clinical Specialty Discipline Construction Program of Fujian, P.R.C	Sponsored by key Clinical Specialty Discipline Construction Program of Fujian, P.R.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang JTC, 2005, INT J RADIAT ONCOL, V63, P1354, DOI 10.1016/j.ijrobp.2005.05.042; Chong VFH, 1997, HEAD NECK-J SCI SPEC, V19, P121; Edge SB, 2009, AJCC CANC STAGING MA, V7; Ginsberg LE, 1999, SEMIN ULTRASOUND CT, V20, P175, DOI 10.1016/S0887-2171(99)90018-5; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Lee AWM, 2005, J CLIN ONCOL, V23, P6966, DOI 10.1200/JCO.2004.00.7542; Lee AWM, 1999, INT J CANCER, V84, P179, DOI 10.1002/(SICI)1097-0215(19990420)84:2<179::AID-IJC15>3.0.CO;2-6; Lee N, 2002, INT J RADIAT ONCOL, V53, P12, DOI 10.1016/S0360-3016(02)02724-4; Lin SJ, 2009, INT J RADIAT ONCOL, V75, P1071, DOI 10.1016/j.ijrobp.2008.12.015; Liu LZ, 2009, CANCER-AM CANCER SOC, V115, P1995, DOI 10.1002/cncr.24201; Lu TX, 2001, INT J RADIAT ONCOL, V51, P589, DOI 10.1016/S0360-3016(01)01678-9; Majoie CBLM, 1997, EUR J RADIOL, V24, P191, DOI 10.1016/S0720-048X(96)01122-9; Mo HY, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-149; Nemzek WR, 1998, AM J NEURORADIOL, V19, P701; Pan J, 2013, AM J CLIN ONCOL; Peng G, 2012, RADIOTHER ONCOL, V104, P286, DOI 10.1016/j.radonc.2012.08.013; Razek AAKA, 2012, AM J ROENTGENOL, V198, P11, DOI 10.2214/AJR.11.6954; Su CY, 1996, CANCER, V78, P2063, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2063::AID-CNCR5>3.0.CO;2-P; Tham IWK, 2009, INT J RADIAT ONCOL, V75, P1481, DOI 10.1016/j.ijrobp.2009.01.018; Wee J, 2005, J CLIN ONCOL, V23, P6730, DOI 10.1200/JCO.2005.16.790; Yap ML, 2012, J MED IMAG RADIAT ON, V56, P548, DOI 10.1111/j.1754-9485.2012.02391.x	21	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100571	10.1371/journal.pone.0100571	http://dx.doi.org/10.1371/journal.pone.0100571			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963626	Green Published, Green Submitted, gold			2022-12-25	WOS:000338709500063
J	Dave, S; Nanduri, R; Dkhar, HK; Bhagyaraj, E; Rao, A; Gupta, P				Dave, Sandeep; Nanduri, Ravikanth; Dkhar, Hedwin Kitdorlang; Bhagyaraj, Ella; Rao, Alka; Gupta, Pawan			Nuclear MEK1 Sequesters PPAR gamma and Bisects MEK1/ERK Signaling: A Non-Canonical Pathway of Retinoic Acid Inhibition of Adipocyte Differentiation	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; MAP KINASE; TRANSCRIPTIONAL CONTROL; RETINOYLATION REACTION; COVALENT MODIFICATION; CELL-DIFFERENTIATION; BINDING PROTEIN; RECEPTOR; ADIPOGENESIS	Uncontrolled adipogenesis and adipocyte proliferation have been connected to human comorbidities. Retinoic acid (RA) is known to inhibit adipocyte differentiation, however the underlying mechanisms have not been adequately understood. This study reports that RA acting as a ligand to RA receptors (RARs and RXRs) is not a sine qua non to the inhibition of adipogenesis. Our intriguing observation of a negative correlation between increased retinoylation and adipogenesis led us to explore retinoylated proteins in adipocytes. Exportin (CRM1) was found to be retinoylated, which in turn can affect the spatio-temporal regulation of the important signaling molecule mitogen-activated protein kinase kinase 1 (MEK1), likely by disrupting its export from the nucleus. Nuclear enrichment of MEK1 physically sequesters peroxisome proliferator-activated receptor gamma (PPAR gamma), the master regulator of adipogenesis, from its target genes and thus inhibits adipogenesis while also disrupting the MEK1-extracellular-signal regulated kinase (ERK) signaling cascade. This study is first to report the inhibition of adipocyte differentiation by retinoylation.	[Dave, Sandeep; Nanduri, Ravikanth; Dkhar, Hedwin Kitdorlang; Bhagyaraj, Ella; Rao, Alka; Gupta, Pawan] CSIR, Inst Microbial Technol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Gupta, P (corresponding author), CSIR, Inst Microbial Technol, Chandigarh, India.	pawan@imtech.res.in	Rao, Alka/F-9826-2010; NANDURI, RAVIKANTH/Q-9729-2018	NANDURI, RAVIKANTH/0000-0002-0031-2333; Ella, Bhagyaraj/0000-0002-5887-9228; Dave, Sandeep/0000-0003-2832-2098	Department of Science & Technology SERC-FAST Track project; Department of Biotechnology-India project [BT/01/IYBA/2009]; CSIR [BSC0210, BSC0120]	Department of Science & Technology SERC-FAST Track project(Department of Science & Technology (DOST), Philippines); Department of Biotechnology-India project; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Department of Science & Technology SERC-FAST Track project to PG, Department of Biotechnology-India project BT/01/IYBA/2009 and CSIR 12th Plan Network project Infectious Disease and Biodiscovery (BSC0210 & BSC0120) to PG and facilities provided by IMTech-CSIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2006, MOL BIOL CELL, V17, P566, DOI 10.1091/mbc.E05-06-0519; Aguilar V, 2010, ENDOCRINOLOGY, V151, P5247, DOI 10.1210/en.2010-0461; Aubert J, 1999, CELL MOL LIFE SCI, V56, P538, DOI 10.1007/s000180050450; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Berry DC, 2010, J BIOL CHEM, V285, P15324, DOI 10.1074/jbc.M110.110635; Bhat AH, 2012, NUCLEIC ACIDS RES, V40, pD388, DOI 10.1093/nar/gkr911; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; Burgermeister E, 2007, CELL CYCLE, V6, P1539, DOI 10.4161/cc.6.13.4453; Burgermeister E, 2007, MOL CELL BIOL, V27, P803, DOI 10.1128/MCB.00601-06; Camp HS, 1997, J BIOL CHEM, V272, P10811; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Cione E, 2005, MOL CELL BIOCHEM, V276, P55, DOI 10.1007/s11010-005-2845-2; Cione E, 2005, J BIOENERG BIOMEMBR, V37, P43, DOI 10.1007/s10863-005-4122-1; Cione E, 2004, J BIOENERG BIOMEMBR, V36, P211, DOI 10.1023/B:JOBB.0000023625.22324.f0; Cione E, 2009, BBA-MOL CELL BIOL L, V1791, P3, DOI 10.1016/j.bbalip.2008.09.004; CONRAD DH, 1973, IMMUNOCHEMISTRY, V10, P273, DOI 10.1016/0019-2791(73)90205-X; Dave S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030831; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Genchi G, 2001, BBA-MOL CELL BIOL L, V1530, P146, DOI 10.1016/S1388-1981(00)00175-X; Gupta P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004363; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Iankova I, 2006, MOL ENDOCRINOL, V20, P1494, DOI 10.1210/me.2005-0222; Jaaro H, 1997, P NATL ACAD SCI USA, V94, P3742, DOI 10.1073/pnas.94.8.3742; KAMEI Y, 1993, BIOCHEM J, V293, P807, DOI 10.1042/bj2930807; KAMEI Y, 1994, LIFE SCI, V55, pPL307, DOI 10.1016/0024-3205(94)90073-6; KEIDEL S, 1993, EUR J BIOCHEM, V212, P13, DOI 10.1111/j.1432-1033.1993.tb17627.x; Kim SW, 2007, MOL CELL BIOL, V27, P6933, DOI 10.1128/MCB.02385-06; Kubo Y, 2005, J BIOCHEM, V138, P493, DOI 10.1093/jb/mvi145; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; Mahajan S, 2012, J IMMUNOL, V188, P5593, DOI 10.4049/jimmunol.1103038; Mangelsdorf David J., 1994, P319; Moon HS, 2007, J NUTR BIOCHEM, V18, P322, DOI 10.1016/j.jnutbio.2006.06.004; Myhre AM, 1996, J LIPID RES, V37, P1971; Napoli JL, 1996, FASEB J, V10, P993, DOI 10.1096/fasebj.10.9.8801182; Persaud SD, 2009, FASEB J, V23; Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200; Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535; RENSTROM B, 1989, BIOCHIM BIOPHYS ACTA, V998, P69, DOI 10.1016/0167-4838(89)90120-9; Rosen ED, 2000, GENE DEV, V14, P1293; SALE EM, 1995, EMBO J, V14, P674, DOI 10.1002/j.1460-2075.1995.tb07046.x; SCHALLREUTER KU, 1991, SKIN PHARMACOL, V4, P14, DOI 10.1159/000210919; Schupp M, 2007, MOL PHARMACOL, V71, P1251, DOI 10.1124/mol.106.033662; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Senatore V, 2010, J BIOENERG BIOMEMBR, V42, P321, DOI 10.1007/s10863-010-9293-8; SURYAWAN A, 1993, COMP BIOCHEM PHYS A, V105, P485, DOI 10.1016/0300-9629(93)90424-3; TAKAHASHI N, 1992, P NATL ACAD SCI USA, V89, P10807, DOI 10.1073/pnas.89.22.10807; TAKAHASHI N, 1991, ARCH BIOCHEM BIOPHYS, V285, P105, DOI 10.1016/0003-9861(91)90334-F; Takahashi N, 2005, SEIKAGAKU, V77, P527; Takahashi N, 1997, BIOCHEM BIOPH RES CO, V239, P80, DOI 10.1006/bbrc.1997.7434; Takahashi N, 2010, BRIT J DERMATOL, V162, P974, DOI 10.1111/j.1365-2133.2009.09592.x; Takahashi N, 1995, CLIN CANCER RES, V1, P637; Takahashi N, 2002, YAKUGAKU ZASSHI, V122, P547, DOI 10.1248/yakushi.122.547; TAKAHASHI N, 1991, BIOCHEM BIOPH RES CO, V180, P393, DOI 10.1016/S0006-291X(05)81306-3; TAKAHASHI N, 1994, J BIOL CHEM, V269, P5913; TAKAHASHI N, 1989, J BIOL CHEM, V264, P5159; Takahashi N., 1994, Vitamin A in health and disease., P257; TAKAHASHI N, 1990, METHOD ENZYMOL, V189, P233; TAKAHASHI N, 1991, ARCH BIOCHEM BIOPHYS, V290, P293, DOI 10.1016/0003-9861(91)90544-S; Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tucci P, 2008, J BIOENERG BIOMEMBR, V40, P111, DOI 10.1007/s10863-008-9132-3; Villarroya F, 1999, INT J OBESITY, V23, P1, DOI 10.1038/sj.ijo.0800799; Wada M, 2001, J BIOCHEM-TOKYO, V130, P457, DOI 10.1093/oxfordjournals.jbchem.a003006; Wang P, 2009, J CELL SCI, V122, P3772, DOI 10.1242/jcs.057026; Xue JC, 1996, MOL CELL BIOL, V16, P1567; Yael Asscher SP, 2001, LEPTOMYCIN B; Yamamoto Y, 2002, METABOLISM, V51, P1407, DOI 10.1053/meta.2002.35586; Yao Z, 2001, ONCOGENE, V20, P7588, DOI 10.1038/sj.onc.1204963; Zehorai E, 2010, MOL CELL ENDOCRINOL, V314, P213, DOI 10.1016/j.mce.2009.04.008	78	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100862	10.1371/journal.pone.0100862	http://dx.doi.org/10.1371/journal.pone.0100862			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959884	gold, Green Published, Green Submitted			2022-12-25	WOS:000338633900097
J	Diep, TA; Madsen, AN; Krogh-Hansen, S; Al-Shahwani, M; Al-Sabagh, L; Holst, B; Hansen, HS				Diep, Thi Ai; Madsen, Andreas N.; Krogh-Hansen, Sandra; Al-Shahwani, Marwa; Al-Sabagh, Laila; Holst, Birgitte; Hansen, Harald S.			Dietary Non-Esterified Oleic Acid Decreases the Jejunal Levels of Anorectic N-Acylethanolamines	PLOS ONE			English	Article							PHOSPHOLIPASE-D; FATTY-ACIDS; INTESTINAL LEVELS; GUT; ANANDAMIDE; RAT; OLEOYLETHANOLAMIDE; GPR119; ACYLPHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLETHANOLAMINE	Background and Aims: Oleoylethanolamide and several other N-acylethanolamines (NAEs), e.g. linoleoylethanolamide and palmitoylethanolamide, have anorectic properties in rats, and prolonged intake of a high-fat diet decreases the levels of the anorectic NAEs in jejunum. Jejunal anorectic NAEs are thought to add to the control of food intake via activation of PPARalpha and the vagus nerve. The fat-induced decrease may explain part of the hyperphagic effect of high-fat diets. In the present study, we investigated 1) whether the reduced levels of anorectic NAEs were reversible in rats, 2) whether mice respond to dietary fat (olive oil) by reducing levels of anorectic NAEs, and 3) whether dietary non-esterified oleic acid also can decrease levels of anorectic NAEs in mice. We are searching for the fat sensor in the intestine, which mediates the decreased levels of anorectic NAEs. Methods: Male rats and mice were fed diets high (45 energy% fat) in either triacylglycerol or free fatty acids for 7-14 days, and jejunal NAE and N-acylphosphatidylethanolamine (NAPE) levels were determined by liquid-chromatography mass spectrometry. Results: In rats, reduced levels of anorectic NAEs could be reversed after 3 days from changing the diet from high-fat to chow. Corresponding NAPE levels tended to show the same changes. In mice, jejunal levels of anorectic NAEs were also reduced when fed a high-fat diet. In addition, we found that non-esterified oleic acid were also able to reduce levels of anorectic NAEs in mice. Conclusions: These results suggest that the down-regulation of the jejunal level of anorectic NAEs by dietary fat is not restricted to rats, and that the fatty acid component oleic acid, in dietary olive oil may be sufficient to mediate this regulation. Thus, a fatty acid sensor may mediate this effect of dietary fat.	[Diep, Thi Ai; Krogh-Hansen, Sandra; Al-Shahwani, Marwa; Al-Sabagh, Laila; Hansen, Harald S.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Madsen, Andreas N.; Holst, Birgitte] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Hansen, HS (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark.	hsh@sund.ku.dk		Hansen, Harald S./0000-0001-7360-7418; Diep, Thi Ai/0000-0003-2681-1090; Holst, Birgitte/0000-0001-7432-097X	Danish Ministry of Science, Technology and Innovation; Augustinus Foundation; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF12OC1016214] Funding Source: researchfish	Danish Ministry of Science, Technology and Innovation; Augustinus Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was carried out as a part of the research programme of the UNIK: Food, Fitness & Pharma for Healt and Disease (see www.foodfitnesspharma.ku.dk). The UNIK programme is supported by the Danish Ministry of Science, Technology and Innovation. This project was also supported by the Augustinus Foundation, and the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artmann A, 2008, BBA-MOL CELL BIOL L, V1781, P200, DOI 10.1016/j.bbalip.2008.01.006; Aviello G, 2008, J MOL MED, V86, P413, DOI 10.1007/s00109-008-0305-7; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; Diep TA, 2011, FASEB J, V25, P765, DOI 10.1096/fj.10-166595; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Fu J, 2008, AM J PHYSIOL-REG I, V295, pR45, DOI 10.1152/ajpregu.00126.2008; Gaetani S, 2003, NEUROPSYCHOPHARMACOL, V28, P1311, DOI 10.1038/sj.npp.1300166; Gillum MP, 2008, CELL, V135, P813, DOI 10.1016/j.cell.2008.10.043; Hansen HS, 2014, PHARMACOL RES, V86, P18, DOI 10.1016/j.phrs.2014.03.006; Hansen HS, 2012, TRENDS PHARMACOL SCI, V33, P374, DOI 10.1016/j.tips.2012.03.014; Hansen HS, 2010, EXP NEUROL, V224, P48, DOI 10.1016/j.expneurol.2010.03.022; Hansen HS, 2009, BIOCHEM PHARMACOL, V78, P553, DOI 10.1016/j.bcp.2009.04.024; Hansen KB, 2011, J CLIN ENDOCR METAB, V96, pE1409, DOI 10.1210/jc.2011-0647; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Iakoubov R, 2011, ENDOCRINOLOGY, V152, P1244, DOI 10.1210/en.2010-1352; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jaggar SI, 1998, NEUROSCI LETT, V253, P123, DOI 10.1016/S0304-3940(98)00621-1; Judge MK, 2008, AM J PHYSIOL-REG I, V295, pR773, DOI 10.1152/ajpregu.00727.2007; Kleberg K, 2014, BIOFACTORS, V40, P363, DOI 10.1002/biof.1158; Langhans W, 2011, AM J PHYSIOL-REG I, V300, pR554, DOI 10.1152/ajpregu.00610.2010; Liou AP, 2011, GASTROENTEROLOGY, V140, P903, DOI 10.1053/j.gastro.2010.10.012; Madsen AN, 2010, J ENDOCRINOL, V206, P287, DOI 10.1677/JOE-10-0004; Mazzari S, 1996, EUR J PHARMACOL, V300, P227, DOI 10.1016/0014-2999(96)00015-5; Naville D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030686; Nielsen MJ, 2004, J LIPID RES, V45, P1027, DOI 10.1194/jlr.C300008-JLR200; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Petersen G, 2000, J LIPID RES, V41, P1532; Petersen G, 2006, BBA-MOL CELL BIOL L, V1761, P143, DOI 10.1016/j.bbalip.2005.12.011; Piomelli D, 2013, TRENDS ENDOCRIN MET, V24, P332, DOI 10.1016/j.tem.2013.03.001; Prentice AM, 1998, AM J CLIN NUTR, V67, p535S, DOI 10.1093/ajcn/67.3.535S; Rasmussen BA, 2012, TRENDS ENDOCRIN MET, V23, P49, DOI 10.1016/j.tem.2011.11.001; Rasoamanana R, 2012, P NUTR SOC, V27, P1; Reimann F, 2012, CELL METAB, V15, P421, DOI 10.1016/j.cmet.2011.12.019; ROTHWELL NJ, 1983, INT J OBESITY, V7, P263; SCHMID PC, 1986, CHEM PHYS LIPIDS, V41, P195, DOI 10.1016/0009-3084(86)90022-8; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Sclafani A, 2012, AM J PHYSIOL-REG I, V302, pR1119, DOI 10.1152/ajpregu.00038.2012; Skonberg C, 2010, J LIPID RES, V51, P3062, DOI 10.1194/jlr.D004606; Solorzano C, 2009, P NATL ACAD SCI USA, V106, P20966, DOI 10.1073/pnas.0907417106; Syed SK, 2012, AM J PHYSIOL-ENDOC M, V303, pE1469, DOI 10.1152/ajpendo.00269.2012; Tellez LA, 2013, SCIENCE, V341, P800, DOI 10.1126/science.1239275; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Wellner N, 2013, BBA-MOL CELL BIOL L, V1831, P652, DOI 10.1016/j.bbalip.2012.08.019; Wellner N, 2011, BBA-MOL CELL BIOL L, V1811, P508, DOI 10.1016/j.bbalip.2011.06.020	46	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100365	10.1371/journal.pone.0100365	http://dx.doi.org/10.1371/journal.pone.0100365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959837	Green Published, Green Submitted, gold			2022-12-25	WOS:000338633900040
J	Flores, JA; Balseiro-Gomez, S; Cabeza, JM; Acosta, J; Ramirez-Ponce, P; Ales, E				Flores, Juan A.; Balseiro-Gomez, Santiago; Cabeza, Jose M.; Acosta, Jorge; Ramirez-Ponce, Pilar; Ales, Eva			A New Role for Myosin II in Vesicle Fission	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; ADRENAL CHROMAFFIN CELLS; FUSION PORE; MAST-CELLS; COMPENSATORY ENDOCYTOSIS; NEUROENDOCRINE CELLS; ACTIN CYTOSKELETON; SECRETORY VESICLE; COATED PITS; EXOCYTOSIS	An endocytic vesicle is formed from a flat plasma membrane patch by a sequential process of invagination, bud formation and fission. The scission step requires the formation of a tubular membrane neck ( the fission pore) that connects the endocytic vesicle with the plasma membrane. Progress in vesicle fission can be measured by the formation and closure of the fission pore. Live-cell imaging and sensitive biophysical measurements have provided various glimpses into the structure and behaviour of the fission pore. In the present study, the role of non-muscle myosin II (NM-2) in vesicle fission was tested by analyzing the kinetics of the fission pore with perforated-patch clamp capacitance measurements to detect single vesicle endocytosis with millisecond time resolution in peritoneal mast cells. Blebbistatin, a specific inhibitor of NM-2, dramatically increased the duration of the fission pore and also prevented closure during large endocytic events. Using the fluorescent markers FM1-43 and pHrodo Green dextran, we found that NM-2 inhibition greatly arrested vesicle fission in a late phase of the scission event when the pore reached a final diameter of similar to 5 nm. Our results indicate that loss of the ATPase activity of myosin II drastically reduces the efficiency of membrane scission by making vesicle closure incomplete and suggest that NM-2 might be especially relevant in vesicle fission during compound endocytosis.	[Flores, Juan A.; Balseiro-Gomez, Santiago; Cabeza, Jose M.; Acosta, Jorge; Ramirez-Ponce, Pilar; Ales, Eva] Univ Seville, Fac Med, Dpto Fisiol Med & Biofis, Seville, Spain	University of Sevilla	Ales, E (corresponding author), Univ Seville, Fac Med, Dpto Fisiol Med & Biofis, Seville, Spain.	eales@us.es	Ales, Eva/E-6315-2010; Acosta-Lopez, Jorge/H-6271-2015; Ramírez-Ponce, MP/F-1788-2010	Ales, Eva/0000-0002-5536-4616; Acosta-Lopez, Jorge/0000-0003-1349-4495; Ramírez-Ponce, MP/0000-0003-0299-1269; Cabeza Fernandez, Jose Maria/0000-0002-1784-6219	Ministerio de Ciencia e Innovacion ISCIII; Fondos FEDER [PI11/00257]	Ministerio de Ciencia e Innovacion ISCIII(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Fondos FEDER(European Commission)	This work was supported by the Ministerio de Ciencia e Innovacion ISCIII and Fondos FEDER Grant PI11/00257 (to E. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez de Toledo G, 1993, NATURE, V363, P554; Angleson JK, 1999, NAT NEUROSCI, V2, P440, DOI 10.1038/8107; Aoki R, 2010, BIOCHEM J, V429, P497, DOI 10.1042/BJ20091839; Artalejo CR, 2002, P NATL ACAD SCI USA, V99, P6358, DOI 10.1073/pnas.082658499; Babich V, 2008, BLOOD, V111, P5282, DOI 10.1182/blood-2007-09-113746; Bananis E, 2004, MOL BIOL CELL, V15, P3688, DOI 10.1091/mbc.E04-04-0278; Benesch S, 2005, J CELL SCI, V118, P3103, DOI 10.1242/jcs.02444; Berberian K, 2009, J NEUROSCI, V29, P863, DOI 10.1523/JNEUROSCI.2818-08.2009; Bhat P, 2009, MOL BIOL CELL, V20, P1795, DOI 10.1091/mbc.E08-10-1048; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; Brumback AC, 2004, METHODS, V33, P287, DOI 10.1016/j.ymeth.2004.01.002; Cabeza JM, 2013, J BIOL CHEM, V288, P20293, DOI 10.1074/jbc.M113.459065; Chandrasekar I, 2014, TRAFFIC; Chandrasekar I, 2013, J NEUROSCI, V33, P16131, DOI 10.1523/JNEUROSCI.2229-13.2013; Chen MH, 2013, J NEUROSCI, V33, P2071, DOI 10.1523/JNEUROSCI.3426-12.2013; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Cochilla AJ, 2000, J CELL BIOL, V150, P839, DOI 10.1083/jcb.150.4.839; Debus K, 2000, BIOPHYS J, V78, P2983, DOI 10.1016/S0006-3495(00)76837-8; DETOLEDO GA, 1990, J GEN PHYSIOL, V95, P397, DOI 10.1085/jgp.95.3.397; Doreian BW, 2008, J NEUROSCI, V28, P4470, DOI 10.1523/JNEUROSCI.0008-08.2008; FAWCETT DW, 1954, J EXP MED, V100, P217, DOI 10.1084/jem.100.2.217; Fulop T, 2005, J NEUROSCI, V25, P7324, DOI 10.1523/JNEUROSCI.2042-05.2005; Galletta BJ, 2010, CURR OPIN BIOTECH, V21, P604, DOI 10.1016/j.copbio.2010.06.006; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Gutierrez LM, 2012, INT REV CEL MOL BIO, V295, P109, DOI 10.1016/B978-0-12-394306-4.00009-5; Henkel AW, 2000, EMBO J, V19, P84, DOI 10.1093/emboj/19.1.84; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kobayashi S, 2010, AUTOPHAGY, V6, P36, DOI 10.4161/auto.6.1.10324; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Krendel M, 2007, FEBS LETT, V581, P644, DOI 10.1016/j.febslet.2007.01.021; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Lollike K, 1999, J IMMUNOL METHODS, V232, P111, DOI 10.1016/S0022-1759(99)00169-6; Cabeza JM, 2010, TRAFFIC, V11, P1579, DOI 10.1111/j.1600-0854.2010.01120.x; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Merrifield CJ, 2005, MICROSC MICROANAL S2, V11, P240; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Miserey-Lenkei S, 2010, NAT CELL BIOL, V12, P645, DOI 10.1038/ncb2067; MONCK JR, 1990, P NATL ACAD SCI USA, V87, P7804, DOI 10.1073/pnas.87.20.7804; Neco P, 2004, J BIOL CHEM, V279, P27450, DOI 10.1074/jbc.M311462200; Neco P, 2008, J BIOL CHEM, V283, P10949, DOI 10.1074/jbc.M709058200; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Perrais D, 2004, J PHYSIOL-LONDON, V560, P413, DOI 10.1113/jphysiol.2004.064410; ROHLICH P, 1971, J CELL BIOL, V51, P465, DOI 10.1083/jcb.51.2.465; ROSENBOOM H, 1994, P NATL ACAD SCI USA, V91, P5267, DOI 10.1073/pnas.91.12.5267; SPRUCE AE, 1990, NEURON, V4, P643, DOI 10.1016/0896-6273(90)90192-I; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; Taylor MJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001302; Wu Y, 2011, BIOCHEMISTRY-US, V50, P7493, DOI 10.1021/bi2006288; Yao LH, 2013, J NEUROSCI, V33, P15793, DOI 10.1523/JNEUROSCI.2171-13.2013; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Yu HYE, 2007, MOL BIOL CELL, V18, P4096, DOI 10.1091/mbc.E06-11-0993; Yue HY, 2014, J NEUROSCI, V34, P295, DOI 10.1523/JNEUROSCI.3744-13.2014	55	14	14	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100757	10.1371/journal.pone.0100757	http://dx.doi.org/10.1371/journal.pone.0100757			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959909	gold, Green Published, Green Submitted			2022-12-25	WOS:000338633900082
J	Logez, C; Berger, S; Legros, C; Baneres, JL; Cohen, W; Delagrange, P; Nosjean, O; Boutin, JA; Ferry, G; Simonin, F; Wagner, R				Logez, Christel; Berger, Sylvie; Legros, Celine; Baneres, Jean-Louis; Cohen, William; Delagrange, Philippe; Nosjean, Olivier; Boutin, Jean A.; Ferry, Gilles; Simonin, Frederic; Wagner, Renaud			Recombinant Human Melatonin Receptor MT1 Isolated in Mixed Detergents Shows Pharmacology Similar to That in Mammalian Cell Membranes	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; MOLECULAR PHARMACOLOGY; BINDING-SITE; PURIFICATION; EXPRESSION; SOLUBILIZATION; CHOLESTEROL; STABILIZATION; ACTIVATION; LIGANDS	The human melatonin MT1 receptor-belonging to the large family of G protein-coupled receptors (GPCRs)-plays a key role in circadian rhythm regulation and is notably involved in sleep disorders and depression. Structural and functional information at the molecular level are highly desired for fine characterization of this receptor; however, adequate techniques for isolating soluble MT1 material suitable for biochemical and biophysical studies remain lacking. Here we describe the evaluation of a panel of constructs and host systems for the production of recombinant human MT1 receptors, and the screening of different conditions for their solubilization and purification. Our findings resulted in the establishment of an original strategy using a mixture of Fos14 and CHAPS detergents to extract and purify a recombinant human MT1 from Pichia pastoris membranes. This procedure enabled the recovery of relatively pure, monomeric and ligand-binding active MT1 receptor in the near-milligram range. A comparative study based on extensive ligand-binding characterization highlighted a very close correlation between the pharmacological profiles of MT1 purified from yeast and the same receptor present in mammalian cell membranes. The high quality of the purified MT1 was further confirmed by its ability to activate its cognate G alpha i protein partner when reconstituted in lipid discs, thus opening novel paths to investigate this receptor by biochemical and biophysical approaches.	[Logez, Christel; Simonin, Frederic; Wagner, Renaud] Univ Strasbourg, Inst Rech ESBS, CNRS UMR7242, Lab Excellence MEDALIS, Illkirch Graffenstaden, France; [Logez, Christel; Berger, Sylvie; Legros, Celine; Cohen, William; Nosjean, Olivier; Boutin, Jean A.; Ferry, Gilles] Inst Rech Servier, Croissy Sur Seine, France; [Baneres, Jean-Louis] Univ Montpellier I, Inst Biomol Max Mousseron, CNRS UMR 5247, Montpellier, France; [Baneres, Jean-Louis] Univ Montpellier 2, Fac Pharm, Montpellier, France; [Delagrange, Philippe] Inst Rech Servier, Unite Rech & Decouvertes Neurosci, Croissy Sur Seine, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Servier; Institut de Recherches Internationales Servier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Universite de Montpellier; Servier; Institut de Recherches Internationales Servier	Boutin, JA (corresponding author), Inst Rech Servier, Croissy Sur Seine, France.	jean.boutin@fr.netgrs.com	Boutin, Jean Albert/W-9103-2019	Boutin, Jean Albert/0000-0003-0068-7204; Wagner, Renaud/0000-0002-4249-9853; Baneres, jean-louis/0000-0001-7078-1285	Servier Laboratories; French government	Servier Laboratories; French government	This work was supported by Servier Laboratories (http://www.servier.fr) and by the French government, managed by the "Agence National de la Recherche" under the "Programme d'investissement d'avenir". The present work has been published within the LABEX ANR-10-LABX-0034_Medalis. The Institut de Recherches SERVIER employed some authors in this study and so played a role in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Alkhalfioui F, 2011, PRODUCTION OF MEMBRANE PROTEINS: STRATEGIES FOR EXPRESSION AND ISOLATION, P75; Andre N, 2006, PROTEIN SCI, V15, P1115, DOI 10.1110/ps.062098206; ARENDT J, 1988, CLIN ENDOCRINOL, V29, P205, DOI 10.1111/j.1365-2265.1988.tb00263.x; Audinot V, 2003, N-S ARCH PHARMACOL, V367, P553, DOI 10.1007/s00210-003-0751-2; Audinot V, 2008, BIOCHEM PHARMACOL, V75, P2007, DOI 10.1016/j.bcp.2008.02.022; Boutin JA, 2005, TRENDS PHARMACOL SCI, V26, P412, DOI 10.1016/j.tips.2005.06.006; Boutin JA, 2000, J RECEPT SIGNAL TR R, V20, P105, DOI 10.3109/10799890009150040; Carpentieri A, 2012, PHARMACOL RES, V65, P437, DOI 10.1016/j.phrs.2012.01.003; Chattopadhyay A, 2002, MOL MEMBR BIOL, V19, P211, DOI 10.1080/09687680210149586; Chiu ML, 2008, COMB CHEM HIGH T SCR, V11, P439, DOI 10.2174/138620708784911456; Coge F, 2009, BRIT J PHARMACOL, V158, P1248, DOI 10.1111/j.1476-5381.2009.00453.x; Damian M, 2012, J BIOL CHEM, V287, P3630, DOI 10.1074/jbc.M111.288324; de Bodinat C, 2010, NAT REV DRUG DISCOV, V9, P628, DOI 10.1038/nrd3140; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Devavry S, 2012, J PINEAL RES, V53, P29, DOI 10.1111/j.1600-079X.2011.00968.x; Devavry S, 2012, EUR J PHARMACOL, V677, P15, DOI 10.1016/j.ejphar.2011.12.009; El Moustaine D, 2012, P NATL ACAD SCI USA, V109, P16342, DOI 10.1073/pnas.1205838109; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hassaine G, 2006, PROTEIN EXPRES PURIF, V45, P343, DOI 10.1016/j.pep.2005.06.007; Hassaine G, 2013, BBA-BIOMEMBRANES, V1828, P2544, DOI 10.1016/j.bbamem.2013.05.028; Hino T, 2012, NATURE, V482, P237, DOI 10.1038/nature10750; Jockers R, 2008, BRIT J PHARMACOL, V154, P1182, DOI 10.1038/bjp.2008.184; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kozasa Tohru, 2003, V237, P21; Kunji ERS, 2008, METHODS, V46, P62, DOI 10.1016/j.ymeth.2008.10.020; Lagane B, 2000, J BIOL CHEM, V275, P33197, DOI 10.1074/jbc.C000576200; Leck KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015027; Legros C, 2014, BRIT J PHARMACOL, V171, P186, DOI 10.1111/bph.12457; Liguori L., 2008, CURR PROTOC PROTEIN, V5, P22; Lundstrom Kenneth, 2006, Journal of Structural and Functional Genomics, V7, P77, DOI 10.1007/s10969-006-9011-2; Mailliet F, 2004, BIOCHEM PHARMACOL, V67, P667, DOI 10.1016/j.bcp.2003.09.037; Marques B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000856; McDevitt CA, 2006, STRUCTURE, V14, P1623, DOI 10.1016/j.str.2006.08.014; Nosjean O, 2000, J BIOL CHEM, V275, P31311, DOI 10.1074/jbc.M005141200; O'Malley MA, 2011, BIOPHYS J, V100, pL11, DOI 10.1016/j.bpj.2010.12.3698; Oates J, 2011, CURR OPIN STRUC BIOL, V21, P802, DOI 10.1016/j.sbi.2011.09.007; Oldham WM, 2007, P NATL ACAD SCI USA, V104, P7927, DOI 10.1073/pnas.0702623104; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Opekarova M, 2003, BBA-BIOMEMBRANES, V1610, P11, DOI 10.1016/S0005-2736(02)00708-3; Pawate S, 1998, J BIOL CHEM, V273, P22753, DOI 10.1074/jbc.273.35.22753; Pozza A, 2006, CELL MOL LIFE SCI, V63, P1912, DOI 10.1007/s00018-006-6159-7; Reiter R J, 1980, Endocr Rev, V1, P109; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Steyaert J, 2011, CURR OPIN STRUC BIOL, V21, P567, DOI 10.1016/j.sbi.2011.06.011; Thompson AA, 2011, METHODS, V55, P310, DOI 10.1016/j.ymeth.2011.10.011; Uchiyama M, 2011, SLEEP MED, V12, P119, DOI 10.1016/j.sleep.2010.08.010; Vernier G, 2009, PROTEIN SCI, V18, P1882, DOI 10.1002/pro.199; Vukoti K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046290; Wang XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023076; Weis WI, 2008, CURR OPIN STRUC BIOL, V18, P734, DOI 10.1016/j.sbi.2008.09.010; Yan JH, 2008, ACTA PHARMACOL SIN, V29, P1515, DOI 10.1111/j.1745-7254.2008.00903.x	52	13	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100616	10.1371/journal.pone.0100616	http://dx.doi.org/10.1371/journal.pone.0100616			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959712	Green Submitted, Green Published, gold			2022-12-25	WOS:000338633900062
J	Maganga, GD; Bourgarel, M; Vallo, P; Dallo, TD; Ngoagouni, C; Drexler, JF; Drosten, C; Nakoune, ER; Leroy, EM; Morand, S				Maganga, Gael D.; Bourgarel, Mathieu; Vallo, Peter; Dallo, Thierno D.; Ngoagouni, Carine; Drexler, Jan Felix; Drosten, Christian; Nakoune, Emmanuel R.; Leroy, Eric M.; Morand, Serge			Bat Distribution Size or Shape as Determinant of Viral Richness in African Bats	PLOS ONE			English	Article							SPECIES RICHNESS; FRUIT BAT; ROUSETTUS-AEGYPTIACUS; MOLECULAR PHYLOGENY; GEOGRAPHICAL RANGE; NEOTROPICAL BATS; RESERVOIR HOSTS; WILD MAMMALS; VIRUS; CORONAVIRUSES	The rising incidence of emerging infectious diseases (EID) is mostly linked to biodiversity loss, changes in habitat use and increasing habitat fragmentation. Bats are linked to a growing number of EID but few studies have explored the factors of viral richness in bats. These may have implications for role of bats as potential reservoirs. We investigated the determinants of viral richness in 15 species of African bats (8 Pteropodidae and 7 microchiroptera) in Central and West Africa for which we provide new information on virus infection and bat phylogeny. We performed the first comparative analysis testing the correlation of the fragmented geographical distribution (defined as the perimeter to area ratio) with viral richness in bats. Because of their potential effect, sampling effort, host body weight, ecological and behavioural traits such as roosting behaviour, migration and geographical range, were included into the analysis as variables. The results showed that the geographical distribution size, shape and host body weight have significant effects on viral richness in bats. Viral richness was higher in large-bodied bats which had larger and more fragmented distribution areas. Accumulation of viruses may be related to the historical expansion and contraction of bat species distribution range, with potentially strong effects of distribution edges on virus transmission. Two potential explanations may explain these results. A positive distribution edge effect on the abundance or distribution of some bat species could have facilitated host switches. Alternatively, parasitism could play a direct role in shaping the distribution range of hosts through host local extinction by virulent parasites. This study highlights the importance of considering the fragmentation of bat species geographical distribution in order to understand their role in the circulation of viruses in Africa.	[Maganga, Gael D.; Bourgarel, Mathieu; Leroy, Eric M.] Ctr Int Rech Med Franceville, Franceville, Gabon; [Maganga, Gael D.] Inst Natl Super Agron & Biotechnol, Franceville, Gabon; [Bourgarel, Mathieu; Morand, Serge] CIRAD, UPR AGIRs, Montpellier, France; [Bourgarel, Mathieu] CIRAD, UPR AGIRs, Harare, Zimbabwe; [Vallo, Peter] Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic; [Vallo, Peter] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Dallo, Thierno D.; Drexler, Jan Felix; Drosten, Christian] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany; [Ngoagouni, Carine; Nakoune, Emmanuel R.] Inst Pasteur, Bangui, Cent Afr Republ; [Leroy, Eric M.] Inst Rech Dev, UMR MIVEGEC 224, IRD CNRS UM1, Montpellier, France; [Morand, Serge] Univ Montpellier 2, CNRS UM2, CC065, Inst Sci Evolut, Montpellier, France; [Morand, Serge] Ctr Infectiol Christophe Merieux Laos, Viangchan, Laos	CIRAD; CIRAD; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; Ulm University; University of Bonn; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Bourgarel, M (corresponding author), Ctr Int Rech Med Franceville, BP 769, Franceville, Gabon.	mathieu.bourgarel@cirad.fr	Vallo, Peter/F-9650-2014; Nakoune, Emmanuel/W-2710-2019; Drexler, Jan Felix/GMW-5098-2022; Morand, Serge/M-5433-2018; LEROY, Eric M/I-4347-2016; Bourgarel, Mathieu/F-1750-2017	Morand, Serge/0000-0003-3986-7659; LEROY, Eric M/0000-0003-0022-0890; Bourgarel, Mathieu/0000-0001-9774-7669; Drexler, Jan Felix/0000-0002-3509-0232	Global Viral Forecasting, a "Fonds de Solidarite Prioritaire" grant from the Ministere des Affaires Etrangeres de la France (FSP); government of Gabon; Total-Fina-Elf Gabon; Ministere des Affaires Etrangeres de la France; BONFOR intramural program at the University of Bonn;  [2002005700]	Global Viral Forecasting, a "Fonds de Solidarite Prioritaire" grant from the Ministere des Affaires Etrangeres de la France (FSP); government of Gabon; Total-Fina-Elf Gabon; Ministere des Affaires Etrangeres de la France; BONFOR intramural program at the University of Bonn; 	This work was supported by Global Viral Forecasting, a "Fonds de Solidarite Prioritaire'' grant from the Ministere des Affaires Etrangeres de la France (FSP no 2002005700). CIRMF is supported by the government of Gabon, Total-Fina-Elf Gabon, and the Ministere des Affaires Etrangeres de la France. T.D. Dallo received a personal scholarship from the BONFOR intramural program at the University of Bonn. This study was also made possible by the generous support of the American people through the United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida FC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-281; BICKHAM JW, 1995, J HERED, V86, P140, DOI 10.1093/oxfordjournals.jhered.a111544; Bickham JW, 2004, MOL PHYLOGENET EVOL, V33, P333, DOI 10.1016/j.ympev.2004.06.012; Bordes F, 2008, OECOLOGIA, V158, P109, DOI 10.1007/s00442-008-1115-x; Bordes Frederic, 2011, Infect Ecol Epidemiol, V1, DOI 10.3402/iee.v1i0.7346; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Canuti M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029140; Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0; CWYNAR LC, 1987, AM NAT, V129, P463, DOI 10.1086/284651; Luna LKD, 2007, J CLIN MICROBIOL, V45, P1049, DOI 10.1128/JCM.02426-06; Dobson AP, 2005, SCIENCE, V310, P628, DOI 10.1126/science.1120872; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Drexler JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006367; Dzikwi AA, 2010, J WILDLIFE DIS, V46, P267, DOI 10.7589/0090-3558-46.1.267; Esona MD, 2010, EMERG INFECT DIS, V16, P1844, DOI 10.3201/eid1612.101089; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fortin MJ, 2005, OIKOS, V108, P7, DOI 10.1111/j.0030-1299.2005.13146.x; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Gaston KJ, 1998, PHILOS T R SOC B, V353, P219, DOI 10.1098/rstb.1998.0204; Guegan JF, 1996, PARASITOL TODAY, V12, P367, DOI 10.1016/0169-4758(96)10054-5; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hayman DTS, 2012, EPIDEMIOL INFECT, V140, P2163, DOI 10.1017/S0950268812000167; Hayman DTS, 2008, EMERG INFECT DIS, V14, P926, DOI 10.3201/eid1406.071421; Hayman DTS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011978; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; Hochberg ME, 1999, ECOGRAPHY, V22, P268, DOI 10.1111/j.1600-0587.1999.tb00502.x; Holt RD, 2003, EVOL ECOL RES, V5, P159; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; IUCN, 2012, IUCN RED LIST THREAT; Janoska M, 2011, VET J, V189, P118, DOI 10.1016/j.tvjl.2010.06.020; KALUNDA M, 1986, AM J TROP MED HYG, V35, P387, DOI 10.4269/ajtmh.1986.35.387; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; KEMP GE, 1988, B SOC PATHOL EXOT, V81, P40; KEMP GE, 1975, B WORLD HEALTH ORGAN, V52, P615; Konstantinov O. K., 2006, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P34; Kunz T.H., 2009, ECOLOGICAL BEHAV MET; Kuzmin IV, 2008, J CLIN MICROBIOL, V46, P1451, DOI 10.1128/JCM.00016-08; Kuzmin IV, 2010, EMERG INFECT DIS, V16, P352, DOI 10.3201/eid1602.091269; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Lindenfors P, 2007, GLOBAL ECOL BIOGEOGR, V16, P496, DOI 10.1111/j.1466-8238.2006.00301.x; Luis AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2753; Maganga GD, 2011, J INFECT DIS, V204, pS800, DOI 10.1093/infdis/jir358; Markotter W, 2008, VIRUS RES, V135, P10, DOI 10.1016/j.virusres.2008.02.001; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Messenger SL, 2003, BAT ECOLOGY, P622; Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206; Muller MA, 2007, EMERG INFECT DIS, V13, P1367, DOI 10.3201/eid1309.070342; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patterson BD, 2008, PARASITOL RES, V103, P1091, DOI 10.1007/s00436-008-1097-y; Pfefferle S, 2009, EMERG INFECT DIS, V15, P1377, DOI 10.3201/eid1509.090224; Pourrut X, 2007, J INFECT DIS, V196, pS176, DOI 10.1086/520541; Pourrut X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-159; Quan PL, 2010, MBIO, V1, DOI 10.1128/mBio.00208-10; Razafindratsimandresy R, 2009, J GEN VIROL, V90, P44, DOI 10.1099/vir.0.006825-0; Rector A, 2006, VET MICROBIOL, V117, P267, DOI 10.1016/j.vetmic.2006.06.010; Sakai T, 2003, GENES GENET SYST, V78, P179; Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836; Swanepoel R, 2007, EMERG INFECT DIS, V13, P1847, DOI 10.3201/eid1312.071115; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Tong SX, 2009, EMERG INFECT DIS, V15, P482, DOI 10.3201/eid1503.081013; Torres J, 2006, BIODIVERS CONSERV, V15, P4619, DOI 10.1007/s10531-005-5824-8; Towner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000764; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Turmelle AS, 2009, ECOHEALTH, V6, P522, DOI 10.1007/s10393-009-0263-8; Wang LF, 2006, EMERG INFECT DIS, V12, P1834; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; Wright E, 2010, VIROLOGY, V408, P183, DOI 10.1016/j.virol.2010.09.014	69	26	27	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100172	10.1371/journal.pone.0100172	http://dx.doi.org/10.1371/journal.pone.0100172			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959855	Green Published, gold			2022-12-25	WOS:000338633900024
J	Chen, J; Pan, HN; Chen, C; Wu, W; Iskandar, K; He, J; Piermartiri, T; Jacobowitz, DM; Yu, QS; McDonough, JH; Greig, NH; Marini, AM				Chen, Jun; Pan, Hongna; Chen, Cynthia; Wu, Wei; Iskandar, Kevin; He, Jeffrey; Piermartiri, Tetsade; Jacobowitz, David M.; Yu, Qian-Sheng; McDonough, John H.; Greig, Nigel H.; Marini, Ann M.			(-)-Phenserine Attenuates Soman-Induced Neuropathology	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; SUBWAY SARIN ATTACK; POSTTRAUMATIC-STRESS-DISORDER; ORGANOPHOSPHORUS NERVE AGENTS; ALZHEIMERS-DISEASE; INDUCED SEIZURES; ACETYLCHOLINESTERASE INHIBITION; CHOLINESTERASE-INHIBITORS; TRANSCRIPTION FACTOR; NEURONAL SURVIVAL	Organophosphorus (OP) nerve agents are deadly chemical weapons that pose an alarming threat to military and civilian populations. The irreversible inhibition of the critical cholinergic degradative enzyme acetylcholinesterase (AChE) by OP nerve agents leads to cholinergic crisis. Resulting excessive synaptic acetylcholine levels leads to status epilepticus that, in turn, results in brain damage. Current countermeasures are only modestly effective in protecting against OP-induced brain damage, supporting interest for evaluation of new ones. (-)-Phenserine is a reversible AChE inhibitor possessing neuroprotective and amyloid precursor protein lowering actions that reached Phase III clinical trials for Alzheimer's Disease where it exhibited a wide safety margin. This compound preferentially enters the CNS and has potential to impede soman binding to the active site of AChE to, thereby, serve in a protective capacity. Herein, we demonstrate that (-)-phenserine protects neurons against soman-induced neuronal cell death in rats when administered either as a pretreatment or post-treatment paradigm, improves motoric movement in soman-exposed animals and reduces mortality when given as a pretreatment. Gene expression analysis, undertaken to elucidate mechanism, showed that (-)-phenserine pretreatment increased select neuroprotective genes and reversed a Homer1expression elevation induced by soman exposure. These studies suggest that (-)-phenserine warrants further evaluation as an OP nerve agent protective strategy.	[Chen, Jun; Pan, Hongna; Chen, Cynthia; Wu, Wei; Iskandar, Kevin; He, Jeffrey; Piermartiri, Tetsade; Marini, Ann M.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Jacobowitz, David M.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Yu, Qian-Sheng; Greig, Nigel H.] NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [McDonough, John H.] US Army Med Res Inst Chem Def, Pharmacol Branch, Div Res, Aberdeen Proving Ground, MD USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); United States Department of Defense; United States Army	Marini, AM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA.	ann.marini@usuhs.edu	McDonough, John/AAJ-9213-2021	Piermartiri, Tetsade/0000-0002-9773-6983	Defense Threat Reduction Agency-Joint Science and Technology Office, Medical ST Division [CBM.NEURO.01.10.US.012, CBM.NEURO.01.10.US.019]; Intramural Research Program, National Institute on Aging, National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000311] Funding Source: NIH RePORTER	Defense Threat Reduction Agency-Joint Science and Technology Office, Medical ST Division(United States Department of DefenseDefense Threat Reduction Agency); Intramural Research Program, National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Defense Threat Reduction Agency-Joint Science and Technology Office, Medical S&T Division [Grant Numbers CBM.NEURO.01.10.US.012 and CBM.NEURO.01.10.US.019] (AMM); Intramural Research Program, National Institute on Aging, National Institutes of Health (NHG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jafari AA, 1998, BIOCHEM BIOPH RES CO, V248, P180, DOI 10.1006/bbrc.1998.8931; Albuquerquet EX, 2006, P NATL ACAD SCI USA, V103, P13220, DOI 10.1073/pnas.0605370103; Alkondon M, 2009, J PHARMACOL EXP THER, V328, P69, DOI 10.1124/jpet.108.146068; ASTHANA S, 1995, CLIN PHARMACOL THER, V58, P299, DOI 10.1016/0009-9236(95)90246-5; Bajgar J, 1991, Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove, V34, P5; Bajgar J, 2004, INHAL TOXICOL, V16, P497, DOI 10.1080/08958370490442430; Bajgar J, 2004, ADV CLIN CHEM, V38, P151, DOI 10.1016/S0065-2423(04)38006-6; Bajgar Jiri, 2005, Acta Medica (Hradec Kralove), V48, P3; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Becker RE, 2013, ALZHEIMERS DEMENT, V9, P50, DOI 10.1016/j.jalz.2012.01.007; Brown MA, 1998, J APPL TOXICOL, V18, P393, DOI 10.1002/(SICI)1099-1263(199811/12)18:6<393::AID-JAT528>3.0.CO;2-0; Buckley NA, 2004, J TOXICOL-CLIN TOXIC, V42, P113, DOI 10.1081/CLT-120028756; Carpentier P, 2008, TOXICOLOGY, V253, P97, DOI 10.1016/j.tox.2008.08.016; Chen J, 2011, DOSE-RESPONSE, V9, P416, DOI 10.2203/dose-response.10-041.Marini; Chen Y, 2012, NEUROTOXICOLOGY, V33, P391, DOI 10.1016/j.neuro.2012.03.011; Cho Y, 2012, ENVIRON TOXICOL PHAR, V33, P1, DOI 10.1016/j.etap.2011.10.002; Darreh-Shori T, 2014, J ALZHEIMERS DIS, V39, P423, DOI 10.3233/JAD-130845; Darvesh S, 2003, NAT REV NEUROSCI, V4, P131, DOI 10.1038/nrn1035; de la Monte SM, 2003, LAB INVEST, V83, P287, DOI 10.1097/01.LAB.0000056995.07053.C0; Dijkmans TF, 2009, BRAIN RES, V1249, P19, DOI 10.1016/j.brainres.2008.10.050; Dillman JF, 2009, CHEM RES TOXICOL, V22, P633, DOI 10.1021/tx800466v; Dolgin E, 2013, NAT MED, V19, P1194, DOI 10.1038/nm1013-1194; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.2005.11.027; Fritsch B, 2009, NEUROSCIENCE, V163, P415, DOI 10.1016/j.neuroscience.2009.06.034; Geerts H, 2005, BRAIN RES, V1033, P186, DOI 10.1016/j.brainres.2004.11.042; Grahn H., 2004, SE90182 UMEA SWED DE; Greig NH, 2005, P NATL ACAD SCI USA, V102, P17213, DOI 10.1073/pnas.0508575102; Greig NH, 2000, ACTA NEUROL SCAND, V102, P74, DOI 10.1034/j.1600-0404.2000.00311.x; GREIG NH, 1995, MED RES REV, V15, P3, DOI 10.1002/med.2610150103; Greig Nigel H., 2005, Current Alzheimer Research, V2, P483, DOI 10.2174/156720505774330564; Greig Nigel H., 2005, Current Alzheimer Research, V2, P281, DOI 10.2174/1567205054367829; GRUNWALD J, 1994, LIFE SCI, V54, P991, DOI 10.1016/0024-3205(94)00501-X; Ikushima S, 1997, P NATL ACAD SCI USA, V94, P2609, DOI 10.1073/pnas.94.6.2609; ISAACS KR, 1994, EXP BRAIN RES, V99, P34; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Johnson EA, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-41; Joosen MJA, 2011, ARCH TOXICOL, V85, P227, DOI 10.1007/s00204-010-0571-3; Joosen MJA, 2009, NEUROTOXICOLOGY, V30, P72, DOI 10.1016/j.neuro.2008.11.010; Junghans D, 2004, DEVELOPMENT, V131, P4425, DOI 10.1242/dev.01313; Kadir A, 2008, ANN NEUROL, V63, P621, DOI 10.1002/ana.21345; Kassa J, 2001, Acta Medica (Hradec Kralove), V44, P21; Khan S, 2004, BRAIN RES, V1016, P48, DOI 10.1016/j.brainres.2004.04.062; Kuijpers M, 2010, J NEUROIMMUNOL, V229, P73, DOI 10.1016/j.jneuroim.2010.07.004; Lahiri DK, 2007, J PHARMACOL EXP THER, V320, P386, DOI 10.1124/jpet.106.112102; LALLEMENT G, 1991, BRAIN RES, V563, P234, DOI 10.1016/0006-8993(91)91539-D; Lallement G, 1997, FUNDAM CLIN PHARM, V11, P387, DOI 10.1111/j.1472-8206.1997.tb00200.x; Lilja AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058752; Lilja AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054887; Maccecchini ML, 2012, J NEUROL NEUROSUR PS, V83, P894, DOI 10.1136/jnnp-2012-302589; Marutle A, 2007, P NATL ACAD SCI USA, V104, P12506, DOI 10.1073/pnas.0705346104; MCDONOUGH JH, 1986, NEUROBEH TOXICOL TER, V8, P179; McDonough JH, 1997, NEUROSCI BIOBEHAV R, V21, P559, DOI 10.1016/S0149-7634(96)00050-4; MCDONOUGH JH, 1993, NEUROSCI BIOBEHAV R, V17, P203, DOI 10.1016/S0149-7634(05)80151-4; Midorikawa R, 2006, CELL, V125, P371, DOI 10.1016/j.cell.2006.02.039; Mikkilineni S, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/142372; Miyaki K, 2005, J OCCUP HEALTH, V47, P299, DOI 10.1539/joh.47.299; MORITA H, 1995, LANCET, V346, P290; Morris MA, 2004, CURR MOL MED, V4, P431, DOI 10.2174/1566524043360609; Myers TM, 2011, NEUROTOXICOLOGY, V32, P342, DOI 10.1016/j.neuro.2011.03.001; Myhrer T, 2005, NEUROTOXICOLOGY, V26, P39, DOI 10.1016/j.neuro.2004.07.011; Ness JM, 2008, J NEUROSCI RES, V86, P1115, DOI 10.1002/jnr.21573; Newmark J, 2007, NEUROLOGIST, V13, P20, DOI 10.1097/01.nrl.0000252923.04894.53; Nishiwaki Y, 2001, ENVIRON HEALTH PERSP, V109, P1169, DOI 10.2307/3454865; Okumura T, 1996, ANN EMERG MED, V28, P129, DOI 10.1016/S0196-0644(96)70052-5; Pan HN, 2012, NEUROTOXICOLOGY, V33, P1219, DOI 10.1016/j.neuro.2012.07.001; Romano J A Jr, 2001, Mil Med, V166, P21; Schultz MK, 2012, TOXICOL APPL PHARM, V259, P376, DOI 10.1016/j.taap.2012.01.017; Shaw KTY, 2001, P NATL ACAD SCI USA, V98, P7605, DOI 10.1073/pnas.131152998; Shih TM, 1999, PHARMACOL BIOCHEM BE, V64, P147, DOI 10.1016/S0091-3057(99)00114-8; Shih TM, 2003, TOXICOL APPL PHARM, V188, P69, DOI 10.1016/S0041-008X(03)00019-X; Shih TM, 2010, CHEM-BIOL INTERACT, V187, P207, DOI 10.1016/j.cbi.2010.03.006; Shin JN, 2009, EXP CELL RES, V315, P2249, DOI 10.1016/j.yexcr.2009.04.004; Speer RE, 2013, FREE RADICAL BIO MED, V62, P26, DOI 10.1016/j.freeradbiomed.2013.01.026; Tan YW, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-48; Taylor DM, 2013, J NEUROSCI, V33, P2313, DOI 10.1523/JNEUROSCI.4965-11.2013; Tonduli LS, 2001, NEUROTOXICOLOGY, V22, P29, DOI 10.1016/S0161-813X(00)00015-2; U.S. Department of Health and Human Services Food and Drug Administration. Center for Drug Evaluation and Research (CDER), GUID IND EST MAX STA; Wang Y, 2013, CHEM-BIOL INTERACT, V203, P120, DOI 10.1016/j.cbi.2012.10.016; Winblad B, 2010, J ALZHEIMERS DIS, V22, P1201, DOI 10.3233/JAD-2010-101311; WONG ML, 1995, NEUROREPORT, V6, P1785, DOI 10.1097/00001756-199509000-00019; Wu XM, 2012, J MOL NEUROSCI, V47, P357, DOI 10.1007/s12031-012-9761-1; Yamasue H, 2003, P NATL ACAD SCI USA, V100, P9039, DOI 10.1073/pnas.1530467100; Yamasue H, 2007, ANN NEUROL, V61, P37, DOI 10.1002/ana.21024; Yokoyama K, 1998, ARCH ENVIRON HEALTH, V53, P249, DOI 10.1080/00039899809605705; Yu Qian-sheng, 2013, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V12, P117; Yu QS, 1997, J MED CHEM, V40, P2895, DOI 10.1021/jm970210v; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zhao Y, 2007, ACTA PHARMACOL SIN, V28, P273, DOI 10.1111/j.1745-7254.2007.00486.x	88	11	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99818	10.1371/journal.pone.0099818	http://dx.doi.org/10.1371/journal.pone.0099818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955574	gold, Green Submitted, Green Published			2022-12-25	WOS:000338917900019
J	Lai, WF; Jung, HS				Lai, Wing-Fu; Jung, Han-Sung			Cell Transfection with a beta-Cyclodextrin-PEI-Propane1,2,3-Triol Nanopolymer	PLOS ONE			English	Article							CHITOSAN-GRAFT-POLYETHYLENIMINE; NONVIRAL GENE DELIVERY; NUCLEIC-ACID DELIVERY; LOW-MOLECULAR-WEIGHT; BETA-CYCLODEXTRIN; IN-VITRO; BRANCHED POLYETHYLENIMINE; ABSORPTION ENHANCER; DERIVATIVES; VECTOR	Successful gene therapy necessitates safe and efficient gene transfer. This article describes the use of a cationic polymer, which was synthesized by cross-linking low molecular weight branched poly(ethylenimine) (PEI) with both beta-cyclodextrin and propane-1,2,3-triol, for efficient and safe non-viral gene delivery. Experimentation demonstrated that the polymer had a pH buffering capacity and DNA condensing ability comparable to those of PEI 25 kDa. In B16-F0 cells, the polymer increased the transfection efficiency of naked DNA by 700-fold and yielded better transfection efficiencies than Fugene HD (threefold higher) and PEI 25 kDa (fivefold higher). The high transfection efficiency of the polymer was not affected by the presence of serum during transfection. In addition to B16-F0 cells, the polymer enabled efficient transfection of HepG2 and U87 cells with low cytotoxicity. Our results indicated that our polymer is a safe and efficient transfection reagent that warrants further development for in vitro, in vivo and clinical applications.	[Lai, Wing-Fu; Jung, Han-Sung] Yonsei Univ, PLUS Project BK21, Div Anat & Dev Biol, Dept Oral Biol,Oral Sci Res Ctr,Coll Dent, Seoul 120749, South Korea; [Jung, Han-Sung] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China	Yonsei University; Yonsei University Health System; University of Hong Kong	Jung, HS (corresponding author), Yonsei Univ, PLUS Project BK21, Div Anat & Dev Biol, Dept Oral Biol,Oral Sci Res Ctr,Coll Dent, Seoul 120749, South Korea.	hsjung@yuhs.ac	Lai, Wing-Fu/J-3170-2015; Jung, Han-Sung/I-3848-2012	Lai, Wing-Fu/0000-0003-0585-6396; Jung, Han-Sung/0000-0003-2795-531X	National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology (MEST), Republic of Korea [2012M3A9B4028738]	National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology (MEST), Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This work was supported by a grant for the Bio and Medical Technology Development Program (2012M3A9B4028738) funded by the National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology (MEST), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner A, 2002, GENE THER, V9, P1700, DOI 10.1038/sj.gt.3301839; Bandyopadhyay P, 1999, J BIOL CHEM, V274, P10163, DOI 10.1074/jbc.274.15.10163; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Creusat G, 2008, CHEMBIOCHEM, V9, P2787, DOI 10.1002/cbic.200800540; Diaz-Alvarez AE, 2011, CHEM COMMUN, V47, P6208, DOI 10.1039/c1cc10620a; Dong W, 2006, ACTA BIOCH BIOPH SIN, V38, P780, DOI 10.1111/j.1745-7270.2006.00220.x; Fischer D, 1999, PHARMACEUT RES, V16, P1273, DOI 10.1023/A:1014861900478; FORMOSO C, 1973, BIOCHEM BIOPH RES CO, V50, P999, DOI 10.1016/0006-291X(73)91505-2; Forrest ML, 2005, BIOTECHNOL BIOENG, V89, P416, DOI 10.1002/bit.20356; Godbey WT, 1999, J BIOMED MATER RES, V45, P268, DOI 10.1002/(SICI)1097-4636(19990605)45:3<268::AID-JBM15>3.0.CO;2-Q; Gosselin MA, 2001, BIOCONJUGATE CHEM, V12, P989, DOI 10.1021/bc0100455; Grosse S, 2008, J CONTROL RELEASE, V132, P105, DOI 10.1016/j.jconrel.2008.08.018; Hwang SJ, 2001, BIOCONJUGATE CHEM, V12, P280, DOI 10.1021/bc0001084; Jiang HL, 2007, GENE THER, V14, P1389, DOI 10.1038/sj.gt.3302997; Jiang HL, 2007, J CONTROL RELEASE, V117, P273, DOI 10.1016/j.jconrel.2006.10.025; Lai WF, 2011, RECENT PAT NANOMED, V1, P7; Lai WF, 2010, J MAT SCI ENG, V4, P34; Lai WF, 2014, BIOMATERIALS, V35, P401, DOI 10.1016/j.biomaterials.2013.09.061; Lai WF, 2011, EXPERT REV MED DEVIC, V8, P173, DOI [10.1586/erd.10.83, 10.1586/ERD.10.83]; Lai WF, 2009, J CONTROL RELEASE, V134, P158, DOI 10.1016/j.jconrel.2008.11.021; LEE RJ, 1995, BBA-BIOMEMBRANES, V1233, P134, DOI 10.1016/0005-2736(94)00235-H; Li S, 1999, GENE THER, V6, P585, DOI 10.1038/sj.gt.3300865; Liu Y, 2009, POLYMER, V50, P3895, DOI 10.1016/j.polymer.2009.06.043; Martins PS, 2006, INT J PHARM, V325, P39, DOI 10.1016/j.ijpharm.2006.06.014; Neu M, 2005, J GENE MED, V7, P992, DOI 10.1002/jgm.773; Ng SSM, 2007, J NATL CANCER I, V99, P936, DOI 10.1093/jnci/djm011; Pun SH, 2004, BIOCONJUGATE CHEM, V15, P831, DOI 10.1021/bc049891g; Rashidzadeh H, 1998, ANAL CHEM, V70, P131, DOI 10.1021/ac970568z; Redenti E, 2001, ADV DRUG DELIVER REV, V53, P235, DOI 10.1016/S0169-409X(01)00230-7; SCHIPPER NGM, 1993, BRIT J PHARMACOL, V110, P1335, DOI 10.1111/j.1476-5381.1993.tb13965.x; Yang CA, 2007, BIOMATERIALS, V28, P3245, DOI 10.1016/j.biomaterials.2007.03.033; Yao H, 2009, BIOMATERIALS, V30, P5793, DOI 10.1016/j.biomaterials.2009.06.051; Zou SM, 2000, J GENE MED, V2, P128, DOI 10.1002/(SICI)1521-2254(200003/04)2:2<128::AID-JGM95>3.0.CO;2-W	33	15	16	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100258	10.1371/journal.pone.0100258	http://dx.doi.org/10.1371/journal.pone.0100258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956480	gold, Green Submitted, Green Published			2022-12-25	WOS:000338917900036
J	Houghton, C				Houghton, Conor			Supervised Learning with Complex Spikes and Spike-Timing-Dependent Plasticity	PLOS ONE			English	Article							CEREBELLAR PURKINJE-CELLS; LONG-TERM DEPRESSION; PARALLEL FIBER SYNAPSES; SYNAPTIC PLASTICITY; CLIMBING FIBERS; MOTOR CONTROL; MOSSY FIBER; OLIVOCEREBELLAR SYSTEM; HIPPOCAMPAL-NEURONS; ACTION-POTENTIALS	One distinctive feature of Purkinje cells is that they have two types of discharge: in addition to simple spikes they fire complex spikes in response to input from the climbing fibers. These complex spikes have an initial rapid burst of spikes and spikelets followed by a sustained depolarization; in some models of cerebellar function this climbing fiber input supervises learning in Purkinje cells. On the other hand, synaptic plasticity is often thought to rely on the timing of pre-synaptic and post-synaptic spikes. It is suggested here that the period of depolarization following a complex spike, combined with a simple spike-timing-dependent plasticity rule, gives a mechanism for the climbing fiber to supervise learning in the Purkinje cell. This proposal is illustrated using a simple simulation in which it is seen that the climbing fiber succeeds in supervising the learning.	Univ Bristol, Dept Comp Sci, Bristol, Avon, England	University of Bristol	Houghton, C (corresponding author), Univ Bristol, Dept Comp Sci, Bristol, Avon, England.	conor.houghton@bristol.ac.uk	Houghton, Conor/H-3793-2014	Houghton, Conor/0000-0001-5017-9473	James S. McDonnell Foundation	James S. McDonnell Foundation	The author is grateful to the James S. McDonnell Foundation for financial support through a Scholar Award in Human Cognition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; Bell C, 1997, BRAIN BEHAV EVOLUT, V50, P17, DOI 10.1159/000113352; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; BELL CC, 1969, J NEUROPHYSIOL, V32, P1044, DOI 10.1152/jn.1969.32.6.1044; BENEDETTI F, 1984, EXP BRAIN RES, V55, P368; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Blakemore SJ, 2001, NEUROREPORT, V12, P3741, DOI 10.1097/00001756-200112040-00027; Brown IE, 2001, J COMP NEUROL, V429, P59, DOI 10.1002/1096-9861(20000101)429:1<59::AID-CNE5>3.0.CO;2-3; Brown S., 1892, BRAIN, V15, P250; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/j.neuron.2004.08.023; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Cerminara NL, 2004, J NEUROSCI, V24, P4510, DOI 10.1523/JNEUROSCI.4530-03.2004; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Clopath Claudia, 2010, Front Synaptic Neurosci, V2, P25, DOI 10.3389/fnsyn.2010.00025; COLIN F, 1980, BRAIN RES, V187, P3, DOI 10.1016/0006-8993(80)90491-6; D'Angelo E, 2009, TRENDS NEUROSCI, V32, P30, DOI 10.1016/j.tins.2008.09.007; Davie JT, 2008, J NEUROSCI, V28, P7599, DOI 10.1523/JNEUROSCI.0559-08.2008; Dean P, 2010, NAT REV NEUROSCI, V11, P30, DOI 10.1038/nrn2756; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DIENER HC, 1992, MOVEMENT DISORD, V7, P95, DOI 10.1002/mds.870070202; Dow RS, 1942, J NEUROPHYSIOL, V5, P363, DOI 10.1152/jn.1942.5.5.363; Dow RS, 1991, CLIN NEUROLOGY, V3, P34; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; ECCLES JC, 1966, J PHYSIOL-LONDON, V182, P268, DOI 10.1113/jphysiol.1966.sp007824; EKEROT CF, 1989, NEUROSCI RES, V6, P264, DOI 10.1016/0168-0102(89)90065-5; EKEROT CF, 1985, BRAIN RES, V342, P357, DOI 10.1016/0006-8993(85)91136-9; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Flourens P, 1825, RECHERCHES EXPT PROP; FRITH C. D., 1992, COGNITIVE NEUROPSYCH; Frith CD, 2000, PHILOS T R SOC B, V355, P1771, DOI 10.1098/rstb.2000.0734; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; FUJITA M, 1982, BIOL CYBERN, V45, P195, DOI 10.1007/BF00336192; FUJITA Y, 1968, J NEUROPHYSIOL, V31, P131, DOI 10.1152/jn.1968.31.2.131; Gao JH, 1996, SCIENCE, V272, P545, DOI 10.1126/science.272.5261.545; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; GILBERT PFC, 1977, BRAIN RES, V128, P309, DOI 10.1016/0006-8993(77)90997-0; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Holmes G, 1917, BRAIN, V40, P461, DOI 10.1093/brain/40.4.461; HOUNSGAARD J, 1979, EXP BRAIN RES, V37, P387; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1971, BRAIN RES, V31, P215, DOI 10.1016/0006-8993(71)90648-2; Ito M, 1984, CEREBELLUM NEURAL CO; Jacob V, 2007, J NEUROSCI, V27, P1271, DOI 10.1523/JNEUROSCI.4264-06.2007; Kampa BM, 2007, TRENDS NEUROSCI, V30, P456, DOI 10.1016/j.tins.2007.06.010; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; Kempter R, 1999, PHYS REV E, V59, P4498, DOI 10.1103/PhysRevE.59.4498; Kitazawa S, 1998, NATURE, V392, P494, DOI 10.1038/33141; LLINAS R, 1968, SCIENCE, V160, P1132, DOI 10.1126/science.160.3832.1132; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Markram H, 1995, SOC NEUR, V21; Markram Henry, 2011, Front Synaptic Neurosci, V3, P4, DOI 10.3389/fnsyn.2011.00004; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Mauk MD, 1998, NEURON, V20, P359, DOI 10.1016/S0896-6273(00)80978-2; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; MONTAROLO PG, 1982, J PHYSIOL-LONDON, V332, P187, DOI 10.1113/jphysiol.1982.sp014409; Palay S.L., 1974, CEREBELLAR CORTEX; Rancz EA, 2007, NATURE, V450, P1245, DOI 10.1038/nature05995; REKATE HL, 1985, ARCH NEUROL-CHICAGO, V42, P697, DOI 10.1001/archneur.1985.04060070091023; Russell J.S.R., 1894, PHILOS T R SOC LON B, V185, P819; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; SHIDARA M, 1993, NATURE, V365, P50, DOI 10.1038/365050a0; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; Sjostrom J., 2010, SCHOLARPEDIA, V5, P1362, DOI [10.4249/scholarpedia.1362, DOI 10.4249/SCHOLARPEDIA.1362]; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song S, 2001, NEURON, V32, P339, DOI 10.1016/S0896-6273(01)00451-2; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; Voogd J, 1998, TRENDS NEUROSCI, V21, P370, DOI 10.1016/S0166-2236(98)01318-6; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; WELSH JP, 1995, NATURE, V374, P453, DOI 10.1038/374453a0; Wolpert DM, 1997, TRENDS COGN SCI, V1, P209, DOI 10.1016/S1364-6613(97)01070-X; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	79	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99635	10.1371/journal.pone.0099635	http://dx.doi.org/10.1371/journal.pone.0099635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945786	Green Submitted, Green Published, gold			2022-12-25	WOS:000340721500025
J	Kastrati, I; Canestrari, E; Frasor, J				Kastrati, I.; Canestrari, E.; Frasor, J.			PHLDA1 expression is controlled by an estrogen receptor-NF kappa B-miR-181 regulatory loop and is essential for formation of ER plus mammospheres	ONCOGENE			English	Article							CANCER STEM-CELLS; NF-KAPPA-B; RESISTANT BREAST-CANCER; IN-VITRO PROPAGATION; PROINFLAMMATORY CYTOKINES; RECEPTOR; METASTASIS; SURVIVAL; ACTIVATION; INHIBITOR	Crosstalk between estrogen receptor (ER) and the inflammatory nuclear factor kappa B (NF kappa B) pathway in ER+ breast cancers may contribute to a more aggressive phenotype. Pleckstrin Homology-Like Domain, Family A, member 1 (PHLDA1), a target gene of ER-NF kappa B crosstalk, has been implicated in cell survival and stem cell properties. 17 beta-estradiol (E2), acting through ER alpha, and pro-inflammatory cytokines, acting through NF kappa B, increase the nascent transcript and PHLDA1 messenger RNA stability, indicating both transcriptional and post-transcriptional control of PHLDA1 expression. We show that PHLDA1 is a direct target of miR-181 and that mature miR-181a and b, as well as their host gene, are synergistically downregulated by E2 and tumor necrosis factor a, also in an ER-and NF kappa B-dependent manner. Thus, ER and NF kappa B work together to upregulate PHLDA1 directly through enhanced transcription and indirectly through repression of miR-181a and b. Previous studies have suggested that PHLDA1 may be a stem cell marker in the human intestine that contributes to tumorigenesis. Our findings that PHLDA1 is upregulated in mammospheres (MS) of ER+ breast cancer cells and that PHLDA1 knockdown impairs both MS formation and the expansion of aldehyde dehydrogenase (ALDH)-positive population, suggest that PHLDA1 may play a similar role in breast cancer cells. Upregulation of PHLDA1 in MS is largely dependent on the NF kappa B pathway, with downregulated miR-181 expression a contributing factor. Over-expression of miR-181 phenocopied PHLDA1 knockdown and significantly impaired MS formation, which was reversed, in part, by protection of the PHLDA1 3' untranslated region (UTR) or overexpression of PHLDA1 lacking the 3' UTR. Furthermore, we find that elevated PHLDA1 expression is associated with a higher risk of distant metastasis in ER+ breast cancer patients. Altogether, these data suggest that high PHLDA1 expression is controlled through an ER-NF kappa B-miR-181 regulatory axis and may contribute to a poor clinical outcome in patients with ER+ breast tumors by enhancing stem-like properties in these tumors.	[Kastrati, I.; Canestrari, E.; Frasor, J.] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Frasor, J (corresponding author), Univ Illinois, Dept Physiol & Biophys, 835 S Wolcott,E202 MSB,MC901, Chicago, IL 60612 USA.	jfrasor@uic.edu	Kastrati, Irida/L-4641-2019	Kastrati, Irida/0000-0002-8086-1411	National Institute of Health [R01 CA130932-05]; University of Illinois at Chicago through the Chancellor's Discovery Fund; Susan G Komen for the Cure [PDF12229484]; NATIONAL CANCER INSTITUTE [R01CA130932] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois at Chicago through the Chancellor's Discovery Fund; Susan G Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Shuangping Zhao, Bryant Marure and Tuan-Ahn Tran for technical assistance. We are grateful for the financial support provided by the National Institute of Health (R01 CA130932-05 to JF), the University of Illinois at Chicago through the Chancellor's Discovery Fund (JF), and by a postdoctoral fellowship grant from Susan G Komen for the Cure to IK (PDF12229484).	Baumgarten SC, 2012, MOL ENDOCRINOL, V26, P360, DOI 10.1210/me.2011-1302; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bisso A, 2013, CELL CYCLE, V12, P1679, DOI 10.4161/cc.24757; Bridge G, 2012, BLOOD, V120, P5063, DOI 10.1182/blood-2012-04-423004; Cao YX, 2007, P NATL ACAD SCI USA, V104, P15852, DOI 10.1073/pnas.0706728104; Charafe-Jauffret E, 2008, PATHOBIOLOGY, V75, P75, DOI 10.1159/000123845; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Cormier Catherine Y., 2011, Journal of Structural and Functional Genomics, V12, P55, DOI 10.1007/s10969-011-9100-8; Cormier CY, 2010, NUCLEIC ACIDS RES, V38, pD743, DOI 10.1093/nar/gkp999; Croker AK, 2008, J CELL MOL MED, V12, P374, DOI 10.1111/j.1582-4934.2007.00211.x; deGraffenried LA, 2004, ANN ONCOL, V15, P885, DOI 10.1093/annonc/mdh232; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Frasor J, 2009, CANCER RES, V69, P8918, DOI 10.1158/0008-5472.CAN-09-2608; Frasor J, 2008, ENDOCRINOLOGY, V149, P6272, DOI 10.1210/en.2008-0352; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Johnson EO, 2011, J CELL SCI, V124, P2711, DOI 10.1242/jcs.084970; Jones RL, 2011, J CLIN PATHOL, V64, P130, DOI 10.1136/jcp.2010.082966; Kim K, 2013, HORM CANCER-US, V4, P78, DOI 10.1007/s12672-012-0129-3; Knauss JL, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00163; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lobry C, 2014, BLOOD, V123, P2451, DOI 10.1182/blood-2013-08-355818; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Makino K, 2013, J INVEST DERMATOL, V133, P110, DOI 10.1038/jid.2012.252; Meier-Noorden M, 2004, GENE, V338, P197, DOI 10.1016/j.gene.2004.05.006; Murohashi M, 2010, BRIT J CANCER, V102, P206, DOI 10.1038/sj.bjc.6605468; Neel JC, 2013, CELL SIGNAL, V25, P1556, DOI 10.1016/j.cellsig.2013.03.013; O'Brien CS, 2009, J MAMMARY GLAND BIOL, V14, P45, DOI 10.1007/s10911-009-9115-y; Ouyang YB, 2012, MITOCHONDRION, V12, P213, DOI 10.1016/j.mito.2011.09.001; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Pradhan M, 2012, MOL CELL BIOL, V32, P569, DOI 10.1128/MCB.05869-11; Pradhan M, 2010, J BIOL CHEM, V285, P31100, DOI 10.1074/jbc.M110.155309; Riggins RB, 2005, MOL CANCER THER, V4, P33; Sakthianandeswaren A, 2011, CANCER RES, V71, P3709, DOI 10.1158/0008-5472.CAN-10-2342; Seiler CY, 2014, NUCLEIC ACIDS RES, V42, pD1253, DOI 10.1093/nar/gkt1060; Stanculescu Adina, 2010, Hormones & Cancer, V1, P127, DOI 10.1007/s12672-010-0018-6; Taylor MA, 2013, J CLIN INVEST, V123, P150, DOI 10.1172/JCI64946; Thorner AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013073; Toyoshima Y, 2004, J BIOL CHEM, V279, P25898, DOI 10.1074/jbc.M400661200; Van Laere S, 2010, CANCER-AM CANCER SOC, V116, P2794, DOI 10.1002/cncr.25180; Velasco-Velazquez MA, 2011, AM J PATHOL, V179, P2, DOI 10.1016/j.ajpath.2011.03.005; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Zhou YM, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-59; Zhou YM, 2005, INT J BIOCHEM CELL B, V37, P1130, DOI 10.1016/j.biocel.2004.09.006	50	41	42	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 30	2015	34	18					2309	2316		10.1038/onc.2014.180	http://dx.doi.org/10.1038/onc.2014.180			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CH2AH	24954507	Green Accepted			2022-12-25	WOS:000353824800004
J	Kimura, Y; Kawawaki, J; Kakiyama, Y; Shimoda, A; Tanaka, K				Kimura, Yoko; Kawawaki, Junko; Kakiyama, Yukie; Shimoda, Ayumi; Tanaka, Keiji			The ESCRT-III Adaptor Protein Bro1 Controls Functions of Regulator for Free Ubiquitin Chains 1 (Rfu1) in Ubiquitin Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOA4 DEUBIQUITINATING ENZYME; MULTIVESICULAR BODY PATHWAY; SACCHAROMYCES-CEREVISIAE; ENDOCYTIC PATHWAY; HIGH-TEMPERATURES; STRUCTURAL BASIS; MVB PATHWAY; IN-VIVO; YEAST; ALIX	Yeast Rfu1 (regulator for free ubiquitin chain 1) localizes to endosomes and plays a role in ubiquitin homeostasis by inhibiting the activity of Doa4. We show that Bro1, a member of the class E vacuolar protein sorting proteins that recruits Doa4 to endosomes and stimulates Doa4 deubiquitinating activity, also recruits Rfu1 to endosomes for involvement in ubiquitin homeostasis. This recruitment was mediated by the direct interaction between a region containing the YPEL motif in Rfu1 and the V domain in Bro1, which could be analogous to the interaction between the mammalian Alix V domain and YPXnL motifs of viral and cellular proteins. Furthermore, overexpression of Bro1, particularly the V domain, prevented Rfu1 degradation in response to heat shock. Thus, Bro1, a Doa4 positive regulator, regulated Rfu1, a negative regulator of Doa4. Rfu1 degradation partly involved the proteasome and a ubiquitin ligase Rsp5, suggesting that Rfu1 stability was regulated by ubiquitin-proteasome pathways.	[Kimura, Yoko; Kawawaki, Junko; Kakiyama, Yukie; Shimoda, Ayumi; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1138613, Japan; [Kimura, Yoko] Shizuoka Univ, Grad Sch Agr, Dept Appl Biol Chem, Shizuoka 4228529, Japan	Tokyo Metropolitan Institute of Medical Science; Shizuoka University	Kimura, Y (corresponding author), Shizuoka Univ, Grad Sch Agr, Dept Appl Biol Chem, Shizuoka 4228529, Japan.	kimura.yoko@shizuoka.ac.jp	Kimura, Yoko/E-6845-2013	Kimura, Yoko/0000-0002-3054-9753	Takeda Science Foundation; Grants-in-Aid for Scientific Research [26000014] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aids for Scientific Research (C) (to Y. K.), Specially Promoted Research, Scientific Research on Innovative Areas (to Y. K.), and the Takeda Science Foundation (to K. T.).	Amerik A, 2006, J CELL BIOL, V175, P825, DOI 10.1083/jcb.200605134; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Amerik AY, 1997, EMBO J, V16, P4826; Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Anderson C, 2005, J NEUROCHEM, V95, P724, DOI 10.1111/j.1471-4159.2005.03409.x; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; Clague MJ, 2012, DEV CELL, V23, P457, DOI 10.1016/j.devcel.2012.08.011; Dores MR, 2012, J CELL BIOL, V197, P407, DOI 10.1083/jcb.201110031; Dowlatshahi DP, 2012, DEV CELL, V23, P1247, DOI 10.1016/j.devcel.2012.10.023; Dupre S, 2001, MOL CELL BIOL, V21, P4482, DOI 10.1128/MCB.21.14.4482-4494.2001; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Keren-Kaplan T, 2013, EMBO J, V32, P538, DOI 10.1038/emboj.2013.4; Kim JW, 2005, DEV CELL, V8, P937, DOI 10.1016/j.devcel.2005.04.001; Kimata Y, 1997, BIOCHEM BIOPH RES CO, V232, P69, DOI 10.1006/bbrc.1997.6235; Kimura Y, 2001, GENES CELLS, V6, P887, DOI 10.1046/j.1365-2443.2001.00472.x; Kimura Y, 2010, J BIOCHEM, V147, P793, DOI 10.1093/jb/mvq044; Kimura Y, 2009, CELL, V137, P549, DOI 10.1016/j.cell.2009.02.028; Krsmanovic T, 2004, FEBS LETT, V577, P215, DOI 10.1016/j.febslet.2004.10.006; Lee S, 2007, NAT STRUCT MOL BIOL, V14, P194, DOI 10.1038/nsmb1203; Luhtala N, 2004, J CELL BIOL, V166, P717, DOI 10.1083/jcb.200403139; Nikko E, 2007, EUKARYOT CELL, V6, P1266, DOI 10.1128/EC.00024-07; Nikko E, 2007, TRAFFIC, V8, P566, DOI 10.1111/j.1600-0854.2007.00553.x; Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Pashkova N, 2013, DEV CELL, V25, P520, DOI 10.1016/j.devcel.2013.04.007; Richter C, 2007, EMBO J, V26, P2454, DOI 10.1038/sj.emboj.7601692; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; VANNOCKER S, 1993, J BIOL CHEM, V268, P24766; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wang GL, 2001, MOL CELL BIOL, V21, P3564, DOI 10.1128/MCB.21.10.3564-3575.2001; Wemmer M, 2011, J CELL BIOL, V192, P295, DOI 10.1083/jcb.201007018	41	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21760	21769		10.1074/jbc.M114.550871	http://dx.doi.org/10.1074/jbc.M114.550871			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24962567	Green Published, hybrid			2022-12-25	WOS:000340558300049
J	Friedlander, AM; Caselle, JE; Ballesteros, E; Brown, EK; Turchik, A; Sala, E				Friedlander, Alan M.; Caselle, Jennifer E.; Ballesteros, Enric; Brown, Eric K.; Turchik, Alan; Sala, Enric			The Real Bounty: Marine Biodiversity in the Pitcairn Islands	PLOS ONE			English	Article							HENDERSON ISLAND; ALGAL FLORA; CLIMATE-CHANGE; CORAL-REEFS; PHAEOPHYCEAE; EXTINCTION; FISHES; IMPACT; LIMITS; ATOLL	In 2012 we conducted an integrated ecological assessment of the marine environment of the Pitcairn Islands, which are four of the most remote islands in the world. The islands and atolls (Ducie, Henderson, Oeno, and Pitcairn) are situated in the central South Pacific, halfway between New Zealand and South America. We surveyed algae, corals, mobile invertebrates, and fishes at 97 sites between 5 and 30 m depth, and found 51 new records for algae, 23 for corals, and 15 for fishes. The structure of the ecological communities was correlated with age, isolation, and geomorphology of the four islands. Coral and algal assemblages were significantly different among islands with Ducie having the highest coral cover (56%) and Pitcairn dominated by erect macroalgae (42%). Fish biomass was dominated by top predators at Ducie (62% of total fish biomass) and at Henderson (35%). Herbivorous fishes dominated at Pitcairn, while Oeno showed a balanced fish trophic structure. We found high levels of regional endemism in the fish assemblages across the islands (45%), with the highest level observed at Ducie (56% by number). We conducted the first surveys of the deep habitats around the Pitcairn Islands using drop-cameras at 21 sites from depths of 78 to 1,585 m. We observed 57 fish species from the drop-cams, including rare species such as the false catshark (Pseudotriakis microdon) and several new undescribed species. In addition, we made observations of typically shallow reef sharks and other reef fishes at depths down to 300 m. Our findings highlight the uniqueness and high biodiversity value of the Pitcairn Islands as one of the least impacted in the Pacific, and suggest the need for immediate protection.	[Friedlander, Alan M.; Turchik, Alan; Sala, Enric] Natl Geog Soc, Washington, DC 20036 USA; [Friedlander, Alan M.] Univ Hawaii, Dept Biol, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA; [Caselle, Jennifer E.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Ballesteros, Enric; Sala, Enric] Ctr Estudis Avancats Blanes, Blanes, Spain; [Brown, Eric K.] Natl Pk Serv, Kalaupapa Natl Hist Pk, Kalaupapa, HI USA	National Geographic Society; University of Hawaii System; University of California System; University of California Santa Barbara; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); United States Department of the Interior	Friedlander, AM (corresponding author), Natl Geog Soc, Washington, DC 20036 USA.	alan.friedlander@hawaii.edu			National Geographic; Blancpain; Davidoff Cool Water	National Geographic(National Geographic Society); Blancpain; Davidoff Cool Water	Funding was provided by National Geographic, Blancpain, and Davidoff Cool Water to ES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDER B M, 1983, Brunonia, V6, P73, DOI 10.1071/BRU9830073; Althaus F, 2009, MAR ECOL PROG SER, V397, P279, DOI 10.3354/meps08248; Amoamo M, 2013, TOURISM GEOGR, V15, P107, DOI 10.1080/14616688.2012.699093; Amoamo M, 2011, TOUR PLAN DEV, V8, P1, DOI 10.1080/21568316.2011.554035; Ault JS, 1998, FISH B-NOAA, V96, P395; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Bellwood DR, 2005, ECOL LETT, V8, P643, DOI 10.1111/j.1461-0248.2005.00763.x; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; BENTON TG, 1995, BIOL J LINN SOC, V56, P243, DOI 10.1111/j.1095-8312.1995.tb01088.x; BLAKE SG, 1995, BIOL J LINN SOC, V56, P43, DOI 10.1006/bijl.1995.0053; Brooke Michael, 2010, British Birds, V103, P428; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chassot E, 2010, ECOL LETT, V13, P495, DOI 10.1111/j.1461-0248.2010.01443.x; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Connolly SR, 2003, ECOLOGY, V84, P2178, DOI 10.1890/02-0254; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Denis V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054330; Devine JA, 2006, NATURE, V439, P29, DOI 10.1038/439029a; Friedlander AM, 2013, AQUAT CONSERV, V23, P515, DOI 10.1002/aqc.2333; Friedlander AM, 2010, MAR ECOL PROG SER, V410, P219, DOI 10.3354/meps08634; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Government of Pitcairn, 2013, IMM POL; Graham Nicholas A.J., 2013, P253; Graham NAJ, 2013, BIOSCIENCE, V63, P397, DOI 10.1525/bio.2013.63.5.13; Green R., 1979, SAMPLING DESIGN STAT; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hendry Ian, 2011, BRIT OVERSEAS TERRIT; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Irving R, 2012, MARINE ENV PITCAIRN; IRVING RA, 1995, BIOL J LINN SOC, V56, P309, DOI 10.1111/j.1095-8312.1995.tb01092.x; Irving Robert, 2013, P299; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jerlov N. G., 1976, MARINE OPTICS; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Kingston N, 2009, ENCY ISLANDS, P744; Kirk R. W., 2008, PITCAIRN ISLAND BOUN; Kleypas JA, 1999, AM ZOOL, V39, P146; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Kulbicki M, 2005, CYBIUM, V29, P235; Letourneur Y, 1998, NAGA, V21, P39; Littler D. S., 2003, S PACIFIC REEF PLANT; LITTLER MM, 1985, SCIENCE, V227, P57, DOI 10.1126/science.227.4682.57; Ludwig J. A., 1988, STAT ECOLOGY; Marten GG, 1982, ICLARM C P, V9, P254; Mattio L, 2008, J PHYCOL, V44, P1541, DOI 10.1111/j.1529-8817.2008.00597.x; McArthur RH, 1967, THEORY ISLAND BIOGEO; McClanahan TR, 2011, P NATL ACAD SCI USA, V108, P17230, DOI 10.1073/pnas.1106861108; N'Yeurt ADR, 2007, CRYPTOGAMIE ALGOL, V28, P3; N'Yeurt ADR, 2006, CRYPTOGAMIE ALGOL, V27, P111; N'Yeurt ADR, 2010, CRYPTOGAMIE ALGOL, V31, P3; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Nordhoff CB, 1936, BOUNTY TRILOGY MUTIN; Nunn PD, 2010, GEOMORPHOLOGICAL LANDSCAPES OF THE WORLD, P349, DOI 10.1007/978-90-481-3055-9_36; OKAL EA, 1985, EARTH PLANET SC LETT, V72, P99, DOI 10.1016/0012-821X(85)90120-7; Oldfield S, 1997, J APPL ECOL, V34, P1111, DOI 10.2307/2405225; PANDOLFI JM, 1995, BIOL J LINN SOC, V56, P63, DOI 10.1006/bijl.1995.0054; PAULAY G, 1989, ATOLL RES B, V326, P1, DOI DOI 10.5479/SI.00775630.326.1; Pichon M, 1985, P 5 INT COR REEF C T, V1, P399; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; PREECE RC, 1995, BIOL J LINN SOC, V56, P339, DOI 10.1111/j.1095-8312.1995.tb01095.x; Randall John E., 1999, Atoll Research Bulletin, V461, P1; Randall RE, 2005, REEF SHORE FISHES S; Rooney J, 2010, CORAL REEFS, V29, P361, DOI 10.1007/s00338-010-0596-3; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Sivadas M., 2005, J MARINE BIOL ASS IN, V47, P111; Spencer T., 1989, Atoll Research Bulletin, P1; SPENCER T, 1995, BIOL J LINN SOC, V56, P13, DOI 10.1111/j.1095-8312.1995.tb01076.x; STODDART D R, 1992, Pacific Science, V46, P276; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; ter Braak CJF, 1994, ECOSCIENCE, V1, P127, DOI 10.1080/11956860.1994.11682237; Thomson DP, 2010, CORAL REEFS, V29, P923, DOI 10.1007/s00338-010-0650-1; Thrush SF, 2002, ANNU REV ECOL SYST, V33, P449, DOI 10.1146/annurev.ecolsys.33.010802.150515; Tsuda R. T., 1976, REV ALGOLOGIQUE, V11, P325; Vlaams Instituut voor de Zee (Flanders Marine Institute), 2005, MAR BOUND GEOD; WEISLER MI, 1995, BIOL J LINN SOC, V56, P377, DOI 10.1111/j.1095-8312.1995.tb01099.x; WHATLEY R, 1995, BIOL J LINN SOC, V56, P359, DOI 10.1006/bijl.1995.0072; WHITTAKER JE, 1995, BIOL J LINN SOC, V56, P365; WOODHEAD JD, 1993, EARTH PLANET SC LETT, V116, P81, DOI 10.1016/0012-821X(93)90046-C; Young R. A., 1894, MUTINY BOUNTY STORY; Zar JH, 1999, BIOSTATISTICAL ANAL	82	38	40	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100142	10.1371/journal.pone.0100142	http://dx.doi.org/10.1371/journal.pone.0100142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963808	gold, Green Submitted, Green Published			2022-12-25	WOS:000338709500030
J	Schilder, AJ; Anema, A; Pai, J; Rich, A; Miller, CL; Chan, K; Strathdee, SA; Moore, D; Montaner, JSG; Hogg, RS				Schilder, Arn J.; Anema, Aranka; Pai, Jay; Rich, Ashleigh; Miller, Cari L.; Chan, Keith; Strathdee, Steffanie A.; Moore, David; Montaner, Julio S. G.; Hogg, Robert S.			Association between Childhood Physical Abuse, Unprotected Receptive Anal Intercourse and HIV Infection among Young Men Who Have Sex with Men in Vancouver, Canada	PLOS ONE			English	Article							TRANSMISSION RISK BEHAVIOR; UNITED-STATES; POSITIVE MEN; ANTIRETROVIRAL THERAPY; DOMESTIC VIOLENCE; SUBSTANCE-ABUSE; HEALTH OUTCOMES; BISEXUAL MEN; HISTORY; ADULTS	Introduction: The association between childhood sexual abuse and HIV risk among men who have sex with men (MSM) is well established. However, no studies have examined the potential impact of other forms of childhood maltreatment on HIV incidence in this population. Methods: We explored the impact of child physical abuse (CPA) on HIV seroconversion in a cohort of gay/bisexual men aged 15 to 30 in Vancouver, Canada. Cox proportional hazard models were used, controlling for confounders. Results: Among 287 participants, 211 (73.5%) reported experiencing CPA before the age of 17, and 42 (14.6%) reporting URAI in the past year. After a median of 6.6 years follow-up, 16 (5.8%) participants HIV-seroconverted. In multivariate analysis, CPA was significantly associated with HIV seroconversion (adjusted hazard ratio [AHR] = 4.89, 95% confidence interval (CI): 1.65-14.48), after controlling for potential confounders. Conclusion: Our study uncovered a link between childhood physical violence and HIV incidence. Results highlight an urgent need for screening of young gay and bisexual men for histories of violence, and social and structural supports to prevent HIV transmission in this population.	[Schilder, Arn J.; Anema, Aranka; Pai, Jay; Rich, Ashleigh; Chan, Keith; Strathdee, Steffanie A.; Moore, David; Montaner, Julio S. G.; Hogg, Robert S.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Miller, Cari L.; Hogg, Robert S.] Simon Fraser, Fac Hlth Sci, Burnaby, BC, Canada; [Strathdee, Steffanie A.] Univ Calif San Diego, Dept Med, Div Global Publ Hlth, San Diego, CA 92103 USA; [Moore, David; Montaner, Julio S. G.] Univ British Columbia, Fac Med, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; University of California System; University of California San Diego; University of British Columbia	Hogg, RS (corresponding author), British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	robert_hogg@sfu.ca	Strathdee, Steffanie A/B-9042-2009; Hogg, Robert S/B-2783-2012	Hogg, Robert S/0000-0003-3463-5488; Rich, Ashleigh/0000-0003-3742-7086; Strathdee, Steffanie/0000-0002-7724-691X	Canadian Institutes for Health Research (CIHR); British Columbia Ministry of Health; National Institute of Drug Abuse (NIDA), at the US National Institutes of Health (NIH) [1DP1DA026182]; Canadian Institutes of Health Research (CIHR); International AIDS Society; United Nations AIDS Program; World Health Organization; National Institutes of Health Research-Office of AIDS Research; National Institute of Allergy & Infectious Diseases; United States President's Emergency Plan for AIDS Relief (PEPfAR); UNICEF; University of British Columbia; Simon Fraser University; Providence Health Care; Vancouver Coastal Health Authority; National Institutes of Health; Canadian Institutes of Health Research National Health Research Development Program; Health Canada; Agouron Pharmaceuticals Inc; Boehringer Ingelheim Pharmaceuticals Inc; Bristol-Myers Squibb; GlaxoSmithKline; Merck Frosst Laboratories; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031055, R01DA019829, R01DA036307, R37DA019829] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); British Columbia Ministry of Health; National Institute of Drug Abuse (NIDA), at the US National Institutes of Health (NIH); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); International AIDS Society; United Nations AIDS Program; World Health Organization(World Health Organization); National Institutes of Health Research-Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy & Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States President's Emergency Plan for AIDS Relief (PEPfAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); UNICEF; University of British Columbia; Simon Fraser University; Providence Health Care; Vancouver Coastal Health Authority; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research National Health Research Development Program(Canadian Institutes of Health Research (CIHR)); Health Canada; Agouron Pharmaceuticals Inc; Boehringer Ingelheim Pharmaceuticals Inc(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); Merck Frosst Laboratories; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the Canadian Institutes for Health Research (CIHR). Dr. Julio Montaner is supported by the British Columbia Ministry of Health; through an Avant-Garde Award (No. 1DP1DA026182) from the National Institute of Drug Abuse (NIDA), at the US National Institutes of Health (NIH); and through a KT Award from the Canadian Institutes of Health Research (CIHR). He has also received financial support from the International AIDS Society, United Nations AIDS Program, World Health Organization, National Institutes of Health Research-Office of AIDS Research, National Institute of Allergy & Infectious Diseases, The United States President's Emergency Plan for AIDS Relief (PEPfAR), UNICEF, the University of British Columbia, Simon Fraser University, Providence Health Care and Vancouver Coastal Health Authority. Dr. Robert Hogg has held grants from the National Institutes of Health, Canadian Institutes of Health Research National Health Research Development Program, and Health Canada. He has also received funding from Agouron Pharmaceuticals Inc, Boehringer Ingelheim Pharmaceuticals Inc, Bristol-Myers Squibb, GlaxoSmithKline, and Merck Frosst Laboratories for participating in continued medical education programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Arreola SG, 2009, AM J PUBLIC HEALTH, V99, pS432, DOI 10.2105/AJPH.2008.138925; Beattie N, 2009, J NERV MENT DIS, V197, P56, DOI 10.1097/NMD.0b013e31819273a8; Bensley LS, 2000, AM J PREV MED, V18, P151, DOI 10.1016/S0749-3797(99)00084-7; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Brennan DJ, 2007, AM J PUBLIC HEALTH, V97, P1107, DOI 10.2105/AJPH.2005.071423; Briere J, 2003, CHILD ABUSE NEGLECT, V27, P1205, DOI 10.1016/j.chiabu.2003.09.008; Buckingham ET, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-012-0342-3; Canada PHA, 2009, EST HIV PREV INC CAN; CARBALLODIEGUEZ A, 1995, CHILD ABUSE NEGLECT, V19, P595, DOI 10.1016/0145-2134(95)00018-4; Catania JA, 2008, CHILD ABUSE NEGLECT, V32, P925, DOI 10.1016/j.chiabu.2007.12.010; Cohen M, 2000, AM J PUBLIC HEALTH, V90, P560, DOI 10.2105/AJPH.90.4.560; Corliss HL, 2002, CHILD ABUSE NEGLECT, V26, P1165, DOI 10.1016/S0145-2134(02)00385-X; CUNNINGHAM RN, 1994, CHILD ABUSE NEGLECT, V18, P233, DOI 10.1016/0145-2134(94)90108-2; Currie J, 2010, CHILD MALTREATMENT, V15, P111, DOI 10.1177/1077559509355316; Diaz RM, 1999, HISPANIC J BEHAV SCI, V21, P480, DOI 10.1177/0739986399214007; Dube SR, 2010, PREV CHRONIC DIS, V7; Epstein Michelle A, 2002, Child Maltreat, V7, P210, DOI 10.1177/1077559502007003004; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Fuller-Thomson E, 2012, SUICIDE LIFE-THREAT, V42, P279, DOI 10.1111/j.1943-278X.2012.00089.x; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Greenfield EA, 2001, CHILD ABUSE NEGL, V34, P161; Greenfield EA, 2009, J AGING HEALTH, V21, P943, DOI 10.1177/0898264309343905; Griffing S, 2006, J INTERPERS VIOLENCE, V21, P936, DOI 10.1177/0886260506288938; Grulich AE, 2010, INT J EPIDEMIOL, V39, P1064, DOI 10.1093/ije/dyq101; Hall HI, 2008, JAIDS-J ACQ IMM DEF, V49, P294, DOI 10.1097/QAI.0b013e3181893f17; Hart GJ, 2010, CURR OPIN INFECT DIS, V23, P39, DOI 10.1097/QCO.0b013e328334feb1; Herida M, 2007, EUROSURVEILLANCE EUR, V12; Herrenkohl RC, 2005, CHILD ABUSE NEGLECT, V29, P413, DOI 10.1016/j.chiabu.2005.04.002; Hogg RS, 2001, AIDS, V15, P1321, DOI 10.1097/00002030-200107060-00020; Jacobs RJ, 2010, AIDS CARE, V22, P1204, DOI 10.1080/09540121003615137; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Jinich S, 1998, AIDS BEHAV, V2, P41, DOI DOI 10.1023/A:1022307323744; Jong E, 2010, AIDS, V24, P1387, DOI 10.1097/QAD.0b013e328339d004; Joseph HA, 2011, SEX TRANSM INFECT, V87, P442, DOI 10.1136/sextrans-2011-050010; Kalichman Seth C, 2004, J Child Sex Abus, V13, P1, DOI 10.1300/J070v13n01_01; Lampinen TM, 2005, JAIDS-J ACQ IMM DEF, V40, P242, DOI 10.1097/01.qai.0000168182.14523.d4; Lampinen TM, 2005, CAN MED ASSOC J, V172, P479, DOI 10.1503/cmaj.1031785; Leeb RebeccaT., 2008, CHILD MALTREATMENT; Lenderking WR, 1997, J GEN INTERN MED, V12, P250, DOI 10.1046/j.1525-1497.1997.012004250.x; Levitan RD, 1998, AM J PSYCHIAT, V155, P1746, DOI 10.1176/ajp.155.12.1746; Lima VD, 2007, AIDS, V21, P1175, DOI 10.1097/QAD.0b013e32811ebf57; Liu Y, 2013, SOC PSYCH PSYCH EPID, V48, P357, DOI 10.1007/s00127-012-0554-1; Lloyd S, 2012, AIDS EDUC PREV, V24, P228, DOI 10.1521/aeap.2012.24.3.228; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; McLaughlin KA, 2012, CHILD ABUSE NEGLECT, V36, P645, DOI 10.1016/j.chiabu.2012.07.004; Meade CS, 2009, AIDS BEHAV, V13, P207, DOI 10.1007/s10461-007-9326-4; Milloy MJ, 2012, AIDS PATIENT CARE ST, V26, P60, DOI 10.1089/apc.2011.0169; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V51, P340, DOI 10.1097/QAI.0b013e3181a24b38; Newman PA, 2004, AM J PUBLIC HEALTH, V94, P1998, DOI 10.2105/AJPH.94.11.1998; O'Leary A, 2003, AIDS CARE, V15, P17, DOI 10.1080/0954012021000039725; Paul JP, 2001, CHILD ABUSE NEGLECT, V25, P557, DOI 10.1016/S0145-2134(01)00226-5; Pence BW, 2007, SOUTH MED J, V100, P1114, DOI 10.1097/01.smj.0000286756.54607.9f; Pence BW, 2009, J ANTIMICROB CHEMOTH, V63, P636, DOI 10.1093/jac/dkp006; Purcell DW, 2001, J SUBST ABUSE, V13, P185, DOI 10.1016/S0899-3289(01)00072-4; Roberts AL, 2010, AM J PUBLIC HEALTH, V100, P2433, DOI 10.2105/AJPH.2009.168971; Rocha GM, 2013, AIDS BEHAV      0117, V17; Rodgers CS, 2004, CHILD ABUSE NEGLECT, V28, P575, DOI 10.1016/j.chiabu.2004.01.002; Rosenberg M., 1979, CONCEIVING SELF; Rothman K., 1998, MODERN EPIDEMIOLOGY; Saunders BE, 2003, J INTERPERS VIOLENCE, V18, P356, DOI 10.1177/0886260502250840; Scott KM, 2011, ARCH GEN PSYCHIAT, V68, P838, DOI 10.1001/archgenpsychiatry.2011.77; Seedat S, 2012, CURR HIV-AIDS REP, V9, P344, DOI 10.1007/s11904-012-0139-3; Sikkema KJ, 2007, AIDS BEHAV, V11, P49, DOI 10.1007/s10461-006-9149-8; Strathdee SA, 2000, CAN MED ASSOC J, V162, P21; United States Centres for Disease Control and Prevention (CDC) Adverse Childhood Experiences (ACE) Study, DAT STAT PREV IND AD; Welles SL, 2009, AM J PUBLIC HEALTH, V99, P1079, DOI 10.2105/AJPH.2007.133280; Wolitski RJ, 2011, AIDS BEHAV, V15, pS9, DOI 10.1007/s10461-011-9901-6; Wu NS, 2010, ADDICT BEHAV, V35, P68, DOI 10.1016/j.addbeh.2009.09.003; Zielinski DS, 2009, CHILD ABUSE NEGLECT, V33, P666, DOI 10.1016/j.chiabu.2009.09.001	70	16	17	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100501	10.1371/journal.pone.0100501	http://dx.doi.org/10.1371/journal.pone.0100501			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8WO	24963804	Green Published, gold, Green Submitted			2022-12-25	WOS:000338709500057
J	Xu, S; Xu, WD; Chen, W; He, XY; Huang, YQ; Wen, H				Xu, Sheng; Xu, Wenduo; Chen, Wei; He, Xingyuan; Huang, Yanqing; Wen, Hua			Leaf Phenological Characters of Main Tree Species in Urban Forest of Shenyang	PLOS ONE			English	Article							CANOPY; PLANTS; PHOTOSYNTHESIS; LONGEVITIES; DYNAMICS; GROWTH; CHINA	Background: Plant leaves, as the main photosynthetic organs and the high energy converters among primary producers in terrestrial ecosystems, have attracted significant research attention. Leaf lifespan is an adaptive characteristic formed by plants to obtain the maximum carbon in the long-term adaption process. It determines important functional and structural characteristics exhibited in the environmental adaptation of plants. However, the leaf lifespan and leaf characteristics of urban forests were not studied up to now. Methods: By using statistic, linear regression methods and correlation analysis, leaf phenological characters of main tree species in urban forest of Shenyang were observed for five years to obtain the leafing phenology (including leafing start time, end time, and duration), defoliating phenology (including defoliation start time, end time, and duration), and the leaf lifespan of the main tree species. Moreover, the relationships between temperature and leafing phenology, defoliating phenology, and leaf lifespan were analyzed. Findings: The timing of leafing differed greatly among species. The early leafing species would have relatively early end of leafing; the longer it took to the end of leafing would have a later time of completed leafing. The timing of defoliation among different species varied significantly, the early defoliation species would have relatively longer duration of defoliation. If the mean temperature rise for 1uC in spring, the time of leafing would experience 5 days earlier in spring. If the mean temperature decline for 1 degrees C, the time of defoliation would experience 3 days delay in autumn. Interpretation: There is significant correlation between leaf longevity and the time of leafing and defoliation. According to correlation analysis and regression analysis, there is significant correlation between temperature and leafing and defoliation phenology. Early leafing species would have a longer life span and consequently have advantage on carbon accumulation compared with later defoliation species.	[Xu, Sheng; Xu, Wenduo; Chen, Wei; He, Xingyuan; Huang, Yanqing; Wen, Hua] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	He, XY (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	hexy1962@126.com	huang, yan/GWM-4747-2022		National Natural Science Foundation of China [31270518, 31170573]; Key Project of NNSFC [90411019]; Key Project in the National Science and Technology Pillar Program [2012BAC05B05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of NNSFC; Key Project in the National Science and Technology Pillar Program	The study was supported by National Natural Science Foundation of China (31270518, 31170573), and Key Project of NNSFC (90411019), and Key Project in the National Science and Technology Pillar Program (2012BAC05B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHABOT BF, 1982, ANNU REV ECOL SYST, V13, P229, DOI 10.1146/annurev.es.13.110182.001305; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; [段喜华 Duan Xihua], 2003, [植物研究, Bulletin of Botanical Research], V23, P334; GOWER ST, 1993, TREE PHYSIOL, V12, P327, DOI 10.1093/treephys/12.4.327; Hang Yue-yu, 2004, Acta Botanica Yunnanica, V26, P398; HANNINEN H, 1995, CAN J BOT, V73, P183, DOI 10.1139/b95-022; [何兴元 He Xingyuan], 2003, [生态学杂志, Chinese Journal of Ecology], V22, P162; Hu Jianbo, 2006, Shengtaixue Zazhi, V25, P1455; KIKUZAWA K, 1995, CAN J BOT, V73, P158, DOI 10.1139/b95-019; Kikuzawa K, 1995, VEGETATIO, V121, P89, DOI 10.1007/BF00044675; KIKUZAWA K, 1991, AM NAT, V138, P1250, DOI 10.1086/285281; Kitajima K, 1997, AM J BOT, V84, P702, DOI 10.2307/2445906; Kttppers M, 1984, OECOLOGIA, V64, P332; KULL O, 1995, PLANT CELL ENVIRON, V18, P1174, DOI 10.1111/j.1365-3040.1995.tb00627.x; Li DW, 2011, APPL MECH MATER, V71-78, P2891, DOI 10.4028/www.scientific.net/AMM.71-78.2891; Lin XianQing, 2003, Chinese Journal of Rice Science, V17, P281; Liu Chang-fu, 2008, Yingyong Shengtai Xuebao, V19, P1173; Liu CF, 2012, URBAN FOR URBAN GREE, V11, P121, DOI 10.1016/j.ufug.2011.03.002; Liu J., 2007, J CHANGCHUN U TRADIT, V23, P29; MAILLETTE L, 1982, J APPL ECOL, V19, P203, DOI 10.2307/2403005; McDowell SCL, 2002, AM J BOT, V89, P1431, DOI 10.3732/ajb.89.9.1431; REICH PB, 1992, ECOL MONOGR, V62, P365, DOI 10.2307/2937116; Seiwa K, 1998, J ECOL, V86, P219, DOI 10.1046/j.1365-2745.1998.00245.x; Song L, 2007, J LIAONING TECHNICAL, V26, P136; SUN SC, 1998, ACTA PHYTOECOL SIN, V22, P538; Wan M., 1979, METHOD PHENOLOGY OBS; Wang X., 2000, ACTA PHYTOECOL SIN, V24, P625; Wenduo X., 1983, CHIN B BOTANY, V25, P264; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Xu CY, 2007, OECOLOGIA, V154, P11, DOI 10.1007/s00442-007-0807-y; Xu W., 1985, CHINESE J ECOL, V3, P35; Xu WD, 2005, CHIN J APPL ECOL, V16; Xu WD, 2004, CHIN J APPL ECOL, V14, P2095; Xu Wen-duo, 2008, Shengtaixue Zazhi, V27, P1461; Xu Wenduo, 2006, Yingyong Shengtai Xuebao, V17, P1777; Xu Wenduo, 2006, Yingyong Shengtai Xuebao, V17, P1999; [徐雨晴 Xu Yuqing], 2005, [地理研究, Geographical Research], V24, P412; Yang YF, 2003, CHIN J APPL ECOL, V14, P30; Zhang FC, 1995, ACTA GEOGR SIN, V50, P402; Zhang Lin, 2004, Acta Phytoecologica Sinica, V28, P844; Zhang Ya-jie, 2004, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V30, P269; Zhao JB, 2013, J TROP ECOL, V29, P161, DOI 10.1017/S0266467413000114; Zhu N, 1990, CHIN J PLANT ECOL, V14, P336; [朱旭斌 ZHU XuBin], 2006, [植物生态学报, Acta Phytoecologica Sinica], V30, P25; 谢寿昌, 1997, 生态学报, V17, P51	45	6	6	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99277	10.1371/journal.pone.0099277	http://dx.doi.org/10.1371/journal.pone.0099277			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963625	Green Published, gold, Green Submitted			2022-12-25	WOS:000338709500009
J	Jongbloed, F; de Bruin, RWF; Pennings, JLA; Payan-Gomez, C; van den Engel, S; van Oostrom, CT; de Bruin, A; Hoeijmakers, JHJ; van Steeg, H; IJzermans, JNM; Dolle, MET				Jongbloed, Franny; de Bruin, Ron W. F.; Pennings, Jeroen L. A.; Payan-Gomez, Cesar; van den Engel, Sandra; van Oostrom, Conny T.; de Bruin, Alain; Hoeijmakers, Jan H. J.; van Steeg, Harry; IJzermans, Jan N. M.; Dolle, Martijn E. T.			Preoperative Fasting Protects against Renal Ischemia-Reperfusion Injury in Aged and Overweight Mice	PLOS ONE			English	Article							CALORIC RESTRICTION; ISCHEMIA/REPERFUSION INJURY; KIDNEY-TRANSPLANTATION; DIETARY RESTRICTION; OXIDATIVE STRESS; SUSCEPTIBILITY; MECHANISMS; OUTCOMES; OLDER	Ischemia-reperfusion injury (IRI) is inevitable during kidney transplantation leading to oxidative stress and inflammation. We previously reported that preoperative fasting in young-lean male mice protects against IRI. Since patients are generally of older age with morbidities possibly leading to a different response to fasting, we investigated the effects of preoperative fasting on renal IRI in aged-overweight male and female mice. Male and female F1-FVB/C57BL6-hybrid mice, average age 73 weeks weighing 47.2 grams, were randomized to preoperative ad libitum feeding or 3 days fasting, followed by renal IRI. Body weight, kidney function and survival of the animals were monitored until day 28 postoperatively. Kidney histopathology was scored for all animals and gene expression profiles after fasting were analyzed in kidneys of young and aged male mice. Preoperative fasting significantly improved survival after renal IRI in both sexes compared with normal fed mice. Fasted groups had a better kidney function shown by lower serum urea levels after renal IRI. Histopathology showed less acute tubular necrosis and more regeneration in kidneys from fasted mice. A mRNA analysis indicated the involvement of metabolic processes including fatty acid oxidation and retinol metabolism, and the NRF2-mediated stress response. Similar to young-lean, healthy male mice, preoperative fasting protects against renal IRI in aged-overweight mice of both genders. These findings suggest a general protective response of fasting against renal IRI regardless of age, gender, body weight and genetic background. Therefore, fasting could be a non-invasive intervention inducing increased oxidative stress resistance in older and overweight patients as well.	[Jongbloed, Franny; de Bruin, Ron W. F.; van den Engel, Sandra; IJzermans, Jan N. M.] Erasmus Univ, Med Ctr, Dept Surg, Lab Expt Transplantat & Intestinal Surg, Rotterdam, Netherlands; [Jongbloed, Franny; Pennings, Jeroen L. A.; van Oostrom, Conny T.; van Steeg, Harry; Dolle, Martijn E. T.] Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands; [Payan-Gomez, Cesar; Hoeijmakers, Jan H. J.] Erasmus Univ, Med Ctr, Dept Genet, Rotterdam, Netherlands; [Payan-Gomez, Cesar] Univ Rosario, Fac Ciencias Nat & Matemat, Bogota, Colombia; [de Bruin, Alain] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Dutch Mol Pathol Ctr, Utrecht, Netherlands; [van Steeg, Harry] Leiden Univ, Med Ctr, Dept Toxicogenet, Leiden, Netherlands	Erasmus University Rotterdam; Erasmus MC; Netherlands National Institute for Public Health & the Environment; Erasmus University Rotterdam; Erasmus MC; Universidad del Rosario; Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Dolle, MET (corresponding author), Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands.	Martijn.Dolle@rivm.nl	de Bruin, Alain/AAL-9195-2020; Payan-Gomez, Cesar/G-8589-2016; Hoeijmakers, Jan/AAX-6972-2021	Payan-Gomez, Cesar/0000-0002-0633-1332; de Bruin, Alain/0000-0001-8579-2649; Pennings, Jeroen L.A./0000-0002-9188-6358	National Institute for Public Health and the Environment; Ministry of Health, Welfare and Sport of The Netherlands [S/340005]	National Institute for Public Health and the Environment; Ministry of Health, Welfare and Sport of The Netherlands	This research was funded by a grant from the National Institute for Public Health and the Environment and the Ministry of Health, Welfare and Sport of The Netherlands (S/340005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoh JA, 2013, J TRANSPLANT, V2013, DOI 10.1155/2013/475964; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carrier M, 2012, TRANSPL P, V44, P2227, DOI 10.1016/j.transproceed.2012.07.120; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Cruzen C, 2009, CLIN GERIATR MED, V25, P733, DOI 10.1016/j.cger.2009.07.001; Dolle MET, 2011, PATHOBIOL AGING AGE, V1, DOI 10.3402/pba.v1i0.7219; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Goldstein JL, 2011, COLD SH Q B, V76, P121, DOI 10.1101/sqb.2011.76.010447; Hu HL, 2009, TOHOKU J EXP MED, V218, P325, DOI 10.1620/tjem.218.325; Jaeschke H, 2012, TRANSPLANT REV-ORLAN, V26, P103, DOI 10.1016/j.trre.2011.10.006; Kosieradzki M, 2008, TRANSPL P, V40, P3279, DOI 10.1016/j.transproceed.2008.10.004; Lim WH, 2013, TRANSPLANTATION, V95, P106, DOI 10.1097/TP.0b013e318277b2be; Liu M, 2013, KIDNEY INT; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; MCCAY CM, 1989, NUTRITION, V5, P155; Mitchell JR, 2010, AGING CELL, V9, P40, DOI 10.1111/j.1474-9726.2009.00532.x; Nakagawa S, 2012, AGING CELL, V11, P401, DOI 10.1111/j.1474-9726.2012.00798.x; Pamplona R, 2006, BBA-BIOENERGETICS, V1757, P496, DOI 10.1016/j.bbabio.2006.01.009; Park KM, 2004, J BIOL CHEM, V279, P52282, DOI 10.1074/jbc.M407629200; Port FK, 2002, TRANSPLANTATION, V74, P1281, DOI 10.1097/00007890-200211150-00014; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Rao PS, 2007, TRANSPLANTATION, V83, P1069, DOI 10.1097/01.tp.0000259621.56861.31; Saxena R, 2009, INT UROL NEPHROL, V41, P195, DOI 10.1007/s11255-008-9489-6; Sharif A, 2013, AM J KIDNEY DIS, V62, P150, DOI 10.1053/j.ajkd.2012.11.050; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Spindler SR, 2010, AGEING RES REV, V9, P324, DOI 10.1016/j.arr.2009.10.003; Sykiotis GP, 2011, CURR OPIN CLIN NUTR, V14, P41, DOI 10.1097/MCO.0b013e32834136f2; Tonelli M, 2011, AM J TRANSPLANT, V11, P2093, DOI 10.1111/j.1600-6143.2011.03686.x; van Ginhoven TM, 2010, NUTR RES, V30, P865, DOI 10.1016/j.nutres.2010.09.014; van Ginhoven TM, 2010, TRANSPL INT, V23, P1171, DOI 10.1111/j.1432-2277.2010.01116.x; van Ginhoven TM, 2009, LIVER TRANSPLANT, V15, P1183, DOI 10.1002/lt.21871; Verweij M, 2011, LIVER TRANSPLANT, V17, P695, DOI 10.1002/lt.22243; Yamagishi T, 2010, HEART VESSELS, V25, P417, DOI 10.1007/s00380-009-1222-6; Yu ZF, 1999, J NEUROSCI RES, V57, P830, DOI 10.1002/(SICI)1097-4547(19990915)57:6&lt;830::AID-JNR8&gt;3.0.CO;2-2	35	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100853	10.1371/journal.pone.0100853	http://dx.doi.org/10.1371/journal.pone.0100853			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959849	Green Published, Green Submitted, gold			2022-12-25	WOS:000338633900096
J	Kim, HJ; Kim, HJ; Jeong, JE; Baek, JY; Jeong, J; Kim, S; Kim, YM; Kim, Y; Nam, JH; Huh, SH; Seo, J; Jin, BK; Lee, KJ				Kim, Hee-Jung; Kim, Hyun Jung; Jeong, Jae-Eun; Baek, Jeong Yeob; Jeong, Jaeho; Kim, Sun; Kim, Young-Mee; Kim, Youhwa; Nam, Jin Han; Huh, Sue Hee; Seo, Jawon; Jin, Byung Kwan; Lee, Kong-Joo			N-Terminal Truncated UCH-L1 Prevents Parkinson's Disease Associated Damage	PLOS ONE			English	Article							COMPLEX-I DEFICIENCY; NIGROSTRIATAL DOPAMINERGIC-NEURONS; TRANSLATION START SITES; ALPHA-SYNUCLEIN; POSTTRANSLATIONAL MODIFICATIONS; ANTIOXIDATIVE STRESS; OXIDATIVE STRESS; NULL MICE; PGP 9.5; UBIQUITIN	Ubiquitin C-terminal hydrolase-L1 (UCH-L1) has been proposed as one of the Parkinson's disease (PD) related genes, but the possible molecular connection between UCH-L1 and PD is not well understood. In this study, we discovered an N-terminal 11 amino acid truncated variant UCH-L1 that we called NT-UCH-L1, in mouse brain tissue as well as in NCI-H157 lung cancer and SH-SY5Y neuroblastoma cell lines. In vivo experiments and hydrogen-deuterium exchange (HDX) with tandem mass spectrometry (MS) studies showed that NT-UCH-L1 is readily aggregated and degraded, and has more flexible structure than UCH-L1. Post-translational modifications including monoubiquitination and disulfide crosslinking regulate the stability and cellular localization of NT-UCH-L1, as confirmed by mutational and proteomic studies. Stable expression of NT-UCH-L1 decreases cellular ROS levels and protects cells from H2O2, rotenone and CCCP-induced cell death. NT-UCH-L1-expressing transgenic mice are less susceptible to degeneration of nigrostriatal dopaminergic neurons seen in the MPTP mouse model of PD, in comparison to control animals. These results suggest that NT-UCH-L1 may have the potential to prevent neural damage in diseases like PD.	[Kim, Hee-Jung; Kim, Hyun Jung; Jeong, Jae-Eun; Jeong, Jaeho; Kim, Sun; Kim, Young-Mee; Kim, Youhwa; Seo, Jawon; Lee, Kong-Joo] Ewha Womans Univ, Coll Pharm, Grad Sch Pharmaceut Sci, Seoul, South Korea; [Baek, Jeong Yeob; Nam, Jin Han; Huh, Sue Hee; Jin, Byung Kwan] Kyung Hee Univ, Sch Med, Neurodegenerat Control Res Ctr, Dept Biochem & Mol Biol, Seoul, South Korea	Ewha Womans University; Kyung Hee University	Jin, BK (corresponding author), Kyung Hee Univ, Sch Med, Neurodegenerat Control Res Ctr, Dept Biochem & Mol Biol, Seoul, South Korea.	bkjin@khu.ac.kr; kjl@ewha.ac.kr		Lee, Kong-Joo/0000-0001-7972-6020; Nam, Jinhan/0000-0003-4153-3711	Global Research Lab Program [2012K1A1A2045441]; Proteogenomics Research Program of the National Research Foundation of Korea [2012M3A9B90036680]; Brain Korea 21 project; Ewha Womans University; Basic Science Research Program through the NRF - Ministry of Education, Science, and Technology [20090063274]; Ministry of Education [2013R1A1A2061412]	Global Research Lab Program; Proteogenomics Research Program of the National Research Foundation of Korea(National Research Foundation of Korea); Brain Korea 21 project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Ewha Womans University; Basic Science Research Program through the NRF - Ministry of Education, Science, and Technology(National Research Foundation of Korea); Ministry of Education	This work was supported by the Global Research Lab Program (No. 2012K1A1A2045441), and the Proteogenomics Research Program (No. 2012M3A9B90036680) of the National Research Foundation of Korea. Kim HJ, Kim HJ, Jeong JE, Kim S, Kim YM, Kim Y, and Seo J were supported by the Brain Korea 21 project. Kim HJ was supported by RP-Grant 2010 of Ewha Womans University. This work was also supported by the Basic Science Research Program through the NRF funded by the Ministry of Education, Science, and Technology (Grant 20090063274) and by the Ministry of Education (No. 2013R1A1A2061412. The funder's had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardley HC, 2003, MOL BIOL CELL, V14, P4541, DOI 10.1091/mbc.E03-02-0078; Bazykin GA, 2011, NUCLEIC ACIDS RES, V39, P567, DOI 10.1093/nar/gkq806; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Callio J, 2005, J BIOL CHEM, V280, P18536, DOI 10.1074/jbc.M413224200; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Casarejos MJ, 2006, J NEUROCHEM, V97, P934, DOI 10.1111/j.1471-4159.2006.03777.x; Chung YC, 2011, NEUROPHARMACOLOGY, V60, P963, DOI 10.1016/j.neuropharm.2011.01.043; Chung YC, 2010, J IMMUNOL, V185, P1230, DOI 10.4049/jimmunol.1000208; Cookson MR, 2008, INT J CLIN EXP PATHO, V1, P217; Das C, 2006, P NATL ACAD SCI USA, V103, P4675, DOI 10.1073/pnas.0510403103; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; DAY INM, 1987, FEBS LETT, V210, P157, DOI 10.1016/0014-5793(87)81327-3; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; FORNO LS, 1969, J AM GERIATR SOC, V17, P557, DOI 10.1111/j.1532-5415.1969.tb01316.x; Gandre S, 2003, MITOCHONDRION, V2, P245, DOI 10.1016/S1567-7249(02)00105-8; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hao LY, 2010, P NATL ACAD SCI USA, V107, P9747, DOI 10.1073/pnas.0911175107; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; HEIKKILA R, 1971, SCIENCE, V172, P1257, DOI 10.1126/science.172.3989.1257; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Huh SH, 2011, J IMMUNOL, V187, P960, DOI 10.4049/jimmunol.1100009; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Jeong JH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000513; Kabuta T, 2008, HUM MOL GENET, V17, P1482, DOI 10.1093/hmg/ddn037; Kaipio K, 2005, BIOCHEM BIOPH RES CO, V337, P633, DOI 10.1016/j.bbrc.2005.09.093; Kim HJ, 2009, ONCOGENE, V28, P117, DOI 10.1038/onc.2008.364; Kim MS, 2013, ACTA CRYSTALLOGR D, V69, P669, DOI 10.1107/S0907444913001194; Kochetov AV, 2008, BIOESSAYS, V30, P683, DOI 10.1002/bies.20771; Koharudin LMI, 2010, P NATL ACAD SCI USA, V107, P6835, DOI 10.1073/pnas.1002295107; Lee E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007949; Lee T, 2005, J MOL BIOL, V353, P600, DOI 10.1016/j.jmb.2005.08.029; Leissring MA, 2004, BIOCHEM J, V383, P439, DOI 10.1042/BJ20041081; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Lotharius J, 2000, J BIOL CHEM, V275, P38581, DOI 10.1074/jbc.M005385200; LOWE J, 1990, J PATHOL, V161, P153, DOI 10.1002/path.1711610210; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Meray RK, 2007, J BIOL CHEM, V282, P10567, DOI 10.1074/jbc.M611153200; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Oueslati A, 2010, PROG BRAIN RES, V183, P115, DOI 10.1016/S0079-6123(10)83007-9; Parker WD, 2008, BRAIN RES, V1189, P215, DOI 10.1016/j.brainres.2007.10.061; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Parkkinen L, 2005, NEUROPATHOLOGY, V25, P304, DOI 10.1111/j.1440-1789.2005.00644.x; Perier C, 2003, TRENDS NEUROSCI, V26, P345, DOI 10.1016/S0166-2236(03)00144-9; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Richardson JR, 2005, TOXICOL SCI, V88, P193, DOI 10.1093/toxsci/kfi304; Rosas SLB, 2001, CANCER LETT, V170, P73, DOI 10.1016/S0304-3835(01)00449-9; Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P742, DOI 10.1093/jnen/63.7.742; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Seo J, 2008, J PROTEOME RES, V7, P587, DOI 10.1021/pr700657y; Shim JH, 2011, MITOCHONDRION; SPECTOR A, 1978, P NATL ACAD SCI USA, V75, P3244, DOI 10.1073/pnas.75.7.3244; Sunderland PA, 2004, BIOCHEM SOC T, V32, P614, DOI 10.1042/BST0320614; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200; Tompkins MM, 1997, BRAIN RES, V775, P24, DOI 10.1016/S0006-8993(97)00874-3; Tsika E, 2010, J NEUROSCI, V30, P3409, DOI 10.1523/JNEUROSCI.4977-09.2010; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Wilkinson KD, 1999, J MOL BIOL, V291, P1067; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103	73	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99654	10.1371/journal.pone.0099654	http://dx.doi.org/10.1371/journal.pone.0099654			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959670	Green Published, Green Submitted, gold			2022-12-25	WOS:000338633900013
J	Li, Y; Thompson, CM; Lipsitch, M				Li, Yuan; Thompson, Claudette M.; Lipsitch, Marc			A Modified Janus Cassette (Sweet Janus) to Improve Allelic Replacement Efficiency by High-Stringency Negative Selection in Streptococcus pneumoniae	PLOS ONE			English	Article							SUCROSE SENSITIVITY; GENE; SACB; TRANSFORMATION; EXPRESSION; VARIANTS	The Janus cassette permits marker-free allelic replacement or knockout in streptomycin-resistant Streptococcus pneumoniae (pneumococcus) through sequential positive and negative selection. Spontaneous revertants of Janus can lead to high level of false-positives during negative selection, which necessitate a time-consuming post-selection screening process. We hypothesized that an additional counter-selectable marker in Janus would decrease the revertant frequency and reduce false-positives, since simultaneous reversion of both counter-selectable makers is much less likely. Here we report a modified cassette, Sweet Janus (SJ), in which the sacB gene from Bacillus subtilis conferring sucrose sensitivity is added to Janus. By using streptomycin and sucrose simultaneously as selective agents, the frequency of SJ double revertants was about 10(5)-fold lower than the frequency of Janus revertants. Accordingly, the frequency of false-positives in the SJ-mediated negative selection was about 100-fold lower than what was seen for Janus. Thus, SJ enhances negative selection stringency and can accelerate allelic replacement in pneumococcus, especially when transformation frequency is low due to strain background or suboptimal transformation conditions. Results also suggested the sacB gene alone can function as a counter-selectable marker in the Gram-positive pneumococcus, which will have the advantage of not requiring a streptomycin-resistant strain for allelic replacement.	[Li, Yuan] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Li, Y (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	liyuan@hsph.harvard.edu			United States National Institute of Allergy and Infectious Diseases [5R01AI048935-12]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048935] Funding Source: NIH RePORTER	United States National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by award 5R01AI048935-12 to ML from the United States National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dedonder R, 1966, METHOD ENZYMOL, V8, P6; Evans BA, 2013, ISME J, V7, P791, DOI 10.1038/ismej.2012.170; JAGER W, 1992, J BACTERIOL, V174, P5462; Joloba ML, 2010, INT J ANTIMICROB AG, V36, P124, DOI 10.1016/j.ijantimicag.2010.03.024; Li Y, 2013, INFECT IMMUN, V81, P4519, DOI 10.1128/IAI.00724-13; Li Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002989; Pelicic V, 1996, J BACTERIOL, V178, P1197, DOI 10.1128/jb.178.4.1197-1199.1996; Pozzi G, 1996, J BACTERIOL, V178, P6087, DOI 10.1128/jb.178.20.6087-6090.1996; Reyrat JM, 1998, INFECT IMMUN, V66, P4011; STEINMETZ M, 1983, MOL GEN GENET, V191, P138, DOI 10.1007/BF00330901; Sun XY, 2013, APPL MICROBIOL BIOT, V97, P8629, DOI 10.1007/s00253-013-5058-8; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Trzcinski K, 2003, APPL ENVIRON MICROB, V69, P7364, DOI 10.1128/AEM.69.12.7364-7370.2003; Trzcinski K, 2008, INFECT IMMUN, V76, P2678, DOI 10.1128/IAI.00141-08	14	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100510	10.1371/journal.pone.0100510	http://dx.doi.org/10.1371/journal.pone.0100510			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959661	Green Published, gold, Green Submitted			2022-12-25	WOS:000338633900053
J	Radiloff, D; Zhao, YL; Boico, A; Blueschke, G; Palmer, G; Fontanella, A; Dewhirst, M; Piantadosi, CA; Noveck, R; Irwin, D; Hamilton, K; Klitzman, B; Schroeder, T				Radiloff, Daniel; Zhao, Yulin; Boico, Alina; Blueschke, Gert; Palmer, Gregory; Fontanella, Andrew; Dewhirst, Mark; Piantadosi, Claude A.; Noveck, Robert; Irwin, David; Hamilton, Karyn; Klitzman, Bruce; Schroeder, Thies			Anti-Hypotensive Treatment and Endothelin Blockade Synergistically Antagonize Exercise Fatigue in Rats under Simulated High Altitude	PLOS ONE			English	Article							HYPOXIC PULMONARY VASOCONSTRICTION; BLOOD-FLOW-VELOCITY; CEREBRAL RESISTANCE ARTERIOLES; LIMITING FACTOR; RECEPTOR ANTAGONISM; EPHEDRINE; CAPACITY; AUTOREGULATION; PERFORMANCE; SILDENAFIL	Rapid ascent to high altitude causes illness and fatigue, and there is a demand for effective acute treatments to alleviate such effects. We hypothesized that increased oxygen delivery to the tissue using a combination of a hypertensive agent and an endothelin receptor A antagonist drugs would limit exercise-induced fatigue at simulated high altitude. Our data showed that the combination of 0.1 mg/kg ambrisentan with either 20 mg/kg ephedrine or 10 mg/kg methylphenidate significantly improved exercise duration in rats at simulated altitude of 4,267 m, whereas the individual compounds did not. In normoxic, anesthetized rats, ephedrine alone and in combination with ambrisentan increased heart rate, peripheral blood flow, carotid and pulmonary arterial pressures, breathing rate, and vastus lateralis muscle oxygenation, but under inspired hypoxia, only the combination treatment significantly enhanced muscle oxygenation. Our results suggest that sympathomimetic agents combined with endothelin-A receptor blockers offset altitude-induced fatigue in rats by synergistically increasing the delivery rate of oxygen to hypoxic muscle by concomitantly augmenting perfusion pressure and improving capillary conductance in the skeletal muscle. Our findings might therefore serve as a basis to develop an effective treatment to prevent high-altitude illness and fatigue in humans.	[Radiloff, Daniel; Zhao, Yulin; Boico, Alina; Palmer, Gregory; Fontanella, Andrew; Dewhirst, Mark] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA; [Blueschke, Gert; Klitzman, Bruce] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Piantadosi, Claude A.] Duke Univ, Med Ctr, Dept Pulm Med, Durham, NC USA; [Noveck, Robert] Duke Univ, Med Ctr, Dept Med Clin Pharmacol, Durham, NC USA; [Irwin, David] Univ Colorado Denver, Dept Cardiol, Aurora, CO USA; [Hamilton, Karyn] Colorado State Univ, Dept Hlth & Exercise Sci, Ft Collins, CO 80523 USA; [Schroeder, Thies] Johannes Gutenberg Univ Mainz, Dept Phys Chem, D-55122 Mainz, Germany	Duke University; Duke University; Duke University; Duke University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado State University; Johannes Gutenberg University of Mainz	Schroeder, T (corresponding author), Johannes Gutenberg Univ Mainz, Dept Phys Chem, D-55122 Mainz, Germany.	tschroeder28@gmail.com	Palmer, Gregory M/C-6910-2008; Dewhirst, Mark/Q-1302-2019; Schroeder, Thies/G-5244-2014	Palmer, Gregory M/0000-0003-2955-8297; Dewhirst, Mark/0000-0003-3459-6546; 	U.S. Defense Advanced Research Projects Agency (DARPA) [N66001-10-C-2134]	U.S. Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was funded by the U.S. Defense Advanced Research Projects Agency (DARPA) Prime Award Number N66001-10-C-2134. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie PN, 2007, AM J PHYSIOL-HEART C, V292, pH976, DOI 10.1152/ajpheart.00639.2006; Amann M, 2006, J APPL PHYSIOL, V101, P119, DOI 10.1152/japplphysiol.01596.2005; Anholm JD, 2011, HIGH ALT MED BIOL, V12, P313, DOI 10.1089/ham.2011.1059; Anholm JD, 2011, HIGH ALT MED BIOL, V12, P321, DOI 10.1089/ham.2011.1075; Avois L, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2006.027557; Bada AA, 2012, J PHYSIOL-LONDON, V590, P2051, DOI 10.1113/jphysiol.2011.225334; Barst RJ, 2007, VASC HEALTH RISK MAN, V3, P11; Bartsch P, 2005, J APPL PHYSIOL, V98, P1101, DOI 10.1152/japplphysiol.01167.2004; Bartsch P, 2007, CIRCULATION, V116, P2191, DOI 10.1161/CIRCULATIONAHA.106.650796; Bordeleau R, 1999, CAFFEINE EPHEDRINE T; Buehler PW, 2012, AM J PHYSIOL-LUNG C, V303, pL312, DOI 10.1152/ajplung.00074.2012; Casey DP, 2011, J APPL PHYSIOL, V111, P1527, DOI 10.1152/japplphysiol.00895.2011; Cho SC, 2012, J PSYCHOPHARMACOL, V26, P380, DOI 10.1177/0269881111405356; CUNNINGHAM WL, 1965, J APPL PHYSIOL, V20, P607, DOI 10.1152/jappl.1965.20.4.607; DALY PA, 1993, INT J OBESITY, V17, pS73; de Bisschop C, 2012, J APPL PHYSIOL, V112, P20, DOI 10.1152/japplphysiol.00670.2011; Doi Y, 2002, HISTOL HISTOPATHOL, V17, P97, DOI 10.14670/HH-17.97; Dunnick JK, 2007, TOXICOL PATHOL, V35, P657, DOI 10.1080/01926230701459978; Eccles R, 2007, BRIT J CLIN PHARMACO, V63, P10, DOI 10.1111/j.1365-2125.2006.02833.x; Fernandez N, 1998, EUR J PHARMACOL, V348, P199, DOI 10.1016/S0014-2999(98)00144-7; Fulco CS, 1998, AVIAT SPACE ENVIR MD, V69, P793; Ghofrani HA, 2004, ANN INTERN MED, V141, P169, DOI 10.7326/0003-4819-141-3-200408030-00005; Goerge T, 2002, J MEMBRANE BIOL, V187, P203, DOI 10.1007/s00232-001-0164-4; Hamilton N.B., 2010, FRONT NEUROENERGETIC, V2, DOI 10.3389/fnene.2010.00005; Hanna G, 2013, AM J PHYSIOL-LUNG C, V304, pL86, DOI 10.1152/ajplung.00178.2012; HASSOUN PM, 1992, P SOC EXP BIOL MED, V199, P165; Hergenroder S, 1998, VASA-J VASCULAR DIS, V27, P216; HESTER RL, 1993, AM J PHYSIOL, V265, pH146; Hopkins SR, 2007, J APPL PHYSIOL, V103, P2112, DOI 10.1152/japplphysiol.00306.2007; Irwin DC, 2008, AM J PHYSIOL-HEART C, V295, pH1090, DOI 10.1152/ajpheart.00303.2008; Joyner MJ, 2013, J APPL PHYSL; Kelly JJ, 1999, CLIN EXP PHARMACOL P, V26, P158, DOI 10.1046/j.1440-1681.1999.03011.x; Kobayashi S, 2003, ANESTH ANALG, V97, P1239, DOI 10.1213/01.ANE.0000092917.96558.3C; KUWAHIRA I, 1994, RESP PHYSIOL, V97, P309, DOI 10.1016/0034-5687(94)90067-1; Laughlin M H, 1985, Exerc Sport Sci Rev, V13, P95; LAUGHLIN MH, 1988, J APPL PHYSIOL, V64, P2420, DOI 10.1152/jappl.1988.64.6.2420; Levine BD, 1997, CIRCULATION, V96, P1224, DOI 10.1161/01.CIR.96.4.1224; Liles JT, 2006, J PHARMACOL EXP THER, V316, P95, DOI 10.1124/jpet.105.090035; LOUGEE L, 1990, MICROCIRC ENDOTH LYM, V6, P355; Luks AM, 2010, CONGENIT HEART DIS, V5, P220, DOI 10.1111/j.1747-0803.2010.00415.x; Lundby C, 2008, J APPL PHYSIOL, V105, P581, DOI 10.1152/japplphysiol.90484.2008; Lundby C, 2008, J PHYSIOL-LONDON, V586, P123, DOI 10.1113/jphysiol.2007.146035; Maggiorini M, 2010, PROG CARDIOVASC DIS, V52, P500, DOI 10.1016/j.pcad.2010.03.001; Magkos Faidon, 2004, Sports Med, V34, P871, DOI 10.2165/00007256-200434130-00002; McGoon MD, 2009, CHEST, V135, P122, DOI 10.1378/chest.08-1028; McMahon LR, 2003, DRUG ALCOHOL DEPEN, V70, P255, DOI 10.1016/S0376-8716(03)00011-5; Miller DK, 1998, PSYCHOPHARMACOLOGY, V140, P52; Mitchell D, 2002, MICROVASC RES, V64, P179, DOI 10.1006/mvre.2002.2427; Mortensen SP, 2009, HYPERTENSION, V53, P993, DOI 10.1161/HYPERTENSIONAHA.109.130880; Naeije R, 2010, EUR RESPIR J, V36, P1049, DOI 10.1183/09031936.00024410; Naeije R, 2011, HIGH ALT MED BIOL, V12, P319, DOI 10.1089/ham.2011.1074; Naeije R, 2011, HIGH ALT MED BIOL, V12, P309, DOI 10.1089/ham.2011.1060; Naeije R, 2010, PROG CARDIOVASC DIS, V52, P456, DOI 10.1016/j.pcad.2010.03.004; Osmond JM, 2014, AM J PHYSL HEART CIR; PACE N, 1945, SCIENCE, V102, P589, DOI 10.1126/science.102.2658.589; Patel TR, 1996, EUR J PHARMACOL, V307, P41, DOI 10.1016/0014-2999(96)00188-4; PENTEL P, 1984, JAMA-J AM MED ASSOC, V252, P1898, DOI 10.1001/jama.252.14.1898; PING PP, 1992, AM J PHYSIOL, V263, pH1177, DOI 10.1152/ajpheart.1992.263.4.H1177; Pitman JT, 2012, WILD ENVIRON MED, V23, P374, DOI 10.1016/j.wem.2012.06.006; Powers ME, 2001, J ATHL TRAINING, V36, P420; Prommer E, 2012, AM J HOSP PALLIAT ME, V29, P483, DOI 10.1177/1049909111427029; Querido JS, 2013, J APPL PHYSIOL, V114, P1183, DOI 10.1152/japplphysiol.00024.2013; Radiloff DR, 2012, J APPL PHYSL; Richalet JP, 2005, AM J RESP CRIT CARE, V171, P275, DOI 10.1164/rccm.200406-804OC; Roelands B, 2008, MED SCI SPORT EXER, V40, P879, DOI 10.1249/MSS.0b013e3181659c4d; Rubin LJ, 2012, LIFE SCI, V91, P517, DOI 10.1016/j.lfs.2012.07.033; Scherrer U, 2010, PROG CARDIOVASC DIS, V52, P485, DOI 10.1016/j.pcad.2010.02.004; Shekelle P, 2003, Evid Rep Technol Assess (Summ), P1; Siebenmann C, 2011, HIGH ALT MED BIOL, V12, P169, DOI 10.1089/ham.2010.1075; Spence R, 2008, J CLIN PHARMACOL, V48, P1451, DOI 10.1177/0091270008324180; Spilk S, 2013, AM J PHYSIOL-HEART C, V305, pH1639, DOI 10.1152/ajpheart.00073.2013; Spratt JCS, 2001, BRIT J PHARMACOL, V134, P648, DOI 10.1038/sj.bjp.0704304; Thomas KN, 2010, HIGH ALT MED BIOL, V11, P163, DOI 10.1089/ham.2009.1056; Touzani O, 1997, J CEREBR BLOOD F MET, V17, P1157, DOI 10.1097/00004647-199711000-00004; Umbrello M, 2014, J PHYSL; Varsos GV, 2014, NEUROCRIT CARE, V20, P40, DOI 10.1007/s12028-013-9913-3; Wagenaar GT, 2013, AM J PHYSL LUNG CELL; Wellman PJ, 1998, PSYCHOPHARMACOLOGY, V135, P133, DOI 10.1007/s002130050494; WIXSON SK, 1987, LAB ANIM SCI, V37, P736; Young AJ, 1996, J APPL PHYSIOL, V81, P252, DOI 10.1152/jappl.1996.81.1.252; Zheng ZJ, 2012, XENOBIOTICA, V42, P775, DOI 10.3109/00498254.2012.658884	81	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99309	10.1371/journal.pone.0099309	http://dx.doi.org/10.1371/journal.pone.0099309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960187	Green Published, Green Submitted, gold			2022-12-25	WOS:000338633900004
J	Sepako, E; Glennie, SJ; Jambo, KC; Mzinza, D; Iwajomo, OH; Banda, D; van Oosterhout, JJ; Williams, NA; Gordon, SB; Heyderman, RS				Sepako, Enoch; Glennie, Sarah J.; Jambo, Kondwani C.; Mzinza, David; Iwajomo, Oluwadamilola H.; Banda, Dominic; van Oosterhout, Joep J.; Williams, Neil A.; Gordon, Stephen B.; Heyderman, Robert S.			Incomplete Recovery of Pneumococcal CD4 T Cell Immunity after Initiation of Antiretroviral Therapy in HIV-Infected Malawian Adults	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; POLYFUNCTIONAL CD4(+); BRONCHOALVEOLAR LAVAGE; DISEASE; VACCINE; MEMORY; PNEUMOLYSIN; RESPONSES; CHILDREN; PROTECTION	HIV-infected African adults are at a considerably increased risk of life-threatening invasive pneumococcal disease (IPD) which persists despite antiretroviral therapy (ART). Defects in naturally acquired pneumococcal-specific T-cell immunity have been identified in HIV-infected adults. We have therefore determined the extent and nature of pneumococcal antigenspecific immune recovery following ART. HIV-infected adults were followed up at 3, 6 and 12 months after initiating ART. Nasopharyngeal swabs were cultured to determine carriage rates. Pneumococcal-specific CD4 T-cell immunity was assessed by IFN-gamma ELISpot, proliferation assay, CD154 expression and intracellular cytokine assay. S. pneumoniae colonization was detected in 27% (13/48) of HIV-infected patients prior to ART. The rates remained elevated after 12 months ART, 41% (16/39) (p = 0.17) and significantly higher than in HIV-uninfected individuals (HIVneg 14%(4/29); p = 0.0147). CD4(+) T-cell proliferative responses to pneumococcal antigens increased significantly to levels comparable with HIV-negative individuals at 12 months ART (p = 0.0799). However, recovery of the pneumococcal-specific CD154 expression was incomplete (p = 0.0015) as were IFN-gamma ELISpot responses (p = 0.0040) and polyfunctional CD4(+) T-cell responses (TNF-alpha, IL-2 and IFN-gamma expression) (p = 0.0040) to a pneumolysin-deficient mutant strain. Impaired control of pneumococcal colonisation and incomplete restoration of pneumococcal-specific immunity may explain the persistently higher risk of IPD amongst HIV-infected adults on ART. Whether vaccination and prolonged ART can overcome this immunological defect and reduce the high levels of pneumococcal colonisation requires further evaluation.	[Sepako, Enoch; Glennie, Sarah J.; Jambo, Kondwani C.; Mzinza, David; Iwajomo, Oluwadamilola H.; Banda, Dominic; Heyderman, Robert S.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust, Clin Res Programme, Blantyre, Malawi; [Sepako, Enoch; Jambo, Kondwani C.; Gordon, Stephen B.] Univ Liverpool, Liverpool Sch Trop Med, Resp Infect Grp, Liverpool L3 5QA, Merseyside, England; [van Oosterhout, Joep J.] Dignitas Int Zomba, Zomba, Malawi; [Iwajomo, Oluwadamilola H.] Univ Toronto, Div Clin Sci, Toronto, ON M5S 1A1, Canada; [Glennie, Sarah J.; Iwajomo, Oluwadamilola H.; Williams, Neil A.] Univ Bristol, Bristol, Avon, England	University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of Toronto; University of Bristol	Sepako, E (corresponding author), Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust, Clin Res Programme, Blantyre, Malawi.	enoch.sepako@mopipi.ub.bw		Heyderman, Robert/0000-0003-4573-449X; Mzinza, David/0000-0002-5999-8616; Jambo, Kondwani/0000-0002-3195-2210; Gordon, Stephen/0000-0001-6576-1116	Wellcome Trust (United Kingdom); Liverpool School of Tropical Medicine	Wellcome Trust (United Kingdom)(Wellcome Trust); Liverpool School of Tropical Medicine	The work was supported by a grant to R. S. H from the Wellcome Trust (United Kingdom). E. S. received a PhD studentship from the Liverpool School of Tropical Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; AHDAHL BM, 1995, AM J RESP CRIT CARE, V152, P2000, DOI 10.1164/ajrccm.152.6.8520768; Basset A, 2007, INFECT IMMUN, V75, P5460, DOI 10.1128/IAI.00773-07; Berry AM, 1999, INFECT IMMUN, V67, P981, DOI 10.1128/IAI.67.2.981-985.1999; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P49, DOI 10.1038/mi.2007.5; Cao W, 2009, AIDS RES HUM RETROV, V25, P183, DOI 10.1089/aid.2008.0140; Chattopadhyay PK, 2006, NAT PROTOC, V1, P1, DOI 10.1038/nprot.2006.1; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dworkin MS, 2001, CLIN INFECT DIS, V32, P794, DOI 10.1086/319218; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; French MA, 2007, HIV MED, V8, P148, DOI 10.1111/j.1468-1293.2007.00445.x; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; Gilks CF, 1996, LANCET, V347, P718, DOI 10.1016/S0140-6736(96)90076-8; Glennie SJ, 2013, CLIN INFECT DIS, V56, P291, DOI 10.1093/cid/cis842; Glennie SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025610; Gordon SB, 2002, AIDS, V16, P1409, DOI 10.1097/00002030-200207050-00013; Greenwood B, 1999, PHILOS T R SOC B, V354, P777, DOI 10.1098/rstb.1999.0430; Heffernan RT, 2005, J INFECT DIS, V191, P2038, DOI 10.1086/430356; Iwajomo OH, 2011, J INFECT DIS, V204, P534, DOI 10.1093/infdis/jir316; Jambo KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038628; Jambo KC, 2011, THORAX, V66, P375, DOI 10.1136/thx.2010.153825; Kalsdorf B, 2009, AM J RESP CRIT CARE, V180, P1262, DOI 10.1164/rccm.200907-1011OC; Klugman KP, 2007, CURR OPIN INFECT DIS, V20, P11, DOI 10.1097/QCO.0b013e328012c5f1; Knox KS, 2010, J VIROL, V84, P9010, DOI 10.1128/JVI.01138-10; Lange CG, 2002, CLIN IMMUNOL, V102, P154, DOI 10.1006/clim.2001.5164; Lederman HM, 2003, J INFECT DIS, V188, P1794, DOI 10.1086/379900; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; McEllistrem MC, 2002, J INFECT DIS, V185, P1364, DOI 10.1086/339882; Mureithi MW, 2009, J INFECT DIS, V200, P783, DOI 10.1086/605023; Nunes MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027929; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Pido-Lopez J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002396; Rapola S, 2000, J INFECT DIS, V182, P1146, DOI 10.1086/315822; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Steg SF, 2002, J INFECT DIS, V185, P1401; Sutherland JS, 2010, J IMMUNOL, V184, P6537, DOI 10.4049/jimmunol.1000399; Van Braeckel E, 2013, VACCINE, V31, P3739, DOI 10.1016/j.vaccine.2013.05.021; WHO, 2008, 23 VAL PNEUM POL VAC; Wilkinson KA, 2009, AM J RESP CRIT CARE, V180, P674, DOI 10.1164/rccm.200904-0568OC; Zhang QB, 2007, J INFECT DIS, V195, P1194, DOI 10.1086/512617	44	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100640	10.1371/journal.pone.0100640	http://dx.doi.org/10.1371/journal.pone.0100640			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959834	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000338633900064
J	Zhu, H; Li, DF; Liu, MY; Copie, V; Lei, BF				Zhu, Hui; Li, Dengfeng; Liu, Mengyao; Copie, Valerie; Lei, Benfang			Non-Heme-Binding Domains and Segments of the Staphylococcus aureus IsdB Protein Critically Contribute to the Kinetics and Equilibrium of Heme Acquisition from Methemoglobin	PLOS ONE			English	Article							CELL-SURFACE PROTEIN; HEMOGLOBIN RECEPTOR ISDB; IRON; STREPTOCOCCUS; HTSA; IDENTIFICATION; SHP; MECHANISM; PATHWAY; SYSTEM	The hemoglobin receptor IsdB rapidly acquires heme from methemoglobin (metHb) in the heme acquisition pathway of Staphylococcus aureus. IsdB consists of N-terminal segment (NS), NEAT1 (N1), middle (MD), and heme binding NEAT2 (N2) domains, and C-terminal segment (CS). This study aims to elucidate the roles of these domains or segments in the metHb/IsdB reaction. Deletion of CS does not alter the kinetics and equilibrium of the reaction. Sequential deletions of NS and N1 in NS-N1-MD-N2 progressively reduce heme transfer rates and change the kinetic pattern from one to two phases, but have no effect on the equilibrium of the heme transfer reaction, whereas further deletion of MD reduces the percentage of transferred metHb heme. MD-N2 has higher affinity for heme than N2. MD in trans reduces rates of heme dissociation from holo-N2 and increases the percentage of metHb heme captured by N2 by 4.5 fold. NS-N1-MD and N2, but not NS-N1, MD, and N2, reconstitute the rapid metHb/IsdB reaction. NS-N1-MD-N-IsdC, a fusion protein of NS-N1-MD and the NEAT domain of IsdC, slowly acquires heme from metHb by itself but together with N2 results in rapid heme loss from metHb. Thus, NS-N1 and MD domains specifically and critically contribute to the kinetics and equilibrium of the metHb/IsdB reaction, respectively. These findings support a mechanism of direct heme acquisition by IsdB in which MD enhances the affinity of N2 for heme to thermodynamically drive heme transfer from metHb to IsdB and in which NS is required for the rapid and single phase kinetics of the metHb/IsdB reaction.	[Zhu, Hui; Li, Dengfeng; Liu, Mengyao; Lei, Benfang] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA; [Copie, Valerie] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Zhu, Hui] Harbin Med Univ, Dept Physiol, Harbin, Peoples R China	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Harbin Medical University	Zhu, H (corresponding author), Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA.	dzhuhui@aliyun.com; blei@montana.edu	Copie, Valerie/GPW-9767-2022	Copie, Valerie/0000-0002-2778-1463; Lei, Benfang Lei/0000-0001-8133-6021	National Institutes of Health (NIH) [R01AI095704, AI095704, GM103500-09]; USDA Animal Formula Fund; Montana State University Agricultural Experimental Station; Bureau of Harbin City Science and Technology [2013RFLXJ021]; Heilongjiang Provincial Science and Technology Innovation Team in Higher Education Institutes for Infection and Immunity; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097703, R01AI095704] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA Animal Formula Fund; Montana State University Agricultural Experimental Station; Bureau of Harbin City Science and Technology; Heilongjiang Provincial Science and Technology Innovation Team in Higher Education Institutes for Infection and Immunity; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported in part by National Institutes of Health (NIH) Grants R01AI095704, AI095704, and GM103500-09, USDA Animal Formula Fund, and the Montana State University Agricultural Experimental Station. The work done at Harbin Medical University was supported by grant 2013RFLXJ021 from the Bureau of Harbin City Science and Technology and a grant from Heilongjiang Provincial Science and Technology Innovation Team in Higher Education Institutes for Infection and Immunity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CE, 2009, J BACTERIOL, V191, P2638, DOI 10.1128/JB.01784-08; Andrade MA, 2002, GENOME BIOL, V3; Bates CS, 2003, INFECT IMMUN, V71, P1042, DOI 10.1128/IAI.71.3.1042-1055.2003; Dickson CF, 2014, J BIOL CHEM, V289, P6728, DOI 10.1074/jbc.M113.545566; Eichenbaum Z, 1996, INFECT IMMUN, V64, P5428, DOI 10.1128/IAI.64.12.5428-5429.1996; Fonner BA, 2014, BIOCHEMISTRY; Fonner BA, 2014, BIOMOL NMR ASSIGN, V8, P201, DOI 10.1007/s12104-013-9483-5; Fuhrhop J. H., 1975, PORPHYRINS METALLOPO, P804; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Lei BF, 2003, INFECT IMMUN, V71, P5962, DOI 10.1128/IAI.71.10.5962-5969.2003; Lei BF, 2002, INFECT IMMUN, V70, P4494, DOI 10.1128/IAI.70.8.4494-4500.2002; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Liu MY, 2005, INFECT IMMUN, V73, P5086, DOI 10.1128/IAI.73.8.5086-5092.2005; Lu CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037556; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; Marraffini LA, 2005, J BIOL CHEM, V280, P16263, DOI 10.1074/jbc.M500071200; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Nygaard TK, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-82; Nygaard TK, 2006, J BIOL CHEM, V281, P20761, DOI 10.1074/jbc.M601832200; OTTO BR, 1992, CRIT REV MICROBIOL, V18, P217, DOI 10.3109/10408419209114559; Ouattara M, 2010, MOL MICROBIOL, V78, P739, DOI 10.1111/j.1365-2958.2010.07367.x; Pishchany G, 2014, J INFECT DIS, V209, P1764, DOI 10.1093/infdis/jit817; Ran YC, 2007, J BIOL CHEM, V282, P31380, DOI 10.1074/jbc.M705967200; Ran YC, 2013, BIOCHEMISTRY-US, V52, P6537, DOI 10.1021/bi400965u; Ran YC, 2010, BIOCHEMISTRY-US, V49, P2834, DOI 10.1021/bi901987h; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Spirig T, 2013, J BIOL CHEM, V288, P1065, DOI 10.1074/jbc.M112.419119; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200; Zhu H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-15	32	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100744	10.1371/journal.pone.0100744	http://dx.doi.org/10.1371/journal.pone.0100744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959723	gold, Green Submitted, Green Published			2022-12-25	WOS:000338633900078
J	Jiang, NH; Zhang, GH; Zhang, JJ; Shu, LP; Zhang, W; Long, GQ; Liu, T; Meng, ZG; Chen, JW; Yang, SC				Jiang, Ni-Hao; Zhang, Guang-Hui; Zhang, Jia-Jin; Shu, Li-Ping; Zhang, Wei; Long, Guang-Qiang; Liu, Tao; Meng, Zheng-Gui; Chen, Jun-Wen; Yang, Sheng-Chao			Analysis of the Transcriptome of Erigeron breviscapus Uncovers Putative Scutellarin and Chlorogenic Acids Biosynthetic Genes and Genetic Markers	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; FLAVONOID BIOSYNTHESIS; IDENTIFICATION; PURIFICATION; GENERATION; DATABASE; PROTEIN; HYDROXYCINNAMOYLTRANSFERASE; REGULATOR; ARTICHOKE	Background: Erigeron breviscapus (Vant.) Hand-Mazz. is a famous medicinal plant. Scutellarin and chlorogenic acids are the primary active components in this herb. However, the mechanisms of biosynthesis and regulation for scutellarin and chlorogenic acids in E. breviscapus are considerably unknown. In addition, genomic information of this herb is also unavailable. Principal Findings: Using Illumina sequencing on GAIIx platform, a total of 64,605,972 raw sequencing reads were generated and assembled into 73,092 non-redundant unigenes. Among them, 44,855 unigenes (61.37%) were annotated in the public databases Nr, Swiss-Prot, KEGG, and COG. The transcripts encoding the known enzymes involved in flavonoids and in chlorogenic acids biosynthesis were discovered in the Illumina dataset. Three candidate cytochrome P450 genes were discovered which might encode flavone 6-hydroase converting apigenin to scutellarein. Furthermore, 4 unigenes encoding the homologues of maize P1 (R2R3-MYB transcription factors) were defined, which might regulate the biosynthesis of scutellarin. Additionally, a total of 11,077 simple sequence repeat (SSR) were identified from 9,255 unigenes. Of SSRs, tri-nucleotide motifs were the most abundant motif. Thirty-six primer pairs for SSRs were randomly selected for validation of the amplification and polymorphism. The result revealed that 34 (94.40%) primer pairs were successfully amplified and 19 (52.78%) primer pairs exhibited polymorphisms. Conclusion: Using next generation sequencing (NGS) technology, this study firstly provides abundant genomic data for E. breviscapus. The candidate genes involved in the biosynthesis and transcriptional regulation of scutellarin and chlorogenic acids were obtained in this study. Additionally, a plenty of genetic makers were generated by identification of SSRs, which is a powerful tool for molecular breeding and genetics applications in this herb.	[Jiang, Ni-Hao; Zhang, Guang-Hui; Zhang, Jia-Jin; Zhang, Wei; Long, Guang-Qiang; Liu, Tao; Meng, Zheng-Gui; Chen, Jun-Wen; Yang, Sheng-Chao] Yunnan Agr Univ, Yunnan Res Ctr Good Agr Practice Dominant Chinese, Kunming, Yunnan, Peoples R China; [Shu, Li-Ping] Kunming Univ Sci & Technol, Kunming, Yunnan, Peoples R China	Yunnan Agricultural University; Kunming University of Science & Technology	Chen, JW (corresponding author), Yunnan Agr Univ, Yunnan Res Ctr Good Agr Practice Dominant Chinese, Kunming, Yunnan, Peoples R China.	cjw31412@hotmail.com; shengchaoyang@163.com			National Natural Science Foundation of China [81160499, 81260614]; Yunan Base Construction Project of Technical Industry Actions for TCM Modernization	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunan Base Construction Project of Technical Industry Actions for TCM Modernization	This work was supported by National Natural Science Foundation of China (no. 81160499 and no. 81260614), and Yunan Base Construction Project of Technical Industry Actions for TCM Modernization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 2007, THEOR APPL GENET, V114, P359, DOI 10.1007/s00122-006-0440-x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anzellotti D, 2000, ARCH BIOCHEM BIOPHYS, V382, P161, DOI 10.1006/abbi.2000.2002; Berim A, 2013, J BIOL CHEM, V288, P1795, DOI 10.1074/jbc.M112.420448; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Cardle L, 2000, GENETICS, V156, P847; Comino C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-30; Comino C, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-14; Czemmel S, 2009, PLANT PHYSIOL, V151, P1513, DOI 10.1104/pp.109.142059; [董媛 Dong Yuan], 2010, [中国医药工业杂志, Chinese Journal of Pharmaceuticals], V41, P447; Flora of China Editorial Committee, 1985, FLORA CHINA; Fu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057686; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo JX, 1987, TRADITIONAL PATENT M, V9, P31; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Halbwirth H, 2010, INT J MOL SCI, V11, P595, DOI 10.3390/ijms11020595; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hoffmann L, 2003, J BIOL CHEM, V278, P95, DOI 10.1074/jbc.M209362200; Hong H, 2004, LIFE SCI, V74, P2959, DOI 10.1016/j.lfs.2003.09.074; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kantartzi SK, 2009, GENETICA, V136, P141, DOI 10.1007/s10709-008-9327-x; Latunde-Dada AO, 2001, J BIOL CHEM, V276, P1688, DOI 10.1074/jbc.M006277200; Lee D, 1996, PLANT PHYSIOL, V112, P193, DOI 10.1104/pp.112.1.193; Li Xiao-Bo, 2013, Zhongguo Zhong Yao Za Zhi, V38, P2237; Liu Chun-Xia, 2010, Wuhan Zhiwuxue Yanjiu, V28, P682, DOI 10.3724/SP.J.1142,2010.60682; [刘鹏 LIU Peng], 2006, [第四军医大学学报, Journal of the Fourth Military Medical University], V27, P781; Liu Tao, 2013, Zhongguo Zhong Yao Za Zhi, V38, P2241; Mahesh V, 2007, PLANT MOL BIOL, V64, P145, DOI 10.1007/s11103-007-9141-3; Martens S, 2005, PHYTOCHEMISTRY, V66, P2399, DOI 10.1016/j.phytochem.2005.07.013; Mehrtens F, 2005, PLANT PHYSIOL, V138, P1083, DOI 10.1104/pp.104.058032; Menin B, 2010, PLANT SCI, V179, P338, DOI 10.1016/j.plantsci.2010.06.010; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Nagashima S, 2000, PHYTOCHEMISTRY, V53, P533, DOI 10.1016/S0031-9422(99)00593-2; Nakatsuka T, 2012, J EXP BOT, V63, P6505, DOI 10.1093/jxb/ers306; Niggeweg R, 2004, NAT BIOTECHNOL, V22, P746, DOI 10.1038/nbt966; Noguchi A, 2009, PLANT CELL, V21, P1556, DOI 10.1105/tpc.108.063826; Qu J, 2001, J CHROMATOGR A, V928, P155, DOI 10.1016/S0021-9673(01)01111-6; ROHLF F, 2000, NTSYS NUMERICAL TAXO; Sonnante G, 2010, PLANT PHYSIOL, V153, P1224, DOI 10.1104/pp.109.150144; Spelt C, 2000, PLANT CELL, V12, P1619, DOI 10.1105/tpc.12.9.1619; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Strickler SR, 2012, AM J BOT, V99, P257, DOI 10.3732/ajb.1100292; Sun HD, 2009, PROG CHEM, V21, P77; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Wang S, 2011, NEUROSCIENCE, V185, P150, DOI 10.1016/j.neuroscience.2011.04.005; Wang YF, 2010, CHROMATOGRAPHIA, V71, P845, DOI 10.1365/s10337-010-1540-y; Weir, 1990, GENETIC DATA ANAL ME; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Yang Shengchao, 2010, Zhongguo Zhong Yao Za Zhi, V35, P554; Yang XF, 2003, ACTA PHARMACOL SIN, V24, P1118; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; Yu Hong-Yuan, 2002, Acta Botanica Yunnanica, V24, P115; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang Guang-Hui, 2013, Zhongguo Zhong Yao Za Zhi, V38, P2231; Zhang RW, 1981, ACTA PHARM SIN, V16, P68; Zhang ZF, 2008, J PHARMACEUT BIOMED, V48, P980, DOI 10.1016/j.jpba.2008.06.010	60	18	25	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100357	10.1371/journal.pone.0100357	http://dx.doi.org/10.1371/journal.pone.0100357			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956277	Green Published, Green Submitted, gold			2022-12-25	WOS:000338917900043
J	Natoli, L; Maher, L; Shephard, M; Hengel, B; Tangey, A; Badman, SG; Ward, J; Guy, RJ				Natoli, Lisa; Maher, Lisa; Shephard, Mark; Hengel, Belinda; Tangey, Annie; Badman, Steven G.; Ward, James; Guy, Rebecca J.		TTANGO Investigators	Point-of-Care Testing for Chlamydia and Gonorrhoea: Implications for Clinical Practice	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; REMOTE ABORIGINAL COMMUNITIES; NEISSERIA-GONORRHOEAE; TRACHOMATIS INFECTION; AUSTRALIA; PERFORMANCE; PREVALENCE; MANAGEMENT; PROGRAMS; OUTCOMES	Objectives: Point-of-care (POC) testing for chlamydia (CT) and gonorrhoea (NG) offers a new approach to the diagnosis and management of these sexually transmitted infections (STIs) in remote Australian communities and other similar settings. Diagnosis of STIs in remote communities is typically symptom driven, and for those who are asymptomatic, treatment is generally delayed until specimens can be transported to the reference laboratory, results returned and the patient recalled. The objective of this study was to explore the clinical implications of using CT/NG POC tests in routine clinical care in remote settings. Methods: In-depth qualitative interviews were conducted with a purposively selected group of 18 key informants with a range of sexual health and laboratory expertise. Results: Participants highlighted the potential impact POC testing would have on different stages of the current STI management pathway in remote Aboriginal communities and how the pathway would change. They identified implications for offering a POC test, specimen collection, conducting the POC test, syndromic management of STIs, pelvic inflammatory disease diagnosis and management, interpretation and delivery of POC results, provision of treatment, contact tracing, management of client flow and wait time, and re-testing at 3 months after infection. Conclusions: The introduction of POC testing to improve STI service delivery requires careful consideration of both its advantages and limitations. The findings of this study will inform protocols for the implementation of CT/NG POC testing, and also STI testing and management guidelines.	[Natoli, Lisa; Maher, Lisa; Badman, Steven G.; Guy, Rebecca J.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Natoli, Lisa] Burnet Inst, Melbourne, Vic, Australia; [Hengel, Belinda] Apunipima Cape York Hlth Council, Cairns, Qld, Australia; [Tangey, Annie] Ngaanyatjarra Hlth Serv, Alice Springs, NT, Australia; [Shephard, Mark] Flinders Univ S Australia, Int Ctr Point Of Care Testing, Adelaide, SA 5001, Australia; [Ward, James] Baker IDI, Alice Springs, NT, Australia	University of New South Wales Sydney; Kirby Institute; Burnet Institute; Flinders University South Australia; Baker Heart and Diabetes Institute	Natoli, L (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	lisan@burnet.edu.au	Ward, James/ABD-1439-2020; Whiley, David M/E-8955-2011	Ward, James/0000-0002-2892-4542; Whiley, David M/0000-0001-5969-3161; Maher, Lisa/0000-0001-6020-6519; Badman, Steven G/0000-0003-4222-3176; Hengel, Belinda/0000-0002-3013-7716; Shephard, Mark DS/0000-0002-9181-1874; Anderson, David/0000-0002-9969-3905; Regan, David/0000-0002-2893-0969; Guy, Rebecca/0000-0002-2929-4634; Tangey, Annie/0000-0003-0798-0542	National Health and Medical Research Council (NHMRC) [109902]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	TTANGO is funded by a National Health and Medical Research Council (NHMRC) Project Grant # 109902. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alary M, 2006, SEX TRANSM INFECT, V82, pV29, DOI 10.1136/sti.2006.021865; Allaire A D, 1998, Infect Dis Obstet Gynecol, V6, P116, DOI 10.1002/(SICI)1098-0997(1998)6:3<116::AID-IDOG4>3.0.CO;2-V; [Anonymous], 2011, RAP SYPH TEST TOOLK; Bowden FJ, 2002, MED J AUSTRALIA, V176, P551, DOI 10.5694/j.1326-5377.2002.tb04554.x; Bradshaw N, 2004, FERTIL STERIL, V82, pS15, DOI 10.1016/j.fertnstert.2004.07.043; Cecil JA, 2001, J INFECT DIS, V184, P1216, DOI 10.1086/323662; Centre for Disease Control, 2008, NT GUID MAN SEX TRAN; Communicable Disease Control Directorate, 2006, GUID MAN SEX TRANSM; Dallabetta GA, 1998, SEX TRANSM INFECT, V74, pS1; Fagan P, 2001, VENEREOLOGY, V14, P55; Farley TA, 2003, PREV MED, V36, P502, DOI 10.1016/S0091-7435(02)00058-0; Foundation for Innovative New Diagnostics, 2013, MAL REP DIAGN TESTS; Gaydos CA, 2013, J CLIN MICROBIOL, V51, P1666, DOI 10.1128/JCM.03461-12; Geisler WM, 2008, SEX TRANSM DIS, V35, P119, DOI 10.1097/OLQ.0b013e318151497d; Gibbs L, 2007, AUST NZ J PUBL HEAL, V31, P540, DOI 10.1111/j.1753-6405.2007.00140.x; Goldenberg SM, 2008, CAN J PUBLIC HEALTH, V99, P350, DOI 10.1007/BF03403770; Guy R, 2011, AUSTR SEX HLTH C CAN; Guy R, 2012, SEX HEALTH, V9, P205, DOI 10.1071/SH11074; Guy RJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-485; HOOK EW, 1994, JAMA-J AM MED ASSOC, V272, P867, DOI 10.1001/jama.272.11.867; KATZ BP, 1994, ADOLESCENT PEDIAT G, V7, P147, DOI 10.1016/S0932-8610(19)80118-4; Korenromp EL, 2002, INT J STD AIDS, V13, P91, DOI 10.1258/0956462021924712; Lewis D, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-113; Low N, 2006, SEX TRANSM INFECT, V82, P212, DOI 10.1136/sti.2005.017186; Mayaud P, 2004, SEX TRANSM INFECT, V80, P174, DOI 10.1136/sti.2002.004101; McDonagh P, 2009, SEX HEALTH, V6, P241, DOI 10.1071/SH09025; NACCHO/RACGP, 2012, NAT GUID PREV HLTH A; Oakeshott P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1642; Peeling RW, 2006, SEX TRANSM INFECT, V82, pV1, DOI 10.1136/sti.2006.024265; Peeling RW, 2013, SEX TRANSM INFECT, V89, P115, DOI 10.1136/sextrans-2012-050617; Peeling RW, 2011, SEX TRANSM INFECT, V87, pII28, DOI 10.1136/sti.2010.047647; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Regan DG, 2008, J INFECT DIS, V198, P349, DOI 10.1086/589883; Shephard M, 2013, POINT CARE, V12, P41, DOI 10.1097/POC.0b013e318265f79e; Skov S, 2003, CARPA REFERENCE MANU; SMITH L, 2013, SEX TRANSM INFECT, P89; STI in Gay Men Action Group, 2010, SEX TRANSM INF GUID; STIGMA, 2019, GUID MAN SEX TRANSM; Tabrizi SN, 2013, J CLIN MICROBIOL, V51, P1945, DOI 10.1128/JCM.00806-13; The Royal Australian College of General Practitioners, 2012, GUID PREV ACT GEN PR; van Dommelen L, 2010, SEX TRANSM INFECT, V86, P355, DOI 10.1136/sti.2010.042598; Weinstein SA, 2011, SEX HEALTH, V8, P143, DOI 10.1071/SH10065; Whiley DM, 2012, J ANTIMICROB CHEMOTH, V67, P2059, DOI 10.1093/jac/dks188	43	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100518	10.1371/journal.pone.0100518	http://dx.doi.org/10.1371/journal.pone.0100518			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956111	gold, Green Submitted, Green Published			2022-12-25	WOS:000338917900059
J	Walk, EL; McLaughlin, S; Coad, J; Weed, SA				Walk, Elyse L.; McLaughlin, Sarah; Coad, James; Weed, Scott A.			Use of High Frequency Ultrasound to Monitor Cervical Lymph Node Alterations in Mice	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; FINE-NEEDLE-ASPIRATION; ORAL-CAVITY TUMORS; NECK-CANCER; BREAST-CANCER; HEAD; CARCINOGENESIS; MODEL; MOUSE; ULTRASONOGRAPHY	Cervical lymph node evaluation by clinical ultrasound is a non-invasive procedure used in diagnosing nodal status, and when combined with fine-needle aspiration cytology (FNAC), provides an effective method to assess nodal pathologies. Development of high-frequency ultrasound (HF US) allows real-time monitoring of lymph node alterations in animal models. While HF US is frequently used in animal models of tumor biology, use of HF US for studying cervical lymph nodes alterations associated with murine models of head and neck cancer, or any other model of lymphadenopathy, is lacking. Here we utilize HF US to monitor cervical lymph nodes changes in mice following exposure to the oral cancer-inducing carcinogen 4-nitroquinoline-1-oxide (4-NQO) and in mice with systemic autoimmunity. 4-NQO induces tumors within the mouse oral cavity as early as 19 wks that recapitulate HNSCC. Monitoring of cervical (mandibular) lymph nodes by gray scale and power Doppler sonography revealed changes in lymph node size eight weeks after 4-NQO treatment, prior to tumor formation. 4-NQO causes changes in cervical node blood flow resulting from oral tumor progression. Histological evaluation indicated that the early 4-NQO induced changes in lymph node volume were due to specific hyperproliferation of T-cell enriched zones in the paracortex. We also show that HF US can be used to perform image-guided fine needle aspirate (FNA) biopsies on mice with enlarged mandibular lymph nodes due to genetic mutation of Fas ligand (Fasl). Collectively these studies indicate that HF US is an effective technique for the non-invasive study of cervical lymph node alterations in live mouse models of oral cancer and other mouse models containing cervical lymphadenopathy.	[Walk, Elyse L.; Weed, Scott A.] W Virginia Univ, Dept Neurobiol & Anat, Morgantown, WV 26506 USA; [Coad, James] W Virginia Univ, Dept Pathol, Morgantown, WV 26506 USA; [Walk, Elyse L.; Weed, Scott A.] W Virginia Univ, Program Canc Cell Biol, Morgantown, WV 26506 USA; [McLaughlin, Sarah] W Virginia Univ, Anim Models & Imaging Facil, Morgantown, WV 26506 USA; [Walk, Elyse L.; McLaughlin, Sarah; Weed, Scott A.] W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University; West Virginia University; West Virginia University	Weed, SA (corresponding author), W Virginia Univ, Dept Neurobiol & Anat, Morgantown, WV 26506 USA.	scweed@hsc.wvu.edu		McLaughlin, Sarah/0000-0002-8413-3585; Weed, Scott/0000-0001-7033-9999	West Virginia University, Mary Babb Randolph Cancer Center, Dorothy D. Radford Endowment; Mary Babb Randolph Cancer Center; National Institute of Health [P20 RR016440, P30 RR032138/GM103488, S10 RR026378]; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR032138, S10RR026378, P20RR016440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103488] Funding Source: NIH RePORTER	West Virginia University, Mary Babb Randolph Cancer Center, Dorothy D. Radford Endowment; Mary Babb Randolph Cancer Center; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds from the West Virginia University, Mary Babb Randolph Cancer Center, Dorothy D. Radford Endowment. The West Virginia University Animal Models & Imaging Facility is supported by the Mary Babb Randolph Cancer Center and National Institute of Health grants P20 RR016440, P30 RR032138/GM103488 and S10 RR026378. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja AT, 2008, CANCER IMAGING, V8, P48, DOI 10.1102/1470-7330.2008.0006; Alyas F, 2005, BRIT J RADIOL, V78, P362, DOI 10.1259/bjr/93120352; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Bosisio MR, 2009, ULTRASOUND MED BIOL, V35, P1209, DOI 10.1016/j.ultrasmedbio.2009.02.005; CHANG DB, 1994, AM J ROENTGENOL, V162, P965, DOI 10.2214/ajr.162.4.8141027; Charles RP, 2011, CANCER RES, V71, P3863, DOI 10.1158/0008-5472.CAN-10-4463; Chung MK, 2012, ANN SURG ONCOL, V19, P1595, DOI 10.1245/s10434-011-2154-9; Czeminski R, 2009, CANCER PREV RES, V2, P27, DOI 10.1158/1940-6207.CAPR-08-0147; de Bondt RBJ, 2007, EUR J RADIOL, V64, P266, DOI 10.1016/j.ejrad.2007.02.037; Diallo-Krou E, 2009, ENDOCRINOLOGY, V150, P5181, DOI 10.1210/en.2009-0701; Ehlers S, 2003, J IMMUNOL, V170, P5210, DOI 10.4049/jimmunol.170.10.5210; Greco A, 2011, J BIOMEDICINE BIOTEC, V2012; Hasina R, 2009, CANCER PREV RES, V2, P385, DOI 10.1158/1940-6207.CAPR-08-0211; Jugold M, 2008, EUR RADIOL, V18, P753, DOI 10.1007/s00330-007-0825-5; Kanojia D, 2006, ORAL ONCOL, V42, P655, DOI 10.1016/j.oraloncology.2005.10.013; Kim S, 2009, CLIN EXP OTORHINOLAR, V2, P55, DOI 10.3342/ceo.2009.2.2.55; Kodama T, 2011, CANCER RES, V71, P6957, DOI 10.1158/0008-5472.CAN-11-2389; Lee SY, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-206; Leeman-Neill RJ, 2011, CANCER PREV RES, V4, P230, DOI 10.1158/1940-6207.CAPR-10-0249; LEEMANS CR, 1993, CANCER, V71, P452, DOI 10.1002/1097-0142(19930115)71:2<452::AID-CNCR2820710228>3.0.CO;2-B; Li J, 2012, ORAL ONCOL; Li L, 2013, CANC RES; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055797; Liao LJ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-236; Loveless ME, 2008, J ULTRAS MED, V27, P1699, DOI 10.7863/jum.2008.27.12.1699; Lu SL, 2006, HEAD NECK-J SCI SPEC, V28, P945, DOI 10.1002/hed.20397; Mancini M, 2009, ENDOCRINOLOGY, V150, P4810, DOI 10.1210/en.2009-0417; Ng Shu-Hang, 2006, Chang Gung Med J, V29, P119; Noguti J, 2012, CANCER GENOM PROTEOM, V9, P329; Pezold JC, 2006, ORL-J OTO-RHIN-LARYN, V68, P159, DOI 10.1159/000091324; Qian CN, 2006, CANCER RES, V66, P10365, DOI 10.1158/0008-5472.CAN-06-2977; ROTHS JB, 1984, J EXP MED, V159, P1, DOI 10.1084/jem.159.1.1; Rubaltelli L, 2004, J ULTRAS MED, V23, P829, DOI 10.7863/jum.2004.23.6.829; Sano D, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-32; Sapino A, 2003, BRIT J CANCER, V88, P702, DOI 10.1038/sj.bjc.6600744; Snyder CS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-106; Stoeckli SJ, 2012, HEAD NECK-J SCI SPEC, V34, P469, DOI 10.1002/hed.21764; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Tang XH, 2004, CLIN CANCER RES, V10, P301, DOI 10.1158/1078-0432.CCR-0999-3; Van den Broeck W, 2006, J IMMUNOL METHODS, V312, P12, DOI 10.1016/j.jim.2006.01.022; van Herpen CML, 2005, CLIN CANCER RES, V11, P1899, DOI 10.1158/1078-0432.CCR-04-1524; VANDENBREKEL MWM, 1994, RADIOLOGY, V192, P617, DOI 10.1148/radiology.192.3.8058923; Vered M, 2007, ORAL ONCOL, V43, P999, DOI 10.1016/j.oraloncology.2006.11.007; Vitale-Cross L, 2012, CANCER PREV RES, V5, P562, DOI 10.1158/1940-6207.CAPR-11-0502; Vitale-Cross L, 2009, CANCER PREV RES, V2, P419, DOI 10.1158/1940-6207.CAPR-09-0058; Wilkey JF, 2009, MOL CARCINOGEN, V48, P853, DOI 10.1002/mc.20531; Woolgar JA, 2012, EUROPEAN ARCH OTORHI, P1; Ying M, 2006, RADIOGRAPHY, V12, P105, DOI 10.1016/j.radi.2005.04.004; Yuan B, 1997, ONCOGENE, V15, P1161, DOI 10.1038/sj.onc.1201269; Zagorianakou P, 2005, EUR J GYNAECOL ONCOL, V26, P143; Zenk J, 2005, ANN OTO RHINOL LARYN, V114, P43, DOI 10.1177/000348940511400108; Zhou GL, 2010, CANCER PREV RES, V3, P1493, DOI 10.1158/1940-6207.CAPR-10-0135	52	4	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100185	10.1371/journal.pone.0100185	http://dx.doi.org/10.1371/journal.pone.0100185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955984	Green Submitted, gold, Green Published			2022-12-25	WOS:000338917900031
J	Crane, MM; Clark, IBN; Bakker, E; Smith, S; Swain, PS				Crane, Matthew M.; Clark, Ivan B. N.; Bakker, Elco; Smith, Stewart; Swain, Peter S.			A Microfluidic System for Studying Ageing and Dynamic Single-Cell Responses in Budding Yeast	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; KINASE PATHWAY; DEVICE; NOISE; STRESS; SIGNAL; POLY(DIMETHYLSILOXANE)	Recognition of the importance of cell-to-cell variability in cellular decision-making and a growing interest in stochastic modeling of cellular processes has led to an increased demand for high density, reproducible, single-cell measurements in time-varying surroundings. We present ALCATRAS (A Long-term Culturing And TRApping System), a microfluidic device that can quantitatively monitor up to 1000 cells of budding yeast in a well-defined and controlled environment. Daughter cells are removed by fluid flow to avoid crowding allowing experiments to run for over 60 hours, and the extracellular media may be changed repeatedly and in seconds. We illustrate use of the device by measuring ageing through replicative life span curves, following the dynamics of the cell cycle, and examining history-dependent behaviour in the general stress response.	[Crane, Matthew M.; Clark, Ivan B. N.; Bakker, Elco; Swain, Peter S.] Univ Edinburgh, SynthSys Ctr Synthet & Syst Biol, Edinburgh, Midlothian, Scotland; [Crane, Matthew M.; Clark, Ivan B. N.; Bakker, Elco; Swain, Peter S.] Univ Edinburgh, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Smith, Stewart] Univ Edinburgh, Scottish Microelect Ctr, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Swain, PS (corresponding author), Univ Edinburgh, SynthSys Ctr Synthet & Syst Biol, Edinburgh, Midlothian, Scotland.	peter.swain@ed.ac.uk	Swain, Peter S/AAW-3265-2020; Smith, Stewart/C-1178-2008	Smith, Stewart/0000-0002-7004-9219; Swain, Peter/0000-0001-7489-8587	Biotechnology and Biological Sciences Research Council of the United Kingdom; Scottish University Life Sciences Alliance; Biotechnology and Biological Sciences Research Council [BB/I00906X/1, 1064638] Funding Source: researchfish; BBSRC [BB/I00906X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish University Life Sciences Alliance; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council of the United Kingdom and the Scottish University Life Sciences Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; CHANT J, 1995, J CELL BIOL, V129, P751, DOI 10.1083/jcb.129.3.751; Charvin G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001468; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; Denervaud N, 2013, P NATL ACAD SCI USA, V110, P15842, DOI 10.1073/pnas.1308265110; Di Carlo D, 2006, LAB CHIP, V6, P1445, DOI 10.1039/b605937f; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Edelstein A, 2010, CURR PROTOC MOL BIOL, V92; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Enfors SO, 2001, J BIOTECHNOL, V85, P175, DOI 10.1016/S0168-1656(00)00365-5; Falconnet D, 2011, LAB CHIP, V11, P466, DOI [10.1039/c0lc00228c, 10.1039/c01c00228c]; Fehrmann S, CELL REPORTS, V5, P1589; Gorner W, 2002, EMBO J, V21, P135, DOI 10.1093/emboj/21.1.135; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Hao N, 2013, SCIENCE, V339, P460, DOI 10.1126/science.1227299; Hao N, 2012, NAT STRUCT MOL BIOL, V19, P31, DOI 10.1038/nsmb.2192; Hersen P, 2008, P NATL ACAD SCI USA, V105, P7165, DOI 10.1073/pnas.0710770105; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jacquet M, 2003, J CELL BIOL, V161, P497, DOI 10.1083/jcb.200303030; Lee PJ, 2008, BIOTECHNIQUES, V44, P91, DOI 10.2144/000112673; Lee SS, 2012, P NATL ACAD SCI USA, V109, P4916, DOI 10.1073/pnas.1113505109; McClean MN, 2011, METHODS MOL BIOL, V734, P101, DOI 10.1007/978-1-61779-086-7_6; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Ricicova M, 2013, P NATL ACAD SCI USA, V110, P11403, DOI 10.1073/pnas.1215850110; Ryley J, 2006, YEAST, V23, P1065, DOI 10.1002/yea.1412; Shahrezaei V, 2008, CURR OPIN BIOTECH, V19, P369, DOI 10.1016/j.copbio.2008.06.011; Skelley AM, 2009, NAT METHODS, V6, P147, DOI [10.1038/NMETH.1290, 10.1038/nmeth.1290]; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; Tan WH, 2007, P NATL ACAD SCI USA, V104, P1146, DOI 10.1073/pnas.0606625104; Taylor RJ, 2009, P NATL ACAD SCI USA, V106, P3758, DOI 10.1073/pnas.0813416106; Wheeler AR, 2003, ANAL CHEM, V75, P3581, DOI 10.1021/ac0340758; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Xie ZW, 2012, AGING CELL, V11, P599, DOI 10.1111/j.1474-9726.2012.00821.x; Zechner C, 2014, NAT METHODS, V11, P197, DOI [10.1038/NMETH.2794, 10.1038/nmeth.2794]; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048275; Zhou CK, 2011, CELL, V147, P1186, DOI 10.1016/j.cell.2011.11.002	42	39	41	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100042	10.1371/journal.pone.0100042	http://dx.doi.org/10.1371/journal.pone.0100042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950344	Green Submitted, Green Published, gold			2022-12-25	WOS:000338276300031
J	Dong, WW; Liu, YX; Zhu, WJ; Mou, Q; Wang, JL; Hu, Y				Dong, Weiwei; Liu, Yixuan; Zhu, Weijie; Mou, Quan; Wang, Jinliang; Hu, Yi			Simulation of Swanson's Literature-Based Discovery: Anandamide Treatment Inhibits Growth of Gastric Cancer Cells In Vitro and In Silico	PLOS ONE			English	Article							ENDOCANNABINOID SYSTEM; HYPOTHESES; TARGET	Swanson's literature-based discovery focus on resurrecting previously published but neglected knowledge. In this study, we propose a two-step model of the discovery process and generate a hypothesis between anandamide and gastric cancer. Further, the potential relationship was confirmed by follow-up experimentation. The anandamide treatment resulted in cell cycle redistribution of gastric cancer cells. Most importantly, the variation of cell cycle was mediated by some genes from the B-terms of the closed discovery, indicating the potential role of the B-terms. Swanson's literature-based discovery not only collates data for possible interactions, but also provides the potential to observe the larger background behind these direct links and is an invaluable discovery tool for investigators.	[Dong, Weiwei; Wang, Jinliang; Hu, Yi] Gen Hosp PLA, Dept Oncol, Beijing, Peoples R China; [Liu, Yixuan] Peking Univ, Dept Gastroenterol, Hosp 3, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Zhu, Weijie] Beijing Ctr Dis Control & Prevent CDC, Beijing, Peoples R China; [Zhu, Weijie] Ctr Prevent Med Res, Beijing, Peoples R China; [Mou, Quan] PLA 252 Hosp, Dept Surg, Baoding, Peoples R China	Chinese People's Liberation Army General Hospital; Peking University	Hu, Y (corresponding author), Gen Hosp PLA, Dept Oncol, Beijing, Peoples R China.	13810869059@163.com			Chinese Geriatric Oncology Society [CGOS-03-2013-1-1-00600]	Chinese Geriatric Oncology Society	This study was funded by the Chinese Geriatric Oncology Society (oncology program, grants CGOS-03-2013-1-1-00600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic LA, 2002, CSB2002: IEEE COMPUTER SOCIETY BIOINFORMATICS CONFERENCE, P109, DOI 10.1109/CSB.2002.1039334; Allum WH, 2011, GUT, V60, P1449, DOI 10.1136/gut.2010.228254; Bari M, 2006, MINI-REV MED CHEM, V6, P257, DOI 10.2174/138955706776073466; Borrelli F, 2009, BEST PRACT RES CL EN, V23, P33, DOI 10.1016/j.beem.2008.10.003; Gaetani S, 2009, INT REV NEUROBIOL, V85, P57, DOI 10.1016/S0074-7742(09)85005-8; Gu Chen-yi, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P973; Hamtiaux L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-92; Hamtiaux L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026823; Hur J, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-49; Karam SM, 2008, ANN NY ACAD SCI, V1138, P162, DOI 10.1196/annals.1414.023; Maccarrone M, 2003, CELL DEATH DIFFER, V10, P946, DOI 10.1038/sj.cdd.4401284; Miyato H, 2009, J SURG RES, V155, P40, DOI 10.1016/j.jss.2008.06.045; Nithipatikom K, 2012, ENDOCRINOLOGY, V153, P29, DOI 10.1210/en.2011-1144; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Smalheiser NR, 2009, COMPUT METH PROG BIO, V94, P190, DOI 10.1016/j.cmpb.2008.12.006; Smalheiser NR, 1998, COMPUT METH PROG BIO, V57, P149, DOI 10.1016/S0169-2607(98)00033-9; Srinivasan P, 2004, J AM SOC INF SCI TEC, V55, P396, DOI 10.1002/asi.10389; Swanson DR, 2006, J AM SOC INF SCI TEC, V57, P1427, DOI 10.1002/asi.20438; Swanson DR, 2011, J BIOMED DISCOV COLL, V6, DOI 10.5210/disco.v6i0.3515; SWANSON DR, 1990, B MED LIBR ASSOC, V78, P29; Weeber M, 2001, J AM SOC INF SCI TEC, V52, P548, DOI 10.1002/asi.1104	21	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100436	10.1371/journal.pone.0100436	http://dx.doi.org/10.1371/journal.pone.0100436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949851	gold, Green Published, Green Submitted			2022-12-25	WOS:000338276300074
J	Hays, T; Ma'ayan, A; Clark, NR; Tan, CM; Teixeira, A; Teixeira, A; Choi, JW; Burdis, N; Jung, SY; Bajaj, AO; O'Malley, BW; He, JC; Hyink, DP; Klotman, PE				Hays, Thomas; Ma'ayan, Avi; Clark, Neil R.; Tan, Christopher M.; Teixeira, Avelino; Teixeira, Angela; Choi, Jae W.; Burdis, Nora; Jung, Sung Yun; Bajaj, Amol O.; O'Malley, Bert W.; He, John C.; Hyink, Deborah P.; Klotman, Paul E.			Proteomics Analysis of the Non-Muscle Myosin Heavy Chain IIa-Enriched Actin-Myosin Complex Reveals Multiple Functions within the Podocyte	PLOS ONE			English	Article							INTERACTION NETWORK; MYH9; DISEASE; RESOURCE; DATABASE; NEF; EXPRESSION; GENES; PATHOGENICITY; ASSOCIATION	MYH9 encodes non-muscle myosin heavy chain IIA (NMMHCIIA), the predominant force-generating ATPase in non-muscle cells. Several lines of evidence implicate a role for MYH9 in podocytopathies. However, NMMHCIIA` s function in podocytes remains unknown. To better understand this function, we performed immuno-precipitation followed by mass-spectrometry proteomics to identify proteins interacting with the NMMHCIIA-enriched actin-myosin complexes. Computational analyses revealed that these proteins belong to functional networks including regulators of cytoskeletal organization, metabolism and networks regulated by the HIV-1 gene nef. We further characterized the subcellular localization of NMMHCIIA within podocytes in vivo, and found it to be present within the podocyte major foot processes. Finally, we tested the effect of loss of MYH9 expression in podocytes in vitro, and found that it was necessary for cytoskeletal organization. Our results provide the first survey of NMMHCIIA-enriched actin-myosin-interacting proteins within the podocyte, demonstrating the important role of NMMHCIIA in organizing the elaborate cytoskeleton structure of podocytes. Our characterization of NMMHCIIA's functions goes beyond the podocyte, providing important insights into its general molecular role.	[Hays, Thomas; Teixeira, Avelino; Teixeira, Angela; He, John C.] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Ma'ayan, Avi; Clark, Neil R.; Tan, Christopher M.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Choi, Jae W.; Burdis, Nora; Jung, Sung Yun; Hyink, Deborah P.; Klotman, Paul E.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Bajaj, Amol O.; O'Malley, Bert W.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Baylor College of Medicine; Baylor College of Medicine	Hays, T (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA.	thomas.hays@mssm.edu	Bajaj, Amol/AHA-0698-2022; Hyink, Deborah/AAT-6821-2021; Hays, Thomas/ABA-6640-2020; Ma'ayan, Avi/AAG-3131-2019	Hyink, Deborah/0000-0001-5820-4995; Ma'ayan, Avi/0000-0002-6904-1017; Bajaj, Amol/0000-0001-5099-1365; Jung, Sung Yun/0000-0003-1521-7977	 [P01 DK056492];  [1RC4DK090860];  [3T32GM007280-33S1];  [R01GM098316-01A1];  [P50GM071558-05];  [R01DK088541-01A1];  [U54HG006097-02S1]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558, T32GM007280, R01GM098316] Funding Source: NIH RePORTER	; ; ; ; ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following grants: P01 DK056492 and 1RC4DK090860 to PK; 3T32GM007280-33S1 to TH; R01GM098316-01A1, P50GM071558-05, R01DK088541-01A1, and U54HG006097-02S1 to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashley-Koch AE, 2011, BRIT J HAEMATOL, V155, P386, DOI 10.1111/j.1365-2141.2011.08832.x; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Barisoni L, 2003, CURR OPIN NEPHROL HY, V12, P251, DOI 10.1097/00041552-200305000-00005; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chatr-aryamontri A, 2009, NUCLEIC ACIDS RES, V37, pD669, DOI 10.1093/nar/gkn739; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chuang PY, 2009, NEPHRON PHYSIOL, V111, P9, DOI 10.1159/000191075; Clauset A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026132; Cooke JN, 2012, NEPHROL DIAL TRANSPL, V27, P1505, DOI 10.1093/ndt/gfr522; Dannenfelser R, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-156; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Garg P, 2007, NEPHRON EXP NEPHROL, V106, pE67, DOI 10.1159/000101795; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hamosh A, 2002, NUCLEIC ACIDS RES, V30, P52, DOI 10.1093/nar/30.1.52; Hanna Z, 2001, J VIROL, V75, P9378, DOI 10.1128/JVI.75.19.9378-9392.2001; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Hays T, 2012, AIDS, V26, P797, DOI 10.1097/QAD.0b013e328351f6cf; He JCJ, 2004, J CLIN INVEST, V114, P643, DOI 10.1172/JCI200421004; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Johnstone DB, 2011, MOL CELL BIOL, V31, P2162, DOI 10.1128/MCB.05234-11; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Lachmann A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-87; Lachmann A, 2009, BIOINFORMATICS, V25, P684, DOI 10.1093/bioinformatics/btp026; Li Y, 2008, CELL MOTIL CYTOSKEL, V65, P393, DOI 10.1002/cm.20268; Lu TC, 2008, J BIOL CHEM, V283, P8173, DOI 10.1074/jbc.M708920200; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092; Mundel P, 1997, J AM SOC NEPHROL, V8, P697; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sekine T, 2010, KIDNEY INT, V78, P207, DOI 10.1038/ki.2010.21; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Seri M, 2003, MEDICINE, V82, P203, DOI 10.1097/00005792-200305000-00006; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Singh N, 2009, AM J KIDNEY DIS, V54, P732, DOI 10.1053/j.ajkd.2009.06.023; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tan CM, 2013, BIOINFORMATICS, V29, P1872, DOI 10.1093/bioinformatics/btt319; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wei CC, 2010, OTOLARYNG HEAD NECK, V142, P699, DOI 10.1016/j.otohns.2009.12.030; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]; Zhu L, 2011, J AM SOC NEPHROL, V22, P1621, DOI 10.1681/ASN.2010111146	57	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100660	10.1371/journal.pone.0100660	http://dx.doi.org/10.1371/journal.pone.0100660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949636	Green Submitted, gold, Green Published			2022-12-25	WOS:000338276300104
J	Wendt, D; Brand, T; Kollmeier, B				Wendt, Dorothea; Brand, Thomas; Kollmeier, Birger			An Eye-Tracking Paradigm for Analyzing the Processing Time of Sentences with Different Linguistic Complexities	PLOS ONE			English	Article							SPEECH-INTELLIGIBILITY; SPOKEN LANGUAGE; CUE-INTEGRATION; NOISE-REDUCTION; WORLD KNOWLEDGE; COMPREHENSION; INFORMATION; MOVEMENTS; HEARING; CONTEXT	An eye-tracking paradigm was developed for use in audiology in order to enable online analysis of the speech comprehension process. This paradigm should be useful in assessing impediments in speech processing. In this paradigm, two scenes, a target picture and a competitor picture, were presented simultaneously with an aurally presented sentence that corresponded to the target picture. At the same time, eye fixations were recorded using an eye-tracking device. The effect of linguistic complexity on language processing time was assessed from eye fixation information by systematically varying linguistic complexity. This was achieved with a sentence corpus containing seven German sentence structures. A novel data analysis method computed the average tendency to fixate the target picture as a function of time during sentence processing. This allowed identification of the point in time at which the participant understood the sentence, referred to as the decision moment. Systematic differences in processing time were observed as a function of linguistic complexity. These differences in processing time may be used to assess the efficiency of cognitive processes involved in resolving linguistic complexity. Thus, the proposed method enables a temporal analysis of the speech comprehension process and has potential applications in speech audiology and psychoacoustics.	[Wendt, Dorothea] Carl von Ossietzky Univ Oldenburg, D-26111 Oldenburg, Germany; Carl von Ossietzky Univ Oldenburg, Cluster Excellence Hearing4all, D-26111 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Wendt, D (corresponding author), Carl von Ossietzky Univ Oldenburg, D-26111 Oldenburg, Germany.	wendt@elektro.dtu.dk		Wendt, Dorothea/0000-0002-3340-1180	Deutsche Forschungsgemeinschaft (DFG) within the AULIN Project [KO 942/20-1, BR 3668/1-2]	Deutsche Forschungsgemeinschaft (DFG) within the AULIN Project(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (DFG) within the AULIN Project (grant numbers KO 942/20-1 and BR 3668/1-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allopenna PD, 1998, J MEM LANG, V38, P419, DOI 10.1006/jmla.1997.2558; Altmann GTM, 2007, J MEM LANG, V57, P502, DOI 10.1016/j.jml.2006.12.004; Altmann GTM, 1998, TRENDS COGN SCI, V2, P146, DOI 10.1016/S1364-6613(98)01153-X; Altmann GTM, 1999, COGNITION, V73, P247, DOI 10.1016/S0010-0277(99)00059-1; Arnold JE, 2003, J PSYCHOLINGUIST RES, V32, P25, DOI 10.1023/A:1021980931292; Bader M, 1999, J PSYCHOLINGUIST RES, V28, P121, DOI 10.1023/A:1023206208142; Bader M, 2006, STUD THEOR PSYCHOLIN, V34, P1, DOI 10.1007/1-4020-4344-9; Barr DJ, 2011, ACTA PSYCHOL, V137, P201, DOI 10.1016/j.actpsy.2010.09.011; Ben-David BM, 2011, J SPEECH LANG HEAR R, V54, P243, DOI 10.1044/1092-4388(2010/09-0233); Bentler Ruth A, 2005, J Am Acad Audiol, V16, P473, DOI 10.3766/jaaa.16.7.7; BOOTHROYD A, 1988, J ACOUST SOC AM, V84, P101, DOI 10.1121/1.396976; Brons I, 2013, EAR HEARING, V34, P29, DOI 10.1097/AUD.0b013e31825f299f; Carroll R, 2013, J PSYCHOLINGUIST RES, V42, P139, DOI 10.1007/s10936-012-9213-7; CERELLA J, 1994, ACTA PSYCHOL, V86, P109, DOI 10.1016/0001-6918(94)90002-7; Chambers CG, 2002, J MEM LANG, V47, P30, DOI 10.1006/jmla.2001.2832; COOPER RM, 1974, COGNITIVE PSYCHOL, V6, P84, DOI 10.1016/0010-0285(74)90005-X; EBERHARD KM, 1995, J PSYCHOLINGUIST RES, V24, P409, DOI 10.1007/BF02143160; Efron B., 1994, INTRO BOOTSTRAP; Fanselow G, 2008, LANGUAGE CONTEXT COG, P413; Fredelake S, 2012, INT J AUDIOL, V51, P299, DOI 10.3109/14992027.2011.645075; Gibson E, 2000, IMAGE, LANGUAGE, BRAIN, P95; Gordon PC, 2002, PSYCHOL SCI, V13, P425, DOI 10.1111/1467-9280.00475; Gorrell Paul, 2000, GERMAN SENTENCE PROC, P25; HAGERMAN B, 1982, SCAND AUDIOL, V11, P79, DOI 10.3109/01050398209076203; Haumann S, 2012, AUDIOL RES, V2, P55, DOI 10.4081/audiores.2012.e12; Huettig F, 2007, J MEM LANG, V57, P460, DOI 10.1016/j.jml.2007.02.001; Huettig F, 2011, ACTA PSYCHOL, V137, P151, DOI 10.1016/j.actpsy.2010.11.003; Kaiser E, 2008, LANG COGNITIVE PROC, V23, P709, DOI 10.1080/01690960701771220; KALIKOW DN, 1977, J ACOUST SOC AM, V61, P1337, DOI 10.1121/1.381436; Kamide Y, 2003, J MEM LANG, V49, P133, DOI 10.1016/S0749-596X(03)00023-8; Knoeferle P, 2005, COGNITION, V95, P95, DOI 10.1016/j.cognition.2004.03.002; Knoeferle P, 2007, J MEM LANG, V57, P519, DOI 10.1016/j.jml.2007.01.003; Knoeferle P, 2006, COGNITIVE SCI, V30, P481, DOI 10.1207/s15516709cog0000_65; Knoeferle Pia, 2007, P517, DOI 10.1016/B978-008044980-7/50026-4; Kollmeier B, 1997, J ACOUST SOC AM, V102, P2412, DOI 10.1121/1.419624; Laroche C, 2003, Noise Health, V6, P17; Marzinzik M, 2000, THESIS C VONOSSIETZK; McMurray B, 2008, PSYCHON B REV, V15, P1064, DOI 10.3758/PBR.15.6.1064; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; Ozimek E, 2010, INT J AUDIOL, V49, P444, DOI 10.3109/14992021003681030; Piquado T, 2010, PSYCHOPHYSIOLOGY, V47, P560, DOI 10.1111/j.1469-8986.2009.00947.x; PLOMP R, 1979, AUDIOLOGY, V18, P43; Pratt J, 2006, J MOTOR BEHAV, V38, P373, DOI 10.3200/JMBR.38.5.373-382; Sarampalis A, 2009, J SPEECH LANG HEAR R, V52, P1230, DOI 10.1044/1092-4388(2009/08-0111); Schlueter A, 2014, J ACOUST SOC AM, V135, P1541, DOI 10.1121/1.4863654; Sherbecoe RL, 2004, INT J AUDIOL, V43, P442, DOI 10.1080/14992020400050056; Snedeker J, 2004, COGNITIVE PSYCHOL, V49, P238, DOI 10.1016/j.cogpsych.2004.03.001; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Toscano JC, 2012, ATTEN PERCEPT PSYCHO, V74, P1284, DOI 10.3758/s13414-012-0306-z; Tun PA, 2010, PSYCHOL AGING, V25, P730, DOI 10.1037/a0019300; Uslar V, 2011, INT J AUDIOL, V50, P621, DOI 10.3109/14992027.2011.582166; Uslar VN, 2013, J ACOUST SOC AM, V134, P3039, DOI 10.1121/1.4818760; Van Zandt T, 2002, STEVENSHANDBOOK EXPT, V4, P461, DOI DOI 10.1002/0471214426.PAS0412; Weskott Thomas., 2011, LINGUISTISCHE BERICH, V225, P3; Wingfield A, 2007, J AM ACAD AUDIOL, V18, P548, DOI 10.3766/jaaa.18.7.3; Wingfield A, 2006, J AM ACAD AUDIOL, V17, P487, DOI 10.3766/jaaa.17.7.4; Zokoll MA, 2013, AM J AUDIOL, V22, P175, DOI 10.1044/1059-0889(2013/12-0061)	57	25	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100186	10.1371/journal.pone.0100186	http://dx.doi.org/10.1371/journal.pone.0100186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2UZ	24950184	gold, Green Published, Green Submitted			2022-12-25	WOS:000338276300045
J	Narayanan, S; Mohan, A; Gill, KS; Prasad, PVV				Narayanan, Sruthi; Mohan, Amita; Gill, Kulvinder S.; Prasad, P. V. Vara			Variability of Root Traits in Spring Wheat Germplasm	PLOS ONE			English	Article							CICER-ARIETINUM L.; COLEOPTILE LENGTH; GRAIN-YIELD; ARCHITECTURAL TRAITS; STAND ESTABLISHMENT; GENETIC-VARIABILITY; DROUGHT-AVOIDANCE; ISOGENIC LINES; WINTER-WHEAT; SEED YIELD	Root traits influence the amount of water and nutrient absorption, and are important for maintaining crop yield under drought conditions. The objectives of this research were to characterize variability of root traits among spring wheat genotypes and determine whether root traits are related to shoot traits (plant height, tiller number per plant, shoot dry weight, and coleoptile length), regions of origin, and market classes. Plants were grown in 150-cm columns for 61 days in a greenhouse under optimal growth conditions. Rooting depth, root dry weight, root: shoot ratio, and shoot traits were determined for 297 genotypes of the germplasm, Cultivated Wheat Collection (CWC). The remaining root traits such as total root length and surface area were measured for a subset of 30 genotypes selected based on rooting depth. Significant genetic variability was observed for root traits among spring wheat genotypes in CWC germplasm or its subset. Genotypes Sonora and Currawa were ranked high, and genotype Vandal was ranked low for most root traits. A positive relationship (R-2 >= 0.35) was found between root and shoot dry weights within the CWC germplasm and between total root surface area and tiller number; total root surface area and shoot dry weight; and total root length and coleoptile length within the subset. No correlations were found between plant height and most root traits within the CWC germplasm or its subset. Region of origin had significant impact on rooting depth in the CWC germplasm. Wheat genotypes collected from Australia, Mediterranean, and west Asia had greater rooting depth than those from south Asia, Latin America, Mexico, and Canada. Soft wheat had greater rooting depth than hard wheat in the CWC germplasm. The genetic variability identified in this research for root traits can be exploited to improve drought tolerance and/or resource capture in wheat.	[Narayanan, Sruthi; Prasad, P. V. Vara] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Mohan, Amita; Gill, Kulvinder S.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA	Kansas State University; Washington State University	Prasad, PVV (corresponding author), Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA.	vara@ksu.edu	Prasad, P.V. Vara/B-3835-2012	Prasad, P.V. Vara/0000-0001-6632-3361	Kansas Wheat Alliance, Coordinated Agricultural Project from the USDA National Institute of Food and Agriculture [2011-68002-30029]; USAID Feed the Future Innovation Lab on Climate-Resilient Wheat	Kansas Wheat Alliance, Coordinated Agricultural Project from the USDA National Institute of Food and Agriculture; USAID Feed the Future Innovation Lab on Climate-Resilient Wheat(United States Agency for International Development (USAID))	This research was funded by Kansas Wheat Alliance, Coordinated Agricultural Project Grant no. 2011-68002-30029 (Triticeae- CAP) from the USDA National Institute of Food and Agriculture, and USAID Feed the Future Innovation Lab on Climate-Resilient Wheat. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blum A, 2005, AUST J AGR RES, V56, P1159, DOI 10.1071/AR05069; Botwright TL, 2001, EUPHYTICA, V119, P349, DOI 10.1023/A:1017527911084; Boyer JS, 1996, ADV AGRON, V56, P187, DOI 10.1016/S0065-2113(08)60182-0; BUSH MG, 1988, FIELD CROP RES, V18, P243, DOI 10.1016/0378-4290(88)90018-4; CAASSEN N, 1976, AGRON J, V68, P961, DOI 10.2134/agronj1976.00021962006800060030x; CHAMPOUX MC, 1995, THEOR APPL GENET, V90, P969, DOI 10.1007/BF00222910; CHASTAIN TG, 1995, CROP SCI, V35, P213, DOI 10.2135/cropsci1995.0011183X003500010040x; Clark LJ, 2008, FUNCT PLANT BIOL, V35, P1163, DOI 10.1071/FP08132; CORNISH PS, 1988, AUST J EXP AGR, V28, P521, DOI 10.1071/EA9880521; EISSENSTAT DM, 1992, J PLANT NUTR, V15, P763, DOI 10.1080/01904169209364361; FAO, 2011, FAOSTAT; Fitter A., 2002, PLANT ROOTS HIDDEN H, P15; FUKAI S, 1995, FIELD CROP RES, V40, P67, DOI 10.1016/0378-4290(94)00096-U; Gupta P. K., 2012, Plant Breeding Reviews, V36, P85; Hodge A, 1999, PLANT CELL ENVIRON, V22, P811, DOI 10.1046/j.1365-3040.1999.00454.x; Huang BR, 1998, CROP SCI, V38, P1017, DOI [10.2135/cropsci1998.0011183X003800040022x, 10.2135/cropsci1998.0011183X003800050018x]; Jones H, 2008, MOL BIOL EVOL, V25, P2211, DOI 10.1093/molbev/msn167; Kashiwagi J, 2005, EUPHYTICA, V146, P213, DOI 10.1007/s10681-005-9007-1; Kashiwagi J, 2006, FIELD CROP RES, V95, P171, DOI 10.1016/j.fcr.2005.02.012; KAUFMANN ML, 1968, CAN J PLANT SCI, V48, P357, DOI 10.4141/cjps68-068; Krishnamurthy L, 1999, J AGRON CROP SCI, V183, P9, DOI 10.1046/j.1439-037x.1999.00306.x; Krishnamurthy L, 1996, ROOT NITROGEN CROPPI, P234; Ludlow M. M., 1990, ADV AGRONOMY, V43, P107; Manschadi AM, 2008, PLANT SOIL, V303, P115, DOI 10.1007/s11104-007-9492-1; Manschadi AM, 2006, FUNCT PLANT BIOL, V33, P823, DOI 10.1071/FP06055; Manske G. G. B., 2002, Plant roots: the hidden half, P249; Manske GGB, 2000, PLANT SOIL, V221, P189, DOI 10.1023/A:1004727201568; McPhee K, 2005, CROP SCI, V45, P1758, DOI 10.2135/cropsci2004.0544; MIAN AR, 1992, J PROD AGRIC, V5, P265, DOI 10.2134/jpa1992.0265; Mohan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073314; Nik M. M., 2011, Scientific Research and Essays, V6, P2019; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pierret A, 2005, NEW PHYTOL, V166, P967, DOI 10.1111/j.1469-8137.2005.01389.x; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P1191, DOI 10.1071/PP99173; Rebetzke GJ, 2007, THEOR APPL GENET, V114, P1173, DOI 10.1007/s00122-007-0509-1; Rebetzke GJ, 2007, FIELD CROP RES, V100, P10, DOI 10.1016/j.fcr.2006.05.001; RICHARDS RA, 1989, AUST J AGR RES, V40, P943, DOI 10.1071/AR9890943; Sanguineti MC, 2007, ANN APPL BIOL, V151, P291, DOI 10.1111/j.1744-7348.2007.00198.x; Schillinger WF, 1998, AGRON J, V90, P582, DOI 10.2134/agronj1998.00021962009000050002x; Serraj R, 2004, FIELD CROP RES, V88, P115, DOI 10.1016/j.fcr.2003.12.001; SINCLAIR TR, 1994, PHYSIOLOGY AND DETERMINATION OF CROP YIELD, P509; Singh V, 2011, CROP SCI, V51, P2011, DOI 10.2135/cropsci2011.01.0038; Smucker A. J. M., 1984, Roots, nutrient and water influx, and plant growth . ASA Special PublicationNo. 49., P27; Wojciechowski T, 2009, J EXP BOT, V60, P2565, DOI 10.1093/jxb/erp107; Yoshida S., 1982, Drought resistance in crops with emphasis on rice, P97	45	78	86	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100317	10.1371/journal.pone.0100317	http://dx.doi.org/10.1371/journal.pone.0100317			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945438	Green Published, Green Submitted, gold			2022-12-25	WOS:000340721500059
J	Rakhmanov, M; Sic, H; Kienzler, AK; Fischer, B; Rizzi, M; Seidl, M; Melkaoui, K; Unger, S; Moehle, L; Schmit, NE; Deshmukh, SD; Ayata, CK; Schuh, W; Zhang, ZB; Cosset, FL; Verhoeyen, E; Peter, HH; Voll, RE; Salzer, U; Eibel, H; Warnatz, K				Rakhmanov, Mirzokhid; Sic, Heiko; Kienzler, Anne-Kathrin; Fischer, Beate; Rizzi, Marta; Seidl, Maximilian; Melkaoui, Kerstina; Unger, Susanne; Moehle, Luisa; Schmit, Nadine E.; Deshmukh, Sachin D.; Ayata, Cemil Korcan; Schuh, Wolfgang; Zhang, Zhibing; Cosset, Francois-Loic; Verhoeyen, Els; Peter, Hans-Hartmut; Voll, Reinhard E.; Salzer, Ulrich; Eibel, Hermann; Warnatz, Klaus			High Levels of SOX5 Decrease Proliferative Capacity of Human B Cells, but Permit Plasmablast Differentiation	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; LENTIVIRAL VECTORS; GENE-EXPRESSION; DNA-BINDING; LONG FORM; L-SOX5; CARTILAGE; PROTEINS; MOUSE; GENERATION	Currently very little is known about the differential expression and function of the transcription factor SOX5 during B cell maturation. We identified two new splice variants of SOX5 in human B cells, encoding the known L-SOX5B isoform and a new shorter isoform L-SOX5F. The SOX5 transcripts are highly expressed during late stages of B-cell differentiation, including atypical memory B cells, activated CD21(low) B cells and germinal center B cells of tonsils. In tonsillar sections SOX5 expression was predominantly polarized to centrocytes within the light zone. After in vitro stimulation, SOX5 expression was down-regulated during proliferation while high expression levels were permissible for plasmablast differentiation. Overexpression of L-SOX5F in human primary B lymphocytes resulted in reduced proliferation, less survival of CD138(neg) B cells, but comparable numbers of CD138(+)CD38(hi) plasmablasts compared to control cells. Thus, our findings describe for the first time a functional role of SOX5 during late B cell development reducing the proliferative capacity and thus potentially affecting the differentiation of B cells during the germinal center response.	[Rakhmanov, Mirzokhid; Sic, Heiko; Kienzler, Anne-Kathrin; Fischer, Beate; Rizzi, Marta; Seidl, Maximilian; Melkaoui, Kerstina; Unger, Susanne; Moehle, Luisa; Schmit, Nadine E.; Deshmukh, Sachin D.; Peter, Hans-Hartmut; Voll, Reinhard E.; Salzer, Ulrich; Eibel, Hermann; Warnatz, Klaus] Univ Med Ctr, Ctr Chron Immunodeficiency, Freiburg, Germany; [Rakhmanov, Mirzokhid; Sic, Heiko; Kienzler, Anne-Kathrin; Fischer, Beate; Rizzi, Marta; Seidl, Maximilian; Melkaoui, Kerstina; Unger, Susanne; Moehle, Luisa; Schmit, Nadine E.; Deshmukh, Sachin D.; Ayata, Cemil Korcan; Peter, Hans-Hartmut; Voll, Reinhard E.; Salzer, Ulrich; Eibel, Hermann; Warnatz, Klaus] Univ Freiburg, D-79106 Freiburg, Germany; [Ayata, Cemil Korcan] Univ Med Ctr, Dept Pneumol, Freiburg, Germany; [Schuh, Wolfgang] Univ Erlangen Nurnberg, Div Mol Immunol, Nikolaus Fiebiger Ctr, Dept Internal Med 3, D-91054 Erlangen, Germany; [Zhang, Zhibing] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA USA; [Cosset, Francois-Loic; Verhoeyen, Els] Univ Lyon, Ecole Normale Super Lyon, CIRI, INSERM U1111,EVIR, Lyon, France; [Verhoeyen, Els] C3M, INSERM U1065, Nice, France; [Peter, Hans-Hartmut; Voll, Reinhard E.; Salzer, Ulrich; Eibel, Hermann; Warnatz, Klaus] Univ Med Ctr Freiburg, Div Rheumatol & Clin Immunol, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Erlangen Nuremberg; Virginia Commonwealth University; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Freiburg	Rakhmanov, M (corresponding author), Univ Med Ctr, Ctr Chron Immunodeficiency, Freiburg, Germany.	mirzokhid.rakhmanov@uniklinik-freiburg.de	Rakhmanov, Mirzokhid/GMW-5383-2022; Cosset, François-Loïc/M-5862-2019; Verhoeyen, Els/AAW-4853-2021; Verhoeyen, Els/H-6360-2016; Warnatz, Klaus/AAD-3464-2022; Ayata, Korcan/G-8626-2013; Rakhmanov, Mirzokhid/P-8351-2019; Seidl, Maxmilian/ABF-3322-2021; Rizzi, Marta/ABE-7264-2020	Cosset, François-Loïc/0000-0001-8842-3726; Verhoeyen, Els/0000-0001-9224-5491; Ayata, Korcan/0000-0001-7043-6692; Seidl, Maxmilian/0000-0002-5559-4980; Rizzi, Marta/0000-0002-5153-6089; Mohle, Luisa/0000-0002-4535-9952; Kienzler, Anne-Kathrin/0000-0002-3082-9210; Salzer, Ulrich/0000-0002-1769-1157; Unger, Susanne/0000-0001-6916-7544	German Federal Ministry of Education and Research [BMBF 01 EO 0803]; German Research Foundation (DFG) [SFB620]; 7th Framework Program (FP7) of the European Union [HEALTH-F2-2008-201549]; FP7-E-Rare "GENTHALTHER''; Virginia Commonwealth University (VCU) Presidential Research Incentive Program (PRIP); VCU Massey Cancer Center/American Cancer Society Institutional Research Awards; NIH [HD076257]; University Freiburg (UF) Medical Faculty Research Committee; UF Scientific Society Freiburg Research Grants; PERSIST [FP7-HEALTH-2007-B/222878]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD076257] Funding Source: NIH RePORTER	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); 7th Framework Program (FP7) of the European Union; FP7-E-Rare "GENTHALTHER''; Virginia Commonwealth University (VCU) Presidential Research Incentive Program (PRIP); VCU Massey Cancer Center/American Cancer Society Institutional Research Awards; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Freiburg (UF) Medical Faculty Research Committee; UF Scientific Society Freiburg Research Grants; PERSIST; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was funded by the German Federal Ministry of Education and Research (BMBF 01 EO 0803) (to K.W., H.E., U.S. and R.V.), the German Research Foundation (DFG) Grant SFB620, Projects C1 (to K.W. and H.H.P.) and C7 (to US), the 7th Framework Program (FP7) of the European Union Grant Nr. HEALTH-F2-2008-201549 (to K. W., H. E. and U.S.); FP7-HEALTH-2007-B/222878 "PERSIST" and FP7-E-Rare "GENTHALTHER'' Grants (to EV and FLC); Virginia Commonwealth University (VCU) Presidential Research Incentive Program (PRIP), VCU Massey Cancer Center/American Cancer Society Institutional Research Awards and NIH Award HD076257 (to Z.Z.); University Freiburg (UF) Medical Faculty Research Committee and UF Scientific Society Freiburg Research Grants (to M.Ra.). The authors are responsible for the contents of this publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Charles ED, 2011, BLOOD, V117, P5425, DOI 10.1182/blood-2010-10-312942; Chew LJ, 2009, J NEUROSCI RES, V87, P3277, DOI 10.1002/jnr.22128; CONNER F, 1994, NUCLEIC ACIDS RES, V22, P3339, DOI 10.1093/nar/22.16.3339; CONNOR F, 1995, NUCLEIC ACIDS RES, V23, P3365, DOI 10.1093/nar/23.17.3365; da Silva GN, 2012, MOL BIOL REP, V39, P10373, DOI 10.1007/s11033-012-1916-1; DENNY P, 1992, EMBO J, V11, P3705, DOI 10.1002/j.1460-2075.1992.tb05455.x; Edwards SKE, 2014, LEUKEMIA RES, V38, P393, DOI 10.1016/j.leukres.2013.12.016; Ehrhardt GRA, 2008, J EXP MED, V205, P1807, DOI 10.1084/jem.20072682; Frecha C, 2009, BLOOD, V114, P3173, DOI 10.1182/blood-2009-05-220798; Funke S, 2008, MOL THER, V16, P1427, DOI 10.1038/mt.2008.128; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Ikeda T, 2004, ARTHRITIS RHEUM-US, V50, P3561, DOI 10.1002/art.20611; Ikeda T, 2002, GENE, V298, P59, DOI 10.1016/S0378-1119(02)00927-7; Isnardi I, 2010, BLOOD, V115, P5026, DOI 10.1182/blood-2009-09-243071; Kiselak EA, 2010, J BIOL CHEM, V285, P30496, DOI 10.1074/jbc.M110.121590; Kwan KY, 2008, P NATL ACAD SCI USA, V105, P16021, DOI 10.1073/pnas.0806791105; Lai T, 2008, NEURON, V57, P232, DOI 10.1016/j.neuron.2007.12.023; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Lefebvre V, 2010, INT J BIOCHEM CELL B, V42, P429, DOI 10.1016/j.biocel.2009.07.016; Lefebvre W, 2002, J BONE MINER METAB, V20, P121, DOI 10.1007/s007740200017; Lioubinski O, 2003, DEV DYNAM, V227, P402, DOI 10.1002/dvdy.10311; Martinez-Morales PL, 2010, EMBO REP, V11, P466, DOI 10.1038/embor.2010.61; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Perez-Alcala S, 2004, DEVELOPMENT, V131, P4455, DOI 10.1242/dev.01329; Rakhmanov M, 2009, P NATL ACAD SCI USA, V106, P13451, DOI 10.1073/pnas.0901984106; Reiser J, 2000, J VIROL, V74, P10589, DOI 10.1128/JVI.74.22.10589-10599.2000; Reiser J, 1996, P NATL ACAD SCI USA, V93, P15266, DOI 10.1073/pnas.93.26.15266; Reiser J, 2000, GENE THER, V7, P910, DOI 10.1038/sj.gt.3301188; Saito T, 2007, EMBO REP, V8, P504, DOI 10.1038/sj.embor.7400934; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Stolt CC, 2008, NUCLEIC ACIDS RES, V36, P5427, DOI 10.1093/nar/gkn527; Stolt CC, 2006, DEV CELL, V11, P697, DOI 10.1016/j.devcel.2006.08.011; Tchougounova E, 2009, ONCOGENE, V28, P1537, DOI 10.1038/onc.2009.9; Warnatz K, 2009, P NATL ACAD SCI USA, V106, P13945, DOI 10.1073/pnas.0903543106; Wegner M, 2010, INT J BIOCHEM CELL B, V42, P381, DOI 10.1016/j.biocel.2009.07.006; Wunderle VM, 1996, GENOMICS, V36, P354, DOI 10.1006/geno.1996.0474; Zhang XY, 2002, MOL THER, V5, P555, DOI 10.1006/mthe.2002.0585	38	11	12	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100328	10.1371/journal.pone.0100328	http://dx.doi.org/10.1371/journal.pone.0100328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945754	Green Published, gold, Green Submitted			2022-12-25	WOS:000340721500062
J	Arribas, M; Kubota, K; Cabanillas, L; Lazaro, E				Arribas, Maria; Kubota, Kirina; Cabanillas, Laura; Lazaro, Ester			Adaptation to Fluctuating Temperatures in an RNA Virus Is Driven by the Most Stringent Selective Pressure	PLOS ONE			English	Article							OF-ALL-TRADES; BENEFICIAL MUTATIONS; LOCAL ADAPTATION; EXPERIMENTAL EVOLUTION; HOST ADAPTATION; FITNESS; COST; ARBOVIRUS; MEMORY; SPECIALIZATION	The frequency of change in the selective pressures is one of the main factors driving evolution. It is generally accepted that constant environments select specialist organisms whereas changing environments favour generalists. The particular outcome achieved in either case also depends on the relative strength of the selective pressures and on the fitness costs of mutations across environments. RNA viruses are characterized by their high genetic diversity, which provides fast adaptation to environmental changes and helps them evade most antiviral treatments. Therefore, the study of the adaptive possibilities of RNA viruses is highly relevant for both basic and applied research. In this study we have evolved an RNA virus, the bacteriophage Q beta, under three different temperatures that either were kept constant or alternated periodically. The populations obtained were analyzed at the phenotypic and the genotypic level to characterize the evolutionary process followed by the virus in each case and the amount of convergent genetic changes attained. Finally, we also investigated the influence of the pre-existent genetic diversity on adaptation to high temperature. The main conclusions that arise from our results are: i) under periodically changing temperature conditions, evolution of bacteriophage Qb is driven by the most stringent selective pressure, ii) there is a high degree of evolutionary convergence between replicated populations and also among populations evolved at different temperatures, iii) there are mutations specific of a particular condition, and iv) adaptation to high temperatures in populations differing in their pre-existent genetic diversity takes place through the selection of a common set of mutations.	[Arribas, Maria; Cabanillas, Laura; Lazaro, Ester] CSIC, Ctr Astrobiol, INTA, Madrid 28850, Spain; [Kubota, Kirina] Univ Autonoma Madrid, Fac Ciencias, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Autonomous University of Madrid	Lazaro, E (corresponding author), CSIC, Ctr Astrobiol, INTA, Madrid 28850, Spain.	lazarole@cab.inta-csic.es	Lázaro, Ester/L-3398-2017; Arribas, María/L-2934-2014	Lázaro, Ester/0000-0001-7477-7822; Arribas, María/0000-0002-5802-3315	Spanish Ministry of Science and Innovation [FIS2011-27569, BFU2011-25271]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Spanish Ministry of Science and Innovation (www.micinn.es) through grants FIS2011-27569 and BFU2011-25271. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo-Romero P, 2008, INFECT GENET EVOL, V8, P806, DOI 10.1016/j.meegid.2008.07.010; Alto BW, 2013, EVOLUTION, V67, P969, DOI 10.1111/evo.12034; Arribas M, 2011, VIROLOGY, V417, P343, DOI 10.1016/j.virol.2011.06.016; BARRERA I, 1993, J MOL BIOL, V232, P512, DOI 10.1006/jmbi.1993.1407; Bedhomme S, 2012, MOL BIOL EVOL, V29, P1481, DOI 10.1093/molbev/msr314; Bollback JP, 2009, GENETICS, V181, P225, DOI 10.1534/genetics.107.085225; Briones C, 2008, AIDS REV, V10, P93; Bull JJ, 1997, GENETICS, V147, P1497; Cabanillas L, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-11; Cases-Gonzalez C, 2008, J MOL BIOL, V384, P1120, DOI 10.1016/j.jmb.2008.10.014; Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105; Coffey LL, 2011, J VIROL, V85, P1025, DOI 10.1128/JVI.01918-10; Cooper LA, 2001, GENETICS, V157, P1403; Deardorff ER, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002335; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Dessau M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003102; Domingo E, 2003, PROG DRUG RES, V60, P133; Domingo E, 2002, VIRUS RES, V82, P39; Domingo E, 1997, Prog Drug Res, V48, P99; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Elena SF, 2010, CHAOS, V20, DOI 10.1063/1.3449300; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Gandon S, 2004, EVOLUTION, V58, P455, DOI 10.1111/j.0014-3820.2004.tb01669.x; Garcia-Villada L, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130043; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Greene IP, 2005, J VIROL, V79, P14253, DOI 10.1128/JVI.79.22.14253-14260.2005; Hellgren O, 2009, ECOLOGY, V90, P2840, DOI 10.1890/08-1059.1; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Holder KK, 2001, GENETICS, V159, P1393; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; KAWECKI TJ, 1994, AM NAT, V144, P833, DOI 10.1086/285709; Kidmose RT, 2010, P NATL ACAD SCI USA, V107, P10884, DOI 10.1073/pnas.1003015107; Knies JL, 2009, AM NAT, V173, P419, DOI 10.1086/597224; Krasnov BR, 2004, AM NAT, V164, P506, DOI 10.1086/423716; Lalic J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002378; Lang GI, 2011, GENETICS, V188, P647, DOI 10.1534/genetics.111.128942; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Lee KH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025640; Legros M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-159; LEVINS RICHARD, 1968; LYNCH M, 1983, AM NAT, V122, P745, DOI 10.1086/284169; Magalhaes S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-182; Malpica JM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000041; Novella IS, 1999, J MOL BIOL, V287, P459, DOI 10.1006/jmbi.1999.2635; Palaima A, 2007, BIOL J LINN SOC, V90, P583, DOI 10.1111/j.1095-8312.2007.00745.x; Poulin R, 1998, ECOL LETT, V1, P118; Remold SK, 2008, MOL BIOL EVOL, V25, P1138, DOI 10.1093/molbev/msn059; Rokyta DR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002075; Ruiz-Jarabo CM, 2000, J VIROL, V74, P3543, DOI 10.1128/JVI.74.8.3543-3547.2000; Rumnieks J, 2011, PROTEIN SCI, V20, P1707, DOI 10.1002/pro.704; Sanjuan R, 2012, FUTURE VIROL, V7, P391, DOI 10.2217/FVL.12.19; Sniegowski PD, 2010, PHILOS T R SOC B, V365, P1255, DOI 10.1098/rstb.2009.0290; Stearns S.C., 1992, pi; Straub CS, 2011, AM NAT, V177, P389, DOI 10.1086/658177; Takeshita D, 2010, P NATL ACAD SCI USA, V107, P15733, DOI 10.1073/pnas.1006559107; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Turner PE, 2000, GENETICS, V156, P1465; Vasilakis N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000467; VIA S, 1990, ANNU REV ENTOMOL, V35, P421, DOI 10.1146/annurev.en.35.010190.002225; Wallis CM, 2007, J GEN VIROL, V88, P2839, DOI 10.1099/vir.0.82814-0; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999; Weinreich DM, 2005, EVOLUTION, V59, P1165; Whitlock MC, 1996, AM NAT, V148, pS65, DOI 10.1086/285902; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422	65	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100940	10.1371/journal.pone.0100940	http://dx.doi.org/10.1371/journal.pone.0100940			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963780	Green Published, Green Submitted, gold			2022-12-25	WOS:000338709500102
J	Bednarz, M; Halliday, JA; Herman, C; Golding, I				Bednarz, Michael; Halliday, Jennifer A.; Herman, Christophe; Golding, Ido			Revisiting Bistability in the Lysis/Lysogeny Circuit of Bacteriophage Lambda	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; ESCHERICHIA-COLI; PHAGE-LAMBDA; DECISION-MAKING; IN-VIVO; PROTEIN EXPRESSION; REGULATORY CIRCUIT; SINGLE CELLS; CI REPRESSOR; NOISE	The lysis/lysogeny switch of bacteriophage lambda serves as a paradigm for binary cell fate decision, long-term maintenance of cellular state and stimulus-triggered switching between states. In the literature, the system is often referred to as "bistable.'' However, it remains unclear whether this term provides an accurate description or is instead a misnomer. Here we address this question directly. We first quantify transcriptional regulation governing lysogenic maintenance using a single-cell fluorescence reporter. We then use the single-cell data to derive a stochastic theoretical model for the underlying regulatory network. We use the model to predict the steady states of the system and then validate these predictions experimentally. Specifically, a regime of bistability, and the resulting hysteretic behavior, are observed. Beyond the steady states, the theoretical model successfully predicts the kinetics of switching from lysogeny to lysis. Our results show how the physics-inspired concept of bistability can be reliably used to describe cellular phenotype, and how an experimentally-calibrated theoretical model can have accurate predictive power for cell-state switching.	[Bednarz, Michael; Golding, Ido] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Golding, Ido] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Halliday, Jennifer A.; Herman, Christophe; Golding, Ido] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Halliday, Jennifer A.; Herman, Christophe] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Halliday, Jennifer A.; Herman, Christophe] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Golding, I (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	igolding@illinois.edu			US National Institutes of Health [R01 GM082837]; US National Science Foundation [082265, PHY-1147498]; Welch Foundation [Q-1759]; National Institutes of Health [R01 GM088653]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088653, R01GM082837] Funding Source: NIH RePORTER; Division Of Physics [1147498] Funding Source: National Science Foundation	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work received financial support from the following sources: US National Institutes of Health grant R01 GM082837, US National Science Foundation grants 082265 (CPLC) and PHY-1147498 (CAREER), Welch Foundation grant Q-1759 to IG; and a National Institutes of Health grant R01 GM088653 to CH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, INTRO SYSTEMS BIOL D; Anderson LM, 2008, P NATL ACAD SCI USA, V105, P5827, DOI 10.1073/pnas.0705570105; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Arkin A, 1998, GENETICS, V149, P1633; Aurell E, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.048101; Bakk A, 2004, FEBS LETT, V563, P66, DOI 10.1016/S0014-5793(04)00249-2; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Bialek W, 2001, ADV NEUR IN, V13, P103; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Crews ST, 2009, CURR BIOL, V19, pR241, DOI 10.1016/j.cub.2009.01.015; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dodd IB, 2004, GENE DEV, V18, P344, DOI 10.1101/gad.1167904; Dodd IB, 2001, GENE DEV, V15, P3013, DOI 10.1101/gad.937301; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; EISEN H, 1970, P NATL ACAD SCI USA, V66, P855, DOI 10.1073/pnas.66.3.855; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Farewell A, 1998, J BACTERIOL, V180, P4704, DOI 10.1128/JB.180.17.4704-4710.1998; Ferrell JE, 2012, CURR BIOL, V22, pR458, DOI 10.1016/j.cub.2012.03.045; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; GAITANARIS GA, 1994, MOL MICROBIOL, V14, P861, DOI 10.1111/j.1365-2958.1994.tb01322.x; Golding I, 2011, ANNU REV BIOPHYS, V40, P63, DOI 10.1146/annurev-biophys-042910-155227; Gordon AJE, 2009, PLOS BIOL, V7, P364, DOI 10.1371/journal.pbio.1000044; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; Hensel Z, 2012, NAT STRUCT MOL BIOL, V19, P797, DOI 10.1038/nsmb.2336; HERENDEEN SL, 1979, J BACTERIOL, V139, P185, DOI 10.1128/JB.139.1.185-194.1979; Hershey A. D., 1971, BACTERIOPHAGE LAMBDA; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; JOHNSON AD, 1981, NATURE, V294, P217, DOI 10.1038/294217a0; Kampen NGv, 1981, STOCHASTIC PROCESSES; Lawrence Peter A, 1993, MAKING FLY GENETICS, V6; LEVINE A, 1979, J MOL BIOL, V131, P655, DOI 10.1016/0022-2836(79)90014-7; Lewis D, 2011, P NATL ACAD SCI USA, V108, P14807, DOI 10.1073/pnas.1111221108; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; Little JW, 1999, EMBO J, V18, P4299, DOI 10.1093/emboj/18.15.4299; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Mehta P, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026005; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Moler C, 2003, SIAM REV, V45, P3, DOI 10.1137/S00361445024180; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; PIRROTTA V, 1970, NATURE, V227, P41, DOI 10.1038/227041a0; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Press W. H., 1992, ART SCI COMPUTING; Ptashne M, 2004, GENETIC SWITCH PHAGE; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; REICHARDT L, 1971, P NATL ACAD SCI USA, V68, P2185, DOI 10.1073/pnas.68.9.2185; REINITZ J, 1990, J THEOR BIOL, V145, P295, DOI 10.1016/S0022-5193(05)80111-0; Santillan M, 2004, BIOPHYS J, V86, P75, DOI 10.1016/S0006-3495(04)74085-0; Schubert RA, 2007, GENE DEV, V21, P2461, DOI 10.1101/gad.1584907; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Slack J. M. W., 1991, REGIONAL SPECIFICATI; So LH, 2011, NAT GENET, V43, P554, DOI 10.1038/ng.821; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Svenningsen SL, 2005, P NATL ACAD SCI USA, V102, P4465, DOI 10.1073/pnas.0409839102; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; To TL, 2010, SCIENCE, V327, P1142, DOI 10.1126/science.1178962; TOMAN Z, 1985, J MOL BIOL, V186, P97, DOI 10.1016/0022-2836(85)90260-8; VILLAVERDE A, 1993, APPL ENVIRON MICROB, V59, P3485, DOI 10.1128/AEM.59.10.3485-3487.1993; Young JW, 2012, NAT PROTOC, V7, P80, DOI 10.1038/nprot.2011.432; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zeng LY, 2010, CELL, V141, P682, DOI 10.1016/j.cell.2010.03.034; Zong CH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.96	69	31	31	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100876	10.1371/journal.pone.0100876	http://dx.doi.org/10.1371/journal.pone.0100876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963924	Green Published, gold, Green Submitted			2022-12-25	WOS:000338709500094
J	Hauerslev, S; Vissing, J; Krag, TO				Hauerslev, Simon; Vissing, John; Krag, Thomas O.			Muscle Atrophy Reversed by Growth Factor Activation of Satellite Cells in a Mouse Muscle Atrophy Model	PLOS ONE			English	Article							SKELETAL-MUSCLE; IN-VITRO; MYOBLAST DIFFERENTIATION; TRANSCRIPTION FACTORS; MUSCULAR-DYSTROPHY; UBIQUITIN LIGASES; MYOSTATIN; PROLIFERATION; EXPRESSION; REGENERATION	Muscular dystrophies comprise a large group of inherited disorders that lead to progressive muscle wasting. We wanted to investigate if targeting satellite cells can enhance muscle regeneration and thus increase muscle mass. We treated mice with hepatocyte growth factor and leukemia inhibitory factor under three conditions: normoxia, hypoxia and during myostatin deficiency. We found that hepatocyte growth factor treatment led to activation of the Akt/mTOR/p70S6K protein synthesis pathway, up-regulation of the myognic transcription factors MyoD and myogenin, and subsequently the negative growth control factor, myostatin and atrophy markers MAFbx and MuRF1. Hypoxia-induced atrophy was partially restored by hepatocyte growth factor combined with leukemia inhibitory factor treatment. Dividing satellite cells were three-fold increased in the treatment group compared to control. Finally, we demonstrated that myostatin regulates satellite cell activation and myogenesis in vivo following treatment, consistent with previous findings in vitro. Our results suggest, not only a novel in vivo pharmacological treatment directed specifically at activating the satellite cells, but also a myostatin dependent mechanism that may contribute to the progressive muscle wasting seen in severely affected patients with muscular dystrophy and significant on-going regeneration. This treatment could potentially be applied to many conditions that feature muscle wasting to increase muscle bulk and strength.	[Hauerslev, Simon; Vissing, John; Krag, Thomas O.] Univ Copenhagen, Rigshosp, Dept Neurol, Neuromuscular Res Unit, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Krag, TO (corresponding author), Univ Copenhagen, Rigshosp, Dept Neurol, Neuromuscular Res Unit, DK-2100 Copenhagen, Denmark.	thomas.krag@regionh.dk	Krag, Thomas/AAD-3307-2021	Krag, Thomas/0000-0001-9330-668X	Lundbeck Foundation [R9-A783]; Aase og Ejnar Danielsen Fond [106179]; AP MAller Foundations [070126, 080140]; Research Council at Rigshospitalet	Lundbeck Foundation(Lundbeckfonden); Aase og Ejnar Danielsen Fond; AP MAller Foundations; Research Council at Rigshospitalet	This work was supported by the Lundbeck Foundation grant #R9-A783 (http://www.lundbeckfonden.com), Aase og Ejnar Danielsen Fond #106179 (http://www.danielsensfond.dk), AP MAller Foundations #070126,080140 (http://www.apmollerfonde.dk), and The Research Council at Rigshospitalet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RE, 1995, J CELL PHYSIOL, V165, P307, DOI 10.1002/jcp.1041650211; BARNARD W, 1994, J NEUROL SCI, V123, P108, DOI 10.1016/0022-510X(94)90211-9; Bersanini C, 2012, EUR RESPIR J, V39, P1206, DOI 10.1183/09031936.00087511; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Farkas GA, 2007, MUSCLE NERVE, V36, P708, DOI 10.1002/mus.20858; Gill R, 2010, J CELL SCI, V123, P1873, DOI 10.1242/jcs.061242; Grounds MD, 2002, J HISTOCHEM CYTOCHEM, V50, P589, DOI 10.1177/002215540205000501; Hauerslev S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066929; Hauerslev S, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-43; Koning M, 2011, TISSUE ENG PT A, V17, P1747, DOI 10.1089/ten.tea.2010.0624; Kook SH, 2008, CELL BIOL INT, V32, P871, DOI 10.1016/j.cellbi.2008.03.017; Krag TO, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-31; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Lokireddy S, 2011, MOL ENDOCRINOL, V25, P1936, DOI 10.1210/me.2011-1124; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McFarlane C, 2011, AM J PHYSIOL-CELL PH, V301, pC195, DOI 10.1152/ajpcell.00012.2011; Melacini P, 1996, NEUROMUSCULAR DISORD, V6, P367, DOI 10.1016/0960-8966(96)00357-4; Miller KJ, 2000, AM J PHYSIOL-CELL PH, V278, pC174, DOI 10.1152/ajpcell.2000.278.1.C174; Mosqueira M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069567; Mosqueira M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013450; Pistilli EE, 2010, AM J PHYSIOL-REG I, V298, pR96, DOI 10.1152/ajpregu.00138.2009; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Sheehan SM, 1999, J CELL PHYSIOL, V181, P499, DOI 10.1002/(SICI)1097-4652(199912)181:3<499::AID-JCP14>3.0.CO;2-1; Song YH, 2005, J INVEST MED, V53, P135, DOI 10.2310/6650.2005.00309; Spiller MP, 2002, MOL CELL BIOL, V22, P7066, DOI 10.1128/MCB.22.20.7066-7082.2002; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; TOMAS FM, 1992, BIOCHEM J, V282, P91, DOI 10.1042/bj2820091; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Villena J, 2004, J CELL PHYSIOL, V198, P169, DOI 10.1002/jcp.10422; White JD, 2001, MUSCLE NERVE, V24, P695, DOI 10.1002/mus.1057; White JD, 2001, CELL TISSUE RES, V306, P129, DOI 10.1007/s004410100432; Yamada M, 2010, AM J PHYSIOL-CELL PH, V298, pC465, DOI 10.1152/ajpcell.00449.2009	37	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100594	10.1371/journal.pone.0100594	http://dx.doi.org/10.1371/journal.pone.0100594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963862	Green Submitted, Green Published, gold			2022-12-25	WOS:000338709500067
J	Ryan, VH; Primiani, CT; Rao, JS; Ahn, K; Rapoport, SI; Blanchard, H				Ryan, Veronica H.; Primiani, Christopher T.; Rao, Jagadeesh S.; Ahn, Kwangmi; Rapoport, Stanley I.; Blanchard, Helene			Coordination of Gene Expression of Arachidonic and Docosahexaenoic Acid Cascade Enzymes during Human Brain Development and Aging	PLOS ONE			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); ALZHEIMERS-DISEASE BRAIN; HUMAN PREFRONTAL CORTEX; MICROARRAY DATA; SYNAPTIC MARKERS; CEREBRAL-CORTEX; STEM-CELLS; RAT-BRAIN; N-3 PUFA; METABOLISM	Background: The polyunsaturated arachidonic and docosahexaenoic acids (AA and DHA) participate in cell membrane synthesis during neurodevelopment, neuroplasticity, and neurotransmission throughout life. Each is metabolized via coupled enzymatic reactions within separate but interacting metabolic cascades. Hypothesis: AA and DHA pathway genes are coordinately expressed and underlie cascade interactions during human brain development and aging. Methods: The BrainCloud database for human non-pathological prefrontal cortex gene expression was used to quantify postnatal age changes in mRNA expression of 34 genes involved in AA and DHA metabolism. Results: Expression patterns were split into Development (0 to 20 years) and Aging (21 to 78 years) intervals. Expression of genes for cytosolic phospholipases A(2) (cPLA(2)), cyclooxygenases (COX)-1 and -2, and other AA cascade enzymes, correlated closely with age during Development, less so during Aging. Expression of DHA cascade enzymes was less inter-correlated in each period, but often changed in the opposite direction to expression of AA cascade genes. Except for the PLA2G4A (cPLA(2) IVA) and PTGS2 (COX-2) genes at 1q25, highly inter-correlated genes were at distant chromosomal loci. Conclusions: Coordinated age-related gene expression during the brain Development and Aging intervals likely underlies coupled changes in enzymes of the AA and DHA cascades and largely occur through distant transcriptional regulation. Healthy brain aging does not show upregulation of PLA2G4 or PTGS2 expression, which was found in Alzheimer's disease.	[Ryan, Veronica H.; Primiani, Christopher T.; Rao, Jagadeesh S.; Rapoport, Stanley I.; Blanchard, Helene] NIA, Brain Physiol & Metab Sect, Lab Neurosci, NIH, Bethesda, MD 20892 USA; [Ahn, Kwangmi] NIMH, Child Psychiat Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Ryan, VH (corresponding author), NIA, Brain Physiol & Metab Sect, Lab Neurosci, NIH, Bethesda, MD 20892 USA.	veronica.ryan@nih.gov	Ahn, Kwangmi/GLV-4077-2022	Ryan, Veronica/0000-0001-5121-4672	Intramural Research Programs of the National Institute on Aging at the National Institutes of Health	Intramural Research Programs of the National Institute on Aging at the National Institutes of Health	This work was supported by the Intramural Research Programs of the National Institute on Aging at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZARI NP, 1992, BRAIN RES, V589, P279, DOI 10.1016/0006-8993(92)91288-P; Balsinde J, 1998, P NATL ACAD SCI USA, V95, P7951, DOI 10.1073/pnas.95.14.7951; Basselin M, 2010, J LIPID RES, V51, P3166, DOI 10.1194/jlr.M008334; Bazan NG, 2002, PROSTAG OTH LIPID M, V68-9, P197, DOI 10.1016/S0090-6980(02)00031-X; Bazan NG, 2007, CURR OPIN CLIN NUTR, V10, P136, DOI 10.1097/MCO.0b013e32802b7030; Bazan NG, 2009, J LIPID RES, V50, pS400, DOI 10.1194/jlr.R800068-JLR200; Belkind-Gerson J, 2008, J PEDIATR GASTR NUTR, V47, pS7, DOI 10.1097/MPG.0b013e3181818e3f; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; Colantuoni C, 2002, BIOINFORMATICS, V18, P1540, DOI 10.1093/bioinformatics/18.11.1540; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Cunnane SC, 2013, PROSTAG LEUKOTR ESS, V88, P61, DOI 10.1016/j.plefa.2012.04.006; Dayan J, 2010, J PHYSIOL-PARIS, V104, P279, DOI 10.1016/j.jphysparis.2010.08.007; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Di Nunzio M, 2009, LIPIDS, V44, P1073, DOI 10.1007/s11745-009-3362-y; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Duplus E, 2002, BIOCHEM PHARMACOL, V64, P893, DOI 10.1016/S0006-2952(02)01157-7; Eisen M, 1998, CLUSTER 3 0 MANUAL; Esposito G, 2008, J NUCL MED, V49, P1414, DOI 10.2967/jnumed.107.049619; Freo U, 2005, AM J PSYCHIAT, V162, P2061, DOI 10.1176/appi.ajp.162.11.2061; FURTH EE, 1988, J BIOL CHEM, V263, P15951; Giovacchini G, 2004, J NUCL MED, V45, P1471; Gogtay N, 2007, J CHILD PSYCHOL PSYC, V48, P852, DOI 10.1111/j.1469-7610.2007.01747.x; Gogtay N, 2007, ARCH GEN PSYCHIAT, V64, P772, DOI 10.1001/archpsyc.64.7.772; Hatanpaa K, 1999, J NEUROPATH EXP NEUR, V58, P637, DOI 10.1097/00005072-199906000-00008; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Ho L, 2001, ARCH NEUROL-CHICAGO, V58, P487, DOI 10.1001/archneur.58.3.487; Hodzic M, 2013, Z GERONTOL GERIATR, V46, P629, DOI 10.1007/s00391-013-0531-7; HUTTENLOCHER PR, 1990, NEUROPSYCHOLOGIA, V28, P517, DOI 10.1016/0028-3932(90)90031-I; Igarashi M, 2011, J ALZHEIMERS DIS, V24, P507, DOI 10.3233/JAD-2011-101608; Igarashi M, 2010, J PSYCHIATR RES, V44, P177, DOI 10.1016/j.jpsychires.2009.08.001; Ilbanez V, 2004, BRAIN RES BULL, V63, P147, DOI 10.1016/j.brainresbull.2004.02.003; Kam PCA, 2000, ANAESTHESIA, V55, P442, DOI 10.1046/j.1365-2044.2000.01271.x; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; Keleshian VL, 2013, J NEUROCHEM, V125, P63, DOI 10.1111/jnc.12153; Kim HW, 2011, MOL PSYCHIATR, V16, P419, DOI 10.1038/mp.2009.137; Kim HW, 2011, PROSTAG LEUKOTR ESS, V85, P361, DOI 10.1016/j.plefa.2011.08.002; KOSS E, 1991, DEV NEUROPSYCHOL, V7, P99, DOI 10.1080/87565649109540479; Lands W., 1976, ENZYMES BIOL MEMBRAN, V2, P3; LAPOSATA M, 1987, METHOD ENZYMOL, V141, P350; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LESLIE JB, 1985, J NEUROSURG, V63, P659, DOI 10.3171/jns.1985.63.5.0659; Loerch PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003329; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Morrison JH, 2012, NAT REV NEUROSCI, V13, P240, DOI 10.1038/nrn3200; Moses GSD, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-28; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; Naraba H, 1998, J IMMUNOL, V160, P2974; NEUFELD EJ, 1985, J CELL BIOL, V101, P573, DOI 10.1083/jcb.101.2.573; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; O'Banion, 1999, Expert Opin Investig Drugs, V8, P1521, DOI 10.1517/13543784.8.10.1521; Ong WY, 2005, J NEUROCYTOL, V34, P447, DOI 10.1007/s11068-006-8730-4; Ong WY, 1999, J BRAIN RES, V39, P391; Pardue S, 2003, MOL BRAIN RES, V116, P106, DOI 10.1016/S0169-328X(03)00262-6; Persengiev S, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00032; Purdon A.D., 2007, HDB NEUROCHEMISTRY M, P401; Purdon AD, 1998, BIOCHEM J, V335, P313, DOI 10.1042/bj3350313; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rao JS, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.27; Rao JS, 2007, SOC NEUR ABSTR; Rapoport SI, 2008, J NUTR, V138, P2515, DOI 10.1093/jn/138.12.2515; Rapoport SI, 2009, BRAIN RES REV, V61, P185, DOI 10.1016/j.brainresrev.2009.06.003; Rapoport SI, 2008, PROSTAG LEUKOTR ESS, V79, P153, DOI 10.1016/j.plefa.2008.09.010; Rhie BH, 2013, BIOCHEM BIOPH RES CO, V439, P570, DOI 10.1016/j.bbrc.2013.09.017; ROBINSON PJ, 1992, BRAIN RES REV, V17, P187, DOI 10.1016/0165-0173(92)90016-F; Saiz L, 2001, BIOPHYS J, V81, P204, DOI 10.1016/S0006-3495(01)75692-5; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Scott KF, 1999, J LEUKOCYTE BIOL, V66, P535, DOI 10.1002/jlb.66.4.535; Serhan CN, 2005, CURR OPIN CLIN NUTR, V8, P115, DOI 10.1097/00075197-200503000-00003; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; SHIMIZU T, 1990, J NEUROCHEM, V55, P1, DOI 10.1111/j.1471-4159.1990.tb08813.x; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; SODERBERG M, 1991, LIPIDS, V26, P421, DOI 10.1007/BF02536067; Somel M, 2013, NAT REV NEUROSCI, V14, P112, DOI 10.1038/nrn3372; Somel M, 2010, GENOME RES, V20, P1207, DOI 10.1101/gr.106849.110; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Stephenson DT, 1996, NEUROBIOL DIS, V3, P51, DOI 10.1006/nbdi.1996.0005; SUN GY, 1989, ANN NY ACAD SCI, V559, P37; TAY A, 1995, GENOMICS, V26, P138, DOI 10.1016/0888-7543(95)80093-2; Ueno N, 2001, J BIOL CHEM, V276, P34918, DOI 10.1074/jbc.M100429200; Wang YS, 2013, J CELL BIOCHEM, V114, P2231, DOI 10.1002/jcb.24569; Xu LZ, 1996, J BIOL CHEM, V271, P24711; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3; Yamashita A, 1997, J BIOCHEM-TOKYO, V122, P1; Yu YQ, 2004, PROSTAG LEUKOTR ESS, V71, P405, DOI 10.1016/j.plefa.2004.09.001	88	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100858	10.1371/journal.pone.0100858	http://dx.doi.org/10.1371/journal.pone.0100858			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963629	gold, Green Published, Green Submitted			2022-12-25	WOS:000338709500090
J	Banno, T; Blumenberg, M				Banno, Tomohiro; Blumenberg, Miroslav			Keratinocyte Detachment-Differentiation Connection Revisited, or Anoikis-Pityriasi Nexus Redux	PLOS ONE			English	Article							EPIDERMAL-KERATINOCYTES; TERMINAL DIFFERENTIATION; INTERFERON-GAMMA; STEM-CELLS; ADHESION; EXPRESSION; INTEGRIN; PATHWAY; SKIN; ACTIVATION	Epidermis, a continuously self-renewing and differentiating organ, produces a protective stratum corneum that shields us from external chemical, physical and microbial threats. Epidermal differentiation is a multi-step process regulated by influences, some unknown, others insufficiently explored. Detachment of keratinocytes from the basement membrane is one such pro-differentiation stimulus. Here, we define the transcriptional changes during differentiation, especially those caused by detachment from the substratum. Using comprehensive transcriptional profiling, we revisited the effects of detachment as a differentiation signal to keratinocytes. We identified the genes regulated by detachment, the corresponding ontological categories and, using metaanalysis, compared the genes and categories to those regulated by other pro-differentiating stimuli. We identified 762 genes overexpressed in suspended keratinocyte, including known and novel differentiation markers, and 1427 in attached cells, including basal layer markers. Detachment induced epidermis development, cornification and desmosomal genes, but also innate immunity, proliferation inhibitors, transcription regulators and MAPKs; conversely the attached cells overexpressed cell cycle, anchoring, motility, splicing and mitochondrial genes, and both positive and negative regulators of apoptosis. Metaanalysis identified which detachment-regulated categories overlap with those induced by suprabasal location in vivo, by reaching confluency in vitro, and by inhibition of JUN kinases. Attached and in vivo basal cells shared overexpression of mitochondrial components. Interestingly, melanosome trafficking components were also overexpressed in the attached and in vivo basal keratinocytes. These results suggest that specific pro-differentiation signals induce specific features of the keratinization process, which are in vivo orchestrated into harmonious epidermal homeostasis.	[Banno, Tomohiro; Blumenberg, Miroslav] NYU, Langone Med Ctr, RO Perelman Dept Dermatol, New York, NY 10012 USA; [Blumenberg, Miroslav] NYU, Dept Mol Pharmacol & Biochem, Langone Med Ctr, New York, NY USA; [Blumenberg, Miroslav] NYU, Inst Canc, Langone Med Ctr, New York, NY USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Blumenberg, M (corresponding author), NYU, Langone Med Ctr, RO Perelman Dept Dermatol, New York, NY 10012 USA.	Miroslav.Blumenberg@nyumc.org		Blumenberg, Miroslav/0000-0002-8672-7774	R.O. Perelman Department of Dermatology, NYU Langone Medical Center	R.O. Perelman Department of Dermatology, NYU Langone Medical Center	The R.O. Perelman Department of Dermatology, NYU Langone Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1990, CELL, V63, P425, DOI 10.1016/0092-8674(90)90175-E; ADAMS JC, 1989, NATURE, V340, P307, DOI 10.1038/340307a0; Banno T, 2005, J BIOL CHEM, V280, P18973, DOI 10.1074/jbc.M411758200; Banno T, 2003, ANTIVIR THER, V8, P541; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Bertrand-Vallery V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010462; Bikle DD, 2012, EXPERT REV ENDOCRINO, V7, P461, DOI 10.1586/EEM.12.34; BLUMENBERG M, 1992, J INVEST DERMATOL, V98, pS42, DOI 10.1111/1523-1747.ep12462194; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; Chiricozzi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090284; Darmon Michel, 1993, P181; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; Efimova T, 2010, CELL CYCLE, V9, P498, DOI 10.4161/cc.9.3.10541; Feingold KR, 2013, BIOCHIM BIOPHYS ACTA, V18, P00249; Gazel A, 2006, J BIOL CHEM, V28, P28; Hamada T, 2013, EXP DERMATOL, V22, P83, DOI 10.1111/exd.12021; Hamanaka RB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003638; Han BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036941; Harmon RM, 2013, J CLIN INVEST, V123, P1556, DOI 10.1172/JCI65220; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jensen MA, 2014, NAT STRUCT MOL BIOL, V21, P189, DOI 10.1038/nsmb.2756; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Kretz M, 2012, GENE DEV, V26, P338, DOI 10.1101/gad.182121.111; Lee DD, 2009, J CELL PHYSIOL, V220, P427, DOI 10.1002/jcp.21784; Lee JS, 2009, EXP MOL MED, V41, P42, DOI 10.3858/emm.2009.41.1.006; Li DL, 2001, FASEB J, V15, P2533, DOI 10.1096/fj.01-0172fje; Lippens S, 2005, CELL DEATH DIFFER, V12, P1497, DOI 10.1038/sj.cdd.4401722; Lopez-Pajares V, 2013, TRENDS GENET, V29, P31, DOI 10.1016/j.tig.2012.10.005; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Mahadevappa M, 1999, NAT BIOTECHNOL, V17, P1134, DOI 10.1038/15124; Marconi A, 2004, J CELL SCI, V117, P5815, DOI 10.1242/jcs.01490; Marconi A, 2007, STEM CELLS, V25, P149, DOI 10.1634/stemcells.2006-0165; Margadant C, 2010, FASEB J, V24, P4133, DOI 10.1096/fj.09-151449; Mimoso C, 2013, METHOD MOL BIOL, V3, P3; MORRIS GM, 1987, CELL TISSUE KINET, V20, P161, DOI 10.1111/j.1365-2184.1987.tb01095.x; Perdigoto CN, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015263; Pyeon D, 2013, METHOD MOL BIOL, V27, P27; Radoja N, 2006, PHYSIOL GENOMICS, V27, P65, DOI 10.1152/physiolgenomics.00031.2006; Shen B, 2012, CURR OPIN CELL BIOL, V24, P600, DOI 10.1016/j.ceb.2012.08.011; Stojadinovic O, 2007, J BIOL CHEM, V282, P4021, DOI 10.1074/jbc.M606262200; Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000; Tiberio R, 2002, FEBS LETT, V524, P139, DOI 10.1016/S0014-5793(02)03040-5; Tran QT, 2012, PHYSIOL GENOMICS, V44, P455, DOI 10.1152/physiolgenomics.00176.2011; Tsuruta D, 2011, J DERMATOL SCI, V62, P1, DOI 10.1016/j.jdermsci.2011.01.005; Ura H, 2004, J DERMATOL SCI, V35, P19, DOI 10.1016/j.jdermsci.2004.03.005; Vukelic S, 2010, J BIOL CHEM, V285, P1980, DOI 10.1074/jbc.M109.016741; Walsh R, 2011, J BIOL CHEM, V286, P9419, DOI 10.1074/jbc.M110.197087; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Wu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045761; Yin TF, 2004, SEMIN CELL DEV BIOL, V15, P665, DOI 10.1016/j.semcdb.2004.09.005	50	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100279	10.1371/journal.pone.0100279	http://dx.doi.org/10.1371/journal.pone.0100279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960166	Green Submitted, Green Published, gold			2022-12-25	WOS:000338633900036
J	Kapadia, M; Zhao, H; Ma, DL; Hatkar, R; Marchese, M; Sakic, B				Kapadia, Minesh; Zhao, Hui; Ma, Donglai; Hatkar, Rupal; Marchese, Monica; Sakic, Boris			Zoopharmacognosy in Diseased Laboratory Mice: Conflicting Evidence	PLOS ONE			English	Article							MRL-LPR MICE; DIETARY SELF-SELECTION; CHRONIC MILD STRESS; AUTOIMMUNE-DISEASE; SOIL CONSUMPTION; FAS ANTIGEN; LUPUS; SUCROSE; MOUSE; CYCLOPHOSPHAMIDE	Zoopharmacognosy denotes a constellation of learned ingestive responses that promote healing and survival of infected or poisoned animals. A similar self-medication phenomenon was reported in diseased laboratory rodents. In particular, a series of studies revealed that autoimmune MRL/lpr mice readily consume solutions paired or laced with cyclophosphamide (CY), an immunosuppressive drug that prevents inflammatory damage to internal organs. However, due to design limitations, it could not be elucidated whether such a response reflects the learned therapeutic effect of CY, or a deficit in sensory input. We presently assess the behavioural effects of prolonged consumption of CY-laced, 16% sucrose solution in a continuous choice paradigm, with tap water available ad lib. Contrary to overall expectation, MRL/lpr mice did not increase their intake of CY with disease progression. Moreover, they ingested lower doses of CY and preferred less CY-laced sucrose solution than age-matched controls. The results obtained could not confirm zoopharmacognosy in diseased MRL/lpr mice, likely due to impaired responsiveness to palatable stimulation, or attenuated survival mechanisms after prolonged inbreeding in captivity. However, by revealing the effectiveness of unrestricted drinking of drug-laced sucrose solution on behavior and immunity, the current study supports broader use of such an administration route in behavioural studies sensitive to external stressors.	[Kapadia, Minesh; Zhao, Hui; Hatkar, Rupal; Sakic, Boris] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Ma, Donglai] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Marchese, Monica] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Sakic, B (corresponding author), McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada.	sakic@mcmaster.ca		Kapadia, Minesh/0000-0003-1380-7551	Father Sean O'Sullivan Foundation (St. Joseph's hospital, Hamilton, Ontario)	Father Sean O'Sullivan Foundation (St. Joseph's hospital, Hamilton, Ontario)	This project was funded by PhD scholarship from the Father Sean O'Sullivan Foundation (St. Joseph's hospital, Hamilton, Ontario) to Minesh Kapadia. The Father Sean O'Sullivan Foundation had no role in the in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Attardo C, 2003, Boll Chim Farm, V142, P54; Ballok DA, 2004, HIPPOCAMPUS, V14, P649, DOI 10.1002/hipo.10205; Ballok DA, 2003, BEHAV BRAIN RES, V140, P119, DOI 10.1016/S0166-4328(02)00276-0; BELLUSH LL, 1986, BRAIN RES BULL, V17, P653, DOI 10.1016/0361-9230(86)90197-8; DAVIES AG, 1988, BIOTROPICA, V20, P252, DOI 10.2307/2388241; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Diamond JM, 1999, NATURE, V400, P120, DOI 10.1038/22014; Dixon F J, 1978, Arthritis Rheum, V21, pS64, DOI 10.1002/art.1780210909; GALEF BG, 1991, PSYCHOL REV, V98, P218, DOI 10.1037/0033-295X.98.2.218; GARCIA J, 1974, SCIENCE, V185, P824, DOI 10.1126/science.185.4154.824; GROTA L J, 1989, Brain Behavior and Immunity, V3, P263, DOI 10.1016/0889-1591(89)90041-X; GROTA L J, 1987, Brain Behavior and Immunity, V1, P238, DOI 10.1016/0889-1591(87)90026-2; GROTA LJ, 1990, PHARMACOL BIOCHEM BE, V37, P527, DOI 10.1016/0091-3057(90)90023-B; Huffman MA, 2003, P NUTR SOC, V62, P371, DOI 10.1079/PNS2003257; Huffman MA, 2001, INT J PRIMATOL, V22, P329, DOI 10.1023/A:1010734310002; JIMENEZ JA, 1994, SCIENCE, V266, P271, DOI 10.1126/science.7939661; Kim A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035588; KREULEN DA, 1985, MAMMAL REV, V15, P107, DOI 10.1111/j.1365-2907.1985.tb00391.x; Loheswaran G, 2010, CLIN EXP NEUROIMMUNO, V1, P141; Loheswaran G, 2013, BRAIN BEHAV IMMUN, V32, P86, DOI 10.1016/j.bbi.2013.02.006; Meagher S, 2000, P NATL ACAD SCI USA, V97, P3324, DOI 10.1073/pnas.060284797; MONLEON S, 1995, PSYCHOPHARMACOLOGY, V117, P453, DOI 10.1007/BF02246218; Mukherjee N, 2011, NEUROSCIENCE, V192, P732, DOI 10.1016/j.neuroscience.2011.07.006; Mukherjee N, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061607, 10.1371/annotation/5487e265-8175-47cb-b9a4-d85862a4a96f]; MUSCAT R, 1992, NEUROSCI BIOBEHAV R, V16, P507, DOI 10.1016/S0149-7634(05)80192-7; OATES JF, 1978, BIOTROPICA, V10, P241, DOI 10.2307/2387676; Raman R, 2008, RESONANCE, V13, P245, DOI 10.1007/s12045-008-0038-5; SAKIC B, 1994, PHYSIOL BEHAV, V56, P609, DOI 10.1016/0031-9384(94)90309-3; SAKIC B, 1992, BRAIN BEHAV IMMUN, V6, P265; Sakic B, 1996, BRAIN RES BULL, V41, P305, DOI 10.1016/S0361-9230(96)00190-6; SAKIC B, 1995, PHYSIOL BEHAV, V58, P797; Sakic B, 1998, J NEUROIMMUNOL, V87, P162, DOI 10.1016/S0165-5728(98)00085-X; SAKIC B, 1993, BEHAV BRAIN RES, V54, P57, DOI 10.1016/0166-4328(93)90048-U; Sled JG, 2009, ARTHRITIS RHEUM-US, V60, P1764, DOI 10.1002/art.24523; Theofilopoulos AN, 1992, SYSTEMIC LUPUS ERYTH, P121; Villalba JJ, 2012, SMALL RUMINANT RES, V103, P50, DOI 10.1016/j.smallrumres.2011.10.018; WATANABEFUKUNAGA R, 1992, J IMMUNOL, V148, P1274; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Williams S, 2010, J NEUROIMMUNOL, V218, P73, DOI 10.1016/j.jneuroim.2009.10.008; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; WRANGHAM RW, 1995, AM J PRIMATOL, V37, P297, DOI 10.1002/ajp.1350370404; ZAHORIK DM, 1974, J COMP PHYSIOL PSYCH, V87, P1083, DOI 10.1037/h0037585	43	4	4	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100684	10.1371/journal.pone.0100684	http://dx.doi.org/10.1371/journal.pone.0100684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956477	Green Published, gold, Green Submitted			2022-12-25	WOS:000338917900081
J	Claidiere, N; Bowler, M; Brookes, S; Brown, R; Whiten, A				Claidiere, Nicolas; Bowler, Mark; Brookes, Sarah; Brown, Rebecca; Whiten, Andrew			Frequency of Behavior Witnessed and Conformity in an Everyday Social Context	PLOS ONE			English	Article							CULTURAL TRANSMISSION; EVOLUTION; ENVIRONMENT; MAJORITY	Conformity is thought to be an important force in human evolution because it has the potential to stabilize cultural homogeneity within groups and cultural diversity between groups. However, the effects of such conformity on cultural and biological evolution will depend much on the particular way in which individuals are influenced by the frequency of alternative behavioral options they witness. In a previous study we found that in a natural situation people displayed a tendency to be 'linear-conformist'. When visitors to a Zoo exhibit were invited to write or draw answers to questions on cards to win a small prize and we manipulated the proportion of text versus drawings on display, we found a strong and significant effect of the proportion of text displayed on the proportion of text in the answers, a conformist effect that was largely linear with a small non-linear component. However, although this overall effect is important to understand cultural evolution, it might mask a greater diversity of behavioral responses shaped by variables such as age, sex, social environment and attention of the participants. Accordingly we performed a further study explicitly to analyze the effects of these variables, together with the quality of the information participants' responses made available to further visitors. Results again showed a largely linear conformity effect that varied little with the variables analyzed.	[Claidiere, Nicolas; Bowler, Mark; Brookes, Sarah; Brown, Rebecca; Whiten, Andrew] Univ St Andrews, Sch Psychol & Neurosci, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland; [Claidiere, Nicolas] Aix Marseille Univ, CNRS, Lab Psychol Cognit, UMR 7290, Marseille, France; [Bowler, Mark] San Diego Zoo Global, Inst Conservat Res, Iquitos, Peru	University of St Andrews; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Claidiere, N (corresponding author), Univ St Andrews, Sch Psychol & Neurosci, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland.	nicolas.claidiere@normalesup.org	Claidiere, Nicolas/HGE-8036-2022; Bowler, Mark/I-1967-2019	Bowler, Mark/0000-0001-5236-3477; Claidiere, Nicolas/0000-0002-4472-6597; Whiten, Andrew/0000-0003-2426-5890	Wellcome Trust [WT094440MA]; Fyssen Foundation; John Templeton Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Fyssen Foundation; John Templeton Foundation	MB was supported by grant WT094440MA from the Wellcome Trust to AW. The study was begun while NC was supported by a Research Fellowship from the Fyssen Foundation and later by a John Templeton Foundation grant to AW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerbi A, 2014, EVOL HUM BEHAV, V35, P228, DOI 10.1016/j.evolhumbehav.2014.02.003; ASCH SE, 1955, SCI AM, V193, P31, DOI 10.1038/scientificamerican1155-31; ASCH SE, 1956, PSYCHOL MONOGR, V70, P1, DOI 10.1037/h0093718; Bentley RA, 2004, P ROY SOC B-BIOL SCI, V271, P1443, DOI 10.1098/rspb.2004.2746; Bowler MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034505; Boyd R., 1985, CULTURE EVOLUTIONARY; Boyd R., 2005, ORIGIN EVOLUTION CUL; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Claidiere N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030970; Claidiere N, 2012, PSYCHOL BULL, V138, P126, DOI 10.1037/a0025868; Corriveau KH, 2010, DEV PSYCHOL, V46, P437, DOI 10.1037/a0017553; Corriveau KH, 2009, PSYCHOL SCI, V20, P372, DOI 10.1111/j.1467-9280.2009.02291.x; Coultas JC, 2004, GROUP PROCESS INTERG, V7, P317, DOI 10.1177/1368430204046141; Efferson C, 2008, EVOL HUM BEHAV, V29, P56, DOI 10.1016/j.evolhumbehav.2007.08.003; Efferson C, 2007, EVOL HUM BEHAV, V28, P11, DOI 10.1016/j.evolhumbehav.2006.05.005; Eriksson K., 2009, J EVOL PSYCHOL, V7, P5, DOI [10.1556/JEP.7.2009.1.3, DOI 10.1556/JEP.7.2009.1.3]; Eriksson K., 2007, J EVOL PSYCHOL, V5, P67, DOI [10.1556/JEP.2007.1009, DOI 10.1556/JEP.2007.1009]; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; Henrich J, 2001, J THEOR BIOL, V208, P79, DOI 10.1006/jtbi.2000.2202; Kameda T, 2002, EVOL HUM BEHAV, V23, P373, DOI 10.1016/S1090-5138(02)00101-0; Kendal J, 2009, J THEOR BIOL, V260, P210, DOI 10.1016/j.jtbi.2009.05.029; Macdonald C., 2011, International Zoo Yearbook, V45, P7, DOI 10.1111/j.1748-1090.2010.00120.x; McElreath R, 2005, EVOL HUM BEHAV, V26, P483, DOI 10.1016/j.evolhumbehav.2005.04.003; McElreath R, 2008, PHILOS T R SOC B, V363, P3515, DOI 10.1098/rstb.2008.0131; Mesoudi A, 2009, EVOL HUM BEHAV, V30, P41, DOI 10.1016/j.evolhumbehav.2008.07.005; Morgan TJH, 2012, P ROY SOC B-BIOL SCI, V279, P653, DOI 10.1098/rspb.2011.1172; Nakahashi W, 2007, THEOR POPUL BIOL, V72, P52, DOI 10.1016/j.tpb.2007.03.003; Wakano JY, 2007, THEOR POPUL BIOL, V72, P504, DOI 10.1016/j.tpb.2007.04.003; Walker MB, 1996, J SOC PSYCHOL, V136, P367, DOI 10.1080/00224545.1996.9714014	29	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99874	10.1371/journal.pone.0099874	http://dx.doi.org/10.1371/journal.pone.0099874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2UZ	24950212	gold, Green Published, Green Submitted			2022-12-25	WOS:000338276300022
J	Fulham, WR; Michie, PT; Ward, PB; Rasser, PE; Todd, J; Johnston, PJ; Thompson, PM; Schall, U				Fulham, W. Ross; Michie, Patricia T.; Ward, Philip B.; Rasser, Paul E.; Todd, Juanita; Johnston, Patrick J.; Thompson, Paul M.; Schall, Ulrich			Mismatch Negativity in Recent-Onset and Chronic Schizophrenia: A Current Source Density Analysis	PLOS ONE			English	Article							AUDITORY CHANGE-DETECTION; INFORMATION-PROCESSING DEFICITS; ULTRA-HIGH-RISK; PREFRONTAL CORTEX; FREQUENCY CHANGES; ELECTROPHYSIOLOGICAL EVIDENCE; 1ST-EPISODE PSYCHOSIS; SPECTRUM DISORDERS; NEURAL CIRCUITRY; PARIETAL LOBULE	Mismatch negativity (MMN) is a component of the event-related potential elicited by deviant auditory stimuli. It is presumed to index pre-attentive monitoring of changes in the auditory environment. MMN amplitude is smaller in groups of individuals with schizophrenia compared to healthy controls. We compared duration-deviant MMN in 16 recent-onset and 19 chronic schizophrenia patients versus age-and sex-matched controls. Reduced frontal MMN was found in both patient groups, involved reduced hemispheric asymmetry, and was correlated with Global Assessment of Functioning (GAF) and negative symptom ratings. A cortically-constrained LORETA analysis, incorporating anatomical data from each individual's MRI, was performed to generate a current source density model of the MMN response over time. This model suggested MMN generation within a temporal, parietal and frontal network, which was right hemisphere dominant only in controls. An exploratory analysis revealed reduced CSD in patients in superior and middle temporal cortex, inferior and superior parietal cortex, precuneus, anterior cingulate, and superior and middle frontal cortex. A region of interest (ROI) analysis was performed. For the early phase of the MMN, patients had reduced bilateral temporal and parietal response and no lateralisation in frontal ROIs. For late MMN, patients had reduced bilateral parietal response and no lateralisation in temporal ROIs. In patients, correlations revealed a link between GAF and the MMN response in parietal cortex. In controls, the frontal response onset was 17 ms later than the temporal and parietal response. In patients, onset latency of the MMN response was delayed in secondary, but not primary, auditory cortex. However amplitude reductions were observed in both primary and secondary auditory cortex. These latency delays may indicate relatively intact information processing upstream of the primary auditory cortex, but impaired primary auditory cortex or cortico-cortical or thalamo-cortical communication with higher auditory cortices as a core deficit in schizophrenia.	[Fulham, W. Ross; Michie, Patricia T.; Rasser, Paul E.; Todd, Juanita; Schall, Ulrich] Univ Newcastle, Ctr Translat Neurosci & Mental Hlth, Newcastle, NSW 2300, Australia; [Fulham, W. Ross; Michie, Patricia T.; Rasser, Paul E.; Todd, Juanita; Thompson, Paul M.; Schall, Ulrich] Schizophrenia Res Inst, Darlinghurst, NSW, Australia; [Fulham, W. Ross; Rasser, Paul E.; Schall, Ulrich] Hunter Med Res Inst, Newcastle, NSW, Australia; [Michie, Patricia T.; Todd, Juanita] Univ Newcastle, Sch Psychol, Newcastle, NSW 2300, Australia; [Ward, Philip B.] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Ward, Philip B.] South Western Sydney Local Hlth Dist, Schizophrenia Res Unit, Sydney, NSW, Australia; [Johnston, Patrick J.] Univ York, Dept Psychol, Heslington, Yorks, England; [Johnston, Patrick J.] Univ York, York Neuroimaging Ctr, Heslington, Yorks, England; [Thompson, Paul M.] Univ So Calif, Keck Sch Med, Imaging Genet Ctr, Inst Neuroimaging & Informat, Los Angeles, CA 90033 USA; [Thompson, Paul M.] Univ So Calif, Dept Neurol, Los Angeles, CA USA; [Thompson, Paul M.] Univ So Calif, Dept Psychiat, Los Angeles, CA USA; [Thompson, Paul M.] Univ So Calif, Dept Radiol, Los Angeles, CA USA; [Thompson, Paul M.] Univ So Calif, Dept Engn, Los Angeles, CA USA; [Thompson, Paul M.] Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA; [Thompson, Paul M.] Univ So Calif, Dept Ophthalmol, Los Angeles, CA 90089 USA	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of New South Wales Sydney; University of York - UK; University of York - UK; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Fulham, WR (corresponding author), Univ Newcastle, Ctr Translat Neurosci & Mental Hlth, Newcastle, NSW 2300, Australia.	ross.fulham@newcastle.edu.au	Ward, Philip/E-3959-2010; Thompson, Paul M/C-4194-2018; Johnston, Patrick/P-3158-2014; SCHALL, ULRICH ANDREAS/G-7452-2013; , Juanita/B-6191-2013	Ward, Philip/0000-0002-5779-7722; Thompson, Paul M/0000-0002-4720-8867; Johnston, Patrick/0000-0001-7703-1073; SCHALL, ULRICH ANDREAS/0000-0001-9041-4562; , Juanita/0000-0002-0443-600X	National Health and Medical Research Council of Australia [252480]; NSW Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015922] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NSW Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This project was funded by a National Health and Medical Research Council of Australia Project Grant, ID 252480. The contents of this article are solely the responsibility of the authors and do not reflect the views of NHMRC (http://www.nhmrc.gov.au/). Infrastructure support was received from the Hunter Medical Research Institute (http://www.hmri.com.au/) and the Schizophrenia Research Institute (http://www.schizophreniaresearch.org.au/), which are supported by infrastructure funding from NSW Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alho K, 1998, PSYCHOPHYSIOLOGY, V35, P211, DOI 10.1111/1469-8986.3520211; Andreasen N. C., 1984, SCALE ASSESSMENT POS; Andreasen NC, 1983, SCALE ASSESSMENT NEG; Atkinson RJ, 2012, BIOL PSYCHIAT, V71, P98, DOI 10.1016/j.biopsych.2011.08.023; Ayala Y, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00089; Baldeweg T, 2004, SCHIZOPHR RES, V69, P203, DOI 10.1016/j.schres.2003.09.009; Bodatsch M, 2011, BIOL PSYCHIAT, V69, P959, DOI 10.1016/j.biopsych.2010.09.057; Brockhaus-Dumke A, 2005, SCHIZOPHR RES, V73, P297, DOI 10.1016/j.schres.2004.05.016; CATTS SV, 1995, AM J PSYCHIAT, V152, P213; Cheng CH, 2013, INT J PSYCHOPHYSIOL, V90, P165, DOI 10.1016/j.ijpsycho.2013.06.026; CSEPE V, 1991, INT J PSYCHOPHYSIOL, V11, P19, DOI 10.1016/0167-8760(91)90093-D; Devrim-Ucok M, 2007, EUR ARCH PSY CLIN N, V258, P179; Dickey CC, 2008, SCHIZOPHR RES, V103, P26, DOI 10.1016/j.schres.2008.04.041; Dima D, 2012, SCHIZOPHR RES, V135, P23, DOI 10.1016/j.schres.2011.12.024; Dittmann-Balcar A, 2001, NEUROSCI LETT, V308, P119, DOI 10.1016/S0304-3940(01)01995-4; Doeller CF, 2003, NEUROIMAGE, V20, P1270, DOI 10.1016/S1053-8119(03)00389-6; Edwards E, 2005, J NEUROPHYSIOL, V94, P4269, DOI 10.1152/jn.00324.2005; Escera C, 2013, BRAIN TOPOG IN PRESS, DOI [10.1007/s10548-10013-10328-10544, DOI 10.1007/S10548-10013-10328-10544]; First M. B., 1997, STRUCTURED CLIN INTE; Fisher DJ, 2011, INT J PSYCHOPHYSIOL, V81, P245, DOI 10.1016/j.ijpsycho.2011.06.018; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Garrido MI, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002999; Garrido MI, 2009, J NEUROPHYSIOL, V101, P2620, DOI 10.1152/jn.90291.2008; GIARD MH, 1990, PSYCHOPHYSIOLOGY, V27, P627, DOI 10.1111/j.1469-8986.1990.tb03184.x; Grimm S, 2012, INT J PSYCHOPHYSIOL, V85, P88, DOI 10.1016/j.ijpsycho.2011.05.012; Grimm S, 2011, PSYCHOPHYSIOLOGY, V48, P377, DOI 10.1111/j.1469-8986.2010.01073.x; Grzella I, 2001, J PSYCHIATR NEUROSCI, V26, P235; HALGREN E, 1995, ELECTROEN CLIN NEURO, V94, P191, DOI 10.1016/0013-4694(94)00259-N; Hermens DF, 2010, PROG NEURO-PSYCHOPH, V34, P822, DOI 10.1016/j.pnpbp.2010.03.019; Hirayasu Y, 1998, AM J PSYCHIAT, V155, P1281, DOI 10.1176/ajp.155.9.1281; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Hsiao FJ, 2010, BIOL PSYCHOL, V84, P336, DOI 10.1016/j.biopsycho.2010.03.019; Hu B, 2003, EXP BRAIN RES, V153, P543, DOI 10.1007/s00221-003-1611-5; Hughes HC, 2001, NEUROIMAGE, V13, P1073, DOI 10.1006/nimg.2001.0766; Jaaskelainen IP, 1996, BIOL PSYCHOL, V43, P13, DOI 10.1016/0301-0511(95)05174-0; Jablensky A, 2000, AUST NZ J PSYCHIAT, V34, P221, DOI 10.1046/j.1440-1614.2000.00728.x; Jacobsen T, 2003, CLIN NEUROPHYSIOL, V114, P1133, DOI 10.1016/S1388-2457(03)00043-9; Jahshan C, 2012, PSYCHOL MED, V42, P85, DOI 10.1017/S0033291711001061; Javitt DC, 2000, CLIN NEUROPHYSIOL, V111, P1733, DOI 10.1016/S1388-2457(00)00377-1; Jemel B, 2002, BRAIN TOPOGR, V15, P13, DOI 10.1023/A:1019944805499; Kasai K, 1999, NEUROREPORT, V10, P2267, DOI 10.1097/00001756-199908020-00008; Kasai K, 2002, AM J PSYCHIAT, V159, P546, DOI 10.1176/appi.ajp.159.4.546; Kaur M, 2013, PROG NEURO-PSYCHOPH, V46, P161, DOI 10.1016/j.pnpbp.2013.07.002; Kaur M, 2011, SCHIZOPHR RES, V130, P203, DOI 10.1016/j.schres.2011.03.025; Kawakubo Y, 2006, PROG NEURO-PSYCHOPH, V30, P1367, DOI 10.1016/j.pnpbp.2006.03.003; Kiang M, 2007, J INT NEUROPSYCH SOC, V13, P653, DOI 10.1017/S1355617707070816; Kiang M, 2009, CLIN NEUROPHYSIOL, V120, P1949, DOI 10.1016/j.clinph.2009.08.019; Kircher TTJ, 2004, AM J PSYCHIAT, V161, P294, DOI 10.1176/appi.ajp.161.2.294; Kujala T, 2007, BIOL PSYCHOL, V74, P1, DOI 10.1016/j.biopsycho.2006.06.001; Lappe C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061296; LAVIKAINEN J, 1995, EVOKED POTENTIAL, V96, P93, DOI 10.1016/0013-4694(94)00283-Q; Leung S, 2013, CLIN NEUROPHYSIOL, V124, P2397, DOI 10.1016/j.clinph.2013.06.001; Levanen S, 1996, CEREB CORTEX, V6, P288, DOI 10.1093/cercor/6.2.288; Lewis DA, 2009, J CLIN INVEST, V119, P706, DOI 10.1172/JCI37335; Lieder F, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002911; Light GA, 2005, AM J PSYCHIAT, V162, P1741, DOI 10.1176/appi.ajp.162.9.1741; Light GA, 2005, ARCH GEN PSYCHIAT, V62, P127, DOI 10.1001/archpsyc.62.2.127; Light GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039434; LUBORSKY L, 1962, ARCH GEN PSYCHIAT, V7, P407; Magno E, 2008, BIOL PSYCHIAT, V64, P385, DOI 10.1016/j.biopsych.2008.03.019; Marco-Pallares J, 2005, NEUROIMAGE, V25, P471, DOI 10.1016/j.neuroimage.2004.11.028; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Michie PT, 2000, CLIN NEUROPHYSIOL, V111, P1054, DOI 10.1016/S1388-2457(00)00275-3; Michie PT, 2002, BIOL PSYCHIAT, V52, P749, DOI 10.1016/S0006-3223(02)01379-3; Michie PT, 2001, INT J PSYCHOPHYSIOL, V42, P177, DOI 10.1016/S0167-8760(01)00166-0; Miller J, 1998, PSYCHOPHYSIOLOGY, V35, P99, DOI 10.1111/1469-8986.3510099; Miyanishi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061152; Molholm S, 2005, CEREB CORTEX, V15, P545, DOI 10.1093/cercor/bhh155; Molholm S, 2006, J NEUROPHYSIOL, V96, P721, DOI 10.1152/jn.00285.2006; Mordkoff JT, 2000, PSYCHOPHYSIOLOGY, V37, P347; Morey RA, 2008, J NEUROPSYCH CLIN N, V20, P419, DOI 10.1176/appi.neuropsych.20.4.419; Muller BW, 2002, NEUROIMAGE, V17, P231, DOI 10.1006/nimg.2002.1176; NAATANEN R, 1979, BIOL PSYCHOL, V8, P81, DOI 10.1016/0301-0511(79)90053-X; Naatanen R, 2012, CLIN NEUROPHYSIOL, V123, P424, DOI 10.1016/j.clinph.2011.09.020; Naatanen R, 2009, INT J NEUROPSYCHOPH, V12, P125, DOI 10.1017/S1461145708009322; Nagai T, 2013, SCHIZOPHR RES, V150, P547, DOI 10.1016/j.schres.2013.08.005; Novitski N, 2006, J NEUROSCI METH, V155, P149, DOI 10.1016/j.jneumeth.2006.01.030; Oades RD, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-7; Oertel-Knochell V, 2011, NEUROSCIENTIST, V17, P456, DOI 10.1177/1073858410386493; Oknina LB, 2005, SCHIZOPHR RES, V76, P25, DOI 10.1016/j.schres.2004.10.003; Opitz B, 2002, NEUROIMAGE, V15, P167, DOI 10.1006/nimg.2001.0970; Paavilainen P, 2003, NEUROSCI LETT, V349, P79, DOI 10.1016/S0304-3940(03)00787-0; Park HJ, 2002, HUM BRAIN MAPP, V17, P168, DOI 10.1002/hbm.10059; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P91; Pekkonen E, 2002, SCHIZOPHRENIA BULL, V28, P467, DOI 10.1093/oxfordjournals.schbul.a006954; Perez VB, 2013, BIOL PSYCHIAT, DOI [10.1016/j.biopsych.2013.1007.1038, DOI 10.1016/J.BIOPSYCH.2013.1007.1038]; Rasser PE, 2011, SCHIZOPHRENIA BULL, V37, P131, DOI 10.1093/schbul/sbp060; Rauschecker JP, 2011, HEARING RES, V271, P16, DOI 10.1016/j.heares.2010.09.001; Restuccia D, 2005, COGNITIVE BRAIN RES, V25, P891, DOI 10.1016/j.cogbrainres.2005.09.023; Rinne T, 2005, NEUROIMAGE, V26, P66, DOI 10.1016/j.neuroimage.2005.01.017; Rinne T, 2000, NEUROIMAGE, V12, P14, DOI 10.1006/nimg.2000.0591; Rinne T, 2007, NEUROSCI LETT, V416, P247, DOI 10.1016/j.neulet.2007.01.077; Rissling AJ, 2012, CLIN NEUROPHYSIOL, V123, P1942, DOI 10.1016/j.clinph.2012.02.079; Rosburg T, 2004, HUM BRAIN MAPP, V21, P44, DOI 10.1002/hbm.10146; Salisbury DF, 2007, ARCH GEN PSYCHIAT, V64, P521, DOI 10.1001/archpsyc.64.5.521; Salisbury DF, 2002, ARCH GEN PSYCHIAT, V59, P686, DOI 10.1001/archpsyc.59.8.686; Salmi J, 2009, BRAIN RES, V1286, P155, DOI 10.1016/j.brainres.2009.06.083; Sato Y, 2000, NEUROREPORT, V11, P3703, DOI 10.1097/00001756-200011270-00023; Sato Y, 2003, BIOL PSYCHOL, V62, P49, DOI 10.1016/S0301-0511(02)00113-8; Schall U, 1999, INT J NEUROPSYCHOPH, V2, P83, DOI 10.1017/S1461145799001418; Schall U, 2003, NEUROIMAGE, V20, P729, DOI 10.1016/S1053-8119(03)00398-7; Schmidt A, 2013, CEREB CORTEX, V23, P2394, DOI 10.1093/cercor/bhs238; Schonwiesner M, 2007, J NEUROPHYSIOL, V97, P2075, DOI 10.1152/jn.01083.2006; Schwarzenau P, 1998, BEHAV RES METH INS C, V30, P110, DOI 10.3758/BF03209421; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; SHELLEY AM, 1991, BIOL PSYCHIAT, V30, P1059, DOI 10.1016/0006-3223(91)90126-7; Shin KS, 2012, SCHIZOPHRENIA BULL, V38, P1258, DOI 10.1093/schbul/sbr138; Shin KS, 2009, BIOL PSYCHIAT, V65, P1071, DOI 10.1016/j.biopsych.2008.12.024; Shinozaki N, 2002, BIOL PSYCHOL, V59, P105, DOI 10.1016/S0301-0511(01)00129-6; Swadlow HA, 2012, SCHOLARPEDIA, V7, P1451, DOI DOI 10.4249/SCHOLARPEDIA.1451; Sweet RA, 2007, BIOL PSYCHIAT, V61, P854, DOI 10.1016/j.biopsych.2006.07.033; Sweet RA, 2009, NEUROPSYCHOPHARMACOL, V34, P374, DOI 10.1038/npp.2008.67; Takahashi H, 2013, NEUROIMAGE, V66, P594, DOI 10.1016/j.neuroimage.2012.09.074; Tervaniemi M, 2005, CLIN NEUROPHYSIOL, V116, P1897, DOI 10.1016/j.clinph.2005.03.025; Thonnessen H, 2008, BIOL PSYCHOL, V77, P205, DOI 10.1016/j.biopsycho.2007.10.009; Thompson PM, 2001, P NATL ACAD SCI USA, V98, P11650, DOI 10.1073/pnas.201243998; Todd J, 2008, BIOL PSYCHIAT, V63, P58, DOI 10.1016/j.biopsych.2007.02.016; Torrey EF, 2007, SCHIZOPHR RES, V97, P215, DOI 10.1016/j.schres.2007.08.023; Tse CY, 2008, NEUROIMAGE, V41, P1462, DOI 10.1016/j.neuroimage.2008.03.043; Tse CY, 2013, NEUROIMAGE, V83, P870, DOI 10.1016/j.neuroimage.2013.07.037; Tse CY, 2007, IEEE ENG MED BIOL, V26, P52, DOI 10.1109/MEMB.2007.384096; Turetsky BI, 2009, PSYCHIAT RES, V165, P27, DOI 10.1016/j.psychres.2008.04.013; Umbricht D, 2005, SCHIZOPHR RES, V76, P1, DOI 10.1016/j.schres.2004.12.002; Umbricht D, 2003, BIOL PSYCHIAT, V53, P1120, DOI 10.1016/S0006-3223(02)01642-6; Umbricht DSG, 2006, BIOL PSYCHIAT, V59, P762, DOI 10.1016/j.biopsych.2005.08.030; Wagner M., 1996, NEUROIMAGE, V3, pS168; Watkins S, 2007, CEREB CORTEX, V17, P1694, DOI 10.1093/cercor/bhl080; Wible CG, 2001, AM J PSYCHIAT, V158, P938; Winkler I, 2007, J PSYCHOPHYSIOL, V21, P147, DOI 10.1027/0269-8803.21.34.147; Wynn JK, 2010, BIOL PSYCHIAT, V67, P940, DOI 10.1016/j.biopsych.2009.11.024; Yago E, 2001, NEUROREPORT, V12, P2583, DOI 10.1097/00001756-200108080-00058; Yildiz M, 2011, SCHIZOPHRENIA RES TR, V2011, P1; Youn T, 2004, HUM BRAIN MAPP, V21, P46, DOI 10.1002/hbm.10147; Youn T, 2003, SCHIZOPHR RES, V59, P253, DOI 10.1016/S0920-9964(02)00154-8	135	39	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100221	10.1371/journal.pone.0100221	http://dx.doi.org/10.1371/journal.pone.0100221			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949859	gold, Green Published			2022-12-25	WOS:000338276300050
J	Jones-Smith, JC; Dieckmann, MG; Gottlieb, L; Chow, J; Fernald, LCH				Jones-Smith, Jessica C.; Dieckmann, Marlowe Gates; Gottlieb, Laura; Chow, Jessica; Fernald, Lia C. H.			Socioeconomic Status and Trajectory of Overweight from Birth to Mid-Childhood: The Early Childhood Longitudinal Study-Birth Cohort	PLOS ONE			English	Article							OBESITY; PREVALENCE; CHILDREN; HEALTH; DISPARITIES; ADOLESCENTS; POVERTY; TRENDS; RISK; ASSOCIATIONS	Objective: Our objective was to use longitudinal data from a US birth cohort to test whether the probability of overweight or obesity during the first 6 years of life varied according to socioeconomic status. Design and Methods: Using six waves of longitudinal data from full-term children in the Early Childhood Longitudinal Study-Birth Cohort (2001-2007; n approximate to 4,950), we examined the prevalence of overweight or obesity (Body Mass Index (BMI)>2 standard deviations above age- and sex- specific WHO Childhood Growth Standard reference mean; henceforth, "overweight/obesity") according to age, socioeconomic status, and race/ethnicity using generalized estimating equation models. Results: The association between socioeconomic status and overweight/obesity varied significantly by race/ethnicity, but not by sex. Overweight/obesity was significantly associated with socioeconomic status among whites, Hispanics and Asians; the adjusted odds of overweight/obesity began to diverge according to SES after the first 9 months of life. By approximately 4 years, children with the highest SES had a significantly lower odds of overweight/obesity. SES was not significantly related to overweight/obesity among African Americans and American Indians during early childhood. Conclusions: Few studies have assessed the associations between SES and overweight/obesity within racial/ethnic groups in the US. We find that in contemporary, US-born children, SES was inversely associated with overweight/obesity among more racial/ethnic groups (whites, Hispanics, and Asians) than previously reported.	[Jones-Smith, Jessica C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth Human Nutr, Baltimore, MD 21205 USA; [Jones-Smith, Jessica C.; Dieckmann, Marlowe Gates; Fernald, Lia C. H.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Dieckmann, Marlowe Gates] Univ Louisville, Sch Med, Louisville, KY 40292 USA; [Gottlieb, Laura] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA; [Gottlieb, Laura] Univ Calif San Francisco, Ctr Hlth & Commun, San Francisco, CA 94143 USA; [Chow, Jessica] Univ Calif San Francisco, Univ Calif Berkeley, JMP, Berkeley, CA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Berkeley; University of Louisville; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California San Francisco	Jones-Smith, JC (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth Human Nutr, Baltimore, MD 21205 USA.	jonessmith@jhu.edu		Jones-Smith, Jessica/0000-0001-8962-1695; Fernald, Lia C.H./0000-0003-1555-4607	National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development [1K99HD073327, R21 HD056581]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD073327, K99HD073327, R24HD042854] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD056581] Funding Source: NIH RePORTER	National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	JCJS was funded in part by the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (Grant numbers: 1K99HD073327 and R21 HD056581). No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SE, 2009, ARCH PEDIAT ADOL MED, V163, P344, DOI 10.1001/archpediatrics.2009.18; Bocca-Tjeertes IFA, 2012, J PEDIATR-US, V161, P460, DOI 10.1016/j.jpeds.2012.03.016; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; CDC, 2021, FLUV WEEKL INFL SURV; Chang VW, 2006, SOC SCI MED, V63, P1289, DOI 10.1016/j.socscimed.2006.03.049; Chang VW, 2003, AM J PREV MED, V24, P332, DOI 10.1016/S0749-3797(03)00020-5; Coogan PF, 2012, ETHNIC DIS, V22, P198; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; de Onis M, 2010, INT J PEDIATR OBES, V5, P458, DOI 10.3109/17477161003615583; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Freedman DS, 2009, PEDIATRICS, V124, pS23, DOI 10.1542/peds.2008-3586E; Fujioka Y, 2009, COMMUN RES, V36, P451, DOI 10.1177/0093650209333031; Gordon-Larsen P, 2006, PEDIATRICS, V117, P417, DOI 10.1542/peds.2005-0058; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Hajat A, 2011, AM J EPIDEMIOL, V173, P192, DOI 10.1093/aje/kwq348; Heeringa SG, 2017, APPL SURVEY DATA ANA, VSecond, DOI DOI 10.1201/9781315153278; JEWELL N. P., 2004, STAT EPIDEMIOLOGY; KLEINBAUM DG, 2007, APPL REGRESSION ANAL; LaVeist TA, 2005, J URBAN HEALTH, V82, pIII26, DOI 10.1093/jurban/jti061; LaVeist T, 2011, HEALTH AFFAIR, V30, P1880, DOI 10.1377/hlthaff.2011.0640; Lee H, 2014, AM J PUBLIC HEALTH, V104, pE70, DOI 10.2105/AJPH.2013.301806; Lovasi GS, 2009, EPIDEMIOL REV, V31, P7, DOI 10.1093/epirev/mxp005; Madsen KA, 2010, PEDIATRICS, V126, P434, DOI 10.1542/peds.2009-3411; Miech RA, 2006, JAMA-J AM MED ASSOC, V295, P2385, DOI 10.1001/jama.295.20.2385; Mujahid MS, 2005, OBES RES, V13, P1412, DOI 10.1038/oby.2005.171; Nader PR, 2006, PEDIATRICS, V118, pE594, DOI 10.1542/peds.2005-2801; National Center for Education Statisitics, US MAN ECLS B LONG 9; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Wang YF, 2006, AM J CLIN NUTR, V84, P707, DOI 10.1093/ajcn/84.4.707; Wei Yang KS, 2012, J OBES, V2012, P9; Williams DR, 1999, ANN NY ACAD SCI, V896, P173, DOI 10.1111/j.1749-6632.1999.tb08114.x; Wolfe B, 2012, DEMOGRAPHY, V49, P499, DOI 10.1007/s13524-012-0098-8	34	34	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100181	10.1371/journal.pone.0100181	http://dx.doi.org/10.1371/journal.pone.0100181			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2UZ	24950056	gold, Green Published			2022-12-25	WOS:000338276300044
J	Zhang, YY; Huang, Y; He, QZ; Liu, JY; Luo, J; Zhu, L; Lu, SS; Huang, PF; Chen, XY; Zeng, XZ; Liang, SP				Zhang, Yiya; Huang, Yong; He, Quanze; Liu, Jinyan; Luo, Ji; Zhu, Li; Lu, Shanshan; Huang, Pengfei; Chen, Xinyi; Zeng, Xiongzhi; Liang, Songping			Toxin Diversity Revealed by a Transcriptomic Study of Ornithoctonus huwena	PLOS ONE			English	Article							SPIDER SELENOCOSMIA-HUWENA; CHINESE BIRD SPIDER; GATED SODIUM-CHANNELS; VENOM-GLAND TRANSCRIPTOME; HUWENTOXIN-I; TARANTULA TOXINS; VOLTAGE SENSORS; DUCT TRANSCRIPTOME; CALCIUM-CHANNELS; CONUS-CONSORS	Spider venom comprises a mixture of compounds with diverse biological activities, which are used to capture prey and defend against predators. The peptide components bind a broad range of cellular targets with high affinity and selectivity, and appear to have remarkable structural diversity. Although spider venoms have been intensively investigated over the past few decades, venomic strategies to date have generally focused on high-abundance peptides. In addition, the lack of complete spider genomes or representative cDNA libraries has presented significant limitations for researchers interested in molecular diversity and understanding the genetic mechanisms of toxin evolution. In the present study, second-generation sequencing technologies, combined with proteomic analysis, were applied to determine the diverse peptide toxins in venom of the Chinese bird spider Ornithoctonus huwena. In total, 626 toxin precursor sequences were retrieved from transcriptomic data. All toxin precursors clustered into 16 gene superfamilies, which included six novel superfamilies and six novel cysteine patterns. A surprisingly high number of hypermutations and fragment insertions/deletions were detected, which accounted for the majority of toxin gene sequences with low-level expression. These mutations contribute to the formation of diverse cysteine patterns and highly variable isoforms. Furthermore, intraspecific venom variability, in combination with variable transcripts and peptide processing, contributes to the hypervariability of toxins in venoms, and associated rapid and adaptive evolution of toxins for prey capture and defense.	[Zhang, Yiya; Liu, Jinyan; Luo, Ji; Zhu, Li; Lu, Shanshan; Huang, Pengfei; Chen, Xinyi; Zeng, Xiongzhi; Liang, Songping] Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China; [Huang, Yong] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [He, Quanze] Fudan Univ, State Key Lab Genet Engn, Inst Biomed Sci, Shanghai 200433, Peoples R China	Hunan Normal University; Beijing Institute of Microbiology & Epidemiology; Fudan University	Zeng, XZ (corresponding author), Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China.	xiongzhizeng@yahoo.com.cn; liangsp@hunnu.edu.cn		Zhang, Yiya/0000-0003-3644-3500	National Basic Research Program of China (973) [2010CB529800, 2012CB22305]; Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province [20134486]	National Basic Research Program of China (973)(National Basic Research Program of China); Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province	Funding came from: 1. The National Basic Research Program of China (973), 2010CB529800 and 2012CB22305 and 2. The Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province (20134486). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Buczek O, 2007, BIOCHEMISTRY-US, V46, P9929, DOI 10.1021/bi700797f; Chen JJ, 2008, TOXICON, V52, P794, DOI 10.1016/j.toxicon.2008.08.003; Chuang RSI, 1998, NAT NEUROSCI, V1, P668, DOI 10.1038/3669; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davis J, 2009, PEPTIDES, V30, P1222, DOI 10.1016/j.peptides.2009.03.019; Deng MC, 2008, EUR J PHARMACOL, V582, P12, DOI 10.1016/j.ejphar.2007.12.014; Diego-Garcia E, 2010, CELL MOL LIFE SCI, V67, P2799, DOI 10.1007/s00018-010-0359-x; Duan Z, 2012, J PROTEOMICS; Duda TF, 2000, MOL BIOL EVOL, V17, P1286, DOI 10.1093/oxfordjournals.molbev.a026412; Durban J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-259; Dutertre S, 2010, TOXICON, V55, P1453, DOI 10.1016/j.toxicon.2010.02.025; Dutertre S, 2010, J BIOL CHEM, V285, P13315, DOI 10.1074/jbc.R109.076596; Escoubas P, 2008, J MASS SPECTROM, V43, P279, DOI 10.1002/jms.1389; Fernandes-Pedrosa MD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-279; Gao B, 2012, COMP BIOCHEM PHYS B, V163, P238, DOI 10.1016/j.cbpb.2012.06.002; Gong JP, 1997, J BIOL CHEM, V272, P8320, DOI 10.1074/jbc.272.13.8320; Gunning SJ, 2003, FEBS LETT, V554, P211, DOI 10.1016/S0014-5793(03)01175-X; Huang RH, 2003, ACTA BIOCH BIOPH SIN, V35, P976; Isbister GK, 2011, LANCET, V378, P2039, DOI 10.1016/S0140-6736(10)62230-1; Jakubowski JA, 2005, J EXP BIOL, V208, P2873, DOI 10.1242/jeb.01713; Jiang LP, 2008, TOXICON, V51, P1479, DOI 10.1016/j.toxicon.2008.03.024; Jiang LP, 2010, COMP BIOCHEM PHYS D, V5, P81, DOI 10.1016/j.cbd.2010.01.001; Jimenez EC, 2003, J NEUROCHEM, V85, P610, DOI 10.1046/j.1471-4159.2003.01685.x; Jin AH, 2013, MOL CELL PROTEOMICS, V12, P3824, DOI 10.1074/mcp.M113.030353; Klint JK, 2012, TOXICON, V60, P478, DOI 10.1016/j.toxicon.2012.04.337; Kozlov S, 2005, PROTEINS, V59, P131, DOI 10.1002/prot.20390; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lavergne V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-708; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Li ZH, 2006, J BIOL CHEM, V281, P8628, DOI 10.1074/jbc.M513542200; Liang S, 2008, EXPERT REV PROTEOMIC, V5, P731, DOI 10.1586/14789450.5.5.731; Liang SP, 2000, J PROTEIN CHEM, V19, P225, DOI 10.1023/A:1007011904904; Liang SP, 2004, TOXICON, V43, P575, DOI 10.1016/j.toxicon.2004.02.005; Liao Z, 2007, PROTEOMICS, V7, P1892, DOI 10.1002/pmic.200600785; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Lluisma AO, 2012, MAR GENOM, V5, P43, DOI 10.1016/j.margen.2011.09.002; Lu SY, 1999, J PROTEIN CHEM, V18, P609, DOI 10.1023/A:1020663619657; Margres MJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-531; Milescu M, 2007, J GEN PHYSIOL, V130, P497, DOI 10.1085/jgp.200709869; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; Morgenstern D, 2011, TOXICON, V57, P695, DOI 10.1016/j.toxicon.2011.02.001; Nisani Z, 2007, COMP BIOCHEM PHYS A, V147, P509, DOI 10.1016/j.cbpa.2007.01.027; Pan ZS, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-32; Peng K, 2001, TOXICON, V39, P491, DOI 10.1016/S0041-0101(00)00150-1; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; Peng K, 2006, ACTA BIOCH BIOPH SIN, V38, P457, DOI 10.1111/j.1745-7270.2006.00191.x; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Rash LD, 2002, TOXICON, V40, P225, DOI 10.1016/S0041-0101(01)00199-4; Rong MQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065984; Sanz L, 2006, BIOCHEM J, V395, P385, DOI 10.1042/BJ20051678; Sharma M, 2006, J STRUCT BIOL, V155, P52, DOI 10.1016/j.jsb.2005.12.005; Sidach SS, 2002, J NEUROSCI, V22, P2023, DOI 10.1523/JNEUROSCI.22-06-02023.2002; Swartz KJ, 2007, TOXICON, V49, P213, DOI 10.1016/j.toxicon.2006.09.024; Tang X, 2010, J PROTEOME RES, V9, P2550, DOI 10.1021/pr1000016; Tawfik DS, 2010, NAT CHEM BIOL, V6, P692, DOI 10.1038/nchembio.441; Terrat Y, 2012, TOXICON, V59, P34, DOI 10.1016/j.toxicon.2011.10.001; Vassilevski AA, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1505, DOI 10.1134/S0006297909130069; Vetter I, 2011, AMINO ACIDS, V40, P15, DOI 10.1007/s00726-010-0516-4; Violette A, 2012, J PROTEOMICS; Wang MC, 2012, PEPTIDES, V34, P19, DOI 10.1016/j.peptides.2011.10.029; Wang RL, 2010, J ZHEJIANG UNIV-SC B, V11, P451, DOI 10.1631/jzus.B0900393; Xiao YC, 2011, J BIOL CHEM, V286, P27301, DOI 10.1074/jbc.M111.246876; Yuan CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003414; Yuan CH, 2007, J PROTEOME RES, V6, P2792, DOI 10.1021/pr0700192; Zakharova E, 2008, J MOL BIOL, V382, P998, DOI 10.1016/j.jmb.2008.07.063; Zelanis A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001554; ZHANG DG, 1993, J PROTEIN CHEM, V12, P735, DOI 10.1007/BF01024931; Zhang J, 2011, J GENET GENOMICS, V38, P95, DOI 10.1016/j.jgg.2011.02.003; Zhang YQ, 2010, ZOOLOGY, V113, P10, DOI 10.1016/j.zool.2009.04.001; Zhou PA, 1997, TOXICON, V35, P39, DOI 10.1016/S0041-0101(96)00072-4; ZHOU XH, 1989, BIOCHEM J, V257, P509, DOI 10.1042/bj2570509	74	13	14	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100682	10.1371/journal.pone.0100682	http://dx.doi.org/10.1371/journal.pone.0100682			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949878	Green Published, Green Submitted, gold			2022-12-25	WOS:000338276300106
J	Ganz, J; Arie, I; Buch, S; Ben Zur, T; Barhum, Y; Pour, S; Araidy, S; Pitaru, S; Offen, D				Ganz, Javier; Arie, Ina; Buch, Sigal; Ben Zur, Tali; Barhum, Yael; Pour, Sammy; Araidy, Shareef; Pitaru, Sandu; Offen, Daniel			Dopaminergic-Like Neurons Derived from Oral Mucosa Stem Cells by Developmental Cues Improve Symptoms in the Hemi-Parkinsonian Rat Model	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; NUCLEAR RECEPTOR NURR1; NEURAL CREST; BONE-MARROW; LAMINA PROPRIA; IN-VIVO; DISEASE; MIDBRAIN; DIFFERENTIATION; TRANSPLANTATION	Achieving safe and readily accessible sources for cell replacement therapy in Parkinson's disease (PD) is still a challenging unresolved issue. Recently, a primitive neural crest stem cell population (hOMSC) was isolated from the adult human oral mucosa and characterized in vitro and in vivo. In this study we assessed hOMSC ability to differentiate into dopamine-secreting cells with a neuronal-dopaminergic phenotype in vitro in response to dopaminergic developmental cues and tested their therapeutic potential in the hemi-Parkinsonian rat model. We found that hOMSC express constitutively a repertoire of neuronal and dopaminergic markers and pivotal transcription factors. Soluble developmental factors induced a reproducible neuronal-like morphology in the majority of hOMSC, downregulated stem cells markers, upregulated the expression of the neuronal and dopaminergic markers that resulted in dopamine release capabilities. Transplantation of these dopaminergic-induced hOMSC into the striatum of hemi-Parkinsonian rats improved their behavioral deficits as determined by amphetamine-induced rotational behavior, motor asymmetry and motor coordination tests. Human TH expressing cells and increased levels of dopamine in the transplanted hemispheres were observed 10 weeks after transplantation. These results demonstrate for the first time that soluble factors involved in the development of DA neurons, induced a DA phenotype in hOMSC in vitro that significantly improved the motor function of hemiparkinsonian rats. Based on their neural-related origin, their niche accessibility by minimal-invasive procedures and their propensity for DA differentiation, hOMSC emerge as an attractive tool for autologous cell replacement therapy in PD.	[Ganz, Javier; Ben Zur, Tali; Barhum, Yael; Offen, Daniel] Tel Aviv Univ, Neurosci Lab, Felsenstein Med Res Ctr, Rabin Med Ctr, IL-69978 Tel Aviv, Israel; [Arie, Ina; Buch, Sigal; Pitaru, Sandu] Tel Aviv Univ, Dept Oral Biol, Sch Dent Med, Fac Med, IL-69978 Tel Aviv, Israel; [Pour, Sammy; Araidy, Shareef] Baruch Padeh Med Ctr, Oral & Maxillofacial Dept, Poria, Lower Galilee, Israel	Rabin Medical Center; Tel Aviv University; Tel Aviv University	Offen, D (corresponding author), Tel Aviv Univ, Neurosci Lab, Felsenstein Med Res Ctr, Rabin Med Ctr, IL-69978 Tel Aviv, Israel.	danioffen@gmail.com		Ganz, Javier/0000-0002-2370-9819	Binational United States - Israel Science Foundation [9007002, 2011017]; Israel Science Foundation of the Israeli Academy of Science [646/09, 384/13]; MOIA fellowship; SAIA	Binational United States - Israel Science Foundation; Israel Science Foundation of the Israeli Academy of Science; MOIA fellowship; SAIA	This work was supported, in part, by the Binational United States - Israel Science Foundation [Grants number 9007002 and 2011017] to Sandu Pitaru [SP]; the Israel Science Foundation of the Israeli Academy of Science [Grants number 646/09 and 384/13] to S. P.; SAIA and MOIA fellowship to J.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas E, 2008, CELL STEM CELL, V2, P110, DOI 10.1016/j.stem.2008.01.012; BACKLUND EO, 1985, J NEUROSURG, V62, P169, DOI 10.3171/jns.1985.62.2.0169; Bartold PM, 2000, PERIODONTOL 2000, V24, P253, DOI 10.1034/j.1600-0757.2000.2240113.x; Barzilay R, 2009, STEM CELLS DEV, V18, P591, DOI 10.1089/scd.2008.0138; Blondheim NR, 2006, STEM CELLS DEV, V15, P141, DOI 10.1089/scd.2006.15.141; Bronner ME, 2012, DEV BIOL, V366, P2, DOI 10.1016/j.ydbio.2011.12.042; Cai JL, 2009, STEM CELLS, V27, P220, DOI 10.1634/stemcells.2008-0734; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Chang YS, 2011, CELL TRANSPLANT; Chung S, 2011, P NATL ACAD SCI USA, V108, P9703, DOI 10.1073/pnas.1016443108; Chung S, 2009, CELL STEM CELL, V5, P646, DOI 10.1016/j.stem.2009.09.015; Datta I, 2011, CYTOTHERAPY, V13, P918, DOI 10.3109/14653249.2011.579957; Davies LC, 2010, STEM CELLS DEV, V19, P819, DOI 10.1089/scd.2009.0089; Debernard KAB, 2012, NEUROCHEM INT, V61, P79, DOI 10.1016/j.neuint.2012.04.002; Fasano Caroline, 2008, Curr Protoc Neurosci, VChapter 3, DOI 10.1002/0471142301.ns0321s44; FREED CR, 1992, NEW ENGL J MED, V327, P1549, DOI 10.1056/NEJM199211263272202; FREED WJ, 1981, NATURE, V292, P351, DOI 10.1038/292351a0; Ganz J, 2011, EXPERT REV NEUROTHER, V11, P1325, DOI [10.1586/ERN.11.74, 10.1586/ern.11.74]; Hargus G, 2010, P NATL ACAD SCI USA, V107, P15921, DOI 10.1073/pnas.1010209107; Iancu R, 2005, BEHAV BRAIN RES, V162, P1, DOI 10.1016/j.bbr.2005.02.023; Inamoto T, 2010, CANCER-AM CANCER SOC, V116, P340, DOI 10.1002/cncr.24737; Kim DS, 2007, CELL TRANSPLANT, V16, P117; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kim TE, 2003, BIOCHEM BIOPH RES CO, V305, P1040, DOI 10.1016/S0006-291X(03)00879-9; Kirik D, 1998, EXP NEUROL, V152, P259, DOI 10.1006/exnr.1998.6848; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Levy YS, 2008, CYTOTHERAPY, V10, P340, DOI 10.1080/14653240802021330; MADRAZO I, 1987, NEW ENGL J MED, V316, P831, DOI 10.1056/NEJM198704023161402; Maijenburg MW, 2012, STEM CELLS DEV, V21, P228, DOI 10.1089/scd.2011.0076; Marynka-Kalmani K, 2010, STEM CELLS, V28, P984, DOI 10.1002/stem.425; MASSAS R, 1993, J DENT RES, V72, P1005, DOI 10.1177/00220345930720060201; Montzka K, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-16; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Nakatani T, 2010, DEV BIOL, V339, P101, DOI 10.1016/j.ydbio.2009.12.017; Nishimura K, 2013, BIOL PHARM BULL, V36, P171, DOI 10.1248/bpb.b12-00929; O'Kane M, 2008, J INVEST DERMATOL, V128, P300, DOI 10.1038/sj.jid.5701023; Papanikolaou T, 2009, EUR J NEUROSCI, V29, P2264, DOI 10.1111/j.1460-9568.2009.06784.x; Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181; Prakash N, 2006, J PHYSIOL-LONDON, V575, P403, DOI 10.1113/jphysiol.2006.113464; RITCHIE AK, 1979, J PHYSIOL-LONDON, V286, P541, DOI 10.1113/jphysiol.1979.sp012636; Rozas G, 1997, BRAIN RES, V749, P188, DOI 10.1016/S0006-8993(96)01162-6; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schwarting RKW, 1996, PROG NEUROBIOL, V50, P275, DOI 10.1016/S0301-0082(96)00040-8; Smidt MP, 2009, ADV EXP MED BIOL, V651, P47; Smits SM, 2006, J NEURAL TRANSM-SUPP, P57; SNAPE BM, 1985, J NEUROSCI METH, V14, P53, DOI 10.1016/0165-0270(85)90114-1; Studer L, 1998, NAT NEUROSCI, V1, P290, DOI 10.1038/1105; Svendsen CN, 1997, EXP NEUROL, V148, P135, DOI 10.1006/exnr.1997.6634; Tondreau T, 2004, DIFFERENTIATION, V72, P319, DOI 10.1111/j.1432-0436.2004.07207003.x; Torres EM, 2008, NEUROSCIENCE, V154, P631, DOI 10.1016/j.neuroscience.2008.03.048; Treves-Manusevitz S, 2013, J CLIN PERIODONTOL, V40, P73, DOI 10.1111/jcpe.12016; Trzaska KA, 2007, STEM CELLS, V25, P2797, DOI 10.1634/stemcells.2007-0212; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wallen A, 2003, ANN NY ACAD SCI, V991, P48; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Whishaw IQ, 1997, BEHAV BRAIN RES, V89, P167, DOI 10.1016/S0166-4328(97)00057-0; Widera D, 2011, STEM CELLS DEV, V20, P2053, DOI 10.1089/scd.2010.0525; Widera D, 2009, STEM CELLS, V27, P1899, DOI 10.1002/stem.104; Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062; Yan CH, 2011, J NEUROSCI, V31, P12413, DOI 10.1523/JNEUROSCI.1077-11.2011	62	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100445	10.1371/journal.pone.0100445	http://dx.doi.org/10.1371/journal.pone.0100445			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945922	Green Published, Green Submitted, gold			2022-12-25	WOS:000340721500076
J	Sitkiewicz, E; Oledzki, J; Poznanski, J; Dadlez, M				Sitkiewicz, Ewa; Oledzki, Jacek; Poznanski, Jaroslaw; Dadlez, Michal			Di-Tyrosine Cross-Link Decreases the Collisional Cross-Section of A beta Peptide Dimers and Trimers in the Gas Phase: An Ion Mobility Study	PLOS ONE			English	Article							AMYLOID-BETA; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; SYNAPTIC PLASTICITY; SECRETED OLIGOMERS; LIPID-PEROXIDATION; ACTIN RODS; AMINO-ACID; PROTEIN; DITYROSINE	Oligomeric forms of A beta peptide are most likely the main synaptotoxic and neurotoxic agent in Alzheimer's disease. Toxicity of various A beta oligomeric forms has been confirmed in vivo and also in vitro. However, in vitro preparations were found to be orders of magnitude less toxic than oligomers obtained from in vivo sources. This difference can be explained by the presence of a covalent cross-link, which would stabilize the oligomer. In the present work, we have characterized the structural properties of A beta dimers and trimers stabilized by di- and tri-tyrosine cross-links. Using ion mobility mass spectrometry we have compared the collisional cross-section of non-cross-linked and cross-linked species. We have found that the presence of cross-links does not generate new unique forms but rather shifts the equilibrium towards more compact oligomer types that can also be detected for non-cross-linked peptide. In consequence, more extended forms, probable precursors of off-pathway oligomeric species, become relatively destabilized in cross-linked oligomers and the pathway of oligomer evolution becomes redirected towards fibrillar structures.	[Sitkiewicz, Ewa; Oledzki, Jacek; Poznanski, Jaroslaw; Dadlez, Michal] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Dadlez, Michal] Warsaw Univ, Dept Biol, Inst Genet & Biotechnol, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw	Dadlez, M (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	michald@ibb.waw.pl	Poznanski, Jaroslaw/F-7705-2014	Poznanski, Jaroslaw/0000-0003-2684-1775; Dadlez, Michal/0000-0001-8811-5176; Sitkiewicz, Ewa/0000-0002-9511-8575; Oledzki, Jacek/0000-0002-8622-3218	NanoFun [POIGT.02.02.00-00-025/09-00]; Foundation for Polish Science TEAM program [TEAM/2011-7/1]; CEPT [POIG.02.02.00-14-024/08-00]	NanoFun; Foundation for Polish Science TEAM program; CEPT	Financial support was received from NanoFun (POIGT.02.02.00-00-025/09-00), the Foundation for Polish Science TEAM program (TEAM/2011-7/1), and CEPT (POIG.02.02.00-14-024/08-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hilaly YK, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-83; Ali FE, 2006, FREE RADICAL RES, V40, P1, DOI 10.1080/10715760500329721; Ando Y, 1998, J NEUROL SCI, V156, P172, DOI 10.1016/S0022-510X(98)00042-2; Ashcroft AE, 2010, J AM SOC MASS SPECTR, V21, P1087, DOI 10.1016/j.jasms.2010.02.026; Atwood CS, 2004, BIOCHEMISTRY-US, V43, P560, DOI 10.1021/bi0358824; Bamburg JR, 2010, CURR ALZHEIMER RES, V7, P241, DOI 10.2174/156720510791050902; Barnham KJ, 2004, FASEB J, V18, P1427, DOI 10.1096/fj.04-1890fje; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bernstein SL, 2005, J AM CHEM SOC, V127, P2075, DOI 10.1021/ja044531p; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bitan G, 2005, AMYLOID, V12, P88, DOI 10.1080/13506120500106958; Bleiholder C, 2011, NAT CHEM, V3, P172, DOI 10.1038/NCHEM.945; Butterfield DA, 2004, BRAIN PATHOL, V14, P426; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Davis RC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-10; DUDEK SM, 1994, BRAIN RES, V651, P129, DOI 10.1016/0006-8993(94)90688-2; Frimpong AK, 2010, PROTEINS, V78, P714, DOI 10.1002/prot.22604; Galeazzi L, 1999, AMYLOID, V6, P7, DOI 10.3109/13506129908993282; Gessel MM, 2012, ACS CHEM NEUROSCI, V3, P909, DOI 10.1021/cn300050d; Gessel MM, 2012, BIOCHEMISTRY-US, V51, P108, DOI 10.1021/bi201520b; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Grabenauer M, 2010, J AM CHEM SOC, V132, P532, DOI 10.1021/ja905595k; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hartley DM, 2008, J BIOL CHEM, V283, P16790, DOI 10.1074/jbc.M802215200; Hensley K, 1998, J NEUROSCI, V18, P8126; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kalback W, 2002, BIOCHEMISTRY-US, V41, P922, DOI 10.1021/bi015685+; Kaltashov IA, 2002, MASS SPECTROM REV, V21, P37, DOI 10.1002/mas.10017; Kato Y, 2000, BIOCHEM BIOPH RES CO, V275, P11, DOI 10.1006/bbrc.2000.3265; Kloniecki M, 2011, J MOL BIOL, V407, P110, DOI 10.1016/j.jmb.2011.01.012; Klyubin I, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-25; Kok WM, 2013, CHEM SCI, V4, P4449, DOI 10.1039/c3sc22295k; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Markesbery WR, 1998, NEUROBIOL AGING, V19, P33, DOI 10.1016/S0197-4580(98)00009-8; McGrath LT, 2001, QJM-MON J ASSOC PHYS, V94, P485, DOI 10.1093/qjmed/94.9.485; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Mennucci B, 1999, INT J QUANTUM CHEM, V75, P767, DOI 10.1002/(SICI)1097-461X(1999)75:4/5<767::AID-QUA43>3.0.CO;2-L; Moore BD, 2009, BIOCHEMISTRY-US, V48, P11796, DOI 10.1021/bi901571t; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Murray IVJ, 2007, J BIOL CHEM, V282, P9335, DOI 10.1074/jbc.M608589200; Noguchi A, 2009, J BIOL CHEM, V284, P32895, DOI 10.1074/jbc.M109.000208; NOMURA K, 1990, BIOCHEMISTRY-US, V29, P4525, DOI 10.1021/bi00471a004; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; Reed MN, 2011, NEUROBIOL AGING, V32, P1784, DOI 10.1016/j.neurobiolaging.2009.11.007; Rozga M, 2007, BIOCHEM BIOPH RES CO, V364, P714, DOI 10.1016/j.bbrc.2007.10.080; Sayre LM, 1997, J NEUROCHEM, V68, P2092; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Siegel SJ, 2007, BIOCHEMISTRY-US, V46, P1503, DOI 10.1021/bi061853s; Smith DP, 2007, BIOCHEMISTRY-US, V46, P2881, DOI 10.1021/bi0620961; Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Wakshlag JJ, 2006, PROTEIN J, V25, P83, DOI 10.1007/s10930-006-0009-1; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Watt AD, 2013, ACTA NEUROPATHOL, V125, P549, DOI 10.1007/s00401-013-1083-z; Wilhelmus MMM, 2009, BRAIN PATHOL, V19, P612, DOI 10.1111/j.1750-3639.2008.00197.x; Woods LA, 2013, BBA-PROTEINS PROTEOM, V1834, P1257, DOI 10.1016/j.bbapap.2012.10.002; Yamaguchi T, 2010, BIOCHEMISTRY-US, V49, P7100, DOI 10.1021/bi100583x; Yoburn JC, 2003, CHEM RES TOXICOL, V16, P531, DOI 10.1021/tx025666g	64	19	19	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100200	10.1371/journal.pone.0100200	http://dx.doi.org/10.1371/journal.pone.0100200			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945725	Green Published, gold, Green Submitted			2022-12-25	WOS:000340721500049
J	Wei, SC; Tan, YY; Weng, MT; Lai, LC; Hsiao, JH; Chuang, EY; Shun, CT; Wu, DC; Kao, AW; Chuang, CS; Ni, YH; Shieh, MJ; Tung, CC; Chen, Y; Wang, CY; Xavier, RJ; Podolsky, DK; Wong, JM				Wei, Shu-Chen; Tan, Yan-Yin; Weng, Meng-Tzu; Lai, Liang-Chuan; Hsiao, Jen-Hao; Chuang, Eric Y.; Shun, Chia-Tung; Wu, Deng-Cheng; Kao, Ai-Wen; Chuang, Chiao-Shung; Ni, Yen-Hsuan; Shieh, Ming-Jium; Tung, Chien-Chih; Chen, Yun; Wang, Cheng-Yi; Xavier, Ramnik J.; Podolsky, Daniel K.; Wong, Jau-Min			SLCO3A1, a Novel Crohn's Disease-Associated Gene, Regulates NF-kappa B Activity and Associates with Intestinal Perforation	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; NICOTINE DEPENDENCE; POLYMORPHISMS; ACTIVATION; EXPRESSION; VARIANTS; MUTATION; ELEMENTS; TNFSF15	Background & Aims: To date, only one gene (TNFSF15) has been identified and validated as a Crohn's disease (CD)-associated gene in non-Caucasian populations. This study was designed to identify novel CD-associated single nucleotide polymorphisms (SNPs)/genes and to validate candidate genes using a functional assay. Methods: SNPs from 16 CD patients and 16 age-and sex-matched control patients were analyzed using Illumina platform analysis. Subsequently, we expanded the study and followed 53 CD patients and 41 control patients by Sequenom MassArray analysis. Quantitative PCR and immunohistochemical staining were performed to assess mRNA and protein expression of the candidate gene on tissue isolated from CD patients. Genotype was correlated with CD phenotypes. Finally, the candidate gene was cloned and its effect on NF-kappa B activity assessed using a reporter luciferase assay. Results: SLCO3A1 (rs207959) reached statistical significance in the first-stage analysis (P = 2.3E-02) and was further validated in the second-stage analysis (P = 1.0E-03). Genotype and phenotype analysis showed that the rs207959 (T) allele is a risk allele that alters SLCO3A1 mRNA expression and is associated with intestinal perforation in CD patients. Higher levels of mRNA and protein expression of SLCO3A1 were seen in CD patients compared with the control group. Overexpression of SLCO3A1 induced increased NF-kappa B activity and increased phosphorylation of P65, ERK, and JNK. Nicotine augmented the activation of NF-kappa B in the presence of SLCO3A1. Conclusions: SLCO3A1, a novel CD-associated gene, mediates inflammatory processes in intestinal epithelial cells through NF-kB transcription activation, resulting in a higher incidence of bowel perforation in CD patients.	[Wei, Shu-Chen; Weng, Meng-Tzu; Wang, Cheng-Yi; Wong, Jau-Min] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Tan, Yan-Yin; Wong, Jau-Min] Natl Taiwan Univ, Grad Inst Med Engn, Taipei 10764, Taiwan; [Weng, Meng-Tzu] Far Eastern Mem Hosp, Dept Internal Med, New Taipei, Taiwan; [Lai, Liang-Chuan] Natl Taiwan Univ, Coll Med, Grad Inst Physiol, Taipei, Taiwan; [Lai, Liang-Chuan; Hsiao, Jen-Hao; Chuang, Eric Y.] Natl Taiwan Univ, Bioinformat & Biostat Core, Ctr Genom Med, Taipei 10764, Taiwan; [Chuang, Eric Y.] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Shun, Chia-Tung] Natl Taiwan Univ Hosp, Dept Pathol & Forens Med, Taipei, Taiwan; [Wu, Deng-Cheng] Kaohsiung Med Univ, Dept Internal Med, Kaohsiung, Taiwan; [Kao, Ai-Wen; Chuang, Chiao-Shung] Natl Cheng Kung Univ, Dept Internal Med, Tainan 70101, Taiwan; [Ni, Yen-Hsuan] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Shieh, Ming-Jium] Natl Taiwan Univ Hosp, Deparment Oncol, Taipei, Taiwan; [Tung, Chien-Chih] Natl Taiwan Univ Hosp, Dept Integrated Diagnost & Therapeut, Taipei, Taiwan; [Chen, Yun] Far Eastern Mem Hosp, New Taipei, Taiwan; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Podolsky, Daniel K.] UT Southwestern Med Ctr, Dallas, TX USA	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Kaohsiung Medical University; National Cheng Kung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wong, JM (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	jmwong@ntu.edu.tw	Lai, Liang-Chuan/B-4768-2009; Shun, Chia-Tung/M-1400-2019	Lai, Liang-Chuan/0000-0002-3913-5338; Ni, Yen-Hsuan/0000-0002-1158-5249; Chuang, Chiao-Hsiung/0000-0003-3283-9145; SHUN, CHIA-TUNG/0000-0002-0468-4468	National Science Council of Taiwan [NSC-98-2314-B-002-139-, 99-2314-B-002-124-MY3]; Liver Disease Prevention & Treatment Research Foundation, Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Liver Disease Prevention & Treatment Research Foundation, Taiwan	This work was supported by National Science Council of Taiwan (NSC-98-2314-B-002-139-) (99-2314-B-002-124-MY3); Liver Disease Prevention & Treatment Research Foundation, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 2003, AM J PHYSIOL-RENAL, V285, pF1188, DOI 10.1152/ajprenal.00402.2002; Asakura K, 2009, J GASTROENTEROL, V44, P659, DOI 10.1007/s00535-009-0057-3; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Beohar N, 1998, J BIOL CHEM, V273, P9168, DOI 10.1074/jbc.273.15.9168; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carbonnel F, 2009, GASTROEN CLIN BIOL, V33, pS145, DOI 10.1016/S0399-8320(09)73150-1; Cosnes J, 2001, GASTROENTEROLOGY, V120, P1093, DOI 10.1053/gast.2001.23231; Crowley-Weber CL, 2003, CHEM-BIOL INTERACT, V145, P53, DOI 10.1016/S0009-2797(02)00162-X; Hsiao CH, 2007, J PEDIATR GASTR NUTR, V44, P342, DOI 10.1097/MPG.0b013e31802c6997; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677; Jian ZH, 2013, J CANCER, V4, P691, DOI 10.7150/jca.7269; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kindla J, 2011, CANCER BIOL THER, V11, P584, DOI 10.4161/cbt.11.6.14533; Lee Gin Hyug, 2005, Korean J Gastroenterol, V45, P162; Li M, 2008, WORLD J GASTROENTERO, V14, P4923, DOI 10.3748/wjg.14.4923; Monaco C, 2004, P NATL ACAD SCI USA, V101, P5634, DOI 10.1073/pnas.0401060101; Obaidat A, 2012, ANNU REV PHARMACOL, V52, P135, DOI 10.1146/annurev-pharmtox-010510-100556; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Volpi S, 2009, MOL PSYCHIATR, V14, P1024, DOI 10.1038/mp.2008.52; Wang KS, 2012, DRUG ALCOHOL DEPEN, V124, P325, DOI 10.1016/j.drugalcdep.2012.02.003; Wei SC, 2011, J FORMOS MED ASSOC, V110, P600, DOI 10.1016/j.jfma.2011.07.009; Xavier RJ, 2008, NAT REV IMMUNOL, V8, P631, DOI 10.1038/nri2361; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Yamazaki K, 2002, J HUM GENET, V47, P469, DOI 10.1007/s100380200067; Yang SK, 2008, AM J GASTROENTEROL, V103, P1437, DOI 10.1111/j.1572-0241.2007.01752.x; Zhang XY, 2010, PSYCHOPHARMACOLOGY, V212, P301, DOI 10.1007/s00213-010-1956-y	32	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100515	10.1371/journal.pone.0100515	http://dx.doi.org/10.1371/journal.pone.0100515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945726	Green Published, Green Submitted, gold			2022-12-25	WOS:000340721500084
J	Chou, SD; Murshid, A; Eguchi, T; Gong, J; Calderwood, SK				Chou, S-D; Murshid, A.; Eguchi, T.; Gong, J.; Calderwood, S. K.			HSF1 regulation of beta-catenin in mammary cancer cells through control of HuR/elavL1 expression	ONCOGENE			English	Article							HEAT-SHOCK FACTOR-1; TRANSCRIPTION FACTOR HSF1; RNA STABILITY FACTOR; RICH ELEMENTS; STEM-CELLS; PHOSPHORYLATION; BINDING; HUR; ACTIVATION; PROTEINS	There is now compelling evidence to indicate a place for heat shock factor 1 (HSF1) in mammary carcinogenesis, tumour progression and metastasis. Here we have investigated a role for HSF1 in regulating the expression of the stem cell renewal factor beta-catenin in immortalized human mammary epithelial and carcinoma cells. We found HSF1 to be involved in regulating the translation of beta-catenin, by investigating effects of gain and loss of HSF1 on this protein. Interestingly, although HSF1 is a potent transcription factor, it was not directly involved in regulating levels of beta-catenin mRNA. Instead, our data suggest a complex role in translational regulation. HSF1 was shown to regulate levels of the RNA-binding protein HuR that controlled beta-catenin translation. An extra complexity was added to this scenario when it was shown that the long non-coding RNA molecule lincRNA-p21, known to be involved in beta-catenin mRNA (CTNNB1) translational regulation, was controlled by HSF1 repression. We have shown previously that HSF1 was positively regulated through phosphorylation by mammalian target of rapamycin (mTOR) kinase on a key residue, serine 326, essential for transcriptional activity. In this study, we found that mTOR knockdown not only decreased HSF1-S326 phosphorylation in mammary cells, but also decreased beta-catenin expression through a mechanism requiring HuR. Our data point to a complex role for HSF1 in the regulation of HuR and beta-catenin expression that may be significant in mammary carcinogenesis.	[Chou, S-D; Murshid, A.; Eguchi, T.; Calderwood, S. K.] Harvard Univ, Sch Med, Dept Radiat Oncol, BIDMC, Boston, MA 02215 USA; [Gong, J.] Boston Univ, Med Ctr, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Boston University	Calderwood, SK (corresponding author), Harvard Univ, Sch Med, Dept Radiat Oncol, BIDMC, 21-27 Burlington Ave,99 Brookline Ave, Boston, MA 02215 USA.	scalderw@bidmc.harvard.edu		Eguchi, Takanori/0000-0002-3297-6126	NIH [RO-1CA047407, R01CA119045, RO-1CA094397]; NATIONAL CANCER INSTITUTE [R01CA094397, R01CA176326, R01CA119045, R01CA047407] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Department of Radiation Oncology, Beth Israel Deaconess Medical Center for support and encouragement. We are very grateful for help with construct preparation from Dr Tom Prince. This work was supported by NIH research grants RO-1CA047407, R01CA119045 and RO-1CA094397.	Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Calderwood SK, 2012, CURR MOL MED, V12, P1102, DOI 10.2174/156652412803306675; Calderwood SK, 2012, J CELL BIOCHEM, V113, P1096, DOI 10.1002/jcb.23461; Charafe-Jauffret E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-202; Chou SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039679; Chu BY, 1998, J BIOL CHEM, V273, P18640, DOI 10.1074/jbc.273.29.18640; Chu BY, 1996, J BIOL CHEM, V271, P30847, DOI 10.1074/jbc.271.48.30847; Ciocca DR, 2013, ARCH TOXICOL, V87, P19, DOI 10.1007/s00204-012-0918-z; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; de Silanes IL, 2003, ONCOGENE, V22, P7146, DOI 10.1038/sj.onc.1206862; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gabai VL, 2012, MOL CELL BIOL, V32, P929, DOI 10.1128/MCB.05921-11; Gotoh J, 2003, CARCINOGENESIS, V24, P435, DOI 10.1093/carcin/24.3.435; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Jin XJ, 2011, CELL METAB, V14, P91, DOI 10.1016/j.cmet.2011.03.025; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; Khaleque M, 2008, ONCOGENE, V27, P1886, DOI 10.1038/sj.onc.1210834; Khaleque MA, 2005, ONCOGENE, V24, P6564, DOI 10.1038/sj.onc.1208798; Kim G, 2012, AGING CELL, V11, P617, DOI 10.1111/j.1474-9726.2012.00827.x; Kline MP, 1997, MOL CELL BIOL, V17, P2107, DOI 10.1128/MCB.17.4.2107; Knauf U, 1996, GENE DEV, V10, P2782, DOI 10.1101/gad.10.21.2782; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Lindvall C, 2007, STEM CELL REV, V3, P157, DOI 10.1007/s12015-007-0025-3; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Metcalfe C, 2011, J CELL SCI, V124, P3537, DOI 10.1242/jcs.091991; Min JN, 2007, ONCOGENE, V26, P5086, DOI 10.1038/sj.onc.1210317; Murshid A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013830; Nabors LB, 2001, CANCER RES, V61, P2154; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Santagata S, 2013, SCIENCE, V341, P250, DOI 10.1126/science.1238303; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; Saydam O, 2009, MOL CELL BIOL, V29, P5923, DOI 10.1128/MCB.00332-09; Srikantan S, 2012, FRONT BIOSCI-LANDMRK, V17, P189, DOI 10.2741/3921; Su J, 2012, INT J ONCOL, V40, P1162, DOI 10.3892/ijo.2011.1322; Veronese A, 2011, P NATL ACAD SCI USA, V108, P4840, DOI 10.1073/pnas.1101734108; Vleminckx K, 1999, MECH DEVELOP, V81, P65, DOI 10.1016/S0925-4773(98)00225-1; Wang XZ, 2004, J BIOL CHEM, V279, P49460, DOI 10.1074/jbc.M406059200; Wang XZ, 2003, MOL CELL BIOL, V23, P6013, DOI 10.1128/MCB.23.17.6013-6026.2003; Weng DS, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3102; Yecies JL, 2011, J MOL MED, V89, P221, DOI 10.1007/s00109-011-0726-6; Yoon JH, 2012, MOL CELL, V47, P648, DOI 10.1016/j.molcel.2012.06.027; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028950	47	69	70	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 23	2015	34	17					2178	2188		10.1038/onc.2014.177	http://dx.doi.org/10.1038/onc.2014.177			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CG7HG	24954509	Green Accepted, Green Submitted			2022-12-25	WOS:000353473000004
J	Antanasijevic, A; Basu, A; Bowlin, TL; Mishra, RK; Rong, LJ; Caffrey, M				Antanasijevic, Aleksandar; Basu, Arnab; Bowlin, Terry L.; Mishra, Rama K.; Rong, Lijun; Caffrey, Michael			Mutagenesis Studies of the H5 Influenza Hemagglutinin Stem Loop Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS HEMAGGLUTININ; RECEPTOR-BINDING; MEMBRANE-FUSION; PH; IDENTIFICATION; RESIDUES; ANTIBODY; PEPTIDE; COMPLEX; PROTEIN	Influenza outbreaks, particularly the pandemic 1918 H1 and avian H5 strains, are of high concern to public health. The hemagglutinin envelope protein of influenza plays a critical role in viral entry and thus is an attractive target for inhibition of virus entry. The highly conserved stem loop region of hemagglutinin has been shown to undergo critically important conformational changes during the entry process and, moreover, to be a site for inhibition of virus entry by antibodies, small proteins, and small drug-like molecules. In this work we probe the structure- function properties of the H5 hemagglutinin stem loop region by site-directed mutagenesis. We find that most mutations do not disrupt expression, proteolytic processing, incorporation into virus, or receptor binding; however, many of the mutations disrupt the entry process. We further assess the effects of mutations on inhibition of entry by a neutralizing monoclonal antibody (C179) and find examples of increased and decreased sensitivity to the antibody, consistent with the antibody binding site observed by x-ray crystallography. In addition, we tested the sensitivity of the mutants to MBX2329, a small molecule inhibitor of influenza entry. Interestingly, the mutants exhibit increased and decreased sensitivities to MBX2329, which gives further insight into the binding site of the compound on HA and potential mechanisms of escape. Finally, we have modeled the binding site of MBX2329 using molecular dynamics and find that the resulting structure is in good agreement with the mutagenesis results. Together these studies underscore the importance of the stem loop region to HA function and suggest potential sites for therapeutic intervention of influenza entry.	[Antanasijevic, Aleksandar; Caffrey, Michael] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Basu, Arnab; Bowlin, Terry L.] Microbiotix Inc, Worcester, MA 01605 USA; [Mishra, Rama K.] Northwestern Univ, Ctr Mol Innovat & Drug Discovery, Evanston, IL 60208 USA; [Rong, Lijun] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Caffrey, M (corresponding author), 900 S Ashland, Chicago, IL 60607 USA.	caffrey@uic.edu			National Institutes of Health from DHHS [5R44AI072861, 1R21AI101676]; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI072861, R21AI101676, R43AI072861] Funding Source: NIH RePORTER	National Institutes of Health from DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R44AI072861 and 1R21AI101676 from the DHHS. Molecular Modeling work was provided by the Center for Molecular Innovation and Drug Discovery, Northwestern University, supported by the Chicago Biomedical Consortium with support from the Searle Funds at The Chicago Community Trust.	Antanasijevic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076363; Basu A, 2014, J VIROL, V88, P1447, DOI 10.1128/JVI.01225-13; Caffrey M, 2011, TRENDS MICROBIOL, V19, P191, DOI 10.1016/j.tim.2011.02.001; Casali M, 2008, PROTEIN ENG DES SEL, V21, P395, DOI 10.1093/protein/gzn018; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Dreyfus C, 2013, J VIROL, V87, P7149, DOI 10.1128/JVI.02975-12; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Guo Y, 2009, J MOL BIOL, V394, P600, DOI 10.1016/j.jmb.2009.10.032; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hoffman LR, 1997, J VIROL, V71, P8808, DOI 10.1128/JVI.71.11.8808-8820.1997; Jacobs A, 2005, J BIOL CHEM, V280, P27284, DOI 10.1074/jbc.M414411200; Jiang Haiqing, 2009, Virologica Sinica, V24, P121, DOI 10.1007/s12250-009-3015-6; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Lagoja IM, 2008, MED RES REV, V28, P1, DOI 10.1002/med.20096; Neumann G, 2010, CELL RES, V20, P51, DOI 10.1038/cr.2009.124; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Qiao H, 1998, J CELL BIOL, V141, P1335, DOI 10.1083/jcb.141.6.1335; Reed ML, 2009, J VIROL, V83, P3568, DOI 10.1128/JVI.02238-08; Russell RJ, 2008, P NATL ACAD SCI USA, V105, P17736, DOI 10.1073/pnas.0807142105; Sakabe S, 2010, ANTIVIR RES, V88, P249, DOI 10.1016/j.antiviral.2010.09.007; Schrodinger LLC, 2012, MACR VERS 9 8; Sen J, 2010, BIOCHEMISTRY-US, V49, P5057, DOI 10.1021/bi1005267; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Tripos International, 2013, SYBYLX 1 3; van der Vries E, 2010, NEW ENGL J MED, V363, P1381, DOI 10.1056/NEJMc1003749; Vanderlinden E, 2010, J VIROL, V84, P4277, DOI 10.1128/JVI.02325-09; Wang MX, 2012, J VIROL, V86, P4455, DOI 10.1128/JVI.07187-11; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992	31	6	7	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22237	22245		10.1074/jbc.M114.572974	http://dx.doi.org/10.1074/jbc.M114.572974			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24947513	hybrid, Green Published			2022-12-25	WOS:000340593500037
J	Sistiaga, A; Mallol, C; Galvan, B; Summons, RE				Sistiaga, Ainara; Mallol, Carolina; Galvan, Bertila; Everett Summons, Roger			The Neanderthal Meal: A New Perspective Using Faecal Biomarkers	PLOS ONE			English	Article							HUMAN GUT; STEROLS; CHOLESTEROL; COPROSTANOL; CONVERSION; POLLUTION; FECES; CAVE; CONTAMINATION; SEDIMENT	Neanderthal dietary reconstructions have, to date, been based on indirect evidence and may underestimate the significance of plants as a food source. While zooarchaeological and stable isotope data have conveyed an image of Neanderthals as largely carnivorous, studies on dental calculus and scattered palaeobotanical evidence suggest some degree of contribution of plants to their diet. However, both views remain plausible and there is no categorical indication of an omnivorous diet. Here we present direct evidence of Neanderthal diet using faecal biomarkers, a valuable analytical tool for identifying dietary provenance. Our gas chromatography-mass spectrometry results from El Salt (Spain), a Middle Palaeolithic site dating to ca. 50,000 yr. BP, represents the oldest positive identification of human faecal matter. We show that Neanderthals, like anatomically modern humans, have a high rate of conversion of cholesterol to coprostanol related to the presence of required bacteria in their guts. Analysis of five sediment samples from different occupation floors suggests that Neanderthals predominantly consumed meat, as indicated by high coprostanol proportions, but also had significant plant intake, as shown by the presence of 5 beta-stigmastanol. This study highlights the applicability of the biomarker approach in Pleistocene contexts as a provider of direct palaeodietary information and supports the opportunity for further research into cholesterol metabolism throughout human evolution.	[Sistiaga, Ainara; Mallol, Carolina; Galvan, Bertila] Univ La Laguna, Dept Geog & Hist, Tenerife, Spain; [Sistiaga, Ainara; Everett Summons, Roger] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA USA; [Sistiaga, Ainara; Mallol, Carolina] Inst Univ Bioorgan Antonio Gonzalez, Tenerife, Spain	Universidad de la Laguna; Massachusetts Institute of Technology (MIT); Universidad de la Laguna	Sistiaga, A (corresponding author), Univ La Laguna, Dept Geog & Hist, Tenerife, Spain.	msistiag@ull.es	Sistiaga, Ainara/AAB-7769-2021; Summons, Roger Everett/AAL-3789-2020	Sistiaga, Ainara/0000-0003-1732-7010; 	Spanish Government I+D project [HAR2012-32703 MEC-FEDER]; Canarian Government predoctoral grant; EAOG travel award; NASA Astrobiology Institute [NNA13AA90A]	Spanish Government I+D project; Canarian Government predoctoral grant; EAOG travel award; NASA Astrobiology Institute	Archaeological research at El Salt is funded by the Spanish Government I+D project (HAR2012-32703 MEC-FEDER), and a Canarian Government predoctoral grant and EAOG travel award to A. S. Research at MIT was supported by a grant (NNA13AA90A) from the NASA Astrobiology Institute to R. E. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BETHELL PH, 1994, J ARCHAEOL SCI, V21, P619, DOI 10.1006/jasc.1994.1061; Bocherens H, 2009, VERTEBR PALEOBIOL PA, P241, DOI 10.1007/978-1-4020-9699-0_19; Bouchet F, 2003, MEM I OSWALDO CRUZ, V98, P95, DOI 10.1590/S0074-02762003000900015; Buck LT, 2013, QUAT SCI REV; Bull ID, 2002, ENVIRON INT, V27, P647, DOI 10.1016/S0160-4120(01)00124-6; Bull ID, 2001, GEOARCHAEOLOGY, V16, P223, DOI 10.1002/1520-6548(200102)16:2<223::AID-GEA1002>3.0.CO;2-7; Chizzolini R, 1999, TRENDS FOOD SCI TECH, V10, P119, DOI 10.1016/S0924-2244(99)00034-5; D'Anjou RM, 2012, P NATL ACAD SCI USA, V109, P20332, DOI 10.1073/pnas.1212730109; Ecker M, 2013, J HUM EVOL, V65, P363, DOI 10.1016/j.jhevol.2013.06.013; Elhmmali MM, 2000, ENVIRON SCI TECHNOL, V34, P39, DOI 10.1021/es990076z; Evershed RP, 1997, J ARCHAEOL SCI, V24, P485, DOI 10.1006/jasc.1996.0132; EYSSEN HJ, 1973, EUR J BIOCHEM, V36, P411, DOI 10.1111/j.1432-1033.1973.tb02926.x; FLOATE M J S, 1970, Soil Biology and Biochemistry, V2, P173, DOI 10.1016/0038-0717(70)90005-2; FREIER TA, 1994, INT J SYST BACTERIOL, V44, P137, DOI 10.1099/00207713-44-1-137; Furtula V, 2012, WATER RES, V46, P1079, DOI 10.1016/j.watres.2011.12.002; Garralda MD, 2014, J HUMAN EVO IN PRESS; GASKELL SJ, 1975, NATURE, V254, P209, DOI 10.1038/254209b0; Gaudzinski-Windheuser S, 2012, QUATERN INT, V252, P1, DOI 10.1016/j.quaint.2011.10.017; Gerard P, 2007, APPL ENVIRON MICROB, V73, P5742, DOI 10.1128/AEM.02806-06; Gerard P, 2014, PATHOGENS, V3, P14, DOI 10.3390/pathogens3010014; GRIMALT JO, 1990, ENVIRON SCI TECHNOL, V24, P357, DOI 10.1021/es00073a011; GULACAR FO, 1990, J ARCHAEOL SCI, V17, P691, DOI 10.1016/0305-4403(90)90050-F; Hardy BL, 2010, QUATERNARY SCI REV, V29, P662, DOI 10.1016/j.quascirev.2009.11.016; Hardy K, 2012, NATURWISSENSCHAFTEN, V99, P617, DOI 10.1007/s00114-012-0942-0; Henry AG, 2011, P NATL ACAD SCI USA, V108, P486, DOI 10.1073/pnas.1016868108; ILLMAN RJ, 1993, J NUTR, V123, P1094; Leeming R, 1996, WATER RES, V30, P2893, DOI 10.1016/S0043-1354(96)00011-5; Lev E, 2005, J ARCHAEOL SCI, V32, P475, DOI 10.1016/j.jas.2004.11.006; LIN DS, 1978, J LIPID RES, V19, P215; MACDONALD IA, 1983, J LIPID RES, V24, P675; Madella M, 2002, J ARCHAEOL SCI, V29, P703, DOI 10.1006/jasc.2001.0743; Mallol C, 2013, J ARCHAEOL SCI, V40, P2515, DOI 10.1016/j.jas.2012.09.017; MIDTVEDT AC, 1993, J PEDIATR GASTR NUTR, V17, P161, DOI 10.1097/00005176-199308000-00006; MIDTVEDT T, 1990, APMIS, V98, P839, DOI 10.1111/j.1699-0463.1990.tb05004.x; MURTAUGH JJ, 1967, J WATER POLLUT CON F, V39, P404; Navder K P, 1992, Indian J Med Sci, V46, P275; Nichols PD, 1996, J CHROMATOGR A, V733, P497, DOI 10.1016/0021-9673(95)00807-1; Normen L, 1999, EUR J NUTR, V38, P84, DOI 10.1007/s003940050048; Peters K.E., 2005, BIOMARKER GUIDE; Poinar H, 2009, SCIENCE, V325, DOI [10.1126/science.1167531, 10.1126/science.1168182]; Pumpin C, 2010, 550 JAHR WISS BEW UN; Ren DW, 1996, STEROIDS, V61, P33, DOI 10.1016/0039-128X(95)00173-N; Richards MP, 2009, P NATL ACAD SCI USA, V106, P16034, DOI 10.1073/pnas.0903821106; Shah VG, 2007, WATER RES, V41, P3691, DOI 10.1016/j.watres.2007.04.006; Sistiaga A, 2014, J ARCHAEOL SCI, V41, P813, DOI 10.1016/j.jas.2013.10.016; Trinkaus E, 2007, P NATL ACAD SCI USA, V104, P7367, DOI 10.1073/pnas.0702214104; Tyagi P, 2008, WATER AIR SOIL POLL, V187, P263, DOI 10.1007/s11270-007-9514-x; Veiga P, 2005, FEMS MICROBIOL LETT, V242, P81, DOI 10.1016/j.femsle.2004.10.042; WILKINS TD, 1974, CANCER RES, V34, P2250	49	83	86	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e101045	10.1371/journal.pone.0101045	http://dx.doi.org/10.1371/journal.pone.0101045			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963925	Green Published, gold, Green Submitted			2022-12-25	WOS:000338709500112
J	Cohen, A; Sendersky, E; Carmeli, S; Schwarz, R				Cohen, Assaf; Sendersky, Eleonora; Carmeli, Shmuel; Schwarz, Rakefet			Collapsing Aged Culture of the Cyanobacterium Synechococcus elongatus Produces Compound(s) Toxic to Photosynthetic Organisms	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; OXIDATIVE STRESS; NATURAL ALGICIDE; PHOTOSYSTEM-II; PHYTOPLANKTON; COCCOLITHOPHORE; TERRESTRIAL; POPULATION; DYNAMICS; PCC-7942	Phytoplankton mortality allows effective nutrient cycling, and thus plays a pivotal role in driving biogeochemical cycles. A growing body of literature demonstrates the involvement of regulated death programs in the abrupt collapse of phytoplankton populations, and particularly implicates processes that exhibit characteristics of metazoan programmed cell death. Here, we report that the cell-free, extracellular fluid (conditioned medium) of a collapsing aged culture of the cyanobacterium Synechococcus elongatus is toxic to exponentially growing cells of this cyanobacterium, as well as to a large variety of photosynthetic organisms, but not to eubacteria. The toxic effect, which is light-dependent, involves oxidative stress, as suggested by damage alleviation by antioxidants, and the very high sensitivity of a catalase-mutant to the conditioned medium. At relatively high cell densities, S. elongatus cells survived the deleterious effect of conditioned medium in a process that required de novo protein synthesis. Application of conditioned medium from a collapsing culture caused severe pigment bleaching not only in S. elongatus cells, but also resulted in bleaching of pigments in a cell free extract. The latter observation indicates that the elicited damage is a direct effect that does not require an intact cell, and therefore, is mechanistically different from the metazoan-like programmed cell death described for phytoplankton. We suggest that S. elongatus in aged cultures are triggered to produce a toxic compound, and thus, this process may be envisaged as a novel regulated death program.	[Cohen, Assaf; Sendersky, Eleonora; Schwarz, Rakefet] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Carmeli, Shmuel] Tel Aviv Univ, Dept Chem, IL-69978 Tel Aviv, Israel	Bar Ilan University; Tel Aviv University	Schwarz, R (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	Rakefet.Schwarz@biu.ac.il	Carmeli, shmuel/N-1273-2018	Carmeli, shmuel/0000-0002-9641-9943	Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University	Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University	This work was supported by the Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Balint I, 2006, FEBS LETT, V580, P2117, DOI 10.1016/j.febslet.2006.03.020; Berman-Frank I, 2004, LIMNOL OCEANOGR, V49, P997, DOI 10.4319/lo.2004.49.4.0997; Bidle KD, 2007, P NATL ACAD SCI USA, V104, P6049, DOI 10.1073/pnas.0701240104; Bidle KD, 2004, NAT REV MICROBIOL, V2, P643, DOI 10.1038/nrmicro956; Brussaard CPD, 2004, J EUKARYOT MICROBIOL, V51, P125, DOI 10.1111/j.1550-7408.2004.tb00537.x; Choi CJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.21; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Franklin DJ, 2006, EUR J PHYCOL, V41, P1, DOI 10.1080/09670260500505433; Geider RJ, 2001, GLOBAL CHANGE BIOL, V7, P849, DOI 10.1046/j.1365-2486.2001.00448.x; GLEASON FK, 1984, ARCH MICROBIOL, V138, P273, DOI 10.1007/BF00402134; GLEASON FK, 1986, PLANT PHYSIOL, V80, P834, DOI 10.1104/pp.80.4.834; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Jimenez C, 2009, J EXP BOT, V60, P815, DOI 10.1093/jxb/ern330; KALFF J, 1978, ANNU REV ECOL SYST, V9, P475, DOI 10.1146/annurev.es.09.110178.002355; Larom S, 2010, P NATL ACAD SCI USA, V107, P9650, DOI 10.1073/pnas.1000187107; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Mayali X, 2004, J EUKARYOT MICROBIOL, V51, P139, DOI 10.1111/j.1550-7408.2004.tb00538.x; Moharikar S, 2006, J PHYCOL, V42, P423, DOI 10.1111/j.1529-8817.2006.00207.x; Murik O, 2009, ENVIRON MICROBIOL, V11, P2301, DOI 10.1111/j.1462-2920.2009.01957.x; Ning SB, 2002, J APPL MICROBIOL, V93, P15, DOI 10.1046/j.1365-2672.2002.01651.x; NIXON PJ, 1991, PLANT CELL, V3, P383, DOI 10.1105/tpc.3.4.383; Paul C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021032; Perelman A, 2003, J BACTERIOL, V185, P3654, DOI 10.1128/JB.185.12.3654-3660.2003; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Sakamoto T, 1998, APPL ENVIRON MICROB, V64, P2361; Schatz D, 2013, ENVIRON MICROBIOL, V15, P1786, DOI 10.1111/1462-2920.12070; Schwarz R, 1998, P NATL ACAD SCI USA, V95, P11008, DOI 10.1073/pnas.95.18.11008; Sedmak B, 2008, MICROB ECOL, V56, P201, DOI 10.1007/s00248-007-9336-9; Segovia M, 2003, PLANT PHYSIOL, V132, P99, DOI 10.1104/pp.102.017129; SILVERBERG BA, 1974, NEW PHYTOL, V73, P143, DOI 10.1111/j.1469-8137.1974.tb04615.x; Suginaka K, 1999, BIOSCI BIOTECH BIOCH, V63, P1112, DOI 10.1271/bbb.63.1112; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Vardi A, 1999, CURR BIOL, V9, P1061, DOI 10.1016/S0960-9822(99)80459-X; Vardi A, 2007, ENVIRON MICROBIOL, V9, P360, DOI 10.1111/j.1462-2920.2006.01146.x; Vardi A, 2012, P NATL ACAD SCI USA, V109, P19327, DOI 10.1073/pnas.1208895109; Vardi A, 2009, SCIENCE, V326, P861, DOI 10.1126/science.1177322; Zito F, 1997, PLANT MOL BIOL, V33, P79, DOI 10.1023/A:1005734809834	39	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100747	10.1371/journal.pone.0100747	http://dx.doi.org/10.1371/journal.pone.0100747			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959874	Green Published, gold, Green Submitted			2022-12-25	WOS:000338633900080
J	Reifenstein, E; Stemmler, M; Herz, AVM; Kempter, R; Schreiber, S				Reifenstein, Eric; Stemmler, Martin; Herz, Andreas V. M.; Kempter, Richard; Schreiber, Susanne			Movement Dependence and Layer Specificity of Entorhinal Phase Precession in Two-Dimensional Environments	PLOS ONE			English	Article							GRID CELLS; SPATIAL REPRESENTATION; STELLATE CELLS; PLACE CELLS; THETA; OSCILLATIONS; POSITION; INTEGRATION; EXPERIENCE; RESONANCE	As a rat moves, grid cells in its entorhinal cortex (EC) discharge at multiple locations of the external world, and the firing fields of each grid cell span a hexagonal lattice. For movements on linear tracks, spikes tend to occur at successively earlier phases of the theta-band filtered local field potential during the traversal of a firing field - a phenomenon termed phase precession. The complex movement patterns observed in two-dimensional (2D) open-field environments may fundamentally alter phase precession. To study this question at the behaviorally relevant single-run level, we analyzed EC spike patterns as a function of the distance traveled by the rat along each trajectory. This analysis revealed that cells across all EC layers fire spikes that phase-precess; indeed, the rate and extent of phase precession were the same, only the correlation between spike phase and path length was weaker in EC layer III. Both slope and correlation of phase precession were surprisingly similar on linear tracks and in 2D open-field environments despite strong differences in the movement statistics, including running speed. While the phase-precession slope did not correlate with the average running speed, it did depend on specific properties of the animal's path. The longer a curving path through a grid-field in a 2D environment, the shallower was the rate of phase precession, while runs that grazed a grid field tangentially led to a steeper phase-precession slope than runs through the field center. Oscillatory interference models for grid cells do not reproduce the observed phenomena.	[Reifenstein, Eric; Kempter, Richard; Schreiber, Susanne] Humboldt Univ, Dept Biol, Inst Theoret Biol, Berlin, Germany; [Reifenstein, Eric; Kempter, Richard; Schreiber, Susanne] Bernstein Ctr Computat Neurosci Berlin, Berlin, Germany; [Stemmler, Martin; Herz, Andreas V. M.] Univ Munich, Dept Biol 2, Planegg Martinsried, Germany; [Stemmler, Martin; Herz, Andreas V. M.] Bernstein Ctr Computat Neurosci Munich, Munich, Germany	Humboldt University of Berlin; University of Munich	Reifenstein, E (corresponding author), Humboldt Univ, Dept Biol, Inst Theoret Biol, Berlin, Germany.	eric.reifenstein@bccn-berlin.de		Reifenstein, Eric/0000-0002-6898-0178	Deutsche Forschungsgemeinschaft [SFB 618 TP B3, GRK 1123]; German Federal Ministry for Education and Research [01GQ0440, 01GQ0901, 01GQ0972, 01GQ1001A]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the Deutsche Forschungsgemeinschaft Grants SFB 618 TP B3 and GRK 1123, and the German Federal Ministry for Education and Research Grants 01GQ0440, 01GQ0901, 01GQ0972, and 01GQ1001A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; Beed P, 2010, NEURON, V68, P1059, DOI 10.1016/j.neuron.2010.12.009; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burgess N, 2008, HIPPOCAMPUS, V18, P1157, DOI 10.1002/hipo.20518; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Canto CB, 2012, HIPPOCAMPUS, V22, P1277, DOI 10.1002/hipo.20993; Chance FS, 2012, J NEUROSCI, V32, P16693, DOI 10.1523/JNEUROSCI.2786-12.2012; Climer JR, 2013, EUR J NEUROSCI, V38, P2526, DOI 10.1111/ejn.12256; Couey JJ, 2013, NAT NEUROSCI, V16, P318, DOI 10.1038/nn.3310; Derdikman D, 2009, NAT NEUROSCI, V12, P1325, DOI 10.1038/nn.2396; Engel TA, 2008, J NEUROPHYSIOL, V100, P1576, DOI 10.1152/jn.01282.2007; Erchova I, 2004, J PHYSIOL-LONDON, V560, P89, DOI 10.1113/jphysiol.2004.069930; Fernandez FR, 2013, J NEUROSCI, V33, P6027, DOI 10.1523/JNEUROSCI.3892-12.2013; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Hayman R, 2011, NAT NEUROSCI, V14, P1182, DOI 10.1038/nn.2892; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Huxter JR, 2008, NAT NEUROSCI, V11, P587, DOI 10.1038/nn.2106; Jaramillo J SR, 2014, J NEUROSCI IN PRESS; Jeewajee A, 2014, PHILOS T ROYAL SOC B, V369; Jensen O, 2000, J NEUROPHYSIOL, V83, P2602, DOI 10.1152/jn.2000.83.5.2602; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kayser C, 2009, NEURON, V61, P597, DOI 10.1016/j.neuron.2009.01.008; Kempter R, 2012, J NEUROSCI METH, V207, P113, DOI 10.1016/j.jneumeth.2012.03.007; Klink R, 1997, HIPPOCAMPUS, V7, P571; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Navratilova Z, 2012, HIPPOCAMPUS, V22, P772, DOI 10.1002/hipo.20939; Nitz DA, 2011, J NEUROPHYSIOL, V105, P1815, DOI 10.1152/jn.00573.2010; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Rao JS., 2001, TOPICS CIRCULAR STAT; Reifenstein ET, 2012, P NATL ACAD SCI USA, V109, P6301, DOI 10.1073/pnas.1109599109; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Schmidt R, 2009, J NEUROSCI, V29, P13232, DOI 10.1523/JNEUROSCI.2270-09.2009; Schmidt-Hieber C, 2013, NAT NEUROSCI, V16, P325, DOI 10.1038/nn.3340; Schreiber S, 2004, J NEUROPHYSIOL, V92, P408, DOI 10.1152/jn.01116.2003; Siegel M, 2009, P NATL ACAD SCI USA, V106, P21341, DOI 10.1073/pnas.0908193106; Singer AC, 2010, J NEUROSCI, V30, P11586, DOI 10.1523/JNEUROSCI.0926-10.2010; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Varga C, 2010, NAT NEUROSCI, V13, P822, DOI 10.1038/nn.2570; Zar JH, 1999, BIOSTATISCAL ANAL BI; Zilli EA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000573	46	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100638	10.1371/journal.pone.0100638	http://dx.doi.org/10.1371/journal.pone.0100638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959748	Green Published, gold, Green Submitted			2022-12-25	WOS:000338633900063
J	Anadon-Rosell, A; Rixen, C; Cherubini, P; Wipf, S; Hagedorn, F; Dawes, MA				Anadon-Rosell, Alba; Rixen, Christian; Cherubini, Paolo; Wipf, Sonja; Hagedorn, Frank; Dawes, Melissa A.			Growth and Phenology of Three Dwarf Shrub Species in a Six-Year Soil Warming Experiment at the Alpine Treeline	PLOS ONE			English	Article							SIMULATED ENVIRONMENTAL-CHANGE; SHORT-TERM RESPONSES; FLOWERING PHENOLOGY; CLIMATE-CHANGE; NITROGEN MINERALIZATION; VACCINIUM-MYRTILLUS; PLANT PERFORMANCE; HEATH COMMUNITY; CO2 ENRICHMENT; CARBON-DIOXIDE	Global warming can have substantial impacts on the phenological and growth patterns of alpine and Arctic species, resulting in shifts in plant community composition and ecosystem dynamics. We evaluated the effects of a six-year experimental soil warming treatment (+4 degrees C, 2007-2012) on the phenology and growth of three co-dominant dwarf shrub species growing in the understory of Larix decidua and Pinus uncinata at treeline in the Swiss Alps. We monitored vegetative and reproductive phenology of Vaccinium myrtillus, Vaccinium gaultherioides and Empetrum hermaphroditum throughout the early growing season of 2012 and, following a major harvest at peak season, we measured the biomass of above-ground ramet fractions. For all six years of soil warming we measured annual shoot growth of the three species and analyzed ramet age and xylem ring width of V. myrtillus. Our results show that phenology of the three species was more influenced by snowmelt timing, and also by plot tree species (Larix or Pinus) in the case of V. myrtillus, than by soil warming. However, the warming treatment led to increased V. myrtillus total above-ground ramet biomass (+36% in 2012), especially new shoot biomass (+63% in 2012), as well as increased new shoot increment length and xylem ring width (+22% and +41%, respectively; average for 2007-2012). These results indicate enhanced overall growth of V. myrtillus under soil warming that was sustained over six years and was not caused by an extended growing period in early summer. In contrast, E. hermaphroditum only showed a positive shoot growth response to warming in 2011 (+21%), and V. gaultherioides showed no significant growth response. Our results indicate that V. myrtillus might have a competitive advantage over the less responsive co-occurring dwarf shrub species under future global warming.	[Anadon-Rosell, Alba] Univ Barcelona, Dept Plant Biol, Barcelona, Catalonia, Spain; [Anadon-Rosell, Alba; Rixen, Christian; Wipf, Sonja; Dawes, Melissa A.] WSL Inst Snow & Avalanche Res SLF, Davos, Switzerland; [Anadon-Rosell, Alba; Cherubini, Paolo; Hagedorn, Frank] Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland	University of Barcelona; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Anadon-Rosell, A (corresponding author), Univ Barcelona, Dept Plant Biol, Barcelona, Catalonia, Spain.	a.anadon@ub.edu	Anadon-Rosell, Alba/AAA-5464-2020; Anadon-Rosell, Alba/GLR-2455-2022; Cherubini, Paolo/N-9702-2013; Wipf, Sonja/A-5075-2010; Cherubini, Paolo/AAC-3121-2021	Anadon-Rosell, Alba/0000-0002-9447-7795; Anadon-Rosell, Alba/0000-0002-9447-7795; Cherubini, Paolo/0000-0002-9809-250X; Wipf, Sonja/0000-0002-3492-1399; Cherubini, Paolo/0000-0002-9809-250X; Dawes, Melissa A./0000-0003-4919-0151; Rixen, Christian/0000-0002-2486-9988; Hagedorn, Frank/0000-0001-5218-7776	University of Barcelona; Spanish Ministry of Education (FPU); WSL; Swiss National Science Foundation [315200-116861]; Velux Foundation	University of Barcelona; Spanish Ministry of Education (FPU)(Spanish Government); WSL; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Velux Foundation(Velux Fonden)	Funding came from University of Barcelona (collaborative grant to AAR); Spanish Ministry of Education (FPU grant to AAR); WSL (funding for MAD and AAR); Swiss National Science Foundation from 2007 to 2009 (grant 315200-116861 to CR); Velux Foundation (funding for SW and FH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2006, PLANT ECOL, V182, P65, DOI 10.1007/s11258-005-9031-1; Aerts R, 2004, GLOBAL CHANGE BIOL, V10, P1599, DOI 10.1111/j.1365-2486.2004.00815.x; Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; Atkin OK, 2006, J EXP BOT, V57, P267, DOI 10.1093/jxb/erj029; Barbeito I, 2012, ECOLOGY, V93, P389, DOI 10.1890/11-0384.1; Bret-Harte MS, 2002, J ECOL, V90, P251, DOI 10.1046/j.1365-2745.2001.00657.x; Campioli M, 2012, PLOS ONE, V7, DOI [10.1371/journal.-pone.0034842, DOI 10.1371/JOURNAL.-PONE.0034842]; Campioli M, 2013, PLANT ECOL, V214, P1049, DOI 10.1007/s11258-013-0230-x; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Chapin FS, 2000, GLOBAL CHANGE BIOL, V6, P211, DOI 10.1046/j.1365-2486.2000.06022.x; Cook BI, 2012, P NATL ACAD SCI USA, V109, P9000, DOI 10.1073/pnas.1118364109; Cornelissen JHC, 2001, J ECOL, V89, P984, DOI 10.1111/j.1365-2745.2001.00625.x; Dawes MA, 2014, NEW PHYTOL, V202, P1237, DOI 10.1111/nph.12742; Dawes MA, 2013, OECOLOGIA, V171, P623, DOI 10.1007/s00442-012-2576-5; Dawes MA, 2011, NEW PHYTOL, V191, P806, DOI 10.1111/j.1469-8137.2011.03722.x; Dawes MA, 2011, J ECOL, V99, P383, DOI 10.1111/j.1365-2745.2010.01764.x; Dunne JA, 2003, ECOL MONOGR, V73, P69, DOI 10.1890/0012-9615(2003)073[0069:SMFPRT]2.0.CO;2; Elmendorf SC, 2012, NAT CLIM CHANGE, V2, P453, DOI 10.1038/NCLIMATE1465; Elmendorf SC, 2012, ECOL LETT, V15, P164, DOI 10.1111/j.1461-0248.2011.01716.x; Esau K., 1977, Anatomy of seed plants.; Gomez-Aparicio L, 2008, J VEG SCI, V19, P161, DOI 10.3170/2008-8-18347; Goulden ML, 1996, SCIENCE, V271, P1576, DOI 10.1126/science.271.5255.1576; Graglia E, 1997, ECOSCIENCE, V4, P191, DOI 10.1080/11956860.1997.11682395; Grau O, 2012, OIKOS, V121, P1680, DOI 10.1111/j.1600-0706.2011.20032.x; Hagedorn F, 2010, BIOGEOCHEMISTRY, V97, P1, DOI 10.1007/s10533-009-9386-9; Hartley AE, 1999, OIKOS, V86, P331, DOI 10.2307/3546450; Hattenschwiler S, 2002, NEW PHYTOL, V156, P363, DOI 10.1046/j.1469-8137.2002.00537.x; Hill GB, 2011, GLOBAL CHANGE BIOL, V17, P276, DOI 10.1111/j.1365-2486.2010.02244.x; Hoffmann AA, 2010, J ECOL, V98, P927, DOI 10.1111/j.1365-2745.2010.01667.x; Hudson JMG, 2009, ECOLOGY, V90, P2657, DOI 10.1890/09-0102.1; Klanderud K, 2008, J VEG SCI, V19, P363, DOI 10.3170/2008-8-18376; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; Korner C., 2003, ALPINE PLANT LIFE FU, V2nd ed.; Lauber K., 2018, FLORA HELVETICA; Marion GM, 1997, GLOB CHANGE BIOL, V3, P20, DOI 10.1111/j.1365-2486.1997.gcb136.x; Martin M, 2010, GLOBAL CHANGE BIOL, V16, P1057, DOI 10.1111/j.1365-2486.2009.01987.x; McEwan RW, 2011, PLANT ECOL, V212, P55, DOI 10.1007/s11258-010-9801-2; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Natali SM, 2012, J ECOL, V100, P488, DOI 10.1111/j.1365-2745.2011.01925.x; Oberbauer SF, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0481; PARSONS AN, 1994, J ECOL, V82, P307, DOI 10.2307/2261298; Pato J, 2012, ECOSCIENCE, V19, P59, DOI 10.2980/19-1-3407; Pau S, 2011, GLOBAL CHANGE BIOL, V17, P3633, DOI 10.1111/j.1365-2486.2011.02515.x; Pinheiro J, 2008, R PACKAGE VERSION, V57, P1; Press MC, 1998, J ECOL, V86, P315, DOI 10.1046/j.1365-2745.1998.00261.x; R Core Team, 2021, R LANG ENV STAT COMP; Regent Instruments Inc, 2001, WINCELL PRO 2001 IM; Rixen C, 2012, OIKOS, V121, P1532, DOI 10.1111/j.1600-0706.2011.20031.x; Rixen C, 2010, POLAR RES, V29, P85, DOI 10.1111/j.1751-8369.2010.00155.x; Ropars P, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/015501; Rundqvist S, 2011, AMBIO, V40, P683, DOI 10.1007/s13280-011-0174-0; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Schwartz MD, 2014, INT J BIOMETEOROL, V58, P1699, DOI 10.1007/s00484-013-0723-2; Schweingruber F. H., 1978, Microscopic wood anatomy : structural variability of stems and twigs in recent and subfossil woods from Central Europe.; Smith JG, 2012, ARCT ANTARCT ALP RES, V44, P135, DOI 10.1657/1938-4246-44.1.135; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Streit K, 2014, GLOBAL CHANGE BIOL, V20, P1327, DOI 10.1111/gcb.12396; Suzuki S, 2000, ECOGRAPHY, V23, P553, DOI 10.1034/j.1600-0587.2000.230506.x; Suzuki S, 1997, GLOB CHANGE BIOL, V3, P108, DOI 10.1111/j.1365-2486.1997.gcb146.x; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; Totland O, 2002, OECOLOGIA, V133, P168, DOI 10.1007/s00442-002-1028-z; van Wijk MT, 2004, GLOBAL CHANGE BIOL, V10, P105, DOI 10.1111/j.1365-2486.2003.00719.x; Walther GR, 2004, PERSPECT PLANT ECOL, V6, P169, DOI 10.1078/1433-8319-00076; Wipf S, 2010, PLANT ECOL, V207, P53, DOI 10.1007/s11258-009-9653-9; Wolkovich EM, 2012, NATURE, V485, P494, DOI 10.1038/nature11014; Wookey PA, 2009, GLOBAL CHANGE BIOL, V15, P1153, DOI 10.1111/j.1365-2486.2008.01801.x; Xu ZF, 2009, PLANT SPEC BIOL, V24, P27, DOI 10.1111/j.1442-1984.2009.00229.x; Zumbrunn T, 2004, THESIS U BASEL BASEL	69	23	26	3	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100577	10.1371/journal.pone.0100577	http://dx.doi.org/10.1371/journal.pone.0100577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956273	gold, Green Published, Green Submitted			2022-12-25	WOS:000338917900070
J	Guo, HW; Yun, CX; Hou, GH; Du, J; Huang, X; Lu, Y; Keller, ET; Zhang, J; Deng, JG				Guo, Hong-Wei; Yun, Chen-Xia; Hou, Guang-Han; Du, Jun; Huang, Xin; Lu, Yi; Keller, Evan T.; Zhang, Jian; Deng, Jia-Gang			Mangiferin Attenuates Th1/Th2 Cytokine Imbalance in an Ovalbumin-Induced Asthmatic Mouse Model	PLOS ONE			English	Article							ALLERGIC AIRWAY INFLAMMATION; INDICA L. EXTRACT; INDUCED MYOCARDIAL-INFARCTION; T-BET; INTERFERON-GAMMA; TH2 DEVELOPMENT; DIABETIC-RATS; MURINE MODEL; MICE; CELLS	Mangiferin is a major bioactive ingredient in Mangifera indica Linn. (Anacardiaceae) leaves. Aqueous extract of such leaves have been used as an indigenous remedy for respiratory diseases like asthma and coughing in traditional Chinese medicine. However, underlying molecular mechanisms of mangiferin on anti-asthma remain unclear. In our present study, we investigated the anti-asthmatic effect of mangiferin on Th1/Th2 cytokine profiles and explored its underlying immunoregulatory mechanism in mouse model of allergic asthma. Mangiferin significantly reduced the total inflammatory cell counts and eosinophil infiltration, decreased the production of ovalbumin-specific IgE in serum and PGD(2) in BALF. The antibody array analysis showed that mangiferin down-regulated the levels of one group of cytokines/chemokines including Th2-related IL-4, IL-5, IL-13, and others IL-3, IL-9, IL-17, RANTES, TNF-alpha, but simultaneously up-regulated Th1-related IFN-gamma, IL2 and IL-10 and IL-12 expression in serum. Thus it attenuates the imbalance of Th1/Th2 cells ratio by diminishing the abnormal mRNA levels of Th1 cytokines (IFN-gamma and IL-12) and Th2 cytokines (IL-4, IL-5 and IL-13). Finally, mangiferin substantially inhibited the activation and expression of STAT-6 and GATA-3 in excised lung tissues. Our results suggest that mangiferin can exert anti-asthmatic effect. The underlying mechanism may attribute to the modulation of Th1/Th2 cytokine imbalance via inhibiting the STAT6 signaling pathway.	[Guo, Hong-Wei; Huang, Xin; Lu, Yi; Zhang, Jian] Guangxi Med Univ, Ctr Translat Med, Nanning, Guangxi, Peoples R China; [Guo, Hong-Wei; Huang, Xin; Lu, Yi; Zhang, Jian] Chinese Minist Educ, Key Lab Longev & Aging Related Dis, Nanning, Guangxi, Peoples R China; [Guo, Hong-Wei; Hou, Guang-Han; Du, Jun; Deng, Jia-Gang] Guangxi Key Lab Pharmacodynam Studies Tradit Chin, Nanning, Guangxi, Peoples R China; [Yun, Chen-Xia] Guangxi Univ Tradit Chinese Med, Sch Basic Med Sci, Nanning, Guangxi, Peoples R China; [Keller, Evan T.] Univ Michigan, Sch Med, Dept Urol & Pathol, Ann Arbor, MI USA	Guangxi Medical University; Guangxi University of Chinese Medicine; University of Michigan System; University of Michigan	Zhang, J (corresponding author), Guangxi Med Univ, Ctr Translat Med, Nanning, Guangxi, Peoples R China.	jzhangqi@gmail.com; dengjg53@hotmail.com	Keller, Evan T/M-1446-2016; ZHANG, JIAN/Q-6334-2018; guo, hongwei/GVS-9412-2022; Lu, Yi/J-6746-2018	Keller, Evan T/0000-0002-7592-7535; guo, hongwei/0000-0002-4046-2643; Lu, Yi/0000-0002-1060-6925	National Natural Science Foundation of China [30973916, 81260666]; Guangxi Projects of China [2013GXNSFBA019177, GZPT13-35, 1355004-5, 09-007-06-14, 11-031-05-K2]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Projects of China	This work was supported by the National Natural Science Foundation of China (30973916, 81260666) and the Guangxi Projects of China (2013GXNSFBA019177, GZPT13-35, 1355004-5, 09-007-06-14, 11-031-05-K2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkarian M, 2002, NAT; Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; BRUSSELLE GG, 1994, CLIN EXP ALLERGY, V24, P73, DOI 10.1111/j.1365-2222.1994.tb00920.x; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Carneiro ER, 2010, CYTOKINE, V50, P335, DOI 10.1016/j.cyto.2010.01.005; Chang HC, 2009, BLOOD, V113, P5887, DOI 10.1182/blood-2008-09-179820; Chen WG, 2007, J ALLERGY CLIN IMMUN, V119, P529, DOI 10.1016/j.jaci.2007.01.004; Coffey M, 2003, CURR OPIN ALLERGY CL, V3, P57, DOI 10.1097/01.all.0000053269.39029.50; Das J, 2012, TOXICOL APPL PHARM, V260, P35, DOI 10.1016/j.taap.2012.01.015; Fujitani Y, 2002, J IMMUNOL, V168, P443, DOI 10.4049/jimmunol.168.1.443; Garcia D, 2003, PHYTOTHER RES, V17, P1203, DOI 10.1002/ptr.1343; Rivera DG, 2011, J PHARM PHARMACOL, V63, P1336, DOI 10.1111/j.2042-7158.2011.01328.x; Garcia-Rivera D, 2011, CANCER LETT, V305, P21, DOI 10.1016/j.canlet.2011.02.011; Garrido G, 2001, PHYTOTHER RES, V15, P18, DOI 10.1002/1099-1573(200102)15:1&lt;18::AID-PTR676&gt;3.0.CO;2-R; Guha S, 1996, CHEMOTHERAPY, V42, P443, DOI 10.1159/000239478; Hammad H, 2011, ALLERGY, V66, P579, DOI 10.1111/j.1398-9995.2010.02528.x; Hirahara K, 2008, J ALLERGY CLIN IMMUN, V122, P512, DOI 10.1016/j.jaci.2008.06.004; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; Jagetia GC, 2005, PHYTOMEDICINE, V12, P209, DOI 10.1016/j.phymed.2003.08.003; Kanda Akira, 2009, P95, DOI 10.1007/978-4-431-88315-9_7; Kaplan MH, 2005, IMMUNOL RES, V31, P231, DOI 10.1385/IR:31:3:231; Kiwamoto T, 2006, AM J RESP CRIT CARE, V174, P142, DOI 10.1164/rccm.200601-079OC; Lee CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034554; Lee CC, 2008, MOL THER, V16, P60, DOI 10.1038/sj.mt.6300309; Lee SY, 2001, CLIN IMMUNOL, V101, P220, DOI 10.1006/clim.2001.5122; Leiro J, 2004, INT IMMUNOPHARMACOL, V4, P991, DOI 10.1016/j.intimp.2004.02.003; Li Chang-Chong, 2007, Zhonghua Er Ke Za Zhi, V45, P727; Li Chang-Chong, 2006, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V22, P210; Li XM, 2009, J ALLERGY CLIN IMMUN, V123, P297, DOI 10.1016/j.jaci.2008.12.026; Li XA, 2010, PHYTOTHER RES, V24, P893, DOI 10.1002/ptr.3045; Li Y, 2013, ARCH MED SCI, V9, P906, DOI 10.5114/aoms.2013.33180; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Makare N, 2001, J ETHNOPHARMACOL, V78, P133, DOI 10.1016/S0378-8741(01)00326-9; Molfino NA, 2012, CLIN EXP ALLERGY, V42, P712, DOI 10.1111/j.1365-2222.2011.03854.x; Mowen KA, 2004, IMMUNOL REV, V202, P203, DOI 10.1111/j.0105-2896.2004.00209.x; Mukherjee AB, 2011, J BIOL CHEM, V286, P32883, DOI 10.1074/jbc.R110.197046; Muruganandan S, 2005, J ETHNOPHARMACOL, V97, P497, DOI 10.1016/j.jep.2004.12.010; Muruganandan S, 2002, TOXICOLOGY, V176, P165, DOI 10.1016/S0300-483X(02)00069-0; Oh CK, 2010, EUR RESPIR REV, V19, P46, DOI 10.1183/09059180.00007609; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Pernis AB, 2002, J CLIN INVEST, V109, P1279, DOI 10.1172/JCI200215786; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Prabhu S, 2006, J ETHNOPHARMACOL, V107, P126, DOI 10.1016/j.jep.2006.02.014; Prabhu S., 2006, Indian Journal of Experimental Biology, V44, P209; Prabhu S, 2006, VASC PHARMACOL, V44, P519, DOI 10.1016/j.vph.2006.03.012; RACKE MK, 1994, J EXP MED, V180, P1961, DOI 10.1084/jem.180.5.1961; Ram A, 2004, INT IMMUNOPHARMACOL, V4, P1697, DOI 10.1016/j.intimp.2004.08.001; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Sanchez GM, 2000, PHARMACOL RES, V42, P565, DOI 10.1006/phrs.2000.0727; Shi YH, 2011, CHINESE MED J-PEKING, V124, P1951, DOI 10.3760/cma.j.issn.0366-6999.2011.13.006; Singh SK, 2009, INDIAN J PHARM SCI, V71, P328, DOI 10.4103/0250-474X.56023; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Telang M, 2013, EXPERT OPIN THER PAT, V23, P1561, DOI 10.1517/13543776.2013.836182; Underwood S, 1995, EUR RESPIR J, V8, P2104, DOI 10.1183/109031936.95.08122104; Wang Qin, 2011, Zhongguo Zhong Yao Za Zhi, V36, P1348; Wei Zhiquan, 2011, Zhongguo Zhong Yao Za Zhi, V36, P1798; Yuan Y, 2013, J ETHNOPHARMACOL, V149, P701, DOI 10.1016/j.jep.2013.07.032	58	71	82	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100394	10.1371/journal.pone.0100394	http://dx.doi.org/10.1371/journal.pone.0100394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955743	Green Published, Green Submitted, gold			2022-12-25	WOS:000338917900047
J	Xie, SS; Shen, B; Zhang, CB; Huang, XX; Zhang, YL				Xie, Shengsong; Shen, Bin; Zhang, Chaobao; Huang, Xingxu; Zhang, Yonglian			sgRNAcas9: A Software Package for Designing CRISPR sgRNA and Evaluating Potential Off-Target Cleavage Sites	PLOS ONE			English	Article							SEQUENCE-SPECIFIC CONTROL; ONE-STEP GENERATION; CONDITIONAL ALLELES; GENE-EXPRESSION; CAS9 NUCLEASE; HUMAN-CELLS; GENOME; SPECIFICITY; ZEBRAFISH; SYSTEM	Although the CRISPR/Cas9/sgRNA system efficiently cleaves intracellular DNA at desired target sites, major concerns remain on potential "off-target'' cleavage that may occur throughout the whole genome. In order to improve CRISPR-Cas9 specificity for targeted genome editing and transcriptional control, we describe a bioinformatics tool "sgRNAcas9'', which is a software package developed for fast design of CRISPR sgRNA with minimized off-target effects. This package consists of programs to perform a search for CRISPR target sites (protospacers) with user-defined parameters, predict genome-wide Cas9 potential off-target cleavage sites (POT), classify the POT into three categories, batch-design oligonucleotides for constructing 20-nt (nucleotides) or truncated sgRNA expression vectors, extract desired length nucleotide sequences flanking the on-or off-target cleavage sites for designing PCR primer pairs to validate the mutations by T7E1 cleavage assay. Importantly, by identifying potential off-target sites in silico, the sgRNAcas9 allows the selection of more specific target sites and aids the identification of bona fide off-target sites, significantly facilitating the design of sgRNA for genome editing applications. sgRNAcas9 software package is publicly available at BiooTools website (www.biootools.com) under the terms of the GNU General Public License.	[Xie, Shengsong; Zhang, Chaobao; Zhang, Yonglian] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Shen, Bin; Huang, Xingxu] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210008, Jiangsu, Peoples R China; [Zhang, Yonglian] Shanghai Inst Planned Parenthood Res, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanjing University	Huang, XX (corresponding author), Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210008, Jiangsu, Peoples R China.	xingxuhuang@mail.nju.edu.cn; ylzhang@sibs.ac.cn	Shen, Bin/ABD-5084-2021	Shen, Bin/0000-0002-8946-8448; huang, xingxu/0000-0001-8934-1247	National Natural Science Foundation of China [31301226]; Chinese Academy of Sciences (CAS) [KSXC2-EW-R-07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences)	The Project was supported by the National Natural Science Foundation of China (Grant No. 31301226) and the Chinese Academy of Sciences (CAS) Knowledge Innovation Program (KSXC2-EW-R-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Bae S., 2014, BIOINFORMATICS; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bassett AR, 2014, J GENET GENOMICS, V41, P7, DOI 10.1016/j.jgg.2013.12.004; Bikard David, 2013, F1000Prime Rep, V5, P47, DOI 10.12703/P5-47; Carroll D, 2013, NAT BIOTECHNOL, V31, P807, DOI 10.1038/nbt.2684; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI 10.1038/NMETH.2641; Fu Y, 2014, NAT BIOTECHNOL; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fujii W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt772; Guilinger J.P., 2014, NAT BIOTECHNOL; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hisano Y, 2014, DEV GROWTH DIFFER, V56, P26, DOI 10.1111/dgd.12094; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Ma M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/270805; Ma YW, 2014, CELL RES, V24, P122, DOI 10.1038/cr.2013.157; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Matsunaga T, 2014, BIOCHEM BIOPH RES CO, V444, P158, DOI 10.1016/j.bbrc.2014.01.037; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Tsai S. Q., 2014, NAT BIOTECHNOL; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Xiao A, 2014, BIOINFORMATICS; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhou JK, 2014, INT J BIOCHEM CELL B, V46, P49, DOI 10.1016/j.biocel.2013.10.010	40	179	200	4	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100448	10.1371/journal.pone.0100448	http://dx.doi.org/10.1371/journal.pone.0100448			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956386	gold, Green Published, Green Submitted			2022-12-25	WOS:000338917900053
J	Asaoka, R				Asaoka, Ryo			Mapping Glaucoma Patients' 30-2 and 10-2 Visual Fields Reveals Clusters of Test Points Damaged in the 10-2 Grid That Are Not Sampled in the Sparse 30-2 Grid	PLOS ONE			English	Article							NERVE-FIBER LAYER; PERIMETRY; SECTORIZATION; PROGRESSION; PARAFOVEAL; LOCATIONS; STIMULUS; DEFECTS; RATES	Purpose: To cluster test points in glaucoma patients' 30-2 and 10-2 visual field (VF) (Humphrey Field Analyzer: HFA, Carl Zeiss Meditec, Dublin, CA) in order to map the different regions damaged by the disease. Method: This retrospective study included 128 eyes from 128 patients. 142 total deviation (TD) values (74 from the 30-2 VF and 68 from the 10-2 VF) were clustered using the 'Hierarchical Ordered Partitioning And Collapsing Hybrid -Partitioning Around Medoids' algorithm. The stability of the identified clusters was evaluated using bootstrapping. Results: 65 sectors were identified in total: 38 sectors were located outside the 10-2 VF whereas 29 sectors were located inside the 10-2 VF (two sectors overlap in both grids). The mapping of many sectors appeared to follow the distribution of retinal nerve fiber bundles. The results of bootstrapping suggested clusters were stable whether they were outside or inside the 10-2 VF. Conclusion: A considerable number of sectors were identified in the 10-2 VF area, despite the fact that clustering was carried out on all points in both the 30-2 VF and 10-2 VF simultaneously. These findings suggest that glaucomatous central VF deterioration cannot be picked up by the 30-2 test grid alone, because of poor spatial sampling; denser estimation of the central ten degrees, than offered by the 30-2 test grid alone, is needed. It may be beneficial to develop a new VF test grid that combines test points from 30-2 and 10-2 VFs - the results of this study could help to devise this test grid.	Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan	University of Tokyo	Asaoka, R (corresponding author), Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan.	rasaoka-tky@umin.ac.jp						ANCTIL JL, 1984, ARCH OPHTHALMOL-CHIC, V102, P363; AULHORN E., 1967, P151; Aulhorn E., 1977, DOC OPHTHALMOL PROC, V14, P75; Bengtsson B, 2000, INVEST OPHTH VIS SCI, V41, P2201; Chauhan BC, 2008, BRIT J OPHTHALMOL, V92, P569, DOI 10.1136/bjo.2007.135012; CHAUHAN BC, 1989, GRAEF ARCH CLIN EXP, V227, P216, DOI 10.1007/BF02172752; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; COWEY A, 1974, EXP BRAIN RES, V21, P447; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; DRANCE SM, 1969, INVEST OPHTH VISUAL, V8, P84; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; Glinca S, 2013, J CHEM INF MODEL, V53, P2082, DOI 10.1021/ci300550a; HEIJL A, 1984, ACTA OPHTHALMOL, V62, P658; Hennig C, 2007, COMPUT STAT DATA AN, V52, P258, DOI 10.1016/j.csda.2006.11.025; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; KATZ J, 1991, ARCH OPHTHALMOL-CHIC, V109, P1684, DOI 10.1001/archopht.1991.01080120068028; KOSEKI N, 1995, GRAEF ARCH CLIN EXP, V233, P621, DOI 10.1007/BF00185282; Lamparter J, 2013, INVEST OPHTH VIS SCI, V54, P6074, DOI 10.1167/iovs.13-11902; Langerhorst C., 1997, MEASUREMENTS DESCRIP, P67; Malik R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002067; MANDAVA S, 1993, AM J OPHTHALMOL, V116, P684, DOI 10.1016/S0002-9394(14)73466-X; Nouri-Mahdavi K, 2012, INVEST OPHTH VIS SCI, V53, P2390, DOI 10.1167/iovs.11-9021; Park SC, 2013, OPHTHALMOLOGY, V120, P1546, DOI 10.1016/j.ophtha.2013.01.045; Park SC, 2011, OPHTHALMOLOGY, V118, P1782, DOI 10.1016/j.ophtha.2011.02.013; Pollard KS, 2002, 6TH WORLD MULTICONFERENCE ON SYSTEMICS, CYBERNETICS AND INFORMATICS, VOL II, PROCEEDINGS, P318; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Schiefer U, 2010, INVEST OPHTH VIS SCI, V51, P5685, DOI 10.1167/iovs.09-5067; Sumi I, 2003, OPHTHALMOLOGY, V110, P332, DOI 10.1016/S0161-6420(02)01742-6; SUZUKI Y, 1993, OPHTHALMOLOGY, V100, P69; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Traynis I, 2014, JAMA OPHTHALMOL; van der Laan MJ, 2003, J STAT PLAN INFER, V117, P275, DOI 10.1016/S0378-3758(02)00388-9; WEBER J, 1989, INT OPHTHALMOL, V13, P47, DOI 10.1007/BF02028637; ZALTA AH, 1991, BRIT J OPHTHALMOL, V75, P151, DOI 10.1136/bjo.75.3.151; ZEYEN TG, 1993, OPHTHALMOLOGY, V100, P518	36	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e98525	10.1371/journal.pone.0098525	http://dx.doi.org/10.1371/journal.pone.0098525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950300	Green Submitted, Green Published, gold			2022-12-25	WOS:000338276300007
J	Chen, XY; Zhao, Y; Mo, B; Mi, HX				Chen, Xiao-Yan; Zhao, Yu; Mo, Bin; Mi, Hong-Xing			An Improved Experimental Method for Simulating Erosion Processes by Concentrated Channel Flow	PLOS ONE			English	Article							SOIL-EROSION; SEDIMENT TRANSPORT; RILL EROSION; SHEAR-STRESS; SLOPE; DETACHMENT; HYDRAULICS; MODEL; RATES; CATCHMENT	Rill erosion is an important process that occurs on hill slopes, including sloped farmland. Laboratory simulations have been vital to understanding rill erosion. Previous experiments obtained sediment yields using rills of various lengths to get the sedimentation process, which disrupted the continuity of the rill erosion process and was time-consuming. In this study, an improved experimental method was used to measure the rill erosion processes by concentrated channel flow. By using this method, a laboratory platform, 12 m long and 3 m wide, was used to construct rills of 0.1 m wide and 12 m long for experiments under five slope gradients (5, 10, 15, 20, and 25 degrees) and three flow rates (2, 4, and 8 L min(-1)). Sediment laden water was simultaneously sampled along the rill at locations 0.5 m, 1 m, 2 m, 3 m, 4 m, 5 m, 6 m, 7 m, 8 m, 10 m, and 12 m from the water inlet to determine the sediment concentration distribution. The rill erosion process measured by the method used in this study and that by previous experimental methods are approximately the same. The experimental data indicated that sediment concentrations increase with slope gradient and flow rate, which highlights the hydraulic impact on rill erosion. Sediment concentration increased rapidly at the initial section of the rill, and the rate of increase in sediment concentration reduced with the rill length. Overall, both experimental methods are feasible and applicable. However, the method proposed in this study is more efficient and easier to operate. This improved method will be useful in related research.	[Chen, Xiao-Yan; Zhao, Yu; Mo, Bin; Mi, Hong-Xing] Southwest Univ, Minist Educ, Key Lab Ecoenvironm Three Gorges Reg, Coll Resources & Environm, Chongqing, Peoples R China; [Chen, Xiao-Yan] Chinese Acad Sci, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China; [Chen, Xiao-Yan] MWR, Yangling, Peoples R China	Southwest University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Chinese Academy of Sciences	Chen, XY (corresponding author), Southwest Univ, Minist Educ, Key Lab Ecoenvironm Three Gorges Reg, Coll Resources & Environm, Chongqing, Peoples R China.	guangguang14@163.com			Foundation of State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau [K318009902-1312]	Foundation of State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau	The funding which supported this work is Foundation of State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau under project No. K318009902-1312 (http://english.iswc.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy H, 2005, CATENA, V64, P247, DOI 10.1016/j.catena.2005.08.008; Aksoy H, 2013, HYDROLOG SCI J, V58, P1505, DOI 10.1080/02626667.2013.824085; Aksoy H, 2012, CATENA, V98, P63, DOI 10.1016/j.catena.2012.06.009; Bhattarai R, 2007, WATER RESOUR MANAG, V21, P1635, DOI 10.1007/s11269-006-9118-z; Ellison WD, 1949, SCI MON, V68, P241; FOSTER GR, 1984, T ASAE, V27, P797; FOSTER GR, 1984, T ASAE, V27, P790; FOSTER GR, 1981, T ASAE, V24, P1253, DOI 10.13031/2013.34429; Fox DM, 2000, CATENA, V38, P211, DOI 10.1016/S0341-8162(99)00072-7; GILLEY JE, 1993, J HYDROL, V142, P251, DOI 10.1016/0022-1694(93)90013-Y; Gimenez R, 2002, SOIL SCI SOC AM J, V66, P1475, DOI 10.2136/sssaj2002.1475; GOVERS G, 1986, EARTH SURF PROCESSES, V11, P515, DOI 10.1002/esp.3290110506; Huang C, 1998, SOIL SCI SOC AM J, V62, P423, DOI 10.2136/sssaj1998.03615995006200020019x; Kavvas ML, 2006, J HYDROL ENG, V11, P261, DOI 10.1061/(ASCE)1084-0699(2006)11:3(261); Kinnell PIA, 2000, SOIL SCI SOC AM J, V64, P1004, DOI 10.2136/sssaj2000.6431004x; Lei TW, 2006, EUR J SOIL SCI, V57, P287, DOI 10.1111/j.1365-2389.2005.00737.x; Lei T.W., 2000, J HYDRAUL ENG, V11, P49, DOI [10.13243/j.cnki.slxb.2000.11.008, DOI 10.13243/J.CNKI.SLXB.2000.11.008]; Lei TW, 1998, WATER RESOUR RES, V34, P3157, DOI 10.1029/98WR02162; Lei TW, 2002, T ASAE, V45, P1897; Lei TW, 2001, T ASAE, V44, P1537; Lei TW, 2009, PHYS BASED RILL EROS; Li M, 2006, APPL RADIAT ISOTOPES, V64, P402, DOI 10.1016/j.apradiso.2005.08.006; Li M, 2005, APPL RADIAT ISOTOPES, V62, P109, DOI 10.1016/j.apradiso.2004.06.005; Miao CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044659; Miao CY, 2011, GLOBAL PLANET CHANGE, V76, P196, DOI 10.1016/j.gloplacha.2011.01.008; Miao CY, 2010, PROG PHYS GEOG, V34, P541, DOI 10.1177/0309133310369434; Nearing MA, 1997, WATER RESOUR RES, V33, P865, DOI 10.1029/97WR00013; NEARING MA, 1989, T ASAE, V32, P1587; Polyakov VO, 2003, CATENA, V51, P33, DOI 10.1016/S0341-8162(02)00090-5; Porto P, 2013, HYDROL PROCESS, V27, P795, DOI 10.1002/hyp.9471; Schuller P, 2004, APPL RADIAT ISOTOPES, V60, P759, DOI 10.1016/j.apradiso.2003.11.087; Shi ZH, 2012, J HYDROL, V454, P123, DOI 10.1016/j.jhydrol.2012.06.004; Sirjani E, 2014, ARAB J GEOSCI, V7, P203, DOI 10.1007/s12517-012-0728-x; Sun LY, 2013, CHINESE GEOGR SCI, V23, P389, DOI 10.1007/s11769-013-0612-y; TISCARENOLOPEZ M, 1993, T ASAE, V36, P1659; Wirtz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064861; Yang DW, 2003, HYDROL PROCESS, V17, P2913, DOI 10.1002/hyp.1441; Zhang GH, 2009, SOIL SCI SOC AM J, V73, P1298, DOI 10.2136/sssaj2009.0074; Zhang XC, 2001, SOIL SCI SOC AM J, V65, P1508, DOI 10.2136/sssaj2001.6551508x; Zhu MY, 2011, J ENVIRON RADIOACTIV, V102, P1078, DOI 10.1016/j.jenvrad.2011.07.007	40	3	4	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99660	10.1371/journal.pone.0099660	http://dx.doi.org/10.1371/journal.pone.0099660			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949621	Green Submitted, gold, Green Published			2022-12-25	WOS:000338276300016
J	Mayhoub, F; Berton, T; Bach, V; Tack, K; Deguines, C; Floch-Barneaud, A; Desmots, S; Stephan-Blanchard, E; Chardon, K				Mayhoub, Flora; Berton, Thierry; Bach, Veronique; Tack, Karine; Deguines, Caroline; Floch-Barneaud, Adeline; Desmots, Sophie; Stephan-Blanchard, Erwan; Chardon, Karen			Self-Reported Parental Exposure to Pesticide during Pregnancy and Birth Outcomes: The MecoExpo Cohort Study	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; FETAL-GROWTH; WEIGHT; MORTALITY; ASSOCIATION; POPULATION; MORBIDITY; NEWBORNS; INFANTS; MOTHERS	The MecoExpo study was performed in the Picardy region of northern France, in order to investigate the putative relationship between parental exposures to pesticides (as reported by the mother) on one hand and neonatal parameters on the other. The cohort comprised 993 mother-newborn pairs. Each mother completed a questionnaire that probed occupational, domestic, environmental and dietary sources of parental exposure to pesticides during her pregnancy. Multivariate regression analyses were then used to test for associations between the characteristics of parental pesticide exposure during pregnancy and the corresponding birth outcomes. Maternal occupational exposure was associated with an elevated risk of low birth weight (odds ratio (OR) [95% confidence interval]: 4.2 [1.2, 15.4]). Paternal occupational exposure to pesticides was associated with a lower than average gestational age at birth (-0.7 weeks; p = 0.0002) and an elevated risk of prematurity (OR: 3.7 [1.4, 9.7]). Levels of domestic exposure to veterinary antiparasitics and to pesticides for indoor plants were both associated with a low birth weight (-70 g; p = 0.02 and -160 g; p = 0.005, respectively). Babies born to women living in urban areas had a lower birth length and a higher risk of low birth length (-0.4 cm, p = 0.006 and OR: 2.9 [1.5, 5.5], respectively). The present study results mainly demonstrate a negative correlation between fetal development on one hand and parental occupational and domestic exposure to pesticides on the other. Our study highlights the need to perform a global and detailed screening of all potential physiological effects when assessing in utero exposure to pesticides.	[Mayhoub, Flora; Berton, Thierry; Bach, Veronique; Deguines, Caroline; Floch-Barneaud, Adeline; Desmots, Sophie; Stephan-Blanchard, Erwan; Chardon, Karen] Univ Picardie Jules Verne, Unite Mixte Univ INERIS EA 4285 UMI 01, Lab PeriTox, Amiens, France; [Berton, Thierry; Tack, Karine] Inst Natl Environm Ind & Risques, Unite NOVA, Verneuil En Halatte, France; [Deguines, Caroline] Ctr Hosp Univ Amiens, Amiens, France; [Floch-Barneaud, Adeline] Inst Natl Environm Ind & Risques, Unite ISAE, Verneuil En Halatte, France; [Desmots, Sophie] Inst Natl Environm Ind & Risques, Unite TOXI, Verneuil En Halatte, France; [Mayhoub, Flora] Tishreen Univ, Fac Med, Latakia, Syria	Picardie Universites; Universite de Picardie Jules Verne (UPJV); Institut National de l'Environnement Industriel et des Risques (INERIS); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Institut National de l'Environnement Industriel et des Risques (INERIS); Institut National de l'Environnement Industriel et des Risques (INERIS)	Chardon, K (corresponding author), Univ Picardie Jules Verne, Unite Mixte Univ INERIS EA 4285 UMI 01, Lab PeriTox, Amiens, France.	karen.chardon@u-picardie.fr	chardon, Karen/AAD-5837-2022; Bach, Veronique/AAD-5958-2022	Bach, Veronique/0000-0002-0684-0305; Stephan-Blanchard, Erwan/0000-0002-9427-4699	Picardy Regional Council; Tishreen University (Latakia, Syria); European Regional Development Fund	Picardy Regional Council(Region Hauts-de-France); Tishreen University (Latakia, Syria); European Regional Development Fund(European Commission)	This work was funded by the Picardy Regional Council. F. Mayhoub was funded by Tishreen University (Latakia, Syria) and T. Berton was funded by the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association des Utilisateurs de Dossiers Informatises en Pediatrie Obstetrique et Gynecologie, ET CROISS FOET INF; Bedos C, 2002, AGRONOMIE, V22, P21, DOI 10.1051/agro:2001003; Berkowitz GS, 2004, ENVIRON HEALTH PERSP, V112, P388, DOI 10.1289/ehp.6414; Brucker-Davis F, 2010, CHEMOSPHERE, V81, P169, DOI 10.1016/j.chemosphere.2010.06.068; Eskenazi B, 2004, ENVIRON HEALTH PERSP, V112, P1116, DOI 10.1289/ehp.6789; KRAMER MS, 1990, PEDIATRICS, V86, P707; Kristensen P, 1997, AM J EPIDEMIOL, V146, P329, DOI 10.1093/oxfordjournals.aje.a009274; Mamelle N, 2006, EUR J PEDIATR, V165, P717, DOI 10.1007/s00431-005-0045-4; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Petit C, 2012, AM J EPIDEMIOL, V175, P1182, DOI 10.1093/aje/kwr422; Petit C, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-71; RESTREPO M, 1990, SCAND J WORK ENV HEA, V16, P232, DOI 10.5271/sjweh.1790; Sathyanarayana S, 2010, J AGROMEDICINE, V15, P127, DOI 10.1080/10599241003622699; SAVITZ DA, 1989, PUBLIC HEALTH REP, V104, P473; Strauss RS, 1997, J PEDIATR-US, V130, P95, DOI 10.1016/S0022-3476(97)70316-0; Whyatt RM, 2005, TOXICOL APPL PHARM, V206, P246, DOI 10.1016/j.taap.2004.11.027; Whyatt RM, 2003, ENVIRON HEALTH PERSP, V111, P749, DOI 10.1289/ehp.5768; Wohlfahrt-Veje C, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-79; Xiang HY, 2000, ENVIRON RES, V82, P160, DOI 10.1006/enrs.1999.4009; Yanney Michael, 2004, Semin Fetal Neonatal Med, V9, P411, DOI 10.1016/j.siny.2004.03.005	21	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99090	10.1371/journal.pone.0099090	http://dx.doi.org/10.1371/journal.pone.0099090			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949871	gold, Green Published, Green Submitted			2022-12-25	WOS:000338276300010
J	Torres, MJ; Argandona, M; Vargas, C; Bedmar, EJ; Fischer, HM; Mesa, S; Delgado, MJ				Torres, Maria J.; Argandona, Montserrat; Vargas, Carmen; Bedmar, Eulogio J.; Fischer, Hans-Martin; Mesa, Socorro; Delgado, Maria J.			The Global Response Regulator RegR Controls Expression of Denitrification Genes in Bradyrhizobium japonicum	PLOS ONE			English	Article							2-COMPONENT SYSTEM; RNA-POLYMERASE; OXIDE REDUCTASE; NAPEDABC GENES; RESPIRATION; NIFA; IDENTIFICATION; CASCADE; NITRATE; SENSOR	Bradyrhizobium japonicum RegSR regulatory proteins belong to the family of two-component regulatory systems, and orthologs are present in many Proteobacteria where they globally control gene expression mostly in a redox-responsive manner. In this work, we have performed a transcriptional profiling of wild-type and regR mutant cells grown under anoxic denitrifying conditions. The comparative analyses of wild-type and regR strains revealed that almost 620 genes induced in the wild type under denitrifying conditions were regulated (directly or indirectly) by RegR, pointing out the important role of this protein as a global regulator of denitrification. Genes controlled by RegR included nor and nos structural genes encoding nitric oxide and nitrous oxide reductase, respectively, genes encoding electron transport proteins such as cycA (blr7544) or cy(2) (bll2388), and genes involved in nitric oxide detoxification (blr2806-09) and copper homeostasis (copCAB), as well as two regulatory genes (bll3466, bll4130). Purified RegR interacted with the promoters of norC (blr3214), nosR (blr0314), a fixK-like gene (bll3466), and bll4130, which encodes a LysR-type regulator. By using fluorescently labeled oligonucleotide extension (FLOE), we were able to identify two transcriptional start sites located at about 35 (P1) and 22 (P2) bp upstream of the putative translational start codon of norC. P1 matched with the previously mapped 5' end of norC mRNA which we demonstrate in this work to be under FixK2 control. P2 is a start site modulated by RegR and specific for anoxic conditions. Moreover, qRT-PCR experiments, expression studies with a norC-lacZ fusion, and heme c-staining analyses revealed that anoxia and nitrate are required for RegR-dependent induction of nor genes, and that this control is independent of the sensor protein RegS.	[Torres, Maria J.; Bedmar, Eulogio J.; Mesa, Socorro; Delgado, Maria J.] CSIC, Estn Expt Zaidin, Granada, Spain; [Argandona, Montserrat; Vargas, Carmen] Univ Seville, Dept Microbiol & Parasitol, Seville, Spain; [Fischer, Hans-Martin] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); University of Sevilla; Swiss Federal Institutes of Technology Domain; ETH Zurich	Delgado, MJ (corresponding author), CSIC, Estn Expt Zaidin, Granada, Spain.	mdelgado@eez.csic.es	Vargas, Carmen/A-6283-2018; Torres, María J./X-7746-2018; Argandoña, Montserrat/H-5531-2015; Mesa, Socorro/G-7775-2015; Delgado, Maria J/F-2683-2017; Rojas, Cristian/X-1027-2018	Vargas, Carmen/0000-0002-4094-4319; Torres, María J./0000-0003-0706-7833; Mesa, Socorro/0000-0001-7285-3940; Delgado, Maria J/0000-0003-2410-9484; Vandepoele, Klaas/0000-0003-4790-2725; Rojas, Cristian/0000-0002-9085-6261; Argandona, Montserrat/0000-0002-2635-1023; Van Bel, Michiel/0000-0002-1873-2563	Fondo Europeo de Desarrollo Regional (FEDER), Ministerio de Economia y Competitividad (Spain) [AGL2010-18607, AGL2011-23383, BIO2011-22833]; Spanish National Network on Extremophilic Microorganisms [BIO2011-12879-E]; Junta de Andalucia [BIO-275, CVI-7293]; Consejo Superior de Investigaciones Cientificas I3P Programme; ETH Zurich; Functional Genomics Centre of ETH Zurich; University of Zurich (FGCZ)	Fondo Europeo de Desarrollo Regional (FEDER), Ministerio de Economia y Competitividad (Spain); Spanish National Network on Extremophilic Microorganisms; Junta de Andalucia(Junta de Andalucia); Consejo Superior de Investigaciones Cientificas I3P Programme; ETH Zurich(ETH Zurich); Functional Genomics Centre of ETH Zurich; University of Zurich (FGCZ)	Support was provided by Fondo Europeo de Desarrollo Regional (FEDER)-cofinanced grants AGL2010-18607, AGL2011-23383 and BIO2011-22833 from Ministerio de Economia y Competitividad (Spain) (to MJD CV SM); Spanish National Network on Extremophilic Microorganisms (BIO2011-12879-E) (to CV); Junta de Andalucia to Group BIO-275 and CVI-7293 (to EJB CV); Consejo Superior de Investigaciones Cientificas I3P Programme (to MJT); Grants from ETH Zurich and Functional Genomics Centre of ETH Zurich and University of Zurich (FGCZ) (to H-MF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou E, 2013, INFECT IMMUN, V81, P2053, DOI 10.1128/IAI.00063-13; Babst M, 1996, MOL MICROBIOL, V19, P827, DOI 10.1046/j.1365-2958.1996.438968.x; Baek SH, 2008, J BACTERIOL, V190, P78, DOI 10.1128/JB.00792-07; BARRIOS H, 1995, J BACTERIOL, V177, P1760, DOI 10.1128/jb.177.7.1760-1765.1995; Barrios H, 1998, P NATL ACAD SCI USA, V95, P1014, DOI 10.1073/pnas.95.3.1014; Bauer E, 1998, J BACTERIOL, V180, P3853, DOI 10.1128/JB.180.15.3853-3863.1998; Bedmar EJ, 2005, BIOCHEM SOC T, V33, P141, DOI 10.1042/BST0330141; Bergersen F.J., 1977, BIOLOGY, P519; Blanco AG, 2012, BIOL CHEM, V393, P1165, DOI 10.1515/hsz-2012-0230; Bothe H, 2007, BIOLOGY OF THE NITROGEN CYCLE, P1; Bueno Emilio, 2008, FEMS Microbiol Lett, V279, P188, DOI 10.1111/j.1574-6968.2007.01034.x; Bueno E, 2012, ANTIOXID REDOX SIGN, V16, P819, DOI 10.1089/ars.2011.4051; Bueno E, 2010, ENVIRON MICROBIOL, V12, P393, DOI 10.1111/j.1462-2920.2009.02076.x; Cabrera JJ, 2011, BIOCHEM SOC T, V39, P1880, DOI 10.1042/BST20110732; Comolli JC, 2002, MOL MICROBIOL, V45, P755, DOI 10.1046/j.1365-2958.2002.03046.x; DANIEL RM, 1972, BIOCHIM BIOPHYS ACTA, V275, P347, DOI 10.1016/0005-2728(72)90215-0; Carrica MD, 2013, MOL MICROBIOL, V88, P222, DOI 10.1111/mmi.12181; Carrica MD, 2012, MOL MICROBIOL, V85, P39, DOI 10.1111/j.1365-2958.2012.08095.x; Delgado MJ, 2007, BIOLOGY OF THE NITROGEN CYCLE, P83, DOI 10.1016/B978-044452857-5.50007-2; Delgado MJ, 1998, ADV MICROB PHYSIOL, V40, P191, DOI 10.1016/S0065-2911(08)60132-0; Delgado MJ, 2003, MICROBIOL-SGM, V149, P3395, DOI 10.1099/mic.0.26620-0; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; Emmerich R, 1999, EUR J BIOCHEM, V263, P455, DOI 10.1046/j.1432-1327.1999.00517.x; Fekete RA, 2003, BIOTECHNIQUES, V35, P90, DOI 10.2144/03351rr01; FISCHER HM, 1994, MICROBIOL REV, V58, P352, DOI 10.1128/MMBR.58.3.352-386.1994; Gourion B, 2009, MOL MICROBIOL, V73, P291, DOI 10.1111/j.1365-2958.2009.06769.x; Hauser F, 2006, MOL GENET GENOMICS, V275, P55, DOI 10.1007/s00438-005-0059-7; Hauser F, 2007, MOL GENET GENOMICS, V278, P255, DOI 10.1007/s00438-007-0246-9; Hernandez-Montes G, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-249; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Kommineni S, 2010, MOL MICROBIOL, V78, P1280, DOI 10.1111/j.1365-2958.2010.07407.x; Kraft B, 2011, J BIOTECHNOL, V155, P104, DOI 10.1016/j.jbiotec.2010.12.025; KULLIK I, 1991, J BACTERIOL, V173, P1125, DOI 10.1128/jb.173.3.1125-1138.1991; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Laratta WP, 2002, J BACTERIOL, V184, P3521, DOI 10.1128/JB.184.13.3521-3529.2002; Lindemann A, 2007, J BACTERIOL, V189, P8928, DOI 10.1128/JB.01088-07; Lindemann A, 2010, FEMS MICROBIOL LETT, V312, P184, DOI 10.1111/j.1574-6968.2010.02115.x; Mesa S, 2005, J BACTERIOL, V187, P3329, DOI 10.1128/JB.187.10.3329-3338.2005; Mesa S, 2003, J BACTERIOL, V185, P3978, DOI 10.1128/JB.185.13.3978-3982.2003; Mesa S, 2002, MICROBIOL-SGM, V148, P3553, DOI 10.1099/00221287-148-11-3553; Mesa S, 2008, J BACTERIOL, V190, P6568, DOI 10.1128/JB.00748-08; MOSLEY CS, 1994, J BACTERIOL, V176, P7566, DOI 10.1128/JB.176.24.7566-7573.1994; Nellen-Anthamatten D, 1998, J BACTERIOL, V180, P5251, DOI 10.1128/JB.180.19.5251-5255.1998; Nienaber A, 2000, J BACTERIOL, V182, P1472, DOI 10.1128/JB.182.6.1472-1480.2000; Pessi G, 2007, MOL PLANT MICROBE IN, V20, P1353, DOI 10.1094/MPMI-20-11-1353; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; REGENSBURGER B, 1983, ARCH MICROBIOL, V135, P103, DOI 10.1007/BF00408017; Reutimann L, 2010, MOL GENET GENOMICS, V284, P25, DOI 10.1007/s00438-010-0547-2; Richardson D, 2011, NITROGEN CYCLING IN BACTERIA: MOLECULAR ANALYSIS, P23; Robles EF, 2006, BIOCHEM SOC T, V34, P108, DOI 10.1042/BST0340108; Rodionov DA, 2005, PLOS COMPUT BIOL, V1, P415, DOI 10.1371/journal.pcbi.0010055; Roop RM, 2012, MOL MICROBIOL, V85, P5, DOI 10.1111/j.1365-2958.2012.08096.x; Sanchez C, 2011, NITROGEN CYCLING IN BACTERIA: MOLECULAR ANALYSIS, P197; Sciotti MA, 2003, J BACTERIOL, V185, P5639, DOI 10.1128/JB.185.18.5639-5642.2003; Simon J, 2008, BBA-BIOENERGETICS, V1777, P1480, DOI 10.1016/j.bbabio.2008.09.008; Simon R., 1983, MOL GENETICS BACTERI, V1st ed., P98; Swem LR, 2006, J BIOL CHEM, V281, P6768, DOI 10.1074/jbc.M509687200; Swem LR, 2003, EMBO J, V22, P4699, DOI 10.1093/emboj/cdg461; Torres MJ, 2011, BIOCHEM SOC T, V39, P284, DOI 10.1042/BST0390284; VARGAS C, 1993, ANAL BIOCHEM, V209, P323, DOI 10.1006/abio.1993.1127; Velasco L, 2004, ANTON LEEUW INT J G, V85, P229, DOI 10.1023/B:ANTO.0000020156.42470.db; Velasco L, 2001, BBA-GENE STRUCT EXPR, V1521, P130, DOI 10.1016/S0167-4781(01)00279-2; Wu J, 2008, ADV EXP MED BIOL, V631, P131, DOI 10.1007/978-0-387-78885-2_9; Wu J, 2013, J BIOL CHEM, V288, P4755, DOI 10.1074/jbc.M112.413492; Wu JA, 2010, MBIO, V1, DOI 10.1128/mBio.00272-10; Zhang X, 2000, MOD ASP IMMUNOBIOL, V1, P160; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	67	65	66	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99011	10.1371/journal.pone.0099011	http://dx.doi.org/10.1371/journal.pone.0099011			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949739	Green Published, gold			2022-12-25	WOS:000338276300009
J	Warrier, I; Hicks, LD; Battisti, JM; Raghavan, R; Minnick, MF				Warrier, Indu; Hicks, Linda D.; Battisti, James M.; Raghavan, Rahul; Minnick, Michael F.			Identification of Novel Small RNAs and Characterization of the 65 RNA of Coxiella burnetii	PLOS ONE			English	Article							SMALL NONCODING RNAS; 6S RNA; ESCHERICHIA-COLI; LISTERIA-MONOCYTOGENES; REGULATORY RNAS; VIBRIO-CHOLERAE; CHAPERONE HFQ; HOST-CELL; PHASE-II; Q-FEVER	Coxiella bumetii, an obligate intracellular bacterial pathogen that causes Q fever, undergoes a biphasic developmental cycle that alternates between a metabolically-active large cell variant (L(V) and a dormant small cell variant (S(V). As such, the bacterium undoubtedly employs complex modes of regulating its lifecycle, metabolism and pathogenesis. Small RNAs (sRNAs) have been shown to play important regulatory roles in controlling metabolism and virulence in several pathogenic bacteria. We hypothesize that sRNAs are involved in regulating growth and development of C. bumetii and its infection of host cells. To address the hypothesis and identify potential sRNAs, we subjected total RNA isolated from Coxiella cultured axenically and in Vero host cells to deep-sequencing. Using this approach, we identified fifteen novel C. bumetii sRNAs (CbSRs). Fourteen CbSRs were validated by Northern blotting. Most CbSRs showed differential expression, with increased levels in LCVs. Eight CbSRs were upregulated (>= 2-fold) during intracellular growth as compared to growth in axenic medium. Along with the fifteen sRNAs, we also identified three sRNAs that have been previously described from other bacteria, including RNase P RNA, tmRNA and 6S RNA. The 6S regulatory sRNA of C. bumetii was found to accumulate over log phase-growth with a maximum level attained in the SCV stage. The 6S RNA-encoding gene (ssrS) was mapped to the 5' UTR of ygfA; a highly conserved linkage in eubacteria. The predicted secondary structure of the 6S RNA possesses three highly conserved domains found in 6S RNAs of other eubacteria. We also demonstrate that Coxiella's 6S RNA interacts with RNA polymerase (RNAP) in a specific manner. Finally, transcript levels of 65 RNA were found to be at much higher levels when Coxiella was grown in host cells relative to axenic culture, indicating a potential role in regulating the bacterium's intracellular stress response by interacting with RNAP during transcription.	[Warrier, Indu; Hicks, Linda D.; Battisti, James M.; Minnick, Michael F.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Raghavan, Rahul] Portland State Univ, Dept Biol, Portland, OR 97207 USA	University of Montana System; University of Montana; Portland State University	Minnick, MF (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	mike.minnick@mso.umt.edu		Minnick, Michael/0000-0002-1131-7930	National Institutes of Health [R15 AI103511]; Portland State University; Collins Medical Trust; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Portland State University; Collins Medical Trust; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by grants from the National Institutes of Health (R15 AI103511) to J.M.B, from Portland State University and Collins Medical Trust to R.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Barrick JE, 2005, RNA, V11, P774, DOI 10.1261/rna.7286705; Cavanagh AT, 2010, MICROBIOL-SGM, V156, P3791, DOI 10.1099/mic.0.043992-0; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Cockrell DC, 2008, J MICROBIOL METH, V72, P321, DOI 10.1016/j.mimet.2007.12.015; Coleman SA, 2004, J BACTERIOL, V186, P7344, DOI 10.1128/JB.186.21.7344-7352.2004; Faucher SP, 2010, P NATL ACAD SCI USA, V107, P7533, DOI 10.1073/pnas.0911764107; Gildehaus N, 2007, NUCLEIC ACIDS RES, V35, P1885, DOI 10.1093/nar/gkm085; Gong H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002120; HINDLEY J, 1967, J MOL BIOL, V30, P125, DOI 10.1016/0022-2836(67)90248-3; Kazantsev AV, 2006, NAT REV MICROBIOL, V4, P729, DOI 10.1038/nrmicro1491; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Klocko AD, 2009, MOL MICROBIOL, V73, P152, DOI 10.1111/j.1365-2958.2009.06758.x; Koo JT, 2011, P NATL ACAD SCI USA, V108, pE709, DOI 10.1073/pnas.1101655108; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liu JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp080; Lybecker MC, 2010, MOL MICROBIOL, V78, P622, DOI 10.1111/j.1365-2958.2010.07374.x; Mandin P, 2007, NUCLEIC ACIDS RES, V35, P962, DOI 10.1093/nar/gkl1096; Mandin P, 2010, EMBO J, V29, P3094, DOI 10.1038/emboj.2010.179; Mann B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002788; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; MCCAUL TF, 1981, J BACTERIOL, V147, P1063, DOI 10.1128/JB.147.3.1063-1076.1981; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Mraheil MA, 2011, NUCLEIC ACIDS RES, V39, P4235, DOI 10.1093/nar/gkr033; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Padalon-Brauch G, 2008, NUCLEIC ACIDS RES, V36, P1913, DOI 10.1093/nar/gkn050; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Raghavan R, 2008, J BACTERIOL, V190, P5934, DOI 10.1128/JB.00602-08; Raghavan R, 2011, GENOME RES, V21, P1487, DOI 10.1101/gr.119370.110; Romano PS, 2007, CELL MICROBIOL, V9, P891, DOI 10.1111/j.1462-5822.2006.00838.x; Romby P, 2006, CURR OPIN MICROBIOL, V9, P229, DOI 10.1016/j.mib.2006.02.005; Romby P, 2010, CELL MOL LIFE SCI, V67, P217, DOI 10.1007/s00018-009-0162-8; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sahr T, 2012, RNA BIOL, V9, P503, DOI 10.4161/rna.20270; Sandoz KM, 2014, J MICROBIOL METH, V96, P104, DOI 10.1016/j.mimet.2013.11.010; Sato K, 2009, NUCLEIC ACIDS RES, V37, pW277, DOI 10.1093/nar/gkp367; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seshadri R, 2001, INFECT IMMUN, V69, P4874, DOI 10.1128/IAI.69.8.4874-4883.2001; Solovyev V., 2011, AUTOMATIC ANNOTATION; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Tesorero RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064021; Tjaden B, 2008, NUCLEIC ACIDS RES, V36, pW109, DOI 10.1093/nar/gkn264; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Trotochaud AE, 2005, NAT STRUCT MOL BIOL, V12, P313, DOI 10.1038/nsmb917; Trotochaud AE, 2004, J BACTERIOL, V186, P4978, DOI 10.1128/JB.186.15.4978-4985.2004; Verstraeten N, 2011, MICROBIOL MOL BIOL R, V75, P507, DOI 10.1128/MMBR.00009-11; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; Vogel J, 2007, CURR OPIN MICROBIOL, V10, P262, DOI 10.1016/j.mib.2007.06.001; Wassarman KM, 2007, MOL MICROBIOL, V65, P1425, DOI 10.1111/j.1365-2958.2007.05894.x; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Weissenmayer BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017570; WILLIAMS JC, 1981, INFECT IMMUN, V32, P840, DOI 10.1128/IAI.32.2.840-851.1981; Yan YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074495	56	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100147	10.1371/journal.pone.0100147	http://dx.doi.org/10.1371/journal.pone.0100147			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949863	Green Published, gold, Green Submitted			2022-12-25	WOS:000338276300042
J	Zyryanova, T; Schneider, R; Adams, V; Sittig, D; Kerner, C; Gebhardt, C; Ruffert, H; Glasmacher, S; Hepp, P; Punkt, K; Neuhaus, J; Hamann, J; Aust, G				Zyryanova, Tatiana; Schneider, Rick; Adams, Volker; Sittig, Doreen; Kerner, Christiane; Gebhardt, Claudia; Ruffert, Henrik; Glasmacher, Stefan; Hepp, Pierre; Punkt, Karla; Neuhaus, Jochen; Hamann, Jorg; Aust, Gabriela			Skeletal Muscle Expression of the Adhesion-GPCR CD97: CD97 Deletion Induces an Abnormal Structure of the Sarcoplasmatic Reticulum but Does Not Impair Skeletal Muscle Function	PLOS ONE			English	Article							RECEPTOR CD97; CHONDROITIN SULFATE; LIGAND CD55; CELLS; GENE; RHABDOMYOSARCOMAS; LEUKOCYTES; INHIBITION; DOMAINS; ANTIGEN	CD97 is a widely expressed adhesion class G-protein-coupled receptor (aGPCR). Here, we investigated the presence of CD97 in normal and malignant human skeletal muscle as well as the ultrastructural and functional consequences of CD97 deficiency in mice. In normal human skeletal muscle, CD97 was expressed at the peripheral sarcolemma of all myofibers, as revealed by immunostaining of tissue sections and surface labeling of single myocytes using flow cytometry. In muscle cross-sections, an intracellular polygonal, honeycomb-like CD97-staining pattern, typical for molecules located in the T-tubule or sarcoplasmatic reticulum (SR), was additionally found. CD97 co-localized with SR Ca2+-ATPase (SERCA), a constituent of the longitudinal SR, but not with the receptors for dihydropyridine (DHPR) or ryanodine (RYR), located in the T-tubule and terminal SR, respectively. Intracellular expression of CD97 was higher in slow-twitch compared to most fast-twitch myofibers. In rhabdomyosarcomas, CD97 was strongly upregulated and in part more N-glycosylated compared to normal skeletal muscle. All tumors were strongly CD97-positive, independent of the underlying histological subtype, suggesting high sensitivity of CD97 for this tumor. Ultrastructural analysis of murine skeletal myofibers confirmed the location of CD97 in the SR. CD97 knock-out mice had a dilated SR, resulting in a partial increase in triad diameter yet not affecting the T-tubule, sarcomeric, and mitochondrial structure. Despite these obvious ultrastructural changes, intracellular Ca2+ release from single myofibers, force generation and fatigability of isolated soleus muscles, and wheel-running capacity of mice were not affected by the lack of CD97. We conclude that CD97 is located in the SR and at the peripheral sarcolemma of human and murine skeletal muscle, where its absence affects the structure of the SR without impairing skeletal muscle function.	[Zyryanova, Tatiana; Schneider, Rick; Sittig, Doreen; Kerner, Christiane; Gebhardt, Claudia; Aust, Gabriela] Univ Leipzig, Res Labs, Dept Surg, D-04109 Leipzig, Germany; [Adams, Volker] Univ Leipzig, Heart Ctr Leipzig, D-04109 Leipzig, Germany; [Ruffert, Henrik] Univ Leipzig, Dept Anaesthesiol & Intens Care Med, D-04109 Leipzig, Germany; [Glasmacher, Stefan; Hepp, Pierre] Univ Leipzig, Clin Trauma & Reconstruct Surg, D-04109 Leipzig, Germany; [Punkt, Karla] Univ Leipzig, Inst Anat, D-04109 Leipzig, Germany; [Neuhaus, Jochen] Univ Leipzig, Urol Clin, Res Labs, D-04109 Leipzig, Germany; [Hamann, Jorg] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands	Leipzig University; Heart Center Leipzig GMBH; Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University; University of Amsterdam; Academic Medical Center Amsterdam	Aust, G (corresponding author), Univ Leipzig, Res Labs, Dept Surg, D-04109 Leipzig, Germany.	gabriela.aust@medizin.uni-leipzig.de		Hamann, Jorg/0000-0002-9448-1727	German Academic Exchange Service (DAAD) [A /10/76169]	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	T.Z. received a 6-months research scholarship from the German Academic Exchange Service (DAAD, grant A /10/76169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Aust G, 2006, CELL TISSUE RES, V324, P139, DOI 10.1007/s00441-005-0103-2; Aust G, 1997, CANCER RES, V57, P1798; Becker S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008507; Bottinelli R, 2000, PROG BIOPHYS MOL BIO, V73, P195, DOI 10.1016/S0079-6107(00)00006-7; Calderon JC, 2009, J MUSCLE RES CELL M, V30, P125, DOI 10.1007/s10974-009-9181-1; Cerletti M, 2006, J CELL SCI, V119, P3117, DOI 10.1242/jcs.03056; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; EICHLER W, 1994, SCAND J IMMUNOL, V39, P111, DOI 10.1111/j.1365-3083.1994.tb03348.x; Galle J, 2006, AM J PATHOL, V169, P1802, DOI 10.2353/ajpath.2006.060006; Grange RW, 2002, AM J PHYSIOL-CELL PH, V283, pC1090, DOI 10.1152/ajpcell.00450.2001; Gray JX, 1996, J IMMUNOL, V157, P5438; Hamann J, 1999, ARTHRITIS RHEUM-US, V42, P650, DOI 10.1002/1529-0131(199904)42:4<650::AID-ANR7>3.0.CO;2-S; Hamann J, 1996, J EXP MED, V184, P1185, DOI 10.1084/jem.184.3.1185; Hamann J, 2000, INT IMMUNOL, V12, P439, DOI 10.1093/intimm/12.4.439; Hamann J, 1997, LEUCOCYTE TYPING, P527; Hochreiter-Hufford AE, 2013, NATURE, V497, P263, DOI 10.1038/nature12135; Hsiao CC, 2009, FEBS LETT, V583, P3285, DOI 10.1016/j.febslet.2009.09.001; Jaspars LH, 2001, TISSUE ANTIGENS, V57, P325, DOI 10.1034/j.1399-0039.2001.057004325.x; Juretic N, 2007, J CELL PHYSIOL, V210, P819, DOI 10.1002/jcp.20902; Karpus ON, 2013, J IMMUNOL, V190, P3740, DOI 10.4049/jimmunol.1202192; Keire Paul, 2013, Methods Mol Biol, V946, P431, DOI 10.1007/978-1-62703-128-8_28; Kwakkenbos MJ, 2005, J LEUKOCYTE BIOL, V77, P112, DOI 10.1189/jlb.0704402; Kwakkenbos MJ, 2001, LEUCOCYTE TYPING, P381; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; Leemans JC, 2004, J IMMUNOL, V172, P1125, DOI 10.4049/jimmunol.172.2.1125; Lin HH, 2004, J BIOL CHEM, V279, P31823, DOI 10.1074/jbc.M402974200; PARHAM DM, 1991, CANCER-AM CANCER SOC, V67, P3072, DOI 10.1002/1097-0142(19910615)67:12<3072::AID-CNCR2820671223>3.0.CO;2-Z; Pickl W.F., 1995, LEUCOCYTE TYPING, P1151; Poelkens F, 2013, EXP PHYSIOL, V98, P1485, DOI 10.1113/expphysiol.2013.072710; Punkt K, 2006, HISTOCHEM CELL BIOL, V125, P567, DOI 10.1007/s00418-005-0108-7; Punkt Karla, 2002, Adv Anat Embryol Cell Biol, V162, pIII; Rossi AE, 2006, MUSCLE NERVE, V33, P715, DOI 10.1002/mus.20512; SCHMIDT RA, 1988, AM J PATHOL, V131, P19; Shaw MA, 2003, BIOCHEMISTRY-US, V42, P6128, DOI 10.1021/bi026964f; Sjaland C, 2011, J PHYSIOL-LONDON, V589, P6139, DOI 10.1113/jphysiol.2011.211987; Stacey M, 2003, BLOOD, V102, P2916, DOI 10.1182/blood-2002-11-3540; Steinert M, 2002, AM J PATHOL, V161, P1657, DOI 10.1016/S0002-9440(10)64443-4; Veninga H, 2008, J IMMUNOL, V181, P6574, DOI 10.4049/jimmunol.181.9.6574; Wandel E, 2012, J IMMUNOL, V188, P1442, DOI 10.4049/jimmunol.1003944; Wang T, 2005, BLOOD, V105, P2836, DOI 10.1182/blood-2004-07-2878; Wehner M, 2002, CLIN GENET, V62, P135, DOI 10.1034/j.1399-0004.2002.620206.x; Weibel E R, 1969, Int Rev Cytol, V26, P235, DOI 10.1016/S0074-7696(08)61637-X; Wetzel P, 1998, ARCH BIOCHEM BIOPHYS, V356, P151, DOI 10.1006/abbi.1998.0762; Wobus M, 2004, INT J CANCER, V112, P815, DOI 10.1002/ijc.20483; Wu MP, 2013, FEBS J, V280, P6097, DOI 10.1111/febs.12529; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005; Yoshida M, 2005, J BIOL CHEM, V280, P3500, DOI 10.1074/jbc.M406618200	48	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100513	10.1371/journal.pone.0100513	http://dx.doi.org/10.1371/journal.pone.0100513			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949957	Green Published, Green Submitted, gold			2022-12-25	WOS:000338276300083
J	Natarajan, R; Singal, V; Benes, R; Gao, JL; Chan, H; Chen, HJ; Yu, YJ; Zhou, J; Wu, P				Natarajan, Rajalaxmi; Singal, Vinamrata; Benes, Richard; Gao, Junling; Chan, Hoi; Chen, Haijun; Yu, Yongjia; Zhou, Jia; Wu, Ping			STAT3 Modulation to Enhance Motor Neuron Differentiation in Human Neural Stem Cells	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FIBROBLAST-GROWTH-FACTOR; SMALL-MOLECULE INHIBITOR; SPINAL-CORD-INJURY; ASTROCYTE DIFFERENTIATION; PROMOTES NEUROGENESIS; REACTIVE ASTROCYTES; SIGNALING PATHWAY; FETAL BRAIN; ACTIVATION	Spinal cord injury or amyotrophic lateral sclerosis damages spinal motor neurons and forms a glial scar, which prevents neural regeneration. Signal transducer and activator of transcription 3 (STAT3) plays a critical role in astrogliogenesis and scar formation, and thus a fine modulation of STAT3 signaling may help to control the excessive gliogenic environment and enhance neural repair. The objective of this study was to determine the effect of STAT3 inhibition on human neural stem cells (hNSCs). In vitro hNSCs primed with fibroblast growth factor 2 (FGF2) exhibited a lower level of phosphorylated STAT3 than cells primed by epidermal growth factor (EGF), which correlated with a higher number of motor neurons differentiated from FGF2-primed hNSCs. Treatment with STAT3 inhibitors, Stattic and Niclosamide, enhanced motor neuron differentiation only in FGF2-primed hNSCs, as shown by increased homeobox gene Hb9 mRNA levels as well as HB9(+) and microtubule-associated protein 2 (MAP2)(+) co-labeled cells. The increased motor neuron differentiation was accompanied by a decrease in the number of glial fibrillary acidic protein (GFAP)-positive astrocytes. Interestingly, Stattic and Niclosamide did not affect the level of STAT3 phosphorylation; rather, they perturbed the nuclear translocation of phosphorylated STAT3. In summary, we demonstrate that FGF2 is required for motor neuron differentiation from hNSCs and that inhibition of STAT3 further increases motor neuron differentiation at the expense of astrogliogenesis. Our study thus suggests a potential benefit of targeting the STAT3 pathway for neurotrauma or neurodegenerative diseases.	[Natarajan, Rajalaxmi; Singal, Vinamrata; Benes, Richard; Gao, Junling; Chan, Hoi; Wu, Ping] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Chen, Haijun; Zhou, Jia] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Yu, Yongjia] Univ Texas Med Branch, Dept Radiat Oncol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Wu, P (corresponding author), Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.	piwu@utmb.edu			John S. Dunn Research Foundation; TIRR Foundation Mission Connect; Gillson Longenbaugh Foundation; Moody Foundation	John S. Dunn Research Foundation; TIRR Foundation Mission Connect; Gillson Longenbaugh Foundation; Moody Foundation	This study is supported by John S. Dunn Research Foundation, TIRR Foundation Mission Connect, Gillson Longenbaugh Foundation, and Moody Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Cao F, 2010, BIOCHEM BIOPH RES CO, V394, P843, DOI 10.1016/j.bbrc.2010.03.092; Chen HJ, 2013, EUR J MED CHEM, V62, P498, DOI 10.1016/j.ejmech.2013.01.023; Chen HJ, 2013, ACS MED CHEM LETT, V4, P180, DOI 10.1021/ml3003082; Cheng PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022018; Diaz-Amarilla P, 2011, P NATL ACAD SCI USA, V108, P18126, DOI 10.1073/pnas.1110689108; Dominguez E, 2008, J NEUROCHEM, V107, P50, DOI 10.1111/j.1471-4159.2008.05566.x; Fukuda S, 2007, MOL CELL BIOL, V27, P4931, DOI 10.1128/MCB.02435-06; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gritti A, 1996, J NEUROSCI, V16, P1091; Gu F, 2005, J NEUROSCI RES, V81, P163, DOI 10.1002/jnr.20561; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Jordan PM, 2009, J NEUROSCI RES, V87, P318, DOI 10.1002/jnr.21856; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Lee S, 2013, P NATL ACAD SCI USA, V110, P11445, DOI 10.1073/pnas.1302676110; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Ojeda L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023414; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Qiu J, 2005, J NEUROSCI, V25, P1645, DOI 10.1523/JNEUROSCI.3269-04.2005; Rai KS, 2007, EUR J NEUROSCI, V26, P1765, DOI 10.1111/j.1460-9568.2007.05820.x; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Rajan P, 1998, J NEUROSCI, V18, P3620; Ren XM, 2010, ACS MED CHEM LETT, V1, P454, DOI 10.1021/ml100146z; Schubert KO, 2005, EXP BRAIN RES, V165, P520, DOI 10.1007/s00221-005-2330-x; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Shibata N, 2010, NEUROPATHOLOGY, V30, P353, DOI 10.1111/j.1440-1789.2009.01078.x; Shibata N, 2009, NEURODEGENER DIS, V6, P118, DOI 10.1159/000213762; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tao Y, 1996, J COMP NEUROL, V376, P653, DOI 10.1002/(SICI)1096-9861(19961223)376:4<653::AID-CNE11>3.0.CO;2-N; Tsuda M, 2011, BRAIN, V134, P1127, DOI 10.1093/brain/awr025; Walker Sarah R, 2012, JAKSTAT, V1, P292, DOI 10.4161/jkst.22662; Werner S, 2011, J NEUROSCI RES, V89, P1605, DOI 10.1002/jnr.22680; Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974; Yamauchi K, 2006, J NEUROCHEM, V96, P1060, DOI 10.1111/j.1471-4159.2005.03559.x	37	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100405	10.1371/journal.pone.0100405	http://dx.doi.org/10.1371/journal.pone.0100405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945434	Green Published, gold, Green Submitted			2022-12-25	WOS:000340721500070
J	Trapp-Fragnet, L; Bencherit, D; Chabanne-Vautherot, D; Le Vern, Y; Remy, S; Boutet-Robinet, E; Mirey, G; Vautherot, JF; Denesvre, C				Trapp-Fragnet, Laetitia; Bencherit, Djihad; Chabanne-Vautherot, Daniele; Le Vern, Yves; Remy, Sylvie; Boutet-Robinet, Elisa; Mirey, Gladys; Vautherot, Jean-Francois; Denesvre, Caroline			Cell Cycle Modulation by Marek's Disease Virus: The Tegument Protein VP22 Triggers S-Phase Arrest and DNA Damage in Proliferating Cells	PLOS ONE			English	Article							LYTIC REPLICATION; H2AX PHOSPHORYLATION; PSEUDORABIES VIRUS; SEROTYPE-1 MDV-1; GENE UL49; TYPE-1; HERPESVIRUS; EXPRESSION; INFECTION; KINASE	Marek's disease is one of the most common viral diseases of poultry affecting chicken flocks worldwide. The disease is caused by an alphaherpesvirus, the Marek's disease virus (MDV), and is characterized by the rapid onset of multifocal aggressive T-cell lymphoma in the chicken host. Although several viral oncogenes have been identified, the detailed mechanisms underlying MDV-induced lymphomagenesis are still poorly understood. Many viruses modulate cell cycle progression to enhance their replication and persistence in the host cell, in the case of some oncogenic viruses ultimately leading to cellular transformation and oncogenesis. In the present study, we found that MDV, like other viruses, is able to subvert the cell cycle progression by triggering the proliferation of low proliferating chicken cells and a subsequent delay of the cell cycle progression into S-phase. We further identified the tegument protein VP22 (pUL49) as a major MDV-encoded cell cycle regulator, as its vector-driven overexpression in cells lead to a dramatic cell cycle arrest in S-phase. This striking functional feature of VP22 appears to depend on its ability to associate with histones in the nucleus. Finally, we established that VP22 expression triggers the induction of massive and severe DNA damages in cells, which might cause the observed intra S-phase arrest. Taken together, our results provide the first evidence for a hitherto unknown function of the VP22 tegument protein in herpesviral reprogramming of the cell cycle of the host cell and its potential implication in the generation of DNA damages.	[Trapp-Fragnet, Laetitia; Bencherit, Djihad; Chabanne-Vautherot, Daniele; Remy, Sylvie; Vautherot, Jean-Francois; Denesvre, Caroline] INRA, Infectiol & Sante Publ UMR1282, Equipe Biol Virus Aviaires, F-37380 Nouzilly, France; [Le Vern, Yves] INRA, Infectiol & Sante Publ UMR1282, Lab Cytometrie, F-37380 Nouzilly, France; [Boutet-Robinet, Elisa; Mirey, Gladys] INRA, UMR 1331, Toxalim, Res Ctr Food Toxicol, F-31931 Toulouse, France; [Boutet-Robinet, Elisa; Mirey, Gladys] Univ Toulouse, UPS, UMR1331, Toxalim, Toulouse, France	INRAE; INRAE; INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Trapp-Fragnet, L (corresponding author), INRA, Infectiol & Sante Publ UMR1282, Equipe Biol Virus Aviaires, F-37380 Nouzilly, France.	fragnet@tours.inra.fr	Boutet-Robinet, Elisa/Q-1342-2015; Mirey, Gladys/H-5676-2019; Boutet-Robinet, Elisa/AGU-6469-2022	Boutet-Robinet, Elisa/0000-0002-5223-4568; Mirey, Gladys/0000-0002-0095-1864; Boutet-Robinet, Elisa/0000-0002-5223-4568	Ligue contre le Cancer du Grand-Ouest; Indre et Loire; Vendee	Ligue contre le Cancer du Grand-Ouest; Indre et Loire; Vendee	This study was supported by the "Ligue contre le Cancer du Grand-Ouest'', comities of "Indre et Loire'' and "Vendee'' (http://www.ligue-cancer.net). The "Cluster en Infectiologie de la Region Centre'' (http://www.infectiologie-regioncentre.fr) supported the technical collaboration between the "Biologie des Virus Aviaires'' laboratory and the Research Center in Food Toxicology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Berthet C, 2005, P NATL ACAD SCI USA, V102, P13634, DOI 10.1073/pnas.0504583102; Blondeau C, 2008, J VIROL, V82, P9278, DOI 10.1128/JVI.00598-08; Bontems S, 2002, J BIOL CHEM, V277, P21050, DOI 10.1074/jbc.M111872200; CALNEK BW, 1970, AVIAN DIS, V14, P219, DOI 10.2307/1588466; CARROZZA JH, 1973, AVIAN DIS, V17, P767, DOI 10.2307/1589045; Che XB, 2008, J VIROL, V82, P5825, DOI 10.1128/JVI.00303-08; COULTER LJ, 1993, J GEN VIROL, V74, P387, DOI 10.1099/0022-1317-74-3-387; del Rio T, 2002, J VIROL, V76, P774, DOI 10.1128/JVI.76.2.774-782.2002; Denesvre C, 2007, J VIROL, V81, P12348, DOI 10.1128/JVI.01177-07; Dheekollu J, 2011, J VIROL; DICKMANNS A, 1994, J VIROL, V68, P5496, DOI 10.1128/JVI.68.9.5496-5508.1994; Dorange F, 2002, J VIROL, V76, P1959, DOI 10.1128/JVI.76.4.1959-1970.2002; Dorange F, 2000, J GEN VIROL, V81, P2219, DOI 10.1099/0022-1317-81-9-2219; Duffy C, 2006, J VIROL, V80, P8664, DOI 10.1128/JVI.00498-06; Elliott G, 2005, J VIROL, V79, P9735, DOI 10.1128/JVI.79.15.9735-9745.2005; Elliott G, 2000, J VIROL, V74, P2131, DOI 10.1128/JVI.74.5.2131-2141.2000; Elliott G, 1998, J VIROL, V72, P6448, DOI 10.1128/JVI.72.8.6448-6455.1998; ELLIOTT GD, 1992, J GEN VIROL, V73, P723, DOI 10.1099/0022-1317-73-3-723; Flemington EK, 2001, J VIROL, V75, P4475, DOI 10.1128/JVI.75.10.4475-4481.2001; Fuchs W, 2002, J VIROL, V76, P6729, DOI 10.1128/JVI.76.13.6729-6742.2002; Fujimuro M, 2003, NAT MED, V9, P300, DOI 10.1038/nm829; Geiss BJ, 2001, J VIROL, V75, P10721, DOI 10.1128/JVI.75.22.10721-10729.2001; GILBERT DM, 1987, CELL, V50, P59, DOI 10.1016/0092-8674(87)90662-3; Grallert B, 2008, CELL CYCLE, V7, P2315, DOI 10.4161/cc.6389; Gruhne B, 2009, ONCOGENE, V28, P3997, DOI 10.1038/onc.2009.258; Guo KK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-236; Helt AM, 2005, J VIROL, V79, P13218, DOI 10.1128/JVI.79.21.13218-13230.2005; Ingvarsdottir K, 2010, BBA-GENE REGUL MECH, V1799, P200, DOI 10.1016/j.bbagrm.2009.08.002; Jarosinski KW, 2011, J VIROL; Jha HC, 2013, J VIROL, V87, P5255, DOI 10.1128/JVI.03575-12; Kudoh A, 2005, J BIOL CHEM, V280, P8156, DOI 10.1074/jbc.M411405200; Kudoh A, 2004, J VIROL, V78, P104, DOI 10.1128/JVI.78.1.104-115.2004; Labiuk SL, 2010, J GEN VIROL, V91, P1117, DOI 10.1099/vir.0.016600-0; Lebailly P, 2003, OCCUP ENVIRON MED, V60, P910, DOI 10.1136/oem.60.12.910; Liang MH, 2002, J VIROL, V76, P4022, DOI 10.1128/JVI.76.8.4022-4033.2002; LIANG XP, 1995, J VIROL, V69, P3863, DOI 10.1128/JVI.69.6.3863-3867.1995; Lilley CE, 2007, TRENDS MICROBIOL, V15, P119, DOI 10.1016/j.tim.2007.01.003; Lilley CE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002084; Lomonte P, 1999, J VIROL, V73, P9456, DOI 10.1128/JVI.73.11.9456-9467.1999; Luo MH, 2007, J VIROL, V81, P1934, DOI 10.1128/JVI.01670-06; Ma W, 2011, BIOLOGICALS; Maringer K, 2012, J VIROL, V86, P12971, DOI 10.1128/JVI.01913-12; Moffat JF, 2004, BBA-PROTEINS PROTEOM, V1697, P225, DOI 10.1016/j.bbapap.2003.11.026; Mohni KN, 2013, J VIROL, V87, P531, DOI 10.1128/JVI.02504-12; Nascimento R, 2012, PROTOPLASMA, V249, P519, DOI 10.1007/s00709-011-0327-9; NAZERIAN K, 1968, CANCER RES, V28, P2454; Nikitin PA, 2012, BRIT J CANCER, V106, P429, DOI 10.1038/bjc.2011.612; Nikitin PA, 2011, FUTURE VIROL, V6, P813, DOI 10.2217/FVL.11.55; O'Donnell LA, 2002, VIROLOGY, V292, P235, DOI 10.1006/viro.2001.1223; Remy S, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-125; Ren XD, 2001, J VIROL, V75, P8251, DOI 10.1128/JVI.75.17.8251-8258.2001; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sandri-Goldin RM, 2011, FUTURE MICROBIOL, V6, P1261, DOI [10.2217/FMB.11.119, 10.2217/fmb.11.119]; Schonn I, 2010, APOPTOSIS, V15, P162, DOI 10.1007/s10495-009-0440-9; Schumacher D, 2000, J VIROL, V74, P11088, DOI 10.1128/JVI.74.23.11088-11098.2000; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Song BW, 2001, VIROLOGY, V290, P320, DOI 10.1006/viro.2001.1175; Tarakanova VL, 2010, VIROLOGY, V405, P50, DOI 10.1016/j.virol.2010.05.027; Teissier S, 2010, ONCOGENE, V29, P5061, DOI 10.1038/onc.2010.246; Turnell AS, 2012, J GEN VIROL, V93, P2076, DOI 10.1099/vir.0.044412-0; van Leeuwen H, 2003, J GEN VIROL, V84, P2501, DOI 10.1099/vir.0.19326-0; Weitzman MD, 2010, ANNU REV MICROBIOL, V64, P61, DOI 10.1146/annurev.micro.112408.134016; Xiao Y, 2013, J GEN VIROL, V94, P1870, DOI 10.1099/vir.0.053033-0; ZhuO J, 2005, J BIOL CHEM, V280, P16038, DOI 10.1074/jbc.M500054200	65	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100004	10.1371/journal.pone.0100004	http://dx.doi.org/10.1371/journal.pone.0100004			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945933	Green Published, Green Submitted, gold			2022-12-25	WOS:000340721500040
J	Terajima, M; Perdivara, I; Sricholpech, M; Deguchi, Y; Pleshko, N; Tomer, KB; Yamauchi, M				Terajima, Masahiko; Perdivara, Irina; Sricholpech, Marnisa; Deguchi, Yoshizumi; Pleshko, Nancy; Tomer, Kenneth B.; Yamauchi, Mitsuo			Glycosylation and Cross-linking in Bone Type I Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL MODIFICATIONS; LYSYL HYDROXYLASE; OSTEOGENESIS IMPERFECTA; EHRLICH CHROMOGEN; ARTICULAR-CARTILAGE; MOLECULAR PACKING; FIBRILS; IDENTIFICATION; PROTEIN; FIBRILLOGENESIS	Fibrillar type I collagen is the major organic component in bone, providing a stable template for mineralization. During collagen biosynthesis, specific hydroxylysine residues become glycosylated in the form of galactosyl- and glucosylgalactosylhydroxylysine. Furthermore, key glycosylated hydroxylysine residues, alpha 1/2-87, are involved in covalent intermolecular cross-linking. Although cross-linking is crucial for the stability and mineralization of collagen, the biological function of glycosylation in cross-linking is not well understood. In this study, we quantitatively characterized glycosylation of non-cross-linked and cross-linked peptides by biochemical and nanoscale liquid chromatography-high resolution tandem mass spectrometric analyses. The results showed that glycosylation of non-crosslinked hydroxylysine is different from that involved in cross-linking. Among the cross-linked species involving alpha 1/2-87, divalent cross-links were glycosylated with both mono- and disaccharides, whereas the mature, trivalent cross-links were primarily monoglycosylated. Markedly diminished diglycosylation in trivalent cross-links at this locus was also confirmed in type II collagen. The data, together with our recent report (Sricholpech, M., Perdivara, I., Yokoyama, M., Nagaoka, H., Terajima, M., Tomer, K. B., and Yamauchi, M. (2012) Lysyl hydroxylase 3-mediated glucosylation in type I collagen: molecular loci and biological significance. J. Biol. Chem. 287, 22998-23009), indicate that the extent and pattern of glycosylation may regulate cross-link maturation in fibrillar collagen.	[Terajima, Masahiko; Deguchi, Yoshizumi; Yamauchi, Mitsuo] Univ N Carolina, North Carolina Oral Hlth Inst, Sch Dent, Chapel Hill, NC 27599 USA; [Perdivara, Irina; Tomer, Kenneth B.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Sricholpech, Marnisa] Srinakharinwirot Univ, Fac Dent, Dept Oral Surg & Oral Med, Bangkok 10110, Thailand; [Pleshko, Nancy] Temple Univ, Dept Bioengn, Tissue Imaging & Spect Lab, Philadelphia, PA 19122 USA	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Srinakharinwirot University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania	Yamauchi, M (corresponding author), Univ N Carolina, North Carolina Oral Hlth Inst, 385 S Columbia St, Chapel Hill, NC 27599 USA.	yamauchm@dentistry.unc.edu			National Institutes of Health [DE020909, AR060978]; National Institutes of Health, NIEHS [ES050171]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR060978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE020909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants DE020909 and AR060978 (to M. Y.) and the Intramural Research Program of National Institutes of Health, NIEHS, Project ES050171 (to K. B. T.).	AMUDESWARI S, 1987, COLLAGEN REL RES, V7, P215; Bank RA, 1999, P NATL ACAD SCI USA, V96, P1054, DOI 10.1073/pnas.96.3.1054; Batge B, 1997, J BIOCHEM, V122, P109; Brady JD, 2001, J BIOL CHEM, V276, P18812, DOI 10.1074/jbc.M009506200; Byers PH, 2012, ANNU REV GENET, V46, P475, DOI 10.1146/annurev-genet-110711-155608; Eriksen HA, 2004, BONE, V34, P720, DOI 10.1016/j.bone.2003.12.009; Eyre DR, 2008, METHODS, V45, P65, DOI 10.1016/j.ymeth.2008.01.002; Eyre DR, 2013, CALCIFIED TISSUE INT, V93, P338, DOI 10.1007/s00223-013-9723-9; Eyre DR, 2010, J BIOL CHEM, V285, P16675, DOI 10.1074/jbc.M110.111534; EYRE DR, 1988, BIOCHEM J, V252, P495, DOI 10.1042/bj2520495; Eyre DR, 2004, J BIOL CHEM, V279, P2568, DOI 10.1074/jbc.M311653200; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; EYRE DR, 1980, BIOCHEM BIOPH RES CO, V92, P403, DOI 10.1016/0006-291X(80)90347-2; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; Glatter T, 2012, J PROTEOME RES, V11, P5145, DOI 10.1021/pr300273g; Hanson DA, 1996, J BIOL CHEM, V271, P26508, DOI 10.1074/jbc.271.43.26508; Heikkinen J, 2000, J BIOL CHEM, V275, P36158, DOI 10.1074/jbc.M006203200; Henkel W, 2007, J PROTEOME RES, V6, P4269, DOI 10.1021/pr070318r; KUBOKI Y, 1981, BIOCHEM BIOPH RES CO, V102, P119, DOI 10.1016/0006-291X(81)91497-2; KUYPERS R, 1992, BIOCHEM J, V283, P129, DOI 10.1042/bj2830129; LANDIS WJ, 1991, J STRUCT BIOL, V107, P116, DOI 10.1016/1047-8477(91)90015-O; Moro L, 2000, CALCIFIED TISSUE INT, V66, P151, DOI 10.1007/s002230010030; Myers LK, 2004, J IMMUNOL, V172, P2970, DOI 10.4049/jimmunol.172.5.2970; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 2001, ANN MED, V33, P7, DOI 10.3109/07853890109002055; Notbohm H, 1999, J BIOL CHEM, V274, P8988, DOI 10.1074/jbc.274.13.8988; Perdivara I, 2013, J AM SOC MASS SPECTR, V24, P1072, DOI 10.1007/s13361-013-0624-y; Rautavuoma K, 2004, P NATL ACAD SCI USA, V101, P14120, DOI 10.1073/pnas.0404966101; Rautavuoma K, 2002, J BIOL CHEM, V277, P23084, DOI 10.1074/jbc.M112077200; ROYCE PM, 1977, BIOCHIM BIOPHYS ACTA, V498, P132, DOI 10.1016/0304-4165(77)90094-0; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Saito M, 1997, ANAL BIOCHEM, V253, P26, DOI 10.1006/abio.1997.2350; SCOTT JE, 1981, BIOSCIENCE REP, V1, P611, DOI 10.1007/BF01116276; SCOTT JE, 1983, J BIOCHEM-TOKYO, V93, P921, DOI 10.1093/jb/93.3.921; SEGREST JP, 1970, J CLIN INVEST, V49, P1497, DOI 10.1172/JCI106367; Silver FH, 2011, CONNECT TISSUE RES, V52, P242, DOI 10.3109/03008207.2010.551567; Song EW, 2013, J PROTEOME RES, V12, P3599, DOI 10.1021/pr400101t; Sricholpech M, 2012, J BIOL CHEM, V287, P22998, DOI 10.1074/jbc.M112.343954; Sricholpech M, 2011, J BIOL CHEM, V286, P8846, DOI 10.1074/jbc.M110.178509; Suarez KN, 1996, CALCIFIED TISSUE INT, V58, P65, DOI 10.1007/s002239900012; TORREBLANCO A, 1992, J BIOL CHEM, V267, P2650; VEIS A, 1993, J BONE MINER RES, V8, pS493; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Wang CG, 2002, J BIOL CHEM, V277, P18568, DOI 10.1074/jbc.M201389200; WEINER S, 1986, FEBS LETT, V206, P262, DOI 10.1016/0014-5793(86)80993-0; Yamauchi M, 1989, Connect Tissue Res, V21, P159, DOI 10.3109/03008208909050006; YAMAUCHI M, 1993, CONNECT TISSUE RES, V29, P81, DOI 10.3109/03008209309014236; YAMAUCHI M, 1986, BIOCHEMISTRY-US, V25, P4907, DOI 10.1021/bi00365a027; Yamauchi M, 2012, ESSAYS BIOCHEM, V52, P113, DOI DOI 10.1042/BSE0520113; Yamauchi M, 1988, COLLAGEN, P157; Yamauchi M., 1989, CONNECT TISSUE RES, V21, P168; YANG CLL, 1993, EUR J BIOCHEM, V213, P1297, DOI 10.1111/j.1432-1033.1993.tb17881.x	52	69	72	3	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22636	22647		10.1074/jbc.M113.528513	http://dx.doi.org/10.1074/jbc.M113.528513			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24958722	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000341017200010
J	Luhnsdorf, B; Epe, B; Khobta, A				Luehnsdorf, Bork; Epe, Bernd; Khobta, Andriy			Excision of Uracil from Transcribed DNA Negatively Affects Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; REPAIR ENZYME; STRANDED-DNA; BASE; DEAMINATION; GLYCOSYLASE; NUCLEAR; DAMAGE; CONSEQUENCES; ELONGATION	Uracil is an unavoidable aberrant base in DNA, the repair of which takes place by a highly efficient base excision repair mechanism. The removal of uracil from the genome requires a succession of intermediate products, including an abasic site and a single strand break, before the original DNA structure can be reconstituted. These repair intermediates are harmful for DNA replication and also interfere with transcription under cell-free conditions. However, their relevance for cellular transcription has not been proved. Here we investigated the influence of uracil incorporated into a reporter vector on gene expression in human cells. The expression constructs contained a single uracil opposite an adenine (to mimic dUTP misincorporation during DNA synthesis) or a guanine (imitating a product of spontaneous cytosine deamination). We found no evidence for a direct transcription arrest by uracil in either of the two settings because the vectors containing the base modification exhibited unaltered levels of enhanced GFP reporter gene expression at early times after delivery to cells. However, the gene expression showed a progressive decline during subsequent hours. In the case of U: A pairs, this effect was retarded significantly by knockdown of UNG1/2 but not by knockdown of SMUG1 or thymine-DNA glycosylase uracil-DNA glycosylases, proving that it is base excision by UNG1/2 that perturbs transcription of the affected gene. By contrast, the decline of expression of the U: G constructs was not influenced by either UNG1/2, SMUG1, or thymine-DNA glycosylase knockdown, strongly suggesting that there are substantial mechanistic or kinetic differences between the processing of U: A and U: G lesions in cells.	[Luehnsdorf, Bork; Epe, Bernd; Khobta, Andriy] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55128 Mainz, Germany	Johannes Gutenberg University of Mainz	Khobta, A (corresponding author), Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Staudingerweg 5, D-55128 Mainz, Germany.	khobta@uni-mainz.de	Khobta, Andriy/B-6622-2014	Khobta, Andriy/0000-0001-9165-3557	Deutsche Forschungsgemeinschaft [KH 263/1, KH 263/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants KH 263/1 and KH 263/2 (to A. K.).	Aguilera A, 2013, ANNU REV GENET, V47, P1, DOI 10.1146/annurev-genet-111212-133232; Akbari M, 2004, NUCLEIC ACIDS RES, V32, P5486, DOI 10.1093/nar/gkh872; Allgayer J, 2013, NUCLEIC ACIDS RES, V41, P8559, DOI 10.1093/nar/gkt620; BARZILAY G, 1995, NAT STRUCT BIOL, V2, P561, DOI 10.1038/nsb0795-561; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Doseth B, 2011, J BIOL CHEM, V286, P16669, DOI 10.1074/jbc.M111.230052; EFTEDAL I, 1993, NUCLEIC ACIDS RES, V21, P2095, DOI 10.1093/nar/21.9.2095; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; Helmrich A, 2013, NAT STRUCT MOL BIOL, V20, P412, DOI 10.1038/nsmb.2543; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Kathe SD, 2004, J BIOL CHEM, V279, P18511, DOI 10.1074/jbc.M313598200; Kavli B, 2005, J EXP MED, V201, P2011, DOI 10.1084/jem.20050042; Kavli B, 2002, J BIOL CHEM, V277, P39926, DOI 10.1074/jbc.M207107200; Khobta A, 2012, MUTAT RES-FUND MOL M, V736, P5, DOI 10.1016/j.mrfmmm.2011.07.014; Khobta A, 2010, NUCLEIC ACIDS RES, V38, P4285, DOI 10.1093/nar/gkq170; Kitsera N, 2011, NUCLEIC ACIDS RES, V39, P5926, DOI 10.1093/nar/gkr163; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; Kuraoka I, 2003, J BIOL CHEM, V278, P7294, DOI 10.1074/jbc.M208102200; Lagerwerf S, 2011, DNA REPAIR, V10, P743, DOI 10.1016/j.dnarep.2011.04.024; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Luhnsdorf B, 2012, ANAL BIOCHEM, V425, P47, DOI 10.1016/j.ab.2012.03.001; Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750; Nilsen H, 2001, EMBO J, V20, P4278, DOI 10.1093/emboj/20.15.4278; Prorok P, 2013, P NATL ACAD SCI USA, V110, pE3695, DOI 10.1073/pnas.1305624110; Roy D, 2010, MOL CELL BIOL, V30, P146, DOI 10.1128/MCB.00897-09; Schanz S, 2009, P NATL ACAD SCI USA, V106, P5593, DOI 10.1073/pnas.0901726106; SHEN JC, 1994, NUCLEIC ACIDS RES, V22, P972, DOI 10.1093/nar/22.6.972; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; Soboleski MR, 2005, FASEB J, V19, P440, DOI 10.1096/fj.04-3180fje; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Tornaletti S, 2006, CHEM RES TOXICOL, V19, P1215, DOI 10.1021/tx060103g; VERRI A, 1990, NUCLEIC ACIDS RES, V18, P5775, DOI 10.1093/nar/18.19.5775; Visnes T, 2008, DNA REPAIR, V7, P1869, DOI 10.1016/j.dnarep.2008.07.012; Warmerdam DO, 2010, MUTAT RES-REV MUTAT, V704, P2, DOI 10.1016/j.mrrev.2009.12.001; Waters TR, 1998, J BIOL CHEM, V273, P20007, DOI 10.1074/jbc.273.32.20007	37	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22008	22018		10.1074/jbc.M113.521807	http://dx.doi.org/10.1074/jbc.M113.521807			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24951587	Green Published, hybrid			2022-12-25	WOS:000340593500017
J	Zhang, YB; Baranovskiy, AG; Tahirov, TH; Pavlov, YI				Zhang, Yinbo; Baranovskiy, Andrey G.; Tahirov, Tahir H.; Pavlov, Youri I.			The C-terminal Domain of the DNA Polymerase Catalytic Subunit Regulates the Primase and Polymerase Activities of the Human DNA Polymerase alpha-Primase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION FORK; EUKARYOTIC REPLISOME; ACCESSORY SUBUNITS; SACCHAROMYCES-CEREVISIAE; PRIMER SYNTHESIS; P58 SUBUNIT; ZETA; MUTAGENESIS; ARCHITECTURE; MECHANISM	The initiation of DNA synthesis during replication of the human genome is accomplished primarily by the DNA polymerase alpha-primase complex, which makes the RNA-DNA primers accessible to processive DNA pols. The structural information needed to understand the mechanism of regulation of this complex biochemical reaction is incomplete. The presence of two enzymes in one complex poses the question of how these two enzymes cooperate during priming of DNA synthesis. Yeast two-hybrid and direct pulldown assays revealed that the N-terminal domain of the large subunit of primase (p58N) directly interacts with the C-terminal domain of the catalytic subunit of pol alpha (p180C). We found that a complex of the C-terminal domain of the catalytic subunit of pol alpha with the second subunit (p180C-p70) stimulated primase activity, whereas the whole catalytically active heterodimer of pol alpha (p180 Delta N-p70) inhibited RNA synthesis by primase. Conversely, the pol alpha catalytic domain without the C-terminal part (p180 Delta N-core) possessed a much higher propensity to extend the RNA primer than the two-subunit pol alpha (p180 Delta N-p70), suggesting that p180C and/or p70 are involved in the negative regulation of DNA pol activity. We conclude that the interaction between p180C, p70, and p58 regulates the proper primase and polymerase function. The composition of the template DNA is another important factor determining the activity of the complex. We have found that pol alpha activity strongly depends on the sequence of the template and that homopyrimidine runs create a strong barrier for DNA synthesis by pol alpha	[Zhang, Yinbo; Baranovskiy, Andrey G.; Tahirov, Tahir H.; Pavlov, Youri I.] Univ Nebraska Med Ctr, Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Zhang, Yinbo; Pavlov, Youri I.] Univ Nebraska Med Ctr, Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Pavlov, Youri I.] Univ Nebraska Med Ctr, Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Tahirov, TH (corresponding author), Univ Nebraska Med Ctr, Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	ttahirov@unmc.edu; ypavlov@unmc.edu	; Pavlov, Youri/T-7532-2017	Tahirov, Tahir/0000-0002-1238-0069; Pavlov, Youri/0000-0003-1179-5796	National Institutes of Health [GM101167, CA129925]; NATIONAL CANCER INSTITUTE [P30CA036727, R01CA129925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM101167 (NIGMS; to T. H. T.) and CA129925 (NCI; to Y. I. P.).	Agarkar VB, 2011, CELL CYCLE, V10, P926, DOI 10.4161/cc.10.6.15010; Aguirre JD, 2009, INORG CHEM, V48, P4435, DOI 10.1021/ic900164j; Baranovskiy AG, 2014, ACTA CRYSTALLOGR F, V70, P206, DOI 10.1107/S2053230X13034432; Baranovskiy AG, 2012, J BIOL CHEM, V287, P17281, DOI 10.1074/jbc.M112.351122; Bebenek A, 2002, GENETICS, V162, P1003; BOHN EW, 1974, CANCER RES, V34, P1977; Carr AM, 2011, SEMIN CELL DEV BIOL, V22, P866, DOI 10.1016/j.semcdb.2011.10.008; CHOMILIER J, 1992, BIOPHYS CHEM, V45, P143, DOI 10.1016/0301-4622(92)87006-5; COPELAND WC, 1995, J BIOL CHEM, V270, P3905, DOI 10.1074/jbc.270.8.3905; COPELAND WC, 1993, J BIOL CHEM, V268, P26179; Dua R, 1998, J BIOL CHEM, V273, P30046, DOI 10.1074/jbc.273.45.30046; Feng WY, 2001, MOL CELL BIOL, V21, P4495, DOI 10.1128/MCB.21.14.4495-4504.2001; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Garcia-Gomez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Gomez-Llorente Y, 2013, CELL REP, V5, P79, DOI 10.1016/j.celrep.2013.08.046; Hile SE, 2004, J MOL BIOL, V335, P745, DOI 10.1016/j.jmb.2003.10.075; Hogg Matthew, 2012, Subcell Biochem, V62, P237, DOI 10.1007/978-94-007-4572-8_13; Huang H, 2010, J BIOL CHEM, V285, P17112, DOI 10.1074/jbc.M110.116830; Huang SG, 1998, BIOCHEMISTRY-US, V37, P15345, DOI 10.1021/bi9810959; Johansson E, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012799; Johnson RE, 2012, P NATL ACAD SCI USA, V109, P12455, DOI 10.1073/pnas.1206052109; Kilkenny ML, 2012, J BIOL CHEM, V287, P23740, DOI 10.1074/jbc.M112.368951; Kilkenny ML, 2013, P NATL ACAD SCI USA, V110, P15961, DOI 10.1073/pnas.1311185110; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Klinge S, 2009, EMBO J, V28, P1978, DOI 10.1038/emboj.2009.150; Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011; Kunkel TA, 2009, COLD SH Q B, V74, P91, DOI 10.1101/sqb.2009.74.027; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Lao-Sirieix SH, 2005, NAT STRUCT MOL BIOL, V12, P1137, DOI 10.1038/nsmb1013; Lawrence CW, 1996, CANCER SURV, V28, P21; Lee YS, 2014, P NATL ACAD SCI USA, V111, P2954, DOI 10.1073/pnas.1324001111; MacNeill Stuart, 2012, Subcell Biochem, V62, P1, DOI 10.1007/978-94-007-4572-8_1; Makarova AV, 2012, NUCLEIC ACIDS RES, V40, P11618, DOI 10.1093/nar/gks948; Makiniemi M, 1999, TRENDS BIOCHEM SCI, V24, P14, DOI 10.1016/S0968-0004(98)01327-9; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; MIRKIN SM, 1994, ANNU REV BIOPH BIOM, V23, P541, DOI 10.1146/annurev.bb.23.060194.002545; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; Mizuno T, 1998, MOL CELL BIOL, V18, P3552, DOI 10.1128/MCB.18.6.3552; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Northam MR, 2010, GENETICS, V184, P27, DOI 10.1534/genetics.109.107482; Oguey C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015931; Pavlov YI, 2006, INT REV CYTOL, V255, P41, DOI 10.1016/S0074-7696(06)55002-8; Pavlov YI, 2010, MUTAT RES-FUND MOL M, V685, P45, DOI 10.1016/j.mrfmmm.2009.08.002; Pellegrini Luca, 2012, Subcell Biochem, V62, P157, DOI 10.1007/978-94-007-4572-8_9; Perera RL, 2013, ELIFE, V2, DOI 10.7554/eLife.00482; Sauguet L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010083; SHEAFF RJ, 1994, BIOCHEMISTRY-US, V33, P2247, DOI 10.1021/bi00174a035; Simon AC, 2014, NATURE, V510, P293, DOI 10.1038/nature13234; Smith DJ, 2012, NATURE, V483, P434, DOI 10.1038/nature10895; Tahirov Tahir H, 2012, Subcell Biochem, V62, P217, DOI 10.1007/978-94-007-4572-8_12; Tahirov TH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-11; Tanaka S, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010371; Vaithiyalingam S, 2014, J MOL BIOL, V426, P558, DOI 10.1016/j.jmb.2013.11.007; Vaithiyalingam S, 2010, P NATL ACAD SCI USA, V107, P13684, DOI 10.1073/pnas.1002009107; Waisertreiger ISR, 2012, ENVIRON MOL MUTAGEN, V53, P699, DOI 10.1002/em.21735; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Yao NY, 2013, P NATL ACAD SCI USA, V110, P12942, DOI 10.1073/pnas.1309506110; Zerbe LK, 2002, BIOCHEMISTRY-US, V41, P4891, DOI 10.1021/bi016030b	61	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22021	22034		10.1074/jbc.M114.570333	http://dx.doi.org/10.1074/jbc.M114.570333			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24962573	hybrid, Green Published			2022-12-25	WOS:000340593500020
J	Buckland, S; Cole, NC; Groombridge, JJ; Kupper, C; Burke, T; Dawson, DA; Gallagher, LE; Harris, S				Buckland, Steeves; Cole, Nik C.; Groombridge, Jim J.; Kuepper, Clemens; Burke, Terry; Dawson, Deborah A.; Gallagher, Laura E.; Harris, Stephen			High Risks of Losing Genetic Diversity in an Endemic Mauritian Gecko: Implications for Conservation	PLOS ONE			English	Article							COMPUTER-PROGRAM; POPULATION-STRUCTURE; INBREEDING DEPRESSION; BAYESIAN-INFERENCE; ASSIGNMENT METHODS; GENOTYPING ERRORS; DNA; MICROSATELLITE; SOFTWARE; TESTS	Genetic structure can be a consequence of recent population fragmentation and isolation, or a remnant of historical localised adaptation. This poses a challenge for conservationists since misinterpreting patterns of genetic structure may lead to inappropriate management. Of 17 species of reptile originally found in Mauritius, only five survive on the main island. One of these, Phelsuma guimbeaui (lowland forest day gecko), is now restricted to 30 small isolated subpopulations following severe forest fragmentation and isolation due to human colonisation. We used 20 microsatellites in ten subpopulations and two mitochondrial DNA (mtDNA) markers in 13 subpopulations to: (i) assess genetic diversity, population structure and genetic differentiation of subpopulations; (ii) estimate effective population sizes and migration rates of subpopulations; and (iii) examine the phylogenetic relationships of haplotypes found in different subpopulations. Microsatellite data revealed significant population structure with high levels of genetic diversity and isolation by distance, substantial genetic differentiation and no migration between most subpopulations. MtDNA, however, showed no evidence of population structure, indicating that there was once a genetically panmictic population. Effective population sizes of ten subpopulations, based on microsatellite markers, were small, ranging from 44 to 167. Simulations suggested that the chance of survival and allelic diversity of some subpopulations will decrease dramatically over the next 50 years if no migration occurs. Our DNA-based evidence reveals an urgent need for a management plan for the conservation of P. guimbeaui. We identified 18 threatened and 12 viable subpopulations and discuss a range of management options that include translocation of threatened subpopulations to retain maximum allelic diversity, and habitat restoration and assisted migration to decrease genetic erosion and inbreeding for the viable subpopulations.	[Buckland, Steeves; Cole, Nik C.; Harris, Stephen] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Buckland, Steeves; Kuepper, Clemens; Burke, Terry; Dawson, Deborah A.] Univ Sheffield, Dept Anim & Plant Sci, NERC Biomol Anal Facil, Sheffield S10 2TN, S Yorkshire, England; [Buckland, Steeves; Gallagher, Laura E.] Natl Pk & Conservat Serv, Reduit, Mauritius; [Cole, Nik C.] Durrell Wildlife Conservat Trust, Jersey, England; [Cole, Nik C.] Mauritian Wildlife Fdn, Vacoas, Mauritius; [Groombridge, Jim J.] Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury CT2 7NZ, Kent, England	University of Bristol; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Sheffield; University of Kent	Buckland, S (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	steeves.buckland@bristol.ac.uk	Burke, Terry/B-3196-2011; Küpper, Clemens/D-8116-2011	Burke, Terry/0000-0003-3848-1244; Küpper, Clemens/0000-0002-1507-8033	Natural Environment Research Council (NERC); University of Bristol; Rufford Small Grant; Interessengruppe Phelsuma sponsor; NERC [NBAF010001] Funding Source: UKRI; Natural Environment Research Council [NBAF010001] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of Bristol; Rufford Small Grant; Interessengruppe Phelsuma sponsor; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Natural Environment Research Council (NERC). SB was supported by the University of Bristol, a Rufford Small Grant and Interessengruppe Phelsuma sponsors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EC, 2008, MOL ECOL RESOUR, V8, P1219, DOI 10.1111/j.1755-0998.2008.02355.x; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Arnold E.N., 2000, BONN ZOOL MONOGR, V46, P309; Austin JJ, 2004, MOL PHYLOGENET EVOL, V31, P109, DOI 10.1016/j.ympev.2003.07.011; Balmer O, 2011, J HERED, V102, P29, DOI 10.1093/jhered/esq096; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Bijlsma R, 2000, J EVOLUTION BIOL, V13, P502, DOI 10.1046/j.1420-9101.2000.00177.x; Brunner PC, 1998, MOL ECOL, V7, P209, DOI 10.1046/j.1365-294x.1998.00341.x; Buckland S, 2013, CONSERV GENET RESOUR, V5, P1013, DOI 10.1007/s12686-013-9957-x; Busch JD, 2007, MOL ECOL, V16, P2450, DOI 10.1111/j.1365-294X.2007.03283.x; Cheke A., 2008, LOST LAND DODO ECOLO; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cornuet JM, 1996, GENETICS, V144, P2001; Da Silva A, 2006, CONSERV GENET, V7, P371, DOI 10.1007/s10592-005-9048-y; Dixo M, 2009, BIOL CONSERV, V142, P1560, DOI 10.1016/j.biocon.2008.11.016; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Falush D, 2003, GENETICS, V164, P1567; Frankham R., 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Franklin IR, 1998, ANIM CONSERV, V1, P69, DOI 10.1111/j.1469-1795.1998.tb00228.x; Fu YX, 1997, GENETICS, V147, P915; Gardner MG, 2000, J EVOLUTION BIOL, V13, P551; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Janecka JE, 2008, CONSERV GENET, V9, P869, DOI 10.1007/s10592-007-9412-1; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kenta T, 2008, MOL ECOL RESOUR, V8, P1230, DOI 10.1111/j.1755-0998.2008.02190.x; Kupper C, 2012, MOL ECOL, V21, P5864, DOI 10.1111/mec.12064; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Levy E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046351; Liberg O, 2005, BIOL LETT-UK, V1, P17, DOI 10.1098/rsbl.2004.0266; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Nicholls JA, 2000, J AVIAN BIOL, V31, P165, DOI 10.1034/j.1600-048X.2000.310208.x; NyHagen DF, 2001, J TROP ECOL, V17, P755, DOI 10.1017/S0266467401001560; Ovenden JR, 2007, MOL ECOL, V16, P127, DOI 10.1111/j.1365-294X.2006.03132.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Page W, 1997, VEGETATION SUR UNPUB; Palsboll PJ, 2013, MOL ECOL, V22, P22, DOI 10.1111/mec.12094; Palstra FP, 2012, ECOL EVOL, V2, P2357, DOI 10.1002/ece3.329; Park SDE, 2002, THESIS U DUBLIN; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2009, DOCUMENTATION STRUCT; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rocha S, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-3; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozen S, 2000, Methods Mol Biol, V132, P365; Safford RJ, 1997, BIOL CONSERV, V80, P181, DOI 10.1016/S0006-3207(96)00048-1; Schtickzelle N, 2006, ECOLOGY, V87, P1057, DOI 10.1890/0012-9658(2006)87[1057:DDWHFI]2.0.CO;2; Seddon PJ, 2010, RESTOR ECOL, V18, P796, DOI 10.1111/j.1526-100X.2010.00724.x; Slate J, 2000, P ROY SOC B-BIOL SCI, V267, P1657, DOI 10.1098/rspb.2000.1192; SLATKIN M, 1991, GENETICS, V129, P555; TAJIMA F, 1989, GENETICS, V123, P585; Ujvari B, 2002, BIOL CONSERV, V105, P127, DOI 10.1016/S0006-3207(01)00176-8; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vaughan RE, 1937, J ECOL, V25, P289, DOI 10.2307/2256197; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Wang JP, 2004, MOL PHYLOGENET EVOL, V31, P1143, DOI 10.1016/j.ympev.2003.10.001; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Weiser EL, 2012, MOL ECOL RESOUR, V12, P1161, DOI 10.1111/j.1755-0998.2012.03176.x; Wilson GA, 2003, GENETICS, V163, P1177; Wright S, 1943, GENETICS, V28, P114; Wright S., 1969, THEORY GENE FREQUENC, V2, P520	80	3	3	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e93387	10.1371/journal.pone.0093387	http://dx.doi.org/10.1371/journal.pone.0093387			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963708	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000338709500002
J	Eriksen, KT; Halkjaer, J; Sorensen, M; Meliker, JR; McElroy, JA; Tjonneland, A; Raaschou-Nielsen, O				Eriksen, Kirsten T.; Halkjaer, Jytte; Sorensen, Mette; Meliker, Jaymie R.; McElroy, Jane A.; Tjonneland, Anne; Raaschou-Nielsen, Ole			Dietary Cadmium Intake and Risk of Breast, Endometrial and Ovarian Cancer in Danish Postmenopausal Women: A Prospective Cohort Study	PLOS ONE			English	Article							EXPOSURE; ESTROGEN; ACTIVATION; HEALTH; ALPHA; CELL	Purpose: Cadmium is a human lung carcinogen and possesses estrogen-like activity. This combination of carcinogenic and estrogenic activity makes cadmium a contaminant of high concern for hormone-related cancers. Diet and smoking are the main sources of cadmium exposure. The aim of this study was to investigate the association between dietary cadmium intake and risk of breast, endometrial and ovarian cancer in Danish postmenopausal woman. Methods: We estimated dietary cadmium intake in the Diet, Cancer and Health cohort at enrolment 1993-97. The estimates were based on food frequency questionnaires and cadmium contents in all foods. Among 23,815 postmenopausal women we identified 1390 breast, 192 endometrial, and 146 ovarian cancer cases from enrolment through December 31, 2010 using the Danish Cancer Registry. Cox regression was used to analyse the association between dietary cadmium intake and cancer risk. Results: Mean dietary cadmium intake was 14 mu g/day. Cadmium was not associated with breast cancer, incidence rate ratio (IRR) = 0.99, 95% confidence interval (CI): 0.87-1.13 per 10 mu g higher dietary cadmium intake/day; endometrial cancer, IRR = 1.08, 95% CI: 0.76-1.53; or ovarian cancer, IRR = 1.15, 95% CI: 0.78-1.70. We found a positive association between cadmium and endometrial cancer for the women with BMI<25 (IRR = 1.50, 95% CI: 0.94-2.39), whereas an inverse association was seen for the women with BMI >= 25 (IRR = 0.69, 95% CI: 0.42-1.12); p value for interaction = 0.02. Conclusions: Our study does not indicate that our estimated dietary cadmium intake is associated with hormone-related cancers in women.	[Eriksen, Kirsten T.; Halkjaer, Jytte; Sorensen, Mette; Tjonneland, Anne; Raaschou-Nielsen, Ole] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Meliker, Jaymie R.] SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA; [Meliker, Jaymie R.] SUNY Stony Brook, Grad Program Publ Hlth, Stony Brook, NY 11794 USA; [McElroy, Jane A.] Univ Missouri, Columbia, MT USA	Danish Cancer Society; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Missouri System; University of Missouri Columbia	Eriksen, KT (corresponding author), Danish Canc Soc, Res Ctr, Copenhagen, Denmark.	kirsthor@cancer.dk	Raaschou-Nielsen, Ole/GOK-0338-2022	Raaschou-Nielsen, Ole/0000-0002-1223-0909; McElroy, Jane/0000-0001-7518-747X; Tjonneland, Anne/0000-0003-4385-2097; Meliker, Jaymie/0000-0002-6408-8596; Sorensen, Mette/0000-0002-7302-4789	National Institutes of Health (NIH) [R01ES019209]; Danish Cancer Society [R20A93010S2]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019209] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Cancer Society(Danish Cancer Society); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by research grants from the National Institutes of Health (NIH) (grant no.: R01ES019209) and from the Danish Cancer Society (grant no: R20A93010S2). The funders had no role in the design of the study, data collection, interpretation of results, or writing of the manuscript.	Abshire MK, 1996, J TOXICOL ENV HEALTH, V48, P359, DOI 10.1080/009841096161258; Adams SV, 2012, CANCER CAUSE CONTROL, V23, P845, DOI 10.1007/s10552-012-9953-6; Akesson A, 2008, CANCER RES, V68, P6435, DOI 10.1158/0008-5472.CAN-08-0329; Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; BARON JA, 1990, AM J OBSTET GYNECOL, V162, P502, DOI 10.1016/0002-9378(90)90420-C; Brama M, 2007, MOL CELL ENDOCRINOL, V264, P102, DOI 10.1016/j.mce.2006.10.013; Coyle YM, 2004, BREAST CANCER RES TR, V84, P273, DOI 10.1023/B:BREA.0000019964.33963.09; FISCHERMAN K, 1988, ACTA ONCOL, V27, P593, DOI 10.3109/02841868809091756; FLANAGAN PR, 1978, GASTROENTEROLOGY, V74, P841; Gallagher CM, 2010, AGING-US, V2, P804, DOI 10.18632/aging.100226; GARCIAMORALES P, 1994, J BIOL CHEM, V269, P16896; International Agency for Research on Cancer, IARC MONOGRAPHS EVAL; Itoh H, 2014, INT J HYG ENVIR HEAL, V217, P70, DOI 10.1016/j.ijheh.2013.03.010; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Jarup Lars, 1998, Scandinavian Journal of Work Environment and Health, V24, P1; Johnson MD, 2003, NAT MED, V9, P1081, DOI 10.1038/nm902; Joseph P, 2009, TOXICOL APPL PHARM, V238, P272, DOI 10.1016/j.taap.2009.01.011; Julin B, 2011, BRIT J CANCER, V105, P441, DOI 10.1038/bjc.2011.238; Julin B, 2012, CANCER RES, V72, P1459, DOI 10.1158/0008-5472.CAN-11-0735; KAJI T, 1992, TOXICOLOGY, V76, P257, DOI 10.1016/0300-483X(92)90194-J; Larsen EH, 2002, FOOD ADDIT CONTAM, V19, P33, DOI 10.1080/02652030110087447; Lauritsen J., 1998, FOODCALC 1 3; Liu ZW, 2008, TOXICOL APPL PHARM, V228, P286, DOI 10.1016/j.taap.2007.12.017; MADIGAN MP, 1995, J NATL CANCER I, V87, P1681, DOI 10.1093/jnci/87.22.1681; Martinez-Campa C, 2006, J PINEAL RES, V40, P291, DOI 10.1111/j.1600-079X.2006.00315.x; McElroy JA, 2006, JNCI-J NATL CANCER I, V98, P869, DOI 10.1093/jnci/djj233; Sartor F, 1992, IARC Sci Publ, P101; Sawada N, 2012, EPIDEMIOLOGY, V23, P368, DOI 10.1097/EDE.0b013e31824d063c; Schottenfeld D, 2006, CANC EPIDEMIOLOGY PR; Stoica A, 2000, MOL ENDOCRINOL, V14, P545, DOI 10.1210/me.14.4.545; Strumylaite L, 2010, MEDICINA-LITHUANIA, V46, P867, DOI 10.3390/medicina46120121; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; van Wijngaarden E, 2008, PROSTATE, V68, P122, DOI 10.1002/pros.20668; Waalkes MP, 2003, MUTAT RES-FUND MOL M, V533, P107, DOI 10.1016/j.mrfmmm.2003.07.011; Wilson VS, 2004, TOXICOL SCI, V81, P69, DOI 10.1093/toxsci/kfh180; Yu XY, 2010, TOXICOL APPL PHARM, V245, P83, DOI 10.1016/j.taap.2010.02.005	37	43	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100815	10.1371/journal.pone.0100815	http://dx.doi.org/10.1371/journal.pone.0100815			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963789	gold, Green Published, Green Submitted			2022-12-25	WOS:000338709500084
J	Stratoulias, V; Heino, TI; Michon, F				Stratoulias, Vassilis; Heino, Tapio I.; Michon, Frederic			Lin-28 Regulates Oogenesis and Muscle Formation in Drosophila melanogaster	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; LET-7 MICRORNA; RNA; EXPRESSION; DIFFERENTIATION; PROTEIN; LIN28; TRANSCRIPTOME; TRANSLATION; ACTIVATION	Understanding the control of stem cell (SC) differentiation is important to comprehend developmental processes as well as to develop clinical applications. Lin28 is a conserved molecule that is involved in SC maintenance and differentiation by regulating let-7 miRNA maturation. However, little is known about the in vivo function of Lin28. Here, we report critical roles for lin-28 during oogenesis. We found that let-7 maturation was increased in lin-28 null mutant fly ovaries. We showed that lin-28 null mutant female flies displayed reduced fecundity, due to defects in egg chamber formation. More specifically, we demonstrated that in mutant ovaries, the egg chambers fuse during early oogenesis resulting in abnormal late egg chambers. We also showed that this phenotype is the combined result of impaired germline SC differentiation and follicle SC differentiation. We suggest a model in which these multiple oogenesis defects result from a misregulation of the ecdysone signaling network, through the fine-tuning of Abrupt and Fasciclin2 expression. Our results give a better understanding of the evolutionarily conserved role of lin-28 on GSC maintenance and differentiation.	[Stratoulias, Vassilis; Heino, Tapio I.] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Michon, Frederic] Univ Helsinki, Inst Biotechnol, Dev Biol Program, Helsinki, Finland	University of Helsinki; University of Helsinki	Heino, TI (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	Tapio.Heino@helsinki.fi; Frederic.Michon@helsinki.fi	Stratoulias, Vassilis/P-6724-2018; Stratoulias, Vassilis/M-7074-2019; MICHON, Frédéric/ABH-6712-2020	Stratoulias, Vassilis/0000-0002-9724-6589; Stratoulias, Vassilis/0000-0002-9724-6589; Michon, Frederic/0000-0003-4305-305X	Finnish Cultural Foundation; University of Helsinki Funds; Academy of Finland	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); University of Helsinki Funds; Academy of Finland(Academy of Finland)	This work was supported by the Finnish Cultural Foundation (V.S., www. skr.fi/en), University of Helsinki Funds (T.H.), and the Academy of Finland (F.M., www.aka.fi/en-GB/A/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HW, 2010, MOL HUM REPROD, V16, P463, DOI 10.1093/molehr/gaq017; AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Bhartiya D, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-32; Caygill EE, 2008, CURR BIOL, V18, P943, DOI 10.1016/j.cub.2008.06.020; Chawla G, 2012, DEVELOPMENT, V139, P1788, DOI 10.1242/dev.077743; Childs AJ, 2012, STEM CELLS DEV, V21, P2343, DOI 10.1089/scd.2011.0730; Coulom H, 2004, J NEUROSCI, V24, P10993, DOI 10.1523/JNEUROSCI.2993-04.2004; deCuevas M, 1996, DEVELOPMENT, V122, P3959; Djagaeva I, 2005, DEV BIOL, V284, P143, DOI 10.1016/j.ydbio.2005.05.012; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Foley K, 1998, DEVELOPMENT, V125, P1075; Hopf C, 2011, DEV GENES EVOL, V221, P209, DOI 10.1007/s00427-011-0373-5; Jang ACC, 2009, NAT CELL BIOL, V11, P569, DOI 10.1038/ncb1863; Jin JY, 2011, NUCLEIC ACIDS RES, V39, P3724, DOI 10.1093/nar/gkq1350; Konig A, 2011, EMBO J, V30, P1549, DOI 10.1038/emboj.2011.73; Kucherenko MM, 2012, EMBO J, V31, P4511, DOI 10.1038/emboj.2012.298; LANTZ V, 1994, GENE DEV, V8, P598, DOI 10.1101/gad.8.5.598; Li J, 2010, P NATL ACAD SCI USA, V107, P10280, DOI 10.1073/pnas.1001198107; Li X, 2012, CELL DEATH DIFFER, V19, P378, DOI 10.1038/cdd.2011.127; Li Y, 2012, DEVELOPMENT, V139, P1547, DOI 10.1242/dev.077412; Loughlin FE, 2012, NAT STRUCT MOL BIOL, V19, P84, DOI 10.1038/nsmb.2202; Michon F, 2010, DEV BIOL, V340, P355, DOI 10.1016/j.ydbio.2010.01.019; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; O'Reilly AM, 2006, DEVELOPMENT, V133, P2627, DOI 10.1242/dev.02423; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Pritchett TL, 2009, APOPTOSIS, V14, P969, DOI 10.1007/s10495-009-0369-z; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Sato K, 2011, GENE DEV, V25, P2361, DOI 10.1101/gad.174110.111; SCHWARTZ MB, 1989, INSECT BIOCHEM, V19, P243, DOI 10.1016/0020-1790(89)90068-1; Sempere LF, 2002, DEV BIOL, V244, P170, DOI 10.1006/dbio.2002.0594; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Szafranski P, 2004, DEVELOPMENT, V131, P2023, DOI 10.1242/dev.01097; Virant-Klun I, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/381928; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; WHITE RAH, 1984, J EMBRYOL EXP MORPH, V84, P275; White YAR, 2012, NAT MED, V18, P413, DOI 10.1038/nm.2669; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Wong LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024355; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607	51	17	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e101141	10.1371/journal.pone.0101141	http://dx.doi.org/10.1371/journal.pone.0101141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963666	gold, Green Published, Green Submitted			2022-12-25	WOS:000338709500118
J	Goodman, CA; Bennie, JA; Leikis, MJ; McKenna, MJ				Goodman, Craig A.; Bennie, Jason A.; Leikis, Murray J.; McKenna, Michael J.			Unaccustomed Eccentric Contractions Impair Plasma K+ Regulation in the Absence of Changes in Muscle Na+, K+- ATPase Content	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; MESSENGER-RNA EXPRESSION; POTASSIUM KINETICS; INTENSE EXERCISE; NA+,K+-ATPASE ACTIVITY; MOUSE MUSCLE; FATIGUE; HUMANS; DAMAGE; ACTIVATION	The Na+, K+-ATPase (NKA) plays a fundamental role in the regulation of skeletal muscle membrane Na+ and K+ gradients, excitability and fatigue during repeated intense contractions. Many studies have investigated the effects of acute concentric exercise on K+ regulation and skeletal muscle NKA, but almost nothing is known about the effects of repeated eccentric contractions. We therefore investigated the effects of unaccustomed maximal eccentric knee extensor contractions on K+ regulation during exercise, peak knee extensor muscle torque, and vastus lateralis muscle NKA content and 3-O-MFPase activity. Torque measurements, muscle biopsies, and venous blood samples were taken before, during and up to 7 days following the contractions in six healthy adults. Eccentric contractions reduced peak isometric muscle torque immediately post-exercise by 26 +/- 11% and serum creatine kinase concentration peaked 24 h post-exercise at 339 +/- 90 IU/L. During eccentric contractions, plasma [K+] rose during Set 1 and remained elevated at similar to 4.9 mM during sets 4-10; this was despite a decline in work output by Set 4, which fell by 18.9% at set 10. The rise in plasma [K+].work(-1) ratio was elevated over Set 2 from Set 4- Set 10. Eccentric contractions had no effect on muscle NKA content or maximal in-vitro 3-O-MFPase activity immediately post- or up to 7 d post-exercise. The sustained elevation in plasma [K+] despite a decrease in work performed by the knee extensor muscles suggests an impairment in K+ regulation during maximal eccentric contractions, possibly due to increased plasma membrane permeability or to excitation-contraction uncoupling.	[Goodman, Craig A.; Bennie, Jason A.; Leikis, Murray J.; McKenna, Michael J.] Victoria Univ, Muscle Ions & Exercise Grp, Inst Sport Exercise & Act Living, Melbourne, Vic 8001, Australia; [Goodman, Craig A.] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA; [Leikis, Murray J.] Univ Melbourne, Royal Melbourne Hosp, Dept Nephrol, Dept Med, Melbourne, Vic 3050, Australia	Victoria University; University of Wisconsin System; University of Wisconsin Madison; Royal Melbourne Hospital; University of Melbourne	McKenna, MJ (corresponding author), Victoria Univ, Muscle Ions & Exercise Grp, Inst Sport Exercise & Act Living, Melbourne, Vic 8001, Australia.	michael.mckenna@vu.edu.au	Goodman, Craig/H-8085-2019; McKenna, Michael/AAH-3697-2021; Bennie, Jason/AAY-2915-2020	Goodman, Craig/0000-0002-5874-7743; Bennie, Jason/0000-0002-8668-8998; McKenna, Michael/0000-0001-9998-0093				ASP S, 1995, J APPL PHYSIOL, V79, P1338, DOI 10.1152/jappl.1995.79.4.1338; ASP S, 1995, J PHYSIOL-LONDON, V482, P705, DOI 10.1113/jphysiol.1995.sp020553; Beaton LJ, 2002, J PHYSIOL-LONDON, V544, P849, DOI 10.1113/jphysiol.2002.022350; Benziane B, 2012, J BIOL CHEM, V287, P23451, DOI 10.1074/jbc.M111.331926; Bloch RJ, 2002, CLIN ORTHOP RELAT R, pS203, DOI 10.1097/01.blo.0000031982.92980.da; BONDEPETERSEN F, 1972, J APPL PHYSIOL, V33, P792, DOI 10.1152/jappl.1972.33.6.792; Cairns SP, 2008, J PHYSIOL-LONDON, V586, P4039, DOI 10.1113/jphysiol.2008.155424; Chen ZP, 2003, DIABETES, V52, P2205, DOI 10.2337/diabetes.52.9.2205; Clarkson PM, 2002, AM J PHYS MED REHAB, V81, pS52, DOI [10.1097/00002060-200211001-00007, 10.1097/01.PHM.0000029772.45258.43]; Clarkson PM, 1999, CAN J APPL PHYSIOL, V24, P234, DOI 10.1139/h99-020; Clausen T, 2008, ACTA PHYSIOL, V192, P339, DOI 10.1111/j.1748-1716.2007.01798.x; Clausen T, 2003, PHYSIOL REV, V83, P1269, DOI 10.1152/physrev.00011.2003; Enoka RM, 1996, J APPL PHYSIOL, V81, P2339, DOI 10.1152/jappl.1996.81.6.2339; Fraser SF, 2002, J APPL PHYSIOL, V93, P1650, DOI 10.1152/japplphysiol.01247.2001; Fraser SF, 1998, ANAL BIOCHEM, V258, P63, DOI 10.1006/abio.1998.2572; Green HJ, 2001, MUSCLE NERVE, V24, P69, DOI 10.1002/1097-4598(200101)24:1<69::AID-MUS8>3.0.CO;2-O; Hargreaves M, 1998, J APPL PHYSIOL, V84, P1687, DOI 10.1152/jappl.1998.84.5.1687; Ingalls CP, 1998, J APPL PHYSIOL, V85, P58, DOI 10.1152/jappl.1998.85.1.58; Ingwersen MS, 2011, J MEMBRANE BIOL, V242, P1, DOI 10.1007/s00232-011-9365-7; Juel C, 2000, AM J PHYSIOL-REG I, V278, pR400, DOI 10.1152/ajpregu.2000.278.2.R400; Juel C, 2013, AM J PHYSIOL-REG I, V304, pR1161, DOI 10.1152/ajpregu.00591.2012; Lovering RM, 2004, AM J PHYSIOL-CELL PH, V286, pC230, DOI 10.1152/ajpcell.00199.2003; MacIntyre DL, 2001, EUR J APPL PHYSIOL, V84, P180, DOI 10.1007/s004210170002; McKenna MJ, 2008, J APPL PHYSIOL, V104, P288, DOI 10.1152/japplphysiol.01037.2007; McKenna MJ, 2006, J PHYSIOL-LONDON, V576, P279, DOI 10.1113/jphysiol.2006.115352; McKenna MJ, 2003, J PHYSIOL-LONDON, V547, P567, DOI 10.1113/jphysiol.2003.034512; MCKENNA MJ, 1993, J APPL PHYSIOL, V75, P173, DOI 10.1152/jappl.1993.75.1.173; McKenna MJ, 1997, J PHYSIOL-LONDON, V501, P687, DOI 10.1111/j.1469-7793.1997.687bm.x; MEDBO JI, 1990, J PHYSIOL-LONDON, V421, P105, DOI 10.1113/jphysiol.1990.sp017935; Mohr M, 2004, PFLUG ARCH EUR J PHY, V448, P452, DOI 10.1007/s00424-004-1257-6; Murphy KT, 2007, ACTA PHYSIOL, V189, P259, DOI 10.1111/j.1748-1716.2006.01635.x; Murphy RM, 2007, J APPL PHYSIOL, V103, P926, DOI 10.1152/japplphysiol.01422.2006; Nielsen JS, 2007, ACTA PHYSIOL, V191, P217, DOI 10.1111/j.1748-1716.2007.01732.x; Nielsen JJ, 2004, J PHYSIOL-LONDON, V554, P857, DOI 10.1113/jphysiol.2003.050658; Nordsborg N, 2005, J PHYSIOL-LONDON, V567, P583, DOI 10.1113/jphysiol.2005.087031; Nordsborg N, 2003, AM J PHYSIOL-REG I, V285, pR143, DOI 10.1152/ajpregu.00029.2003; NORGAARD A, 1984, SCAND J CLIN LAB INV, V44, P509, DOI 10.3109/00365518409083604; NORGAARD A, 1986, ACTA PHARMACOL TOX, V58, P1; Pedersen TH, 2004, SCIENCE, V305, P1144, DOI 10.1126/science.1101141; Petersen AC, 2005, AM J PHYSIOL-REG I, V289, pR266, DOI 10.1152/ajpregu.00378.2004; Pilegaard H, 1998, AM J PHYSIOL-ENDOC M, V274, pE554, DOI 10.1152/ajpendo.1998.274.3.E554; Ryschon TW, 1997, J APPL PHYSIOL, V83, P867, DOI 10.1152/jappl.1997.83.3.867; Sejersted OM, 2000, PHYSIOL REV, V80, P1411, DOI 10.1152/physrev.2000.80.4.1411; Street D, 2005, J PHYSIOL-LONDON, V566, P481, DOI 10.1113/jphysiol.2005.086801; Takekura H, 2001, J PHYSIOL-LONDON, V533, P571, DOI 10.1111/j.1469-7793.2001.0571a.x; VOLLESTAD NK, 1994, J PHYSIOL-LONDON, V475, P359, DOI 10.1113/jphysiol.1994.sp020077; Warren G L, 2001, Exerc Sport Sci Rev, V29, P82; Warren GL, 1999, J PHYSIOL-LONDON, V515, P609, DOI 10.1111/j.1469-7793.1999.609ac.x; Williams MW, 2001, J CELL SCI, V114, P751; Yeung EW, 2002, J PHYSIOL-LONDON, V540, P581, DOI 10.1113/jphysiol.2001.013839; Zheng D, 2008, AM J PHYSIOL-CELL PH, V294, pC126, DOI 10.1152/ajpcell.00464.2007	51	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e101039	10.1371/journal.pone.0101039	http://dx.doi.org/10.1371/journal.pone.0101039			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959836	Green Accepted, gold, Green Published			2022-12-25	WOS:000338633900112
J	Li, MV; Shukla, D; Rhodes, BH; Lall, A; Shu, JM; Moriarity, BS; Largaespada, DA				Li, Ming V.; Shukla, Dip; Rhodes, Brian H.; Lall, Anjali; Shu, Jingmin; Moriarity, Branden S.; Largaespada, David A.			HomeRun Vector Assembly System: A Flexible and Standardized Cloning System for Assembly of Multi-Modular DNA Constructs	PLOS ONE			English	Article							IN-VITRO; HOMING ENDONUCLEASES; RECOMBINATION; EXPRESSION; CRE; EFFICIENCY; EXCHANGE	Advances in molecular and synthetic biology call for efficient assembly of multi-modular DNA constructs. We hereby present a novel modular cloning method that obviates the need for restriction endonucleases and significantly improves the efficiency in the design and construction of complex DNA molecules by standardizing all DNA elements and cloning reactions. Our system, named HomeRun Vector Assembly System (HVAS), employs a three-tiered vector series that utilizes both multisite gateway cloning and homing endonucleases, with the former building individual functional modules and the latter linking modules into the final construct. As a proof-of-principle, we first built a two-module construct that supported doxycycline-induced expression of green fluorescent protein (GFP). Further, with a three-module construct we showed quantitatively that there was minimal promoter leakage between neighbouring modules. Finally, we developed a method, in vitro Cre recombinase-mediated cassette exchange (RMCE) cloning, to regenerate a gateway destination vector from a previous multisite gateway cloning reaction, allowing access to existing DNA element libraries in conventional gateway entry clones, and simple creation of constructs ready for in vivo RMCE. We believe these methods constitute a useful addition to the standard molecular cloning techniques that could potentially support industrial scale synthesis of DNA constructs.	[Li, Ming V.; Shu, Jingmin] Univ Minnesota, Dept Med, Div Endocrinol & Diabet, Minneapolis, MN 55455 USA; [Shukla, Dip; Lall, Anjali; Shu, Jingmin; Moriarity, Branden S.; Largaespada, David A.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Rhodes, Brian H.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA; [Shu, Jingmin; Moriarity, Branden S.; Largaespada, David A.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA; [Shu, Jingmin; Moriarity, Branden S.; Largaespada, David A.] Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; [Shu, Jingmin; Moriarity, Branden S.; Largaespada, David A.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Li, MV (corresponding author), Univ Minnesota, Dept Med, Div Endocrinol & Diabet, Box 736 UMHC, Minneapolis, MN 55455 USA.	lixx1138@umn.edu		Shukla, Dip/0000-0002-1636-7830	National Institutes of Health [5 T32 DK007203-35]; Margaret Harvey Schering Land Grant Chair in Cancer Genetics; National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Margaret Harvey Schering Land Grant Chair in Cancer Genetics; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health T32 training grant [5 T32 DK007203-35 to MVL and JS] and Margaret Harvey Schering Land Grant Chair in Cancer Genetics [to DAL]. Funding for open access charge: National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azaro MA, 1997, EMBO J, V16, P3744, DOI 10.1093/emboj/16.12.3744; Bechtel S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-399; Belfort M, 1997, NUCLEIC ACIDS RES, V25, P3379, DOI 10.1093/nar/25.17.3379; Burgess-Beusse B, 2002, P NATL ACAD SCI USA, V99, P16433, DOI 10.1073/pnas.162342499; BUSHMAN W, 1985, SCIENCE, V230, P906, DOI 10.1126/science.2932798; Casini A, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt915; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Feng YQ, 1999, J MOL BIOL, V292, P779, DOI 10.1006/jmbi.1999.3113; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Guye P, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt605; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Heinz N, 2011, HUM GENE THER, V22, P166, DOI 10.1089/hum.2010.099; Knight T., 2003, IDEMPOTENT VECTOR DE; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Li MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr764; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marcaida MJ, 2010, CELL MOL LIFE SCI, V67, P727, DOI 10.1007/s00018-009-0188-y; Moriarity BS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt115; Petersen LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024531; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Sarrion-Perdigones A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021622; Sasaki Y, 2004, J BIOTECHNOL, V107, P233, DOI 10.1016/j.jbiotec.2003.10.001; Sauer B, 2004, NUCLEIC ACIDS RES, V32, P6086, DOI 10.1093/nar/gkh941; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Slusarczyk AL, 2012, NAT REV GENET, V13, P406, DOI 10.1038/nrg3227; Takata Y, 2011, GENES CELLS, V16, P765, DOI 10.1111/j.1365-2443.2011.01526.x; Temple G, 2009, GENOME RES, V19, P2324, DOI 10.1101/gr.095976.109; Yahata K, 2007, J MOL BIOL, V374, P580, DOI 10.1016/j.jmb.2007.09.054; Zeevi V, 2012, PLANT PHYSIOL, V158, P132, DOI 10.1104/pp.111.184374; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288	34	9	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100948	10.1371/journal.pone.0100948	http://dx.doi.org/10.1371/journal.pone.0100948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959875	Green Published, gold, Green Submitted			2022-12-25	WOS:000338633900105
J	Song, S; Hwang, S; Lee, S; Ha, NC; Lee, K				Song, Saemee; Hwang, Soonhye; Lee, Seunghwa; Ha, Nam-Chul; Lee, Kangseok			Interaction Mediated by the Putative Tip Regions of MdsA and MdsC in the Formation of a Salmonella-Specific Tripartite Efflux Pump	PLOS ONE			English	Article							ALPHA-BARREL TIP; MULTIDRUG EFFLUX; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PERIPLASMIC COMPONENT; TOLC HOMOLOGS; PROTEIN; TRANSPORTER; ACRAB; RESISTANCE	To survive in the presence of a wide range of toxic compounds, gram-negative bacteria expel such compounds via tripartite efflux pumps that span both the inner and outer membranes. The Salmonella-specific MdsAB pump consists of MdsB, a resistance-nodulation-division (RND)-type inner membrane transporter (IMT) that requires the membrane fusion protein (MFP) MdsA, and an outer membrane protein (OMP; MdsC or TolC) to form a tripartite efflux complex. In this study, we investigated the role of the putative tip regions of MdsA and its OMPs, MdsC and TolC, in the formation of a functional MdsAB-mediated efflux pump. Comparative analysis indicated that although sequence homologies of MdsA and MdsC with other MFPs and OMPs, respectively, are extremely low, key residues in the putative tip regions of these proteins are well conserved. Mutagenesis studies on these conserved sites demonstrated their importance for the physical and functional interactions required to form an MdsAB-mediated pump. Our studies suggest that, despite differences in the primary amino acid sequences and functions of various OMPs and MFPs, interactions mediated by the conserved tip regions of OMP and MFP are required for the formation of functional tripartite efflux pumps in gram-negative bacteria.	[Song, Saemee; Hwang, Soonhye; Lee, Seunghwa; Lee, Kangseok] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea; [Ha, Nam-Chul] Seoul Natl Univ, Res Inst Agr & Life Sci, Dept Agr Biotechnol, Dept Food & Anim Biotechnol, Seoul, South Korea	Chung Ang University; Seoul National University (SNU)	Ha, NC (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Dept Agr Biotechnol, Dept Food & Anim Biotechnol, Seoul, South Korea.	hanc210@snu.ac.kr; kangseok@cau.ac.kr			Next-Generation BioGreen 21 Program (SSAC) [PJ009025]; Rural Development Administration; Korean Healthcare Technology R&D Project, Korean Ministry of Health and Welfare, Republic of Korea [H12C0947]	Next-Generation BioGreen 21 Program (SSAC)(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Korean Healthcare Technology R&D Project, Korean Ministry of Health and Welfare, Republic of Korea	This work was supported by the Next-Generation BioGreen 21 Program (SSAC, Grant no. PJ009025), Rural Development Administration and a grant from the Korean Healthcare Technology R&D Project, Korean Ministry of Health and Welfare (Grant no. H12C0947), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; Bavro VN, 2008, MOL CELL, V30, P114, DOI 10.1016/j.molcel.2008.02.015; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DuPont HL, 2007, CLIN INFECT DIS, V45, P1353, DOI 10.1086/522662; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Fralick JA, 1996, J BACTERIOL, V178, P5803, DOI 10.1128/jb.178.19.5803-5805.1996; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Kim HM, 2010, J BACTERIOL, V192, P4498, DOI 10.1128/JB.00334-10; Koronakis V, 2004, ANNU REV BIOCHEM, V73, P467, DOI 10.1146/annurev.biochem.73.011303.074104; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Lee M, 2013, J MICROBIOL, V51, P154, DOI 10.1007/s12275-013-2699-3; Lee M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040460; Lee S, 2014, J MICROBIOL, V52, P148, DOI 10.1007/s12275-014-3578-2; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Misra R, 2009, BBA-PROTEINS PROTEOM, V1794, P817, DOI 10.1016/j.bbapap.2009.02.017; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Nikaido H, 1999, CURR OPIN INFECT DIS, V12, P529, DOI 10.1097/00001432-199912000-00001; Nikaido H, 2001, J MOL MICROB BIOTECH, V3, P215; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Nishino K, 2006, MOL MICROBIOL, V59, P126, DOI 10.1111/j.1365-2958.2005.04940.x; Nishino K, 2003, ANTIMICROB AGENTS CH, V47, P3030, DOI 10.1128/AAC.47.9.3030-3033.2003; Pei XY, 2011, P NATL ACAD SCI USA, V108, P2112, DOI 10.1073/pnas.1012588108; Reffay M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005035; Su CC, 2011, NATURE, V470, P558, DOI 10.1038/nature09743; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; Weeks JW, 2014, MOL MICROBIOL, V91, P965, DOI 10.1111/mmi.12508; Weybridge UK, 2003, REP SALM POULTR, P83; Xu Y, 2012, J BIOL CHEM, V287, P11240; Xu Y, 2011, J BIOL CHEM, V286, P17910, DOI 10.1074/jbc.M111.238535; Xu Y, 2011, J BIOL CHEM, V286, P13541, DOI 10.1074/jbc.M110.202598; Xu YB, 2010, BIOCHEM BIOPH RES CO, V394, P962, DOI 10.1016/j.bbrc.2010.03.097; Yeom JH, 2006, BIOCHEM BIOPH RES CO, V345, P1372, DOI 10.1016/j.bbrc.2006.05.018; Yum SW, 2009, J MOL BIOL, V387, P1286, DOI 10.1016/j.jmb.2009.02.048; Zgurskaya HI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00189	36	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100881	10.1371/journal.pone.0100881	http://dx.doi.org/10.1371/journal.pone.0100881			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960027	Green Submitted, Green Published, gold			2022-12-25	WOS:000338633900099
J	Menalled, LB; Kudwa, AE; Oakeshott, S; Farrar, A; Paterson, N; Filippov, I; Miller, S; Kwan, M; Olsen, M; Beltran, J; Torello, J; Fitzpatrick, J; Mushlin, R; Cox, K; McConnell, K; Mazzella, M; He, DS; Osborne, GF; Al-Nackkash, R; Bates, GP; Tuunanen, P; Lehtimaki, K; Brunner, D; Ghavami, A; Ramboz, S; Park, L; Macdonald, D; Munoz-Sanjuan, I; Howland, D				Menalled, Liliana B.; Kudwa, Andrea E.; Oakeshott, Steve; Farrar, Andrew; Paterson, Neil; Filippov, Igor; Miller, Sam; Kwan, Mei; Olsen, Michael; Beltran, Jose; Torello, Justin; Fitzpatrick, Jon; Mushlin, Richard; Cox, Kimberly; McConnell, Kristi; Mazzella, Matthew; He, Dansha; Osborne, Georgina F.; Al-Nackkash, Rand; Bates, Gill P.; Tuunanen, Pasi; Lehtimaki, Kimmo; Brunner, Dani; Ghavami, Afshin; Ramboz, Sylvie; Park, Larry; Macdonald, Douglas; Munoz-Sanjuan, Ignacio; Howland, David			Genetic Deletion of Transglutaminase 2 Does Not Rescue the Phenotypic Deficits Observed in R6/2 and zQ175 Mouse Models of Huntington's Disease	PLOS ONE			English	Article							TISSUE TRANSGLUTAMINASE; TRANSGENIC MOUSE; NEURODEGENERATIVE DISEASES; CAG REPEAT; MICE; INHIBITORS; CYSTAMINE; SURVIVAL; STIMULATION; CONTRIBUTES	Huntington's disease (HD) is an autosomal dominant, progressive neurodegenerative disorder caused by expansion of CAG repeats in the huntingtin gene. Tissue transglutaminase 2 (TG2), a multi-functional enzyme, was found to be increased both in HD patients and in mouse models of the disease. Furthermore, beneficial effects have been reported from the genetic ablation of TG2 in R6/2 and R6/1 mouse lines. To further evaluate the validity of this target for the treatment of HD, we examined the effects of TG2 deletion in two genetic mouse models of HD: R6/2 CAG 240 and zQ175 knock in (KI). Contrary to previous reports, under rigorous experimental conditions we found that TG2 ablation had no effect on either motor or cognitive deficits, or on the weight loss. In addition, under optimal husbandry conditions, TG2 ablation did not extend R6/2 lifespan. Moreover, TG2 deletion did not change the huntingtin aggregate load in cortex or striatum and did not decrease the brain atrophy observed in either mouse line. Finally, no amelioration of the dysregulation of striatal and cortical gene markers was detected. We conclude that TG2 is not a valid therapeutic target for the treatment of HD.	[Menalled, Liliana B.; Kudwa, Andrea E.; Oakeshott, Steve; Farrar, Andrew; Paterson, Neil; Filippov, Igor; Miller, Sam; Kwan, Mei; Olsen, Michael; Beltran, Jose; Torello, Justin; Fitzpatrick, Jon; Mushlin, Richard; Cox, Kimberly; McConnell, Kristi; Mazzella, Matthew; He, Dansha; Brunner, Dani; Ghavami, Afshin; Ramboz, Sylvie] PsychoGenics Inc, Tarrytown, NY USA; [Osborne, Georgina F.; Al-Nackkash, Rand; Bates, Gill P.] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Tuunanen, Pasi; Lehtimaki, Kimmo] Charles River Discovery Res Serv, Kuopio, Finland; [Park, Larry; Macdonald, Douglas; Munoz-Sanjuan, Ignacio; Howland, David] CHDI Fdn, CHDI Management, Princeton, NJ 08540 USA	University of London; King's College London	Howland, D (corresponding author), CHDI Fdn, CHDI Management, Princeton, NJ 08540 USA.	David.Howland@CHDIFoundation.org	Lehtimäki, Kimmo K/A-6018-2009; Bates, Gillian/E-1146-2012	Lehtimäki, Kimmo K/0000-0003-2750-8229; Mazzella, Matthew/0000-0003-3584-1670; Osborne, Georgina/0000-0001-8308-3179; Bates, Gillian/0000-0002-4041-6305	CHDI Foundation; PsychoGenics, Inc.; Charles River Discovery Research Services; Kings College London	CHDI Foundation; PsychoGenics, Inc.; Charles River Discovery Research Services; Kings College London(General Electric)	CHDI Foundation is a privately-funded not-for-profit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease. CHDI Foundation conducts research in a number of different ways; for the purposes of this manuscript, research was conducted at the contract research organizations PsychoGenics, Inc. and Charles River Discovery Research Services under a fee-for-service agreement, and at Kings College London under a sponsored research agreement. The authors listed all contributed to the conception, planning, and direction of the research; the specific roles of each author is outlined in the 'author contributions' section.	Bailey CDC, 2005, J NEUROCHEM, V92, P83, DOI 10.1111/j.1471-4159.2004.02839.x; Bailey CDC, 2006, NEUROBIOL AGING, V27, P871, DOI 10.1016/j.neurobiolaging.2005.04.001; Balci F., 2013, PLOS CURR, V5; BATES G, 2002, HUNTINGTONS DIS; Carter RJ, 2000, MOVEMENT DISORD, V15, P925, DOI 10.1002/1531-8257(200009)15:5<925::AID-MDS1025>3.0.CO;2-Z; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; Chun WJ, 2001, J CELL BIOL, V153, P25, DOI 10.1083/jcb.153.1.25; Cowin RM, 2012, BEHAV BRAIN RES, V229, P308, DOI 10.1016/j.bbr.2011.12.045; D'Eletto M, 2012, CELL DEATH DIFFER, V19, P1228, DOI 10.1038/cdd.2012.2; Dedeoglu A, 2002, J NEUROSCI, V22, P8942; Dragatsis I, 2009, NEUROBIOL DIS, V33, P315, DOI 10.1016/j.nbd.2008.10.009; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; Hasegawa G, 2003, BIOCHEM J, V373, P793, DOI 10.1042/BJ20021084; Heikkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050717; IM MJ, 1990, J BIOL CHEM, V265, P18952; Jacobs GH, 1999, J NEUROSCI, V19, P3258; Jeitner TM, 2008, J NEUROCHEM, V106, P37, DOI 10.1111/j.1471-4159.2008.05350.x; Karpuj MV, 2002, NAT MED, V8, P143, DOI 10.1038/nm0202-143; Kumar A, 2012, EXP NEUROL, V237, P78, DOI 10.1016/j.expneurol.2012.05.015; Lai TS, 1998, J BIOL CHEM, V273, P1776, DOI 10.1074/jbc.273.3.1776; Lesort M, 1999, J NEUROCHEM, V73, P2018; Mangala LS, 2005, PROG EXP TUMOR RES, V38, P125; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mastroberardino P, 2002, CELL DEATH DIFFER, V9, P873, DOI 10.1038/sj.cdd.4401093; Mastroberardino PG, 2006, BBA-BIOENERGETICS, V1757, P1357, DOI 10.1016/j.bbabio.2006.07.007; McConoughey SJ, 2010, EMBO MOL MED, V2, P349, DOI 10.1002/emmm.201000084; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Molberg O, 2000, J PEDIATR GASTR NUTR, V30, P232, DOI 10.1097/00005176-200003000-00005; Morton AJ, 2009, NEUROBIOL DIS, V33, P331, DOI 10.1016/j.nbd.2008.11.015; Munsie L, 2011, HUM MOL GENET, V20, P1937, DOI 10.1093/hmg/ddr075; Nanda N, 2001, J BIOL CHEM, V276, P20673, DOI 10.1074/jbc.M010846200; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Prime ME, 2012, J MED CHEM, V55, P1021, DOI 10.1021/jm201310y; Sathasivam K, 2001, HUM MOL GENET, V10, P2425, DOI 10.1093/hmg/10.21.2425; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Schaertl S, 2010, J BIOMOL SCREEN, V15, P478, DOI 10.1177/1087057110366035; Siegel M, 2007, PHARMACOL THERAPEUT, V115, P232, DOI 10.1016/j.pharmthera.2007.05.003; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; TAHRIJOUTEI A, 1989, ENDOCRINOLOGY, V125, P605, DOI 10.1210/endo-125-2-605; Wood NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009077; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	42	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99520	10.1371/journal.pone.0099520	http://dx.doi.org/10.1371/journal.pone.0099520			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955833	Green Published, Green Submitted, gold			2022-12-25	WOS:000338917900012
J	Nakamura, T; Sakata, Y; Otsuka-Kanazawa, S; Ichii, O; Chihara, M; Nagasaki, K; Namiki, Y; Kon, Y				Nakamura, Teppei; Sakata, Yuko; Otsuka-Kanazawa, Saori; Ichii, Osamu; Chihara, Masataka; Nagasaki, Ken-ichi; Namiki, Yuka; Kon, Yasuhiro			Genomic Analysis of the Appearance of Ovarian Mast Cells in Neonatal MRL/MpJ Mice	PLOS ONE			English	Article							CCL17; DIFFERENTIATION; SPERMATOCYTES; REGENERATION; RESISTANCE; MIGRATION; TISSUE	In MRL/MpJ mice, ovarian mast cells (OMCs) are more abundant than in other mouse strains, and tend to distribute beneath the ovarian surface epithelium at birth. This study investigated the factors regulating the appearance of neonatal OMCs in progeny of the cross between MRL/MpJ and C57BL/6N strains. F1 neonates had less than half the number of OMCs than MRL/MpJ. Interestingly, MRLB6F1 had more neonatal OMCs than B6MRLF1, although they were distributed over comparable areas. Furthermore, in MRL/MpJ fetuses for which parturition was delayed until embryonic day 21.5, the number of OMCs was significantly higher than in age-matched controls at postnatal day 2. These results suggest that the number of OMCs was influenced by the environmental factors during pregnancy. Quantitative trait locus analysis using N2 backcross progeny revealed two significant loci on chromosome 8: D8Mit343-D8Mit312 for the number of OMCs and D8Mit86-D8Mit89 for their distribution, designated as mast cell in the ovary of MRL/MpJ 1 (mcom1) and mcom2, respectively. Among MC migration-associated genes, ovarian expression of chemokine (C-C motif) ligand 17 at mcom1 locus was significantly higher in MRL/MpJ than in C57BL/6N, and positively correlated with the expression of OMC marker genes. These results indicate that the appearance of neonatal OMCs in MRL/MpJ is controlled by environmental factors and filial genetic factors, and that the abundance and distribution of OMCs are regulated by independent filial genetic elements.	[Nakamura, Teppei; Otsuka-Kanazawa, Saori; Ichii, Osamu; Chihara, Masataka; Kon, Yasuhiro] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Anat Lab, Sapporo, Hokkaido, Japan; [Nakamura, Teppei; Sakata, Yuko; Nagasaki, Ken-ichi] Japan Food Res Labs, Chitose Lab, Sect Biol Safety Res, Chitose, Hokkaido, Japan; [Namiki, Yuka] Hokkaido Univ, Grad Sch Vet Med, Off Fac Dev & Teaching Enriched Vet Med, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Kon, Y (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Anat Lab, Sapporo, Hokkaido, Japan.	y-kon@vetmed.hokudai.ac.jp		Kon, Yasuhiro/0000-0002-8859-6122; NAKAMURA, Teppei/0000-0003-3204-0245	Ministry of Education, Culture, Sports and Technology of Japan [24380156]; Japan Society for the Promotion of Science [24002135]	Ministry of Education, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research B from the Ministry of Education, Culture, Sports and Technology of Japan (No. 24380156), and a Research fellowship from the Japan Society for the Promotion of Science (No. 24002135). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRANNSTROM M, 1993, BIOL REPROD, V48, P277, DOI 10.1095/biolreprod48.2.277; Clark LD, 1998, CLIN IMMUNOL IMMUNOP, V88, P35, DOI 10.1006/clin.1998.4519; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Gersch C, 2002, HISTOCHEM CELL BIOL, V118, P41, DOI 10.1007/s00418-002-0425-z; Jackson NE, 2005, EUR J IMMUNOL, V35, P2376, DOI 10.1002/eji.200526154; Juremalm M, 2005, CLIN EXP ALLERGY, V35, P708, DOI 10.1111/j.1365-2222.2005.02203.x; Kezele PR, 2005, BIOL REPROD, V72, P241, DOI 10.1095/biolreprod.104.032060; Kokubu K, 2005, J REPROD DEVELOP, V51, P773, DOI 10.1262/jrd.17033; Kon Y, 1999, CELL TISSUE RES, V296, P359, DOI 10.1007/s004410051296; Kon Y, 2007, ANAT HISTOL EMBRYOL, V36, P172, DOI 10.1111/j.1439-0264.2006.00728.x; Kon Y, 2001, MOL REPROD DEV, V58, P216, DOI 10.1002/1098-2795(200102)58:2&lt;216::AID-MRD11&gt;3.0.CO;2-C; Lee S, 2010, MAMM GENOME, V21, P162, DOI 10.1007/s00335-010-9254-x; Lee YM, 2003, J KOREAN MED SCI, V18, P97; Leferovich JM, 2001, P NATL ACAD SCI USA, V98, P9830, DOI 10.1073/pnas.181329398; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Nakamura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077246; Namiki Y, 2005, MAMM GENOME, V16, P96, DOI 10.1007/s00335-004-2424-y; Namiki Y, 2003, MOL REPROD DEV, V64, P179, DOI 10.1002/mrd.10208; Nose M, 2000, INT J CARDIOL, V75, pS53, DOI 10.1016/S0167-5273(00)00191-1; Otsuka S, 2008, BIOL REPROD, V79, P9, DOI 10.1095/biolreprod.107.064519; Otsuka S, 2012, MAMM GENOME, V23, P741, DOI 10.1007/s00335-012-9405-3; Papadopoulos EJ, 2000, EUR J IMMUNOL, V30, P2355, DOI 10.1002/1521-4141(2000)30:8<2355::AID-IMMU2355>3.0.CO;2-#; QUAIFE CJ, 1994, BIOCHEMISTRY-US, V33, P7250, DOI 10.1021/bi00189a029; Robbie-Ryan M, 2002, CURR OPIN IMMUNOL, V14, P728, DOI 10.1016/S0952-7915(02)00394-1; SKALKO RG, 1968, ANAT REC, V161, P459, DOI 10.1002/ar.1091610407; Stutte S, 2010, P NATL ACAD SCI USA, V107, P8736, DOI 10.1073/pnas.0906126107; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Tsunemi Y, 2006, EUR J IMMUNOL, V36, P2116, DOI 10.1002/eji.200535564; Woldacki K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.214; Yin X., 2005, BMC IMMUNOL, V2005, P6, DOI 10.1186%2F1471-2172-6-21; Yu HR, 2005, MAMM GENOME, V16, P918, DOI 10.1007/s00335-005-0077-0; Zierau O, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00169	34	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100617	10.1371/journal.pone.0100617	http://dx.doi.org/10.1371/journal.pone.0100617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956472	gold, Green Published			2022-12-25	WOS:000338917900072
J	Ocampo, G; Michelangeli, FA; Almeda, F				Ocampo, Gilberto; Michelangeli, Fabian A.; Almeda, Frank			Seed Diversity in the Tribe Miconieae (Melastomataceae): Taxonomic, Systematic, and Evolutionary Implications	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; CLADISTIC-ANALYSIS; DNA-SEQUENCES; MORPHOLOGY; CHARACTERS; MODEL; SIGNAL; TREES; FIRE; SIZE	Miconieae is the largest tribe in the Melastomataceae with over 1,850 species. The members of Miconieae display a wide range of morphological diversity, and seed morphology is no exception. Previous studies have found that seed morphological diversity is not congruent with traditional classifications, and suggest that it may reflect evolutionary relationships within Miconieae. Here we characterize seed morphology of 364 species of Miconieae. The morphological data set and a DNA sequence data matrix were analyzed under a parsimony and Bayesian framework. Seed characters were used to test taxonomic and clade hypotheses, to estimate morphological ancestral character states, and to assess phylogenetic signal. The phylogenetic analyses of morphological data retrieved a poorly-resolved, low-supported phylogeny; in contrast, a relatively strongly supported phylogeny was estimated using the molecular data. Hypothesis testing procedures could only reject the monophyly of Clidemia, Leandra, and Miconia. The results indicated that the seed morphological characters were homoplasious, but contained phylogenetic signal. The morphological seed types that were described in previous studies did not support any of the clades retrieved by the molecular phylogeny. In contrast with previous investigations, our study shows that although seed morphology is very variable, it does not provide information for supporting some genera or clades within Miconieae. However, it is suggested that seed characters in combination with other vegetative and reproductive traits may aid in the characterization of smaller clades. The presence of phylogenetic signal retrieved by homoplasious characters may indicate that diversification of seed characters could have an adaptive component. Further studies that increase taxon sampling, refine seed trait characterization, and evaluate the alleged relationships between environmental variables and seed diversification will contribute to a better understanding of seed morphology and evolution in this species-rich tribe.	[Ocampo, Gilberto; Almeda, Frank] Calif Acad Sci, Inst Biodivers Sci & Sustainabil, Dept Bot, San Francisco, CA 94118 USA; [Michelangeli, Fabian A.] New York Bot Garden, Bronx, NY 10458 USA	California Academy of Sciences; New York Botanical Garden	Ocampo, G (corresponding author), Calif Acad Sci, Inst Biodivers Sci & Sustainabil, Dept Bot, San Francisco, CA 94118 USA.	gocampo@calacademy.org	Michelangeli, Fabian A/A-7945-2011	Michelangeli, Fabian A/0000-0001-7348-143X	U.S. National Science Foundation [DEB 0818399]; California Academy of Sciences; Division Of Environmental Biology [0818399] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); California Academy of Sciences; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the U.S. National Science Foundation (DEB 0818399-Planetary Biodiversity Inventory: Miconieae) and the California Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Almeda F, 2003, NATURAL HIST MADAGAS, P375; Almeda F., 2011, SYST BOT MONOGR, V93, P1; Barker FK, 2002, SYST BIOL, V51, P625, DOI 10.1080/10635150290102302; Barthlott W., 1981, Nordic Journal of Botany, V1, P345, DOI 10.1111/j.1756-1051.1981.tb00704.x; Barthlott W., 1984, CURRENT CONCEPTPLA, P95; Barthlott W, 2000, SEED DIVERSITY CACTA, VV; Baumgratz J.F.A., 1985, ARQ JARD BOT RIO J, V27, P113; Becquer ER, 2014, PHYTOTAXA, V166, P241, DOI 10.11646/phytotaxa.166.4.1; Becquer-Granados ER, 2008, BOT REV, V74, P37, DOI 10.1007/s12229-008-9010-z; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; Celep F, 2012, SYST BOT, V37, P893, DOI 10.1600/036364412X656563; Clausing G, 2001, AM J BOT, V88, P486, DOI 10.2307/2657114; Cogniaux A.C., 1891, MONOGRAPHIAE PHANERO, P1, DOI DOI 10.5962/BHL.TITLE.45961; Davitashvili N, 2010, BOT J LINN SOC, V162, P101, DOI 10.1111/j.1095-8339.2009.01020.x; De Candolle A.P., 1828, PRODROMUS SYSTEMATIS, V3, P99; Don D., 1823, MEMOIRS WERNERIAN NA, V4, P276, DOI DOI 10.1086/703517; Donoghue MJ, 2000, AM ZOOL, V40, P759, DOI 10.1668/0003-1569(2000)040[0759:HADCAM]2.0.CO;2; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EHLER N, 1978, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V99, P329; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FARRIS JS, 1966, EVOLUTION, V20, P587, DOI 10.1111/j.1558-5646.1966.tb03389.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gamarra R, 2012, PLANT SYST EVOL, V298, P597, DOI 10.1007/s00606-011-0569-1; Gamba D, 2014, PHYTOTAXA IN PRESS; Goldenberg R, 2008, INT J PLANT SCI, V169, P963, DOI 10.1086/589697; Goldenberg R, 2012, TAXON, V61, P1040, DOI 10.1002/tax.615010; Gomez-Gonzalez S, 2011, P NATL ACAD SCI USA, V108, P18743, DOI 10.1073/pnas.1108863108; Groenendijk JP, 1996, ACTA BOT NEERL, V45, P323; HSIAO YC, 1981, AM J BOT, V68, P1155, DOI 10.2307/2443037; Hu ZB, 2013, GENETICA, V141, P247, DOI 10.1007/s10709-013-9723-8; Johnson LA, 2004, INT J PLANT SCI, V165, P153, DOI 10.1086/380748; JUDD W S, 1991, Bulletin of the Florida Museum of Natural History Biological Sciences, V36, P25; JUDD WS, 1989, ANN MO BOT GARD, V76, P476, DOI 10.2307/2399496; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Laurin M, 2004, SYST BIOL, V53, P594, DOI 10.1080/10635150490445706; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Li SY, 2000, J AM STAT ASSOC, V95, P493, DOI 10.2307/2669394; MADDISON D. R., 2005, MACCLADE 4 ANAL PHYL; Maddison WP, 2011, MESQUITE MODULAR SYS; Martin CV, 2008, CLADISTICS, V24, P315, DOI 10.1111/j.1096-0031.2007.00185.x; Martin CV, 2009, BRITTONIA, V61, P175, DOI 10.1007/s12228-008-9060-x; Mendes-Rodrigues C, 2012, PLANT BIOLOGY, V14, P845, DOI 10.1111/j.1438-8677.2011.00551.x; Mendoza H, 2006, GUIA ILUSTRADA GENER; Michelanceli FA, 2000, SYST BOT, V25, P211, DOI 10.2307/2666640; Michelangeli FA, 2004, TAXON, V53, P279, DOI 10.2307/4135608; Michelangeli FA, 2008, BOT REV, V74, P53, DOI 10.1007/s12229-008-9004-x; Moazzeni H, 2007, FLORA, V202, P447, DOI 10.1016/j.flora.2006.10.004; Muller KF, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-58; Naudin CV, 1849, ANN SCI NAT, V12-18; Neinhuis C, 1997, ANN BOT-LONDON, V79, P667, DOI 10.1006/anbo.1997.0400; Nylander JAA, 2004, MRMODELTEST VER 2; Ocampo G, 2014, PHYTOTAXA, V163, P166, DOI 10.11646/phytotaxa.163.3.3; Ocampo G, 2013, PHYTOTAXA, V80, P1; Ossi K, 2006, BEHAV ECOL SOCIOBIOL, V61, P53, DOI 10.1007/s00265-006-0236-7; Parisca L., 1972, B SOC VENEZOLANA CIE, V29, P633; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/BF02338839; REEVES JH, 1992, J MOL EVOL, V35, P17, DOI 10.1007/BF00160257; Reginato M, 2013, BRITTONIA, V65, P16, DOI 10.1007/s12228-012-9258-9; RENNER SS, 1993, NORD J BOT, V13, P519, DOI 10.1111/j.1756-1051.1993.tb00096.x; Revell LJ, 2008, SYST BIOL, V57, P591, DOI 10.1080/10635150802302427; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Simmons MP, 2002, CLADISTICS, V18, P354, DOI 10.1006/clad.2002.0201; Swenson NG, 2007, AM J BOT, V94, P451, DOI 10.3732/ajb.94.3.451; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x; Thompson K, 2003, SEED SCI RES, V13, P97, DOI 10.1079/SSR2003128; WHIFFIN T, 1972, AM J BOT, V59, P411, DOI 10.2307/2441552; Wiens JJ, 1999, ANNU REV ECOL SYST, V30, P327, DOI 10.1146/annurev.ecolsys.30.1.327; Wiens JJ, 1995, SYST BIOL, V44, P482, DOI 10.2307/2413656; Wilkinson M, 1995, CLADISTICS, V11, P297, DOI 10.1016/0748-3007(95)90017-9; Wurdack J. J., 1980, FLORA ECUADOR NO 13, P1; Wurdack J. J., 1993, FLORA GUIANAS, P1; Wurdack JJ, 1973, FLORA VENEZUELA, P1; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Zaia J. E., 1998, Acta Botanica Brasilica, V12, P221, DOI 10.1590/S0102-33061998000300004; Zanne AE, 2005, AM J BOT, V92, P972, DOI 10.3732/ajb.92.6.972	82	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100561	10.1371/journal.pone.0100561	http://dx.doi.org/10.1371/journal.pone.0100561			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955964	Green Submitted, Green Published, gold			2022-12-25	WOS:000338917900067
J	Umemura, T; Katsuyama, Y; Yoshizawa, K; Kimura, T; Joshita, S; Komatsu, M; Matsumoto, A; Tanaka, E; Ota, M				Umemura, Takeji; Katsuyama, Yoshihiko; Yoshizawa, Kaname; Kimura, Takefumi; Joshita, Satoru; Komatsu, Michiharu; Matsumoto, Akihiro; Tanaka, Eiji; Ota, Masao			Human Leukocyte Antigen Class II Haplotypes Affect Clinical Characteristics and Progression of Type 1 Autoimmune Hepatitis in Japan	PLOS ONE			English	Article							PRIMARY BILIARY-CIRRHOSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; HEPATOCELLULAR-CARCINOMA; BERYLLIUM DISEASE; PEPTIDE BINDING; AMINO-ACIDS; HLA-C; HLA-DPB1; SUSCEPTIBILITY; ALLELES	Although we earlier demonstrated that the human leukocyte antigen (HLA) DRB1*04:05 allele was associated with susceptibility to autoimmune hepatitis (AIH) in Japan, the precise relationship of HLA haplotype and the role of amino acid alignment with disease susceptibility and progression has not been fully clarified. We reinvestigated HLA class I A, B, and C and HLA class II DRB1, DQB1, and DPB1 alleles and haplotypes in a larger new cohort of 156 Japanese patients with type 1 AIH and compared them with the published data of 210 healthy subjects. The DRB1*04: 05-DQB1*04:01 haplotype was significantly associated with AIH susceptibility (30% vs. 11%, P = 1.2x10(-10); odds ratio [OR] = 3.51) and correlated with elevated serum IgG (3042 vs. 2606 mg/dL, P = 0.041) and anti-smooth muscle antigen positivity (77% vs. 34%, P = 0.000006). No associations with HLA-DPB1 alleles were found. The HLA A*24:02 and C*01:02 alleles were associated with disease susceptibility (corrected P = 0.0053 and 0.036, respectively), but this likely constituents of a long ranged haplotype including DRB1*04:05-DQB1*04:01 haplotype. Conversely, the DRB1*15:01-DQB1*06:02 haplotype was associated with protection from both disease onset (5% vs. 13%, P = 0.00057; OR = 0.38) and the development of hepatocellular carcinoma (25% vs. 5%, P = 0.017; OR = 6.81). The frequency of the DRB1*08:03-DQB1*06:01 haplotype was significantly higher in patients who developed hepatic failure (22% vs. 6%, P = 0.034; OR = 4.38). In conclusion, this study established the role of HLA haplotypes in determining AIH susceptibility and progression in the Japanese population. Additional sequencing of the entire HLA region is required to more precisely identify the genetic components of AIH.	[Umemura, Takeji; Yoshizawa, Kaname; Kimura, Takefumi; Joshita, Satoru; Komatsu, Michiharu; Matsumoto, Akihiro; Tanaka, Eiji] Shinshu Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Matsumoto, Nagano 390, Japan; [Katsuyama, Yoshihiko] Shinshu Univ Hosp, Dept Pharm, Matsumoto, Nagano, Japan; [Ota, Masao] Shinshu Univ, Sch Med, Dept Legal Med, Matsumoto, Nagano 390, Japan; [Yoshizawa, Kaname] NHO Ueda Med Ctr, Dept Gastroenterol, Ueda, Nagano, Japan	Shinshu University; Shinshu University; Shinshu University	Umemura, T (corresponding author), Shinshu Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Matsumoto, Nagano 390, Japan.	tumemura@shinshu-u.ac.jp; otamasao@shinshu-u.ac.jp	Joshita, Satoru/K-5679-2019	Joshita, Satoru/0000-0002-6364-9654; Ota, Masao/0000-0002-6400-5658	Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan [23590969]; Grants-in-Aid for Scientific Research [26460996] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by a research grant from the Ministry of Health, Labor and Welfare of Japan and the Ministry of Education, Culture, Sports, Science, and Technology of Japan (23590969). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Barber LD, 1996, J EXP MED, V184, P735, DOI 10.1084/jem.184.2.735; Czaja AJ, 1997, HEPATOLOGY, V25, P317; Czaja AJ, 2010, GASTROENTEROLOGY, V139, P58, DOI 10.1053/j.gastro.2010.04.053; DOHERTY DG, 1994, HEPATOLOGY, V19, P609, DOI 10.1002/hep.1840190311; Donaldson PT, 2006, HEPATOLOGY, V44, P667, DOI 10.1002/hep.21316; Donaldson PT, 2002, SEMIN LIVER DIS, V22, P353, DOI 10.1055/s-2002-35705; Fernando MMA, 2012, ANN RHEUM DIS, V71, P777, DOI 10.1136/annrheumdis-2011-200808; Furukawa H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053910; Gronbaek L, 2013, J HEPATOL; Heneghan MA, 2013, LANCET; Hino-Arinaga T, 2012, J GASTROENTEROL, V47, P569, DOI 10.1007/s00535-011-0519-2; Hoeroldt B, 2011, GASTROENTEROLOGY, V140, P1980, DOI 10.1053/j.gastro.2011.02.065; Invernizzi P, 2008, HEPATOLOGY, V48, P1906, DOI 10.1002/hep.22567; Krawitt EL, 2006, NEW ENGL J MED, V354, P54, DOI 10.1056/NEJMra050408; Lyons PA, 2012, NEW ENGL J MED, V367, P214, DOI 10.1056/NEJMoa1108735; Mandelboim O, 1996, J EXP MED, V184, P913, DOI 10.1084/jem.184.3.913; Migita K, 2012, LIVER INT, V32, P837, DOI 10.1111/j.1478-3231.2011.02734.x; Montano-Loza AJ, 2008, AM J GASTROENTEROL, V103, P1944, DOI 10.1111/j.1572-0241.2008.01922.x; Ngu JH, 2012, HEPATOLOGY, V55, P522, DOI 10.1002/hep.24743; NOMURA N, 1991, HUM IMMUNOL, V32, P261, DOI 10.1016/0198-8859(91)90089-R; Ohira H, 2013, J GASTROENTEROL, V48, P109, DOI 10.1007/s00535-012-0616-x; OTA M, 1991, TISSUE ANTIGENS, V38, P60, DOI 10.1111/j.1399-0039.1991.tb01882.x; OTA M, 1992, IMMUNOGENETICS, V36, P49, DOI 10.1007/BF00209292; RICHELDI L, 1993, SCIENCE, V262, P242, DOI 10.1126/science.8105536; Saito S, 2000, TISSUE ANTIGENS, V56, P522, DOI 10.1034/j.1399-0039.2000.560606.x; SEKI T, 1992, GASTROENTEROLOGY, V103, P1041, DOI 10.1016/0016-5085(92)90041-V; Shiina T, 2012, TISSUE ANTIGENS, V80, P305, DOI 10.1111/j.1399-0039.2012.01941.x; Silveira LJ, 2012, J IMMUNOL, V189, P4014, DOI 10.4049/jimmunol.1200798; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Strettell MDJ, 1997, GASTROENTEROLOGY, V112, P2028, DOI 10.1053/gast.1997.v112.pm9178696; Strettell MDJ, 1997, HEPATOLOGY, V26, P1023, DOI 10.1002/hep.510260434; Umemura T, 2006, HEPATOLOGY, V43, P91, DOI 10.1002/hep.20917; Umemura T, 2003, J INFECT DIS, V188, P1545, DOI 10.1086/379216; Umemura T, 2007, HEPATOLOGY, V46, P463, DOI 10.1002/hep.21700; Umemura T, 2012, HEPATOLOGY, V55, P506, DOI 10.1002/hep.24705; Varney MD, 2010, DIABETES, V59, P2055, DOI 10.2337/db09-0680; Xie G, 2013, ARTHRITIS RHEUM-US, V65, P2457, DOI 10.1002/art.38036; Yoshizawa K, 2005, J HEPATOL, V42, P578, DOI 10.1016/j.jhep.2004.12.019; Yoshizawa K, 2012, HEPATOLOGY, V56, P668, DOI 10.1002/hep.25658	40	42	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100565	10.1371/journal.pone.0100565	http://dx.doi.org/10.1371/journal.pone.0100565			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956105	Green Published, gold, Green Submitted			2022-12-25	WOS:000338917900068
J	Hakimi, M; Grassmann, JP; Betsch, M; Schneppendahl, J; Gehrmann, S; Hakimi, AR; Kropil, P; Sager, M; Herten, M; Wild, M; Windolf, J; Jungbluth, P				Hakimi, Mohssen; Grassmann, Jan-Peter; Betsch, Marcel; Schneppendahl, Johannes; Gehrmann, Sebastian; Hakimi, Ahmad-Reza; Kroepil, Patric; Sager, Martin; Herten, Monika; Wild, Michael; Windolf, Joachim; Jungbluth, Pascal			The Composite of Bone Marrow Concentrate and PRP as an Alternative to Autologous Bone Grafting	PLOS ONE			English	Article							PLATELET-RICH PLASMA; MESENCHYMAL STEM-CELLS; CRITICAL-SIZE DEFECTS; CONE-BEAM CT; OSTEOGENIC DIFFERENTIATION; DISTRACTION OSTEOGENESIS; AUTOGENOUS BONE; PHOSPHATE; PROLIFERATION; TRANSPLANTATION	One possible alternative to the application of autologous bone grafts represents the use of autologous bone marrow concentrate (BMC). The purpose of our study was to evaluate the potency of autologous platelet-rich plasma (PRP) in combination with BMC. In 32 mini-pigs a metaphyseal critical-size defect was surgically created at the proximal tibia. The animals were allocated to four treatment groups of eight animals each (1. BMC+CPG group, 2. BMC+CPG+PRP group, 3. autograft group, 4. CPG group). In the BMC+CPG group the defect was filled with autologous BMC in combination with calcium phosphate granules (CPG), whereas in the BMC+CPG+PRP group the defect was filled with the composite of autologous BMC, CPG and autologous PRP. In the autograft group the defect was filled with autologous cancellous graft, whereas in the CPG group the defect was filled with CPG solely. After 6 weeks radiological and histomorphometrical analysis showed significantly more new bone formation in the BMC+CPG+PRP group compared to the BMC+CPG group and the CPG group. There were no significant differences between the BMC+CPG+PRP group and the autograft group. In the PRP platelets were enriched significantly about 4.7-fold compared to native blood. In BMC the count of mononuclear cells increased significantly (3.5-fold) compared to the bone marrow aspirate. This study demonstrates that the composite of BMC+CPG+PRP leads to a significantly higher bone regeneration of critical-size defects at the proximal tibia in mini-pigs than the use of BMC+CPG without PRP. Furthermore, within the limits of the present study the composite BMC+CPG+PRP represents a comparable alternative to autologous bone grafting.	[Hakimi, Mohssen; Grassmann, Jan-Peter; Betsch, Marcel; Schneppendahl, Johannes; Gehrmann, Sebastian; Wild, Michael; Windolf, Joachim; Jungbluth, Pascal] Heinrich Heine Univ Hosp Duesseldorf, Dept Trauma & Handsurg, Dusseldorf, Germany; [Sager, Martin] Heinrich Heine Univ Hosp Duesseldorf, Anim Res Inst, Dusseldorf, Germany; [Hakimi, Ahmad-Reza] Heinrich Heine Univ Hosp Duesseldorf, Dept Oral Surg, Dusseldorf, Germany; [Herten, Monika] Heinrich Heine Univ Hosp Duesseldorf, Dept Orthopaed, Dusseldorf, Germany; [Kroepil, Patric] Heinrich Heine Univ Hosp Duesseldorf, Dept Diagnost & Intervent Radiol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Grassmann, JP (corresponding author), Heinrich Heine Univ Hosp Duesseldorf, Dept Trauma & Handsurg, Dusseldorf, Germany.	Jan.Grassmann@med.uni-duesseldorf.de	Jungbluth, Pascal/L-6703-2017; Herten, Monika/J-1547-2015	Herten, Monika/0000-0001-9697-0287; Hakimi, Ahmad-Reza/0000-0001-5393-7735; Wild, Michael/0000-0002-6306-4867	medical faculty of the Heinrich Heine University Duesseldorf, Germany [9772443]	medical faculty of the Heinrich Heine University Duesseldorf, Germany	This study was supported by a research grant (9772443) from the medical faculty of the Heinrich Heine University Duesseldorf, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrington ED, 1996, CLIN ORTHOP RELAT R, P300, DOI 10.1097/00003086-199608000-00037; Bohner M, 2004, BIOMATERIALS, V25, P3569, DOI 10.1016/j.biomaterials.2003.10.032; CASTROMALASPINA H, 1980, BLOOD, V56, P289; Chen TL, 2014, J CRANIOFAC SURG, V25, P215, DOI 10.1097/SCS.0000000000000420; Dallari D, 2007, J BONE JOINT SURG AM, V89A, P2413, DOI 10.2106/JBJS.F.01026; Dallari D, 2006, J ORTHOP RES, V24, P877, DOI 10.1002/jor.20112; Delorme Bruno, 2007, V140, P67; Duan JM, 2011, MOL BIOL REP, V38, P2485, DOI 10.1007/s11033-010-0385-7; Faour O, 2011, INJURY, V42, pS87, DOI 10.1016/j.injury.2011.06.020; Fellah BH, 2008, BIOMATERIALS, V29, P1177, DOI 10.1016/j.biomaterials.2007.11.034; Gan YK, 2008, BIOMATERIALS, V29, P3973, DOI 10.1016/j.biomaterials.2008.06.026; Hakimi M, 2010, INJURY, V41, P717, DOI 10.1016/j.injury.2009.12.005; Hatzokos I, 2011, J BONE JOINT SURG AM, V93A, P671, DOI 10.2106/JBJS.J.00514; Hermann PC, 2007, CELL TRANSPLANT, V16, P1059, DOI 10.3727/000000007783472363; Hernigou P, 2005, J BONE JOINT SURG AM, V87A, P1430, DOI 10.2106/JBJS.D.02215; Hernigou P, 2006, J BONE JOINT SURG AM, V88A, P2565, DOI 10.2106/JBJS.E.01455; Herten M, 2013, VET COMP ORTHOPAED, V26, P34, DOI 10.3415/VCOT-11-11-0165; Huang SY, 2010, ORAL SURG ORAL MED O, V110, P453, DOI 10.1016/j.tripleo.2010.02.009; Jager M, 2010, ORTHOPADE, V39, P449, DOI [10.1007/s00132-009-1583-7, 10.4081/or.2010.e20]; Jager M, 2011, J ORTHOP RES, V29, P173, DOI 10.1002/jor.21230; Jager M, 2010, J ORTHOP RES; Jager M, ORTHOPADE, V39, P463; Kasten P, 2012, CELLS TISSUES ORGANS, V196, P523, DOI 10.1159/000337490; Kasten P, 2008, J BIOMATER APPL, V23, P169, DOI 10.1177/0885328207088269; Kasten P, 2008, BIOMATERIALS, V29, P3983, DOI 10.1016/j.biomaterials.2008.06.014; Kasten P, 2006, CELLS TISSUES ORGANS, V183, P68, DOI 10.1159/000095511; Kitoh H, 2004, BONE, V35, P892, DOI 10.1016/j.bone.2004.06.013; Kitoh H, 2007, BONE, V40, P522, DOI 10.1016/j.bone.2006.09.019; Kropil P, 2012, ACAD RADIOL, V19, P320, DOI 10.1016/j.acra.2011.10.022; Kurkalli BGS, 2010, CURR STEM CELL RES T, V5, P49, DOI 10.2174/157488810790442831; Lucarelli E, 2003, BIOMATERIALS, V24, P3095, DOI 10.1016/S0142-9612(03)00114-5; Mahendra A, 2007, INJURY, V38, pS7, DOI 10.1016/S0020-1383(08)70004-4; Marx R E, 2001, Implant Dent, V10, P225; Marx RE, 2004, J ORAL MAXIL SURG, V62, P489, DOI 10.1016/j.joms.2003.12.003; Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4; Murphy MB, 2012, BIOMATERIALS, V33, P5308, DOI 10.1016/j.biomaterials.2012.04.007; Muschler GF, 2001, J ORTHOP RES, V19, P117, DOI 10.1016/S0736-0266(00)00010-3; Nagata M, 2009, BONE, V45, P339, DOI 10.1016/j.bone.2009.04.246; Riegger C, 2012, SKELETAL RADIOL, V41, P531, DOI 10.1007/s00256-011-1203-6; Rosset P, 2014, ORTHOP TRAUMATOL-SUR, V100, pS107, DOI 10.1016/j.otsr.2013.11.010; Sarkar MR, 2006, BIOMATERIALS, V27, P1817, DOI 10.1016/j.biomaterials.2005.10.039; Schlegel K A, 2003, Mund Kiefer Gesichtschir, V7, P112; Schwarz F, 2014, J CLIN PERIODONTOLOG; Tas AC, 2008, J MATER SCI-MATER M, V19, P2231, DOI 10.1007/s10856-007-3326-9; Thoesen MS, 2006, AM J VET RES, V67, P1655, DOI 10.2460/ajvr.67.10.1655; Thor A, 2007, INT J ORAL MAX SURG, V36, P1164, DOI 10.1016/j.ijom.2007.05.023; Vogl M, 2013, J ORTHOP RES, V31, P1786, DOI 10.1002/jor.22433; Weibrich G, 2004, BONE, V34, P665, DOI 10.1016/j.bone.2003.12.010; Weibrich G, 2003, CLIN ORAL IMPLAN RES, V14, P357, DOI 10.1034/j.1600-0501.2003.00810.x; Weiss P, 2003, BIOMATERIALS, V24, P4591, DOI 10.1016/S0142-9612(03)00335-1; Wiltfang J, 2004, CLIN ORAL IMPLAN RES, V15, P187, DOI 10.1111/j.1600-0501.2004.00980.x; Yamashina A, 2008, DENTOMAXILLOFAC RAD, V37, P245, DOI 10.1259/dmfr/45926904; Yoshimi R, 2009, J CRANIOFAC SURG, V20, P1523, DOI 10.1097/SCS.0b013e3181b09b7e	53	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100143	10.1371/journal.pone.0100143	http://dx.doi.org/10.1371/journal.pone.0100143			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950251	Green Submitted, Green Published, gold			2022-12-25	WOS:000338276300039
J	Masvekar, RR; El-Hage, N; Hauser, KF; Knapp, PE				Masvekar, Ruturaj R.; El-Hage, Nazira; Hauser, Kurt F.; Knapp, Pamela E.			Morphine Enhances HIV-1 (SF162)-Mediated Neuron Death and Delays Recovery of Injured Neurites	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; 3-(4,5-DIMETHYLTHIAZOL-2-YL)-2,5-DIPHENYLTETRAZOLIUM BROMIDE MTT; IMMUNODEFICIENCY VIRUS-1 TAT; CEREBROSPINAL-FLUID; STRIATAL NEURONS; DIFFERENTIAL INVOLVEMENT; ANTIRETROVIRAL THERAPY; NERVOUS-SYSTEM; G-PROTEIN; ACTIVATION	HIV-1 enters the CNS soon after initial systemic infection; within the CNS parenchyma infected and/or activated perivascular macrophages, microglia and astrocytes release viral and cellular toxins that drive secondary toxicity in neurons and other cell types. Our previous work has largely modeled HIV-neuropathology using the individual viral proteins Tat or gp120, with murine striatal neurons as targets. To model disease processes more closely, the current study uses supernatant from HIV-1-infected cells. Supernatant from HIV-1(SF162)-infected differentiated-U937 cells (HIVsup+) was collected and p24 level was measured by ELISA to assess the infection. Injection drug abuse is a significant risk factor for HIV-infection, and opiate drug abusers show increased HIV-neuropathology, even with anti-retroviral treatments. We therefore assessed HIVsup+ effects on neuronal survival and neurite growth/pruning with or without concurrent exposure to morphine, an opiate that preferentially acts through mu-opioid receptors. Effects of HIVsup+ +/- morphine were assessed on neuronal populations, and also by time-lapse imaging of individual cells. HIVsup+ caused dose-dependent toxicity over a range of p24 levels (10-500 pg/ml). Significant interactions occurred with morphine at lower p24 levels (10 and 25 pg/ml), and GSK3 beta was implicated as a point of convergence. In the presence of glia, selective neurotoxic measures were significantly enhanced and interactions with morphine were also augmented, perhaps related to a decreased level of BDNF. Importantly, the arrest of neurite growth that occurred with exposure to HIVsup+ was reversible unless neurons were continuously exposed to morphine. Thus, while reducing HIV-infection levels may be protective, ongoing exposure to opiates may limit recovery. Opiate interactions observed in this HIV-infective environment were similar, though not entirely concordant, with Tat/gp120 interactions reported previously, suggesting unique interactions with virions or other viral or cellular proteins released by infected and/or activated cells.	[Masvekar, Ruturaj R.; Knapp, Pamela E.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23284 USA; [El-Hage, Nazira; Hauser, Kurt F.; Knapp, Pamela E.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA USA; [Hauser, Kurt F.; Knapp, Pamela E.] Virginia Commonwealth Univ, Inst Drug & Alcohol Studies, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Knapp, PE (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23284 USA.	peknapp@vcu.edu	Hauser, Kurt/AAX-8361-2020; Masvekar, Ruturaj/ABD-8417-2020; Masvekar, Ruturaj/AAN-4044-2021	Hauser, Kurt/0000-0001-7886-0332	NIH \ National Institute on Drug Abuse (NIDA) [DA034231, DA027374, DA033200]; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA027374, R01DA033200, R01DA034231, R01DA036154] Funding Source: NIH RePORTER	NIH \ National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	NIH vertical bar National Institute on Drug Abuse (NIDA) - DA034231 [Knapp]; NIH vertical bar National Institute on Drug Abuse (NIDA) - DA034231 [Hauser]; NIH vertical bar National Institute on Drug Abuse (NIDA) - DA027374 [Hauser]; NIH vertical bar National Institute on Drug Abuse (NIDA) - DA033200 [Hauser]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony IC, 2010, BRAIN, V133, P3685, DOI 10.1093/brain/awq263; ARVIDSSON U, 1995, J NEUROSCI, V15, P3328; Bell JE, 2002, JAIDS-J ACQ IMM DEF, V31, pS35, DOI 10.1097/00126334-200210012-00003; Bellizzi MJ, 2006, J NEUROIMMUNE PHARM, V1, P20, DOI 10.1007/s11481-005-9006-y; Berger JR, 1997, INTERVIROLOGY, V40, P122, DOI 10.1159/000150539; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Bokhari SM, 2011, J NEUROIMMUNE PHARM, V6, P626, DOI 10.1007/s11481-011-9272-9; Bokhari SM, 2009, J NEUROVIROL, V15, P219, DOI 10.1080/13550280902913628; Bruce-Keller AJ, 2008, GLIA, V56, P1414, DOI 10.1002/glia.20708; Byrd DA, 2011, JAIDS-J ACQ IMM DEF, V58, P154, DOI 10.1097/QAI.0b013e318229ba41; Chao CC, 1997, J PHARMACOL EXP THER, V281, P998; CHENGMAYER C, 1988, ANN NEUROL, V23, pS58, DOI 10.1002/ana.410230716; Chung WS, 2013, NATURE; Crews L, 2009, INT J MOL SCI, V10, P1045, DOI 10.3390/ijms10031045; Cysique LA, 2004, J NEUROVIROL, V10, P350, DOI 10.1080/13550280490521078; Cysique LA, 2009, NEUROPSYCHOL REV, V19, P169, DOI 10.1007/s11065-009-9092-3; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; Dore GJ, 2003, AIDS, V17, P1539, DOI 10.1097/00002030-200307040-00015; Dou HY, 2005, J NEUROSCI, V25, P8375, DOI 10.1523/JNEUROSCI.2164-05.2005; Dou HY, 2003, J NEUROSCI, V23, P9162; El-Hage N, 2005, GLIA, V50, P91, DOI 10.1002/glia.20148; El-Hage N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004093; Ellis R, 2007, NAT REV NEUROSCI, V8, P33, DOI 10.1038/nrn2040; EPSTEIN LG, 1993, ANN NEUROL, V33, P429, DOI 10.1002/ana.410330502; Everall IP, 1999, BRAIN PATHOL, V9, P209; Everall IP, 2002, MOL CELL NEUROSCI, V21, P493, DOI 10.1006/mcne.2002.1196; Fitting S, 2010, AM J PATHOL, V177, P1397, DOI 10.2353/ajpath.2010.090945; Fitting S, 2010, J PROTEOME RES, V9, P1795, DOI 10.1021/pr900926n; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Garden GA, 2002, GLIA, V40, P240, DOI 10.1002/glia.10155; Gilman CP, 2002, NEUROMOL MED, V2, P197, DOI 10.1385/NMM:2:2:197; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Gurwell JA, 2001, NEUROSCIENCE, V102, P555, DOI 10.1016/S0306-4522(00)00461-9; HATTEN ME, 1988, DEV BIOL, V125, P280, DOI 10.1016/0012-1606(88)90211-4; Hauser KF, 2007, J NEUROCHEM, V100, P567, DOI 10.1111/j.1471-4159.2006.04227.x; Hauser KF, 2009, GLIA, V57, P194, DOI 10.1002/glia.20746; Hu SX, 2005, J INFECT DIS, V191, P886, DOI 10.1086/427830; Ikeda H, 2010, J BIOL CHEM, V285, P38415, DOI 10.1074/jbc.M110.109827; ISHIGURO K, 1993, FEBS LETT, V325, P167, DOI 10.1016/0014-5793(93)81066-9; Jacobs Keith M, 2012, Int J Cell Biol, V2012, P930710, DOI 10.1155/2012/930710; Johnson TP, 2013, P NATL ACAD SCI USA, V110, P13588, DOI 10.1073/pnas.1308673110; Jones G, 2005, VIROLOGY, V334, P178, DOI 10.1016/j.virol.2005.01.027; Kaytor MD, 2002, CURR OPIN NEUROBIOL, V12, P275, DOI 10.1016/S0959-4388(02)00320-3; Kim HJ, 2008, J NEUROSCI, V28, P12604, DOI 10.1523/JNEUROSCI.2958-08.2008; Kramer-Hammerle S, 2005, VIRUS RES, V111, P194, DOI 10.1016/j.virusres.2005.04.009; Kumar R, 2006, VIROLOGY, V354, P192, DOI 10.1016/j.virol.2006.06.020; Le Roux PD, 2002, NEUROL RES, V24, P81, DOI 10.1179/016164102101199459; Liu SJ, 2003, J NEUROCHEM, V87, P1333, DOI 10.1046/j.1471-4159.2003.02070.x; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; Liu YL, 2000, J NEUROVIROL, V6, pS70; Maggirwar SB, 1999, J NEUROCHEM, V73, P578, DOI 10.1046/j.1471-4159.1999.0730578.x; MANDELKOW EM, 1992, FEBS LETT, V314, P315, DOI 10.1016/0014-5793(92)81496-9; MARTINEZ AJ, 1995, PATHOL RES PRACT, V191, P427, DOI 10.1016/S0344-0338(11)80730-2; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; MCMILLIAN MK, 1995, CRIT REV NEUROBIOL, V9, P91; Miyatake M, 2009, J NEUROCHEM, V110, P662, DOI 10.1111/j.1471-4159.2009.06156.x; O'Brien SJ, 2000, IMMUNOL REV, V177, P99, DOI 10.1034/j.1600-065X.2000.17710.x; Pang XS, 2013, J NEUROIMMUNE PHARM, V8, P691, DOI 10.1007/s11481-013-9454-8; Peterson PK, 2004, J NEUROIMMUNOL, V147, P123, DOI 10.1016/j.jneuroim.2003.10.026; Petito CK, 1999, J NEUROVIROL, V5, P327, DOI 10.3109/13550289909029474; PLYTE SE, 1992, BIOCHIM BIOPHYS ACTA, V1114, P147, DOI 10.1016/0304-419X(92)90012-N; Podhaizer EM, 2012, J NEUROIMMUNE PHARM, V7, P877, DOI 10.1007/s11481-011-9326-z; Proudnikov D, 2012, J INFECT DIS, V205, P1745, DOI 10.1093/infdis/jis264; Ramage SN, 2005, NEUROPATH APPL NEURO, V31, P439, DOI 10.1111/j.1365-2990.2005.00670.x; Reid W, 2001, P NATL ACAD SCI USA, V98, P9271, DOI 10.1073/pnas.161290298; ROBERTSON JR, 1994, BRIT MED J, V309, P369, DOI 10.1136/bmj.309.6951.369; Robertson K, 2012, J NEUROVIROL, V18, P388, DOI 10.1007/s13365-012-0120-3; Robertson KR, 2007, AIDS, V21, P1915, DOI 10.1097/QAD.0b013e32828e4e27; Rogers TJ, 2003, TRENDS IMMUNOL, V24, P116, DOI 10.1016/S1471-4906(03)00003-6; ROUSSELET A, 1988, DEV BIOL, V129, P495, DOI 10.1016/0012-1606(88)90395-8; ROYAL W, 1994, ANN NEUROL, V36, P32, DOI 10.1002/ana.410360109; Sacktor N, 2002, J NEUROVIROL, V8, P115, DOI 10.1080/13550280290101094; Sargeant TJ, 2008, J NEUROCHEM, V107, P883, DOI 10.1111/j.1471-4159.2008.05671.x; SAWYNOK J, 1986, CAN J PHYSIOL PHARM, V64, P1, DOI 10.1139/y86-001; Shacklett BL, 2008, PLOS MED, V5, P16, DOI 10.1371/journal.pmed.0050013; Sheng Wen S., 1997, Archivum Immunologiae et Therapiae Experimentalis, V45, P359; SHOLL DA, 1953, J ANAT, V87, P387; Singh IN, 2005, NEUROSCIENCE, V135, P781, DOI 10.1016/j.neuroscience.2005.05.028; Singh IN, 2004, J NEUROVIROL, V10, P141, DOI 10.1080/13550280490441103; Soulie C, 2009, JAIDS-J ACQ IMM DEF, V51, P60, DOI 10.1097/QAI.0b013e31819fb903; Spudich SS, 2005, J INFECT DIS, V191, P890, DOI 10.1086/428095; Sui ZY, 2006, EUR J NEUROSCI, V23, P2623, DOI 10.1111/j.1460-9568.2006.04813.x; Suzuki M, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-78; Takayama N, 2005, J NEUROSCI, V25, P430, DOI 10.1523/JNEUROSCI.3170-04.2005; van Meerloo J, 2011, METHODS MOL BIOL, V731, P237, DOI 10.1007/978-1-61779-080-5_20; Xiong HG, 2000, J NEUROVIROL, V6, pS14; Zimmerman PA, 1997, MOL MED, V3, P23, DOI 10.1007/BF03401665; Zou SP, 2011, BRAIN, V134, P3613, DOI 10.1093/brain/awr281	88	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100196	10.1371/journal.pone.0100196	http://dx.doi.org/10.1371/journal.pone.0100196			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949623	gold, Green Published, Green Submitted			2022-12-25	WOS:000338276300048
J	Nijboer, TCW; Kollen, BJ; Kwakkel, G				Nijboer, Tanja C. W.; Kollen, Boudewijn J.; Kwakkel, Gert			The Impact of Recovery of Visuo-Spatial Neglect on Motor Recovery of the Upper Paretic Limb after Stroke	PLOS ONE			English	Article							IMPROVEMENT; IMPAIRMENT; POSTSTROKE	The aim of the current study was to investigate the longitudinal relationship between improvements of synergism and strength of the upper paretic limb and severity of visuo-spatial neglect during the first 52 weeks post-stroke. The longitudinal association between severity of VSN and motor impairment using Fugl Meyer motor score and Motricity Index of the arm was measured in an intensive repeated measurement design including 18 measurement sessions for each subject. Neglect was assessed using the letter cancellation test applied in a prospective cohort of 101 ischemic, first-ever, hemispheric stroke patients. All time-dependent measures were taken weekly, starting within 14 days post-stroke. From week 10 to 20 biweekly measurements are obtained. The longitudinal relationship of (bi)weekly time on improvement of motor functions and severity of neglect was investigated using random coefficient analysis and trend analyses. Fifty-one of the 101 stroke patients showed neglect at stroke onset. Less improvement of synergism and strength of the upper paretic limb was associated with more severe neglect. This association was most pronounced in the first 10 weeks post-stroke. The seemingly suppressive effect of neglect on upper-limb motor recovery appears to take place mainly during spontaneous neurological recovery of first 10 weeks post-stroke. This finding suggests that damage to large-scale white matter tracts of especially the perceptual-attention networks suppress recovery of other networks at distance in the brain suggesting a common underlying mechanism.	[Nijboer, Tanja C. W.] Univ Utrecht, Utrecht, Netherlands; [Nijboer, Tanja C. W.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Nijboer, Tanja C. W.] Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, Utrecht, Netherlands; [Nijboer, Tanja C. W.] Hoogstr Rehabil Ctr, Utrecht, Netherlands; [Kollen, Boudewijn J.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands; [Kwakkel, Gert] Vrije Univ Amsterdam, Med Ctr, Dept Rehabil Med, Res Inst MOVE, Amsterdam, Netherlands; [Kwakkel, Gert] Ctr Rehabil & & Rheumatol READE, Dept Neurorehabil, Amsterdam, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen; Vrije Universiteit Amsterdam	Nijboer, TCW (corresponding author), Univ Utrecht, Utrecht, Netherlands.	t.c.w.nijboer@uu.nl		Kwakkel, Gert/0000-0002-4041-4043; Nijboer, Tanja/0000-0001-6683-0267	NWO (Netherlands Organization for Scientific Research) [451-10-013]; EXPLICIT-stroke grant of ZonMw [89000001]; 4D-EEG (ERC) [291339-4D-EEG]	NWO (Netherlands Organization for Scientific Research)(Netherlands Organization for Scientific Research (NWO)); EXPLICIT-stroke grant of ZonMw; 4D-EEG (ERC)	Supported by a grant from NWO (Netherlands Organization for Scientific Research; grant 451-10-013 to TCWN, and by the EXPLICIT-stroke grant of ZonMw (grant 89000001) and 4D-EEG (ERC advanced grant 291339-4D-EEG) to GK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelros P, 2002, J REHABIL MED, V34, P215, DOI 10.1080/165019702760279206; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Buma F, 2013, RESTOR NEUROL NEUROS, V31, P707, DOI 10.3233/RNN-130332; Buxbaum LJ, 2004, NEUROLOGY, V62, P749, DOI 10.1212/01.WNL.0000113730.73031.F4; Carey LM, 2013, FUTUR NEUROL, V8, P507, DOI 10.2217/FNL.13.39; Carmichael ST, 2004, STROKE, V35, P758, DOI 10.1161/01.STR.0000117235.11156.55; Collin C, 1988, Int Disabil Stud, V10, P61; COLLIN C, 1990, J NEUROL NEUROSUR PS, V53, P576, DOI 10.1136/jnnp.53.7.576; Corbetta M, 2005, NAT NEUROSCI, V8, P1603, DOI 10.1038/nn1574; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; Deelman BG, 1981, STICHTING AFASIE NED; DUNCAN PW, 1994, STROKE, V25, P1181, DOI 10.1161/01.STR.25.6.1181; DUNCAN PW, 1992, STROKE, V23, P1084, DOI 10.1161/01.STR.23.8.1084; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; KALRA L, 1993, J AM GERIATR SOC, V41, P396, DOI 10.1111/j.1532-5415.1993.tb06947.x; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kinsbourne M., 1978, ATTENTION PERFORM, VVII, P345; Kollen B, 2005, STROKE, V36, P2676, DOI 10.1161/01.STR.0000190839.29234.50; Krakauer JW, 2012, NEUROREHAB NEURAL RE, V26, P923, DOI 10.1177/1545968312440745; Krakauer JW, 2005, SEMIN NEUROL, V25, P384, DOI 10.1055/s-2005-923533; Kwakkel G, 2004, RESTOR NEUROL NEUROS, V22, P281; Kwakkel G, 1999, LANCET, V354, P191, DOI 10.1016/S0140-6736(98)09477-X; Kwakkel G, 2006, STROKE, V37, P2348, DOI 10.1161/01.STR.0000238594.91938.1e; Kwakkel G, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-49; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Nijboer TCW, 2013, CORTEX, V49, P2021, DOI 10.1016/j.cortex.2012.11.006; Pedersen PM, 1997, ARCH PHYS MED REHAB, V78, P161, DOI 10.1016/S0003-9993(97)90258-6; PRESCOTT RJ, 1982, STROKE, V13, P641, DOI 10.1161/01.STR.13.5.641; Rasbash J, 2009, USERS GUIDE MLWIN V2, V2, P10; Rasbash J, 2009, MLWIN VERSION 21; Rasbash J, 2009, MANUAL SUPPLEMENT ML; Rengachary J, 2011, FRONT HUM NEUROSCI, V5, DOI [10.3389/fnhum.2011.00029, 10.3389/fnhum.2011.00069]; Rieck M, 2005, DISABIL REHABIL, V27, P1425, DOI 10.1080/09638280500330435; TWITCHELL TE, 1951, BRAIN, V74, P443, DOI 10.1093/brain/74.4.443; van Kordelaar J, 2013, NEUROREHAB NEURAL RE, V27, P854, DOI 10.1177/1545968313496327; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Zarahn E, 2011, CEREB CORTEX, V21, P2712, DOI 10.1093/cercor/bhr047	40	79	82	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100584	10.1371/journal.pone.0100584	http://dx.doi.org/10.1371/journal.pone.0100584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2UZ	24950224	Green Published, gold, Green Submitted			2022-12-25	WOS:000338276300094
J	Steiner, JL; Pruznak, A; Deiter, G; Navaratnarajah, M; Kutzler, L; Kimball, SR; Lang, CH				Steiner, Jennifer L.; Pruznak, Annem.; Deiter, Gina; Navaratnarajah, Maithili; Kutzler, Lydia; Kimball, Scot R.; Lang, Charles H.			Disruption of Genes Encoding eIF4E Binding Proteins-1 And-2 Does Not Alter Basal or Sepsis-Induced Changes in Skeletal Muscle Protein Synthesis in Male or Female Mice	PLOS ONE			English	Article							INSULIN-RESISTANCE; SIGNALING PATHWAY; MESSENGER-RNA; GROWTH-FACTOR; PHOSPHORYLATION; TRANSLATION; MTOR; ACTIVATION; CYTOKINE; LEUCINE	Sepsis decreases skeletal muscle protein synthesis in part by impairing mTOR activity and the subsequent phosphorylation of 4E-BP1 and S6K1 thereby controlling translation initiation; however, the relative importance of changes in these two downstream substrates is unknown. The role of 4E-BP1 (and -BP2) in regulating muscle protein synthesis was assessed in wild-type (WT) and 4E-BP1/BP2 double knockout (DKO) male mice under basal conditions and in response to sepsis. At 12 months of age, body weight, lean body mass and energy expenditure did not differ between WT and DKO mice. Moreover, in vivo rates of protein synthesis in gastrocnemius, heart and liver did not differ between DKO and WT mice. Sepsis decreased skeletal muscle protein synthesis and S6K1 phosphorylation in WT and DKO male mice to a similar extent. Sepsis only decreased 4E-BP1 phosphorylation in WT mice as no 4E-BP1/BP2 protein was detected in muscle from DKO mice. Sepsis decreased the binding of eIF4G to eIF4E in WT mice; however, eIF4E center dot eIF4G binding was not altered in DKO mice under either basal or septic conditions. A comparable sepsis-induced increase in eIF4B phosphorylation was seen in both WT and DKO mice. eEF2 phosphorylation was similarly increased in muscle from WT septic mice and both control and septic DKO mice, compared to WT control values. The sepsis-induced increase in muscle MuRF1 and atrogin-1 (markers of proteolysis) as well as TNF alpha and IL-6 (inflammatory cytokines) mRNA was greater in DKO than WT mice. The sepsis-induced decrease in myocardial and hepatic protein synthesis did not differ between WT and DKO mice. These data suggest overall basal protein balance and synthesis is maintained in muscle of mice lacking both 4E-BP1/BP2 and that sepsis-induced changes in mTOR signaling may be mediated by a down-stream mechanism independent of 4E-BP1 phosphorylation and eIF4E center dot eIF4G binding.	[Steiner, Jennifer L.; Pruznak, Annem.; Deiter, Gina; Navaratnarajah, Maithili; Kutzler, Lydia; Kimball, Scot R.; Lang, Charles H.] Penn State Coll Med, Dept Cellular & Mol Physiol & Surg, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Lang, CH (corresponding author), Penn State Coll Med, Dept Cellular & Mol Physiol & Surg, Hershey, PA 17033 USA.	clang@psu.edu			National Institutes of Health [GM38032, DK13499, DK15658]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK013499, R01DK015658, R37DK013499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM038032, R01GM038032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support for this study was provided by National Institutes of Health grants GM38032, DK13499 and DK15658. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaugh VL, 2011, MOL PSYCHIATR, V16, P569, DOI 10.1038/mp.2010.33; BLACKBURN GL, 1976, SURG CLIN N AM, V56, P1195; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Callahan Leigh Ann, 2009, Crit Care Med, V37, pS354, DOI 10.1097/CCM.0b013e3181b6e439; Constantin D, 2011, J PHYSIOL-LONDON, V589, P3883, DOI 10.1113/jphysiol.2011.206193; Demers G, 2006, SCIENCE, V312, P700, DOI 10.1126/science.1124036; Dennis MD, 2012, J BIOL CHEM, V287, P42890, DOI 10.1074/jbc.M112.404822; Fortin CF, 2011, EUR J IMMUNOL, V41, P1709, DOI 10.1002/eji.201040945; Frost RA, 2007, J APPL PHYSIOL, V103, P378, DOI 10.1152/japplphysiol.00089.2007; Frost RA, 2007, AM J PHYSIOL-ENDOC M, V292, pE501, DOI 10.1152/ajpendo.00359.2006; Frost RA, 2011, PHYSIOLOGY, V26, P83, DOI 10.1152/physiol.00044.2010; Frost RA, 2011, ENDOCRINOLOGY, V152, P151, DOI 10.1210/en.2010-0248; Frost RA, 2009, SHOCK, V32, P416, DOI 10.1097/SHK.0b013e3181a034d2; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; Hill GL, 1998, NUTRITION, V14, P557, DOI 10.1016/S0899-9007(98)00045-8; Hong-Brown LQ, 2003, AM J PHYSIOL-ENDOC M, V285, pE63, DOI 10.1152/ajpendo.00555.2002; Huang BPH, 2009, AM J PHYSIOL-HEART C, V296, pH505, DOI 10.1152/ajpheart.01105.2008; Jeschke MG, 2008, ANN SURG, V248, P387, DOI 10.1097/SLA.0b013e3181856241; Jewell JL, 2013, TRENDS BIOCHEM SCI, V38, P233, DOI 10.1016/j.tibs.2013.01.004; Kazi AA, 2011, SHOCK, V35, P117, DOI 10.1097/SHK.0b013e3181ecb57c; Kumar NB, 2010, CURR TREAT OPTION ON, V11, P107, DOI 10.1007/s11864-010-0127-z; Lang CH, 2005, J CELL BIOCHEM, V94, P419, DOI 10.1002/jcb.20311; Lang CH, 1996, AM J PHYSIOL-ENDOC M, V270, pE430, DOI 10.1152/ajpendo.1996.270.3.E430; Lang CH, 2006, MOL MED, V12, P291, DOI 10.2119/2006-00071.Lang; Lang CH, 2007, METABOLISM, V56, P49, DOI 10.1016/j.metabol.2006.08.025; Lang CH, 2010, AM J PHYSIOL-REG I, V299, pR935, DOI 10.1152/ajpregu.00297.2010; Lang CH, 2010, AM J PHYSIOL-ENDOC M, V298, pE1283, DOI 10.1152/ajpendo.00676.2009; Lang SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038910; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Nielsen KH, 2011, NUCLEIC ACIDS RES, V39, P2678, DOI 10.1093/nar/gkq1206; Nystrom G, 2009, METABOLISM, V58, P787, DOI 10.1016/j.metabol.2009.01.015; Nystrom GJ, 2008, INT J CLIN EXP MED, V1, P50; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Phillips SM, 2009, J APPL PHYSIOL, V107, P645, DOI 10.1152/japplphysiol.00452.2009; Poulin F, 1998, J BIOL CHEM, V273, P14002, DOI 10.1074/jbc.273.22.14002; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Smith IJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE762, DOI 10.1152/ajpendo.90226.2008; Thibault R, 2011, CURR OPIN CLIN NUTR, V14, P261, DOI 10.1097/MCO.0b013e3283455d60; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Vary Thomas C., 2008, V447, P343, DOI 10.1007/978-1-59745-242-7_22; vonManteuffel SR, 1997, MOL CELL BIOL, V17, P5426, DOI 10.1128/MCB.17.9.5426; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Zhai LD, 2009, J ENDOCRINOL, V203, P365, DOI 10.1677/JOE-09-0269	45	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99582	10.1371/journal.pone.0099582	http://dx.doi.org/10.1371/journal.pone.0099582			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945486	Green Published, gold, Green Submitted			2022-12-25	WOS:000340721500022
J	Vereshchaka, AL; Anokhina, LL				Vereshchaka, Alexander L.; Anokhina, Ludmila L.			Composition and Dynamics of the Black Sea Benthopelagic Plankton and Its Contribution to the Near-Shore Plankton Communities	PLOS ONE			English	Article							ENVIRONMENT CONCEPTION BAY; HYPERBENTHIC CRUSTACEANS; POPULATION BIOLOGY; NEARSHORE HABITATS; BOUNDARY-LAYER; ZOOPLANKTON; BEHAVIOR; FAUNA; SUPRABENTHOS; MYSIDS	At a shallow (7 m) near-shore sampling site in the Black Sea we analyzed composition, abundance, and biomass of benthopelagic organisms and the contribution these animals make to the total plankton. The site was monitored across several years (1996-2001; 2006-2007) whilst for 1999-2000 the seasonal variations were analysed. A total of 321 samples from Golubaja Bay near Novorossiysk (44 degrees 34'31.04 '' N, 37 degrees 58'45.11 '' E) in 1996-2007 were taken with a Judey net. The benthopelagic fauna was represented by 69 taxa, a diversity comparable to similar shelf areas. The benthopelagic component played an important role in near-shore plankton communities in the Black Sea accounting for 50% of the total zooplankton biomass at night during all seasons. Abundance and biomass of the benthopelagic animals showed seasonal fluctuations, the highest biomass being recorded during winter (>75% of the total zooplankton biomass) and early spring due to large amphipods, whilst the highest abundances occur during late summer because of numerous young stages of various taxa. Amphipods, mysids, and decapods are the main contributors to the plankton biomass and abundances. Both night and daytime samples are strongly recommended for the adequate description of the near-shore plankton communities.	[Vereshchaka, Alexander L.; Anokhina, Ludmila L.] Russian Acad Sci, PP Shirshov Oceanol Inst, Lab Struct & Dynam Plankton Communities, Moscow, Russia; [Vereshchaka, Alexander L.] Moscow State Univ Geodesy & Cartog, Dept Appl Ecol, Moscow, Russia	Russian Academy of Sciences; Shirshov Institute of Oceanology	Vereshchaka, AL (corresponding author), Russian Acad Sci, PP Shirshov Oceanol Inst, Lab Struct & Dynam Plankton Communities, Moscow, Russia.	alv@ocean.ru	Vereshchaka, Alexander L/E-6205-2014; Anokhina, Ludmila/K-6740-2014	Vereshchaka, Alexander L/0000-0002-6756-2468; Anokhina, Ludmila/0000-0001-6178-154X	Ministry of Education and Science of the Russian Federation; Program for a Basic Research of the Presidium of the Russian Academy of Sciences	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Program for a Basic Research of the Presidium of the Russian Academy of Sciences(Russian Academy of Sciences)	The studies were supported by the Ministry of Education and Science of the Russian Federation and by the Program for a Basic Research of the Presidium of the Russian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMI L, 1976, J GEOPHYS RES-OC ATM, V81, P4983, DOI 10.1029/JC081i027p04983; Beyst B, 2001, ESTUAR COAST SHELF S, V53, P877, DOI 10.1006/ecss.2001.0808; BOYSEN HO, 1977, MEERESFORSCHUNG, V25, P54; BUHLJENSEN L, 1991, MAR BIOL, V109, P245, DOI 10.1007/BF01319393; Carleton JH, 2007, MAR ECOL PROG SER, V336, P77, DOI 10.3354/meps336077; Cartes JE, 2001, DEEP-SEA RES PT I, V48, P2209, DOI 10.1016/S0967-0637(01)00012-7; Cartes JE, 2007, ESTUAR COAST SHELF S, V75, P501, DOI 10.1016/j.ecss.2007.05.047; Chukhchin VD, 1960, P SEVASTOPOL BIOL ST, V13, P89; Dauvin JC, 1996, J MAR BIOL ASSOC UK, V76, P909, DOI 10.1017/S0025315400040881; Dauvin JC, 2008, MAR POLLUT BULL, V56, P77, DOI 10.1016/j.marpolbul.2007.09.041; Demidov AB, 2008, OCEANOLOGY+, V48, P664, DOI 10.1134/S0001437008050068; Dewicke A, 2002, J SEA RES, V47, P121, DOI 10.1016/S1385-1101(02)00106-5; Dolgopolskaia M. A., 1940, Travaux de la Station Biologique de Karadagh, VNo. 6, P57; Dyakonov V.Y., 2002, OCEANOLOGICAL STUDIE, P111; Fanelli E, 2009, J SEA RES, V61, P174, DOI 10.1016/j.seares.2008.10.005; FOSSA JH, 1985, SARSIA, V70, P297, DOI 10.1080/00364827.1985.10419684; GRANT J, 1980, MAR BIOL, V56, P79, DOI 10.1007/BF00390597; Greenwood Jack G., 2002, Plankton Biology and Ecology, V49, P17; Greze V.N., 1971, BIOL MORYA-VLAD+, V24, P12; GRICE G D, 1972, Crustaceana (Leiden), V23, P219, DOI 10.1163/156854072X00138; GRICE G D, 1970, Bulletin of the Museum of Comparative Zoology, V139, P185; HAGERMAN L, 1986, MAR ECOL PROG SER, V34, P125, DOI 10.3354/meps034125; HAMMER R M, 1979, Bulletin Southern California Academy of Sciences, V78, P199; Hesthagen IH, 1978, KIELER MEERESFORSCH, V27, P19; HUBERDEAU L, 1982, MAR BIOL, V69, P331, DOI 10.1007/BF00397498; KAARTVEDT S, 1989, MAR ECOL PROG SER, V57, P119, DOI 10.3354/meps057119; KISELEVA M I, 1967, Zoologicheskii Zhurnal, V46, P764; Klyucharev KV, 1952, P KARADAG BIOL STATI, V12, P78; Kouassi E, 2006, ESTUAR COAST SHELF S, V67, P355, DOI 10.1016/j.ecss.2005.10.019; Kringel K, 2003, LIMNOL OCEANOGR, V48, P1223, DOI 10.4319/lo.2003.48.3.1223; Kusmorskaya AP, 1955, P SOVIET HYDROBIOL S, V6, P158; Lebedeva LP, 2003, OCEANOLOGY+, V43, P670; MACQUART-MOULIN C, 1984, Tethys, V11, P171; MACQUARTMOULIN C, 1995, J PLANKTON RES, V17, P531, DOI 10.1093/plankt/17.3.531; Makarov A. C., 1938, Zool J Moscow, V17, P1055; Marshall N.B., 1977, VOVAGE DISCOVERY, P483; Mees J, 1993, NETHERLAND J AQUATIC, V27, P2; Melo PAMC, 2010, MAR BIOL RES, V6, P530, DOI 10.1080/17451000903426557; Mordukhai-Boltovskoi F.D., 1968, KEY FAUNA BLACK SEA, V1; Mordukhai-Boltovskoi F.D., 1969, KEY FAUNA BLACK SEA, V2; Mordukhai-Boltovskoi FD, 1972, KEY FAUNA BLACK SEA, V2; Nikitin VN, 1939, PLANKTON BATUMI BAY; Pasternak A.F., 1983, P139; Pitt KA, 2008, ESTUAR COAST SHELF S, V76, P827, DOI 10.1016/j.ecss.2007.08.011; Richoux NB, 2004, MAR BIOL, V144, P881, DOI 10.1007/s00227-003-1249-7; Richoux NB, 2004, MAR BIOL, V144, P895, DOI 10.1007/s00227-003-1250-1; Roast SD, 2002, MAR ECOL PROG SER, V237, P185, DOI 10.3354/meps237185; ROBERTSON AI, 1987, MAR BIOL, V96, P193, DOI 10.1007/BF00427019; ROBERTSON AI, 1988, MAR ECOL PROG SER, V43, P139, DOI 10.3354/meps043139; SanVicente C, 1995, SCI MAR, V59, P71; SORBE J-C, 1989, Scientia Marina, V53, P335; TULLY O, 1986, J MAR BIOL ASSOC UK, V66, P931, DOI 10.1017/S0025315400048530; TULLY O, 1987, Irish Naturalists' Journal, V22, P190; TULLY O, 1987, P ROY IRISH ACAD B, V87, P43; Vallet C, 1998, J MAR BIOL ASSOC UK, V78, P387, DOI 10.1017/S0025315400041527; Vereshchaka A. L., 2000, THE DEEP SEA BENTHOP; Vereshchaka AL, 2002, CAH BIOL MAR, V43, P303; VERESHCHAKA AL, 1995, DEEP-SEA RES PT I, V42, P1639, DOI 10.1016/0967-0637(95)00065-E; Vereshchaka AL, 2000, GALATHEA REP, V19, P1; Vereshchaka AL, 2009, GALATHEA REP, V22, P1; Vinogradov KA, 1931, P KARADAG BIOL STA, V4, P5; Vinogradov KA, 1949, P KARADAG BIOL STA, V8, P1; Vinogradov M. E., 1970, VERTICAL DISTRIBUTIO; Vinogradov ME, 2005, OCEANOLOGY+, V45, P356; Vinogradov ME, 1980, PELAGIC ECOSYSTEMS B, P179; Williams AB, 1972, CHESAPEAKE SCI, V44, P171; WISHNER KF, 1980, DEEP-SEA RES, V27, P203, DOI 10.1016/0198-0149(80)90012-6; Yahel R, 2005, LIMNOL OCEANOGR, V50, P930, DOI 10.4319/lo.2005.50.3.0930; Yoshida T., 2012, P 2012 15 INT C ELEC, P1; Zaitsev YP, 1962, ENV STUDIES, V104, P107; ZAITSEV YU. P., 1961, ZOOL ZHUR, V40, P818; Zakhvatkina KA, 1959, P SEVASTOPOL BIOL ST, V11, P108; Zakutsky V.P., 1965, J HYDROBIOL, V1, P63; Zakutsky V. P., 1965, 1 C VGBO PROBL HYDR, P163; Zakutsky VP, 1965, OCEANOLOGY, V5, P495	75	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99595	10.1371/journal.pone.0099595	http://dx.doi.org/10.1371/journal.pone.0099595			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945680	Green Published, Green Submitted, gold			2022-12-25	WOS:000340721500024
J	Mukherjee, N; Jose, MD; Birkner, JP; Walko, M; Ingolfsson, HI; Dimitrova, A; Arnarez, C; Marrink, SJ; Kocer, A				Mukherjee, Nobina; Jose, Mac Donald; Birkner, Jan Peter; Walko, Martin; Ingolfsson, Helgi I.; Dimitrova, Anna; Arnarez, Clement; Marrink, Siewert J.; Kocer, Armagan			The activation mode of the mechanosensitive ion channel, MscL, by lysophosphatidylcholine differs from tension-induced gating	FASEB JOURNAL			English	Article						spectroscopy; protein-lipid interaction; mechanosensation; critical micelle concentration of LPC	COARSE-GRAINED MODEL; ESCHERICHIA-COLI; MOLECULAR-DYNAMICS; MEMBRANE-PROTEINS; MYCOBACTERIUM-TUBERCULOSIS; FUNCTIONAL RECONSTITUTION; LIPID-BILAYERS; SINGLE RESIDUE; FORCE-FIELD; SIMULATIONS	One of the best-studied mechanosensitive channels is the mechanosensitive channel of large conductance (MscL). MscL senses tension in the membrane evoked by an osmotic down shock and directly couples it to large conformational changes leading to the opening of the channel. Spectroscopic techniques offer unique possibilities to monitor these conformational changes if it were possible to generate tension in the lipid bilayer, the native environment of MscL, during the measurements. To this end, asymmetric insertion of L-alpha-lysophosphatidylcholine (LPC) into the lipid bilayer has been effective; however, how LPC activates MscL is not fully understood. Here, the effects of LPC on tension-sensitive mutants of a bacterial MscL and on MscL homologs with different tension sensitivities are reported, leading to the conclusion that the mode of action of LPC is different from that of applied tension. Our results imply that LPC shifts the free energy of gating by interfering with MscL-membrane coupling. Furthermore, we demonstrate that the fine-tuned addition of LPC can be used for controlled activation of MscL in spectroscopic studies.	[Mukherjee, Nobina; Jose, Mac Donald; Birkner, Jan Peter; Walko, Martin; Ingolfsson, Helgi I.; Dimitrova, Anna; Arnarez, Clement; Marrink, Siewert J.; Kocer, Armagan] Univ Groningen, Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [Birkner, Jan Peter] Univ Groningen, Zernike Inst Adv Mat, Groningen, Netherlands; [Kocer, Armagan] Univ Groningen, Univ Med Ctr Groningen, Neurosci Dept, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Kocer, A (corresponding author), Univ Med Ctr Groningen, Antonius Deusinglaan 1,Bldg 3215, NL-9713 AV Groningen, Netherlands.	a.kocer@umcg.nl	Marrink, Siewert J/G-3706-2014; Birkner, Jan Peter/E-8316-2014; Institute, Zernike/W-7033-2019; Ingolfsson, Helgi I./AAQ-5946-2020	Marrink, Siewert J/0000-0001-8423-5277; Ingolfsson, Helgi I./0000-0002-7613-9143; kocer, Armagan/0000-0001-7343-3139; Birkner, Jan Peter/0000-0002-5536-2274; Walko, Martin/0000-0002-7160-6136; Mukherjee, Nobina/0000-0003-4655-2188	Netherlands Organization for Scientific Research; European Research Council-Ideas Program [208814]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council-Ideas Program	The authors thank G. T. Robillard for critical reading of the manuscript. This work was supported by a Rubicon grant from the Netherlands Organization for Scientific Research (to H.I.I.) and European Research Council-Ideas Program Starting Grant 208814 (to A.K.). Author contributions: N.M. and A.K. designed the research; N.M. performed fluorescence experiments and analyzed data; M.D.J. and J.P.B. performed patch-clamp experiments; N.M. and A.K. analyzed patch-clamp data; A.D. performed EPR experiments; N.M. and M.W. designed the CMC experiment; N.M. determined the CMC of LPC; C.A., H.I.I., and S.J.M. performed and analyzed MD simulations; and N.M. and A.K. wrote the manuscript with input from all coauthors. The authors declare no conflicts of interest.	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Betanzos M, 2002, NAT STRUCT BIOL, V9, P704, DOI 10.1038/nsb828; Birkner JP, 2012, P NATL ACAD SCI USA, V109, P12944, DOI 10.1073/pnas.1205270109; Blount P, 1999, TRENDS MICROBIOL, V7, P420, DOI 10.1016/S0966-842X(99)01594-2; Blount P, 1996, P NATL ACAD SCI USA, V93, P11652, DOI 10.1073/pnas.93.21.11652; Bordignon E, 2012, TOP CURR CHEM, V321, P121, DOI 10.1007/128_2011_243; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Chiang CS, 2004, BIOPHYS J, V86, P2846, DOI 10.1016/S0006-3495(04)74337-4; Corry B, 2010, J GEN PHYSIOL, V136, P483, DOI 10.1085/jgp.200910376; Cruickshank CC, 1997, BIOPHYS J, V73, P1925, DOI 10.1016/S0006-3495(97)78223-7; Dominguez A, 1997, J CHEM EDUC, V74, P1227, DOI 10.1021/ed074p1227; Esteban-Martin S, 2009, J AM CHEM SOC, V131, P15194, DOI 10.1021/ja904450t; Folgering JHA, 2005, J BIOL CHEM, V280, P8784, DOI 10.1074/jbc.M411732200; Girard P, 2004, BIOPHYS J, V87, P419, DOI 10.1529/biophysj.104.040360; Gullingsrud J, 2004, BIOPHYS J, V86, P3496, DOI 10.1529/biophysj.103.034322; Gullingsrud J, 2001, BIOPHYS J, V80, P2074, DOI 10.1016/S0006-3495(01)76181-4; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HASE CC, 1995, J BIOL CHEM, V270, P18329, DOI 10.1074/jbc.270.31.18329; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kocer A, 2007, NAT PROTOC, V2, P1426, DOI 10.1038/nprot.2007.196; Kung C, 2010, ANNU REV MICROBIOL, V64, P313, DOI 10.1146/annurev.micro.112408.134106; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Louhivuori M, 2010, P NATL ACAD SCI USA, V107, P19856, DOI 10.1073/pnas.1001316107; Lundbaek JA, 2010, J R SOC INTERFACE, V7, P373, DOI 10.1098/rsif.2009.0443; Machiyama H, 2009, BIOPHYS J, V97, P1048, DOI 10.1016/j.bpj.2009.05.021; Maingret F, 2000, J BIOL CHEM, V275, P10128, DOI 10.1074/jbc.275.14.10128; MANDERSLOOT JG, 1975, BIOCHIM BIOPHYS ACTA, V382, P22, DOI 10.1016/0005-2736(75)90368-5; Markin VS, 2004, PHYS BIOL, V1, P110, DOI 10.1088/1478-3967/1/2/007; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; Marsh D, 2008, BBA-BIOMEMBRANES, V1778, P1545, DOI 10.1016/j.bbamem.2008.01.015; MARTINAC B, 1990, NATURE, V348, P261, DOI 10.1038/348261a0; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; Maurer JA, 2000, J BIOL CHEM, V275, P22238, DOI 10.1074/jbc.M003056200; Mika JT, 2013, FASEB J, V27, P882, DOI 10.1096/fj.12-214361; Moe PC, 2000, J BIOL CHEM, V275, P31121, DOI 10.1074/jbc.M002971200; Moe PC, 1998, MOL MICROBIOL, V28, P583, DOI 10.1046/j.1365-2958.1998.00821.x; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; MORRIS DAN, 1980, BIOCHIM BIOPHYS ACTA, V599, P380, DOI 10.1016/0005-2736(80)90185-6; Nomura T, 2012, P NATL ACAD SCI USA, V109, P8770, DOI 10.1073/pnas.1200051109; Ollila OHS, 2011, BIOPHYS J, V100, P1651, DOI 10.1016/j.bpj.2011.02.027; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992; Sachs F, 2010, PHYSIOLOGY, V25, P50, DOI 10.1152/physiol.00042.2009; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Sukharev S, 2001, BIOPHYS J, V81, P917, DOI 10.1016/S0006-3495(01)75751-7; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; SUKHAREV SI, 1993, BIOPHYS J, V65, P177, DOI 10.1016/S0006-3495(93)81044-0; van den Bogaart G, 2007, BIOPHYS J, V92, P1233, DOI 10.1529/biophysj.106.088708; Vasquez V, 2008, SCIENCE, V321, P1210, DOI 10.1126/science.1159674; Wiggins P, 2004, P NATL ACAD SCI USA, V101, P4071, DOI 10.1073/pnas.0307804101; Yefimov S, 2008, BIOPHYS J, V94, P2994, DOI 10.1529/biophysj.107.119966; Yoo J, 2009, BIOPHYS J, V97, P2267, DOI 10.1016/j.bpj.2009.07.051; Yoshimura K, 1999, BIOPHYS J, V77, P1960, DOI 10.1016/S0006-3495(99)77037-2; Yoshimura K, 2010, J R SOC INTERFACE, V7, pS307, DOI 10.1098/rsif.2010.0095.focus; Zhelev DV, 1998, BIOPHYS J, V75, P321, DOI 10.1016/S0006-3495(98)77516-2	62	32	32	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4292	4302		10.1096/fj.14-251579	http://dx.doi.org/10.1096/fj.14-251579			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	24958207	Green Published			2022-12-25	WOS:000342222700009
J	Lackey, SWK; Taylor, RD; Go, NE; Wong, A; Sherman, EL; Nargang, FE				Lackey, Sebastian W. K.; Taylor, Rebecca D.; Go, Nancy E.; Wong, Annie; Sherman, E. Laura; Nargang, Frank E.			Evidence Supporting the 19 beta-Strand Model for Tom40 from Cysteine Scanning and Protease Site Accessibility Studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER MITOCHONDRIAL-MEMBRANE; BLUE NATIVE ELECTROPHORESIS; BARREL PROTEINS; IMPORT PORE; CHANNEL; VDAC; COMPLEX; TRANSLOCASE; TOPOLOGY; SELECTIVITY	Most proteins found in mitochondria are translated in the cytosol and enter the organelle via the TOM complex (translocase of the outer mitochondrial membrane). Tom40 is the pore forming component of the complex. Although the three-dimensional structure of Tom40 has not been determined, the structure of porin, a related protein, has been shown to be a beta-barrel containing 19 membrane spanning beta-trands and an N-terminal alpha-helical region. The evolutionary relationship between the two proteins has allowed modeling of Tom40 into a similar structure by several laboratories. However, it has been suggested that the 19-strand porin structure does not represent the native form of the protein. If true, modeling of Tom40 based on the porin structure would also be invalid. We have used substituted cysteine accessibility mapping to identify several potential beta-trands in the Tom40 protein in isolated mitochondria. These data, together with protease accessibility studies, support the 19 beta-strand model for Tom40 with the C-terminal end of the protein localized to the intermembrane space.	[Lackey, Sebastian W. K.; Taylor, Rebecca D.; Go, Nancy E.; Wong, Annie; Sherman, E. Laura; Nargang, Frank E.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada	University of Alberta	Nargang, FE (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada.	frank.nargang@ualberta.ca			Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the Canadian Institutes of Health Research and Natural Sciences and Engineering Research Council (to F. E. N.).	Ahting U, 1999, J CELL BIOL, V147, P959, DOI 10.1083/jcb.147.5.959; Ahting U, 2001, J CELL BIOL, V153, P1151, DOI 10.1083/jcb.153.6.1151; BAKER KP, 1990, NATURE, V348, P605, DOI 10.1038/348605a0; Bay DC, 2012, BBA-BIOMEMBRANES, V1818, P1502, DOI 10.1016/j.bbamem.2011.11.027; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Becker L, 2005, J MOL BIOL, V353, P1011, DOI 10.1016/j.jmb.2005.09.019; Becker T, 2012, TRENDS BIOCHEM SCI, V37, P85, DOI 10.1016/j.tibs.2011.11.004; BLACHLYDYSON E, 1990, SCIENCE, V247, P1233, DOI 10.1126/science.1690454; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Colombini M, 2012, CHEM REV, V112, P6373, DOI 10.1021/cr3002033; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Colombini M, 2009, TRENDS BIOCHEM SCI, V34, P382, DOI 10.1016/j.tibs.2009.05.001; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; Dudek J, 2013, BBA-MOL CELL RES, V1833, P274, DOI 10.1016/j.bbamcr.2012.05.028; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; Gessmann D, 2011, BBA-BIOENERGETICS, V1807, P1647, DOI 10.1016/j.bbabio.2011.08.006; GOOD AG, 1989, PLANT PHYSIOL, V90, P1305, DOI 10.1104/pp.90.4.1305; Harbauer AB, 2014, CELL METAB, V19, P357, DOI 10.1016/j.cmet.2014.01.010; HARKNESS TAA, 1994, J CELL BIOL, V124, P637, DOI 10.1083/jcb.124.5.637; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hiller S, 2010, TRENDS BIOCHEM SCI, V35, P514, DOI 10.1016/j.tibs.2010.03.005; Hoogenraad NJ, 2002, BBA-MOL CELL RES, V1592, P97, DOI 10.1016/S0167-4889(02)00268-9; Hoppins SC, 2004, J BIOL CHEM, V279, P12396, DOI 10.1074/jbc.M313037200; Hoppins SC, 2007, GENETICS, V177, P137, DOI 10.1534/genetics.107.075051; Imai K, 2008, CELL, V135, P1158, DOI 10.1016/j.cell.2008.12.017; Kunkele KP, 1998, J BIOL CHEM, V273, P31032, DOI 10.1074/jbc.273.47.31032; Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; Mager F, 2011, J MEMBRANE BIOL, V242, P11, DOI 10.1007/s00232-011-9372-8; McDonald BM, 2009, FEBS LETT, V583, P739, DOI 10.1016/j.febslet.2009.01.039; Model K, 2002, J MOL BIOL, V316, P657, DOI 10.1006/jmbi.2001.5365; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Model K, 2008, J MOL BIOL, V383, P1049, DOI 10.1016/j.jmb.2008.07.087; Nargang Frank E, 2007, Methods Mol Biol, V372, P107, DOI 10.1007/978-1-59745-365-3_8; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Perry AJ, 2008, PLANT PHYSIOL BIOCH, V46, P265, DOI 10.1016/j.plaphy.2007.12.012; Pusnik M, 2009, MOL BIOL EVOL, V26, P671, DOI 10.1093/molbev/msn288; Qiu J, 2013, CELL, V154, P596, DOI 10.1016/j.cell.2013.06.033; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Sherman EL, 2006, J BIOL CHEM, V281, P22554, DOI 10.1074/jbc.M601630200; Sherman EL, 2005, MOL BIOL CELL, V16, P4172, DOI 10.1091/mbc.E05-03-0187; Song JM, 1996, J BIOENERG BIOMEMBR, V28, P153, DOI 10.1007/BF02110646; Song JM, 1998, J BIOL CHEM, V273, P24406, DOI 10.1074/jbc.273.38.24406; Summers WAT, 2010, BIOCHEM CELL BIOL, V88, P425, DOI [10.1139/O09-115, 10.1139/o09-115]; Taylor RD, 2003, J BIOL CHEM, V278, P765, DOI 10.1074/jbc.M208083200; THOMAS L, 1993, P NATL ACAD SCI USA, V90, P5446, DOI 10.1073/pnas.90.12.5446; THOMAS L, 1991, J STRUCT BIOL, V106, P161, DOI 10.1016/1047-8477(91)90085-B; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Wideman JG, 2010, MOL BIOL CELL, V21, P1725, DOI 10.1091/mbc.E09-10-0844; Zeth K, 2010, BBA-BIOENERGETICS, V1797, P1292, DOI 10.1016/j.bbabio.2010.04.019	56	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21640	21650		10.1074/jbc.M114.578765	http://dx.doi.org/10.1074/jbc.M114.578765			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24947507	hybrid, Green Published			2022-12-25	WOS:000340558300038
J	Lukacs, P; Gawali, VS; Cervenka, R; Ke, S; Koenig, X; Rubi, L; Zarrabi, T; Hilber, K; Stary-Weinzinger, A; Todt, H				Lukacs, Peter; Gawali, Vaibhavkumar S.; Cervenka, Rene; Ke, Song; Koenig, Xaver; Rubi, Lena; Zarrabi, Touran; Hilber, Karlheinz; Stary-Weinzinger, Anna; Todt, Hannes			Exploring the Structure of the Voltage-gated Na+ Channel by an Engineered Drug Access Pathway to the Receptor Site for Local Anesthetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL; SELECTIVITY FILTER; CRYSTAL-STRUCTURE; BINDING-SITE; MOLECULAR DETERMINANTS; SLOW INACTIVATION; IONIC SELECTIVITY; LIDOCAINE BLOCK; SEGMENT IVS6; PORE	Despite the availability of several crystal structures of bacterial voltage-gated Na+ channels, the structure of eukaryotic Na+ channels is still undefined. We used predictions from available homology models and crystal structures to modulate an external access pathway for the membrane-impermeant local anesthetic derivative QX-222 into the internal vestibule of the mammalian rNa(V)1.4 channel. Potassium channel-based homology models predict amino acid Ile-1575 in domain IV segment 6 to be in close proximity to Lys-1237 of the domain III pore-loop selectivity filter. The mutation K1237E has been shown previously to increase the diameter of the selectivity filter. We found that an access pathway for external QX-222 created by mutations of Ile-1575 was abolished by the additional mutation K1237E, supporting the notion of a close spatial relationship between sites 1237 and 1575. Crystal structures of bacterial voltage-gated Na+ channels predict that the side chain of rNa(V)1.4 Trp-1531 of the domain IV pore-loop projects into the space between domain IV segment 6 and domain III pore-loop and, therefore, should obstruct the putative external access pathway. Indeed, mutations W1531A and W1531G allowed for exceptionally rapid access of QX-222. In addition, W1531G created a second non-selective ion-conducting pore, bypassing the outer vestibule but probably merging into the internal vestibule, allowing for control by the activation gate. These data suggest a strong structural similarity between bacterial and eukaryotic voltage-gated Na+ channels.	[Lukacs, Peter; Gawali, Vaibhavkumar S.; Cervenka, Rene; Koenig, Xaver; Rubi, Lena; Zarrabi, Touran; Hilber, Karlheinz; Todt, Hannes] Med Univ Vienna, Dept Neurophysiol & Neuropharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria; [Ke, Song; Stary-Weinzinger, Anna] Univ Vienna, Dept Pharmacol & Toxicol, A-1090 Vienna, Austria	Medical University of Vienna; University of Vienna	Todt, H (corresponding author), Med Univ Vienna, Dept Neurophysiol & Neuropharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria.	hannes.todt@meduniwien.ac.at	Gawali, Vaibhavkumar/AAZ-3459-2021; Koenig, Xaver/Y-5588-2019; Stary-Weinzinger, Anna/A-3629-2014	Gawali, Vaibhavkumar/0000-0002-7917-4913; Koenig, Xaver/0000-0002-2423-4966; Stary-Weinzinger, Anna/0000-0002-9202-0484; Rubi, Lena/0000-0003-4793-3724; Hilber, Karlheinz/0000-0002-3033-0874	Austrian Science Fund (FWF) [P210006-B11, W1232-B11]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by Austrian Science Fund (FWF) Grants P210006-B11 and W1232-B11.	ALPERT LA, 1989, AM J PHYSIOL, V257, pH79, DOI 10.1152/ajpheart.1989.257.1.H79; Amin AS, 2005, ACTA PHYSIOL SCAND, V185, P291, DOI 10.1111/j.1365-201X.2005.01496.x; Bai CX, 2003, NEUROSCI LETT, V337, P41, DOI 10.1016/S0304-3940(02)01288-0; Balser JR, 1996, J CLIN INVEST, V98, P2874, DOI 10.1172/JCI119116; BEAN BP, 1983, J GEN PHYSIOL, V81, P613, DOI 10.1085/jgp.81.5.613; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Boehm S, 1999, J NEUROSCI, V19, P737; Bruhova I, 2008, MOL PHARMACOL, V74, P1033, DOI 10.1124/mol.108.049759; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chiamvimonvat N, 1996, NEURON, V16, P1037, DOI 10.1016/S0896-6273(00)80127-0; Cordomi A, 2012, J CHEM THEORY COMPUT, V8, P948, DOI 10.1021/ct200491c; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dudley SC, 1995, BIOPHYS J, V69, P1657, DOI 10.1016/S0006-3495(95)80045-7; Fan Z, 1996, J PHYSIOL-LONDON, V496, P275, DOI 10.1113/jphysiol.1996.sp021684; Favre I, 1996, BIOPHYS J, V71, P3110, DOI 10.1016/S0006-3495(96)79505-X; Fozzard HA, 2010, MAR DRUGS, V8, P219, DOI 10.3390/md8020219; FRAZIER DT, 1970, J PHARMACOL EXP THER, V171, P45; Fukuda K, 2005, J PHYSIOL-LONDON, V564, P21, DOI 10.1113/jphysiol.2004.081646; Furini S, 2009, PROTEINS, V74, P437, DOI 10.1002/prot.22163; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang CJ, 2001, BIOPHYS J, V80, P1262, DOI 10.1016/S0006-3495(01)76102-4; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Ke S, 2013, BIOCHEM BIOPH RES CO, V430, P1272, DOI 10.1016/j.bbrc.2012.12.055; Knape K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028778; Kutzner C, 2011, BIOPHYS J, V101, P809, DOI 10.1016/j.bpj.2011.06.010; Lee PJ, 2001, CIRC RES, V89, P1014, DOI 10.1161/hh2301.100002; Lipkind GM, 2000, BIOCHEMISTRY-US, V39, P8161, DOI 10.1021/bi000486w; McCusker EC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2077; MCPHEE JC, 1994, P NATL ACAD SCI USA, V91, P12346, DOI 10.1073/pnas.91.25.12346; MCPHEE JC, 1995, J BIOL CHEM, V270, P12025, DOI 10.1074/jbc.270.20.12025; O'Reilly JP, 2000, BIOPHYS J, V78, P773, DOI 10.1016/S0006-3495(00)76635-5; Ong BH, 2000, J GEN PHYSIOL, V116, P653, DOI 10.1085/jgp.116.5.653; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Prutting S, 2011, J BIOL CHEM, V286, P20031, DOI 10.1074/jbc.M110.185405; QU YS, 1995, P NATL ACAD SCI USA, V92, P11839, DOI 10.1073/pnas.92.25.11839; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; Sasaki K, 2004, MOL PHARMACOL, V66, P330, DOI 10.1124/mol.66.2.330; Schlief T, 1996, EUR BIOPHYS J BIOPHY, V25, P75, DOI 10.1007/s002490050020; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; STRICHARTZ GR, 1973, J GEN PHYSIOL, V62, P37, DOI 10.1085/jgp.62.1.37; Sun YM, 1997, J GEN PHYSIOL, V110, P693, DOI 10.1085/jgp.110.6.693; Sunami A, 2000, P NATL ACAD SCI USA, V97, P2326, DOI 10.1073/pnas.030438797; Sunami A, 2001, MOL PHARMACOL, V59, P684, DOI 10.1124/mol.59.4.684; Sunami A, 1997, P NATL ACAD SCI USA, V94, P14126, DOI 10.1073/pnas.94.25.14126; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; Tikhonov DB, 2005, BIOPHYS J, V88, P184, DOI 10.1529/biophysj.104.048173; Tikhonov DB, 2012, MOL PHARMACOL, V82, P97, DOI 10.1124/mol.112.078212; Todt H, 1999, BIOPHYS J, V76, P1335, DOI 10.1016/S0006-3495(99)77296-6; Tsang SY, 2005, MOL PHARMACOL, V67, P424, DOI 10.1124/mol.67.2.424; Tsushima RG, 1997, J GEN PHYSIOL, V109, P463, DOI 10.1085/jgp.109.4.463; Wang SY, 2003, BIOPHYS J, V85, P911, DOI 10.1016/S0006-3495(03)74530-5; Yang YC, 2009, J GEN PHYSIOL, V134, P95, DOI 10.1085/jgp.200810158; Zarrabi T, 2010, J BIOL CHEM, V285, P39458, DOI 10.1074/jbc.M110.132886; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	58	6	6	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21770	21781		10.1074/jbc.M113.541763	http://dx.doi.org/10.1074/jbc.M113.541763			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24947510	hybrid, Green Published			2022-12-25	WOS:000340558300050
J	Butterworth, MB; Zhang, L; Liu, XN; Shanks, RM; Thibodeau, PH				Butterworth, Michael B.; Zhang, Liang; Liu, Xiaoning; Shanks, Robert M.; Thibodeau, Patrick H.			Modulation of the Epithelial Sodium Channel (ENaC) by Bacterial Metalloproteases and Protease Inhibitors	PLOS ONE			English	Article							AERUGINOSA ALKALINE PROTEASE; SURFACE LIQUID VOLUME; PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS; CRYSTAL-STRUCTURE; SERRATIA-MARCESCENS; VIRULENCE FACTORS; ESCHERICHIA-COLI; AIRWAY EPITHELIA; EXOTOXIN-A	The serralysin family of metalloproteases is associated with the virulence of multiple gram-negative human pathogens, including Pseudomonas aeruginosa and Serratia marcescens. The serralysin proteases share highly conserved catalytic domains and show evolutionary similarity to the mammalian matrix metalloproteases. Our previous studies demonstrated that alkaline protease (AP) from Pseudomonas aeruginosa is capable of activating the epithelial sodium channel (ENaC), leading to an increase in sodium absorption in airway epithelia. The serralysin proteases are often co-expressed with endogenous, intracellular or periplasmic inhibitors, which putatively protect the bacterium from unwanted or unregulated protease activities. To evaluate the potential use of these small protein inhibitors in regulating the serralysin induced activation of ENaC, proteases from Pseudomonas aeruginosa and Serratia marcescens were purified for characterization along with a high affinity inhibitor from Pseudomonas. Both proteases showed activity against in vitro substrates and could be blocked by near stoichiometric concentrations of the inhibitor. In addition, both proteases were capable of activating ENaC when added to the apical surfaces of multiple epithelial cells with similar slow activation kinetics. The high-affinity periplasmic inhibitor from Pseudomonas effectively blocked this activation. These data suggest that multiple metalloproteases are capable of activating ENaC. Further, the endogenous, periplasmic bacterial inhibitors may be useful for modulating the downstream effects of the serralysin virulence factors under physiological conditions.	[Butterworth, Michael B.; Zhang, Liang; Liu, Xiaoning; Thibodeau, Patrick H.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA; [Shanks, Robert M.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Thibodeau, PH (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA.	thibodea@pitt.edu	Shanks, Robert M. Q./AFO-0831-2022; Zhang, Liang/D-9446-2015	Shanks, Robert M. Q./0000-0002-7699-5396; Zhang, Liang/0000-0003-4268-6939	NIH [DK083284, AI085570, DK078917, DK072506]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083284, R00DK078917, K99DK078917, R56DK083284, P30DK072506] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported, in part, by NIH grants DK083284 to PHT, AI085570 to RMS, DK078917 and a Gilead CF Scholars grant to MBB. The University of Pittsburgh Cystic Fibrosis Center Cell Core facility is supported, in part, by NIH grant DK072506. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelos JA, 2003, VET MICROBIOL, V92, P363, DOI 10.1016/S0378-1135(02)00410-8; Bardoel BW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002206; BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; BAUMANN U, 1994, J MOL BIOL, V242, P244, DOI 10.1006/jmbi.1994.1576; BAUMANN U, 1995, J MOL BIOL, V248, P653, DOI 10.1006/jmbi.1995.0249; Bens M, 1999, J AM SOC NEPHROL, V10, P923; BURKE V, 1991, PATHOLOGY, V23, P145, DOI 10.3109/00313029109060814; Butterworth MB, 2012, J BIOL CHEM, V287, P32556, DOI 10.1074/jbc.M112.369520; Butterworth MB, 2012, AM J PHYSIOL-RENAL, V302, pF581, DOI 10.1152/ajprenal.00304.2011; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; Coote K, 2009, J PHARMACOL EXP THER, V329, P764, DOI 10.1124/jpet.108.148155; DUONG F, 1992, GENE, V121, P47, DOI 10.1016/0378-1119(92)90160-Q; Edinger RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046593; Emody L, 2003, INT J ANTIMICROB AG, V22, pS29, DOI 10.1016/S0924-8579(03)00236-X; Feltzer RE, 2000, J BIOL CHEM, V275, P21002, DOI 10.1074/jbc.M002088200; GUZZO J, 1990, J BACTERIOL, V172, P942, DOI 10.1128/jb.172.2.942-948.1990; Hege T, 2001, J BIOL CHEM, V276, P35087, DOI 10.1074/jbc.M104020200; Hejazi A, 1997, J MED MICROBIOL, V46, P903, DOI 10.1099/00222615-46-11-903; HORVAT RT, 1988, INFECT IMMUN, V56, P2925, DOI 10.1128/IAI.56.11.2925-2932.1988; JAFFARBANDJEE MC, 1995, J CLIN MICROBIOL, V33, P924, DOI 10.1128/JCM.33.4.924-929.1995; JAGGER KN, 1983, J CLIN MICROBIOL, V17, P55, DOI 10.1128/JCM.17.1.55-59.1983; JAGGER KS, 1982, J CLIN MICROBIOL, V15, P1054, DOI 10.1128/JCM.15.6.1054-1058.1982; Jaswal SS, 2002, NATURE, V415, P343, DOI 10.1038/415343a; Kachlany SC, 2000, INFECT IMMUN, V68, P6094, DOI 10.1128/IAI.68.11.6094-6100.2000; Kashlan OB, 2010, J BIOL CHEM, V285, P35216, DOI 10.1074/jbc.M110.167064; KLINGER JD, 1984, J CLIN INVEST, V74, P1669, DOI 10.1172/JCI111583; KOSMIDIS J, 1986, SCAND J INFECT DIS, P135; Leidal KG, 2003, J INTERF CYTOK RES, V23, P307, DOI 10.1089/107999003766628151; Lilie H, 2000, FEBS LETT, V470, P173, DOI 10.1016/S0014-5793(00)01308-9; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Maekawa A, 2009, J HYPERTENS, V27, P181, DOI 10.1097/HJH.0b013e328317a762; Mall MA, 2010, J BIOL CHEM, V285, P26945, DOI 10.1074/jbc.M110.151803; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Myerburg MM, 2010, AM J RESP CELL MOL, V43, P712, DOI 10.1165/rcmb.2009-0348OC; Myerburg MM, 2008, AM J PHYSIOL-LUNG C, V294, pL932, DOI 10.1152/ajplung.00437.2007; Myerburg MM, 2006, J BIOL CHEM, V281, P27942, DOI 10.1074/jbc.M606449200; Pinna A, 2011, ACTA OPHTHALMOL, V89, P382, DOI 10.1111/j.1755-3768.2009.01689.x; Sarkisova S, 2005, J BACTERIOL, V187, P4327, DOI 10.1128/JB.187.13.4327-4337.2005; SEBO P, 1993, MOL MICROBIOL, V9, P999, DOI 10.1111/j.1365-2958.1993.tb01229.x; Sisirak Maida, 2013, Acta Med Acad, V42, P25, DOI 10.5644/ama2006-124.67; Song YL, 2009, AM J PHYSIOL-LUNG C, V297, pL1131, DOI 10.1152/ajplung.00085.2009; SUTER S, 1994, AM J RESP CRIT CARE, V150, pS118, DOI 10.1164/ajrccm/150.6_Pt_2.S118; Tarran R, 2006, J GEN PHYSIOL, V127, P591, DOI 10.1085/jgp.200509468; Thanassi DG, 2000, CURR OPIN CELL BIOL, V12, P420, DOI 10.1016/S0955-0674(00)00111-3; Tingpej P, 2007, J CLIN MICROBIOL, V45, P1697, DOI 10.1128/JCM.02364-06; Zhang L, 2012, J BIOL CHEM, V287, P4311, DOI 10.1074/jbc.M111.310300	47	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100313	10.1371/journal.pone.0100313	http://dx.doi.org/10.1371/journal.pone.0100313			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963801	Green Accepted, Green Published, gold			2022-12-25	WOS:000338709500039
J	Caggiano, V; Sur, M; Bizzi, E				Caggiano, Vittorio; Sur, Mirganka; Bizzi, Emilio			Rostro-Caudal Inhibition of Hindlimb Movements in the Spinal Cord of Mice	PLOS ONE			English	Article							LOCOMOTOR-LIKE ACTIVITY; MODULAR ORGANIZATION; MUSCLE AFFERENTS; MOTOR CONTROL; NEONATAL-RAT; NEURONS; MOUSE; GABA; LUMBAR; CAT	Inhibitory neurons in the adult mammalian spinal cord are known to locally modulate afferent feedback - from muscle proprioceptors and from skin receptors - to pattern motor activity for locomotion and postural control. Here, using optogenetic tools, we explored how the same population of inhibitory interneurons globally affects hindlimb movements in the spinal cord of both anesthetized and freely moving mice. Activation of inhibitory interneurons up to the middle/lower spinal cord i.e. T8-T9, were able to completely and globally suppress all ipsilateral hindlimb movements. Furthermore, the same population of interneurons - which inhibited movements - did not significantly change the sensory and proprioceptive information from the affected limbs to the cortex. These results suggest a rostro-caudal organization of inhibition in the spinal cord motor output without modulation of ascending sensory pathways.	[Caggiano, Vittorio; Bizzi, Emilio] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Sur, Mirganka] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health	Caggiano, V (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	caggiano@mit.edu; ebizzi@mit.edu		/0000-0002-7644-4498; Caggiano, Vittorio/0000-0002-2186-1550	Human Frontier Science Program fellowship [LT001234/2011-L]; NSF [IIS-0904594]	Human Frontier Science Program fellowship(Human Frontier Science Program); NSF(National Science Foundation (NSF))	V.C. is supported by the Human Frontier Science Program fellowship (LT001234/2011-L). Contributing grants include NSF IIS-0904594. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alilain WJ, 2008, J NEUROSCI, V28, P11862, DOI 10.1523/JNEUROSCI.3378-08.2008; Allain AE, 2006, J COMP NEUROL, V496, P832, DOI 10.1002/cne.20967; Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; Berg RW, 2007, SCIENCE, V315, P390, DOI 10.1126/science.1134960; Bertrand S, 1999, EUR J NEUROSCI, V11, P583, DOI 10.1046/j.1460-9568.1999.00473.x; Bertrand S, 2002, EUR J NEUROSCI, V16, P1741, DOI 10.1046/j.1460-9568.2002.02233.x; Betley JN, 2009, CELL, V139, P161, DOI 10.1016/j.cell.2009.08.027; Bizzi E, 2002, NEUROSCIENTIST, V8, P437, DOI 10.1177/107385802236969; Bonnot A, 2002, BRAIN RES REV, V40, P141, DOI 10.1016/S0165-0173(02)00197-2; Bonnot AS, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-03-j0001.2002; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Cowley KC, 1997, J NEUROPHYSIOL, V77, P247, DOI 10.1152/jn.1997.77.1.247; Cowley KC, 2010, ANN NY ACAD SCI, V1198, P42, DOI 10.1111/j.1749-6632.2009.05421.x; Delivet-Mongrain H, 2008, J NEUROPHYSIOL, V100, P907, DOI 10.1152/jn.90454.2008; Farrar MJ, 2012, NAT METHODS, V9, P297, DOI [10.1038/NMETH.1856, 10.1038/nmeth.1856]; Frigon A, 2012, EXP NEUROL, V235, P588, DOI 10.1016/j.expneurol.2012.03.013; Ghosh A, 2009, J NEUROSCI, V29, P12210, DOI 10.1523/JNEUROSCI.1828-09.2009; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; Guan Y, 2006, J NEUROSCI, V26, P4298, DOI 10.1523/JNEUROSCI.0960-06.2006; HOLSTEGE JC, 1991, J NEUROSCI, V11, P159; JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9; Jankowska E, 2008, J NEUROSCI, V28, P3615, DOI 10.1523/JNEUROSCI.0466-08.2008; Jasmin L, 2004, CNS NEUROL DISORD-DR, V3, P487, DOI 10.2174/1568007043336716; Jean A, 2001, PHYSIOL REV, V81, P929, DOI 10.1152/physrev.2001.81.2.929; Kiehn O, 1998, ANN NY ACAD SCI, V860, P110, DOI 10.1111/j.1749-6632.1998.tb09043.x; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Krenzer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024998; Levine AJ, 2014, NAT NEUROSCI, V17, P586, DOI 10.1038/nn.3675; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; Miller KE, 1998, BRAIN RES BULL, V47, P43, DOI 10.1016/S0361-9230(98)00065-3; Nadeau S, 2010, NEUROREHAB NEURAL RE, V24, P377, DOI 10.1177/1545968309349945; Ovsepian SV, 2004, NEUROSCIENCE, V129, P639, DOI 10.1016/j.neuroscience.2004.07.050; Pearson KG, 1998, ANN NY ACAD SCI, V860, P203, DOI 10.1111/j.1749-6632.1998.tb09050.x; Quinlan KA, 2007, J NEUROSCI, V27, P6521, DOI 10.1523/JNEUROSCI.1618-07.2007; Saltiel P, 2001, J NEUROPHYSIOL, V85, P605, DOI 10.1152/jn.2001.85.2.605; Saltiel P, 1998, J NEUROPHYSIOL, V80, P2323, DOI 10.1152/jn.1998.80.5.2323; TAAL W, 1994, NEUROREPORT, V5, P2225, DOI 10.1097/00001756-199411000-00005; Taepavarapruk N, 2008, J NEUROPHYSIOL, V100, P598, DOI 10.1152/jn.01231.2007; Talpalar AE, 2011, NEURON, V71, P1071, DOI 10.1016/j.neuron.2011.07.011; Tripodi M, 2011, NATURE, V479, P61, DOI 10.1038/nature10538; Wang Y, 2009, NEUROSCIENCE, V164, P1031, DOI 10.1016/j.neuroscience.2009.09.010; Windhorst U, 1996, PROG NEUROBIOL, V49, P517, DOI 10.1016/0301-0082(96)00023-8; Zhang JM, 2014, NEURON, V82, P138, DOI 10.1016/j.neuron.2014.02.013; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	46	22	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100865	10.1371/journal.pone.0100865	http://dx.doi.org/10.1371/journal.pone.0100865			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963653	Green Published, gold			2022-12-25	WOS:000338709500091
J	Kato, A; Okura, T; Hamada, C; Miyoshi, S; Katayama, H; Higaki, J; Ito, R				Kato, Aki; Okura, Takafumi; Hamada, Chizuru; Miyoshi, Seigo; Katayama, Hitoshi; Higaki, Jitsuo; Ito, Ryoji			Cell Stress Induces Upregulation of Osteopontin via the ERK Pathway in Type II Alveolar Epithelial Cells	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; ACTIVATED PROTEIN-KINASE; ENDOPLASMIC-RETICULUM STRESS; GENE-EXPRESSION; DNA-DAMAGE; INHIBITOR; APOPTOSIS; INTERLEUKIN-1-BETA; PATHOGENESIS; INDUCTION	Osteopontin (OPN) is a multifunctional protein that plays important roles in cell growth, differentiation, migration and tissue fibrosis. In human idiopathic pulmonary fibrosis and murine bleomycin-induced lung fibrosis, OPN is upregulated in type II alveolar epithelial cells (AEC II). However, the mechanism of OPN induction in AEC II is not fully understood. In this study, we demonstrate the molecular mechanism of OPN induction in AEC II and elucidate the functions of OPN in AEC II and lung fibroblasts. Human lung adenocarcinoma cells (A549) and mouse alveolar epithelial cells (MLE12), used as type II alveolar epithelial cell lines for in vitro assays, and human pulmonary alveolar epithelial cells (HPAEpiC) were treated with either bleomycin, doxorubicin or tunicamycin. The mechanism of OPN induction in these cells and its function as a pro-fibrotic cytokine on A549 and lung fibroblasts were analyzed. The DNA damaging reagents bleomycin and doxorubicin were found to induce OPN expression in A549, MLE12 and HPAEpiC. OPN expression was induced via activation of the extracellular signal-regulated protein kinase (ERK)-dependent signaling pathway in A549 and MLE12. The endoplasmic reticulum (ER) stress-inducing reagent tunicamycin induced OPN mRNA expression in A549, MLE12 and HPAEpiC, and OPN mRNA expression was induced via activation of the ERK-dependent signaling pathway in A549 and MLE12. Another ER stress-inducing reagent thapsigargin induced the expression of OPN mRNA as well as the subsequent production of OPN in A549 and MLE12. Furthermore, OPN promoted the proliferation of A549 and the migration of normal human lung fibroblasts. Inhibition of OPN by small interference RNA or neutralizing antibody suppressed both of these responses. The results of this study suggest that cell stress induces the upregulation of OPN in AEC II by signaling through the ERK pathway, and that upregulated OPN may play a role in fibrogenesis of the lung.	[Kato, Aki; Okura, Takafumi; Hamada, Chizuru; Miyoshi, Seigo; Katayama, Hitoshi; Higaki, Jitsuo; Ito, Ryoji] Ehime Univ, Grad Sch Med, Dept Cardiol Pulmonol Hypertens & Nephrol, Toon, Ehime, Japan	Ehime University	Okura, T (corresponding author), Ehime Univ, Grad Sch Med, Dept Cardiol Pulmonol Hypertens & Nephrol, Toon, Ehime, Japan.	okura@m.ehime-u.ac.jp						ADAMSON IYR, 1988, AM J PATHOL, V130, P377; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Barbas-Filho JV, 2001, J CLIN PATHOL, V54, P132, DOI 10.1136/jcp.54.2.132; Berman JS, 2004, AM J PHYSIOL-LUNG C, V286, pL1311, DOI 10.1152/ajplung.00394.2003; BJORKMAN U, 1982, EUR J BIOCHEM, V125, P585, DOI 10.1111/j.1432-1033.1982.tb06723.x; Buckley S, 1999, AM J PHYSIOL-LUNG C, V277, pL159, DOI 10.1152/ajplung.1999.277.1.L159; Day RM, 2001, AM J RESP CELL MOL, V25, P613, DOI 10.1165/ajrcmb.25.5.4521; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Hodgson U, 2002, THORAX, V57, P338, DOI 10.1136/thorax.57.4.338; Hong SY, 2010, MOL CELL BIOCHEM, V335, P263, DOI 10.1007/s11010-009-0276-1; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kelly MM, 2006, AM J RESP CRIT CARE, V174, P557, DOI 10.1164/rccm.200510-1648OC; KUHN C, 1991, AM J PATHOL, V138, P1257; Lawson WE, 2011, P NATL ACAD SCI USA, V108, P10562, DOI 10.1073/pnas.1107559108; Lee VY, 2005, AM J PHYSIOL-LUNG C, V289, pL521, DOI 10.1152/ajplung.00340.2004; Leleu X, 2009, BLOOD, V113, P626, DOI 10.1182/blood-2007-10-116848; Maitra M, 2012, P NATL ACAD SCI USA, V109, P21064, DOI 10.1073/pnas.1217069110; Matsuoka H, 2002, AM J PHYSIOL-LUNG C, V283, pL103, DOI 10.1152/ajplung.00187.2001; Mishra A, 2000, AM J RESP CELL MOL, V22, P543, DOI 10.1165/ajrcmb.22.5.3851; MIYAZAKI Y, 1995, ANN NY ACAD SCI, V760, P334, DOI 10.1111/j.1749-6632.1995.tb44651.x; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Selman Moises, 2006, Proc Am Thorac Soc, V3, P364, DOI 10.1513/pats.200601-003TK; Serlin DM, 2006, J CELL BIOCHEM, V97, P519, DOI 10.1002/jcb.20661; Takahashi F, 2001, AM J RESP CELL MOL, V24, P264, DOI 10.1165/ajrcmb.24.3.4293; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; Wang XK, 1996, ARTERIOSCL THROM VAS, V16, P1365, DOI 10.1161/01.ATV.16.11.1365; WICTOME M, 1992, BIOCHEM J, V283, P525, DOI 10.1042/bj2830525; Xie ZL, 2004, J CELL PHYSIOL, V198, P399, DOI 10.1002/jcp.10419; Yoshida K, 2002, J PATHOL, V198, P388, DOI 10.1002/path.1208	31	28	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100106	10.1371/journal.pone.0100106	http://dx.doi.org/10.1371/journal.pone.0100106			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963635	Green Published, Green Submitted, gold			2022-12-25	WOS:000338709500027
J	Martin-Merino, E; Fortuny, J; Rivero-Ferrer, E; Garcia-Rodriguez, LA				Martin-Merino, Elisa; Fortuny, Joan; Rivero-Ferrer, Elena; Alberto Garcia-Rodriguez, Luis			Incidence of Retinal Complications in a Cohort of Newly Diagnosed Diabetic Patients	PLOS ONE			English	Article							SIGHT-THREATENING RETINOPATHY; NIDDM; PROGRESSION; POPULATION; PREVALENCE; MELLITUS; WALES; EYE	Purpose: We aimed at estimating the incidence of diabetic retinopathy (DR) and maculopathy (DMP) among newly diagnosed type 1 (t1DM) and type 2 diabetic patients (t2DM) in the United Kingdom primary care system. The incidence of DMP among patients with DR was also estimated. Method: We conducted a cohort study using The Health Improvement Network database. The cohort included 64,983 incident diabetic patients (97.3% were t2DM) aged 1-84 years diagnosed between 2000 and 2007. This cohort was followed from the date of diabetes diagnosis until recording of DR or DMP in two separate follow-ups. Follow-up was censored at 85 years of age, death, or end of 2008. An additional follow-up was conducted from DR to DMP diagnosis using similar censoring reasons. DR and DMP cumulative incidences were calculated as well as incidence rates (IR; cases per 1,000 person-years) per calendar period (2000-2001 and 2006-2007). Results: Follow-up for DR: 9 years after diabetes diagnosis, 28% of t2DM and 24% of t1DM patients had developed DR (7,899 incident DR cases). During the first 2 years with diabetes, the IR was almost 2 times higher in patients diagnosed with diabetes in 2006-2007 (47.7) than among those diagnosed in 2000-2001 (24.5). Follow-up for DMP: 9 years after diabetes diagnosis, 3.6% of t2DM and 4.4% of t2DM patients had developed DMP (912 incident DMP cases). During the first 2 years with diabetes, the IR was three times higher in patients diagnosed with diabetes in 2006-2007 (5.8) than among those diagnosed in 2000-2001 (1.8). Macular oedema occurred in 0.8% of patients. Conclusions: In a cohort of incident diabetes, 28% of patients developed retinopathy and 4% maculopathy within the first 9 years. The 2-year IRs of DR and DMP were higher in patients diagnosed with diabetes during the period 2006-2007 than in those diagnosed during the 2000-2001 period.	[Martin-Merino, Elisa; Alberto Garcia-Rodriguez, Luis] Ctr Espanol Invest Farmacoepidemiol, Madrid, Spain; [Fortuny, Joan; Rivero-Ferrer, Elena] Novartis Farmaceut SA, DS&E Global Clin Epidemiol, Barcelona, Spain		Martin-Merino, E (corresponding author), Ctr Espanol Invest Farmacoepidemiol, Madrid, Spain.	elisaceife@gmail.com	rodriguez, luis a garcia/B-1980-2010; Rivero, Elena/ABC-3314-2021	RIVERO FERRER, MARIA ELENA/0000-0001-5093-2445; Fortuny, Joan/0000-0001-9401-5243; Martin Merino, Elisa/0000-0002-3576-8605	Novartis Farmaceutica	Novartis Farmaceutica	This study was funded by Novartis Farmaceutica S.A. The funder also provided support in the form of salaries for the authors JF and ERF but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	[Anonymous], 2008, ANN REP 1 APR 2007 3; Blak Betina T, 2011, Inform Prim Care, V19, P251; Bunce C, 2008, EYE, V22, P905, DOI 10.1038/sj.eye.6702767; Cegedim Strategic Data Medical Research UK, THIN DAT STAT; Evans JMM, 2007, DIABETOLOGIA, V50, P729, DOI 10.1007/s00125-006-0585-9; HARDING SP, 1995, BMJ-BRIT MED J, V311, P1131, DOI 10.1136/bmj.311.7013.1131; HARRIS MI, 1993, DIABETES CARE, V16, P642, DOI 10.2337/diacare.16.4.642; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Jones CD, 2012, DIABETES CARE, V35, P592, DOI 10.2337/dc11-0943; KLEIN R, 1995, OPHTHALMOLOGY, V102, P7; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P520, DOI 10.1001/archopht.1984.01040030398010; Kohner EM, 2001, DIABETIC MED, V18, P178; Martin-Merino E, 2012, DIABETES CARE, V35, P762, DOI 10.2337/dc11-2069; Gonzalez ELM, 2009, J EPIDEMIOL COMMUN H, V63, P332, DOI 10.1136/jech.2008.080382; Multilex. First DataBank Europe Ltd, 2010, MULT; ONEIL M, 1995, METHOD INFORM MED, V34, P187; Rosner B, 2011, FUNDAMENTALS BIOSTAT, P71; Rosner B, 2011, FUNDAMENTALS BIOSTAT, P760; Ruigomez A, 1998, EUR J EPIDEMIOL, V14, P439, DOI 10.1023/A:1007484920656; Semeraro F, 2011, J DIABETES COMPLICAT, V25, P292, DOI 10.1016/j.jdiacomp.2010.12.002; StataCorp, 2009, STAT STAT SOFTW REL; Stuart-Buttle C D, 1996, Proc AMIA Annu Fall Symp, P75; Thomas RL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e874; Younis N, 2003, DIABETIC MED, V20, P758, DOI 10.1046/j.1464-5491.2003.01035.x; Younis N, 2003, LANCET, V361, P195, DOI 10.1016/S0140-6736(03)12267-2	25	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100283	10.1371/journal.pone.0100283	http://dx.doi.org/10.1371/journal.pone.0100283			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963628	Green Published, gold, Green Submitted			2022-12-25	WOS:000338709500036
J	Wan, NF; Ji, XY; Jiang, JX				Wan, Nian-Feng; Ji, Xiang-Yun; Jiang, Jie-Xian			Testing the Enemies Hypothesis in Peach Orchards in Two Different Geographic Areas in Eastern China: The Role of Ground Cover Vegetation	PLOS ONE			English	Article							NATURAL ENEMIES; BENEFICIAL ARTHROPODS; APPLE ORCHARD; DIVERSITY; COMMUNITIES; POPULATIONS; ABUNDANCE; PESTS; CROP; MANAGEMENT	Many studies have supported the enemies hypothesis, which suggests that natural enemies are more efficient at controlling arthropod pests in polyculture than in monoculture agro-ecosystems. However, we do not yet have evidence as to whether this hypothesis holds true in peach orchards over several geographic locations. In the two different geographic areas in eastern China (Xinchang a town in the Shanghai municipality, and Hudai, a town in Jiangsu Province) during a continuous three-year (2010-2012) investigation, we sampled arthropod pests and predators in Trifolium repens L. and in tree canopies of peach orchards with and without the ground cover plant T. repens. No significant differences were found in the abundances of the main groups of arthropod pests and predators in T. repens between Hudai and Xinchang. The abundance, richness, Simpson's index, Shannon-Wiener index, and Pielou evenness index of canopy predators in ground cover areas increased by 85.5, 27.5, 3.5, 16.7, and 7.9% in Xinchang, and by 87.0, 27.6, 3.5, 17.0 and 8.0% in Hudai compared to those in the controls, respectively. The average abundance of Lepidoptera, Coleoptera, Homoptera, true bugs and Acarina canopy pests in ground cover areas decreased by 9.2, 10.2, 17.2, 19.5 and 14.1% in Xinchang, and decreased by 9.5, 8.2, 16.8, 20.1 and 16.6% in Hudai compared to that in control areas, respectively. Our study also found a higher density of arthropod species resources in T. repens, as some omnivorous pests and predators residing in T. repens could move between the ground cover and the orchard canopy. In conclusion, ground cover in peach orchards supported the enemies hypothesis, as indicated by the fact that ground cover T. repens promoted the abundance and diversity of predators and reduced the number of arthropod pests in tree canopies in both geographical areas.	[Wan, Nian-Feng; Ji, Xiang-Yun; Jiang, Jie-Xian] Shanghai Acad Agr Sci, Shanghai Key Lab Protected Hort Technol, Ecoenvironm Protect Res Inst, Shanghai, Peoples R China	Shanghai Academy of Agricultural Sciences	Jiang, JX (corresponding author), Shanghai Acad Agr Sci, Shanghai Key Lab Protected Hort Technol, Ecoenvironm Protect Res Inst, Shanghai, Peoples R China.	jiangjiexian@163.com			Shanghai Agriculture Committee for young-talent growth [2014.1-22]; Shanghai Municipal Science and Technology Commission [12ZR1449100, 08dz1900401, 123919N0400]	Shanghai Agriculture Committee for young-talent growth; Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was funded by the grants from Shanghai Agriculture Committee for young-talent growth ( No. 2014.1-22), and from Shanghai Municipal Science and Technology Commission (12ZR1449100, 08dz1900401, 123919N0400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDOW DA, 1991, ANNU REV ENTOMOL, V36, P561, DOI 10.1146/annurev.en.36.010191.003021; [毕守东 Bi Shoudong], 2003, [生态学杂志, Chinese Journal of Ecology], V22, P113; Bjorkman M, 2010, AGR FOREST ENTOMOL, V12, P123, DOI 10.1111/j.1461-9563.2009.00452.x; Bone NJ, 2009, CROP PROT, V28, P675, DOI 10.1016/j.cropro.2009.03.021; Carvalheiro LG, 2011, ECOL LETT, V14, P251, DOI 10.1111/j.1461-0248.2010.01579.x; Castagneyrol B, 2014, J APPL ECOL, V51, P134, DOI 10.1111/1365-2664.12175; Chen LL, 2011, BIOL CONTROL, V59, P326, DOI 10.1016/j.biocontrol.2011.09.007; Costello MJ, 1998, ECOL ENTOMOL, V23, P33, DOI 10.1046/j.1365-2311.1998.00108.x; Dong Jie, 2005, Great Lakes Entomologist, V38, P186; Downey RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041672; Frechette B, 2008, EUR J ENTOMOL, V105, P521, DOI 10.14411/eje.2008.069; Giffard B, 2012, OECOLOGIA, V168, P415, DOI 10.1007/s00442-011-2089-7; Gray DM, 2012, APPL SOIL ECOL, V60, P41, DOI 10.1016/j.apsoil.2012.06.007; GRUYS P, 1982, ENTOMOL EXP APPL, V31, P70, DOI 10.1111/j.1570-7458.1982.tb03120.x; Hossain Z, 2000, AUST J ENTOMOL, V39, P39, DOI 10.1046/j.1440-6055.2000.00132.x; Hughes AR, 2012, ECOLOGY, V93, P1411, DOI 10.1890/11-1555.1; Jiang Jie-xian, 2011, Yingyong Shengtai Xuebao, V22, P2303; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Letourneau DK, 2011, ECOL APPL, V21, P9, DOI 10.1890/09-2026.1; LETOURNEAU DK, 1987, ECOLOGY, V68, P1616, DOI 10.2307/1939853; Lundgren JG, 2010, ENVIRON ENTOMOL, V39, P1816, DOI 10.1603/EN10041; Mailloux Julie, 2010, Experimental and Applied Acarology, V52, P275, DOI 10.1007/s10493-010-9367-7; Norris RF, 2005, ANNU REV ENTOMOL, V50, P479, DOI 10.1146/annurev.ento.49.061802.123218; Penvern S, 2010, CROP PROT, V29, P1148, DOI 10.1016/j.cropro.2010.06.010; Podgaiski LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060207; Riihimaki J, 2005, OECOLOGIA, V142, P90, DOI 10.1007/s00442-004-1696-y; RISCH SJ, 1981, ECOLOGY, V62, P1325, DOI 10.2307/1937296; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Schuldt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022905; Schut AGT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082778; Silva EB, 2010, B ENTOMOL RES, V100, P489, DOI 10.1017/S0007485309990526; Simon S, 2007, AGR ECOSYST ENVIRON, V122, P340, DOI 10.1016/j.agee.2007.01.020; Smith MW, 1996, BIOL CONTROL, V6, P164, DOI 10.1006/bcon.1996.0021; Song BZ, 2010, BIOCONTROL, V55, P741, DOI 10.1007/s10526-010-9301-2; TEDDERS WL, 1984, J GEORGIA ENTOMOL SO, V19, P498; Uliarte EM, 2013, AGR FOREST METEOROL, V181, P1, DOI 10.1016/j.agrformet.2013.06.019; Wan NF, 2014, ECOL ENG, V64, P62, DOI 10.1016/j.ecoleng.2013.12.033; Wan Nian-feng, 2011, Shengtaixue Zazhi, V30, P30; Wasser L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054776; Wilson AR, 2010, EUR J HORTIC SCI, V75, P269; Wyss E, 1996, AGR ECOSYST ENVIRON, V60, P47, DOI 10.1016/S0167-8809(96)01060-2; Zou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082792	42	15	16	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99850	10.1371/journal.pone.0099850	http://dx.doi.org/10.1371/journal.pone.0099850			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963719	gold, Green Published, Green Submitted			2022-12-25	WOS:000338709500020
J	Chen, R; Wu, X; Shen, LJ; Wang, B; Ma, MM; Yang, Y; Zhao, BW				Chen, Ran; Wu, Xia; Shen, Li-Jun; Wang, Bei; Ma, Ming-Ming; Yang, Yuan; Zhao, Bo-Wen			Left Ventricular Myocardial Function in Hemodialysis and Nondialysis Uremia Patients: A Three-Dimensional Speckle-Tracking Echocardiography Study	PLOS ONE			English	Article							2-DIMENSIONAL STRAIN; KIDNEY-DISEASE; QUANTIFICATION; CARDIOMYOPATHY; ASSOCIATION; TORSION	Background: Several studies have demonstrated that uremic patients who have preserved left ventricular ejection fraction (LVEF) could still have the potential for systolic dysfunction. The aim of this study was to assess the differences between the left ventricular (LV) myocardial function in hemodialysis and nondialysis uremic patients based on three-dimensional speckle-tracking echocardiography. Methods: The study population consisted of 35 maintenance hemodialysis patients (the hemodialysis group), 30 uremic patients who were hospitalized for the creation of a primary arteriovenous fistula (the nondialysis group), and 32 healthy volunteers. All of the patients had normal left ventricular ejection fractions (i.e., 55% or greater). Three-dimensional speckle tracking echocardiography was performed to assess the left ventricle's global three-dimensional strain, regional longitudinal strain, circumferential strain, and radial strain. Results: The left ventricular regional longitudinal strain, radial strain, circumferential strain, and global three-dimensional strain were significantly decreased in the nondialysis patients compared with the other two groups (all, P<0.001). However, the three-dimensional strain and the regional longitudinal strain were lower in the hemodialysis patients than in the controls (P<0.01). In the hemodialysis patients and the control group, the longitudinal strain, circumferential strain, and radial strain were higher at the apical level than they were at the basal level and midlevels. A multivariate linear regression analysis showed that the blood urea nitrogen and creatinine levels were independently associated with the values of the global three-dimensional strain (beta = -0.217, P = 0.000; beta = -0.243, P = 0.011, respectively) and the longitudinal strain (beta = -0.154, P = 0.032; beta = -0.188, P = 0.029, respectively). Conclusions: Three-dimensional speckle-tracking echocardiography may detect myocardial dysfunction in patients with uremia who have preserved LVEF. The global three-dimensional strain and the regional longitudinal strain appear to be superior in hemodialysis patients compared with nondialysis patients.	[Chen, Ran; Wang, Bei; Ma, Ming-Ming; Yang, Yuan; Zhao, Bo-Wen] Zhejiang Univ, Dept Diagnost Ultrasound & Echocardiog, Sir Run Run Shaw Hosp, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Ran; Wu, Xia; Wang, Bei; Ma, Ming-Ming; Yang, Yuan; Zhao, Bo-Wen] Zhejiang Univ, Sir Run Run Shaw Inst Clin Med, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Xia] Zhejiang Univ, Dept Radiol, Sir Run Run Shaw Hosp, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Shen, Li-Jun] First Peoples Hosp, Dept Ultrasound, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Zhao, BW (corresponding author), Zhejiang Univ, Dept Diagnost Ultrasound & Echocardiog, Sir Run Run Shaw Hosp, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China.	zbwcjp@163.com			Specialized Research Fund for the Doctoral Program of Higher Education [20110101120136]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	The research is supported by Specialized Research Fund for the Doctoral Program of Higher Education (20110101120136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AURIGEMMA GP, 1995, CURR PROB CARDIOLOGY, V20, P367; Bogaert J, 2001, AM J PHYSIOL-HEART C, V280, pH610; Buckberg G D, 2001, Semin Thorac Cardiovasc Surg, V13, P402; Fagugli RM, 2001, AM J KIDNEY DIS, V38, P371, DOI 10.1053/ajkd.2001.26103; Fleiss JL, 1986, DESIGN ANAL CLIN EXP, Vxiv; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; Gotte MJW, 2006, J AM COLL CARDIOL, V48, P2002, DOI 10.1016/j.jacc.2006.07.048; Hayashi SY, 2004, NEPHROL DIAL TRANSPL, V19, P1497, DOI 10.1093/ndt/gfh205; Kang Y, 2012, ACTA CARDIOL, V67, P423, DOI 10.1080/AC.67.4.2170683; Kim HK, 2007, J AM SOC ECHOCARDIOG, V20, P45, DOI 10.1016/j.echo.2006.07.007; Kleijn SA, 2012, EUR HEART J-CARD IMG, V13, P834, DOI 10.1093/ehjci/jes030; Lekawanvijit S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041281; Liu YW, 2011, AM J NEPHROL, V33, P84, DOI 10.1159/000322709; Maizel J, 2009, CIRCULATION, V119, P306, DOI 10.1161/CIRCULATIONAHA.108.797407; Marks AR, 1997, AM J PHYSIOL-HEART C, V272, pH597, DOI 10.1152/ajpheart.1997.272.2.H597; Mendes Ligia, 2008, Rev Port Cardiol, V27, P1011; Ng ACT, 2008, AM J CARDIOL, V102, P784, DOI 10.1016/j.amjcard.2008.05.027; Perk G, 2007, J AM SOC ECHOCARDIOG, V20, P234, DOI 10.1016/j.echo.2006.08.023; Popovic ZB, 2008, J AM SOC ECHOCARDIOG, V21, P1299, DOI 10.1016/j.echo.2008.09.011; Rakhit DJ, 2007, AM HEART J, V153, P656, DOI 10.1016/j.ahj.2007.01.028; Saito K, 2009, J AM SOC ECHOCARDIOG, V22, P1025, DOI 10.1016/j.echo.2009.05.021; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Semple D, 2011, J AM SOC NEPHROL, V22, P207, DOI 10.1681/ASN.2009090900; Serri K, 2006, J AM COLL CARDIOL, V47, P1175, DOI 10.1016/j.jacc.2005.10.061; Smith GL, 2006, ARCH INTERN MED, V166, P1134, DOI 10.1001/archinte.166.10.1134; Yan P, 2011, NEPHRON CLIN PRACT, V118, pC232, DOI 10.1159/000321383	26	20	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100265	10.1371/journal.pone.0100265	http://dx.doi.org/10.1371/journal.pone.0100265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959903	Green Published, Green Submitted, gold			2022-12-25	WOS:000338633900034
J	Sydow, JF; Lipsmeier, F; Larraillet, V; Hilger, M; Mautz, B; Molhoj, M; Kuentzer, J; Klostermann, S; Schoch, J; Voelger, HR; Regula, JT; Cramer, P; Papadimitriou, A; Kettenberger, H				Sydow, Jasmin F.; Lipsmeier, Florian; Larraillet, Vincent; Hilger, Maximiliane; Mautz, Bjoern; Molhoj, Michael; Kuentzer, Jan; Klostermann, Stefan; Schoch, Juergen; Voelger, Hans R.; Regula, Joerg T.; Cramer, Patrick; Papadimitriou, Apollon; Kettenberger, Hubert			Structure-Based Prediction of Asparagine and Aspartate Degradation Sites in Antibody Variable Regions	PLOS ONE			English	Article							RECOMBINANT MONOCLONAL-ANTIBODY; COMPLEMENTARITY-DETERMINING REGIONS; X-L DEAMIDATION; PROTEIN DEAMIDATION; PEPTIDE DEGRADATION; CHEMICAL PATHWAYS; SUCCINIMIDE FORMATION; NONENZYMATIC DEAMIDATION; CHARGE HETEROGENEITY; MODEL HEXAPEPTIDES	Monoclonal antibodies (mAbs) and proteins containing antibody domains are the most prevalent class of biotherapeutics in diverse indication areas. Today, established techniques such as immunization or phage display allow for an efficient generation of new mAbs. Besides functional properties, the stability of future therapeutic mAbs is a key selection criterion which is essential for the development of a drug candidate into a marketed product. Therapeutic proteins may degrade via asparagine (Asn) deamidation and aspartate (Asp) isomerization, but the factors responsible for such degradation remain poorly understood. We studied the structural properties of a large, uniform dataset of Asn and Asp residues in the variable domains of antibodies. Their structural parameters were correlated with the degradation propensities measured by mass spectrometry. We show that degradation hotspots can be characterized by their conformational flexibility, the size of the C-terminally flanking amino acid residue, and secondary structural parameters. From these results we derive an accurate in silico prediction method for the degradation propensity of both Asn and Asp residues in the complementarity-determining regions (CDRs) of mAbs.	[Sydow, Jasmin F.; Larraillet, Vincent; Hilger, Maximiliane; Mautz, Bjoern; Molhoj, Michael; Voelger, Hans R.; Regula, Joerg T.; Kettenberger, Hubert] Roche Pharmaceut Res & Early Dev, Large Mol Res, Penzberg, Germany; [Kuentzer, Jan] Roche Pharmaceut Res & Early Dev, Dis & Translat Informat, Penzberg, Germany; [Lipsmeier, Florian; Klostermann, Stefan; Schoch, Juergen] Roche Pharmaceut Res & Early Dev, Therapeut Modal Informat, Penzberg, Germany; [Papadimitriou, Apollon] Roche Pharmaceut Res & Early Dev, Pharmaceut Sci, Penzberg, Germany; [Cramer, Patrick] Univ Munich, Gene Ctr Munich, Munich, Germany; [Cramer, Patrick] Univ Munich, Ctr Integrated Prot Sci CIPSM, Dept Biochem, Munich, Germany	University of Munich; University of Munich	Kettenberger, H (corresponding author), Roche Pharmaceut Res & Early Dev, Large Mol Res, Penzberg, Germany.	hubert.kettenberger@roche.com		Regula, Joerg Thomas/0000-0002-7343-1077	Roche PostDoc Fellowship programme	Roche PostDoc Fellowship programme	J.F.S. was funded by the Roche PostDoc Fellowship programme. All other authors, except P.C., are current employees of Roche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accelrys Software Inc, 2012, DISC STUD MOD ENV VE; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Athiner L, 2002, J BIOL CHEM, V277, P30502, DOI 10.1074/jbc.M205314200; Beck A, 2013, ANAL CHEM, V85, P715, DOI 10.1021/ac3032355; BISCHOFF R, 1994, J CHROMATOGR B, V662, P261, DOI 10.1016/0378-4347(94)00203-7; Bohme L, 2008, BIOL CHEM, V389, P1043, DOI 10.1515/BC.2008.123; Bohme L, 2008, BIOL CHEM, V389, P1055, DOI 10.1515/BC.2008.125; BRENNAN TV, 1995, INT J PEPT PROT RES, V45, P547; BRENNAN TV, 1993, PROTEIN SCI, V2, P331; Cacia J, 1996, BIOCHEMISTRY-US, V35, P1897, DOI 10.1021/bi951526c; Capasso S, 2000, J PEPT RES, V55, P224, DOI 10.1034/j.1399-3011.2000.00172.x; CAPASSO S, 1992, PEPTIDE RES, V5, P325; Catak S, 2009, J PHYS CHEM A, V113, P1111, DOI 10.1021/jp808597v; Chelius D, 2005, ANAL CHEM, V77, P6004, DOI 10.1021/ac050672d; Chennamsetty N, 2009, P NATL ACAD SCI USA, V106, P11937, DOI 10.1073/pnas.0904191106; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; Chu GC, 2007, PHARM RES-DORDR, V24, P1145, DOI 10.1007/s11095-007-9241-4; CLARKE S, 1987, INT J PEPT PROT RES, V30, P808, DOI 10.1111/j.1399-3011.1987.tb03390.x; Deverman BE, 2002, CELL, V111, P51, DOI 10.1016/S0092-8674(02)00972-8; Diepold K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030295; Dimitriadou E, 2011, MISC FUNCTIONS DEP S; GEIGER T, 1987, J BIOL CHEM, V262, P785; Haberger M, 2014, MABS-AUSTIN, V6, P327, DOI 10.4161/mabs.27876; Hambly DM, 2009, ANAL CHEM, V81, P7454, DOI 10.1021/ac901258g; HARDING JJ, 1989, MECH AGEING DEV, V50, P7, DOI 10.1016/0047-6374(89)90054-7; Harris RJ, 2001, J CHROMATOGR B, V752, P233, DOI 10.1016/S0378-4347(00)00548-X; Huang LH, 2005, ANAL CHEM, V77, P1432, DOI 10.1021/ac0494174; Joshi AB, 2005, J PHARM SCI-US, V94, P1912, DOI 10.1002/jps.20405; Karatzoglou A, 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i09, DOI 10.18637/JSS.V011.I09]; Kosky AA, 1999, PROTEIN SCI, V8, P2519; Kosky AA, 2009, PHARM RES-DORDR, V26, P2417, DOI 10.1007/s11095-009-9953-8; KOSSIAKOFF AA, 1988, SCIENCE, V240, P191, DOI 10.1126/science.3353715; Kosugi S, 2008, BIOCHEM BIOPH RES CO, V371, P22, DOI 10.1016/j.bbrc.2008.03.109; KROON DJ, 1992, PHARMACEUT RES, V9, P1386, DOI 10.1023/A:1015894409623; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liu HC, 2006, J CHROMATOGR B, V837, P35, DOI 10.1016/j.jchromb.2006.03.053; Liu HJ, 2008, J CHROMATOGR A, V1210, P76, DOI 10.1016/j.chroma.2008.09.059; MANNING MC, 1989, PHARM RES-DORDR, V6, P903, DOI 10.1023/A:1015929109894; Martin ACR, 1996, J MOL BIOL, V263, P800, DOI 10.1006/jmbi.1996.0617; Morea V, 1998, J MOL BIOL, V275, P269, DOI 10.1006/jmbi.1997.1442; Neergaard MS, 2014, J PHARM SCI-US, V103, P115, DOI 10.1002/jps.23788; OLIYAI C, 1994, PHARMACEUT RES, V11, P751, DOI 10.1023/A:1018944800691; OLIYAI C, 1994, PHARM RES-DORDR, V11, P901, DOI 10.1023/A:1018998312503; OLIYAI C, 1993, PHARMACEUT RES, V10, P95, DOI 10.1023/A:1018981231468; PATEL K, 1990, PHARMACEUT RES, V7, P703, DOI 10.1023/A:1015807303766; Perkins M, 2000, PHARMACEUT RES, V17, P1110, DOI 10.1023/A:1026461830617; Pilot Pipeline, 2012, PIP PIL VERS 8 5 0 2; Rehder DS, 2008, BIOCHEMISTRY-US, V47, P2518, DOI 10.1021/bi7018223; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Ripley B, 2011, TREE CLASSIFICATION; ROBINSON AB, 1970, P NATL ACAD SCI USA, V66, P753, DOI 10.1073/pnas.66.3.753; Robinson NE, 2002, P NATL ACAD SCI USA, V99, P5283, DOI 10.1073/pnas.082102799; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P4367, DOI 10.1073/pnas.071066498; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P12409, DOI 10.1073/pnas.221463198; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P944, DOI 10.1073/pnas.98.3.944; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schrodinger, SCHRODINGERTHE PYMOL; SHAO J, 1993, J AM STAT ASSOC, V88, P486, DOI 10.2307/2290328; Shimizu T, 2005, BIOL PHARM BULL, V28, P1590, DOI 10.1248/bpb.28.1590; Simpson R.J., 2010, COLD SPRING HARB PRO, V2010; Sinha S, 2009, PROTEIN SCI, V18, P1573, DOI 10.1002/pro.173; Spassov VZ, 2008, PROTEIN ENG DES SEL, V21, P91, DOI 10.1093/protein/gzm083; Sreedhara A, 2012, PHARM RES-DORDR, V29, P187, DOI 10.1007/s11095-011-0534-2; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; Swann PG, 2008, CURR OPIN IMMUNOL, V20, P493, DOI 10.1016/j.coi.2008.05.013; Takata T, 2008, PROTEIN SCI, V17, P1565, DOI 10.1110/ps.035410.108; Takata T, 2007, BIOCHEMISTRY-US, V46, P8861, DOI 10.1021/bi700487q; Therneau RM, 2010, RPART RECURSIVE PART; Timm V, 2010, J CHROMATOGR B, V878, P777, DOI 10.1016/j.jchromb.2010.01.036; TOMIZAWA H, 1994, BIOCHEMISTRY-US, V33, P8770, DOI 10.1021/bi00195a019; TYLERCROSS R, 1991, J BIOL CHEM, V266, P22549; Valliere-Douglass J, 2008, ANAL CHEM, V80, P3168, DOI 10.1021/ac702245c; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Vlasak J, 2008, CURR PHARM BIOTECHNO, V9, P468, DOI 10.2174/138920108786786402; Vlasak J, 2009, ANAL BIOCHEM, V392, P145, DOI 10.1016/j.ab.2009.05.043; Wakankar AA, 2007, J PHARM SCI-US, V96, P1708, DOI 10.1002/jps.20823; Wakankar AA, 2007, BIOCHEMISTRY-US, V46, P1534, DOI 10.1021/bi061500t; Wakankar AA, 2006, J PHARM SCI-US, V95, P2321, DOI 10.1002/jps.20740; Weihs C, 2005, ST CLASS DAT ANAL, P335; Weintraub SJ, 2004, MECH AGEING DEV, V125, P255, DOI 10.1016/j.mad.2004.03.002; Weintraub Steven J, 2007, Sci STKE, V2007, pre7, DOI 10.1126/stke.4092007re7; Whitelegg Nicholas, 2004, Methods Mol Biol, V248, P51; WRIGHT HT, 1991, PROTEIN ENG, V4, P283, DOI 10.1093/protein/4.3.283; WRIGHT HT, 1991, CRIT REV BIOCHEM MOL, V26, P1, DOI 10.1080/10409230490440532; Xiao G, 2008, J PHARMACEUT BIOMED, V47, P23, DOI 10.1016/j.jpba.2007.11.050; Xiao G, 2007, ANAL CHEM, V79, P2714, DOI 10.1021/ac0617870; Xie M, 2000, J PEPT RES, V56, P165, DOI 10.1034/j.1399-3011.2000.00764.x; Xie ML, 1999, J PHARM SCI, V88, P8, DOI 10.1021/js9802493; Xu QS, 2001, CHEMOMETR INTELL LAB, V56, P1, DOI 10.1016/S0169-7439(00)00122-2; Yan BX, 2009, J PHARM SCI-US, V98, P3509, DOI 10.1002/jps.21655; Yang HQ, 2010, ELECTROPHORESIS, V31, P1764, DOI 10.1002/elps.201000027; Yang XY, 2013, MABS-AUSTIN, V5, P787, DOI 10.4161/mabs.25269; Yi L, 2013, J PHARM SCI-US, V102, P947, DOI 10.1002/jps.23423; Yu XC, 2011, ANAL CHEM, V83, P5912, DOI 10.1021/ac200750u; Zabrouskov V, 2006, BIOCHEMISTRY-US, V45, P987, DOI 10.1021/bi0517584; Zhang J, 2011, ANAL BIOCHEM, V410, P234, DOI 10.1016/j.ab.2010.11.040; Zhang W, 2003, J PHARMACEUT BIOMED, V30, P1479, DOI 10.1016/S0731-7085(02)00479-X; Zhao R, 2004, CANCER CELL, V5, P37, DOI 10.1016/S1535-6108(03)00333-7; Zhao R, 2007, PLOS BIOL, V5, P39, DOI 10.1371/journal.pbio.0050001; Zheng JY, 2006, INT J PHARM, V308, P46, DOI 10.1016/j.ijpharm.2005.10.024	100	88	98	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100736	10.1371/journal.pone.0100736	http://dx.doi.org/10.1371/journal.pone.0100736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959685	Green Published, Green Submitted, gold			2022-12-25	WOS:000338633900077
J	Amigo-Jimenez, I; Bailon, E; Ugarte-Berzal, E; Aguilera-Montilla, N; Garcia-Marco, JA; Garcia-Pardo, A				Amigo-Jimenez, Irene; Bailon, Elvira; Ugarte-Berzal, Estefania; Aguilera-Montilla, Noemi; Garcia-Marco, Jose A.; Garcia-Pardo, Angeles			Matrix Metalloproteinase-9 Is Involved in Chronic Lymphocytic Leukemia Cell Response to Fludarabine and Arsenic Trioxide	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ALPHA-4-BETA-1 INTEGRIN; B-CELLS; MATRIX METALLOPROTEINASES; SIGNALING PATHWAYS; MOLECULAR-BIOLOGY; INDUCED APOPTOSIS; GELATINASE-B; CLL; MICROENVIRONMENT	Background: Matrix metalloproteinase-9 (MMP-9) contributes to chronic lymphocytic leukemia (CLL) pathology by regulating cell migration and preventing spontaneous apoptosis. It is not known if MMP-9 is involved in CLL cell response to chemotherapy and we address this in the present study, using arsenic trioxide (ATO) and fludarabine as examples of cytotoxic drugs. Methods: We used primary cells from the peripheral blood of CLL patients and MEC-1 cells stably transfected with an empty vector or a vector containing MMP-9. The effect of ATO and fludarabine was determined by flow cytometry and by the MTT assay. Expression of mRNA was measured by RT-PCR and qPCR. Secreted and cell-bound MMP-9 was analyzed by gelatin zymography and flow cytometry, respectively. Protein expression was analyzed by Western blotting and immunoprecipitation. Statistical analyses were performed using the two-tailed Student's t-test. Results: In response to ATO or fludarabine, CLL cells transcriptionally upregulated MMP-9, preceding the onset of apoptosis. Upregulated MMP-9 primarily localized to the membrane of early apoptotic cells and blocking apoptosis with Z-VAD prevented MMP-9 upregulation, thus linking MMP-9 to the apoptotic process. Culturing CLL cells on MMP-9 or stromal cells induced drug resistance, which was overcome by anti-MMP-9 antibodies. Accordingly, MMP-9-MEC-1 transfectants showed higher viability upon drug treatment than Mock-MEC-1 cells, and this effect was blocked by silencing MMP-9 with specific siRNAs. Following drug exposure, expression of anti-apoptotic proteins (Mcl-1, Bcl-xL, Bcl-2) and the Mcl-1/Bim, Mcl-1/Noxa, Bcl-2/Bax ratios were higher in MMP-9-cells than in Mock-cells. Similar results were obtained upon culturing primary CLL cells on MMP-9. Conclusions: Our study describes for the first time that MMP-9 induces drug resistance by modulating proteins of the Bcl-2 family and upregulating the corresponding anti-apoptotic/pro-apoptotic ratios. This is a novel role for MMP-9 contributing to CLL progression. Targeting MMP-9 in combined therapies may thus improve CLL response to treatment.	[Amigo-Jimenez, Irene; Bailon, Elvira; Ugarte-Berzal, Estefania; Aguilera-Montilla, Noemi; Garcia-Pardo, Angeles] CSIC, Ctr Invest Biol, Cellular & Mol Med Dept, Madrid, Spain; [Garcia-Marco, Jose A.] Hosp Univ Puerta Hierro, Hematol Unit, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Hospital Puerta de Hierro-Majadahonda	Garcia-Pardo, A (corresponding author), CSIC, Ctr Invest Biol, Cellular & Mol Med Dept, Madrid, Spain.	agarciapardo@cib.csic.es	Garcia Marco, Jose/H-2554-2015; Garcia Pardo, Angeles/G-5987-2015; Bailón, Elvira/G-5057-2015; Aguilera-Montilla, Noemi/G-4277-2015	Garcia Marco, Jose/0000-0002-8993-5982; Garcia Pardo, Angeles/0000-0001-5577-2954; Aguilera-Montilla, Noemi/0000-0002-6925-6069	Ministry of Economy and Competitiveness (MINECO), Spain [SAF2012-31613, RD12/0036/0061]; Comunidad de Madrid/European Union [S2010/BMD-2314-Neoplasbim]; Fundacioen Puerta de Hierro, Madrid; Junta de Ampliacion de Estudios program, CSIC/EU, Spain	Ministry of Economy and Competitiveness (MINECO), Spain; Comunidad de Madrid/European Union; Fundacioen Puerta de Hierro, Madrid; Junta de Ampliacion de Estudios program, CSIC/EU, Spain	This work was supported by grants SAF2012-31613 (AGP) and RTICC (Red Tematica de Investigacion Cooperativa en Cancer) RD12/0036/0061 (AGP), from the Ministry of Economy and Competitiveness (MINECO), Spain; S2010/BMD-2314-Neoplasbim (AGP) from the Comunidad de Madrid/European Union; and by a grant from the Fundacioen Puerta de Hierro, Madrid (JAGM). IAJ and EB were were supported by the Junta de Ampliacion de Estudios program, CSIC/EU, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailon E, 2014, J LEUK BIOL IN PRESS; Balakrishnan K, 2009, BLOOD, V113, P149, DOI 10.1182/blood-2008-02-138560; Bauvois B, 2002, LEUKEMIA, V16, P791, DOI 10.1038/sj.leu.2402472; Baysan A, 2007, INT J ONCOL, V30, P313; Buchner M, 2010, BLOOD, V115, P4497, DOI 10.1182/blood-2009-07-233692; Burger JA, 2014, SEMIN CANCER BIOL, V24, P71, DOI 10.1016/j.semcancer.2013.08.011; Burger JA, 2012, CURR OPIN ONCOL, V24, P643, DOI 10.1097/CCO.0b013e3283589950; Chetty C, 2010, MOL CANCER THER, V9, P2605, DOI 10.1158/1535-7163.MCT-10-0245; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; de la Fuente MT, 2002, J LEUKOCYTE BIOL, V71, P495; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Gaidano G, 2012, J CLIN INVEST, V122, P3432, DOI 10.1172/JCI64101; Gandhi V, 2008, BLOOD, V112, P3538, DOI 10.1182/blood-2008-07-170241; Gingis-Velitski S, 2011, CANCER RES, V71, P6986, DOI 10.1158/0008-5472.CAN-11-0629; Hallek M, 2013, AM J HEMATOL, V88, P803, DOI 10.1002/ajh.23491; Jayo A, 2010, HAEMATOL-HEMATOL J, V95, P1158, DOI 10.3324/haematol.2009.018572; Lunghi P, 2008, BLOOD, V112, P2450, DOI 10.1182/blood-2007-10-114348; Mannello F, 2005, APOPTOSIS, V10, P19, DOI 10.1007/s10495-005-6058-7; Merkel O, 2008, J MOL MED-JMM, V86, P541, DOI 10.1007/s00109-008-0314-6; Meyer E, 2005, CANCER RES, V65, P4261, DOI 10.1158/0008-5472.CAN-04-2908; Mi JQ, 2012, LEUKEMIA, V26, P1743, DOI 10.1038/leu.2012.57; Morales AA, 2008, BLOOD, V111, P5152, DOI 10.1182/blood-2007-10-116889; MORODOMI T, 1992, BIOCHEM J, V285, P603, DOI 10.1042/bj2850603; Nyormoi O, 2003, CELL DEATH DIFFER, V10, P558, DOI 10.1038/sj.cdd.4401209; Pleyer L, 2009, NAT REV CLIN ONCOL, V6, P405, DOI 10.1038/nrclinonc.2009.72; Ramsay AD, 2013, BRIT J HAEMATOL, V162, P15, DOI 10.1111/bjh.12344; Redondo-Munoz J, 2008, BLOOD, V112, P169, DOI 10.1182/blood-2007-08-109249; Redondo-Munoz J, 2008, BLOOD, V111, P383, DOI 10.1182/blood-2007-08-107300; Redondo-Munoz J, 2006, BLOOD, V108, P3143, DOI 10.1182/blood-2006-03-007294; Redondo-Munoz J, 2010, CLIN CANCER RES, V16, P4382, DOI 10.1158/1078-0432.CCR-10-0072; Redondo-Munoz J, 2010, CANCER CELL, V17, P160, DOI 10.1016/j.ccr.2009.12.044; Sharma A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.155; Shooshtari P, 2010, CYTOM PART A, V77A, P873, DOI 10.1002/cyto.a.20943; Stacchini A, 1999, LEUKEMIA RES, V23, P127, DOI 10.1016/S0145-2126(98)00154-4; Stephens DM, 2013, HEMATOL ONCOL CLIN N, V27, P303, DOI 10.1016/j.hoc.2012.12.003; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Wang R, 2013, LEUKEMIA, V27, P315, DOI 10.1038/leu.2012.180; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Zeng Z, 2006, MOL CANCER THER, V5, P3113, DOI 10.1158/1535-7163.MCT-06-0228; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764	41	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99993	10.1371/journal.pone.0099993	http://dx.doi.org/10.1371/journal.pone.0099993			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956101	Green Published, gold			2022-12-25	WOS:000338917900023
J	Omori, H; Onoue, A; Katoh, T; Ogata, Y; Kawashima, H; Miyao, N; Tsuji, T; Aoshiba, K; Nagai, A; Yamaguchi, K				Omori, Hisamitsu; Onoue, Ayumi; Katoh, Takahiko; Ogata, Yasuhiro; Kawashima, Hidetoshi; Miyao, Naoki; Tsuji, Takao; Aoshiba, Kazutetsu; Nagai, Atsushi; Yamaguchi, Kazuhiro			A Large Cohort Study Concerning Age-Dependent Impacts of Anthropometric Variables on Spirometric Parameters in Nonsmoking Healthy Adults	PLOS ONE			English	Article							FAT-FREE MASS; LUNG-FUNCTION; REFERENCE EQUATIONS; PULMONARY-FUNCTION; REFERENCE VALUES; REFERENCE RANGES; BODY-WEIGHT; POPULATION; CAPACITY; WOMEN	Backgrounds: Although height (H) has been considered the principal anthropometric variable governing lung function, the age-dependent differences in its influences on determining spirometric parameters (SPs) have not been conclusively investigated. Moreover, there has been no study centered on age-dependent effects of other anthropometric variables, including body weight (BW) and body fat mass (BFM) on SPs. In addition, the age-dependent influences of these anthropometric variables are anticipated to differ quantitatively between male and female participants. Methods: A total of 16,919 nonsmoking healthy Japanese adults (men: 6,116, women: 10,803) were partitioned into six groups stratified by gender and age at intervals of 20-years: young-, middle-, and advanced-age groups of either gender. Using a model in which a SP was described by a logarithmic additive function of age, H, BW, and BFM, we determined the partial regression coefficients of the respective anthropometric variables to predict the reference means of SPs, including FVC, FEV1, FEV1/FVC, PEF, FEF50, and FEF75, in the six groups. Results/Discussion: Although the impact of H on FVC and FEV1 was relatively homogeneous irrespective of gender and age, its homogeneity faded for flow parameters, particularly in the female middle-and advanced-age groups, indicating that the age-dependent contribution of H to SPs was enhanced more in women. The impact of BW on SPs differed depending on age, and this effect was also more conspicuous for female participants. H and BW generally exerted positive effects on SPs, whereas BFM had negative effects. Opposite effects of BW and BFM were observed in the female middle-age group in particular. Conclusions: The effects of anthropometric variables on spirometric parameters are highly age-dependent, particularly in women, leading to the conclusion that the assumption of age-independent, constant partial regression coefficients of anthropometric variables while predicting the reference mean of a certain spirometric parameter may result in substantial errors.	[Omori, Hisamitsu] Kumamoto Univ, Dept Biomed Lab Sci, Kumamoto, Japan; [Onoue, Ayumi; Katoh, Takahiko] Kumamoto Univ, Fac Life Sci, Dept Publ Hlth, Kumamoto, Japan; [Ogata, Yasuhiro; Kawashima, Hidetoshi] Japanese Red Cross Kumamoto, Hlth Care Ctr, Kumamoto, Japan; [Miyao, Naoki] Nihon Koukan Hosp, Kawasaki, Kanagawa, Japan; [Tsuji, Takao; Aoshiba, Kazutetsu] Tokyo Med Univ, Ibaraki Med Ctr, Dept Resp Med, Ibaraki, Japan; [Nagai, Atsushi] Tokyo Womens Med Univ, Dept Med 1, Tokyo, Japan; [Yamaguchi, Kazuhiro] Tokyo Womens Med Univ, Med Ctr East, Tokyo, Japan	Kumamoto University; Kumamoto University; Tokyo Medical University; Tokyo Women's Medical University; Tokyo Women's Medical University	Yamaguchi, K (corresponding author), Tokyo Womens Med Univ, Med Ctr East, Tokyo, Japan.	yamaguc@sirius.ocn.ne.jp			Teijin Home Healthcare Limited Japan [873]	Teijin Home Healthcare Limited Japan	The present study was undertaken using the research funds (Consent No. 873) donated from Teijin Home Healthcare Limited Japan (http://www.teijin.co.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEN Y, 1993, THORAX, V48, P375, DOI 10.1136/thx.48.4.375; Chinn DJ, 1996, THORAX, V51, P699, DOI 10.1136/thx.51.7.699; Cole TJ, 2009, STAT MED, V28, P880, DOI 10.1002/sim.3504; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Cotes JE, 2001, THORAX, V56, P839, DOI 10.1136/thorax.56.11.839; COTES JE, 1979, ANN HUM BIOL, V6, P307, DOI 10.1080/03014467900003691; Cotes JE, 1993, LUNG FUNCTION; Garcia-Rio F, 2004, EUR RESPIR J, V24, P397, DOI 10.1183/09031936.04.00088403; Garcia-Rio F, 2009, AM J RESP CRIT CARE, V180, P1083, DOI 10.1164/rccm.200901-0127OC; GORE CJ, 1995, EUR RESPIR J, V8, P773; HALL AM, 1979, THORAX, V34, P359, DOI 10.1136/thx.34.3.359; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; JENKINS SC, 1991, RESP MED, V85, P309, DOI 10.1016/S0954-6111(06)80102-2; Lung Function in Growth and Aging, 2012, PUBL REF VAL; MENGESHA YA, 1985, THORAX, V40, P465, DOI 10.1136/thx.40.6.465; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mohamed EI, 2002, LUNG, V180, P149, DOI 10.1007/s004080000089; Pistelli F, 2000, AM J RESP CRIT CARE, V161, P899, DOI 10.1164/ajrccm.161.3.9906006; Quanjer P, 2012, GAMLSS ACTION ANNOTA; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; SCHOENBERG JB, 1978, RESP PHYSIOL, V33, P367, DOI 10.1016/0034-5687(78)90063-4; Stanojevic S, 2008, AM J RESP CRIT CARE, V177, P253, DOI 10.1164/rccm.200708-1248OC; Stocks J, 2012, TF 2009 03 ESTABLISH; Wu YH, 2009, J OCCUP HEALTH, V51, P471, DOI 10.1539/joh.L9006; [No title captured]	25	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100733	10.1371/journal.pone.0100733	http://dx.doi.org/10.1371/journal.pone.0100733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955585	Green Published, gold, Green Submitted			2022-12-25	WOS:000338917900091
J	Toutounchian, JJ; Steinle, JJ; Makena, PS; Waters, CM; Wilson, MW; Haik, BG; Miller, DD; Yates, CR				Toutounchian, Jordan J.; Steinle, Jena J.; Makena, Patrudu S.; Waters, Christopher M.; Wilson, Matthew W.; Haik, Barrett G.; Miller, Duane D.; Yates, Charles R.			Modulation of Radiation Injury Response in Retinal Endothelial Cells by Quinic Acid Derivative KZ-41 Involves p38 MAPK	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; OXYGEN-INDUCED RETINOPATHY; PROTEIN-KINASE INHIBITORS; COMS RANDOMIZED TRIAL; CHOROIDAL MELANOMA; GROWTH-FACTOR; IODINE-125 BRACHYTHERAPY; SIGNAL-TRANSDUCTION; ICAM-1 EXPRESSION; PLAQUE RADIOTHERAPY	Radiation-induced damage to the retina triggers leukostasis, retinal endothelial cell (REC) death, and subsequent hypoxia. Resultant ischemia leads to visual loss and compensatory retinal neovascularization (RNV). Using human RECs, we demonstrated that radiation induced leukocyte adhesion through mechanisms involving p38MAPK, p53, and ICAM-1 activation. Additional phenotypic changes included p38MAPK-dependent tyrosine phosphorylation of the focal adhesion scaffolding protein, paxillin (Tyr118). The quinic acid derivative KZ-41 lessened leukocyte adhesion and paxillin-dependent proliferation via inhibition of p38MAPK-p53-ICAM-1 signaling. Using the murine oxygen-induced retinopathy (OIR) model, we examined the effect of KZ-41 on pathologic RNV. Daily ocular application of a KZ-41-loaded nanoemulsion significantly reduced both the avascular and neovascular areas in harvested retinal flat mounts when compared to the contralateral eye receiving vehicle alone. Our data highlight the potential benefit of KZ-41 in reducing both the retinal ischemia and neovascularization provoked by genotoxic insults. Further research into how quinic acid derivatives target and mitigate inflammation is needed to fully appreciate their therapeutic potential for the treatment of inflammatory retinal vasculopathies.	[Toutounchian, Jordan J.; Steinle, Jena J.; Miller, Duane D.; Yates, Charles R.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Steinle, Jena J.; Wilson, Matthew W.; Haik, Barrett G.; Yates, Charles R.] Univ Tennessee, Ctr Hlth Sci, Dept Ophthalmol, Memphis, TN 38163 USA; [Steinle, Jena J.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Makena, Patrudu S.; Waters, Christopher M.] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Yates, CR (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA.	cyates4@uthsc.edu		Steinle, Jena/0000-0002-7539-2892	College of Pharmacy (Pharmaceutical Sciences), National Heart, Lung, and Blood Institute (NHLBI) [HL094366]; College of Medicine (Ophthalmology), National Heart, Lung, and Blood Institute (NHLBI) [HL094366]; National Institute of Allergy and Infectious Diseases (NIAID) [R33 AI080534-01]; Dept. of Ophthalmology from Research to Prevent Blindness, NY, NY; National Eye Institute (NEI) Vision Core Grant [PHS 3P30, EY013080]; St. Giles Foundation; NATIONAL EYE INSTITUTE [P30EY013080, P30EY021721] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI080534] Funding Source: NIH RePORTER	College of Pharmacy (Pharmaceutical Sciences), National Heart, Lung, and Blood Institute (NHLBI); College of Medicine (Ophthalmology), National Heart, Lung, and Blood Institute (NHLBI); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Dept. of Ophthalmology from Research to Prevent Blindness, NY, NY; National Eye Institute (NEI) Vision Core Grant; St. Giles Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Colleges of Pharmacy (Pharmaceutical Sciences) and Medicine (Ophthalmology), National Heart, Lung, and Blood Institute (NHLBI) grant HL094366, and National Institute of Allergy and Infectious Diseases (NIAID) R33 AI080534-01 (Duane D. Miller). This work was supported by an unrestricted grant to the Dept. of Ophthalmology from Research to Prevent Blindness, NY, NY; a National Eye Institute (NEI) Vision Core Grant: PHS 3P30, EY013080; and an unrestricted grant from the St. Giles Foundation. This technology has a US patent number (8,115,031) and is owned by the University of Tennessee Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsaid MA, 2010, J PHARMACOL EXP THER, V332, P125, DOI 10.1124/jpet.109.157941; Alon R, 1996, J CELL BIOL, V135, P849, DOI 10.1083/jcb.135.3.849; Ammar HO, 2009, AAPS PHARMSCITECH, V10, P808, DOI 10.1208/s12249-009-9268-4; ARCHER D B, 1991, Eye (London), V5, P239; Archer D B, 1994, Curr Opin Ophthalmol, V5, P59, DOI 10.1097/00055735-199406000-00011; Arnold TD, 2012, J NEUROSCI, V32, P1197, DOI 10.1523/JNEUROSCI.5648-11.2012; Avery RB, 2008, ARCH OPHTHALMOL-CHIC, V126, P207, DOI 10.1001/archophthalmol.2007.50; Bai YY, 2011, EXP MOL PATHOL, V91, P471, DOI 10.1016/j.yexmp.2011.04.016; Beinke C, 2003, INT J RADIAT BIOL, V79, P721, DOI 10.1080/09553000310001610231; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Bianciotto C, 2010, OPHTHALMOLOGY, V117, P1005, DOI 10.1016/j.ophtha.2009.10.015; BROWN GC, 1982, OPHTHALMOLOGY, V89, P1494; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Burns AR, 1999, J LEUKOCYTE BIOL, V65, P299, DOI 10.1002/jlb.65.3.299; Chang WC, 2010, EUR J NUTR, V49, P267, DOI 10.1007/s00394-009-0083-1; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Diener-West M, 2001, ARCH OPHTHALMOL-CHIC, V119, P969; Figueroa Marta S, 2011, Retin Cases Brief Rep, V5, P171, DOI 10.1097/ICB.0b013e3181d427ed; Finger PT, 2009, OPHTHALMOLOGY, V116, P790, DOI 10.1016/j.ophtha.2008.12.027; FRANGOS JA, 1988, BIOTECHNOL BIOENG, V32, P1053, DOI 10.1002/bit.260320812; Funatsu H, 2005, OPHTHALMOLOGY, V112, P806, DOI 10.1016/j.ophtha.2004.11.045; Gaber MW, 2003, INT J RADIAT BIOL, V79, P359, DOI 10.1080/0955300031000114738; Giuliari GP, 2011, ACTA ONCOL, V50, P6, DOI 10.3109/0284186X.2010.500299; Gorgoulis VG, 2003, EMBO J, V22, P1567, DOI 10.1093/emboj/cdg157; GRAGOUDAS ES, 1987, OPHTHALMOLOGY, V94, P349; Gunduz K, 1999, AM J OPHTHALMOL, V127, P579, DOI 10.1016/S0002-9394(98)00445-0; Haas A, 2002, OPHTHALMOLOGY, V109, P909, DOI 10.1016/S0161-6420(02)01011-4; Hiroshiba N, 1999, INVEST OPHTH VIS SCI, V40, P1217; Huang CS, 1999, J BIOL CHEM, V274, P12229, DOI 10.1074/jbc.274.18.12229; Ishida S, 2003, NAT MED, V9, P781, DOI 10.1038/nm877; Jampol LM, 2002, OPHTHALMOLOGY, V109, P2197, DOI 10.1016/S0161-6420(02)01277-0; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Jung JW, 2007, EUR J CANCER, V43, P1214, DOI 10.1016/j.ejca.2007.01.034; Kanno S, 2000, ONCOGENE, V19, P2138, DOI 10.1038/sj.onc.1203533; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kornberg LJ, 2004, INVEST OPHTH VIS SCI, V45, P4463, DOI 10.1167/iovs.03-1201; Langston W, 2007, FREE RADICAL BIO MED, V42, P720, DOI 10.1016/j.freeradbiomed.2006.12.010; LAWRENCE MB, 1987, BLOOD, V70, P1284; McCarty OJT, 2000, BLOOD, V96, P1789, DOI 10.1182/blood.V96.5.1789.h8001789_1789_1797; Meineke V, 2002, INT J RADIAT BIOL, V78, P577, DOI 10.1080/09553000110113056; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; PANES J, 1995, GASTROENTEROLOGY, V108, P1761, DOI 10.1016/0016-5085(95)90138-8; Radisavljevic Z, 2000, J BIOL CHEM, V275, P20770, DOI 10.1074/jbc.M002448200; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; Shafiq-Un-Nabi S, 2007, AAPS PHARMSCITECH, V8, DOI 10.1208/pt0802028; She QB, 2000, J BIOL CHEM, V275, P20444, DOI 10.1074/jbc.M001020200; Shields CL, 2002, OPHTHALMOLOGY, V109, P1838, DOI 10.1016/S0161-6420(02)01181-8; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stahl A, 2009, ANGIOGENESIS, V12, P297, DOI 10.1007/s10456-009-9155-3; Steinle JJ, 2012, INVEST OPHTH VIS SCI, V53, P2439, DOI 10.1167/iovs.12-9466; Steinle JJ, 2012, INVEST OPHTHALMOL VI; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Thompson KE, 2014, DRUG DISCOV IN PRESS; Wagers AJ, 1998, J EXP MED, V188, P2225, DOI 10.1084/jem.188.12.2225; Wang XJ, 1997, J RADIAT RES, V38, P179, DOI 10.1269/jrr.38.179; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yan WS, 2002, SHOCK, V17, P433, DOI 10.1097/00024382-200205000-00016; Yates CR, 2013, Provisional US Patent Application, Patent No. [14/074,457, 14074457]; Yates CR, 2012, US Patent, Patent No. [2012/0283331 A1, 20120283331]; Yu YM, 2007, BRIT J NUTR, V97, P692, DOI 10.1017/S0007114507666409; Yusuf-Makagiansar H, 2002, MED RES REV, V22, P146, DOI 10.1002/med.10001; ZAMBER RW, 1992, WESTERN J MED, V157, P530; Zeng K, 2009, BIOORG MED CHEM LETT, V19, P5458, DOI 10.1016/j.bmcl.2009.07.096; Zhang QH, 2013, INVEST OPHTH VIS SCI, V54, P5937, DOI 10.1167/iovs.13-12326; Zhang QH, 2011, J BIOL CHEM, V286, P22489, DOI 10.1074/jbc.M110.217786	70	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100210	10.1371/journal.pone.0100210	http://dx.doi.org/10.1371/journal.pone.0100210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956278	Green Submitted, gold, Green Published			2022-12-25	WOS:000338917900034
J	Littlejohns, B; Pasdois, P; Duggan, S; Bond, AR; Heesom, K; Jackson, CL; Angelini, GD; Halestrap, AP; Suleiman, MS				Littlejohns, Ben; Pasdois, Philippe; Duggan, Simon; Bond, Andrew R.; Heesom, Kate; Jackson, Christopher L.; Angelini, Gianni D.; Halestrap, Andrew P.; Suleiman, M. -Saadeh			Hearts from Mice Fed a Non-Obesogenic High-Fat Diet Exhibit Changes in Their Oxidative State, Calcium and Mitochondria in Parallel with Increased Susceptibility to Reperfusion Injury	PLOS ONE			English	Article							METABOLIC INHIBITION; CARDIAC DYSFUNCTION; INTRACELLULAR CA2+; ACID-METABOLISM; INDUCED OBESITY; ISOLATED RAT; GUINEA-PIG; INSULIN; CARDIOMYOCYTES; RETICULUM	Rationale: High-fat diet with obesity-associated co-morbidities triggers cardiac remodeling and renders the heart more vulnerable to ischemia/reperfusion injury. However, the effect of high-fat diet without obesity and associated co-morbidities is presently unknown. Objectives: To characterize a non-obese mouse model of high-fat diet, assess the vulnerability of hearts to reperfusion injury and to investigate cardiac cellular remodeling in relation to the mechanism(s) underlying reperfusion injury. Methods and Results: Feeding C57BL/6J male mice high-fat diet for 20 weeks did not induce obesity, diabetes, cardiac hypertrophy, cardiac dysfunction, atherosclerosis or cardiac apoptosis. However, isolated perfused hearts from mice fed high-fat diet were more vulnerable to reperfusion injury than those from mice fed normal diet. In isolated cardiomyocytes, high-fat diet was associated with higher diastolic intracellular Ca2+ concentration and greater damage to isolated cardiomyocytes following simulated ischemia/reperfusion. High-fat diet was also associated with changes in mitochondrial morphology and expression of some related proteins but not mitochondrial respiration or reactive oxygen species turnover rates. Proteomics, western blot and high-performance liquid chromatography techniques revealed that high-fat diet led to less cardiac oxidative stress, higher catalase expression and significant changes in expression of putative components of the mitochondrial permeability transition pore (mPTP). Inhibition of the mPTP conferred relatively more cardio-protection in the high-fat fed mice compared to normal diet. Conclusions: This study shows for the first time that high-fat diet, independent of obesity-induced co-morbidities, triggers changes in cardiac oxidative state, calcium handling and mitochondria which are likely to be responsible for increased vulnerability to cardiac insults.	[Littlejohns, Ben; Bond, Andrew R.; Jackson, Christopher L.; Angelini, Gianni D.; Suleiman, M. -Saadeh] Univ Bristol, Sch Clin Sci, Fac Med & Dent, Bristol Heart Inst, Bristol, Avon, England; [Pasdois, Philippe] Univ Bordeaux, Inst Rythmol & Modelisat Cardiaque, Pessac, France; [Duggan, Simon] John Radcliffe Hosp, Oxford Heart Ctr, Oxford OX3 9DU, England; [Heesom, Kate] Univ Bristol, Fac Med & Vet Sci, Prote Facil, Bristol, Avon, England; [Halestrap, Andrew P.] Univ Bristol, Sch Biochem, Fac Med & Vet Sci, Bristol, Avon, England	University of Bristol; UDICE-French Research Universities; Universite de Bordeaux; University of Oxford; University of Bristol; University of Bristol	Suleiman, MS (corresponding author), Univ Bristol, Sch Clin Sci, Fac Med & Dent, Bristol Heart Inst, Bristol, Avon, England.	M.S.Suleiman@bristol.ac.uk	Bond, Andrew/AAC-5941-2020; Pasdois, Philippe/AAH-9365-2020; Duggan, Simon/AAG-4404-2020; Suleiman, M.-Saadeh/AAF-2946-2019	Bond, Andrew/0000-0002-4255-4488; Pasdois, Philippe/0000-0002-2385-4469; angelini, gianni/0000-0002-1753-3730; Suleiman, M.-Saadeh/0000-0001-6080-480X; Halestrap, Andrew/0000-0001-5374-2778	British Heart Foundation [FS/11/57/28936]; National Institute for Health Research Bristol Biomedical Research Unit in Cardiovascular Disease; British Heart Foundation [RG/08/001/24717] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10022] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); National Institute for Health Research Bristol Biomedical Research Unit in Cardiovascular Disease; British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the British Heart Foundation (www.bhf.org.uk) grant number FS/11/57/28936. The authors also acknowledge the support of the National Institute for Health Research Bristol Biomedical Research Unit in Cardiovascular Disease. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adameova A, 2006, PHARMAZIE, V61, P807; Alpert MA, 2001, AM J MED SCI, V321, P225, DOI 10.1097/00000441-200104000-00003; Anflous-Pharayra K, 2007, BBA-BIOENERGETICS, V1767, P136, DOI 10.1016/j.bbabio.2006.11.013; Ballal K, 2010, MOL CELL BIOCHEM, V344, P221, DOI 10.1007/s11010-010-0546-y; Belke DD, 2004, DIABETES, V53, P3201, DOI 10.2337/diabetes.53.12.3201; Bonnard C, 2008, DIABETES METAB, V34, P52, DOI 10.1016/j.diabet.2007.09.006; Boudina S, 2012, DIABETES, V61, P3260, DOI 10.2337/db12-0063; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Calligaris SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060931; Chase A, 2007, CRIT CARE MED, V35, P2344, DOI 10.1097/01.CCM.0000282085.63409.FB; Chen Q, 2007, AM J PHYSIOL-CELL PH, V292, pC137, DOI 10.1152/ajpcell.00270.2006; Chess DJ, 2008, CARDIOVASC RES, V79, P269, DOI 10.1093/cvr/cvn074; Cole MA, 2011, BASIC RES CARDIOL, V106, P447, DOI 10.1007/s00395-011-0156-1; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Dabkowski ER, 2009, AM J PHYSIOL-HEART C, V296, pH359, DOI 10.1152/ajpheart.00467.2008; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; Diano S, 2011, NAT MED, V17, P1121, DOI 10.1038/nm.2421; Gallou-Kabani C, 2007, OBESITY, V15, P1996, DOI 10.1038/oby.2007.238; Griffiths EJ, 1998, BIOCHEM PHARMACOL, V56, P173, DOI 10.1016/S0006-2952(98)00016-1; Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1402, DOI 10.1016/j.bbabio.2008.12.017; Halestrap AP, 2009, J BIOENERG BIOMEMBR, V41, P113, DOI 10.1007/s10863-009-9206-x; HALLFRISCH J, 1981, J NUTR, V111, P531, DOI 10.1093/jn/111.3.531; Harmancey R, 2008, HYPERTENSION, V52, P181, DOI 10.1161/HYPERTENSIONAHA.108.110031; Harper CR, 2001, ARCH INTERN MED, V161, P2185, DOI 10.1001/archinte.161.18.2185; Hom J, 2010, BBA-BIOENERGETICS, V1797, P913, DOI 10.1016/j.bbabio.2010.03.018; Howarth FC, 2005, MOL CELL BIOCHEM, V273, P87, DOI 10.1007/s11010-005-7758-6; Hwang H, 2009, CIRCULATION, V120, pS16, DOI 10.1161/CIRCULATIONAHA.108.844167; John S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017674; Johnson JL, 2006, CARDIOVASC RES, V71, P586, DOI 10.1016/j.cardiores.2006.05.009; Johnson JL, 2001, ATHEROSCLEROSIS, V154, P399, DOI 10.1016/S0021-9150(00)00515-3; Khaliulin I, 2011, EXP BIOL MED, V236, P736, DOI 10.1258/ebm.2011.010357; Lee J, 2013, J MOL MED, V91, P965, DOI 10.1007/s00109-013-1013-5; Liu J, 2013, NUTR RES, V33, P311, DOI 10.1016/j.nutres.2013.02.005; Lopaschuk GD, 2007, CIRC RES, V101, P335, DOI 10.1161/CIRCRESAHA.107.150417; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Ma KL, 2013, INT J MED SCI, V10, P420, DOI 10.7150/ijms.5723; Mateos R, 2004, J CHROMATOGR B, V805, P33, DOI 10.1016/j.jchromb.2004.02.004; MILLS E, 1993, AM J PHYSIOL, V264, pR73, DOI 10.1152/ajpregu.1993.264.1.R73; Noyan-Ashraf MH, 2013, CIRCULATION, V127, P74, DOI 10.1161/CIRCULATIONAHA.112.091215; Olofsson CS, 2004, J PHYSIOL-LONDON, V557, P935, DOI 10.1113/jphysiol.2004.066258; Ong SB, 2010, CARDIOVASC RES, V88, P16, DOI 10.1093/cvr/cvq237; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Ouwens DM, 2005, DIABETOLOGIA, V48, P1229, DOI 10.1007/s00125-005-1755-x; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Panagia M, 2005, AM J PHYSIOL-HEART C, V288, pH2677, DOI 10.1152/ajpheart.00200.2004; Papanicolaou KN, 2012, AM J PHYSIOL-HEART C, V302, pH167, DOI 10.1152/ajpheart.00833.2011; Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10; Pasdois P, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005645; Pasdois P, 2011, BIOCHEM J, V436, P493, DOI 10.1042/BJ20101957; Pereira L, 2006, DIABETES, V55, P608, DOI 10.2337/diabetes.55.03.06.db05-1284; Piquereau J, 2012, CARDIOVASC RES, V94, P408, DOI 10.1093/cvr/cvs117; REISER S, 1977, J NUTR, V107, P147, DOI 10.1093/jn/107.1.147; REISER S, 1979, AM J CLIN NUTR, V32, P2206, DOI 10.1093/ajcn/32.11.2206; Relling DP, 2006, J HYPERTENS, V24, P549, DOI 10.1097/01.hjh.0000203846.34314.94; Rennison JH, 2009, J MOL CELL CARDIOL, V46, P883, DOI 10.1016/j.yjmcc.2009.02.019; Rindler PM, 2013, J BIOL CHEM, V288, P1979, DOI 10.1074/jbc.M112.412890; Saini HK, 2005, AM J PHYSIOL-HEART C, V288, pH2260, DOI 10.1152/ajpheart.01153.2004; Saini-Chohan HK, 2009, CAN J PHYSIOL PHARM, V87, P1110, DOI 10.1139/Y09-103; Schreyer SA, 1998, ATHEROSCLEROSIS, V136, P17, DOI 10.1016/S0021-9150(97)00165-2; Seifert EL, 2010, J BIOL CHEM, V285, P5748, DOI 10.1074/jbc.M109.026203; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Temsah RM, 1999, AM J PHYSIOL-HEART C, V277, pH584, DOI 10.1152/ajpheart.1999.277.2.H584; Thakker GD, 2006, AM J PHYSIOL-HEART C, V291, pH2504, DOI 10.1152/ajpheart.00322.2006; Thakker GD, 2008, OBESITY, V16, P2593, DOI 10.1038/oby.2008.414; Toida S, 1996, OBES RES, V4, P561, DOI 10.1002/j.1550-8528.1996.tb00270.x; Unger RH, 2003, TRENDS ENDOCRIN MET, V14, P398, DOI 10.1016/j.tem.2003.09.008; Varanyuwatana P, 2012, MITOCHONDRION, V12, P120, DOI 10.1016/j.mito.2011.04.006; Wang PP, 2008, LIFE SCI, V83, P836, DOI 10.1016/j.lfs.2008.09.024; Williams H, 2000, EXP PHYSIOL, V85, P505, DOI 10.1017/S095806700002025X; Williams H, 2001, J MOL CELL CARDIOL, V33, P2109, DOI 10.1006/jmcc.2000.1474; Williams TD, 2003, CLIN EXP PHARMACOL P, V30, P769, DOI 10.1046/j.1440-1681.2003.t01-1-03808.x; Williamson CL, 2010, AM J PHYSIOL-HEART C, V298, pH633, DOI 10.1152/ajpheart.00668.2009; Wilson CR, 2007, BIOCHEM J, V406, P457, DOI 10.1042/BJ20070392; Woodfield K, 1998, BIOCHEM J, V336, P287, DOI 10.1042/bj3360287; Wright JJ, 2009, CARDIOVASC RES, V82, P351, DOI 10.1093/cvr/cvp017; Xu KY, 1997, CIRC RES, V80, P76, DOI 10.1161/01.RES.80.1.76; Yu TZ, 2008, CARDIOVASC RES, V79, P341, DOI 10.1093/cvr/cvn104; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	80	46	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100579	10.1371/journal.pone.0100579	http://dx.doi.org/10.1371/journal.pone.0100579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950187	Green Published, gold, Green Submitted			2022-12-25	WOS:000338276300093
J	Shi, R; Yang, X; Chen, L; Chang, HT; Liu, HY; Zhao, J; Wang, XW; Wang, CQ				Shi, Run; Yang, Xia; Chen, Lu; Chang, Hong-tao; Liu, Hong-ying; Zhao, Jun; Wang, Xin-wei; Wang, Chuan-qing			Pathogenicity of Shigella in Chickens	PLOS ONE			English	Article							ANIMAL-MODEL; GUINEA-PIG; FLEXNERI; INFECTION	Shigellosis in chickens was first reported in 2004. This study aimed to determine the pathogenicity of Shigella in chickens and the possibility of cross-infection between humans and chickens. The pathogenicity of Shigella in chickens was examined via infection of three-day-old SPF chickens with Shigella strain ZD02 isolated from a human patient. The virulence and invasiveness were examined by infection of the chicken intestines and primary chicken intestinal epithelial cells. The results showed Shigella can cause death via intraperitoneal injection in SPF chickens, but only induce depression via crop injection. Immunohistochemistry and transmission electron microscopy revealed the Shigella can invade the intestinal epithelia. Immunohistochemistry of the primary chicken intestinal epithelial cells infected with Shigella showed the bacteria were internalized into the epithelial cells. Electron microscopy also confirmed that Shigella invaded primary chicken intestinal epithelia and was encapsulated by phagosome-like membranes. Our data demonstrate that Shigella can invade primary chicken intestinal epithelial cells in vitro and chicken intestinal mucosa in vivo, resulting in pathogenicity and even death. The findings suggest Shigella isolated from human or chicken share similar pathogenicity as well as the possibility of human-poultry cross-infection, which is of public health significance.	[Shi, Run; Yang, Xia; Chen, Lu; Chang, Hong-tao; Liu, Hong-ying; Zhao, Jun; Wang, Xin-wei; Wang, Chuan-qing] Henan Agr Univ, Collage Anim Sci & Vet Med, Zhengzhou, Peoples R China	Henan Agricultural University	Chen, L (corresponding author), Henan Agr Univ, Collage Anim Sci & Vet Med, Zhengzhou, Peoples R China.	chenluhau@hotmail.com	Zhao, Jun/GVS-6159-2022		National Natural Science Foundation of China [30972187]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20114105110031/4boolean AND]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	The project was supported by National Natural Science Foundation of China grant 30972187 (http://www.nsfc.gov.cn) and Specialized Research Fund for the Doctoral Program of Higher Education of China grants 20114105110031/4 boolean AND http://www.cutech.edu.cn/cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashida H, 2011, CURR OPIN IMMUNOL, V23, P448, DOI 10.1016/j.coi.2011.06.001; Athman R, 2005, CELL MICROBIOL, V7, P1109, DOI 10.1111/j.1462-5822.2005.00535.x; Bardhan P, 2010, EMERG INFECT DIS, V16, P1718, DOI 10.3201/eid1611.090934; Barman S, 2011, FEMS IMMUNOL MED MIC, V62, P304, DOI 10.1111/j.1574-695X.2011.00810.x; Delaney NF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002511; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Fernandez MI, 2003, CELL MICROBIOL, V5, P481, DOI 10.1046/j.1462-5822.2003.00295.x; Franco NH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002399; Ingersoll MA, 2003, CELL MICROBIOL, V5, P797, DOI 10.1046/j.1462-5822.2003.00320.x; Jeong KI, 2010, J INFECT DIS, V201, P903, DOI 10.1086/650995; [蒋建军 Jiang Jianjun], 2005, [安徽农业科学, Journal of anhui agricultural sciences], V33, P1666; Kisiela DI, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002733; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Lafont F, 2002, EMBO J, V21, P4449, DOI 10.1093/emboj/cdf457; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Lv WQ, 2013, CLIN J VET SCI, V33, P53; Martino MC, 2005, J INFECT DIS, V192, P136, DOI 10.1086/430740; Maurelli AT, 1998, MICROB PATHOGENESIS, V25, P189, DOI 10.1006/mpat.1998.0230; MOUNIER J, 1992, INFECT IMMUN, V60, P237, DOI 10.1128/IAI.60.1.237-248.1992; MURAYAMA SY, 1986, INFECT IMMUN, V51, P696, DOI 10.1128/IAI.51.2.696-698.1986; Nhieu GTV, 2000, CELL MICROBIOL, V2, P187; NIESEL DW, 1985, J CLIN MICROBIOL, V22, P897, DOI 10.1128/JCM.22.6.897-902.1985; Ogawa M, 2008, NAT REV MICROBIOL, V6, P11, DOI 10.1038/nrmicro1814; Pan BJ, 2006, GUANGXI AGR SCI, V37, P331; Prakash R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027046; Priamukhina N S, 1984, Zh Mikrobiol Epidemiol Immunobiol, P20; RABBANI GH, 1995, INFECT IMMUN, V63, P4350, DOI 10.1128/IAI.63.11.4350-4357.1995; Rudel T, 2012, CELL HOST MICROBE, V11, P219, DOI 10.1016/j.chom.2012.02.004; [师润 Shi Run], 2013, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V44, P95; Shim DH, 2007, J IMMUNOL, V178, P2476, DOI 10.4049/jimmunol.178.4.2476; Streicker DG, 2012, P NATL ACAD SCI USA, V109, P19715, DOI 10.1073/pnas.1203456109; Toft C, 2010, NAT REV GENET, V11, P465, DOI 10.1038/nrg2798; Watarai M, 1996, J EXP MED, V183, P991, DOI 10.1084/jem.183.3.991; [许兰菊 Xu Lanju], 2004, [中国预防兽医学报, Chinase Journal of Preventive Veterinary Medicine], V26, P281; Xu LanJu, 2005, Chinese Journal of Veterinary Science, V25, P594; Xu LJ, 2004, ACTA VET ZOOTECHNICA, V35, P362; Yang JY, 2014, J INFECT DIS, V209, P203, DOI 10.1093/infdis/jit399; [杨霞 YANG Xia], 2009, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V40, P402	38	21	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100264	10.1371/journal.pone.0100264	http://dx.doi.org/10.1371/journal.pone.0100264			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949637	gold, Green Submitted, Green Published			2022-12-25	WOS:000338276300056
J	Chou, ML; Burnouf, T; Wang, TJ				Chou, Ming-Li; Burnouf, Thierry; Wang, Tsung-Jen			Ex vivo Expansion of Bovine Corneal Endothelial Cells in Xeno-Free Medium Supplemented with Platelet Releasate	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; HEPATOCYTE GROWTH-FACTOR; NEUROTROPHIC FACTOR; STEM-CELLS; SERUM; BRAIN; CULTURE; PROLIFERATION; TRANSPARENCY; KERATOPLASTY	Clinical-grade ex vivo expansion of corneal endothelial cells can increase the availability of corneal tissues for transplantation and treatment of corneal blindness. However, these cells have very limited proliferative capacity. Successful propagation has required so far to use very complex growth media supplemented with fetal bovine serum and other xenocomponents. We hypothesized that human platelet releasates rich in multiple growth factors, and in particular neurotrophins, could potentially be a useful supplement for ex vivo expansion of corneal endothelium cells due to their neural crest origin. Platelet releasates were prepared by calcium salt activation of apheresis platelet concentrates, subjected or not to complement inactivation by heat treatment at 56 degrees C for 30 minutes. Platelet releasates were characterized for their content in proteins and were found to contain high amount of growth factors including platelet-derived growth factor-AB (30.56 to 39.08 ng/ml) and brain-derived neurotrophic factor (30.57 to 37.11 ng/ml) neurotrophins. We compared the growth and viability of corneal endothelium cells in DMEM-F12 medium supplemented with different combinations of components, including 2.5%similar to 10% of the platelet releasates. Corneal endothelium cells expanded in platelet releasates exhibited good adhesion and a typical hexagonal morphology. Their growth and viability were enhanced when using the complement-inactivated platelet releasate at a concentration of 10%. Immunostaining and Western blots showed that CECs maintained the expressions of four important membrane markers: Na-K ATPase alpha 1, zona occludens-1, phospho-connexin 43 and N-cadherin. In conclusion, our study provides the first proof-of-concept that human platelet releasates can be used for ex vivo expansion of corneal endothelium cells. These findings open a new paradigm for ex vivo propagation protocols of corneal endothelium cells in compliance with good tissue culture practices and regulatory recommendations to limit the use of xenogenic materials.	[Chou, Ming-Li] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Burnouf, Thierry] Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Taipei, Taiwan; [Wang, Tsung-Jen] Taipei Med Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Wang, Tsung-Jen] Taipei Med Univ, Coll Med, Sch Med, Dept Ophthalmol, Taipei, Taiwan; [Wang, Tsung-Jen] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Wang, Tsung-Jen] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Wang, TJ (corresponding author), Taipei Med Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.	tjw@tmu.edu.tw	Burnouf, Thierry/H-4784-2019	Burnouf, Thierry/0000-0002-0507-9243	National Science Council, Taipei, Taiwan [NCS102-2320-B-038-012]; Taipei Medical University, Taipei, Taiwan [TMU101-AE1-B65]	National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University, Taipei, Taiwan	This work was funded by the National Science Council, Taipei, Taiwan (grant no. NCS102-2320-B-038-012), and Taipei Medical University, Taipei, Taiwan (grant no. TMU101-AE1-B65). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anitua E, 2014, EXP EYE RES, V119, P27, DOI 10.1016/j.exer.2013.12.005; Anitua E, 2007, BIOMATERIALS, V28, P4551, DOI 10.1016/j.biomaterials.2007.06.037; [Anonymous], 2009, EYE BANKING STAT 200; Bahar I, 2008, OPHTHALMOLOGY, V115, P1525, DOI 10.1016/j.ophtha.2008.02.010; BARFORT P, 1974, EXP EYE RES, V19, P11, DOI 10.1016/0014-4835(74)90067-0; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Burnouf T, 2011, VOX SANG, V101, P215, DOI 10.1111/j.1423-0410.2011.01486.x; Burnouf T, 2008, TRANSFUSION, V48, P1090, DOI 10.1111/j.1537-2995.2008.01691.x; Burnouf T, 2013, BLOOD REV, V27, P77, DOI 10.1016/j.blre.2013.02.001; Burnouf T, 2012, TRANSFUSION, V52, P1721, DOI 10.1111/j.1537-2995.2011.03494.x; Burnouf T, 2012, BIOLOGICALS, V40, P21, DOI 10.1016/j.biologicals.2011.09.017; Chen KH, 2002, EXP EYE RES, V75, P61, DOI 10.1006/exer.2002.1180; CHMP, 2003, CPMPBWP179302 CHMP E; Choi JS, 2010, BIOMATERIALS, V31, P6738, DOI 10.1016/j.biomaterials.2010.05.020; ENGELMANN K, 1989, IN VITRO CELL DEV B, V25, P1065; ENGELMANN K, 1988, INVEST OPHTH VIS SCI, V29, P1656; Fujimura H, 2002, THROMB HAEMOSTASIS, V87, P728; Hassell JR, 2010, EXP EYE RES, V91, P326, DOI 10.1016/j.exer.2010.06.021; Heiskanen A, 2007, STEM CELLS, V25, P197, DOI 10.1634/stemcells.2006-0444; Hemeda H, 2013, CYTOTHERAPY, V15, P1174, DOI 10.1016/j.jcyt.2013.05.006; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Horn P, 2010, CYTOTHERAPY, V12, P888, DOI 10.3109/14653249.2010.501788; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; Iserovich P, 2003, ARVO ANN M, V2003, P4734; Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016; Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4; Kimoto M, 2012, INVEST OPHTH VIS SCI, V53, P7583, DOI 10.1167/iovs.12-10146; KONONEN J, 1994, MOL BRAIN RES, V27, P347, DOI 10.1016/0169-328X(94)90022-1; Li W, 2007, INVEST OPHTH VIS SCI, V48, P614, DOI 10.1167/iovs.06-1126; Luo WJ, 2012, INT J OPHTHALMOL-CHI, V5, P419, DOI 10.3980/j.issn.2222-3959.2012.04.03; Miyamoto Takeshi, 2010, Cornea, V29 Suppl 1, pS52; Miyata K, 2001, CORNEA, V20, P59, DOI 10.1097/00003226-200101000-00012; Mojica-Henshaw MP, 2013, CYTOTHERAPY, V15, P1458, DOI 10.1016/j.jcyt.2013.06.014; MURPHY RA, 1993, J NEUROSCI, V13, P2853; Peh GSL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028310; Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01; Price MO, 2010, CLIN EXP OPHTHALMOL, V38, P128, DOI 10.1111/j.1442-9071.2010.02213.x; Radka SF, 1996, BRAIN RES, V709, P122, DOI 10.1016/0006-8993(95)01321-0; RILEY MV, 1977, EXP EYE RES, V25, P483, DOI 10.1016/0014-4835(77)90177-4; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; Robertson JS, 2006, DEV BIOLOGICALS, V123, P269; Shao Yingfeng, 2008, Yan Ke Xue Bao, V24, P9; Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.ymthe.2004.02.012; STIEMKE MM, 1991, INVEST OPHTH VIS SCI, V32, P2757; Su CY, 2009, VOX SANG, V97, P119, DOI 10.1111/j.1423-0410.2009.01180.x; Su CY, 2008, TRANSFUSION, V48, P2414, DOI 10.1111/j.1537-2995.2008.01862.x; Wang TJ, 2012, COLLOID SURFACE B, V90, P236, DOI 10.1016/j.colsurfb.2011.10.043; Wang TJ, 2012, J BIOMED MATER RES A, V100A, P252, DOI 10.1002/jbm.a.33274; WARING GO, 1982, OPHTHALMOLOGY, V89, P531; WHO, 2006, WHO GUID TISS INF DI; WILSON SE, 1994, EXP EYE RES, V59, P63, DOI 10.1006/exer.1994.1081; WILSON SE, 1993, INVEST OPHTH VIS SCI, V34, P2544; YAMAMOTO H, 1990, J NEUROSCI, V10, P3469; Yanez-Soto B, 2013, BIOMATERIALS, V34, P9244, DOI 10.1016/j.biomaterials.2013.08.042; You LT, 2000, INVEST OPHTH VIS SCI, V41, P692; Zavala J, 2013, EYE, V27, P579, DOI 10.1038/eye.2013.15; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814; Zhu YT, 2008, INVEST OPHTH VIS SCI, V49, P3879, DOI 10.1167/iovs.08-1693	58	19	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99145	10.1371/journal.pone.0099145	http://dx.doi.org/10.1371/journal.pone.0099145			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945500	Green Published, Green Submitted, gold			2022-12-25	WOS:000340721500011
J	Ha, SY; Yeo, SY; Xuan, YH; Kim, SH				Ha, Sang Yun; Yeo, So-Young; Xuan, Yan-hiua; Kim, Seok-Hyung			The Prognostic Significance of Cancer-Associated Fibroblasts in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							STROMAL MYOFIBROBLASTS; ACTIVATION PROTEIN; EXPRESSION; INFILTRATION; ANGIOGENESIS	Background: Cancer-associated fibroblasts (CAF) are activated fibroblasts in the cancer stroma and play an important role in cancer progression. Some reports have indicated the correlation between the expression of CAF markers and adverse prognosis in several cancers. However, no reports have studied CAF phenotype and its clinical relevance in esophageal squamous cell carcinoma (ESCC). Methods: We investigated CAF phenotype of ESCC based on histology and immunohistochemical expressions of five CAF markers such as fibroblast activation protein (FAP), smooth muscle actin (SMA), fibroblast-specific protein-1 (FSP1), platelet-derived growth factor receptor (PDGFR alpha), and PDGFR beta in 116 ESCC tissue samples. Besides, we also examined the correlation of the CAF phenotype with clinical relevance as well as other cancer-microenvironment related factors. Results: Histologically immature CAF phenotype was correlated with poor prognosis (p<0.001) and associated with increased microvessel density, increased tumor associated macrophages, and epithelial to mesenchymal transition. CAF markers were characteristically expressed in stromal fibroblast close to tumor cells and the expression pattern of 5 CAF markers was highly heterogeneous in every individual cases. Of five CAF markers, SMA, FSP1, and PDGFR alpha were unfavorable prognostic indicators of ESCC. The number of positive CAF markers was greater in ESCC with immature CAFs than in those with mature ones. Conclusions: Our results demonstrate that histologic classification of CAF phenotype is a reliable and significant prognostic predictor in ESCC. CAF markers have the potential to be diagnostic and therapeutic targets in ESCC.	[Ha, Sang Yun; Kim, Seok-Hyung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Yeo, So-Young; Kim, Seok-Hyung] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea; [Xuan, Yan-hiua] Yanbian Univ, Minist Educ, Key Lab Nat Resources Changbai Mt & Funct Mol, Yanji, Peoples R China; [Xuan, Yan-hiua] Yanbian Univ, Sch Med, Dept Pathol, Yanji, Peoples R China	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Yanbian University; Yanbian University	Xuan, YH (corresponding author), Yanbian Univ, Minist Educ, Key Lab Nat Resources Changbai Mt & Funct Mol, Yanji, Peoples R China.	xuanyh1@ybu.edu.cn; platoshkim@daum.net			Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI11C17620000]; Samsung Biomedical Research Institute [SS1B30131]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Samsung Biomedical Research Institute(Samsung)	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI11C17620000), and Samsung Biomedical Research Institute grant SS1B30131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bello IO, 2011, ORAL ONCOL, V47, P33, DOI 10.1016/j.oraloncology.2010.10.013; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Cardone A, 1997, PANMINERVA MED, V39, P174; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Cirri P, 2011, AM J CANCER RES, V1, P482; Dirkx AEM, 2006, J LEUKOCYTE BIOL, V80, P1183, DOI 10.1189/jlb.0905495; Fred T., 2009, WHO CLASSIFICATION T; Hagglof C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010747; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kitadai Y, 2009, CANC MICROENVIRON; Kubota Y, 2009, FRONT BIOSCI-LANDMRK, V14, P3872, DOI [10.2735/3495, 10.2741/3495]; Leek RD, 1996, CANCER RES, V56, P4625; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Liu JZ, 2012, TUMOR BIOL, V33, P495, DOI 10.1007/s13277-011-0281-3; Liu M, 2011, INT J CANCER, V129, P1795, DOI 10.1002/ijc.26116; Maeshima AM, 2002, CANCER, V95, P2546, DOI 10.1002/cncr.11006; Mao Y, 2013, CANCER METAST REV, V32, P303, DOI 10.1007/s10555-012-9415-3; Marsh D, 2011, J PATHOL, V223, P470, DOI 10.1002/path.2830; Marsh T., 2012, BIOCHIM BIOPHYS ACTA, V1832, P1070; Mukherjee S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-91; Noma K, 2008, GASTROENTEROLOGY, V134, P1981, DOI 10.1053/j.gastro.2008.02.061; Shi M, 2012, WORLD J GASTROENTERO, V18, P840, DOI 10.3748/wjg.v18.i8.840; Sung CO, 2011, AM J PATHOL, V179, P1827, DOI 10.1016/j.ajpath.2011.06.032; Sung CO, 2011, MODERN PATHOL, V24, P1060, DOI 10.1038/modpathol.2011.59; Takenaga K, 1997, CLIN CANCER RES, V3, P2309; Tejada ML, 2006, CLIN CANCER RES, V12, P2676, DOI 10.1158/1078-0432.CCR-05-1770; Tsujino T, 2007, CLIN CANCER RES, V13, P2082, DOI 10.1158/1078-0432.CCR-06-2191; Ueno H, 2004, GUT, V53, P581, DOI 10.1136/gut.2003.028365; Wang K, 2012, J THORAC ONCOL, V7, P1457, DOI 10.1097/JTO.0b013e318260dfe8; WEIDNER N, 1995, BREAST CANCER RES TR, V36, P169, DOI 10.1007/BF00666038; Wikberg ML, 2013, TUMOR BIOL, V34, P1013, DOI 10.1007/s13277-012-0638-2; Yamashita M, 2012, BREAST CANCER-TOKYO, V19, P170, DOI 10.1007/s12282-010-0234-5; Yuzawa S, 2012, MED ONCOL, V29, P2824, DOI 10.1007/s12032-012-0193-0; Zhang CY, 2009, CLIN CANCER RES, V15, P4017, DOI 10.1158/1078-0432.CCR-08-2824; Zhang QW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050946	35	78	86	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99955	10.1371/journal.pone.0099955	http://dx.doi.org/10.1371/journal.pone.0099955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945657	Green Published, Green Submitted, gold			2022-12-25	WOS:000340721500036
J	Waligorska-Stachura, J; Andrusiewicz, M; Sawicka-Gutaj, N; Biczysko, M; Jankowska, A; Kubiczak, M; Czarnywojtek, A; Wrotkowska, E; Ruchala, M				Waligorska-Stachura, Joanna; Andrusiewicz, Miroslaw; Sawicka-Gutaj, Nadia; Biczysko, Maciej; Jankowska, Anna; Kubiczak, Marta; Czarnywojtek, Agata; Wrotkowska, Elzbieta; Ruchala, Marek			Survivin Delta Ex3 Overexpression in Thyroid Malignancies	PLOS ONE			English	Article							ANTI-APOPTOSIS GENE; CELL LUNG CANCERS; PROGNOSTIC VALUE; EXPRESSION; CARCINOMA; TUMORS; ASSOCIATION; RISK	Context: Thyroid cancer incidence has increased significantly during the past decades and is the most common type of endocrine malignancy. Many factors in thyroid cancers were studied as independent predictors of a poor prognosis. Objective: The objective of the study was to evaluate survivin expression - BIRC5 and its splice variants: survivin delta Ex3 and survivin 2B in benign and malignant thyroid nodules. Design: Thyroid tissues samples from a group of 50 patients consisting of: 29 patients with thyroid cancers (including medullary, papillary, follicular and undifferentiated types), as well as from 21 patients with non-cancerous thyroid tissues (including: 11 benign thyroid lesions and 10 healthy thyroid samples). Main Outcome Measures: The analysis of the survivin gene expression and evaluation of the level of splice variants were performed using quantitative RT-PCR. Results: A statistically significant higher level of expression of survivin gene - BIRC5 was detected in thyroid malignant nodules, when compared with benign lesions and healthy thyroid samples. Moreover, the comparison of survivin relative expression in different staged tumors (pT1, pT3, and pT4) revealed a much higher amount of BIRC5 transcripts in tumor tissues of pT3/pT4. The comparison of survivin expression between benign thyroid nodules and healthy thyroid did not reveal significant differences. Importantly, high expression rate of the survivin delta Ex3 splice variant characterized thyroid carcinomas. Conclusion: The results suggest that survivin, especially survivin delta Ex3 splice variant being overexpress, is a characteristic feature of thyroid malignancy.	[Waligorska-Stachura, Joanna; Sawicka-Gutaj, Nadia; Czarnywojtek, Agata; Wrotkowska, Elzbieta; Ruchala, Marek] Poznan Univ Med Sci, Dept Endocrinol Metab & Internal Med, Poznan, Poland; [Andrusiewicz, Miroslaw; Jankowska, Anna; Kubiczak, Marta] Poznan Univ Med Sci, Dept Cell Biol, Poznan, Poland; [Biczysko, Maciej] Poznan Univ Med Sci, Dept Gen Gastroenterol & Endocrine Surg, Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Medical Sciences; Poznan University of Medical Sciences	Ruchala, M (corresponding author), Poznan Univ Med Sci, Dept Endocrinol Metab & Internal Med, Poznan, Poland.	mruchala@ump.edu.pl	Andrusiewicz, Mirosław/ABG-4949-2021; Andrusiewicz, Mirosław/N-3449-2017	Andrusiewicz, Mirosław/0000-0002-8781-3447; Andrusiewicz, Mirosław/0000-0002-8781-3447; Wrotkowska, Elzbieta/0000-0003-0965-7300; Czarnywojtek, Agata/0000-0003-3595-8449	Polish Committee for Scientific Research Award [N N402 523640]	Polish Committee for Scientific Research Award	This paper was supported by The Polish Committee for Scientific Research Award nr N N402 523640. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Azuhata T, 2001, J PEDIATR SURG, V36, P1785, DOI 10.1053/jpsu.2001.28839; Chen ZX, 2012, INT J MOL MED, V30, P465, DOI 10.3892/ijmm.2012.1046; Cohen C, 2003, MODERN PATHOL, V16, P574, DOI 10.1097/01.MP.0000073868.31297.B0; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Grabowski P, 2003, BRIT J CANCER, V88, P115, DOI 10.1038/sj.bjc.6600696; Grabowski P, 2005, NEUROENDOCRINOL, V81; Hart CD, 2013, ONCOTARGETS THER, V6, P1, DOI 10.2147/OTT.S27671; Hassounah M, 2005, J NEURO-ONCOL, V72, P203, DOI 10.1007/s11060-004-2397-4; Ito Y, 2009, ENDOCR J, V56, P177, DOI 10.1507/endocrj.K08E-166; Jankowska A, 2008, NEUROENDOCRINOL LETT, V29, P1033; Kappler M, 2001, INT J CANCER, V95, P360, DOI 10.1002/1097-0215(20011120)95:6<360::AID-IJC1063>3.0.CO;2-1; Kato J, 2001, INT J CANCER, V95, P92; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Monzo M, 1999, J CLIN ONCOL, V17, P2100, DOI 10.1200/JCO.1999.17.7.2100; Naduparambil KJ, 2012, ONCO TARGETS THER, V5, P7; Nakano J, 2008, BRIT J CANCER, V98, P1109, DOI 10.1038/sj.bjc.6604253; Pannone G, 2013, THYROID         1213; Riesco-Eizaguirre G, 2007, ENDOCR-RELAT CANCER, V14, P957, DOI 10.1677/ERC-07-0085; Ryan BM, 2009, CANCER TREAT REV, V35, P553, DOI 10.1016/j.ctrv.2009.05.003; Selernetjev S, 2014, PATHOL RES PRACT, V210, P30, DOI 10.1016/j.prp.2013.09.014; Ueda M, 2002, J CLIN ENDOCR METAB, V87, P3452, DOI 10.1210/jc.87.7.3452; Vikman S, 2005, ACTA ONCOL, V44, P32, DOI 10.1080/02841860510007404; Waligorska-Stachura J, 2012, GINEKOL POL, V83, P537; Wang YX, 2013, PATHOL RES PRACT, V209, P151, DOI 10.1016/j.prp.2013.01.004; Xing M, 2005, ENDOCR-RELAT CANCER, V12, P245, DOI 10.1677/erc.1.0978; Yazdani N, 2012, PATHOL RES PRACT, V208, P100, DOI 10.1016/j.prp.2011.12.009; Zhang HY, 2009, CLIN EXP MED, V9, P207, DOI 10.1007/s10238-009-0031-7	30	14	14	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100534	10.1371/journal.pone.0100534	http://dx.doi.org/10.1371/journal.pone.0100534			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945990	gold, Green Published, Green Submitted			2022-12-25	WOS:000340721500088
J	Zheng, SQ; Liao, ST; Zou, YX; Qu, Z; Liu, F				Zheng, Shanqing; Liao, Sentai; Zou, Yuxiao; Qu, Zhi; Liu, Fan			ins-7 Gene Expression Is Partially Regulated by the DAF-16/IIS Signaling Pathway in Caenorhabditis elegans under Celecoxib Intervention	PLOS ONE			English	Article							LONG-LIVED MUTANTS; C-ELEGANS; LIFE-SPAN; INSULIN; LONGEVITY; RESTRICTION; INHIBITION; PEPTIDE; AKT/PKB; MEMBER	DAF-16 target genes are employed as reporters of the insulin/IGF-1 like signal pathway (IIS), and this is notably true when Caenorhabditis elegans (C. elegans) is used to study the action of anti-aging compounds on IIS activity. However, some of these genes may not be specific to DAF-16, even if their expression levels are altered when DAF-16 is activated. Celecoxib was reported to extend the lifespan of C. elegans through activation of DAF-16. Our results confirmed the function of celecoxib on aging; however, we found that the expression of ins-7, a DAF-16 target gene, was abnormally regulated by celecoxib. ins-7 plays an important role in regulating aging, and its expression is suppressed in C. elegans when DAF-16 is activated. However, we found that celecoxib upregulated the expression of ins-7 in contrast to its role in DAF-16 activation. Our subsequent analysis indicated that the expression level of ins-7 in C. elegans was negatively regulated by DAF-16 activity. Additionally, its expression was also positively regulated by DAF-16-independent mechanisms, at least following external pharmacological intervention. Our study suggests that ins-7 is not a specific target gene of DAF-16, and should not be chosen as a reporter for IIS activity. This conclusion is important in the study of INSs on aging in C. elegans, especially under the circumstance of drug intervention.	[Zheng, Shanqing; Liao, Sentai; Zou, Yuxiao; Qu, Zhi; Liu, Fan] Guangdong Acad Agr Sci, Sericulture & Agri Food Res Inst, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Agricultural Sciences	Zheng, SQ (corresponding author), Guangdong Acad Agr Sci, Sericulture & Agri Food Res Inst, Guangzhou, Guangdong, Peoples R China.	zhengshanqing@mail.kib.ac.cn; liaost@163.com		Zheng, Shanqing/0000-0002-5039-0196	Zhujiang Science and Technology New Star of Guangzhou [2013J2200085]	Zhujiang Science and Technology New Star of Guangzhou	This work was supported by the project for Zhujiang Science and Technology New Star of Guangzhou (No. 2013J2200085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavez S, 2011, NATURE, V472, P226, DOI 10.1038/nature09873; Apfeld Jak C, 1999, REGULATION LIFE SPAN; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1064, DOI 10.1152/ajpendo.00296.2003; Brenner S., 1974, GENETICS CAENORHABDI; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chavez V, 2007, GENETICS, V176, P1567, DOI 10.1534/genetics.107.072587; Chen ZN, 2013, NEURON, V77, P572, DOI 10.1016/j.neuron.2012.11.025; Ching TT, 2011, AGING CELL, V10, P506, DOI 10.1111/j.1474-9726.2011.00688.x; Clancy D, 2013, AGEING RES REV, V12, P404, DOI 10.1016/j.arr.2012.03.011; Collins JJ, 2006, EXP GERONTOL, V41, P1032, DOI 10.1016/j.exger.2006.06.038; Glauser DA, 2011, P NATL ACAD SCI USA, V108, P20790, DOI 10.1073/pnas.1116712108; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Honda Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00487; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kawano T, 2000, BIOCHEM BIOPH RES CO, V273, P431, DOI 10.1006/bbrc.2000.2971; Kawano T, 2006, BIOSCI BIOTECH BIOCH, V70, P3084, DOI 10.1271/bbb.60472; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kenyon C, 2011, PHILOS T R SOC B, V366, P9, DOI 10.1098/rstb.2010.0276; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Matsunaga Y, 2012, BIOSCI BIOTECH BIOCH, V76, P2168, DOI 10.1271/bbb.120540; Murphy CT, 2007, P NATL ACAD SCI USA, V104, P19046, DOI 10.1073/pnas.0709613104; Murphy CT, 2006, EXP GERONTOL, V41, P910, DOI 10.1016/j.exger.2006.06.040; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Narasimhan SD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001377; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Ritter AD, 2013, GENOME RES; Shaw WM, 2007, CURR BIOL, V17, P1635, DOI 10.1016/j.cub.2007.08.058; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tepper RG, 2013, CELL, V154, P676, DOI 10.1016/j.cell.2013.07.006	36	2	2	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100320	10.1371/journal.pone.0100320	http://dx.doi.org/10.1371/journal.pone.0100320			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945567	Green Published, Green Submitted, gold			2022-12-25	WOS:000340721500060
J	Chung, H; Jung, H; Lee, JH; Oh, HY; Kim, OB; Han, IO; Oh, ES				Chung, Heesung; Jung, Hyejung; Lee, Jung-Hyun; Oh, Hye Yun; Kim, Ok Bin; Han, Inn-Oc; Oh, Eok-Soo			Keratinocyte-derived Laminin-332 Protein Promotes Melanin Synthesis via Regulation of Tyrosine Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MELANOCYTE-STIMULATING HORMONE; EXTRACELLULAR-MATRIX; CELL-MIGRATION; INTEGRIN; PIGMENTATION; PROLIFERATION; ACTIVATION; KINASE; GROWTH; MAPK	Melanocytes, which produce the pigment melanin, are known to be closely regulated by neighboring keratinocytes. However, how keratinocytes regulate melanin production is unclear. Here we report that melanin production in melanoma cells (B16F10 and MNT-1) was increased markedly on a keratinocyte-derived extracellular matrix compared with a melanoma cell-derived extracellular matrix. siRNA-mediated reduction of keratinocyte-derived laminin-332 expression decreased melanin synthesis in melanoma cells, and laminin-332, but not fibronectin, enhanced melanin content and alpha-melanocyte-stimulating hormone-regulated melanin production in melanoma cells. Similar effects were observed in human melanocytes. Interestingly, however, laminin-332 did not affect the expression or activity of tyrosinase. Instead, laminin-332 promoted the uptake of extracellular tyrosine and, subsequently, increased intracellular levels of tyrosine in both melanocytes and melanoma cells. Taken together, these data strongly suggest that keratinocyte-derived laminin-332 contributes to melanin production by regulating tyrosine uptake.	[Chung, Heesung; Jung, Hyejung; Lee, Jung-Hyun; Oh, Eok-Soo] Ewha Womans Univ, Dept Life Sci, Res Ctr Cellular Homeostasis, Seoul 120750, South Korea; [Oh, Hye Yun; Kim, Ok Bin] Ewha Womans Univ, Dept Life Sci, Interdisciplinary Program EcoCreat, Seoul 120750, South Korea; [Han, Inn-Oc] Inha Univ, Dept Physiol & Biophys, Coll Med, Inchon 402751, South Korea	Ewha Womans University; Ewha Womans University; Inha University	Oh, ES (corresponding author), Ewha Womans Univ, Dept Life Sci, 52 Ewhayeodae Gil, Seoul 120750, South Korea.	OhES@ewha.ac.kr			Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology [2010-0007336]; National Research Foundation of Korea by the Korean government [2012R1A5A1048236]; Korean Health Technology RAMP;D Project, Ministry of Health and Welfare, Republic of Korea [HI12C0050]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology(National Research Foundation of Korea); National Research Foundation of Korea by the Korean government(National Research Foundation of Korea); Korean Health Technology RAMP;D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science, and Technology Grant 2010-0007336; by National Research Foundation of Korea Grant 2012R1A5A1048236 funded by the Korean government; and by Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea Grant HI12C0050.	Ando H, 1999, J LIPID RES, V40, P1312; Ando H, 2012, J INVEST DERMATOL, V132, P1222, DOI 10.1038/jid.2011.413; Bellei B, 2010, J BIOL CHEM, V285, P7288, DOI 10.1074/jbc.M109.070573; Brenner M, 2008, PHOTOCHEM PHOTOBIOL, V84, P539, DOI 10.1111/j.1751-1097.2007.00226.x; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Cheli Y, 2010, PIGM CELL MELANOMA R, V23, P27, DOI 10.1111/j.1755-148X.2009.00653.x; Chen J, 2001, J BIOL CHEM, V276, P47901, DOI 10.1074/jbc.M107574200; Choma DP, 2004, J CELL SCI, V117, P3947, DOI 10.1242/jcs.01251; Chung H, 2011, J BIOL CHEM, V286, P13438, DOI 10.1074/jbc.M110.166751; Cook AL, 2009, J INVEST DERMATOL, V129, P392, DOI 10.1038/jid.2008.211; Crean JKG, 2002, J BIOL CHEM, V277, P44187, DOI 10.1074/jbc.M203715200; D'Alessio S, 2008, J CELL SCI, V121, P3922, DOI 10.1242/jcs.037549; Dores RM, 2011, ANN NY ACAD SCI, V1220, P34, DOI 10.1111/j.1749-6632.2010.05928.x; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Frijns E, 2010, J BIOL CHEM, V285, P37650, DOI 10.1074/jbc.M110.138818; Fuller BB, 2000, J INVEST DERMATOL, V114, P268, DOI 10.1046/j.1523-1747.2000.00860.x; Guyonneau L, 2004, MOL CELL BIOL, V24, P3396, DOI 10.1128/MCB.24.8.3396-3403.2004; Hearing Vincent J, 2011, J Invest Dermatol, V131, pE8, DOI 10.1038/skinbio.2011.4; Herraiz C, 2009, FEBS LETT, V583, P3269, DOI 10.1016/j.febslet.2009.09.023; Hirobe T, 2005, PIGM CELL RES, V18, P2, DOI 10.1111/j.1600-0749.2004.00198.x; HUNT G, 1994, J CELL SCI, V107, P205; Illario M, 2005, J CLIN ENDOCR METAB, V90, P2865, DOI 10.1210/jc.2004-1520; Kiefer JA, 2001, MATRIX BIOL, V20, P429, DOI 10.1016/S0945-053X(01)00159-7; Kim DS, 2006, PIGM CELL RES, V19, P146, DOI 10.1111/j.1600-0749.2005.00287.x; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Marinkovich MP, 2007, NAT REV CANCER, V7, P370, DOI 10.1038/nrc2089; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; O'Toole EA, 2001, CLIN EXP DERMATOL, V26, P525, DOI 10.1046/j.1365-2230.2001.00891.x; Olivares C, 2009, PIGM CELL MELANOMA R, V22, P750, DOI 10.1111/j.1755-148X.2009.00636.x; Ongenae K, 2003, PIGM CELL RES, V16, P90, DOI 10.1034/j.1600-0749.2003.00023.x; Potterf SB, 1998, BIOCHEM BIOPH RES CO, V248, P795, DOI 10.1006/bbrc.1998.9019; Primot A, 2010, PIGM CELL MELANOMA R, V23, P93, DOI 10.1111/j.1755-148X.2009.00652.x; Rodeck U, 1997, J CELL SCI, V110, P113; Sarangarajan R, 2001, PIGM CELL RES, V14, P437, DOI 10.1034/j.1600-0749.2001.140603.x; Schwahn DJ, 2001, PIGM CELL RES, V14, P32, DOI 10.1034/j.1600-0749.2001.140106.x; Scott GA, 1999, EXP DERMATOL, V8, P212, DOI 10.1111/j.1600-0625.1999.tb00373.x; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Summers CG, 2009, OPTOMETRY VISION SCI, V86, P659, DOI 10.1097/OPX.0b013e3181a5254c; Tsuji T, 2002, CLIN EXP METASTAS, V19, P127, DOI 10.1023/A:1014573204062; Vumma R, 2008, NEUROSCI LETT, V434, P56, DOI 10.1016/j.neulet.2008.01.028; WAYNER EA, 1993, J CELL BIOL, V121, P1141, DOI 10.1083/jcb.121.5.1141; Weber GF, 2011, J CELL SCI, V124, P1183, DOI 10.1242/jcs.064618; Ye Y, 2011, EXP DERMATOL, V20, P755, DOI 10.1111/j.1600-0625.2011.01297.x; Zou L, 2012, J BIOL CHEM, V287, P7190, DOI 10.1074/jbc.M111.304972	47	14	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21751	21759		10.1074/jbc.M113.541177	http://dx.doi.org/10.1074/jbc.M113.541177			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24951591	hybrid, Green Published			2022-12-25	WOS:000340558300048
J	Kodera, C; Yorimitsu, T; Sato, K				Kodera, Chie; Yorimitsu, Tomohiro; Sato, Ken			Sec23 Homolog Nel1 Is a Novel GTPase-activating Protein for Sar1 but Does Not Function as a Subunit of the Coat Protein Complex II (COPII) Coat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORT VESICLE FORMATION; PLASMA-MEMBRANE ATPASE; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; GOLGI-APPARATUS; SECRETORY PATHWAY; PICHIA-PASTORIS; BINDING PROTEIN; BUDDING YEAST; EXIT SITES	The coat protein complex II (COPII) generates transport carriers from the endoplasmic reticulum (ER) under the control of the small GTPase Sar1. Sec23 is well known as a structural component of the COPII coat and as a GTPase-activating protein (GAP) for Sar1. Here, we showed that Saccharomyces cerevisiae contains a novel Sec23 paralog, Nel1, which appears not to function as a subunit of the COPII coat. Nel1 does not associate with any of the COPII components, but it exhibits strong Sar1 GAP activity. We also demonstrated that the chromosomal deletion of NEL1 leads to a significant growth defect in the temperature-sensitive sar1D32G background, suggesting a possible functional link between these proteins. In contrast to Sec23, which is predominantly localized at ER exit sites on the ER membrane, a major proportion of Nel1 is localized throughout the cytosol. Our findings highlight a possible role of Nel1 as a novel GAP for Sar1.	[Kodera, Chie; Sato, Ken] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Yorimitsu, Tomohiro; Sato, Ken] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan	University of Tokyo; University of Tokyo	Sato, K (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan.	kensato@bio.c.u-tokyo.ac.jp		KODERA, Chie/0000-0002-3078-8930	Ministry of Education, Culture, Sports, Science and Technology; Kurata Memorial Hitachi Science and Technology Foundation; Noda Institute for Scientific Research; Naito Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kurata Memorial Hitachi Science and Technology Foundation; Noda Institute for Scientific Research(Noda Institute for Scientific Research); Naito Foundation(Naito Memorial Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grant-in-aid for scientific research ( C), grant-in-aid for scientific research on innovation areas "Supramolecular Motility Machinery" and "Dynamical Ordering of Biomolecular Systems for Creation of Integrated Functions" from the Ministry of Education, Culture, Sports, Science and Technology, the Naito Foundation, the Kurata Memorial Hitachi Science and Technology Foundation, and the Noda Institute for Scientific Research.	Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; BARLOWE C, 1993, J BIOL CHEM, V268, P873; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; Barlowe CK, 2013, GENETICS, V193, P383, DOI 10.1534/genetics.112.142810; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; D'Arcangelo JG, 2013, BBA-MOL CELL RES, V1833, P2464, DOI 10.1016/j.bbamcr.2013.02.003; Esaki M, 2006, FEBS LETT, V580, P5215, DOI 10.1016/j.febslet.2006.08.058; Futai E, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600428; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; James P, 1996, GENETICS, V144, P1425; Kung LF, 2012, EMBO J, V31, P1014, DOI 10.1038/emboj.2011.444; Kurihara T, 2000, MOL BIOL CELL, V11, P983, DOI 10.1091/mbc.11.3.983; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Matsuoka K, 2000, METHODS, V20, P417, DOI 10.1006/meth.2000.0955; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Michelsen K, 2006, TRAFFIC, V7, P903, DOI 10.1111/j.1600-0854.2006.00430.x; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Miller EA, 2013, CURR OPIN CELL BIOL, V25, P420, DOI 10.1016/j.ceb.2013.04.005; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; NAKANO A, 1988, J CELL BIOL, V107, P851, DOI 10.1083/jcb.107.3.851; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; ORCI L, 1991, P NATL ACAD SCI USA, V88, P8611, DOI 10.1073/pnas.88.19.8611; Paccaud JP, 1996, MOL BIOL CELL, V7, P1535, DOI 10.1091/mbc.7.10.1535; Roberg KJ, 1999, J CELL BIOL, V145, P659, DOI 10.1083/jcb.145.4.659; Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69; Saito Y, 1999, J BIOCHEM-TOKYO, V125, P130, DOI 10.1093/oxfordjournals.jbchem.a022249; Sato K, 2005, NAT STRUCT MOL BIOL, V12, P167, DOI 10.1038/nsmb893; Shimoni Y, 2000, J CELL BIOL, V151, P973, DOI 10.1083/jcb.151.5.973; Shindiapina P, 2010, MOL BIOL CELL, V21, P1530, DOI 10.1091/mbc.E09-07-0605; Tabata KV, 2009, EMBO J, V28, P3279, DOI 10.1038/emboj.2009.269; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; VIDA TA, 1990, J CELL BIOL, V111, P2871, DOI 10.1083/jcb.111.6.2871; Yamanushi T, 1996, J BIOCHEM-TOKYO, V120, P452; Yang YD, 2005, PLANT CELL, V17, P1513, DOI 10.1105/tpc.104.026757; Yorimitsu T, 2012, MOL BIOL CELL, V23, P2930, DOI 10.1091/mbc.E12-05-0356; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644; Zou SS, 2012, GENETICS, V191, P451, DOI 10.1534/genetics.112.139378	41	3	3	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21423	21432		10.1074/jbc.M114.553917	http://dx.doi.org/10.1074/jbc.M114.553917			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24947508	Green Published, hybrid			2022-12-25	WOS:000340558300021
J	Deng, HZ; Deng, H; Cen, CQ; Chen, KY; Du, ML				Deng, Hong-Zhu; Deng, Hong; Cen, Chao-Qun; Chen, Kai-Yun; Du, Min-Lian			Post-Receptor Crosstalk between Growth Hormone and Insulin Signal in Rats Born Small for Gestational Age with Catch-Up Growth	PLOS ONE			English	Article							SKELETAL-MUSCLE; ADIPOSE-TISSUE; YOUNG-ADULTS; RESISTANCE; GLUCOSE; SENSITIVITY; WEIGHT; MODEL; RESTRICTION; METABOLISM	Objective: Insulin resistance has been observed in individuals born small for gestational age (SGA) with catch-up growth (CUG), yet the mechanisms involved remain unclear. This study examined the role of GH and insulin signaling crosstalk in insulin resistance of SGA rats with CUG. Design and Methods: SGA rats were developed by dietary restriction in pregnant rats. GH receptor inhibition was performed on four-week old CUG-SGA and AGA rats. Phosphorylation of IRS-1, AKT, and ERK, and expression of SOCS3 in the skeletal muscle were determined via immunoblot analysis at baseline and after insulin stimulation in CUG-SGA, NCUG-SGA and AGA groups. Results: Compared to AGA controls, phosphorylation of IRS-1 and AKT in response to insulin stimulation in CUG-SGA rats was significantly blunted (P<0.05), and phosphorylation of ERK at baseline was dramatically activated (P<0.05). SOCS3 expression was significantly increased in CUG-SGA compared to AGA (P = 0.001) and NCUG-SGA (P = 0.006) rats, and was significantly suppressed following GHR inhibition (P<0.05). Furthermore, phosphorylation of IRS-1 and AKT in response to insulin stimulation increased after GHR inhibition (P<0.05). Conclusions: Insulin resistance in CUG-SGA rats is associated with impairment of IRS-1-PI3K-AKT signaling, which may result from GH signaling-induced up-regulation of SOCS3.	[Deng, Hong-Zhu; Cen, Chao-Qun; Chen, Kai-Yun] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Pediat, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Hong] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Hong-Zhu; Du, Min-Lian] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pediat, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Deng, H (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510275, Guangdong, Peoples R China.	denghong2@foxmail.com			Natural Science Foundation of China [81100571]; Natural Science Foundation of Guangdong Province [S2011020005224]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	The study was supported by the Natural Science Foundation of China (grant number 81100571) and the Natural Science Foundation of Guangdong Province (grant number S2011020005224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; De Blasio MJ, 2012, ENDOCRINOLOGY, V153, P2142, DOI 10.1210/en.2011-1955; Deng HZ, 2011, EUR J PEDIATR, V170, P75, DOI 10.1007/s00431-010-1274-8; [邓红珠 DENG Hongzhu], 2011, [中国病理生理杂志, Chinese Journal of Pathophysiology], V27, P1360; Dominici FP, 2005, GROWTH HORM IGF RES, V15, P324, DOI 10.1016/j.ghir.2005.07.001; Dulloo AG, 2002, INT J OBESITY, V26, pS46, DOI 10.1038/sj.ijo.0802127; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Fasshauer M, 2004, J ENDOCRINOL, V181, P129, DOI 10.1677/joe.0.1810129; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Huang TT, 2008, HORM RES, V70, P29, DOI 10.1159/000129675; Irving RJ, 2000, LANCET, V355, P2135, DOI 10.1016/S0140-6736(00)02384-9; Jorgensen JOL, 2006, AM J PHYSIOL-ENDOC M, V291, pE899, DOI 10.1152/ajpendo.00024.2006; Jorgensen SB, 2013, DIABETES, V62, P56, DOI 10.2337/db12-0443; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Peraldi P, 2001, J BIOL CHEM, V276, P24614, DOI 10.1074/jbc.M102209200; Rotteveel J, 2008, PEDIATRICS, V122, P313, DOI 10.1542/peds.2007-2012; Shirakami A, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740309; Varvarigou AA, 2010, J PEDIATR ENDOCR MET, V23, P215, DOI 10.1515/JPEM.2010.23.3.215; Vijayakumar A, 2012, DIABETES, V61, P94, DOI 10.2337/db11-0814; Vuguin P, 2004, DIABETES, V53, P2617, DOI 10.2337/diabetes.53.10.2617; Xu J, 2009, VITAM HORM, V80, P125, DOI 10.1016/S0083-6729(08)00606-7; Ye J, 2012, PEDIATR RES, V72, P550, DOI 10.1038/pr.2012.123	24	6	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100459	10.1371/journal.pone.0100459	http://dx.doi.org/10.1371/journal.pone.0100459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963636	gold, Green Published, Green Submitted			2022-12-25	WOS:000338709500054
J	Bulir, DC; Waltho, DA; Stone, CB; Mwawasi, KA; Nelson, JC; Mahony, JB				Bulir, David C.; Waltho, Daniel A.; Stone, Christopher B.; Mwawasi, Kenneth A.; Nelson, Jordan C.; Mahony, James B.			Chlamydia pneumoniae CopD Translocator Protein Plays a Critical Role in Type III Secretion (T3S) and Infection	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; COILED-COIL DOMAIN; CHLAMYDOPHILA-PNEUMONIAE; SYSTEMS; IPAB; INJECTISOME; CHAPERONES; BINDING; DELIVERY; INSIGHTS	Pathogenic Gram-negative bacteria use type III secretion (T3S) to inject effector proteins into the host cell to create appropriate conditions for infection and intracellular replication. Chlamydia spp. are believed to use T3S to infect their host cell, and the translocator proteins are an essential component of this system. Chlamydia pneumoniae contains genes encoding two sets of translocator proteins; CopB and CopD, and CopB2 and CopD2. In this study, we identified novel interactions between CopD and three type III secretion proteins; namely, CopN, CdsN, and CdsF. We identified a CopD putative chaperone binding motif, PxLxxP, within the N-terminal region (CopD amino acids 120-125), which was necessary for interaction with its putative chaperone LcrH_1. Using size exclusion chromatography, we showed that CopD and LcrH_1 formed higher order structures in solution with CopD and LcrH_1 binding in a ratio of 1:1, which is unique for T3SS translocator proteins. Lastly, we showed that antibodies to CopD reduced C. pneumoniae infectivity by >95%. Collectively, this data suggests that CopD plays a critical role in pathogenesis and likely functions as a hydrophobic translocator of the type III secretion system in Chlamydia pneumoniae.	[Mahony, James B.] McMaster Univ, Fac Hlth Sci, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; St Josephs Healthcare, Father Sean OSullivan Res Ctr, Hamilton, ON, Canada	McMaster University; McMaster University	Mahony, JB (corresponding author), McMaster Univ, Fac Hlth Sci, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada.	mahonyj@mcmaster.ca						Adam PR, 2012, BIOCHEMISTRY-US, V51, P4062, DOI 10.1021/bi300243z; Beeckman DSA, 2010, CURR ISSUES MOL BIOL, V12, P17; Betts-Hampikian HJ, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00114; Blaylock B, 2006, J BACTERIOL, V188, P3525, DOI 10.1128/JB.188.10.3525-3534.2006; Chellas-Gery B, 2011, INFECT IMMUN, V79, P3036, DOI 10.1128/IAI.00159-11; Cordes FS, 2005, J MOL BIOL, V354, P206, DOI 10.1016/j.jmb.2005.09.062; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Cornelis GR, 2010, BIOL CHEM, V391, P745, DOI 10.1515/BC.2010.079; Daniell SJ, 2001, INFECT IMMUN, V69, P4055, DOI 10.1128/IAI.69.6.4055-4064.2001; Dautry-Varsat A, 2005, CELL MICROBIOL, V7, P1714, DOI 10.1111/j.1462-5822.2005.00627.x; Delahay RM, 2002, MOL MICROBIOL, V45, P905, DOI 10.1046/j.1365-2958.2002.03083.x; Delahay RM, 1999, J BIOL CHEM, V274, P35969, DOI 10.1074/jbc.274.50.35969; Dickenson NE, 2013, PROTEIN SCI, V22, P614, DOI 10.1002/pro.2245; Diepold A, 2010, EMBO J, V29, P1928, DOI 10.1038/emboj.2010.84; Edqvist PJ, 2006, MOL MICROBIOL, V59, P31, DOI 10.1111/j.1365-2958.2005.04923.x; Espina M, 2007, PROTEIN SCI, V16, P704, DOI 10.1110/ps.062645007; Fields KA, 2005, J BACTERIOL, V187, P6466, DOI 10.1128/JB.187.18.6466-6478.2005; Gazi AD, 2009, CELL MICROBIOL, V11, P719, DOI 10.1111/j.1462-5822.2009.01297.x; Heine SJ, 2014, J IMMUNOL, V192, P1630, DOI 10.4049/jimmunol.1302743; Iriarte M, 1998, EMBO J, V17, P1907, DOI 10.1093/emboj/17.7.1907; Ivanov MI, 2008, INFECT IMMUN, V76, P5181, DOI 10.1128/IAI.00189-08; Johnson DL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-218; Lunelli M, 2009, P NATL ACAD SCI USA, V106, P9661, DOI 10.1073/pnas.0812900106; Martinez-Becerra FJ, 2013, INFECT IMMUN, V81, P4470, DOI 10.1128/IAI.00859-13; Mattei PJ, 2011, FEBS J, V278, P414, DOI 10.1111/j.1742-4658.2010.07974.x; Ouellette SP, 2005, J BACTERIOL, V187, P7853, DOI 10.1128/JB.187.22.7853-7856.2005; Pallen MJ, 2005, FEMS MICROBIOL REV, V29, P201, DOI 10.1016/j.femsre.2005.01.001; Pallen MJ, 1997, MOL MICROBIOL, V25, P423, DOI 10.1046/j.1365-2958.1997.4901850.x; Pallen MJ, 2003, FEMS MICROBIOL LETT, V223, P53, DOI 10.1016/S0378-1097(03)00344-6; Parsot C, 2003, CURR OPIN MICROBIOL, V6, P7, DOI 10.1016/S1369-5274(02)00002-4; Shen DK, 2010, INFECT IMMUN, V78, P4999, DOI 10.1128/IAI.00470-10; Stone CB, 2008, J BACTERIOL, V190, P6580, DOI 10.1128/JB.00761-08; Stone CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030220; Veenendaal AKJ, 2007, MOL MICROBIOL, V63, P1719, DOI 10.1111/j.1365-2958.2007.05620.x	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99315	10.1371/journal.pone.0099315	http://dx.doi.org/10.1371/journal.pone.0099315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959658	Green Published, gold, Green Submitted			2022-12-25	WOS:000338633900005
J	Zhou, C; Ma, Q; Li, GJ				Zhou, Chuan; Ma, Qin; Li, Guojun			Elucidation of Operon Structures across Closely Related Bacterial Genomes	PLOS ONE			English	Article							SEQUENCE; PREDICTION; DATABASE; IDENTIFICATION; CONSERVATION; AGENT; ODB	About half of the protein-coding genes in prokaryotic genomes are organized into operons to facilitate co-regulation during transcription. With the evolution of genomes, operon structures are undergoing changes which could coordinate diverse gene expression patterns in response to various stimuli during the life cycle of a bacterial cell. Here we developed a graph-based model to elucidate the diversity of operon structures across a set of closely related bacterial genomes. In the constructed graph, each node represents one orthologous gene group (OGG) and a pair of nodes will be connected if any two genes, from the corresponding two OGGs respectively, are located in the same operon as immediate neighbors in any of the considered genomes. Through identifying the connected components in the above graph, we found that genes in a connected component are likely to be functionally related and these identified components tend to form treelike topology, such as paths and stars, corresponding to different biological mechanisms in transcriptional regulation as follows. Specifically, (i) a path-structure component integrates genes encoding a protein complex, such as ribosome; and (ii) a star-structure component not only groups related genes together, but also reflects the key functional roles of the central node of this component, such as the ABC transporter with a transporter permease and substrate-binding proteins surrounding it. Most interestingly, the genes from organisms with highly diverse living environments, i.e., biomass degraders and animal pathogens of clostridia in our study, can be clearly classified into different topological groups on some connected components.	[Zhou, Chuan; Li, Guojun] Shandong Univ, Sch Math, Jinan 250100, Peoples R China; [Ma, Qin] Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA; [Ma, Qin] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA	Shandong University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Li, GJ (corresponding author), Shandong Univ, Sch Math, Jinan 250100, Peoples R China.	guojunsdu@gmail.com	Ma, Qin/O-1525-2013; Ma, Qin/V-7920-2019	Ma, Qin/0000-0002-3264-8392; Ma, Qin/0000-0002-3264-8392	 [61272016]		This work was supported by 61272016 (http://www.nsfc.gov.cn/). GL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang-Jensen J, 2007, SPRINGER MONOGR MATH; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bettegowda C, 2006, NAT BIOTECHNOL, V24, P1573, DOI 10.1038/nbt1256; Brazier JS, 2002, J MED MICROBIOL, V51, P985, DOI 10.1099/0022-1317-51-11-985; Brouwer RWW, 2008, BRIEF BIOINFORM, V9, P367, DOI 10.1093/bib/bbn019; Bruggemann H, 2003, P NATL ACAD SCI USA, V100, P1316, DOI 10.1073/pnas.0335853100; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dam P, 2007, NUCLEIC ACIDS RES, V35, P288, DOI 10.1093/nar/gkl1018; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; de Daruvar A, 2002, J MOL EVOL, V55, P211, DOI 10.1007/s00239-002-2317-1; Ermolaeva MD, 2001, NUCLEIC ACIDS RES, V29, P1216, DOI 10.1093/nar/29.5.1216; Feinberg L, 2011, J BACTERIOL, V193, P2906, DOI 10.1128/JB.00322-11; Hemme CL, 2010, J BACTERIOL, V192, P6494, DOI 10.1128/JB.01064-10; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Itoh T, 1999, MOL BIOL EVOL, V16, P332, DOI 10.1093/oxfordjournals.molbev.a026114; JACOB F, 1961, COLD SPRING HARB SYM, V26, P193, DOI 10.1101/SQB.1961.026.01.024; Kopke M, 2010, P NATL ACAD SCI USA, V107, P13087, DOI 10.1073/pnas.1004716107; Li GJ, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr766; Li GJ, 2011, NUCLEIC ACIDS RES, V39, pE42, DOI 10.1093/nar/gkq948; Li Guojun, 2009, Journal of Bioinformatics and Computational Biology, V7, P19, DOI 10.1142/S0219720009003984; Ma Q, 2013, BIOINFORMATICS, V29, P2261, DOI 10.1093/bioinformatics/btt397; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Mao XZ, 2014, NUCLEIC ACIDS RES, V42, pD654, DOI 10.1093/nar/gkt1048; Miller DA, 2011, J BACTERIOL, V193, P2357, DOI 10.1128/JB.00239-11; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; Nolling J, 2001, J BACTERIOL, V183, P4823, DOI 10.1128/JB.183.16.4823-4838.2001; Okuda S, 2006, NUCLEIC ACIDS RES, V34, pD358, DOI 10.1093/nar/gkj037; Okuda S, 2011, NUCLEIC ACIDS RES, V39, pD552, DOI 10.1093/nar/gkq1090; Omelchenko MV, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r55; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Pertea M, 2009, NUCLEIC ACIDS RES, V37, pD479, DOI 10.1093/nar/gkn784; Price MN, 2006, PLOS GENET, V2, P859, DOI 10.1371/journal.pgen.0020096; Qin M, 2014, NUCL ACIDS IN PRESS; Rocha EPC, 2006, MOL BIOL EVOL, V23, P513, DOI 10.1093/molbev/msj052; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Seedorf H, 2008, P NATL ACAD SCI USA, V105, P2128, DOI 10.1073/pnas.0711093105; Skarin H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-185; Taboada B, 2012, NUCLEIC ACIDS RES, V40, pD627, DOI 10.1093/nar/gkr1020; Taboada B, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq254; Van Dongen SM, 2001, GRAPH CLUSTERING FLO; Wang Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-479; Wolf YI, 2001, GENOME RES, V11, P356, DOI 10.1101/gr.GR-1619R; Yokoyama S, 2011, J BACTERIOL, V193, P5568, DOI 10.1128/JB.05637-11; Zheng Y, 2002, GENOME RES, V12, P1221, DOI 10.1101/gr.200602; Zhou C, 2014, BIOENERG RES, V7, P1481, DOI 10.1007/s12155-014-9486-9	47	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100999	10.1371/journal.pone.0100999	http://dx.doi.org/10.1371/journal.pone.0100999			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959722	Green Published, Green Submitted, gold			2022-12-25	WOS:000338633900110
J	Beinder, L; Faehrmann, N; Wachtveitl, R; Winterfeld, I; Hartner, A; Menendez-Castro, C; Rauh, M; Ruebner, M; Huebner, H; Noegel, SC; Doerr, HG; Rascher, W; Fahlbusch, FB				Beinder, Lea; Faehrmann, Nina; Wachtveitl, Rainer; Winterfeld, Ilona; Hartner, Andrea; Menendez-Castro, Carlos; Rauh, Manfred; Ruebner, Matthias; Huebner, Hanna; Noegel, Stephanie C.; Doerr, Helmuth G.; Rascher, Wolfgang; Fahlbusch, Fabian B.			Detection of Expressional Changes Induced by Intrauterine Growth Restriction in the Developing Rat Mammary Gland via Exploratory Pathways Analysis	PLOS ONE			English	Article							SUPPRESSOR GENE WT1; BREAST-CANCER CELLS; FACTOR-I ACTION; BIRTH-WEIGHT; DIABETES-MELLITUS; FETAL NUTRITION; PROTEIN; RISK; AGE; MORPHOGENESIS	Background: Intrauterine growth restriction (IUGR) is thought to lead to fetal programming that in turn contributes to developmental changes of many organs postnatally. There is evidence that IUGR is a risk factor for the development of metabolic and cardiovascular disease later in life. A higher incidence of breast cancer was also observed after IUGR. This could be due to changes in mammary gland developmental pathways. We sought to characterise IUGR-induced alterations of the complex pathways of mammary development at the level of the transcriptome in a rat model of IUGR, using pathways analysis bioinformatics. Methodology/Principal Findings: We analysed the mammary glands of Wistar rats with IUGR induced by maternal low protein (LP) diet at the beginning (d21) and the end (d28) of pubertal ductal morphogenesis. Mammary glands of the LP group were smaller in size at d28, however did not show morphologic changes. We identified multiple differentially expressed genes in the mammary gland using Agilent SurePrint arrays at d21 and d28. In silico analysis was carried out using Ingenuity Pathways Analysis. In mammary gland tissue of LP rats at d21 of life a prominent upregulation of WT1 and CDKN1A (p21) expression was observed. Differentially regulated genes were associated with the extracellular regulated kinase (ERK)-1/-2 pathway. Western Blot analysis showed reduced levels of phosphorylated ERK-1/-2 in the mammary glands of the LP group at d21. To identify possible changes in circulating steroid levels, serum LC-Tandem mass-spectrometry was performed. LP rats showed higher serum progesterone levels and an increased corticosterone/dehydrocorticosterone-ratio at d28. Conclusions/Significance: Our data obtained from gene array analysis support the hypothesis that IUGR influences pubertal development of the rat mammary gland. We identified prominent differential regulation of genes and pathways for factors regulating cell cycle and growth. Moreover, we detected new pathways which appear to be programmed by IUGR.	[Beinder, Lea; Faehrmann, Nina; Wachtveitl, Rainer; Winterfeld, Ilona; Hartner, Andrea; Menendez-Castro, Carlos; Rauh, Manfred; Noegel, Stephanie C.; Doerr, Helmuth G.; Rascher, Wolfgang; Fahlbusch, Fabian B.] Univ Erlangen Nurnberg, Dept Pediat & Adolescent Med, D-91054 Erlangen, Germany; [Ruebner, Matthias; Huebner, Hanna] Univ Erlangen Nurnberg, Dept Gynecol & Obstet, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Fahlbusch, FB (corresponding author), Univ Erlangen Nurnberg, Dept Pediat & Adolescent Med, D-91054 Erlangen, Germany.	fabian.fahlbusch@uk-erlangen.de	Huebner, Hanna/U-1003-2019	Huebner, Hanna/0000-0001-6889-1493; Fahlbusch, Fabian/0000-0001-5480-0204	ELAN-Fonds of the University of Erlangen-Nurnberg, Germany [KI - 10.01.20.1]	ELAN-Fonds of the University of Erlangen-Nurnberg, Germany	This research project was supported by the ELAN-Fonds (KI - 10.01.20.1) of the University of Erlangen-Nurnberg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts L, 2003, PLACENTA, V24, P905, DOI 10.1016/S0143-4004(03)00115-2; Alcazar MAA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026371; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Anthony FW, 2003, J SOC GYNECOL INVEST, V10, P509, DOI 10.1016/S1071-5576(03)00147-3; Barcellos-Hoff MH, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2224; Burwell EA, 2007, ONCOGENE, V26, P3423, DOI 10.1038/sj.onc.1210127; Caldon C, 2008, ONCOGENE, V27, P126, DOI 10.1038/sj.onc.1210622; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Carvajal A, 2005, BREAST CANCER RES TR, V94, P171, DOI 10.1007/s10549-005-7726-6; Cayrol C, 1998, ONCOGENE, V16, P311, DOI 10.1038/sj.onc.1201543; Cooper C, 1996, BRIT J OBSTET GYNAEC, V103, P814, DOI 10.1111/j.1471-0528.1996.tb09879.x; Daniel AR, 2007, STEROIDS, V72, P188, DOI 10.1016/j.steroids.2006.11.009; de Assis S, 2006, INT J CANCER, V119, P1537, DOI 10.1002/ijc.21936; Desai M, 1996, BRIT J NUTR, V76, P591, DOI 10.1079/BJN19960065; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Englert C, 1997, CANCER RES, V57, P1429; Fernandez-Twinn DS, 2007, CARCINOGENESIS, V28, P545, DOI 10.1093/carcin/bgl166; Fernandez-Twinn DS, 2010, CARCINOGENESIS, V31, P1873, DOI 10.1093/carcin/bgq095; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Han YQ, 2008, MOL CANCER RES, V6, P1347, DOI 10.1158/1541-7786.MCR-07-2179; Harms C, 2007, J NEUROSCI, V27, P4562, DOI 10.1523/JNEUROSCI.5110-06.2007; Hartner A, 2008, AM J NEPHROL, V28, P168, DOI 10.1159/000110022; Haugaard CT, 2001, SCAND J LAB ANIM SCI, V28, P10; Hinck L, 2005, BREAST CANCER RES, V7, P245, DOI 10.1186/bcr1331; Huff V, 2011, NAT REV CANCER, V11, P111, DOI 10.1038/nrc3002; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Innes K, 2000, AM J EPIDEMIOL, V152, P1121, DOI 10.1093/aje/152.12.1121; Kariagina A, 2007, ENDOCRINOLOGY, V148, P2723, DOI 10.1210/en.2006-1493; KENNEDY GC, 1963, J PHYSIOL-LONDON, V166, P408, DOI 10.1113/jphysiol.1963.sp007112; Lagoa CE, 2006, SHOCK, V26, P592, DOI 10.1097/01.shk.0000232272.03602.0a; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Leong NM, 2003, INT J CANCER, V103, P789, DOI 10.1002/ijc.10886; Leung YF, 2003, TRENDS GENET, V19, P649, DOI 10.1016/j.tig.2003.09.015; Li CJ, 2007, FUNCT INTEGR GENOMIC, V7, P193, DOI 10.1007/s10142-006-0043-2; Mazurek N, 2013, EXP TOXICOL PATHOL, V65, P949, DOI 10.1016/j.etp.2013.01.009; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Mellemkjaer L, 2003, CANCER CAUSE CONTROL, V14, P61, DOI 10.1023/A:1022570305704; Menendez-Castro C, 2013, NEPHROL DIAL TRANSPL, V28, P1407, DOI 10.1093/ndt/gfs517; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Nusken KD, 2011, ENDOCRINOLOGY, V152, P1327, DOI 10.1210/en.2010-1116; Owen GI, 1998, J BIOL CHEM, V273, P10696, DOI 10.1074/jbc.273.17.10696; Ozanne SE, 1999, P NUTR SOC, V58, P615, DOI 10.1017/S0029665199000804; Ozanne SE, 2001, BRIT MED BULL, V60, P143, DOI 10.1093/bmb/60.1.143; Ozanne Susan E, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005240; Painter RC, 2006, AM J HUM BIOL, V18, P853, DOI 10.1002/ajhb.20564; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Plank C, 2006, KIDNEY INT, V70, P1974, DOI 10.1038/sj.ki.5001966; Plank C, 2007, CLIN ENDOCRINOL, V67, P304, DOI 10.1111/j.1365-2265.2007.02884.x; Rauh M, 2006, STEROIDS, V71, P450, DOI 10.1016/j.steroids.2006.01.015; Rauh M, 2009, MOL CELL ENDOCRINOL, V301, P272, DOI 10.1016/j.mce.2008.10.007; Ruan WF, 2006, MOL ENDOCRINOL, V20, P426, DOI 10.1210/me.2005-0283; Ruan WF, 2005, ENDOCRINOLOGY, V146, P1170, DOI 10.1210/en.2004-1360; Russo IH, 1998, J MAMMARY GLAND BIOL, V3, P49, DOI 10.1023/A:1018770218022; Russo J, 1996, BREAST CANCER RES TR, V39, P7, DOI 10.1007/BF01806074; Sanderson M, 1996, EPIDEMIOLOGY, V7, P34, DOI 10.1097/00001648-199601000-00007; Santen RJ, 2002, J STEROID BIOCHEM, V80, P239, DOI 10.1016/S0960-0760(01)00189-3; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Silberstein GB, 2001, MICROSC RES TECHNIQ, V52, P155, DOI 10.1002/1097-0029(20010115)52:2<155::AID-JEMT1001>3.0.CO;2-P; Simmons RA, 2005, J BIOL CHEM, V280, P28785, DOI 10.1074/jbc.M505695200; SINHA YN, 1966, AM J PHYSIOL, V210, P601, DOI 10.1152/ajplegacy.1966.210.3.601; Sloboda DM, 2007, J CLIN ENDOCR METAB, V92, P46, DOI 10.1210/jc.2006-1378; Sloboda DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006744; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Stoll BA, 1998, BREAST CANCER RES TR, V49, P187, DOI 10.1023/A:1006003110909; TEMPEL DL, 1994, J NEUROENDOCRINOL, V6, P479, DOI 10.1111/j.1365-2826.1994.tb00611.x; van Weissenbruch MM, 2005, ENDOCRIN DEV, V8, P15, DOI 10.1159/000084084; Warfel NA, 2013, CURR OPIN ONCOL, V25, P52, DOI 10.1097/CCO.0b013e32835b639e; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Whyte J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2361; Wognum S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005852; Wolf I, 2005, LANCET ONCOL, V6, P103, DOI 10.1016/S1470-2045(05)01736-5; Zheng SS, 2012, BRIT J NUTR, V108, P998, DOI 10.1017/S0007114511006222	73	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100504	10.1371/journal.pone.0100504	http://dx.doi.org/10.1371/journal.pone.0100504			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955840	Green Submitted, Green Published, gold			2022-12-25	WOS:000338917900057
J	Giebeler, A; Streetz, KL; Soehnlein, O; Neumann, U; Wang, JM; Brandenburg, LO				Giebeler, Arne; Streetz, Konrad L.; Soehnlein, Oliver; Neumann, Ulf; Wang, Ji Ming; Brandenburg, Lars-Ove			Deficiency of Formyl Peptide Receptor 1 and 2 Is Associated with Increased Inflammation and Enhanced Liver Injury after LPS-Stimulation	PLOS ONE			English	Article							N-FORMYLPEPTIDE RECEPTOR; BILE-DUCT LIGATION; 1-42-INDUCED SIGNAL-TRANSDUCTION; HEPATIC-FIBROSIS; GLIAL-CELLS; TRANSCRIPTIONAL REGULATION; HUMAN NEUTROPHILS; GENE-CLUSTER; C-MET; EXPRESSION	Introduction: Formyl peptide-receptor 1 and 2 (FPR1 and FPR2) in mice were identified as receptors with contrary affinity for the PAMP fMLF. Formyl-methionyl-leucyl-phenylalanine is either part of the bacterial membrane and is secreted by the mitochondria of eukaryotic ceslls during apoptosis. Furthermore FPR1 and 2 are described as highly relevant factors for the chemotaxis of immune cells. Their role during the acute liver injury has not been investigated yet. Materials and Methods: Constitutive knockout mice for FPR1 (mFPR1(-/-)), FPR2 (mFPR2(-/-)) and wild type (WT) mice were challenged with LPS i.p. for 3 h and 6 h. Liver and serum were sampled for further analysis. Results: Liver transaminases were elevated in all mice 3 h and 6 h post LPS stimulation. Gene expression analysis displayed a reduced expression of the pro-inflammatory cytokines IL-6 and CXCL1 after 3 h in the mFPR1(-/-) compared to wild type and mFPR2(-/-) mice. After 6 h, IL-6, TNF-alpha and CXCL1 were significantly higher in mice lacking mFPR1 or 2. Consistent to these findings the numbers of CD11b(+) and Ly6G(+) immune cells were altered in the livers. The analysis of TLR2 and TLR4 revealed time and genotype specific changes in theirs gene expression. Additionally, the liver in mFPR1- and mFPR2-deficient mice seem to be more susceptible to apoptosis by showing a significant higher number of TUNEL+-cells in the liver than WT-mice and displayed less Ki67-positive nuclei in the liver. Conclusion: The results suggest a prominent role of FPRs in the regulation of the hepatic inflammatory response after LPS induced liver injury. Deletion of mFPR1 or mFPR2 leads to deregulation of the inflammatory response compared to WT mice, associated with more severe liver injury represented by higher levels of transaminases, apoptotic cells and a reduced regenerative capacity.	[Giebeler, Arne; Neumann, Ulf] Rhein Westfal TH Aachen, Dept Surg, Univ Hosp, Aachen, Germany; [Brandenburg, Lars-Ove] Rhein Westfal TH Aachen, Dept Anat & Cell Biol, Aachen, Germany; [Streetz, Konrad L.] Rhein Westfal TH Aachen, Dept Med 3, Univ Hosp, Aachen, Germany; [Soehnlein, Oliver] Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany; [Wang, Ji Ming] NCI, Mol Immunoregulat Lab, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21701 USA	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University Hospital; University of Munich; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Giebeler, A (corresponding author), Rhein Westfal TH Aachen, Dept Surg, Univ Hosp, Aachen, Germany.	agiebeler@ukaachen.de			Department of Surgery, University Hospital Aachen, RWTH Aachen	Department of Surgery, University Hospital Aachen, RWTH Aachen	This work was supported by the Department of Surgery, University Hospital Aachen, RWTH Aachen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliberti J, 2002, MOL IMMUNOL, V38, P891, DOI 10.1016/S0161-5890(02)00015-9; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Becker EL, 1998, CELL TISSUE RES, V292, P129, DOI 10.1007/s004410051042; Best J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00258; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Brandenburg LO, 2007, J NEUROCHEM, V101, P718, DOI 10.1111/j.1471-4159.2006.04351.x; Brandenburg LO, 2010, J NEUROCHEM, V113, P749, DOI 10.1111/j.1471-4159.2010.06637.x; Brenner David A, 2009, Trans Am Clin Climatol Assoc, V120, P361; CARP H, 1982, J EXP MED, V155, P264, DOI 10.1084/jem.155.1.264; Cattaneo F, 2010, NEUROCHEM RES, V35, P2018, DOI 10.1007/s11064-010-0301-5; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Christenson K, 2008, J LEUKOCYTE BIOL, V83, P139, DOI 10.1189/jlb.0507276; CRAIG PM, 1992, GUT, V33, P1020, DOI 10.1136/gut.33.8.1020; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Czapiga M, 2005, EXP HEMATOL, V33, P73, DOI 10.1016/j.exphem.2004.09.010; DURSTIN M, 1994, BIOCHEM BIOPH RES CO, V201, P174, DOI 10.1006/bbrc.1994.1685; Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97; Friedman SL, 2008, TOXICOLOGY, V254, P120, DOI 10.1016/j.tox.2008.06.013; Gao JL, 1998, GENOMICS, V51, P270, DOI 10.1006/geno.1998.5376; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; Georgiev P, 2008, BRIT J SURG, V95, P646, DOI 10.1002/bjs.6050; Giebeler A, 2012, LAB INVEST, V92, P1726, DOI 10.1038/labinvest.2012.122; Giebeler A, 2009, GASTROENTEROLOGY, V137, P297, DOI 10.1053/j.gastro.2009.01.068; Grommes J, 2013, J INNATE IMMUN; He HQ, 2013, MOL PHARMACOL, V83, P389, DOI 10.1124/mol.112.081315; Kim SD, 2009, J IMMUNOL, V183, P5511, DOI 10.4049/jimmunol.0802986; Klein C, 2005, J CLIN INVEST, V115, P860, DOI 10.1172/JCI200523640; Kovalovich K, 2001, J BIOL CHEM, V276, P26605, DOI 10.1074/jbc.M100740200; Le YY, 2002, INT IMMUNOPHARMACOL, V2, P1, DOI 10.1016/S1567-5769(01)00150-3; Lee RJ, 1997, BIOCHEM BIOPH RES CO, V235, P812, DOI 10.1006/bbrc.1997.6874; Leoni G, 2013, J CLIN INVEST, V123, P443, DOI 10.1172/JCI65831; Liang TS, 2000, BIOCHEM BIOPH RES CO, V270, P331, DOI 10.1006/bbrc.2000.2416; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; MCCOY R, 1995, J EXP MED, V182, P207, DOI 10.1084/jem.182.1.207; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; McLeish KR, 1998, J LEUKOCYTE BIOL, V64, P537, DOI 10.1002/jlb.64.4.537; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Mukhopadhyay B, 2011, P NATL ACAD SCI USA, V108, P6323, DOI 10.1073/pnas.1017689108; Mukhopadhyay B, 2010, J BIOL CHEM, V285, P19002, DOI 10.1074/jbc.M109.068460; Nagaoka I, 2006, J IMMUNOL, V176, P3044, DOI 10.4049/jimmunol.176.5.3044; Norling LV, 2013, J INNATE IMMUN, V5, P367, DOI 10.1159/000350612; SCHIFFMANN E, 1975, J IMMUNOL, V114, P1831; SCHIFFMANN E, 1975, P NATL ACAD SCI USA, V72, P1059, DOI 10.1073/pnas.72.3.1059; Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Selzner M, 1999, HEPATOLOGY, V30, P469, DOI 10.1002/hep.510300215; Shin MK, 2011, J BIOL CHEM, V286, P17133, DOI 10.1074/jbc.M110.197772; Slowik A, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-55; Stefanovic L, 2005, EXP BIOL MED, V230, P573, DOI 10.1177/153537020523000809; Waechter V, 2012, J IMMUNOL, V188, P1856, DOI 10.4049/jimmunol.1101788; Wantha S, 2013, CIRC RES, V112, P792, DOI 10.1161/CIRCRESAHA.112.300666; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhao Y, 2007, J CELL PHYSIOL, V213, P556, DOI 10.1002/jcp.21136	53	24	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100522	10.1371/journal.pone.0100522	http://dx.doi.org/10.1371/journal.pone.0100522			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956481	Green Published, Green Submitted, gold			2022-12-25	WOS:000338917900063
J	Kingsley, LJ; Lill, MA				Kingsley, Laura J.; Lill, Markus A.			Ensemble Generation and the Influence of Protein Flexibility on Geometric Tunnel Prediction in Cytochrome P450 Enzymes	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; LIGAND-BINDING; ACCESS TUNNELS; P450S; CHANNELS; SUBSTRATE; IDENTIFICATION; MECHANISM; KINETICS	Computational prediction of ligand entry and egress paths in proteins has become an emerging topic in computational biology and has proven useful in fields such as protein engineering and drug design. Geometric tunnel prediction programs, such as Caver3.0 and MolAxis, are computationally efficient methods to identify potential ligand entry and egress routes in proteins. Although many geometric tunnel programs are designed to accommodate a single input structure, the increasingly recognized importance of protein flexibility in tunnel formation and behavior has led to the more widespread use of protein ensembles in tunnel prediction. However, there has not yet been an attempt to directly investigate the influence of ensemble size and composition on geometric tunnel prediction. In this study, we compared tunnels found in a single crystal structure to ensembles of various sizes generated using different methods on both the apo and holo forms of cytochrome P450 enzymes CYP119, CYP2C9, and CYP3A4. Several protein structure clustering methods were tested in an attempt to generate smaller ensembles that were capable of reproducing the data from larger ensembles. Ultimately, we found that by including members from both the apo and holo data sets, we could produce ensembles containing less than 15 members that were comparable to apo or holo ensembles containing over 100 members. Furthermore, we found that, in the absence of either apo or holo crystal structure data, pseudo-apo or -holo ensembles (e.g. adding ligand to apo protein throughout MD simulations) could be used to resemble the structural ensembles of the corresponding apo and holo ensembles, respectively. Our findings not only further highlight the importance of including protein flexibility in geometric tunnel prediction, but also suggest that smaller ensembles can be as capable as larger ensembles at capturing many of the protein motions important for tunnel prediction at a lower computational cost.	[Kingsley, Laura J.; Lill, Markus A.] Purdue Univ, Coll Pharm, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Lill, MA (corresponding author), Purdue Univ, Coll Pharm, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.	mlill@purdue.edu	Lill, Markus A/E-5118-2017	Lill, Markus A/0000-0003-3023-5188; Kingsley, Laura/0000-0002-5566-3974	NIH, Department of Education Graduate Assistantship for Areas of National Need (GAANN) Fellowship [GM092855]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092855] Funding Source: NIH RePORTER	NIH, Department of Education Graduate Assistantship for Areas of National Need (GAANN) Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH GM092855, Department of Education Graduate Assistantship for Areas of National Need (GAANN) Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berka K, 2013, J PHYS CHEM B, V117, P11556, DOI 10.1021/jp4059559; Berka K, 2012, NUCLEIC ACIDS RES, V40, pW222, DOI 10.1093/nar/gks363; Biedermannova L, 2012, J BIOL CHEM, V287, P29062, DOI 10.1074/jbc.M112.377853; Brezovsky J, 2013, BIOTECHNOL ADV, V31, P38, DOI 10.1016/j.biotechadv.2012.02.002; Brouk M, 2010, J MOL CATAL B-ENZYM, V66, P72, DOI 10.1016/j.molcatb.2010.03.006; Buch I, 2011, P NATL ACAD SCI USA, V108, P10184, DOI 10.1073/pnas.1103547108; Caillat C, 2008, P NATL ACAD SCI USA, V105, P16900, DOI 10.1073/pnas.0804525105; Case D, 2012, AMBER 12; Cheng LS, 2008, J MED CHEM, V51, P3878, DOI 10.1021/jm8001197; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; Cojocaru V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002152; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Cui Y-L, 2013, J CHEM INF MODEL; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Haines DC, 2001, BIOCHEMISTRY-US, V40, P13456, DOI 10.1021/bi011197q; Hendrychova T, 2012, CURR DRUG METAB, V13, P177, DOI 10.2174/138920012798918408; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Korb O, 2012, J CHEM INF MODEL, V52, P1262, DOI 10.1021/ci2005934; Najmanovich R, 2000, PROTEINS, V39, P261, DOI 10.1002/(SICI)1097-0134(20000515)39:3<261::AID-PROT90>3.0.CO;2-4; Oda A, 2005, J COMPUT CHEM, V26, P818, DOI 10.1002/jcc.20221; Otyepka M, 2007, BBA-GEN SUBJECTS, V1770, P376, DOI 10.1016/j.bbagen.2006.09.013; Pavlova M, 2009, NAT CHEM BIOL, V5, P727, DOI 10.1038/nchembio.205; Schleinkofer K, 2005, EMBO REP, V6, P584, DOI 10.1038/sj.embor.7400420; Seifert A, 2006, PROTEINS, V64, P147, DOI 10.1002/prot.20951; Setny P, 2013, P NATL ACAD SCI USA, V110, P1197, DOI 10.1073/pnas.1221231110; Skopalik J, 2008, J PHYS CHEM B, V112, P8165, DOI 10.1021/jp800311c; Stepankova V, 2013, CHEMBIOCHEM, V14, P890, DOI 10.1002/cbic.201200733; Totrov M, 2008, CURR OPIN STRUC BIOL, V18, P178, DOI 10.1016/j.sbi.2008.01.004; Ulmschneider MB, 2013, P NATL ACAD SCI USA, V110, P6364, DOI 10.1073/pnas.1214667110; Vargiu AV, 2012, P NATL ACAD SCI USA, V109, P20637, DOI 10.1073/pnas.1218348109; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Winn PJ, 2002, P NATL ACAD SCI USA, V99, P5361, DOI 10.1073/pnas.082522999; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Yaffe E, 2008, PROTEINS, V73, P72, DOI 10.1002/prot.22052; Yu XF, 2013, BIOTECHNOL APPL BIOC, V60, P134, DOI 10.1002/bab.1074	38	16	16	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99408	10.1371/journal.pone.0099408	http://dx.doi.org/10.1371/journal.pone.0099408			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956479	Green Published, Green Submitted, gold			2022-12-25	WOS:000338917900009
J	Shutler, D; Head, K; Burgher-MacLellan, KL; Colwell, MJ; Levitt, AL; Ostiguy, N; Williams, GR				Shutler, Dave; Head, Krista; Burgher-MacLellan, Karen L.; Colwell, Megan J.; Levitt, Abby L.; Ostiguy, Nancy; Williams, Geoffrey R.			Honey Bee Apis mellifera Parasites in the Absence of Nosema ceranae Fungi and Varroa destructor Mites	PLOS ONE			English	Article							DEFORMED-WING VIRUS; MICROSPORIDIAN PARASITE; PATHOGENS; DISEASES; INFECTION; SPREAD; HOST	Few areas of the world have western honey bee (Apis mellifera) colonies that are free of invasive parasites Nosema ceranae (fungi) and Varroa destructor (mites). Particularly detrimental is V. destructor; in addition to feeding on host haemolymph, these mites are important vectors of several viruses that are further implicated as contributors to honey bee mortality around the world. Thus, the biogeography and attendant consequences of viral communities in the absence of V. destructor are of significant interest. The island of Newfoundland, Province of Newfoundland and Labrador, Canada, is free of V. destructor; the absence of N. ceranae has not been confirmed. Of 55 Newfoundland colonies inspected visually for their strength and six signs of disease, only K-wing had prevalence above 5% (40/55 colonies = 72.7%). Similar to an earlier study, screenings again confirmed the absence of V. destructor, small hive beetles Aethina tumida (Murray), tracheal mites Acarapis woodi (Rennie), and Tropilaelaps spp. ectoparasitic mites. Of a subset of 23 colonies screened molecularly for viruses, none had Israeli acute paralysis virus, Kashmir bee virus, or sacbrood virus. Sixteen of 23 colonies (70.0%) were positive for black queen cell virus, and 21 (91.3%) had some evidence for deformed wing virus. No N. ceranae was detected in molecular screens of 55 colonies, although it is possible extremely low intensity infections exist; the more familiar N. apis was found in 53 colonies (96.4%). Under these conditions, K-wing was associated (positively) with colony strength; however, viruses and N. apis were not. Furthermore, black queen cell virus was positively and negatively associated with K-wing and deformed wing virus, respectively. Newfoundland honey bee colonies are thus free of several invasive parasites that plague operations in other parts of the world, and they provide a unique research arena to study independent pathology of the parasites that are present.	[Shutler, Dave; Colwell, Megan J.; Williams, Geoffrey R.] Acadia Univ, Dept Biol, Wolfville, NS B0P 1X0, Canada; [Head, Krista] Govt Newfoundland & Labrador, Dept Nat Resources, Agri Foods Branch, Forestry & Agri Foods Agcy, Corner Brook, NF, Canada; [Burgher-MacLellan, Karen L.] Agr & Agri Food Canada, Atlantic Food & Hort Res Ctr, Kentville, NS, Canada; [Levitt, Abby L.; Ostiguy, Nancy] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Williams, Geoffrey R.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Williams, Geoffrey R.] Univ Bern, Inst Bee Hlth, Vetsuisse Fac, Bern, Switzerland; [Williams, Geoffrey R.] Swiss Bee Res Ctr, Agroscope, Bern, Switzerland	Acadia University; Natural Resources Canada; Agriculture & Agri Food Canada; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Dalhousie University; University of Bern; Swiss Federal Research Station Agroscope	Williams, GR (corresponding author), Acadia Univ, Dept Biol, Wolfville, NS B0P 1X0, Canada.	geoffrey.r.williams@gmail.com	Williams, Geoffrey/C-9637-2015	Williams, Geoffrey/0000-0002-0093-1126; Colwell, Megan/0000-0001-8956-5179	Agriculture and Agrifoods Research and Development Program, Forestry and Agrifoods Agency, Production and Market Development Division, Province of Newfoundland and Labrador; Natural Sciences and Engineering Research Council of Canada; USDA NIFA AFRI [2009-85118-05718]	Agriculture and Agrifoods Research and Development Program, Forestry and Agrifoods Agency, Production and Market Development Division, Province of Newfoundland and Labrador; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); USDA NIFA AFRI(United States Department of Agriculture (USDA))	The research was supported by the Agriculture and Agrifoods Research and Development Program, Forestry and Agrifoods Agency, Production and Market Development Division, Province of Newfoundland and Labrador, an Industrial Postgraduate Scholarship from the Natural Sciences and Engineering Research Council of Canada to G. R. W. and by a USDA NIFA AFRI grant "Managed Pollinator Coordinated Agricultural Project'' 2009-85118-05718. Partial funding was provided by the affiliation of KH. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. KH collected data.	American Bee Journal, 1987, American Bee Journal, V127, P745; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; BAILEY L, 1983, ANN APPL BIOL, V103, P13, DOI 10.1111/j.1744-7348.1983.tb02735.x; BAILEY L, 1981, ANN APPL BIOL, V97, P109, DOI 10.1111/j.1744-7348.1981.tb02999.x; Botias C, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-25; Britton JR, 2013, TRENDS ECOL EVOL, V28, P93, DOI 10.1016/j.tree.2012.08.020; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; CANTWELL G E, 1970, American Bee Journal, V110, P222; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Costa C, 2011, J INVERTEBR PATHOL, V108, P224, DOI 10.1016/j.jip.2011.08.012; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Crawley MJ, 2005, STATISTICS AN INTROD; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; Elton C S., 1958, THE ECOLOGY OF INVAS; Fayer R, 2000, J PARASITOL, V86, P1174, DOI 10.2307/3284998; Flottum K., 1997, HONEY BEE PESTS PRED, P11; Forsgren E, 2012, J APICULT RES, V51, P136, DOI 10.3896/IBRA.1.51.1.17; Forsgren E, 2010, J INVERTEBR PATHOL, V103, pS5, DOI 10.1016/j.jip.2009.06.016; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; Goblirsch M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058165, 10.1371/journal.pone.0069831]; Guzman-Novoa E, 2010, APIDOLOGIE, V41, P443, DOI 10.1051/apido/2009076; Hedtke K, 2011, J INVERTEBR PATHOL, V108, P167, DOI 10.1016/j.jip.2011.08.006; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Higes M, 2013, ENV MICROBIOL REP, V5, P17, DOI 10.1111/1758-2229.12024; Innes EA, 1999, PARASITOL TODAY, V15, P427, DOI 10.1016/S0169-4758(99)01529-X; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kevan PG, 2006, AM BEE J, V146, P694; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Martin SJ, 2013, ENVIRON MICROBIOL RE; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Martin-Hernandez R, 2007, APPL ENVIRON MICROB, V73, P6331, DOI 10.1128/AEM.00270-07; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Mutinelli F, 2011, REV SCI TECH OIE, V30, P257; Palacios G, 2008, J VIROL, V82, P6209, DOI 10.1128/JVI.00251-08; Ravoet J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072443; Rozen S, 2000, Methods Mol Biol, V132, P365; Sammataro D, 2000, ANNU REV ENTOMOL, V45, P519, DOI 10.1146/annurev.ento.45.1.519; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; Shen MQ, 2005, J GEN VIROL, V86, P2281, DOI 10.1099/vir.0.80824-0; Shimanuki H, 2000, AGRICULTURE HANDBOOK; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Sumpter DJT, 2004, J ANIM ECOL, V73, P51, DOI 10.1111/j.1365-2656.2004.00776.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Whitney H, 2005, IMPORT REGULATIONS F; Williams GR, 2008, J INVERTEBR PATHOL, V97, P189, DOI 10.1016/j.jip.2007.08.005; Williams GR, 2011, APIDOLOGIE, V42, P15, DOI 10.1051/apido/2010030; Williams GR, 2010, CAN ENTOMOL, V142, P584, DOI 10.4039/n10-029; Williams GR, 2010, BIOESSAYS, V32, P845, DOI 10.1002/bies.201000075; Williams GR, 2009, J INVERTEBR PATHOL, V101, P77, DOI 10.1016/j.jip.2009.01.004; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Yue C, 2005, J GEN VIROL, V86, P3419, DOI 10.1099/vir.0.81401-0	58	18	23	1	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e98599	10.1371/journal.pone.0098599	http://dx.doi.org/10.1371/journal.pone.0098599			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955834	Green Published, gold			2022-12-25	WOS:000338917900003
J	Rahman, MM				Rahman, Mohammed M.			Reusable and Mediator-Free Cholesterol Biosensor Based on Cholesterol Oxidase Immobilized onto TGA-SAM Modified Smart Bio-Chips	PLOS ONE			English	Article							CARBON-FIBER MICROELECTRODES; CHARGE-TRANSFER TECHNIQUE; ELECTROCHEMICAL DETECTION; HYDROGEN-PEROXIDE; COMPOSITE FILM; POLYMER-FILM; SENSOR; NANOPARTICLES; STABILIZATION; ACETYLCHOLINE	A reusable and mediator-free cholesterol biosensor based on cholesterol oxidase (ChOx) was fabricated based on self-assembled monolayer (SAM) of thioglycolic acid (TGA) (covalent enzyme immobilization by dropping method) using bio-chips. Cholesterol was detected with modified bio-chip (Gold/Thioglycolic-acid/Cholesterol-oxidase i.e., Au/TGA/ChOx) by reliable cyclic voltammetric (CV) technique at room conditions. The Au/TGA/ChOx modified bio-chip sensor demonstrates good linearity (1.0 nM to 1.0 mM; R = 0.9935), low-detection limit (similar to 0.42 nM, SNR similar to 3), and higher sensitivity (similar to 74.3 mu A mu M-1 cm(-2)), lowest-small sample volume (50.0 mu L), good stability, and reproducibility. To the best of our knowledge, this is the first statement with a very high sensitivity, low-detection limit, and low-sample volumes are required for cholesterol biosensor using Au/TGA/ChOx-chips assembly. The result of this facile approach was investigated for the biomedical applications for real samples at room conditions with significant assembly (Au/TGA/ChOx) towards the development of selected cholesterol biosensors, which can offer analytical access to a large group of enzymes for wide range of biomedical applications in health-care fields.	[Rahman, Mohammed M.] King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah, Saudi Arabia; [Rahman, Mohammed M.] King Abdulaziz Univ, Fac Sci, CEAMR, Jeddah, Saudi Arabia	King Abdulaziz University; King Abdulaziz University	Rahman, MM (corresponding author), King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah, Saudi Arabia.	mmrahman@kau.edu.sa	Rahman, Mohammed M./H-5823-2012	Rahman, Mohammed M./0000-0003-2773-1244				Ansari AA, 2008, ELECTROCHEM COMMUN, V10, P1246, DOI 10.1016/j.elecom.2008.06.003; Arya SK, 2007, BIOSENS BIOELECTRON, V22, P2516, DOI 10.1016/j.bios.2006.10.011; Betancor L, 2008, TRENDS BIOTECHNOL, V26, P566, DOI 10.1016/j.tibtech.2008.06.009; Brady D, 2009, BIOTECHNOL LETT, V31, P1639, DOI 10.1007/s10529-009-0076-4; Brahim S, 2001, ANAL CHIM ACTA, V448, P27, DOI 10.1016/S0003-2670(01)01321-6; CARAS S, 1980, ANAL CHEM, V52, P1935, DOI 10.1021/ac50062a035; Chauhan N, 2012, AM J ANAL CHEM, V2, P41; Dhand C, 2007, ANAL CHIM ACTA, V602, P244, DOI 10.1016/j.aca.2007.09.028; Fernandez-Lafuente R, 2009, ENZYME MICROB TECH, V45, P405, DOI 10.1016/j.enzmictec.2009.08.009; Garcia-Galan C, 2011, ADV SYNTH CATAL, V353, P2885, DOI 10.1002/adsc.201100534; HAFEMAN DG, 1988, SCIENCE, V240, P1182, DOI 10.1126/science.3375810; HAUBRICH DR, 1981, BIOCHEM PHARMACOL, V30, P2993, DOI 10.1016/0006-2952(81)90265-3; Hernandez K, 2012, CURR ORG CHEM, V16, P2652, DOI 10.2174/138527212804004526; Hernandez K, 2011, ENZYME MICROB TECH, V48, P107, DOI 10.1016/j.enzmictec.2010.10.003; Holtz JH, 1997, NATURE, V389, P829, DOI 10.1038/39834; Hwang ET, 2013, ENG LIFE SCI, V13, P49, DOI 10.1002/elsc.201100225; Iyer PV, 2008, PROCESS BIOCHEM, V43, P1019, DOI 10.1016/j.procbio.2008.06.004; Izaki Y, 1998, NEUROSCI LETT, V258, P33, DOI 10.1016/S0304-3940(98)00841-6; Khan R, 2008, ANAL CHIM ACTA, V616, P207, DOI 10.1016/j.aca.2008.04.010; Kim Gwangseong, 2013, Methods Mol Biol, V1028, P101, DOI 10.1007/978-1-62703-475-3_6; Kon Y, 2012, J JPN PETROL INST, V55, P277, DOI 10.1627/jpi.55.277; KULLICK T, 1995, ANAL CHIM ACTA, V300, P25, DOI 10.1016/0003-2670(94)00376-W; Kumar A, 2000, ANAL CHIM ACTA, V414, P43, DOI 10.1016/S0003-2670(00)00792-3; Lee SR, 2008, BIOSENS BIOELECTRON, V24, P410, DOI 10.1016/j.bios.2008.04.017; Lee SR, 2009, BIOSENS BIOELECTRON, V24, P1877, DOI 10.1016/j.bios.2008.09.008; Lee SR, 2009, TRAC-TREND ANAL CHEM, V28, P196, DOI 10.1016/j.trac.2008.11.009; Levy RI, 1972, METABOLIC BASIS INHE, V3, P545; Marharu Z, 2012, ANALYST, V137, P747; Martin KF, 1947, LIFE SCI, V41, P865; Mateo C, 2007, ENZYME MICROB TECH, V40, P1451, DOI 10.1016/j.enzmictec.2007.01.018; McNally M, 2001, ANAL CHEM, V73, P4793, DOI 10.1021/ac0104532; Nauck M, 2000, CLIN CHEM, V46, P436; Nauck M, 1997, CLIN CHEM, V43, P1622; Netchiporouk LI, 1996, ANAL CHEM, V68, P4358, DOI 10.1021/ac960190p; Nyamsi Hendji A. M., 1993, Analytica Chimica Acta, V281, P3; Pearson A, 2003, P NATL ACAD SCI USA, V100, P15352, DOI 10.1073/pnas.2536559100; Pijanowska DG, 1997, SENSOR ACTUAT B-CHEM, V44, P370, DOI 10.1016/S0925-4005(97)00194-9; Poghossian AS, 1997, SENSOR ACTUAT B-CHEM, V44, P361, DOI 10.1016/S0925-4005(97)00202-5; POTTER PE, 1983, J NEUROCHEM, V41, P188, DOI 10.1111/j.1471-4159.1983.tb13668.x; QIAOCUI S, 2005, ELECTROANAL, V17, P857, DOI DOI 10.1002/ELAN.200403162; Rahman MM, 2009, ADV SCI LETT, V2, P28, DOI 10.1166/asl.2009.1013; Rakow NA, 2000, NATURE, V406, P710, DOI 10.1038/35021028; Rodrigues RC, 2013, CHEM SOC REV, V42, P6290, DOI 10.1039/c2cs35231a; Rodrigues RC, 2011, ADV SYNTH CATAL, V353, P2216, DOI 10.1002/adsc.201100163; ROISIN MP, 1991, J NEUROSCI METH, V37, P183, DOI 10.1016/0165-0270(91)90129-N; Sawada K, 2004, SENSOR ACTUAT B-CHEM, V98, P69, DOI 10.1016/j.snb.2003.09.027; Singh S, 2006, SENSOR ACTUAT B-CHEM, V115, P534, DOI 10.1016/j.snb.2005.10.025; Singh S, 2004, ANAL CHIM ACTA, V502, P229, DOI 10.1016/j.aca.2003.09.064; Singh SP, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2768302; Soldatkin AP, 1997, MAT SCI ENG C-BIOMIM, V5, P35, DOI 10.1016/S0928-4931(97)00020-9; STANTON TB, 1987, INFECT IMMUN, V55, P309, DOI 10.1128/IAI.55.2.309-313.1987; Stepankova V, 2013, ACS CATAL, V3, P2823, DOI 10.1021/cs400684x; Tan XC, 2005, ANAL BIOCHEM, V337, P111, DOI 10.1016/j.ab.2004.10.040; Tian CY, 1998, SENSOR ACTUAT B-CHEM, V52, P119, DOI 10.1016/S0925-4005(98)00265-2; Umar A, 2008, CHEM COMMUN, P166, DOI 10.1039/b711215g; Umar A, 2009, ELECTROCHEM COMMUN, V11, P118, DOI 10.1016/j.elecom.2008.10.046; Umar A, 2009, TALANTA, V78, P284, DOI 10.1016/j.talanta.2008.11.018; VANDERSCHOOT BH, 1987, BIOSENSORS, V3, P161; Venton BJ, 2002, ANAL CHEM, V74, P539, DOI 10.1021/ac010819a; Yang MH, 2006, ANAL CHIM ACTA, V571, P211, DOI 10.1016/j.aca.2006.04.061; Yao T, 2003, ANAL SCI, V19, P767, DOI 10.2116/analsci.19.767; Zhang S, 2001, ANAL CHIM ACTA, V427, P45, DOI 10.1016/S0003-2670(00)01124-7; Zhou N, 2006, ANAL CHEM, V78, P5227, DOI 10.1021/ac0605492; ZURN A, 1994, FRESEN J ANAL CHEM, V349, P666, DOI 10.1007/BF00323477	64	20	21	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100327	10.1371/journal.pone.0100327	http://dx.doi.org/10.1371/journal.pone.0100327			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949733	Green Submitted, Green Published, gold			2022-12-25	WOS:000338276300065
J	Si, Y; Wang, ZY; Yu, T; Lin, GZ; Zhang, J; Zhang, K; Zhang, H; Li, YC				Si, Yu; Wang, Zhenyu; Yu, Tao; Lin, Guo Zhong; Zhang, Jia; Zhang, Kuo; Zhang, Hua; Li, Yuan Chao			Results of Cervical Recapping Laminoplasty: Gross Anatomical Changes, Biomechanical Evaluation at Different Time Points and Degrees of Level Involvement	PLOS ONE			English	Article							OPEN-DOOR LAMINOPLASTY; SPINAL-CORD TUMORS; BILATERAL LAMINOTOMY; LUMBAR SPINE; IN-VITRO; LAMINECTOMY; MYELOPATHY; DEFORMITY; MODEL; FLEXIBILITY	Background: Recapping laminoplasty has become the frequently-used approach to the spinal canal when bone decompression of the vertebral canal is not the goal. However, what changes will occur after surgery, and whether recapping laminoplasty can actually reduce the risk of delayed deformities remains unknown. Methodology: We designed an animal experiment using a caprine model, and partitioned the animals into in vitro and in vivo surgical groups. We performed recapping laminoplasty on one group and laminectomy on another group. These animals were sacrificed six months after operating, cervical spines removed, biomechanically tested, and these data were compared to determine whether the recapping laminoplasty technique leads to subsequent differences in range of motion. Image data were also obtained before the surgery and when the animals were killed. Besides, we investigated the initial differences in kinetics between recapping laminoplasty and laminectomy. We did this by comparing data obtained from biomechanical testing of in vitro-performed recapping laminoplasty and laminectomy. Finally, we investigated the effect that longitudinal distance has on cervical mechanics. This was determined by performing a two-level recapping laminoplasty, and then extending the laminoplasty to the next level and repeating the mechanical testing at each step. Principal Findings: There were three mainly morphological changes at the six months after laminoplasty: volume reduction and bone nonunion of the recapping laminae, irregular fibrosis formation around the facet joints and re-implanted lamina-ligamentous complex. In the biomechanical test, comparing with laminectomy, recapping laminoplasty didn't show significant differences in the immediate postoperative comparison, while recapping laminoplasty demonstrated significantly decreased motion in flexion/extension six months later. Inclusion of additional levels in the laminotomy procedure didn't lead to changes in immediate biomechanics. Conclusions: Recapping laminoplasty can't fully restore the posterior structure, but still reduced the risk of delayed cervical instability in a caprine model.	[Si, Yu; Wang, Zhenyu; Yu, Tao; Lin, Guo Zhong; Zhang, Jia] Peking Univ, Hosp 3, Dept Neurosurg, Beijing 100871, Peoples R China; [Zhang, Kuo] Dept Lab Anim Sci, Beijing, Peoples R China; [Zhang, Hua] Peking Univ, Hosp 3, Clin Epidemiol Res Ctr, Beijing 100871, Peoples R China; [Li, Yuan Chao] Shanghai Jiao Tong Univ, Sch Mech Engn, Shanghai 200030, Peoples R China	Peking University; Peking University; Shanghai Jiao Tong University	Wang, ZY (corresponding author), Peking Univ, Hosp 3, Dept Neurosurg, Beijing 100871, Peoples R China.	wzyu502@yahoo.com	Li, Yuan/GXV-1310-2022		National Natural Science Foundation of China [5443002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported financially by the National Natural Science Foundation of China (grant 5443002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agazzi S, 2007, J NEUROSURG-SPINE, V7, P549, DOI 10.3171/SPI-07/11/549; Baisden J, 1999, SPINE, V24, P1283, DOI 10.1097/00007632-199907010-00003; Cunningham BW, 2010, J NEUROSURG-SPINE, V13, P216, DOI 10.3171/2010.3.SPINE09512; Detwiler PW, 2003, J NEUROSURG, V99, P214, DOI 10.3171/spi.2003.99.2.0214; Hara M, 2001, NEUROSURGERY, V48, P235; Kandziora F, 2001, SPINE, V26, P1028, DOI 10.1097/00007632-200105010-00008; Kawahara N, 1999, SPINE, V24, P1363, DOI 10.1097/00007632-199907010-00015; Kikkawa J, 2010, SPINE, V35, pE1465, DOI 10.1097/BRS.0b013e3181f06ca8; Kode S, 2012, SPINE, V37, pE1165, DOI 10.1097/BRS.0b013e31825e6251; Kubo S, 2003, SPINE, V28, P227, DOI 10.1097/00007632-200302010-00005; Lee MJ, 2010, SPINE, V35, P1789, DOI 10.1097/BRS.0b013e3181c9b8d6; Liu Xin-yu, 2009, Orthop Surg, V1, P275, DOI 10.1111/j.1757-7861.2009.00050.x; McGirt MJ, 2008, J NEUROS-PEDIATR, V1, P57, DOI 10.3171/PED-08/01/057; McGirt MJ, 2010, NEUROSURGERY, V66, P1005, DOI 10.1227/01.NEU.0000367721.73220.C9; NOWINSKI GP, 1993, SPINE, V18, P1995, DOI 10.1097/00007632-199310001-00012; Otani K, 2009, SPINE, V34, P268, DOI 10.1097/BRS.0b013e318195b27a; Paul CPL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033147; Puttlitz CM, 2004, EUR SPINE J, V13, P213, DOI 10.1007/s00586-004-0684-6; Raab P, 2008, INT ORTHOP, V32, P355, DOI 10.1007/s00264-007-0325-x; Rao Raj D, 2002, Spine J, V2, P320, DOI 10.1016/S1529-9430(02)00402-3; Ruggeri A, 2012, EUR SPINE J, V21, P364, DOI 10.1007/s00586-011-1826-2; Ryken TC, 2009, J NEUROSURG-SPINE, V11, P142, DOI 10.3171/2009.1.SPINE08725; Subramaniam V, 2009, SPINE, V34, pE573, DOI 10.1097/BRS.0b013e3181aa0214; Tai CL, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-84; Valentin S, 2012, J BIOMECH, V45, P2506, DOI 10.1016/j.jbiomech.2012.07.022; Wilke HJ, 1997, ANAT RECORD, V247, P542, DOI 10.1002/(SICI)1097-0185(199704)247:4<542::AID-AR13>3.0.CO;2-P; Yang LL, 2013, ORTHOPEDICS, V36, pE79, DOI 10.3928/01477447-20121217-23	27	1	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100689	10.1371/journal.pone.0100689	http://dx.doi.org/10.1371/journal.pone.0100689			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950103	gold, Green Published, Green Submitted			2022-12-25	WOS:000338276300108
J	Zhang, JA; Yin, Z; Ma, LW; Yin, ZQ; Hu, YY; Xu, Y; Wu, D; Permatasari, F; Luo, D; Zhou, BR				Zhang, Jia-an; Yin, Zhi; Ma, Li-wen; Yin, Zhi-qiang; Hu, Yan-yan; Xu, Yang; Wu, Di; Permatasari, Felicia; Luo, Dan; Zhou, Bing-rong			The Protective Effect of Baicalin against UVB Irradiation Induced Photoaging: An In Vitro and In Vivo Study	PLOS ONE			English	Article							INDUCED PREMATURE SENESCENCE; INDUCED OXIDATIVE DAMAGE; HUMAN SKIN FIBROBLASTS; MOUSE SKIN; MOLECULAR-MECHANISMS; CONNECTIVE-TISSUE; DNA-DAMAGE; ULTRAVIOLET; LIGHT; APOPTOSIS	Objective: This study was aimed to evaluate the anti-photoaging effects of baicalin on Ultraviolet B (UVB)-induced photoaging in the dorsal skin of hairless mice and premature senescence in human dermal fibroblasts. Methods: We established in vivo and in vitro photoaging models by repeated exposures to UVB irradiation. By HE staining, masson staining, immunohistostaing and real-time RT-PCR, we analyzed epidermal thickness, collagen expression and the mRNA and protein levels of type I collagen, type III collagen, interstitial collagenase (MMP-1 and MMP-3) in UVB exposed dorsal mice skin. The aging condition in human dermal fibroblasts was determined by senescence-associated beta-galactosidase (SA-beta-gal) staining. Cell viability was determined using the Cell Counting Kit-8 (CCK-8). The G1 phase cell growth arrest was analyzed by flow cytometry. The senescence-related protein levels of p16(INK-4a), p21(WAF-1), and p53 and protein levels of phosphorylated histone H2AX were estimated by Western blotting. Results: Topically application of baicalin treatment reduced UVB-induced epidermal thickening of mouse skin and also result in an increase in the production of collagen I and III, and a decrease in the expression of MMP-1 and MMP-3. Compared with the UVB-irradiated group, we found that the irradiated fibroblasts additionally treated with baicalin demonstrated a decrease in the expression of SA-beta-gal, a increase in the cell viability, a decrease in the G1 phase cell proportion, a downregulation in the level of senescence-associated and gamma-H2AX proteins. However, Baicalin had no difference in the normal fibroblasts without UVB irradiation and long-term Baicalin incubation of UVB-SIPS fibroblasts gave no effects on the cell proliferation. Conclusions: Taken together, these results suggest that baicalin significantly antagonizes photoaging induced by UVB in vivo and in vitro, indicating the potential of baicalin application for anti-photoaging treatment.	[Zhang, Jia-an; Yin, Zhi; Ma, Li-wen; Yin, Zhi-qiang; Hu, Yan-yan; Xu, Yang; Wu, Di; Permatasari, Felicia; Luo, Dan; Zhou, Bing-rong] Nanjing Med Univ, Affiliated Hosp 1, Dept Dermatol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Luo, D (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Dermatol, Nanjing, Jiangsu, Peoples R China.	daniluo2013@njmu.edu.cn; bingrong.2002@163.com	Permatasari, Felicia/I-2601-2016	Permatasari, Felicia/0000-0002-6432-2637	China National Natural Science Foundation [81000700, 81171518]; science project from traditional Chinese medicine Bureau of Jiangsu Province [LZ11084]; Jiangsu National Natural Science Foundation [BK2012877]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); science project from traditional Chinese medicine Bureau of Jiangsu Province; Jiangsu National Natural Science Foundation	This work was supported by grants from the China National Natural Science Foundation (81000700 and 81171518), science project from traditional Chinese medicine Bureau of Jiangsu Province (LZ11084) and Jiangsu National Natural Science Foundation (BK2012877). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes L, 2010, PHOTOCHEM PHOTOBIOL, V86, P933, DOI 10.1111/j.1751-1097.2010.00744.x; BLACK HS, 1987, PHOTOCHEM PHOTOBIOL, V46, P213, DOI 10.1111/j.1751-1097.1987.tb04759.x; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Chainiaux F, 2002, INT J BIOCHEM CELL B, V34, P1331, DOI 10.1016/S1357-2725(02)00022-5; Chen WQ, 2008, INT J MOL MED, V21, P645; Cho HS, 2007, PHOTODERMATOL PHOTO, V23, P155, DOI 10.1111/j.1600-0781.2007.00298.x; Chung JH, 2001, J INVEST DERMATOL, V117, P1218, DOI 10.1046/j.0022-202x.2001.01544.x; Debacq-Chainiaux F, 2006, J PHARM PHARMACOL, V58, P1577, DOI 10.1211/jpp.58.12.0003; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; Gilchrest BA, 1996, BRIT J DERMATOL, V135, P867, DOI 10.1046/j.1365-2133.1996.d01-1088.x; Kang J, 2008, INT J MOL MED, V21, P777; Kielbassa C, 1997, CARCINOGENESIS, V18, P811, DOI 10.1093/carcin/18.4.811; Kino K, 2005, MUTAT RES-FUND MOL M, V571, P33, DOI 10.1016/j.mrfmmm.2004.10.010; Kosmadaki MG, 2004, MICRON, V35, P155, DOI 10.1016/j.micron.2003.11.002; Lee JH, 2010, J FOOD SCI, V75, pH212, DOI 10.1111/j.1750-3841.2010.01755.x; Liou SF, 2012, J NAT MED-TOKYO, V66, P311, DOI 10.1007/s11418-011-0592-0; Scharffetter-Kochanek K, 2000, EXP GERONTOL, V35, P307, DOI 10.1016/S0531-5565(00)00098-X; Severino J, 2000, EXP CELL RES, V257, P162, DOI 10.1006/excr.2000.4875; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SMITH JG, 1962, J INVEST DERMATOL, V39, P347, DOI 10.1038/jid.1962.122; Tierney EP, 2010, DERMATOL SURG, V36, P829, DOI 10.1111/j.1524-4725.2010.01557.x; Toussaint O, 2000, EXP GERONTOL, V35, P927, DOI 10.1016/S0531-5565(00)00180-7; UITTO J, 1989, J AM ACAD DERMATOL, V21, P614, DOI 10.1016/S0190-9622(89)70228-0; Vayalil PK, 2004, J INVEST DERMATOL, V122, P1480, DOI 10.1111/j.0022-202X.2004.22622.x; Wen YF, 2011, EXP TOXICOL PATHOL; Yaar M, 2007, BRIT J DERMATOL, V157, P874, DOI 10.1111/j.1365-2133.2007.08108.x; Zhang Y, 2011, NAT PROD RES, V25, P1150, DOI 10.1080/14786419.2010.495070; Zhou BR, 2008, ARCH DERMATOL RES, V300, P331, DOI 10.1007/s00403-008-0851-4; Zhou BR, 2008, PHOTODERMATOL PHOTO, V24, P175, DOI 10.1111/j.1600-0781.2008.00356.x; Zhou BR, 2012, FREE RADICAL RES, V46, P1458, DOI 10.3109/10715762.2012.726355; Zhou BR, 2011, ARCH PHARM RES, V34, P261, DOI 10.1007/s12272-011-0212-2; Zhou BR, 2009, PHOTODERMATOL PHOTO, V25, P250, DOI 10.1111/j.1600-0781.2009.00454.x	32	43	46	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99703	10.1371/journal.pone.0099703	http://dx.doi.org/10.1371/journal.pone.0099703			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949843	Green Published, gold, Green Submitted			2022-12-25	WOS:000338276300018
J	Mucaj, V; Lee, SS; Skuli, N; Giannoukos, DN; Qiu, B; Eisinger-Mathason, TSK; Nakazawa, MS; Shay, JES; Gopal, PP; Venneti, S; Lal, P; Minn, AJ; Simon, MC; Mathew, LK				Mucaj, V.; Lee, S. S.; Skuli, N.; Giannoukos, D. N.; Qiu, B.; Eisinger-Mathason, T. S. K.; Nakazawa, M. S.; Shay, J. E. S.; Gopal, P. P.; Venneti, S.; Lal, P.; Minn, A. J.; Simon, M. C.; Mathew, L. K.			MicroRNA-124 expression counteracts pro-survival stress responses in glioblastoma	ONCOGENE			English	Article							GENE-EXPRESSION; HYPOXIA; MIR-124; PROLIFERATION; PATHWAY; GLIOMA; RADIOTHERAPY; PROGRESSION	Glioblastomas are aggressive adult brain tumors, characterized by inadequately organized vasculature and consequent nutrient and oxygen (O-2)-depleted areas. Adaptation to low nutrients and hypoxia supports glioblastoma cell survival, progression and therapeutic resistance. However, specific mechanisms promoting cellular survival under nutrient and O-2 deprivation remain incompletely understood. Here, we show that miR-124 expression is negatively correlated with a hypoxic gene signature in glioblastoma patient samples, suggesting that low miR-124 levels contribute to pro-survival adaptive pathways in this disease. As miR-124 expression is repressed in various cancer types (including glioblastoma), we quantified miR-124 abundance in normoxic and hypoxic regions in glioblastoma patient tissue, and investigated whether ectopic miR-124 expression compromises cell survival during tumor ischemia. Our results indicate that miR-124 levels are further diminished in hypoxic/ischemic regions within individual glioblastoma patient samples, compared with regions replete in O-2 and nutrients. Importantly, we also show that increased miR-124 expression affects the ability of tumor cells to survive under O-2 and/or nutrient deprivation. Moreover, miR-124 re-expression increases cell death in vivo and enhances the survival of mice bearing intracranial xenograft tumors. miR-124 exerts this phenotype in part by directly regulating TEAD1, MAPK14/p38a and SERP1, factors involved in cell proliferation and survival under stress. Simultaneous suppression of these miR-124 targets results in similar levels of cell death as caused by miR-124 restoration. Importantly, we further demonstrate that SERP1 reintroduction reverses the hypoxic cell death elicited by miR-124, indicating the importance of SERP1 in promoting tumor cell survival. In support of our experimental data, we observed a significant correlation between high SERP1 levels and poor patient outcome in glioblastoma patients. Collectively, among the many pro-tumorigeneic properties of miR-124 repression in glioblastoma, we delineated a novel role in promoting tumor cell survival under stressful microenvironments, thereby supporting tumor progression.	[Mucaj, V.; Lee, S. S.; Skuli, N.; Giannoukos, D. N.; Qiu, B.; Eisinger-Mathason, T. S. K.; Nakazawa, M. S.; Shay, J. E. S.; Minn, A. J.; Simon, M. C.; Mathew, L. K.] Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lee, S. S.; Skuli, N.; Giannoukos, D. N.; Simon, M. C.; Mathew, L. K.] Univ Penn, Howard Hughes Med Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Skuli, N.] Inst Claudius Regaud, INSERM U1037, Toulouse, France; [Gopal, P. P.; Venneti, S.; Lal, P.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of Pennsylvania; Pennsylvania Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Claudius Regaud; University of Pennsylvania; Pennsylvania Medicine	Simon, MC (corresponding author), Univ Penn, Dept Cell & Dev Biol, Sch Med, Abramson Family Canc Res Inst,Howard Hughes Med I, 456 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	celeste2@mail.med.upenn.edu	Simon, Celeste/AAG-3941-2021	Shay, Jessica/0000-0001-7799-1349; Gopal, Pallavi/0000-0003-4708-8479; Minn, Andy/0000-0003-1418-0906; Qiu, Bo/0000-0003-4199-1659	Howard Hughes Medical Institute; National Institutes of Health [T32 GM-07229, F31CA174211]; NATIONAL CANCER INSTITUTE [F31CA174211, K08CA181475, R01CA172651, F30CA177106, P01CA104838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr Hongwei Yu for assistance with histological preparations, Dr Jeremy Rich for providing the patient-derived tumor sphere cells, Dr Stephen Prouty for assistance with Laser-Capture Microdissection and the Simon laboratory for helpful discussions. This work was funded by the Howard Hughes Medical Institute and the National Institutes of Health (T32 GM-07229; F31CA174211). MCS is an investigator of the Howard Hughes Medical Institute.	Amberger-Murphy V, 2009, CURR CANCER DRUG TAR, V9, P381, DOI 10.2174/156800909788166637; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Ben-Hamo R, 2011, GENOME MED, V3, DOI 10.1186/gm293; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cloninger C, 2011, MOL CANCER THER, V10, P2244, DOI 10.1158/1535-7163.MCT-11-0478; Demuth T, 2007, MOL CANCER THER, V6, P1212, DOI 10.1158/1535-7163.MCT-06-0711; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Evans SM, 2010, TRANSL ONCOL, V3, P160, DOI 10.1593/tlo.09265; Gao FB, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-25; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Hori O, 2006, MOL CELL BIOL, V26, P4257, DOI 10.1128/MCB.02055-05; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Hunt S, 2011, FEBS LETT, V585, P187, DOI 10.1016/j.febslet.2010.11.038; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kang K, 2013, J BIOL CHEM, V288, P25414, DOI 10.1074/jbc.M113.460287; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Krex D, 2007, BRAIN, V130, P2596, DOI 10.1093/brain/awm204; Lawson SK, 2013, MOL CELL BIOL, V33, P127, DOI 10.1128/MCB.00695-12; Li D, 2011, OMICS, V15, P673, DOI 10.1089/omi.2011.0064; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023461; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Malt AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045498; Mathew LK, 2014, P NATL ACAD SCI USA, V111, P291, DOI 10.1073/pnas.1314341111; Nelson PT, 2006, RNA, V12, P187, DOI 10.1261/rna.2258506; Paillas S, 2012, AUTOPHAGY, V8, P1098, DOI 10.4161/auto.20268; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Sonntag KC, 2012, EXP NEUROL, V235, P427, DOI 10.1016/j.expneurol.2011.11.035; Spence AM, 2008, CLIN CANCER RES, V14, P2623, DOI 10.1158/1078-0432.CCR-07-4995; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wu ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047270; Yamaguchi A, 1999, J CELL BIOL, V147, P1195, DOI 10.1083/jcb.147.6.1195; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001	41	45	47	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 23	2015	34	17					2204	2214		10.1038/onc.2014.168	http://dx.doi.org/10.1038/onc.2014.168			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CG7HG	24954504	Green Accepted			2022-12-25	WOS:000353473000006
J	Naegeli, A; Michaud, G; Schubert, M; Lin, CW; Lizak, C; Darbre, T; Reymond, JL; Aebi, M				Naegeli, Andreas; Michaud, Gaelle; Schubert, Mario; Lin, Chia-Wei; Lizak, Christian; Darbre, Tamis; Reymond, Jean-Louis; Aebi, Markus			Substrate Specificity of Cytoplasmic N-Glycosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Glycosylation; Glycosyltransferase; Post-translational Modification (PTM); Substrate Specificity; Actinobacillus Pleuropneumoniae	O-GLCNAC TRANSFERASE; INFLUENZAE HMW1 ADHESIN; ACTINOBACILLUS-PLEUROPNEUMONIAE; PROTEIN GLYCOSYLATION; ACTIVE-SITE; BINDING; OLIGOSACCHARYLTRANSFERASE; MECHANISM; INSIGHTS; ENZYME	Background:N-Glycosyltransferases represent a novel class of N-glycosylation-catalyzing enzymes. Results: A quantitative activity assay allowed us to determine substrate specificities of N-glycosyltransferase. Conclusion:N-Glycosyltransferase exhibits a relaxed sugar substrate specificity and a peptide specificity strikingly similar to that of oligosaccharyltransferase. Significance: This study highlights the convergent evolution of two N-glycosylation systems and might lay the basis for a novel route for glycoengineering in bacteria. N-Linked protein glycosylation is a very common post-translational modification that can be found in all kingdoms of life. The classical, highly conserved pathway entails the assembly of a lipid-linked oligosaccharide and its transfer to an asparagine residue in the sequon NX(S/T) of a secreted protein by the integral membrane protein oligosaccharyltransferase. A few species in the class of -proteobacteria encode a cytoplasmic N-glycosylation system mediated by a soluble N-glycosyltransferase (NGT). This enzyme uses nucleotide-activated sugars to modify asparagine residues with single monosaccharides. As these enzymes are not related to oligosaccharyltransferase, NGTs constitute a novel class of N-glycosylation catalyzing enzymes. To characterize the NGT-catalyzed reaction, we developed a sensitive and quantitative in vitro assay based on HPLC separation and quantification of fluorescently labeled substrate peptides. With this assay we were able to directly quantify glycopeptide formation by Actinobacillus pleuropneumoniae NGT and determine its substrate specificities: NGT turns over a number of different sugar donor substrates and allows for activation by both UDP and GDP. Quantitative analysis of peptide substrate turnover demonstrated a strikingly similar specificity as the classical, oligosaccharyltransferase-catalyzed N-glycosylation, with NX(S/T) sequons being the optimal NGT substrates.	[Aebi, Markus] ETH, Inst Microbiol, Dept Biol, CH-8093 Zurich, Switzerland; [Michaud, Gaelle; Darbre, Tamis; Reymond, Jean-Louis] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; [Schubert, Mario; Lizak, Christian] ETH, Inst Mol Biol & Biophys, Dept Biol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich	Aebi, M (corresponding author), ETH, Inst Microbiol, Vladimir Prelog Weg 4, CH-8093 Zurich, Switzerland.	markus.aebi@micro.biol.ethz.ch	Lin, Chia-wei/ABA-6065-2021; Schubert, Mario/B-3972-2008	Lin, Chia-wei/0000-0003-4777-2916; Schubert, Mario/0000-0003-0278-4091; Reymond, Jean-Louis/0000-0003-2724-2942; Naegeli, Andreas/0000-0002-5938-9124	Swiss National Science Foundation [CRSII3_12733, 31003A-127098, 200020_140349]; ETH Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich)	The work was supported in part by the Swiss National Science Foundation Grants CRSII3_12733 and 31003A-127098 (to M. A.) and 200020_140349 (to J. L. R.) and ETH Zurich.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Bause E, 1995, BIOCHEM J, V312, P979, DOI 10.1042/bj3120979; Calo D, 2010, GLYCOBIOLOGY, V20, P1065, DOI 10.1093/glycob/cwq055; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Choi KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015888; Dorfmueller HC, 2011, AMINO ACIDS, V40, P781, DOI 10.1007/s00726-010-0688-y; Gawthorne JA, 2014, BIOCHEM BIOPH RES CO, V445, P633, DOI 10.1016/j.bbrc.2014.02.044; Gerber S, 2013, J BIOL CHEM, V288, P8849, DOI 10.1074/jbc.M112.445940; Goddard TD, 2008, SPARKY VERSION 3; Grass S, 2003, MOL MICROBIOL, V48, P737, DOI 10.1046/j.1365-2958.2003.03450.x; Grass S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000919; Gross J, 2008, J BIOL CHEM, V283, P26010, DOI 10.1074/jbc.M801819200; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; IMPERIALI B, 1992, J AM CHEM SOC, V114, P7944, DOI 10.1021/ja00046a069; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; KASTURI L, 1995, J BIOL CHEM, V270, P14756, DOI 10.1074/jbc.270.24.14756; Kawai F, 2011, J BIOL CHEM, V286, P38546, DOI 10.1074/jbc.M111.237602; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kirby AJ, 2001, J CHEM SOC PERK T 2, P522, DOI 10.1039/b008270h; Kubota T, 2006, J MOL BIOL, V359, P708, DOI 10.1016/j.jmb.2006.03.061; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Landstrom J, 2012, GLYCOCONJUGATE J, V29, P491, DOI 10.1007/s10719-012-9411-4; Lazarus MB, 2013, SCIENCE, V342, P1235, DOI 10.1126/science.1243990; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lizak C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3627; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lolli F, 2005, J NEUROIMMUNOL, V167, P131, DOI 10.1016/j.jneuroim.2005.05.016; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; MARSHALL RD, 1972, ANNU REV BIOCHEM, V41, P673, DOI 10.1146/annurev.bi.41.070172.003325; Matsumoto S, 2013, P NATL ACAD SCI USA, V110, P17868, DOI 10.1073/pnas.1309777110; Morera S, 1999, J MOL BIOL, V292, P717, DOI 10.1006/jmbi.1999.3094; Naegeli A, 2014, J BIOL CHEM, V289, P2170, DOI 10.1074/jbc.M113.524462; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Raman J, 2008, J BIOL CHEM, V283, P22942, DOI 10.1074/jbc.M803387200; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Schimpl M, 2012, NAT CHEM BIOL, V8, P969, DOI [10.1038/nchembio.1108, 10.1038/NCHEMBIO.1108]; Schwarz F, 2011, J BIOL CHEM, V286, P35267, DOI 10.1074/jbc.M111.277160; Sharon N, 1995, ESSAYS BIOCHEM, V30, P59; Soya N, 2009, GLYCOBIOLOGY, V19, P1224, DOI 10.1093/glycob/cwp114; Sun HY, 2007, J BIOL CHEM, V282, P9973, DOI 10.1074/jbc.M610285200; Valliere-Douglass JF, 2010, J BIOL CHEM, V285, P16012, DOI 10.1074/jbc.M109.096412; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	46	41	42	3	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24521	24532		10.1074/jbc.M114.579326	http://dx.doi.org/10.1074/jbc.M114.579326			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	24962585	Green Published, hybrid			2022-12-25	WOS:000341505600044
J	Shibata, E; Dar, A; Dutta, A				Shibata, Etsuko; Dar, Ashraf; Dutta, Anindya			CRL4(Cdt2) E3 Ubiquitin Ligase and Proliferating Cell Nuclear Antigen (PCNA) Cooperate to Degrade Thymine DNA Glycosylase in S Phase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION; PIP BOX; DESTRUCTION; UBIQUITYLATION; DEAMINATION; EXPRESSION; INHIBITOR; FAMILY; CDT2; GENE	Thymine DNA glycosylase (TDG) is an essential enzyme playing multiple roles in base excision repair, transcription regulation, and DNA demethylation. TDG mediates the cytotoxicity of the anti-cancer chemotherapeutic drug 5-fluorouracil (5-FU) by prolonging S phase, generating DNA strand breaks, and inducing DNA damage signaling. During S phase of the cell cycle, TDG is degraded via the proteasomal pathway. Here we show that CRL4(Cdt2) E3 ubiquitin ligase promotes ubiquitination and proteasomal degradation of TDG in S phase in a reaction that is dependent on the interaction of TDG with proliferating cell nuclear antigen (PCNA). siRNA-mediated depletion of PCNA or components of CRL4(Cdt2), specifically cullin4A/B or substrate adaptor Cdt2, stabilizes TDG in human cells. Mutations in the PCNA-interacting peptide (PIP) motif of TDG that disrupt the interaction of TDG with PCNA or change critical basic residues essential for the action of the PIP degron prevent the ubiquitination and degradation of TDG. Thus physical interaction of TDG with PCNA through the PIP degron is required for targeting TDG to the CRL4(Cdt2) E3 ubiquitin ligase complex. Compared with forced expression of wild type TDG, CRL4(Cdt2)-resistant TDG (Delta PIP) slows cell proliferation and slightly increases the toxicity of 5-FU. Thus, CRL4(Cdt2)-dependent degradation of TDG occurs in S phase because of the requirement for TDG to interact with chromatin-loaded PCNA, and this degradation is important for preventing toxicity from excess TDG.	[Shibata, Etsuko; Dar, Ashraf; Dutta, Anindya] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Dutta, A (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	ad8q@virginia.edu	Dutta, Anindya/P-3203-2016	Dutta, Anindya/0000-0002-4319-0073	National Institutes of Health [R01 CA60499, CA166054]; NATIONAL CANCER INSTITUTE [R01CA060499, P30CA044579, R01CA166054] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA60499 and CA166054 (to A. D.).	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2013, MOL CELL, V49, P1147, DOI 10.1016/j.molcel.2013.02.003; Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Berdal KG, 1998, EMBO J, V17, P363, DOI 10.1093/emboj/17.2.363; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Chen DS, 2003, J BIOL CHEM, V278, P38586, DOI 10.1074/jbc.M304286200; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dar A, 2013, MOL CELL BIOL, V33, P3309, DOI 10.1128/MCB.00358-13; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hardeland U, 2001, PROG NUCLEIC ACID RE, V68, P235; Hardeland U, 2007, NUCLEIC ACIDS RES, V35, P3859, DOI 10.1093/nar/gkm337; Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; HEIDELBERGER C, 1957, NATURE, V179, P663, DOI 10.1038/179663a0; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kim DH, 2010, MOL CELL BIOL, V30, P4120, DOI 10.1128/MCB.01135-09; Kunz C, 2009, PLOS BIOL, V7, P967, DOI 10.1371/journal.pbio.1000091; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Michishita M, 2011, GENES CELLS, V16, P12, DOI 10.1111/j.1365-2443.2010.01464.x; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Slenn TJ, 2014, J BIOL CHEM, V289, P23043, DOI 10.1074/jbc.M114.574194; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Terai K, 2013, J BIOL CHEM, V288, P30509, DOI 10.1074/jbc.C113.505586; Um S, 1998, J BIOL CHEM, V273, P20728, DOI 10.1074/jbc.273.33.20728	33	39	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23056	23064		10.1074/jbc.M114.574210	http://dx.doi.org/10.1074/jbc.M114.574210			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24962565	Green Published, hybrid			2022-12-25	WOS:000341017200043
J	Yamashita, M; Shepherd, M; Booth, WI; Xie, H; Postis, V; Nyathi, Y; Tzokov, SB; Poole, RK; Baldwin, SA; Bullough, PA				Yamashita, Masao; Shepherd, Mark; Booth, Wesley I.; Xie, Hao; Postis, Vincent; Nyathi, Yvonne; Tzokov, Svetomir B.; Poole, Robert K.; Baldwin, Stephen A.; Bullough, Per A.			Structure and Function of the Bacterial Heterodimeric ABC Transporter CydDC STIMULATION OF ATPASE ACTIVITY BY THIOL AND HEME COMPOUNDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL OXIDASE COMPLEX; ESCHERICHIA-COLI; P-GLYCOPROTEIN; MEMBRANE-PROTEINS; BINDING; LOCUS; CRYSTALLIZATION; IDENTIFICATION; BIOSYNTHESIS; GLUTATHIONE	In Escherichia coli, the biogenesis of both cytochrome bd-type quinol oxidases and periplasmic cytochromes requires the ATP-binding cassette-type cysteine/GSH transporter, CydDC. Recombinant CydDC was purified as a heterodimer and found to be an active ATPase both in soluble form with detergent and when reconstituted into a lipid environment. Two-dimensional crystals of CydDC were analyzed by electron cryomicroscopy, and the protein was shown to be made up of two non-identical domains corresponding to the putative CydD and CydC subunits, with dimensions characteristic of other ATP-binding cassette transporters. CydDC binds heme b. Detergent-solubilized CydDC appears to adopt at least two structural states, each associated with a characteristic level of bound heme. The purified protein in detergent showed a weak basal ATPase activity (approximately 100 nmol Pi/min/mg) that was stimulated similar to 3-fold by various thiol compounds, suggesting that CydDC could act as a thiol transporter. The presence of heme (either intrinsic or added in the form of hemin) led to a further enhancement of thiol-stimulated ATPase activity, although a large excess of heme inhibited activity. Similar responses of the ATPase activity were observed with CydDC reconstituted into E. coli lipids. These results suggest that heme may have a regulatory role in CydDC-mediated transmembrane thiol transport.	[Tzokov, Svetomir B.; Poole, Robert K.; Bullough, Per A.] Univ Sheffield, Dept Mol Biol & Biotechnol, Krebs Inst Biomol Res, Sheffield S10 2TN, S Yorkshire, England; [Xie, Hao; Postis, Vincent; Nyathi, Yvonne; Baldwin, Stephen A.; Bullough, Per A.] Univ Leeds, Astbury Ctr Struct Mol Biol, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England	University of Sheffield; University of Leeds	Bullough, PA (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Krebs Inst Biomol Res, Sheffield S10 2TN, S Yorkshire, England.	p.bullough@sheffield.ac.uk	Postis, Vincent/D-7736-2013	Postis, Vincent/0000-0001-9251-4567; Bullough, Per/0000-0001-8147-1127; Tzokov, Svetomir/0000-0001-7256-5279; Shepherd, Mark/0000-0002-7472-2300	Biotechnology and Biological Sciences Research Council [BBS/B/14418]; BBSRC [BB/H016805/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H016805/1, BB/C514174/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council grant BBS/B/14418 (Membrane Protein Structure Initiative).	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; ANRAKU Y, 1988, ANNU REV BIOCHEM, V57, P101, DOI 10.1146/annurev.bi.57.070188.000533; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Chang XB, 1997, J BIOL CHEM, V272, P30962, DOI 10.1074/jbc.272.49.30962; CHEPURI V, 1990, J BIOL CHEM, V265, P12978; Cole SPC, 2006, TRENDS PHARMACOL SCI, V27, P438, DOI 10.1016/j.tips.2006.06.008; Cook GM, 2002, ARCH MICROBIOL, V178, P358, DOI 10.1007/s00203-002-0467-6; Cook GM, 2000, MICROBIOL-SGM, V146, P527, DOI 10.1099/00221287-146-2-527; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Fabianek RA, 2000, FEMS MICROBIOL REV, V24, P303, DOI 10.1111/j.1574-6976.2000.tb00544.x; Frawley ER, 2009, P NATL ACAD SCI USA, V106, P10201, DOI 10.1073/pnas.0903132106; Fuhrhop J. H., 1975, PORPHYRINS METALLOPO, P804; GEORGIOU CD, 1987, J BACTERIOL, V169, P2107, DOI 10.1128/jb.169.5.2107-2112.1987; Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020; Glover CAP, 2011, J STRUCT BIOL, V176, P419, DOI 10.1016/j.jsb.2011.09.005; Goldman BS, 1996, J BACTERIOL, V178, P6338, DOI 10.1128/jb.178.21.6338-6347.1996; GONZALEZROMO P, 1992, ANAL BIOCHEM, V200, P235, DOI 10.1016/0003-2697(92)90458-J; GREEN GN, 1988, J BIOL CHEM, V263, P13138; HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2; JAP BK, 1992, ULTRAMICROSCOPY, V46, P45, DOI 10.1016/0304-3991(92)90007-7; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Kadner R. J., 1996, ESCHERICHIA COLI SAL, P58; Kalnenieks U, 1998, FEMS MICROBIOL LETT, V168, P91; Khan AA, 2011, BBA-MOL CELL RES, V1813, P668, DOI 10.1016/j.bbamcr.2011.01.008; Kuhnke G, 2006, MOL MEMBR BIOL, V23, P173, DOI 10.1080/09687860500473630; Lee JY, 2002, J BIOL CHEM, V277, P40125, DOI 10.1074/jbc.M206871200; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Pittman MS, 2005, J BIOL CHEM, V280, P32254, DOI 10.1074/jbc.M503075200; Pittman MS, 2002, J BIOL CHEM, V277, P49841, DOI 10.1074/jbc.M205615200; POOLE RK, 1989, J GEN MICROBIOL, V135, P1865; POOLE RK, 1993, MOL MICROBIOL, V10, P421, DOI 10.1111/j.1365-2958.1993.tb02673.x; Poole RK, 2000, ADV MICROB PHYSIOL, V43, P165, DOI 10.1016/S0065-2911(00)43005-5; Rahman M, 2007, MOL MEMBR BIOL, V24, P407, DOI 10.1080/09687860701243998; SHAPIRO AB, 1994, J BIOL CHEM, V269, P3745; Shepherd M, 2007, BIOCHEMISTRY-US, V46, P5030, DOI 10.1021/bi700183u; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; WOOD PM, 1984, BIOCHIM BIOPHYS ACTA, V768, P293, DOI 10.1016/0304-4173(84)90020-X	39	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23177	23188		10.1074/jbc.M114.590414	http://dx.doi.org/10.1074/jbc.M114.590414			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24958725	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000341017200054
J	Friis, S; Sales, KU; Schafer, JM; Vogel, LK; Kataoka, H; Bugge, TH				Friis, Stine; Sales, Katiuchia Uzzun; Schafer, Jeffrey Martin; Vogel, Lotte K.; Kataoka, Hiroaki; Bugge, Thomas H.			The Protease Inhibitor HAI-2, but Not HAI-1, Regulates Matriptase Activation and Shedding through Prostasin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOUND SERINE-PROTEASE; NEURAL-TUBE CLOSURE; MOLECULAR-CLONING; EPITHELIAL-CELLS; EPIDERMAL DIFFERENTIATION; CELLULAR-LOCALIZATION; PLACENTAL DEVELOPMENT; PROTEOLYTIC CASCADE; ZYMOGEN ACTIVATION; BARRIER FUNCTION	The membrane-anchored serine proteases, matriptase and prostasin, and the membrane-anchored serine protease inhibitors, hepatocyte growth factor activator inhibitor (HAI)-1 and HAI-2, are critical effectors of epithelial development and postnatal epithelial homeostasis. Matriptase and prostasin form a reciprocal zymogen activation complex that results in the formation of active matriptase and prostasin that are targets for inhibition by HAI-1 and HAI-2. Conflicting data, however, have accumulated as to the existence of auxiliary functions for both HAI-1 and HAI-2 in regulating the intracellular trafficking and activation of matriptase. In this study, we, therefore, used genetically engineered mice to determine the effect of ablation of endogenous HAI-1 and endogenous HAI-2 on endogenous matriptase expression, subcellular localization, and activation in polarized intestinal epithelial cells. Whereas ablation of HAI-1 did not affect matriptase in epithelial cells of the small or large intestine, ablation of HAI-2 resulted in the loss of matriptase from both tissues. Gene silencing studies in intestinal Caco-2 cell monolayers revealed that this loss of cell-associated matriptase was mechanistically linked to accelerated activation and shedding of the protease caused by loss of prostasin regulation by HAI-2. Taken together, these data indicate that HAI-1 regulates the activity of activated matriptase, whereas HAI-2 has an essential role in regulating prostasin-dependent matriptase zymogen activation.	[Friis, Stine; Sales, Katiuchia Uzzun; Schafer, Jeffrey Martin; Bugge, Thomas H.] NIDCR, Proteases & Tissue Remodeling Sect, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Sales, Katiuchia Uzzun] NIDCR, Clin Res Core, NIH, Bethesda, MD 20892 USA; [Friis, Stine; Vogel, Lotte K.] Univ Copenhagen, Dept Cellular & Mol Med, Fac Hlth Sci, DK-2200 Copenhagen N, Denmark; [Schafer, Jeffrey Martin] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Kataoka, Hiroaki] Miyazaki Univ, Sect Oncopathol & Regenerat Biol, Dept Pathol, Fac Med, Miyazaki 8891692, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Copenhagen; University System of Ohio; Ohio State University; University of Miyazaki	Bugge, TH (corresponding author), NIDCR, Proteases & Tissue Remodeling Sect, Oral & Pharyngeal Canc Branch, NIH, 30 Convent Dr,Room 320, Bethesda, MD 20892 USA.	thomas.bugge@nih.gov	sales, katiuchia u/J-4880-2012	Vogel, Lotte K./0000-0001-9920-0982; sales, katiuchia/0000-0002-3768-5790	Harboe Foundation; Lundbeck Foundation; Foundation of 17.12.1981; NIDCR; National Institutes of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER; Lundbeck Foundation [R93-2011-8735] Funding Source: researchfish	Harboe Foundation; Lundbeck Foundation(Lundbeckfonden); Foundation of 17.12.1981; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the NIDCR, National Institutes of Health, Intramural Research Program (to T. H. B.), by The Harboe Foundation, The Lundbeck Foundation, and The Foundation of 17.12.1981 (to S. F.), and by The Lundbeck Foundation (to L. V.).	ALAM J, 1990, ANAL BIOCHEM, V188, P245, DOI 10.1016/0003-2697(90)90601-5; Buzza MS, 2013, J BIOL CHEM, V288, P10328, DOI 10.1074/jbc.M112.443432; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Carney TJ, 2007, DEVELOPMENT, V134, P3461, DOI 10.1242/dev.004556; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Cho EG, 2001, J BIOL CHEM, V276, P44581, DOI 10.1074/jbc.M107059200; COLMAN RW, 1979, ANNU REV MED, V30, P359, DOI 10.1146/annurev.me.30.020179.002043; Davis AE, 2005, CLIN IMMUNOL, V114, P3, DOI 10.1016/j.clim.2004.05.007; Faller N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094267; Fan B, 2005, J BIOL CHEM, V280, P34513, DOI 10.1074/jbc.M502119200; Fogh J., 1975, HUMAN TUMOR CELLS IN, VVolume 1, P115, DOI [10.1007/978-1-4757-1647-4_5, DOI 10.1007/978-1-4757-1647-4_5]; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Friis S, 2011, J BIOL CHEM, V286, P5793, DOI 10.1074/jbc.M110.186874; Guo JH, 2004, TRENDS BIOCHEM SCI, V29, P172, DOI 10.1016/j.tibs.2004.02.007; Heinz-Erian P, 2009, AM J HUM GENET, V84, P188, DOI 10.1016/j.ajhg.2009.01.004; Itoh H, 1999, BIOCHEM BIOPH RES CO, V255, P740, DOI 10.1006/bbrc.1999.0268; Katsantoni EZ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-108; Kawaguchi M, 2011, AM J PATHOL, V179, P1815, DOI 10.1016/j.ajpath.2011.06.038; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Kim MG, 1999, IMMUNOGENETICS, V49, P420, DOI 10.1007/s002510050515; Kosa P, 2012, ONCOGENE, V31, P3679, DOI 10.1038/onc.2011.545; Larsen BR, 2013, EXP CELL RES, V319, P918, DOI 10.1016/j.yexcr.2013.01.008; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; Lin CY, 1997, J BIOL CHEM, V272, P9147; List K, 2006, AM J PATHOL, V168, P1513, DOI 10.2353/ajpath.2006.051071; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Macao B, 2006, NAT STRUCT MOL BIOL, V13, P71, DOI 10.1038/nsmb1035; Malsure S, 2014, J AM SOC NEPHROL, V25, P1453, DOI 10.1681/ASN.2013090936; Miyake Y, 2010, BIOSCI BIOTECH BIOCH, V74, P848, DOI 10.1271/bbb.90696; Miyake Y, 2009, CYTOTECHNOLOGY, V60, P95, DOI 10.1007/s10616-009-9219-7; Miyake Y, 2009, J BIOCHEM, V146, P273, DOI 10.1093/jb/mvp066; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Sales KU, 2015, ONCOGENE, V34, P288, DOI 10.1038/onc.2013.563; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; Shipway A, 2004, BIOCHEM BIOPH RES CO, V324, P953, DOI 10.1016/j.bbrc.2004.09.123; Spacek DV, 2010, EXP DERMATOL, V19, P527, DOI 10.1111/j.1600-0625.2009.01054.x; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Szabo R, 2009, AM J PATHOL, V174, P2015, DOI 10.2353/ajpath.2009.090053; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Tsuzuki S, 2005, BIOCHEM J, V388, P679, DOI 10.1042/BJ20041639; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009; Xu H, 2012, AM J PHYSIOL-CELL PH, V302, pC453, DOI 10.1152/ajpcell.00344.2011; YU JX, 1995, J BIOL CHEM, V270, P13483, DOI 10.1074/jbc.270.22.13483; YU JX, 1994, J BIOL CHEM, V269, P18843	56	37	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22319	22332		10.1074/jbc.M114.574400	http://dx.doi.org/10.1074/jbc.M114.574400			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24962579	Green Published, hybrid			2022-12-25	WOS:000340593500043
J	Longet, S; Vonarburg, C; Lotscher, M; Miescher, S; Zuercher, A; Corthesy, B				Longet, Stephanie; Vonarburg, Cedric; Loetscher, Marius; Miescher, Sylvia; Zuercher, Adrian; Corthesy, Blaise			Reconstituted Human Polyclonal Plasma-derived Secretory-like IgM and IgA Maintain the Barrier Function of Epithelial Cells Infected with an Enteropathogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-M ANTIBODIES; SHIGELLA-FLEXNERI; POLYMERIC IGA; IPA PROTEINS; PROTECTION; COMPONENT; DEFICIENT; CLEARANCE; BACTERIA; THERAPY	Intravenous administration of polyclonal and monoclonal antibodies has proven to be a clinically valid approach in the treatment, or at least relief, of many acute and chronic pathologies, such as infection, immunodeficiency, and a broad range of autoimmune conditions. Plasma-derived IgG or recombinant IgG are most frequently used for intravenous or subcutaneous administration, whereas a few IgM-based products are available as well. We have established recently that secretory-like IgA and IgM can be produced upon association of plasma-derived polymeric IgA and IgM with a recombinant secretory component. As a next step toward potential future mucosal administration, we sought to unravel the mechanisms by which these secretory Igs protect epithelial cells located at the interface between the environment and the inside of the body. By using polarized epithelial Caco-2 cell monolayers and Shigella flexneri as a model enteropathogen, we found that polyspecific plasma-derived SIgA and SIgM fulfill many protective functions, including dose-dependent recognition of the antigen via formation of aggregated immune complexes, reduction of bacterial infectivity, maintenance of epithelial cell integrity, and inhibition of proinflammatory cytokine/chemokine production by epithelial cells. In this in vitro model devoid of other cellular or molecular interfering partners, IgM and secretory IgM showed stronger bacterial neutralization than secretory IgA. Together, these data suggest that mucosally delivered antibody preparations may be most effective when combining both secretory-like IgA and IgM, which, together, play a crucial role in preserving several levels of epithelial cell integrity.	[Longet, Stephanie; Corthesy, Blaise] CHU Vaudois, Div Immunol & Allergy, R&D Lab, CH-1011 Lausanne, Switzerland; [Vonarburg, Cedric; Loetscher, Marius; Miescher, Sylvia; Zuercher, Adrian; Corthesy, Blaise] CSL Behring AG, CH-3000 Bern 22, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); CSL	Corthesy, B (corresponding author), CHU Vaudois, Div Immunol & Allergy, R&D Lab, Rue Bugnon, CH-1011 Lausanne, Switzerland.	blaise.corthesy@chuv.ch		Longet, Stephanie/0000-0001-5026-431X	Swiss Science Research Foundation [3100-138422]; CSL Behring Ph.D. scholarship	Swiss Science Research Foundation(Swiss National Science Foundation (SNSF)); CSL Behring Ph.D. scholarship	This work was supported by Swiss Science Research Foundation Grant 3100-138422.; Recipient of a CSL Behring Ph.D. scholarship.	Alugupalli KR, 2003, J IMMUNOL, V170, P3819, DOI 10.4049/jimmunol.170.7.3819; Bahrani FK, 1997, INFECT IMMUN, V65, P4005, DOI 10.1128/IAI.65.10.4005-4010.1997; Baral TN, 2007, J INFECT DIS, V195, P1513, DOI 10.1086/515577; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; BEHRE G, 1992, ANTIMICROB AGENTS CH, V36, P2139, DOI 10.1128/AAC.36.10.2139; Berstad AE, 1998, GUT, V42, P522, DOI 10.1136/gut.42.4.522; Blander JM, 2012, NAT REV IMMUNOL, V12, P215, DOI 10.1038/nri3167; Boes M, 1998, J EXP MED, V188, P2381, DOI 10.1084/jem.188.12.2381; Boes M, 1998, J IMMUNOL, V160, P4776; BRANDTZAEG P, 1987, CLIN EXP IMMUNOL, V67, P626; BRANDTZAEG P, 1984, NATURE, V311, P71, DOI 10.1038/311071a0; Brandtzaeg P, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00222; CLERC P, 1987, INFECT IMMUN, V55, P2681, DOI 10.1128/IAI.55.11.2681-2688.1987; Corthesy B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00185; Cottet S, 2002, J BIOL CHEM, V277, P33978, DOI 10.1074/jbc.M201726200; Couper KN, 2005, INFECT IMMUN, V73, P8060, DOI 10.1128/IAI.73.12.8060-8068.2005; Cramer M, 2009, VOX SANG, V96, P219, DOI 10.1111/j.1423-0410.2008.01143.x; Croft NM, 2005, SCAND J GASTROENTERO, V40, P965, DOI 10.1080/00365520510015908; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Durandy A, 2009, CLIN EXP IMMUNOL, V158, P2, DOI [10.1111/j.1365-2249.2009.04022.X, 10.1111/j.1365-2249.2009.04022.x]; Ehrenstein MR, 1998, P NATL ACAD SCI USA, V95, P10089, DOI 10.1073/pnas.95.17.10089; Favre LI, 2003, J CHROMATOGR B, V786, P143, DOI 10.1016/S1570-0232(02)00723-7; Fiorentino M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085211; Forbes SJ, 2011, MBIO, V2, DOI 10.1128/mBio.00042-11; Gronwall C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00066; Klimovich VB, 2011, BIOCHEMISTRY-MOSCOW+, V76, P534, DOI 10.1134/S0006297911050038; KONISHI E, 1992, PARASITOLOGY, V104, P427, DOI 10.1017/S003118200006368X; Lachmann RA, 2004, EXP LUNG RES, V30, P251, DOI 10.1080/01902140490439013; LAMPERT IA, 1993, J PATHOL, V170, P115, DOI 10.1002/path.1711700204; Longet S, 2013, J BIOL CHEM, V288, P4085, DOI 10.1074/jbc.M112.410811; Mathias A, 2013, INFECT IMMUN, V81, P3027, DOI 10.1128/IAI.00303-13; Mestecky J, 2009, IMMUNOL LETT, V124, P57, DOI 10.1016/j.imlet.2009.03.013; Mueller M, 2013, PHARM RES-DORDR, V30, P735, DOI 10.1007/s11095-012-0914-2; Norrby-Teglund A, 2006, J INTERN MED, V260, P509, DOI 10.1111/j.1365-2796.2006.01726.x; Norrby-Teglund A, 2000, CLIN INFECT DIS, V31, P1175, DOI 10.1086/317423; Orange JS, 2006, J ALLERGY CLIN IMMUN, V117, pS525, DOI 10.1016/j.jaci.2006.01.015; Perrier C, 2006, J BIOL CHEM, V281, P14280, DOI 10.1074/jbc.M512958200; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; Racine R, 2011, J IMMUNOL, V186, P1011, DOI 10.4049/jimmunol.1002836; Rathman M, 2000, MOL MICROBIOL, V35, P974, DOI 10.1046/j.1365-2958.2000.01770.x; Renegar KB, 2004, J IMMUNOL, V173, P1978, DOI 10.4049/jimmunol.173.3.1978; Rol N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405001; Salinas-Carmona MC, 2004, INFECT IMMUN, V72, P5597, DOI 10.1128/IAI.72.10.5597-5604.2004; SCHEDEL I, 1991, CRIT CARE MED, V19, P1104, DOI 10.1097/00003246-199109000-00003; Seiler P, 1998, J VIROL, V72, P2253, DOI 10.1128/JVI.72.3.2253-2258.1998; Singh K, 2014, AUTOIMMUN REV, V13, P163, DOI 10.1016/j.autrev.2013.10.005; Stehr SN, 2008, SHOCK, V29, P167, DOI 10.1097/shk.0b013e318067df15; Stubbe H, 2000, J IMMUNOL, V164, P1952, DOI 10.4049/jimmunol.164.4.1952; Subramaniam KS, 2010, J IMMUNOL, V184, P5755, DOI 10.4049/jimmunol.0901638; Watarai M, 1996, J EXP MED, V183, P991, DOI 10.1084/jem.183.3.991; Yang JY, 2014, J INFECT DIS, V209, P203, DOI 10.1093/infdis/jit399; Zurawski DV, 2006, INFECT IMMUN, V74, P5964, DOI 10.1128/IAI.00594-06	52	18	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21617	21626		10.1074/jbc.M114.549139	http://dx.doi.org/10.1074/jbc.M114.549139			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24951593	hybrid, Green Published			2022-12-25	WOS:000340558300036
J	Shao, YT; Wang, FY; Fu, WC; Yan, HY; Anraku, K; Chen, IS; Borg, B				Shao, Yi Ta; Wang, Feng-Yu; Fu, Wen-Chun; Yan, Hong Young; Anraku, Kazuhiko; Chen, I-Shiung; Borg, Bertil			Androgens Increase Iws Opsin Expression and Red Sensitivity in Male Three-Spined Sticklebacks	PLOS ONE			English	Article							SALMON ONCORHYNCHUS-KISUTCH; SPECTRAL SENSITIVITY; GENE-EXPRESSION; THYROID-HORMONE; GASTEROSTEUS-ACULEATUS; ONTOGENIC CHANGES; RAINBOW-TROUT; BLACK BREAM; EVOLUTION; RETINA	Optomotor studies have shown that three-spined sticklebacks (Gasterosteus aculeatus) are more sensitive to red during summer than winter, which may be related to the need to detect the red breeding colour of males. This study aimed to determine whether this change of red light sensitivity is specifically related to reproductive physiology. The mRNA levels of opsin genes were examined in the retinae of sexually mature and immature fish, as well as in sham-operated males, castrated control males, or castrated males implanted with androgen 11-ketoandrostenedione (11 KA), maintained under stimulatory (L16:D8) or inhibitory (L8:D16) photoperiods. In both sexes, red-sensitive opsin gene (Iws) mRNA levels were higher in sexually mature than in immature fish. Under L16:D8, lws mRNA levels were higher in intact than in castrated males, and were up-regulated by 11 KA treatment in castrated males. Moreover, electroretinogram data confirmed that sexual maturation resulted in higher relative red spectral sensitivity. Mature males under L16:D8 were more sensitive to red light than males under L8:D16. Red light sensitivity under L16:D8 was diminished by castration, but increased by 11 KA treatment. Thus, in sexually mature male sticklebacks, androgen is a key factor in enhancing sensitivity to red light via regulation of opsin gene expression. This is the first study to demonstrate that sex hormones can regulate spectral vision sensitivity.	[Shao, Yi Ta; Borg, Bertil] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden; [Wang, Feng-Yu] Taiwan Ocean Res Inst, Natl Appl Res Labs, Kaohsiung, Taiwan; [Shao, Yi Ta; Fu, Wen-Chun; Yan, Hong Young] Acad Sinica, Marine Res Stn, Sensory Physiol Lab, I Iain, Taiwan; [Yan, Hong Young] Hanse Wissenschaftskolleg Inst Adv Study, Delmenhorst, Germany; [Anraku, Kazuhiko] Kagoshima Univ, Fac Fisheries, Kagoshima 890, Japan; [Chen, I-Shiung] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan	Stockholm University; National Applied Research Laboratories - Taiwan; Kagoshima University; National Taiwan Ocean University	Yan, HY (corresponding author), Acad Sinica, Marine Res Stn, Sensory Physiol Lab, I Iain, Taiwan.	hyyan@gate.sinica.edu.tw; bertil.borg@zoologi.su.se		Anraku, Kazuhiko/0000-0001-8173-8741	Swedish Research Council Formas; Academia Sinica; Hanse Wissenschaftskolleg Institute for Advanced Study, Delmenhorst, Germany	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Academia Sinica(Academia Sinica - Taiwan); Hanse Wissenschaftskolleg Institute for Advanced Study, Delmenhorst, Germany	This study was supported by the Swedish Research Council Formas to B.Borg, and intramural research grants from Academia Sinica to H. Y. Yan.During the course of the manuscript preparation, H. Y. Yan was supported by a fellowship from Hanse Wissenschaftskolleg Institute for Advanced Study, Delmenhorst, Germany. Y. T. Shao was supported in part by a postdoctoral fellowship from Academia Sinica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseyenko OV, 2006, NEUROSCIENCE, V140, P1349, DOI 10.1016/j.neuroscience.2006.03.001; Allison WT, 2003, J COMP NEUROL, V461, P294, DOI 10.1002/cne.10682; Amano M, 1997, ZOOL SCI, V14, P1, DOI 10.2108/zsj.14.1; Andersson E, 1992, THESIS STOCKHOLM U S; Andersson Malte, 1994; BORG B, 1994, COMP BIOCHEM PHYS C, V109, P219, DOI 10.1016/0742-8413(94)00063-G; BORG B, 1993, CAN J ZOOL, V71, P2327, DOI 10.1139/z93-326; Borg B, 1995, BEHAVIOUR, V132, P1025, DOI 10.1163/156853995X00432; BORG B, 1985, BEHAVIOUR, V93, P153, DOI 10.1163/156853986X00810; Borg Bertil, 2010, P371; Boulcott P, 2007, EVOL ECOL, V21, P601, DOI 10.1007/s10682-006-9138-4; Bowmaker JK, 2008, SENSES COMPREHENSIVE, V1, P53; CARDWELL JR, 1995, J COMP PHYSIOL A, V176, P55; Carleton KL, 2001, MOL BIOL EVOL, V18, P1540, DOI 10.1093/oxfordjournals.molbev.a003940; Cheng CL, 2009, INVEST OPHTH VIS SCI, V50, P3024, DOI 10.1167/iovs.08-2713; CLARK L, 1990, J EXP ZOOL, V255, P22, DOI 10.1002/jez.1402550105; CRONLYDILLON J, 1968, J EXP BIOL, V49, P679; Cyr DG, 1996, REV FISH BIOL FISHER, V6, P165, DOI 10.1007/BF00182342; Darwin C, 1871, DESCENT MAN SELECTIO, P387; Dedden I, 2011, THESIS QUEENS U CANA; ENDLER JA, 1993, PHILOS T R SOC B, V340, P215, DOI 10.1098/rstb.1993.0060; Engstrom-Ost J, 2007, BEHAV ECOL, V18, P393, DOI 10.1093/beheco/arl097; Fisher RA, 1915, EUGEN REV, V7, P184; Flamarique IN, 2005, J COMP PHYSIOL A, V191, P37, DOI 10.1007/s00359-004-0573-9; Flamarique IN, 2013, J EXP BIOL, V216, P656, DOI 10.1242/jeb.078840; Fuller RC, 2004, J COMP PHYSIOL A, V190, P147, DOI 10.1007/s00359-003-0478-z; Habibi HR, 2012, GEN COMP ENDOCR, V175, P19, DOI 10.1016/j.ygcen.2011.11.003; Harbott LK, 2007, J COMP NEUROL, V504, P57, DOI 10.1002/cne.21435; Hellqvist A, 2006, GEN COMP ENDOCR, V145, P263, DOI 10.1016/j.ygcen.2005.09.012; Hoffmann E, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-23; Hofmann CM, 2010, MOL ECOL, V19, P2064, DOI 10.1111/j.1365-294X.2010.04621.x; Jakobsson S, 1999, FISH PHYSIOL BIOCHEM, V20, P79, DOI 10.1023/A:1007776016610; KIRKPATRICK M, 1982, EVOLUTION, V36, P1, DOI 10.1111/j.1558-5646.1982.tb05003.x; Kunzler R, 2001, BEHAV ECOL, V12, P681, DOI 10.1093/beheco/12.6.681; Largiader CR, 2001, HEREDITY, V86, P459, DOI 10.1046/j.1365-2540.2001.00850.x; Li P, 2005, J EXP BIOL, V208, P497, DOI 10.1242/jeb.01424; Lisney TJ, 2010, J EXP BIOL, V213, P1453, DOI 10.1242/jeb.036897; Maximov VV, 2000, PHILOS T ROY SOC B, V355, P1239, DOI 10.1098/rstb.2000.0675; MOORE A, 1991, PHILOS T ROY SOC B, V332, P241, DOI 10.1098/rstb.1991.0052; Morita Y, 1997, PHYSIOL BEHAV, V61, P159, DOI 10.1016/S0031-9384(96)00354-X; Rowland William J., 1994, P297; ROWLAND WJ, 1995, ANIM BEHAV, V49, P1559, DOI 10.1016/0003-3472(95)90077-2; Seeliger Mathias W., 2002, Documenta Ophthalmologica, V104, P57, DOI 10.1023/A:1014454927931; Shand J, 1999, J COMP NEUROL, V412, P203, DOI 10.1002/(SICI)1096-9861(19990920)412:2<203::AID-CNE2>3.0.CO;2-3; Shand J, 2008, J EXP BIOL, V211, P1495, DOI 10.1242/jeb.012047; Shao YT, 2013, GEN COMP ENDOCR, V182, P16, DOI 10.1016/j.ygcen.2012.10.017; Shao YT, 2012, ZOOL STUD, V51, P1282; Spady TC, 2006, MOL BIOL EVOL, V23, P1538, DOI 10.1093/molbev/msl014; Suliman T, 2014, J COMP NEUROL, V522, P98, DOI 10.1002/cne.23391; Tchoudakova A, 1999, GEN COMP ENDOCR, V113, P388, DOI 10.1006/gcen.1998.7217; Temple SE, 2008, J EXP BIOL, V211, P3879, DOI 10.1242/jeb.020289; Temple SE, 2006, J COMP PHYSIOL A, V192, P301, DOI 10.1007/s00359-005-0068-3; van der Assem J, 1967, BEHAVIOUR S, V16; WAI EVELYN HUI, 1963, CANADIAN JOUR ZOOL, V41, P611, DOI 10.1139/z63-034; WILLIAMS DD, 1989, ENVIRON BIOL FISH, V24, P33, DOI 10.1007/BF00001608; WOOD P, 1993, P ROY SOC B-BIOL SCI, V254, P227, DOI 10.1098/rspb.1993.0150; Wu DM, 2001, INVEST OPHTH VIS SCI, V42, P2115; Yokoyama S, 2008, GENETICS, V179, P2037, DOI 10.1534/genetics.108.090449; YOUNG G, 1989, GEN COMP ENDOCR, V74, P335, DOI 10.1016/S0016-6480(89)80029-2	59	29	31	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100330	10.1371/journal.pone.0100330	http://dx.doi.org/10.1371/journal.pone.0100330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963891	gold, Green Submitted, Green Published			2022-12-25	WOS:000338709500040
J	Fernandes, J; Vieira, M; Carreto, L; Santos, MAS; Duarte, CB; Carvalho, AL; Santos, AE				Fernandes, Joana; Vieira, Marta; Carreto, Laura; Santos, Manuel A. S.; Duarte, Carlos B.; Carvalho, Ana Luisa; Santos, Armanda E.			In Vitro Ischemia Triggers a Transcriptional Response to Down-Regulate Synaptic Proteins in Hippocampal Neurons	PLOS ONE			English	Article							GLUTAMATE-RECEPTOR SUBUNIT; D-ASPARTATE RECEPTOR; OXYGEN-GLUCOSE DEPRIVATION; GENE-EXPRESSION; AMPA RECEPTORS; GLOBAL-ISCHEMIA; OXYGEN/GLUCOSE DEPRIVATION; MICROARRAY ANALYSIS; SURFACE EXPRESSION; NR1 SUBUNIT	Transient global cerebral ischemia induces profound changes in the transcriptome of brain cells, which is partially associated with the induction or repression of genes that influence the ischemic response. However, the mechanisms responsible for the selective vulnerability of hippocampal neurons to global ischemia remain to be clarified. To identify molecular changes elicited by ischemic insults, we subjected hippocampal primary cultures to oxygen-glucose deprivation (OGD), an in vitro model for global ischemia that resulted in delayed neuronal death with an excitotoxic component. To investigate changes in the transcriptome of hippocampal neurons submitted to OGD, total RNA was extracted at early (7 h) and delayed (24 h) time points after OGD and used in a whole-genome RNA microarray. We observed that at 7 h after OGD there was a general repression of genes, whereas at 24 h there was a general induction of gene expression. Genes related with functions such as transcription and RNA biosynthesis were highly regulated at both periods of incubation after OGD, confirming that the response to ischemia is a dynamic and coordinated process. Our analysis showed that genes for synaptic proteins, such as those encoding for PICK1, GRIP1, TARP gamma 3, calsyntenin-2/3, SAPAP2 and SNAP-25, were down-regulated after OGD. Additionally, OGD decreased the mRNA and protein expression levels of the GluA1 AMPA receptor subunit as well as the GluN2A and GluN2B subunits of NMDA receptors, but increased the mRNA expression of the GluN3A subunit, thus altering the composition of ionotropic glutamate receptors in hippocampal neurons. Together, our results present the expression profile elicited by in vitro ischemia in hippocampal neurons, and indicate that OGD activates a transcriptional program leading to down-regulation in the expression of genes coding for synaptic proteins, suggesting that the synaptic proteome may change after ischemia.	[Fernandes, Joana; Vieira, Marta; Duarte, Carlos B.; Carvalho, Ana Luisa; Santos, Armanda E.] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Fernandes, Joana; Vieira, Marta; Santos, Armanda E.] Univ Coimbra, Fac Pharm, Coimbra, Portugal; [Carreto, Laura; Santos, Manuel A. S.] Univ Aveiro, Dept Biol, RNA Biol Lab, P-3800 Aveiro, Portugal; [Carreto, Laura; Santos, Manuel A. S.] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Duarte, Carlos B.; Carvalho, Ana Luisa] Univ Coimbra, Fac Sci & Technol, Dept Life Sci, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Aveiro; Universidade de Aveiro; Universidade de Coimbra	Carvalho, AL (corresponding author), Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal.	alc@cnc.uc.pt	Santos, Armanda E/AAV-1242-2020; Fernandes, Joana/L-9384-2014; Duarte, Carlos B/K-6358-2013; Carvalho, Ana Luisa/K-6367-2013; Vieira, M/G-3703-2012	Fernandes, Joana/0000-0002-4505-4809; Duarte, Carlos B/0000-0002-1474-0208; Carvalho, Ana Luisa/0000-0001-8368-6666; Vieira, M/0000-0001-7332-6181; Santos, Manuel/0000-0002-0437-1146	FEDER funding via Programa Operacional Factores de Competitividade -COMPETE; Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/SAU-NEU/099440/2008, PTDC/NEU-NMC/ 0750/2012, PTDC/SAU-NMC/12144/2010, PTDC/NEU-SCC/1351/2012, PEst-C/SAU/LA0001/2013-2014]; FCT [SFRH/BD/ 62600/2009, SFRH/BD/47739/2008]; Fundação para a Ciência e a Tecnologia [PTDC/NEU-SCC/1351/2012, PTDC/SAU-GMG/098850/2008, PTDC/SAU-NEU/099440/2008, PTDC/NEU-NMC/0750/2012] Funding Source: FCT	FEDER funding via Programa Operacional Factores de Competitividade -COMPETE; Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This work was supported by FEDER funding via Programa Operacional Factores de Competitividade -COMPETE and Portuguese national funding by Fundacao para a Ciencia e Tecnologia (FCT) in the scope of the following grants: PTDC/SAU-GMG/098850/2008, PTDC/SAU-NEU/099440/2008, PTDC/NEU-NMC/ 0750/2012, PTDC/SAU-NMC/12144/2010, PTDC/NEU-SCC/1351/2012 and PEst-C/SAU/LA0001/2013-2014. J. F. and M. V. received PhD grants from FCT (SFRH/BD/ 62600/2009 and SFRH/BD/47739/2008, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benardete EA, 2009, BRAIN RES, V1292, P107, DOI 10.1016/j.brainres.2009.07.027; Bevers MB, 2008, J CEREBR BLOOD F MET, V28, P655, DOI 10.1038/sj.jcbfm.9600595; Bonde C, 2005, NEUROSCIENCE, V136, P779, DOI 10.1016/j.neuroscience.2005.07.020; Bonfoco Emanuela, 1997, V29, P237; Bottiger BW, 1998, J CEREBR BLOOD F MET, V18, P1077; Buttner F, 2009, BRAIN RES, V1252, P1, DOI 10.1016/j.brainres.2008.10.045; Calderone A, 2003, J NEUROSCI, V23, P2112; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Clinkinbeard T, 2013, BRAIN RES, V1499, P129, DOI 10.1016/j.brainres.2012.12.039; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Dennis SH, 2011, J NEUROSCI, V31, P11941, DOI 10.1523/JNEUROSCI.1183-11.2011; Dixon RM, 2009, J BIOL CHEM, V284, P14230, DOI 10.1074/jbc.M901203200; Dos-Anjos S, 2009, NEUROSCIENCE, V164, P1119, DOI 10.1016/j.neuroscience.2009.09.019; Dos-Anjos S, 2009, NEUROCHEM INT, V54, P180, DOI 10.1016/j.neuint.2008.09.016; Formisano L, 2007, P NATL ACAD SCI USA, V104, P4170, DOI 10.1073/pnas.0611704104; Formisano L, 2013, NEUROBIOL DIS, V50, P76, DOI 10.1016/j.nbd.2012.10.010; Friedman LK, 2001, MOL BRAIN RES, V86, P34, DOI 10.1016/S0169-328X(00)00252-7; Garcia-Bonilla L, 2006, NEUROCHEM RES, V31, P1433, DOI 10.1007/s11064-006-9195-7; Gascon S, 2005, J BIOL CHEM, V280, P35018, DOI 10.1074/jbc.M504108200; Gorter JA, 1997, J NEUROSCI, V17, P6179; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Henson MA, 2010, PROG NEUROBIOL, V91, P23, DOI 10.1016/j.pneurobio.2010.01.004; Hofmeijer J, 2012, STROKE, V43, P607, DOI 10.1161/STROKEAHA.111.632943; Hsu JC, 1998, J CEREBR BLOOD F MET, V18, P768, DOI 10.1097/00004647-199807000-00008; Jayanthi S, 2014, BIOL PSYCHIAT, V76, P47, DOI 10.1016/j.biopsych.2013.09.034; Jin KL, 2001, ANN NEUROL, V50, P93, DOI 10.1002/ana.1073; Jung YJ, 2012, KOREAN J PHYSIOL PHA, V16, P423, DOI 10.4196/kjpp.2012.16.6.423; Kaneko N, 2014, J NEUROSCI, V34, P6030, DOI 10.1523/JNEUROSCI.4045-13.2014; Kawahara N, 2004, J CEREBR BLOOD F MET, V24, P212, DOI 10.1097/01.WCB.0000106012.33322.A2; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim YD, 2002, BRAIN RES BULL, V58, P491, DOI 10.1016/S0361-9230(02)00823-7; Kovalenko T, 2006, HIPPOCAMPUS, V16, P814, DOI 10.1002/hipo.20211; Kwak S, 2006, CURR OPIN NEUROBIOL, V16, P281, DOI 10.1016/j.conb.2006.05.004; Lai TW, 2013, PROG NEUROBIOL; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lau CG, 2010, J NEUROSCI, V30, P242, DOI 10.1523/JNEUROSCI.4933-08.2010; Liu BS, 2006, J NEUROSCI, V26, P5309, DOI 10.1523/JNEUROSCI.0567-06.2006; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Lobo AC, 2011, NEUROBIOL DIS, V44, P292, DOI 10.1016/j.nbd.2011.07.010; Low CM, 2010, MOL PHARMACOL, V78, P1, DOI 10.1124/mol.110.064006; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Lu XCM, 2004, J NEUROSCI RES, V77, P843, DOI 10.1002/jnr.20218; Lunyak VV, 2005, CELL, V121, P499, DOI 10.1016/j.cell.2005.05.003; Manadas B, 2009, J PROTEOME RES, V8, P4536, DOI 10.1021/pr900366x; Matsuda K, 2002, MOL BRAIN RES, V100, P43, DOI 10.1016/S0169-328X(02)00173-0; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; Mele M, 2014, NEUROBIOL DIS, V65, P220, DOI 10.1016/j.nbd.2014.01.019; Naisbitt S, 1997, J NEUROSCI, V17, P5687; Nakanishi N, 2009, J NEUROSCI, V29, P5260, DOI 10.1523/JNEUROSCI.1067-09.2009; Newcomb-Fernandez JK, 2001, J CEREBR BLOOD F MET, V21, P1281, DOI 10.1097/00004647-200111000-00004; Nishi M, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-23-j0003.2001; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; Noh KM, 2012, P NATL ACAD SCI USA, V109, pE962, DOI 10.1073/pnas.1121568109; Optiz T, 2000, P NATL ACAD SCI USA, V97, P13360; Otto SJ, 2007, J NEUROSCI, V27, P6729, DOI 10.1523/JNEUROSCI.0091-07.2007; Pachernegg S, 2012, TRENDS NEUROSCI, V35, P240, DOI 10.1016/j.tins.2011.11.010; Palm K, 1998, J NEUROSCI, V18, P1280; Papadopoulos MC, 2000, BRIT J NEUROSURG, V14, P305; PELLEGRINIGIAMPIETRO DE, 1992, P NATL ACAD SCI USA, V89, P10499, DOI 10.1073/pnas.89.21.10499; Perez-Otano I, 2001, J NEUROSCI, V21, P1228; PETITO CK, 1987, NEUROLOGY, V37, P1281, DOI 10.1212/WNL.37.8.1281; Pettem KL, 2013, NEURON, V80, P113, DOI 10.1016/j.neuron.2013.07.016; Pina-Crespo JC, 2010, J NEUROSCI, V30, P11501, DOI 10.1523/JNEUROSCI.1593-10.2010; Prasad SS, 2012, J MOL NEUROSCI, V47, P322, DOI 10.1007/s12031-012-9751-3; Ramos-Cejudo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052121; Schutt J, 2009, J BIOL CHEM, V284, P25479, DOI 10.1074/jbc.M109.042663; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Tang Y, 2002, EUR J NEUROSCI, V15, P1937, DOI 10.1046/j.1460-9568.2002.02030.x; Tomita S, 2007, P NATL ACAD SCI USA, V104, P18784, DOI 10.1073/pnas.0708970104; Wang H, 2013, ASN NEURO, V5, P231, DOI 10.1042/AN20130009; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wee KSL, 2008, J COMP NEUROL, V509, P118, DOI 10.1002/cne.21747; Wong HK, 2002, J COMP NEUROL, V450, P303, DOI 10.1002/cne.10314; Zhou M, 2006, J NEUROSCI, V26, P2956, DOI 10.1523/JNEUROSCI.4299-05.2006; Zhu MX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051552; Zukin R.S., 2004, STROKE, Vfourth, P829	77	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99958	10.1371/journal.pone.0099958	http://dx.doi.org/10.1371/journal.pone.0099958			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960035	Green Published, gold, Green Submitted			2022-12-25	WOS:000338633900019
J	Rodamilans, B; Leon, DS; Muhlberger, L; Candresse, T; Neumuller, M; Oliveros, JC; Garcia, JA				Rodamilans, Bernardo; San Leon, David; Muehlberger, Louisa; Candresse, Thierry; Neumueller, Michael; Carlos Oliveros, Juan; Antonio Garcia, Juan			Transcriptomic Analysis of Prunus domestica Undergoing Hypersensitive Response to Plum Pox Virus Infection	PLOS ONE			English	Article							TOBACCO-MOSAIC-VIRUS; RESISTANCE GENE; RNA-SEQ; EXPRESSION ANALYSIS; SHARKA DISEASE; PROTEIN; QUANTIFICATION; BOTTLENECKS; POPULATIONS; DISCOVERY	Plum pox virus (PPV) infects Prunus trees around the globe, posing serious fruit production problems and causing severe economic losses. One variety of Prunus domestica, named 'Jojo', develops a hypersensitive response to viral infection. Here we compared infected and non-infected samples using next-generation RNA sequencing to characterize the genetic complexity of the viral population in infected samples and to identify genes involved in development of the resistance response. Analysis of viral reads from the infected samples allowed reconstruction of a PPV-D consensus sequence. De novo reconstruction showed a second viral isolate of the PPV-Rec strain. RNA-seq analysis of PPV-infected 'Jojo' trees identified 2,234 and 786 unigenes that were significantly up-or downregulated, respectively (false discovery rate; FDR <= 0.01). Expression of genes associated with defense was generally enhanced, while expression of those related to photosynthesis was repressed. Of the total of 3,020 differentially expressed unigenes, 154 were characterized as potential resistance genes, 10 of which were included in the NBS-LRR type. Given their possible role in plant defense, we selected 75 additional unigenes as candidates for further study. The combination of next-generation sequencing and a Prunus variety that develops a hypersensitive response to PPV infection provided an opportunity to study the factors involved in this plant defense mechanism. Transcriptomic analysis presented an overview of the changes that occur during PPV infection as a whole, and identified candidates suitable for further functional characterization.	[Rodamilans, Bernardo; San Leon, David; Carlos Oliveros, Juan; Antonio Garcia, Juan] CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Muehlberger, Louisa; Neumueller, Michael] Tech Univ Munich, Unit Fruit Sci, Ctr Life & Food Sci Weihenstephan, Freising Weihenstephan, Germany; [Candresse, Thierry] UMR 1332 Biol Fruit & Pathol, Villenave Dornon, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Technical University of Munich; UDICE-French Research Universities; Universite de Bordeaux	Rodamilans, B (corresponding author), CSIC, Ctr Nacl Biotecnol, Campus Univ Autonoma Madrid, Madrid, Spain.	brodamilans@cnb.csic.es	Garcia, Juan Antonio/N-3723-2014; Rodamilans, Bernardo/ABA-9093-2021	Garcia, Juan Antonio/0000-0002-4861-9609; Rodamilans, Bernardo/0000-0002-6541-2589; Candresse, Thierry/0000-0001-9757-1835; San Leon Granado, David/0000-0001-8138-500X; Oliveros, Juan Carlos/0000-0002-4520-0853	EU; Spanish MCI [BIO2010-18541]	EU(European Commission); Spanish MCI(Spanish Government)	The authors acknowledge support of the EU in the frame of the FP7 KBBE-204429 SharCo project. Research is also supported by grants BIO2010-18541 from the Spanish MCI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adams M.J., 2012, VIRUS TAXONOMY, P1069; Garcia JA, 2014, MOL PLANT PATHOL, V15, P226, DOI 10.1111/mpp.12083; Babraham Bioinformatics, FASTQC QUAL TOOL HIG; Babu M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-325; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; Cambra M., 2006, Bulletin OEPP, V36, P202; Candresse T., 2006, Bulletin OEPP, V36, P239; Carrier G, 2011, AM J BOT, V98, pE13, DOI 10.3732/ajb.1000371; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cox, 2008, PLUM POX DIS STONE F; Dardick C, 2007, MOL PLANT MICROBE IN, V20, P1004, DOI 10.1094/MPMI-20-8-1004; Decroocq V, 2005, MOL GENET GENOMICS, V272, P680, DOI 10.1007/s00438-004-1099-0; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Diaz-Vivancos P, 2008, J EXP BOT, V59, P2147, DOI 10.1093/jxb/ern082; Dietrich C, 2003, J GEN VIROL, V84, P2871, DOI 10.1099/vir.0.19245-0; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gahlan P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-126; Gildow F, 2004, PHYTOPATHOLOGY, V94, P868, DOI 10.1094/PHYTO.2004.94.8.868; Glasa M, 2013, PHYTOPATHOLOGY, V103, P972, DOI 10.1094/PHYTO-11-12-0285-R; Gururani MA, 2012, PHYSIOL MOL PLANT P, V78, P51, DOI 10.1016/j.pmpp.2012.01.002; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Ivanov KI, 2014, J GEN VIROL, DOI 10.10999/vir.0.064220-0; Jridi C, 2006, J VIROL, V80, P2349, DOI 10.1128/JVI.80.5.2349-2357.2006; Kawahara-Miki R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026043; Kim MJ, 2005, PLANT MOL BIOL, V59, P981, DOI 10.1007/s11103-005-2619-y; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Kuss SK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000082; Kwok H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036939; Kwon SJ, 2009, PLANT J, V58, P235, DOI 10.1111/j.1365-313X.2008.03772.x; Labonne G, 1995, ACTA HORTIC, P207, DOI 10.17660/ActaHortic.1995.386.27; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levy M, 2004, PLANT PHYSIOL, V135, P2392, DOI 10.1104/pp.104.044859; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li HY, 2004, J VIROL, V78, P10582, DOI 10.1128/JVI.78.19.10582-10587.2004; Li L, 2002, PLANTA, V215, P239, DOI 10.1007/s00425-002-0750-4; Lichtenegger L., 2010, Julius-Kuhn-Archiv, P327; Llacer G., 2006, Bulletin OEPP, V36, P219; Lopez-Moya J. J., 2008, ENCY VIROLOGY, P313; Lopez-Moya JJ, 2000, J BIOTECHNOL, V76, P121, DOI 10.1016/S0168-1656(99)00196-0; Ma KW, 2011, PLANT PHYSIOL, V157, P535, DOI 10.1104/pp.111.182295; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mazorra-Manzano MA, 2010, PHYTOCHEMISTRY, V71, P515, DOI 10.1016/j.phytochem.2009.12.005; Mes JJ, 2000, PLANT J, V23, P183, DOI 10.1046/j.1365-313x.2000.00765.x; Moffett P, 2009, ADV VIRUS RES, V75, P1, DOI 10.1016/S0065-3527(09)07501-0; Mohr TJ, 2010, MOL PLANT MICROBE IN, V23, P1303, DOI 10.1094/MPMI-01-10-0022; Neumuller M, 2008, HORTIC SCI, V35, P50, DOI 10.17221/639-HORTSCI; Neumuller M., 2005, PHYTOPATHOL POL, V36, P77; Oliveros JC., 2007, FIESTA BIOINFOGP INT; Pacheco R, 2012, MOL PLANT MICROBE IN, V25, P709, DOI 10.1094/MPMI-11-11-0305; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Predajna L, 2012, VIRUS RES, V167, P112, DOI 10.1016/j.virusres.2012.04.002; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodrigo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040526; Rozen S, 2000, Methods Mol Biol, V132, P365; Sacristan S, 2003, J VIROL, V77, P9906, DOI 10.1128/JVI.77.18.9906-9911.2003; Sanseverino W, 2010, NUCLEIC ACIDS RES, V38, pD814, DOI 10.1093/nar/gkp978; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Serce CU, 2009, VIRUS RES, V142, P121, DOI 10.1016/j.virusres.2009.01.022; Sochor J, 2012, VIRUSES-BASEL, V4, P2853, DOI 10.3390/v4112853; Soriano JM, 2005, THEOR APPL GENET, V110, P980, DOI 10.1007/s00122-005-1920-0; Subr Z, 2013, ACTA VIROL, V57, P217, DOI 10.4149/av_2013_02_217; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan XP, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-56; Topfer A, 2013, J COMPUT BIOL, V20, P113, DOI 10.1089/cmb.2012.0232; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wright CF, 2011, J VIROL, V85, P2266, DOI 10.1128/JVI.01396-10; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Xu DL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-133; Yoshimura S, 1998, P NATL ACAD SCI USA, V95, P1663, DOI 10.1073/pnas.95.4.1663; Zagordi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047046; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	78	29	32	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100477	10.1371/journal.pone.0100477	http://dx.doi.org/10.1371/journal.pone.0100477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959894	Green Published, gold, Green Submitted			2022-12-25	WOS:000338633900049
J	Shpigler, H; Amsalem, E; Huang, ZY; Cohen, M; Siegel, AJ; Hefetz, A; Bloch, G				Shpigler, Hagai; Amsalem, Etya; Huang, Zachary Y.; Cohen, Mira; Siegel, Adam J.; Hefetz, Abraham; Bloch, Guy			Gonadotropic and Physiological Functions of Juvenile Hormone in Bumblebee (Bombus terrestris) Workers	PLOS ONE			English	Article							DIVISION-OF-LABOR; HONEYBEE APIS-MELLIFERA; DUFOURS GLAND SECRETION; FORAGING BEHAVIOR; SOCIAL-ORGANIZATION; OVARIAN DEVELOPMENT; DOMINANCE BEHAVIOR; GENE-EXPRESSION; BEE; PHEROMONE	The evolution of advanced sociality in bees is associated with apparent modifications in juvenile hormone (JH) signaling. By contrast to most insects in which JH is a gonadotropin regulating female fertility, in the highly eusocial honey bee (Apis mellifera) JH has lost its gonadotrophic function in adult females, and instead regulates age-related division of labor among worker bees. In order to shed light on the evolution of JH signaling in bees we performed allatectomy and replacement therapies to manipulate JH levels in workers of the "primitively eusocial" bumblebee Bombus terrestris. Allatectomized worker bees showed remarkable reduction in ovarian development, egg laying, Vitellogenin and Kruppel homolog 1 fat body transcript levels, hemolymph Vitellogenin protein abundance, wax secretion, and egg-cell construction. These effects were reverted, at least partially, by treating allatectomized bees with JH-III, the natural JH of bees. Allatectomy also affected the amount of ester component in Dufour's gland secretion, which is thought to convey a social signal relating to worker fertility. These findings provide a strong support for the hypothesis that in contrast to honey bees, JH is a gonadotropin in bumblebees and lend credence to the hypothesis that the evolution of advanced eusociality in honey bees was associated with major modifications in JH signaling.	[Shpigler, Hagai; Cohen, Mira; Siegel, Adam J.; Bloch, Guy] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Ecol Evolut & Behav, Jerusalem, Israel; [Amsalem, Etya; Hefetz, Abraham] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel; [Huang, Zachary Y.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA	Hebrew University of Jerusalem; Tel Aviv University; Michigan State University	Shpigler, H (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Ecol Evolut & Behav, Jerusalem, Israel.	hagai.shpigler@mail.huji.ac.il	Bloch, Guy/I-5861-2019; Huang, Zachary/D-5485-2011; Hefetz, Abraham/I-3853-2015	Bloch, Guy/0000-0003-1624-4926; Huang, Zachary/0000-0001-5354-5547; 	United States - Israel Binational Agricultural Research and Development Fund [IS-4418-11]; US-Israel Binational Science Foundation - BSF [2007465]; "Hoffman Leadership and Responsibility" doctoral scholarship; Vaadia-BARD Postdoctoral Fellowship Award from BARD [FI-462-2012]	United States - Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation); US-Israel Binational Science Foundation - BSF(US-Israel Binational Science Foundation); "Hoffman Leadership and Responsibility" doctoral scholarship; Vaadia-BARD Postdoctoral Fellowship Award from BARD	This work was supported by United States - Israel Binational Agricultural Research and Development Fund, #IS-4418-11, http://www.bard-isus.com to GB; US-Israel Binational Science Foundation - BSF #2007465, http://www.bsf.org.il/BSFPublic/Default.aspx to GB and GVA; the "Hoffman Leadership and Responsibility" doctoral scholarship to HS; and the Vaadia-BARD Postdoctoral Fellowship Award No. FI-462-2012 from BARD to HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; Amdam GV, 2003, J THEOR BIOL, V223, P451, DOI 10.1016/S0022-5193(03)00121-8; Amdam GV, 2003, P NATL ACAD SCI USA, V100, P1799, DOI 10.1073/pnas.0333979100; Amsalem E, 2013, J INSECT PHYSIOL, V59, P1250, DOI 10.1016/j.jinsphys.2013.09.007; Amsalem E, 2010, BEHAV ECOL SOCIOBIOL, V64, P1685, DOI 10.1007/s00265-010-0982-4; Amsalem E, 2009, P R SOC B, V276, P1295, DOI 10.1098/rspb.2008.1688; [Anonymous], 1974, SOCIAL BEHAV BEES; BELL WJ, 1973, INSECT SOC, V20, P253, DOI 10.1007/BF02223194; Bloch G, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1027; Bloch G, 2001, J BIOL RHYTHM, V16, P444, DOI 10.1177/074873001129002123; Bloch G, 1999, BEHAV ECOL SOCIOBIOL, V45, P125, DOI 10.1007/s002650050546; Bloch G, 1996, PHYSIOL ENTOMOL, V21, P257, DOI 10.1111/j.1365-3032.1996.tb00863.x; Bloch G, 2000, J INSECT PHYSIOL, V46, P47, DOI 10.1016/S0022-1910(99)00101-8; Bloch Guy, 2002, P195; Bortolotti L., 2000, Insect Social Life, V3, P85; CAMERON SA, 1990, ANN ENTOMOL SOC AM, V83, P626, DOI 10.1093/aesa/83.3.626; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; De Loof A, 2001, ARCH INSECT BIOCHEM, V47, P129, DOI 10.1002/arch.1044; Dor R, 2005, BEHAV ECOL SOCIOBIOL, V58, P270, DOI 10.1007/s00265-005-0923-9; DUCHATEAU MJ, 1989, ENTOMOL EXP APPL, V51, P199, DOI 10.1007/BF00347883; ENGELS W, 1976, J INSECT PHYSIOL, V22, P1427, DOI 10.1016/0022-1910(76)90167-0; Fussnecker B, 2008, INSECT MOL BIOL, V17, P515, DOI 10.1111/j.1365-2583.2008.00819.x; Geva S, 2005, J INSECT PHYSIOL, V51, P811, DOI 10.1016/j.jinsphys.2005.03.009; GILBERT LI, 1980, ANNU REV PHYSIOL, V42, P493, DOI 10.1146/annurev.ph.42.030180.002425; Grozinger CM, 2007, J COMP PHYSIOL A, V193, P461, DOI 10.1007/s00359-006-0202-x; Grozinger CM, 2002, INTEGR COMP BIOL, V42, P1237; Guidugli KR, 2005, FEBS LETT, V579, P4961, DOI 10.1016/j.febslet.2005.07.085; Hagai T, 2007, INSECT BIOCHEM MOLEC, V37, P689, DOI 10.1016/j.ibmb.2007.04.002; Hartfelder K, 2000, BRAZ J MED BIOL RES, V33, P157, DOI 10.1590/S0100-879X2000000200003; Hartfelder K, 1998, CURR TOP DEV BIOL, V40, P45, DOI 10.1016/S0070-2153(08)60364-6; HUANG ZY, 1992, P NATL ACAD SCI USA, V89, P11726, DOI 10.1073/pnas.89.24.11726; HUANG ZY, 1991, J INSECT PHYSIOL, V37, P733, DOI 10.1016/0022-1910(91)90107-B; KAATZ HH, 1992, J COMP PHYSIOL B, V162, P588, DOI 10.1007/BF00296638; Katzav-Gozansky T, 2003, INSECT SOC, V50, P20, DOI 10.1007/s000400300003; Katzav-Gozansky T, 2001, BEHAV ECOL SOCIOBIOL, V51, P76, DOI 10.1007/s002650100406; Katzav-Gozansky T, 2000, J INSECT PHYSIOL, V46, P993, DOI 10.1016/S0022-1910(99)00209-7; Kayukawa T, 2013, SCI REP, V3, P1; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; Malka O, 2008, AGGRESSIVE REPROD CO; MEDLER JOHN T., 1962, ANN ENTOMOL SOC AMER, V55, P212; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; MULLER WJ, 1994, J INSECT PHYSIOL, V40, P873, DOI 10.1016/0022-1910(94)90021-3; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Pankiw T, 1998, J INSECT PHYSIOL, V44, P685, DOI 10.1016/S0022-1910(98)00040-7; Pinto LZ, 2000, J INSECT PHYSIOL, V46, P153, DOI 10.1016/S0022-1910(99)00111-0; RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245; Riddiford LM, 2008, J INSECT PHYSIOL, V54, P895, DOI 10.1016/j.jinsphys.2008.01.014; Riddiford LM, 2012, INTEGR COMP BIOL, V52, pE146; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; ROBINSON GE, 1987, BEHAV ECOL SOCIOBIOL, V20, P329, DOI 10.1007/BF00300679; ROBINSON GE, 1992, GEN COMP ENDOCR, V87, P471, DOI 10.1016/0016-6480(92)90055-O; Robinson GE, 1997, ARCH INSECT BIOCHEM, V35, P559, DOI 10.1002/(SICI)1520-6327(1997)35:4<559::AID-ARCH13>3.0.CO;2-9; ROBINSON GE, 1985, J INSECT PHYSIOL, V31, P277, DOI 10.1016/0022-1910(85)90003-4; ROSELER PF, 1978, J INSECT PHYSIOL, V24, P707, DOI 10.1016/0022-1910(78)90068-9; ROSELER PF, 1974, INSECT SOC, V21, P249, DOI 10.1007/BF02226917; ROSELER PF, 1981, EXPERIENTIA, V37, P348, DOI 10.1007/BF01959856; ROSELER PF, 1977, J INSECT PHYSIOL, V23, P985, DOI 10.1016/0022-1910(77)90126-3; ROSELER PF, 1988, INSECT BIOCHEM, V18, P557, DOI 10.1016/0020-1790(88)90007-8; Shpigler H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-120; Smith AR, 2013, HORM BEHAV, V63, P1, DOI 10.1016/j.yhbeh.2012.08.012; Sullivan JP, 2000, HORM BEHAV, V37, P1, DOI 10.1006/hbeh.1999.1552; VANDOORN A, 1989, PHYSIOL ENTOMOL, V14, P211, DOI 10.1111/j.1365-3032.1989.tb00954.x; VANDOORN A, 1987, NETH J ZOOL, V37, P255, DOI 10.1163/002829687X00080; Wasielewski O, 2011, J INSECT PHYSIOL, V57, P1682, DOI 10.1016/j.jinsphys.2011.09.002; West-Eberhard Mary Jane, 1996, P290; West-Eberhard Mary Jane, 2003, pi; Wilson E.O., 1971, INSECT SOC; Wyatt GR, 1996, ADV INSECT PHYSIOL, V26, P1, DOI 10.1016/S0065-2806(08)60030-2; Yerushalmi S, 2006, J EXP BIOL, V209, P1044, DOI 10.1242/jeb.02125	69	50	51	5	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100650	10.1371/journal.pone.0100650	http://dx.doi.org/10.1371/journal.pone.0100650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959888	Green Submitted, Green Published, gold			2022-12-25	WOS:000338633900066
J	Taylor, A; Herrmann, A; Moss, D; See, V; Davies, K; Williams, SR; Murray, P				Taylor, Arthur; Herrmann, Anne; Moss, Diana; See, Violaine; Davies, Karen; Williams, Steve R.; Murray, Patricia			Assessing the Efficacy of Nano- and Micro-Sized Magnetic Particles as Contrast Agents for MRI Cell Tracking	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; STEM-CELLS; FEASIBILITY; MODEL; T1; T2	Iron-oxide based contrast agents play an important role in magnetic resonance imaging (MRI) of labelled cells in vivo. Currently, a wide range of such contrast agents is available with sizes varying from several nanometers up to a few micrometers and consisting of single or multiple magnetic cores. Here, we evaluate the effectiveness of these different particles for labelling and imaging stem cells, using a mouse mesenchymal stem cell line to investigate intracellular uptake, retention and processing of nano- and microsized contrast agents. The effect of intracellular confinement on transverse relaxivity was measured by MRI at 7 T and in compliance with the principles of the '3Rs', the suitability of the contrast agents for MR-based cell tracking in vivo was tested using a chick embryo model. We show that for all particles tested, relaxivity was markedly reduced following cellular internalisation, indicating that contrast agent relaxivity in colloidal suspension does not accurately predict performance in MR-based cell tracking studies. Using a bimodal imaging approach comprising fluorescence and MRI, we demonstrate that labelled MSC remain viable following in vivo transplantation and can be tracked effectively using MRI. Importantly, our data suggest that larger particles might confer advantages for longer-term imaging.	[Taylor, Arthur; Moss, Diana; Murray, Patricia] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Herrmann, Anne; See, Violaine] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Davies, Karen] Univ Manchester, Ctr Imaging Sci, Manchester, Lancs, England	University of Liverpool; University of Liverpool; University of Manchester	Taylor, A (corresponding author), Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England.	taylora@liv.ac.uk	Taylor, Arthur W/F-4393-2012; Williams, Steve C/D-6979-2011; Williams, Steve R/C-8945-2011	Taylor, Arthur W/0000-0003-2028-6694; Williams, Steve C/0000-0003-4299-1941; Williams, Steve R/0000-0001-5940-1675; Murray, Patricia/0000-0003-1316-148X; Herrmann, Anne/0000-0002-0858-419X	United Kingdom EPSRC [EP/H046143]; European Union [PERG08-GA-2010-276909]; Alder Hey Children's NHS Foundation Trust; EPSRC [EP/H046143/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H046143/1] Funding Source: researchfish	United Kingdom EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Union(European Commission); Alder Hey Children's NHS Foundation Trust; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported in part by the United Kingdom EPSRC (http://www.epsrc.ac.uk/, Grant EP/H046143) and by the European Union (http://ec.europa.eu/research/mariecurieactions/, grant PERG08-GA-2010-276909). AH is funded by Alder Hey Children's NHS Foundation Trust (http://www.alderhey.nhs.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]; Billotey C, 2003, MAGN RESON MED, V49, P646, DOI 10.1002/mrm.10418; Boss A, 2008, J MAGN RESON IMAGING, V28, P1510, DOI 10.1002/jmri.21601; Brader P, 2013, J NUCL MED, V54, P167, DOI 10.2967/jnumed.111.099788; Bulte JWM, 2009, AM J ROENTGENOL, V193, P314, DOI 10.2214/AJR.09.3107; Carroll MRJ, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/3/035103; Cengelli F, 2006, J PHARMACOL EXP THER, V318, P108, DOI 10.1124/jpet.106.101915; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Frank JA, 2003, RADIOLOGY, V228, P480, DOI 10.1148/radiol.2281020638; Geraldes CFGC, 2009, CONTRAST MEDIA MOL I, V4, P1, DOI 10.1002/cmmi.265; Grainger DW, 2009, ADV DRUG DELIVER REV, V61, P419, DOI 10.1016/j.addr.2009.04.003; JUNG CW, 1995, MAGN RESON IMAGING, V13, P661, DOI 10.1016/0730-725X(95)00024-B; Kalva S.P., 2006, APPL RADIOL, V35, P18; Kircher MF, 2011, NAT REV CLIN ONCOL, V8, P677, DOI 10.1038/nrclinonc.2011.141; Klug G, 2010, MAGN RESON MED, V64, P1607, DOI 10.1002/mrm.22557; Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e; Laurent S, 2012, PLOS ONE, V7, P306, DOI 10.1371/journal.pone.0029997; Levy M, 2012, CONTRAST MEDIA MOL I, V7, P373, DOI 10.1002/cmmi.504; Levy M, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/39/395103; Matuszewski L, 2005, RADIOLOGY, V235, P155, DOI 10.1148/radiol.2351040094; Monopoli MP, 2012, NAT NANOTECHNOL, V7, P779, DOI [10.1038/nnano.2012.207, 10.1038/NNANO.2012.207]; Rashidi H, 2009, BIOESSAYS, V31, P459, DOI 10.1002/bies.200800168; Ren GW, 2012, STEM CELL TRANSL MED, V1, P51, DOI 10.5966/sctm.2011-0019; Rezwan K, 2005, J PHYS CHEM B, V109, P14469, DOI 10.1021/jp050528w; Richards JMJ, 2012, CIRC-CARDIOVASC IMAG, V5, P509, DOI 10.1161/CIRCIMAGING.112.972596; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; Shapiro EM, 2005, MAGNET RESON MED, V53, P329, DOI 10.1002/mrm.20342; Shapiro EM, 2008, FUND BIOMED TECHNOL, V3, P141; Simon GH, 2006, EUR RADIOL, V16, P738, DOI 10.1007/s00330-005-0031-2; Skotland T, 2002, J PHARMACEUT BIOMED, V28, P323, DOI 10.1016/S0731-7085(01)00592-1; Soenen SJH, 2010, SMALL, V6, P2136, DOI 10.1002/smll.201000763; Sun C, 2008, ADV DRUG DELIVER REV, V60, P1252, DOI 10.1016/j.addr.2008.03.018; Taylor A, 2012, CHEM SOC REV, V41, P2707, DOI 10.1039/c2cs35031a; Toso C, 2008, AM J TRANSPLANT, V8, P701, DOI 10.1111/j.1600-6143.2007.02120.x; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304	36	31	32	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100259	10.1371/journal.pone.0100259	http://dx.doi.org/10.1371/journal.pone.0100259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959883	gold, Green Published, Green Submitted			2022-12-25	WOS:000338633900033
J	Dimitrijevic, A; Qin, ZX; Aswad, DW				Dimitrijevic, Aleksandra; Qin, Zhenxia; Aswad, Dana W.			Isoaspartyl Formation in Creatine Kinase B Is Associated with Loss of Enzymatic Activity; Implications for the Linkage of Isoaspartate Accumulation and Neurological Dysfunction in the PIMT Knockout Mouse	PLOS ONE			English	Article							PROTEIN CARBOXYL METHYLTRANSFERASE; AGE-DAMAGED PROTEINS; O-METHYLTRANSFERASE; BRAIN-TYPE; REPAIR METHYLTRANSFERASE; OXIDATIVE MODIFICATION; ALZHEIMERS-DISEASE; PROTEOMIC ANALYSIS; ASPARTYL RESIDUES; MASS-SPECTROMETRY	Isoaspartate (isoAsp) formation is a common type of spontaneous protein damage that is normally kept in check by the repair enzyme protein-L-isoaspartyl methyltransferase (PIMT). PIMT-KO (knockout) mice exhibit a pronounced neuropathology highlighted by death from an epileptic seizure at 30 to 60 days after birth. The mechanisms by which isoaspartyl damage disrupts normal brain function are incompletely understood. Proteomic analysis of the PIMT-KO mouse brain has shown that a number of key neuronal proteins accumulate high levels of isoAsp, but the extent to which their cellular functions is altered has yet to be determined. One of the major neuronal targets of PIMT is creatine kinase B (CKB), a well-characterized enzyme whose activity is relatively easy to assay. We show here that (1) the specific activity of CKB is significantly reduced in the brains of PIMT-deficient mice, (2) that in vitro aging of recombinant CKB results in significant accumulation of isoAsp sites with concomitant loss of enzymatic activity, and (3) that incubation of in vitro aged CKB with PIMT and its methyl donor S-adenosyl-L-methionine substantially repairs the aged CKB with regard to both its isoAsp content and its enzymatic activity. These results, combined with similarity in phenotypes of PIMT-KO and CKB-KO mice, suggests that loss of normal CKB structure and function contributes to the mechanisms by which isoAsp accumulation leads to CNS dysfunction in the PIMT-KO mouse.	[Dimitrijevic, Aleksandra; Qin, Zhenxia; Aswad, Dana W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA	University of California System; University of California Irvine	Aswad, DW (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.	dwaswad@uci.edu			National Institutes of Health, USA [NS-17269]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017269] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding provided by National Institutes of Health, USA, grant # NS-17269 to DWA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenov M, 2000, J NEUROCHEM, V74, P2520, DOI 10.1046/j.1471-4159.2000.0742520.x; Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; Aswad DW, 2000, J PHARMACEUT BIOMED, V21, P1129, DOI 10.1016/S0731-7085(99)00230-7; ASWAD DW, 1984, J BIOL CHEM, V259, P714; Barbariga M, 2014, J BIOL CHEM, V289, P3736, DOI 10.1074/jbc.M113.520981; BESSMAN SP, 1985, ANNU REV BIOCHEM, V54, P831, DOI 10.1146/annurev.bi.54.070185.004151; BOIVIN D, 1995, BIOCHEM J, V309, P993, DOI 10.1042/bj3090993; BRENNAN TV, 1994, J BIOL CHEM, V269, P24586; Burklen TS, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/35936; Cantor JR, 2009, BIOCHEMISTRY-US, V48, P11026, DOI 10.1021/bi901397h; Carter WG, 2008, BIOCHEMISTRY-US, V47, P10757, DOI 10.1021/bi8013467; Chavous DA, 2001, P NATL ACAD SCI USA, V98, P14814, DOI 10.1073/pnas.251446498; Cimmino A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003258; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; D'Angelo S, 2005, FREE RADICAL BIO MED, V38, P908, DOI 10.1016/j.freeradbiomed.2004.12.015; Dai SJ, 2013, ANAL CHEM, V85, P2423, DOI 10.1021/ac303428h; Desrosiers Richard R, 2011, Curr Aging Sci, V4, P8; DeVry CG, 1999, J HUM GENET, V44, P275, DOI 10.1007/s100380050161; DILIBERTO EJ, 1976, J NEUROCHEM, V26, P1159, DOI 10.1111/j.1471-4159.1976.tb07001.x; Eder M, 1999, PROTEIN SCI, V8, P2258; Eliuk SM, 2007, CHEM RES TOXICOL, V20, P1260, DOI 10.1021/tx7000948; Ikegaya Y, 2001, HIPPOCAMPUS, V11, P287, DOI 10.1002/hipo.1043; Ingrosso D, 2000, EUR J BIOCHEM, V267, P4397, DOI 10.1046/j.1432-1327.2000.01485.x; Jazin E, 2010, NAT REV NEUROSCI, V11, P9, DOI 10.1038/nrn2754; JOHNSON BA, 1987, J BIOL CHEM, V262, P12283; JOHNSON BA, 1993, J BIOL CHEM, V268, P6174; JOHNSON BA, 1991, NEUROBIOL AGING, V12, P19, DOI 10.1016/0197-4580(91)90034-H; JOHNSON BA, 1987, J BIOL CHEM, V262, P5622; JOHNSON BA, 1991, ANAL BIOCHEM, V192, P384, DOI 10.1016/0003-2697(91)90553-6; JOHNSON BA, 1989, J BIOL CHEM, V264, P14262; Jost CR, 2002, EUR J NEUROSCI, V15, P1692, DOI 10.1046/j.1460-9568.2002.02001.x; Khare S, 2009, MECH AGEING DEV, V130, P670, DOI 10.1016/j.mad.2009.08.002; Khoury MK, 2010, ANAL BIOCHEM, V397, P129, DOI 10.1016/j.ab.2009.09.041; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Kosugi S, 2008, BIOCHEM BIOPH RES CO, V371, P22, DOI 10.1016/j.bbrc.2008.03.109; Liu M, 2012, ANAL CHEM, V84, P1056, DOI 10.1021/ac202652z; MACFARLANE DE, 1984, J BIOL CHEM, V259, P1357; Mamula MJ, 1999, J BIOL CHEM, V274, P22321, DOI 10.1074/jbc.274.32.22321; MCFADDEN PN, 1987, P NATL ACAD SCI USA, V84, P2595, DOI 10.1073/pnas.84.9.2595; McLeish MJ, 2005, CRIT REV BIOCHEM MOL, V40, P1, DOI 10.1080/10409230590918577; MIZOBUCHI M, 1994, J NEUROCHEM, V62, P322; MURRAY ED, 1984, J BIOL CHEM, V259, P722; Nuss JE, 2009, AGING-US, V1, P557, DOI 10.18632/aging.100055; OCONNOR CM, 1988, J BIOL CHEM, V263, P1386; Okunuki Y, 2008, MOL VIS, V14, P1094; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; PARANANDI MV, 1994, J BIOL CHEM, V269, P243; Patananan AN, 2014, J BIOL CHEM; Qin Z, 2014, INVEST OPHTHALMOL VI; Qin ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080758; Reissner KJ, 2006, J BIOL CHEM, V281, P8389, DOI 10.1074/jbc.M510716200; Shimizu T, 2005, BIOL PHARM BULL, V28, P1590, DOI 10.1248/bpb.28.1590; Steen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010811; Tetsuka S, 2013, J NEUROL SCI, V335, P48, DOI 10.1016/j.jns.2013.08.022; Vitali R, 2004, BEHAV BRAIN RES, V153, P129, DOI 10.1016/j.bbr.2003.11.007; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Yamamoto A, 1998, J NEUROSCI, V18, P2063; Young GW, 2005, J BIOL CHEM, V280, P26094, DOI 10.1074/jbc.M503624200; Zhu JX, 2006, J BIOL CHEM, V281, P33802, DOI 10.1074/jbc.M606958200; Zhu L, 2013, INVEST OPHTH VIS SCI, V54, P5675, DOI 10.1167/iovs.13-12050	61	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100622	10.1371/journal.pone.0100622	http://dx.doi.org/10.1371/journal.pone.0100622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955845	Green Published, gold			2022-12-25	WOS:000338917900075
J	Kunz, S; Pesquet, E; Kleczkowski, LA				Kunz, Sabine; Pesquet, Edouard; Kleczkowski, Leszek A.			Functional Dissection of Sugar Signals Affecting Gene Expression in Arabidopsis thaliana	PLOS ONE			English	Article							PLANT-GROWTH; SUCROSE; GLUCOSE; CARBON; CELLS; BIOSYNTHESIS; DEGRADATION; RESPONSES; 3-O-METHYLGLUCOSE; TRANSCRIPTOME	Background: Sugars modulate expression of hundreds of genes in plants. Previous studies on sugar signaling, using intact plants or plant tissues, were hampered by tissue heterogeneity, uneven sugar transport and/or inter-conversions of the applied sugars. This, in turn, could obscure the identity of a specific sugar that acts as a signal affecting expression of given gene in a given tissue or cell-type. Methodology/Principal Findings: To bypass those biases, we have developed a novel biological system, based on stem-cell-like Arabidopsis suspension culture. The cells were grown in a hormone-free medium and were sustained on xylose as the only carbon source. Using functional genomics we have identified 290 sugar responsive genes, responding rapidly (within 1 h) and specifically to low concentration (1 mM) of glucose, fructose and/or sucrose. For selected genes, the true nature of the signaling sugar molecules and sites of sugar perception were further clarified using non-metabolizable sugar analogues. Using both transgenic and wild-type A. thaliana seedlings, it was shown that the expression of selected sugar-responsive genes was not restricted to a specific tissue or cell type and responded to photoperiod-related changes in sugar availability. This suggested that sugar-responsiveness of genes identified in the cell culture system was not biased toward heterotrophic background and resembled that in whole plants. Conclusions: Altogether, our research strategy, using a combination of cell culture and whole plants, has provided an unequivocal evidence for the identity of sugar-responsive genes and the identity of the sugar signaling molecules, independently from their inter-conversions or use for energy metabolism.	[Kunz, Sabine; Pesquet, Edouard; Kleczkowski, Leszek A.] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden	Umea University	Pesquet, E (corresponding author), Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden.	edouard.pesquet@umu.se; leszek.kleczkowski@umu.se	; Pesquet, Edouard/K-5627-2017	Kleczkowski, Leszek A./0000-0001-8685-9665; Pesquet, Edouard/0000-0002-6959-3284	Swedish Research Council; Bio4Energy; Kempe foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Bio4Energy; Kempe foundation	This research was supported, in part, by the Swedish Research Council (LAK, EP) and by Bio4Energy and the Kempe foundation (EP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; CARPITA NC, 1982, PLANT PHYSIOL, V69, P1173, DOI 10.1104/pp.69.5.1173; Caspar Timothy, 1994, V27, P913; Chandran D, 2003, J BIOL CHEM, V278, P44320, DOI 10.1074/jbc.M308490200; Chaudhuri B, 2008, PLANT J, V56, P948, DOI 10.1111/j.1365-313X.2008.03652.x; Cho YH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001263; Ciereszko I, 2005, J PLANT PHYSIOL, V162, P343, DOI 10.1016/j.jplph.2004.08.003; Contento AL, 2004, PLANT PHYSIOL, V135, P2330, DOI 10.1104/pp.104.044362; Cortes S, 2003, PLANT PHYSIOL, V131, P824, DOI 10.1104/pp.010538; Fernie AR, 2001, PLANT PHYSIOL, V125, P1967, DOI 10.1104/pp.125.4.1967; Gibon Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r76; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Ito Y, 2006, SCIENCE, V313, P842, DOI 10.1126/science.1128436; JANG JC, 1994, PLANT CELL, V6, P1665, DOI 10.1105/tpc.6.11.1665; Jung B, 2009, PLANT CELL, V21, P876, DOI 10.1105/tpc.108.062612; Kato A, 2007, J PLANT RES, V120, P713, DOI 10.1007/s10265-007-0117-9; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; Li P, 2011, P NATL ACAD SCI USA, V108, P3436, DOI 10.1073/pnas.1018665108; Lloyd JC, 2004, J EXP BOT, V55, P1221, DOI 10.1093/jxb/erh143; Mandadi KK, 2009, PLANT PHYSIOL, V150, P1930, DOI 10.1104/pp.109.139220; Matiolli CC, 2011, PLANT PHYSIOL, V157, P692, DOI 10.1104/pp.111.181743; Menand B, 2002, P NATL ACAD SCI USA, V99, P6422, DOI 10.1073/pnas.092141899; Osuna D, 2007, PLANT J, V49, P463, DOI 10.1111/j.1365-313X.2006.02979.x; Paparelli E, 2013, PLANT CELL, V25, P3760, DOI 10.1105/tpc.113.115519; Pesquet E, 2010, CURR BIOL, V20, P744, DOI 10.1016/j.cub.2010.02.057; Robaglia C, 2012, CURR OPIN PLANT BIOL, V15, P301, DOI 10.1016/j.pbi.2012.01.012; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Sairanen I, 2012, PLANT CELL, V24, P4907, DOI 10.1105/tpc.112.104794; Sinha AK, 2002, PLANT PHYSIOL, V128, P1480, DOI 10.1104/pp.010771; Smith AM, 2007, PLANT CELL ENVIRON, V30, P1126, DOI 10.1111/j.1365-3040.2007.01708.x; Stevenson CC, 2009, PLANT GROWTH REGUL, V59, P255, DOI 10.1007/s10725-009-9412-x; Stitt M, 2007, FUNCT PLANT BIOL, V34, P526, DOI 10.1071/FP06249; Sugimoto K, 2011, TRENDS CELL BIOL, V21, P212, DOI 10.1016/j.tcb.2010.12.004; Usadel B, 2008, PLANT PHYSIOL, V146, P1834, DOI 10.1104/pp.107.115592; Vaughn MW, 2002, P NATL ACAD SCI USA, V99, P10876, DOI 10.1073/pnas.172198599; Villadsen D, 2004, PLANT MOL BIOL, V55, P467, DOI 10.1007/s11103-004-1050-0; Weltmeier F, 2009, PLANT MOL BIOL, V69, P107, DOI 10.1007/s11103-008-9410-9; Xiong Y, 2013, NATURE, V496, P181, DOI 10.1038/nature12030; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568	41	38	44	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100312	10.1371/journal.pone.0100312	http://dx.doi.org/10.1371/journal.pone.0100312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950222	gold, Green Published, Green Submitted			2022-12-25	WOS:000338276300062
J	Latire, T; Legendre, F; Bigot, N; Carduner, L; Kellouche, S; Bouyoucef, M; Carreiras, F; Marin, F; Lebel, JM; Galera, P; Serpentini, A				Latire, Thomas; Legendre, Florence; Bigot, Nicolas; Carduner, Ludovic; Kellouche, Sabrina; Bouyoucef, Mouloud; Carreiras, Franck; Marin, Frederic; Lebel, Jean-Marc; Galera, Philippe; Serpentini, Antoine			Shell Extracts from the Marine Bivalve Pecten maximus Regulate the Synthesis of Extracellular Matrix in Primary Cultured Human Skin Fibroblasts	PLOS ONE			English	Article							I COLLAGEN EXPRESSION; PINCTADA-MAXIMA; SCLERODERMA FIBROBLASTS; HALIOTIS-TUBERCULATA; CARBONIC-ANHYDRASE; PROTEOMIC ANALYSIS; NACRE FORMATION; ORGANIC MATRIX; WOUND REPAIR; C-KROX	Mollusc shells are composed of more than 95% calcium carbonate and less than 5% of an organic matrix consisting mostly of proteins, glycoproteins and polysaccharides. Previous studies have elucidated the biological activities of the shell matrices from bivalve molluscs on skin, especially on the expression of the extracellular matrix components of fibroblasts. In this work, we have investigated the potential biological activities of shell matrix components extracted from the shell of the scallop Pecten maximus on human fibroblasts in primary culture. Firstly, we demonstrated that shell matrix components had different effects on general cellular activities. Secondly, we have shown that the shell matrix components stimulate the synthesis of type I and III collagens, as well as that of sulphated GAGs. The increased expression of type I collagen is likely mediated by the recruitment of transactivating factors (Sp1, Sp3 and human c-Krox) in the -112/-61 bp COL1A1 promoter region. Finally, contrarily to what was obtained in previous works, we demonstrated that the scallop shell extracts have only a small effect on cell migration during in vitro wound tests and have no effect on cell proliferation. Thus, our research emphasizes the potential use of shell matrix of Pecten maximus for dermo-cosmetic applications.	[Latire, Thomas; Lebel, Jean-Marc; Serpentini, Antoine] Univ Caen Basse Normandie, IBFA, UMR BOREA Biol ORganismes & Ecosyst Aquat, MNHN,UPMC,UCBN,CNRS 7208,IRD 207, Caen 5, France; [Latire, Thomas; Legendre, Florence; Bigot, Nicolas; Bouyoucef, Mouloud; Galera, Philippe] Univ Caen Basse Normandie, Fac Med, Lab Microenvironm Cellulaire & Pathol MILPAT, EA 4652,SFR ICORE 146,CHU Niveau 3, Caen 5, France; [Carduner, Ludovic; Kellouche, Sabrina; Carreiras, Franck] Univ Cergy Pontoise, Inst Mat, EA 1391, Equipe Rech Relat Matrice Extracellulaire Cellule, Cergy Pontoise, France; [Marin, Frederic] Univ Bourgogne, UMR CNRS Biogeosci 6282, Dijon, France	Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite de Caen Normandie; Universite de Caen Normandie; CY Cergy Paris Universite; Universite de Bourgogne	Serpentini, A (corresponding author), Univ Caen Basse Normandie, IBFA, UMR BOREA Biol ORganismes & Ecosyst Aquat, MNHN,UPMC,UCBN,CNRS 7208,IRD 207, Campus 1,Sci C, Caen 5, France.	antoine.serpentini@unicaen.fr		Bigot, Nicolas/0000-0002-4247-0217; legendre, florence/0000-0002-9951-1585	"Fonds Unique Interministeriel" (FUI, French Government)	"Fonds Unique Interministeriel" (FUI, French Government)	This work was financially supported by the "Fonds Unique Interministeriel" (FUI, French Government). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Atlan G, 1997, CR ACAD SCI III-VIE, V320, P253, DOI 10.1016/S0764-4469(97)86933-8; Beauchef G, 2012, J BIOL CHEM, V287, P3462, DOI 10.1074/jbc.M111.286443; Bedouet L, 2001, COMP BIOCHEM PHYS B, V128, P389, DOI 10.1016/S1096-4959(00)00337-7; Bedouet L, 2006, COMP BIOCHEM PHYS B, V144, P532, DOI 10.1016/j.cbpb.2006.05.012; Bedouet L, 2012, MAR BIOTECHNOL, V14, P446, DOI 10.1007/s10126-011-9425-0; Bigot N, 2012, J INVEST DERMATOL, V132, P2360, DOI 10.1038/jid.2012.164; Dai JP, 2010, PHARM BIOL, V48, P122, DOI 10.3109/13880200903046211; David-Raoudi M, 2008, WOUND REPAIR REGEN, V16, P274, DOI 10.1111/j.1524-475X.2007.00342.x; Ghayor C, 2000, J BIOL CHEM, V275, P27421; Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4; Hunt T K, 2000, Adv Skin Wound Care, V13, P6; Jiao Y, 2012, BIOCHEM BIOPH RES CO, V425, P679, DOI 10.1016/j.bbrc.2012.07.099; Jorgensen Peter Holmberg, 1997, APMIS, V105, P1; Kypriotou M, 2007, J BIOL CHEM, V282, P32000, DOI 10.1074/jbc.M705197200; Le Faou A, 1995, CALCIFIED TISSUE INT, V56, pA156; Lebonvallet N, 2010, EUR J DERMATOL, V20, P671, DOI 10.1684/ejd.2010.1054; Lee M, 2011, MOL BIOL REP, V38, P5211, DOI 10.1007/s11033-010-0672-3; Legendre F, 2003, J BIOL CHEM, V278, P2903, DOI 10.1074/jbc.M110773200; Liu YC, 2002, FISHERIES SCI, V68, P1330, DOI 10.1046/j.1444-2906.2002.00572.x; Liu YC, 2008, FISHERIES SCI, V74, P217, DOI 10.1111/j.1444-2906.2007.01515.x; Liu YC, 2006, FISHERIES SCI, V72, P388, DOI 10.1111/j.1444-2906.2006.01161.x; Lopez E, 2000, TISSUE CELL, V32, P95, DOI 10.1054/tice.1999.0091; LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8; Lowenstam HA, 1989, BIOMINERALIZATION; Malladi P, 2006, AM J PHYSIOL-CELL PH, V290, pC1139, DOI 10.1152/ajpcell.00415.2005; Mann K, 2000, EUR J BIOCHEM, V267, P5257, DOI 10.1046/j.1432-1327.2000.01602.x; Mann K, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-28; Marie B, 2007, FEBS J, V274, P2933, DOI 10.1111/j.1742-4658.2007.05825.x; Marie B, 2012, AMINO ACIDS, V42, P2009, DOI 10.1007/s00726-011-0932-0; Marie B, 2011, J MOL EVOL, V72, P531, DOI 10.1007/s00239-011-9451-6; Marie B, 2011, FEBS J, V278, P2117, DOI 10.1111/j.1742-4658.2011.08129.x; Marie B, 2011, MAR BIOTECHNOL, V13, P955, DOI 10.1007/s10126-010-9357-0; Marie B, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-54; Marie B, 2010, CHEMBIOCHEM, V11, P2138, DOI 10.1002/cbic.201000276; Marin F, 2005, J BIOL CHEM, V280, P33895, DOI 10.1074/jbc.M506526200; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Marin Frederic, 2012, Front Biosci (Schol Ed), V4, P1099; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Pereira-Mouries L, 2002, EUR J BIOCHEM, V269, P4994, DOI 10.1046/j.1432-1033.2002.03203.x; Rousseau M, 2003, COMP BIOCHEM PHYS B, V135, P1, DOI 10.1016/S1096-4959(03)00032-0; Sarashina I, 2006, J MOL EVOL, V62, P307, DOI 10.1007/s00239-005-0095-2; Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472; Shen YT, 2006, BIOMATERIALS, V27, P281, DOI 10.1016/j.biomaterials.2005.05.088; SILVE C, 1992, CALCIFIED TISSUE INT, V51, P363, DOI 10.1007/BF00316881; Sorrell JM, 2009, INT REV CEL MOL BIO, V276, P161, DOI 10.1016/S1937-6448(09)76004-6; Sorrell JM, 2004, J CELL SCI, V117, P667, DOI 10.1242/jcs.01005; Strodtbeck F, 2001, NEWBORN INFANT NURS, V1, P43, DOI [10.1053/nbin.2001.23176, DOI 10.1053/NBIN.2001.23176]; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Torita A, 2004, FISHERIES SCI, V70, P910, DOI 10.1111/j.1444-2906.2004.00886.x; Torita A, 2007, FISHERIES SCI, V73, P1388, DOI 10.1111/j.1444-2906.2007.01482.x; Treccani L, 2006, BIOPHYS J, V91, P2601, DOI 10.1529/biophysj.106.086108; Valacchi G, 2012, ANN NY ACAD SCI, V1259, P136, DOI 10.1111/j.1749-6632.2012.06636.x; VUORIO E, 1990, ANNU REV BIOCHEM, V59, P837, DOI 10.1146/annurev.bi.59.070190.004201; Weiss IM, 2000, BIOCHEM BIOPH RES CO, V267, P17, DOI 10.1006/bbrc.1999.1907; Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798; Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7; Zhang C, 2006, MAR BIOTECHNOL, V8, P572, DOI 10.1007/s10126-005-6029-6	58	18	19	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99931	10.1371/journal.pone.0099931	http://dx.doi.org/10.1371/journal.pone.0099931			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949635	Green Published, gold, Green Submitted			2022-12-25	WOS:000338276300024
J	Shan, T; Lu, HW; Ji, H; Li, YM; Guo, J; Chen, X; Wu, T				Shan, Tao; Lu, Hongwei; Ji, Hong; Li, Yiming; Guo, Jian; Chen, Xi; Wu, Tao			Loss of Stromal Caveolin-1 Expression: A Novel Tumor Microenvironment Biomarker That Can Predict Poor Clinical Outcomes for Pancreatic Cancer	PLOS ONE			English	Article							LASER CAPTURE MICRODISSECTION; BREAST-CANCER; AEROBIC GLYCOLYSIS; CELL; GROWTH; FIBROBLASTS; METASTASIS; HER-2/NEU; RECEPTOR; WARBURG	Aims: Cancer development and progression is not only associated with the tumor cell proliferation but also depends on the interaction between tumor cells and the stromal microenvironment. A new understanding of the role of the tumor microenvironment suggests that the loss of stromal caveolin-1 (Cav-1) as a key regulator may become a potential therapy target. This study aims to elucidate whether stromal Cav-1 expression in pancreatic cancer can be a strong prognosis biomarker. Methods: Tissue samples from 45 pancreatic cancer patients were studied. Parenchyma and stroma were separated and purified using laser capture microdissection. Stromal Cav-1 expression was measured from pancreatic cancer, paraneoplastic, and normal tissue using immunohistochemistry. We analyzed the correlation of stromal Cav-1 expression with clinicopathologic features and prognostic indicators, such as tumor marker HER-2/neu gene. Results: Specimens from six patients (13.3%) showed high levels of stromal Cav-1 staining, those from eight patients (17.8%) showed a lower, intermediate level of staining, whereas those from 31 patients (68.9%) showed an absence of staining. Cav-1 expression in cancer-associated fibroblasts was lower than that in paracancer-associated and in normal fibroblasts. Stromal Cav-1 loss was associated with TNM stage (P=0.018), lymph node metastasis (P = 0.014), distant metastasis (P = 0.027), and HER-2/neu amplification (P = 0.007). The relationships of age, sex, histological grade, and tumor size with stromal Cav-1 expression were not significant (P > 0.05). A negative correlation was found between circulating tumor cells and stromal Cav-1 expression (P < 0.05). Conclusion: The loss of stromal Cav-1 in pancreatic cancer was an independent prognostic indicator, thus suggesting that stromal Cav-1 may be an effective therapeutic target for patients with pancreatic cancer.	[Shan, Tao; Lu, Hongwei; Ji, Hong; Li, Yiming; Chen, Xi; Wu, Tao] Xi An Jiao Tong Univ, Affiliated Hosp 2, Coll Med, Dept Gen Surg, Xian 710049, Shaanxi, Peoples R China; [Guo, Jian] Xi An Jiao Tong Univ, Affiliated Hosp 1, Coll Med, Dept Hepatobiliary Surg, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Shan, T (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Coll Med, Dept Gen Surg, Xian 710049, Shaanxi, Peoples R China.	shantao820304@163.com			Scientific Grand of Shaanxi [2012SXKG-21]	Scientific Grand of Shaanxi	This study was funded by Scientific Grand of Shaanxi (2012SXKG-21). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleric Ivan, 2012, Med Pregl, V65, P210; Ayala G, 2013, J PATHOL, V231, P77, DOI 10.1002/path.4217; Balkwill FR, 2012, J CELL SCI, V125, P5591, DOI 10.1242/jcs.116392; Bonuccelli G, 2010, CELL CYCLE, V9, P1960, DOI 10.4161/cc.9.10.11601; Braakman RBH, 2011, METHODS MOL BIOL, V755, P143, DOI 10.1007/978-1-61779-163-5_11; Cirri P, 2012, CANCER METAST REV, V31, P195, DOI 10.1007/s10555-011-9340-x; Coumans FAW, 2012, CLIN CANCER RES, V18, P5711, DOI 10.1158/1078-0432.CCR-12-1585; Deng W, 2011, AFR J BIOTECHNOL, V10, P16732, DOI 10.5897/AJB11.2397; Du XL, 2012, CANCER RES, V72, P4405, DOI 10.1158/0008-5472.CAN-12-0777; Engelstaedter V, 2012, DIAGN MOL PATHOL, V21, P77, DOI 10.1097/PDM.0b013e31823b6e43; Gobbi PG, 2013, CANCER EPIDEMIOL, V37, P186, DOI 10.1016/j.canep.2012.12.002; Gumulec J, 2012, ONCOL REP, V27, P831, DOI 10.3892/or.2011.1587; Ha TK, 2012, CANCER RES, V72, P4097, DOI 10.1158/0008-5472.CAN-12-0448; Heublein S, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-6; Koontongkaew S, 2013, J CANCER, V4, P66, DOI 10.7150/jca.5112; Kuboki Y, 2013, ANTICANCER RES, V33, P3905; Kurt M, 2012, INT J RADIAT ONCOL, V84, pS419, DOI 10.1016/j.ijrobp.2012.07.1110; Liu XJ, 2010, HUM GENE THER, V21, P157, DOI 10.1089/hum.2009.083; Lustberg Maryam, 2012, Recent Results Cancer Res, V195, P97, DOI 10.1007/978-3-642-28160-0_9; Lyu MA, 2008, BIOCHEM PHARMACOL, V75, P836, DOI 10.1016/j.bcp.2007.10.013; Mao Y, 2012, CANCER METAST REV, V32, P305; Neri E, 2013, EUR J RADIOL, V82, P1166, DOI 10.1016/j.ejrad.2012.03.035; Pancotti F, 2012, CELL SIGNAL, V24, P1390, DOI 10.1016/j.cellsig.2012.02.015; Patani N, 2012, BREAST CANCER RES TR, V131, P1, DOI 10.1007/s10549-011-1751-4; Pavlides S, 2012, ANTIOXID REDOX SIGN, V16, P1264, DOI 10.1089/ars.2011.4243; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; Salani B, 2012, FASEB J, V26, P788, DOI 10.1096/fj.11-192088; Sharon Y, 2013, JOVE-J VIS EXP, DOI 10.3791/4425; Simpkins SA, 2012, J PATHOL, V227, P490, DOI 10.1002/path.4034; Song Y, 2012, BIOMED PHARMACOTHER, V66, P439, DOI 10.1016/j.biopha.2012.03.001; Sotgia F, 2012, ANNU REV PATHOL-MECH, V7, P423, DOI 10.1146/annurev-pathol-011811-120856; Sun MZ, 2012, BIOMED PHARMACOTHER, V66, P242, DOI 10.1016/j.biopha.2011.11.003; Tahir AA, 2009, CANCER BIOL THER, V8, P2286; Tang Y, 2012, MED ONCOL, V29, P977, DOI 10.1007/s12032-011-9900-5; Trimmer C, 2011, CANCER BIOL THER, V11, P383, DOI 10.4161/cbt.11.4.14101; Winterhoff B, 2012, GYNECOL ONCOL, V125, pS166, DOI 10.1016/j.ygyno.2011.12.407; Witkiewicz AK, 2008, CELL CYCLE, V7, P3021, DOI 10.4161/cc.7.19.6719; Witkiewicz AK, 2010, CANCER BIOL THER, V10, P135, DOI 10.4161/cbt.10.2.11983; Wu KN, 2011, CELL CYCLE, V10, P4250, DOI 10.4161/cc.10.24.18551; Yang XH, 2012, CANCER INVEST, V30, P453, DOI 10.3109/07357907.2012.675384; Zanni KL, 2011, BIOL RES NURS, V13, P297, DOI 10.1177/1099800411402054; Zhao XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059102; Zheng J, 2012, ONCOL LETT, V4, P1151, DOI 10.3892/ol.2012.928; Zhou F, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-274	44	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e97239	10.1371/journal.pone.0097239	http://dx.doi.org/10.1371/journal.pone.0097239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949874	gold, Green Published, Green Submitted			2022-12-25	WOS:000338276300002
J	Borgman, KJE; van Zanten, TS; Manzo, C; Cabezon, R; Cambi, A; Benitez-Ribas, D; Garcia-Parajo, MF				Borgman, Kyra J. E.; van Zanten, Thomas S.; Manzo, Carlo; Cabezon, Raquel; Cambi, Alessandra; Benitez-Ribas, Daniel; Garcia-Parajo, Maria F.			Priming by Chemokines Restricts Lateral Mobility of the Adhesion Receptor LFA-1 and Restores Adhesion to ICAM-1 Nano-Aggregates on Human Mature Dendritic Cells	PLOS ONE			English	Article							INTEGRIN ACTIVATION; IMMUNOLOGICAL SYNAPSE; CONFORMATIONAL-CHANGES; LYMPHOCYTE ARREST; STRUCTURAL BASIS; LIGAND; TALIN; NANOCLUSTERS; AFFINITY; ORGANIZATION	LFA-1 is a leukocyte specific beta(2) integrin that plays a major role in regulating adhesion and migration of different immune cells. Recent data suggest that LFA-1 on mature dendritic cells (mDCs) may function as a chemokine-inducible anchor during homing of DCs through the afferent lymphatics into the lymph nodes, by transiently switching its molecular conformational state. However, the role of LFA-1 mobility in this process is not yet known, despite that the importance of lateral organization and dynamics for LFA-1-mediated adhesion regulation is broadly recognized. Using single particle tracking approaches we here show that LFA-1 exhibits higher mobility on resting mDCs compared to monocytes. Lymphoid chemokine CCL21 stimulation of the LFA-1 high affinity state on mDCs, led to a significant reduction of mobility and an increase on the fraction of stationary receptors, consistent with re-activation of the receptor. Addition of soluble monomeric ICAM-1 in the presence of CCL21 did not alter the diffusion profile of LFA-1 while soluble ICAM-1 nano-aggregates in the presence of CCL21 further reduced LFA-1 mobility and readily bound to the receptor. Overall, our results emphasize the importance of LFA-1 lateral mobility across the membrane on the regulation of integrin activation and its function as adhesion receptor. Importantly, our data show that chemokines alone are not sufficient to trigger the high affinity state of the integrin based on the strict definition that affinity refers to the adhesion capacity of a single receptor to its ligand in solution. Instead our data indicate that nanoclustering of the receptor, induced by multi-ligand binding, is required to maintain stable cell adhesion once LFA-1 high affinity state is transiently triggered by inside-out signals.	[Borgman, Kyra J. E.; van Zanten, Thomas S.; Manzo, Carlo; Garcia-Parajo, Maria F.] ICFO Inst Ciencies Foton, Barcelona, Spain; [Cabezon, Raquel] Hosp Clin Barcelona, IDIBAPS, Dept Gastroenterol, Barcelona, Spain; [Cambi, Alessandra] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Tumor Immunol, NL-6525 ED Nijmegen, Netherlands; [Benitez-Ribas, Daniel] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Benitez-Ribas, Daniel] Ctr Esther Koplowitz, Barcelona, Spain; [Garcia-Parajo, Maria F.] ICREA Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Radboud University Nijmegen; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; ICREA	Garcia-Parajo, MF (corresponding author), ICFO Inst Ciencies Foton, Barcelona, Spain.	maria.garcia-parajo@icfo.es	Cabezón, Raquel/F-4208-2016; Manzo, Carlo/B-9745-2012; van Zanten, Thomas S/H-5765-2012; Borgman, Kyra/F-7826-2013; Garcia-Parajo, Maria F./I-4610-2015; Cambi, Alessandra/L-4242-2015	Manzo, Carlo/0000-0002-8625-0996; van Zanten, Thomas S/0000-0002-8810-7149; Garcia-Parajo, Maria F./0000-0001-6618-3944; Cambi, Alessandra/0000-0003-1597-1582	Plan Nacional Immunanoforce [MAT2011-22887]; Human Frontier Science Program [RGP0027/2012]; European Commission (FP7-ICT-2011-7) [288263]; Netherlands Organisation for Scientific Research (NWO) [836.09.002]; ICREA Funding Source: Custom	Plan Nacional Immunanoforce; Human Frontier Science Program(Human Frontier Science Program); European Commission (FP7-ICT-2011-7); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ICREA(ICREA)	This work was supported by grant MAT2011-22887 from the Plan Nacional Immunanoforce (http://www.idi.mineco.gob.es) (MFG-P) (http://www.idi.mineco.gob.es/%29%28MFG-P%29), grant RGP0027/2012 from the Human Frontier Science Program (http://www.hfsp.org/) (MFG-P and AC) and by the European Commission (FP7-ICT-2011-7, under grant agreement No. 288263) to MFG-P and AC (http://www.nanovista.eu). AC is the recipient of a Meervoud grant (836.09.002) from The Netherlands Organisation for Scientific Research (NWO) (http://www.nwo.nl/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon R, 2011, EXP CELL RES, V317, P632, DOI 10.1016/j.yexcr.2010.12.007; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; Bakker G-J, 2011, LFA 1 DYNAMICS MEMBR; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; CABANAS C, 1993, P NATL ACAD SCI USA, V90, P5838, DOI 10.1073/pnas.90.12.5838; Cairo CW, 2006, IMMUNITY, V25, P297, DOI 10.1016/j.immuni.2006.06.012; Cambi A, 2006, MOL BIOL CELL, V17, P4270, DOI 10.1091/mbc.E05-12-1098; Chen W, 2012, J CELL BIOL, V199, P497, DOI 10.1083/jcb.201201091; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; de Vries IJM, 2002, J IMMUNOTHER, V25, P429, DOI 10.1097/00002371-200209000-00007; Diez-Ahedo R, 2009, SMALL, V5, P1258, DOI 10.1002/smll.200801699; Eich C, 2011, IMMUNOL CELL BIOL, V89, P458, DOI 10.1038/icb.2010.103; Feigelson SW, 2010, J IMMUNOL, V185, P7394, DOI 10.4049/jimmunol.1002246; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hemmings L, 1996, J CELL SCI, V109, P2715; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Bakker GJ, 2012, P NATL ACAD SCI USA, V109, P4869, DOI 10.1073/pnas.1116425109; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; KURZINGER K, 1981, J IMMUNOL, V127, P596; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; LUB M, 1995, IMMUNOL TODAY, V16, P479, DOI 10.1016/0167-5699(95)80031-X; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; MAKGOBA MW, 1988, NATURE, V331, P86, DOI 10.1038/331086a0; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; Rossier O, 2012, NAT CELL BIOL, V14, P1057, DOI 10.1038/ncb2588; Sampath R, 1998, J BIOL CHEM, V273, P33588, DOI 10.1074/jbc.273.50.33588; Schurpf T, 2011, EMBO J, V30, P4712, DOI 10.1038/emboj.2011.333; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Schutz GJ, 1997, BIOPHYS J, V73, P1073, DOI 10.1016/S0006-3495(97)78139-6; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; van den Dries K, 2013, MOL BIOL CELL, V24, P2112, DOI 10.1091/mbc.E12-12-0856; van den Dries K, 2012, CELL MOL LIFE SCI, V69, P1889, DOI 10.1007/s00018-011-0908-y; van Kooyk Y, 1999, J BIOL CHEM, V274, P26869, DOI 10.1074/jbc.274.38.26869; van Zanten TS, 2009, P NATL ACAD SCI USA, V106, P18557, DOI 10.1073/pnas.0905217106; VANKOOYK Y, 1989, NATURE, V342, P811, DOI 10.1038/342811a0; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Xie C, 2004, P NATL ACAD SCI USA, V101, P15422, DOI 10.1073/pnas.0406680101; Ye F, 2014, CELL, V156, DOI 10.1016/j.cell.2014.02.048; Yoshida R, 1998, J BIOL CHEM, V273, P7118, DOI 10.1074/jbc.273.12.7118	48	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99589	10.1371/journal.pone.0099589	http://dx.doi.org/10.1371/journal.pone.0099589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945611	Green Published, gold, Green Submitted			2022-12-25	WOS:000340721500023
J	Joseph, SB; Peck, KM; Burch, CL				Joseph, Sarah B.; Peck, Kayla M.; Burch, Christina L.			Dominance Effects of Deleterious and Beneficial Mutations in a Single Gene of the RNA Virus phi 6	PLOS ONE			English	Article							MOLECULAR-BASIS; BACTERIOPHAGE PHI-6; FITNESS; EVOLUTION; CORE	Most of our knowledge of dominance stems from studies of deleterious mutations. From these studies we know that most deleterious mutations are recessive, and that this recessivity arises from a hyperbolic relationship between protein function (i.e., protein concentration or activity) and fitness. Here we investigate whether this knowledge can be used to make predictions about the dominance of beneficial and deleterious mutations in a single gene. We employed a model system the bacteriophage phi 6 - that allowed us to generate a collection of mutations in haploid conditions so that it was not biased toward either dominant beneficial or recessive deleterious mutations. Screening for the ability to infect a bacterial host that does not permit infection by the wildtype w6, we generated a collection of mutations in P3, a gene involved in attachment to the host and in phage particle assembly. The resulting collection contained mutations with both deleterious and beneficial effects on fitness. The deleterious mutations in our collection had additive effects on fitness and the beneficial mutations were recessive. Neither of these observations were predicted from previous studies of dominance. This pattern is not consistent with the hyperbolic (diminishing returns) relationship between protein function and fitness that is characteristic of enzymatic genes, but could have resulted from a curve of increasing returns.	[Joseph, Sarah B.; Peck, Kayla M.; Burch, Christina L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Joseph, SB (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	sbjoseph@email.unc.edu		Burch, Christina/0000-0001-7830-0124; Peck, Kayla/0000-0001-7745-6995	National Institutes of Health [F32-GM080086-01A1, R01-GM067940]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health grants F32-GM080086-01A1 to S.B.J. and R01-GM067940 to C.L.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartonova V, 2008, J BIOL CHEM, V283, P32024, DOI 10.1074/jbc.M804230200; Bourguet D, 1998, J EVOLUTION BIOL, V11, P103, DOI 10.1046/j.1420-9101.1998.11010103.x; Burch CL, 2007, GENETICS, V176, P467, DOI 10.1534/genetics.106.067199; Burch CL, 2004, GENETICS, V167, P559, DOI 10.1534/genetics.103.021196; Burch CL, 1999, GENETICS, V151, P921; Condit RC, 2007, FIELDS VIROLOGY, P50; Duffy S, 2006, GENETICS, V172, P751, DOI 10.1534/genetics.105.051136; DYKHUIZEN DE, 1990, TRENDS ECOL EVOL, V5, P257, DOI 10.1016/0169-5347(90)90067-N; Ferris MT, 2007, GENETICS, V176, P1013, DOI 10.1534/genetics.106.064634; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Garcia-Dorado A, 2000, GENETICS, V155, P1991; Gilchrist MA, 2001, GENETICS, V159, P423; GOTTLIEB P, 1988, VIROLOGY, V163, P183, DOI 10.1016/0042-6822(88)90245-0; Haldane J. B. S., 1924, Trans Phil Soc Cambridge U K, V23, P19; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; KACSER H, 1981, GENETICS, V97, P639; KENNEY JM, 1992, VIROLOGY, V190, P635, DOI 10.1016/0042-6822(92)90901-Z; Linger BR, 2004, RNA, V10, P128, DOI 10.1261/rna.5127104; Lopez-Bigas N, 2006, BIOINFORMATICS, V22, P269, DOI 10.1093/bioinformatics/bti781; Manocheewa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066065; Mendel G., 1865, VERHANDLUNGEN NATURF, V4, P3; Mindich L, 1999, J BACTERIOL, V181, P4505, DOI 10.1128/JB.181.15.4505-4508.1999; Mindich L, 1999, MICROBIOL MOL BIOL R, V63, P149, DOI 10.1128/MMBR.63.1.149-160.1999; MINDICH L, 1976, VIROLOGY, V75, P224, DOI 10.1016/0042-6822(76)90021-0; MINDICH L, 1985, J BACTERIOL, V162, P992, DOI 10.1128/JB.162.3.992-999.1985; Mukherjee S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000765; Nijhout H. Frederik, 2006, P61; OLKKONEN VM, 1989, VIROLOGY, V171, P229, DOI 10.1016/0042-6822(89)90530-8; Omholt SW, 2000, GENETICS, V155, P969; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; Phadnis N, 2005, GENETICS, V171, P385, DOI 10.1534/genetics.104.039016; SIMMONS MJ, 1977, ANNU REV GENET, V11, P49, DOI 10.1146/annurev.ge.11.120177.000405; Szafraniec K, 2003, GENET RES, V82, P19, DOI 10.1017/S001667230300630X; Tang SX, 2001, J VIROL, V75, P9357, DOI 10.1128/JVI.75.19.9357-9366.2001; Tuma R, 1999, BIOCHEMISTRY-US, V38, P15025, DOI 10.1021/bi991473p; Turner PE, 1999, J VIROL, V73, P2420, DOI 10.1128/JVI.73.3.2420-2424.1999; Veitia RA, 2003, J THEOR BIOL, V220, P19, DOI 10.1006/jtbi.2003.3105; VIDAVER AK, 1973, J VIROL, V11, P799, DOI 10.1128/JVI.11.5.799-805.1973; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89; Wright S, 1934, AM NAT, V68, P24, DOI 10.1086/280521	43	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e97717	10.1371/journal.pone.0097717	http://dx.doi.org/10.1371/journal.pone.0097717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945910	Green Published, Green Submitted, gold			2022-12-25	WOS:000340721500003
J	Kobrsi, I				Kobrsi, Issam			Pendant Ancillary Ligand Switches Off Auto-Oxidation of Group 13 Metal Alkyl Compounds Bearing Non-Bulky Alkyl Groups	PLOS ONE			English	Article								The reaction of 3,5-di-2-pyridyl-1,2,4-triazole with excess Al(CH3)(3) and Ga(CH3)(3) afforded (3,5-di-2-pyridyl-1,2,4-triazolate) Al(CH3)(2)center dot 3Al(CH3)(3) (1) and (3,5-di-2-pyridyl-1,2,4-triazolate) Ga(CH3)(2)center dot 3Ga(CH3)(3) (2) respectively. 1 and 2 reacted with oxygen gas to produce (CH3)(2)M(mu-3,5-di-2-pyridyl-1,2,4-triazolate)(mu-OCH3)M(CH3)(2) (M = Al, 3; M = Ga, 4). 3 and 4 contain the non-bulky dimethylalumino moiety, yet they are indefinitely stable in the presence of oxygen gas. This increased stability towards oxygen is due to ancillary 2-pyridyl groups bonding to the metal centers producing a pseudotrigonal pyramidal Al and Ga environments. This environment blocks oxygen from further inserting into the M-C bond. The Al-N(pyridine) and Ga-N(pyridine) bonds reported herein are extremely elongated yet inactive towards dissociation due to the chelate effect.	Petr Inst, Dept Chem, Abu Dhabi, U Arab Emirates	Khalifa University of Science & Technology	Kobrsi, I (corresponding author), Petr Inst, Dept Chem, Abu Dhabi, U Arab Emirates.	ikobrsi@pi.ac.ae		Kobrsi, Issam/0000-0002-2017-9015	United Arab Emirates(RIFP) [13329]; Petroleum Institute Abu Dhabi	United Arab Emirates(RIFP); Petroleum Institute Abu Dhabi	The author is grateful for funding from the Petroleum Institute Abu Dhabi, United Arab Emirates(RIFP Grant No. 13329). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ault BS, 1999, J ORGANOMET CHEM, V572, P169, DOI 10.1016/S0022-328X(98)00915-2; BARRON AR, 1993, CHEM SOC REV, V22, P93, DOI 10.1039/cs9932200093; Cameron PA, 1999, CHEM COMMUN, P1883, DOI 10.1039/a905120a; CLEAVER WM, 1989, J AM CHEM SOC, V111, P8966, DOI 10.1021/ja00206a056; Kobrsi I, 2006, SYNTHESIS CHARACTERI; Lewinski J, 1999, INORG CHEM COMMUN, V2, P131, DOI 10.1016/S1387-7003(99)00029-5; Lobl J, 2007, INORG CHEM, V46, P5678, DOI 10.1021/ic700488p; McPhail AT, 1976, JCHEMSOC DA; Mukherjee D, 2012, J AM CHEM SOC, V134, P13018, DOI 10.1021/ja303440n; POWER MB, 1992, POLYHEDRON, V11, P477, DOI 10.1016/S0277-5387(00)83205-2; Qiao S, 2011, J ORGANOMET CHEM, V696, P2746, DOI 10.1016/j.jorganchem.2011.04.028; Thomas F, 2003, ORGANOMETALLICS, V22, P3471, DOI 10.1021/om0303451; Uhl W, 2009, Z NATURFORSCH B, V64, P1369, DOI 10.1515/znb-2009-11-1217; Yu ZK, 2001, ORGANOMETALLICS, V20, P4301, DOI 10.1021/om010531b	14	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100626	10.1371/journal.pone.0100626	http://dx.doi.org/10.1371/journal.pone.0100626			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945752	Green Published, gold, Green Submitted			2022-12-25	WOS:000340721500098
J	Zhang, YJ; Yang, JH; Shi, QS; Zheng, LL; Liu, J; Zhou, H; Zhang, H; Qu, LH				Zhang, Yi-Jun; Yang, Jian-Hua; Shi, Qiao-Su; Zheng, Ling-Ling; Liu, Jun; Zhou, Hui; Zhang, Hui; Qu, Liang-Hu			Rapid Birth-and-Death Evolution of Imprinted snoRNAs in the Prader-Willi Syndrome Locus: Implications for Neural Development in Euarchontoglires	PLOS ONE			English	Article							SMALL NUCLEOLAR RNA; NONCODING RNAS; MOLECULAR EVOLUTION; RIBOSE METHYLATION; GENETICS ANALYSIS; ANTISENSE RNA; SNURF-SNRPN; GENES; CLUSTER; SOFTWARE	Imprinted small nucleolar RNAs (snoRNAs) are only found in eutherian genomes and closely related to brain functions. A complex human neurological disease, Prader-Willi syndrome (PWS), is primarily attributed to the deletion of imprinted snoRNAs in chromosome 15q11-q13. Here we investigated the snoRNA repertoires in the PWS locus of 12 mammalian genomes and their evolution processes. A total of 613 imprinted snoRNAs were identified in the PWS homologous loci and the gene number was highly variable across lineages, with a peak in Euarchontoglires. Lineage-specific gene gain and loss events account for most extant genes of the HBII-52 (SNORD115) and the HBII-85 (SNORD116) gene family, and remarkable high gene-birth rates were observed in the primates and the rodents. Meanwhile, rapid sequence substitution occurred only in imprinted snoRNA genes, rather than their flanking sequences or the protein-coding genes located in the same imprinted locus. Strong selective constraints on the functional elements of these imprinted snoRNAs further suggest that they are subjected to birth-and-death evolution. Our data suggest that the regulatory role of HBII-52 on 5-HT2CR pre-mRNA might originate in the Euarchontoglires through adaptive process. We propose that the rapid evolution of PWS-related imprinted snoRNAs has contributed to the neural development of Euarchontoglires.	[Zhang, Yi-Jun; Yang, Jian-Hua; Zheng, Ling-Ling; Zhou, Hui; Qu, Liang-Hu] Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Yi-Jun; Yang, Jian-Hua; Zheng, Ling-Ling; Zhou, Hui; Qu, Liang-Hu] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Shi, Qiao-Su] Sun Yat Sen Univ, Affiliated Hosp 3, Lab Liver Dis Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Jun; Zhang, Hui] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Qu, LH (corresponding author), Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	lssqlh@mail.sysu.edu.cn	zheng, lingling/Q-7227-2016; Zhang, Yijun/J-5485-2017	Zhang, Yijun/0000-0001-7971-2200; Qu, Liang-Hu/0000-0003-3657-2863; Zhou, Hui/0000-0001-9157-3792	National Natural Science Foundation of China [30830066, 81301431, 31370791]; China Postdoctoral Science Foundation [2012M511866, 2013T60824]; Guangdong Province [S2012010010510, S2013010012457]; project of Science and Technology New Star in ZhuJiang Guangzhou city [2012J2200025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Guangdong Province; project of Science and Technology New Star in ZhuJiang Guangzhou city	This research was supported by the National Natural Science Foundation of China (No. 30830066) to Liang-Hu Qu. National Natural Science Foundation of China (No. 81301431), China Postdoctoral Science Foundation (No. 2012M511866 and No. 2013T60824) to Yi-Jun Zhang. The National Natural Science Foundation of China (No. 31370791); the funds from Guangdong Province (No. S2012010010510, S2013010012457); the project of Science and Technology New Star in ZhuJiang Guangzhou city (No. 2012J2200025) to Jian-Hua Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachellerie JP, 2002, BIOCHIMIE, V84, P775, DOI 10.1016/S0300-9084(02)01402-5; Belmonte MK, 2004, MOL PSYCHIATR, V9, P646, DOI 10.1038/sj.mp.4001499; Bolton PF, 2004, PSYCHIAT GENET, V14, P131, DOI 10.1097/00041444-200409000-00002; Bortolin-Cavaille ML, 2012, NUCLEIC ACIDS RES, V40, P6800, DOI 10.1093/nar/gks321; Brown JWS, 2003, TRENDS PLANT SCI, V8, P42, DOI 10.1016/S1360-1385(02)00007-9; Cassidy SB, 1997, J MED GENET, V34, P917, DOI 10.1136/jmg.34.11.917; Castle JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011779; Cavaille J, 2002, HUM MOL GENET, V11, P1527, DOI 10.1093/hmg/11.13.1527; Cavaille J, 1996, NATURE, V383, P732, DOI 10.1038/383732a0; Cavaille J, 1998, NUCLEIC ACIDS RES, V26, P1576, DOI 10.1093/nar/26.7.1576; Cavaille J, 2001, J BIOL CHEM, V276, P26374, DOI 10.1074/jbc.M103544200; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Curley JP, 2004, P ROY SOC B-BIOL SCI, V271, P1303, DOI 10.1098/rspb.2004.2725; de los Santos T, 2000, AM J HUM GENET, V67, P1067, DOI 10.1086/303106; de Smith AJ, 2009, HUM MOL GENET, V18, P3257, DOI 10.1093/hmg/ddp263; Ding F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001709; Doe CM, 2009, HUM MOL GENET, V18, P2140, DOI 10.1093/hmg/ddp137; Duker AL, 2010, EUR J HUM GENET, V18, P1196, DOI 10.1038/ejhg.2010.102; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Glazov EA, 2008, MOL BIOL EVOL, V25, P939, DOI 10.1093/molbev/msn045; GOODMAN M, 1979, SYST ZOOL, V28, P132, DOI 10.2307/2412519; Gurevich I, 2002, J NEUROSCI, V22, P10529; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Heisler LK, 2007, GENES BRAIN BEHAV, V6, P491, DOI 10.1111/j.1601-183X.2007.00316.x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Keverne EB, 1996, P ROY SOC B-BIOL SCI, V263, P689, DOI 10.1098/rspb.1996.0103; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kishore S, 2010, HUM MOL GENET, V19, P1153, DOI 10.1093/hmg/ddp585; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Koonin EV, 2010, NAT REV GENET, V11, P487, DOI 10.1038/nrg2810; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Leister D, 2004, TRENDS GENET, V20, P116, DOI 10.1016/j.tig.2004.01.007; Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li JJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002578; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lu J, 2008, MOL BIOL EVOL, V25, P929, DOI 10.1093/molbev/msn040; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; Meunier J, 2013, GENOME RES, V23, P34, DOI 10.1101/gr.140269.112; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Nahkuri S, 2008, J MOL BIOL, V381, P810, DOI 10.1016/j.jmb.2008.06.057; Nam J, 2005, MOL BIOL EVOL, V22, P2386, DOI 10.1093/molbev/msi229; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Niimura Y, 2003, P NATL ACAD SCI USA, V100, P12235, DOI 10.1073/pnas.1635157100; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Ogorelkova M, 2009, MOL BIOL EVOL, V26, P2563, DOI 10.1093/molbev/msp173; Page RDM, 1997, MOL PHYLOGENET EVOL, V7, P231, DOI 10.1006/mpev.1996.0390; Peters J, 2008, NAT GENET, V40, P688, DOI 10.1038/ng0608-688; Piekna-Przybylska D, 2007, RNA, V13, P305, DOI 10.1261/rna.373107; Plagge A, 2004, NAT GENET, V36, P818, DOI 10.1038/ng1397; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rapkins RW, 2006, PLOS GENET, V2, P1666, DOI 10.1371/journal.pgen.0020182; Richly E, 2002, MOL BIOL EVOL, V19, P76, DOI 10.1093/oxfordjournals.molbev.a003984; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Royo H, 2008, BIOL CELL, V100, P149, DOI 10.1042/BC20070126; Royo H, 2007, MOL BIOL CELL, V18, P2817, DOI 10.1091/mbc.E06-10-0920; Runte M, 2005, HUM GENET, V116, P228, DOI 10.1007/s00439-004-1219-2; Runte M, 2004, HUM GENET, V114, P553, DOI 10.1007/s00439-004-1104-z; Runte M, 2001, HUM MOL GENET, V10, P2687, DOI 10.1093/hmg/10.23.2687; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; Sandovici I, 2006, PLOS GENET, V2, P944, DOI 10.1371/journal.pgen.0020101; Schmitz J, 2008, GENOME RES, V18, P1005, DOI 10.1101/gr.7177908; Skryabin BV, 2007, PLOS GENET, V3, P2529, DOI 10.1371/journal.pgen.0030235; Soni S, 2007, J INTELL DISABIL RES, V51, P32, DOI 10.1111/j.1365-2788.2006.00895.x; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vitali P, 2005, J CELL BIOL, V169, P745, DOI 10.1083/jcb.200411129; Wang Yu, 2010, BMC Evol Biol, V10, P119, DOI 10.1186/1471-2148-10-119; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P5112, DOI 10.1093/nar/gkl672; Zhang R, 2008, MOL BIOL EVOL, V25, P1493, DOI 10.1093/molbev/msn094; Zhang YJ, 2009, SCI CHINA SER C, V52, P195, DOI 10.1007/s11427-009-0035-2; Zheng GXY, 2011, P NATL ACAD SCI USA, V108, P15804, DOI 10.1073/pnas.1112772108	77	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100329	10.1371/journal.pone.0100329	http://dx.doi.org/10.1371/journal.pone.0100329			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945811	Green Published, gold			2022-12-25	WOS:000340721500063
J	Eichmann, C; Tzitzilonis, C; Bordignon, E; Maslennikov, I; Choe, S; Riek, R				Eichmann, Cedric; Tzitzilonis, Christos; Bordignon, Enrica; Maslennikov, Innokentiy; Choe, Senyon; Riek, Roland			Solution NMR Structure and Functional Analysis of the Integral Membrane Protein YgaP from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Catalysis; Membrane Enzyme; Nuclear Magnetic Resonance (NMR); Structural Biology; Sulfotransferase; Three-dimensional Structure; Membrane Protein; Rhodanese; Sulfurtransferase	NUCLEAR-MAGNETIC-RESONANCE; BACKBONE DYNAMICS; CHEMICAL-SHIFTS; TRANSMEMBRANE HELIX; POTASSIUM CHANNEL; SPECTROSCOPY; RHODANESE; DOMAIN; RELAXATION; OMPX	Background:E. coli YgaP is a membrane-bound sulfurtransferase with a cytoplasmic rhodanese domain. Results: The three-dimensional structure is composed of a cytoplasmic rhodanese domain and two transmembrane helices forming the interface of the homodimer. Conclusion: The structure-activity relationship of YgaP suggests a sulfurtransferase activity. Significance: YgaP may have a role in the detoxification of CN- to the less toxic SCN-. The solution NMR structure of the -helical integral membrane protein YgaP from Escherichia coli in mixed 1,2-diheptanoyl-sn-glycerol-3-phosphocholine/1-myristoyl-2-hydroxy-sn-glycero-3-phospho-(1-rac-glycerol) micelles is presented. In these micelles, YgaP forms a homodimer with the two transmembrane helices being the dimer interface, whereas the N-terminal cytoplasmic domain includes a rhodanese-fold in accordance to its sequence homology to the rhodanese family of sulfurtransferases. The enzymatic sulfur transfer activity of full-length YgaP as well as of the N-terminal rhodanese domain only was investigated performing a series of titrations with sodium thiosulfate and potassium cyanide monitored by NMR and EPR. The data indicate the thiosulfate concentration-dependent addition of several sulfur atoms to the catalytic Cys-63, which process can be reversed by the addition of potassium cyanide. The catalytic reaction induces thereby conformational changes within the rhodanese domain, as well as on the transmembrane -helices of YgaP. These results provide insights into a potential mechanism of YgaP during the catalytic thiosulfate activity in vivo.	[Eichmann, Cedric; Tzitzilonis, Christos; Bordignon, Enrica; Riek, Roland] ETH Honggerberg, Swiss Fed Inst Technol, Phys Chem Lab, CH-8093 Zurich, Switzerland; [Tzitzilonis, Christos; Maslennikov, Innokentiy; Choe, Senyon; Riek, Roland] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Salk Institute	Riek, R (corresponding author), ETH Honggerberg, Swiss Fed Inst Technol, Phys Chem Lab, CH-8093 Zurich, Switzerland.	roland.riek@phys.chem.ethz.ch	Eichmann, Cédric/U-1360-2018	Eichmann, Cédric/0000-0002-8476-1936; Maslennikov, Innokentiy/0000-0003-4292-5821; Bordignon, Enrica/0000-0003-2450-5161; Riek, Roland/0000-0002-6333-066X				Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Bayrhuber M, 2011, J MAGN RESON, V209, P310, DOI 10.1016/j.jmr.2011.01.031; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Braun P, 1999, BIOCHEMISTRY-US, V38, P9778, DOI 10.1021/bi990923a; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Cipollone R, 2008, J MOL MICROB BIOTECH, V15, P199, DOI 10.1159/000121331; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fernandez C, 2001, FEBS LETT, V504, P173, DOI 10.1016/S0014-5793(01)02742-9; Fernandez C, 2001, P NATL ACAD SCI USA, V98, P2358, DOI 10.1073/pnas.051629298; FESIK SW, 1988, J MAGN RESON, V78, P588, DOI 10.1016/0022-2364(88)90144-8; Gueune H, 2008, APPL ENVIRON MICROB, V74, P1954, DOI 10.1128/AEM.02294-07; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hanzelmann P, 2009, PROTEIN SCI, V18, P2480, DOI 10.1002/pro.260; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hilty C, 2004, CHEMBIOCHEM, V5, P467, DOI 10.1002/cbic.200300815; Hilty C, 2002, J BIOMOL NMR, V23, P289, DOI 10.1023/A:1020218419190; IKURA M, 1990, J MAGN RESON, V86, P204, DOI 10.1016/0022-2364(90)90227-Z; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuntz I. D., 1991, J AM CHEM SOC, V105, P5948; Lee D, 2008, J AM CHEM SOC, V130, P13822, DOI 10.1021/ja803686p; Li HW, 2008, BIOCHEMISTRY-US, V47, P4377, DOI 10.1021/bi800039n; Li HW, 2011, BIOMOL NMR ASSIGN, V5, P101, DOI 10.1007/s12104-010-9277-y; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lorieau JL, 2010, P NATL ACAD SCI USA, V107, P11341, DOI 10.1073/pnas.1006142107; LUGINBUHL P, 1995, J MAGN RESON SER B, V109, P229, DOI 10.1006/jmrb.1995.0016; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; MESSERLE BA, 1989, J MAGN RESON, V85, P608, DOI 10.1016/0022-2364(89)90252-7; Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Papenbrock J, 2011, AMINO ACIDS, V41, P43, DOI 10.1007/s00726-010-0478-6; PENG JW, 1991, J MAGN RESON, V94, P82, DOI 10.1016/0022-2364(91)90296-6; PLOEGMAN JH, 1978, NATURE, V273, P124, DOI 10.1038/273124a0; Polyhach Y, 2012, PHYS CHEM CHEM PHYS, V14, P10762, DOI 10.1039/c2cp41520h; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Ray WK, 2000, J BACTERIOL, V182, P2277, DOI 10.1128/JB.182.8.2277-2284.2000; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521; Shenkarev ZO, 2010, J AM CHEM SOC, V132, P5630, DOI 10.1021/ja909752r; Spallarossa A, 2001, STRUCTURE, V9, P1117, DOI 10.1016/S0969-2126(01)00666-9; Tzitzilonis C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054378; VANHOLDE KE, 1998, PRINCIPLES PHYS BIOC, P605; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; WUTHRICH K, 1986, NMR PROTEINS NUCLEIC, P17; ZHOU NE, 1992, J AM CHEM SOC, V114, P4320, DOI 10.1021/ja00037a042	50	10	11	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23482	23503		10.1074/jbc.M114.571935	http://dx.doi.org/10.1074/jbc.M114.571935			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24958726	hybrid, Green Published			2022-12-25	WOS:000341505000021
J	Qiao, YN; He, WQ; Chen, CP; Zhang, CH; Zhao, W; Wang, P; Zhang, L; Wu, YZ; Yang, X; Peng, YJ; Gao, JM; Kamm, KE; Stull, JT; Zhu, MS				Qiao, Yan-Ning; He, Wei-Qi; Chen, Cai-Ping; Zhang, Cheng-Hai; Zhao, Wei; Wang, Pei; Zhang, Lin; Wu, Yan-Ze; Yang, Xiao; Peng, Ya-Jing; Gao, Ji-Min; Kamm, Kristine E.; Stull, James T.; Zhu, Min-Sheng			Myosin Phosphatase Target Subunit 1 (MYPT1) Regulates the Contraction and Relaxation of Vascular Smooth Muscle and Maintains Blood Pressure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; DEPENDENT PROTEIN-KINASE; SALT-INDUCED HYPERTENSION; RENIN-ANGIOTENSIN SYSTEM; CYCLIC-GMP; CA2+ SENSITIZATION; SIGNAL-TRANSDUCTION; MYOGENIC RESPONSE; RAT AORTA; I-ALPHA	Myosin light chain phosphatase with its regulatory subunit, myosin phosphatase target subunit 1 (MYPT1) modulates Ca2+ dependent phosphorylation of myosin light chain by myosin light chain kinase, which is essential for smooth muscle contraction. The role of MYPT1 in vascular smooth muscle was investigated in adult MYPT1 smooth muscle specific knock-out mice. MYPT1 deletion enhanced phosphorylation of myosin regulatory light chain and contractile force in isolated mesenteric arteries treated with KCl and various vascular agonists. The contractile responses of arteries from knock-out mice to norepinephrine were inhibited by Rho-associated kinase (ROCK) and protein kinase C inhibitors and were associated with inhibition of phosphorylation of the myosin light chain phosphatase inhibitor CPI-17. Additionally, stimulation of the NO/cGMP/protein kinase G (PKG) signaling pathway still resulted in relaxation of MYPT1-deficient mesenteric arteries, indicating phosphorylation of MYPT1 by PKG is not a major contributor to the relaxation response. Thus, MYPT1 enhances myosin light chain phosphatase activity sufficient for blood pressure maintenance. Rho-associated kinase phosphorylation of CPI-17 plays a significant role in enhancing vascular contractile responses, whereas phosphorylation of MYPT1 in the NO/cGMP/PKG signaling module is not necessary for relaxation.	[Qiao, Yan-Ning; Wu, Yan-Ze] Shaanxi Normal Univ, Key Lab MOE Modern Teaching Technol, Xian 710062, Peoples R China; [Qiao, Yan-Ning; He, Wei-Qi; Chen, Cai-Ping; Zhang, Cheng-Hai; Zhao, Wei; Wang, Pei; Peng, Ya-Jing; Zhu, Min-Sheng] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China; [Qiao, Yan-Ning; He, Wei-Qi; Chen, Cai-Ping; Zhang, Cheng-Hai; Zhao, Wei; Wang, Pei; Peng, Ya-Jing; Zhu, Min-Sheng] Nanjing Univ, MOE Key Lab Anim Models Dis, Nanjing 210061, Jiangsu, Peoples R China; [Zhang, Lin; Gao, Ji-Min; Zhu, Min-Sheng] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou 325035, Peoples R China; [Yang, Xiao] Inst Biotechnol, State Key Lab Prote, Genet Lab Dev & Dis, Beijing 100071, Peoples R China; [Kamm, Kristine E.; Stull, James T.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	Shaanxi Normal University; Nanjing University; Nanjing University; Wenzhou Medical University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhu, MS (corresponding author), 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China.	zhums@nju.edu.cn	He, Weiqi/I-7935-2013; He, Weiqi/L-2502-2019; XIAO, YANG/GPW-5529-2022; Chen, Caiping/HII-8998-2022	He, Weiqi/0000-0003-3137-8420; He, Weiqi/0000-0003-3137-8420; Yang, Xiao/0000-0002-0298-9831; Qiao, Yanning/0000-0002-8092-4662	National Institutes of Health [1R01HL112778, 5P01HL110869]; National Key Scientific Research Program of China [2014CB964701]; National Natural Science Funding of China [31272311, 31330034]; Moss Heart Fund; Fouad A. and Val Imm Bashour Distinguished Chair in Physiology; Fundamental Research Funds for the Central Universities [GK201402057]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112778, P01HL110869] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Key Scientific Research Program of China; National Natural Science Funding of China(National Natural Science Foundation of China (NSFC)); Moss Heart Fund; Fouad A. and Val Imm Bashour Distinguished Chair in Physiology; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01HL112778 and 5P01HL110869. This work was also supported by the National Key Scientific Research Program of China (2014CB964701), National Natural Science Funding of China (31272311 and 31330034; to M.-S.Z.), the Moss Heart Fund, the Fouad A. and Val Imm Bashour Distinguished Chair in Physiology (to J. T. S.), and the Fundamental Research Funds for the Central Universities (GK201402057 to Y.-N.Q.).	Cole WC, 2011, ARCH BIOCHEM BIOPHYS, V510, P160, DOI 10.1016/j.abb.2011.02.024; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; Crowley SD, 2005, J CLIN INVEST, V115, P1092, DOI 10.1172/JCI200523378; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; Dey NB, 2012, MOL CELL BIOCHEM, V368, P27, DOI 10.1007/s11010-012-1339-2; Dimopoulos GJ, 2007, CIRC RES, V100, P121, DOI 10.1161/01.RES.0000253902.90489.df; Endo S, 1999, P NATL ACAD SCI USA, V96, P2467, DOI 10.1073/pnas.96.5.2467; Eto M, 2004, P NATL ACAD SCI USA, V101, P8888, DOI 10.1073/pnas.0307812101; Gao N, 2013, J BIOL CHEM, V288, P7596, DOI 10.1074/jbc.M112.427112; Grassie ME, 2012, J BIOL CHEM, V287, P36356, DOI 10.1074/jbc.M112.398479; Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Hartshorne DJ, 1998, J MUSCLE RES CELL M, V19, P325, DOI 10.1023/A:1005385302064; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; He WQ, 2013, GASTROENTEROLOGY, V144, P1456, DOI 10.1053/j.gastro.2013.02.045; He WQ, 2011, AM J PHYSIOL-HEART C, V301, pH584, DOI 10.1152/ajpheart.01212.2010; HIMPENS B, 1989, J PHYSIOL-LONDON, V413, P489, DOI 10.1113/jphysiol.1989.sp017665; HIRATA M, 1990, J BIOL CHEM, V265, P1268; Hofmann F, 2005, J BIOL CHEM, V280, P1, DOI 10.1074/jbc.R400035200; Isotani E, 2004, P NATL ACAD SCI USA, V101, P6279, DOI 10.1073/pnas.0308742101; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kato M, 2012, J BIOL CHEM, V287, P41342, DOI 10.1074/jbc.M112.421040; Khromov A, 2009, J BIOL CHEM, V284, P21569, DOI 10.1074/jbc.M109.019729; Kitazawa T, 2012, J PHYSIOL-LONDON, V590, P5401, DOI 10.1113/jphysiol.2012.241315; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Lincoln TM, 2007, CIRC RES, V100, P10, DOI 10.1161/01.RES.0000255894.25293.82; Lowey S, 2010, J BIOL CHEM, V285, P16403, DOI 10.1074/jbc.R109.025551; MASUO M, 1994, J GEN PHYSIOL, V104, P265, DOI 10.1085/jgp.104.2.265; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; Michael SK, 2008, P NATL ACAD SCI USA, V105, P6702, DOI 10.1073/pnas.0802128105; Mizuno Y, 2008, AM J PHYSIOL-CELL PH, V295, pC358, DOI 10.1152/ajpcell.90645.2007; Moosmang S, 2005, PHARMACOL THERAPEUT, V106, P347, DOI 10.1016/j.pharmthera.2004.12.003; Morgado M, 2012, CELL MOL LIFE SCI, V69, P247, DOI 10.1007/s00018-011-0815-2; Murad F, 2006, NEW ENGL J MED, V355, P2003, DOI 10.1056/NEJMsa063904; Ogut O, 2003, J MOL CELL CARDIOL, V35, P347, DOI 10.1016/S0022-2828(03)00045-2; Okamoto R, 2005, TRANSGENIC RES, V14, P337, DOI 10.1007/s11248-005-3453-3; Puetz S, 2009, PHYSIOLOGY, V24, P342, DOI 10.1152/physiol.00023.2009; RAPOPORT RM, 1986, CIRC RES, V58, P407, DOI 10.1161/01.RES.58.3.407; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Scotto-Lavino E, 2010, J BIOL CHEM, V285, P6419, DOI 10.1074/jbc.M109.074773; Shin HM, 2002, CIRC RES, V90, P546, DOI 10.1161/01.RES.0000012822.23273.EC; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; STRALFORS P, 1989, EUR J BIOCHEM, V180, P143, DOI 10.1111/j.1432-1033.1989.tb14624.x; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Woodsome TP, 2001, J PHYSIOL-LONDON, V535, P553, DOI 10.1111/j.1469-7793.2001.t01-1-00553.x; Wu Z, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-1; Zhang WC, 2010, J BIOL CHEM, V285, P5522, DOI 10.1074/jbc.M109.062836; Zhou XB, 2001, J BIOL CHEM, V276, P43239, DOI 10.1074/jbc.M104202200	52	68	69	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22512	22523		10.1074/jbc.M113.525444	http://dx.doi.org/10.1074/jbc.M113.525444			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24951589	Green Published, hybrid			2022-12-25	WOS:000340593500060
J	El Albani, A; Bengtson, S; Canfield, DE; Riboulleau, A; Bard, CR; Macchiarelli, R; Pemba, LN; Hammarlund, E; Meunier, A; Mouele, IM; Benzerara, K; Bernard, S; Boulvais, P; Chaussidon, M; Cesari, C; Fontaine, C; Chi-Fru, E; Ruiz, JMG; Gauthier-Lafaye, F; Mazurier, A; Pierson-Wickmann, AC; Rouxel, O; Trentesaux, A; Vecoli, M; Versteegh, GJM; White, L; Whitehouse, M; Bekker, A				El Albani, Abderrazak; Bengtson, Stefan; Canfield, Donald E.; Riboulleau, Armelle; Bard, Claire Rollion; Macchiarelli, Roberto; Pemba, Lauriss Ngombi; Hammarlund, Emma; Meunier, Alain; Mouele, Idalina Moubiya; Benzerara, Karim; Bernard, Sylvain; Boulvais, Philippe; Chaussidon, Marc; Cesari, Christian; Fontaine, Claude; Chi-Fru, Ernest; Garcia Ruiz, Juan Manuel; Gauthier-Lafaye, Francois; Mazurier, Arnaud; Pierson-Wickmann, Anne Catherine; Rouxel, Olivier; Trentesaux, Alain; Vecoli, Marco; Versteegh, Gerard J. M.; White, Lee; Whitehouse, Martin; Bekker, Andrey			The 2.1 Ga Old Francevillian Biota: Biogenicity, Taphonomy and Biodiversity	PLOS ONE			English	Article							ORGANIC-WALLED MICROFOSSILS; NATURAL FISSION REACTORS; DEVONIAN HUNSRUCK SLATE; ISOTOPE FRACTIONATION; ATMOSPHERIC OXYGEN; GREAT OXIDATION; SULFUR ISOTOPES; BLACK SHALES; BASIN; PRESERVATION	The Paleoproterozoic Era witnessed crucial steps in the evolution of Earth's surface environments following the first appreciable rise of free atmospheric oxygen concentrations similar to 2.3 to 2.1 Ga ago, and concomitant shallow ocean oxygenation. While most sedimentary successions deposited during this time interval have experienced thermal overprinting from burial diagenesis and metamorphism, the ca. 2.1 Ga black shales of the Francevillian B Formation (FB2) cropping out in southeastern Gabon have not. The Francevillian Formation contains centimeter-sized structures interpreted as organized and spatially discrete populations of colonial organisms living in an oxygenated marine ecosystem. Here, new material from the FB2 black shales is presented and analyzed to further explore its biogenicity and taphonomy. Our extended record comprises variably sized, shaped, and structured pyritized macrofossils of lobate, elongated, and rodshaped morphologies as well as abundant non-pyritized disk-shaped macrofossils and organic-walled acritarchs. Combined microtomography, geochemistry, and sedimentary analysis suggest a biota fossilized during early diagenesis. The emergence of this biota follows a rise in atmospheric oxygen, which is consistent with the idea that surface oxygenation allowed the evolution and ecological expansion of complex megascopic life.	[El Albani, Abderrazak; Pemba, Lauriss Ngombi; Meunier, Alain; Mouele, Idalina Moubiya; Fontaine, Claude] Univ Poitiers, CNRS INSU, UMR 7285, Inst IC2MP, Poitiers, France; [Bengtson, Stefan; Hammarlund, Emma] Swedish Museum Nat Hist, Dept Palaeozool, S-10405 Stockholm, Sweden; [Bengtson, Stefan; Hammarlund, Emma] Swedish Museum Nat Hist, Nord Ctr Earth Evolut, S-10405 Stockholm, Sweden; [Canfield, Donald E.; Hammarlund, Emma] Nord Ctr Earth Evolut, Odense M, Denmark; [Riboulleau, Armelle; Cesari, Christian; Trentesaux, Alain; Vecoli, Marco] Univ Lille 1, CNRS, UMR 8217, Lab Geosyst, F-59655 Villeneuve Dascq, France; [Bard, Claire Rollion; Chaussidon, Marc] CNRS, UMR 7358, Ctr Rech Petrog & Geochim, Vandoeuvre Les Nancy, France; [Macchiarelli, Roberto] Univ Poitiers, Dept Geosci, Poitiers, France; [Macchiarelli, Roberto] Museum Natl Hist Nat, CNRS, UMR 7194, Dept Prehist, Paris, France; [Benzerara, Karim; Bernard, Sylvain] Univ Paris 04, IMPMC, UMR 7590, MNHN,UPMC,IRD UMR 206, Paris, France; [Boulvais, Philippe; Pierson-Wickmann, Anne Catherine] Univ Rennes, UMR 6118, Dept Geosci, Rennes, France; [Chi-Fru, Ernest] Stockholm Univ, Dept Geol Sci, SE-10691 Stockholm, Sweden; [Garcia Ruiz, Juan Manuel] Univ Granada, CSIC, Inst Andaluz Ciencias Tierra, Granada 18100, Spain; [Gauthier-Lafaye, Francois] CNRS, UMR 7517, Lab Hydrol & Geochim Strasbourg, Strasbourg, France; [Mazurier, Arnaud] CRI Biopole, Soc Etud Rech Mat, Poitiers, France; [Rouxel, Olivier] IFREMER, Dept Phys Resources & Deep Sea Ecosyst Technopole, Plouzane, France; [Versteegh, Gerard J. M.] Marum Ctr Marine Environm Sci, Bremen, Germany; [White, Lee] Agence Natl Parcs Nationaux, Libreville, Gabon; [Whitehouse, Martin] Swedish Museum Nat Hist, Lab Isotope Geol, S-10405 Stockholm, Sweden; [Whitehouse, Martin] Swedish Museum Nat Hist, Nord Ctr Earth Evolut, S-10405 Stockholm, Sweden; [Bekker, Andrey] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Poitiers; Swedish Museum of Natural History; Swedish Museum of Natural History; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine; Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Rennes; Stockholm University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT); University of Granada; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Poitiers; Ifremer; University of Bremen; Swedish Museum of Natural History; Swedish Museum of Natural History; University of California System; University of California Riverside	El Albani, A (corresponding author), Univ Poitiers, CNRS INSU, UMR 7285, Inst IC2MP, Poitiers, France.	abder.albani@univ-poitiers.fr	Garcia-Ruiz, Juan Manuel/C-4389-2015; García-Ruiz, Juan Manuel/U-1085-2019; Canfield, Don/C-1735-2012; IMPMC, ROCKS @/U-8478-2017; Arnaud, Mazurier/R-4577-2019; Chaussidon, Marc/E-7067-2017; Trentesaux, Alain P. G./A-5607-2010; Versteegh, Gerardus/H-2119-2011; Pierson-Wickmann, Anne-Catherine/J-3383-2012; Bernard, Sylvain/B-6756-2013; Whitehouse, Martin J/E-1425-2013; Vecoli, Marco/AAK-5473-2020; Arnaud, Mazurier/Q-3199-2017; Rouxel, Olivier J/F-3954-2014; Benzerara, Karim/J-1532-2016	Garcia-Ruiz, Juan Manuel/0000-0002-4743-8718; García-Ruiz, Juan Manuel/0000-0002-4743-8718; Canfield, Don/0000-0001-7602-8366; Arnaud, Mazurier/0000-0003-1894-0554; Trentesaux, Alain P. G./0000-0001-6186-1005; Versteegh, Gerardus/0000-0002-9320-3776; Pierson-Wickmann, Anne-Catherine/0000-0002-7715-3772; Whitehouse, Martin J/0000-0003-2227-577X; Arnaud, Mazurier/0000-0003-1894-0554; Rouxel, Olivier J/0000-0002-1431-222X; Hammarlund, Emma/0000-0001-7625-4793; Riboulleau, Armelle/0000-0002-2717-8330; Benzerara, Karim/0000-0002-0553-0137; Chi Fru, Ernest/0000-0003-2673-0565; Vecoli, Marco/0000-0001-9203-7625; Bekker, Andrey/0000-0002-1154-0585; Bengtson, Stefan/0000-0003-0206-5791	University of Poitiers, Centre National pour la Recherche Scientifique	University of Poitiers, Centre National pour la Recherche Scientifique	Funding of this study was provided by University of Poitiers, Centre National pour la Recherche Scientifique and Fond Europeen pour le Developpement Regional. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekker A, 2012, EARTH PLANET SC LETT, V317, P295, DOI 10.1016/j.epsl.2011.12.012; Bengtson S, 2007, PALEOBIOLOGY, V33, P351, DOI 10.1666/04040.1; Bengtson Stefan, 2002, Paleontological Society Papers, V8, P289; BERTRANDSARFATI J, 1994, PRECAMBRIAN RES, V65, P341, DOI 10.1016/0301-9268(94)90112-0; Blumenberg M, 2012, PRECAMBRIAN RES, V196, P113, DOI 10.1016/j.precamres.2011.11.010; BONHOMME MG, 1982, PRECAMBRIAN RES, V18, P87, DOI 10.1016/0301-9268(82)90038-9; Bonner JT., 2000, 1 SIGNALS EVOLUTION; Borkow PS, 2003, SED REC, V1, P4, DOI DOI 10.2110/SEDRED.2003.3.4; Briggs DEG, 1996, AM J SCI, V296, P633, DOI 10.2475/ajs.296.6.633; BROS R, 1992, EARTH PLANET SC LETT, V113, P207, DOI 10.1016/0012-821X(92)90220-P; Bryant C, 1991, METAZOAN LIFE OXYGEN; Butterfield NJ, 2009, GEOBIOLOGY, V7, P1, DOI 10.1111/j.1472-4669.2009.00188.x; Butterfield NJ, 2007, PALAEONTOLOGY, V50, P41, DOI 10.1111/j.1475-4983.2006.00613.x; Butterfield NJ, 2009, PRECAMBRIAN RES, V173, P201, DOI 10.1016/j.precamres.2009.01.008; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Canfield DE, 2001, GEOCHIM COSMOCHIM AC, V65, P1117, DOI 10.1016/S0016-7037(00)00584-6; Canfield DE, 1991, TAPHONOMY RELEASING, P338; Canfield DE, 2013, P NATL ACAD SCI USA, V110, P16736, DOI 10.1073/pnas.1315570110; Chang Z, 2008, GEOLOGY, V36, P971, DOI 10.1130/G25001A.1; CRIMES TP, 1985, J PALEONTOL, V59, P310; DILL H, 1990, SEDIMENTOLOGY, V37, P427, DOI 10.1111/j.1365-3091.1990.tb00145.x; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; El Albani A, 2010, NATURE, V466, P100, DOI 10.1038/nature09166; Ferrini V, 2010, J GEOL SOC LONDON, V167, P1009, DOI 10.1144/0016-76492009-161; Fisher ISJ, 1987, GEOLOGICAL SOC LONDO, V26, P69, DOI DOI 10.1144/GSL.SP.1987.026.01.04; Gabbott SE, 2004, GEOLOGY, V32, P901, DOI 10.1130/G20640.1; GARCIARUIZ JM, 1993, NATO ADV SCI INST SE, V304, P183; Gauthier-Lafaye F, 2006, GEOL SOC AM MEM, V198, P157, DOI 10.1130/2006.1198(09); GAUTHIERLAFAYE F, 1989, ECON GEOL, V84, P2286, DOI 10.2113/gsecongeo.84.8.2286; GauthierLafaye F, 1996, GEOCHIM COSMOCHIM AC, V60, P4831, DOI 10.1016/S0016-7037(96)00245-1; Grimes ST, 2002, J GEOL SOC LONDON, V159, P493, DOI 10.1144/0016-764901-176; Grosberg RK, 2007, ANNU REV ECOL EVOL S, V38, P621, DOI 10.1146/annurev.ecolsys.36.102403.114735; Hagadorn JW, 2011, ATL GEOL, V47, P66, DOI 10.4138/atlgeol.2011.002; Horie K, 2005, GEOCHIM COSMOCHIM AC, V69, pA11; Javaux EJ, 2010, NATURE, V463, P934, DOI 10.1038/nature08793; Jensen S., 2006, 22 JORN SOC ESP PAL, P132; Johnston DT, 2012, EARTH PLANET SC LETT, V335, P25, DOI 10.1016/j.epsl.2012.05.010; Kakegawa T, 1998, GEOCHIM COSMOCHIM AC, V62, P3205, DOI 10.1016/S0016-7037(98)00229-4; Knoll AH, 2006, PHILOS T R SOC B, V361, P1023, DOI 10.1098/rstb.2006.1843; KNOLL A. H., 1996, PALEONTOLOGY PRINCIP, V1, P51; Knoll AH, 2011, ANNU REV EARTH PL SC, V39, P217, DOI 10.1146/annurev.earth.031208.100209; Kump LR, 2011, SCIENCE, V334, P1694, DOI 10.1126/science.1213999; Lamb DM, 2009, PRECAMBRIAN RES, V173, P93, DOI 10.1016/j.precamres.2009.05.005; Leonov MV, 2007, GEOL SOC SPEC PUBL, V286, P259, DOI 10.1144/SP286.18; MacGabhann BA, 2007, GEOL SOC SPEC PUBL, V286, P297, DOI 10.1144/SP286.21; MANGUM C, 1991, J EXP ZOOL, V260, P33, DOI 10.1002/jez.1402600105; Marshall CP, 2005, PRECAMBRIAN RES, V138, P208, DOI 10.1016/j.precamres.2005.05.006; Ossa FO, 2013, CHEM GEOL, V362, P181, DOI 10.1016/j.chemgeo.2013.08.011; Parfrey LW, 2013, BIOESSAYS, V35, P339, DOI 10.1002/bies.201200143; Partin CA, 2013, EARTH PLANET SC LETT, V369, P284, DOI 10.1016/j.epsl.2013.03.031; Payne JL, 2011, PHOTOSYNTH RES, V107, P37, DOI 10.1007/s11120-010-9593-1; Peng YB, 2009, PRECAMBRIAN RES, V168, P223, DOI 10.1016/j.precamres.2008.10.005; Planavsky NJ, 2012, P NATL ACAD SCI USA, V109, P18300, DOI 10.1073/pnas.1120387109; RAISWELL R, 1993, AM J SCI, V293, P569, DOI 10.2475/ajs.293.6.569; Raiswell R, 1997, J GEOL SOC LONDON, V154, P343, DOI 10.1144/gsjgs.154.2.0343; RONA PA, 1978, B MAR SCI, V28, P371; Rona PA, 2009, DEEP-SEA RES PT II, V56, P1700, DOI 10.1016/j.dsr2.2009.05.015; Schiffbauer JD, 2012, GEOBIOLOGY, V10, P402, DOI 10.1111/j.1472-4669.2012.00332.x; Scott C, 2014, EARTH PLANET SC LETT, V389, P95, DOI 10.1016/j.epsl.2013.12.010; Seilacher A, 2001, SEDIMENT GEOL, V143, P41, DOI 10.1016/S0037-0738(01)00092-6; Talyzina NM, 2000, PRECAMBRIAN RES, V102, P123, DOI 10.1016/S0301-9268(00)00062-0; Thomassot E, 2009, EARTH PLANET SC LETT, V282, P79, DOI 10.1016/j.epsl.2009.03.001; UNDERWOOS CJ, 1994, GEOL MAG, V131, P315, DOI 10.1017/S0016756800011080; Wacey D., 2009, EARLY LIFE EARTH PRA; Wagner T, 2006, AM J SCI, V306, P525, DOI 10.2475/07.2006.02; Wang QW, 1996, MAR CHEM, V52, P99, DOI 10.1016/0304-4203(95)00082-8; Weber F., 1968, SERIE PRECAMBRIENNE; Whitehouse MJ, 2005, CHEM GEOL, V222, P112, DOI 10.1016/j.chemgeo.2005.06.004; Wilkins MR, 1995, EXPERIENTIA, V51, P1189, DOI 10.1007/BF01944736	69	42	42	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99438	10.1371/journal.pone.0099438	http://dx.doi.org/10.1371/journal.pone.0099438			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963687	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000338709500010
J	Chien, CC; Wu, MS; Shen, SC; Ko, CH; Chen, CH; Yang, LL; Chen, YC				Chien, Chih-Chiang; Wu, Ming-Shun; Shen, Shing-Chuan; Ko, Ching-Huai; Chen, Chih-Hung; Yang, Ling-Ling; Chen, Yen-Chou			Activation of JNK Contributes to Evodiamine-Induced Apoptosis and G(2)/M Arrest in Human Colorectal Carcinoma Cells: A Structure-Activity Study of Evodiamine	PLOS ONE			English	Article							BREAST-CANCER CELLS; INDEPENDENT APOPTOSIS; ROS; INHIBITION; PHOSPHORYLATION; TELOMERASE; PATHWAY; GROWTH; BINDS	Evodiamine (EVO; 8,13,13b,14-tetrahydro-14-methylindolo[2'3'-3,4]pyrido[2,1-b]quinazolin-5-[7H]-one derived from the traditional herbal medicine Evodia rutaecarpa was reported to possess anticancer activity; however, the anticancer mechanism is still unclear. In this study, we investigated the anticancer effects of EVO on human colon COLO205 and HT-29 cells and their potential mechanisms. MTT and lactate dehydrogenase (LDH) release assays showed that the viability of COLOL205 and HT-29 cells was inhibited by EVO at various concentrations in accordance with increases in the percentage of apoptotic cells and cleavage of caspase-3 and poly(ADP ribose) polymerase (PARP) proteins. Disruption of the mitochondrial membrane potential by EVO was accompanied by increased Bax, caspase-9 protein cleavage, and cytochrome (Cyt) c protein translocation in COLO205 and HT-29 cells. Application of the antioxidant N-acetyl-L-cysteine (NAC) inhibited H2O2-induced reactive oxygen species (ROS) production and apoptosis, but did not affect EVO-induced apoptosis of COLO205 or HT-29 cells. Significant increases in the G(2)/M ratio and cyclinB1/cdc25c protein expression by EVO were respectively identified in colon carcinoma cells via a flow cytometric analysis and Western blotting. Induction of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) protein phosphorylation was detected in EVO-treated cells, and the JNK inhibitor, SP600125, but not the ERK inhibitor, U0126, inhibited EVO-induced phosphorylated JNK protein expression, apoptosis, and G(2)/M arrest of colon carcinoma cells. Data of the structure-activity analysis showed that EVO-related chemicals containing an alkyl group at position 14 were able to induce apoptosis, G(2)/M arrest associated with increased DNA ladder formation, cleavage of caspase-3 and PARP, and elevated cycB1 and cdc25c protein expressions in COLO205 and HT-29 cells. Evidence supporting JNK activation leading to EVO-induced apoptosis and G(2)/M arrest in colon carcinoma cells is provided, and alkylation at position 14 of EVO is a critical substitution for treatment of colonic cancer.	[Chien, Chih-Chiang] Chi Mei Med Ctr, Dept Nephrol, Tainan, Taiwan; [Chien, Chih-Chiang] Chung Hwa Univ Med Technol, Dept Food Nutr, Tainan, Taiwan; [Wu, Ming-Shun] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Shen, Shing-Chuan; Chen, Yen-Chou] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Ko, Ching-Huai; Chen, Chih-Hung] Ind Technol Res Inst, Strateg Business & Innovat Technol Dev Div, Hsinchu, Taiwan; [Ko, Ching-Huai; Chen, Chih-Hung] Ind Technol Res Inst, Biomed Technol & Device Res Labs, Hsinchu, Taiwan; [Yang, Ling-Ling] Fo Guang Univ, Coll LOHAS, Yilan, Taiwan; [Chen, Yen-Chou] Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan; [Chen, Yen-Chou] Taipei Med Univ Hosp, Orthoped Res Ctr, Taipei, Taiwan	Chi Mei Hospital; Chung Hua University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Industrial Technology Research Institute - Taiwan; Industrial Technology Research Institute - Taiwan; Fo Guang University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital	Chen, YC (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.	yc3270@tmu.edu.tw			National Science Council of Taiwan [NSC 101-2320-B-038-025-MY3, NSC 102-2320-B-038-050]; Taipei Medical University-Wan Fang Hospital [103TMU-WFH-01-2]; Taipei Medical University-Chi Mei Hospital [103CM-TMU-04]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University-Wan Fang Hospital; Taipei Medical University-Chi Mei Hospital	This study was supported by the National Science Council of Taiwan (NSC 101-2320-B-038-025-MY3 and NSC 102-2320-B-038-050), Taipei Medical University-Wan Fang Hospital (103TMU-WFH-01-2), and Taipei Medical University-Chi Mei Hospital (103CM-TMU-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carnesecchi S, 2002, J PHARMACOL EXP THER, V301, P625, DOI 10.1124/jpet.301.2.625; Chae HD, 2011, BMB REP, V44, P553, DOI 10.5483/BMBRep.2011.44.8.553; Chen YC, 2005, BBA-MOL CELL RES, V1743, P291, DOI 10.1016/j.bbamcr.2004.10.016; Chien CC, 2012, J CELL PHYSIOL, V227, P3128, DOI 10.1002/jcp.23067; Chien CC, 2009, J CELL PHYSIOL, V218, P405, DOI 10.1002/jcp.21613; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; De Chiara G, 2006, J BIOL CHEM, V281, P21353, DOI 10.1074/jbc.M511052200; Du J, 2013, ONCOL REP, V30, P685, DOI 10.3892/or.2013.2498; Fei XF, 2003, CANCER SCI, V94, P92, DOI 10.1111/j.1349-7006.2003.tb01358.x; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Huang YC, 2004, LIFE SCI, V75, P35, DOI 10.1016/j.lfs.2003.11.025; Jang BC, 2004, BIOCHEM PHARMACOL, V68, P263, DOI 10.1016/j.bcp.2004.03.007; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Johansson M, 2008, ANTI-CANCER AGENT ME, V8, P723, DOI 10.2174/187152008785914833; Kan SF, 2007, J CELL BIOCHEM, V101, P44, DOI 10.1002/jcb.21036; Ko CH, 2005, BIOCHEM PHARMACOL, V69, P913, DOI 10.1016/j.bcp.2004.12.005; Ko CH, 2007, INT J CANCER, V121, P1670, DOI 10.1002/ijc.22910; Kobayashi Y, 2003, PLANTA MED, V69, P425, DOI 10.1055/s-2003-39701; Lee TJ, 2006, MOL CANCER THER, V5, P2398, DOI 10.1158/1535-7163.MCT-06-0167; Line-Edwige M, 2009, AFR J TRADIT COMPLEM, V6, P112; Mahindroo N, 2006, EXPERT OPIN THER PAT, V16, P647, DOI 10.1517/13543776.16.5.647; Maryanovich M, 2013, TRENDS CELL BIOL, V23, P129, DOI 10.1016/j.tcb.2012.09.007; Muller GA, 2012, NUCLEIC ACIDS RES, V40, P1561, DOI 10.1093/nar/gkr793; Muller GA, 2010, FEBS J, V277, P877, DOI 10.1111/j.1742-4658.2009.07508.x; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Ogasawara M, 2004, BIOL PHARM BULL, V27, P578, DOI 10.1248/bpb.27.578; Seo HR, 2008, J BIOL CHEM, V283, P15601, DOI 10.1074/jbc.M800987200; Shen SC, 2008, TOXICOL APPL PHARM, V229, P239, DOI 10.1016/j.taap.2008.01.018; Sun QR, 2010, J CELL PHYSIOL, V222, P421, DOI 10.1002/jcp.21982; Wang KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067297; Wang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083264; Yang J, 2010, FREE RADICAL RES, V44, P792, DOI 10.3109/10715762.2010.481302; Yang JC, 2011, FREE RADICAL BIO MED, V51, P641, DOI 10.1016/j.freeradbiomed.2011.05.012; Zhang C, 2010, ANTI-CANCER DRUG, V21, P766, DOI 10.1097/CAD.0b013e32833d26a9; Zhou Jun, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P65, DOI 10.2174/1568011053352569	35	56	59	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99729	10.1371/journal.pone.0099729	http://dx.doi.org/10.1371/journal.pone.0099729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959718	gold, Green Submitted, Green Published			2022-12-25	WOS:000338633900014
J	Fukumasu, H; Rochetti, AL; Pires, PRL; Silva, ER; Mesquita, LG; Strefezzi, RF; De Carvalho, DD; Dagli, ML				Fukumasu, Heidge; Rochetti, Arina L.; Pires, Pedro R. L.; Silva, Edson R.; Mesquita, Ligia G.; Strefezzi, Ricardo F.; De Carvalho, Daniel D.; Dagli, Maria L.			Constitutive Androstane Receptor Ligands Modulate the Anti-Tumor Efficacy of Paclitaxel in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							NUCLEAR RECEPTOR; ACTIVE/ANDROSTANE RECEPTOR; XENOBIOTIC RECEPTOR; GENE-EXPRESSION; CAR; PXR; METABOLISM; ACTIVATION; RESISTANCE; THERAPY	Background: Lung tumors are the leading cause of cancer deaths worldwide and paclitaxel has proven to be useful for patients with lung cancer, however, acquired resistance is a major problem. To overcome this problem, one promising option is the use of Constitutive Androstane Receptor (CAR) ligands in combination with chemotherapeutics against cancer cells. Therefore, we wish to elucidate the effects of CAR ligands on the antineoplastic efficacy of paclitaxel in lung cancer cells. Methodology/Principal Findings: Our results from cell viability assays exposing CAR agonist or inverse-agonist to mouse and human lung cancer cells modulated the antineoplastic effect of paclitaxel. The CAR agonists increased the effect of Paclitaxel in 6 of 7 lung cancer cell lines, whereas the inverse-agonist had no effect on paclitaxel cytotoxicity. Interestingly, the mCAR agonist TCPOBOP enhanced the expression of two tumor suppressor genes, namely WT1 and MGMT, which were additively enhanced in cells treated with CAR agonist in combination with paclitaxel. Also, in silico analysis showed that both paclitaxel and CAR agonist TCPOBOP docked into the mCAR structure but not the inverse agonist androstenol. Paclitaxel per se increases the expression of CAR in cancer cells. At last, we analyzed the expression of CAR in two public independent studies from The Cancer Genome Atlas (TCGA) of Non Small Cell Lung Cancer (NSCLC). CAR is expressed in variable levels in NSCLC samples and no association with overall survival was noted. Conclusions/Significance: Taken together, our results demonstrated that CAR agonists modulate the antineoplastic efficacy of paclitaxel in mouse and human cancer cell lines. This effect was probably related by the enhanced expression of two tumor suppressor genes, viz. WT1 and MGMT. Most of NSCLC cases present CAR gene expression turning it possible to speculate the use of CAR modulation by ligands along with Paclitaxel in NSCLC therapy.	[Fukumasu, Heidge; Rochetti, Arina L.; Pires, Pedro R. L.; Silva, Edson R.; Mesquita, Ligia G.; Strefezzi, Ricardo F.] Univ Sao Paulo, Sch Anim Sci & Food Engn, Dept Vet Med, Lab Comparat & Translat Oncol, Pirassununga, Brazil; [De Carvalho, Daniel D.] Univ Hlth Network, Princess Margaret Canc Ctr, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON, Canada; [De Carvalho, Daniel D.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Dagli, Maria L.] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Pathol, Lab Expt & Comparat Oncol, Sao Paulo, Brazil	Universidade de Sao Paulo; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Universidade de Sao Paulo	Fukumasu, H (corresponding author), Univ Sao Paulo, Sch Anim Sci & Food Engn, Dept Vet Med, Lab Comparat & Translat Oncol, Pirassununga, Brazil.	fukumasu@usp.br	Fukumasu, Heidge/B-3866-2013; Strefezzi, Ricardo F/B-8754-2010; Mesquita, Ligia/C-4935-2012; De Carvalho, Daniel D/J-5503-2014; Pires, Pedro R L/N-4864-2016; Dagli, Maria/C-5809-2012; da Silva, Edson Roberto/G-3913-2012; De Carvalho, Daniel/J-5503-2014	Fukumasu, Heidge/0000-0002-3265-5090; Strefezzi, Ricardo F/0000-0002-8810-2815; De Carvalho, Daniel D/0000-0002-8572-5259; Pires, Pedro R L/0000-0003-0827-7445; Dagli, Maria/0000-0001-7031-6711; da Silva, Edson Roberto/0000-0002-6246-4404; Rochetti, Arina/0000-0002-1225-1953; De Carvalho, Daniel/0000-0003-0771-2265; Garcia Mesquita, Ligia/0000-0001-9938-4275	Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/56584-2, 2009/11081-6, 2010/00535-3, 2010/05650-5, 2011/05690-0]	Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors thanks Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP) for financial support (process. numbers: 2008/56584-2; 2009/11081-6; 2010/00535-3; 2010/05650-5; 2011/05690-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berhoune M, 2008, ANN PHARMACOTHER, V42, P1640, DOI 10.1345/aph.1L200; Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208; Cancer multidrug resistance, 2000, NAT BIOTECHNOL S, V18, pIT18; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chakraborty S, 2011, BRIT J CANCER, V104, P448, DOI 10.1038/sj.bjc.6606064; Chen YK, 2012, BIOCHEM PHARMACOL, V83, P1112, DOI 10.1016/j.bcp.2012.01.030; Chu Q, 2005, LUNG CANCER, V50, P355, DOI 10.1016/j.lungcan.2005.06.010; Ekim M, 2011, GENET TEST MOL BIOMA, V15, P357, DOI 10.1089/gtmb.2010.0211; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Fukumasu H, 2013, MOL CARCINOGEN, V52, P497, DOI 10.1002/mc.21884; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Goodwin B, 2002, MOL PHARMACOL, V62, P359, DOI 10.1124/mol.62.2.359; Gu CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072633; Harmsen S, 2010, CANCER CHEMOTH PHARM, V66, P765, DOI 10.1007/s00280-009-1221-4; Hayashi S, 2012, CANCER INVEST, V30, P165, DOI 10.3109/07357907.2011.633291; Huang WD, 2005, MOL ENDOCRINOL, V19, P1646, DOI 10.1210/me.2004-0520; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malkinson AM, 1997, TOXICOLOGY, V123, P53, DOI 10.1016/S0300-483X(97)00108-X; Mennecier G, 2012, MOL CARCINOG; Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200; Moreau A, 2014, MOL PHARM, V5, P35; Moustakas DT, 2014, J COMPUT AID MOL DES, V20, P601; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pondugula SR, 2013, CANCER LETT, V328, P1, DOI 10.1016/j.canlet.2012.08.030; Qiao EQ, 2013, ONCOL LETT, V5, P1093, DOI 10.3892/ol.2013.1149; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; Rozen S, 2000, Methods Mol Biol, V132, P365; Scripture CD, 2006, NAT REV CANCER, V6, P546, DOI 10.1038/nrc1887; Shan L, 2004, MOL CELL, V16, P907, DOI 10.1016/S1097-2765(04)00728-2; Shiao YH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007505; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sithanandam G, 2005, AM J RESP CELL MOL, V33, P490, DOI 10.1165/rcmb.2005-0049OC; Suino K, 2004, MOL CELL, V16, P893, DOI 10.1016/j.molcel.2004.11.036; Takizawa D, 2011, CARCINOGENESIS, V32, P576, DOI 10.1093/carcin/bgq277; Thomas CR, 1998, J CLIN ONCOL, V16, P1631, DOI 10.1200/JCO.1998.16.4.1631; Wada T, 2009, TRENDS ENDOCRIN MET, V20, P273, DOI 10.1016/j.tem.2009.03.003; Wang D, 2013, BLOOD, V121, P329, DOI 10.1182/blood-2012-06-436691; Willson TM, 2002, NAT REV DRUG DISCOV, V1, P259, DOI 10.1038/nrd753; Wu C, 2013, J THORAC ONCOL, V8, P1163, DOI 10.1097/JTO.0b013e31829f6a5f; Xu CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068837; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459	44	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99484	10.1371/journal.pone.0099484	http://dx.doi.org/10.1371/journal.pone.0099484			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959746	Green Published, gold, Green Submitted			2022-12-25	WOS:000338633900006
J	Knapp, DJHF; McGovern, RA; Poon, AFY; Zhong, XY; Chan, D; Swenson, LC; Dong, WN; Harrigan, PR				Knapp, David J. H. F.; McGovern, Rachel A.; Poon, Art F. Y.; Zhong, Xiaoyin; Chan, Dennison; Swenson, Luke C.; Dong, Winnie; Harrigan, P. Richard			"Deep'' Sequencing Accuracy and Reproducibility Using Roche/454 Technology for Inferring Co-Receptor Usage in HIV-1	PLOS ONE			English	Article							MARAVIROC; MUTATIONS; CANCER; TRIAL; RNA	Next generation, "deep'', sequencing has increasing applications both clinically and in disparate fields of research. This study investigates the accuracy and reproducibility of "deep'' sequencing as applied to co-receptor prediction using the V3 loop of Human Immunodeficiency Virus-1. Despite increasing use in HIV co-receptor prediction, the accuracy and reproducibility of deep sequencing technology, and the factors which can affect it, have received only a limited level of investigation. To accomplish this, repeated deep sequencing results were generated using the Roche GS-FLX (454) from a number of sources including a non-homogeneous clinical sample (N = 47 replicates over 18 deep sequencing runs), and a large clinical cohort from the MOTIVATE and A400129 studies (N = 1521). For repeated measurements of a non-homogeneous clinical sample, increasing input copy number both decreased variance in the measured proportion of non-R5 using virus (p << 0.001 and 0.02 for single replicates and triplicates respectively) and increased measured viral diversity (p < 0.001; multiple measures). Detection of sequences with a mean abundance less than 1% abundance showed a 2 fold increase in median coefficient of variation (CV) in repeated measurements of a non-homogeneous clinical sample, and a 2.7 fold increase in CV in the MOTIVATE/A400129 dataset compared to sequences with >= 1% abundance. An unexpected source of error included read position, with low accuracy reads occurring more frequently towards the edge of sequencing regions (p << 0.001). Overall, the primary source of variability was sampling error caused by low input copy number/minority species prevalence, though other sources of error including sequence intrinsic, temporal, and read-position related errors were detected.	[Knapp, David J. H. F.; McGovern, Rachel A.; Poon, Art F. Y.; Zhong, Xiaoyin; Chan, Dennison; Swenson, Luke C.; Dong, Winnie; Harrigan, P. Richard] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Harrigan, P. Richard] Univ British Columbia, Fac Med, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia	Harrigan, PR (corresponding author), BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	prharrigan@cfenet.ubc.ca	Poon, Art/W-9811-2019	Poon, Art/0000-0003-3779-154X; Knapp, David JHF/0000-0002-2161-9959	Canadian Institutes of Health Research (CIHR) [200802HFE]; CIHR/GSK; Pfizer; Glaxo-Smith Kline; Abbott; Merck; Virco; Monogram	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR/GSK(Canadian Institutes of Health Research (CIHR)); Pfizer(Pfizer); Glaxo-Smith Kline(GlaxoSmithKline); Abbott(Abbott Laboratories); Merck(Merck & Company); Virco; Monogram	Funding for this paper was provided by CIHR and by Pfizer/ViiV healthcare. Art F.Y. Poon is funded by a Canadian Institutes of Health Research (CIHR) Fellowships Award in HIV/AIDS Research (200802HFE). PRH is funded by a CIHR/GSK Research Chair in Clinical Virology and has received grants from, served as an ad hoc advisor to, or spoke at various events sponsored by: Pfizer, Glaxo-Smith Kline, Abbott, Merck, Virco and Monogram. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer J, 2009, AIDS, V23, P1209, DOI 10.1097/QAD.0b013e32832b4399; Balwierz PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r79; Beerenwinkel N, 2011, CURR OPIN VIROL, V1, P413, DOI 10.1016/j.coviro.2011.07.008; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Bunnik EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002106; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Cornils K, 2013, EXP HEMATOL, V41, P28, DOI 10.1016/j.exphem.2012.09.003; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Este JA, 2007, LANCET, V370, P81, DOI 10.1016/S0140-6736(07)61052-6; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Knapp DJ, 2012, J CLIN MICROBIOL; Kohlmann A, 2011, LEUKEMIA, V25, P1840, DOI 10.1038/leu.2011.155; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Ma QLC, 2012, CURR OPIN GENET DEV, V22, P3, DOI 10.1016/j.gde.2012.01.008; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mild M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022741; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Saag M, 2009, J INFECT DIS, V199, P1638, DOI 10.1086/598965; Swenson LC, 2009, EUR AIDS CLIN SOC CO; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Swenson LC, 2011, J INFECT DIS, V203, P237, DOI 10.1093/infdis/jiq030; Swenson LC, 2010, JAIDS-J ACQ IMM DEF, V54, P506, DOI 10.1097/QAI.0b013e3181d0558f	25	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99508	10.1371/journal.pone.0099508	http://dx.doi.org/10.1371/journal.pone.0099508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959876	Green Published, gold, Green Submitted			2022-12-25	WOS:000338633900008
J	Kogiso, T; Nagahara, H; Hashimoto, E; Ariizumi, S; Yamamoto, M; Shiratori, K				Kogiso, Tomomi; Nagahara, Hikaru; Hashimoto, Etsuko; Ariizumi, Shunichi; Yamamoto, Masakazu; Shiratori, Keiko			Efficient Induction of Apoptosis by Wee1 Kinase Inhibition in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							PHOSPHORYLATION SITES; THERAPEUTIC TARGET; ACTIVATING KINASE; PROTEIN-KINASE; P34CDC2 KINASE; CYCLE ARREST; CANCER; CHECKPOINT; IDENTIFICATION; RADIOSENSITIZATION	Transforming growth factor-beta 1 (TGF-beta 1) potently inhibits human hepatocellular carcinoma (HCC) cell growth. Here we demonstrated that TGF-beta 1-induced apoptosis is mediated by decreased phosphorylation of cdc2 at Tyr15 accompanied by down-regulation of Wee1 kinase expression. As expected from these results, a Wee1 kinase inhibitor efficiently induced apoptosis in HCC cells in the absence of TGF-beta 1 treatment. In surgically resected samples, Wee1 kinase was expressed in moderately to poorly differentiated HCC, whereas no Wee1 kinase expression was observed in non-cancerous tissue, including cirrhotic tissue. Our results suggest that Wee1 kinase inhibitors may be a practical novel therapeutic option against advanced HCC.	[Kogiso, Tomomi; Hashimoto, Etsuko; Shiratori, Keiko] Tokyo Womens Med Univ, Dept Internal Med, Inst Gastroenterol, Tokyo, Japan; [Nagahara, Hikaru] Tokyo Womens Med Univ, Aoyama Hosp, Tokyo, Japan; [Ariizumi, Shunichi; Yamamoto, Masakazu] Tokyo Womens Med Univ, Inst Gastroenterol, Dept Surg, Tokyo, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University; Tokyo Women's Medical University	Kogiso, T (corresponding author), Tokyo Womens Med Univ, Dept Internal Med, Inst Gastroenterol, Tokyo, Japan.	kogiso@ige.twmu.ac.jp	Ariizumi, Shunichi/AAG-3829-2020		Ministry of Education, Culture, Sports, Science, and Technology, Japan [26461024-0001]; Nakayama Cancer Research Institute Scholarship; Itoe Okamoto Scholarship Grant; Hisako Yamakawa Award; Takako Satake Award at Tokyo Women's Medical University	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nakayama Cancer Research Institute Scholarship; Itoe Okamoto Scholarship Grant; Hisako Yamakawa Award; Takako Satake Award at Tokyo Women's Medical University	Support for this study was received from Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (#26461024-0001), a Nakayama Cancer Research Institute Scholarship, an Itoe Okamoto Scholarship Grant, the Hisako Yamakawa Award and the Takako Satake Award at Tokyo Women's Medical University to T.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Block TM, 2003, ONCOGENE, V22, P5093, DOI 10.1038/sj.onc.1206557; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Chang CC, 2004, P NATL ACAD SCI USA, V101, P13239, DOI 10.1073/pnas.0405407101; Choi KS, 1999, J BIOL CHEM, V274, P31775, DOI 10.1074/jbc.274.45.31775; Claassen GF, 2000, P NATL ACAD SCI USA, V97, P9498, DOI 10.1073/pnas.150006697; Gauthier A, 2012, HEPATOL RES; Hamer PCD, 2011, CLIN CANCER RES, V17, P4200, DOI 10.1158/1078-0432.CCR-10-2537; Harris PS, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-72; Jang CW, 2002, NAT CELL BIOL, V4, P51, DOI 10.1038/ncb731; Janssen A, 2011, ONCOGENE, V30, P2799, DOI 10.1038/onc.2011.30; KREK W, 1992, NEW BIOL, V4, P323; KREK W, 1991, EMBO J, V10, P3331, DOI 10.1002/j.1460-2075.1991.tb04897.x; KREK W, 1991, EMBO J, V10, P305, DOI 10.1002/j.1460-2075.1991.tb07951.x; Leijen S, 2010, CURR CLIN PHARMACOL, V5, P186, DOI 10.2174/157488410791498824; Li J, 2002, RADIAT RES, V157, P322, DOI 10.1667/0033-7587(2002)157[0322:WTTIGP]2.0.CO;2; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Nagahara H, 1999, P NATL ACAD SCI USA, V96, P14961, DOI 10.1073/pnas.96.26.14961; NORBURY C, 1991, EMBO J, V10, P3321, DOI 10.1002/j.1460-2075.1991.tb04896.x; O'Connor DS, 2002, CANCER CELL, V2, P43, DOI 10.1016/S1535-6108(02)00084-3; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Porter CC, 2012, LEUKEMIA, V26, P1266, DOI 10.1038/leu.2011.392; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; SOLOMON MJ, 1992, MOL BIOL CELL, V3, P13, DOI 10.1091/mbc.3.1.13; Wang YL, 2001, CANCER RES, V61, P8211; Yilmaz M, 2011, EMBO J, V30, P4489, DOI 10.1038/emboj.2011.319	30	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100495	10.1371/journal.pone.0100495	http://dx.doi.org/10.1371/journal.pone.0100495			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960176	Green Published, Green Submitted, gold			2022-12-25	WOS:000338633900052
J	Liu, YB; Pan, JY; Jin, KK; Liu, CL; Wang, J; Chen, L; Chen, L; Yuan, JD				Liu, Yangbo; Pan, Jingye; Jin, Keke; Liu, Cailong; Wang, Jing; Chen, Li; Chen, Lei; Yuan, Jiandong			Analysis of 30 Patients with Acupuncture-Induced Primary Inoculation Tuberculosis	PLOS ONE			English	Article							CUTANEOUS TUBERCULOSIS	Primary inoculation tuberculosis is a skin condition that develops at the site of inoculation of Mycobacterium tuberculosis in tuberculosis-free individuals. This report describes the diagnosis, treatment and >1 year follow-up of 30 patients presenting with acupuncture-induced primary inoculation tuberculosis. Our data provide a deeper insight into this rare route of infection of tuberculosis. We also review effective treatment options.	[Liu, Yangbo; Liu, Cailong; Wang, Jing; Chen, Lei; Yuan, Jiandong] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China; [Pan, Jingye] Wenzhou Med Univ, Affiliated Hosp 1, Intens Care Unit, Wenzhou, Zhejiang, Peoples R China; [Jin, Keke] Wenzhou Med Univ, Wenzhou, Zhejiang, Peoples R China; [Chen, Li] Univ Melbourne, Melbourne, Vic, Australia	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; University of Melbourne	Yuan, JD (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China.	chenlei@wzhospital.cn; liuybwz@me.com		yangbo, liu/0000-0002-1180-4974; CHEN, LI/0000-0002-6717-5708				American Thoracic Society C and Infectious Diseases Society of America, 2003, MMWR RECOMMENDATIONS; [Anonymous], 2011, GLOB TUB CONTR 2011; BLOCH AB, 1989, CLIN CHEST MED, V10, P297; Centers for Disease Control and Prevention, MANT TB SKINT FAC GU; Jardin OD, 2010, ENFERM INFEC MICR CL, V28, P596, DOI 10.1016/j.eimc.2009.08.003; GOETTE DK, 1978, ARCH DERMATOL, V114, P567, DOI 10.1001/archderm.114.4.567; HAIM S, 1978, CUTIS, V21, P643; Ho C. K., 2006, Hong Kong Medical Journal, V12, P272; Lee JJ, 2003, INT J TUBERC LUNG D, V7, P569; Lu Hong-qing, 2012, Zhongguo Zhen Jiu, V32, P570; Luca Simona, 2013, Maedica (Bucur), V8, P53; Otu J, 2008, J INFECT DEV COUNTR, V2, P200; Rook G, 2000, ANN NY ACAD SCI, V917, P913; Rook GAW, 1997, PSYCHONEUROENDOCRINO, V22, pS109, DOI 10.1016/S0306-4530(97)00014-0; Saitoh H, 2000, Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi, V11, P19; Tappeiner G, 2008, FITZPATRICKS DERMATO; Tigoulet F, 2003, Bull Soc Pathol Exot, V96, P362; Walker LA, 2002, COMPLEMENT THER MED, V10, P8, DOI 10.1054/ctim.2002.0522; Wong Hoong-Wai, 2005, Australas J Dermatol, V46, P84, DOI 10.1111/j.1440-0960.2005.00147.x; Zhao Xiu-Ping, 2009, Zhongguo Zhen Jiu, V29, P10	20	3	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100377	10.1371/journal.pone.0100377	http://dx.doi.org/10.1371/journal.pone.0100377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959854	Green Submitted, Green Published, gold			2022-12-25	WOS:000338633900041
J	Xie, X; Wu, QH; Hao, YH; Yin, H; Fu, WQ; Ning, N; Xu, L; Liu, CJ; Li, Y; Kang, Z; He, CZ; Liu, GX				Xie, Xin; Wu, Qunhong; Hao, Yanhua; Yin, Hui; Fu, Wenqi; Ning, Ning; Xu, Ling; Liu, Chaojie; Li, Ye; Kang, Zheng; He, Changzhi; Liu, Guoxiang			Identifying Determinants of Socioeconomic Inequality in Health Service Utilization among Patients with Chronic Non-Communicable Diseases in China	PLOS ONE			English	Article							CARE UTILIZATION; RURAL CHINA; HORIZONTAL INEQUITY; EQUITY; ACCESS; POLICY	Background: People with chronic non-communicable diseases (NCD) are particularly vulnerable to socioeconomic inequality due to their long-term expensive health needs. This study aimed to assess socioeconomic-related inequality in health service utilization among NCD patients in China and to analyze factors associated with this disparity. Methods: Data were taken from the 2008 Chinese National Health Survey, in which a multiple stage stratified random sampling method was employed to survey 56,456 households. We analyzed the distribution of actual use, need-expected use, and need-standardized usage of outpatient services (over a two-week period) and inpatient services (over one-year) across different income groups in 27,233 adult respondents who reported as having a NCD. We used a concentration index to measure inequality in the distribution of health services, which was expressed as HI (Horizontal Inequity Index) for need-standardized use of services. A non-linear probit regression model was employed to detect inequality across socioeconomic groups. Results: Pro-rich inequity in health services among NCD patients was more substantial than the average population. A higher degree of pro-rich inequity (HI = 0.253) was found in inpatient services compared to outpatient services (HI = 0.089). Despite a greater need for health services amongst those of lower socio-economic status, their actual use is much less than their more affluent counterparts. Health service underuse by the poor and overuse by the affluent are evident. Household income disparity was the greatest inequality factor in NCD service use for both outpatients (71.3%) and inpatients (108%), more so than health insurance policies. Some medical insurance schemes, such as the MIUE, actually made a pro-rich contribution to health service inequality (16.1% for outpatient and 12.1% for inpatient). Conclusions: Inequality in health services amongst NCD patients in China remains largely determined by patient financial capability. The current insurance schemes are insufficient to address this inequity. A comprehensive social policy that encompasses a more progressive taxation package and redistribution of social capital as well as pro-poor welfare is needed.	[Xie, Xin; Wu, Qunhong; Hao, Yanhua; Yin, Hui; Fu, Wenqi; Ning, Ning; Li, Ye; Kang, Zheng; He, Changzhi; Liu, Guoxiang] Harbin Med Univ, Sch Hlth Management, Dept Social Med, Harbin, Heilongjiang, Peoples R China; [Xie, Xin] Harbin Med Univ Daqing, Dept Humanities & Social Sci, Daqing, Heilongjiang, Peoples R China; [Xu, Ling] Minist Hlth, Ctr Hlth Stat & Informat, Beijing, Peoples R China; [Xie, Xin; Wu, Qunhong; Hao, Yanhua; Yin, Hui; Fu, Wenqi; Ning, Ning; Li, Ye; Kang, Zheng; Liu, Guoxiang] Harbin Med Univ, Modern Hlth Management Tech Dev & Applicat Lab, Harbin, Heilongjiang, Peoples R China; [Liu, Chaojie] La Trobe Univ, Sch Publ Hlth, Melbourne, Vic, Australia	Harbin Medical University; Harbin Medical University; Harbin Medical University; La Trobe University	Wu, QH (corresponding author), Harbin Med Univ, Sch Hlth Management, Dept Social Med, Harbin, Heilongjiang, Peoples R China.	wuqunhong@163.com; hyhyjw@126.com	Liu, Chaojie/Q-6915-2018; hao, yan/HGB-0465-2022	Liu, Chaojie/0000-0003-0877-0424; 	Key National Natural Science Fund [71333003]; China Medical Board [09-979]	Key National Natural Science Fund; China Medical Board	This work was supported by the Key National Natural Science Fund (71333003) and the China Medical Board (09-979). Website of Key National Natural Science Fund (71333003): http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list. Website of China Medical Board (09-979):http://chinamedicalboard.org/grants/evaluation_and_capacity_building_chinas_hospital_reform_pilots-09_979. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Zaineh M, 2011, SOC SCI MED, V72, P133, DOI 10.1016/j.socscimed.2010.10.018; Anson O, 2004, HEALTH PLACE, V10, P75, DOI 10.1016/S1353-8292(03)00048-0; Center for Health Statistics and Information of MOH, 2009, AN REP 2008 NAT HLTH; Chinese Diabetes Society, 2012, CHINESE J DIABETES, V20, P1; Chinese National Center for Cardiovascular Diseases, 2011, REP CARD DIS CHIN 20; Chou WL, 2009, HEALTH ECON, V18, pS137, DOI 10.1002/hec.1511; d'Uva TB, 2009, J HEALTH ECON, V28, P280, DOI 10.1016/j.jhealeco.2008.09.008; Fang PQ, 2010, HEALTH POLICY, V94, P14, DOI 10.1016/j.healthpol.2009.08.002; Feng XL, 2012, B WORLD HEALTH ORGAN, V90, P30, DOI 10.2471/BLT.11.090399; Feng XL, 2011, B WORLD HEALTH ORGAN, V89, P432, DOI 10.2471/BLT.10.085274; Feng Xing Lin, 2011, Environmental Health and Preventive Medicine, V16, P209, DOI 10.1007/s12199-010-0187-5; Gao J, 2001, HEALTH POLICY PLANN, V16, P302, DOI 10.1093/heapol/16.3.302; Hajizadeh M, 2012, APPL ECON LETT, V19, P1765, DOI 10.1080/13504851.2012.659337; Hosseinpoor AR, 2006, INT J EPIDEMIOL, V35, P1211, DOI 10.1093/ije/dyl164; Hu J, 2007, CHIN J PREVCONTRCHRO, V15, P189; Hu SL, 2008, LANCET, V372, P1846, DOI 10.1016/S0140-6736(08)61368-9; Hu Z., 2011, CHINA EC Q, V10, P1423; Jian W, 2009, HEALTH AFFAIR, V29, P2189; Jing SS, 2010, CHINESE HLTH EC, V29, P35; Li Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093253; Lisheng L, 2011, ZHONGHUA XIN XUE GUA, P701; Liu C, 2003, CLOSING GAP POLICY R; Liu GG, 2002, SOC SCI MED, V55, P1779, DOI 10.1016/S0277-9536(01)00306-9; Liu S, 2011, PUBLIC HEALTH, V125, P669, DOI 10.1016/j.puhe.2011.08.004; Liu YL, 1999, SOC SCI MED, V49, P1349, DOI 10.1016/S0277-9536(99)00207-5; Lu JFR, 2007, SOC SCI MED, V64, P199, DOI 10.1016/j.socscimed.2006.08.033; Luo JH, 2009, HEALTH POLICY, V93, P111, DOI 10.1016/j.healthpol.2009.06.003; Ma X, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-44; McGrail KM, 2009, AM J PUBLIC HEALTH, V99, P1856, DOI 10.2105/AJPH.2007.129361; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Ministry of Health, 2005, CHIN HLTH STAT DIG 2; Ministry of Health-People's Republic of China, 2010, CHIN HLTH STAT YB 20; Ramesh M, 2008, POLICY SOC, V27, P129, DOI DOI 10.1016/J.POLSOC.2008.09.004; Shi WX, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-7; Shin H, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-17; Somkotra T, 2011, ASIA-PAC J PUBLIC HE, V23, P980, DOI 10.1177/1010539509360674; Song L, 2010, CHINESE MED J-PEKING, V123, P664, DOI 10.3760/cma.j.issn.0366-6999.2010.06.005; State Council, 2012, PLANS DEEP REF HEALT; Sun P, 2012, SOC SCI MED, V74, P84, DOI 10.1016/j.socscimed.2011.10.010; Sun Q, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-42; Sun XJ, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-2; van Doorslaer E, 2004, HEALTH ECON, V13, P629, DOI 10.1002/hec.919; van Doorslaer E, 2003, J HEALTH ECON, V22, P61, DOI 10.1016/S0167-6296(02)00080-2; Van Doorslaer E, 2004, INCOME RELATED INEQU, P109; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; WAGSTAFF A, 1991, J HEALTH ECON, V10, P169, DOI 10.1016/0167-6296(91)90003-6; Wagstaff A, 2003, J ECONOMETRICS, V112, P207, DOI 10.1016/S0304-4076(02)00161-6; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; Wang X, 2010, HUMAN RESOURCES, V8, P51; World Bank, 2006, MEAS IN HLTH SERV DE; World Health Organization, WHO HLTH SYST; Wu ZC, 2012, MATERN CHILD HLTH J, V16, P501, DOI 10.1007/s10995-011-0773-1; Xu J, 2010, J HUAZHONG U SCI-MED, V30, P141, DOI 10.1007/s11596-010-0201-6; Yip W, 2009, SOC SCI MED, V68, P201, DOI 10.1016/j.socscimed.2008.09.066; Yu BR, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-116; Zhang LY, 2010, TROP MED INT HEALTH, V15, P468, DOI 10.1111/j.1365-3156.2010.02469.x; Zhou ZL, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-201	57	40	42	7	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100231	10.1371/journal.pone.0100231	http://dx.doi.org/10.1371/journal.pone.0100231			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7UT	24960168	Green Submitted, Green Published, gold			2022-12-25	WOS:000338633900028
J	Zeng, J; Zhao, DY; Yu, ZB; Huang, R; Wu, QLL				Zeng, Jin; Zhao, Dayong; Yu, Zhongbo; Huang, Rui; Wu, Qinglong L.			Temperature Responses of Ammonia-Oxidizing Prokaryotes in Freshwater Sediment Microcosms	PLOS ONE			English	Article							COMMUNITY STRUCTURE; LAKE TAIHU; ARCHAEA; BACTERIA; DIVERSITY; NITRIFICATION; ABUNDANCE; SOIL; GROWTH; CULTIVATION	In order to investigate the effects of temperature on the abundances and community compositions of ammonia-oxidizing archaea (AOA) and bacteria (AOB), lake microcosms were constructed and incubated at 15 degrees C, 25 degrees C and 35 degrees C for 40 days, respectively. Temperature exhibited different effects on the abundance and diversity of archaeal and bacterial amoA gene. The elevated temperature increased the abundance of archaeal amoA gene, whereas the abundance of bacterial amoA gene decreased. The highest diversity of bacterial amoA gene was found in the 25 degrees C treatment sample. However, the 25 degrees C treatment sample maintained the lowest diversity of archaeal amoA gene. Most of the archaeal amoA sequences obtained in this study affiliated with the Nitrosopumilus cluster. Two sequences obtained from the 15 degrees C treatment samples were affiliated with the Nitrosotalea cluster. N. oligotropha lineage was the most dominant bacterial amoA gene group. Several sequences affiliated to Nitrosospira and undefined N. europaea/NC. mobilis like lineage were found in the pre-incubation and 25 degrees C treatment groups.	[Zeng, Jin; Wu, Qinglong L.] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China; [Zhao, Dayong; Yu, Zhongbo] Hohai Univ, State Key Lab Hydrol Water Resources & Hydraul En, Nanjing, Jiangsu, Peoples R China; [Zhao, Dayong; Yu, Zhongbo; Huang, Rui] Hohai Univ, Coll Hydrol & Water Resources, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Hohai University; Hohai University	Zeng, J (corresponding author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China.	jzeng@niglas.ac.cn	Zeng, Jin/AAQ-7810-2020		National Natural Science Foundation of China [41101052, 31225004, 41371098, U1202231]; Natural Science Foundation of Jiangsu Province, China [BK2011876]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Natural Science Foundation of China (41101052, 31225004, 41371098, U1202231) and Natural Science Foundation of Jiangsu Province, China (BK2011876). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Avrahami S, 2003, ENVIRON MICROBIOL, V5, P691, DOI 10.1046/j.1462-2920.2003.00457.x; Beman JM, 2006, APPL ENVIRON MICROB, V72, P7767, DOI 10.1128/AEM.00946-06; Cao HL, 2011, ANTON LEEUW INT J G, V100, P545, DOI 10.1007/s10482-011-9610-1; Chen GY, 2009, RES MICROBIOL, V160, P173, DOI 10.1016/j.resmic.2009.01.003; Dang HY, 2010, APPL ENVIRON MICROB, V76, P4691, DOI 10.1128/AEM.02563-09; de Bie MJM, 2001, AQUAT MICROB ECOL, V23, P225, DOI 10.3354/ame023225; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; Fierer N, 2009, MICROB ECOL, V58, P435, DOI 10.1007/s00248-009-9517-9; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Hatzenpichler R, 2012, APPL ENVIRON MICROB, V78, P7501, DOI 10.1128/AEM.01960-12; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; Horz HP, 2004, P NATL ACAD SCI USA, V101, P15136, DOI 10.1073/pnas.0406616101; Hou J, 2013, WATER RES, V47, P2285, DOI 10.1016/j.watres.2013.01.042; Jantti H, 2011, AQUAT MICROB ECOL, V63, P171, DOI 10.3354/ame01492; Jia ZJ, 2009, ENVIRON MICROBIOL, V11, P1658, DOI 10.1111/j.1462-2920.2009.01891.x; Jin X., 1990, SURVEY SPECIFICATION, P208; Koops HP, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P778, DOI 10.1007/0-387-30745-1_36; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Lehtovirta-Morley LE, 2011, P NATL ACAD SCI USA, V108, P15892, DOI 10.1073/pnas.1107196108; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Offre P, 2009, FEMS MICROBIOL ECOL, V70, P99, DOI 10.1111/j.1574-6941.2009.00725.x; Park HD, 2004, WATER RES, V38, P3275, DOI 10.1016/j.watres.2004.04.047; Pester M, 2012, ENVIRON MICROBIOL, V14, P525, DOI 10.1111/j.1462-2920.2011.02666.x; Racz L, 2010, BIORESOURCE TECHNOL, V101, P6454, DOI 10.1016/j.biortech.2010.03.058; Reigstad LJ, 2008, FEMS MICROBIOL ECOL, V64, P167, DOI 10.1111/j.1574-6941.2008.00466.x; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Seitzinger SP, 1990, DENITRIFICATION AQUA; Spang A, 2010, TRENDS MICROBIOL, V18, P331, DOI 10.1016/j.tim.2010.06.003; Stark JM, 1996, BIOGEOCHEMISTRY, V35, P433, DOI 10.1007/BF02183035; Starry OS, 2005, J N AM BENTHOL SOC, V24, P753, DOI 10.1899/05-015.1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thamdrup B, 1998, AQUAT MICROB ECOL, V15, P191, DOI 10.3354/ame015191; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Urakawa H, 2008, APPL ENVIRON MICROB, V74, P894, DOI 10.1128/AEM.01529-07; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wu YC, 2013, APPL ENVIRON MICROB, V79, P3076, DOI 10.1128/AEM.00061-13; Wu YC, 2010, ENV MICROBIOL REP, V2, P569, DOI 10.1111/j.1758-2229.2010.00146.x; Zeng J, 2009, WORLD J MICROB BIOT, V25, P225, DOI 10.1007/s11274-008-9883-3; Zeng J, 2012, CAN J MICROBIOL, V58, P1018, DOI [10.1139/w2012-078, 10.1139/W2012-078]; Zhao WD, 2011, GEOMICROBIOL J, V28, P149, DOI 10.1080/01490451003753076	47	26	31	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100653	10.1371/journal.pone.0100653	http://dx.doi.org/10.1371/journal.pone.0100653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959960	Green Submitted, gold, Green Published			2022-12-25	WOS:000338633900067
J	Brown, HM; Knowlton, AE; Snavely, E; Nguyen, BD; Richards, TS; Grieshaber, SS				Brown, Heather M.; Knowlton, Andrea E.; Snavely, Emily; Nguyen, Bidong D.; Richards, Theresa S.; Grieshaber, Scott S.			Multinucleation during C. trachomatis Infections Is Caused by the Contribution of Two Effector Pathways	PLOS ONE			English	Article							INVASIVE CERVICAL-CANCER; CHLAMYDIAL INCLUSION MEMBRANE; INTRAEPITHELIAL NEOPLASIA; RISK-FACTORS; HOST-CELLS; INHIBITION; DEFECTS; WOMEN; ABNORMALITIES; GRISEOFULVIN	Chlamydia trachomatis is an obligate intracellular bacterial pathogen and the second leading cause of sexually transmitted infections in the US. Infections cause significant morbidity and can lead to serious reproductive sequelae, including an epidemiological link to increased rates of reproductive cancers. One of the overt changes that infected cells exhibit is the development of genomic instability leading to multinucleation. Here we demonstrate that the induction of multinucleation is not conserved equally across chlamydial species; C. trachomatis L2 caused high levels of multinucleation, C. muridarum intermediate levels, and C. caviae had very modest effects on multinucleation. Our data show that at least two effector pathways together cause genomic instability during infection leading to multinucleation. We find that the highly conserved chlamydial protease CPAF is a key effector for one of these pathways. CPAF secretion is required for the loss of centrosome duplication regulation as well as inducing early mitotic exit. The second effector pathway involves the induction of centrosome position errors. This function is not conserved in three chlamydial species tested. Together these two pathways contribute to the induction of high levels of genomic instability and multinucleation seen in C. trachomatis infections.	[Brown, Heather M.; Knowlton, Andrea E.; Richards, Theresa S.; Grieshaber, Scott S.] Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA; [Snavely, Emily; Nguyen, Bidong D.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Ctr Microbial Pathogenesis, Durham, NC USA	State University System of Florida; University of Florida; Duke University	Grieshaber, SS (corresponding author), Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA.	sgriesha@ufl.edu	Brown-Harding, Heather/GRF-0385-2022	Brown-Harding, Heather/0000-0001-9636-2345	NIAID, NIH [R01 AI077583]; NIDCR, NIH [T32 DE007200, T90 DE021990]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007200] Funding Source: NIH RePORTER	NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors would like to acknowledge the NIAID, NIH for funding this work from the grant R01 AI077583 Grieshaber (PI). HB and AK were supported by fellowships from the NIDCR, NIH, T32 DE007200 and T90 DE021990. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibek K, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-35; Anttila T, 2001, JAMA-J AM MED ASSOC, V285, P47, DOI 10.1001/jama.285.1.47; Bannantine JP, 2000, CELL MICROBIOL, V2, P35; Brown HM, 2012, CELL MICROBIOL, V14, P1554, DOI 10.1111/j.1462-5822.2012.01820.x; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; CATES W, 1991, AM J OBSTET GYNECOL, V164, P1771, DOI 10.1016/0002-9378(91)90559-A; Chen D, 2010, MICROBIOL-SGM, V156, P3031, DOI 10.1099/mic.0.040527-0; Barros NKD, 2012, J MED VIROL, V84, P1143, DOI 10.1002/jmv.23312; Deluca GD, 2011, BRAZ J INFECT DIS, V15, P567, DOI 10.1016/S1413-8670(11)70252-5; Greene W, 2003, J INFECTION, V47, P45, DOI 10.1016/S0163-4453(03)00039-2; Grieshaber SS, 2006, TRAFFIC, V7, P940, DOI 10.1111/j.1600-0854.2006.00439.x; GUPTA PK, 1979, ACTA CYTOL, V23, P315; Hinkula M, 2004, BRIT J CANCER, V90, P1025, DOI 10.1038/sj.bjc.6601650; Huang ZW, 2008, CELL HOST MICROBE, V4, P529, DOI 10.1016/j.chom.2008.10.005; Knowlton AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054022; Knowlton AE, 2011, TRAFFIC, V12, P854, DOI 10.1111/j.1600-0854.2011.01204.x; Koskela P, 2000, INT J CANCER, V85, P35, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;35::AID-IJC6&gt;3.0.CO;2-A; Kramer A, 2008, CELL ONCOL, V30, P505, DOI 10.3233/CLO-2008-0450; Lehtinen M, 2011, SEX TRANSM INFECT, V87, P372, DOI 10.1136/sti.2010.044354; Luostarinen T, 2013, INT J CANCER, V133, P1756, DOI 10.1002/ijc.28173; Madeleine MM, 2007, INT J CANCER, V120, P650, DOI 10.1002/ijc.22325; Matsumoto K, 2003, BRIT J CANCER, V89, P831, DOI 10.1038/sj.bjc.6601220; Mital J, 2010, CELL MICROBIOL, V12, P1235, DOI 10.1111/j.1462-5822.2010.01465.x; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Nguyen BD, 2012, P NATL ACAD SCI USA, V109, P1263, DOI 10.1073/pnas.1117884109; Peitsidis P, 2012, BRATISL MED J, V113, P357, DOI 10.4149/BLL_2012_081; Pihan G, 2003, CANCER CELL, V4, P89, DOI 10.1016/S1535-6108(03)00195-8; Pihan GA, 1998, CANCER RES, V58, P3974; Read TD, 2003, NUCLEIC ACIDS RES, V31, P2134, DOI 10.1093/nar/gkg321; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Read TD, 2013, MBIO, V4, DOI 10.1128/mBio.00604-12; Rebacz B, 2007, CANCER RES, V67, P6342, DOI 10.1158/0008-5472.CAN-07-0663; Ronnest MH, 2009, J MED CHEM, V52, P3342, DOI 10.1021/jm801517j; Samaras V, 2010, J INFECT DEV COUNTR, V4, P267, DOI 10.3855/jidc.819; Seda J, 2011, P R HEALTH SCI J, V30, P14; Smith JS, 2004, INT J CANCER, V111, P431, DOI 10.1002/ijc.20257; Smith JS, 2002, J INFECT DIS, V185, P324, DOI 10.1086/338569; Sun HS, 2011, MOL CELL BIOL, V31, P5011, DOI 10.1128/MCB.05734-11; Wallin KL, 2002, INT J CANCER, V101, P371, DOI 10.1002/ijc.10639; World Health Organization, OV EST, P1; Zhang WH, 2011, CANCER-AM CANCER SOC, V117, P4092, DOI 10.1002/cncr.26021	41	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100763	10.1371/journal.pone.0100763	http://dx.doi.org/10.1371/journal.pone.0100763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955832	gold, Green Published, Green Submitted			2022-12-25	WOS:000338917900093
J	Demaegd, D; Colinet, AS; Deschamps, A; Morsomme, P				Demaegd, Didier; Colinet, Anne-Sophie; Deschamps, Antoine; Morsomme, Pierre			Molecular Evolution of a Novel Family of Putative Calcium Transporters	PLOS ONE			English	Article							X-RAY-STRUCTURE; MEMBRANE-PROTEINS; NA+/H+ ANTIPORTER; SEQUENCE; YEAST; GENE; HOMEOSTASIS; POLYPLOIDY; PREDICTION; EXCHANGER	The UPF0016 family is a group of uncharacterized membrane proteins, well conserved through evolution and defined by the presence of one or two copies of an E-Phi-G-D-(KR)-(ST) consensus motif. Our previous results have shown that two members of this family, the human TMEM165 and the budding yeast Gdt1p, are functionally related and might form a new group of cationCa(2+) exchangers. Most members of the family are made of two homologous clusters of three transmembrane spans, separated by a central loop and assembled with an opposite orientation in the membrane. However, some bacterial members of the family have only one cluster of transmembrane domains. Among these 'single-domain membrane proteins' some cyanobacterial members were found as pairs of adjacent genes within the genome, but each gene was slightly different. We performed a bioinformatic analysis to propose the molecular evolution of the UPF0016 family and the emergence of the antiparallel topology. Our hypotheses were confirmed experimentally using functional complementation in yeast. This suggests an important and conserved function for UPF0016 proteins in a fundamental cellular process. We also show that members of the UPF0016 family share striking similarities, but no primary sequence homology, with members of the cation/Ca2+ exchangers (CaCA) superfamily. Such similarities could be an example of convergent evolution, supporting the previous hypothesis that members of the UPF0016 family are cation/Ca2+ exchangers.	[Demaegd, Didier; Colinet, Anne-Sophie; Deschamps, Antoine; Morsomme, Pierre] Catholic Univ Louvain, Inst Sci Vie, Louvain La Neuve, Belgium	Universite Catholique Louvain	Morsomme, P (corresponding author), Catholic Univ Louvain, Inst Sci Vie, Louvain La Neuve, Belgium.	pierre.morsomme@uclouvain.be	Morsomme, Pierre/AAD-9600-2019	Morsomme, Pierre/0000-0001-7780-7230	Belgian National Fund for Scientific Research (FNRS); Communaute francaise de Belgique-Actions de Recherches Concertees	Belgian National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Communaute francaise de Belgique-Actions de Recherches Concertees	The work was supported by grants from the Belgian National Fund for Scientific Research (FNRS) and the "Communaute francaise de Belgique-Actions de Recherches Concertees". DD and ASC are research fellows at the "Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEIJON C, 1989, P NATL ACAD SCI USA, V86, P6935, DOI 10.1073/pnas.86.18.6935; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Cui JJ, 2009, FEMS YEAST RES, V9, P1137, DOI 10.1111/j.1567-1364.2009.00552.x; Demaegd D, 2013, P NATL ACAD SCI USA, V110, P6859, DOI 10.1073/pnas.1219871110; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hodgkin J, 2000, NATURE, V404, P442, DOI 10.1038/35006526; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; IVEY DM, 1993, J BIOL CHEM, V268, P11296; Kapp K., 2009, PROTEIN TRANSPORT EN, P1; Lolkema JS, 2008, J MOL BIOL, V378, P596, DOI 10.1016/j.jmb.2008.03.005; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nugent T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-169; PERSSON B, 1994, J MOL BIOL, V237, P182, DOI 10.1006/jmbi.1994.1220; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pittman JK, 2011, CELL CALCIUM, V50, P139, DOI 10.1016/j.ceca.2011.01.004; Poolman B, 2007, SCIENCE, V315, P1229, DOI 10.1126/science.1140073; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Reinhardt TA, 2014, BIOCH BIOPHYS RES CO; Rosnoblet C, 2013, HUM MOL GENET, V22, P2914, DOI 10.1093/hmg/ddt146; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Veitia RA, 2005, PLANT CELL, V17, P4, DOI 10.1105/tpc.104.170130; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Waight AB, 2013, NATURE, V499, P107, DOI 10.1038/nature12233; Wong S, 2002, P NATL ACAD SCI USA, V99, P9272, DOI 10.1073/pnas.142101099; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	37	40	41	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100851	10.1371/journal.pone.0100851	http://dx.doi.org/10.1371/journal.pone.0100851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955841	Green Published, Green Submitted, gold			2022-12-25	WOS:000338917900102
J	Sim, M; Lim, B; Sim, SH; Kim, D; Jung, E; Lee, Y; Lee, K				Sim, Minji; Lim, Boram; Sim, Se-Hoon; Kim, Daeyoung; Jung, Euihan; Lee, Younghoon; Lee, Kangseok			Two Tandem RNase III Cleavage Sites Determine betT mRNA Stability in Response to Osmotic Stress in Escherichia coli	PLOS ONE			English	Article							GLYCINE BETAINE PATHWAY; SALMONELLA-TYPHIMURIUM; RIBONUCLEASE-III; TRANSPORT-SYSTEM; RIBOSOMAL-RNA; CHOLINE; DEGRADATION; EXPRESSION; GENES; PRODUCTS	While identifying genes regulated by ribonuclease III (RNase III) in Escherichia coli, we observed that steady-state levels of betT mRNA, which encodes a transporter mediating the influx of choline, are dependent on cellular concentrations of RNase III. In the present study, we also observed that steady-state levels of betT mRNA are dependent on RNase III activity upon exposure to osmotic stress, indicating the presence of cis-acting elements controlled by RNase III in betT mRNA. Primer extension analyses of betT mRNA revealed two tandem RNase III cleavage sites in its stem-loop region, which were biochemically confirmed via in vitro cleavage assays. Analyses of cleavage sites suggested the stochastic selection of cleavage sites by RNase III, and mutational analyses indicated that RNase III cleavage at either site individually is insufficient for efficient betT mRNA degradation. In addition, both the half-life and abundance of betT mRNA were significantly increased in association with decreased RNase III activity under hyper-osmotic stress conditions. Our findings demonstrate that betT mRNA stability is controlled by RNase III at the post-transcriptional level under conditions of osmotic stress.	[Sim, Minji; Lim, Boram; Sim, Se-Hoon; Kim, Daeyoung; Lee, Kangseok] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea; [Jung, Euihan; Lee, Younghoon] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea	Chung Ang University; Korea Advanced Institute of Science & Technology (KAIST)	Lee, K (corresponding author), Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea.	kangseok@cau.ac.kr	Lee, Younghoon/C-1991-2011	Lee, Younghoon/0000-0002-3841-719X	National Research Foundation of Korea [2010-0029167, 2011-0028553]; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea (SSAC) [PJ009025]	National Research Foundation of Korea(National Research Foundation of Korea); Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea (SSAC)	This work was supported by the National Research Foundation of Korea (2010-0029167 to Y Lee and 2011-0028553 to K Lee) and the Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea (SSAC, PJ009025 to K Lee). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasinghe AK, 2001, METHOD ENZYMOL, V342, P143, DOI 10.1016/S0076-6879(01)42542-0; ANDRESEN PA, 1988, J GEN MICROBIOL, V134, P1737; CAIRNEY J, 1985, J BACTERIOL, V164, P1218, DOI 10.1128/JB.164.3.1218-1223.1985; CAIRNEY J, 1985, J BACTERIOL, V164, P1224, DOI 10.1128/JB.164.3.1224-1232.1985; Court DL, 2013, ANNU REV GENET, V47, P405, DOI 10.1146/annurev-genet-110711-155618; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DUNN JJ, 1976, J BIOL CHEM, V251, P3807; Gravenbeek ML, 2008, MICROBIOL-SGM, V154, P3547, DOI 10.1099/mic.0.2008/022095-0; Kavalchuk K, 2012, RNA BIOL, V9, P98, DOI 10.4161/rna.9.1.18228; Kim KS, 2005, J BIOL CHEM, V280, P34667, DOI 10.1074/jbc.M505005200; Kim KS, 2008, GENE DEV, V22, P3497, DOI 10.1101/gad.1729508; LAMARK T, 1991, MOL MICROBIOL, V5, P1049, DOI 10.1111/j.1365-2958.1991.tb01877.x; LAMARK T, 1992, FEMS MICROBIOL LETT, V96, P149; Lamark T, 1996, J BACTERIOL, V178, P1655, DOI 10.1128/jb.178.6.1655-1662.1996; LANDFALD B, 1986, J BACTERIOL, V165, P849, DOI 10.1128/jb.165.3.849-855.1986; Lee K, 2001, J NUTR, V131, p2994S, DOI 10.1093/jn/131.11.2994S; Lee KS, 1997, J MOL BIOL, V269, P732, DOI 10.1006/jmbi.1997.1092; Lim B, 2014, CURR MICROBIOL, V68, P518, DOI 10.1007/s00284-013-0504-5; Lim B, 2012, J BACTERIOL, V194, P2214, DOI 10.1128/JB.00099-12; Matsunaga J, 1997, MOL MICROBIOL, V26, P1125, DOI 10.1046/j.1365-2958.1997.6652007.x; Matsunaga J, 1996, MOL MICROBIOL, V22, P977, DOI 10.1046/j.1365-2958.1996.01529.x; MAYER JE, 1983, J BIOL CHEM, V258, P5340; Miller JH., 1972, EXPT MOL GENETICS; Sim SH, 2010, MOL MICROBIOL, V75, P413, DOI 10.1111/j.1365-2958.2009.06986.x; Song W, 2014, NUCLEIC ACIDS RES, V42, P4669, DOI 10.1093/nar/gku093; STYRVOLD OB, 1986, J BACTERIOL, V165, P856, DOI 10.1128/jb.165.3.856-863.1986; Tondervik A, 2007, MICROBIOL-SGM, V153, P803, DOI 10.1099/mic.0.2006/003608-0; Wood Janet M, 2006, Sci STKE, V2006, ppe43; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230, DOI 10.1128/MMBR.63.1.230-262.1999; Xiao JP, 2009, RNA, V15, P984, DOI 10.1261/rna.1196509; Yeom JH, 2008, FEMS MICROBIOL LETT, V285, P10, DOI 10.1111/j.1574-6968.2008.01205.x; Yeom JH, 2006, BIOCHEM BIOPH RES CO, V345, P1372, DOI 10.1016/j.bbrc.2006.05.018; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	34	15	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100520	10.1371/journal.pone.0100520	http://dx.doi.org/10.1371/journal.pone.0100520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956275	Green Published, Green Submitted, gold			2022-12-25	WOS:000338917900061
J	Sollai, G; Barbarossa, IT; Masala, C; Solari, P; Crnjar, R				Sollai, Giorgia; Barbarossa, Iole Tomassini; Masala, Carla; Solari, Paolo; Crnjar, Roberto			Gustatory Sensitivity and Food Acceptance in Two Phylogenetically Closely Related Papilionid Species: Papilio hospiton and Papilio machaon	PLOS ONE			English	Article							BITTER TASTE STIMULI; HOST RECOGNITION CUE; HELICOVERPA-ARMIGERA; RECEPTOR NEURONS; MANDUCA-SEXTA; POLYPHAGOUS CATERPILLAR; PYRROLIZIDINE ALKALOIDS; CONTACT CHEMORECEPTION; LEPIDOPTEROUS LARVAE; PLANT-CHEMICALS	In herbivorous insects, food selection depends on sensitivity to specific chemical stimuli from host-plants as well as to secondary metabolites (bitter) and to sugars (phagostimulatory). Bitter compounds are noxious, unpalatable or both and evoke an aversive feeding response. Instead, sugars and sugar alcohols play a critical role in determining and enhancing the palatability of foods. We assumed that peripheral taste sensitivity may be related to the width of the host selection. Our model consists of two closely phylogenetically related Papilionid species exhibiting a difference in host plant choice: Papilio hospiton and Papilio machaon. The spike activity of the lateral and medial maxillary styloconic taste sensilla was recorded following stimulation with several carbohydrates, nicotine and NaCl, with the aim of characterizing their gustatory receptor neurons and of comparing their response patterns in the light of their different acceptability in feeding behaviour. The results show that: a) each sensillum houses phagostimulant and phagodeterrent cells; b) the spike activity of the gustatory neurons in response to different taste stimuli is higher in P. hospiton than in P. machaon; c) sugar solutions inhibit the spike activity of the deterrent and salt cells, and the suppression is higher in P. machaon than in P. hospiton. In conclusion, we propose that the different balance between the phagostimulant and phagodeterrent inputs from GRNs of maxillary sensilla may contribute in determining the difference in food choice and host range.	[Sollai, Giorgia; Barbarossa, Iole Tomassini; Masala, Carla; Solari, Paolo; Crnjar, Roberto] Univ Cagliari, Dept Biomed Sci, Physiol Sect, Cagliari, Italy	University of Cagliari	Crnjar, R (corresponding author), Univ Cagliari, Dept Biomed Sci, Physiol Sect, Cagliari, Italy.	crnjar@unica.it	SOLLAI, GIORGIA/AAR-1130-2021; Masala, Carla/L-1373-2015	SOLLAI, GIORGIA/0000-0001-7341-582X; Masala, Carla/0000-0001-5272-8421; TOMASSINI BARBAROSSA, IOLE/0000-0002-2849-4052; /0000-0001-8785-1438	Regione Autonoma della Sardegna [CRP-59859]; Fondazione Banco di Sardegna [2012/0245]	Regione Autonoma della Sardegna(Regione Sardegna); Fondazione Banco di Sardegna(Fondazione Banco di Sardegna)	This work was supported by the Regione Autonoma della Sardegna [grant number CRP-59859], and the Fondazione Banco di Sardegna [grant number 2012/0245]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernays EA, 2004, J INSECT PHYSIOL, V50, P1113, DOI 10.1016/j.jinsphys.2004.09.006; Bernays EA, 2000, J CHEM ECOL, V26, P547, DOI 10.1023/A:1005430010314; Bernays EA, 2003, J EXP BIOL, V206, P4487, DOI 10.1242/jeb.00705; Bernays EA, 2000, J COMP PHYSIOL A, V186, P13, DOI 10.1007/s003590050002; Bernays EA, 2001, J INSECT PHYSIOL, V47, P1029, DOI 10.1016/S0022-1910(01)00079-8; Caicedo A, 2002, J PHYSIOL-LONDON, V544, P501, DOI 10.1113/jphysiol.2002.027862; Chapman RF, 2003, J COMP PHYSIOL A, V189, P833, DOI 10.1007/s00359-003-0461-8; Chapman RF, 2003, ANNU REV ENTOMOL, V48, P455, DOI 10.1146/annurev.ento.48.091801.112629; Cocco N, 2012, J EXP BIOL, V215, P1412, DOI 10.1242/jeb.059832; del Campo ML, 2003, J EXP BIOL, V206, P3979, DOI 10.1242/jeb.00626; DETHIER VG, 1973, J COMP PHYSIOL, V82, P103, DOI 10.1007/BF00696148; DETHIER VG, 1982, J GEN PHYSIOL, V79, P549, DOI 10.1085/jgp.79.4.549; DETHIER VG, 1971, Z VERGL PHYSIOL, V72, P343, DOI 10.1007/BF00300708; DETHIER VG, 1977, AM SCI, V65, P744; Dethier VG, 1976, HUNGRY FLY; Dolzer J, 2003, J EXP BIOL, V206, P1575, DOI 10.1242/jeb.00302; Dolzer J, 2001, J EXP BIOL, V204, P2781; Dulcis D, 2005, J NEUROSCI, V25, P271, DOI 10.1523/JNEUROSCI.2906-04.2005; EVANS DR, 1962, J GEN PHYSIOL, V45, P487, DOI 10.1085/jgp.45.3.487; Flecke C, 2006, J EXP BIOL, V209, P3898, DOI 10.1242/jeb.02432; Glendinning JI, 1999, J EXP BIOL, V202, P2091; Glendinning JI, 2000, J EXP BIOL, V203, P1299; Glendinning JI, 1996, J EXP BIOL, V199, P1523; Glendinning JI, 1997, J NEUROPHYSIOL, V78, P734, DOI 10.1152/jn.1997.78.2.734; Glendinning JI, 2001, J NEUROSCI, V21, P3688, DOI 10.1523/JNEUROSCI.21-10-03688.2001; Glendinning JI, 2001, J EXP BIOL, V204, P3355; Glendinning JI, 2007, J EXP BIOL, V210, P3054, DOI 10.1242/jeb.004671; Glendinning JI, 2006, J NEUROSCI, V26, P8900, DOI 10.1523/JNEUROSCI.2351-06.2006; Glendinning JI, 2009, J COMP PHYSIOL A, V195, P591, DOI 10.1007/s00359-009-0434-7; GRISS C, 1991, J INSECT PHYSIOL, V37, P477, DOI 10.1016/0022-1910(91)90023-S; Hiroi M, 2004, J NEUROBIOL, V61, P333, DOI 10.1002/neu.20063; Hiroi M, 2002, ZOOL SCI, V19, P1009, DOI 10.2108/zsj.19.1009; HODGSON ES, 1955, SCIENCE, V122, P417, DOI 10.1126/science.122.3166.417-a; Inoue T, 2009, NATURWISSENSCHAFTEN, V96, P355, DOI 10.1007/s00114-008-0483-8; ISHIKAWA S, 1963, J CELL COMPAR PHYSL, V61, P99, DOI 10.1002/jcp.1030610111; Ishimaru Y, 2009, ODONTOLOGY, V97, P1, DOI 10.1007/s10266-008-0095-y; Jorgensen K, 2006, J COMP NEUROL, V496, P121, DOI 10.1002/cne.20908; Miles CI, 2005, J COMP PHYSIOL A, V191, P147, DOI 10.1007/s00359-004-0580-x; Mitchell BK, 1999, MICROSC RES TECHNIQ, V47, P401, DOI 10.1002/(SICI)1097-0029(19991215)47:6<401::AID-JEMT4>3.0.CO;2-7; Munch D, 2013, CHEM SENSES, V38, P293, DOI 10.1093/chemse/bjs138; Murphy SM, 2006, ECOL MONOGR, V76, P399, DOI 10.1890/0012-9615(2006)076[0399:CFOANO]2.0.CO;2; Oka Y, 2013, NATURE, V494, P472, DOI 10.1038/nature11905; Pezier A, 2007, CHEM SENSES, V32, P305, DOI 10.1093/chemse/bjl059; ROWELL CHF, 1992, J INSECT PHYSIOL, V38, P475, DOI 10.1016/0022-1910(92)90072-L; Ryuda M, 2013, J NEUROSCI, V33, P914, DOI 10.1523/JNEUROSCI.1405-12.2013; Schoonhoven LM, 2002, ACTA ZOOL ACAD SCI H, V48, P215; SIMMONDS MSJ, 1991, ENTOMOL EXP APPL, V61, P73, DOI 10.1007/BF00367170; SIMMONDS MSJ, 1991, SYMP BIOL HUNG, V39, P17; SMITH JJB, 1990, CHEM SENSES, V15, P253, DOI 10.1093/chemse/15.3.253; Sollai G, 2012, J INSECT PHYSIOL, V58, P1686, DOI 10.1016/j.jinsphys.2012.10.010; Su CY, 2012, NATURE, V492, P66, DOI 10.1038/nature11712; Tang DL, 2000, SCI CHINA SER C, V43, P606, DOI 10.1007/BF02882281; Tepper BJ, 2008, ANNU REV NUTR, V28, P367, DOI 10.1146/annurev.nutr.28.061807.155458; van Loon JJA, 1999, ENTOMOL EXP APPL, V91, P29, DOI 10.1046/j.1570-7458.1999.00463.x; WIKLUND C, 1975, OECOLOGIA, V18, P185, DOI 10.1007/BF00345421; Wilkie L, 2013, CHEMOSENS PERCEPT, V6, P127, DOI 10.1007/s12078-013-9151-2; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Zakharov EV, 2004, SYST BIOL, V53, P193, DOI 10.1080/10635150490423403; Zhang HJ, 2013, J CHEM ECOL, V39, P1070, DOI 10.1007/s10886-013-0303-2; Zhang YF, 2010, J EXP BIOL, V213, P2889, DOI 10.1242/jeb.042705; Zhou DS, 2009, J INSECT PHYSIOL, V55, P788, DOI 10.1016/j.jinsphys.2009.04.011; Zhou DS, 2010, J COMP PHYSIOL A, V196, P791, DOI 10.1007/s00359-010-0558-9	62	22	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100675	10.1371/journal.pone.0100675	http://dx.doi.org/10.1371/journal.pone.0100675			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956387	Green Submitted, Green Published, gold			2022-12-25	WOS:000338917900080
J	Aoude, LG; Xu, M; Zhao, ZZ; Kovacs, M; Palmer, JM; Johansson, P; Symmons, J; Trent, JM; Martin, NG; Montgomery, GW; Brown, KM; Hayward, NK				Aoude, Lauren G.; Xu, Mai; Zhao, Zhen Zhen; Kovacs, Michael; Palmer, Jane M.; Johansson, Peter; Symmons, Judith; Trent, Jeffrey M.; Martin, Nicholas G.; Montgomery, Grant W.; Brown, Kevin M.; Hayward, Nicholas K.			Assessment of PALB2 as a Candidate Melanoma Susceptibility Gene	PLOS ONE			English	Article							ONSET BREAST-CANCER; BRCA2-INTERACTING PROTEIN PALB2; PANCREATIC-CANCER; FANCONI-ANEMIA; GERMLINE MUTATIONS; PREVALENCE; PARTNER	Partner and localizer of BRCA2 (PALB2) interacts with BRCA2 to enable double strand break repair through homologous recombination. Similar to BRCA2, germline mutations in PALB2 have been shown to predispose to Fanconi anaemia as well as pancreatic and breast cancer. The PALB2/BRCA2 protein interaction, as well as the increased melanoma risk observed in families harbouring BRCA2 mutations, makes PALB2 a candidate for melanoma susceptibility. In order to assess PALB2 as a melanoma predisposition gene, we sequenced the entire protein-coding sequence of PALB2 in probands from 182 melanoma families lacking pathogenic mutations in known high penetrance melanoma susceptibility genes: CDKN2A, CDK4, and BAP1. In addition, we interrogated whole-genome and exome data from another 19 kindreds with a strong family history of melanoma for deleterious mutations in PALB2. Here we report a rare known deleterious PALB2 mutation (rs118203998) causing a premature truncation of the protein (p. Y1183X) in an individual who had developed four different cancer types, including melanoma. Three other family members affected with melanoma did not carry the variant. Overall our data do not support a case for PALB2 being associated with melanoma predisposition.	[Aoude, Lauren G.; Zhao, Zhen Zhen; Palmer, Jane M.; Johansson, Peter; Symmons, Judith; Martin, Nicholas G.; Montgomery, Grant W.; Hayward, Nicholas K.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Aoude, Lauren G.] Univ Queensland, Brisbane, Qld, Australia; [Xu, Mai; Kovacs, Michael; Brown, Kevin M.] NCI, Bethesda, MD 20892 USA; [Trent, Jeffrey M.; Brown, Kevin M.] Translat Genom Res Inst, Phoenix, AZ USA	QIMR Berghofer Medical Research Institute; University of Queensland; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Translational Genomics Research Institute	Aoude, LG (corresponding author), QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.	Lauren.Aoude@qimrberghofer.edu.au	hayward, nicholas k/C-1367-2015; Johansson, Peter A/K-1053-2014; Montgomery, Grant W/B-7148-2008; hayward, nick/AAV-8802-2020; Aoude, Lauren/C-7484-2014; Martin, Nicholas/R-9235-2019	hayward, nicholas k/0000-0003-4760-1033; Johansson, Peter A/0000-0001-7015-5452; Montgomery, Grant W/0000-0002-4140-8139; Aoude, Lauren/0000-0003-1448-3923; Martin, Nicholas/0000-0003-4069-8020	Melanoma Research Alliance; National Health and Medical Research Council (NHMRC) of Australia; NHMRC; Australia and New Zealand Banking Group Limited Trustees PhD scholarship; Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA; NATIONAL CANCER INSTITUTE [ZIACP010201] Funding Source: NIH RePORTER	Melanoma Research Alliance; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australia and New Zealand Banking Group Limited Trustees PhD scholarship; Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Melanoma Research Alliance and the National Health and Medical Research Council (NHMRC) of Australia. NKH and GWM receive salary support through a NHMRC Senior Principal Research Fellowship. LGA receives salary support by the Australia and New Zealand Banking Group Limited Trustees PhD scholarship. KMB is supported by the Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken JF, 1996, MELANOMA RES, V6, P155, DOI 10.1097/00008390-199604000-00011; Blanco A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067538; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Cao AY, 2009, BREAST CANCER RES TR, V114, P457, DOI 10.1007/s10549-008-0036-z; Casadei S, 2011, CANCER RES, V71, P2222, DOI 10.1158/0008-5472.CAN-10-3958; Catucci I, 2012, FAM CANCER, V11, P483, DOI 10.1007/s10689-012-9540-8; Dansonka-Mieszkowska A, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-20; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Foulkes WD, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1828; Garcia MJ, 2009, BREAST CANCER RES TR, V113, P545, DOI 10.1007/s10549-008-9945-0; Ghadirian P, 2009, CLIN GENET, V76, P421, DOI 10.1111/j.1399-0004.2009.01277.x; Goldstein AM, 2006, CANCER RES, V66, P9818, DOI 10.1158/0008-5472.CAN-06-0494; Hellebrand H, 2011, HUM MUTAT, V32, pE2176, DOI 10.1002/humu.21478; Hofstatter EW, 2011, FAM CANCER, V10, P225, DOI 10.1007/s10689-011-9426-1; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McGregor B, 1999, GENET EPIDEMIOL, V16, P40, DOI 10.1002/(SICI)1098-2272(1999)16:1<40::AID-GEPI4>3.3.CO;2-T; Moran A, 2012, FAM CANCER, V11, P235, DOI 10.1007/s10689-011-9506-2; Papi L, 2010, FAM CANCER, V9, P181, DOI 10.1007/s10689-009-9295-z; Peterlongo P, 2011, BREAST CANCER RES TR, V126, P825, DOI 10.1007/s10549-010-1305-1; Phuah SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073638; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Sabbaghian N, 2011, FAM CANCER, V10, P315, DOI 10.1007/s10689-010-9405-y; Slater EP, 2010, CLIN GENET, V78, P490, DOI 10.1111/j.1399-0004.2010.01425.x; Sluiter M, 2009, FAM CANCER, V8, P347, DOI 10.1007/s10689-009-9241-0; Stadler ZK, 2011, J MED GENET, V48, P523, DOI 10.1136/jmg.2010.087379; Teo ZL, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3392; Tischkowitz M, 2012, HUM MUTAT; Tischkowitz M, 2008, PROSTATE, V68, P675, DOI 10.1002/pros.20729; Tischkowitz MD, 2009, GASTROENTEROLOGY, V137, P1183, DOI 10.1053/j.gastro.2009.06.055; Wiesner T, 2012, J CLIN ONCOL, V30, pE337, DOI 10.1200/JCO.2011.41.2965; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yang XHR, 2011, FAM CANCER, V10, P545, DOI 10.1007/s10689-011-9447-9; Zheng YL, 2012, CANCER-AM CANCER SOC, V118, P1362, DOI 10.1002/cncr.26388	36	11	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100683	10.1371/journal.pone.0100683	http://dx.doi.org/10.1371/journal.pone.0100683			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949998	gold, Green Submitted, Green Published			2022-12-25	WOS:000338276300107
J	Gaikwad, KB; Singh, N; Bhatia, D; Kaur, R; Bains, NS; Bharaj, TS; Singh, K				Gaikwad, Kiran B.; Singh, Naveen; Bhatia, Dharminder; Kaur, Rupinder; Bains, Navtej S.; Bharaj, Tajinder S.; Singh, Kuldeep			Yield-Enhancing Heterotic QTL Transferred from Wild Species to Cultivated Rice Oryza sativa L.	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ADVANCED BACKCROSS POPULATION; INTROGRESSION LINES; RUFIPOGON GRIFF.; MORPHOLOGICAL TRAITS; GENETIC-STRUCTURE; AGRONOMIC TRAITS; O-RUFIPOGON; IDENTIFICATION; COMPONENTS	Utilization of "hidden genes" from wild species has emerged as a novel option for enrichment of genetic diversity for productivity traits. In rice we have generated more than 2000 lines having introgression from 'A' genome-donor wild species of rice in the genetic background of popular varieties PR114 and Pusa44 were developed. Out of these, based on agronomic acceptability, 318 lines were used for developing rice hybrids to assess the effect of introgressions in heterozygous state. These introgression lines and their recurrent parents, possessing fertility restoration ability for wild abortive (WA) cytoplasm, were crossed with cytoplasmic male sterile (CMS) line PMS17A to develop hybrids. Hybrids developed from recurrent parents were used as checks to compare the performance of 318 hybrids developed by hybridizing alien introgression lines with PMS17A. Seventeen hybrids expressed a significant increase in yield and its component traits over check hybrids. These 17 hybrids were re-evaluated in large-size replicated plots. Of these, four hybrids, viz., ILH299, ILH326, ILH867 and ILH901, having introgressions from O. rufipogon and two hybrids (ILH921 and ILH951) having introgressions from O. nivara showed significant heterosis over parental introgression line, recurrent parents and check hybrids for grain yield-related traits. Alien introgressions were detected in the lines taken as male parents for developing six superior hybrids, using a set of 100 polymorphic simple sequence repeat (SSR) markers. Percent introgression showed a range of 2.24 from in O. nivara to 7.66 from O. rufipogon. The introgressed regions and their putative association with yield components in hybrids is reported and discussed.	[Gaikwad, Kiran B.; Singh, Naveen; Bhatia, Dharminder; Kaur, Rupinder; Bains, Navtej S.; Bharaj, Tajinder S.] Punjab Agr Univ, Dept Plant Breeding & Genet, Ludhiana 141004, Punjab, India; [Singh, Kuldeep] Punjab Agr Univ, Sch Agr Biotechnol, Ludhiana 141004, Punjab, India	Punjab Agricultural University; Punjab Agricultural University	Singh, K (corresponding author), Punjab Agr Univ, Sch Agr Biotechnol, Ludhiana 141004, Punjab, India.	kuldeep35@pau.edu		Bhatia, Dharminder/0000-0001-6088-3886; Gaikwad, Kiran/0000-0002-9076-8640; Singh, Kuldeep/0000-0001-5239-6586	Dept. Biotechnology, Ministry of Science and Technology, Govt. of India [BT PR2159/AGR/07/107/2000]	Dept. Biotechnology, Ministry of Science and Technology, Govt. of India	This project was supported by Dept. Biotechnology, Ministry of Science and Technology, Govt. of India vide its grant no. BT PR2159/AGR/07/107/2000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluko G, 2004, THEOR APPL GENET, V109, P630, DOI 10.1007/s00122-004-1668-y; [Anonymous], SPAR 2 0 STAT PACK A; Bhasin H, 2012, MOL BREEDING, V30, P607, DOI 10.1007/s11032-011-9646-y; Brondani C, 2002, THEOR APPL GENET, V104, P1192, DOI 10.1007/s00122-002-0869-5; Cheema KK, 2008, EUPHYTICA, V160, P401, DOI 10.1007/s10681-007-9560-x; Chen ZW, 2009, BREEDING SCI, V59, P441, DOI 10.1270/jsbbs.59.441; [邓启云 Deng Qiyun], 2004, [杂交水稻, Hybrid Rice], V19, P6; ESHED Y, 1995, GENETICS, V141, P1147; Frey K. J., 1984, Genetics: new frontiers. XV International Congress of Genetics. Volume IV. Applied genetics, P51; Gur A, 2004, PLOS BIOL, V2, P1610, DOI 10.1371/journal.pbio.0020245; He GM, 2006, GENOME RES, V16, P618, DOI 10.1101/gr.4814006; Hua JP, 2003, P NATL ACAD SCI USA, V100, P2574, DOI 10.1073/pnas.0437907100; Ikeda R., 1990, JPN J BREED S1, V40, P280; International Rice Research Institute, 2002, STAND EV SYST RIC; Jin Feng-Xue, 2009, Journal of Crop Science and Biotechnology, V12, P9; Khush G. S., 1977, 3rd International Congress of the Society for the Advancement of Breeding Researches in Asia and Oceania (SABRAO). Plant Breeding Papers: 1. 4. Breeding for resistance to pests and diseases. (b) Resistance to other pests and diseases., P3; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Khush GS, 1991, RICE GENET NEWSL, Vl7, P121; Khush GS, 2013, PLANT BREEDING, V132, P433, DOI 10.1111/pbr.1991; Kuroda Y, 2007, CONSERV GENET, V8, P149, DOI 10.1007/s10592-006-9156-3; Lee SJ, 2005, PLANT BREEDING, V124, P209, DOI 10.1111/j.1439-0523.2005.01092.x; Li Z, 1988, RICE MALE STERILE CY, P85; Linh LH, 2008, PLANT BREEDING, V127, P262, DOI 10.1111/j.1439-0523.2007.01462.x; Luo LJ, 2001, GENETICS, V158, P1755; Luo XJ, 2011, PLANT SCI, V181, P14, DOI 10.1016/j.plantsci.2010.12.009; Marri PR, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-33; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Moncada P, 2001, THEOR APPL GENET, V102, P41, DOI 10.1007/s001220051616; Monforte AJ, 2000, THEOR APPL GENET, V100, P471, DOI 10.1007/s001220050061; Oka H. I., 1988, Origin of cultivated rice.; Rangel PN, 2008, GENET MOL RES, V7, P184, DOI 10.4238/vol7-1gmr406; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sang T, 2007, CURR OPIN GENET DEV, V17, P533, DOI 10.1016/j.gde.2007.09.005; Semel Y, 2006, P NATL ACAD SCI USA, V103, P12981, DOI 10.1073/pnas.0604635103; Septiningsih EM, 2003, THEOR APPL GENET, V107, P1419, DOI 10.1007/s00122-003-1373-2; Song ZP, 2006, EVOL ECOL, V20, P501, DOI 10.1007/s10682-006-9113-0; Sun CQ, 2001, THEOR APPL GENET, V102, P157, DOI 10.1007/s001220051631; Tan LB, 2007, J INTEGR PLANT BIOL, V49, P871, DOI 10.1111/j.1744-7909.2007.00497.x; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tanksley SD, 1996, THEOR APPL GENET, V92, P191, DOI 10.1007/BF00223376; Temnykh S, 2000, THEOR APPL GENET, V100, P697, DOI 10.1007/s001220051342; Thomson MJ, 2003, THEOR APPL GENET, V107, P479, DOI 10.1007/s00122-003-1270-8; Tian F, 2006, THEOR APPL GENET, V112, P570, DOI 10.1007/s00122-005-0165-2; van Berloo R, 2008, J HERED, V99, P232, DOI 10.1093/jhered/esm109; Vaughan DA, 2003, CURR OPIN PLANT BIOL, V6, P139, DOI 10.1016/S1369-5266(03)00009-8; Xiao JH, 1996, NATURE, V384, P223, DOI 10.1038/384223a0; Xiao JH, 1998, GENETICS, V150, P899; Xie XB, 2008, THEOR APPL GENET, V116, P613, DOI 10.1007/s00122-007-0695-x; Yoon DB, 2006, THEOR APPL GENET, V112, P1052, DOI 10.1007/s00122-006-0207-4; ZHANG Q, 2000, ACTA AGRONOMICA SINI, V26, P536; Zhang QF, 2007, P NATL ACAD SCI USA, V104, P16402, DOI 10.1073/pnas.0708013104; Zhou HF, 2008, THEOR APPL GENET, V117, P1181, DOI 10.1007/s00122-008-0855-7	52	30	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e96939	10.1371/journal.pone.0096939	http://dx.doi.org/10.1371/journal.pone.0096939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949743	Green Submitted, Green Published, gold			2022-12-25	WOS:000338276300001
J	Hsieh, SC; Tsai, WY; Nerurkar, VR; Wang, WK				Hsieh, Szu-Chia; Tsai, Wen-Yang; Nerurkar, Vivek R.; Wang, Wei-Kung			Characterization of the Ectodomain of the Envelope Protein of Dengue Virus Type 4: Expression, Membrane Association, Secretion and Particle Formation in the Absence of Precursor Membrane Protein	PLOS ONE			English	Article							TICK-BORNE ENCEPHALITIS; HEPATITIS-C VIRUS; RECOMBINANT SUBVIRAL PARTICLES; PROTECTIVE IMMUNE-RESPONSE; STEM-ANCHOR REGION; ENDOPLASMIC-RETICULUM; GLYCOPROTEIN; MATURATION; PRM; GLYCOSYLATION	Background: The envelope (E) of dengue virus (DENV) is the major target of neutralizing antibodies and vaccine development. After biosynthesis E protein forms a heterodimer with precursor membrane (prM) protein. Recent reports of infection enhancement by anti-prM monoclonal antibodies (mAbs) suggest anti-prM responses could be potentially harmful. Previously, we studied a series of C-terminal truncation constructs expressing DENV type 4 prM/E or E proteins and found the ectodomain of E protein alone could be recognized by all 12 mAbs tested, suggesting E protein ectodomain as a potential subunit immunogen without inducing anti-prM response. The characteristics of DENV E protein ectodomain in the absence of prM protein remains largely unknown. Methodology/Principal Findings: In this study, we investigated the expression, membrane association, glycosylation pattern, secretion and particle formation of E protein ectodomain of DENV4 in the presence or absence of prM protein. E protein ectodomain associated with membrane in or beyond trans-Golgi and contained primarily complex glycans, whereas full-length E protein associated with ER membrane and contained high mannose glycans. In the absence of prM protein, E protein ectodomain can secrete as well as form particles of approximately 49 nm in diameter, as revealed by sucrose gradient ultracentrifugation with or without detergent and electron microscopy. Mutational analysis revealed that the secretion of E protein ectodomain was affected by N-linked glycosylation and could be restored by treatment with ammonia chloride. Conclusions/Significance: Considering the enhancement of DENV infectivity by anti-prM antibodies, our findings provide new insights into the expression and secretion of E protein ectodomain in the absence of prM protein and contribute to future subunit vaccine design.	[Hsieh, Szu-Chia; Tsai, Wen-Yang; Nerurkar, Vivek R.; Wang, Wei-Kung] Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, John A Burns Sch Med, Honolulu, HI 96822 USA; [Nerurkar, Vivek R.; Wang, Wei-Kung] Univ Hawaii Manoa, Pacific Ctr Emerging Infect Dis Res, John A Burns Sch Med, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Wang, WK (corresponding author), Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, John A Burns Sch Med, Honolulu, HI 96822 USA.	wangwk@hawaii.edu	Nerurkar, Vivek R/F-5533-2011		International Vaccine Institute/Pediatric Dengue Vaccine Initiative; JABSOM; National Institute of General Medical Sciences, National Institutes of Health [P20GM103516]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103516] Funding Source: NIH RePORTER	International Vaccine Institute/Pediatric Dengue Vaccine Initiative; JABSOM; National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by Cooperative Research Agreement by International Vaccine Institute/Pediatric Dengue Vaccine Initiative, start-up fund from JABSOM and Award Number P20GM103516 from the National Institute of General Medical Sciences, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Allison SL, 2003, J VIROL, V77, P11357, DOI 10.1128/JVI.77.21.11357-11366.2003; Allison SL, 1999, J VIROL, V73, P5605, DOI 10.1128/JVI.73.7.5605-5612.1999; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021; Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; BRAY M, 1991, VIROLOGY, V185, P505, DOI 10.1016/0042-6822(91)90809-P; Bryant JE, 2007, VIROLOGY, V366, P415, DOI 10.1016/j.virol.2007.05.007; Coller BAG, 2011, VACCINE, V29, P7267, DOI 10.1016/j.vaccine.2011.07.021; Crill WD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004991; De Beeck AO, 2003, J VIROL, V77, P813, DOI 10.1128/JVI.77.2.813-820.2003; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4; Gladnikoff M, 2009, BIOPHYS J, V97, P2419, DOI 10.1016/j.bpj.2009.08.016; Goto A, 2005, VACCINE, V23, P3043, DOI 10.1016/j.vaccine.2004.11.068; GUIRAKHOO F, 1993, VIROLOGY, V194, P219, DOI 10.1006/viro.1993.1252; GUIRAKHOO F, 1992, VIROLOGY, V191, P921, DOI 10.1016/0042-6822(92)90267-S; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Han ZY, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-92; Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005; Hsieh SC, 2008, VIROLOGY, V374, P338, DOI 10.1016/j.virol.2007.12.041; Hsieh SC, 2011, VIROLOGY, V410, P170, DOI 10.1016/j.virol.2010.11.006; Hu HP, 2007, VIROLOGY, V368, P376, DOI 10.1016/j.virol.2007.06.026; Huang KJ, 2006, J IMMUNOL, V176, P2825, DOI 10.4049/jimmunol.176.5.2825; Keelapang P, 2004, J VIROL, V78, P2367, DOI 10.1128/JVI.78.5.2367-2381.2004; KONISHI E, 1993, J VIROL, V67, P1672, DOI 10.1128/JVI.67.3.1672-1675.1993; Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13; Lee E, 1997, VIROLOGY, V232, P281, DOI 10.1006/viro.1997.8570; Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09; Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263; Lin HE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001447; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Lorenz IC, 2003, J VIROL, V77, P4370, DOI 10.1128/JVI.77.7.4370-4382.2003; Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315; MURRAY JM, 1993, J GEN VIROL, V74, P175, DOI 10.1099/0022-1317-74-2-175; Ohtaki N, 2010, VACCINE, V28, P6588, DOI 10.1016/j.vaccine.2010.07.055; Orlinger KK, 2006, J VIROL, V80, P12197, DOI 10.1128/JVI.01540-06; RANDOLPH VB, 1990, J GEN VIROL, V71, P1845, DOI 10.1099/0022-1317-71-8-1845; Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718; Shi ST, 2003, J VIROL, V77, P4160, DOI 10.1128/JVI.77.7.4160-4168.2003; Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997; Stiasny K, 1996, J VIROL, V70, P8142, DOI 10.1128/JVI.70.11.8142-8147.1996; Tsai WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052600; Vieyres G, 2010, J VIROL, V84, P10159, DOI 10.1128/JVI.01180-10; Wang JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004908; Wang SL, 1999, J VIROL, V73, P2547, DOI 10.1128/JVI.73.3.2547-2551.1999; Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; White LJ, 2013, J VIROL, V87, P3409, DOI 10.1128/JVI.02298-12; WHO, 2009, DENG HEM FEV DIAGN T; Yu IM, 2009, J VIROL, V83, P12101, DOI 10.1128/JVI.01637-09; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990; Zhang XM, 2012, ADV ENG FORUM, V5, P20, DOI 10.4028/www.scientific.net/AEF.5.20	65	11	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100641	10.1371/journal.pone.0100641	http://dx.doi.org/10.1371/journal.pone.0100641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950216	Green Published, Green Submitted, gold			2022-12-25	WOS:000338276300102
J	Chen, JM; Chiazza, F; Collino, M; Patel, NSA; Coldewey, SM; Thiemermann, C				Chen, Jianmin; Chiazza, Fausto; Collino, Massimo; Patel, Nimesh S. A.; Coldewey, Sina M.; Thiemermann, Christoph			Gender Dimorphism of the Cardiac Dysfunction in Murine Sepsis: Signalling Mechanisms and Age-Dependency	PLOS ONE			English	Article							FACTOR-ALPHA EXPRESSION; NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; ESTROGEN-RECEPTOR; INFLAMMATORY RESPONSE; CONTRACTILE FUNCTION; ORGAN DYSFUNCTION; TRAUMA-HEMORRHAGE; IMMUNE FUNCTIONS; SEPTIC SHOCK	Development of cardiac dysfunction is associated with increased morbidity and mortality in patients with sepsis. Increasing evidence shows that gender determines the degree of inflammatory response of the host and that females tolerate sepsis better than males. It is unknown whether gender affects the cardiac dysfunction in animals or patients with sepsis. To investigate this, male or female C57BL/6 mice were subjected to either lipopolysaccharide (LPS)/peptidoglycan (PepG) co-administration or cecal ligation and puncture (CLP). At 18 hours after LPS/PepG injection or 24 hours after CLP, cardiac function was evaluated by echocardiography. The septic insult caused a significant cardiac dysfunction in both genders. However, the cardiac dysfunction was significantly less pronounced in females in comparison with males subjected to LPS (3 mg/kg)/PepG (0.1 mg/kg) or CLP. Compared with males injected with LPS (3 mg/kg)/PepG (0.1 mg/kg), western blotting analysis of the myocardium from females injected with LPS/PepG revealed i) profound increases in phosphorylation of Akt and eNOS; ii) significant decreases in phosphorylation of I kappa B alpha, nuclear translocation of the NF-kappa B subunit p65, decreased expression of iNOS and decreased synthesis of TNF-alpha and IL-6 in the heart. However, the gender dimorphism of the cardiac dysfunction secondary to LPS/PepG was not observed when higher doses of LPS (9 mg/kg)/PepG (1 mg/kg) were used. In conclusion, the cardiac dysfunction caused by sepsis was less pronounced in female than in male mice. The protection of female hearts against the dysfunction associated with sepsis is (at least in part) attributable to cardiac activation of the Akt/eNOS survival pathway, decreased activation of NF-kappa B, and decreased expression of iNOS, TNF-alpha and IL-6. It should be noted that the observed gender dimorphism of the cardiac dysfunction in sepsis was not seen when a very severe stimulus (high dose of LPS/PepG co-administration) was used to cause cardiac dysfunction.	[Chen, Jianmin; Patel, Nimesh S. A.; Thiemermann, Christoph] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Chiazza, Fausto; Collino, Massimo] Univ Turin, Dept Drug Sci & Technol, Turin, Italy; [Coldewey, Sina M.] Jena Univ Hosp, Dept Anesthesiol & Intens Care Med, Jena, Germany	University of London; Queen Mary University London; University of Turin; Friedrich Schiller University of Jena	Thiemermann, C (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England.	c.thiemermann@qmul.ac.uk	Chiazza, Fausto/I-5559-2015; Collino, Massimo/AAK-8532-2020	Collino, Massimo/0000-0001-8782-3496; Chiazza, Fausto/0000-0001-7273-0051; Thiemermann, Christoph/0000-0003-4228-9722	PhD-studentship of the China Scholarship Council [201206240146]; Queen Mary University of London (QMUL); Research Fellowship of the German Research Foundation (Deutsche Forschungsgemeinschaft); DFG [CO 912/1-1]; Bart's and The London Charity [753/1722]; William Harvey Research Foundation; University of Turin (Ricerca Locale); National Institute of Health Research; Barts and The London Charity [753/1722]	PhD-studentship of the China Scholarship Council(China Scholarship Council); Queen Mary University of London (QMUL); Research Fellowship of the German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Bart's and The London Charity; William Harvey Research Foundation; University of Turin (Ricerca Locale); National Institute of Health Research(National Institute for Health Research (NIHR)); Barts and The London Charity	JC is supported by a jointly funded PhD-studentship of the China Scholarship Council (grant number 201206240146) and Queen Mary University of London (QMUL). SMC is supported by a Research Fellowship of the German Research Foundation (Deutsche Forschungsgemeinschaft; DFG CO 912/1-1). NSAP is, in part, supported by the Bart's and The London Charity (753/1722). This work is supported, in part, by the William Harvey Research Foundation and by a grant from the University of Turin (Ricerca Locale ex-60% 2013). This work forms part of the research themes contributing to the translational research portfolio of Barts and the London Cardiovascular Biomedical Research Unit, which is supported and funded by the National Institute of Health Research. This work also contributes to the Organ Protection research theme of the Barts Centre for Trauma Sciences, supported by the Barts and The London Charity (Award 753/1722). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angele MK, 1997, ARCH SURG-CHICAGO, V132, P1207; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bae SC, 2005, J PHARMACOL EXP THER, V315, P1125, DOI 10.1124/jpet.105.090803; Barth E, 2006, CRIT CARE MED, V34, P307, DOI 10.1097/01.CCM.0000199070.46812.21; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; BONE RC, 1992, JAMA-J AM MED ASSOC, V268, P3452, DOI 10.1001/jama.268.24.3452; Brown MA, 2004, FRONT BIOSCI-LANDMRK, V9, P1201, DOI 10.2741/1304; Camper-Kirby D, 2001, CIRC RES, V88, P1020, DOI 10.1161/hh1001.090858; Coldewey SM, 2013, DIS MODEL MECH, V6, P1031, DOI 10.1242/dmm.012435; Collino M, 2013, DIS MODEL MECH, V6, P1012, DOI 10.1242/dmm.011528; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Drechsler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051457; Fernandes CJ, 1999, INTENS CARE MED, V25, P1165, DOI 10.1007/s001340051030; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Ghuman AK, 2013, J PEDIATR-US, V163, P835, DOI 10.1016/j.jpeds.2013.04.018; Horton JW, 2004, AM J PHYSIOL-HEART C, V286, pH202, DOI 10.1152/ajpheart.00706.2003; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hsieh YC, 2007, AM J PHYSIOL-LUNG C, V292, pL1227, DOI 10.1152/ajplung.00479.2006; Hsu JT, 2009, CRIT CARE MED, V37, P2338, DOI 10.1097/CCM.0b013e3181a030ce; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Kapoor A, 2010, AM J RESP CRIT CARE, V182, P1506, DOI 10.1164/rccm.201002-0240OC; Khan AI, 2013, DIS MODEL MECH, V6, P1021, DOI 10.1242/dmm.011908; Khan R, 2010, SHOCK, V33, P242, DOI 10.1097/SHK.0b013e3181b0f96f; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim YD, 1996, CIRCULATION, V94, P2901, DOI 10.1161/01.CIR.94.11.2901; Kleinert H, 1998, HYPERTENSION, V31, P582, DOI 10.1161/01.HYP.31.2.582; Kolodgie FD, 1997, J MOL CELL CARDIOL, V29, P2403, DOI 10.1006/jmcc.1997.0476; Liu CJ, 2009, J CELL MOL MED, V13, P3655, DOI 10.1111/j.1582-4934.2009.00669.x; Mahmood K, 2012, CRIT CARE, V16, DOI [10.1186/cc11355, 10.1186/CC11355]; Mannella P, 2006, J NEUROSCI, V26, P9439, DOI 10.1523/JNEUROSCI.1443-06.2006; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Melamed A, 2009, CRIT CARE, V13, DOI 10.1186/cc7733; MIYAMOTO S, 1995, ADV CANCER RES, V66, P255, DOI 10.1016/S0065-230X(08)60257-2; NATANSON C, 1989, J EXP MED, V169, P823, DOI 10.1084/jem.169.3.823; NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327; Oberholzer A, 2000, J TRAUMA, V48, P932, DOI 10.1097/00005373-200005000-00019; Padkin A, 2003, CRIT CARE MED, V31, P2332, DOI 10.1097/01.CCM.0000085141.75513.2B; PARRILLO JE, 1985, J CLIN INVEST, V76, P1539, DOI 10.1172/JCI112135; Rajesh KG, 2005, J MOL CELL CARDIOL, V39, P766, DOI 10.1016/j.yjmcc.2005.07.014; Ren J, 2003, AM J PHYSIOL-HEART C, V284, pH1800, DOI 10.1152/ajpheart.00866.2002; Schroder J, 1998, ARCH SURG-CHICAGO, V133, P1200, DOI 10.1001/archsurg.133.11.1200; Sener G, 2005, J SURG RES, V128, P70, DOI 10.1016/j.jss.2005.02.019; Senftleben U, 2002, CRIT CARE MED, V30, pS18, DOI 10.1097/00003246-200201001-00003; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Szalay L, 2006, AM J PHYSIOL-REG I, V290, pR812, DOI 10.1152/ajpregu.00658.2005; THIEMERMANN C, 1990, EUR J PHARMACOL, V182, P591, DOI 10.1016/0014-2999(90)90062-B; Von Aulock S, 2006, J INTERF CYTOK RES, V26, P887, DOI 10.1089/jir.2006.26.887; Wang MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE321, DOI 10.1152/ajpendo.00278.2004; WEINER CP, 1994, P NATL ACAD SCI USA, V91, P5212, DOI 10.1073/pnas.91.11.5212; Weixelbaumer KM, 2014, SHOCK, V41, P145, DOI 10.1097/SHK.0000000000000070; Wichmann MW, 2000, INTENS CARE MED, V26, P167, DOI 10.1007/s001340050041; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2; Yu HP, 2007, ANN SURG, V245, P971, DOI 10.1097/01.sla.0000254417.15591.88; Zellweger R, 1997, CRIT CARE MED, V25, P106, DOI 10.1097/00003246-199701000-00021; Zhu HQ, 2009, J MOL CELL CARDIOL, V47, P264, DOI 10.1016/j.yjmcc.2009.05.002	56	29	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100631	10.1371/journal.pone.0100631	http://dx.doi.org/10.1371/journal.pone.0100631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945834	gold, Green Submitted, Green Published			2022-12-25	WOS:000340721500100
J	Sarraf, NS; Shi, R; McDonald, L; Baardsnes, J; Zhang, LH; Cygler, M; Ekiel, I				Sarraf, Naghmeh S.; Shi, Rong; McDonald, Laura; Baardsnes, Jason; Zhang, Linhua; Cygler, Miroslaw; Ekiel, Irena			Structure of CbpA J-Domain Bound to the Regulatory Protein CbpM Explains Its Specificity and Suggests Evolutionary Link between CbpM and Transcriptional Regulators	PLOS ONE			English	Article							ESCHERICHIA-COLI; DNAJ HOMOLOG; STREPTOMYCES-COELICOLOR; CHAPERONE; HSP70; BINDING; FAMILY; MODULATOR	CbpA is one of the six E. coli DnaJ/Hsp40 homologues of DnaK co-chaperones and the only one that is additionally regulated by a small protein CbpM, conserved in gamma-proteobacteria. CbpM inhibits the co-chaperone and DNA binding activities of CbpA. This regulatory function of CbpM is accomplished through reversible interaction with the N-terminal J-domain of CbpA, which is essential for the interaction with DnaK. CbpM is highly specific for CbpA and does not bind DnaJ despite the high degree of structural and functional similarity between the J-domains of CbpA and DnaJ. Here we report the crystal structure of the complex of CbpM with the J-domain of CbpA. CbpM forms dimers and the J-domain of CbpA interacts with both CbpM subunits. The CbpM-binding surface of CbpA is highly overlapping with the CbpA interface for DnaK, providing a competitive model for regulation through forming mutually exclusive complexes. The structure also provides the explanation for the strict specificity of CbpM for CbpA, which we confirmed by making mutants of DnaJ that became regulated by CbpM. Interestingly, the structure of CbpM reveals a striking similarity to members of the MerR family of transcriptional regulators, suggesting an evolutionary connection between the functionally distinct bacterial cochaperone regulator CbpM and the transcription regulator HspR.	[Sarraf, Naghmeh S.; McDonald, Laura; Ekiel, Irena] Concordia Univ, Dept Chem & Biochem, Montreal, PQ H3G 1M8, Canada; [Sarraf, Naghmeh S.; McDonald, Laura; Baardsnes, Jason; Ekiel, Irena] Natl Res Council Canada, Montreal, PQ, Canada; [Shi, Rong] Univ Laval, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada; [Shi, Rong] Univ Laval, Inst Biol Integrat & Syst, Quebec City, PQ, Canada; [Shi, Rong] Univ Laval, PROTEO, Quebec City, PQ, Canada; [Zhang, Linhua; Cygler, Miroslaw] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Cygler, Miroslaw] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 0W0, Canada	Concordia University - Canada; National Research Council Canada; Laval University; Laval University; Laval University; McGill University; University of Saskatchewan	Cygler, M (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	miroslaw.cygler@usask.ca; irena.ekiel@bri.nrc.ca			Canadian Institutes of Health Research (CIHR) [MOP-48370]; Canadian Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by a Canadian Institutes of Health Research (CIHR) Grant MOP-48370 (to I.E. and M.C.). The Canadian Macromolecular Crystallography Facility is supported by the Canadian Foundation for Innovation, the Natural Sciences and Engineering Research Council of Canada, and Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Barends TRM, 2013, ACTA CRYSTALLOGR D, V69, P1540, DOI 10.1107/S0907444913010640; Bird JG, 2006, J BIOL CHEM, V281, P34349, DOI 10.1074/jbc.M603365200; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Bucca G, 1997, J BACTERIOL, V179, P5999, DOI 10.1128/jb.179.19.5999-6004.1997; Bucca G, 2000, MOL MICROBIOL, V38, P1093, DOI 10.1046/j.1365-2958.2000.02194.x; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Caguiat JJ, 1999, J BACTERIOL, V181, P3462, DOI 10.1128/JB.181.11.3462-3471.1999; Chae C, 2004, J BIOL CHEM, V279, P33147, DOI 10.1074/jbc.M404862200; Chenoweth MR, 2008, J BACTERIOL, V190, P5153, DOI 10.1128/JB.00437-08; Chenoweth MR, 2007, J BACTERIOL, V189, P3635, DOI 10.1128/JB.01757-06; Chintakayala K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003152; Chintakayala K, 2011, J MOL BIOL, V411, P313, DOI 10.1016/j.jmb.2011.05.043; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gamer J, 1996, EMBO J, V15, P607, DOI 10.1002/j.1460-2075.1996.tb00393.x; Genevaux P, 2002, GENETICS, V162, P1045; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; Hinault MP, 2010, J BIOL CHEM, V285, P38173, DOI 10.1074/jbc.M110.127753; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang K, 1999, PROTEIN SCI, V8, P203; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Karzai AW, 1996, J BIOL CHEM, V271, P11236, DOI 10.1074/jbc.271.19.11236; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Klaiman TN, 2009, COMPUT BIOL CHEM, V33, P275, DOI 10.1016/j.compbiolchem.2009.06.007; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narberhaus F, 1999, MOL MICROBIOL, V31, P1, DOI 10.1046/j.1365-2958.1999.01166.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pellecchia M, 1996, J MOL BIOL, V260, P236, DOI 10.1006/jmbi.1996.0395; Ramos JL, 2001, CURR OPIN MICROBIOL, V4, P166, DOI 10.1016/S1369-5274(00)00183-1; Roncarati D, 2011, J BACTERIOL, V193, P5629, DOI 10.1128/JB.05295-11; Sarraf NS, 2010, J MOL BIOL, V398, P111, DOI 10.1016/j.jmb.2010.03.006; Scarlato V, 2001, INT J MED MICROBIOL, V291, P107, DOI 10.1078/1438-4221-00107; Spohn G, 1999, MOL MICROBIOL, V34, P663, DOI 10.1046/j.1365-2958.1999.01625.x; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; UEGUCHI C, 1994, P NATL ACAD SCI USA, V91, P1054, DOI 10.1073/pnas.91.3.1054; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WALL D, 1994, J BIOL CHEM, V269, P5446; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	42	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100441	10.1371/journal.pone.0100441	http://dx.doi.org/10.1371/journal.pone.0100441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945826	Green Published, Green Submitted, gold			2022-12-25	WOS:000340721500075
J	Teijido, O; Rappaport, SM; Chamberlin, A; Noskov, SY; Aguilella, VM; Rostovtseva, TK; Bezrukov, SM				Teijido, Oscar; Rappaport, Shay M.; Chamberlin, Adam; Noskov, Sergei Y.; Aguilella, Vicente M.; Rostovtseva, Tatiana K.; Bezrukov, Sergey M.			Acidification Asymmetrically Affects Voltage-dependent Anion Channel Implicating the Involvement of Salt Bridges	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electrophysiology; Gating; Mitochondria; Molecular Dynamics; pH Regulation; Voltage-dependent Anion Channel (VDAC); -Barrel Channel Reconstitution	MITOCHONDRIAL OUTER-MEMBRANE; REPERFUSION INJURY; PH PARADOX; MOLECULAR-DYNAMICS; INTRACELLULAR PH; RAT HEPATOCYTES; GATED CHANNEL; ATP TRANSPORT; ION-CHANNEL; VDAC	Background: VDAC voltage gating depends on pH. Results: Acidification asymmetrically and reversibly enhances VDAC closure. Conclusion: pH-sensitive formation of stable salt bridges in the cytosolic side of VDAC explains its asymmetrical response to acidification. Significance: The pronounced sensitivity of the cytosolic side of VDAC to acidification provides new insights into the protective effect of cytosolic acidification during ischemia. The voltage-dependent anion channel (VDAC) is the major pathway for ATP, ADP, and other respiratory substrates through the mitochondrial outer membrane, constituting a crucial point of mitochondrial metabolism regulation. VDAC is characterized by its ability to gate between an open and several closed states under applied voltage. In the early stages of tumorigenesis or during ischemia, partial or total absence of oxygen supply to cells results in cytosolic acidification. Motivated by these facts, we investigated the effects of pH variations on VDAC gating properties. We reconstituted VDAC into planar lipid membranes and found that acidification reversibly increases its voltage-dependent gating. Furthermore, both VDAC anion selectivity and single channel conductance increased with acidification, in agreement with the titration of the negatively charged VDAC residues at low pH values. Analysis of the pH dependences of the gating and open channel parameters yielded similar pK(a) values close to 4.0. We also found that the response of VDAC gating to acidification was highly asymmetric. The presumably cytosolic (cis) side of the channel was the most sensitive to acidification, whereas the mitochondrial intermembrane space (trans) side barely responded to pH changes. Molecular dynamic simulations suggested that stable salt bridges at the cis side, which are susceptible to disruption upon acidification, contribute to this asymmetry. The pronounced sensitivity of the cis side to pH variations found here in vitro might provide helpful insights into the regulatory role of VDAC in the protective effect of cytosolic acidification during ischemia in vivo.	[Teijido, Oscar; Rappaport, Shay M.; Noskov, Sergei Y.; Rostovtseva, Tatiana K.; Bezrukov, Sergey M.] Eunice Kennedy Shriver NICHD, Program Phys Biol, NIH, Bethesda, MD 20892 USA; [Chamberlin, Adam; Noskov, Sergei Y.] Univ Calgary, Ctr Mol Simulat, Dept Biol Sci, Calgary, AB T2N 2N4, Canada; [Aguilella, Vicente M.] Univ Jaume 1, Dept Phys, Castellon de La Plana 12080, Spain	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Calgary; Universitat Jaume I	Rostovtseva, TK (corresponding author), NICHD, Program Phys Biol, NIH, 9000 Rockville Pike,Bldg 9,Rm 1E-106, Bethesda, MD 20892 USA.	rostovtt@mail.nih.gov	Aguilella, Vicente M/B-7592-2008	Aguilella, Vicente M/0000-0002-2420-2649; Noskov, Sergei/0000-0001-7769-335X	National Institutes of Health Intramural Research Program of the Eunice Kennedy Shriver NICHD; National Sciences and Engineering Research Council [RGPIN-315019]; Spanish MINECO [FIS2013-40473]; Universitat Jaume I-Fundacio Caixa Castello-Bancaixa [P1-1B2012-03]; Generalitat Valenciana [Prometeu/2012/069]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000072] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Spanish MINECO(Spanish Government); Universitat Jaume I-Fundacio Caixa Castello-Bancaixa; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program of the Eunice Kennedy Shriver NICHD. This work was also supported by National Sciences and Engineering Research Council Discovery Grant RGPIN-315019 (to S. Y. N.).; Supported by Spanish MINECO Grant FIS2013-40473, Universitat Jaume I-Fundacio Caixa Castello-Bancaixa Grant P1-1B2012-03, and Generalitat Valenciana Grant Prometeu/2012/069.	Anesti V, 2006, BBA-BIOENERGETICS, V1757, P692, DOI 10.1016/j.bbabio.2006.04.013; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; BEZRUKOV SM, 1993, PHYS REV LETT, V70, P2352, DOI 10.1103/PhysRevLett.70.2352; BING OHL, 1973, SCIENCE, V180, P1297, DOI 10.1126/science.180.4092.1297; BLACHLYDYSON E, 1990, SCIENCE, V247, P1233, DOI 10.1126/science.1690454; BOND JM, 1993, AM J PHYSIOL, V265, pC129, DOI 10.1152/ajpcell.1993.265.1.C129; BOND JM, 1994, ANN NY ACAD SCI, V723, P25, DOI 10.1111/j.1749-6632.1994.tb36714.x; BONVENTRE JV, 1985, AM J PHYSIOL, V249, pC149, DOI 10.1152/ajpcell.1985.249.1.C149; BOWEN KA, 1985, J MEMBRANE BIOL, V86, P51, DOI 10.1007/BF01871610; BRAUNWALD E, 1985, J CLIN INVEST, V76, P1713, DOI 10.1172/JCI112160; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Colombini M, 1996, Ion Channels, V4, P169; COLOMBINI M, 1989, J MEMBRANE BIOL, V111, P103, DOI 10.1007/BF01871775; COLOMBINI M, 1987, BIOCHIM BIOPHYS ACTA, V905, P279, DOI 10.1016/0005-2736(87)90456-1; De Pinto V, 2008, J BIOENERG BIOMEMBR, V40, P139, DOI 10.1007/s10863-008-9140-3; DORING C, 1985, J MEMBRANE BIOL, V83, P87, DOI 10.1007/BF01868741; DORING C, 1985, J MEMBRANE BIOL, V83, P81, DOI 10.1007/BF01868740; Eddy MT, 2012, J AM CHEM SOC, V134, P6375, DOI 10.1021/ja300347v; ERMISHKIN LN, 1990, BIOCHIM BIOPHYS ACTA, V1021, P161, DOI 10.1016/0005-2736(90)90029-N; Galluzzi L, 2008, ONCOGENE, V27, P4633, DOI 10.1038/onc.2008.114; Geula S, 2012, BIOCHEM J, V444, P475, DOI 10.1042/BJ20112079; GORES GJ, 1989, J CLIN INVEST, V83, P386, DOI 10.1172/JCI113896; Gurnev PA, 2011, FEBS LETT, V585, P2363, DOI 10.1016/j.febslet.2011.06.008; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; Jo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000880; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karbowski M, 2001, J CELL SCI, V114, P281; KASIANOWICZ JJ, 1995, BIOPHYS J, V69, P94, DOI 10.1016/S0006-3495(95)79879-4; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Lemasters J J, 1996, EXS, V76, P99; Levadny V, 2002, BIOPHYS J, V82, P1773, DOI 10.1016/S0006-3495(02)75528-8; Mannella CA, 1998, J STRUCT BIOL, V121, P207, DOI 10.1006/jsbi.1997.3954; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; McDonald BM, 2009, FEBS LETT, V583, P739, DOI 10.1016/j.febslet.2009.01.039; MIRZABEKOV TA, 1989, FEBS LETT, V249, P375, DOI 10.1016/0014-5793(89)80662-3; Monge C, 2008, MOL CELL BIOCHEM, V318, P147, DOI 10.1007/s11010-008-9865-7; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; NIEMINEN AL, 1990, BIOCHEM BIOPH RES CO, V167, P600, DOI 10.1016/0006-291X(90)92067-A; Noskov SY, 2013, BIOCHEMISTRY-US, V52, P9246, DOI 10.1021/bi4011495; PALMIERI F, 1989, J BIOENERG BIOMEMBR, V21, P417, DOI 10.1007/BF00762514; Pastorino JG, 2008, J BIOENERG BIOMEMBR, V40, P171, DOI 10.1007/s10863-008-9148-8; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P211, DOI 10.1007/s10863-007-9094-x; Pfoh R, 2012, P NATL ACAD SCI USA, V109, P18809, DOI 10.1073/pnas.1209018109; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Robey RB, 2005, CELL CYCLE, V4, P654, DOI 10.4161/cc.4.5.1678; Rosano C, 2011, MITOCHONDRION, V11, P513, DOI 10.1016/j.mito.2011.01.012; Rostovtseva T, 1996, J BIOL CHEM, V271, P28006, DOI 10.1074/jbc.271.45.28006; Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6; Rostovtseva TK, 2008, J BIOENERG BIOMEMBR, V40, P163, DOI 10.1007/s10863-008-9145-y; Rostovtseva TK, 2006, J BIOL CHEM, V281, P37496, DOI 10.1074/jbc.M602548200; Rostovtseva TK, 2012, BBA-BIOMEMBRANES, V1818, P1526, DOI 10.1016/j.bbamem.2011.11.004; Rostovtseva TK, 2000, P NATL ACAD SCI USA, V97, P7819, DOI 10.1073/pnas.140115397; Rostovtseva TK, 1998, BIOPHYS J, V74, P2365, DOI 10.1016/S0006-3495(98)77945-7; Saks V, 2010, BBA-BIOENERGETICS, V1797, P678, DOI 10.1016/j.bbabio.2010.01.011; SCHEIN SJ, 1976, J MEMBRANE BIOL, V30, P99, DOI 10.1007/BF01869662; Schneider R, 2010, ANGEW CHEM INT EDIT, V49, P1882, DOI 10.1002/anie.200906241; Shao L, 1996, BIOPHYS J, V71, P778, DOI 10.1016/S0006-3495(96)79277-9; Sheldon KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025539; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Song JM, 1998, J BIOL CHEM, V273, P24406, DOI 10.1074/jbc.273.38.24406; Song JM, 1998, BIOPHYS J, V74, P2926, DOI 10.1016/S0006-3495(98)78000-2; STANLEY S, 1995, J BIOL CHEM, V270, P16694, DOI 10.1074/jbc.270.28.16694; Teijido O, 2012, J BIOL CHEM, V287, P11437, DOI 10.1074/jbc.M111.314229; THOMAS L, 1993, P NATL ACAD SCI USA, V90, P5446, DOI 10.1073/pnas.90.12.5446; Tomasello MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081522; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Villinger S, 2010, P NATL ACAD SCI USA, V107, P22546, DOI 10.1073/pnas.1012310108; ZIMMERBERG J, 1986, NATURE, V323, P36, DOI 10.1038/323036a0; ZIZI M, 1994, J BIOL CHEM, V269, P1614; Zizi M, 1998, BIOPHYS J, V75, P704, DOI 10.1016/S0006-3495(98)77560-5	71	38	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23670	23682		10.1074/jbc.M114.576314	http://dx.doi.org/10.1074/jbc.M114.576314			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24962576	Green Published, hybrid			2022-12-25	WOS:000341505000035
J	Buhrmann, C; Busch, F; Shayan, P; Shakibaei, M				Buhrmann, Constanze; Busch, Franziska; Shayan, Parviz; Shakibaei, Mehdi			Sirtuin-1 (SIRT1) Is Required for Promoting Chondrogenic Differentiation of Mesenchymal Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SMALL-MOLECULE ACTIVATORS; CHONDROCYTES IN-VITRO; HIGH-DENSITY CULTURES; ARTICULAR-CARTILAGE; DEPENDENT TRANSCRIPTION; LEUKEMIA-CELLS; GENE-EXPRESSION; HUMAN TENOCYTES; RESVERATROL	Sirtuin-1 (SIRT1), NAD(+)-dependent deacetylase, has been linked to anabolic effects in cartilage, although the mechanisms of SIRT1 signaling during differentiation of mesenchymal stem cells (MSCs) to chondrocytes are poorly understood. Therefore, we investigated the role of SIRT1-mediated signaling during chondrogenic differentiation of MSCs in vitro. High density and alginate cultures of MSCs were treated with chondrogenic induction medium with/without the SIRT1 inhibitor nicotinamide, antisense oligonucleotides against SIRT1 (SIRT1-ASO), IL-1 beta, and/or resveratrol. Transient transfection of MSCs with SIRT1-antisense oligonucleotides, nicotinamide, and IL-1 beta inhibited chondrogenesis-induced down-regulation of cartilage-specific proteins, cartilage-specific transcription factor Sox9, and enhanced NF-kappa B-regulated gene products involved in the inflammatory and degradative processes in cartilage (MMP-9, COX-2, and caspase-3), and NF-kappa B phosphorylation, acetylation, and activation of I kappa B alpha kinase. In contrast, the SIRT1 activator resveratrol or BMS-345541 (inhibitor of IKK) inhibited IL-1 beta- and NAM-induced suppression of cartilage-specific proteins, Sox9, and up-regulation of NF-kappa B-regulated gene products. Moreover, SIRT1 was found to interact directly with NF-kappa B and resveratrol-suppressed IL-1 beta and NAM but not SIRT1-ASO-induced NF-kappa B phosphorylation, acetylation, and activation of I kappa B alpha kinase. Knockdown of SIRT1 by mRNA abolished the inhibitory effects of resveratrol on inflammatory and apoptotic signaling and Sox9 expression, suggesting the essential role of this enzyme. Finally, the modulatory effects of resveratrol were found to be mediated at least in part by the association between SIRT1 and Sox9. These results indicate for the first time that SIRT1 supports chondrogenic development of MSCs at least in part through inhibition/deacetylation of NF-kappa B and activation of Sox9.	[Buhrmann, Constanze; Busch, Franziska; Shakibaei, Mehdi] Univ Munich, Inst Anat, Musculoskeletal Res Grp, D-80336 Munich, Germany; [Shayan, Parviz] Investigating Inst Mol Biol Syst Transfer, Tehran 1417863171, Iran; [Shayan, Parviz] Univ Tehran, Dept Parasitol, Fac Vet Med, Tehran 141556453, Iran	University of Munich; University of Tehran	Shakibaei, M (corresponding author), Univ Munich, Inst Anat, Musculoskeletal Res Grp, Pettenkoferstr 11, D-80336 Munich, Germany.	mehdi.shakibaei@med.uni-muenchen.de	Prof. Dr. Shakibaei, Mehdi/AAA-7004-2020	Prof. Dr. Shakibaei, Mehdi/0000-0002-6304-7506; Buhrmann, Constanze/0000-0002-0786-0463				Alsalameh S, 2004, ARTHRITIS RHEUM-US, V50, P1522, DOI 10.1002/art.20269; Backesjo CM, 2006, J BONE MINER RES, V21, P993, DOI 10.1359/JBMR.060415; Buckwalter JA, 2004, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000131638.81519.de; Buhrmann C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3065; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Busch F, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.377028; Busch F, 2012, J BIOL CHEM, V287, P25770, DOI 10.1074/jbc.M112.355420; Cao L, 2011, BIOMATERIALS, V32, P3910, DOI 10.1016/j.biomaterials.2011.02.014; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Csaki C, 2007, HISTOCHEM CELL BIOL, V128, P507, DOI 10.1007/s00418-007-0337-z; Csaki C, 2008, ANN ANAT, V190, P395, DOI 10.1016/j.aanat.2008.07.007; Csaki C, 2008, BIOCHEM PHARMACOL, V75, P677, DOI 10.1016/j.bcp.2007.09.014; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dvir-Ginzberg M, 2008, J BIOL CHEM, V283, P36300, DOI 10.1074/jbc.M803196200; Elmali N, 2007, INFLAMMATION, V30, P1, DOI 10.1007/s10753-006-9012-0; Estrov Z, 2003, BLOOD, V102, P987, DOI 10.1182/blood-2002-11-3550; Gabay O, 2013, JOINT BONE SPINE, V80, P613, DOI 10.1016/j.jbspin.2013.01.001; Gabay O, 2013, ARTHRITIS RHEUM-US, V65, P159, DOI 10.1002/art.37750; Gabay O, 2012, ANN RHEUM DIS, V71, P613, DOI 10.1136/ard.2011.200504; Gautam SC, 2000, BONE MARROW TRANSPL, V25, P639, DOI 10.1038/sj.bmt.1702189; Goepfert C, 2010, ADV BIOCHEM ENG BIOT, V123, P163, DOI 10.1007/10_2010_67; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Gupta SC, 2011, ANN NY ACAD SCI, V1215, P150, DOI 10.1111/j.1749-6632.2010.05852.x; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159; Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kim HJ, 2014, BONE JOINT RES, V3, P51, DOI 10.1302/2046-3758.33.2000226; Knutson MD, 2008, NUTR REV, V66, P591, DOI 10.1111/j.1753-4887.2008.00109.x; Ko JY, 2014, BIOMATERIALS, V35, P3571, DOI 10.1016/j.biomaterials.2014.01.009; Kotas ME, 2013, ADIPOCYTE, V2, P113, DOI 10.4161/adip.23437; Lee EH, 2006, J BONE JOINT SURG BR, V88B, P841, DOI 10.1302/0301-620X.88B7.17305; Leo AJ, 2006, CELLS TISSUES ORGANS, V183, P112, DOI 10.1159/000095985; Liu BL, 2004, PLANTA MED, V70, P305, DOI 10.1055/s-2004-818940; Manna SK, 2000, J IMMUNOL, V164, P6509, DOI 10.4049/jimmunol.164.12.6509; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; MIYAMOTO S, 1994, P NATL ACAD SCI USA, V91, P12740, DOI 10.1073/pnas.91.26.12740; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schulze-Tanzil G, 2004, OSTEOARTHR CARTILAGE, V12, P448, DOI 10.1016/j.joca.2004.02.007; Schulze-Tanzil G, 2002, CELL TISSUE RES, V308, P371, DOI 10.1007/s00441-002-0562-7; Shakibaei M, 1997, CELL BIOL INT, V21, P115, DOI 10.1006/cbir.1996.0118; Shakibaei M, 1997, CELL BIOL INT, V21, P75, DOI 10.1006/cbir.1996.0119; Shakibaei M, 1998, EXP CELL RES, V240, P95, DOI 10.1006/excr.1998.3933; Shakibaei M, 1999, BIOCHEM J, V342, P615, DOI 10.1042/0264-6021:3420615; SHAKIBAEI M, 1993, HISTOL HISTOPATHOL, V8, P463; Shakibaei M, 2001, J BIOL CHEM, V276, P13289, DOI 10.1074/jbc.M010859200; Shakibaei M, 2008, BIOCHEM PHARMACOL, V76, P1426, DOI 10.1016/j.bcp.2008.05.029; Shakibaei M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035712; Shakibaei M, 2011, GENES NUTR, V6, P171, DOI 10.1007/s12263-010-0179-5; Shakibaei M, 2011, J BIOL CHEM, V286, P11492, DOI 10.1074/jbc.M110.198713; Simic P, 2013, EMBO MOL MED, V5, P430, DOI 10.1002/emmm.201201606; Surh YJ, 1999, CANCER LETT, V140, P1, DOI 10.1016/S0304-3835(99)00039-7; Tsan MF, 2000, BRIT J HAEMATOL, V109, P405, DOI 10.1046/j.1365-2141.2000.01980.x; Tseng PC, 2011, J BONE MINER RES, V26, P2552, DOI 10.1002/jbmr.460; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wu LX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018447; Yan H, 2007, ARTHROSCOPY, V23, P178, DOI 10.1016/j.arthro.2006.09.005; Yeh HY, 2013, DIFFERENTIATION, V86, P171, DOI 10.1016/j.diff.2013.11.001; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; ZIMMERMANN B, 1992, CALCIFIED TISSUE INT, V51, P54, DOI 10.1007/BF00296218	69	68	73	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22048	22062		10.1074/jbc.M114.568790	http://dx.doi.org/10.1074/jbc.M114.568790			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24962570	Green Published, hybrid			2022-12-25	WOS:000340593500022
J	Harris, G; Ma, WJ; Maurer, LM; Potts, JR; Mosher, DF				Harris, Gemma; Ma, Wenjiang; Maurer, Lisa M.; Potts, Jennifer R.; Mosher, Deane F.			Borrelia burgdorferi Protein BBK32 Binds to Soluble Fibronectin via the N-terminal 70-kDa Region, Causing Fibronectin to Undergo Conformational Extension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM BETA-ZIPPER; FUNCTIONAL UPSTREAM DOMAIN; STREPTOCOCCUS-PYOGENES; CRYSTAL-STRUCTURES; SITES; ADHERENCE; COMPLEX; IDENTIFICATION; FRAGMENT; ADHESION	BBK32 is a fibronectin (FN)-binding protein expressed on the cell surface of Borrelia burgdorferi, the causative agent of Lyme disease. There is conflicting information about where and how BBK32 interacts with FN. We have characterized interactions of a recombinant 86-mer polypeptide, "Bbk32," comprising the unstructured FN-binding region of BBK32. Competitive enzyme-linked assays utilizing various FN fragments and epitope-mapped anti-FN monoclonal antibodies showed that Bbk32 binding involves both the fibrin-binding and the gelatin-binding domains of the 70-kDa N-terminal region (FN70K). Crystallographic and NMR analyses of smaller Bbk32 peptides complexed, respectively, with 2-3FNI and 8-9FNI, demonstrated that binding occurs by beta-strand addition. Isothermal titration calorimetry indicated that Bbk32 binds to isolated FN70K more tightly than to intact FN. In a competitive enzyme-linked binding assay, complex formation with Bbk32 enhanced binding of FN with mAbIII-10 to the (FNIII)-F-10 module. Thus, Bbk32 binds to multiple FN type 1 modules of the FN70K region by a tandem beta-zipper mechanism, and in doing so increases accessibility of FNIII modules that interact with other ligands. The similarity in the FN-binding mechanism of BBK32 and previously studied streptococcal proteins suggests that the binding and associated conformational change of FN play a role in infection.	[Harris, Gemma; Potts, Jennifer R.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Ma, Wenjiang; Maurer, Lisa M.; Mosher, Deane F.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Ma, Wenjiang; Maurer, Lisa M.; Mosher, Deane F.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA	University of York - UK; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), Univ Wisconsin, Dept Biomol Chem, 420 Henry Mall, Madison, WI 53706 USA.	dfmosher@wisc.edu		Maurer, Lisa/0000-0003-0492-9805; Harris, Gemma/0000-0002-4587-4620	National Institutes of Health [RO1 HL021644]; British Heart Foundation (BHF); BHF [FS/05/083, FS/12/36/29588]; MRC [G1001063] Funding Source: UKRI; British Heart Foundation [PG/09/079/28008, FS/12/36/29588] Funding Source: researchfish; Medical Research Council [G1001063] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007899, R01HL021644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation (BHF)(British Heart Foundation); BHF(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by National Institutes of Health Grant RO1 HL021644 (to D. F. M) and by the British Heart Foundation (BHF).; Supported by a BHF non-clinical Ph. D. studentship (FS/05/083).; Holds a BHF Senior Basic Science Fellowship (FS/12/36/29588). To whom correspondence may be addressed: Dept. of Biology, University of York, Heslington, York YO10 5DD, UK. Tel.: 44-1904-328679; Fax: 44-1904-328825; E-mail: jennifer.potts@york.ac.uk.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Atkin KE, 2010, J BIOL CHEM, V285, P36977, DOI 10.1074/jbc.M110.156935; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Chagnot C, 2012, CELL MICROBIOL, V14, P1687, DOI 10.1111/cmi.12002; Dzamba BJ, 2009, DEV CELL, V16, P421, DOI 10.1016/j.devcel.2009.01.008; Ensenberger MG, 2004, BIOPHYS CHEM, V112, P201, DOI 10.1016/j.bpc.2004.07.020; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Henderson B, 2011, FEMS MICROBIOL REV, V35, P147, DOI 10.1111/j.1574-6976.2010.00243.x; Hyde JA, 2011, MOL MICROBIOL, V82, P99, DOI 10.1111/j.1365-2958.2011.07801.x; Kim JH, 2004, J BIOL CHEM, V279, P41706, DOI 10.1074/jbc.M401691200; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Marjenberg ZR, 2011, J BIOL CHEM, V286, P1884, DOI 10.1074/jbc.M110.183053; Matthews JM, 2013, FEBS LETT, V587, P1164, DOI 10.1016/j.febslet.2013.01.002; Maurer LM, 2012, J BIOL CHEM, V287, P13303, DOI 10.1074/jbc.M111.294041; Maurer LM, 2010, J BIOL CHEM, V285, P41087, DOI 10.1074/jbc.M110.153692; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; MOSHER DF, 1983, J BIOL CHEM, V258, P6595; Moussavi-Harami SF, 2013, J PROTEOME RES, V12, P3393, DOI 10.1021/pr400225p; Norris NC, 2011, J BIOL CHEM, V286, P38311, DOI 10.1074/jbc.M111.276592; Ohashi T, 2011, J BIOL CHEM, V286, P39188, DOI 10.1074/jbc.M111.262337; Ozeri V, 2001, MOL MICROBIOL, V41, P561, DOI 10.1046/j.1365-2958.2001.02535.x; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Prabhakaran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005412; Probert WS, 1998, MOL MICROBIOL, V30, P1003, DOI 10.1046/j.1365-2958.1998.01127.x; Probert WS, 2001, INFECT IMMUN, V69, P4129, DOI 10.1128/IAI.69.6.4129-4133.2001; Raibaud S, 2005, J BIOL CHEM, V280, P18803, DOI 10.1074/jbc.M501731200; Remaut H, 2006, TRENDS BIOCHEM SCI, V31, P436, DOI 10.1016/j.tibs.2006.06.007; ROCCO M, 1987, EMBO J, V6, P2343, DOI 10.1002/j.1460-2075.1987.tb02510.x; Rudino-Pinera E, 2007, J MOL BIOL, V368, P833, DOI 10.1016/j.jmb.2007.02.061; Sachchidanand, 2002, J BIOL CHEM, V277, P50629, DOI 10.1074/jbc.M208956200; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micinf.2006.03.011; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Talay SR, 2000, CELL MICROBIOL, V2, P521, DOI 10.1046/j.1462-5822.2000.00076.x; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; Tucker RP, 2009, INT J BIOCHEM CELL B, V41, P424, DOI 10.1016/j.biocel.2008.08.003; UGAROVA T, 1995, THROMB HAEMOSTASIS, V74, P253; Xu JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004113	46	17	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22490	22499		10.1074/jbc.M114.578419	http://dx.doi.org/10.1074/jbc.M114.578419			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24962582	Green Published, hybrid			2022-12-25	WOS:000340593500058
J	Li, LL; Wang, QF; Li, HL; Yuan, MW; Yuan, ML				Li, Lili; Wang, Qifeng; Li, Hongli; Yuan, Mingwei; Yuan, Minglong			Preparation, Characterization, In Vitro Release and Degradation of Cathelicidin-BF-30-PLGA Microspheres	PLOS ONE			English	Article							AMINO-ACID; PROTEIN; STABILITY; NANOPARTICLES; CYTOTOXICITY; CARRIERS; PLA	Cathelicidin-BF-30 (BF-30), a water-soluble peptide isolated from the snake venom of Bungarus fasciatus containing 30 amino acid residues, was incorporated in poly(D,L-lactide-co-glycolide) (PLGA) 75:25 microspheres (MS) prepared by a water in oil in water W/O/W emulsification solvent extraction method. The aim of this work was to investigate the stability of BF-30 after encapsulation. D-trehalose was used as an excipient to stabilize the peptide. The MS obtained were mostly under 2 mu m in size and the encapsulation efficiency was 88.50 +/- 1.29%. The secondary structure of the peptide released in vitro was determined to be nearly the same as the native peptide using Circular Dichroism (CD). The ability of BF-30 to inhibit the growth of Escherichia coli was also maintained. The cellular relative growth and hemolysis rates were 92.16 +/- 3.55% and 3.52 +/- 0.45% respectively.	[Li, Lili; Li, Hongli; Yuan, Mingwei; Yuan, Minglong] Yunnan Univ Nationalities, Engn Res Ctr Biopolymer Funct Mat Yunnan, Kunming, Yunnan, Peoples R China; [Wang, Qifeng] Sichuan Canc Hosp, Dept Radiat Oncol, Chengdu, Sichuan, Peoples R China	Yunnan Minzu University	Yuan, ML (corresponding author), Yunnan Univ Nationalities, Engn Res Ctr Biopolymer Funct Mat Yunnan, Kunming, Yunnan, Peoples R China.	yml@188.com	Wang, Qifeng/AAX-7678-2021	Wang, Qifeng/0000-0001-8544-9007	National Natural Science Foundation of China [31160198, 31360417]; Applied Basic Research Key Project of Yunnan [2013FA039]; Applied Basic Research Project of Yunnan [2011FB084]; High-End Technology Professionals Introduction Plan in Yunnan province [2010CI119]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Applied Basic Research Key Project of Yunnan; Applied Basic Research Project of Yunnan; High-End Technology Professionals Introduction Plan in Yunnan province	This work was supported by the National Natural Science Foundation of China (31160198, 31360417), the Applied Basic Research Key Project of Yunnan (2013FA039), the Applied Basic Research Project of Yunnan (2011FB084), the High-End Technology Professionals Introduction Plan in Yunnan province (2010CI119). The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crotts G, 1998, J MICROENCAPSUL, V15, P699, DOI 10.3109/02652049809008253; Cui F, 2005, J CONTROL RELEASE, V107, P310, DOI 10.1016/j.jconrel.2005.07.001; Das TK, 2012, AAPS PHARMSCITECH, V13, P732, DOI 10.1208/s12249-012-9793-4; Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3; Ghassemi AH, 2012, PHARM RES-DORDR, V29, P110, DOI 10.1007/s11095-011-0517-3; Hamamoto K, 2002, MICROBIOL IMMUNOL, V46, P741, DOI 10.1111/j.1348-0421.2002.tb02759.x; He ZQ, 2011, J MACROMOL SCI B, V50, P1154, DOI 10.1080/00222348.2010.503106; Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0; Kim K, 2004, J CONTROL RELEASE, V98, P47, DOI 10.1016/j.jconrel.2004.04.009; Kim TH, 2002, BIOMATERIALS, V23, P2311, DOI 10.1016/S0142-9612(01)00365-9; Kostanski JW, 2000, PHARM DEV TECHNOL, V5, P585, DOI 10.1081/PDT-100102043; Li XH, 2000, J CONTROL RELEASE, V68, P41, DOI 10.1016/S0168-3659(00)00235-2; MAGENHEIM B, 1993, INT J PHARMACEUT, V94, P115, DOI 10.1016/0378-5173(93)90015-8; Mohamed F, 2008, J PHARM SCI-US, V97, P71, DOI 10.1002/jps.21082; Monkarsh SP, 1997, ANAL BIOCHEM, V247, P434, DOI 10.1006/abio.1997.2128; Montalvo-Ortiz BL, 2012, AAPS PHARMSCITECH, P1; OGAWA Y, 1988, CHEM PHARM BULL, V36, P1095; Pan H, 2011, WIRES NANOMED NANOBI, V3, P318, DOI 10.1002/wnan.126; Panyam J, 2003, J CONTROL RELEASE, V92, P173, DOI 10.1016/S0168-3659(03)00328-6; Regnier-Delplace C, 2013, J CONTROL RELEASE, V166, P256, DOI 10.1016/j.jconrel.2012.12.024; Samadi N, 2013, BIOMACROMOLECULES, V14, P1044, DOI 10.1021/bm301900t; Shen JM, 2012, BIOCONJUGATE CHEM, V23, P1010, DOI 10.1021/bc300008k; Sun HL, 2011, BIOMACROMOLECULES, V12, P1937, DOI 10.1021/bm200043u; Trindade RA, 2012, INT J PHARMACEUT, V423, P124, DOI 10.1016/j.ijpharm.2011.02.027; Wang YP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003217; Wei Y, 2011, J MATER CHEM, V21, P12691, DOI 10.1039/c1jm12643a; YEH MK, 1995, J CONTROL RELEASE, V33, P437, DOI 10.1016/0168-3659(94)00123-C; Zetterberg MM, 2011, J CONTROL RELEASE, V156, P323, DOI 10.1016/j.jconrel.2011.08.029; Zhang ZX, 2008, J HUAZHONG U SCI-MED, V28, P604, DOI 10.1007/s11596-008-0526-6; Zhou HM, 2011, PEPTIDES, V32, P1131, DOI 10.1016/j.peptides.2011.04.002	30	12	12	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100809	10.1371/journal.pone.0100809	http://dx.doi.org/10.1371/journal.pone.0100809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963652	gold, Green Published, Green Submitted			2022-12-25	WOS:000338709500082
J	Liu, SC; Kuang, HQ; Lai, ZX				Liu, Shengcai; Kuang, Huaqin; Lai, Zhongxiong			Transcriptome Analysis by Illumina High-Throughout Paired-End Sequencing Reveals the Complexity of Differential Gene Expression during In Vitro Plantlet Growth and Flowering in Amaranthus tricolor L.	PLOS ONE			English	Article							GERMIN-LIKE PROTEIN; CIRCADIAN CLOCK; GLOBAL TRANSCRIPTOME; ROOT TRANSCRIPTOME; MESSENGER-RNA; LEAVES; TIME; TUBERCULATUS; TRANSITION; GENERATION	Amaranthus tricolor L. is a C-4 plant, which is consumed as a major leafy vegetable in some tropical countries. Under conditions of high temperature and short daylight, Am. tricolor readily bolts and blooms, degrading leaf quality. A preliminary in vitro flowering study demonstrated that the flowering control pathway in Am. tricolor may differ from that of Arabidopsis. Nevertheless, no transcriptome analysis of the flowering process in Amaranthus has been conducted. To study Am. tricolor floral regulatory mechanisms, we conducted a large-scale transcriptome analysis-based on Illumina HiSeq sequencing of cDNA libraries generated from Am. tricolor at young seedling (YSS), adult seedling (ASS), flower bud (FBS), and flowering (FS) stages. A total of 99,312 unigenes were obtained. Using BLASTX, 43,088 unigenes (43.39%) were found to have significant similarity with accessions in Nr, Nt, and Swiss-Prot databases. Of these unigenes, 11,291 were mapped to 266 KEGG pathways. Further analysis of the four digital transcriptomes revealed that 735, 17,184, 274, and 206 unigenes were specifically expressed during YSS, ASS, FBS, and FS, respectively, with 59,517 unigenes expressed throughout the four stages. These unigenes were involved in many metabolic pathways related to in vitro flowering. Among these pathways, 259 unigenes were associated with ubiquitin-mediated proteolysis, indicating its importance for in vitro flowering in Am. tricolor. Other pathways, such as circadian rhythm and cell cycle, also had important roles. Finally, 26 unigenes were validated by qRT-PCR in samples from Am. tricolor at YSS, ASS, FBS, and FS; their differential expressions at the various stages indicate their possible roles in Am. tricolor growth and development, but the results were somewhat similar to Arabidopsis. Because unigenes involved in many metabolic pathways or of unknown function were revealed to regulate in vitro plantlet growth and flowering in Am. tricolor, the process appears to be highly complex in this species.	[Liu, Shengcai; Kuang, Huaqin; Lai, Zhongxiong] Fujian Agr & Forestry Univ, Inst Hort Biotechnol, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University	Lai, ZX (corresponding author), Fujian Agr & Forestry Univ, Inst Hort Biotechnol, Fuzhou, Fujian, Peoples R China.	laizx01@163.com			Research Fund for the Doctoral Program of Higher Education of the Chinese Ministry of Education [20123515120009]; Science Foundation of Fujian Province, China [2013J05045]; Research Fund of the Education Department of Fujian Province [JA12098]; Fujian Agriculture and Forestry University [132300102]; Special Foundation for Young Scientists of the Horticultural College of Fujian Agriculture and Forestry University [FAFU2012 YYPY10]	Research Fund for the Doctoral Program of Higher Education of the Chinese Ministry of Education; Science Foundation of Fujian Province, China; Research Fund of the Education Department of Fujian Province; Fujian Agriculture and Forestry University; Special Foundation for Young Scientists of the Horticultural College of Fujian Agriculture and Forestry University	This study was supported by the Research Fund for the Doctoral Program of Higher Education of the Chinese Ministry of Education (20123515120009), the Science Foundation of Fujian Province, China (2013J05045), the Research Fund of the Education Department of Fujian Province (JA12098), Horticulture Postdoctoral Funding from Fujian Agriculture and Forestry University (132300102), and the Special Foundation for Young Scientists of the Horticultural College of Fujian Agriculture and Forestry University (FAFU2012 YYPY10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andini R, 2013, AGRONOMY-BASEL, V3, P391, DOI 10.3390/agronomy3020391; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Armour CD, 2009, NAT METHODS, V6, P647, DOI [10.1038/NMETH.1360, 10.1038/nmeth.1360]; Bai S, 2013, PLANT CELL PHYSL; BERNIER G, 1993, PLANT CELL, V5, P1147, DOI 10.1105/tpc.5.10.1147; Biswas M, 2013, FOOD SCI BIOTECHNOL, V22, P1, DOI 10.1007/s10068-013-0041-9; Borner R, 2000, PLANT J, V24, P591, DOI 10.1046/j.1365-313x.2000.00906.x; Chu TingTing, 2010, China Biotechnology, V30, P98; Cong HQ, 2013, PLANT GROWTH REGUL, V69, P247, DOI 10.1007/s10725-012-9767-2; Cruz-Garcia GS, 2012, ACTA SOC BOT POL, V81, P397, DOI 10.5586/asbp.2012.047; Cui X, 2013, PLANT PHYSIOL, V162, P897, DOI 10.1104/pp.112.213009; de Montaigu A, 2010, TRENDS GENET, V26, P296, DOI 10.1016/j.tig.2010.04.003; Delano-Frier JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-363; Dunwell JM, 2008, CRIT REV PLANT SCI, V27, P342, DOI 10.1080/07352680802333938; Fan ZM, 2005, BIOCHEM BIOPH RES CO, V331, P1257, DOI 10.1016/j.bbrc.2005.04.045; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hao DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021220; Hao DC, 2012, SCI CHINA LIFE SCI, V55, P452, DOI 10.1007/s11427-012-4319-6; He CY, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-119; HEINTZEN C, 1994, PLANT PHYSIOL, V106, P905, DOI 10.1104/pp.106.3.905; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; Hicks KA, 2001, PLANT CELL, V13, P1281, DOI 10.1105/tpc.13.6.1281; Horvath D, 2010, CURR GENOMICS, V11, P47, DOI 10.2174/138920210790217972; Hsiao YY, 2013, GENE, V518, P91, DOI 10.1016/j.gene.2012.11.069; Huang YJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-691; Hyodo H, 2003, PLANT MOL BIOL, V52, P473, DOI 10.1023/A:1023904217641; Imaizumi T, 2010, CURR OPIN PLANT BIOL, V13, P83, DOI 10.1016/j.pbi.2009.09.007; Jarillo JA, 2011, PLANT SCI, V181, P364, DOI 10.1016/j.plantsci.2011.06.011; Kim J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-657; Kobayashi M, 2012, MOL BIOL REP, V39, P4367, DOI 10.1007/s11033-011-1224-1; Kobayashi M, 2010, J PLANT PHYSIOL, V167, P812, DOI 10.1016/j.jplph.2009.12.005; Kumar SV, 2010, CELL, V140, P136, DOI 10.1016/j.cell.2009.11.006; Lai ZX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-561; Lau OS, 2011, MOL CELL, V43, P703, DOI 10.1016/j.molcel.2011.07.013; Lee JR, 2008, CONSERV GENET, V9, P243, DOI 10.1007/s10592-007-9323-1; Lee RM, 2009, WEED SCI, V57, P463, DOI 10.1614/WS-09-021.1; [李铁柱 Li Tiezhu], 2012, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V32, P9; Li W, 2012, PLANT PHYSIOL, V159, P239, DOI 10.1104/pp.111.192617; Li ZQ, 2004, LIFE SCI RES, V8, P76; [刘生财 LIU Shengcai], 2011, [热带作物学报, Chinese Journal of Tropical Crops], V32, P1296; Logacheva MD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-30; Lu SX, 2012, PLANT PHYSIOL, V158, P1079, DOI 10.1104/pp.111.189670; LULIN H, 2012, PLOS ONE, V0007; Mallory MA, 2008, CROP SCI, V48, P1098, DOI 10.2135/cropsci2007.08.0457; Sanz-Penella JM, 2012, PLANT FOOD HUM NUTR, V67, P50, DOI 10.1007/s11130-011-0269-6; Maroyi A, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-60; Maughan PJ, 2008, CROP SCI, V48, pS85, DOI 10.2135/cropsci2007.08.0434tpg; Maughan PJ, 2009, PLANT GENOME-US, V2, P260, DOI 10.3835/plantgenome2009.08.0022; Meng XQ, 2013, CURRENT BIOTECHNOLOG, P1; Misra S, 2013, INT J AGR FOOD SCI, V3, P131; Mizoguchi T, 2002, DEV CELL, V2, P629, DOI 10.1016/S1534-5807(02)00170-3; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mosyakin SL, 2003, AMARANTHUS, V4, P410; Natale DA, 2000, GENOME BIOL, V1; Natarajan P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-191; Ono M, 1996, PLANT CELL PHYSIOL, V37, P855, DOI 10.1093/oxfordjournals.pcp.a029022; Pacin M, 2014, PLANT PHYSIOL; Pal A, 2013, IN VITRO CELL DEV-PL, V49, P114, DOI 10.1007/s11627-013-9489-9; Pineiro M, 2013, PLANT SCI, V198, P98, DOI [10.1016/j.plantsci.2012.10.005, 10.1016/j.pla]; Rastogi A, 2013, CRIT REV FOOD SCI, V53, P109, DOI 10.1080/10408398.2010.517876; Riggins CW, 2010, PEST MANAG SCI, V66, P1042, DOI 10.1002/ps.2006; Rowland LJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-46; Samach A, 2012, PLANT BIOTECHNOLOGY AND AGRICULTURE: PROSPECTS FOR THE 21ST CENTURY, P387, DOI 10.1016/B978-0-12-381466-1.00025-0; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Singh VK, 2013, PLANT BIOTECHNOL J, V11, P691, DOI 10.1111/pbi.12059; Sinha R, 2007, INDIAN J TRADIT KNOW, V6, P217; Song YL, 2012, SCI CHINA LIFE SCI, V55, P241, DOI 10.1007/s11427-012-4300-4; Sun Chang-Hui, 2007, Yichuan, V29, P1182, DOI 10.1360/yc-007-1182; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Tanaka N, 2011, PLANT CELL, V23, P2143, DOI 10.1105/tpc.111.083436; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826; Xiong YQ, 2011, PLANT MOL BIOL REP, V29, P835, DOI 10.1007/s11105-011-0291-8; Yaacob J, 2011, 1 INT S SUST VEG PRO, V958, P171; Yang N, 2012, J BEIJING FORESTR S1, P104; Yang WenWen, 2011, Journal of Fujian Agriculture and Forestry University (Natural Science Edition), V40, P360; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109	81	15	17	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100919	10.1371/journal.pone.0100919	http://dx.doi.org/10.1371/journal.pone.0100919			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963660	Green Submitted, Green Published, gold			2022-12-25	WOS:000338709500100
J	Sohoni, SV; Fazio, A; Workman, CT; Mijakovic, I; Lantz, E				Sohoni, Sujata Vijay; Fazio, Alessandro; Workman, Christopher T.; Mijakovic, Ivan; Lantz, Eliasson			Synthetic Promoter Library for Modulation of Actinorhodin Production in Streptomyces coelicolor A3(2)	PLOS ONE			English	Article							ANTIBIOTIC PRODUCTION; SECONDARY METABOLISM; TRANSCRIPTIONAL ACTIVATION; BIOSYNTHETIC GENES; REGULATOR; EXPRESSION; STRESS; SYSTEM; RESISTANCE; GROWTH	The objective of this study was the application of the synthetic promoter library (SPL) technology for modulation of actinorhodin production in Streptomyces coelicolor A3(2). The SPL technology was used to optimize the expression of a pathway specific positive transcriptional regulator Actll orf4, which activates the transcription of the S. coelicolor actinorhodin biosynthetic gene cluster. The native actll orf4 promoter was replaced with synthetic promoters, generating a S. coelicolor library with a broad range of expression levels of actll orf4. The resulting library was screened based on the yield of actinorhodin. Selected strains were further physiologically characterized. One of the strains from the library, ScoSPL20, showed considerably higher yield of actinorhodin and final actinorhodin titer, compared to S. coelicolor wild type and S. coelicolor with actll orf4 expressed from a strong constitutive promoter. ScoSPL20 demonstrated exceptional productivity despite having a comparatively weak expression from the promoter. Interestingly, the ScoSPL20 promoter was activated at a much earlier stage of growth compared to the wild type, demonstrating the advantage of fine-tuning and temporal tuning of gene expression in metabolic engineering. Transcriptome studies were performed in exponential and actinorhodin-producing phase of growth to compare gene expression between ScoSPL20 and the wild type. To our knowledge, this is the first successful application of the SPL technology for secondary metabolite production in filamentous bacteria.	[Sohoni, Sujata Vijay; Fazio, Alessandro; Workman, Christopher T.; Lantz, Eliasson] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Mijakovic, Ivan] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden	Technical University of Denmark; Chalmers University of Technology	Lantz, E (corresponding author), Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark.	ael@bio.dtu.dk	Lantz, Anna Eliasson/G-8569-2012; Workman, Christopher T/K-1066-2015; Mijakovic, Ivan/Q-5583-2016	Lantz, Anna Eliasson/0000-0003-1547-9299; Workman, Christopher T/0000-0002-2210-3743; Mijakovic, Ivan/0000-0002-8860-6853	Denmark Technical University; Danish Biotechnology Research School; European Commission [IP005224]	Denmark Technical University; Danish Biotechnology Research School; European Commission(European CommissionEuropean Commission Joint Research Centre)	Denmark Technical University, the Danish Biotechnology Research School and the European Commission (IP005224 ActinoGEN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFF, 2000, AFF GENECHIP EXPR AN; Alper H, 2006, P NATL ACAD SCI USA, V103, P3006, DOI 10.1073/pnas.0511314103; Andersen HW, 2001, J BACTERIOL, V183, P3458, DOI 10.1128/JB.183.11.3458-3467.2001; Arias P, 1999, J BACTERIOL, V181, P6958, DOI 10.1128/JB.181.22.6958-6968.1999; BAILEY JE, 1991, SCIENCE, V252, P1668, DOI 10.1126/science.2047876; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; Blank LM, 2004, MICROBIOL-SGM, V150, P1085, DOI 10.1099/mic.0.26845-0; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borodina I, 2008, J BIOL CHEM, V283, P25186, DOI 10.1074/jbc.M803105200; Bruheim P, 2002, J IND MICROBIOL BIOT, V28, P103, DOI 10.1038/sj/jim/7000219; Bruheim P, 2002, APPL MICROBIOL BIOT, V58, P735, DOI 10.1007/s00253-002-0969-9; CHATER KF, 1985, EMBO J, V4, P1893, DOI 10.1002/j.1460-2075.1985.tb03866.x; Chong PP, 1998, MICROBIOL-UK, V144, P193, DOI 10.1099/00221287-144-1-193; Craney A, 2012, CHEM BIOL, V19, P1020, DOI 10.1016/j.chembiol.2012.06.013; DOULL JL, 1990, APPL MICROBIOL BIOT, V32, P449, DOI 10.1007/BF00903781; Gao CH, 2012, ADV DIFFER EQU-NY, P1, DOI 10.1186/1687-1847-2012-3; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Huang J, 2005, MOL MICROBIOL, V58, P1276, DOI 10.1111/j.1365-2958.2005.04879.x; Jensen PR, 1998, BIOTECHNOL BIOENG, V58, P191, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<191::AID-BIT11>3.0.CO;2-G; Jensen PR, 1998, APPL ENVIRON MICROB, V64, P82; Kisser T, 2000, PRACTICAL STREPTOMYC; Lian W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-56; Ludwig H, 2001, MOL MICROBIOL, V41, P409, DOI 10.1046/j.1365-2958.2001.02523.x; Mijakovic I, 2005, CURR OPIN BIOTECH, V16, P329, DOI 10.1016/j.copbio.2005.04.003; Miksch G, 2005, J BIOTECHNOL, V120, P25, DOI 10.1016/j.jbiotec.2005.04.027; MUTH G, 1989, MOL GEN GENET, V219, P341, DOI 10.1007/BF00259605; Rigali S, 2008, EMBO REP, V9, P670, DOI 10.1038/embor.2008.83; Rud I, 2006, MICROBIOL-SGM, V152, P1011, DOI 10.1099/mic.0.28599-0; RUDD BAM, 1980, J GEN MICROBIOL, V119, P333; Sambrook J, 2001, MOL CLONING LAB MANU; Santos CNS, 2008, CURR OPIN CHEM BIOL, V12, P168, DOI 10.1016/j.cbpa.2008.01.017; Scotti C, 1996, J BACTERIOL, V178, P7316, DOI 10.1128/jb.178.24.7316-7321.1996; Seghezzi N, 2011, APPL MICROBIOL BIOT, V90, P615, DOI 10.1007/s00253-010-3018-0; Shu D, 2009, APPL MICROBIOL BIOT, V81, P1149, DOI 10.1007/s00253-008-1738-1; Sianidis G, 2006, J BIOTECHNOL, V121, P498, DOI 10.1016/j.jbiotec.2005.08.002; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sohoni SV, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-9; Sola-Landa A, 2003, P NATL ACAD SCI USA, V100, P6133, DOI 10.1073/pnas.0931429100; Solem C, 2002, APPL ENVIRON MICROB, V68, P2397, DOI 10.1128/AEM.68.5.2397-2403.2002; Tanaka A, 2007, J MOL BIOL, V369, P322, DOI 10.1016/j.jmb.2007.02.096; Uguru GC, 2005, MOL MICROBIOL, V58, P131, DOI 10.1111/j.1365-2958.2005.04817.x; VOGTLI M, 1994, MOL MICROBIOL, V14, P643, DOI 10.1111/j.1365-2958.1994.tb01303.x; Wang GJ, 2008, APPL ENVIRON MICROB, V74, P2834, DOI 10.1128/AEM.02800-07; WRIGHT LF, 1976, J GEN MICROBIOL, V96, P289, DOI 10.1099/00221287-96-2-289	46	28	30	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99701	10.1371/journal.pone.0099701	http://dx.doi.org/10.1371/journal.pone.0099701			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963940	Green Submitted, Green Published, gold			2022-12-25	WOS:000338709500013
J	Kuwayama, H; Gotoh, H; Konishi, Y; Nishikawa, H; Yaginuma, T; Niimi, T				Kuwayama, Hisashi; Gotoh, Hiroki; Konishi, Yusuke; Nishikawa, Hideto; Yaginuma, Toshinobu; Niimi, Teruyuki			Establishment of Transgenic Lines for Jumpstarter Method Using a Composite Transposon Vector in the Ladybrid Beetle, Harmonia axyridis	PLOS ONE			English	Article							INSERTIONAL MUTAGENESIS; DROSOPHILA-MELANOGASTER; INSECT TRANSGENESIS; REGULATORY ELEMENTS; ENHANCER DETECTION; LADYBIRD BEETLE; GENE-EXPRESSION; PIGGYBAC; TRANSFORMATION; GERMLINE	In this post-genomic era, genome-wide functional analysis is indispensable. The recent development of RNA interference techniques has enabled researchers to easily analyze gene function even in non-model organisms. On the other hand, little progress has been made in the identification and functional analyses of cis-regulatory elements in non-model organisms. In order to develop experimental platform for identification and analyses of cis-regulatory elements in a non-model organism, in this case, the ladybird beetle, Harmonia axyridis, we established transgenic transposon-tagged lines using a novel composite vector. This vector enables the generation of two types of insertion products (jumpstarter and mutator). The jumpstarter portion carries a transposase gene, while the mutator segment carries a reporter gene for detecting enhancers. The full-composite element is flanked by functional termini (required for movement); however, the mutator region has an extra terminus making it possible for the mutator to remobilize on its own, thus leaving an immobile jumpstarter element behind. Each insertion type is stable on its own, but once crossed, jumpstarters can remobilize mutators. After crossing a jumpstarter and mutator line, all tested G(2) females gave rise to at least one new insertion line in the next generation. This jumping rate is equivalent to the P-element-mediated jumpstarter method in Drosophila. These established transgenic lines will offer us the ideal experimental materials for the effective screening and identification of enhancers in this species. In addition, this jumpstarter method has the potential to be as effective in other non-model insect species and thus applicable to any organism.	[Kuwayama, Hisashi; Gotoh, Hiroki; Konishi, Yusuke; Nishikawa, Hideto; Yaginuma, Toshinobu; Niimi, Teruyuki] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Gotoh, Hiroki] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA	Nagoya University; Washington State University	Niimi, T (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	niimi@agr.nagoya-u.ac.jp	Gotoh, Hiroki/B-7568-2017	Niimi, Teruyuki/0000-0003-3981-0177	Formation and Recognition; PRESTO; Japan Science and Technology Agency; Ministry of Education, Science, Sports and Culture of Japan; Japan Society for the Promotion of Science Research; Ministry of Agriculture, Forestry and Fisheries	Formation and Recognition; PRESTO; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Agriculture, Forestry and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan)	This research was supported in part by Formation and Recognition, PRESTO, Japan Science and Technology Agency, Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan, the Japan Society for the Promotion of Science Research for the Future and Grant-in- Aid (BDP) from the Ministry of Agriculture, Forestry and Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERG CA, 1991, GENETICS, V127, P515; Berghammer AJ, 1999, NATURE, V402, P370, DOI 10.1038/46463; Brown SD, 1999, J CHEMOMETR, V13, P1; COOLEY L, 1988, SCIENCE, V239, P1121, DOI 10.1126/science.2830671; Dupuy AJ, 2001, GENESIS, V30, P82, DOI 10.1002/gene.1037; Gerlitz O, 2002, INT J DEV BIOL, V46, P173; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Handler AM, 2004, NAT BIOTECHNOL, V22, P1150, DOI 10.1038/nbt1002; Hara Kimiko, 2008, Journal of Insect Biotechnology and Sericology, V77, P159; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; Hediger M, 2001, INSECT MOL BIOL, V10, P113, DOI 10.1046/j.1365-2583.2001.00243.x; Horie K, 2001, P NATL ACAD SCI USA, V98, P9191, DOI 10.1073/pnas.161071798; Horn C, 2003, GENETICS, V163, P647; Horn C, 2002, INSECT BIOCHEM MOLEC, V32, P1221, DOI 10.1016/S0965-1748(02)00085-1; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Koch R L, 2003, J Insect Sci, V3, P32; KOMAI T, 1956, ADV GENET, V8, P155, DOI 10.1016/S0065-2660(08)60502-7; Kuwayama H, 2006, INSECT MOL BIOL, V15, P507, DOI 10.1111/j.1365-2583.2006.00665.x; Lewis DL, 1999, CURR BIOL, V9, P1279, DOI 10.1016/S0960-9822(00)80049-4; LONG D, 1993, P NATL ACAD SCI USA, V90, P10370, DOI 10.1073/pnas.90.21.10370; Lorenzen MD, 2007, INSECT MOL BIOL, V16, P265, DOI 10.1111/j.1365-2583.2007.00727.x; Masumoto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049323; Muller GB, 2007, NAT REV GENET, V8, P943, DOI 10.1038/nrg2219; Niimi Teruyuki, 2005, Journal of Insect Biotechnology and Sericology, V74, P95; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; Osawa N, 2000, POPUL ECOL, V42, P115, DOI 10.1007/PL00011990; ROBERTSON HM, 1988, GENETICS, V118, P461; Sasakura Y, 2008, DEV DYNAM, V237, P39, DOI 10.1002/dvdy.21333; Uchino Keiro, 2006, Journal of Insect Biotechnology and Sericology, V75, P89; Uchino K, 2008, INSECT BIOCHEM MOLEC, V38, P1165, DOI 10.1016/j.ibmb.2008.09.009; Wimmer EA, 2003, NAT REV GENET, V4, P225, DOI 10.1038/nrg1021; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Zagoraiou L, 2001, P NATL ACAD SCI USA, V98, P11474, DOI 10.1073/pnas.201392398	33	6	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100804	10.1371/journal.pone.0100804	http://dx.doi.org/10.1371/journal.pone.0100804			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959904	Green Published, Green Submitted, gold			2022-12-25	WOS:000338633900090
J	Rouhier, MF; Raphemot, R; Denton, JS; Piermarini, PM				Rouhier, Matthew F.; Raphemot, Rene; Denton, Jerod S.; Piermarini, Peter M.			Pharmacological Validation of an Inward- Rectifier Potassium (Kir) Channel as an Insecticide Target in the Yellow Fever Mosquito Aedes aegypti	PLOS ONE			English	Article							CHIKUNGUNYA VIRUS; RENAL TUBULES; EXCHANGER	Mosquitoes are important disease vectors that transmit a wide variety of pathogens to humans, including those that cause malaria and dengue fever. Insecticides have traditionally been deployed to control populations of disease-causing mosquitoes, but the emergence of insecticide resistance has severely limited the number of active compounds that are used against mosquitoes. Thus, to improve the control of resistant mosquitoes there is a need to identify new insecticide targets and active compounds for insecticide development. Recently we demonstrated that inward rectifier potassium (Kir) channels and small molecule inhibitors of Kir channels offer promising new molecular targets and active compounds, respectively, for insecticide development. Here we provide pharmacological validation of a specific mosquito Kir channel (AeKir1) in the yellow fever mosquito Aedes aegypti. We show that VU590, a small-molecule inhibitor of mammalian Kir1.1 and Kir7.1 channels, potently inhibits AeKir1 but not another mosquito Kir channel (AeKir2B) in vitro. Moreover, we show that a previously identified inhibitor of AeKir1 (VU573) elicits an unexpected agonistic effect on AeKir2B in vitro. Injection of VU590 into the hemolymph of adult female mosquitoes significantly inhibits their capacity to excrete urine and kills them within 24 h, suggesting a mechanism of action on the excretory system. Importantly, a structurally-related VU590 analog (VU608), which weakly blocks AeKir1 in vitro, has no significant effects on their excretory capacity and does not kill mosquitoes. These observations suggest that the toxic effects of VU590 are associated with its inhibition of AeKir1.	[Rouhier, Matthew F.; Piermarini, Peter M.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA; [Raphemot, Rene; Denton, Jerod S.] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37212 USA; [Raphemot, Rene; Denton, Jerod S.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Denton, Jerod S.] Vanderbilt Univ, Sch Med, Inst Chem Biol, Nashville, TN 37212 USA; [Denton, Jerod S.] Vanderbilt Univ, Sch Med, Inst Global Hlth, Nashville, TN 37212 USA	University System of Ohio; Ohio State University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Denton, JS (corresponding author), Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37212 USA.	jerod.s.denton@vanderbilt.edu; piermarini.1@osu.edu	Piermarini, Peter/AAO-5666-2021	Piermarini, Peter/0000-0003-1020-5774	Foundation for the National Institutes of Health through the Vector-Based Transmission of Control: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative; National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK082884]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082884] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health through the Vector-Based Transmission of Control: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by a grant from the Foundation for the National Institutes of Health through the Vector-Based Transmission of Control: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative. This work was also supported in part by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK082884; JSD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Bhatt S, 2013, NATURE; Bhave G, 2010, FUTURE MED CHEM, V2, P757, DOI 10.4155/FMC.10.179; Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873; Greenwood B, 2012, SCIENCE, V338, P49, DOI 10.1126/science.1229177; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Lewis LM, 2009, MOL PHARMACOL, V76, P1094, DOI 10.1124/mol.109.059840; MAHARAJ R, 2011, OPEN ACCESS INSECT P, V3, P27, DOI DOI 10.2147/OAIP.S8620; Piermarini PM, 2013, INSECT BIOCHEM MOLEC, V43, P75, DOI 10.1016/j.ibmb.2012.09.009; Piermarini PM, 2010, AM J PHYSIOL-REG I, V298, pR642, DOI 10.1152/ajpregu.00729.2009; Piermarini PM, 2009, AM J PHYSIOL-RENAL, V296, pF730, DOI 10.1152/ajprenal.90564.2008; Raphemot R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064905; Raphemot R, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00075; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rouhier MF, 2014, INSECT BIOCHEM MOLEC, V48, P91, DOI 10.1016/j.ibmb.2014.03.003; WHO, 2013, WORLD MALARIA REPORT 2013, P1	17	30	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100700	10.1371/journal.pone.0100700	http://dx.doi.org/10.1371/journal.pone.0100700			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959745	Green Published, Green Submitted, gold			2022-12-25	WOS:000338633900071
J	Avriel, A; Wiessman, MP; Almog, Y; Perl, Y; Novack, V; Galante, O; Klein, M; Pencina, MJ; Douvdevani, A				Avriel, Avital; Wiessman, Maya Paryente; Almog, Yaniv; Perl, Yael; Novack, Victor; Galante, Ori; Klein, Moti; Pencina, Michael J.; Douvdevani, Amos			Admission Cell Free DNA Levels Predict 28-Day Mortality in Patients with Severe Sepsis in Intensive Care	PLOS ONE			English	Article							FREE PLASMA DNA; PROGNOSTIC MARKER; PROCALCITONIN; THERAPY; PROTEIN	Aim: The aim of the current study is to assess the mortality prediction accuracy of circulating cell-free DNA (CFD) level at admission measured by a new simplified method. Materials and Methods: CFD levels were measured by a direct fluorescence assay in severe sepsis patients on intensive care unit (ICU) admission. In-hospital and/or twenty eight day all-cause mortality was the primary outcome. Results: Out of 108 patients with median APACHE II of 20, 32.4% have died in hospital/or at 28-day. CFD levels were higher in decedents: median 3469.0 vs. 1659 ng/ml, p<0.001. In multivariable model APACHE II score and CFD (quartiles) were significantly associated with the mortality: odds ratio of 1.05, p = 0.049 and 2.57, p<0.001 per quartile respectively. C-statistics for the models was 0.79 for CFD and 0.68 for APACHE II. Integrated discrimination improvement (IDI) analyses showed that CFD and CFD+APACHE II score models had better discriminatory ability than APACHE II score alone. Conclusions: CFD level assessed by a new, simple fluorometric-assay is an accurate predictor of acute mortality among ICU patients with severe sepsis. Comparison of CFD to APACHE II score and Procalcitonin (PCT), suggests that CFD has the potential to improve clinical decision making.	[Avriel, Avital] Soroka Univ, Med Ctr, Dept Internal Med, Pulmonol Inst, Beer Sheva, Israel; [Avriel, Avital; Wiessman, Maya Paryente; Almog, Yaniv; Perl, Yael; Novack, Victor; Galante, Ori; Klein, Moti; Douvdevani, Amos] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; [Wiessman, Maya Paryente; Perl, Yael; Novack, Victor] Soroka Univ, Med Ctr, Clin Res Ctr, Beer Sheva, Israel; [Almog, Yaniv] Soroka Univ, Med Ctr, Med Intens Care Unit, Beer Sheva, Israel; [Galante, Ori; Klein, Moti] Soroka Univ, Med Ctr, Gen Intens Care Unit, Beer Sheva, Israel; [Pencina, Michael J.] Duke Clin Res Inst, Durham, NC USA; [Douvdevani, Amos] Soroka Univ, Med Ctr, Beer Sheva, Israel	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Duke University; Ben Gurion University; Soroka Medical Center	Douvdevani, A (corresponding author), Soroka Univ, Med Ctr, Beer Sheva, Israel.	amosd@bgu.ac.il	Douvdevani, Amos/E-3803-2010; klein, moti/AAR-6552-2021	Douvdevani, Amos/0000-0002-0197-6481	Dr. Montague Robin Fleisher Kidney Transplant Unit Fund; Israeli Ministry of Health [3-00000-6087]	Dr. Montague Robin Fleisher Kidney Transplant Unit Fund; Israeli Ministry of Health	This work was supported by the "Dr. Montague Robin Fleisher Kidney Transplant Unit Fund" and by grant number 3-00000-6087 from the Chief Scientist, Israeli Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Calfee CS, 2012, AM J RESP CRIT CARE, V186, P2, DOI 10.1164/rccm.201205-0854ED; Chang CPY, 2003, CLIN CHIM ACTA, V327, P95, DOI 10.1016/S0009-8981(02)00337-6; Coimbra S, 2014, BRIT J DERMATOL, V170, P939, DOI 10.1111/bjd.12738; Czeiger D, 2011, AM J CLIN PATHOL, V135, P264, DOI 10.1309/AJCP4RK2IHVKTTZV; Dwivedi DJ, 2012, CRIT CARE, V16, DOI 10.1186/cc11466; Moreira VG, 2010, ANN CLIN BIOCHEM, V47, P253, DOI 10.1258/acb.2010.009173; Goldshtein H, 2009, ANN CLIN BIOCHEM, V46, P488, DOI 10.1258/acb.2009.009002; Huttunen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021700; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kohlova M, 2013, HEMODIAL INT, V17, P664, DOI 10.1111/hdi.12055; Kumar G, 2011, CHEST, V140, P1223, DOI 10.1378/chest.11-0352; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lichtenstern C, 2012, CURR OPIN INFECT DIS, V25, P328, DOI 10.1097/QCO.0b013e3283522038; Lo YMD, 2000, CLIN CHEM, V46, P319; McDonald B, 2012, CELL HOST MICROBE, V12, P324, DOI 10.1016/j.chom.2012.06.011; Ohayon S, 2012, J NEUROTRAUM, V29, P261, DOI 10.1089/neu.2011.1938; Okkonen M, 2011, CRIT CARE, V15, DOI 10.1186/cc10357; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Rhodes A, 2006, CRIT CARE, V10, DOI 10.1186/cc4894; Rhodes A, 2012, CRIT CARE, V16, DOI 10.1186/cc11508; Riedel S, 2012, DIAGN MICR INFEC DIS, V73, P221, DOI 10.1016/j.diagmicrobio.2012.05.002; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Saukkonen K, 2008, CLIN CHEM, V54, P1000, DOI 10.1373/clinchem.2007.101030; Shimony Avi, 2010, Acute Card Care, V12, P109, DOI 10.3109/17482941.2010.513732; Tovbin D, 2012, NEPHROL DIAL TRANSPL, V27, P3929, DOI 10.1093/ndt/gfs255; Tschaikowsky K, 2011, J CRIT CARE, V26, P54, DOI 10.1016/j.jcrc.2010.04.011; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Wijeratne S, 2004, ANN NY ACAD SCI, V1022, P232, DOI 10.1196/annals.1318.036	32	44	45	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100514	10.1371/journal.pone.0100514	http://dx.doi.org/10.1371/journal.pone.0100514			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955978	Green Submitted, Green Published, gold			2022-12-25	WOS:000338917900058
J	Ouyang, SH; Zhang, D; Han, J; Zhao, XJ; Cui, Y; Song, W; Huo, NX; Liang, Y; Xie, JZ; Wang, ZZ; Wu, QH; Chen, YX; Lu, P; Zhang, DY; Wang, LL; Sun, H; Yang, TM; Keeble-Gagnere, G; Appels, R; Dolezel, J; Ling, HQ; Luo, MC; Gu, YQ; Sun, QX; Liu, ZY				Ouyang, Shuhong; Zhang, Dong; Han, Jun; Zhao, Xiaojie; Cui, Yu; Song, Wei; Huo, Naxin; Liang, Yong; Xie, Jingzhong; Wang, Zhenzhong; Wu, Qiuhong; Chen, Yong-Xing; Lu, Ping; Zhang, De-Yun; Wang, Lili; Sun, Hua; Yang, Tsomin; Keeble-Gagnere, Gabriel; Appels, Rudi; Dolezel, Jaroslav; Ling, Hong-Qing; Luo, Mingcheng; Gu, Yongqiang; Sun, Qixin; Liu, Zhiyong			Fine Physical and Genetic Mapping of Powdery Mildew Resistance Gene MlIW172 Originating from Wild Emmer (Triticum dicoccoides)	PLOS ONE			English	Article							CHROMOSOME BIN MAP; SEQUENCE TAG LOCI; LEAF RUST; AESTIVUM L.; AEGILOPS-TAUSCHII; WHOLE-GENOME; DRAFT GENOME; WHEAT; IDENTIFICATION; RICE	Powdery mildew, caused by Blumeria graminis f. sp. tritici, is one of the most important wheat diseases in the world. In this study, a single dominant powdery mildew resistance gene MlIW172 was identified in the IW172 wild emmer accession and mapped to the distal region of chromosome arm 7AL (bin7AL-16-0.86-0.90) via molecular marker analysis. MlIW172 was closely linked with the RFLP probe Xpsr680-derived STS marker Xmag2185 and the EST markers BE405531 and BE637476. This suggested that MlIW172 might be allelic to the Pm1 locus or a new locus closely linked to Pm1. By screening genomic BAC library of durum wheat cv. Langdon and 7AL-specific BAC library of hexaploid wheat cv. Chinese Spring, and after analyzing genome scaffolds of Triticum urartu containing the marker sequences, additional markers were developed to construct a fine genetic linkage map on the MlIW172 locus region and to delineate the resistance gene within a 0.48 cM interval. Comparative genetics analyses using ESTs and RFLP probe sequences flanking the MlIW172 region against other grass species revealed a general co-linearity in this region with the orthologous genomic regions of rice chromosome 6, Brachypodium chromosome 1, and sorghum chromosome 10. However, orthologous resistance gene-like RGA sequences were only present in wheat and Brachypodium. The BAC contigs and sequence scaffolds that we have developed provide a framework for the physical mapping and map-based cloning of MlIW172.	[Ouyang, Shuhong; Zhang, Dong; Han, Jun; Zhao, Xiaojie; Cui, Yu; Song, Wei; Liang, Yong; Xie, Jingzhong; Wang, Zhenzhong; Wu, Qiuhong; Chen, Yong-Xing; Lu, Ping; Zhang, De-Yun; Wang, Lili; Yang, Tsomin; Sun, Qixin; Liu, Zhiyong] China Agr Univ, Key Lab Crop Heterosis Res & Utilizat, Beijing Key Lab Crop Genet Improvement, State Key Lab Agrobiotechnol,Minist Educ, Beijing 100094, Peoples R China; [Han, Jun] Beijing Agr Univ, Beijing 100094, Peoples R China; [Song, Wei] Beijing Acad Agr & Forestry Sci, Maize Res Ctr, Beijing, Peoples R China; [Huo, Naxin; Gu, Yongqiang] USDA ARS, Western Reg Res Ctr, Albany, CA 94710 USA; [Sun, Hua; Ling, Hong-Qing] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China; [Keeble-Gagnere, Gabriel; Appels, Rudi] Murdoch Univ, Perth, WA, Australia; [Dolezel, Jaroslav] Ctr Plant Struct & Funct Genom, Inst Expt Bot, Olomouc, Czech Republic; [Luo, Mingcheng] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	China Agricultural University; Beijing University of Agriculture; Beijing Academy of Agriculture & Forestry; United States Department of Agriculture (USDA); Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Murdoch University; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; University of California System; University of California Davis	Han, J (corresponding author), China Agr Univ, Key Lab Crop Heterosis Res & Utilizat, Beijing Key Lab Crop Genet Improvement, State Key Lab Agrobiotechnol,Minist Educ, Beijing 100094, Peoples R China.	hanjun4226@163.com; zhiyongliu@cau.edu.cn	Dolezel, Jaroslav/B-7716-2008; Xie, Jingzhong/AAF-5899-2020; Ling, Hong-Qing/ABC-9451-2020; Sun, Hua/O-6729-2018	Dolezel, Jaroslav/0000-0002-6263-0492; Sun, Hua/0000-0003-2169-0808; Luo, Ming-Cheng/0000-0002-9744-5887; Liu liu, Zhiyong zhi yong/0000-0002-6958-5233	Ministry of Agriculture [2014ZX08009-006B]; Ministry of Science & Technology of China [2011AA100104]; National Science Foundation of China [31030056]; Ministry of Education of China [111-2-03]; Chinese Scholarship Council	Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); Ministry of Science & Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Chinese Scholarship Council(China Scholarship Council)	This work was financially supported by Ministry of Agriculture (2014ZX08009-006B), Ministry of Science & Technology of China (2011AA100104), the National Science Foundation of China (31030056), Ministry of Education of China (111-2-03), and Chinese Scholarship Council Fellowship (to Shuhong Ouyang). The funders had no role in study design, data collection and analysis,	Abrouk M, 2010, TRENDS PLANT SCI, V15, P479, DOI 10.1016/j.tplants.2010.06.001; Akhunov ED, 2013, PLANT PHYSIOL, V161, P252, DOI 10.1104/pp.112.205161; Allen GC, 2006, NAT PROTOC, V1, P2320, DOI 10.1038/nprot.2006.384; [Anonymous], 2014, ANN WHEAT NEWSL; Ben-David R, 2010, THEOR APPL GENET, V121, P499, DOI 10.1007/s00122-010-1326-5; Bossolini E, 2007, PLANT J, V49, P704, DOI 10.1111/j.1365-313X.2006.02991.x; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Cenci A, 2003, THEOR APPL GENET, V107, P931, DOI 10.1007/s00122-003-1331-z; Chantret N, 2008, J MOL EVOL, V66, P138, DOI 10.1007/s00239-008-9066-8; Chhuneja P, 2012, THEOR APPL GENET, V124, P1051, DOI 10.1007/s00122-011-1768-4; Cloutier S, 2007, PLANT MOL BIOL, V65, P93, DOI 10.1007/s11103-007-9201-8; Dong LL, 2012, MOL GENET GENOMICS, V287, P855, DOI 10.1007/s00438-012-0721-9; Erayman M, 2004, NUCLEIC ACIDS RES, V32, P3546, DOI 10.1093/nar/gkh639; Everts KL, 2001, PLANT DIS, V85, P423, DOI 10.1094/PDIS.2001.85.4.423; Feuillet C, 2003, P NATL ACAD SCI USA, V100, P15253, DOI 10.1073/pnas.2435133100; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Goyal Aakash, 2005, Functional & Integrative Genomics, V5, P260, DOI 10.1007/s10142-005-0146-1; Gupta P K, 2008, Int J Plant Genomics, V2008, P896451, DOI 10.1155/2008/896451; Guyot Romain, 2004, Functional & Integrative Genomics, V4, P47, DOI 10.1007/s10142-004-0103-4; Hossain KG, 2004, GENETICS, V168, P687, DOI 10.1534/genetics.104.034850; Huang L, 2003, GENETICS, V164, P655; Huo NX, 2009, PLANT MOL BIOL, V70, P47, DOI 10.1007/s11103-009-9456-3; Ji XL, 2008, EUPHYTICA, V159, P385, DOI 10.1007/s10681-007-9540-1; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lazo GR, 2004, GENETICS, V168, P585, DOI 10.1534/genetics.104.034777; Li N, 2014, MOL BREEDING, V33, P669, DOI 10.1007/s11032-013-9983-0; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Liu Q, 2000, NUCLEIC ACIDS RES, V28, P940, DOI 10.1093/nar/28.4.940; Liu Ren-Hu, 2003, Yichuan, V25, P317; Liu ZJ, 2012, THEOR APPL GENET, V124, P1041, DOI 10.1007/s00122-011-1767-5; Luo MC, 2013, P NATL ACAD SCI USA, V110, P7940, DOI 10.1073/pnas.1219082110; MA ZQ, 1994, GENOME, V37, P871, DOI 10.1139/g94-123; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Maxwell JJ, 2009, THEOR APPL GENET, V119, P1489, DOI 10.1007/s00122-009-1150-y; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Miranda LM, 2007, CROP SCI, V47, P2323, DOI 10.2135/cropsci2007.01.0053; Mohler V, 2013, J APPL GENET, V54, P259, DOI 10.1007/s13353-013-0158-9; Neu C, 2002, GENOME, V45, P737, DOI [10.1139/g02-040, 10.1139/G02-040]; Nevo E., 2002, EVOLUTION WILD EMMER; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Peng J. H., 2005, Functional & Integrative Genomics, V5, P80, DOI 10.1007/s10142-004-0128-8; Periyannan S, 2013, SCIENCE, V341, P786, DOI 10.1126/science.1239028; Perugini LD, 2008, THEOR APPL GENET, V116, P417, DOI 10.1007/s00122-007-0679-x; Philippe R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-47; Pont C, 2013, PLANT J, V76, P1030, DOI 10.1111/tpj.12366; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; Qiu JW, 2007, THEOR APPL GENET, V115, P159, DOI 10.1007/s00122-007-0551-z; Qiu YC, 2005, THEOR APPL GENET, V111, P1524, DOI 10.1007/s00122-005-0081-5; Quraishi UM, 2011, FUNCT INTEGR GENOMIC, V11, P71, DOI 10.1007/s10142-010-0183-2; Roder MS, 1998, GENETICS, V149, P2007; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; SCHNEIDER DM, 1991, PLANT BREEDING, V107, P161, DOI 10.1111/j.1439-0523.1991.tb00545.x; SEARS ER, 1969, CROP SCI, V9, P96, DOI 10.2135/cropsci1969.0011183X000900010033x; Singrun C, 2003, THEOR APPL GENET, V106, P1420, DOI 10.1007/s00122-002-1187-7; Singrun C, 2004, THEOR APPL GENET, V109, P210, DOI 10.1007/s00122-004-1619-7; Srnic G, 2005, CROP SCI, V45, P1578, DOI 10.2135/cropsci2004.0530; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang JR, 2013, NEW PHYTOL, V198, P925, DOI 10.1111/nph.12164; Wu HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084691; Xiao MG, 2013, THEOR APPL GENET, V126, P1397, DOI 10.1007/s00122-013-2060-6; Xie ChaoJie, 2003, Journal of Triticeae Crops, V23, P39; Xie WL, 2012, THEOR APPL GENET, V124, P911, DOI 10.1007/s00122-011-1756-8; Xue F, 2012, THEOR APPL GENET, V124, P1549, DOI 10.1007/s00122-012-1809-7; Yahiaoui N, 2004, PLANT J, V37, P528, DOI 10.1046/j.1365-313X.2003.01977.x; Yao G, 2007, THEOR APPL GENET, V114, P351, DOI 10.1007/s00122-006-0438-4; You FM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-331; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Zhang XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057885	70	26	26	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100160	10.1371/journal.pone.0100160	http://dx.doi.org/10.1371/journal.pone.0100160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955773	Green Published, gold, Green Submitted			2022-12-25	WOS:000338917900029
J	Feng, XJ; Scott, A; Wang, Y; Wang, L; Zhao, YQ; Doerner, S; Satake, M; Croniger, CM; Wang, ZH				Feng, Xiujing; Scott, Anthony; Wang, Yong; Wang, Lan; Zhao, Yiqing; Doerner, Stephanie; Satake, Masanobu; Croniger, Colleen M.; Wang, Zhenghe			PTPRT Regulates High-Fat Diet-Induced Obesity and Insulin Resistance	PLOS ONE			English	Article							RETINOL-BINDING-PROTEIN; NEUROPEPTIDE-Y; GLUCOSE-PRODUCTION; ABDOMINAL OBESITY; LEPTIN RESISTANCE; ENERGY-BALANCE; MOUSE STRAINS; RECEPTOR; MICE; IDENTIFICATION	Obesity is a risk factor for many human diseases. However, the underlying molecular causes of obesity are not well understood. Here, we report that protein tyrosine phosphatase receptor T (PTPRT) knockout mice are resistant to high-fat diet-induced obesity. Those mice avoid many deleterious side effects of high-fat diet-induced obesity, displaying improved peripheral insulin sensitivity, lower blood glucose and insulin levels. Compared to wild type littermates, PTPRT knockout mice show reduced food intake. Consistently, STAT3 phosphorylation is up-regulated in the hypothalamus of PTPRT knockout mice. These studies implicate PTPRT-modulated STAT3 signaling in the regulation of high-fat diet-induced obesity.	[Feng, Xiujing; Scott, Anthony; Wang, Yong; Zhao, Yiqing; Doerner, Stephanie; Wang, Zhenghe] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Feng, Xiujing; Scott, Anthony; Wang, Yong; Zhao, Yiqing; Wang, Zhenghe] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Wang, Lan; Croniger, Colleen M.] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Satake, Masanobu] Tohoku Univ, Dept Mol Immunol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Wang, Zhenghe] Cleveland Clin Fdn, Genom Med Inst, Cleveland, OH 44195 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Tohoku University; Cleveland Clinic Foundation	Wang, ZH (corresponding author), Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.	zxw22@case.edu		Scott, Anthony/0000-0003-0644-1790; Wang, Zhenghe/0000-0003-1546-1080	National Institutes of Health [R01CA127590, P50CA150964, U24 DK059630, U24-DK76174]; NATIONAL CANCER INSTITUTE [P50CA150964, R01CA127590, P30CA043703] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK076174, U24DK059630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding came from the National Institutes of Health R01CA127590, P50CA150964, U24 DK059630 and U24-DK76174. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2011, J CLIN INVEST, V121, P2076, DOI 10.1172/JCI58719; Bagherian Ali, 2010, J Oral Sci, V52, P397; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Beck B, 2006, PHILOS T R SOC B, V361, P1159, DOI 10.1098/rstb.2006.1855; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Berry DC, 2013, J BIOL CHEM, V288, P24528, DOI 10.1074/jbc.M113.484014; Bi S, 2012, NEUROPEPTIDES, V46, P309, DOI 10.1016/j.npep.2012.09.002; Borecki I B, 1994, Obes Res, V2, P213; Bray GA, 2010, CURR OPIN LIPIDOL, V21, P51, DOI 10.1097/MOL.0b013e3283346ca2; Brothers SP, 2010, EMBO MOL MED, V2, P429, DOI 10.1002/emmm.201000100; Buchner DA, 2012, MAMM GENOME, V23, P431, DOI 10.1007/s00335-012-9400-8; Carey M, 2013, J BIOL CHEM, V288, P34981, DOI 10.1074/jbc.R113.506782; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Elbein SC, 2011, DIABETES, V60, P1019, DOI 10.2337/db10-1270; Elmquist JK, 1998, NAT NEUROSCI, V1, P445, DOI 10.1038/2164; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Gerozissis K, 2008, EUR J PHARMACOL, V585, P38, DOI 10.1016/j.ejphar.2008.01.050; Han RJ, 2012, FASEB J, V26, P3528, DOI 10.1096/fj.12-203943; Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hussain AH, 2010, J DIABETOLOGY, V2; Jandacek RJ, 2004, GASTROENTEROLOGY, V127, P139, DOI 10.1053/j.gastro.2004.04.007; Jequier E, 2002, INT J OBESITY, V26, pS12, DOI 10.1038/sj.ijo.0802123; Koch L, 2008, J CLIN INVEST, V118, P2132, DOI 10.1172/JCI31073; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; Lam CKL, 2011, DIABETES, V60, P107, DOI 10.2337/db10-0994; Lee JH, 1999, AM J HUM GENET, V64, P196, DOI 10.1086/302195; Lembertas AV, 1997, J CLIN INVEST, V100, P1240, DOI 10.1172/JCI119637; Loh K, 2011, CELL METAB, V14, P684, DOI 10.1016/j.cmet.2011.09.011; Marwarha G, 2013, FASEB J; Marwarha G, 2014, FASEB J, V28, P26, DOI 10.1096/fj.13-234310; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Millward CA, 2010, J LIPID RES, V51, P1452, DOI 10.1194/jlr.M005363; Munzberg H, 2005, CELL MOL LIFE SCI, V62, P642, DOI 10.1007/s00018-004-4432-1; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Pagotto U, 2009, DIABETES CARE, V32, pS174, DOI 10.2337/dc09-S305; Prince A, 2013, ADV EXP MED BIOL, V789, P323, DOI 10.1007/978-1-4614-7411-1_43; Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958; Ruohonen ST, 2008, DIABETES, V57, P1517, DOI 10.2337/db07-0722; Ruohonen Suvi T, 2012, Int J Pept, V2012, P452524, DOI 10.1155/2012/452524; Schreyer SA, 1998, ATHEROSCLEROSIS, V136, P17, DOI 10.1016/S0021-9150(97)00165-2; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; SURWIT RS, 1991, DIABETES, V40, P82, DOI 10.2337/diabetes.40.1.82; Tinsley FC, 2004, OBES RES, V12, P150, DOI 10.1038/oby.2004.20; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Visel A, 2007, PLOS GENET, V3, P1867, DOI 10.1371/journal.pgen.0030178; Warne JP, 2007, NAT MED, V13, P781, DOI 10.1038/nm0707-781; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; Williams KW, 2012, NAT NEUROSCI, V15, P1350, DOI 10.1038/nn.3217; Xu E, 2013, REV ENDOCR METAB DIS; Zhang XD, 2007, P NATL ACAD SCI USA, V104, P4060, DOI 10.1073/pnas.0611665104; Zhao YQ, 2010, P NATL ACAD SCI USA, V107, P2592, DOI 10.1073/pnas.0914884107	52	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100783	10.1371/journal.pone.0100783	http://dx.doi.org/10.1371/journal.pone.0100783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949727	Green Submitted, Green Published, gold			2022-12-25	WOS:000338276300113
J	Sheridan, GK; Moeendarbary, E; Pickering, M; O'Connor, JJ; Murphy, KJ				Sheridan, Graham K.; Moeendarbary, Emad; Pickering, Mark; O'Connor, John J.; Murphy, Keith J.			Theta-Burst Stimulation of Hippocampal Slices Induces Network-Level Calcium Oscillations and Activates Analogous Gene Transcription to Spatial Learning	PLOS ONE			English	Article							LONG-TERM POTENTIATION; NF-KAPPA-B; METABOTROPIC GLUTAMATE-RECEPTOR; ASTROCYTES IN-SITU; OPTICAL QUANTAL ANALYSIS; CAM KINASE-II; SYNAPTIC PLASTICITY; CA2+ OSCILLATIONS; NMDA RECEPTORS; DENTATE GYRUS	Over four decades ago, it was discovered that high-frequency stimulation of the dentate gyrus induces long-term potentiation (LTP) of synaptic transmission. LTP is believed to underlie how we process and code external stimuli before converting it to salient information that we store as 'memories'. It has been shown that rats performing spatial learning tasks display theta-frequency (3-12 Hz) hippocampal neural activity. Moreover, administering theta-burst stimulation (TBS) to hippocampal slices can induce LTP. TBS triggers a sustained rise in intracellular calcium [Ca2+](i) in neurons leading to new protein synthesis important for LTP maintenance. In this study, we measured TBS-induced [Ca2+](i) oscillations in thousands of cells at increasing distances from the source of stimulation. Following TBS, a calcium wave propagates radially with an average speed of 5.2 mu m/s and triggers multiple and regular [Ca2+](i) oscillations in the hippocampus. Interestingly, the number and frequency of [Ca2+](i) fluctuations post-TBS increased with respect to distance from the electrode. During the post-tetanic phase, 18% of cells exhibited 3 peaks in [Ca2+](i) with a frequency of 17 mHz, whereas 2.3% of cells distributed further from the electrode displayed 8 [Ca2+](i) oscillations at 33 mHz. We suggest that these observed [Ca2+](i) oscillations could lead to activation of transcription factors involved in synaptic plasticity. In particular, the transcription factor, NF-kappa B, has been implicated in memory formation and is up-regulated after LTP induction. We measured increased activation of NF-kappa B 30 min post-TBS in CA1 pyramidal cells and also observed similar temporal up-regulation of NF-kappa B levels in CA1 neurons following water maze training in rats. Therefore, TBS of hippocampal slice cultures in vitro can mimic the cell type-specific up-regulations in activated NF-kappa B following spatial learning in vivo. This indicates that TBS may induce similar transcriptional changes to spatial learning and that TBS-triggered [Ca2+](i) oscillations could activate memory-associated gene expression.	[Sheridan, Graham K.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Moeendarbary, Emad] Univ Cambridge, Cambridge, England; [Pickering, Mark] Univ Coll Dublin, Hlth Sci Ctr, Sch Med & Med Sci, Dublin 2, Ireland; [O'Connor, John J.] Univ Coll Dublin, UCD Sch Biomol & Biomed Sci, Conway Inst, Dublin 2, Ireland; [Murphy, Keith J.] Univ Coll Dublin, Conway Inst, Neurotherapeut Res Grp, UCD Sch Biomol & Biomed Sci, Dublin 2, Ireland	University of Cambridge; University of Cambridge; University College Dublin; University College Dublin; University College Dublin	Sheridan, GK (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	gks28@cam.ac.uk		O'Connor, John/0000-0001-8229-8602; , Graham/0000-0002-8493-2651; Moeendarbary, Emad/0000-0002-7019-3907; Pickering, Mark/0000-0002-2454-2897	Science Foundation Ireland [03/IN3/B403C, 07/IN.1/B1322]; University of Cambridge Herchel Smith Postdoctoral Fellowship	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); University of Cambridge Herchel Smith Postdoctoral Fellowship	This work was supported by a research cluster award from Science Foundation Ireland (03/IN3/B403C and 07/IN.1/B1322). E. Moeendarbary is supported by University of Cambridge Herchel Smith Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado F, 2002, J NEUROSCI, V22, P9430; Albensi BC, 2007, EXP NEUROL, V204, P1, DOI 10.1016/j.expneurol.2006.12.009; Ashpole NM, 2012, J BIOL CHEM, V287, P8495, DOI 10.1074/jbc.M111.323915; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Bernardinelli Y, 2011, J NEUROSCI, V31, P8905, DOI 10.1523/JNEUROSCI.6341-10.2011; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Bikbaev A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002155; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Borroni AM, 2000, J NEUROSCI, V20, P9272; CAESER M, 1991, J COMP NEUROL, V307, P87, DOI 10.1002/cne.903070109; Cali C, 2008, J NEUROIMMUNOL, V198, P82, DOI 10.1016/j.jneuroim.2008.04.015; Cali C, 2010, J NEUROIMMUNOL, V224, P13, DOI 10.1016/j.jneuroim.2010.05.004; Carter AG, 2002, J NEUROSCI, V22, P21, DOI 10.1523/JNEUROSCI.22-01-00021.2002; Cavallaro S, 2002, P NATL ACAD SCI USA, V99, P16279, DOI 10.1073/pnas.242597199; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Domercq M, 2006, J BIOL CHEM, V281, P30684, DOI 10.1074/jbc.M606429200; DUPONT G, 1994, BIOPHYS J, V67, P2191, DOI 10.1016/S0006-3495(94)80705-2; DUPONT G, 1993, CELL CALCIUM, V14, P311, DOI 10.1016/0143-4160(93)90052-8; Dupont G, 2003, CELL CALCIUM, V34, P485, DOI 10.1016/S0143-4160(03)00152-0; Dupont G, 1998, BIOESSAYS, V20, P607, DOI 10.1002/(SICI)1521-1878(199808)20:8<607::AID-BIES2>3.3.CO;2-2; Emptage NJ, 2003, NEURON, V38, P797, DOI 10.1016/S0896-6273(03)00325-8; FREEMAN FM, 1995, NEUROBIOL LEARN MEM, V63, P291, DOI 10.1006/nlme.1995.1034; Freudenthal R, 2005, EUR J NEUROSCI, V21, P2845, DOI 10.1111/j.1460-9568.2005.04126.x; Freudenthal R, 2004, HIPPOCAMPUS, V14, P677, DOI 10.1002/hipo.20020; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Giaume C, 1998, GLIA, V24, P50, DOI 10.1002/(SICI)1098-1136(199809)24:1<50::AID-GLIA6>3.0.CO;2-4; Gillespie JM, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00027; Gogolla N, 2006, NAT PROTOC, V1, P2452, DOI 10.1038/nprot.2006.180; Graupner M, 2012, P NATL ACAD SCI USA, V109, P3991, DOI 10.1073/pnas.1109359109; GROVER LM, 1994, SYNAPSE, V16, P66, DOI 10.1002/syn.890160108; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; GUTHRIE PB, 1991, NATURE, V354, P76, DOI 10.1038/354076a0; Hamilton TJ, 2010, P NATL ACAD SCI USA, V107, P18185, DOI 10.1073/pnas.1011558107; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; HILL AJ, 1978, EXP NEUROL, V62, P282, DOI 10.1016/0014-4886(78)90058-4; Honsek SD, 2012, HIPPOCAMPUS, V22, P29, DOI 10.1002/hipo.20843; Hu QDeshpandeS, 1999, J BIOL CHEM, V274; Huang YHH, 2004, J NEUROSCI, V24, P4551, DOI 10.1523/JNEUROSCI.5217-03.2004; Igaz LM, 2002, J NEUROSCI, V22, P6781; Ismailov I, 2004, J NEUROSCI, V24, P9847, DOI 10.1523/JNEUROSCI.0738-04.2004; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243, DOI 10.1152/jn.1961.24.3.243; Kato HK, 2012, J PHYSIOL-LONDON, V590, P3019, DOI 10.1113/jphysiol.2012.232942; Kratzer S, 2012, ANESTHESIOLOGY, V116, P673, DOI 10.1097/ALN.0b013e3182475d66; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Levenson JM, 2004, J NEUROSCI, V24, P3933, DOI 10.1523/JNEUROSCI.5646-03.2004; Leybaert L, 2012, PHYSIOL REV, V92, P1359, DOI 10.1152/physrev.00029.2011; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043810; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; MacDonald John F., 2006, Critical Reviews in Neurobiology, V18, P71; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Meberg PJ, 1996, MOL BRAIN RES, V38, P179, DOI 10.1016/0169-328X(95)00229-L; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Meiri N, 1998, BRAIN RES, V789, P48, DOI 10.1016/S0006-8993(97)01528-X; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; O'Leary DM, 1999, PROG NEURO-PSYCHOPH, V23, P133, DOI 10.1016/S0278-5846(98)00095-5; O'Mahony A, 2006, MOL CELL BIOL, V26, P7283, DOI 10.1128/MCB.00510-06; O'Riordan KJ, 2006, J NEUROSCI, V26, P4870, DOI 10.1523/JNEUROSCI.4527-05.2006; O'Sullivan NC, 2007, J NEUROCHEM, V101, P1085, DOI 10.1111/j.1471-4159.2006.04418.x; O'Sullivan NC, 2012, TRANSCRIPTION FACTORS CREB AND NF-KB: INVOLVEMENT IN SYNAPTIC PLASTICITY AND MEMORY FORMATION, P43; OCONNOR JJ, 1994, NATURE, V367, P557, DOI 10.1038/367557a0; Otto T, 1991, Hippocampus, V1, P181, DOI 10.1002/hipo.450010206; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pascual O, 2012, P NATL ACAD SCI USA, V109, pE197, DOI 10.1073/pnas.1111098109; PASTI L, 1995, J BIOL CHEM, V270, P15203, DOI 10.1074/jbc.270.25.15203; Pasti L, 1997, J NEUROSCI, V17, P7817; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Piochon Claire, 2010, J Neurosci, V30, P15330, DOI 10.1523/JNEUROSCI.4344-10.2010; Pizzo P, 2001, J NEUROCHEM, V79, P98, DOI 10.1046/j.1471-4159.2001.00539.x; Poser S, 2001, INT J DEV NEUROSCI, V19, P387, DOI 10.1016/S0736-5748(00)00094-0; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Raymond CR, 2006, J PHYSIOL-LONDON, V570, P97, DOI 10.1113/jphysiol.2005.098947; Romano A, 2006, EUR J NEUROSCI, V24, P1507, DOI 10.1111/j.1460-9568.2006.05022.x; Rusakov DA, 2011, NEUROSCIENTIST, V17, P513, DOI DOI 10.1177/1073858410387304; Ryan MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040538; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Schipke CG, 2001, FASEB J, V15, P255, DOI 10.1096/fj.01-0514fje; Sergeeva M, 2003, CELL CALCIUM, V33, P283, DOI 10.1016/S0143-4160(03)00011-3; Sheridan GK, 2007, LEARN MEMORY, V14, P525, DOI 10.1101/lm.590007; Song SS, 2012, J BIOL CHEM, V287, P40246, DOI 10.1074/jbc.M112.417154; STAUBLI U, 1987, BRAIN RES, V435, P227, DOI 10.1016/0006-8993(87)91605-2; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Baez MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055244; Ward B, 2006, NEURON, V52, P649, DOI 10.1016/j.neuron.2006.10.007; Wellmann H, 2001, J BIOL CHEM, V276, P11821, DOI 10.1074/jbc.M009253200; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Woodside BL, 2004, NEUROBIOL LEARN MEM, V81, P105, DOI 10.1016/j.nlm.2003.10.003; Yuan Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020486	98	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100546	10.1371/journal.pone.0100546	http://dx.doi.org/10.1371/journal.pone.0100546			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950243	Green Published, Green Submitted, gold			2022-12-25	WOS:000338276300087
J	Weber, M; Bujak, E; Putelli, A; Villa, A; Matasci, M; Gualandi, L; Hemmerle, T; Wulhfard, S; Neri, D				Weber, Marcel; Bujak, Emil; Putelli, Alessia; Villa, Alessandra; Matasci, Mattia; Gualandi, Laura; Hemmerle, Teresa; Wulhfard, Sarah; Neri, Dario			A Highly Functional Synthetic Phage Display Library Containing over 40 Billion Human Antibody Clones	PLOS ONE			English	Article							AFFINITY HUMAN-ANTIBODIES; SINGLE-CHAIN FV; TENASCIN-C; MONOCLONAL-ANTIBODIES; STRUCTURAL REPERTOIRE; CANONICAL STRUCTURES; CANCER-THERAPY; DOMAIN; DESIGN; IMMUNOCYTOKINE	Several synthetic antibody phage display libraries have been created and used for the isolation of human monoclonal antibodies. The performance of antibody libraries, which is usually measured in terms of their ability to yield high-affinity binding specificities against target proteins of interest, depends both on technical aspects (such as library size and quality of cloning) and on design features (which influence the percentage of functional clones in the library and their ability to be used for practical applications). Here, we describe the design, construction and characterization of a combinatorial phage display library, comprising over 40 billion human antibody clones in single-chain fragment variable (scFv) format. The library was designed with the aim to obtain highly stable antibody clones, which can be affinity-purified on protein A supports, even when used in scFv format. The library was found to be highly functional, as >90% of randomly selected clones expressed the corresponding antibody. When selected against more than 15 antigens from various sources, the library always yielded specific and potent binders, at a higher frequency compared to previous antibody libraries. To demonstrate library performance in practical biomedical research projects, we isolated the human antibody G5, which reacts both against human and murine forms of the alternatively spliced BCD segment of tenascin-C, an extracellular matrix component frequently over-expressed in cancer and in chronic inflammation. The new library represents a useful source of binding specificities, both for academic research and for the development of antibody-based therapeutics.	[Weber, Marcel; Bujak, Emil; Putelli, Alessia; Neri, Dario] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Dept Chem & Appl Biosci, Zurich, Switzerland; [Weber, Marcel; Bujak, Emil; Putelli, Alessia; Villa, Alessandra; Matasci, Mattia; Gualandi, Laura; Hemmerle, Teresa; Wulhfard, Sarah] Philochem AG, Otelfingen, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Neri, D (corresponding author), Swiss Fed Inst Technol, Inst Pharmaceut Sci, Dept Chem & Appl Biosci, Zurich, Switzerland.	neri@pharma.ethz.ch	Neri, Dario/P-4368-2016	Neri, Dario/0000-0001-5234-7370; Weber, Marcel/0000-0002-8532-3321	ETH Zurich; ETH Zurich, KTI, Philochem AG	ETH Zurich(ETH Zurich); ETH Zurich, KTI, Philochem AG	ETH Zurich, KTI, Philochem AG. The funder provided support in the form of salaries for authors (MW, EB, AP, AV, TH, MM, LG, SW, DN), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Aloj L, 2014, EUR J NUCL MED MOL I, V41, P867, DOI 10.1007/s00259-013-2658-6; BALZA E, 1993, FEBS LETT, V332, P39, DOI 10.1016/0014-5793(93)80479-E; Bernardes GJL, 2012, ANGEW CHEM INT EDIT, V51, P941, DOI 10.1002/anie.201106527; Borsi L, 2002, INT J CANCER, V102, P75, DOI 10.1002/ijc.10662; Brack SS, 2006, CLIN CANCER RES, V12, P3200, DOI 10.1158/1078-0432.CCR-05-2804; Buss NAPS, 2012, CURR OPIN PHARMACOL, V12, P615, DOI 10.1016/j.coph.2012.08.001; Carnemolla B, 1999, AM J PATHOL, V154, P1345, DOI 10.1016/S0002-9440(10)65388-6; Casi G, 2012, J CONTROL RELEASE, V161, P422, DOI 10.1016/j.jconrel.2012.01.026; Chari RVJ, 2008, ACCOUNTS CHEM RES, V41, P98, DOI 10.1021/ar700108g; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CHOTHIA C, 1992, J MOL BIOL, V227, P799, DOI 10.1016/0022-2836(92)90224-8; CLACKSON T, 1991, NATURE, V352, P624, DOI 10.1038/352624a0; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; Gutbrodt KL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006221; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; HOOGENBOOM HR, 1991, NUCLEIC ACIDS RES, V19, P4133, DOI 10.1093/nar/19.15.4133; HOOGENBOOM HR, 1992, J MOL BIOL, V227, P381, DOI 10.1016/0022-2836(92)90894-P; HOOGENBOOM HR, 1992, IMMUNOL REV, V130, P41, DOI 10.1111/j.1600-065X.1992.tb01520.x; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; LERNER RA, 1992, SCIENCE, V258, P1313, DOI 10.1126/science.1455226; List T, 2012, MABS-AUSTIN, V4, P775, DOI 10.4161/mabs.22271; Ma XL, 2013, J MOL BIOL, V425, P2247, DOI 10.1016/j.jmb.2013.03.020; Marks James D, 2004, Methods Mol Biol, V248, P161; MARKS JD, 1992, BIO-TECHNOL, V10, P779, DOI 10.1038/nbt0792-779; Marlind J, 2008, CLIN CANCER RES, V14, P6515, DOI 10.1158/1078-0432.CCR-07-5041; Merz DC, 1995, J NEUROSCI METH, V62, P213, DOI 10.1016/0165-0270(95)00079-8; Midwood KS, 2011, CELL MOL LIFE SCI, V68, P3175, DOI 10.1007/s00018-011-0783-6; Morea V, 1997, BIOPHYS CHEM, V68, P9, DOI 10.1016/S0301-4622(96)02266-1; Pasche N, 2012, DRUG DISCOV TODAY, V17, P583, DOI 10.1016/j.drudis.2012.01.007; Pedretti M, 2010, BRIT J CANCER, V103, P827, DOI 10.1038/sj.bjc.6605832; Pedretti M, 2010, ATHEROSCLEROSIS, V208, P382, DOI 10.1016/j.atherosclerosis.2009.07.043; Pedretti M, 2009, LUNG CANCER, V64, P28, DOI 10.1016/j.lungcan.2008.07.013; Pini A, 1998, J BIOL CHEM, V273, P21769, DOI 10.1074/jbc.273.34.21769; Ponsel D, 2011, MOLECULES, V16, P3675, DOI 10.3390/molecules16053675; Ravenni N, 2013, MABS, V6; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Rothlisberger D, 2005, J MOL BIOL, V347, P773, DOI 10.1016/j.jmb.2005.01.053; Schliemann C, 2007, BBA-REV CANCER, V1776, P175, DOI 10.1016/j.bbcan.2007.08.002; Schliemann C, 2010, RECENT RESULTS CANC, V180, P201, DOI 10.1007/978-3-540-78281-0_12; Schliemann C, 2009, LEUKEMIA RES, V33, P1718, DOI 10.1016/j.leukres.2009.06.025; Schwager K, 2011, HUM REPROD, V26, P2344, DOI 10.1093/humrep/der195; Schwager K, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-25; Schwager K, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2814; Senter PD, 2009, CURR OPIN CHEM BIOL, V13, P235, DOI 10.1016/j.cbpa.2009.03.023; Silacci M, 2005, PROTEOMICS, V5, P2340, DOI 10.1002/pmic.200401273; Silacci M, 2006, PROTEIN ENG DES SEL, V19, P471, DOI 10.1093/protein/gzl033; Sliwkowski MX, 2013, SCIENCE, V341, P1192, DOI 10.1126/science.1241145; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Steiner M, 2011, CLIN CANCER RES, V17, P6406, DOI 10.1158/1078-0432.CCR-11-0483; TOMLINSON IM, 1995, EMBO J, V14, P4628, DOI 10.1002/j.1460-2075.1995.tb00142.x; Tomlinson IM, 1996, J MOL BIOL, V256, P813, DOI 10.1006/jmbi.1996.0127; TOMLINSON IM, 1992, J MOL BIOL, V227, P776, DOI 10.1016/0022-2836(92)90223-7; Villa A, 2008, INT J CANCER, V122, P2405, DOI 10.1002/ijc.23408; Villa A, 2011, MABS-AUSTIN, V3, P264, DOI 10.4161/mabs.3.3.15616; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Zuberbuhler K, 2009, PROTEIN ENG DES SEL, V22, P169, DOI 10.1093/protein/gzn068	57	29	33	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100000	10.1371/journal.pone.0100000	http://dx.doi.org/10.1371/journal.pone.0100000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950200	Green Submitted, Green Published, gold			2022-12-25	WOS:000338276300029
J	Vinnedge, LMP; Benight, NM; Wagh, PK; Pease, NA; Nashu, MA; Serrano-Lopez, J; Adams, AK; Cancelas, JA; Waltz, SE; Wells, SI				Vinnedge, L. M. Privette; Benight, N. M.; Wagh, P. K.; Pease, N. A.; Nashu, M. A.; Serrano-Lopez, J.; Adams, A. K.; Cancelas, J. A.; Waltz, S. E.; Wells, S. I.			The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor-positive breast cancers	ONCOGENE			English	Article							ACUTE MYELOID-LEUKEMIA; BETA-CATENIN; MAMMARY-GLAND; STEM-CELL; TYROSINE KINASE; ONCOPROTEIN DEK; TUMOR-FORMATION; BLADDER-CANCER; UP-REGULATION; FEMALE MICE	Disease progression and recurrence are major barriers to survival for breast cancer patients. Understanding the etiology of recurrent or metastatic breast cancer and underlying mechanisms is critical for the development of new treatments and improved survival. Here, we report that two commonly overexpressed breast cancer oncogenes, Ron (Recepteur d'Origine Nantaise) and DEK, cooperate to promote advanced disease through multipronged effects on beta-catenin signaling. The Ron receptor is commonly activated in breast cancers, and Ron overexpression in human disease stimulates beta-catenin nuclear translocation and is an independent predictor of metastatic dissemination. Dek is a chromatin-associated oncogene whose expression has been linked to cancer through multiple mechanisms, including beta-catenin activity. We demonstrate here that Dek is a downstream target of Ron receptor activation in murine and human models. The absence of Dek in the MMTV-Ron mouse model led to a significant delay in tumor development, characterized by decreased cell proliferation, diminished metastasis and fewer cells expressing mammary cancer stem cell markers. Dek complementation of cell lines established from this model was sufficient to promote cellular growth and invasion. Mechanistically, Dek expression stimulated the production and secretion of Wnt ligands to sustain an autocrine/paracrine canonical beta-catenin signaling loop. Finally, we show that Dek overexpression promotes tumorigenic phenotypes in immortalized human mammary epithelial MCF10A cells and, in the context of Ron receptor activation, correlates with disease recurrence and metastasis in patients. Overall, our studies demonstrate that DEK overexpression, due in part to Ron receptor activation, drives breast cancer progression through the induction of Wnt/beta-catenin signaling.	[Vinnedge, L. M. Privette; Pease, N. A.; Adams, A. K.; Wells, S. I.] Cincinnati Childrens Hosp Med Ctr, Div Oncol, Cincinnati, OH 45229 USA; [Benight, N. M.; Nashu, M. A.; Waltz, S. E.] Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH USA; [Wagh, P. K.] Cincinnati Childrens Hosp Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH 45229 USA; [Serrano-Lopez, J.; Cancelas, J. A.] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Serrano-Lopez, J.] Univ Hosp Reina Sofia, UCO, IMIBIC, Cordoba, Spain; [Cancelas, J. A.] Univ Cincinnati, Coll Med, Hoxworth Blood Ctr, Cincinnati, OH USA; [Waltz, S. E.] Cincinnati Vet Affairs Med Ctr, Dept Res, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Wells, SI (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Oncol, MLC 7013,3333 Burnet Ave, Cincinnati, OH 45229 USA.	Lisa.Privette@cchmc.org; Susanne.Wells@cchmc.org	Cancelas, Jose/AAR-9324-2020; Vinnedge, Lisa Privette/H-5869-2019; Serano-Lopez, Juana/O-8874-2017	Vinnedge, Lisa Privette/0000-0003-2087-4920; Waltz, Susan/0000-0003-3572-4642; Benight, Nancy/0000-0001-7321-3187; Serrano Lopez, Juana/0000-0001-8140-9040	NIH [AR-47363]; Ride Cincinnati Foundation for Breast Cancer Research [F32CA139931, T32HL091805, K12HD051953]; Public Health Services [R01CA116316, R01HL875109, T32ES007250, T32CA117846-07, T32CA11784]; Department of Defense [W81XWH-12-1-0194]; Veteran's Administration [BX000803]; Government of the Spanish Junta de Andalucia; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD051953] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA117846, R01CA116316, F32CA189685, F32CA139931] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL091805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR047363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007250] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000803] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ride Cincinnati Foundation for Breast Cancer Research; Public Health Services(United States Department of Health & Human ServicesUnited States Public Health Service); Department of Defense(United States Department of Defense); Veteran's Administration(US Department of Veterans Affairs); Government of the Spanish Junta de Andalucia; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	We acknowledge James Lessard and Gerard Grosveld for reagents, Kathryn Wikenheiser-Brokamp for technical assistance and the Research Flow Cytometry Core at Cincinnati Children's, supported by NIH AR-47363. LMPV is supported by the Ride Cincinnati Foundation for Breast Cancer Research in honor of Marlene Harris and Public Health Service Grants F32CA139931, T32HL091805 and K12HD051953. Funding also was provided by Public Health Services Grants R01CA116316 (SIW), R01HL875109 (JAC), T32ES007250 (AKA), T32CA117846-07 (PKW) and T32CA11784 (SEW and NMB), Department of Defense Grant W81XWH-12-1-0194 (SIW and SEW) and the Veteran's Administration Grant BX000803 (SEW). JS-W is supported by the Government of the Spanish Junta de Andalucia.	ACS (American Cancer Society), 2011, BREAST CANC FACTS FI; Adams AK, 2015, ONCOGENE, V34, P868, DOI 10.1038/onc.2014.15; Alexiadis V, 2000, GENE DEV, V14, P1308; Benhaj K, 2006, ONCOL REP, V15, P701; Campillos M, 2003, NUCLEIC ACIDS RES, V31, P1571, DOI 10.1093/nar/gkg247; Carro MS, 2006, CELL CYCLE, V5, P1202, DOI 10.4161/cc.5.11.2801; Danilkovitch-Miagkova A, 2003, CURR CANCER DRUG TAR, V3, P31, DOI 10.2174/1568009033333745; Datta A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-234; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Evans AJ, 2004, AM J PATHOL, V164, P285, DOI 10.1016/S0002-9440(10)63118-5; Florian MC, 2013, NATURE, V503, P392, DOI 10.1038/nature12631; Gamble MJ, 2007, NAT STRUCT MOL BIOL, V14, P548, DOI 10.1038/nsmb1248; Gao B, 2012, CURR TOP DEV BIOL, V101, P263, DOI 10.1016/B978-0-12-394592-1.00008-9; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Habib SJ, 2013, SCIENCE, V339, P1445, DOI 10.1126/science.1231077; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; HUGUET EL, 1994, CANCER RES, V54, P2615; Kappes F, 2011, GENE DEV, V25, P673, DOI 10.1101/gad.2036411; Karam M, 2014, NEOPLASIA, V16, P21, DOI 10.1593/neo.131658; Karner C, 2006, SEMIN CELL DEV BIOL, V17, P214, DOI 10.1016/j.semcdb.2006.05.007; Kavanaugh GM, 2011, NUCLEIC ACIDS RES, V39, P7465, DOI 10.1093/nar/gkr454; Khodadoust MS, 2009, CANCER RES, V69, P6405, DOI 10.1158/0008-5472.CAN-09-1063; Kim DW, 2010, MOL MED REP, V3, P877, DOI 10.3892/mmr.2010.346; Koleva RI, 2012, BLOOD, V119, P4878, DOI 10.1182/blood-2011-10-383083; Kondoh N, 1999, CANCER RES, V59, P4990; Krol M, 2010, J APPL GENET, V51, P37, DOI 10.1007/BF03195709; Kuorelahti A, 2007, ENDOCRINOLOGY, V148, P3694, DOI 10.1210/en.2007-0249; Lane TF, 1997, ONCOGENE, V15, P2133, DOI 10.1038/sj.onc.1201593; Leonis Mike A, 2007, Future Oncol, V3, P441, DOI 10.2217/14796694.3.4.441; Liu KR, 2012, BIOSCIENCE REP, V32, P323, DOI 10.1042/BSR20100141; Lossaint G, 2013, MOL CELL, V51, P678, DOI 10.1016/j.molcel.2013.07.023; Ma J, 2012, TUMOR BIOL, V33, P1983, DOI 10.1007/s13277-012-0458-4; Maggiora P, 1998, ONCOGENE, V16, P2927, DOI 10.1038/sj.onc.1201812; McClaine RJ, 2010, NEOPLASIA, V12, P650, DOI 10.1593/neo.10476; McGarvey T, 2000, J CELL BIOL, V150, P309, DOI 10.1083/jcb.150.2.309; Meier-Abt F, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3419; Soares LMM, 2006, SCIENCE, V312, P1961, DOI 10.1126/science.1128659; Miranda-Carboni GA, 2008, GENE DEV, V22, P3121, DOI 10.1101/gad.1692808; Miyoshi K, 2002, ONCOGENE, V21, P5548, DOI 10.1038/sj.onc.1205686; Moll UM, 2004, MOL CANCER RES, V2, P371; Mor-Vaknin N, 2006, MOL CELL BIOL, V26, P9484, DOI 10.1128/MCB.01030-06; Mor-Vaknin N, 2011, ARTHRITIS RHEUM-US, V63, P556, DOI 10.1002/art.30138; Peace BE, 2005, CANCER RES, V65, P1285, DOI 10.1158/0008-5472.CAN-03-3580; Rajagopal J, 2008, DEVELOPMENT, V135, P1625, DOI 10.1242/dev.015495; Robinson GW, 2000, GENE DEV, V14, P889; Saha AK, 2013, P NATL ACAD SCI USA, V110, P6847, DOI 10.1073/pnas.1220751110; Sammons M, 2006, J BIOL CHEM, V281, P26802, DOI 10.1074/jbc.M600915200; Sanden C, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-440; Sawatsubashi S, 2010, GENE DEV, V24, P159, DOI 10.1101/gad.1857410; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shibata T, 2010, ONCOGENE, V29, P4671, DOI 10.1038/onc.2010.217; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Veltmaat JM, 2004, DEV DYNAM, V229, P349, DOI 10.1002/dvdy.10441; Vinnedge LMP, 2011, ONCOGENE, V30, P2741, DOI 10.1038/onc.2011.2; Vinnedge LMP, 2013, CELL CYCLE, V12, P51, DOI 10.4161/cc.23121; Vinnedge LMP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046985; VONLINDERN M, 1992, MOL CELL BIOL, V12, P1687, DOI 10.1128/MCB.12.4.1687; Wagh PK, 2011, ONCOGENE, V30, P3694, DOI 10.1038/onc.2011.86; Wang JY, 2013, J HISTOCHEM CYTOCHEM, V61, P510, DOI 10.1369/0022155413488120; Wang MH, 2013, J BIOMED RES, V27, P345, DOI 10.7555/JBR.27.20130038; Wend P, 2013, EMBO MOL MED, V5, P264, DOI 10.1002/emmm.201201320; Wise-Draper TM, 2005, J VIROL, V79, P14309, DOI 10.1128/JVI.79.22.14309-14317.2005; Wise-Draper TM, 2006, MOL CELL BIOL, V26, P7506, DOI 10.1128/MCB.00430-06; Wise-Draper TM, 2009, CANCER RES, V69, P1792, DOI 10.1158/0008-5472.CAN-08-2304; Wise-Draper TM, 2009, AM J PATHOL, V174, P71, DOI 10.2353/ajpath.2009.080330; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Yin YJ, 2006, CANCER RES, V66, P5224, DOI 10.1158/0008-5472.CAN-05-4234; Zhao H, 2014, ONCOGENE, V33, P1429, DOI 10.1038/onc.2013.84; Zinser GM, 2006, CANCER RES, V66, P11967, DOI 10.1158/0008-5472.CAN-06-2473	74	45	46	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 30	2015	34	18					2325	2336		10.1038/onc.2014.173	http://dx.doi.org/10.1038/onc.2014.173			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CH2AH	24954505	Green Accepted			2022-12-25	WOS:000353824800006
J	Gese, EM; Thompson, CM				Gese, Eric M.; Thompson, Craig M.			Does Habitat Heterogeneity in a Multi-Use Landscape Influence Survival Rates and Density of a Native Mesocarnivore?	PLOS ONE			English	Article							FOXES VULPES-VELOX; SWIFT FOXES; NORTHWESTERN TEXAS; SOUTHEASTERN COLORADO; EASTERN COLORADO; OCCUPANCY RATES; WESTERN KANSAS; HOME-RANGE; COMMUNITY; GRASSLAND	The relationships between predators, prey, and habitat have long been of interest to applied and basic ecologists. As a native Great Plains mesocarnivore of North America, swift foxes (Vulpes velox) depended on the historic disturbance regime to maintain open grassland habitat. With a decline in native grasslands and subsequent impacts to prairie specialists, notably the swift fox, understanding the influence of habitat on native predators is paramount to future management efforts. From 2001 to 2004, we investigated the influence of vegetation structure on swift fox population ecology (survival and density) on and around the Pinon Canyon Maneuver Site, southeastern Colorado, USA. We monitored 109 foxes on 6 study sites exposed to 3 different disturbance regimes (military training, grazing, unused). On each site we evaluated vegetation structure based on shrub density, basal coverage, vegetation height, and litter. Across all sites, annual fox survival rates ranged from 0.50 to 0.92 for adults and 0.27 to 0.78 for juveniles. Among sites, population estimates ranged from 1 to 7 foxes per 10 km transect. Fox density or survival was not related to the relative abundance of prey. A robust model estimating fox population size and incorporating both shrub density and percent basal cover as explanatory variables far outperformed all other models. Our results supported the idea that, in our region, swift foxes were shortgrass prairie specialists and also indicated a relationship between habitat quality and landscape heterogeneity. We suggest the regulation of swift fox populations may be based on habitat quality through landscape-mediated survival, and managers may effectively use disturbance regimes to create or maintain habitat for this native mesocarnivore.	[Gese, Eric M.] Utah State Univ, USDA, Wildlife Serv, Natl Wildlife Res Ctr,Dept Wildland Resources, Logan, UT 84322 USA; [Thompson, Craig M.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA	United States Department of Agriculture (USDA); Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Gese, EM (corresponding author), Utah State Univ, USDA, Wildlife Serv, Natl Wildlife Res Ctr,Dept Wildland Resources, Logan, UT 84322 USA.	eric.gese@usu.edu	Gese, Eric M/B-4578-2011		United States Army, Directorate of Environmental Compliance and Management, Fort Carson, Colorado, through United States Fish and Wildlife Service, Colorado Assistance Office, Golden, Colorado; Utah Cooperative Fish and Wildlife Research Unit at Utah State University; United States Department of Agriculture, Wildlife Services, National Wildlife Research Center at Utah State University, Logan, Utah	United States Army, Directorate of Environmental Compliance and Management, Fort Carson, Colorado, through United States Fish and Wildlife Service, Colorado Assistance Office, Golden, Colorado; Utah Cooperative Fish and Wildlife Research Unit at Utah State University; United States Department of Agriculture, Wildlife Services, National Wildlife Research Center at Utah State University, Logan, Utah	Funding and logistical assistance was provided by the United States Army, Directorate of Environmental Compliance and Management, Fort Carson, Colorado, through the United States Fish and Wildlife Service, Colorado Assistance Office, Golden, Colorado, and the Utah Cooperative Fish and Wildlife Research Unit at Utah State University. Additional support was provided by the United States Department of Agriculture, Wildlife Services, National Wildlife Research Center at Utah State University, Logan, Utah. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, INT S INF THEOR, P267, DOI DOI 10.2307/2334537; Allington GRH, 2013, ECOL LETT, V16, P158, DOI 10.1111/ele.12023; BARBOUR M., 1999, TERRESTRIAL PLANT EC, V3rd; Brown JR, 1999, ECOLOGY, V80, P2385, DOI 10.1890/0012-9658(1999)080[2385:SIOGRI]2.0.CO;2; Dale M.R.T., 1999, SPATIAL PATTERN ANAL; Disney M, 1992, J WILDLIFE MANAGE, V64, P388; Finley DJ, 2005, J WILDLIFE MANAGE, V69, P861, DOI 10.2193/0022-541X(2005)069[0861:EOSFPS]2.0.CO;2; Fitzgerald J, 1996, POPULATION DYNAMICS; GERMANO DJ, 1983, J RANGE MANAGE, V36, P309, DOI 10.2307/3898476; Guthery Fred S., 1996, P59; Hartnett DC, 1996, J RANGE MANAGE, V49, P413, DOI 10.2307/4002922; Jackson VL, 2000, SOUTHWEST NAT, V45, P212, DOI 10.2307/3672463; Kamler JF, 2003, J MAMMAL, V84, P989, DOI 10.1644/BJK-033; Kamler JF, 2003, J WILDLIFE MANAGE, V67, P317, DOI 10.2307/3802773; Kamler JF, 2003, CAN J ZOOL, V81, P168, DOI 10.1139/Z02-222; Karki SM, 2007, J WILDLIFE MANAGE, V71, P2707, DOI 10.2193/2006-275; Kitchen AM, 1999, CAN J ZOOL, V77, P1645, DOI 10.1139/cjz-77-10-1645; Kozlowski AJ, 2003, WILDLIFE SOC B, V31, P630; List R, 2003, J ZOOL, V259, P1, DOI 10.1017/S0952836902002959; Lyon LJ, 2000, WILDLAND FIRE ECOSYS, P43; Martin DJ, 2007, SOUTHWEST NAT, V52, P541, DOI 10.1894/0038-4909(2007)52[541:ORBSFV]2.0.CO;2; Matlack RS, 2000, SOUTHWEST NAT, V45, P221, DOI 10.2307/3672464; Milchunas DG, 1999, J ENVIRON QUAL, V28, P1533, DOI 10.2134/jeq1999.00472425002800050019x; Moehrenschlager A, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P185; Morin P., 1999, COMMUNITY ECOL; Nicholson KL, 2007, WEST N AM NATURALIST, V67, P102, DOI 10.3398/1527-0904(2007)67[102:DAEMOS]2.0.CO;2; Nicholson KL, 2006, J WILDLIFE MANAGE, V70, P1659, DOI 10.2193/0022-541X(2006)70[1659:SFUOBP]2.0.CO;2; Olson TL, 2002, J MAMMAL, V83, P199, DOI 10.1644/1545-1542(2002)083<0199:SFSAPI>2.0.CO;2; RONGSTAD OJ, 1989, ECOLOGY SWIFT FOX PI; Schauster ER, 2002, WILDLIFE SOC B, V30, P464; Schauster ER, 2002, CAN J ZOOL, V80, P307, DOI 10.1139/Z02-009; SCOTTBROWN JM, 1987, WILD FURBEARER MANAG, P433; SHAW RB, 1990, J ENVIRON QUAL, V19, P234, DOI 10.2134/jeq1990.00472425001900020007x; Shaw RB, 1989, COLORADO STATE U SCI, V37; Sovada MA, 1998, J WILDLIFE MANAGE, V62, P1300, DOI 10.2307/3801994; Sovada MA, 2003, ECOLOGY CONSERVATION; Sovada MA, 2009, CAN FIELD NAT, V123, P346, DOI 10.22621/cfn.v123i4.1004; SWIHART RK, 1985, J WILDLIFE MANAGE, V49, P1019, DOI 10.2307/3801388; Thibault KM, 2010, OIKOS, V119, P1719, DOI 10.1111/j.1600-0706.2010.18378.x; Thompson CM, 2007, ECOLOGY, V88, P334, DOI 10.1890/0012-9658(2007)88[334:FWAIPC]2.0.CO;2; Thompson CM, 2013, ACTA THERIOL, V58, P55, DOI 10.1007/s13364-012-0098-5; Valone TJ, 2002, SOUTHWEST NAT, V47, P557, DOI 10.2307/3672659; Valone TJ, 1999, J ARID ENVIRON, V42, P15, DOI 10.1006/jare.1999.0500; White EP, 2004, AM NAT, V164, P670, DOI 10.1086/424766; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wright HA, 1980, INT85 US FOR SERV	46	4	4	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100500	10.1371/journal.pone.0100500	http://dx.doi.org/10.1371/journal.pone.0100500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963713	Green Published, gold			2022-12-25	WOS:000338709500056
J	Rosenstierne, MW; McLoughlin, KS; Olesen, ML; Papa, A; Gardner, SN; Engler, O; Plumet, S; Mirazimi, A; Weidmann, M; Niedrig, M; Fomsgaard, A; Erlandsson, L				Rosenstierne, Maiken W.; McLoughlin, Kevin S.; Olesen, Majken Lindholm; Papa, Anna; Gardner, Shea N.; Engler, Olivier; Plumet, Sebastien; Mirazimi, Ali; Weidmann, Manfred; Niedrig, Matthias; Fomsgaard, Anders; Erlandsson, Lena			The Microbial Detection Array for Detection of Emerging Viruses in Clinical Samples - A Useful Panmicrobial Diagnostic Tool	PLOS ONE			English	Article							REAL-TIME PCR; RESPIRATORY-TRACT INFECTIONS; HEMORRHAGIC-FEVER VIRUS; WEST-NILE-VIRUS; LABORATORY DETECTION; IDENTIFICATION; RNA; DNA; AMPLIFICATION; ASSAY	Emerging viruses are usually endemic to tropical and sub-tropical regions of the world, but increased global travel, climate change and changes in lifestyle are believed to contribute to the spread of these viruses into new regions. Many of these viruses cause similar disease symptoms as other emerging viruses or common infections, making these unexpected pathogens difficult to diagnose. Broad-spectrum pathogen detection microarrays containing probes for all sequenced viruses and bacteria can provide rapid identification of viruses, guiding decisions about treatment and appropriate case management. We report a modified Whole Transcriptome Amplification (WTA) method that increases unbiased amplification, particular of RNA viruses. Using this modified WTA method, we tested the specificity and sensitivity of the Lawrence Livermore Microbial Detection Array (LLMDA) against a wide range of emerging viruses present in both non-clinical and clinical samples using two different microarray data analysis methods.	[Rosenstierne, Maiken W.; Olesen, Majken Lindholm; Fomsgaard, Anders; Erlandsson, Lena] Statens Serum Inst, Dept Microbiol Diagnost & Virol, DK-2300 Copenhagen, Denmark; [McLoughlin, Kevin S.; Gardner, Shea N.] Lawrence Livermore Natl Lab, Livermore, CA USA; [Papa, Anna] Aristotle Univ Thessaloniki, Dept Microbiol, GR-54006 Thessaloniki, Greece; [Engler, Olivier] Fed Off Civil Protect, Spiez Lab, Spiez, Switzerland; [Plumet, Sebastien] French Army Forces Biomed Inst IRBA, Dept Virol, Marseille, France; [Mirazimi, Ali] Swedish Inst Communicable Dis Control, Solna, Sweden; [Mirazimi, Ali] Natl Vet Inst SVA, Uppsala, Sweden; [Mirazimi, Ali] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Weidmann, Manfred] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland; [Niedrig, Matthias] Robert Koch Inst, Ctr Biosafety, Berlin, Germany; [Fomsgaard, Anders] Univ Southern Denmark, Inst Clin Res, Odense, Denmark	Statens Serum Institut; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Aristotle University of Thessaloniki; Swedish Institute for Infectious Disease Control; National Veterinary Institute SVA; Linkoping University; University of Stirling; Robert Koch Institute; University of Southern Denmark	Rosenstierne, MW (corresponding author), Statens Serum Inst, Dept Microbiol Diagnost & Virol, DK-2300 Copenhagen, Denmark.	MWR@ssi.dk	Weidmann, Manfred/G-1817-2015	Weidmann, Manfred/0000-0002-7063-7491; Lindholm, Majken/0000-0002-1766-8678; Fomsgaard, Anders/0000-0003-4304-0603; , Ali/0000-0003-2371-6055; Erlandsson, Lena/0000-0003-4350-5909	European Commission under the Health Cooperation Work Program of the 7th Framework Program for contributing with CCHFV-positive clinical samples [260427]; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]	European Commission under the Health Cooperation Work Program of the 7th Framework Program for contributing with CCHFV-positive clinical samples; Lawrence Livermore National Laboratory(United States Department of Energy (DOE))	We thank Solvej Jensen, Birgit Knudsen, Bente Ostergaard and Britt Christensen for expert technical help. We thank the CCH Fever Network supported by the European Commission under the Health Cooperation Work Program of the 7th Framework Program (no. 260427) for contributing with CCHFV-positive clinical samples. This work was performed in part under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344.	Ausubel F.M., 1994, CURRENT PROTOCOLS MO, V27, DOI [10.1002/mrd.1080010210, DOI 10.1002/MRD.1080010210]; Berthet N, 2013, J CLIN VIROL, V56, P238, DOI 10.1016/j.jcv.2012.10.022; Berthet N, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-77; Bexfield N, 2011, VET J, V190, P191, DOI 10.1016/j.tvjl.2010.10.014; Blow JA, 2004, J VIROL METHODS, V119, P195, DOI 10.1016/j.jviromet.2004.03.015; Calzolari M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038058; Cavrini F, 2009, EUROSURVEILLANCE, V14, P17; Chiu CY, 2008, J PEDIATR-US, V153, P76, DOI 10.1016/j.jpeds.2007.12.035; Devault AM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04245; Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002; Erlandsson L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022631; Filippone C, 2013, CLIN MICROBIOL INFEC, V19, pE118, DOI 10.1111/1469-0691.12075; Gardner SN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-668; Grubaugh ND, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002349; Grubaugh ND, 2013, AM J TROP MED HYG, V88, P245, DOI 10.4269/ajtmh.2012.12-0048; Heyman P, 2011, EUROSURVEILLANCE, V16, P15; Heyman P, 2010, EXPERT REV ANTI-INFE, V8, P33, DOI 10.1586/ERI.09.118; Karimi-Busheri F, 1998, NUCLEIC ACIDS RES, V26, P4395, DOI 10.1093/nar/26.19.4395; Kistler A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816; Kramski M, 2007, CLIN CHEM, V53, P1899, DOI 10.1373/clinchem.2007.093245; Lambert AJ, 2003, J CLIN MICROBIOL, V41, P379, DOI 10.1128/JCM.41.1.379-385.2003; Maltezou HC, 2010, TRAVEL MED INFECT DI, V8, P139, DOI 10.1016/j.tmaid.2010.04.008; McLoughlin KS, 2011, BRIEF FUNCT GENOMICS, V10, P342, DOI 10.1093/bfgp/elr027; Nichol ST, 2000, P NATL ACAD SCI USA, V97, P12411, DOI 10.1073/pnas.210382297; Okamoto H, 2009, CURR TOP MICROBIOL, V331, P1, DOI 10.1007/978-3-540-70972-5_1; Papa A, 2012, EXPERT REV ANTI-INFE, V10, P743, DOI [10.1586/ERI.12.59, 10.1586/eri.12.59]; Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002; Pecorari M, 2009, EURO SURVEILL B EUR, V14, P9; Ruzek D, 2010, LANCET, V376, P2104, DOI 10.1016/S0140-6736(10)61120-8; Ryschkewitsch C, 2004, J VIROL METHODS, V121, P217, DOI 10.1016/j.jviromet.2004.06.021; Schwaiger M, 2003, J CLIN VIROL, V27, P136, DOI 10.1016/S1386-6532(02)00168-3; Shchelkunov SN, 2011, J VIROL METHODS, V175, P163, DOI 10.1016/j.jviromet.2011.05.002; Shirato K, 2005, J VIROL METHODS, V126, P119, DOI 10.1016/j.jviromet.2005.02.001; Thissen JB, 2014, J VIROL METHODS, V201, P73, DOI 10.1016/j.jviromet.2014.01.024; Tomashek KM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001614; van der Poel WHM, 2006, VECTOR-BORNE ZOONOT, V6, P315, DOI 10.1089/vbz.2006.6.315; Victoria JG, 2010, J VIROL, V84, P6033, DOI 10.1128/JVI.02690-09; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wang Yun-peng, 2011, Virologica Sinica, V26, P73, DOI 10.1007/s12250-011-3186-9; Weidmann M, 2005, J CLIN MICROBIOL, V43, P808, DOI 10.1128/JCM.43.2.808-812.2005; Weidmann M, 2008, J CLIN VIROL, V42, P326, DOI 10.1016/j.jcv.2008.03.005; Weidmann M, 2007, J CLIN VIROL, V39, P65, DOI 10.1016/j.jcv.2006.12.023; Weidmann M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-81; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001; Wood DJ, 1999, J MED VIROL, V58, P188, DOI 10.1002/(SICI)1096-9071(199906)58:2<188::AID-JMV15>3.3.CO;2-8; Yozwiak NL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001485	46	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100813	10.1371/journal.pone.0100813	http://dx.doi.org/10.1371/journal.pone.0100813			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963710	gold, Green Published			2022-12-25	WOS:000338709500083
J	Kwon, M; Lu, ZL; Miller, A; Kazlas, M; Hunter, DG; Bex, PJ				Kwon, MiYoung; Lu, Zhong-Lin; Miller, Alexandra; Kazlas, Melanie; Hunter, David G.; Bex, Peter J.			Assessing Binocular Interaction in Amblyopia and Its Clinical Feasibility	PLOS ONE			English	Article							ANISOMETROPIC AMBLYOPIA; INTEROCULAR SUPPRESSION; STRABISMIC AMBLYOPIA; GLOBAL MOTION; QUANTITATIVE MEASUREMENT; CONTRAST SENSITIVITY; VISUOMOTOR BEHAVIOR; VISUAL DEFICITS; CHILDREN; ACUITY	Purpose: To measure binocular interaction in amblyopes using a rapid and patient-friendly computer-based method, and to test the feasibility of the assessment in the clinic. Methods: Binocular interaction was assessed in subjects with strabismic amblyopia (n = 7), anisometropic amblyopia (n = 6), strabismus without amblyopia (n = 15) and normal vision (n = 40). Binocular interaction was measured with a dichoptic phase matching task in which subjects matched the position of a binocular probe to the cyclopean perceived phase of a dichoptic pair of gratings whose contrast ratios were systematically varied. The resulting effective contrast ratio of the weak eye was taken as an indicator of interocular imbalance. Testing was performed in an ophthalmology clinic under 8 mins. We examined the relationships between our binocular interaction measure and standard clinical measures indicating abnormal binocularity such as interocular acuity difference and stereoacuity. The test-retest reliability of the testing method was also evaluated. Results: Compared to normally-sighted controls, amblyopes exhibited significantly reduced effective contrast (similar to 20%) of the weak eye, suggesting a higher contrast requirement for the amblyopic eye compared to the fellow eye. We found that the effective contrast ratio of the weak eye covaried with standard clincal measures of binocular vision. Our results showed that there was a high correlation between the 1(st) and 2(nd) measurements (r = 0.94, p<0.001) but without any significant bias between the two. Conclusions: Our findings demonstrate that abnormal binocular interaction can be reliably captured by measuring the effective contrast ratio of the weak eye and quantitative assessment of binocular interaction is a quick and simple test that can be performed in the clinic. We believe that reliable and timely assessment of deficits in a binocular interaction may improve detection and treatment of amblyopia.	[Kwon, MiYoung; Miller, Alexandra; Bex, Peter J.] Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst, Boston, MA 02114 USA; [Kwon, MiYoung; Miller, Alexandra; Kazlas, Melanie; Hunter, David G.; Bex, Peter J.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Lu, Zhong-Lin] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Kazlas, Melanie; Hunter, David G.] Boston Childrens Hosp, Dept Ophthalmol, Boston, MA USA	Harvard University; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Harvard University; Harvard Medical School; University System of Ohio; Ohio State University; Harvard University; Boston Children's Hospital	Kwon, M (corresponding author), Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst, Boston, MA 02114 USA.	miyoungkwon02@gmail.com		Hunter, David/0000-0002-4587-4794; Lu, Zhong-Lin/0000-0002-7295-727X	NIH [R01 EY021553]; NATIONAL EYE INSTITUTE [R01EY021553] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grant R01 EY021553. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaen-Stockdale C, 2008, VISION RES, V48, P1965, DOI 10.1016/j.visres.2008.06.012; Baker DH, 2008, VISION RES, V48, P1625, DOI 10.1016/j.visres.2008.04.017; Baker DH, 2007, VISION RES, V47, P3096, DOI 10.1016/j.visres.2007.08.013; Baker DH, 2007, INVEST OPHTH VIS SCI, V48, P5332, DOI 10.1167/iovs.07-0194; Barrett BT, 2003, INVEST OPHTH VIS SCI, V44, P1555, DOI 10.1167/iovs.02-0515; Birch EE, 2007, INVEST OPHTH VIS SCI, V48, pe1108; Birch EE, 2013, PROG RETIN EYE RES, V33, P67, DOI 10.1016/j.preteyeres.2012.11.001; Black JM, 2011, OPTOMETRY VISION SCI, V88, pE334, DOI 10.1097/OPX.0b013e318205a162; BLAKEMORE C, 1976, J PHYSIOL-LONDON, V261, P423, DOI 10.1113/jphysiol.1976.sp011566; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bosworth RG., 2003, INVEST, V44, pE3183; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cameron AC, 1997, J ECONOMETRICS, V77, P329; Ding J, 2006, P NATL ACAD SCI USA, V103, P1141, DOI 10.1073/pnas.0509629103; Ding J, 2013, J VISION, V13, DOI 10.1167/13.2.14; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Gonzalez EG, 2012, INVEST OPHTH VIS SCI, V53, P5386, DOI 10.1167/iovs.12-9941; GOODWIN RT, 1985, INVEST OPHTH VIS SCI, V26, P917; Hess RF, 2007, VISION RES, V47, P1682, DOI 10.1016/j.visres.2007.02.005; Hess RF, 2012, OPTOMETRY, V83, P87; Hess RF, 2010, RESTOR NEUROL NEUROS, V28, P793, DOI 10.3233/RNN-2010-0550; HESS RF, 1977, VISION RES, V17, P1049, DOI 10.1016/0042-6989(77)90009-8; HESS RF, 1983, PROC R SOC SER B-BIO, V217, P309, DOI 10.1098/rspb.1983.0012; HESS RF, 1978, PFLUG ARCH EUR J PHY, V377, P201, DOI 10.1007/BF00584273; Hess RF, 1997, VISION RES, V37, P3145, DOI 10.1016/S0042-6989(96)00281-7; HESS RF, 1980, NATURE, V287, P463, DOI 10.1038/287463a0; Howard IP, 1995, BINOCULAR VISION STE; Huang CB, 2009, J VISION, V9, DOI 10.1167/9.3.17; Huang CB, 2011, J VISION, V11, DOI 10.1167/11.6.4; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; JONES RK, 1981, J EXP PSYCHOL HUMAN, V7, P30, DOI 10.1037/0096-1523.7.1.30; Knox PJ, 2012, INVEST OPHTH VIS SCI, V53, P817, DOI 10.1167/iovs.11-8219; Kwon M, 2014, VIS SCI SOC 13 ANN M; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; LAWDEN MC, 1982, VISION RES, V22, P1005, DOI 10.1016/0042-6989(82)90037-2; Levi DM, 2011, VISION RES, V51, P48, DOI 10.1016/j.visres.2010.09.029; LEVI DM, 1977, INVEST OPHTH VIS SCI, V16, P90; LEVI DM, 1985, VISION RES, V25, P979, DOI 10.1016/0042-6989(85)90208-1; LEVI DM, 1980, DOC OPHTHALMOL, V49, P303, DOI 10.1007/BF01886623; Li JR, 2011, INVEST OPHTH VIS SCI, V52, P4169, DOI 10.1167/iovs.11-7233; Li JR, 2013, OPHTHALMOLOGY, V120, P1672, DOI 10.1016/j.ophtha.2013.01.048; Mansouri B, 2008, VISION RES, V48, P2775, DOI 10.1016/j.visres.2008.09.002; McKee SP, 2003, J VISION, V3, P380, DOI 10.1167/3.5.5; Mitchell DE, 1998, CURR BIOL, V8, P1179, DOI 10.1016/S0960-9822(07)00489-7; Mitchell DE, 2009, PHILOS T R SOC B, V364, P383, DOI 10.1098/rstb.2008.0192; Narasimhan S, 2012, VISION RES, V66, P1, DOI 10.1016/j.visres.2012.06.007; Niechwiej-Szwedo E, 2012, INVEST OPHTH VIS SCI, V53, P7458, DOI 10.1167/iovs.12-10550; Niechwiej-Szwedo E, 2011, INVEST OPHTH VIS SCI, V52, P795, DOI 10.1167/iovs.10-6092; Niechwiej-Szwedo E, 2010, INVEST OPHTH VIS SCI, V51, P6348, DOI 10.1167/iovs.10-5882; O'Connor AR, 2010, OPTOMETRY VISION SCI, V87, P942, DOI 10.1097/OPX.0b013e3181fd132e; Ooi T L, 2001, Optometry, V72, P168; PARDHAN S, 1992, DOC OPHTHALMOL, V82, P239, DOI 10.1007/BF00160771; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Sengpiel F, 2006, CEREB CORTEX, V16, P1750, DOI 10.1093/cercor/bhj110; SHEEDY JE, 1986, AM J OPTOM PHYS OPT, V63, P839; Simmers AJ, 2003, VISION RES, V43, P729, DOI 10.1016/S0042-6989(02)00684-3; Simmons DR, 2005, PERCEPTION, V34, P1035, DOI 10.1068/p5279; SJOSTRAND J, 1981, ACTA OPHTHALMOL, V59, P25; To L, 2011, IEEE T NEUR SYS REH, V19, P280, DOI 10.1109/TNSRE.2011.2115255; Vedamurthy I, 2008, VISION RES, V48, P1522, DOI 10.1016/j.visres.2008.04.004; Vedamurthy I, 2007, VISION RES, V47, P179, DOI 10.1016/j.visres.2006.08.017; Weakley DR, 2001, OPHTHALMOLOGY, V108, P163, DOI 10.1016/S0161-6420(00)00425-5	62	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100156	10.1371/journal.pone.0100156	http://dx.doi.org/10.1371/journal.pone.0100156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959842	Green Published, gold, Green Submitted			2022-12-25	WOS:000338633900023
J	Blom, SM; Rottlander, M; Kehler, J; Bundgaard, C; Schmitt, N; Jensen, HS				Blom, Sigrid Marie; Rottlander, Mario; Kehler, Jan; Bundgaard, Christoffer; Schmitt, Nicole; Jensen, Henrik Sindal			From Pan-Reactive K(V)7 Channel Opener to Subtype Selective Opener/Inhibitor by Addition of a Methyl Group	PLOS ONE			English	Article							KCNQ POTASSIUM CHANNELS; ANTICONVULSANT RETIGABINE; KV7 CHANNELS; GENE; MUTATION; ACETYLCHOLINE; ACTIVATION; ICA-27243; EPILEPSY; RELEASE	The voltage-gated potassium channels of the K(V)7 family (K(V)7.1-5) play important roles in controlling neuronal excitability and are therefore attractive targets for treatment of CNS disorders linked to hyperexcitability. One of the main challenges in developing K(V)7 channel active drugs has been to identify compounds capable of discriminating between the neuronally expressed subtypes (K(V)7.2-5), aiding the identification of the subunit composition of K(V)7 currents in various tissues, and possessing better therapeutic potential for particular indications. By taking advantage of the structure-activity relationship of acrylamide K(V)7 channel openers and the effects of these compounds on mutant K(V)7 channels, we have designed and synthesized a novel K(V)7 channel modulator with a unique profile. The compound, named SMB-1, is an inhibitor of K(V)7.2 and an activator of K(V)7.4. SMB-1 inhibits K(V)7.2 by reducing the current amplitude and increasing the time constant for the slow component of the activation kinetics. The activation of K(V)7.4 is seen as an increase in the current amplitude and a slowing of the deactivation kinetics. Experiments studying mutant channels with a compromised binding site for the K(V)7.2-5 opener retigabine indicate that SMB-1 binds within the same pocket as retigabine for both inhibition of K(V)7.2 and activation of K(V)7.4. SMB-1 may serve as a valuable tool for K(V)7 channel research and may be used as a template for further design of better subtype selective K(V)7 channel modulators. A compound with this profile could hold novel therapeutic potential such as the treatment of both positive and cognitive symptoms in schizophrenia.	[Blom, Sigrid Marie; Jensen, Henrik Sindal] H Lundbeck & Co AS, Div Neurosci Drug Discovery, Copenhagen, Denmark; [Rottlander, Mario; Kehler, Jan; Bundgaard, Christoffer] H Lundbeck & Co AS, Div Discovery Chem, Copenhagen, Denmark; [Rottlander, Mario; Kehler, Jan; Bundgaard, Christoffer] H Lundbeck & Co AS, DMPK, Copenhagen, Denmark; [Blom, Sigrid Marie; Schmitt, Nicole] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark; [Blom, Sigrid Marie; Schmitt, Nicole] Univ Copenhagen, Fac Hlth & Med Sci, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Copenhagen, Denmark	Lundbeck Corporation; Lundbeck Corporation; Lundbeck Corporation; University of Copenhagen; Danmarks Grundforskningsfond; University of Copenhagen	Jensen, HS (corresponding author), H Lundbeck & Co AS, Div Neurosci Drug Discovery, Copenhagen, Denmark.	HSIN@Lundbeck.com	Schmitt, Nicole/B-8725-2012	Schmitt, Nicole/0000-0001-9482-9749	Danish National Research Foundation Centre for Cardiac Arrhythmia	Danish National Research Foundation Centre for Cardiac Arrhythmia(Danmarks Grundforskningsfond)	Funding was provided by the Danish National Research Foundation Centre for Cardiac Arrhythmia (www.DARC.ku.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN SP, 1995, BRIT J PHARMACOL, V115, P1163, DOI 10.1111/j.1476-5381.1995.tb15019.x; Bentzen BH, 2006, NEUROPHARMACOLOGY, V51, P1068, DOI 10.1016/j.neuropharm.2006.07.001; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Blackburn-Munro G, 2003, EUR J PHARMACOL, V460, P109, DOI 10.1016/S0014-2999(02)02924-2; Blom SM, 2010, PHARMACOLOGY, V86, P174, DOI 10.1159/000317525; Blom SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008251; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Chadha PS, 2014, ARTERIOSCL THROM VAS, V34, P887, DOI 10.1161/ATVBAHA.114.303405; Chadha PS, 2012, HYPERTENSION, V59, P877, DOI 10.1161/HYPERTENSIONAHA.111.187427; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; COOK L, 1990, DRUG DEVELOP RES, V19, P301, DOI 10.1002/ddr.430190308; Duncan GE, 1999, BRAIN RES REV, V29, P250, DOI 10.1016/S0165-0173(99)00002-8; Greenwood IA, 2009, BRIT J PHARMACOL, V156, P1196, DOI 10.1111/j.1476-5381.2009.00131.x; Gribkoff VK, 2008, EXPERT OPIN THER TAR, V12, P565, DOI 10.1517/14728222.12.5.565 ; Hansen HH, 2008, J PHYSIOL-LONDON, V586, P1823, DOI 10.1113/jphysiol.2007.149450; Hansen HH, 2007, EUR J PHARMACOL, V570, P77, DOI 10.1016/j.ejphar.2007.05.029; Hansen HH, 2006, J PHARMACOL EXP THER, V318, P1006, DOI 10.1124/jpet.106.106757; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Khanamiri S, 2013, HYPERTENSION, V62, P1090, DOI 10.1161/HYPERTENSIONAHA.113.01244; Korsgaard MPG, 2005, J PHARMACOL EXP THER, V314, P282, DOI 10.1124/jpet.105.083923; Lange W, 2009, MOL PHARMACOL, V75, P272, DOI 10.1124/mol.108.052282; LIEBERMAN JA, 1987, PSYCHOPHARMACOLOGY, V91, P415, DOI 10.1007/BF00216006; Mackie AR, 2008, MOL PHARMACOL, V74, P1171, DOI 10.1124/mol.108.049825; Miceli F, 2008, CURR OPIN PHARMACOL, V8, P65, DOI 10.1016/j.coph.2007.10.003; Mueser KT, 2004, LANCET, V363, P2063, DOI 10.1016/S0140-6736(04)16458-1; NICKOLSON VJ, 1990, DRUG DEVELOP RES, V19, P285, DOI 10.1002/ddr.430190307; Padilla K, 2009, NEUROSCI LETT, V465, P138, DOI 10.1016/j.neulet.2009.08.071; Redrobe JP, 2012, PSYCHOPHARMACOLOGY, V221, P451, DOI 10.1007/s00213-011-2593-9; Risgaard R, 2013, NUCL MED BIOL, V40, P135, DOI 10.1016/j.nucmedbio.2012.09.010; Schenzer A, 2005, J NEUROSCI, V25, P5051, DOI 10.1523/JNEUROSCI.0128-05.2005; SEEMAN P, 1987, SYNAPSE, V1, P133, DOI 10.1002/syn.890010203; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Sogaard R, 2001, AM J PHYSIOL-CELL PH, V280, pC859; Stott JB, 2013, DRUG DISCOV TODAY; Talebizadeh Z, 1999, HUM MUTAT, V14, P493, DOI 10.1002/(SICI)1098-1004(199912)14:6<493::AID-HUMU8>3.0.CO;2-P; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wu YJ, 2004, J MED CHEM, V47, P2887, DOI 10.1021/jm0305826; Wu YJ, 2004, BIOORG MED CHEM LETT, V14, P1991, DOI 10.1016/j.bmcl.2004.01.069; Wu YJ, 2003, J MED CHEM, V46, P3197, DOI 10.1021/jm034073f; Wuttke TV, 2005, MOL PHARMACOL, V67, P1009, DOI 10.1124/mol.104.010793; Xiong QJ, 2008, P NATL ACAD SCI USA, V105, P3128, DOI 10.1073/pnas.0712256105	42	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100209	10.1371/journal.pone.0100209	http://dx.doi.org/10.1371/journal.pone.0100209			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956197	gold, Green Published, Green Submitted			2022-12-25	WOS:000338917900033
J	Green, BJ; Wiriyachaiporn, S; Grainge, C; Rogers, GB; Kehagia, V; Lau, L; Carroll, MP; Bruce, KD; Howarth, PH				Green, Benjamin J.; Wiriyachaiporn, Surasa; Grainge, Christopher; Rogers, Geraint B.; Kehagia, Valia; Lau, Laurie; Carroll, Mary P.; Bruce, Kenneth D.; Howarth, Peter H.			Potentially Pathogenic Airway Bacteria and Neutrophilic Inflammation in Treatment Resistant Severe Asthma	PLOS ONE			English	Article							INDUCED SPUTUM; DIVERSITY; COLONIZATION; COMMUNITIES; HETEROGENEITY; MICROBIOME; DISEASE; SAMPLES	Background: Molecular microbiological analysis of airway samples in asthma has demonstrated an altered microbiome in comparison to healthy controls. Such changes may have relevance to treatment-resistant severe asthma, particularly those with neutrophilic airway inflammation, as bacteria might be anticipated to activate the innate immune response, a process that is poorly steroid responsive. An understanding of the relationship between airway bacterial presence and dominance in severe asthma may help direct alternative treatment approaches. Objective: We aimed to use a culture independent analysis strategy to describe the presence, dominance and abundance of bacterial taxa in induced sputum from treatment resistant severe asthmatics and correlate findings with clinical characteristics and airway inflammatory markers. Methods: Induced sputum was obtained from 28 stable treatment-resistant severe asthmatics. The samples were divided for supernatant IL-8 measurement, cytospin preparation for differential cell count and Terminal Restriction Fragment Length Polymorphism (T-RFLP) profiling for bacterial community analysis. Results: In 17/28 patients, the dominant species within the airway bacterial community was Moraxella catarrhalis or a member of the Haemophilus or Streptococcus genera. Colonisation with these species was associated with longer asthma disease duration (mean (SD) 31.8 years (16.7) vs 15.6 years (8.0), p = 0.008), worse post-bronchodilator percent predicted FEV1 (68.0% (24.0) vs 85.5% (19.7), p = 0.025) and higher sputum neutrophil differential cell counts (median (IQR) 80% (67-83) vs 43% (29-67), p = 0.001). Total abundance of these organisms significantly and positively correlated with sputum IL-8 concentration and neutrophil count. Conclusions: Airway colonisation with potentially pathogenic micro-organisms in asthma is associated with more severe airways obstruction and neutrophilic airway inflammation. This altered colonisation may have a role in the development of an asthma phenotype that responds less well to current asthma therapies.	[Green, Benjamin J.; Grainge, Christopher; Kehagia, Valia; Lau, Laurie; Carroll, Mary P.; Howarth, Peter H.] Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England; [Green, Benjamin J.; Grainge, Christopher; Kehagia, Valia; Lau, Laurie; Carroll, Mary P.; Howarth, Peter H.] Univ Southampton, Fac Med, NIHR Resp Biomed Res Unit, Southampton SO9 5NH, Hants, England; [Wiriyachaiporn, Surasa; Rogers, Geraint B.; Bruce, Kenneth D.] Kings Coll London, Div Pharmaceut Sci, Mol Microbiol Res Lab, London WC2R 2LS, England; [Grainge, Christopher] John Hunter Hosp, Hunter Med Res, Dept Resp & Sleep Med, Newcastle, NSW, Australia; [Rogers, Geraint B.] Flinders Univ S Australia, Sch Med, SAHMRI Infect & Immun Theme, Adelaide, SA 5001, Australia	University of Southampton; University of Southampton; University of London; King's College London; Hunter Medical Research Institute; John Hunter Hospital; Flinders University South Australia; South Australian Health & Medical Research Institute (SAHMRI)	Howarth, PH (corresponding author), Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England.	p.h.howarth@southampton.ac.uk	Rogers, Geraint/AAD-1011-2020; Rogers, Geraint B/N-1957-2013	Rogers, Geraint B/0000-0003-4054-1947; Howarth, Peter/0000-0003-0619-7927; Grainge, Christopher/0000-0002-6565-9928	Medical Research Council [G0900453]; MRC [G0800649, G0900453] Funding Source: UKRI; Medical Research Council [G0800649] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the Medical Research Council (G0900453). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacci E, 2006, CHEST, V129, P565, DOI 10.1378/chest.129.3.565; Banerjee D, 2004, EUR RESPIR J, V23, P685, DOI 10.1183/09031936.04.00056804; British Thoracic Society Scottish Intercollegiate Guidelines Network, 2008, Thorax, V63 Suppl 4, piv1, DOI 10.1136/thx.2008.097741; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Breekveldt-Postma NS, 2008, CURR MED RES OPIN, V24, P975, DOI [10.1185/030079908X280518, 10.1185/030079908X280518 ]; Brusselle GG, 2013, THORAX, V68, P322, DOI 10.1136/thoraxjnl-2012-202698; Cabrera-Rubio R, 2012, J CLIN MICROBIOL, V50, P3562, DOI 10.1128/JCM.00767-12; Gibson PG, 2001, CHEST, V119, P1329, DOI 10.1378/chest.119.5.1329; Goleva E, 2013, AM J RESP CRIT CARE, V188, P1193, DOI 10.1164/rccm.201304-0775OC; Green RH, 2002, THORAX, V57, P875, DOI 10.1136/thorax.57.10.875; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Jatakanon A, 1999, AM J RESP CRIT CARE, V160, P1532, DOI 10.1164/ajrccm.160.5.9806170; Marri PR, 2013, J ALLERGY CLIN IMMUN, V131, P346, DOI 10.1016/j.jaci.2012.11.013; Paggiaro PL, 2002, EUR RESPIR J, V20, p3S, DOI 10.1183/09031936.02.00000302; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Pavord ID, 1999, LANCET, V353, P2213, DOI 10.1016/S0140-6736(99)01813-9; Pizzichini E, 1996, AM J RESP CRIT CARE, V154, P308, DOI 10.1164/ajrccm.154.2.8756799; Proceedings of the ATS workshop on refractory asthma: current understanding recommendations and unanswered questions. American Thoracic Society, 2000, P ATS WORKSH REFR AS, V162, P2341; Richeldi L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002997.pub3; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rogers GB, 2003, J CLIN MICROBIOL, V41, P3548, DOI 10.1128/JCM.41.8.3548-3558.2003; Rogers Geraint B, 2014, Ann Am Thorac Soc, V11, P496, DOI 10.1513/AnnalsATS.201310-335OC; Rogers GB, 2013, THORAX, V68, P731, DOI 10.1136/thoraxjnl-2012-203105; Rogers GB, 2010, J CLIN MICROBIOL, V48, P78, DOI 10.1128/JCM.01324-09; Sethi S, 2006, AM J RESP CRIT CARE, V173, P991, DOI 10.1164/rccm.200509-1525OC; Simpson JL, 2008, AM J RESP CRIT CARE, V177, P148, DOI 10.1164/rccm.200707-1134OC; Simpson JL, 2007, THORAX, V62, P211, DOI 10.1136/thx.2006.061358; Stressmann FA, 2012, THORAX, V67, P867, DOI 10.1136/thoraxjnl-2011-200932; Szefler SJ, 2011, ANN ALLERG ASTHMA IM, V107, P110, DOI 10.1016/j.anai.2011.04.008; Wilkinson TMA, 2003, AM J RESP CRIT CARE, V167, P1090, DOI 10.1164/rccm.200210-1179OC; Yang IA, 2006, CURR OPIN ALLERGY CL, V6, P23, DOI 10.1097/01.all.0000200503.77295.bb	33	180	186	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100645	10.1371/journal.pone.0100645	http://dx.doi.org/10.1371/journal.pone.0100645			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955983	Green Published, gold			2022-12-25	WOS:000338917900076
J	Huang, WQ; Yao, YF; Long, Q; Yang, X; Sun, WJ; Liu, CB; Jin, XM; Li, Y; Chu, XJ; Chen, B; Ma, YB				Huang, Weiwei; Yao, Yufeng; Long, Qiong; Yang, Xu; Sun, Wenjia; Liu, Cunbao; Jin, Xiaomei; Li, Yang; Chu, Xiaojie; Chen, Bin; Ma, Yanbing			Immunization against Multidrug-Resistant Acinetobacter baumannii Effectively Protects Mice in both Pneumonia and Sepsis Models	PLOS ONE			English	Article							OUTER-MEMBRANE VESICLES; VACCINE; MECHANISMS; IL-33; ST2	Objective: Acinetobacter baumannii is considered the prototypical example of a multi-or pan-drug-resistant bacterium. It has been increasingly implicated as a major cause of nosocomial and community-associated infections. This study proposed to evaluate the efficacy of immunological approaches to prevent and treat A. baumannii infections. Methods: Mice were immunized with outer membrane vesicles (OMVs) prepared from a clinically isolated multidrug-resistant strain of A. baumannii. Pneumonia and sepsis models were used to evaluate the efficacy of active and passive immunization with OMVs. The probable effective mechanisms and the protective potential of clonally distinct clinical isolates were investigated in vitro using an opsonophagocytic assay. Results: Intramuscular immunization with OMVs rapidly produced high levels of OMV-specific IgG antibodies, and subsequent intranasal challenge with A. baumannii elicited mucosal IgA and IgG responses. Both active and passive immunization protected the mice from challenges with homologue bacteria in a sepsis model. Bacterial burden in bronchoalveolar lavage fluids (BALF), lung, and spleen, inflammatory cell infiltration in BALF and lung, and inflammatory cytokine accumulation in BALF was significantly suppressed in the pneumonia model by both active and passive immunization strategies. The antisera from immunized mice presented with significant opsonophagocytic activities in a dose-dependent manner against not only homologous strains but also five of the other six clonally distinct clinical isolates. Conclusions: Utilizing immunological characteristics of outer membrane proteins to elevate protective immunity and circumvent complex multidrug-resistance mechanisms might be a viable approach to effectively control A. baumannii infections.	[Huang, Weiwei; Yao, Yufeng; Long, Qiong; Yang, Xu; Sun, Wenjia; Liu, Cunbao; Jin, Xiaomei; Li, Yang; Chu, Xiaojie; Ma, Yanbing] Chinese Acad Med Sci, Inst Med Biol, Lab Mol Immunol, Kunming, Peoples R China; [Huang, Weiwei; Yao, Yufeng; Long, Qiong; Yang, Xu; Sun, Wenjia; Liu, Cunbao; Jin, Xiaomei; Li, Yang; Chu, Xiaojie; Ma, Yanbing] Peking Union Med Coll, Kunming, Peoples R China; [Huang, Weiwei; Yao, Yufeng; Long, Qiong; Yang, Xu; Sun, Wenjia; Liu, Cunbao; Jin, Xiaomei; Li, Yang; Chu, Xiaojie; Ma, Yanbing] Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Peoples R China; [Huang, Weiwei; Yao, Yufeng; Long, Qiong; Yang, Xu; Sun, Wenjia; Liu, Cunbao; Jin, Xiaomei; Li, Yang; Chu, Xiaojie; Ma, Yanbing] Yunnan Engn Res Ctr Vaccine Res & Dev Severe Infe, Kunming, Peoples R China; [Chen, Bin] Kunming Med Univ, Affiliated Hosp 2, Kunming, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases; Kunming Medical University	Ma, YB (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Lab Mol Immunol, Kunming, Peoples R China.	yanbingma@126.com	Chen, Bin/I-6677-2013; Chen, Bin/AAG-3449-2019	Chu, Xiaojie/0000-0002-2745-004X; Li, Yang/0000-0001-6743-4004	Science and Technology Project of Yunnan Province [2013FZ139]; National Natural Science Foundation of China [81301467]; Peking Union Medical College (PUMC) Youth Fund; Fundamental Research Funds for the Central Universities, China [333203084]	Science and Technology Project of Yunnan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking Union Medical College (PUMC) Youth Fund; Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities)	This research was financially supported by Science and Technology Project of Yunnan Province (2013FZ139); National Natural Science Foundation of China (81301467). The Peking Union Medical College (PUMC) Youth Fund and the Fundamental Research Funds for the Central Universities, China (333203084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Alves JC, 2010, NAT MED, V16, P708, DOI 10.1038/nm.2156; Bentancor LV, 2012, INFECT IMMUN, V80, P3381, DOI 10.1128/IAI.06096-11; Bentancor LV, 2012, INFECT IMMUN, V80, P651, DOI 10.1128/IAI.05653-11; Cespedes N, 2013, VACCINE, V31, P4923, DOI 10.1016/j.vaccine.2013.05.082; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Chang HC, 2005, J CLIN MICROBIOL, V43, P1632, DOI 10.1128/JCM.43.4.1632-1639.2005; Chiang SR, 2009, CRIT CARE MED, V37, P2590, DOI 10.1097/CCM.0b013e3181a0f8e1; de Breij A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030673; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Eveillard M, 2010, J INFECTION, V60, P154, DOI 10.1016/j.jinf.2009.09.004; Fattahian Y, 2011, MICROB PATHOGENESIS, V51, P402, DOI 10.1016/j.micpath.2011.09.004; Findlow J, 2007, CLIN VACCINE IMMUNOL, V14, P1451, DOI 10.1128/CVI.00195-07; Findlow J, 2006, INFECT IMMUN, V74, P4557, DOI 10.1128/IAI.00466-06; Gordon NC, 2010, INT J ANTIMICROB AG, V35, P219, DOI 10.1016/j.ijantimicag.2009.10.024; JolyGuillou MC, 1997, ANTIMICROB AGENTS CH, V41, P345, DOI 10.1128/AAC.41.2.345; Kimura A, 2011, CLIN VACCINE IMMUNOL, V18, P483, DOI 10.1128/CVI.00304-10; Koning RI, 2013, RES MICROBIOL, V164, P397, DOI 10.1016/j.resmic.2013.02.007; Kueakhai P, 2013, VACCINE, V31, P5518, DOI 10.1016/j.vaccine.2013.09.027; Kwon SO, 2009, FEMS MICROBIOL LETT, V297, P150, DOI 10.1111/j.1574-6968.2009.01669.x; Lin L, 2013, VACCINE, V31, P313, DOI 10.1016/j.vaccine.2012.11.008; Luo GPS, 2012, PLOS ONE, V7, P46, DOI 10.1371/journal.pone.0029446; Mao QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046043; McConnell MJ, 2011, VACCINE, V29, P5705, DOI 10.1016/j.vaccine.2011.06.001; McConnell MJ, 2011, INFECT IMMUN, V79, P518, DOI 10.1128/IAI.00741-10; McConnell MJ, 2010, VACCINE, V29, P1, DOI 10.1016/j.vaccine.2010.10.052; Mussi MA, 2005, ANTIMICROB AGENTS CH, V49, P1432, DOI 10.1128/AAC.49.4.1432-1440.2005; Nakatsuji T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014797; Qiu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022004; Russo TA, 2013, INFECT IMMUN, V81, P915, DOI 10.1128/IAI.01184-12; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Valentine SC, 2008, J CLIN MICROBIOL, V46, P2499, DOI 10.1128/JCM.00367-08; Zarrilli R, 2007, CLIN MICROBIOL INFEC, V13, P481, DOI 10.1111/j.1469-0691.2006.01675.x; Zavascki AP, 2010, EXPERT REV ANTI-INFE, V8, P71, DOI 10.1586/ERI.09.108	34	61	64	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100727	10.1371/journal.pone.0100727	http://dx.doi.org/10.1371/journal.pone.0100727			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956279	Green Submitted, Green Published, gold			2022-12-25	WOS:000338917900088
J	Katz, MA; Muthoka, P; Emukule, GO; Kalani, R; Njuguna, H; Waiboci, LW; Ahmed, JA; Bigogo, G; Feikin, DR; Njenga, MK; Breiman, RF; Mott, JA				Katz, Mark A.; Muthoka, Philip; Emukule, Gideon O.; Kalani, Rosalia; Njuguna, Henry; Waiboci, Lilian W.; Ahmed, Jamal A.; Bigogo, Godfrey; Feikin, Daniel R.; Njenga, Moses K.; Breiman, Robert F.; Mott, Joshua A.			Results From the First Six Years of National Sentinel Surveillance for Influenza in Kenya, July 2007-June 2013	PLOS ONE			English	Article							WESTERN KENYA; SEASONAL INFLUENZA; YOUNG-CHILDREN; RURAL KENYA; AFRICA; PNEUMONIA; ILLNESS; BURDEN; HOSPITALIZATION; EPIDEMIOLOGY	Background: Recent studies have shown that influenza is associated with significant disease burden in many countries in the tropics, but until recently national surveillance for influenza was not conducted in most countries in Africa. Methods: In 2007, the Kenyan Ministry of Health with technical support from the CDC-Kenya established a national sentinel surveillance system for influenza. At 11 hospitals, for every hospitalized patient with severe acute respiratory illness (SARI), and for the first three outpatients with influenza-like illness (ILI) per day, we collected both nasopharyngeal and oropharyngeal swabs. Beginning in 2008, we conducted in-hospital follow-up for SARI patients to determine outcome. Specimens were tested by real time RT-PCR for influenza A and B. Influenza A-positive specimens were subtyped for H1, H3, H5, and (beginning in May 2009) A(H1N1) pdm09. Results: From July 1, 2007 through June 30, 2013, we collected specimens from 24,762 SARI and 14,013 ILI patients. For SARI and ILI case-patients, the median ages were 12 months and 16 months, respectively, and 44% and 47% were female. In all, 2,378 (9.6%) SARI cases and 2,041 (14.6%) ILI cases were positive for influenza viruses. Most influenza-associated SARI cases (58.6%) were in children <2 years old. Of all influenza-positive specimens, 78% were influenza A, 21% were influenza B, and 1% were influenza A/B coinfections. Influenza circulated in every month. In four of the six years influenza activity peaked during July-November. Of 9,419 SARI patients, 2.7% died; the median length of hospitalization was 4 days. Conclusions: During six years of surveillance in Kenya, influenza was associated with nearly 10 percent of hospitalized SARI cases and one-sixth of outpatient ILI cases. Most influenza-associated SARI and ILI cases were in children <2 years old; interventions to reduce the burden of influenza, such as vaccine, could consider young children as a priority group.	[Katz, Mark A.; Emukule, Gideon O.; Njuguna, Henry; Waiboci, Lilian W.; Ahmed, Jamal A.; Bigogo, Godfrey; Feikin, Daniel R.; Njenga, Moses K.; Breiman, Robert F.; Mott, Joshua A.] Kenya Govt Med Res Ctr, Ctr Dis Control & Prevent Kenya, Nairobi, Kenya; [Muthoka, Philip; Kalani, Rosalia] Kenya Minist Hlth, Nairobi, Kenya	Kenya Medical Research Institute	Katz, MA (corresponding author), Kenya Govt Med Res Ctr, Ctr Dis Control & Prevent Kenya, Nairobi, Kenya.	markakatz@gmail.com	Bigogo, Godfrey/W-3591-2019		US Centers for Disease Control; Kenya Ministry of Health	US Centers for Disease Control; Kenya Ministry of Health	The surveillance described in this manuscript was funded by a cooperative agreement between the US Centers for Disease Control and the Kenya Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, WKLY EPIDEMIOL REC, V87, P461; [Anonymous], 2013, WORLD WEATHER ONLINE; Azziz-Baumgartner E, 2012, B WORLD HEALTH ORGAN, V90, P12, DOI 10.2471/BLT.11.090209; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Breiman RF, 2007, EMERG INFECT DIS, V13, P1453, DOI 10.3201/eid1310.070400; Breiman RF, 2011, J HEALTH POPUL NUTR, V29, P123; Burton DC, 2011, J HEALTH POPUL NUTR, V29, P61, DOI 10.3329/jhpn.v29i1.7567; Chudasama RK, 2013, ANN MED HEALTH SCI R, V3, P334, DOI 10.4103/2141-9248.117929; Feikin DR, 2012, B WORLD HEALTH ORGAN, V90, P256, DOI 10.2471/BLT.11.094326; Freitas FT, 2012, EPIDEMIOL INFECT, P1; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Hayward AC, 2014, LANCET RESP MED; Katz MA, 2012, J INFECT DIS, V206, pS53, DOI 10.1093/infdis/jis530; Kim C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021610; Lutwama JJ, 2012, J INFECT DIS, V206, pS87, DOI 10.1093/infdis/jis578; Murray EL, 2013, EPIDEMIOL INFECT, V141, P212, DOI 10.1017/S095026881200043X; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Onyango CO, 2012, J INFECT DIS, V206, pS61, DOI 10.1093/infdis/jis536; Organization WH, 2011, INTEGRATED MANAGEMEN; Organization WH, 2013, FLUNET; Ortu G, 2008, HEALTH POLICY PLANN, V23, P161, DOI 10.1093/heapol/czn004; Radin JM, 2012, J INFECT DIS, V206, pS14, DOI 10.1093/infdis/jis606; Schoub Barry D, 2010, Expert Rev Respir Med, V4, P167, DOI 10.1586/ers.10.10; Schoub BD, 2002, VACCINE, V20, pS45, DOI 10.1016/S0264-410X(02)00129-9; Sentilhes AC, 2013, INFLUENZA OTHER RESP; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Thompson MG, 2012, J INFECT DIS, V206, P1674, DOI 10.1093/infdis/jis591; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; WHO (World Health Organization), 2006, GUID FIELD OP; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630; Zerr DM, 2008, PEDIATRICS, V121, P345, DOI 10.1542/peds.2007-2812	32	35	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e98615	10.1371/journal.pone.0098615	http://dx.doi.org/10.1371/journal.pone.0098615			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955962	Green Published, Green Submitted, gold			2022-12-25	WOS:000338917900004
J	Adel, A; Boughoufalah, A; Saegerman, C; De Deken, R; Bouchene, Z; Soukehal, A; Berkvens, D; Boelaert, M				Adel, Amel; Boughoufalah, Amel; Saegerman, Claude; De Deken, Redgi; Bouchene, Zahida; Soukehal, Abdelkrim; Berkvens, Dirk; Boelaert, Marleen			Epidemiology of Visceral Leishmaniasis in Algeria: An Update	PLOS ONE			English	Article							RETROSPECTIVE ANALYSIS; CANINE LEISHMANIASIS; INFANTUM; INFECTION; SPREAD; PCR	Visceral leishmaniasis (VL), a zoonotic disease caused by Leishmania infantum, is endemic in Algeria. This report describes a retrospective epidemiological study conducted on human VL to document the epidemiological profile at national level. All human VL cases notified by the National Institute of Public Health between 1998 and 2008 were investigated. In parallel all VL cases admitted to the university hospitals of Algiers were surveyed to estimate the underreporting ratio. Fifteen hundred and sixty-two human VL cases were reported in Algeria between 1998-2008 with an average annual reported incidence rate of 0.45 cases per 100,000 inhabitants, of which 81.42% were in the age range of 0-4 years. Cases were detected year-round, with a peak notification in May and June. One hundred and seventy patients were admitted to the university hospitals in Algiers in the same period, of which less than one in ten had been officially notified. Splenomegaly, fever, pallor and pancytopenia were the main clinical and laboratory features. Meglumine antimoniate was the first-line therapy for paediatric VL whereas the conventional amphotericin B was used for adult patients. Visceral leishmaniasis in Algeria shows the epidemiological profile of a paediatric disease with a decrease of the annual reported incidence rate. However, vigilance is required because of huge underreporting and an apparent propagation towards the south.	[Adel, Amel] Univ Saad Dahlab, Inst Vet Sci, Blida, Algeria; [Adel, Amel; Saegerman, Claude] Univ Liege, Fac Vet Med, Dept Infect & Parasit Dis Epidemiol & Risk Anal A, Liege, Belgium; [Adel, Amel; De Deken, Redgi; Berkvens, Dirk] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Boughoufalah, Amel] Natl Inst Publ Hlth, Dept Hlth Informat, Algiers, Algeria; [Bouchene, Zahida; Soukehal, Abdelkrim] Univ Hosp Beni Messous, Algiers, Algeria; [Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium	Universite Saad Dahlab de Blida; University of Liege; Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM)	Berkvens, D (corresponding author), Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium.	dberkvens@itg.be	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776; Saegerman, Claude/0000-0001-9087-7436	Belgian Directorate-General for Development Co-operation (DGDC)	Belgian Directorate-General for Development Co-operation (DGDC)	The study was funded by the Belgian Directorate-General for Development Co-operation (DGDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRANCHES P, 1991, J PARASITOL, V77, P557, DOI 10.2307/3283159; Addadi K., 1976, Bulletin de la Societe de Pathologie Exotique, V69, P68; Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Aoun K, 2009, MED MALADIES INFECT, V39, P775, DOI 10.1016/j.medmal.2009.08.010; BADARO R, 1986, LANCET, V1, P647; Baneth G, 1998, AM J TROP MED HYG, V59, P722, DOI 10.4269/ajtmh.1998.59.722; BELAZZOUG S, 1985, ANN SOC BELG MED TR, V65, P329; Bern C, 2006, CLIN INFECT DIS, V43, P917, DOI 10.1086/507530; Bessad A., 2012, Bulletin de la Societe de Pathologie Exotique, V105, P5, DOI 10.1007/s13149-011-0182-4; Bouratbine A, 1998, B SOC PATHOL EXOT, V91, P183; Carranza-Tamayo CO, 2010, REV SOC BRAS MED TRO, V43, P396, DOI 10.1590/S0037-86822010000400012; DEDET JP, 1977, B SOC PATHOL EXOT, V70, P250; Dujardin JC, 2006, TRENDS PARASITOL, V22, P4, DOI 10.1016/j.pt.2005.11.004; Dujardin JC, 2008, EMERG INFECT DIS, V14, P1013, DOI 10.3201/eid1407.071589; FAO, 2002, EV WORLD FOR RES 200, P109; Gkolfinopoulou K, 2013, Euro Surveill, V18, P20532, DOI 10.2807/1560-7917.ES2013.18.29.20532; GRADONI L, 1995, B WORLD HEALTH ORGAN, V73, P191; Gradoni L, 2008, TROP MED INT HEALTH, V13, P1272, DOI 10.1111/j.1365-3156.2008.02144.x; Gramiccia M, 2013, EUROSURVEILLANCE, V18, P29, DOI 10.2807/1560-7917.ES2013.18.29.20535; HARRAT Z, 1992, B SOC PATHOL EXOT, V85, P296; Harrat Z, 1996, T ROY SOC TROP MED H, V90, P625, DOI 10.1016/S0035-9203(96)90410-1; IZRI MA, 1990, ANN PARASIT HUM COMP, V65, P151; KILLICKKENDRICK R, 1990, MED VET ENTOMOL, V4, P1, DOI 10.1111/j.1365-2915.1990.tb00255.x; Kowalski K., 1991, MAMMALS ALGERIA; Lachaud L, 2013, Euro Surveill, V18, P20534, DOI 10.2807/1560-7917.ES2013.18.29.20534; Lemaire X, 1911, B SOC PATHOL EXOT, V4, P554; Marty P, 2009, ARCH PEDIATRIE, V16, pS96, DOI 10.1016/S0929-693X(09)75310-2; Pagliano P, 2003, J ANTIMICROB CHEMOTH, V52, P264, DOI 10.1093/jac/dkg340; Petrela R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000814; Seridi N, 2008, T ROY SOC TROP MED H, V102, P556, DOI 10.1016/j.trstmh.2008.03.004; Solano-Gallego L, 2001, J CLIN MICROBIOL, V39, P560, DOI 10.1128/JCM.39.2.560-563.2001; StataCorp, 2011, STAT REL 12 STAT SOF; W. H. Organization, 2005, REP WHO INF CONS LIP; WHO, 2009, LEISHM BURD DIS; Zait H, 2012, MED MALADIES INFECT, V42, P119, DOI 10.1016/j.medmal.2012.01.001; Zougaghi L, 2009, ARCH PEDIATRIE, V16, P1513, DOI 10.1016/j.arcped.2009.05.003	38	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99207	10.1371/journal.pone.0099207	http://dx.doi.org/10.1371/journal.pone.0099207			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949958	Green Submitted, Green Published, gold			2022-12-25	WOS:000338276300011
J	Azarenko, O; Jordan, MA; Wilson, L				Azarenko, Olga; Jordan, Mary Ann; Wilson, Leslie			Erucin, the Major Isothiocyanate in Arugula (Eruca sativa), Inhibits Proliferation of MCF7 Tumor Cells by Suppressing Microtubule Dynamics	PLOS ONE			English	Article							CONSUMING BROCCOLI SPROUTS; CYCLE ARREST; IN-VITRO; PHENETHYL ISOTHIOCYANATE; KINETIC STABILIZATION; MEDIATED APOPTOSIS; ENZYME-SYSTEMS; MITOTIC BLOCK; CANCER CELLS; SULFORAPHANE	Consumption of cruciferous vegetables is associated with reduced risk of various types of cancer. Isothiocyanates including sulforaphane and erucin are believed to be responsible for this activity. Erucin [1-isothiocyanato-4-(methylthio) butane], which is metabolically and structurally related to sulforaphane, is present in large quantities in arugula (Eruca sativa, Mill.), kohlrabi and Chinese cabbage. However, its cancer preventive mechanisms remain poorly understood. We found that erucin inhibits proliferation of MCF7 breast cancer cells (IC50=28 mu M) in parallel with cell cycle arrest at mitosis (IC50=13 mu M) and apoptosis, by a mechanism consistent with impairment of microtubule dynamics. Concentrations of 5-15 mu M erucin suppressed the dynamic instability of microtubules during interphase in the cells. Most dynamic instability parameters were inhibited, including the rates and extents of growing and shortening, the switching frequencies between growing and shortening, and the overall dynamicity. Much higher erucin concentrations were required to reduce the microtubule polymer mass. In addition, erucin suppressed dynamic instability of microtubules reassembled from purified tubulin in similar fashion. The effects of erucin on microtubule dynamics, like those of sulforaphane, are similar qualitatively to those of much more powerful clinically-used microtubule-targeting anticancer drugs, including taxanes and the vinca alkaloids. The results suggest that suppression of microtubule dynamics by erucin and the resulting impairment of critically important microtubule-dependent cell functions such as mitosis, cell migration and microtubule- based transport may be important in its cancer preventive activities.	[Wilson, Leslie] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Wilson, L (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	leslie.wilson@lifesci.ucsb.edu						Azarenko O, 2008, CARCINOGENESIS, V29, P2360, DOI 10.1093/carcin/bgn241; Barcelo S, 1996, CARCINOGENESIS, V17, P277, DOI 10.1093/carcin/17.2.277; Barillari J, 2005, J AGR FOOD CHEM, V53, P2475, DOI 10.1021/jf047945a; Basten GP, 2002, CARCINOGENESIS, V23, P1399, DOI 10.1093/carcin/23.8.1399; Bheemreddy RM, 2007, J AGR FOOD CHEM, V55, P2861, DOI 10.1021/jf0633544; BLOCK G, 1992, NUTR CANCER, V18, P1, DOI 10.1080/01635589209514201; Bunker JM, 2004, MOL BIOL CELL, V15, P2720, DOI 10.1091/mbc.E04-01-0062; Cang SD, 2014, EXP HEMATOL ONCOL, V3, DOI 10.1186/2162-3619-3-5; Chen JG, 2002, CANCER RES, V62, P1935; Clarke JD, 2011, J AGR FOOD CHEM, V59, P10955, DOI 10.1021/jf202887c; Clarke JD, 2011, PHARMACOL RES, V64, P456, DOI 10.1016/j.phrs.2011.07.005; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Fimognari C, 2004, INVEST NEW DRUG, V22, P119, DOI 10.1023/B:DRUG.0000011788.19754.54; Fimognari C, 2007, IN VIVO, V21, P377; Fimognari C, 2012, MUTAT RES-REV MUTAT, V750, P107, DOI 10.1016/j.mrrev.2011.12.001; Gamet-Payrastre L, 2000, CANCER RES, V60, P1426; Grishchuk EL, 2005, NATURE, V438, P384, DOI 10.1038/nature04132; Hanlon N, 2009, CHEM-BIOL INTERACT, V177, P115, DOI 10.1016/j.cbi.2008.08.015; Hanlon N, 2008, BRIT J NUTR, V99, P559, DOI 10.1017/S0007114507824093; Harris KE, 2008, J NUTR BIOCHEM, V19, P246, DOI 10.1016/j.jnutbio.2007.02.014; Jakubikova J, 2005, ANTICANCER RES, V25, P3375; Jordan M. A., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P1, DOI 10.2174/1568011023354290; Jordan MA, 1996, CANCER RES, V56, P816; Jordan MA, 2005, MOL CANCER THER, V4, P1086, DOI 10.1158/1535-7163.MCT-04-0345; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; JORDAN MA, 1991, CANCER RES, V51, P2212; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Jordan MA, 2007, CURR CANCER DRUG TAR, V7, P730, DOI 10.2174/156800907783220417; Jordan Mary Ann, 2008, P47, DOI 10.1007/978-1-59745-336-3_3; Kamath K, 2014, CYTOSKELETON, V71, P46, DOI 10.1002/cm.21153; Kassahun K, 1997, CHEM RES TOXICOL, V10, P1228, DOI 10.1021/tx970080t; KOLM RH, 1995, BIOCHEM J, V311, P453, DOI 10.1042/bj3110453; Langouet S, 2000, CHEM RES TOXICOL, V13, P245, DOI 10.1021/tx990189w; Leoni O, 1997, BIOORGAN MED CHEM, V5, P1799, DOI 10.1016/S0968-0896(97)00112-0; Liu K, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-10; LUDUENA RF, 1991, PHARMACOL THERAPEUT, V49, P133, DOI 10.1016/0163-7258(91)90027-J; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Melchini A, 2010, TOXINS, V2, P593, DOI 10.3390/toxins2040593; Mi LX, 2008, J BIOL CHEM, V283, P22136, DOI 10.1074/jbc.M802330200; Miller HP, 2010, METHOD CELL BIOL, V95, P3, DOI 10.1016/S0091-679X(10)95001-2; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mohan R, 2008, CANCER RES, V68, P6181, DOI 10.1158/0008-5472.CAN-08-0584; Munday R, 2004, J AGR FOOD CHEM, V52, P1867, DOI 10.1021/jf030549s; Nastruzzi C, 2000, J AGR FOOD CHEM, V48, P3572, DOI 10.1021/jf000191p; Nestle M, 1997, P NATL ACAD SCI USA, V94, P11149, DOI 10.1073/pnas.94.21.11149; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 2001, ANNU REV BIOPH BIOM, V30, P397, DOI 10.1146/annurev.biophys.30.1.397; Oroudjev E, 2010, MOL CANCER THER, V9, P2700, DOI 10.1158/1535-7163.MCT-10-0645; Panda D, 1996, J BIOL CHEM, V271, P29807, DOI 10.1074/jbc.271.47.29807; PANDA D, 1995, BIOCHEMISTRY-US, V34, P9921, DOI 10.1021/bi00031a014; Parnaud G, 2004, NUTR CANCER, V48, P198, DOI 10.1207/s15327914nc4802_10; Rudner AD, 1996, CURR OPIN CELL BIOL, V8, P773, DOI 10.1016/S0955-0674(96)80077-9; Saha S, 2012, MOL NUTR FOOD RES, V56, P1906, DOI 10.1002/mnfr.201200225; Singh AV, 2004, CARCINOGENESIS, V25, P83, DOI 10.1093/carcin/bgg178; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Verhoeven DTH, 1996, CANCER EPIDEM BIOMAR, V5, P733; Vermeulen M, 2008, J AGR FOOD CHEM, V56, P10505, DOI 10.1021/jf801989e; WEBSTER DR, 1989, J CELL SCI, V92, P57; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Zhang YS, 2001, CARCINOGENESIS, V22, P425, DOI 10.1093/carcin/22.3.425; Zhang YS, 2004, MUTAT RES-FUND MOL M, V555, P173, DOI 10.1016/j.mrfmmm.2004.04.017; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhang Y, 2007, ACTA PHARMACOL SIN, V28, P1343, DOI 10.1111/j.1745-7254.2007.00679.x	63	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100599	10.1371/journal.pone.0100599	http://dx.doi.org/10.1371/journal.pone.0100599			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950293	Green Published, Green Submitted, gold			2022-12-25	WOS:000338276300095
J	Hu, HL; Tian, DW; Chen, T; Han, RF; Sun, Y; Wu, CL				Hu, Hailong; Tian, Dawei; Chen, Tao; Han, Ruifa; Sun, Yan; Wu, Changli			Metastasis-Associated in Colon Cancer 1 Is a Novel Survival- Related Biomarker for Human Patients with Renal Pelvis Carcinoma	PLOS ONE			English	Article							UPPER URINARY-TRACT; COMPARATIVE GENOMIC HYBRIDIZATION; IN-SITU HYBRIDIZATION; HEPATOCELLULAR-CARCINOMA; UROTHELIAL CARCINOMA; CHROMOSOMAL-ABERRATIONS; ANATOMICAL LOCATION; GENETIC ALTERATIONS; PANCREATIC-CANCER; POOR-PROGNOSIS	Metastasis-associated in colon cancer 1 (MACC1) has recently been identified as a novel independent prognostic indicator for metastasis occurrence, overall survival and cancer-free survival for patients with colon cancer and other solid tumors. In this study, we investigated the role of MACC1 in the development and progression of renal pelvis carcinoma, a form of upper tract urothelial carcinomas. MACC1 protein has been found in the cytoplasm as well as in the nucleus of the transitional epithelial cells of the normal renal pelvis in immunohistochemical (IHC) assays. Quantitative IHC examinations revealed that MACC1 abnormal abundance in cancerous tissues might represent a biological indicator clinically suggestive of tumor malignancy in the renal pelvis. Furthermore, investigation of the association of MACC1 protein levels with clinicopathological parameters in this study has suggested a correlation of MACC1 expression with tumor-node-metastasis stage and histopathological grade of patients with renal pelvis carcinoma, with elevated MACC1 protein levels frequently associated with higher aggressiveness of the disease. Moreover, both disease-free survival and overall survival for the patients in the high MACC1 expression group were significantly lower than those in the low expression group. Multivariate analysis with a Cox proportional-hazards model suggested that MACC1 is indeed an independent prognostic indicator of overall survival and cancer-free survival for patients with renal pelvis carcinoma. Thus, MACC1 may represent a promising prognostic biomarker candidate, as well as a potential therapeutic target for this disease.	[Hu, Hailong; Tian, Dawei; Chen, Tao; Han, Ruifa; Sun, Yan; Wu, Changli] Tianjin Med Univ, Hosp 2, Tianjin Inst Urol, Dept Urol, Tianjin, Peoples R China	Tianjin Medical University	Hu, HL (corresponding author), Tianjin Med Univ, Hosp 2, Tianjin Inst Urol, Dept Urol, Tianjin, Peoples R China.	forwardgen@126.com; wucl2003@163.com			National Natural Science Foundation of China [30700834]; Natural Science Foundation of Tianjin [12ZCDZSY16600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This work was supported by a grant from National Natural Science Foundation of China (Grant Number: 30700834), and another grant from Natural Science Foundation of Tianjin (Grant Number: 12ZCDZSY16600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragane H, 2001, INT J CANCER, V94, P623, DOI 10.1002/ijc.1522; Arlt F, 2009, INT J BIOCHEM CELL B, V41, P2356, DOI 10.1016/j.biocel.2009.08.001; Arslantas A, 2007, PATHOL ONCOL RES, V13, P39, DOI 10.1007/BF02893439; Catto JWF, 2007, J UROLOGY, V177, P1715, DOI 10.1016/j.juro.2007.01.030; Colin P, 2009, BJU INT, V104, P1436, DOI 10.1111/j.1464-410X.2009.08838.x; Galimi F, 2011, CLIN CANCER RES, V17, P3146, DOI 10.1158/1078-0432.CCR-10-3377; Gao J, 2013, MOL CELL BIOCHEM, V376, P21, DOI 10.1007/s11010-012-1545-y; Gu CD, 2011, ANTICANCER RES, V31, P1141; Hagemann C, 2013, NEURO-ONCOLOGY, V15, P1696, DOI 10.1093/neuonc/not136; Harada T, 2007, BRIT J CANCER, V96, P373, DOI 10.1038/sj.bjc.6603563; Herbergs J, 1996, J PATHOL, V179, P243, DOI 10.1002/(SICI)1096-9896(199607)179:3<243::AID-PATH588>3.0.CO;2-Q; Huang YB, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-16; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Lehmann J, 2007, EUR UROL, V51, P1281, DOI 10.1016/j.eururo.2006.11.021; Loeper S, 2001, CYTOGENET CELL GENET, V94, P1, DOI 10.1159/000048773; Lughezzani G, 2012, EUR UROL, V62, P100, DOI 10.1016/j.eururo.2012.02.030; Morohara K, 2006, J CANCER RES CLIN, V132, P363, DOI 10.1007/s00432-005-0062-8; Qu JH, 2012, WORLD J GASTROENTERO, V18, P2995, DOI 10.3748/wjg.v18.i23.2995; Raman JD, 2011, BJU INT, V107, P1059, DOI 10.1111/j.1464-410X.2010.09675.x; Rossi MR, 2005, GENE CHROMOSOME CANC, V44, P392, DOI 10.1002/gcc.20256; Roupret M, 2011, EUR UROL, V59, P584, DOI 10.1016/j.eururo.2010.12.042; Saito K, 2007, BJU INT, V100, P269, DOI 10.1111/j.1464-410X.2007.06934.x; Shapiro JR, 2002, AM J MED GENET, V115, P194, DOI 10.1002/ajmg.10690; Shariat SF, 2006, CLIN CANCER RES, V12, P6663, DOI 10.1158/1078-0432.CCR-06-0372; Shimokawa H, 2011, J THORAC CARDIOV SUR, V141, P895, DOI 10.1016/j.jtcvs.2010.09.044; Shirahata A, 2010, ANTICANCER RES, V30, P2689; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stein U, 2013, EXPERT OPIN THER TAR, V17, P1039, DOI 10.1517/14728222.2013.815727; Stein U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049249; Stein U, 2010, J MOL MED, V88, P11, DOI 10.1007/s00109-009-0537-1; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; Suyama T, 2011, INT J UROL, V18, P43, DOI 10.1111/j.1442-2042.2010.02671.x; Tsiambas E, 2009, PATHOL ONCOL RES, V15, P511, DOI 10.1007/s12253-008-9146-5; Tyler Allison, 2012, Semin Oncol Nurs, V28, P154, DOI 10.1016/j.soncn.2012.05.004; Ubagai T, 2001, ONCOL REP, V8, P83; Wang G, 2012, ONCOL LETT, V4, P783, DOI 10.3892/ol.2012.784; Wang L, 2013, INT J CANCER, V133, P1419, DOI 10.1002/ijc.28140; Yang T, 2014, TUMOR BIOL, V35, P815, DOI 10.1007/s13277-013-1112-5; Yang YP, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-41; Yates DR, 2013, WORLD J UROL, V31, P21, DOI 10.1007/s00345-012-0946-6; Zhang K, 2013, TUMOUR BIOL; Zhang RT, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-83; Zhu MC, 2013, PATHOL ONCOL RES, V19, P749, DOI 10.1007/s12253-013-9638-9; Zimmermann U, 1997, HEPATOLOGY, V26, P1492; Zojer N, 2000, LUNG CANCER, V28, P225, DOI 10.1016/S0169-5002(00)00097-0	45	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100161	10.1371/journal.pone.0100161	http://dx.doi.org/10.1371/journal.pone.0100161			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949951	Green Published, Green Submitted, gold			2022-12-25	WOS:000338276300043
J	Antanaviciute, I; Rysevaite, K; Liutkevicius, V; Marandykina, A; Rimkute, L; Sveikatiene, R; Uloza, V; Skeberdis, VA				Antanaviciute, Ieva; Rysevaite, Kristina; Liutkevicius, Vykintas; Marandykina, Alina; Rimkute, Lina; Sveikatiene, Renata; Uloza, Virgilijus; Skeberdis, Vytenis Arvydas			Long-Distance Communication between Laryngeal Carcinoma Cells	PLOS ONE			English	Article							GAP-JUNCTION CHANNELS; PH-DEPENDENT MODULATION; TUNNELING NANOTUBES; MEMBRANE NANOTUBES; CANCER-CELLS; VOLTAGE; CONNEXIN; CONDUCTANCE; CYTONEMES; PERMEABILITY	Tunneling nanotubes and epithelial bridges are recently discovered new forms of intercellular communication between remote cells allowing their electrical synchronization, transfer of second messengers and even membrane vesicles and organelles. In the present study, we demonstrate for the first time in primary cell cultures prepared from human laryngeal squamous cell carcinoma (LSCC) samples that these cells communicate with each other over long distances (up to 1 mm) through membranous tunneling tubes (TTs), which can be open-ended or contain functional gap junctions formed of connexin 43. We found two types of TTs, containing F-actin alone or F-actin and a-tubulin. In the LSCC cell culture, we identified 5 modes of TT formation and performed quantitative assessment of their electrical properties and permeability to fluorescent dyes of different molecular weight and charge. We show that TTs, containing F-actin and a-tubulin, transport mitochondria and accommodate small DAPI-positive vesicles suggesting possible transfer of genetic material through TTs. We confirmed this possibility by demonstrating that even TTs, containing gap junctions, were capable of transmitting double-stranded small interfering RNA. To support the idea that the phenomenon of TTs is not only typical of cell cultures, we have examined microsections of samples obtained from human LSCC tissues and identified intercellular structures similar to those found in the primary LSCC cell culture.	[Antanaviciute, Ieva; Rysevaite, Kristina; Liutkevicius, Vykintas; Marandykina, Alina; Rimkute, Lina; Sveikatiene, Renata; Skeberdis, Vytenis Arvydas] Lithuanian Univ Hlth Sci, Inst Cardiol, Kaunas, Lithuania; [Rysevaite, Kristina] Lithuanian Univ Hlth Sci, Inst Anat, Kaunas, Lithuania; [Liutkevicius, Vykintas; Uloza, Virgilijus] Lithuanian Univ Hlth Sci, Dept Otorhinolaryngol, Kaunas, Lithuania	Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; Lithuanian University of Health Sciences	Skeberdis, VA (corresponding author), Lithuanian Univ Hlth Sci, Inst Cardiol, Kaunas, Lithuania.	arvydas.skeberdis@lsmuni.lt		Antanaviciute, Ieva/0000-0002-7406-0298; Skeberdis, Vytenis Arvydas/0000-0001-7137-3187	Research Council of Lithuania [LIG-13/2012]	Research Council of Lithuania(Research Council of Lithuania (LMTLT))	This research was funded by a grant (No. LIG-13/2012) from the Research Council of Lithuania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abounit S, 2012, J CELL SCI, V125, P1089, DOI 10.1242/jcs.083279; BINGGELI R, 1980, CANCER RES, V40, P1830; Bobrie A, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22565; Brink PR, 2012, BBA-BIOMEMBRANES, V1818, P2076, DOI 10.1016/j.bbamem.2011.09.025; Bukauskas FF, 2004, BBA-BIOMEMBRANES, V1662, P42, DOI 10.1016/j.bbamem.2004.01.008; Bukoreshtliev NV, 2009, FEBS LETT, V583, P1481, DOI 10.1016/j.febslet.2009.03.065; Chauveau A, 2010, P NATL ACAD SCI USA, V107, P5545, DOI 10.1073/pnas.0910074107; Chernet BT, 2013, DIS MODEL MECH, V6, P595, DOI 10.1242/dmm.010835; Chinnery HR, 2008, J IMMUNOL, V180, P5779, DOI 10.4049/jimmunol.180.9.5779; Cirri P, 2012, CANCER METAST REV, V31, P195, DOI 10.1007/s10555-011-9340-x; Cirri P, 2011, AM J CANCER RES, V1, P482; Galkina SI, 2011, FEMS IMMUNOL MED MIC, V61, P114, DOI 10.1111/j.1574-695X.2010.00754.x; Gerdes HH, 2008, CURR OPIN CELL BIOL, V20, P470, DOI 10.1016/j.ceb.2008.03.005; Gerdes HH, 2007, FEBS LETT, V581, P2194, DOI 10.1016/j.febslet.2007.03.071; Gonzalez D, 2007, PROG BIOPHYS MOL BIO, V94, P66, DOI 10.1016/j.pbiomolbio.2007.03.007; Gurke S, 2008, HISTOCHEM CELL BIOL, V129, P539, DOI 10.1007/s00418-008-0412-0; Hille B, 2001, ION CHANNELS EXCITAB, P1; Hurtig J, 2010, WIRES NANOMED NANOBI, V2, P260, DOI 10.1002/wnan.80; Kimura S, 2012, EXP CELL RES, V318, P1699, DOI 10.1016/j.yexcr.2012.05.013; Koyanagi M, 2005, CIRC RES, V96, P1039, DOI 10.1161/01.RES.0000168650.23479.0c; Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108; Lim PK, 2011, CANCER RES, V71, P1550, DOI 10.1158/0008-5472.CAN-10-2372; Lokar M, 2010, PROTOPLASMA, V246, P81, DOI 10.1007/s00709-010-0143-7; Lou E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033093; Lucas WJ, 2009, TRENDS CELL BIOL, V19, P495, DOI 10.1016/j.tcb.2009.07.003; Margineantu DH, 2002, MITOCHONDRION, V1, P425, DOI 10.1016/S1567-7249(02)00006-5; Minuth WW, 2012, NEPHRON EXP NEPHROL, V122, P131, DOI 10.1159/000351129; Monici M, 2005, BIOTECHNOL ANN REV, V11, P227, DOI 10.1016/S1387-2656(05)11007-2; Oh S, 1999, J GEN PHYSIOL, V114, P339, DOI 10.1085/jgp.114.3.339; Ohno Hiroshi, 2010, Commun Integr Biol, V3, P231; Onfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476; Palacios-Prado N, 2012, BBA-BIOMEMBRANES, V1818, P1884, DOI 10.1016/j.bbamem.2011.09.001; Palacios-Prado N, 2010, P NATL ACAD SCI USA, V107, P9897, DOI 10.1073/pnas.1004552107; Palacios-Prado N, 2009, J PHYSIOL-LONDON, V587, P3251, DOI 10.1113/jphysiol.2009.171496; Pasquier J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-94; Paullauskas N, 2009, BIOPHYS J, V96, P3936, DOI 10.1016/j.bpj.2009.01.059; Rackauskas M, 2007, AM J PHYSIOL-HEART C, V293, pH1729, DOI 10.1152/ajpheart.00234.2007; Rackauskas M, 2010, MEDICINA-LITHUANIA, V46, P1, DOI 10.3390/medicina46010001; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Roy S, 2011, SCIENCE, V332, P354, DOI 10.1126/science.1198949; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Sanchez-Alvarez R, 2013, CELL CYCLE, V12, P172, DOI 10.4161/cc.23058; Schiel JA, 2013, TRENDS CELL BIOL, V23, P319, DOI 10.1016/j.tcb.2013.02.003; Schiller C, 2013, J CELL SCI, V126, P767, DOI 10.1242/jcs.114033; Schneider B, 2002, ORL-J OTO-RHIN-LARYN, V64, P324, DOI 10.1159/000066086; Sherer NM, 2008, TRENDS CELL BIOL, V18, P414, DOI 10.1016/j.tcb.2008.07.003; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; SIMPSON I, 1977, SCIENCE, V195, P294, DOI 10.1126/science.831276; Valiunas V, 2005, J PHYSIOL-LONDON, V568, P459, DOI 10.1113/jphysiol.2005.090985; VERSELIS V, 1986, SCIENCE, V234, P461, DOI 10.1126/science.3489990; WILDERS R, 1992, BIOPHYS J, V63, P942, DOI 10.1016/S0006-3495(92)81664-8; Wolvetang EJ, 2007, BIOCHEM BIOPH RES CO, V363, P610, DOI 10.1016/j.bbrc.2007.09.035; Zani Brett G, 2010, Commun Integr Biol, V3, P215; Zani BG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008930	54	71	71	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99196	10.1371/journal.pone.0099196	http://dx.doi.org/10.1371/journal.pone.0099196			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945745	Green Submitted, Green Published, gold			2022-12-25	WOS:000340721500013
J	Hester, AG; Murphy, RC; Uhlson, CJ; Ivester, P; Lee, TC; Sergeant, S; Miller, LR; Howard, TD; Mathias, RA; Chilton, FH				Hester, Austin G.; Murphy, Robert C.; Uhlson, Charis J.; Ivester, Priscilla; Lee, Tammy C.; Sergeant, Susan; Miller, Leslie R.; Howard, Timothy D.; Mathias, Rasika A.; Chilton, Floyd H.			Relationship between a Common Variant in the Fatty Acid Desaturase (FADS) Cluster and Eicosanoid Generation in Humans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY-HEART-DISEASE; ARACHIDONIC-ACID; GENETIC-VARIANTS; INFLAMMATORY CELLS; AFRICAN-AMERICANS; WHOLE-BLOOD; EXPRESSION; METABOLISM; PHOSPHOLIPIDS; CLONING	Dramatic shifts in the Western diet have led to a marked increase in the dietary intake of the n-6 polyunsaturated fatty acid (PUFA), linoleic acid (LA). Dietary LA can then be converted to arachidonic acid (ARA) utilizing three enzymatic steps. Two of these steps are encoded for by the fatty acid desaturase (FADS) cluster (chromosome 11, 11q12.2-q13) and certain genetic variants within the cluster are highly associated with ARA levels. However, no study to date has examined whether these variants further influence pro-inflammatory, cyclooxygenase and lipoxygenase eicosanoid products. This study examined the impact of a highly influential FADS SNP, rs174537 on leukotriene, HETE, prostaglandin, and thromboxane biosynthesis in stimulated whole blood. Thirty subjects were genotyped at rs174537 (GG, n = 11; GT, n = 13; TT, n = 6), a panel of fatty acids from whole serum was analyzed, and precursor-to-product PUFA ratios were calculated as a marker of the capacity of tissues (particularly the liver) to synthesize long chain PUFAs. Eicosanoids produced by stimulated human blood were measured by LC-MS/MS. We observed an association between rs174537 and the ratio of ARA/LA, leukotriene B-4, and 5-HETE but no effect on levels of cyclooxygenase products. Our results suggest that variation at rs174537 not only impacts the synthesis of ARA but the overall capacity of whole blood to synthesize 5-lipoxygenase products; these genotype-related changes in eicosanoid levels could have important implications in a variety of inflammatory diseases.	[Hester, Austin G.] Wake Forest Univ, Bowman Gray Sch Med, Dept Urol, Winston Salem, NC 27157 USA; [Hester, Austin G.; Ivester, Priscilla; Lee, Tammy C.; Miller, Leslie R.; Chilton, Floyd H.] Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol Pharmacol, Winston Salem, NC 27157 USA; [Murphy, Robert C.; Uhlson, Charis J.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Ivester, Priscilla; Lee, Tammy C.; Sergeant, Susan; Chilton, Floyd H.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Bot Lipids & Inflammatory Dis Prevent, Winston Salem, NC 27157 USA; [Sergeant, Susan] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Howard, Timothy D.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom, Winston Salem, NC 27157 USA; [Mathias, Rasika A.] Johns Hopkins Univ, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD 21224 USA; [Chilton, Floyd H.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Johns Hopkins University; Wake Forest University; Wake Forest Baptist Medical Center	Chilton, FH (corresponding author), Wake Forest Sch Med, Dept Physiol Pharmacol, Med Ctr Blvd, Winston Salem, NC 27101 USA.	schilton@wakehealth.edu	Murphy, Robert/AAO-5349-2020	Murphy, Robert/0000-0002-9430-6515	National Institutes of Health [P50 AT002782]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001420] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P50AT002782] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported, in whole or in part, by National Institutes of Health Grant P50 AT002782. Dr. Chilton is an unpaid consultant for Gene Smart Health and receives no compensation in this role. This information has been disclosed to WFUHS and outside sponsors, as appropriate, and is institutionally managed.	Astudillo AM, 2012, BBA-MOL CELL BIOL L, V1821, P249, DOI 10.1016/j.bbalip.2011.11.006; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Balsinde J, 1999, ANNU REV PHARMACOL, V39, P175, DOI 10.1146/annurev.pharmtox.39.1.175; Balsinde J, 2002, FEBS LETT, V531, P2, DOI 10.1016/S0014-5793(02)03413-0; Baylin A, 2007, AM J CLIN NUTR, V85, P554, DOI 10.1093/ajcn/85.2.554; BELLAVITE P, 1983, EUR J CLIN INVEST, V13, P363; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; CATELLA F, 1986, P NATL ACAD SCI USA, V83, P5861, DOI 10.1073/pnas.83.16.5861; CHILTON FH, 1986, J BIOL CHEM, V261, P7771; Chilton FH, 1996, BBA-LIPID LIPID MET, V1299, P1, DOI 10.1016/0005-2760(95)00169-7; Cho HP, 1999, J BIOL CHEM, V274, P471, DOI 10.1074/jbc.274.1.471; Cho HP, 1999, J BIOL CHEM, V274, P37335, DOI 10.1074/jbc.274.52.37335; Choa H, 2006, BIOORGAN MED CHEM, V14, P6486, DOI 10.1016/j.bmc.2006.06.030; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; EATON SB, 1992, LIPIDS, V27, P814, DOI 10.1007/BF02535856; Ensor CM, 1998, BIOCHEM J, V330, P103, DOI 10.1042/bj3300103; FRADIN A, 1989, J IMMUNOL, V143, P3680; Gerrior S., 2004, 56 USDA CTR NUTR POL, P14; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Gijon MA, 2007, J LIPID RES, V48, P716, DOI 10.1194/jlr.M600508-JLR200; Hibbeln JR, 2006, AM J CLIN NUTR, V83, p1483S, DOI 10.1093/ajcn/83.6.1483S; Howard TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097510; HUI KP, 1991, THORAX, V46, P184, DOI 10.1136/thx.46.3.184; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Koletzko B, 2011, AM J CLIN NUTR, V93, P211, DOI 10.3945/ajcn.110.006189; KUMLIN M, 1986, PROSTAGLANDINS, V32, P741, DOI 10.1016/0090-6980(86)90196-6; LANDS WEM, 1965, J BIOL CHEM, V240, P1905; LANDS WEM, 1992, BIOCHIM BIOPHYS ACTA, V1180, P147, DOI 10.1016/0925-4439(92)90063-S; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Los DA, 1998, BBA-LIPID LIPID MET, V1394, P3, DOI 10.1016/S0005-2760(98)00091-5; Malerba G, 2008, LIPIDS, V43, P289, DOI 10.1007/s11745-008-3158-5; Martinelli N, 2008, AM J CLIN NUTR, V88, P941, DOI 10.1093/ajcn/88.4.941; Mathias RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044926; Mathias RA, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-50; METCALFE LD, 1966, ANAL CHEM, V38, P514, DOI 10.1021/ac60235a044; Nakamura MT, 2003, PROSTAG LEUKOTR ESS, V68, P145, DOI 10.1016/S0952-3278(02)00264-8; Park JH, 2010, PATENTS AND INDUSTRY STANDARDS, P1; Park WJ, 2009, J LIPID RES, V50, P1195, DOI 10.1194/jlr.M800630-JLR200; Reardon HT, 2013, PROSTAG LEUKOTR ESS, V88, P15, DOI 10.1016/j.plefa.2012.02.003; Reardon HT, 2012, PROSTAG LEUKOTR ESS, V87, P25, DOI 10.1016/j.plefa.2012.04.011; Rzehak P, 2009, BRIT J NUTR, V101, P20, DOI 10.1017/S0007114508992564; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Schwedhelm E, 2004, CIRCULATION, V109, P843, DOI 10.1161/01.CIR.0000116761.93647.30; Sergeant S, 2012, BRIT J NUTR, V107, P547, DOI 10.1017/S0007114511003230; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Spector AA, 1999, LIPIDS, V34, pS1, DOI 10.1007/BF02562220; Spector AA, 2001, J MOL NEUROSCI, V16, P159, DOI 10.1385/JMN:16:2-3:159; SPRECHER H, 1981, Progress in Lipid Research, V20, P13, DOI 10.1016/0163-7827(81)90009-6; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Weaver KL, 2009, J BIOL CHEM, V284, P15400, DOI 10.1074/jbc.M109.004861; Wolfram R, 2005, EUR J HEART FAIL, V7, P167, DOI 10.1016/j.ejheart.2004.05.007; Xie L, 2008, J NUTR, V138, P2222, DOI 10.3945/jn.108.096156	54	48	48	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22482	22489		10.1074/jbc.M114.579557	http://dx.doi.org/10.1074/jbc.M114.579557			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24962583	Green Published, hybrid			2022-12-25	WOS:000340593500057
J	Ko, CC; Chen, YJ; Chen, CT; Liu, YC; Cheng, FC; Hsu, KC; Chow, LP				Ko, Chia-Chen; Chen, Yun-Ju; Chen, Chih-Ta; Liu, Yu-Chih; Cheng, Fong-Chi; Hsu, Kai-Chao; Chow, Lu-Ping			Chemical Proteomics Identifies Heterogeneous Nuclear Ribonucleoprotein (hnRNP) A1 as the Molecular Target of Quercetin in Its Anti-cancer Effects in PC-3 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; APOPTOSIS; PROTEINS; EXPRESSION; NUCLEOLIN; SURVIVAL; RELOCALIZATION; PROLIFERATION; INHIBITION; STRATEGIES	Quercetin, a flavonoid abundantly present in plants, is widely used as a phytotherapy in prostatitis and prostate cancer. Although quercetin has been reported to have a number of therapeutic effects, the cellular target(s) responsible for its anti-cancer action has not yet been clearly elucidated. Here, employing affinity chromatography and mass spectrometry, we identified heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) as a direct target of quercetin. A specific interaction between quercetin and hnRNPA1 was validated by immunoblotting and in vitro binding experiments. We found that quercetin bound the C-terminal region of hnRNPA1, impairing the ability of hnRNPA1 to shuttle between the nucleus and cytoplasm and ultimately resulting in its cytoplasmic retention. In addition, hnRNPA1 was recruited to stress granules after treatment of cells with quercetin for up to 48 h, and the levels of cIAP1 (cellular inhibitor of apoptosis), an internal ribosome entry site translation-dependent protein, were reduced by hnRNPA1 regulation. This is the first report that anti-cancer effects of quercetin are mediated, in part, by impairing functions of hnRNPA1, insights that were obtained using a chemical proteomics strategy.	[Ko, Chia-Chen; Chen, Yun-Ju; Chen, Chih-Ta; Liu, Yu-Chih; Hsu, Kai-Chao; Chow, Lu-Ping] Natl Taiwan Univ, Grad Inst Biochem & Mol Biol, Coll Med, Taipei 100, Taiwan; [Cheng, Fong-Chi] Eurofins Panlabs Taiwan Ltd, Taipei 112, Taiwan	National Taiwan University	Chow, LP (corresponding author), Natl Taiwan Univ, Grad Inst Biochem & Mol Biol, Coll Med, Taipei 100, Taiwan.	chowip@ntu.edu.tw		CHOW, LU-PING/0000-0002-4420-211X	National Science Council [NSC 101-2325-B-002-065]; Liver Disease Prevention and Treatment Research Foundation; Ministry of Education, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Liver Disease Prevention and Treatment Research Foundation; Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This study was supported by National Science Council Grant NSC 101-2325-B-002-065, the Liver Disease Prevention and Treatment Research Foundation, and the Ministry of Education, Taiwan.	Al-Maghrebir M, 2005, ANTICANCER RES, V25, P2573; Bantscheff M, 2012, BIOORGAN MED CHEM, V20, P1973, DOI 10.1016/j.bmc.2011.11.003; Bevilacqua E, 2010, J BIOL CHEM, V285, P17098, DOI 10.1074/jbc.M110.109439; Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132; Curtis Nickel J, 2008, Rev Urol, V10, P192; Duncan JS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001682; Ermakova S, 2005, J BIOL CHEM, V280, P16882, DOI 10.1074/jbc.M414185200; Fleischer TC, 2010, CHEM BIOL, V17, P659, DOI 10.1016/j.chembiol.2010.05.008; Gill C, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-39; Ginisty H, 1999, J CELL SCI, V112, P761; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Hovanessian AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015787; Kumar R, 2011, J NUTR BIOCHEM, V22, P723, DOI 10.1016/j.jnutbio.2010.06.003; Lamson D W, 2000, Altern Med Rev, V5, P196; Lee KW, 2008, CANCER RES, V68, P946, DOI 10.1158/0008-5472.CAN-07-3140; Lee KM, 2010, J AGR FOOD CHEM, V58, P5815, DOI 10.1021/jf903698s; Lewis SM, 2007, MOL BIOL CELL, V18, P1302, DOI 10.1091/mbc.E06-06-0515; Liu HZ, 2010, SCAND J UROL NEPHROL, V44, P277, DOI 10.3109/00365599.2010.492787; Ma YL, 2009, J PROTEOME RES, V8, P4525, DOI 10.1021/pr900365e; MARCINKIEWICZ C, 1995, ACTA BIOCHIM POL, V42, P347; Murphy AB, 2009, DRUGS, V69, P71, DOI 10.2165/00003495-200969010-00005; Patry C, 2003, CANCER RES, V63, P7679; Piersma SR, 2010, ANAL BIOANAL CHEM, V397, P3163, DOI 10.1007/s00216-010-3784-7; Pino I, 2003, LUNG CANCER-J IASLC, V41, P131, DOI 10.1016/S0169-5002(03)00193-4; Qi YF, 2012, J BIOL CHEM, V287, P32236, DOI 10.1074/jbc.M112.362160; Ruiz C, 2011, J PATHOL, V223, P543, DOI 10.1002/path.2828; Russo M, 2012, BIOCHEM PHARMACOL, V83, P6, DOI 10.1016/j.bcp.2011.08.010; Schimmer AD, 2004, CANCER RES, V64, P7183, DOI 10.1158/0008-5472.CAN-04-1918; Schirle M, 2012, CHEM BIOL, V19, P72, DOI 10.1016/j.chembiol.2012.01.002; Sengupta TK, 2004, J BIOL CHEM, V279, P10855, DOI 10.1074/jbc.M309111200; Vijayababu MR, 2005, J CANCER RES CLIN, V131, P765, DOI 10.1007/s00432-005-0005-4; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Wang RE, 2011, BIOORGAN MED CHEM, V19, P4710, DOI 10.1016/j.bmc.2011.07.005	35	37	41	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22078	22089		10.1074/jbc.M114.553248	http://dx.doi.org/10.1074/jbc.M114.553248			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24962584	Green Published, hybrid			2022-12-25	WOS:000340593500024
J	Alidousty, C; Rauen, T; Hanssen, L; Wang, Q; Alampour-Rajabi, S; Mertens, PR; Bernhagen, J; Floege, J; Ostendorf, T; Raffetseder, U				Alidousty, Christina; Rauen, Thomas; Hanssen, Lydia; Wang, Qiang; Alampour-Rajabi, Setareh; Mertens, Peter R.; Bernhagen, Juergen; Floege, Juergen; Ostendorf, Tammo; Raffetseder, Ute			Calcineurin-mediated YB-1 Dephosphorylation Regulates CCL5 Expression during Monocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX-BINDING PROTEIN-1; BREAST-CANCER CELLS; COLD SHOCK DOMAIN; TRANSCRIPTION FACTORS; MESSENGER-RNA; NUCLEAR IMPORT; T-CELLS; PROMOTER; ATHEROSCLEROSIS; PHOSPHORYLATION	Y-box (YB) protein-1 serves as a master regulator in gene transcription and mRNA translation. YB-1 itself is regulated at various levels, e. g. through post-translational modifications. In our previous work, we identified RANTES/CCL5 as a transcriptional target of YB-1. We previously demonstrated that YB-1 protein is transiently up-regulated during monocyte/macrophage differentiation evidenced in monocytic cells (THP-1 cells) that were differentiated using phorbol myristate acetate (PMA). Here we provide evidence that YB-1 phosphorylation, specifically at its serine residue 102 (Ser-102), increases early on in THP-1 cells following PMA treatment as well as in differentiated primary human monocytes. This process is mediated through the Akt signaling pathway. Ser-102-phosphorylated YB-1 displays stronger binding affinity and trans-activating capacity at the CCL5 gene promoter. Notably, Ser-102-phosphorylated YB-1 disappears at later stages of the monocyte/macrophage differentiation process. We demonstrate that serine-threonine phosphatase calcineurin (CN) dephosphorylates YB-1 preventing it from binding to and trans-activating the CCL5 promoter. Co-immunoprecipitation assays prove a direct YB-1/CN interaction. Furthermore, analyses in kidney tissues from mice that were treated with the CN inhibitor cyclosporine A revealed an in vivo effect of CN on the YB-1 phosphorylation status. We conclude that YB-1 phosphorylation at Ser-102 is an important prerequisite for CCL5 promoter activation during macrophage differentiation. Our findings point to a critical role of YB-1 in the resolution of inflammatory processes which may largely be due to CN-mediated dephosphorylation.	[Alidousty, Christina; Rauen, Thomas; Hanssen, Lydia; Floege, Juergen; Ostendorf, Tammo; Raffetseder, Ute] Univ Hosp RWTH Aachen, Dept Nephrol & Clin Immunol, D-52057 Aachen, Germany; [Wang, Qiang] Nanjing Med Univ, Dept Rheumatol, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China; [Alampour-Rajabi, Setareh; Bernhagen, Juergen] Univ Hosp RWTH Aachen, Inst Biochem & Mol Cell Biol, Dept Cell & Mol Biol, D-52057 Aachen, Germany; [Mertens, Peter R.] Otto Von Guericke Univ, Dept Nephrol Hypertens Diabet & Endocrinol, D-39120 Magdeburg, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Nanjing Medical University; RWTH Aachen University; RWTH Aachen University Hospital; Otto von Guericke University	Raffetseder, U (corresponding author), RWTH Aachen Univ Hosp, Dept Nephrol & Clin Immunol, Pauwelsstr 30, D-52057 Aachen, Germany.	uraffetseder@ukaachen.de	Mertens, Peter/AAI-7310-2020; Rauen, Thomas/GLR-8682-2022		Fritz-Bender-Stiftung; START-Program (Faculty of Medicine, RWTH, Aachen); DFG [SFB-TRR57/A07, FOR809/TP1-Be1977/4-2]; Interdisciplinary Center for Clinical Research (IZKF) within the Faculty of Medicine at the RWTH Aachen University [E6-10];  [SFB/TRR57];  [SFB854];  [Me1365/7-1];  [SFB 542]	Fritz-Bender-Stiftung; START-Program (Faculty of Medicine, RWTH, Aachen); DFG(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (IZKF) within the Faculty of Medicine at the RWTH Aachen University; ; ; ; 	This work was funded by the Fritz-Bender-Stiftung (to T. R. and U. R.), START-Program (Faculty of Medicine, RWTH, Aachen, to T. R. and U. R.), SFB/TRR57 (to T. O. and J. F.), SFB854 and Me1365/7-1 (to P. R. M.) and SFB 542 projects C12 (to U. R. and P. R. M.).; Recipient of funding from DFG Projects SFB-TRR57/A07 and FOR809/TP1-Be1977/4-2.; Recipient of funding from the Interdisciplinary Center for Clinical Research (IZKF) within the Faculty of Medicine at the RWTH Aachen University (E6-10).	Allemand E, 2007, NAT STRUCT MOL BIOL, V14, P630, DOI 10.1038/nsmb1257; Baksh S, 2000, ONCOGENE, V19, P2820, DOI 10.1038/sj.onc.1203585; Basaki Y, 2007, ONCOGENE, V26, P2736, DOI 10.1038/sj.onc.1210084; Boehlk S, 2000, EUR J IMMUNOL, V30, P1102, DOI 10.1002/(SICI)1521-4141(200004)30:4<1102::AID-IMMU1102>3.0.CO;2-X; Burke BA, 1995, TRANSPLANTATION, V60, P1413, DOI 10.1097/00007890-199560120-00007; Capowski EE, 2001, J IMMUNOL, V167, P5970, DOI 10.4049/jimmunol.167.10.5970; Chen CY, 2000, GENE DEV, V14, P1236; Diamond P, 2001, J BIOL CHEM, V276, P7943, DOI 10.1074/jbc.M009836200; En-Nia A, 2005, J BIOL CHEM, V280, P7702, DOI 10.1074/jbc.M413353200; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Garcia-Cozar FJ, 1998, J BIOL CHEM, V273, P23877, DOI 10.1074/jbc.273.37.23877; Hallhuber M, 2006, CIRC RES, V99, P626, DOI 10.1161/01.RES.0000243208.59795.d8; Hanssen L, 2013, J IMMUNOL, V191, P2604, DOI 10.4049/jimmunol.1300416; Hanssen L, 2011, J IMMUNOL, V187, P298, DOI 10.4049/jimmunol.1100382; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Krohn R, 2007, CIRCULATION, V116, P1812, DOI 10.1161/CIRCULATIONAHA.107.708016; MACDONALD GH, 1995, J BIOL CHEM, V270, P3527, DOI 10.1074/jbc.270.8.3527; Mertens PR, 1998, J BIOL CHEM, V273, P32957, DOI 10.1074/jbc.273.49.32957; Mertens PR, 1999, J AM SOC NEPHROL, V10, P2480; Mihatsch MJ, 1998, CLIN NEPHROL, V49, P356; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Raffetseder U, 2003, J BIOL CHEM, V278, P18241, DOI 10.1074/jbc.M212518200; Raffetseder U, 2012, EUR J CELL BIOL, V91, P567, DOI 10.1016/j.ejcb.2011.07.001; Raffetseder U, 2009, KIDNEY INT, V75, P185, DOI 10.1038/ki.2008.457; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rauen T, 2009, J BIOL CHEM, V284, P26928, DOI 10.1074/jbc.M109.046599; Seo J, 2004, J BIOCHEM MOL BIOL, V37, P35; Shi C, 2006, TRENDS CARDIOVAS MED, V16, P146, DOI 10.1016/j.tcm.2006.03.002; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Sinnberg T, 2012, EXP DERMATOL, V21, P265, DOI 10.1111/j.1600-0625.2012.01448.x; Stratford AL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1767; Stratford AL, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2202; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Wang J, 2003, J NEUROSCI, V23, P826; Wilson HM, 2004, CURR OPIN NEPHROL HY, V13, P285, DOI 10.1097/00041552-200405000-00004; Wu Joyce, 2007, Transl Oncogenomics, V2, P49	39	25	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21401	21412		10.1074/jbc.M114.562991	http://dx.doi.org/10.1074/jbc.M114.562991			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24947514	Green Published, hybrid			2022-12-25	WOS:000340558300019
J	Carver, AR; Andrikopoulou, M; Lei, J; Tamayo, E; Gamble, P; Hou, ZP; Zhang, JY; Mori, S; Saade, GR; Costantine, MM; Burd, I				Carver, Alissa R.; Andrikopoulou, Maria; Lei, Jun; Tamayo, Esther; Gamble, Phyllis; Hou, Zhipeng; Zhang, Jiangyang; Mori, Susumu; Saade, George R.; Costantine, Maged M.; Burd, Irina			Maternal Pravastatin Prevents Altered Fetal Brain Development in a Preeclamptic CD-1 Mouse Model	PLOS ONE			English	Article							COA REDUCTASE INHIBITORS; AUTISM SPECTRUM DISORDER; SEX-DIFFERENCES; IN-UTERO; CARDIOVASCULAR FUNCTION; PRENATAL EXPOSURE; HYPOXIA-ISCHEMIA; GENE-TRANSFER; BIRTH-WEIGHT; STATIN USE	Objective: Using an animal model, we have previously shown that preeclampsia results in long-term adverse neuromotor outcomes in the offspring, and this phenotype was prevented by antenatal treatment with pravastatin. This study aims to localize the altered neuromotor programming in this animal model and to evaluate the role of pravastatin in its prevention. Materials and Methods: For the preeclampsia model, pregnant CD-1 mice were randomly allocated to injection of adenovirus carrying sFlt-1 or its control virus carrying mFc into the tail vein. Thereafter they received pravastatin (sFlt-1-pra "experimental group'') or water (sFlt-1 "positive control'') until weaning. The mFc group ("negative control'') received water. Offspring at 6 months of age were sacrificed, and whole brains underwent magnetic resonance imaging (MRI). MRIs were performed using an 11.7 Tesla vertical bore MRI scanner. T2 weighted images were acquired to evaluate the volumes of 28 regions of interest, including areas involved in adaptation and motor, spatial and sensory function. Cytochemistry and cell quantification was performed using neuron-specific Nissl stain. One-way ANOVA with multiple comparison testing was used for statistical analysis. Results: Compared with control offspring, male sFlt-1 offspring have decreased volumes in the fimbria, periaquaductal gray, stria medullaris, and ventricles and increased volumes in the lateral globus pallidus and neocortex; however, female sFlt-1 offspring showed increased volumes in the ventricles, stria medullaris, and fasciculus retroflexus and decreased volumes in the inferior colliculus, thalamus, and lateral globus pallidus. Neuronal quantification via Nissl staining exhibited decreased cell counts in sFlt-1 offspring neocortex, more pronounced in males. Prenatal pravastatin treatment prevented these changes. Conclusion: Preeclampsia alters brain development in sex-specific patterns, and prenatal pravastatin therapy prevents altered neuroanatomic programming in this animal model.	[Carver, Alissa R.; Tamayo, Esther; Gamble, Phyllis; Saade, George R.; Costantine, Maged M.] Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med, Galveston, TX 77555 USA; [Andrikopoulou, Maria; Lei, Jun; Burd, Irina] Johns Hopkins Univ, Dept Gynecol & Obstet, Integrated Res Ctr Fetal Med, Div Maternal Fetal Med, Baltimore, MD USA; [Hou, Zhipeng; Zhang, Jiangyang; Mori, Susumu] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA	University of Texas System; University of Texas Medical Branch Galveston; Johns Hopkins University; Johns Hopkins University	Carver, AR (corresponding author), Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med, Galveston, TX 77555 USA.	arcarver@utmb.edu	Andrikopoulou, Maria/GYD-9003-2022	Zhang, Jiangyang/0000-0003-0740-2662; Burd, Irina/0000-0001-7256-7784; Zhang, Jiangyang/0000-0003-4146-8163	NICHD [K08 HD073315]; NIH [RO1 EB003543]; Brain Science Institute, Johns Hopkins; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD073315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003543] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Science Institute, Johns Hopkins; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by NICHD K08 HD073315 (www.nichd.nih.gov), NIH RO1 EB003543 (www.nih.gov) and grant support from Brain Science Institute, Johns Hopkins (www.brainscienceinstitute.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG, 2002, OBSTET GYNECOL, V99, P869; Bajo VM, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00114; Beckmann H, 1999, EUR ARCH PSY CLIN N, V249, P44; Brosda J, 2011, NEUROBIOL DIS, V44, P239, DOI 10.1016/j.nbd.2011.07.008; Bushnell CD, 2006, STROKE, V37, P1427, DOI 10.1161/01.STR.0000221315.60282.ca; Bytautiene E, 2010, AM J PHYSIOL-HEART C, V298, pH189, DOI 10.1152/ajpheart.00792.2009; Carver AR, 2014, INT J DEV NEUROSCI, V33, P33, DOI 10.1016/j.ijdevneu.2013.11.004; Cassel JC, 1997, PROG NEUROBIOL, V51, P663, DOI 10.1016/S0301-0082(97)00009-9; Chagraoui H, 2001, EUR CYTOKINE NETW, V12, P561; Chau V, 2013, NEUROLOGY, V81, P2082, DOI 10.1212/01.wnl.0000437298.43688.b9; Costantine M, 2008, AM J OBSTET GYNECOL, V199, pS40, DOI 10.1016/j.ajog.2008.09.117; Costantine MM, 2013, OBSTET GYNECOL, V121, P349, DOI 10.1097/AOG.0b013e31827d8ad5; Costantine MM, 2010, OBSTET GYNECOL, V116, P114, DOI 10.1097/AOG.0b013e3181e10ebd; Dada T, 2014, BRAIN BEHAV IMMUN, V38, P142, DOI 10.1016/j.bbi.2014.01.014; Davies LA, 2008, MOL THER, V16, P812, DOI 10.1038/mt.2008.25; Edison RJ, 2004, AM J MED GENET A, V131A, P287, DOI 10.1002/ajmg.a.30386; Ehrenstein V, 2009, AM J EPIDEMIOL, V170, P1025, DOI 10.1093/aje/kwp223; Elahi MM, 2008, HYPERTENSION, V51, P939, DOI 10.1161/HYPERTENSIONAHA.107.100982; ELLISON G, 1994, BRAIN RES REV, V19, P223, DOI 10.1016/0165-0173(94)90012-4; Folsom TD, 2013, NEUROPHARMACOLOGY, V68, P122, DOI 10.1016/j.neuropharm.2012.08.015; Fox KA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.083; Gabory A, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-5; Gebhart GF, 2004, NEUROSCI BIOBEHAV R, V27, P729, DOI 10.1016/j.neubiorev.2003.11.008; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Golan MH, 2009, NEUROPHARMACOLOGY, V57, P511, DOI 10.1016/j.neuropharm.2009.07.028; Gutierrez J, 2012, ARCH INTERN MED, V172, P909, DOI 10.1001/archinternmed.2012.2145; Hatanaka T, 2000, CLIN PHARMACOKINET, V39, P397, DOI 10.2165/00003088-200039060-00002; Herson PS, 2013, TRANSL STROKE RES, V4, P413, DOI 10.1007/s12975-012-0238-x; Hill CA, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/867531; Hoglund K, 2007, CNS DRUGS, V21, P449; Huang H, 2013, CEREB CORTE IN PRESS; Infante SK, 2013, INT J DEV NEUROSCI, V31, P398, DOI 10.1016/j.ijdevneu.2013.02.003; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Kazmin A, 2007, J OBSTET GYNAECOL CA, V29, P906, DOI 10.1016/S1701-2163(16)32656-1; Kikuchi N, 2002, GENE THER, V9, P1529, DOI 10.1038/sj.gt.3301818; Kikuchi R, 2004, J PHARMACOL EXP THER, V311, P1147, DOI 10.1124/jpet.104.071621; KLOOSTER J, 1995, BRAIN RES, V688, P34, DOI 10.1016/0006-8993(95)00497-E; Kumar A, 2012, BRAIN RES, V1471, P13, DOI 10.1016/j.brainres.2012.06.050; Kumasawa K, 2011, P NATL ACAD SCI USA, V108, P1451, DOI 10.1073/pnas.1011293108; Leung KK, 2013, NEUROLOGY, V80, P648, DOI 10.1212/WNL.0b013e318281ccd3; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Li AP, 2010, NEUROL RES, V32, P945, DOI 10.1179/016164110X12670144737774; Li H, 2005, ANN NEUROL, V58, P317, DOI 10.1002/ana.20538; Liao JK, 2005, AM J CARDIOL, V96, p24F, DOI 10.1016/j.amjcard.2005.06.009; Lu F, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.064; Lu FX, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.024; Machon RA, 1997, ARCH GEN PSYCHIAT, V54, P322; Mahmood A, 2009, NEUROSURGERY, V65, P187, DOI 10.1227/01.NEU.0000343540.24780.D6; Mann JR, 2011, J ATTEN DISORD, V15, P667, DOI 10.1177/1087054710370566; Mann JR, 2010, J AUTISM DEV DISORD, V40, P548, DOI 10.1007/s10803-009-0903-4; Many A, 2003, HYPERTENS PREGNANCY, V22, P25, DOI 10.1081/PRG-120016791; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; McCarthy MM, 2009, J NEUROSCI, V29, P12815, DOI 10.1523/JNEUROSCI.3331-09.2009; McDonnold M, 2014, AM J OBSTET GYNECOL, V210; McDonnold M, 2013, AM J OBSTET GYNECOL, V208, pS28, DOI 10.1016/j.ajog.2012.10.220; Mooradian AD, 2005, DIABETES, V54, P2977, DOI 10.2337/diabetes.54.10.2977; Movsas TZ, 2013, J PEDIATR-US, V163, P73, DOI 10.1016/j.jpeds.2012.12.084; Nanovskaya TN, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.05.038; Ofori B, 2007, BRIT J CLIN PHARMACO, V64, P496, DOI 10.1111/j.1365-2125.2007.02905.x; Paintlia AS, 2009, GLIA, V57, P182, DOI 10.1002/glia.20745; Paul MJ, 2011, EUR J NEUROSCI, V34, P478, DOI 10.1111/j.1460-9568.2011.07762.x; Paxino G, 2001, MOUSE BRAIN STEREOTA; Peacock JL, 2012, PEDIATR RES, V71, P305, DOI 10.1038/pr.2011.50; Petersen EE, 2008, AM J MED GENET A, V146A, P2701, DOI 10.1002/ajmg.a.32493; Prevosto V, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00056; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Saad AF, 2014, REPROD SCI, V21, P138, DOI 10.1177/1933719113492207; Sacco RL, 2005, NAT CLIN PRACT CARD, V2, P576, DOI 10.1038/ncpcardio0348; Senoo M, 2000, MOL GENET METAB, V69, P269, DOI 10.1006/mgme.2000.2984; Sierra S, 2011, J ALZHEIMERS DIS, V23, P307, DOI 10.3233/JAD-2010-101179; Singh J, 2011, HYPERTENSION, V58, P716, DOI 10.1161/HYPERTENSIONAHA.111.175919; Stephenson-Jones M, 2013, P NATL ACAD SCI USA, V110, pE3670, DOI 10.1073/pnas.1314815110; Suren P, 2012, PEDIATRICS, V130, pE152, DOI 10.1542/peds.2011-3217; Taguchi N, 2008, REPROD TOXICOL, V26, P175, DOI 10.1016/j.reprotox.2008.06.009; van Wassenaer AG, 2011, AM J OBSTET GYNECOL, V204; Wagner AK, 2005, CRIT CARE MED, V33, P407, DOI 10.1097/01.CCM.0000153931.23488.DD; Wei KV, 2008, J MOL MED, V86, P161, DOI 10.1007/s00109-007-0261-7; Whitehouse AJO, 2012, PAEDIATR PERINAT EP, V26, P101, DOI 10.1111/j.1365-3016.2011.01257.x; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Winterfeld U, 2013, BJOG-INT J OBSTET GY, V120, P463, DOI 10.1111/1471-0528.12066; Zarek J, 2013, PLACENTA, V34, P719, DOI 10.1016/j.placenta.2013.05.002; Zhan Y, 2014, NAT NEUROSCI, V17, P400, DOI 10.1038/nn.3641; Zhang JY, 2010, NEUROIMAGE, V49, P2340, DOI 10.1016/j.neuroimage.2009.10.027; Zhu CL, 2006, J NEUROCHEM, V96, P1016, DOI 10.1111/j.1471-4159.2005.03639.x	84	27	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100873	10.1371/journal.pone.0100873	http://dx.doi.org/10.1371/journal.pone.0100873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963809	gold, Green Submitted, Green Published			2022-12-25	WOS:000338709500093
J	Feng, DJ; Ji, LQ; Xu, LZ				Feng, Danjun; Ji, Linqin; Xu, Lingzhong			Mediating Effect of Social Support on the Association between Functional Disability and Psychological Distress in Older Adults in Rural China: Does Age Make a Difference?	PLOS ONE			English	Article							DEPRESSIVE SYMPTOMS; AFRICAN-AMERICAN; MENTAL-ILLNESS; LIFE; PREVALENCE; ANXIETY; STRESS	This study aimed to determine the prevalence of psychological distress among elderly people in rural China. Moreover, the mediating effect of social support on the association between functional disability and psychological distress and whether this effect varies with age would be examined. A total of 741 elderly people aged 60-89 years from a rural area of Shandong Province, China participated in a cross-sectional survey. Their psychological distress, perceived social support, enacted social support, and functional disability were assessed through questionnaires. A total of 217 (29.3%) rural elderly people had psychological distress. The functional disability of people >= 75 years old had smaller total effects (0.18) on their psychological distress than in people <75 years old (0.30). Moreover, most of the effects of functional disability on psychological distress among the people >= 75 years old were indirect (0.12; 66.67% of total effects) through the mediating effect of social support especially perceived support, while the direct effect of functional disability was insignificant. In contrast, most of the effects of functional disability on psychological distress among the people <75 years old were direct (0.29; 96.67% of total effects), while the mediating effect of social support was insignificant. In conclusion, the total effect of functional disability, especially the direct effect, on psychological distress decreases sharply with age. The mediating effect of social support on the association between functional disability and psychological distress varies with age and is only found in people >= 75 years.	[Feng, Danjun] Shandong Univ, Sch Nursing, Jinan 250100, Peoples R China; [Ji, Linqin] Shandong Normal Univ, Sch Psychol, Jinan, Peoples R China; [Xu, Lingzhong] Shandong Univ, Dept Hlth Serv Management & Maternal & Child Heal, Jinan 250100, Peoples R China	Shandong University; Shandong Normal University; Shandong University	Xu, LZ (corresponding author), Shandong Univ, Dept Hlth Serv Management & Maternal & Child Heal, Jinan 250100, Peoples R China.	lzxu@sdu.edu.cn			Ministry of Education in China [10YJCXLX007]; Project of Humanities and Social Sciences	Ministry of Education in China(Ministry of Education, China); Project of Humanities and Social Sciences	This study was supported by the Ministry of Education in China, Project of Humanities and Social Sciences (grant No. 10YJCXLX007). The URL of its website is http://www.sinoss.net/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRERA M, 1986, AM J COMMUN PSYCHOL, V14, P413, DOI 10.1007/BF00922627; Bierman A, 2010, J GERONTOL B-PSYCHOL, V65, P631, DOI 10.1093/geronb/gbp128; Briere J, 2010, J TRAUMA STRESS, V23, P767, DOI 10.1002/jts.20578; Chen RL, 2005, ARCH INTERN MED, V165, P2019, DOI 10.1001/archinte.165.17.2019; Department of Human Services, 2008, VICT POP HLTH SURV 2; Elder GH, 2003, HDB LIFE COURSE, P3, DOI DOI 10.1007/978-0-306-48247-2_1; ENSEL WM, 1991, J HEALTH SOC BEHAV, V32, P321, DOI 10.2307/2137101; Hamano T, 2011, STRESS HEALTH, V27, P163, DOI 10.1002/smi.1324; He W.-M., 2007, INT J OPHTHALMOL-CHI, V7, P854; Hooper D, 2008, ELECT J BUSINESS RES, V6, P53, DOI DOI 10.21427/D7CF7R; Huang JP, 2009, AUST NZ J PSYCHIAT, V43, P674, DOI 10.1080/00048670902970817; Hudson CG, 2005, AM J ORTHOPSYCHIAT, V75, P3, DOI 10.1037/0002-9432.75.1.3; Jang Y, 2005, J GERONTOL B-PSYCHOL, V60, pP313, DOI 10.1093/geronb/60.6.P313; Jang YR, 2004, INT J AGING HUM DEV, V59, P125, DOI 10.2190/RT1W-2HD7-KG5X-K1FB; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kuriyama S, 2009, J EPIDEMIOL, V19, P294, DOI 10.2188/jea.JE20080076; Liu JF, 2009, GERIATR GERONTOL INT, V9, P253, DOI 10.1111/j.1447-0594.2009.00529.x; Miller NB, 1998, J FAM ISSUES, V19, P181, DOI 10.1177/019251398019002004; Prelow HM, 2006, J BLACK PSYCHOL, V32, P442, DOI 10.1177/0095798406292677; Prina AM, 2011, BRIT J PSYCHIAT, V199, P485, DOI 10.1192/bjp.bp.110.083915; Ross CE, 2008, J AGING HEALTH, V20, P273, DOI 10.1177/0898264308315428; Schieman S, 1998, J HEALTH SOC BEHAV, V39, P169, DOI 10.2307/2676310; Schnittker J, 2005, SOC SCI MED, V60, P13, DOI 10.1016/j.socscimed.2004.04.020; Sicular T, 2007, REV INCOME WEALTH, V53, P93, DOI 10.1111/j.1475-4991.2007.00219.x; Suttajit S, 2010, PSYCHOL MED, V40, P1711, DOI 10.1017/S003329170999208X; Vaeroy H, 2005, NORD J PSYCHIAT, V59, P109, DOI 10.1080/08039480510022945; Yang Y, 2006, J HEALTH SOC BEHAV, V47, P355, DOI 10.1177/002214650604700404; [周成超 ZHOU Chengchao], 2008, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V16, P627	28	12	13	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100945	10.1371/journal.pone.0100945	http://dx.doi.org/10.1371/journal.pone.0100945			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8WO	24963867	Green Published, gold, Green Submitted			2022-12-25	WOS:000338709500103
J	Rothenstein, AL; Tsotsos, JK				Rothenstein, Albert L.; Tsotsos, John K.			Attentional Modulation and Selection - An Integrated Approach	PLOS ONE			English	Article							WINNER-TAKE-ALL; VISUAL-ATTENTION; NORMALIZATION MODEL; NEURAL MECHANISMS; AREA MT; CORTEX; RECOGNITION; RESPONSES; PERCEPTION; STIMULI	Various models of the neural mechanisms of attentional modulation in the visual cortex have been proposed. In general, these models assume that an 'attention' parameter is provided separately. Its value as well as the selection of neuron(s) to which it applies are assumed, but its source and the selection mechanism are unspecified. Here we show how the Selective Tuning model of visual attention can account for the modulation of the firing rate at the single neuron level, and for the temporal pattern of attentional modulations in the visual cortex, in a self-contained formulation that simultaneously determines the stimulus elements to be attended while modulating the relevant neural processes.	[Rothenstein, Albert L.] York Univ, Dept Elect Engn & Comp Sci, Toronto, ON M3J 2R7, Canada; York Univ, Ctr Vision Res, Toronto, ON M3J 2R7, Canada	York University - Canada; York University - Canada	Rothenstein, AL (corresponding author), York Univ, Dept Elect Engn & Comp Sci, Toronto, ON M3J 2R7, Canada.	albertlr@cse.yorku.ca	Tsotsos, John/N-1131-2019	Tsotsos, John/0000-0002-8621-9147	Canada Research Chairs Program through a Tier I Chair award; Natural Sciences and Engineering Research Council of Canada	Canada Research Chairs Program through a Tier I Chair award(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was funded by the Canada Research Chairs Program through a Tier I Chair award to the second author (http://www.chairs-chaires.gc.ca), and by the Natural Sciences and Engineering Research Council of Canada via a grant to the second author (http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Ardid S, 2007, J NEUROSCI, V27, P8486, DOI 10.1523/JNEUROSCI.1145-07.2007; Boehler CN, 2009, CEREB CORTEX, V19, P982, DOI 10.1093/cercor/bhn139; Boynton GM, 2005, CURR OPIN NEUROBIOL, V15, P465, DOI 10.1016/j.conb.2005.06.009; Broadbent E. Donald, 1958, PERCEPTION COMMUNICA; Buffalo EA, 2010, P NATL ACAD SCI USA, V107, P361, DOI 10.1073/pnas.0907658106; Buia CI, 2008, J NEUROPHYSIOL, V99, P2158, DOI 10.1152/jn.01004.2007; Bundesen C, 2011, NEUROPSYCHOLOGIA, V49, P1446, DOI 10.1016/j.neuropsychologia.2010.12.006; Busse L, 2009, NEURON, V64, P931, DOI 10.1016/j.neuron.2009.11.004; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; CULHANE SM, 1992, LECT NOTES COMPUT SC, V588, P551; Cutzu F, 2003, VISION RES, V43, P205, DOI 10.1016/S0042-6989(02)00491-1; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DUNCAN J, 1980, PSYCHOL REV, V87, P272, DOI 10.1037/0033-295X.87.3.272; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; FUKUSHIMA K, 1986, BIOL CYBERN, V55, P5, DOI 10.1007/BF00363973; FUSTER JM, 1990, J NEUROPHYSIOL, V64, P681, DOI 10.1152/jn.1990.64.3.681; Hamker FH, 2005, CEREB CORTEX, V15, P431, DOI 10.1093/cercor/bhh146; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L., 2005, NEUROBIOLOGY ATTENTI; Khayat PS, 2010, J NEUROSCI, V30, P2188, DOI 10.1523/JNEUROSCI.5314-09.2010; Lauritzen TZ, 2009, J VISION, V9, DOI 10.1167/9.13.18; LAWLER EL, 1966, OPER RES, V14, P699, DOI 10.1287/opre.14.4.699; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Lee J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004651; Maass W, 2000, NEURAL COMPUT, V12, P2519, DOI 10.1162/089976600300014827; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; Mehta SD, 2000, CEREB CORTEX, V10, P343, DOI 10.1093/cercor/10.4.343; MILNER PM, 1974, PSYCHOL REV, V81, P521, DOI 10.1037/h0037149; Neisser U., 1967, COGNITIVE PSYCHOL; NOWLAN SJ, 1995, J NEUROSCI, V15, P1195; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Pashler HE, 1998, PSYCHOL ATTENTION; Pashler HE, 1998, ATTENTION; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Reynolds JH, 1999, NEURON, V24, P19, DOI 10.1016/S0896-6273(00)80819-3; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Roelfsema PR, 2007, NEURON, V56, P785, DOI 10.1016/j.neuron.2007.10.006; Rolls ET, 2002, COMPUTATIONAL NEUROS; Rothenstein AL, 2008, IMAGE VISION COMPUT, V26, P114, DOI 10.1016/j.imavis.2005.08.011; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Spratling MW, 2008, VISION RES, V48, P1391, DOI 10.1016/j.visres.2008.03.009; Spratling MW, 2004, J COGNITIVE NEUROSCI, V16, P219, DOI 10.1162/089892904322984526; TREISMAN A, 1982, COGNITIVE PSYCHOL, V14, P107, DOI 10.1016/0010-0285(82)90006-8; TREISMAN AM, 1969, PSYCHOL REV, V76, P282, DOI 10.1037/h0027242; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Tsotsos J. K., 1989, IJCAI-89 Proceedings of the Eleventh International Joint Conference on Artificial Intelligence, P1571; Tsotsos J. K., 2011, COMPUTATIONAL PERSPE, DOI DOI 10.7551/MITPRESS/9780262015417.001.0001; TSOTSOS JK, 1995, ARTIF INTELL, V78, P507, DOI 10.1016/0004-3702(95)00025-9; TSOTSOS JK, 1990, BEHAV BRAIN SCI, V13, P423, DOI 10.1017/S0140525X00079577; TSOTSOS JK, 1993, SPATIAL VISION IN HUMANS AND ROBOTS, P313; TSOTSOS JK, 1992, INT J COMPUT VISION, V7, P127, DOI 10.1007/BF00128132; Tsotsos JK, 2011, SCHOLARPEDIA, V6, P6201, DOI DOI 10.4249/SCH0LARPEDIA.6201; Tsotsos JK, 1991, RBCVTR9137 U TOR DEP; Tsotsos JK, 1987, INT C COMP VIS HUM M; VanRullen R, 2013, CURRENT BIOL, V23; Walther D, 2006, NEURAL NETWORKS, V19, P1395, DOI 10.1016/j.neunet.2006.10.001	62	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99681	10.1371/journal.pone.0099681	http://dx.doi.org/10.1371/journal.pone.0099681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963827	gold, Green Published, Green Submitted			2022-12-25	WOS:000338709500012
J	Bertaggia, E; Scabia, G; Dalise, S; Lo Verso, F; Santini, F; Vitti, P; Chisari, C; Sandri, M; Maffei, M				Bertaggia, Enrico; Scabia, Gaia; Dalise, Stefania; Lo Verso, Francesca; Santini, Ferruccio; Vitti, Paolo; Chisari, Carmelo; Sandri, Marco; Maffei, Margherita			Haptoglobin Is Required to Prevent Oxidative Stress and Muscle Atrophy	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; SKELETAL-MUSCLE; PROTEIN-DEGRADATION; IN-VIVO; AUTOPHAGY; DISEASE; PATHWAY; HYPERTROPHY; MECHANISMS; EXPRESSION	Background: Oxidative stress (OS) plays a major role on tissue function. Several catabolic or stress conditions exacerbate OS, inducing organ deterioration. Haptoglobin (Hp) is a circulating acute phase protein, produced by liver and adipose tissue, and has an important anti-oxidant function. Hp is induced in pro-oxidative conditions such as systemic inflammation or obesity. The role of systemic factors that modulate oxidative stress inside muscle cells is still poorly investigated. Results: We used Hp knockout mice (Hp(-/-)) to determine the role of this protein and therefore, of systemic OS in maintenance of muscle mass and function. Absence of Hp caused muscle atrophy and weakness due to activation of an atrophy program. When animals were stressed by acute exercise or by high fat diet (HFD), OS, muscle atrophy and force drop were exacerbated in Hp(-/-), Depending from the stress condition, autophagy-lysosome and ubiquitin-proteasome systems were differently induced. Conclusions: Hp is required to prevent OS and the activation of pathways leading to muscle atrophy and weakness in normal condition and upon metabolic challenges.	[Bertaggia, Enrico; Lo Verso, Francesca; Sandri, Marco] Univ Padua, Dept Biomed Sci, Padua, Italy; [Bertaggia, Enrico; Lo Verso, Francesca; Sandri, Marco] Venetian Inst Mol Med, Dulbecco Telethon Inst, Padua, Italy; [Scabia, Gaia; Santini, Ferruccio; Vitti, Paolo; Maffei, Margherita] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Dalise, Stefania; Chisari, Carmelo] Univ Hosp Pisa, Dept Neurosci, Unit Neurorehabil, Pisa, Italy; [Sandri, Marco] CNR, Inst Neurosci, Padua, Italy; [Sandri, Marco] Telethon Inst Genet & Med TIGEM, Naples, Italy; [Maffei, Margherita] CNR, Inst Clin Physiol, I-56100 Pisa, Italy	University of Padua; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Consiglio Nazionale delle Ricerche (CNR); Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Chisari, C (corresponding author), Univ Hosp Pisa, Dept Neurosci, Unit Neurorehabil, Pisa, Italy.	c.chisari@ao-pisa.toscana.it; marco.sandri@unipd.it; maffeim@immr.med.unipi.it	Maffei, Margherita/I-2454-2018; Dalise, Stefania/K-8940-2016; Santini, Ferruccio/J-9272-2018	Maffei, Margherita/0000-0002-8534-2450; Santini, Ferruccio/0000-0002-1706-0822	Telethon fellowship; Telethon-Italy [TCP99016, TCP04009]; European Union (MYOAGE) [223576]; ERC [282310-MyoPHAGY]; Italian Ministry of Education (MiUR) [PRIN 2010/2011]; Foundation Leducq; CARIPARO [PRIN 2009/2011]	Telethon fellowship(Fondazione Telethon); Telethon-Italy(Fondazione Telethon); European Union (MYOAGE)(European Commission); ERC(European Research Council (ERC)European Commission); Italian Ministry of Education (MiUR)(Ministry of Education, Universities and Research (MIUR)); Foundation Leducq(Leducq Foundation); CARIPARO(Fondazione Cariparo)	EB and GS were supported by a Telethon fellowship. This work was supported from Telethon-Italy (TCP99016 to MM and TCP04009 to MS), from the European Union (MYOAGE, contract: 223576 of FP7 to MS), ERC (282310-MyoPHAGY to MS), Italian Ministry of Education (MiUR) (PRIN 2010/2011 to MS), Foundation Leducq and CARIPARO to MS and (MiUR) (PRIN 2009/2011 to CC as coinvestigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Chiellini C, 2004, J CLIN ENDOCR METAB, V89, P2678, DOI 10.1210/jc.2003-031965; Chiellini C, 2002, J CELL PHYSIOL, V190, P251, DOI 10.1002/JCP.10061; Correale Michele, 2012, Cardiovascular & Hematological Agents in Medicinal Chemistry, V10, P352; Della Gatta PA, 2014, BRAIN BEHAV IMMUN; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Dobryszycka W, 1997, EUR J CLIN CHEM CLIN, V35, P647; Farbstein D, 2011, ATHEROSCLEROSIS, V219, P240, DOI 10.1016/j.atherosclerosis.2011.06.005; FRIEDRICHS WE, 1995, BIOCHEM BIOPH RES CO, V209, P250, DOI 10.1006/bbrc.1995.1496; Gamucci O, 2012, ADIPOCYTE, V1, P142, DOI 10.4161/adip.20041; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Grumati P, 2011, AUTOPHAGY, V7, P1415, DOI 10.4161/auto.7.12.17877; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308; Klionsky DJ, 2010, AUTOPHAGY, P6; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lim SK, 1998, BLOOD, V92, P1870, DOI 10.1182/blood.V92.6.1870.418k38_1870_1877; Lisi S, 2011, DIABETES, V60, P2496, DOI 10.2337/db10-1536; Maffei M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-87; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mikel U. V., 1994, ADV LAB METHODS HIST; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Moylan JS, 2007, MUSCLE NERVE, V35, P411, DOI 10.1002/mus.20743; Nakhoul FM, 2007, NAT CLIN PRACT NEPHR, V3, P339, DOI 10.1038/ncpneph0467; Nielsen MJ, 2009, BLOOD, V114, P764, DOI 10.1182/blood-2009-01-198309; Pinkston-Gosse J, 2007, NAT GENET, V39, P1403, DOI 10.1038/ng.2007.1; Raffaello A, 2010, J CELL BIOL, V191, P101, DOI 10.1083/jcb.201001136; Reid MB, 2011, J PHYSIOL-LONDON, V589, P2171, DOI 10.1113/jphysiol.2010.203356; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2013, INT J BIOCH CELL BIO; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Styskal J, 2012, FREE RADICAL BIO MED, V52, P46, DOI 10.1016/j.freeradbiomed.2011.10.441; Tracy K, 2007, AUTOPHAGY, V3, P616, DOI 10.4161/auto.4892; Tufekci K. U., 2011, PARKINSONS DIS, V2011; Vazquez-Medina JP, 2011, J EXP BIOL, V214, P2903, DOI 10.1242/jeb.057935; Wang YP, 2001, REDOX REP, V6, P379, DOI 10.1179/135100001101536580; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	45	35	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100745	10.1371/journal.pone.0100745	http://dx.doi.org/10.1371/journal.pone.0100745			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959824	Green Published, Green Submitted, gold			2022-12-25	WOS:000338633900079
J	Gully, N; Bright, R; Marino, V; Marchant, C; Cantley, M; Haynes, D; Butler, C; Dashper, S; Reynolds, E; Bartold, M				Gully, Neville; Bright, Richard; Marino, Victor; Marchant, Ceilidh; Cantley, Melissa; Haynes, David; Butler, Catherine; Dashper, Stuart; Reynolds, Eric; Bartold, Mark			Porphyromonas gingivalis Peptidylarginine Deiminase, a Key Contributor in the Pathogenesis of Experimental Periodontal Disease and Experimental Arthritis	PLOS ONE			English	Article							PROTEINASE-ADHESIN COMPLEXES; ANTIBODY-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; CITRULLINATED PROTEINS; TREPONEMA-DENTICOLA; BONE LOSS; ANTIFILAGGRIN AUTOANTIBODIES; IMMUNE-RESPONSE; MURINE MODEL; VIRULENCE	Objectives: To investigate the suggested role of Porphyromonas gingivalis peptidylarginine deiminase (PAD) in the relationship between the aetiology of periodontal disease and experimentally induced arthritis and the possible association between these two conditions. Methods: A genetically modified PAD-deficient strain of P. gingivalis W50 was produced. The effect of this strain, compared to the wild type, in an established murine model for experimental periodontitis and experimental arthritis was assessed. Experimental periodontitis was induced following oral inoculation with the PAD-deficient and wild type strains of P. gingivalis. Experimental arthritis was induced via the collagen antibody induction process and was monitored by assessment of paw swelling and micro-CT analysis of the radio-carpal joints. Experimental periodontitis was monitored by micro CT scans of the mandible and histological assessment of the periodontal tissues around the mandibular molars. Serum levels of anti-citrullinated protein antibodies (ACPA) and P. gingivalis were assessed by ELISA. Results: The development of experimental periodontitis was significantly reduced in the presence of the PAD-deficient P. gingivalis strain. When experimental arthritis was induced in the presence of the PAD-deficient strain there was less paw swelling, less erosive bone damage to the joints and reduced serum ACPA levels when compared to the wild type P. gingivalis inoculated group. Conclusion: This study has demonstrated that a PAD-deficient strain of P. gingivalis was associated with significantly reduced periodontal inflammation. In addition the extent of experimental arthritis was significantly reduced in animals exposed to prior induction of periodontal disease through oral inoculation of the PAD-deficient strain versus the wild type. This adds further evidence to the potential role for P. gingivalis and its PAD in the pathogenesis of periodontitis and exacerbation of arthritis. Further studies are now needed to elucidate the mechanisms which drive these processes.	[Gully, Neville; Bright, Richard; Marino, Victor; Marchant, Ceilidh; Bartold, Mark] Univ Adelaide, Colgate Australian Clin Dent Res, Sch Dent, Adelaide, SA, Australia; [Cantley, Melissa; Haynes, David] Univ Adelaide, Sch Med Sci, Discipline Anat & Pathol, Adelaide, SA, Australia; [Butler, Catherine; Dashper, Stuart; Reynolds, Eric] Univ Melbourne, Melbourne Dent Sch, Oral Hlth Collaborat Res Ctr, Melbourne, Vic, Australia	University of Adelaide; University of Adelaide; University of Melbourne	Bartold, M (corresponding author), Univ Adelaide, Colgate Australian Clin Dent Res, Sch Dent, Adelaide, SA, Australia.	mark.bartold@adelaide.edu.au	Cantley, Melissa/V-4674-2019; Bartold, Mark/H-8122-2019; Bright, Richard J/S-5447-2017	Bright, Richard J/0000-0003-1988-0725; Dashper, Stuart/0000-0003-0106-8691; Bartold, Peter/0000-0002-5695-3877; Marchant, Ceilidh/0000-0001-6615-8669; Cantley, Melissa/0000-0002-7188-0928; Butler, Catherine/0000-0001-6371-3954; Reynolds, Eric/0000-0002-6618-4856	Australian Dental Research Fund [ADRF 56/2010]; National Health & Medical Council of Australia [NHMRC 1023747]	Australian Dental Research Fund; National Health & Medical Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported in part by research grants from the Australian Dental Research Fund (ADRF 56/2010) and the National Health & Medical Council of Australia (NHMRC 1023747). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asquith DL, 2009, EUR J IMMUNOL, V39, P2040, DOI 10.1002/eji.200939578; Bartold PM, 2005, J PERIODONTOL, V76, P2066, DOI 10.1902/jop.2005.76.11-S.2066; BIRD PS, 1995, J PERIODONTOL, V66, P351, DOI 10.1902/jop.1995.66.5.351; Byrne SJ, 2009, ORAL MICROBIOL IMMUN, V24, P469, DOI 10.1111/j.1399-302X.2009.00544.x; Cantley MD, 2011, J CLIN PERIODONTOL, V38, P532, DOI 10.1111/j.1600-051X.2011.01714.x; Dashper S, 2014, ANTIMICROB AGENTS CH, V58, P378, DOI 10.1128/AAC.01375-13; de Pablo P, 2009, NAT REV RHEUMATOL, V5, P218, DOI 10.1038/nrrheum.2009.28; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Demoruelle MK, 2014, CURR OPIN RHEUMATOL, V26, P64, DOI 10.1097/BOR.0000000000000017; Doyle HA, 2002, CURR OPIN RHEUMATOL, V14, P244, DOI 10.1097/00002281-200205000-00009; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Girbal-Neuhauser E, 1999, J IMMUNOL, V162, P585; Harvey GP, 2013, J PERIODONTAL RES, V48, P252, DOI 10.1111/jre.12002; Holers VM, 2013, CURR OPIN IMMUNOL, V25, P728, DOI 10.1016/j.coi.2013.09.018; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; Jeong E, 2012, J PERIODONTAL RES, V47, P811, DOI 10.1111/j.1600-0765.2012.01501.x; Kesavalu L, 1998, ORAL MICROBIOL IMMUN, V13, P373, DOI 10.1111/j.1399-302X.1998.tb00694.x; Klareskog L, 2008, ANNU REV IMMUNOL, V26, P651, DOI 10.1146/annurev.immunol.26.021607.090244; Knipp M, 2000, ANAL BIOCHEM, V286, P257, DOI 10.1006/abio.2000.4805; Kornman KS, 2009, J PERIODONTOL, V80, P1019, DOI 10.1902/jop.2009.097002; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Linden GJ, 2013, J CLIN PERIODONTOL, V40, pS8, DOI [10.1902/jop.2013.1340010, 10.1111/jcpe.12064]; Lundberg K, 2010, NAT REV RHEUMATOL, V6, P727, DOI 10.1038/nrrheum.2010.139; Maresz KJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003627; Masson-Bessiere C, 2001, J IMMUNOL, V166, P4177, DOI 10.4049/jimmunol.166.6.4177; McGraw WT, 1999, INFECT IMMUN, V67, P3248, DOI 10.1128/IAI.67.7.3248-3256.1999; Nandakumar KS, 2003, AM J PATHOL, V163, P1827, DOI 10.1016/S0002-9440(10)63542-0; Nandakumar KS, 2003, EUR J IMMUNOL, V33, P2269, DOI 10.1002/eji.200323810; Nandakumar KS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2089; Nesse W, 2012, J CLIN PERIODONTOL, V39, P599, DOI 10.1111/j.1600-051X.2012.01885.x; O'Brien-Simpson NM, 2005, J IMMUNOL, V175, P3980, DOI 10.4049/jimmunol.175.6.3980; O'Brien-Simpson NM, 2001, INFECT IMMUN, V69, P7527, DOI 10.1128/IAI.69.12.7527-7534.2001; Orth RKH, 2011, MOL ORAL MICROBIOL, V26, P229, DOI 10.1111/j.2041-1014.2011.00612.x; Page RC, 1997, PERIODONTOL 2000, V14, P216, DOI 10.1111/j.1600-0757.1997.tb00199.x; Park CH, 2007, J PERIODONTOL, V78, P273, DOI 10.1902/jop.2007.060252; Pathirana RD, 2006, MICROBIOL-SGM, V152, P2381, DOI 10.1099/mic.0.28787-0; Potikuri D, 2012, ANN RHEUM DIS, V71, P1541, DOI 10.1136/annrheumdis-2011-200380; Quirke AM, 2014, ANN RHEUM DIS, V73, P263, DOI 10.1136/annrheumdis-2012-202726; Rajapakse PS, 2002, INFECT IMMUN, V70, P2480, DOI 10.1128/IAI.70.5.2480-2486.2002; Rosenstein ED, 2004, INFLAMMATION, V28, P311, DOI 10.1007/s10753-004-6641-z; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Shiloah J, 2000, J PERIODONTOL, V71, P562, DOI 10.1902/jop.2000.71.4.562; Thiele GM, 2012, INT IMMUNOPHARMACOL, V13, P424, DOI 10.1016/j.intimp.2012.05.007; van Winkelhoff AJ, 2002, J CLIN PERIODONTOL, V29, P1023, DOI 10.1034/j.1600-051X.2002.291107.x; Wegner N, 2010, ARTHRITIS RHEUM-US, V62, P2662, DOI 10.1002/art.27552; Wegner N, 2010, IMMUNOL REV, V233, P34, DOI 10.1111/j.0105-2896.2009.00850.x; Wegner N, 2009, INT J BIOCHEM CELL B, V41, P390, DOI 10.1016/j.biocel.2008.09.012; Willis V, 2011, J IMMUNOL, V186, P4396, DOI 10.4049/jimmunol.1001620	48	71	72	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100838	10.1371/journal.pone.0100838	http://dx.doi.org/10.1371/journal.pone.0100838			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959715	Green Published, gold			2022-12-25	WOS:000338633900094
J	Pisapia, C; Pratchett, MS				Pisapia, Chiara; Pratchett, Morgan S.			Spatial Variation in Background Mortality among Dominant Coral Taxa on Australia's Great Barrier Reef	PLOS ONE			English	Article							SCLERACTINIAN CORALS; BUILDING CORALS; POCILLOPORA-DAMICORNIS; ARTIFICIAL INJURIES; ACROPORA-HYACINTHUS; POPULATION-DYNAMICS; LOCAL VARIABILITY; FRENCH-POLYNESIA; CLIMATE-CHANGE; SIZE STRUCTURE	Even in the absence of major disturbances (e.g., cyclones, bleaching), corals are consistently subject to high levels of background mortality, which undermines individual fitness and resilience of coral colonies. Partial mortality may impact coral response to climate change by reducing colony ability to recover between major acute stressors. This study quantified proportion of injured versus uninjured colonies (the prevalence of injuries) and instantaneous measures of areal extent of injuries across individual colonies (the severity of injuries), in four common coral species along the Great Barrier Reef in Australia: massive Porites, encrusting Montipora, Acropora hyacinthus and Pocillopora damicornis. A total of 2,276 adult colonies were surveyed three latitudinal sectors, nine reefs and 27 sites along 1000 km(2) on the Great Barrier Reef. The prevalence of injuries was very high, especially for Porites spp (91%) and Montipora encrusting (85%) and varied significantly, but most lay at small spatial scales (e.g., among colonies positioned <10-m apart). Similarly, severity of background partial mortality was surprisingly high (between 5% and 21%) but varied greatly among colonies within the same site and habitat. This study suggests that intraspecific variation in partial mortality between adjacent colonies may be more important than variation between colonies in different latitudinal sectors or reefs. Differences in the prevalence and severity of background partial mortality have significant ramifications for coral capacity to cope with increasing acute disturbances, such as climate-induced coral bleaching. These data are important for understanding coral responses to increasing stressors, and in particular for predicting their capacity to recover between subsequent disturbances.	[Pisapia, Chiara; Pratchett, Morgan S.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Pisapia, Chiara] James Cook Univ, Sch Marine Biol, Australian Inst Marine Sci, AIMS JCU, Townsville, Qld 4811, Australia	James Cook University; Australian Institute of Marine Science; James Cook University	Pisapia, C (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	chiara.pisapia@my.jcu.edu.au	Pratchett, Morgan/AAW-5179-2020; Pratchett, Morgan S/A-9256-2010	Pratchett, Morgan/0000-0002-1862-8459; Pratchett, Morgan S/0000-0002-1862-8459	ARC Centre of Excellence for Coral Reef Studies, Townsville; AIMS@JCU, Townsville	ARC Centre of Excellence for Coral Reef Studies, Townsville(Australian Research Council); AIMS@JCU, Townsville	This project was supported by the ARC Centre of Excellence for Coral Reef Studies, Townsville, and AIMS@JCU, Townsville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 2007, HYDROBIOLOGIA, V589, P117, DOI 10.1007/s10750-007-0726-2; BABCOCK RC, 1991, ECOL MONOGR, V61, P225, DOI 10.2307/2937107; BAK RPM, 1983, MAR BIOL, V77, P221, DOI 10.1007/BF00395810; Bak RPM, 1998, MAR ECOL PROG SER, V162, P301, DOI 10.3354/meps162301; BAK RPM, 1980, B MAR SCI, V30, P883; BAK RPM, 1980, OECOLOGIA, V47, P145, DOI 10.1007/BF00346812; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bonaldo RM, 2011, CORAL REEFS, V30, P259, DOI 10.1007/s00338-010-0669-3; BROWN BE, 1985, ADV MAR BIOL, V22, P1, DOI 10.1016/S0065-2881(08)60049-8; Bruckner A. W, 2006, Rev. biol. trop, V54, P45; Bruckner AW, 2012, REV BIOL TROP, V60, P39; Bruckner AW, 2009, DIS AQUAT ORGAN, V87, P19, DOI 10.3354/dao02120; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Bythell JC, 2000, MAR ECOL PROG SER, V204, P93, DOI 10.3354/meps204093; BYTHELL JC, 1993, CORAL REEFS, V12, P143, DOI 10.1007/BF00334474; Connell J.H., 1973, P205; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Cumming RL, 2002, MAR ECOL PROG SER, V242, P131, DOI 10.3354/meps242131; D'Croz L, 2004, CORAL REEFS, V23, P473, DOI 10.1007/s00338-004-0397-7; Darling ES, 2012, ECOL LETT, V15, P1378, DOI 10.1111/j.1461-0248.2012.01861.x; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Denis V, 2011, MAR ECOL PROG SER, V428, P105, DOI 10.3354/meps09060; Dikou A, 2006, MAR POLLUT BULL, V52, P269, DOI 10.1016/j.marpolbul.2005.08.021; DONE TJ, 1988, MAR BIOL, V100, P51, DOI 10.1007/BF00392954; DONE TJ, 1991, CORAL REEFS, V9, P183, DOI 10.1007/BF00290420; Fisher EM, 2007, MAR ECOL PROG SER, V339, P61, DOI 10.3354/meps339061; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Ginsburg RN, 2001, B MAR SCI, V69, P1149; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Hall VR, 1997, J EXP MAR BIOL ECOL, V212, P9, DOI 10.1016/S0022-0981(96)02760-8; Hall VR, 1996, ECOLOGY, V77, P950, DOI 10.2307/2265514; HARRIOTT VJ, 1985, MAR ECOL PROG SER, V21, P81, DOI 10.3354/meps021081; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Henry LA, 2005, INT REV HYDROBIOL, V90, P125, DOI 10.1002/iroh.200410759; HIGHSMITH RC, 1980, OECOLOGIA, V46, P322, DOI 10.1007/BF00346259; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1989, ECOLOGY, V70, P275, DOI 10.2307/1938434; Hughes TP, 1999, NATURE, V397, P59, DOI 10.1038/16237; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; HUGHES TP, 1984, AM NAT, V123, P778, DOI 10.1086/284239; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; HUGHES TP, 1980, SCIENCE, V209, P713, DOI 10.1126/science.209.4457.713; HUTCHINGS PA, 1986, CORAL REEFS, V4, P239, DOI 10.1007/BF00298083; Jackson J.B.C., 1979, Systematics Association Special Volume Series, P499; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; KARLSON RH, 1993, CORAL REEFS, V12, P117, DOI 10.1007/BF00334469; Knowlton N, 1990, CASE STUDY NATURAL P; Linares C, 2011, MAR ECOL PROG SER, V438, P97, DOI 10.3354/meps09272; Lirman D, 2013, ECOL INDIC, DOI [10.1016/2013/10021, DOI 10.1016/2013/10021]; LOYA Y, 1976, NATURE, V261, P490, DOI 10.1038/261490a0; Meesters E.H., 1992, P 7 INT COR REEF S, V2, P681; MEESTERS EH, 1994, MAR ECOL PROG SER, V112, P119, DOI 10.3354/meps112119; Meesters EH, 1997, J SEA RES, V37, P131, DOI 10.1016/S1385-1101(96)00004-4; Meesters EH, 1996, B MAR SCI, V58, P838; Nugues MM, 2003, MAR POLLUT BULL, V46, P314, DOI 10.1016/S0025-326X(02)00402-2; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; Oliver J, 1985, P 5 INT COR REEF C, V4, P201; Osborne K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017516; Pisapia C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091529; Pratchett MS, 2013, MAR ENVIRON RES, V86, P29, DOI 10.1016/j.marenvres.2013.02.007; Rinkevich B., 1989, ENV QUAL ECOSYSTEM S, V4, P257; ROBERTS HH, 1982, J SEDIMENT PETROL, V52, P145; STIMSON J, 1985, ECOLOGY, V66, P40, DOI 10.2307/1941305; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; TANNER JE, 1994, ECOLOGY, V75, P2204, DOI 10.2307/1940877; Titlyanov EA, 2005, J EXP MAR BIOL ECOL, V323, P27, DOI 10.1016/j.jembe.2005.02.015; Toh TC, 2013, B MAR SCI, V89, P583, DOI 10.5343/bms.2012.1089; Trapon ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057788; Trapon Melanie L., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/807625; VANVEGHEL MLJ, 1994, MAR ECOL PROG SER, V109, P229, DOI 10.3354/meps109229; Veron J, 1984, AUST I MAR SCI MONOG, V6, P485; Wakeford M, 2008, CORAL REEFS, V27, P1, DOI 10.1007/s00338-007-0284-0; Wesseling I, 2001, INT REV HYDROBIOL, V86, P77, DOI 10.1002/1522-2632(200101)86:1<77::AID-IROH77>3.0.CO;2-7; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; YAP HT, 1992, MAR ECOL PROG SER, V83, P91, DOI 10.3354/meps083091	80	6	6	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100969	10.1371/journal.pone.0100969	http://dx.doi.org/10.1371/journal.pone.0100969			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959921	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000338633900107
J	Sangalli, JR; Chiaratti, MR; De Bem, THC; de Araujo, RR; Bressan, FF; Sampaio, RV; Perecin, F; Smith, LC; King, WA; Meirelles, FV				Sangalli, Juliano Rodrigues; Chiaratti, Marcos Roberto; Camara De Bem, Tiago Henrique; de Araujo, Reno Roldi; Bressan, Fabiana Fernandes; Sampaio, Rafael Vilar; Perecin, Felipe; Smith, Lawrence Charles; King, Willian Allan; Meirelles, Flavio Vieira			Development to Term of Cloned Cattle Derived from Donor Cells Treated with Valproic Acid	PLOS ONE			English	Article							NUCLEAR TRANSFER EMBRYOS; IN-VITRO DEVELOPMENT; HISTONE DEACETYLASE; STEM-CELLS; GENE-EXPRESSION; BOVINE EMBRYOS; SIGNIFICANT IMPROVEMENT; ACETYLATION PATTERNS; PERINATAL LETHALITY; CLONING EFFICIENCY	Cloning of mammals by somatic cell nuclear transfer (SCNT) is still plagued by low efficiency. The epigenetic modifications established during cellular differentiation are a major factor determining this low efficiency as they act as epigenetic barriers restricting reprogramming of somatic nuclei. In this regard, most factors that promote chromatin decondensation, including histone deacetylase inhibitors (HDACis), have been found to increase nuclear reprogramming efficiency, making their use common to improve SCNT rates. Herein we used valproic acid (VPA) in SCNT to test whether the treatment of nuclear donor cells with this HDACi improves pre- and post-implantation development of cloned cattle. We found that the treatment of fibroblasts with VPA increased histone acetylation without affecting DNA methylation. Moreover, the treatment with VPA resulted in increased expression of IGF2R and PPARGC1A, but not of POU5F1. However, when treated cells were used as nuclear donors no difference of histone acetylation was found after oocyte reconstruction compared to the use of untreated cells. Moreover, shortly after artificial activation the histone acetylation levels were decreased in the embryos produced with VPA-treated cells. With respect to developmental rates, the use of treated cells as donors resulted in no difference during pre-and post-implantation development. In total, five clones developed to term; three produced with untreated cells and two with VPA-treated cells. Among the calves from treated group, one stillborn calf was delivered at day 270 of gestation whereas the other one was delivered at term but died shortly after birth. Among the calves from the control group, one died seven days after birth whereas the other two are still alive and healthy. Altogether, these results show that in spite of the alterations in fibroblasts resulting from the treatment with VPA, their use as donor cells in SCNT did not improve pre- and post-implantation development of cloned cattle.	[Sangalli, Juliano Rodrigues; Camara De Bem, Tiago Henrique; de Araujo, Reno Roldi; Bressan, Fabiana Fernandes; Sampaio, Rafael Vilar; Perecin, Felipe; Meirelles, Flavio Vieira] Univ Sao Paulo, Fac Zootecnia & Engn Alimentos, Dept Vet Med, Sao Paulo, Brazil; [Sangalli, Juliano Rodrigues; Chiaratti, Marcos Roberto; de Araujo, Reno Roldi; Sampaio, Rafael Vilar] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Cirurgia, Sao Paulo, Brazil; [Sangalli, Juliano Rodrigues; Sampaio, Rafael Vilar; King, Willian Allan] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada; [Chiaratti, Marcos Roberto] Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, Dept Genet & Evolucao, BR-13560 Sao Carlos, SP, Brazil; [Camara De Bem, Tiago Henrique] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Sao Paulo, Brazil; [Smith, Lawrence Charles] Univ Montreal, Fac Med Vet, Ctr Rech Reprod Anim, St Hyacinthe, PQ J2S 7C6, Canada	Universidade de Sao Paulo; Universidade de Sao Paulo; University of Guelph; Universidade Federal de Sao Carlos; Universidade de Sao Paulo; Universite de Montreal	Sangalli, JR (corresponding author), Univ Sao Paulo, Fac Zootecnia & Engn Alimentos, Dept Vet Med, Sao Paulo, Brazil.	jrsh5n1@yahoo.com.br	De Bem, Tiago Henrique Camara/K-4780-2016; Sangalli, Juliano Rodrigues/C-1834-2013; Smith, Lawrence C/K-4658-2012; Smith, Lawrence/AAP-4321-2021; Sampaio, Rafael RVS/B-5354-2013; Bressan, Fabiana F./C-6679-2012; Meirelles, Flavio V/B-5048-2010; Perecin, Felipe/C-7268-2012; Chiaratti, Marcos R/C-2727-2012; CTC USP, CEPID 13 18/J-8951-2014	Smith, Lawrence/0000-0001-8766-0148; Sampaio, Rafael RVS/0000-0002-8227-8510; Bressan, Fabiana F./0000-0001-9862-5874; Meirelles, Flavio V/0000-0003-0372-4920; Perecin, Felipe/0000-0003-2009-5863; Chiaratti, Marcos R/0000-0001-8805-9469; Henrique Camara De Bem, Tiago/0000-0001-5969-6514; CTC USP, CEPID 13 18/0000-0002-7123-9524	Sao Paulo Research Foundation (FAPESP) [2013/06673-7, 2011/51126-9, 2010/13384-3, 2010/19768-8]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	JRS is supported by Sao Paulo Research Foundation (FAPESP), grant number 2013/06673-7, and previously by Coordination for the Improvement of Higher Level Personnel (CAPES/DFAIT). This work was granted by Sao Paulo Research Foundation (FAPESP; grant numbers 2011/51126-9, 2010/13384-3, 2010/19768-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi S, 2013, ANIM SCI J, V84, P191, DOI 10.1111/asj.12035; Amold DR, 2008, PLACENTA, V29, pS108, DOI 10.1016/j.placenta.2007.11.010; Aouali N, 2009, BRIT J HAEMATOL, V147, P662, DOI 10.1111/j.1365-2141.2009.07902.x; Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662; Baqir S, 2006, CLONING STEM CELLS, V8, P200, DOI 10.1089/clo.2006.8.200; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Campbell K H, 1999, Cloning, V1, P3, DOI 10.1089/15204559950020058; Chavatte-Palmer P, 2012, PLACENTA, V33, pS99, DOI 10.1016/j.placenta.2011.09.012; Chiang MC, 2013, NEUROSCIENCE, V229, P118, DOI 10.1016/j.neuroscience.2012.11.003; Costa-Borges N, 2010, CELL REPROGRAM, V12, P437, DOI 10.1089/cell.2009.0108; Das ZC, 2010, CELL REPROGRAM, V12, P95, DOI 10.1089/cell.2009.0068; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Detich N, 2003, J BIOL CHEM, V278, P27586, DOI 10.1074/jbc.M303740200; Ding X, 2008, THERIOGENOLOGY, V70, P622, DOI 10.1016/j.theriogenology.2008.04.042; Enright BP, 2005, BIOL REPROD, V72, P944, DOI 10.1095/biolreprod.104.033225; Enright BP, 2003, BIOL REPROD, V69, P896, DOI 10.1095/biolreprod.103.017954; Feil R, 1998, MAMM GENOME, V9, P831, DOI 10.1007/s003359900876; Felisbino MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029144; Galli C, 2014, THERIOGENOLOGY, V81, P138, DOI 10.1016/j.theriogenology.2013.09.008; Gao TL, 2007, CELL RES, V17, P135, DOI 10.1038/cr.2007.2; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Giraldo AM, 2007, MOL REPROD DEV, V74, P1514, DOI 10.1002/mrd.20740; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Gurdon JB, 2011, COLD SPRING HARB PER, V3; Hagemann LJ, 1998, MOL REPROD DEV, V50, P154, DOI 10.1002/(SICI)1098-2795(199806)50:2&lt;154::AID-MRD5&gt;3.0.CO;2-J; Hezroni H, 2011, J BIOL CHEM, V286, P35977, DOI 10.1074/jbc.M111.266254; Hill JR, 2000, BIOL REPROD, V63, P1787, DOI 10.1095/biolreprod63.6.1787; Hu JF, 2000, ENDOCRINOLOGY, V141, P4428, DOI 10.1210/en.141.12.4428; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Johnson AK, 2010, JAVMA-J AM VET MED A, V236, P983, DOI 10.2460/javma.236.9.983; Jullien J, 2011, NAT REV MOL CELL BIO, V12, P453, DOI 10.1038/nrm3140; Kang JD, 2013, THERIOGENOLOGY, V79, P306, DOI 10.1016/j.theriogenology.2012.08.021; Kim YJ, 2011, IN VITRO CELL DEV-AN, V47, P283, DOI 10.1007/s11626-011-9394-7; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; LAU MMH, 1994, GENE DEV, V8, P2953, DOI 10.1101/gad.8.24.2953; Lee MJ, 2011, J REPROD DEVELOP, V57, P34, DOI 10.1262/jrd.10-012A; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig T, 1996, DEV BIOL, V177, P517, DOI 10.1006/dbio.1996.0182; Marchion DC, 2005, CANCER RES, V65, P3815, DOI 10.1158/0008-5472.CAN-04-2478; Martinez-Diaz MA, 2010, CELL REPROGRAM, V12, P85, DOI 10.1089/cell.2009.0047; Meirelles FV, 2010, REPROD FERT DEVELOP, V22, P88, DOI 10.1071/RD09229; Miranda MD, 2009, CLONING STEM CELLS, V11, P565, DOI 10.1089/clo.2009.0028; Miyoshi K, 2010, CELL REPROGRAM, V12, P67, DOI 10.1089/cell.2009.0032; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nasser LF, 2004, THERIOGENOLOGY, V62, P1577, DOI 10.1016/j.theriogenology.2004.03.013; Ogura A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0329; Ono T, 2010, BIOL REPROD, V83, P929, DOI 10.1095/biolreprod.110.085282; Pasque V, 2011, TRENDS GENET, V27, P516, DOI 10.1016/j.tig.2011.08.002; Perecin F, 2009, GENET MOL RES, V8, P76, DOI 10.4238/vol8-1gmr541; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Sangalli JR, 2012, CELL REPROGRAM, V14, P235, DOI 10.1089/cell.2011.0079; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Selokar NL, 2013, CELL REPROGRAM, V15, P531, DOI 10.1089/cell.2013.0018; Shi W, 2003, BIOL REPROD, V69, P301, DOI 10.1095/biolreprod.102.012112; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; Smith LC, 2012, REPROD DOMEST ANIM, V47, P107, DOI 10.1111/j.1439-0531.2012.02063.x; Suzuki J, 2011, BIOL REPROD, V84, P947, DOI 10.1095/biolreprod.110.087833; Teng HF, 2010, J CELL BIOCHEM, V110, P995, DOI 10.1002/jcb.22613; Turner BM, 2007, NAT CELL BIOL, V9, P2, DOI 10.1038/ncb0107-2; VerMilyea MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006086; Wee G, 2006, J BIOL CHEM, V281, P6048, DOI 10.1074/jbc.M511340200; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wilmut I, 2002, NATURE, V419, P583, DOI 10.1038/nature01079; Xu WB, 2012, CELL REPROGRAM, V14, P138, DOI 10.1089/cell.2011.0084; Yang FK, 2007, REPRODUCTION, V133, P219, DOI 10.1530/rep.1.01206; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Young LE, 2003, MECH DEVELOP, V120, P1433, DOI 10.1016/j.mod.2003.09.006; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769; Zhao JG, 2010, CELL REPROGRAM, V12, P75, DOI 10.1089/cell.2009.0038; Zhao JG, 2009, BIOL REPROD, V81, P525, DOI 10.1095/biolreprod.109.077016; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	75	33	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e101022	10.1371/journal.pone.0101022	http://dx.doi.org/10.1371/journal.pone.0101022			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959750	gold, Green Published, Green Submitted			2022-12-25	WOS:000338633900111
J	Chu, MJJ; Hickey, AJR; Tagaloa, S; Zhang, LD; Dare, AJ; MacDonald, JR; Yeong, ML; Bartlett, ASJR; Phillips, ARJ				Chu, Michael J. J.; Hickey, Anthony J. R.; Tagaloa, Sherry; Zhang, Linda; Dare, Anna J.; MacDonald, Julia R.; Yeong, Mee-Ling; Bartlett, Adam S. J. R.; Phillips, Anthony R. J.			Ob/ob Mouse Livers Show Decreased Oxidative Phosphorylation Efficiencies and Anaerobic Capacities after Cold Ischemia	PLOS ONE			English	Article							MITOCHONDRIAL RESPIRATION; LACTATE-DEHYDROGENASE; VERTEBRATE MUSCLE; ORGAN VIABILITY; TRANSPLANTATION; RISK; MACROSTEATOSIS; MICROSTEATOSIS; PRESERVATION; DYSFUNCTION	Background: Hepatic steatosis is a major risk factor for graft failure in liver transplantation. Hepatic steatosis shows a greater negative influence on graft function following prolonged cold ischaemia. As the impact of steatosis on hepatocyte metabolism during extended cold ischaemia is not well-described, we compared markers of metabolic capacity and mitochondrial function in steatotic and lean livers following clinically relevant durations of cold preservation. Methods: Livers from 10-week old leptin-deficient obese (ob/ob, n = 9) and lean C57 mice (n = 9) were preserved in ice-cold University of Wisconsin solution. Liver mitochondrial function was then assessed using high resolution respirometry after 1.5, 3, 5, 8, 12, 16 and 24 hours of storage. Metabolic marker enzymes for anaerobiosis and mitochondrial mass were also measured in conjunction with non-bicarbonate tissue pH buffering capacity. Results: Ob/ob and lean mice livers showed severe (>60%) macrovesicular and mild (<30%) microvesicular steatosis on Oil Red O staining, respectively. Ob/ob livers had lower baseline enzymatic complex I activity but similar adenosine triphosphate (ATP) levels compared to lean livers. During cold storage, the respiratory control ratio and complex I-fueled phosphorylation deteriorated approximately twice as fast in ob/ob livers compared to lean livers. Ob/ob livers also demonstrated decreased ATP production capacities at all time-points analyzed compared to lean livers. Ob/ob liver baseline lactate dehydrogenase activities and intrinsic non-bicarbonate buffering capacities were depressed by 60% and 40%, respectively compared to lean livers. Conclusions: Steatotic livers have impaired baseline aerobic and anaerobic capacities compared to lean livers, and mitochondrial function indices decrease particularly from after 5 hours of cold preservation. These data provide a mechanistic basis for the clinical recommendation of shorter cold storage durations in steatotic donor livers.	[Chu, Michael J. J.; Tagaloa, Sherry; Dare, Anna J.; Bartlett, Adam S. J. R.; Phillips, Anthony R. J.] Univ Auckland, Dept Surg, Auckland 1, New Zealand; [Hickey, Anthony J. R.; Zhang, Linda; MacDonald, Julia R.; Phillips, Anthony R. J.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Hickey, Anthony J. R.; Bartlett, Adam S. J. R.; Phillips, Anthony R. J.] Univ Auckland, Maurice Wilkins Ctr Biodiscovery, Auckland 1, New Zealand; [Yeong, Mee-Ling] Auckland City Hosp, Dept Anat Pathol, Auckland, New Zealand; [Bartlett, Adam S. J. R.; Phillips, Anthony R. J.] Auckland City Hosp, New Zealand Liver Transplant Unit, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland; Auckland City Hospital; Auckland City Hospital	Chu, MJJ (corresponding author), Univ Auckland, Dept Surg, Auckland 1, New Zealand.	michaeljjc@gmail.com		Chu, Michael Jen Jie/0000-0002-9892-7394	University of Auckland Faculty Research Development Fund; Maurice Wilkins Centre for Biodiscovery; Maurice & Phyllis Paykel Trust	University of Auckland Faculty Research Development Fund; Maurice Wilkins Centre for Biodiscovery; Maurice & Phyllis Paykel Trust	This work was directly supported by the University of Auckland Faculty Research Development Fund, Maurice Wilkins Centre for Biodiscovery and the Maurice & Phyllis Paykel Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2000, BIOCHEMISTRY-MOSCOW+, V65, P757; ADAM R, 1991, TRANSPLANT P, V23, P1538; Caraceni P, 2004, J HEPATOL, V41, P82, DOI 10.1016/j.jhep.2004.03.022; CASTELLINI MA, 1981, J COMP PHYSIOL, V143, P191; Chavin KD, 1999, J BIOL CHEM, V274, P5692, DOI 10.1074/jbc.274.9.5692; Colell A, 2003, J BIOL CHEM, V278, P33928, DOI 10.1074/jbc.M210943200; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Fishbein TM, 1997, TRANSPLANTATION, V64, P248, DOI 10.1097/00007890-199707270-00012; Fukumori T, 1997, TRANSPL P, V29, P412, DOI 10.1016/S0041-1345(96)00158-3; Ge FX, 2010, EXP BIOL MED, V235, P1282, DOI 10.1258/ebm.2010.010095; Gnaiger E, 2007, TXB MITOCHONDRIAL PH, P1; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; Hand SC, 2008, J EXP BIOL, V211, P1829, DOI 10.1242/jeb.000299; Hickey AJR, 2012, AGEING RES REV, V11, P242, DOI 10.1016/j.arr.2011.12.002; Hickey AJR, 2009, AM J PHYSIOL-CELL PH, V297, pC766, DOI 10.1152/ajpcell.00111.2009; KAMIIKE W, 1988, TRANSPLANTATION, V45, P138, DOI 10.1097/00007890-198801000-00030; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Kuznetsov AV, 2002, ANAL BIOCHEM, V305, P186, DOI 10.1006/abio.2002.5658; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x; Lemieux H, 2006, BBA-BIOENERGETICS, P201; Llacuna L, 2011, J HEPATOL, V54, P1002, DOI 10.1016/j.jhep.2010.08.031; MacDonald JR, 2011, AM J PHYSIOL-CELL PH, V300, pC246, DOI 10.1152/ajpcell.00294.2010; MARKERT CL, 1984, CELL BIOCHEM FUNCT, V2, P131, DOI 10.1002/cbf.290020302; MARKIN RS, 1993, TRANSPLANTATION, V56, P1403, DOI 10.1097/00007890-199312000-00025; McCormack L, 2011, J HEPATOL, V54, P1055, DOI 10.1016/j.jhep.2010.11.004; Melia HP, 1999, FEBS LETT, V458, P261, DOI 10.1016/S0014-5793(99)01127-8; MJJ Chu, 2013, OPEN J TRANSPLANTATI, V6, P10; Nishimura A, 2004, TRANSPL P, V36, P2246, DOI 10.1016/j.transproceed.2004.08.051; Oyedotun KS, 2004, J BIOL CHEM, V279, P9424, DOI 10.1074/jbc.M311876200; Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9; PEREZ JA, 1982, ELECTROPHORESIS, V3, P102, DOI 10.1002/elps.1150030208; Pessayre D, 2007, J GASTROEN HEPATOL, V22, pS20, DOI 10.1111/j.1440-1746.2006.04640.x; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; PLOEG RJ, 1993, TRANSPLANTATION, V55, P807, DOI 10.1097/00007890-199304000-00024; Selzner N, 2006, J HEPATOL, V44, P694, DOI 10.1016/j.jhep.2005.07.032; Spitzer AL, 2010, LIVER TRANSPLANT, V16, P874, DOI 10.1002/lt.22085; Tonkonogi M, 1999, AM J PHYSIOL-CELL PH, V277, pC288, DOI 10.1152/ajpcell.1999.277.2.C288; Urena MAG, 1998, TRANSPLANT P, V30, P3288, DOI 10.1016/S0041-1345(98)01033-1; Vajdova K, 2002, HEPATOLOGY, V36, P1543, DOI 10.1053/jhep.2002.37189; WILLIAMS RS, 1986, J BIOL CHEM, V261, P376	40	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100609	10.1371/journal.pone.0100609	http://dx.doi.org/10.1371/journal.pone.0100609			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956382	Green Published, gold, Green Submitted			2022-12-25	WOS:000338917900071
J	Khanna, N; Ge, YJ; Chen, J				Khanna, Nidhi; Ge, Yejing; Chen, Jie			MicroRNA-146b Promotes Myogenic Differentiation and Modulates Multiple Gene Targets in Muscle Cells	PLOS ONE			English	Article							SKELETAL-MUSCLE; SATELLITE CELLS; STEM-CELLS; NOTCH; EXPRESSION; PROLIFERATION; REGENERATION; PROTEIN; TRANSCRIPTION; MAINTENANCE	MicroRNAs are established as crucial modulators of skeletal myogenesis, but our knowledge about their identity and targets remains limited. In this study, we have identified microRNA-146b (miR-146b) as a novel regulator of skeletal myoblast differentiation. Following up on a previous microRNA profiling study, we establish that the expression of miR-146b is up-regulated during myoblast differentiation in vitro and muscle regeneration in vivo. Inhibition of miR-146b led to reduced myoblast differentiation, whereas overexpression of miR-146b enhanced differentiation. Computational prediction combined with gene expression information has revealed candidates for miR-146b targets in muscles. Among them, the expression of Smad4, Notch1, and Hmga2 are significantly suppressed by miR-146b overexpression in myocytes. In addition, expression levels of Smad4, Notch1 and Hmga2 are decreased during myoblast differentiation and muscle regeneration, inversely correlating to the levels of miR-146b. Importantly, inhibition of endogenous miR-146b prevents the down-regulation of Smad4, Notch1 and Hmga2 during differentiation. Furthermore, miR-146b directly targets the microRNA response elements (MREs) in the 3'UTR of those genes as assessed by reporter assays. Reporters with the seed regions of MREs mutated are insensitive to miR-146b, further confirming the specificity of targeting. In conclusion, miR-146b is a positive regulator of myogenic differentiation, possibly acting through multiple targets.	[Khanna, Nidhi; Ge, Yejing; Chen, Jie] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Chen, J (corresponding author), Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA.	jiechen@illinois.edu		Chen, Jie/0000-0002-7887-3747	National Institutes of Health (NIH) [AR048914, GM089771]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089771] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) (AR048914, GM089771). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Dey BK, 2012, GENE DEV, V26, P2180, DOI 10.1101/gad.198085.112; Dmitriev P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-265; Felekkis K, 2010, HIPPOKRATIA, V14, P236; Gagan J, 2012, J BIOL CHEM, V287, P40360, DOI 10.1074/jbc.M112.378414; Ge YJ, 2011, CELL CYCLE, V10, P441, DOI 10.4161/cc.10.3.14710; Ge YJ, 2011, J CELL BIOL, V192, P69, DOI 10.1083/jcb.201007165; Ge YJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1434, DOI 10.1152/ajpcell.00248.2009; Geraldo MV, 2012, ONCOGENE, V31, P1910, DOI 10.1038/onc.2011.381; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hebert C, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-5; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Li ZZ, 2012, DEV CELL, V23, P1176, DOI 10.1016/j.devcel.2012.10.019; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; MARTIN JF, 1992, J BIOL CHEM, V267, P10956; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Nakasa T, 2008, ARTHRITIS RHEUM-US, V58, P1284, DOI 10.1002/art.23429; Nakasa T, 2010, J CELL MOL MED, V14, P2495, DOI 10.1111/j.1582-4934.2009.00898.x; Novak J, 2013, PEDIATR BLOOD CANCER, V60, P1739, DOI 10.1002/pbc.24664; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Perry MM, 2009, FEBS LETT, V583, P3349, DOI 10.1016/j.febslet.2009.09.038; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Shawber C, 1996, DEVELOPMENT, V122, P3765; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Sun YT, 2010, J CELL BIOL, V189, P1157, DOI 10.1083/jcb.200912093; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tsang JS, 2010, MOL CELL, V38, P140, DOI 10.1016/j.molcel.2010.03.007; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Wang H, 2010, DEV CELL, V18, P643, DOI 10.1016/j.devcel.2010.02.008; Wen YF, 2012, MOL CELL BIOL, V32, P2300, DOI 10.1128/MCB.06753-11; Wilson-Rawls J, 1999, MOL CELL BIOL, V19, P2853; Xia HP, 2009, BRAIN RES, V1269, P158, DOI 10.1016/j.brainres.2009.02.037; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	51	42	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100657	10.1371/journal.pone.0100657	http://dx.doi.org/10.1371/journal.pone.0100657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956113	Green Published, Green Submitted, gold			2022-12-25	WOS:000338917900077
J	Trenchevska, O; Phillips, DA; Nelson, RW; Nedelkov, D				Trenchevska, Olgica; Phillips, David A.; Nelson, Randall W.; Nedelkov, Dobrin			Delineation of Concentration Ranges and Longitudinal Changes of Human Plasma Protein Variants	PLOS ONE			English	Article							MASS-SPECTROMETRIC IMMUNOASSAY; SERUM CYSTATIN C; RETINOL-BINDING-PROTEIN; RENAL-FUNCTION; QUANTITATIVE-DETERMINATION; COMPREHENSIVE ANALYSIS; RHEUMATOID-ARTHRITIS; TRANSTHYRETIN; BETA-2-MICROGLOBULIN; PROTEOMICS	Human protein diversity arises as a result of alternative splicing, single nucleotide polymorphisms (SNPs) and posttranslational modifications. Because of these processes, each protein can exists as multiple variants in vivo. Tailored strategies are needed to study these protein variants and understand their role in health and disease. In this work we utilized quantitative mass spectrometric immunoassays to determine the protein variants concentration of beta-2-microglobulin, cystatin C, retinol binding protein, and transthyretin, in a population of 500 healthy individuals. Additionally, we determined the longitudinal concentration changes for the protein variants from four individuals over a 6 month period. Along with the native forms of the four proteins, 13 posttranslationally modified variants and 7 SNP-derived variants were detected and their concentration determined. Correlations of the variants concentration with geographical origin, gender, and age of the individuals were also examined. This work represents an important step toward building a catalog of protein variants concentrations and examining their longitudinal changes.	[Trenchevska, Olgica; Nelson, Randall W.; Nedelkov, Dobrin] Arizona State Univ, Biodesign Inst, Mol Biomarkers Lab, Tempe, AZ 85287 USA; [Trenchevska, Olgica; Phillips, David A.; Nedelkov, Dobrin] Intrins Bioprobes, Tempe, AZ USA; [Nedelkov, Dobrin] Inst Populat Prote, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe	Nedelkov, D (corresponding author), Arizona State Univ, Biodesign Inst, Mol Biomarkers Lab, Tempe, AZ 85287 USA.	Dobrin.Nedelkov@asu.edu	Nedelkov, Dobrin/I-3603-2013					Anderson NL, 2004, J PROTEOME RES, V3, P235, DOI 10.1021/pr034086h; BASSET P, 1978, BLOOD, V51, P971; BEETHAM R, 1985, CLIN CHEM, V31, P1364; Connors LH, 2003, AMYLOID, V10, P160, DOI 10.3109/13506120308998998; Erlandsen EJ, 1998, CLIN CHEM LAB MED, V36, P393, DOI 10.1515/CCLM.1998.067; Farley AR, 2009, METHOD ENZYMOL, V463, P725, DOI 10.1016/S0076-6879(09)63040-8; GRUBB A, 1982, P NATL ACAD SCI-BIOL, V79, P3024, DOI 10.1073/pnas.79.9.3024; He K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063724; Hou X, 2007, FEBS J, V274, P1637, DOI 10.1111/j.1742-4658.2007.05712.x; Ignjatovic V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017213; Jackson D, 2009, PROTEOM CLIN APPL, V3, P394, DOI 10.1002/prca.200800066; JACONI S, 1995, J LIPID RES, V36, P1247; Johnson AM, 2007, CLIN CHEM LAB MED, V45, P419, DOI 10.1515/CCLM.2007.051; Kiernan UA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017282; Kim Helen, 2007, Methods Mol Biol, V371, P349; KUEPPERS F, 1978, AM J HUM GENET, V30, P359; MANICOURT D, 1978, ANN RHEUM DIS, V37, P328, DOI 10.1136/ard.37.4.328; MIFFLIN TE, 1986, CLIN LAB MED, V6, P583, DOI 10.1016/S0272-2712(18)30802-3; Nedelkov D, 2004, ANAL CHEM, V76, P1733, DOI 10.1021/ac035105+; Nedelkov D, 2005, P NATL ACAD SCI USA, V102, P10852, DOI 10.1073/pnas.0500426102; Nedelkov D, 2007, MOL CELL PROTEOMICS, V6, P1183, DOI 10.1074/mcp.M700023-MCP200; NELSON RW, 1995, ANAL CHEM, V67, P1153, DOI 10.1021/ac00103a003; NISSEN MH, 1990, EUR J BIOCHEM, V189, P423, DOI 10.1111/j.1432-1033.1990.tb15505.x; NISSEN MH, 1984, CLIN CHIM ACTA, V141, P41, DOI 10.1016/0009-8981(84)90165-7; PETTERSSON T, 1987, BIOCHEMISTRY-US, V26, P4572, DOI 10.1021/bi00388a061; PLESNER T, 1979, SCAND J IMMUNOL, V9, P247, DOI 10.1111/j.1365-3083.1979.tb02728.x; Prakash A, 2012, J PROTEOME RES, V11, P3986, DOI 10.1021/pr300014s; Randers E, 1998, SCAND J CLIN LAB INV, V58, P585, DOI 10.1080/00365519850186210; Randers E, 1999, CLIN CHEM LAB MED, V37, P389, DOI 10.1515/CCLM.1999.064; Roy B, 2013, CURR GENOMICS, V14, P182, DOI 10.2174/1389202911314030004; Saraiva MJM, 2001, FEBS LETT, V498, P201, DOI 10.1016/S0014-5793(01)02480-2; Schaefer C, 2012, BIOINFORMATICS, V28, P601, DOI 10.1093/bioinformatics/btr705; SCHARDIJN GHC, 1987, KIDNEY INT, V32, P635, DOI 10.1038/ki.1987.255; Siuti N, 2007, NAT METHODS, V4, P817, DOI 10.1038/NMETH1097; Stastna M, 2012, PROTEOMICS, V12, P2937, DOI 10.1002/pmic.201200161; Su ZD, 2011, J MOL CELL BIOL, V3, P309, DOI 10.1093/jmcb/mjr024; Tipton JD, 2011, J BIOL CHEM, V286, P25451, DOI 10.1074/jbc.R111.239442; Trenchevska O, 2011, PROTEOMICS, V11, P3633, DOI 10.1002/pmic.201100023; Trenchevska O, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-19; Trenchevska O, 2010, J PROTEOME RES, V9, P5969, DOI 10.1021/pr1007587; Vegvari A, 2013, MOL CELL PROTEOMICS, V12, P2761, DOI 10.1074/mcp.M113.028365; Wu JR, 2012, FEBS LETT, V586, P2841, DOI 10.1016/j.febslet.2012.07.036; Wu J, 2012, BIOMARKERS, V17, P125, DOI 10.3109/1354750X.2011.643485; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934; Zhang H, 2011, CIRC-CARDIOVASC GENE, V4, P711, DOI 10.1161/CIRCGENETICS.110.957829	45	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100713	10.1371/journal.pone.0100713	http://dx.doi.org/10.1371/journal.pone.0100713			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955979	Green Published, gold, Green Submitted			2022-12-25	WOS:000338917900085
J	Jung, HK; Wang, K; Jung, MK; Kim, IS; Lee, BH				Jung, Hyun-Kyung; Wang, Kai; Jung, Min Kyu; Kim, In-San; Lee, Byung-Heon			In Vivo Near-Infrared Fluorescence Imaging of Apoptosis Using Histone H1-Targeting Peptide Probe after Anti-Cancer Treatment with Cisplatin and Cetuximab for Early Decision on Tumor Response	PLOS ONE			English	Article							ADVANCED GASTRIC-CANCER; CHEMOTHERAPY	Early decision on tumor response after anti-cancer treatment is still an unmet medical need. Here we investigated whether in vivo imaging of apoptosis using linear and cyclic (disulfide-bonded) form of ApoPep-1, a peptide that recognizes histone H1 exposed on apoptotic cells, at an early stage after treatment could predict tumor response to the treatment later. Treatment of stomach tumor cells with cistplatin or cetuximab alone induced apoptosis, while combination of cisplatin plus cetuximab more efficiently induced apoptosis, as detected by binding with linear and cyclic form of ApoPep-1. However, the differences between the single agent and combination treatment were more remarkable as detected with the cyclic form compared to the linear form. In tumor-bearing mice, apoptosis imaging was performed 1 week and 2 weeks after the initiation of treatment, while tumor volumes and weights were measured 3 weeks after the treatment. In vivo fluorescence imaging signals obtained by the uptake of ApoPep-1 to tumor was most remarkable in the group injected with cyclic form of ApoPep-1 at 1 week after combined treatment with cisplatin plus cetuximab. Correlation analysis revealed that imaging signals by cyclic ApoPep-1 at 1 week after treatment with cisplatin plus cetuximab in combination were most closely related with tumor volume changes (r(2) = 0.934). These results demonstrate that in vivo apoptosis imaging using Apopep-1, especially cyclic ApoPep-1, is a sensitive and predictive tool for early decision on stomach tumor response after anti-cancer treatment.	[Jung, Hyun-Kyung; Kim, In-San; Lee, Byung-Heon] Kyungpook Natl Univ, Dept Biochem & Cell Biol, Taegu, South Korea; [Jung, Hyun-Kyung; Kim, In-San; Lee, Byung-Heon] Kyungpook Natl Univ, Sch Med, Taegu, South Korea; [Jung, Hyun-Kyung; Kim, In-San; Lee, Byung-Heon] Kyungpook Natl Univ, Grad Sch, Dept Biomed Sci, Plus KNU Biomed Convergence Program BK21, Taegu, South Korea; [Wang, Kai] Henan Prov Peoples Hosp, Dept Plast Surg, Zhengzhou, Henan, Peoples R China; [Jung, Min Kyu] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Taegu, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; Zhengzhou University; Kyungpook National University	Lee, BH (corresponding author), Kyungpook Natl Univ, Dept Biochem & Cell Biol, Taegu, South Korea.	leebh@knu.ac.kr	김, 인산/I-8988-2014; Kim, In-San/D-3956-2017	Jung, Min Kyu/0000-0001-8749-408X	national R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [0720550-2]; National Research Foundation of Korea [NRF-2012M2A2A7035589]	national R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by a grant from the national R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (0720550-2 to Byung-Heon Lee) and a grant NRF-2012M2A2A7035589 (to Byung-Heon Lee) through the National Research Foundation of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya B, 2013, J CONTROL RELEASE, V172, P367, DOI 10.1016/j.jconrel.2013.08.294; Alakus H, 2010, NUCL MED COMMUN, V31, P532, DOI 10.1097/MNM.0b013e32833823ac; Amezcua CA, 2000, GYNECOL ONCOL, V79, P169, DOI 10.1006/gyno.2000.5955; [Anonymous], 2011, MOL PHARM; Bang YJ, 2010, LANCET, V376, P1302; BARRY MA, 1990, BIOCHEM PHARMACOL, V40, P2353, DOI 10.1016/0006-2952(90)90733-2; Belhocine T, 2002, CLIN CANCER RES, V8, P2766; Blankenberg FG, 2012, J NUCL MED, V53, P1659, DOI 10.2967/jnumed.112.108944; Blankenberg FG, 2011, AM J ROENTGENOL, V197, P308, DOI 10.2214/AJR.11.6953; Bogdanowich-Knipp SJ, 1999, J PEPT RES, V53, P530, DOI 10.1034/j.1399-3011.1999.00052.x; Casadei R, 2009, TUMORI J, V95, P811, DOI 10.1177/030089160909500627; Choi CH, 2004, CANCER CELL INT, V4, DOI 10.1186/1475-2867-4-6; DIVE C, 1991, BRIT J CANCER, V64, P192, DOI 10.1038/bjc.1991.269; Edgington LE, 2009, NAT MED, V15, P967, DOI 10.1038/nm.1938; Grimberg H, 2009, APOPTOSIS, V14, P257, DOI 10.1007/s10495-008-0293-7; He X, 2012, J CONTROL RELEASE, V162, P521, DOI 10.1016/j.jconrel.2012.07.023; Keren S, 2008, IEEE T MED IMAGING, V27, P58, DOI 10.1109/TMI.2007.902800; Konig K, 2000, J MICROSC-OXFORD, V200, P83, DOI 10.1046/j.1365-2818.2000.00738.x; Lordick F, 2013, LANCET ONCOL, V14, P490, DOI 10.1016/S1470-2045(13)70102-5; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Manning HC, 2008, CLIN CANCER RES, V14, P7413, DOI 10.1158/1078-0432.CCR-08-0239; Padhani AR, 2001, BRIT J RADIOL, V74, P983, DOI 10.1259/bjr.74.887.740983; Roxin A, 2012, FUTURE MED CHEM, V4, P1601, DOI [10.4155/FMC.12.75, 10.4155/fmc.12.75]; Sastre J, 2006, WORLD J GASTROENTERO, V12, P204, DOI 10.3748/wjg.v12.i2.204; Smith BA, 2012, BIOCONJUGATE CHEM, V23, P1989, DOI 10.1021/bc3003309; Stafford JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084864; Steiner P, 2007, CLIN CANCER RES, V13, P1540, DOI 10.1158/1078-0432.CCR-06-1887; Tu DG, 2009, CLIN IMAG, V33, P468, DOI 10.1016/j.clinimag.2009.02.001; Wang K, 2011, J CONTROL RELEASE; Wang K, 2010, J CONTROL RELEASE, V148, P283, DOI 10.1016/j.jconrel.2010.09.010; Yoo SA, 2005, J IMMUNOL, V174, P5846, DOI 10.4049/jimmunol.174.9.5846; Yoshioka T, 2003, J NUCL MED, V44, P690; Yun J, 2012, LAB INVEST, V92, P1033, DOI 10.1038/labinvest.2012.61	33	18	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100341	10.1371/journal.pone.0100341	http://dx.doi.org/10.1371/journal.pone.0100341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949860	gold, Green Published, Green Submitted			2022-12-25	WOS:000338276300066
J	Ram, ST; Neuberger, A; Thapa, LJ; Singh, RPV; Shofty, B; Schwartz, E				Ram, Sundar Twayana; Neuberger, Ami; Thapa, Lekh Jung; Singh, Rana Pramendra Vir; Shofty, Ben; Schwartz, Eli			Japanese Encephalitis among Patients with Acute Encephalitic Syndrome Admitted to a Tertiary Hospital in Chitwan, Nepal - A Prospective Observational Study	PLOS ONE			English	Article							SURVEILLANCE	Introduction: The reported incidence of JE among patients with acute encephalitic syndrome (RES) in Nepal ranges between 20% to 62%. In light of the lack of up-to-date data, we sought to describe the epidemiology of JE in Chitwan, Nepal. Methods: A prospective observational study was conducted during 2010-2012 in the College of Medical Science in the Chitwan District. Patients with suspected JE were tested for anti-JE IgM in serum and cerebrospinal fluid (CSF). Results: Of 227 all patients tested, 18 (7.9%) were found positive for JE. 17/202 (8.4%) patients with AES had JE. All, with the exception of two patients, were diagnosed on the basis of positive a serologic test, both in serum and CSF samples. Patients with JE were significantly older (42.1 +/- 27.6 years) than patients without JE (25.6 +/- 25.2 years, p = 0.02). Half of JE cases occurred in adults older than 50. More of the JE cases (11/18, 61.1%) occurred during the rainy season when compared to the JE negative patients [71/209, (34%), p = 0.01]. None of the JE patients had a relevant travel history, and one recalled having been immunized against JE. There was a variation in the geographic distribution of cases across the districts of the central Terai. Conclusions: In this cohort, the proportion of patients with AES who had JE was lower than in previous studies. In addition, most patients were adults, and cases were not distributed uniformly across the central Terai region. The risk of acquiring JE by short-term travelers in the area is likely to be low. Vector-control programs and the promotion of mosquito avoidance behavior in the Terai region should continue. The high proportions of adults among patients with JE may suggest recent changes in the epidemiology of JE in the central Terai region, and routine immunization of all adults should be considered.	[Ram, Sundar Twayana] Kathmandu Univ Hosp, Fac Internal Med, Dhulikhel, Nepal; [Neuberger, Ami] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Unit Infect Dis & Internal Med B, Rambam Med Ctr, IL-31096 Haifa, Israel; [Thapa, Lekh Jung; Singh, Rana Pramendra Vir] Coll Med Sci, Dept Neurol, Bharatpur, Nepal; [Singh, Rana Pramendra Vir] Coll Med Sci, Dept Med, Bhartapur, Nepal; [Shofty, Ben] Tel Aviv Med Ctr & Sch Med, Gilbert Israeli Neurofibromatosis Ctr, Tel Aviv, Israel; [Schwartz, Eli] Tel Aviv Univ, Ctr Geog Med & Trop Dis, Sheba Med Ctr, IL-69978 Tel Aviv, Israel; [Schwartz, Eli] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Kathmandu University; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Neuberger, A (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Unit Infect Dis & Internal Med B, Rambam Med Ctr, POB 9649, IL-31096 Haifa, Israel.	a_neuberger@rambam.health.gov.il						Bhattachan A, 2009, EMERG INFECT DIS, V15, P1691, DOI 10.3201/eid1510.081641; Bista M B, 2005, JNMA J Nepal Med Assoc, V44, P51; Dumre SP, 2013, AM J TROP MED HYG, V88, P677, DOI 10.4269/ajtmh.12-0436; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; Griffiths MJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002383; Hills SL, 2014, CDC HLTH INF INT TRA, V3, P78; Hills SL, 2010, AM J TROP MED HYG, V82, P930, DOI 10.4269/ajtmh.2010.09-0676; Kakoti G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/152656; Kari K, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-8; Pant GR, 2006, COMP IMMUNOL MICROB, V29, P166, DOI 10.1016/j.cimid.2006.03.003; Partridge J, 2007, AM J TROP MED HYG, V77, P1146, DOI 10.4269/ajtmh.2007.77.1146; Rayamajhi A, 2007, PEDIATR INT, V49, P978, DOI 10.1111/j.1442-200X.2007.02495.x; Robertson C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066168; Tandan JB, 2007, VACCINE, V25, P5041, DOI 10.1016/j.vaccine.2007.04.052; Wierzba TF, 2008, AM J TROP MED HYG, V78, P1002, DOI 10.4269/ajtmh.2008.78.1002; World Health Organization, 2006, JAP ENC SURV STAND W, V46; World Health Organization, 2007, MAN LAB DIAGN JAP EN, V3, P10; World Health Organization, 2006, WEEKLY EPIDEMIOLOGIC, V81, P332	18	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99999	10.1371/journal.pone.0099999	http://dx.doi.org/10.1371/journal.pone.0099999			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950104	Green Submitted, Green Published, gold			2022-12-25	WOS:000338276300028
J	Haralambieva, IH; Lambert, ND; Ovsyannikova, IG; Kennedy, RB; Larrabee, BR; Pankratz, VS; Poland, GA				Haralambieva, Iana H.; Lambert, Nathaniel D.; Ovsyannikova, Inna G.; Kennedy, Richard B.; Larrabee, Beth R.; Pankratz, V. Shane; Poland, Gregory A.			Associations between Single Nucleotide Polymorphisms in Cellular Viral Receptors and Attachment Factor-Related Genes and Humoral Immunity to Rubella Vaccination	PLOS ONE			English	Article							MEASLES-VACCINE; VITAMIN-A; DC-SIGN; CLINICAL-OUTCOMES; SMALLPOX VACCINE; PROMOTER REGION; CD209 GENE; PVR CD155; TOLL-LIKE; RESPONSES	Background: Viral attachment and cell entry host factors are important for viral replication, pathogenesis, and the generation and sustenance of immune responses after infection and/or vaccination, and are plausible genetic regulators of vaccine-induced immunity. Methods: Using a tag-SNP approach in candidate gene study, we assessed the role of selected cell surface receptor genes, attachment factor-related genes, along with other immune genes in the genetic control of immune response variations after live rubella vaccination in two independent study cohorts. Results: Our analysis revealed evidence for multiple associations between genetic variants in the PVR, PVRL2, CD209/DC-SIGN, RARB, MOG, IL6 and other immune function-related genes and rubella-specific neutralizing antibodies after vaccination (meta p-value <0.05). Conclusion: Our results indicate that multiple SNPs from genes involved in cell adhesion, viral attachment, and viral entry, as well as others in genes involved in signaling and/or immune response regulation, play a role in modulating humoral immune responses following live rubella vaccination.	[Haralambieva, Iana H.; Lambert, Nathaniel D.; Ovsyannikova, Inna G.; Kennedy, Richard B.; Pankratz, V. Shane; Poland, Gregory A.] Mayo Clin, Mayo Vaccine Res Grp, Rochester, MN 55905 USA; [Larrabee, Beth R.; Pankratz, V. Shane] Mayo Clin, Div Biostat, Rochester, MN USA; [Poland, Gregory A.] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN USA; [Haralambieva, Iana H.; Lambert, Nathaniel D.; Ovsyannikova, Inna G.; Kennedy, Richard B.; Poland, Gregory A.] Mayo Clin, Program Translat Immunovirol & Biodef, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Poland, GA (corresponding author), Mayo Clin, Mayo Vaccine Res Grp, Rochester, MN 55905 USA.	poland.gregory@mayo.edu		Kennedy, Rick/0000-0001-6164-4967; Larrabee, Beth/0000-0001-9100-563X	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R37 AI048793-11]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048793, R37AI048793] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R37 AI048793-11 (which recently received a MERIT award). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeler-Dorner L, 2012, TRENDS IMMUNOL, V33, P34, DOI 10.1016/j.it.2011.09.007; Alagarasu K, 2013, INFECT GENET EVOL, V17, P239, DOI 10.1016/j.meegid.2013.04.024; Backovic M, 2012, CURR OPIN VIROL, V2, P4, DOI 10.1016/j.coviro.2011.12.005; Barkhash AV, 2012, ANTIVIR RES, V93, P64, DOI 10.1016/j.antiviral.2011.10.017; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Cleveland WS, 1992, STAT MODELS WADSWORT; Clifford HD, 2012, CLIN VACCINE IMMUNOL, V19, P704, DOI 10.1128/CVI.05652-11; Clifford HD, 2011, VACCINE, V29, P5407, DOI 10.1016/j.vaccine.2011.05.068; Cong HL, 2011, J VIROL, V85, P11038, DOI 10.1128/JVI.05398-11; Dhiman N, 2007, J ALLERGY CLIN IMMUN, V120, P666, DOI 10.1016/j.jaci.2007.04.036; Dhiman N, 2010, IMMUNOGENETICS, V62, P197, DOI 10.1007/s00251-010-0423-6; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Greenland S, 2008, MODERN EPIDEMIOLOGY, P652; Haralambieva IH, 2013, HUM IMMUNOL, V74, P1263, DOI 10.1016/j.humimm.2013.06.031; Haralambieva IH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062149; Haralambieva IH, 2013, EXPERT REV VACCINES, V12, P57, DOI [10.1586/erv.12.134, 10.1586/ERV.12.134]; Haralambieva IH, 2011, VACCINE, V29, P8988, DOI 10.1016/j.vaccine.2011.09.043; Haralambieva IH, 2011, VACCINE, V29, P7883, DOI 10.1016/j.vaccine.2011.08.083; Haralambieva IH, 2011, J INFECT DIS, V204, P433, DOI 10.1093/infdis/jir268; Haralambieva IH, 2011, VACCINE, V29, P4485, DOI 10.1016/j.vaccine.2011.04.037; Haralambieva IH, 2010, HUM IMMUNOL, V71, P383, DOI 10.1016/j.humimm.2010.01.004; Haralambieva LH, 2014, VACCINE, V32, P1946, DOI 10.1016/j.vaccine.2014.01.090; He YN, 2000, P NATL ACAD SCI USA, V97, P79, DOI 10.1073/pnas.97.1.79; Kamran N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054406; Kennedy RB, 2012, HUM GENET, V131, P1433, DOI 10.1007/s00439-012-1179-x; Kennedy RB, 2012, VACCINE, V30, P2159, DOI 10.1016/j.vaccine.2012.01.025; Kindberg E, 2009, J MED VIROL, V81, P933, DOI 10.1002/jmv.21444; Lambert ND, 2014, CLIN VACCINE IMMUNOL, V21, P340, DOI 10.1128/CVI.00681-13; Lambert ND, 2014, IMMUNOL RES, V58, P1, DOI 10.1007/s12026-013-8475-y; Lozach PY, 2011, CELL HOST MICROBE, V10, P75, DOI 10.1016/j.chom.2011.06.007; Maier MK, 2007, EUR J IMMUNOL, V37, P2214, DOI 10.1002/eji.200737072; Malcherek G, 2007, J IMMUNOL, V179, P3804, DOI 10.4049/jimmunol.179.6.3804; Mezger M, 2008, CLIN MICROBIOL INFEC, V14, P228, DOI 10.1111/j.1469-0691.2007.01902.x; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Ovsyannikova IG, 2013, HUM IMMUNOL, V74, P768, DOI 10.1016/j.humimm.2013.01.031; Ovsyannikova IG, 2012, PHARMACOGENET GENOM, V22, P20, DOI 10.1097/FPC.0b013e32834df186; Ovsyannikova IG, 2011, HUM HERED, V72, P206, DOI 10.1159/000331585; Ovsyannikova I, 2011, HUM GENET, V130, P547, DOI 10.1007/s00439-011-0977-x; Ovsyannikova IG, 2010, HUM GENET, V127, P207, DOI 10.1007/s00439-009-0763-1; Ovsyannikova IG, 2010, J INFECT DIS, V201, P207, DOI 10.1086/649588; Ovsyannikova IG, 2009, VACCINE, V27, P6926, DOI 10.1016/j.vaccine.2009.08.109; Pankratz VS, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-48; Poland GA, 2011, OMICS, V15, P625, DOI 10.1089/omi.2011.0032; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Struyf F, 2002, J VIROL, V76, P12940, DOI 10.1128/JVI.76.24.12940-12950.2002; Tahara-Hanaoka S, 2004, INT IMMUNOL, V16, P533, DOI 10.1093/intimm/dxh059; Tan PL, 2001, VACCINE, V19, P2434, DOI 10.1016/S0264-410X(00)00468-0; Villamor E, 2005, CLIN MICROBIOL REV, V18, P446, DOI 10.1128/CMR.18.3.446-464.2005; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218	53	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99997	10.1371/journal.pone.0099997	http://dx.doi.org/10.1371/journal.pone.0099997			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945853	Green Published, Green Submitted, gold			2022-12-25	WOS:000340721500039
J	Ishikane, M; Watanabe, K; Tsukada, K; Nozaki, Y; Yanase, M; Igari, T; Masaki, N; Kikuchi, Y; Oka, S; Gatanaga, H				Ishikane, Masahiro; Watanabe, Koji; Tsukada, Kunihisa; Nozaki, Yuichi; Yanase, Mikio; Igari, Toru; Masaki, Naohiko; Kikuchi, Yoshimi; Oka, Shinichi; Gatanaga, Hiroyuki			Acute Hepatitis C in HIV-1 Infected Japanese Cohort: Single Center Retrospective Cohort Study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED MEN; COMBINATION THERAPY; PLUS RIBAVIRIN; LIVER FIBROSIS; INTERFERON-ALPHA-2B; CLEARANCE; GENOTYPE; EFFICACY; IL28B	Objectives: HCV co-infection is a poor prognostic factor in HIV-1-infected patients. Although the number of newly reported patients who show seroconversion is increasing, the clinical features are still unclear, especially in Asian countries. Design: A single-center retrospective cohort study of patients diagnosed between 2001-2012. Methods: Acute hepatitis C (AHC) was diagnosed upon detection of high serum ALT (>100 IU) followed by anti-HCV seroconversion. Clinical characteristics, HIV-1-related immunological status and IL-28B genotypes (rs12979860, rs8099917) were collected. We compared these variables between patients with and without spontaneous clearance of HCV and between responders and non-responders to treatment with pegylated interferon (PEG-IFN) plus ribavirin. Results: Thirty-five patients were diagnosed with AHC during the study period. The majority (96.9%) were MSM. Three were lost to follow-up. Seventy-five percent of patients with AHC (24/32) were asymptomatic and found incidentally to have high serum ALT. Compared to those who did not show spontaneous clearance, patients with spontaneous HCV viral clearance showed more symptoms and more severe abnormalities related to acute hepatitis. Spontaneous clearance was seen in 4 out of 28 patients with CC+TT genotype, but not in 6 patients with IL-28B CT+TG genotype. PEG-IFN plus ribavirin treatment was initiated in 12 out of 28 cases without spontaneous clearance. The sustained virological response rate was high (81.8%, 9/11), even in cases with CT+TG genotype infected with HCV genotype 1b (SVR 2/2). Conclusions: Careful attention to AHC is needed in HIV-1-infected MSM. Early diagnosis and PEG-IFN plus ribavirin treatment should be considered for AHC cases.	[Ishikane, Masahiro; Watanabe, Koji; Tsukada, Kunihisa; Kikuchi, Yoshimi; Oka, Shinichi; Gatanaga, Hiroyuki] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Yanase, Mikio; Igari, Toru; Masaki, Naohiko] Natl Ctr Global Hlth & Med, Dept Gastroenterol, Tokyo, Japan; [Igari, Toru] Natl Ctr Global Hlth & Med, Pathol Div Clin Lab, Tokyo, Japan; [Masaki, Naohiko] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Tokyo, Japan; [Ishikane, Masahiro] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Field Epidemiol Training Program Japan, Tokyo, Japan; [Ishikane, Masahiro] Tohoku Univ, Grad Sch Med, Med Sci Doctoral Program, Global Infect Dis Infect & Epidemiol, Sendai, Miyagi 980, Japan; [Watanabe, Koji; Oka, Shinichi; Gatanaga, Hiroyuki] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Institute of Infectious Diseases (NIID); Tohoku University; Kumamoto University	Gatanaga, H (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.	higatana@acc.ncgm.go.jp	Ishikane, Masahiro/ABA-9878-2020	Ishikane, Masahirio/0000-0002-4719-651X; Oka, Shinichi/0000-0002-9283-2167	Ministry of Health, Labor, and Welfare [H23-AIDS-001]; Global COE Program (Global Education and Research Center Aiming at the Control of AIDS), MEXT, Japan	Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Global COE Program (Global Education and Research Center Aiming at the Control of AIDS), MEXT, Japan	This work was supported in part by Grants-in Aid for AIDS research from the Ministry of Health, Labor, and Welfare (H23-AIDS-001) and the Global COE Program (Global Education and Research Center Aiming at the Control of AIDS), MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert M, 2011, AIDS, V25, P399, DOI 10.1097/QAD.0b013e328343443b; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Boesecke C, 2014, C RETR OPP INF BOST; Boesecke C, 2011, CURR OPIN HIV AIDS, V6, P459, DOI 10.1097/COH.0b013e32834b87de; Boesecke C, 2011, CURR OPIN HIV AIDS, V6, P278, DOI 10.1097/COH.0b013e32834732cd; CDC, GUID PREV TREATM OPP; Chen TY, 2009, CLIN INFECT DIS, V49, P1605, DOI 10.1086/644771; Deterding K, 2013, LANCET INFECT DIS, V13, P497, DOI 10.1016/S1473-3099(13)70059-8; Dore GJ, 2010, GASTROENTEROLOGY, V138, P123, DOI 10.1053/j.gastro.2009.09.019; Fierer DS, 2008, J INFECT DIS, V198, P683, DOI 10.1086/590430; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Germer JJ, 1999, J CLIN MICROBIOL, V37, P2625, DOI 10.1128/JCM.37.8.2625-2630.1999; Grebely J, 2014, HEPATOLOGY, V59, P109, DOI 10.1002/hep.26639; Grebely J, 2012, AIDS, V26, P1653, DOI 10.1097/QAD.0b013e3283553719; Grebely J, 2010, HEPATOLOGY, V52, P1216, DOI 10.1002/hep.23850; Hadziyannis SJ, 2002, J HEPATOL, V36, P3, DOI 10.1016/S0168-8278(02)80001-0; Jimenez-Sousa MA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-6; Kamal SM, 2004, HEPATOLOGY, V39, P1721, DOI 10.1002/hep.20266; Lambers FAE, 2011, AIDS, V25, pF21, DOI 10.1097/QAD.0b013e32834bac44; Lambers FAE, 2011, AIDS, V25, P1333, DOI 10.1097/QAD.0b013e3283480144; Landau A, 2001, AIDS, V15, P2149, DOI 10.1097/00002030-200111090-00010; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Nasti G, 2001, AIDS, V15, P1783, DOI 10.1097/00002030-200109280-00006; Nattermann J, 2011, J INFECT DIS, V203, P595, DOI 10.1093/infdis/jiq098; Piroth L, 2010, HEPATOLOGY, V52, P1915, DOI 10.1002/hep.23959; Ragonnet R, 2014, C RETR OPP INF BOST; Rivero-Juarez A, 2013, AIDS, V27, P1941, DOI 10.1097/QAD.0b013e328360ea1e; Sauleda S, 2001, HEPATOLOGY, V34, P1035, DOI 10.1053/jhep.2001.29130; Terrault NA, 2013, HEPATOLOGY, V57, P881, DOI 10.1002/hep.26164; Thomson EC, 2011, GUT, V60, P837, DOI 10.1136/gut.2010.217166; van de Laar TJW, 2007, J INFECT DIS, V196, P230, DOI 10.1086/518796; van de Laar TJW, 2010, AIDS, V24, P1799, DOI 10.1097/QAD.0b013e32833c11a5; van den Berg CHBS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027555	34	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100517	10.1371/journal.pone.0100517	http://dx.doi.org/10.1371/journal.pone.0100517			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945812	Green Submitted, Green Published, gold			2022-12-25	WOS:000340721500085
J	Bhattacharya, S; Liang, Z; Quek, AJ; Ploplis, VA; Law, R; Castellino, FJ				Bhattacharya, Sarbani; Liang, Zhong; Quek, Adam J.; Ploplis, Victoria A.; Law, Ruby; Castellino, Francis J.			Dimerization Is Not a Determining Factor for Functional High Affinity Human Plasminogen Binding by the Group A Streptococcal Virulence Factor PAM and Is Mediated by Specific Residues within the PAM a1a2 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO ACID LIGANDS; M-PROTEIN; SURFACE PROTEIN; INTERNAL SEQUENCE; KRINGLE-2 DOMAIN; ALPHA-AMINO; EXPRESSION; PEPTIDE; IDENTIFICATION; PURIFICATION	A emm53 subclass of Group A Streptococcus pyogenes (GAS) interacts tightly with human plasma plasminogen (hPg) and plasmin (hPm) via the kringle 2 (K2(hPg)) domain of hPg/hPm and the N-terminal a1a2 regions of a GAS coiled-coil M-like protein (PAM). Previous studies have shown that a monomeric PAM fragment, VEK30 (residues 97-125 + Tyr), interacted specifically with isolated K2(hPg). However, the binding strength of VEK30 (K-D = 56 nM) was similar to 60-fold weaker than that of full-length dimeric PAM (K-D = 1nM). To assess whether this attenuated binding was due to the inability of VEK30 to dimerize, we defined the minimal length of PAM required to dimerize using a series of peptides with additional PAM residues placed at the NH2 and COOH termini of VEK30.VEK64 (PAM residues 83-145 + Tyr) was found to be the smallest peptide that adopted an alpha-helical dimer, and was bound to K2(hPg) with nearly the same affinity as PAM (K-D = 1-2 nM). However, addition of two PAM residues (Arg(126)-His(127)) to the COOH terminus of VEK30 (VEK32) maintained a monomeric peptidic structure, but exhibited similar K2(hPg) binding affinity as full-length dimeric PAM. We identified five residues in a1a2 (Arg(113), His(114), Glu(116), Arg(126), His(127)), mutation of which reduced PAM binding affinity for K2(hPg) by similar to 1000-fold. Replacement of these critical residues by Ala in the GAS genome resulted in reduced virulence, similar to the effects of inactivating the PAM gene entirely. We conclude that rather than dimerization of PAM, the five key residues in the binding domain of PAM are essential to mediate the high affinity interaction with hPg, leading to increased GAS virulence.	[Bhattacharya, Sarbani; Liang, Zhong; Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; [Bhattacharya, Sarbani; Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Quek, Adam J.; Law, Ruby] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	University of Notre Dame; University of Notre Dame; Monash University	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.	fcastell@nd.edu		law, ruby/0000-0001-5432-5781; Quek, Adam/0000-0002-9120-2681	National Institutes of Health [HL03423]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL013423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL03423.	Agrahari G, 2013, J BIOL CHEM, V288, P27494, DOI 10.1074/jbc.M113.494864; AKERSTROM B, 1992, J IMMUNOL, V148, P3238; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bhattacharya S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/482096; BROCKWAY WJ, 1972, ARCH BIOCHEM BIOPHYS, V151, P194, DOI 10.1016/0003-9861(72)90488-2; CAPARON MG, 1987, P NATL ACAD SCI USA, V84, P8677, DOI 10.1073/pnas.84.23.8677; Castellino FJ, 2003, PLASMINOGEN: STRUCTURE, ACTIVATION AND REGULATION, P3; Chang Y, 1998, BIOCHEMISTRY-US, V37, P3258, DOI 10.1021/bi972284e; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Cheng Y, 2004, BIOCHEM BIOPH RES CO, V317, P401, DOI 10.1016/j.bbrc.2004.03.068; Christen MT, 2010, BIOCHEMISTRY-US, V49, P7131, DOI 10.1021/bi100687f; Cnudde SE, 2006, BIOCHEMISTRY-US, V45, P11052, DOI 10.1021/bi060914j; Figuera-Losada M, 2010, BBA-PROTEINS PROTEOM, V1804, P1342, DOI 10.1016/j.bbapap.2010.01.019; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Fujita D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2093; Godier A, 2013, J THROMB HAEMOST, V11, P26, DOI 10.1111/jth.12064; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Liang Z, 2013, J BIOL CHEM, V288, P6561, DOI 10.1074/jbc.M112.442657; Macheboeuf P, 2011, NATURE, V472, P64, DOI 10.1038/nature09967; MAGNUSSON S, 1975, PROTEASES BIOL CONTR, P123; McKay FC, 2004, INFECT IMMUN, V72, P364, DOI 10.1128/IAI.72.1.364-370.2004; McNamara C, 2008, SCIENCE, V319, P1405, DOI 10.1126/science.1154470; MENHART N, 1991, BIOCHEMISTRY-US, V30, P1948, DOI 10.1021/bi00221a031; MENHART N, 1993, BIOCHEMISTRY-US, V32, P8799, DOI 10.1021/bi00085a010; MENHART N, 1995, INT J PEPT PROT RES, V46, P464; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Nilsen SL, 1999, J BIOL CHEM, V274, P22380, DOI 10.1074/jbc.274.32.22380; Persson J, 2005, J IMMUNOL METHODS, V297, P83, DOI 10.1016/j.jim.2004.11.024; Ringdahl U, 1998, J BIOL CHEM, V273, P6424, DOI 10.1074/jbc.273.11.6424; Ringdahl U, 2000, MOL MICROBIOL, V37, P1318, DOI 10.1046/j.1365-2958.2000.02062.x; Rios-Steiner JL, 2001, J MOL BIOL, V308, P705, DOI 10.1006/jmbi.2001.4646; Sanderson-Smith M, 2006, J BIOL CHEM, V281, P3217, DOI 10.1074/jbc.M508758200; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; Sanderson-Smith ML, 2007, J BACTERIOL, V189, P1435, DOI 10.1128/JB.01218-06; Sanderson-Smith ML, 2006, J BIOL CHEM, V281, P25965, DOI 10.1074/jbc.M603846200; Sandin C, 2002, J IMMUNOL, V169, P1357, DOI 10.4049/jimmunol.169.3.1357; Schenone MM, 2000, J PEPT RES, V56, P438, DOI 10.1034/j.1399-3011.2000.00810.x; Sehl L. C., 1991, THESIS U NOTRE DAME; SEHL LC, 1990, J BIOL CHEM, V265, P5482; Shang C, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.021401; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Svensson MD, 1999, INFECT IMMUN, V67, P3915, DOI 10.1128/IAI.67.8.3915-3920.1999; VIOLAND BN, 1978, J BIOL CHEM, V253, P5395; VIOLAND BN, 1975, ARCH BIOCHEM BIOPHYS, V170, P300, DOI 10.1016/0003-9861(75)90121-6; Wang M, 2010, J STRUCT BIOL, V169, P349, DOI 10.1016/j.jsb.2009.09.011; WISTEDT AC, 1995, MOL MICROBIOL, V18, P569, DOI 10.1111/j.1365-2958.1995.mmi_18030569.x; Wistedt AC, 1998, J BIOL CHEM, V273, P24420, DOI 10.1074/jbc.273.38.24420; Zhang YL, 2012, J BIOL CHEM, V287, P42093, DOI 10.1074/jbc.M112.417808	48	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21684	21693		10.1074/jbc.M114.570218	http://dx.doi.org/10.1074/jbc.M114.570218			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24962580	Green Published, hybrid			2022-12-25	WOS:000340558300042
J	Goto, A; Fukuyama, H; Imler, JL; Hoffmann, JA				Goto, Akira; Fukuyama, Hidehiro; Imler, Jean-Luc; Hoffmann, Jules A.			The Chromatin Regulator DMAP1 Modulates Activity of the Nuclear Factor kappa B (NF-kappa B) Transcription Factor Relish in the Drosophila Innate Immune Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX; DNA; EXPRESSION; RECEPTORS; BACTERIAL; POLARITY	The host defense of the model organism Drosophila is under the control of two major signaling cascades controlling transcription factors of the NF-kappa B family, the Toll and the immune deficiency (IMD) pathways. The latter shares extensive similarities with the mammalian TNF-R pathway and was initially discovered for its role in anti-Gram-negative bacterial reactions. A previous interactome study from this laboratory reported that an unexpectedly large number of proteins are binding to the canonical components of the IMD pathway. Here, we focus on DNA methyltransferase-associated protein 1 (DMAP1), which this study identified as an interactant of Relish, a Drosophila transcription factor reminiscent of the mammalian p105 NF-kappa B protein. We show that silencing of DMAP1 expression both in S2 cells and in flies results in a significant reduction of Escherichia coli-induced expression of antimicrobial peptides. Epistatic analysis indicates that DMAP1 acts in parallel or downstream of Relish. Co-immunoprecipitation experiments further reveal that, in addition to Relish, DMAP1 also interacts with Akirin and the Brahma-associated protein 55 kDa (BAP55). Taken together, these results reveal that DMAP1 is a novel nuclear modulator of the IMD pathway, possibly acting at the level of chromatin remodeling.	[Goto, Akira; Fukuyama, Hidehiro; Imler, Jean-Luc; Hoffmann, Jules A.] IBMC, INSERM, CNRS UPR9022, F-67084 Strasbourg, France; [Imler, Jean-Luc] Univ Strasbourg, Fac Sci Vie, F-67083 Strasbourg, France; [Hoffmann, Jules A.] Univ Strasbourg, Inst Adv Study, F-67000 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Goto, A (corresponding author), IBMC, INSERM, CNRS UPR9022, 15 Rue Rene Descartes, F-67084 Strasbourg, France.	goto@unistra.fr	GOTO, Akira/V-7847-2017; Imler, Jean-Luc/GXH-4323-2022; Fukuyama, Hidehiro/N-5276-2018; Fukuyama, Hidehiro/AAY-6256-2021	GOTO, Akira/0000-0003-3395-484X; Fukuyama, Hidehiro/0000-0002-6457-0630; Fukuyama, Hidehiro/0000-0002-6457-0630	National Institutes of Health [PO1 AI070167]; Agence Nationale de la Recherche [ANR-13-BSV3-0009]; Balzan Foundation; Investissement d'Avenir Programs [ANR-10-LABX-0036, ANR-11-EQPX-0022]; CNRS; INSERM; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de la Recherche(French National Research Agency (ANR)); Balzan Foundation; Investissement d'Avenir Programs(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 AI070167 (to J. L. I. and J. A. H.), the Agence Nationale de la Recherche (Grant ANR-13-BSV3-0009), the Balzan Foundation (to J. A. H.), the Investissement d'Avenir Programs (Grants ANR-10-LABX-0036 and ANR-11-EQPX-0022), CNRS, and INSERM.	ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; Baeg GH, 2005, GENE DEV, V19, P1861, DOI 10.1101/gad.1320705; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Cai Y, 2003, J BIOL CHEM, V278, P42733, DOI 10.1074/jbc.C300389200; Cao Y, 2013, P NATL ACAD SCI USA, V110, pE1752, DOI 10.1073/pnas.1306220110; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Ferrandon D, 2013, CURR OPIN IMMUNOL, V25, P59, DOI 10.1016/j.coi.2012.11.008; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fukuyama H, 2013, P NATL ACAD SCI USA, V110, P10717, DOI 10.1073/pnas.1304380110; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Goto A, 2008, NAT IMMUNOL, V9, P97, DOI 10.1038/ni1543; Guruharsha KG, 2012, FLY, V6, P246, DOI 10.4161/fly.22108; Herceg Z, 2001, NAT GENET, V29, P206, DOI 10.1038/ng725; Hetru C, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000232; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486; Kuttenkeuler D, 2010, J INNATE IMMUN, V2, P181, DOI 10.1159/000248649; Lee KZ, 2011, EMBO J, V30, P988, DOI 10.1038/emboj.2011.47; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Liu X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042725; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Mohan KN, 2011, MOL CELL BIOL, V31, P1861, DOI 10.1128/MCB.01390-10; Mukae N, 2002, GENE DEV, V16, P2662, DOI 10.1101/gad.1022802; Nowak SJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002547; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Penicud K, 2014, ONCOGENE, V33, P525, DOI 10.1038/onc.2012.597; Raddatz G, 2013, P NATL ACAD SCI USA, V110, P8627, DOI 10.1073/pnas.1306723110; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797	37	18	21	9	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20470	20476		10.1074/jbc.C114.553719	http://dx.doi.org/10.1074/jbc.C114.553719			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24947515	Green Published, hybrid			2022-12-25	WOS:000339396600006
J	Galateanu, G; Hermes, R; Saragusty, J; Goritz, F; Potier, R; Mulot, B; Maillot, A; Etienne, P; Bernardino, R; Fernandes, T; Mews, J; Hildebrandt, TB				Galateanu, Gabriela; Hermes, Robert; Saragusty, Joseph; Goeritz, Frank; Potier, Romain; Mulot, Baptiste; Maillot, Alexis; Etienne, Pascal; Bernardino, Rui; Fernandes, Teresa; Mews, Jurgen; Hildebrandt, Thomas Bernd			Rhinoceros Feet Step Out of a Rule-of-Thumb: A Wildlife Imaging Pioneering Approach of Synchronized Computed Tomography-Digital Radiography	PLOS ONE			English	Article							DORSOPROXIMAL-DORSODISTAL PROJECTION; FOOT; FRACTURES; CLOSURE; HORSES; BONE	Currently, radiography is the only imaging technique used to diagnose bone pathology in wild animals situated under "field conditions". Nevertheless, while chronic foot disease in captive mega-herbivores is widely reported, foot radiographic imaging is confronted with scarcity of studies. Numerous hindrances lead to such limited numbers and it became very clear that the traditional perspective on bone imaging in domestic animals based on extensive studies and elaborated statistical evaluations cannot be extrapolated to their non-domestic relatives. For these reasons, the authors initiated a multi-modality imaging study and established a pioneering approach of synchronized computed tomography (CT) and digital radiography (DR), based on X-ray projections derived from three-dimensional CT reconstructed images. Whereas this approach can be applied in any clinical field, as a case of outstanding importance and great concern for zoological institutions, we selected foot bone pathologies in captive rhinoceroses to demonstrate the manifold applications of the method. Several advances were achieved, endowing the wildlife clinician with all-important tools: prototype DR exposure protocols and a modus operandi for foot positioning, advancing both traditional projections and, for the first-time, species-related radiographic views; assessment of radiographic diagnostic value for the whole foot and, in premiere, for each autopodial bone; together with additional insights into radiographic appearance of bone anatomy and pathology with a unique, simultaneous CT-DR correlation. Based on its main advantages in availing a wide range of keystone data in wildlife imaging from a limited number of examined subjects and combining advantages of CT as the golden standard method for bone diseases' diagnostic with DR's clinical feasibility under field conditions, synchronized CT-DR presents a new perspective on wildlife's health management. With this we hope to provide veterinary clinicians with concrete imaging techniques and substantial diagnostic tools, which facilitate straightforward attainment and interpretation of field radiography images taken worldwide.	[Galateanu, Gabriela; Hermes, Robert; Saragusty, Joseph; Goeritz, Frank; Hildebrandt, Thomas Bernd] Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management, Berlin, Germany; [Potier, Romain; Mulot, Baptiste] ZooParc Beauval, St Aignan, France; [Maillot, Alexis] Parc Zool Amneville, Amneville Les Thermes, France; [Etienne, Pascal] Parc Zool La Barben Pelissane, La Barben, France; [Bernardino, Rui; Fernandes, Teresa] Jardim Zool Lisboa, Hosp Vet, Lisbon, Portugal; [Mews, Jurgen] Toshiba Med Syst Europe, Clin Applicat Res Ctr, Zoetermeer, Netherlands	Leibniz Institut fur Zoo und Wildtierforschung; Toshiba Corporation	Galateanu, G (corresponding author), Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management, Berlin, Germany.	galateanu@izw-berlin.de	Saragusty, Joseph/M-5030-2016; Mews, Jürgen/AAE-2494-2020	Saragusty, Joseph/0000-0002-9274-7800; Mews, Jürgen/0000-0001-9745-5818				Adelman JS, 2009, INTEGR COMP BIOL, V49, P202, DOI 10.1093/icb/icp028; [Anonymous], 1998, RHINOCEROS CAPTIVITY; Atkinson Mark W., 2006, P89; Bergman H. J., 2011, Veterinary computed tomography, P457; Biddle R, 2012, E BLACK RHINO EEP DI; Ebedes Hym, 1999, P575; Eksell P, 1999, VET RADIOL ULTRASOUN, V40, P228, DOI 10.1111/j.1740-8261.1999.tb00353.x; Emslie R., 2012, IUCN 2012 IUCN RED L; Farrow CS, 2009, VET DIAGNOSTIC IMAGI, P346; Flach EJ, 2003, TREATMENT OSTEOMYELI, P1; Fowler ME, 2010, RESTRAINT HANDLING W, P343; Fowler Murray E., 2006, P271, DOI 10.1002/9780470344484.ch20; Fowler Murray E., 2006, P75, DOI 10.1002/9780470344484.ch8; Gage Laurie, 2006, P192; Gage Laurie J., 1999, P517; Gage LJ, 1997, J ZOO WILDLIFE MED, V28, P208; Galateanu G, 2013, EXTENSIVE STUDY DIAG, P26; Galateanu G, 2013, NEW CLIN TOOLS RHINO, P128; Galateanu G, 2012, RHINOCEROS FOOT SETP, P40; Galateanu G, 2013, DIAGNOSTIC IMAGING N, P127; Galateanu G, 2012, RHINOCEROS FEET MAKE, P142; Galateanu G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068493; Greer M, 1977, Proceedings of the Oklahoma Academy of Science, V57, P39; Hampson B, 2013, AUST VET J, V91, P23, DOI 10.1111/avj.12017; Harrison TM, 2011, J ZOO WILDLIFE MED, V42, P317, DOI 10.1638/2010-0149.1; Hart BL, 2011, PHILOS T R SOC B, V366, P3406, DOI 10.1098/rstb.2011.0092; Hittmair KM, 2000, VET RADIOL ULTRASOUN, V41, P511, DOI 10.1111/j.1740-8261.2000.tb01879.x; HONNAS CM, 1988, VET RADIOLOGY, V29, P98, DOI 10.1111/j.1740-8261.1988.tb01758.x; Houwald FF, 2001, THESIS U ZURICH ZURI; Hutchinson JR, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P23, DOI 10.1007/978-4-431-76933-0_3; Hutchinson JR, 2011, SCIENCE, V334, P1699, DOI 10.1126/science.1211437; KASERHOTZ B, 1992, VET RADIOL ULTRASOUN, V33, P9, DOI 10.1111/j.1740-8261.1992.tb01949.x; Kaulfers C, 2010, J ZOO WILDLIFE MED, V41, P697, DOI 10.1638/2009-0168.1; Kirberger RM, 1999, VET RADIOL ULTRASOUN, V40, P220, DOI 10.1111/j.1740-8261.1999.tb00352.x; KOCK RA, 1993, RHINOCEROS BIOLOGY AND CONSERVATION, P325; Liem KF., 2001, FUNCTIONAL ANATOMY V; Miller R.E., 2003, FOWLERS ZOO WILD ANI, P559; Mumby C, 2013, VET RECORD IN PRESS; PETERSON PR, 1988, VET RADIOLOGY, V29, P147, DOI 10.1111/j.1740-8261.1988.tb01767.x; Raath J.P., 1999, P556; Roocroft A, 2001, ELEPHANT'S FOOT, P21; Rose PL, 1997, VET RADIOL ULTRASOUN, V38, P424, DOI 10.1111/j.1740-8261.1997.tb00865.x; Ruohoniemi M, 1999, VET RADIOL ULTRASOUN, V40, P275, DOI 10.1111/j.1740-8261.1999.tb00362.x; Schmitt D.L., 2003, ZOO WILD ANIMAL MED, P541; Seeram E, 2009, CLIN APPL QUALITY CO, P536; SHIVELY MJ, 1988, VET RADIOLOGY, V29, P282; Siegal-Willott J, 2008, J ZOO WILDLIFE MED, V39, P320, DOI 10.1638/2007-0031.1; Siegal-Willott Jessica L., 2012, P515; SMALLWOOD JE, 1985, VET RADIOLOGY, V26, P2, DOI 10.1111/j.1740-8261.1985.tb01105.x; Starrak GS, 1996, VET RADIOL ULTRASOUN, V37, P116, DOI 10.1111/j.1740-8261.1996.tb01207.x; Strauss G, 1982, INT S ERKR ZOOT 24, V24, P177; Talukdar BK, 2008, IUCN 2012 IUCN RED L; Uhlhorn H, 1999, VET RADIOL ULTRASOUN, V40, P480, DOI 10.1111/j.1740-8261.1999.tb00379.x; Uhlhorn H, 1998, VET RADIOL ULTRASOUN, V39, P412, DOI 10.1111/j.1740-8261.1998.tb01626.x; van Strien NJ, 2008, IUCN 2012 IUCN RED L; Versteege L, 2012, 2011 EUROPEAN STUDBO; von Houwald F, 2012, INT STUDBOOK 2011; WALLACH JD, 1967, J AM VET MED ASSOC, V151, P887; West Gary, 2006, P263, DOI 10.1002/9780470344484.ch19; Wobeser G.A., 1994, INVESTIGATION MANAGE; Zuba Jeffery R., 2012, P619	61	3	3	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100415	10.1371/journal.pone.0100415	http://dx.doi.org/10.1371/journal.pone.0100415			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963807	Green Published, gold			2022-12-25	WOS:000338709500048
J	Ge, XY; Yang, LQ; Jiang, Y; Yang, WW; Fu, J; Li, SL				Ge, Xi-Yuan; Yang, Lin-Qian; Jiang, Yang; Yang, Wen-Wen; Fu, Jia; Li, Sheng-Lin			Reactive Oxygen Species and Autophagy Associated Apoptosis and Limitation of Clonogenic Survival Induced by Zoledronic Acid in Salivary Adenoid Cystic Carcinoma Cell Line SACC-83	PLOS ONE			English	Article							HUMAN FIBROSARCOMA CELLS; S-PHASE ARREST; IN-VITRO; POSTMENOPAUSAL OSTEOPOROSIS; PANCREATIC-CANCER; MULTIPLE-MYELOMA; PROSTATE-CANCER; BISPHOSPHONATES; METASTASES; GROWTH	Salivary adenoid cystic carcinoma is an epithelial tumor in the head and neck region. Despite its slow growth, patients with salivary adenoid cystic carcinoma exhibit poor long term survival because of a high rate of distant metastasis. Lung and bone are common distant metastasis sites. Zoledronic acid, a third generation bisphosphonate, has been used for tumor-induced osteolysis due to bone metastasis and has direct antitumor activity in several human neoplasms. Here, we observed that zoledronic acid inhibited salivary adenoid cystic carcinoma cell line SACC-83 xenograft tumor growth in nude mice. In vitro, zoledronic acid induced apoptosis and reduced clonogenic survival in SACC-83. Flow cytometry and western blotting indicated that the cell cycle was arrested at G0/G1. Zoledronic acid treatment upregulated reactive oxygen species as well as the autophagy marker protein LC-3B. Reactive oxygen species scavenger N-acetylcysteine and autophagy antagonist 3-methyladenine decreased zoledronic acid-induced apoptosis and increased clonogenic survival. Silencing of the autophagy related gene Beclin-1 also decreased zoledronic acid-induced apoptosis and inhibition of clonogenic formation. In addition, isobolographic analysis revealed synergistic effects on apoptosis when zoledronic acid and paclitaxel/cisplatin were combined. Taken together, our results suggest that zoledronic acid induced apoptosis and reduced clonogenic survival via upregulation of reactive oxygen species and autophagy in the SACC-83 cell line. Thus, zoledronic acid should be considered a promising drug for the treatment of salivary adenoid cystic carcinoma.	[Ge, Xi-Yuan; Fu, Jia; Li, Sheng-Lin] Peking Univ, Cent Lab, Sch & Hosp Stomatol, Beijing 100871, Peoples R China; [Yang, Lin-Qian; Jiang, Yang; Yang, Wen-Wen; Li, Sheng-Lin] Peking Univ, Dept Oral & Maxillofacial Surg, Sch & Hosp Stomatol, Beijing 100871, Peoples R China	Peking University; Peking University	Li, SL (corresponding author), Peking Univ, Cent Lab, Sch & Hosp Stomatol, Beijing 100871, Peoples R China.	kqshlli@bjmu.edu.cn			National Natural Science Foundation of China [81272966, 81272967]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Nos. 81272966 and 81272967). URL: http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almubarak Hussain, 2011, J Carcinog, V10, P2, DOI 10.4103/1477-3163.75723; [Anonymous], ZHONGHUA KOU QIANG Y; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; Berenson JR, 2005, ONCOLOGIST, V10, P52, DOI 10.1634/theoncologist.10-1-52; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Bruzzese F, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.406; Budman DR, 2006, ONCOLOGY-BASEL, V70, P147, DOI 10.1159/000093006; Chang J, 2012, ONCOL LETT, V4, P299, DOI 10.3892/ol.2012.723; Coleman RE, 2004, ONCOLOGIST, V9, P14, DOI 10.1634/theoncologist.9-90004-14; Corey E, 2003, CLIN CANCER RES, V9, P295; Di Salvatore M, 2011, CELL PROLIFERAT, V44, P139, DOI 10.1111/j.1365-2184.2011.00745.x; Dong L, 2011, J DENT RES, V90, P804, DOI 10.1177/0022034511401407; Dong L, 2013, ORAL ONCOL, V49, P1051, DOI 10.1016/j.oraloncology.2013.07.012; Fordice J, 1999, ARCH OTOLARYNGOL, V125, P149, DOI 10.1001/archotol.125.2.149; GRECO WR, 1995, PHARMACOL REV, V47, P331; Green JR, 2003, CANCER, V97, P840, DOI 10.1002/cncr.11128; Grimm M, 2012, INT ENDOD J, V45, P1156, DOI 10.1111/j.1365-2591.2012.02079.x; Han NL, 2000, PAIN, V85, P465, DOI 10.1016/S0304-3959(99)00294-8; Heymann D, 2004, TRENDS MOL MED, V10, P337, DOI 10.1016/j.molmed.2004.05.007; Hiraga T, 2004, CLIN CANCER RES, V10, P4559, DOI 10.1158/1078-0432.CCR-03-0325; Hitre E, 2013, BR J CANC; Ibrahim T, 2013, INT J ONCOL, V42, P1263, DOI 10.3892/ijo.2013.1809; Ibrahim T, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-48; Jagdev SP, 2001, BRIT J CANCER, V84, P1126, DOI 10.1054/bjoc.2001.1727; Jaso J, 2011, ARCH PATHOL LAB MED, V135, P511, DOI 10.1043/2009-0527-RS.1; Koto K, 2013, INT J ONCOL, V42, P525, DOI 10.3892/ijo.2012.1735; Koto K, 2010, ONCOL REP, V24, P233, DOI 10.3892/or_00000851; Li YY, 2008, LUNG CANCER, V59, P180, DOI 10.1016/j.lungcan.2007.08.026; Lin JF, 2011, J UROLOGY, V185, P1490, DOI 10.1016/j.juro.2010.11.045; Liu Q, 2013, CHINESE MED J-PEKING, V126, P1486, DOI 10.3760/cma.j.issn.0366-6999.20122385; MATSUBA HM, 1986, CANCER, V57, P519, DOI 10.1002/1097-0142(19860201)57:3<519::AID-CNCR2820570319>3.0.CO;2-V; Ohnuki H, 2012, ARCH ORAL BIOL, V57, P906, DOI 10.1016/j.archoralbio.2011.11.015; Ozturk OH, 2007, CELL BIOL INT, V31, P1069, DOI 10.1016/j.cellbi.2007.02.004; Polascik Thomas J, 2008, Ther Clin Risk Manag, V4, P261; Recknor C, 2011, EXPERT OPIN PHARMACO, V12, P807, DOI 10.1517/14656566.2011.562201; Richhariya Akshara, 2012, Cancer Manag Res, V4, P55, DOI 10.2147/CMAR.S27693; Romani AA, 2009, BIOCHEM PHARMACOL, V78, P133, DOI 10.1016/j.bcp.2009.04.004; Sewing L, 2008, APOPTOSIS, V13, P782, DOI 10.1007/s10495-008-0211-z; Sieber P, 2013, CLIN DRUG INVEST, V33, P117, DOI 10.1007/s40261-012-0041-1; Silverman SL, 2008, JCR-J CLIN RHEUMATOL, V14, P299, DOI 10.1097/RHU.0b013e318188b1f3; Sung MW, 2003, ARCH OTOLARYNGOL, V129, P1193, DOI 10.1001/archotol.129.11.1193; Tallarida RJ, 2001, J PHARMACOL EXP THER, V298, P865; TALLARIDA RJ, 1992, PAIN, V49, P93, DOI 10.1016/0304-3959(92)90193-F; TALLARIDA RJ, 1992, PAIN, V51, P382, DOI 10.1016/0304-3959(92)90225-Z; Tallarida Ronald J, 2011, Genes Cancer, V2, P1003, DOI 10.1177/1947601912440575; Tassone P, 2003, BRIT J CANCER, V88, P1971, DOI 10.1038/sj.bjc.6600986; van der Wal JE, 2002, HEAD NECK-J SCI SPEC, V24, P779, DOI 10.1002/hed.10126; van Weert S, 2013, ORAL ONCOL, V49, P824, DOI 10.1016/j.oraloncology.2013.05.004; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; XY Li, 2012, MED ONCOL; Zhao M, 2012, CANCER SCI, V103, P58, DOI 10.1111/j.1349-7006.2011.02113.x; Zwolak P, 2010, J BONE JOINT SURG AM, V92A, P162, DOI 10.2106/JBJS.H.01679	52	23	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e101207	10.1371/journal.pone.0101207	http://dx.doi.org/10.1371/journal.pone.0101207			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963720	Green Published, Green Submitted			2022-12-25	WOS:000338709500119
J	Tong, K; Skibbens, RV				Tong, Kevin; Skibbens, Robert V.			Cohesin without Cohesion: A Novel Role for Pds5 in Saccharomyces cerevisiae	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; DNA-DAMAGE; NIPPED-B; FISSION YEAST; WAPL CONTROLS; S-PHASE; ESTABLISHMENT; ACETYLATION; COMPLEX; ECO1	High fidelity chromosome segregation during mitosis requires that cells identify the products of DNA replication during S-phase and then maintain that identity until anaphase onset. Sister chromatid identity is achieved through cohesin complexes (Smc1, Smc3, and Mcd1 and Irr1/Scc3), but the structure through which cohesins perform this task remains enigmatic. In the absence of unambiguous data, a popular model is that a subset of cohesin subunits form a huge ring-like structure that embraces both sister chromatids. This 'one-ring two-sister chromatid embrace' model makes clear predictions - including that premature cohesion loss in mitotic cells must occur through a substantial reduction in cohesin-DNA associations. We used chromatin immunoprecipitation to directly test for cohesin dissociation from well-established cohesin binding sites in mitotic cells inactivated for Pds5 - a key cohesin regulatory protein. The results reveal little if any chromatin dissociation from cohesins, despite a regimen that produces both massive loss of sister chromatid tethering and cell inviability. We further excluded models that cohesion loss in mitotic cells inactivated for Pds5 arises through either cohesin subunit degradation, premature Hos1-dependent Smc3 de-acetylation or Rad61/WAPL-dependent regulation of cohesin dynamics. In combination, our findings support a model that cohesin complexes associate with each sister and that sister chromatid cohesion likely results from cohesin-cohesin interactions. We further assessed the role that Pds5 plays in cohesion establishment during S-phase. The results show that Pds5 inactivation can result in establishment defects despite normal cohesion loading and Smc3 acetylation, revealing a novel establishment role for Pds5 that is independent of these processes. The combination of findings provides important new insights that significantly impact current models of both cohesion establishment reactions and maintenance.	[Tong, Kevin; Skibbens, Robert V.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA	Lehigh University	Skibbens, RV (corresponding author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	rvs3@lehigh.edu		Skibbens, Robert/0000-0003-4216-8306	National Institute of General Medical Sciences [GM083269]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM083269, R15GM110631] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Skibbens lab is funded by the National Institute of General Medical Sciences (grant number GM083269). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniacci LM, 2006, CURR BIOL, V16, P902, DOI 10.1016/j.cub.2006.03.060; Beckouet F, 2010, MOL CELL, V39, P689, DOI 10.1016/j.molcel.2010.08.008; Bellows AM, 2003, NUCLEIC ACIDS RES, V31, P6334, DOI 10.1093/nar/gkg811; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Borges V, 2010, MOL CELL, V39, P677, DOI 10.1016/j.molcel.2010.08.009; Braunholz D, 2012, EUR J HUM GENET, V20, P271, DOI 10.1038/ejhg.2011.175; Chan KL, 2013, P NATL ACAD SCI USA, V110, P13020, DOI 10.1073/pnas.1306900110; Chang CR, 2005, GENE DEV, V19, P3031, DOI 10.1101/gad.1356305; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; D'Ambrosio LM, 2014, CURR BIOL, V24, P361, DOI 10.1016/j.cub.2013.12.038; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Denes V, 2010, ONCOGENE, V29, P3446, DOI 10.1038/onc.2010.100; Dorsett D, 2011, CURR OPIN GENET DEV, V21, P199, DOI 10.1016/j.gde.2011.01.018; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gartenberg M, 2009, CHROMOSOME RES, V17, P229, DOI 10.1007/s10577-008-9012-z; Gause M, 2010, MOL CELL BIOL, V30, P4940, DOI 10.1128/MCB.00642-10; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Guacci V, 2012, MOL BIOL CELL, V23, P729, DOI 10.1091/mbc.E11-08-0696; Heidinger-Pauli JM, 2009, MOL CELL, V34, P311, DOI 10.1016/j.molcel.2009.04.008; Kogut I, 2009, GENE DEV, V23, P2345, DOI 10.1101/gad.1819409; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Kulemzina I, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002856; Laloraya S, 2000, J CELL BIOL, V151, P1047, DOI 10.1083/jcb.151.5.1047; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lopez-Serra L, 2013, CURR BIOL, V23, P64, DOI 10.1016/j.cub.2012.11.030; Losada A, 2005, J CELL SCI, V118, P2133, DOI 10.1242/jcs.02355; Lyons NA, 2013, NAT STRUCT MOL BIOL, V20, P194, DOI 10.1038/nsmb.2478; Lyons NA, 2011, MOL CELL, V42, P378, DOI 10.1016/j.molcel.2011.03.023; Machin F, 2005, J CELL BIOL, V168, P209, DOI 10.1083/jcb.200408087; Maffini M, 2008, J STEROID BIOCHEM, V108, P32, DOI 10.1016/j.jsbmb.2007.05.034; Maradeo ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015381; Maradeo ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004707; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Milutinovich M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030012; Misulovin Z, 2008, CHROMOSOMA, V117, P89, DOI 10.1007/s00412-007-0129-1; Mockel C, 2012, NUCLEIC ACIDS RES, V40, P914, DOI 10.1093/nar/gkr749; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Noble D, 2006, CELL CYCLE, V5, P2528, DOI 10.4161/cc.5.21.3405; Panizza S, 2000, CURR BIOL, V10, P1557, DOI 10.1016/S0960-9822(00)00854-X; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Rudra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075435; Rudra S, 2013, J CELL SCI, V126, P31, DOI 10.1242/jcs.116566; Rudra S, 2012, CELL CYCLE, V11, P2114, DOI 10.4161/cc.20547; Schiller CB, 2012, NAT STRUCT MOL BIOL, V19, P693, DOI 10.1038/nsmb.2323; Sharma U, 2013, MOL CELL BIOL, V33, P3473, DOI 10.1128/MCB.00162-12; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Skibbens RV, 2007, J CELL SCI, V120, P2471, DOI 10.1242/jcs.011999; Skibbens RV, 2000, GENOME RES, V10, P1664, DOI 10.1101/gr.153600; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Skibbens RV, 2005, J CELL BIOL, V169, P841, DOI 10.1083/jcb.200503129; Stead K, 2003, J CELL BIOL, V163, P729, DOI 10.1083/jcb.200305080; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Tanaka K, 2001, EMBO J, V20, P5779, DOI 10.1093/emboj/20.20.5779; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; Wang SW, 2002, J CELL SCI, V115, P587; Xiong B, 2010, CURR BIOL, V20, P1660, DOI 10.1016/j.cub.2010.08.019; Zhang B, 2007, DEVELOPMENT, V134, P3191, DOI 10.1242/dev.005884; Zhang B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005232; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006; Zhang NG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069458; Zhang ZJ, 2005, MOL MICROBIOL, V56, P670, DOI 10.1111/j.1365-2958.2005.04582.x	73	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100470	10.1371/journal.pone.0100470	http://dx.doi.org/10.1371/journal.pone.0100470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963665	Green Published, gold			2022-12-25	WOS:000338709500055
J	Brien, ML; Webb, GJ; McGuinness, K; Christian, KA				Brien, Matthew L.; Webb, Grahame J.; McGuinness, Keith; Christian, Keith A.			The Relationship between Early Growth and Survival of Hatchling Saltwater Crocodiles (Crocodylus porosus) in Captivity	PLOS ONE			English	Article							EGG SIZE VARIATION; BODY-SIZE; EVOLUTIONARY ECOLOGY; OFFSPRING FITNESS; CLUTCH SIZE; PATTERNS; TEMPERATURE; POPULATION; SEX; SURVIVORSHIP	Hatchling fitness in crocodilians is affected by "runtism'' or failure to thrive syndrome (FTT) in captivity. In this study, 300 hatchling C. porosus, artificially incubated at 32 degrees C for most of their embryonic development, were raised in semi-controlled conditions, with growth criteria derived for the early detection of FTT (within 24 days). Body mass, four days after hatching (BM4d), was correlated with egg size and was highly clutch specific, while snout-vent length (SVL4d) was much more variable within and between clutches. For the majority of hatchlings growth trajectories within the first 24 days continued to 90 days and could be used to predict FTT affliction up to 300 days, highlighting the importance of early growth. Growth and survival of hatchling C. porosus in captivity was not influenced by initial size (BM4d), with a slight tendency for smaller hatchlings to grow faster in the immediate post-hatching period. Strong clutch effects (12 clutches) on affliction with FTT were apparent, but could not be explained by measured clutch variables or other factors. Among individuals not afflicted by FTT (N = 245), mean growth was highly clutch specific, and the variation could be explained by an interaction between clutch and season. FTT affliction was 2.5 times higher among clutches (N = 7) that hatched later in the year when mean minimum air temperatures were lower, compared with those clutches (N = 5) that hatched early in the year. The results of this study highlight the importance of early growth in hatchling C. porosus, which has implications for the captive management of this species.	[Brien, Matthew L.; Webb, Grahame J.; McGuinness, Keith; Christian, Keith A.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Brien, Matthew L.; Webb, Grahame J.] Wildlife Management Int Pty Ltd, Karama, NT, Australia	Charles Darwin University	Brien, ML (corresponding author), Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia.	matthew_brien@hotmail.com		Christian, Keith/0000-0001-6135-1670	Holsworth Wildlife Research Endowment (ANZ Trustees Foundation); Northern Territory Research and Innovation Board student grant; Charles Darwin University; Wildlife Management International Pty. Limited	Holsworth Wildlife Research Endowment (ANZ Trustees Foundation); Northern Territory Research and Innovation Board student grant; Charles Darwin University; Wildlife Management International Pty. Limited	This work was supported by a Holsworth Wildlife Research Endowment (ANZ Trustees Foundation), Northern Territory Research and Innovation Board student grant, and Charles Darwin University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Wildlife Management International Pty. Limited provided funding through the Rural Industries Research and Development Corporation. Wildlife Management International Pty. Limited also provided support in the form of salary for authors Matthew L. Brien and Grahame J. Webb, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALLSTEADT J, 1995, PHYSIOL ZOOL, V68, P76, DOI 10.1086/physzool.68.1.30163919; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], [No title captured]; Berger L, 1977, Zoologica pol, V26, P291; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P385, DOI 10.1098/rspb.1999.0649; BOBYN ML, 1994, J ZOOL, V233, P233, DOI 10.1111/j.1469-7998.1994.tb08586.x; Brien ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080872; Brien ML, 2013, AUST J ZOOL, V61, P196, DOI 10.1071/ZO13035; Brien ML, 2013, BEHAVIOUR, V150, P737, DOI 10.1163/1568539X-00003078; Bronikowski AM, 1999, ECOLOGY, V80, P2314, DOI 10.1890/0012-9658(1999)080[2314:TEEOLH]2.0.CO;2; Bronikowski AM, 2000, EVOLUTION, V54, P1760; BUENVIAJE GN, 1994, AUST VET J, V71, P165, DOI 10.1111/j.1751-0813.1994.tb03381.x; Carpenter C.C., 1977, P335; Chalfoun AD, 2007, J APPL ECOL, V44, P983, DOI 10.1111/j.1365-2664.2007.01352.x; CHAMOVE AS, 1988, ZOO BIOL, V7, P359, DOI 10.1002/zoo.1430070407; CHARLAND MB, 1989, CAN J ZOOL, V67, P1620, DOI 10.1139/z89-231; Congdon JD, 1999, OECOLOGIA, V121, P224, DOI 10.1007/s004420050924; Connor RC, 2000, CETACEAN SOCIETIES, P91; Couquiaud L, 2005, AQUAT MAMM, V31, P288; Davis BM, 2001, 01123 RUR IND RES DE; DeKogel CH, 1997, J ANIM ECOL, V66, P167; DUNHAM AE, 1985, AM NAT, V126, P231, DOI 10.1086/284411; Fox CW, 2000, ANNU REV ENTOMOL, V45, P341, DOI 10.1146/annurev.ento.45.1.341; GALATTI U, 1992, J HERPETOL, V26, P23, DOI 10.2307/1565017; GARNETT ST, 1986, J ZOOL, V208, P493; GARNETT ST, 1986, AUST J ZOOL, V34, P211, DOI 10.1071/ZO9860211; GITTLEMAN JL, 1986, AM NAT, V127, P744, DOI 10.1086/284523; GOETZ BGR, 1994, NEW ZEAL J ZOOL, V21, P473, DOI 10.1080/03014223.1994.9518017; Grant P. R., 1986, ECOLOGY EVOLUTION DA; HENRICH S, 1988, OIKOS, V51, P13, DOI 10.2307/3565801; Henry C. K. Jeya, 1996, LONG TERM CONSEQUENC; Huchzermeyer F.W., 2003, CROCODILES BIOL HUSB; HUTCHINGS JA, 1991, EVOLUTION, V45, P1162, DOI 10.1111/j.1558-5646.1991.tb04382.x; HUTCHINGS JA, 1985, OIKOS, V45, P118, DOI 10.2307/3565229; Hutton J.M., 1992, P1; HUTTON JM, 1987, J ZOOL, V211, P143, DOI 10.1111/j.1469-7998.1987.tb07458.x; Isberg S., 2009, IMPROVING AUSTR CROC, P4; Jamerlan ML, 2002, THESIS U QUEENSLAND; Janzen FJ, 2000, J EVOLUTION BIOL, V13, P947, DOI 10.1046/j.1420-9101.2000.00234.x; JAYNE BC, 1990, EVOLUTION, V44, P1204, DOI 10.1111/j.1558-5646.1990.tb05226.x; Joanen T., 1976, Proceedings a Meet Wld Maricult Soc, V7, P201; Joanen T., 1987, P533; JORGENSEN SE, 1992, ECOL MODEL, V62, P195, DOI 10.1016/0304-3800(92)90091-R; KAPLAN RH, 1980, EVOLUTION, V34, P51, DOI 10.1111/j.1558-5646.1980.tb04788.x; KARLSSON B, 1985, ECOL ENTOMOL, V10, P205, DOI 10.1111/j.1365-2311.1985.tb00549.x; KENWARD RE, 1974, J WILDLIFE MANAGE, V38, P751, DOI 10.2307/3800041; Kissner KJ, 2005, J ANIM ECOL, V74, P259, DOI 10.1111/j.1365-2656.2005.00919.x; Lang J.W., 1987, P273; Lindburg D.G., 1984, P162; Maddox JD, 2008, AM NAT, V171, P358, DOI 10.1086/527500; Madsen T, 2000, J ANIM ECOL, V69, P952, DOI 10.1046/j.1365-2656.2000.00477.x; MARSH E, 1986, COPEIA, P18; Mason GJ, 2010, TRENDS ECOL EVOL, V25, P713, DOI 10.1016/j.tree.2010.08.011; Mayer R, 1998, CROCODILE FARMING RE; MAZZOTTI FJ, 1986, HERPETOLOGICA, V42, P191; MCGEHEE MA, 1990, HERPETOLOGICA, V46, P251; MCGINLEY MA, 1989, EVOL ECOL, V3, P150, DOI 10.1007/BF02270917; Messel H, 1981, SURVEYS TIDAL RIVER, V1; Packard G.C., 1988, BIOL REPTILIA, V16, P523; Peter J.-J., 1975, P187; PHILLIPS JA, 1993, PHYSIOL BEHAV, V53, P81, DOI 10.1016/0031-9384(93)90014-7; Riese G, 1991, THESIS U QUEENSLAND; Ross JP., 1998, CROCODILES STATUS SU; SAS Institute, 2010, JMP STAT GRAPH GUID; Seibert LM, 2006, MANUAL OF PARROT BEHAVIOR, P255, DOI 10.1002/9780470344651.ch23; SINERVO B, 1990, EVOLUTION, V44, P279, DOI 10.1111/j.1558-5646.1990.tb05198.x; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Stamps JA, 1998, AM NAT, V152, P470, DOI 10.1086/286183; STEARNS SC, 1983, OIKOS, V41, P173, DOI 10.2307/3544261; STEINWASCHER K, 1984, AM MIDL NAT, V112, P76, DOI 10.2307/2425459; Turton JA, 1997, AUST VET J, V75, P114, DOI 10.1111/j.1751-0813.1997.tb14170.x; van Zeeland YRA, 2009, APPL ANIM BEHAV SCI, V121, P75, DOI 10.1016/j.applanim.2009.09.006; Webb G., 1989, CROCODILES AUSTR; Webb G.J.W., 1987, P423; Webb G.J.W., 1987, P417; Webb G.J.W., 1994, P 12 WORK M CROC SPE, P176; WEBB GJW, 1987, COPEIA, P252; WEBB GJW, 1977, J WILDLIFE MANAGE, V41, P572, DOI 10.2307/3800531; WEBB GJW, 1989, AM ZOOL, V29, P953; WEBB GJW, 1977, COPEIA, P238; WEBB GJW, 1983, AUST WILDLIFE RES, V10, P563; Webb GJW, 1987, WILDLIFE MANAGEMENT, P189; WIGGINS DA, 1991, EVOLUTION, V45, P1169, DOI 10.1111/j.1558-5646.1991.tb04383.x; WILSON PN, 1960, BIOL REV, V35, P324, DOI 10.1111/j.1469-185X.1960.tb01327.x; Worner LLB, 2009, THESIS VICTORIA U	85	8	12	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100276	10.1371/journal.pone.0100276	http://dx.doi.org/10.1371/journal.pone.0100276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960026	Green Published, gold, Green Submitted			2022-12-25	WOS:000338633900035
J	Tian, ZW; Wang, CH; Hu, CJ; Tian, YH; Liu, JB; Wang, XJ				Tian, Zongwen; Wang, Changhua; Hu, Chengjun; Tian, Yihao; Liu, Jinbao; Wang, Xuejun			Autophagic-Lysosomal Inhibition Compromises Ubiquitin-Proteasome System Performance in a p62 Dependent Manner in Cardiomyocytes	PLOS ONE			English	Article							MOUSE MODEL; HEART; DEGRADATION; MATURATION; AGGREGATION; IMPAIRMENT; STARVATION; RECEPTORS; VACUOLES; PATHWAY	Intracellular protein degradation is primarily performed by the ubiquitin-proteasome system (UPS) and the autophagic-lysosomal pathway (ALP). The interplay between these two pathways has been rarely examined in intact animals and the mechanism underlying the interplay remains unclear. Hence, we sought to test in vivo and in vitro the impact of inhibition of the ALP on UPS proteolytic performance in cardiomyocytes and to explore the underlying mechanism. Transgenic mice ubiquitously expressing a surrogate UPS substrate (GFPdgn) were treated with bafilomycin-A1 (BFA) to inhibit the ALP. Myocardial and renal GFPdgn protein levels but not mRNA levels were increased at 24 hours but not 3 hours after the first injection of BFA. Myocardial protein abundance of key proteasome subunits and the activities of proteasomal peptidases were not discernibly altered by the treatment. In cultured neonatal rat ventricular myocytes (NRVMs), the surrogate UPS substrate GFPu and a control red fluorescence protein (RFP) were co-expressed to probe UPS performance. At 12 hours or 24 hours after ALP inhibition by 3-methyladenine (3-MA) or BFA, GFPu/RFP protein ratios and the protein half-life of GFPu were significantly increased, which is accompanied by increases in p62 proteins. Similar findings were obtained when ALP was inhibited genetically via silencing Atg7 or Rab7. ALP inhibition-induced increases in GFPu and p62 are co-localized in NRVMs. siRNA-mediated p62 knockdown prevented ALP inhibition from inducing GFPu accumulation in NRVMs. We conclude that in a p62-dependent fashion, ALP inhibition impairs cardiac UPS proteolytic performance in cardiomyocytes in vitro and in vivo.	[Tian, Zongwen; Wang, Changhua; Hu, Chengjun; Tian, Yihao; Wang, Xuejun] Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA; [Liu, Jinbao] Guangzhou Med Univ, Dept Pathophysiol, Prot Modificat & Degradat Lab, Guangzhou, Guangdong, Peoples R China; [Liu, Jinbao] Guangzhou Med Univ, Dept Biochem, Prot Modificat & Degradat Lab, Guangzhou, Guangdong, Peoples R China	University of South Dakota; Guangzhou Medical University; Guangzhou Medical University	Wang, XJ (corresponding author), Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA.	xuejun.wang@usd.edu	Wang, Xuejun/AAT-9490-2021; Wang, Xuejun/K-8874-2013	Wang, Xuejun/0000-0001-9267-1343; Wang, Xuejun/0000-0001-9267-1343; Hu, Chengjun/0000-0002-7491-3756	US National Institutes of Health [R01HL085629, R01HL072166]; American Heart Association Established Investigator Award [0740025N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072166, R01HL085629] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Established Investigator Award(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by US National Institutes of Health grants R01HL085629 and R01HL072166 and an American Heart Association Established Investigator Award (0740025N) (to X. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao X, 2014, CELL DEATH DIFFER, V21, P348, DOI 10.1038/cdd.2013.187; Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Day SM, 2013, AM J PHYSIOL-HEART C, V304, pH1283, DOI 10.1152/ajpheart.00249.2012; Dong X, 2004, AM J PHYSIOL-HEART C, V287, pH1417, DOI 10.1152/ajpheart.01233.2003; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Giricz Z, 2012, J CARDIOVASC PHARM, V60, P125, DOI 10.1097/FJC.0b013e318256ce10; Guo R, 2012, CARDIOVASC RES, V94, P480, DOI 10.1093/cvr/cvs127; Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427; Ichimura Y, 2008, AUTOPHAGY, V4, P1063, DOI 10.4161/auto.6826; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kaushik S, 2012, TRENDS CELL BIOL, V22, P407, DOI 10.1016/j.tcb.2012.05.006; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Kumarapeli ARK, 2005, FASEB J, V19, P2051, DOI 10.1096/fj.05-3973fje; Lei DX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067793; Lindsten K, 2003, NAT BIOTECHNOL, V21, P897, DOI 10.1038/nbt851; Morales CR, 2014, ANTIOXID REDOX SIGN, V20, P507, DOI 10.1089/ars.2013.5359; Qiao LY, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-17; Ranek MJ, 2014, J MOL CELL CARDIOL, V69, P43, DOI 10.1016/j.yjmcc.2014.01.017; Ranek MJ, 2013, CIRCULATION, V128, P365, DOI 10.1161/CIRCULATIONAHA.113.001971; Schlossarek S, 2012, BASIC RES CARDIOL, V107, DOI [10.1007/s00395-00011-00235-00393, DOI 10.1007/S00395-00011-00235-00393]; Schlossarek S, 2011, CURR OPIN CARDIOL, V26, P190, DOI 10.1097/HCO.0b013e32834598fe; Sciarretta S, 2012, J CARDIOVASC PHARM, V60, P235, DOI 10.1097/FJC.0b013e3182575f61; Su HB, 2011, TRENDS CARDIOVAS MED, V21, P224, DOI 10.1016/j.tcm.2012.05.015; Su HB, 2011, CIRCULATION, V124, P2117, DOI 10.1161/CIRCULATIONAHA.111.048934; Taherbhoy AM, 2011, MOL CELL, V44, P451, DOI 10.1016/j.molcel.2011.08.034; Tang MX, 2010, CARDIOVASC RES, V88, P424, DOI 10.1093/cvr/cvq217; Tannous P, 2008, CIRCULATION, V117, P3070, DOI 10.1161/CIRCULATIONAHA.107.763870; Tian ZW, 2012, CIRC RES, V111, P532, DOI 10.1161/CIRCRESAHA.112.270983; Tydlacka S, 2008, J NEUROSCI, V28, P13285, DOI 10.1523/JNEUROSCI.4393-08.2008; Wang XJ, 2013, AUTOPHAGY, V9, P1500, DOI 10.4161/auto.25573; Wang XJ, 2001, CIRCULATION, V103, P2402, DOI 10.1161/01.cir.103.19.2402; Wang XJ, 2014, J MOL CELL CARDIOL, V71, P16, DOI 10.1016/j.yjmcc.2013.11.006; Wang XJ, 2013, J MOL CELL CARDIOL, V55, P73, DOI 10.1016/j.yjmcc.2012.09.012; Wang XJ, 2013, CIRC RES, V112, P367, DOI 10.1161/CIRCRESAHA.112.268706; Xie M, 2014, CIRCULATION, V129, P1139, DOI 10.1161/CIRCULATIONAHA.113.002416; Xu XH, 2013, CARDIOVASC RES, V99, P412, DOI 10.1093/cvr/cvt116; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Young GW, 2008, TRENDS CARDIOVAS MED, V18, P93, DOI 10.1016/j.tcm.2008.01.004; Zheng QW, 2011, AM J CARDIOVASC DIS, V1, P214; Zheng QW, 2011, CIRC RES, V109, P296, DOI 10.1161/CIRCRESAHA.111.244707	48	29	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100715	10.1371/journal.pone.0100715	http://dx.doi.org/10.1371/journal.pone.0100715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959866	gold, Green Published, Green Submitted			2022-12-25	WOS:000338633900074
J	Fontaine, M; Planel, S; Peronnet, E; Turrel-Davin, F; Piriou, V; Pachot, A; Monneret, G; Lepape, A; Venet, F				Fontaine, Mathieu; Planel, Severine; Peronnet, Estelle; Turrel-Davin, Fanny; Piriou, Vincent; Pachot, Alexandre; Monneret, Guillaume; Lepape, Alain; Venet, Fabienne			S100A8/A9 mRNA Induction in an Ex Vivo Model of Endotoxin Tolerance: Roles of IL-10 and IFN gamma	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; SEPTIC SHOCK; MACROPHAGE EXPRESSION; WHOLE-BLOOD; S100; SEPSIS; IMMUNOSUPPRESSION; CALPROTECTIN; MONOCYTES; INFECTION	Objectives: Septic syndromes are the leading cause of death in intensive care units. They are characterized by the development of immune dysfunctions such as endotoxin tolerance (ET), whose intensity and duration are associated with increased risk of nosocomial infections and mortality. Alarmins S100A8 and S100A9 have been shown to be increased after septic shock. Importantly, a delayed S100A9 mRNA increase predicts hospital-acquired infection in patients. The aim of this study was to investigate the regulation of S100A8 and S100A9 mRNA expression in an ex vivo model of ET. Subjects and Measurements: ET was reproduced ex vivo by priming healthy peripheral blood mononuclear cells (number of donors = 9 to 10) with low-dose endotoxin (2 ng/ml) before stimulation with high dose endotoxin (100 ng/ml). S100A8 and S100A9 mRNA levels were measured by quantitative real-time polymerase chain reactions. Main Results: ET was established by observing decreased TNF alpha and increased IL-10 transcriptomic responses to two subsequent endotoxin challenges. Interestingly, ET was associated with increased S100A8 and S100A9 mRNA expression ex vivo. We showed that IL-10 played a role in this process, since S100A8 and S100A9 mRNA increases were significantly abrogated by IL-10 blockade in the model. Conversely, treatment with rIFN-c, a pro-inflammatory and immunostimulating molecule known to block ET induction, was able to restore normal S100A8 and S100A9 mRNA in this model. Conclusions: In this ex vivo model, we observed that S100A8 and S100A9 mRNA expression was significantly increased during ET. This reproduced ex vivo the observations we had previously made in septic shock patients. Interestingly, IL-10 blockade and rIFN-c treatment partially abrogated S100A8/A9 mRNA increases in this model. Pending confirmation in larger, independent clinical studies, these preliminary results suggest that S100A8 and S100A9 mRNA levels might be used as surrogate markers of ET and as stratification tools for personalized immunotherapy in septic shock patients.	[Fontaine, Mathieu; Piriou, Vincent; Lepape, Alain] Ctr Hosp Lyon Sud, Hosp Civils Lyon, Intens Care Unit, F-69310 Pierre Benite, France; [Fontaine, Mathieu; Planel, Severine; Peronnet, Estelle; Turrel-Davin, Fanny; Pachot, Alexandre; Monneret, Guillaume; Lepape, Alain; Venet, Fabienne] Hop Edouard Herriot, Joint Unit Hosp Civils Lyon BioMerieux, Lyon, France; [Fontaine, Mathieu; Piriou, Vincent; Monneret, Guillaume; Lepape, Alain; Venet, Fabienne] Univ Lyon 1, Hosp Civils Lyon, EAM Hemostasis Inflammat & Sepsis 4174, F-69365 Lyon, France; [Monneret, Guillaume; Venet, Fabienne] Hop Edouard Herriot, Hosp Civils Lyon, Immunol Lab, Lyon, France	CHU Lyon; bioMerieux; CHU Lyon; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Venet, F (corresponding author), Hop Edouard Herriot, Joint Unit Hosp Civils Lyon BioMerieux, Lyon, France.	fabienne.venet@chu-lyon.fr	Piriou, Vincent/AFV-4922-2022	Venet, Fabienne/0000-0003-0462-4235; LEPAPE, Alain/0000-0001-5950-7533; piriou, vincent/0000-0001-6900-1480	Hospices Civils de Lyon; bioMerieux	Hospices Civils de Lyon; bioMerieux	MF, VP, GM, AL and FV were supported by the Hospices Civils de Lyon. SP, EP, FTD and AP were supported by bioMerieux. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achouiti A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002987; Allantaz-Frager F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068218; Anceriz N, 2007, BIOCHEM BIOPH RES CO, V354, P84, DOI 10.1016/j.bbrc.2006.12.203; Bealer JF, 2010, ACAD EMERG MED, V17, P333, DOI 10.1111/j.1553-2712.2010.00663.x; Carroccio A, 2006, DIGEST DIS SCI, V51, P1749, DOI 10.1007/s10620-006-9078-4; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Cavaillon JM, 2003, J ENDOTOXIN RES, V9, P101, DOI 10.1179/096805103125001487; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; De Lorenzo BHP, 2010, IMMUNOBIOLOGY, V215, P341, DOI 10.1016/j.imbio.2009.05.013; del Fresno C, 2009, J IMMUNOL, V182, P6494, DOI 10.4049/jimmunol.0803350; Diercks BP, 2013, SCAND J IMMUNOL, V77, P169, DOI 10.1111/sji.12015; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Eggers K, 2011, EXP CLIN ENDOCR DIAB, V119, P353, DOI 10.1055/s-0030-1268426; Endoh Y, 2009, J IMMUNOL, V182, P2258, DOI 10.4049/jimmunol.0802683; FAGERHOL MK, 1980, SCAND J HAEMATOL, V24, P393; Fontaine M, 2011, CRIT CARE MED, V39, P2684, DOI 10.1097/CCM.0b013e3182282a40; Fuellen G, 2004, OMICS, V8, P334, DOI 10.1089/omi.2004.8.334; Goyette J, 2011, AMINO ACIDS, V41, P821, DOI 10.1007/s00726-010-0528-0; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Hsu K, 2005, J IMMUNOL, V174, P2318, DOI 10.4049/jimmunol.174.4.2318; Hsu Kenneth, 2009, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V8, P290; Ikemoto M, 2003, CLIN CHEM, V49, P594, DOI 10.1373/49.4.594; Katashima T, 2010, CIRC J, V74, P741, DOI 10.1253/circj.CJ-09-0564; Landelle C, 2010, INTENS CARE MED, V36, P1859, DOI 10.1007/s00134-010-1962-x; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Monneret G, 2011, PATHOL BIOL, V59, P329, DOI 10.1016/j.patbio.2011.02.001; Monneret G, 2008, MOL MED, V14, P64, DOI 10.2119/2007-00102.Monneret; Monneret G, 2006, INTENS CARE MED, V32, P1175, DOI 10.1007/s00134-006-0204-8; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; Pachot A, 2005, CRIT CARE MED, V33, P31, DOI 10.1097/01.CCM.0000150958.20209.A3; Pachot A, 2004, J BIOTECHNOL, V114, P121, DOI 10.1016/j.jbiotec.2004.07.001; Payen D, 2008, INTENS CARE MED, V34, P1371, DOI 10.1007/s00134-008-1048-1; Rammes A, 1997, J BIOL CHEM, V272, P9496; Ravasi T, 2004, GENOMICS, V84, P10, DOI 10.1016/j.ygeno.2004.02.002; Riva M, 2012, IMMUNOLOGY, V137, P172, DOI 10.1111/j.1365-2567.2012.03619.x; ROSETH AG, 1992, SCAND J GASTROENTERO, V27, P793, DOI 10.3109/00365529209011186; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Skirecki T, 2013, AM J RESP CRIT CARE, V187, P217, DOI 10.1164/ajrccm.187.2.217; Skrupky LP, 2011, ANESTHESIOLOGY, V115, P1349, DOI 10.1097/ALN.0b013e31823422e8; Sohnle PG, 2000, J INFECT DIS, V182, P1272, DOI 10.1086/315810; Sroussi HY, 2007, J LEUKOCYTE BIOL, V81, P818, DOI 10.1189/jlb.0706433; Turrel-Davin F, 2011, CRIT CARE, V15, DOI 10.1186/cc10513; van Zoelen MAD, 2009, AM J RESP CRIT CARE, V180, P1098, DOI 10.1164/rccm.200810-1552OC; Viemann D, 2005, BLOOD, V105, P2955, DOI 10.1182/blood-2004-07-2520; Viemann D, 2007, BLOOD, V109, P2453, DOI 10.1182/blood-2006-08-040444; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Xu K, 2000, J IMMUNOL, V164, P4916, DOI 10.4049/jimmunol.164.9.4916; Xu K, 2001, J IMMUNOL, V166, P6358, DOI 10.4049/jimmunol.166.10.6358; YOUNG HA, 1995, J LEUKOCYTE BIOL, V58, P373, DOI 10.1002/jlb.58.4.373; Zhao F, 2012, IMMUNOLOGY, V136, P176, DOI 10.1111/j.1365-2567.2012.03566.x; ZWADLO G, 1988, CLIN EXP IMMUNOL, V72, P510	52	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100909	10.1371/journal.pone.0100909	http://dx.doi.org/10.1371/journal.pone.0100909			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956170	Green Published, Green Submitted, gold			2022-12-25	WOS:000338917900105
J	Mao-Ying, QL; Kavelaars, A; Krukowski, K; Huo, XJ; Zhou, WJ; Price, TJ; Cleeland, C; Heijnen, CJ				Mao-Ying, Qi-Liang; Kavelaars, Annemieke; Krukowski, Karen; Huo, Xiao-Jiao; Zhou, Wenjun; Price, Theodore J.; Cleeland, Charles; Heijnen, Cobi J.			The Anti-Diabetic Drug Metformin Protects against Chemotherapy-Induced Peripheral Neuropathy in a Mouse Model	PLOS ONE			English	Article							APOLIPOPROTEIN-E; OVARIAN-CANCER; BREAST-CANCER; CORTICAL-NEURONS; NERVE-FIBERS; PAIN; INJURY; CELLS; REGENERATION; ACTIVATION	Chemotherapy-induced peripheral neuropathy (CIPN) characterized by loss of sensory sensitivity and pain in hands and feet is the major dose-limiting toxicity of many chemotherapeutics. At present, there are no FDA-approved treatments for CIPN. The anti-diabetic drug metformin is the most widely used prescription drug in the world and improves glycemic control in diabetes patients. There is some evidence that metformin enhances the efficacy of cancer treatment. The aim of this study was to test the hypothesis that metformin protects against chemotherapy-induced neuropathic pain and sensory deficits. Mice were treated with cisplatin together with metformin or saline. Cisplatin induced increased sensitivity to mechanical stimulation (mechanical allodynia) as measured using the von Frey test. Co-administration of metformin almost completely prevented the cisplatin-induced mechanical allodynia. Co-administration of metformin also prevented paclitaxel-induced mechanical allodynia. The capacity of the mice to detect an adhesive patch on their hind paw was used as a novel indicator of chemotherapy-induced sensory deficits. Co-administration of metformin prevented the cisplatin-induced increase in latency to detect the adhesive patch indicating that metformin prevents sensory deficits as well. Moreover, metformin prevented the reduction in density of intra-epidermal nerve fibers (IENFs) in the paw that develops as a result of cisplatin treatment. We conclude that metformin protects against pain and loss of tactile function in a mouse model of CIPN. The finding that metformin reduces loss of peripheral nerve endings indicates that mechanism underlying the beneficial effects of metformin includes a neuroprotective activity. Because metformin is widely used for treatment of type II diabetes, has a broad safety profile, and is currently being tested as an adjuvant drug in cancer treatment, clinical translation of these findings could be rapidly achieved.	[Mao-Ying, Qi-Liang; Kavelaars, Annemieke; Krukowski, Karen; Huo, Xiao-Jiao; Zhou, Wenjun; Heijnen, Cobi J.] Univ Texas MD Anderson Canc Ctr, Dept Symptom Res, Neuroimmunol Lab, Houston, TX 77030 USA; [Mao-Ying, Qi-Liang] Fudan Univ, Dept Integrat Med & Neurobiol, State Key Lab Med Neurobiol, Sch Basic Med Sci, Shanghai 200433, Peoples R China; [Price, Theodore J.] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA; [Cleeland, Charles] Univ Texas MD Anderson Canc Ctr, Dept Symptom Res, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Fudan University; University of Texas System; University of Texas Dallas; University of Texas System; UTMD Anderson Cancer Center	Heijnen, CJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Symptom Res, Neuroimmunol Lab, Houston, TX 77030 USA.	cjheijnen@mdanderson.org	Zhou, Wenjun/H-2824-2016; Price, Theodore/M-3810-2018	Zhou, Wenjun/0000-0003-4042-4329; Price, Theodore/0000-0002-6971-6221; Zhou, wenjun/0000-0002-8268-0251	National Cancer Institute of the National Institute of Health [PO1 CA124787]; National Institute of Neurological Diseases and Stroke of the National Institute of Health [RO1 NS073939, RO1 NS74999, RO1 NS065926]; National Institute of General Medical Sciences of the National Institute of Health [RO1 GM102575]; United States Pain Relief Committee; STARS award Universtiy of Texas System; NATIONAL CANCER INSTITUTE [P01CA124787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065926, R01NS074999, R01NS073939] Funding Source: NIH RePORTER	National Cancer Institute of the National Institute of Health; National Institute of Neurological Diseases and Stroke of the National Institute of Health; National Institute of General Medical Sciences of the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Pain Relief Committee; STARS award Universtiy of Texas System; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Cancer Institute of the National Institute of Health PO1 CA124787 (CC); National Institute of Neurological Diseases and Stroke of the National Institute of Health RO1 NS073939 (AK), RO1 NS74999 (AK), and RO1 NS065926 (TJP); National Institute of General Medical Sciences of the National Institute of Health RO1 GM102575 (TJP); United States Pain Relief Committee (CJH, CC); and STARS award Universtiy of Texas System (AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; Boyette-Davis J, 2011, EXP NEUROL, V229, P353, DOI 10.1016/j.expneurol.2011.02.019; Boyette-Davis J, 2011, PAIN, V152, P308, DOI 10.1016/j.pain.2010.10.030; Buac D, 2013, NEOPLASIA, V15, P1379, DOI 10.1593/neo.131434; Cata JP, 2006, MINERVA ANESTESIOL, V72, P151; Cata JP, 2008, BRAIN RES, V1230, P91, DOI 10.1016/j.brainres.2008.07.022; Cata JP, 2007, J PAIN, V8, P296, DOI 10.1016/j.jpain.2006.09.014; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen GF, 2012, J CLIN ENDOCR METAB, V97, pE510, DOI 10.1210/jc.2011-1754; Cheong JH, 2011, MOL CANCER THER, V10, P2350, DOI 10.1158/1535-7163.MCT-11-0497; Correia S, 2008, MED CHEM, V4, P358, DOI 10.2174/157340608784872299; Cufi S, 2012, ONCOTARGET, V3, P395, DOI 10.18632/oncotarget.488; Dilokthornsakul P, 2013, INT J GYNECOL CANCER, V23, P1544, DOI 10.1097/IGC.0b013e3182a80a21; El-Mir MY, 2008, J MOL NEUROSCI, V34, P77, DOI 10.1007/s12031-007-9002-1; Flatters SJL, 2006, PAIN, V122, P245, DOI 10.1016/j.pain.2006.01.037; Garofalo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083832; HANDELMANN GE, 1992, J LIPID RES, V33, P1677; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; IIfH Informatics, 2013, DECLINING MED USE CO; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Kimura Naoko, 2005, Drug Metab Pharmacokinet, V20, P379, DOI 10.2133/dmpk.20.379; Kumar S, 2013, CANCER-AM CANCER SOC, V119, P555, DOI 10.1002/cncr.27706; Lauria G, 2005, J PERIPHER NERV SYST, V10, P202, DOI 10.1111/j.1085-9489.2005.0010210.x; Li FQ, 2010, J PHARMACOL EXP THER, V334, P106, DOI 10.1124/jpet.110.167882; Li J, 2010, STROKE, V41, P2645, DOI 10.1161/STROKEAHA.110.589697; Melemedjian OK, 2013, PAIN, V154, P1080, DOI 10.1016/j.pain.2013.03.021; Melemedjian OK, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-14; Melemedjian OK, 2012, EXP NEUROL, V233, P740, DOI 10.1016/j.expneurol.2011.11.016; Melemedjian OK, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-70; Melemedjian OK, 2013, NEUROSCIENCE LETT; Nolano M, 1999, PAIN, V81, P135, DOI 10.1016/S0304-3959(99)00007-X; Pachman DR, 2011, CLIN PHARMACOL THER, V90, P377, DOI 10.1038/clpt.2011.115; Romero IL, 2012, OBSTET GYNECOL, V119, P61, DOI 10.1097/AOG.0b013e3182393ab3; SCHEEN AJ, 1993, DIABETES METAB, V19, P547; Schuning J, 2009, CLIN J PAIN, V25, P683, DOI 10.1097/AJP.0b013e3181a1260e; Siau C, 2006, EXP NEUROL, V201, P507, DOI 10.1016/j.expneurol.2006.05.007; Sprowl JA, 2013, P NATL ACAD SCI USA, V110, P11199, DOI 10.1073/pnas.1305321110; Ta LE, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-15; Ullah I, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-11; Wang HJ, 2011, PAIN, V152, P1649, DOI 10.1016/j.pain.2011.03.010; Wu JZ, 2004, MED ENG PHYS, V26, P165, DOI 10.1016/j.medengphy.2003.09.004	43	108	112	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100701	10.1371/journal.pone.0100701	http://dx.doi.org/10.1371/journal.pone.0100701			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955774	gold, Green Published, Green Submitted			2022-12-25	WOS:000338917900083
J	Senn, H; Banfield, L; Wacher, T; Newby, J; Rabeil, T; Kaden, J; Kitchener, AC; Abaigar, T; Silva, TL; Maunder, M; Ogden, R				Senn, Helen; Banfield, Lisa; Wacher, Tim; Newby, John; Rabeil, Thomas; Kaden, Jennifer; Kitchener, Andrew C.; Abaigar, Teresa; Silva, Teresa Luisa; Maunder, Mike; Ogden, Rob			Splitting or Lumping? A Conservation Dilemma Exemplified by the Critically Endangered Dama Gazelle (Nanger dama)	PLOS ONE			English	Article							INBREEDING DEPRESSION; GENETIC ADAPTATION; PATTERN; POPULATIONS; SUCCESS; COLOR; REINTRODUCTION; ENVIRONMENTS; BIODIVERSITY; POLYMORPHISM	Managers of threatened species often face the dilemma of whether to keep populations separate to conserve local adaptations and minimize the risk of outbreeding, or whether to manage populations jointly to reduce loss of genetic diversity and minimise inbreeding. In this study we examine genetic relatedness and diversity in three of the five last remaining wild populations of dama gazelle and a number of captive populations, using mtDNA control region and cytochrome b data. Despite the sampled populations belonging to the three putative subspecies, which are delineated according to phenotypes and geographical location, we find limited evidence for phylogeographical structure within the data and no genetic support for the putative subspecies. In the light of these data we discuss the relevance of inbreeding depression, outbreeding depression, adaptive variation, genetic drift, and phenotypic variation to the conservation of the dama gazelle and make some recommendations for its future conservation management. The genetic data suggest that the best conservation approach is to view the dama gazelle as a single species without subspecific divisions.	[Senn, Helen; Kaden, Jennifer; Ogden, Rob] Royal Zool Soc Scotland, WildGenes Lab, Edinburgh, Midlothian, Scotland; [Banfield, Lisa] Al Ain Zoo, Conservat Dept, Al Ain, U Arab Emirates; [Wacher, Tim] Zool Soc London, Conservat Programmes, London, England; [Newby, John] Sahara Conservat Fund, Lisle, Switzerland; [Rabeil, Thomas] Sahara Conservat Fund, Niamey, Niger; [Kitchener, Andrew C.] Natl Museums Scotland, Dept Nat Sci, Edinburgh, Midlothian, Scotland; [Kitchener, Andrew C.] Univ Edinburgh, Sch Geosci, Inst Geog, Edinburgh, Midlothian, Scotland; [Silva, Teresa Luisa] Univ Porto, CIBIO InBIO, Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal; [Abaigar, Teresa; Silva, Teresa Luisa] CSIC, Estn Expt Zonas Aridas, Almeria, Spain; [Silva, Teresa Luisa] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Oporto, Portugal; [Maunder, Mike] Florida Int Univ, Coll Arts & Sci, Miami, FL 33199 USA	Zoological Society of London; University of Edinburgh; Universidade do Porto; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); Universidade do Porto; State University System of Florida; Florida International University	Senn, H (corresponding author), Royal Zool Soc Scotland, WildGenes Lab, Edinburgh, Midlothian, Scotland.	hsenn@rzss.org.uk	Silva, Teresa Luísa/AAF-4772-2021; Abaigar, Teresa/R-3582-2019; Silva, Teresa Luísa/L-7902-2013	Silva, Teresa Luísa/0000-0002-6868-7035; Abaigar, Teresa/0000-0001-5177-4143; Silva, Teresa Luísa/0000-0002-6868-7035; Kitchener, Andrew/0000-0003-2594-0827	Al Ain Zoo; Royal Zoological Society of Scotland; Sahara Conservation Fund; Zoological Society of London; Saint Louis Zoo; Addax; Oryx Foundation; FCT-Fundacao para a Ciencia e a Tecnologia [SFRH/BD/73680/2010]	Al Ain Zoo; Royal Zoological Society of Scotland; Sahara Conservation Fund; Zoological Society of London; Saint Louis Zoo; Addax; Oryx Foundation; FCT-Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology)	Funding for genetic analysis was provided by Al Ain Zoo and the Royal Zoological Society of Scotland. The Sahara Conservation Fund, the Zoological Society of London, Saint Louis Zoo, Al Ain Zoo, the Addax and Oryx Foundation, and HH Sheikh Mohammed bin Zayed funded the collection of the dama gazelle samples from the wild. The authors' time during the project was funded by their own institutions and TLS's work was additionally partially supported by FCT-Fundacao para a Ciencia e a Tecnologia (SFRH/BD/73680/2010). Some funders to the project (Al Ain Zoo, Royal Zoological Society of Scotland, Sahara Conservation Fund, Zoological Society of London) were directly involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript via the participation of their employees in the project. These individuals are authors on this manuscript. The other funders (Saint Louis Zoo, the Addax and Oryx Foundation, FCT-Fundacao para a Ciencia e a Tecnologia and HH Sheikh Mohammed bin Zayed) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaigar T., 1997, International Zoo Yearbook, V35, P311, DOI 10.1111/j.1748-1090.1997.tb01225.x; Abaigar T, 2005, GNUSLETTER, V28, P6; ALADOS CL, 1991, J ZOOL, V223, P307, DOI 10.1111/j.1469-7998.1991.tb04767.x; [Anonymous], 2010, SCF REPORTS; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Bennett E.T., 1833, P ZOOL SOC LOND, P1; Boratynski Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094342; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; Brito JC, 2014, BIOL REV, V89, P215, DOI 10.1111/brv.12049; Buffon G-LL, 1764, HIST NATURELLE GEN P, VXII; Cano, 1991, ANTILOPE MOHOR GAZEL; Cano M., 1993, International Zoo Yearbook, V32, P98; Cano Perez M., 1984, Zeitschrift des Koelner Zoo, V27, P103; Christie MR, 2012, P NATL ACAD SCI USA, V109, P238, DOI 10.1073/pnas.1111073109; Cieslak M, 2011, BIOL REV, V86, P885, DOI 10.1111/j.1469-185X.2011.00177.x; Crnokrak P, 1999, HEREDITY, V83, P260, DOI 10.1038/sj.hdy.6885530; Darwin CR, 1876, EFFECTS CROSS SELF F; Devillers P, 2005, CMS TECHNICAL SERIES, V11, P57; Drummond AJ, 2010, GENEIOUS V6 1 4; Durant SM, 2014, DIVERS DISTRIB, V20, P114, DOI 10.1111/ddi.12157; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; EFFRON M, 1976, GENETICA, V46, P419, DOI 10.1007/BF00128089; Endler J.A., 1977, Monographs in Population Biology, pi; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fernandez MH, 2005, BIOL REV, V80, P269, DOI 10.1017/S1464793104006670; Frankham R, 2010, HEREDITY, V104, P124, DOI 10.1038/hdy.2009.155; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Frankham R., 2002, INTRO CONSERVATION G; Frankham R, 2008, MOL ECOL, V17, P325, DOI 10.1111/j.1365-294X.2007.03399.x; Frankham R, 2012, BIOL CONSERV, V153, P25, DOI 10.1016/j.biocon.2012.04.034; Frankham R, 2011, CONSERV BIOL, V25, P465, DOI 10.1111/j.1523-1739.2011.01662.x; Gasse F, 2000, QUATERNARY SCI REV, V19, P189, DOI 10.1016/S0277-3791(99)00061-X; Gaubert P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042740; Godinho R, 2012, CONSERV GENET, V13, P1003, DOI 10.1007/s10592-012-0348-8; Gratten J, 2010, HEREDITY, V104, P206, DOI 10.1038/hdy.2009.105; Groves C., 2011, UNGULATE TAXONOMY; Hamilton-Smith CH, 1827, THE CLASS MAMMALIA, P33; Hassanin A, 2012, CR BIOL, V335, P32, DOI 10.1016/j.crvi.2011.11.002; Hedrick PW, 2006, ANNU REV ECOL EVOL S, V37, P67, DOI 10.1146/annurev.ecolsys.37.091305.110132; Hoekstra HE, 2004, EVOLUTION, V58, P1329; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hvilsom C, 2013, HEREDITY, V110, P586, DOI 10.1038/hdy.2013.9; Ibanez B, 2013, ANIM CONSERV, V16, P108, DOI 10.1111/j.1469-1795.2012.00580.x; Ibanez B, 2011, MAMM BIOL, V76, P748, DOI 10.1016/j.mambio.2011.04.002; Iyengar A, 2007, MOL ECOL, V16, P2436, DOI 10.1111/j.1365-294X.2007.03291.x; Jebali A, 2008, THESIS MUSEUM NATURA; Ruiz-Lopez MJ, 2012, CONSERV BIOL, V26, P1121, DOI 10.1111/j.1523-1739.2012.01916.x; Kephart SR, 2004, CONSERV GENET, V5, P49, DOI 10.1023/B:COGE.0000014056.65197.c4; Kingdon J, 2013, MAMMALS AFRICA, VIV; Latta RG, 2008, EVOL APPL, V1, P84, DOI 10.1111/j.1752-4571.2007.00008.x; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Lerp H, 2011, ORG DIVERS EVOL, V11, P317, DOI 10.1007/s13127-011-0057-z; Malbrant R., 1952, FAUNE CTR AFRICAIN F; Mullen LM, 2008, EVOLUTION, V62, P1555, DOI 10.1111/j.1558-5646.2008.00425.x; Mungall C, 2007, EXOTIC ANIMAL FIELD; Nei M., 1987, MOL EVOLUTIONARY GEN; Newby J., 2008, IUCN 2012 IUCN RED L; Newby J. E., 1978, ECOLOGICAL RESOURCES; Newby JE, 1984, SAHARA DESERT; NOMBELA JJA, 1990, Z SAUGETIERKD, V55, P194; Nsubuga AM, 2010, CONSERV GENET, V11, P161, DOI 10.1007/s10592-009-0015-x; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Petric A, 2012, AZA N AM REGIONAL ST; RALLS K, 1983, GENETICS CONSERVATIO; Rietkerk F, 2008, EAZA NEWS, V64, P12; Ronquist F, 2010, ANNU REV ENTOMOL, V55, P189, DOI 10.1146/annurev.ento.54.110807.090529; RZSS & IUCN Antelope Specialist Group, 2014, DAM GAZ NANG DAM CON; Schmutz SM, 2007, ANIM GENET, V38, P539, DOI 10.1111/j.1365-2052.2007.01664.x; Scholte P, 2013, MAMMALS AFRICA, P382; Sgro CM, 2011, EVOL APPL, V4, P326, DOI 10.1111/j.1752-4571.2010.00157.x; Simons ND, 2013, ECOL EVOL, V3, P80, DOI 10.1002/ece3.422; Spottiswoode C, 2004, P ROY SOC B-BIOL SCI, V271, P267, DOI 10.1098/rspb.2003.2605; Stanley-Price M, 1989, ARABIAN ORYX OMAN; Swindell WR, 2005, EVOLUTION, V59, P2159, DOI 10.1111/j.0014-3820.2005.tb00925.x; Valverde JA, 2004, SAHARA GUINEA MARRUE; VASSART M, 1993, ANN GENET-PARIS, V36, P117; VASSART M, 1995, J HERED, V86, P216, DOI 10.1093/oxfordjournals.jhered.a111565; Verma SK, 2003, MOL ECOL NOTES, V3, P28, DOI 10.1046/j.1471-8286.2003.00340.x; Vilas C, 2006, CONSERV BIOL, V20, P229, DOI 10.1111/j.1523-1739.2005.00275.x; Weeks AR, 2011, EVOL APPL, V4, P709, DOI 10.1111/j.1752-4571.2011.00192.x; Wiesner H, 1998, NATURWISSENSCHAFTEN, V85, P553, DOI 10.1007/s001140050549; Witzenberger KA, 2013, MAMM BIOL, V78, P379, DOI 10.1016/j.mambio.2013.03.001; Zachos FE, 2013, MAMM BIOL, V78, P1, DOI 10.1016/j.mambio.2012.07.083	84	21	23	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e98693	10.1371/journal.pone.0098693	http://dx.doi.org/10.1371/journal.pone.0098693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956104	Green Published, gold, Green Submitted			2022-12-25	WOS:000338917900005
J	Yang, CH; Wang, HL; Lin, YS; Kumar, KPS; Lin, HC; Chang, CJ; Lu, CC; Huang, TT; Martel, J; Ojcius, DM; Chang, YS; Young, JD; Lai, HC				Yang, Chun-Hung; Wang, Hui-Ling; Lin, Yi-Sheng; Kumar, K. P. Shravan; Lin, Hung-Chi; Chang, Chih-Jung; Lu, Chia-Chen; Huang, Tsung-Teng; Martel, Jan; Ojcius, David M.; Chang, Yu-Sun; Young, John D.; Lai, Hsin-Chih			Identification of CD24 as a Cancer Stem Cell Marker in Human Nasopharyngeal Carcinoma (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							WNT/BETA-CATENIN PATHWAY; SIDE POPULATION CELLS; OVARIAN-CANCER; MESENCHYMAL TRANSITION; SELF-RENEWAL; BETA-CATENIN; EXPRESSION; OCT4; NANOG; LINES	Cancer stem cells (CSCs) represent a unique sub-population of tumor cells with the ability to initiate tumor growth and sustain self-renewal. Although CSC biomarkers have been described for various tumors, only a few markers have been identified for nasopharyngeal carcinoma (NPC). In this study, we show that CD24(+) cells isolated from human NPC cell lines express stem cell genes (Sox2, Oct4, Nanog, Bmi-1, and Rex-1), and show activation of the Wnt/beta-catenin signaling pathway. CD24(+) cells possess typical CSC characteristics that include enhanced cell proliferation, increased colony and sphere formation, maintenance of cell differentiation potential in prolonged culture, and enhanced resistance to chemotherapeutic drugs. Notably, CD24(+) cells produce tumors following inoculation of as few as 500 cells in immunodeficient NOD/SCID mice. CD24(+) cells further show increased invasion ability in vitro, which correlates with enhanced expression of matrix metalloproteinase 2 and 9. In summary, our results suggest that CD24 represents a novel CSC biomarker in NPC.	[Yang, Chun-Hung; Lin, Hung-Chi] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan, Taiwan; [Yang, Chun-Hung; Lin, Hung-Chi] Taiwan Agr Chem & Tox Subst Res Inst, Div Appl Toxicol, Council Agr, Taichung, Taiwan; [Wang, Hui-Ling; Lin, Yi-Sheng; Kumar, K. P. Shravan; Chang, Chih-Jung; Huang, Tsung-Teng; Lai, Hsin-Chih] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Wang, Hui-Ling; Lin, Yi-Sheng; Kumar, K. P. Shravan; Chang, Chih-Jung; Huang, Tsung-Teng; Lai, Hsin-Chih] Linkou Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan; [Chang, Chih-Jung] Chang Gung Univ, Coll Med, Dept Microbiol & Immunol, Taoyuan, Taiwan; [Lu, Chia-Chen] Fu Jen Catholic Univ, Dept Resp Therapy, Taipei, Taiwan; [Huang, Tsung-Teng; Martel, Jan; Ojcius, David M.; Young, John D.; Lai, Hsin-Chih] Chang Gung Univ, Coll Med, Ctr Mol & Clin Immunol, Taoyuan, Taiwan; [Huang, Tsung-Teng; Lai, Hsin-Chih] Chang Gung Univ, Coll Med, Res Ctr Bacterial Pathogenesis, Taoyuan, Taiwan; [Ojcius, David M.] Univ Calif Merced, Dept Mol Cell Biol, Merced, CA USA; [Ojcius, David M.] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA; [Chang, Yu-Sun] Chang Gung Univ, Coll Med, Mol Med Res Ctr, Taoyuan, Taiwan; [Young, John D.] Rockefeller Univ, Lab Cellular Physiol & Immunol, New York, NY 10021 USA; [Young, John D.] Ming Chi Univ Technol, Biochem Engn Res Ctr, Taipei, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Fu Jen Catholic University; Chang Gung University; Chang Gung University; University of California System; University of California Merced; University of California System; University of California Merced; Chang Gung University; Rockefeller University; Ming Chi University of Technology	Young, JD (corresponding author), Chang Gung Univ, Coll Med, Ctr Mol & Clin Immunol, Taoyuan, Taiwan.	dingeyoung@hotmail.com; hclai@mail.cgu.edu.tw	Ojcius, David/ABE-6557-2020	LAI, HSIN-CHIH/0000-0002-0605-5040; Martel, Jan/0000-0003-0879-109X; Chang, Yu-Sun/0000-0002-6457-3890; Ojcius, David/0000-0003-1461-4495	National Science Council of Taiwan [NSC101-2325-B-182-005, NSC101-2320-B-030-011]; Chang Gung Memorial Hospital (Linkou, Taiwan) [CMRPD1B0052]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital (Linkou, Taiwan)(Chang Gung Memorial Hospital)	This study was supported by grants NSC101-2325-B-182-005 and NSC101-2320-B-030-011 from the National Science Council of Taiwan, and grant CMRPD1B0052 from Chang Gung Memorial Hospital (Linkou, Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Aigner S, 1998, FASEB J, V12, P1241, DOI 10.1096/fasebj.12.12.1241; [Anonymous], 2010, CANCER REGISTRY ANNU; Assimakopoulos D, 2002, HISTOL HISTOPATHOL, V17, P1269, DOI 10.14670/HH-17.1269; Atlasi Y, 2007, INT J CANCER, V120, P1598, DOI 10.1002/ijc.22508; Ben-Shushan E, 1998, MOL CELL BIOL, V18, P1866, DOI 10.1128/MCB.18.4.1866; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Cai C, 2012, MOL MED REP, V5, P1191, DOI 10.3892/mmr.2012.802; Campbell PA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000553; Cao Su-Mei, 2011, Chin J Cancer, V30, P114; Cavard C, 2008, FUTURE ONCOL, V4, P647, DOI 10.2217/14796694.4.5.647; Chang JTC, 2004, J FORMOS MED ASSOC, V103, P496; Chu WK, 2013, CARCINOGENESIS, V34, P1497, DOI 10.1093/carcin/bgt104; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Correa S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-303; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; DeNittis AS, 2002, AM J CLIN ONCOL-CANC, V25, P93, DOI 10.1097/00000421-200202000-00020; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Eduardo B, 2010, EUR ARCH OTO-RHINO-L, V267, P1607, DOI 10.1007/s00405-010-1258-3; Facchino Sabrina, 2011, Cancers (Basel), V3, P1777, DOI 10.3390/cancers3021777; Gao MQ, 2010, ONCOGENE, V29, P2672, DOI 10.1038/onc.2010.35; Greenspan EJ, 2011, CANCER PREV RES, V4, P161, DOI 10.1158/1940-6207.CAPR-10-0021; Griend DJV, 2008, CANCER RES, V68, P9703, DOI 10.1158/0008-5472.CAN-08-3084; Guo D, 2012, ONCOL REP, V28, P241, DOI 10.3892/or.2012.1781; Guo Y, 2011, HISTOPATHOLOGY, V59, P763, DOI 10.1111/j.1365-2559.2011.03993.x; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Herzig M, 2007, ONCOGENE, V26, P2290, DOI 10.1038/sj.onc.1210029; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Hou WJ, 2014, EUR ARCH OTO-RHINO-L, V271, P171, DOI 10.1007/s00405-013-2517-x; Kim JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007166; Kim M, 2002, CLIN CANCER RES, V8, P22; Lanzkron SM, 1999, BLOOD, V93, P1916, DOI 10.1182/blood.V93.6.1916.406k15_1916_1921; Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liu AY, 2000, CANCER RES, V60, P3429; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lu J, 2003, CANCER RES, V63, P256; Luo WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056324; Mlarotta LLC, 2009, CURR OPIN GENET DEV, V19, P44, DOI 10.1016/j.gde.2008.12.003; Moriyama T, 2010, CANCER-AM CANCER SOC, V116, P3357, DOI 10.1002/cncr.25121; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Prosperi JR, 2010, CURR DRUG TARGETS, V11, P1074; Rattis FM, 2004, CURR OPIN HEMATOL, V11, P88, DOI 10.1097/01.moh.0000133649.61121.ec; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Su J, 2011, ARCH MED RES, V42, P15, DOI 10.1016/j.arcmed.2011.01.007; Suarez C, 2010, EUR ARCH OTO-RHINO-L, V267, P1811, DOI 10.1007/s00405-010-1385-x; Tang DG, 2012, CELL RES, V22, P457, DOI 10.1038/cr.2012.13; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; Wang S, 2013, FRONT BIOSCI-LANDMRK, V18, P447, DOI 10.2741/4113; Wang WJ, 2013, CANCER RES, V73, P1219, DOI 10.1158/0008-5472.CAN-12-1408; Wei XL, 2010, P NATL ACAD SCI USA, V107, P18874, DOI 10.1073/pnas.1012667107; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zhang Jian-Ting, 2007, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V32, P531; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; ZHANG XG, 1994, BLOOD, V83, P3654; Zhou G, 2007, HUM MUTAT, V28, P1091, DOI 10.1002/humu.20570	65	40	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99412	10.1371/journal.pone.0099412	http://dx.doi.org/10.1371/journal.pone.0099412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955581	gold, Green Published, Green Submitted			2022-12-25	WOS:000338917900010
J	Zander, KK; Ainsworth, GB; Meyerhoff, J; Garnett, ST				Zander, Kerstin K.; Ainsworth, Gillian B.; Meyerhoff, Juergen; Garnett, Stephen T.			Threatened Bird Valuation in Australia	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; CONTINGENT VALUATION; BIODIVERSITY CONSERVATION; ENVIRONMENTAL ATTITUDES; ECONOMIC VALUE; SERVICES; MOTIVATIONS; KNOWLEDGE; ECOSYSTEM; BENEFITS	Threatened species programs need a social license to justify public funding. A contingent valuation survey of a broadly representative sample of the Australian public found that almost two thirds (63%) supported funding of threatened bird conservation. These included 45% of a sample of 645 respondents willing to pay into a fund for threatened bird conservation, 3% who already supported bird conservation in another form, and 15% who could not afford to pay into a conservation fund but who nevertheless thought that humans have a moral obligation to protect threatened birds. Only 6% explicitly opposed such payments. Respondents were willing to pay about AUD 11 annually into a conservation fund (median value), including those who would pay nothing. Highest values were offered by young or middle aged men, and those with knowledge of birds and those with an emotional response to encountering an endangered bird. However, the prospect of a bird going extinct alarmed almost everybody, even most of those inclined to put the interests of people ahead of birds and those who resent the way threatened species sometimes hold up development. The results suggest that funding for threatened birds has widespread popular support among the Australian population. Conservatively they would be willing to pay about AUD 14 million per year, and realistically about AUD 70 million, which is substantially more than the AUD 10 million currently thought to be required to prevent Australian bird extinctions.	[Zander, Kerstin K.] Charles Darwin Univ, Northern Inst, Darwin, NT 0909, Australia; [Ainsworth, Gillian B.; Garnett, Stephen T.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Meyerhoff, Juergen] Tech Univ Berlin, Inst Landscape Architecture & Environm Planning, Berlin, Germany	Charles Darwin University; Charles Darwin University; Technical University of Berlin	Zander, KK (corresponding author), Charles Darwin Univ, Northern Inst, Darwin, NT 0909, Australia.	kerstin.zander@cdu.edu.au	Meyerhoff, Juergen/M-5640-2019; Ainsworth, Gill/P-3013-2019; Zander, Kerstin/M-2888-2013	Meyerhoff, Juergen/0000-0003-4333-8514; Ainsworth, Gill/0000-0003-0460-6563; Zander, Kerstin/0000-0002-2237-1801	Australian Research Council [LP0990395, DP09875528]; BLA Stuart Leslie Bird Research Award	Australian Research Council(Australian Research Council); BLA Stuart Leslie Bird Research Award	The research was undertaken under the aegis of Australian Research Council Linkage Grant LP0990395 and also benefited from Australian Research Council Discovery Grant DP09875528. The survey was funded by the BLA Stuart Leslie Bird Research Award 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics (ABS), 2012, CENS POP HOUS 2011 C; Baker Rick, 2014, ENV POLICY ANAL GUID; Balmford A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000144; BATEMAN I., 2002, EC VALUATION STATED; BirdLife Australia, 2013, VOL; BirdLife Australia, 2011, ANN REP 2011 BIRDLIF; Booth JE, 2011, BIOL CONSERV, V144, P2728, DOI 10.1016/j.biocon.2011.02.018; BOWKER JM, 1988, AM J AGR ECON, V70, P372, DOI 10.2307/1242078; Brouwer R, 2008, ECOL ECON, V64, P575, DOI 10.1016/j.ecolecon.2007.04.001; Bulte EH, 1999, ENVIRON RESOUR ECON, V14, P119, DOI 10.1023/A:1008309816658; CARSON RT, 1994, OXFORD ECON PAP, V46, P727, DOI 10.1093/oep/46.Supplement_1.727; Carson RT, 2005, HANDB ECON, V20, P821; Child D, 2006, ESSENTIALS FACTOR AN, V3rd; Daily GC, 2000, SCIENCE, V289, P395, DOI 10.1126/science.289.5478.395; Edwards P. E. T., 2011, Human Dimensions of Wildlife, V16, P435, DOI 10.1080/10871209.2011.608180; Fleming CM, 2009, J ENVIRON MANAGE, V90, P284, DOI 10.1016/j.jenvman.2007.09.011; Garnett S, 2003, BIOSCIENCE, V53, P658, DOI 10.1641/0006-3568(2003)053[0658:TCAEOF]2.0.CO;2; Garnett S. T., 2011, ACTION PLAN AUSTR BI; Gascoigne WR, 2011, ECOL ECON, V70, P1715, DOI 10.1016/j.ecolecon.2011.04.010; Haab T. C., 2002, VALUING ENV NATURAL; Hanemann W, 1999, VALUING ENV PREFEREN, P302; HANEMANN WM, 1984, AM J AGR ECON, V66, P332, DOI 10.2307/1240800; Heffelfinger James R., 2013, International Journal of Environmental Studies, V70, P399, DOI 10.1080/00207233.2013.800383; Hvenegaard Glen T., 2002, Human Dimensions of Wildlife, V7, P21, DOI 10.1080/108712002753574765; Hynes S, 2009, BIOL CONSERV, V142, P180, DOI 10.1016/j.biocon.2008.10.014; Jakobsson KM, 2001, ENVIRON RESOUR ECON, V19, P211, DOI 10.1023/A:1011128620388; Jeanty PW, 2007, N AM STAT US GROUP M, P8; Jin JJ, 2008, ECOL ECON, V68, P328, DOI 10.1016/j.ecolecon.2008.03.014; Johnson MD, 2010, ANIM CONSERV, V13, P140, DOI 10.1111/j.1469-1795.2009.00310.x; Kellert S.R., 1986, P50; Kotchen MJ, 2000, ECOL ECON, V32, P93, DOI 10.1016/S0921-8009(99)00069-5; KRINSKY I, 1986, REV ECON STAT, V68, P715, DOI 10.2307/1924536; Langford IH, 1998, ENVIRON RESOUR ECON, V12, P443, DOI 10.1023/A:1008286001085; Likert R., 1932, ARCH PSYCHOL, V140, P1, DOI DOI 10.1111/J.1540-5834.2010.00585.X; Lindhjem H, 2011, ECOL ECON, V70, P1628, DOI 10.1016/j.ecolecon.2011.04.002; Loehlin JC, 2004, LATENT VARIABLE MODE; Loomis J, 1998, ECOL ECON, V27, P29, DOI 10.1016/S0921-8009(97)00126-2; Loomis JB, 1996, ECOL ECON, V18, P197, DOI 10.1016/0921-8009(96)00029-8; Loureiro ML, 2008, ECOL ECON, V68, P362, DOI 10.1016/j.ecolecon.2008.04.002; Martin-Lopez B, 2008, CONSERV BIOL, V22, P624, DOI 10.1111/j.1523-1739.2008.00921.x; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; McCarthy MA, 2008, J APPL ECOL, V45, P1428, DOI 10.1111/j.1365-2664.2008.01521.x; MCFARLANE BL, 1994, WILDLIFE SOC B, V22, P361; Meyerhoff J, 2006, ECOL ECON, V57, P583, DOI 10.1016/j.ecolecon.2005.04.021; Meyerhoff J, 2012, ENVIRON SCI POLICY, V23, P109, DOI 10.1016/j.envsci.2012.07.020; Millennium Ecosystem Assessment (MA), 2005, EC HUM WELLB ASS SER; Mitchell Robert Cameron, 1989, USING SURVEY VALUE P; Morrison MD, 2000, ENVIRON RESOUR ECON, V16, P407, DOI 10.1023/A:1008368611972; Ojea E, ECOL EC, V63, P807; Olsen SB, 2009, ENVIRON RESOUR ECON, V44, P591, DOI 10.1007/s10640-009-9303-7; Possingham HP, 2013, SUBMISSION SENATE CO; Prescott-Allen C., 1986, 1 RESOURCE WILD SPEC; RUBIN J, 1991, J FOREST, V89, P25; Sax LJ, 2003, RES HIGH EDUC, V44, P409, DOI 10.1023/A:1024232915870; Sekercioglu CH, 2002, ENVIRON CONSERV, V29, P282, DOI 10.1017/S0376892902000206; Smith VK, 2006, HANDBOOK ON CONTINGENT VALUATION, P7; Spash CL, 2000, ENVIRON SCI TECHNOL, V34, P1433, DOI 10.1021/es990729b; Wenny DG, 2011, AUK, V128, P1, DOI 10.1525/auk.2011.10248; Wilson C, 2005, BIRD CONSERV INT, V15, P225, DOI 10.1017/S0959270905000419; Wilson C, 2007, CONTEMP ECON POLICY, V25, P226, DOI 10.1111/j.1465-7287.2006.00021.x; Wray-Lake L, 2010, ENVIRON BEHAV, V42, P61, DOI 10.1177/0013916509335163; Zander KK, 2014, CONSERV SOC, V12, P27, DOI 10.4103/0972-4923.132126; Zander KK, 2013, ECOL ECON, V93, P219, DOI 10.1016/j.ecolecon.2013.06.002	63	24	25	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100411	10.1371/journal.pone.0100411	http://dx.doi.org/10.1371/journal.pone.0100411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL1WV	24955957	gold, Green Submitted, Green Published			2022-12-25	WOS:000338917900049
J	Delgado, AG; Kang, DW; Nelson, KG; Fajardo-Williams, D; Miceli, JF; Done, HY; Popat, SC; Krajmalnik-Brown, R				Delgado, Anca G.; Kang, Dae-Wook; Nelson, Katherine G.; Fajardo-Williams, Devyn; Miceli, Joseph F., III; Done, Hansa Y.; Popat, Sudeep C.; Krajmalnik-Brown, Rosa			Selective Enrichment Yields Robust Ethene-Producing Dechlorinating Cultures from Microcosms Stalled at cis-Dichloroethene	PLOS ONE			English	Article							REDUCTIVE DEHALOGENASE GENES; DEHALOCOCCOIDES SP STRAIN; 16S RIBOSOMAL-RNA; POLYMERASE-CHAIN-REACTION; VINYL-CHLORIDE REDUCTASE; MICROBIAL COMMUNITY; CONTAMINATED GROUNDWATER; MOLECULAR TECHNIQUES; BACTERIAL COMMUNITY; ELECTRON-ACCEPTORS	Dehalococcoides mccartyi strains are of particular importance for bioremediation due to their unique capability of transforming perchloroethene (PCE) and trichloroethene (TCE) to non-toxic ethene, through the intermediates cis-dichloroethene (cis-DCE) and vinyl chloride (VC). Despite the widespread environmental distribution of Dehalococcoides, biostimulation sometimes fails to promote dechlorination beyond cis-DCE. In our study, microcosms established with garden soil and mangrove sediment also stalled at cis-DCE, albeit Dehalococcoides mccartyi containing the reductive dehalogenase genes tceA, vcrA and bvcA were detected in the soil/sediment inocula. Reductive dechlorination was not promoted beyond cis-DCE, even after multiple biostimulation events with fermentable substrates and a lengthy incubation. However, transfers from microcosms stalled at cis-DCE yielded dechlorination to ethene with subsequent enrichment cultures containing up to 10(9) Dehalococcoides mccartyi cells mL(-1). Proteobacterial classes which dominated the soil/sediment communities became undetectable in the enrichments, and methanogenic activity drastically decreased after the transfers. We hypothesized that biostimulation of Dehalococcoides in the cis-DCE-stalled microcosms was impeded by other microbes present at higher abundances than Dehalococcoides and utilizing terminal electron acceptors from the soil/sediment, hence, outcompeting Dehalococcoides for H-2. In support of this hypothesis, we show that garden soil and mangrove sediment microcosms bioaugmented with their respective cultures containing Dehalococcoides in high abundance were able to compete for H2 for reductive dechlorination from one biostimulation event and produced ethene with no obvious stall. Overall, our results provide an alternate explanation to consolidate conflicting observations on the ubiquity of Dehalococcoides mccartyi and occasional stalling of dechlorination at cis-DCE; thus, bringing a new perspective to better assess biological potential of different environments and to understand microbial interactions governing bioremediation.	[Delgado, Anca G.; Kang, Dae-Wook; Nelson, Katherine G.; Fajardo-Williams, Devyn; Miceli, Joseph F., III; Done, Hansa Y.; Popat, Sudeep C.; Krajmalnik-Brown, Rosa] Arizona State Univ, Biodesign Inst, Swette Ctr Environm Biotechnol, Tempe, AZ 85287 USA; [Krajmalnik-Brown, Rosa] Arizona State Univ, Sch Sustainable Engn & Built Environm, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Krajmalnik-Brown, R (corresponding author), Arizona State Univ, Biodesign Inst, Swette Ctr Environm Biotechnol, Tempe, AZ 85287 USA.	Dr.Rosy@asu.edu	Krajmalnik-Brown, Rosa/AAA-4803-2021; Kang, Dae-Wook/AAP-3589-2020; Delgado, Anca G/K-1924-2012	Kang, Dae-Wook/0000-0002-2585-1974; Magee, Hansa Y./0000-0001-5746-0823; Delgado, Anca/0000-0002-9354-0246; Krajmalnik-Brown, Rosa/0000-0001-6064-3524	National Science Foundation (NSF) CAREER Award [1053939]; Directorate For Engineering [1053939] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM099650] Funding Source: NIH RePORTER	National Science Foundation (NSF) CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation (NSF) CAREER Award number 1053939. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian L, 2000, NATURE, V408, P580, DOI 10.1038/35046063; Adrian L, 2007, ENVIRON SCI TECHNOL, V41, P2318, DOI 10.1021/es062076m; Aulenta F, 2008, PROCESS BIOCHEM, V43, P161, DOI 10.1016/j.procbio.2007.11.006; Aulenta F, 2007, WATER RES, V41, P27, DOI 10.1016/j.watres.2006.09.019; Aziz CE, 2013, SERDP ESTCP REMEDIAT, P141, DOI 10.1007/978-1-4614-4115-1_5; Azizian MF, 2008, J CONTAM HYDROL, V100, P11, DOI 10.1016/j.jconhyd.2008.04.006; Badalamenti JP, 2013, BIOTECHNOL BIOENG, V110, P1020, DOI 10.1002/bit.24779; Berggren DRV, 2013, ENVIRON SCI TECHNOL, V47, P1879, DOI 10.1021/es304244z; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cupples AM, 2003, APPL ENVIRON MICROB, V69, P953, DOI 10.1128/AEM.69.2.953-959.2003; Delgado AG, 2014, APPL MICROBIOL BIOT, V98, P2729, DOI 10.1007/s00253-013-5263-5; Delgado AG, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-128; DISTEFANO TD, 1991, APPL ENVIRON MICROB, V57, P2287, DOI 10.1128/AEM.57.8.2287-2292.1991; Duhamel M, 2002, WATER RES, V36, P4193, DOI 10.1016/S0043-1354(02)00151-3; Ekre R, 2014, GROUND WATER MONIT R, V34, P61, DOI 10.1111/gwmr.12049; Ellis DE, 2000, ENVIRON SCI TECHNOL, V34, P2254, DOI 10.1021/es990638e; Fennell DE, 1998, ENVIRON SCI TECHNOL, V32, P2450, DOI 10.1021/es980136l; Fennell DE, 1997, ENVIRON SCI TECHNOL, V31, P918, DOI 10.1021/es960756r; Fennell DE, 2001, ENVIRON SCI TECHNOL, V35, P1830, DOI 10.1021/es0016203; Futagami T, 2009, APPL ENVIRON MICROB, V75, P6905, DOI 10.1128/AEM.01124-09; Hansel CM, 2008, APPL ENVIRON MICROB, V74, P1620, DOI 10.1128/AEM.01787-07; Harkness MR, 1999, ENVIRON SCI TECHNOL, V33, P1100, DOI 10.1021/es9807690; He J, 2005, ENVIRON MICROBIOL, V7, P1442, DOI 10.1111/j.1462-2920.2005.00830.x; He JZ, 2003, NATURE, V424, P62, DOI 10.1038/nature01717; Holmes VF, 2006, APPL ENVIRON MICROB, V72, P5877, DOI 10.1128/AEM.00516-06; Hug LA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0322; Kang DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068322; Kittelmann S, 2008, ENVIRON MICROBIOL, V10, P31, DOI 10.1111/j.1462-2920.2007.01427.x; Kotsyurbenko OR, 2001, FEMS MICROBIOL ECOL, V38, P153, DOI 10.1111/j.1574-6941.2001.tb00893.x; Krajmalnik-Brown R, 2004, APPL ENVIRON MICROB, V70, P6347, DOI 10.1128/AEM.70.10.6347-6351.2004; Krzmarzick MJ, 2012, APPL ENVIRON MICROB, V78, P393, DOI 10.1128/AEM.06510-11; Lendvay JM, 2003, ENVIRON SCI TECHNOL, V37, P1422, DOI 10.1021/es025985u; Loffler FE, 2013, INT J SYST EVOL MICR, V63, P625, DOI 10.1099/ijs.0.034926-0; Loffler FE, 2005, METHOD ENZYMOL, V397, P77, DOI 10.1016/S0076-6879(05)97005-5; Loffler FE, 2000, APPL ENVIRON MICROB, V66, P1369, DOI 10.1128/AEM.66.4.1369-1374.2000; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Magnuson JK, 2000, APPL ENVIRON MICROB, V66, P5141, DOI 10.1128/AEM.66.12.5141-5147.2000; Major DW, 2002, ENVIRON SCI TECHNOL, V36, P5106, DOI 10.1021/es0255711; May HD, 2008, APPL ENVIRON MICROB, V74, P2089, DOI 10.1128/AEM.01450-07; MaymoGatell X, 1997, SCIENCE, V276, P1568, DOI 10.1126/science.276.5318.1568; Miceli JF, 2012, ENVIRON SCI TECHNOL, V46, P10349, DOI 10.1021/es301902h; Moe WM, 2009, INT J SYST EVOL MICR, V59, P2692, DOI 10.1099/ijs.0.011502-0; Muller JA, 2004, APPL ENVIRON MICROB, V70, P4880, DOI 10.1128/AEM.70.8.4880-4888.2004; Ontiveros-Valencia A, 2013, FEMS MICROBIOL ECOL, V85, P158, DOI 10.1111/1574-6941.12107; Parameswaran P, 2011, BIORESOURCE TECHNOL, V102, P263, DOI 10.1016/j.biortech.2010.03.133; Parameswaran P, 2010, BIOTECHNOL BIOENG, V105, P69, DOI 10.1002/bit.22508; Richardson RE, 2002, ENVIRON SCI TECHNOL, V36, P2652, DOI 10.1021/es0157797; Ritalahti KM, 2006, APPL ENVIRON MICROB, V72, P2765, DOI 10.1128/AEM.72.4.2765-2774.2006; Schaefer CE, 2009, CHEMOSPHERE, V75, P141, DOI 10.1016/j.chemosphere.2008.12.041; Shani N, 2013, ENVIRON SCI TECHNOL, V47, P6836, DOI 10.1021/es304017s; Sleep BE, 2006, ENVIRON SCI TECHNOL, V40, P3623, DOI 10.1021/es051493g; Smatlak CR, 1996, ENVIRON SCI TECHNOL, V30, P2850, DOI 10.1021/es9602455; Stroo HF, 2013, SERDP ESTCP REMEDIAT, P117, DOI 10.1007/978-1-4614-4115-1_4; Sung Y, 2006, APPL ENVIRON MICROB, V72, P2775, DOI 10.1128/AEM.72.4.2775-2782.2006; Tas N, 2010, MICROB BIOTECHNOL, V3, P389, DOI 10.1111/j.1751-7915.2009.00147.x; Vainberg S, 2009, J IND MICROBIOL BIOT, V36, P1189, DOI 10.1007/s10295-009-0600-5; van der Zaan B, 2010, APPL ENVIRON MICROB, V76, P843, DOI 10.1128/AEM.01482-09; Van Trump JI, 2011, MBIO, V2, DOI 10.1128/mBio.00044-11; Wang SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059178; Wolcott RD, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-226; Yang YR, 1998, ENVIRON SCI TECHNOL, V32, P3591, DOI 10.1021/es980363n; Yu SH, 2005, ENVIRON SCI TECHNOL, V39, P195, DOI 10.1021/es0496773; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347; Ziv-El M, 2012, BIOTECHNOL BIOENG, V109, P2230, DOI 10.1002/bit.24504; Ziv-El M, 2012, BIOTECHNOL BIOENG, V109, P2200, DOI 10.1002/bit.24487; Ziv-El M, 2012, APPL MICROBIOL BIOT, V95, P273, DOI 10.1007/s00253-012-4161-6; Ziv-El M, 2011, APPL MICROBIOL BIOT, V92, P1063, DOI 10.1007/s00253-011-3388-y	68	25	28	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100654	10.1371/journal.pone.0100654	http://dx.doi.org/10.1371/journal.pone.0100654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950250	Green Published, Green Submitted, gold			2022-12-25	WOS:000338276300103
J	Gonzalez, AD; Matta, NE; Ellis, VA; Miller, ET; Ricklefs, RE; Gutierrez, HR				Gonzalez, Angie D.; Matta, Nubia E.; Ellis, Vincenzo A.; Miller, Eliot T.; Ricklefs, Robert E.; Rafael Gutierrez, H.			Mixed Species Flock, Nest Height, and Elevation Partially Explain Avian Haemoparasite Prevalence in Colombia	PLOS ONE			English	Article							BLOOD PARASITES; COSTA-RICA; EMBRYONIC-DEVELOPMENT; NEOTROPICAL SAVANNA; PHYLOGENETIC SIGNAL; MALARIA PARASITES; GEOGRAPHIC RANGE; PASSERINE BIRDS; CLIFF SWALLOW; DISEASE RISK	The high avian biodiversity present in the Neotropical region offers a great opportunity to explore the ecology of host-parasite relationships. We present a survey of avian haemoparasites in a megadiverse country and explore how parasite prevalences are related to physical and ecological host characteristics. Using light microscopy, we documented the presence of haemoparasites in over 2000 individuals belonging to 246 species of wild birds, from nine localities and several ecosystems of Colombia. We analysed the prevalence of six avian haemoparasite taxa in relation to elevation and the following host traits: nest height, nest type, foraging strata, primary diet, sociality, migratory behaviour, and participation in mixed species flocks. Our analyses indicate significant associations between both mixed species flocks and nest height and Haemoproteus and Leucocytozoon prevalence. The prevalence of Leucocytozoon increased with elevation, whereas the prevalence of Trypanosoma and microfilariae decreased. Plasmodium and Haemoproteus prevalence did not vary significantly with elevation; in fact, both parasites were found up to 3300m above sea level. The distribution of parasite prevalence across the phylogeny of bird species included in this study showed little host phylogenetic signal indicating that infection rates in this system are evolutionarily labile. Vector distribution as well as the biology of transmission and the maintenance of populations of avian haemoparasites deserve more detailed study in this system.	[Gonzalez, Angie D.; Matta, Nubia E.; Rafael Gutierrez, H.] Univ Nacl Colombia, Dept Biol, Bogota, Colombia; [Ellis, Vincenzo A.; Miller, Eliot T.; Ricklefs, Robert E.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA	Universidad Nacional de Colombia; University of Missouri System; University of Missouri Saint Louis	Gonzalez, AD (corresponding author), Univ Nacl Colombia, Dept Biol, Bogota, Colombia.	adgonzalezg@unal.edu.co	Matta, Nubia E/G-3621-2011	Matta, Nubia E/0000-0003-1775-0804	Departamento Administrativo de Ciencia, Tecnologia e Innovacion COLCIENCIAS [359]; Division de Investigacion Sede Bogota of the Universidad Nacional de Colombia [7509, 14456]; Jardin Botanico Jose Celestino Mutis Bogota; program Estimulos a la investigacion Thomas van der Hammen	Departamento Administrativo de Ciencia, Tecnologia e Innovacion COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Division de Investigacion Sede Bogota of the Universidad Nacional de Colombia; Jardin Botanico Jose Celestino Mutis Bogota; program Estimulos a la investigacion Thomas van der Hammen	This work was partially supported by Departamento Administrativo de Ciencia, Tecnologia e Innovacion COLCIENCIAS contract no. 359, Division de Investigacion Sede Bogota of the Universidad Nacional de Colombia project no. 7509 and no. 14456, and Jardin Botanico Jose Celestino Mutis Bogota with the program Estimulos a la investigacion Thomas van der Hammen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbelaez-Cortes E, 2011, REV MEX BIODIVERS, V82, P639; BASTO NATALIA, 2006, Caldasia, V28, P371; Benedikt V, 2009, ACTA PARASITOL, V54, P197, DOI 10.2478/s11686-009-0043-1; Bennett G. F., 1980, Memorias do Instituto Oswaldo Cruz, Brazil, V75, P117; BENNETT G F, 1976, Journal of Wildlife Diseases, V12, P454; BENNETT GF, 1992, CAN J ZOOL, V70, P188, DOI 10.1139/z92-028; BENNETT GF, 1991, J PARASITOL, V77, P207, DOI 10.2307/3283083; Berkunsky I, 2005, ORNITOL NEOTROP, V16, P573; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Buckland ST, 1997, BIOMETRICS, V53, P603, DOI 10.2307/2533961; Buehler DM, 2008, PHILOS T R SOC B, V363, P247, DOI 10.1098/rstb.2007.2138; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Calcagano V, 2013, GLMULTIMODEL SELECTI; Cerny O, 2011, MED VET ENTOMOL, V25, P104, DOI 10.1111/j.1365-2915.2010.00875.x; Cooper N, 2010, J EVOLUTION BIOL, V23, P2529, DOI 10.1111/j.1420-9101.2010.02144.x; Ellis TM, 2004, AVIAN PATHOL, V33, P405, DOI 10.1080/03079450410001724012; Fecchio A, 2013, PARASITOLOGY, V140, P181, DOI 10.1017/S0031182012001412; Fecchio A, 2011, EMU, V111, P132, DOI 10.1071/MU10063; Fecchio Alan, 2007, Neotropical Biology and Conservation, V2, P127; Felsenstein J, 2008, AM NAT, V171, P713, DOI 10.1086/587525; FOSTER WA, 1968, J MED ENTOMOL, V5, P488, DOI 10.1093/jmedent/5.4.488; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; GABALDON A., 1974, Boletin de la Direccion de Malariologia y Saneamiento Ambiental, V14, P80; Gabaldon A., 1975, Boletin de la Direccion de Malariologia y Saneamiento Ambiental, V15, P73; Garvin MC, 2003, J WILDLIFE DIS, V39, P170, DOI 10.7589/0090-3558-39.1.170; GREGORY RD, 1990, FUNCT ECOL, V4, P645, DOI 10.2307/2389732; GREINER EC, 1975, CAN J ZOOL, V53, P1762, DOI 10.1139/z75-211; Hansen TF, 2012, SYST BIOL, V61, P413, DOI 10.1093/sysbio/syr122; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Harmon LJ, 2010, EVOLUTION, V64, P2385, DOI 10.1111/j.1558-5646.2010.01025.x; Hilty SL, 1986, GUIDE BIRDS COLOMBIA; Instituto Humboldt Colombia, 2013, COL WORLD DIV SPEC C; Ives AR, 2007, SYST BIOL, V56, P252, DOI 10.1080/10635150701313830; Jenkins T, 2012, EVOLUTION, V66, P740, DOI 10.1111/j.1558-5646.2011.01470.x; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Johnson PTJ, 2012, ECOL LETT, V15, P235, DOI 10.1111/j.1461-0248.2011.01730.x; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; LaPointe DA, 2010, J PARASITOL, V96, P318, DOI 10.1645/GE-2290.1; Latta SC, 2010, J AVIAN BIOL, V41, P25, DOI 10.1111/j.1600-048X.2009.04685.x; Lee KA, 2008, J ANIM ECOL, V77, P356, DOI 10.1111/j.1365-2656.2007.01347.x; Levin II, 2013, CONSERV BIOL, V27, P1366, DOI 10.1111/cobi.12127; Lindenfors P, 2007, GLOBAL ECOL BIOGEOGR, V16, P496, DOI 10.1111/j.1466-8238.2006.00301.x; Loiseau C, 2010, J PARASITOL, V96, P21, DOI 10.1645/GE-2123.1; Londono A, 2007, CARIBB J SCI, V43, P87; Martínez Omar, 2003, Ecología en Bolivia, V38, P99; Marzal A, 2005, OECOLOGIA, V142, P541, DOI 10.1007/s00442-004-1757-2; Matta NE, 2014, PARASITOL RES, V113, P457, DOI 10.1007/s00436-013-3675-x; Merino S, 2008, AUSTRAL ECOL, V33, P329, DOI 10.1111/j.1442-9993.2008.01820.x; Moller AP, 2009, BIOL REV, V84, P567, DOI 10.1111/j.1469-185X.2009.00087.x; Moller AP, 2007, ECOLOGY, V88, P871, DOI 10.1890/06-0747; MORSE DH, 1977, BIOSCIENCE, V27, P332, DOI 10.2307/1297632; MOYNIHAN M., 1962, SMITHSONIAN MIS COLLECTIONS, V143, P1; Munkemuller T, 2012, METHODS ECOL EVOL, V3, P743, DOI 10.1111/j.2041-210X.2012.00196.x; Oniki Y, 2002, MEM I OSWALDO CRUZ, V97, P597, DOI 10.1590/S0074-02762002000400027; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pennycott TW, 2002, VET REC, V151, P563, DOI 10.1136/vr.151.19.563; POULIN R, 1991, CONDOR, V93, P418, DOI 10.2307/1368958; Powell G.V., 1985, ORNITH MONOGR, V36, P713, DOI DOI 10.2307/40168313; Raberg L, 1998, P ROY SOC B-BIOL SCI, V265, P1637, DOI 10.1098/rspb.1998.0482; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Remsen JVJ, 2012, CLASSIFICATION BIRD; Ribeiro SF, 2005, PARASITOLOGY, V130, P261, DOI 10.1017/S0031182004006596; Ricklefs RE, 2004, SYST BIOL, V53, P111, DOI 10.1080/10635150490264987; RICKLEFS RE, 1992, P NATL ACAD SCI USA, V89, P4722, DOI 10.1073/pnas.89.10.4722; Rifkin JL, 2012, AM NAT, V180, P70, DOI 10.1086/666081; Rodriguez OA, 2001, MEM I OSWALDO CRUZ, V96, P1173, DOI 10.1590/S0074-02762001000800026; RODRIGUEZ Q., 2003, ALETEO, V9, P1; Salaman P, 2009, CONSERVACION COLOMBI, V8, P1; Scheuerlein A, 2004, P ROY SOC B-BIOL SCI, V271, P1363, DOI 10.1098/rspb.2004.2726; Sebaio F, 2012, REV BRAS PARASITOL V, V21, P7, DOI 10.1590/S1984-29612012000100003; Silveira P, 2010, J WILDLIFE DIS, V46, P1305, DOI 10.7589/0090-3558-46.4.1305; SOUSA OE, 1982, J WILDLIFE DIS, V18, P205, DOI 10.7589/0090-3558-18.2.205; Swanson DA, 2012, MED VET ENTOMOL, V26, P56, DOI 10.1111/j.1365-2915.2011.00963.x; Swanson DA, 2010, MED VET ENTOMOL, V24, P182, DOI 10.1111/j.1365-2915.2010.00862.x; Tella JL, 1999, P NATL ACAD SCI USA, V96, P1785, DOI 10.1073/pnas.96.4.1785; Valkiunas G, 2004, J WILDLIFE DIS, V40, P555, DOI 10.7589/0090-3558-40.3.555; Valkiunas G, 2003, J WILDLIFE DIS, V39, P445, DOI 10.7589/0090-3558-39.2.445; Valkiunas G, 2009, J PARASITOL, V95, P1512, DOI 10.1645/GE-2105.1; van Rooyen J, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-139; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; WHITE EM, 1978, REV BIOL TROP, V26, P43; WOODWORTHLYNAS CB, 1989, MEM I OSWALDO CRUZ, V84, P515, DOI 10.1590/S0074-02761989000400009; YOUNG BE, 1993, J WILDLIFE DIS, V29, P555, DOI 10.7589/0090-3558-29.4.555; Zamora-Vilchis I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039208	84	53	54	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100695	10.1371/journal.pone.0100695	http://dx.doi.org/10.1371/journal.pone.0100695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950223	Green Published, gold			2022-12-25	WOS:000338276300110
J	Hu, XS; Yeh, FC				Hu, Xin-Sheng; Yeh, Francis C.			Assessing Postzygotic Isolation Using Zygotic Disequilibria in Natural Hybrid Zones	PLOS ONE			English	Article							COMPLEX ALLOZYME POLYMORPHISMS; LINKAGE DISEQUILIBRIUM; GENE FLOW; SPECIATION; SELECTION; ADAPTATION; EVOLUTION; DYNAMICS; PATTERNS; GENOMICS	Hybrid zones as windows on evolutionary processes provide a natural laboratory for studying the genetic basis and mechanisms of postzygotic isolation. One resultant pattern in hybrid zones is the Hardy-Weinberg disequilibrium (HWD) for a single locus or the linkage disequilibrium (LD) for multiple loci produced by natural selection against hybrids. However, HWD and the commonly used low-order gametic or composite digenic LD cannot fully reflect the pattern of the high-order genotypic interactions. Here we propose the use of zygotic LD to elucidate the selection mechanisms of postzygotic isolation, and its calculation is based on genotypic frequencies only, irrespective of the type of mating system. We numerically and analytically show that the maximum composite digenic LD is always greater than the maximum absolute zygotic LD under the linear-additive selection, but is comparable to or smaller than the maximum absolute zygotic LD under the strong epistatic selection. Selection mechanisms can be inferred by testing such differences. We analyze a previously reported mouse hybrid zone assayed with genome-wide SNPs, and confirm that the composite digenic LD cannot appropriately indicate all possible significant genotypic interactions for a given SNP pair. A large proportion of significant zygotic LDs, similar to 75% in general in the mouse hybrid zone, cannot be revealed from the composite digenic LD analysis. Statistical tests indicate that epistatic selection occurred among multiple loci in the mouse hybrid zone. The results highlight that the joint patterns of the composite digenic and zygotic LDs can help to elucidate the selection mechanism that is potentially involved in postzygotic isolation.	[Hu, Xin-Sheng] Univ Oxford, Dept Plant Sci, Oxford, England; [Yeh, Francis C.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada	University of Oxford; University of Alberta	Hu, XS (corresponding author), Univ Oxford, Dept Plant Sci, Oxford, England.	xin-sheng.hu@plants.ox.ac.uk						[Anonymous], 1953, ANN REP NATL I GENET, DOI DOI 10.1023/A:1003933603879; ARNOLD J, 1993, ANNU REV ECOL SYST, V24, P521, DOI 10.1146/annurev.es.24.110193.002513; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; AVERY PJ, 1979, GENETICS, V91, P817; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; BARTON NH, 1989, NATURE, V341, P497, DOI 10.1038/341497a0; BARTON NH, 1979, HEREDITY, V43, P341, DOI 10.1038/hdy.1979.87; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Barton NH, 2000, GENET RES, V75, P179, DOI 10.1017/S0016672399004334; Barton NH, 1993, HYBRID ZONES EVOLUTI, P13, DOI DOI 10.1111/J.1558-5646.2009.00849.X; BENNETT J. H., 1956, HEREDITY, V10, P51, DOI 10.1038/hdy.1956.3; BULMER MG, 1971, AM NAT, V105, P201, DOI 10.1086/282718; COCKERHAM CC, 1973, THEOR POPUL BIOL, V4, P300, DOI 10.1016/0040-5809(73)90013-0; Corbett-Detig RB, 2013, NATURE, V504, P135, DOI 10.1038/nature12678; Coyne JA, 2004, SPECIATION, V37; Cucchi T, 2005, BIOL J LINN SOC, V84, P429, DOI 10.1111/j.1095-8312.2005.00445.x; Dobzhansky T., 1937; Ellegren H, 2012, NATURE, V491, P756, DOI 10.1038/nature11584; Endler J.A., 1977, Monographs in Population Biology, pi; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; Ennos RA, 1999, SYST ASSOC SPEC VOL, V57, P1; Feder JL, 2012, TRENDS GENET, V28, P342, DOI 10.1016/j.tig.2012.03.009; Gavrilets S, 1997, EVOLUTION, V51, P1027, DOI 10.2307/2411031; Gavrilets S., 2004, FITNESS LANDSCAPE OR; HALDANE JBS, 1950, ANN EUGENIC, V15, P15, DOI 10.1111/j.1469-1809.1949.tb02418.x; HALDANE JBS, 1948, J GENET, V48, P277, DOI 10.1007/BF02986626; Harrison R.G., 1990, Oxford Surveys in Evolutionary Biology, V7, P69; Harrison RG, 1997, EVOLUTION, V51, P493, DOI 10.1111/j.1558-5646.1997.tb02437.x; Hu XS, 2008, EVOLUTION, V62, P2260, DOI 10.1111/j.1558-5646.2008.00439.x; Hu XS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080538; Hu XS, 2011, CURR GENOMICS, V12, P55, DOI 10.2174/138920211794520141; Hu XS, 2005, THEOR POPUL BIOL, V68, P119, DOI 10.1016/j.tpb.2005.02.003; Jameson DL, 1977, BENCHMARK PAPERS GEN; Jiang Q, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-65; Kruuk LEB, 1999, GENETICS, V153, P1959; Lee Y, 2013, P NATL ACAD SCI USA, V110, P19854, DOI 10.1073/pnas.1316851110; Li CC, 1976, 1 COURSE POPULATION; Mackay TFC, 2014, NAT REV GENET, V15, P22, DOI 10.1038/nrg3627; MALLET J, 1990, GENETICS, V124, P921; Martin SH, 2013, GENOME RES, V23, P1817, DOI 10.1101/gr.159426.113; Mayr E., 1979, ANIMAL SPECIES EVOLU; Muller HJ, 1942, BIOL S, V6, P71; OHTA T, 1980, GENET RES, V36, P181, DOI 10.1017/S0016672300019790; Orr HA, 2005, P NATL ACAD SCI USA, V102, P6522, DOI 10.1073/pnas.0501893102; PRESS WH, 1991, NUMERICAL RECIPES C; Rieseberg LH, 1999, GENETICS, V152, P713; Servedio MR, 2009, HEREDITY, V102, P51, DOI 10.1038/hdy.2008.98; Teeter KC, 2008, GENOME RES, V18, P67, DOI 10.1101/gr.6757907; Wang LY, 2011, MOL ECOL, V20, P2985, DOI 10.1111/j.1365-294X.2011.05148.x; Wang Z, 2010, P 9 WORLD C GEN APPL; WEIR BS, 1974, GENETICS, V78, P911; WEIR BS, 1972, GENETICS, V72, P505; WEIR BS, 1973, GENET RES, V21, P247, DOI 10.1017/S0016672300013446; Weir BS, 1996, GENETIC DATA ANAL; Wu S, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1578; Yang RC, 2003, GENETICS, V165, P447; Yang RC, 2002, GENETICS, V161, P435; Zaykin DV, 2008, GENETICS, V180, P533, DOI 10.1534/genetics.108.089409; [No title captured]	59	3	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100568	10.1371/journal.pone.0100568	http://dx.doi.org/10.1371/journal.pone.0100568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950065	Green Published, Green Submitted, gold			2022-12-25	WOS:000338276300092
J	Martinez, RJ; Wu, CH; Beazley, MJ; Andersen, GL; Conrad, ME; Hazen, TC; Taillefert, M; Sobecky, PA				Martinez, Robert J.; Wu, Cindy H.; Beazley, Melanie J.; Andersen, Gary L.; Conrad, Mark E.; Hazen, Terry C.; Taillefert, Martial; Sobecky, Patricia A.			Microbial Community Responses to Organophosphate Substrate Additions in Contaminated Subsurface Sediments	PLOS ONE			English	Article							PLANT-GROWTH PROMOTION; IN-SITU BIOREDUCTION; PHOSPHATASE-ACTIVITY; URANIUM BIOMINERALIZATION; PHYLOGENETIC ANALYSIS; METHANOGENIC ARCHAEA; BACTERIAL DIVERSITY; REDUCED URANIUM; REDUCTION; REOXIDATION	Background: Radionuclide-and heavy metal-contaminated subsurface sediments remain a legacy of Cold War nuclear weapons research and recent nuclear power plant failures. Within such contaminated sediments, remediation activities are necessary to mitigate groundwater contamination. A promising approach makes use of extant microbial communities capable of hydrolyzing organophosphate substrates to promote mineralization of soluble contaminants within deep subsurface environments. Methodology/Principal Findings: Uranium-contaminated sediments from the U. S. Department of Energy Oak Ridge Field Research Center (ORFRC) Area 2 site were used in slurry experiments to identify microbial communities involved in hydrolysis of 10 mM organophosphate amendments [i.e., glycerol-2-phosphate (G2P) or glycerol-3-phosphate (G3P)] in synthetic groundwater at pH 5.5 and pH 6.8. Following 36 day (G2P) and 20 day (G3P) amended treatments, maximum phosphate (PO43-) concentrations of 4.8 mM and 8.9 mM were measured, respectively. Use of the PhyloChip 16S rRNA microarray identified 2,120 archaeal and bacterial taxa representing 46 phyla, 66 classes, 110 orders, and 186 families among all treatments. Measures of archaeal and bacterial richness were lowest under G2P (pH 5.5) treatments and greatest with G3P (pH 6.8) treatments. Members of the phyla Crenarchaeota, Euryarchaeota, Bacteroidetes, and Proteobacteria demonstrated the greatest enrichment in response to organophosphate amendments and the OTUs that increased in relative abundance by 2-fold or greater accounted for 9%-50% and 3%-17% of total detected Archaea and Bacteria, respectively. Conclusions/Significance: This work provided a characterization of the distinct ORFRC subsurface microbial communities that contributed to increased concentrations of extracellular phosphate via hydrolysis of organophosphate substrate amendments. Within subsurface environments that are not ideal for reductive precipitation of uranium, strategies that harness microbial phosphate metabolism to promote uranium phosphate precipitation could offer an alternative approach for in situ sequestration.	[Martinez, Robert J.; Beazley, Melanie J.; Sobecky, Patricia A.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Wu, Cindy H.; Andersen, Gary L.; Conrad, Mark E.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Hazen, Terry C.] Univ Tennessee, Dept Civil & Environm Engn, Knoxville, TN USA; [Taillefert, Martial] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA	University of Alabama System; University of Alabama Tuscaloosa; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Tennessee System; University of Tennessee Knoxville; University System of Georgia; Georgia Institute of Technology	Martinez, RJ (corresponding author), Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA.	rmartinez@ua.edu	Andersen, Gary/G-2792-2015; Hazen, Terry C/C-1076-2012; Conrad, Mark E/G-2767-2010; Beazley, Melanie J./R-5716-2019	Andersen, Gary/0000-0002-1618-9827; Hazen, Terry C/0000-0002-2536-9993; Conrad, Mark E/0000-0001-9509-7324; Beazley, Melanie J./0000-0001-9973-7798	Office of Science (BER), U.S. Department of Energy [DE-FG02-04ER63906, SC0002530];  [DE-AC02-05CH11231]	Office of Science (BER), U.S. Department of Energy(United States Department of Energy (DOE)); 	This research was supported by the Office of Science (BER), U.S. Department of Energy Grant No. DE-FG02-04ER63906 (University of Alabama), Subcontract No. SC0002530 (Georgia Institute of Technology), and partially by No. DE-AC02-05CH11231 (Lawrence Berkeley National Laboratory). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RT, 2003, APPL ENVIRON MICROB, V69, P5884, DOI 10.1128/AEM.69.10.5884-5891.2003; Angel R, 2012, ISME J, V6, P847, DOI 10.1038/ismej.2011.141; Angel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020453; Athenstaedt K, 1999, EUR J BIOCHEM, V266, P1, DOI 10.1046/j.1432-1327.1999.00822.x; Barkay T, 2003, FEMS MICROBIOL REV, V27, P355, DOI 10.1016/S0168-6445(03)00046-9; Beazley MJ, 2007, ENVIRON SCI TECHNOL, V41, P5701, DOI 10.1021/es070567g; Beazley MJ, 2011, GEOCHIM COSMOCHIM AC, V75, P5648, DOI 10.1016/j.gca.2011.07.006; Beazley MJ, 2009, GEOMICROBIOL J, V26, P431, DOI 10.1080/01490450903060780; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Brodie EL, 2006, APPL ENVIRON MICROB, V72, P6288, DOI 10.1128/AEM.00246-06; Brooks SC, 2003, ENVIRON SCI TECHNOL, V37, P1850, DOI 10.1021/es0210042; Buck EC, 1996, ENVIRON SCI TECHNOL, V30, P81, DOI 10.1021/es9500825; Buenemann EK, 2008, SOIL BIOL BIOCHEM, V40, P1908, DOI 10.1016/j.soilbio.2008.03.017; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Dunbar J, 2002, APPL ENVIRON MICROB, V68, P3035, DOI 10.1128/AEM.68.6.3035-3045.2002; Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47; Francis I, 2010, ENVIRON MICROBIOL, V12, P1, DOI 10.1111/j.1462-2920.2009.01989.x; Fujita Y, 2004, GEOCHIM COSMOCHIM AC, V68, P3261, DOI 10.1016/j.gca.2003.12.018; Geissler A, 2009, GEOBIOLOGY, V7, P282, DOI 10.1111/j.1472-4669.2009.00199.x; Gihring TM, 2011, APPL ENVIRON MICROB, V77, P5955, DOI 10.1128/AEM.00220-11; Green SJ, 2010, APPL ENVIRON MICROB, V76, P3244, DOI 10.1128/AEM.03069-09; Grenthe I., 2003, CHEM THERMODYNAMICS; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Grossart HP, 2011, P NATL ACAD SCI USA, V108, P19657, DOI 10.1073/pnas.1110716108; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; Hayat R, 2010, ANN MICROBIOL, V60, P579, DOI 10.1007/s13213-010-0117-1; Istok JD, 2004, ENVIRON SCI TECHNOL, V38, P468, DOI 10.1021/es034639p; Jerden JL, 2003, APPL GEOCHEM, V18, P823, DOI 10.1016/S0883-2927(02)00179-8; Jones C, 2005, CARBOHYD RES, V340, P403, DOI 10.1016/j.carres.2004.12.009; Jroundi F, 2007, GEOMICROBIOL J, V24, P441, DOI 10.1080/01490450701437651; Langmuir D., 1997, AQUEOUS ENV GEOCHEMI; Liu WT, 2001, ENVIRON MICROBIOL, V3, P110, DOI 10.1046/j.1462-2920.2001.00164.x; Lloyd JR, 2003, FEMS MICROBIOL REV, V27, P411, DOI 10.1016/S0168-6445(03)00044-5; LOVLEY DR, 1991, NATURE, V350, P413, DOI 10.1038/350413a0; MACASKIE LE, 1992, SCIENCE, V257, P782, DOI 10.1126/science.1496397; Maes M, 2009, ENVIRON MICROBIOL, V11, P1453, DOI 10.1111/j.1462-2920.2009.01873.x; Marchant R, 2002, ENVIRON MICROBIOL, V4, P595, DOI 10.1046/j.1462-2920.2002.00344.x; Martinez RJ, 2007, ENVIRON MICROBIOL, V9, P3122, DOI 10.1111/j.1462-2920.2007.01422.x; Mielke PW, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-69813-7; Milanowski R, 2001, INT J SYST EVOL MICR, V51, P773, DOI 10.1099/00207713-51-3-773; Moon HS, 2007, ENVIRON SCI TECHNOL, V41, P4587, DOI 10.1021/es063063b; Novakova E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-143; Oberson A., 2005, Organic phosphorus in the environment, P133, DOI 10.1079/9780851998220.0133; Oh BC, 2004, APPL MICROBIOL BIOT, V63, P362, DOI 10.1007/s00253-003-1345-0; Oliveros JC, 2007, VENNY INTERACTIVE TO; Ovreas L, 1997, APPL ENVIRON MICROB, V63, P3367; Pattanapipitpaisal P, 2002, ENVIRON TECHNOL, V23, P731, DOI 10.1080/09593332308618367; Porat I, 2010, MICROB ECOL, V60, P784, DOI 10.1007/s00248-010-9734-2; Rainey FA, 1998, INT J SYST BACTERIOL, V48, P635, DOI 10.1099/00207713-48-3-635; RASKIN L, 1994, APPL ENVIRON MICROB, V60, P1232, DOI 10.1128/AEM.60.4.1232-1240.1994; Rastogi G, 2010, MICROB ECOL, V60, P539, DOI 10.1007/s00248-010-9657-y; Richardson AE, 2009, PLANT SOIL, V321, P305, DOI 10.1007/s11104-009-9895-2; Rodriguez H, 1999, BIOTECHNOL ADV, V17, P319, DOI 10.1016/S0734-9750(99)00014-2; Roh Y, 2000, SOIL SEDIMENT CONTAM, V9, P463, DOI 10.1080/10588330091134356; Ryan PR, 2009, PLANT SOIL, V321, P363, DOI 10.1007/s11104-009-0001-6; Sani RK, 2005, GEOCHIM COSMOCHIM AC, V69, pA471; Shelobolina ES, 2009, APPL ENVIRON MICROB, V75, P5773, DOI 10.1128/AEM.00628-09; Simek K, 2001, APPL ENVIRON MICROB, V67, P2723, DOI 10.1128/AEM.67.6.2723-2733.2001; Singh G, 2014, CRIT REV ENV SCI TEC, V44, P391, DOI 10.1080/10643389.2012.728522; Sivaswamy V, 2011, BIOTECHNOL BIOENG, V108, P264, DOI 10.1002/bit.22956; Spain AM, 2011, GEOMICROBIOL J, V28, P418, DOI 10.1080/01490451.2010.507642; Stewart BD, 2010, ENVIRON SCI TECHNOL, V44, P928, DOI 10.1021/es902194x; Stubbs JE, 2009, GEOCHIM COSMOCHIM AC, V73, P1563, DOI 10.1016/j.gca.2008.12.004; Tajima K, 1999, FEMS MICROBIOL ECOL, V29, P159, DOI 10.1111/j.1574-6941.1999.tb00607.x; Thummes K, 2007, SYST APPL MICROBIOL, V30, P418, DOI 10.1016/j.syapm.2007.01.006; Tokunaga TK, 2008, ENVIRON SCI TECHNOL, V42, P8901, DOI 10.1021/es8019947; Turner BL, 2003, SOIL SCI SOC AM J, V67, P497, DOI 10.2136/sssaj2003.0497; Valinsky L, 2002, APPL ENVIRON MICROB, V68, P3243, DOI 10.1128/AEM.68.7.3243-3250.2002; Wan JM, 2005, ENVIRON SCI TECHNOL, V39, P6162, DOI 10.1021/es048236g; Wellman DM, 2006, ENVIRON CHEM, V3, P219, DOI 10.1071/EN05023; White C, 1998, NAT BIOTECHNOL, V16, P572, DOI 10.1038/nbt0698-572; Whitehouse CA, 2010, APPL ENVIRON MICROB, V76, P1996, DOI 10.1128/AEM.01919-09; WILSON KH, 1990, J CLIN MICROBIOL, V28, P1942, DOI 10.1128/JCM.28.9.1942-1946.1990; Wu WM, 2007, ENVIRON SCI TECHNOL, V41, P5716, DOI 10.1021/es062657b; Wu WM, 2006, ENVIRON SCI TECHNOL, V40, P3978, DOI 10.1021/es051954y; Wu WM, 2006, ENVIRON SCI TECHNOL, V40, P3986, DOI 10.1021/es051960u; Wu XL, 2006, ENVIRON MICROBIOL, V8, P394, DOI 10.1111/j.1462-2920.2005.00904.x; Yan TF, 2003, ENVIRON MICROBIOL, V5, P13, DOI 10.1046/j.1462-2920.2003.00393.x; Yanke LJ, 1998, MICROBIOL-SGM, V144, P1565, DOI 10.1099/00221287-144-6-1565; Zhang B, 2011, BIORESOURCE TECHNOL, V102, P2474, DOI 10.1016/j.biortech.2010.11.017; Zheng ZP, 2003, ENVIRON SCI TECHNOL, V37, P5603, DOI 10.1021/es0304897; Zinin NV, 2004, FEMS MICROBIOL LETT, V236, P283, DOI [10.1016/j.femsle.2004.05.051, 10.1111/j.1574-6968.2004.tb09659.x]	82	23	25	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100383	10.1371/journal.pone.0100383	http://dx.doi.org/10.1371/journal.pone.0100383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950228	Green Submitted, Green Published, gold			2022-12-25	WOS:000338276300070
J	Kim, M; Ham, A; Kim, KYM; Brown, KM; Lee, HT				Kim, Mihwa; Ham, Ahrom; Kim, Katelyn Yu-Mi; Brown, Kevin M.; Lee, H. Thomas			The Volatile Anesthetic Isoflurane Increases Endothelial Adenosine Generation via Microparticle Ecto-5 '-Nucleotidase (CD73) Release	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; LIPOPOLYSACCHARIDE-INDUCED INFLAMMATION; PROXIMAL TUBULE CELLS; SMOOTH-MUSCLE-CELLS; RENAL ISCHEMIA; VASCULAR DYSFUNCTION; SPHINGOSINE KINASE; RHO-KINASE; PRETREATMENT; PROTECTS	Endothelial dysfunction is common in acute and chronic organ injury. Isoflurane is a widely used halogenated volatile anesthetic during the perioperative period and protects against endothelial cell death and inflammation. In this study, we tested whether isoflurane induces endothelial ecto-5'-nucleotidase (CD73) and cytoprotective adenosine generation to protect against endothelial cell injury. Clinically relevant concentrations of isoflurane induced CD73 activity and increased adenosine generation in cultured human umbilical vein or mouse glomerular endothelial cells. Surprisingly, isoflurane-mediated induction of endothelial CD73 activity occurred within 1 hr and without synthesizing new CD73. We determined that isoflurane rapidly increased CD73 containing endothelial microparticles into the cell culture media. Indeed, microparticles isolated from isoflurane-treated endothelial cells had significantly higher CD73 activity as well as increased CD73 protein. In vivo, plasma from mice anesthetized with isoflurane had significantly higher endothelial cell-derived CD144+ CD73+ microparticles and had increased microparticle CD73 activity compared to plasma from pentobarbital-anesthetized mice. Supporting a critical role of CD73 in isoflurane-mediated endothelial protection, a selective CD73 inhibitor (APCP) prevented isoflurane-induced protection against human endothelial cell inflammation and apoptosis. In addition, isoflurane activated endothelial cells Rho kinase evidenced by myosin phosphatase target subunit-1 and myosin light chain phosphorylation. Furthermore, isoflurane-induced release of CD73 containing microparticles was significantly attenuated by a selective Rho kinase inhibitor (Y27632). Taken together, we conclude that the volatile anesthetic isoflurane causes Rho kinase-mediated release of endothelial microparticles containing preformed CD73 and increase adenosine generation to protect against endothelial apoptosis and inflammation.	[Kim, Mihwa; Ham, Ahrom; Kim, Katelyn Yu-Mi; Brown, Kevin M.; Lee, H. Thomas] Columbia Univ, Coll Phys & Surg, Dept Anesthesiol, New York, NY 10027 USA	Columbia University	Lee, HT (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Anesthesiol, New York, NY 10027 USA.	tl128@columbia.edu			Department of Anesthesiology, Columbia University; National Institutes of Health [R01 GM-067081]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067081] Funding Source: NIH RePORTER	Department of Anesthesiology, Columbia University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Department of Anesthesiology, Columbia University and by National Institutes of Health grant R01 GM-067081. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akis N, 2004, KIDNEY INT, V65, P2223, DOI 10.1111/j.1523-1755.2004.00634.x; Amabile N, 2005, J AM SOC NEPHROL, V16, P3381, DOI 10.1681/ASN.2005050535; Bakar AM, 2012, INT J MOL SCI, V13, P977, DOI 10.3390/ijms13010977; Budzyn K, 2007, CURR OPIN DRUG DISC, V10, P590; Burger D, 2013, CLIN SCI, V124, P423, DOI 10.1042/CS20120309; Burger D, 2011, ARTERIOSCL THROM VAS, V31, P1898, DOI 10.1161/ATVBAHA.110.222703; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Cullen Karen A, 2009, Natl Health Stat Report, P1; de Klaver MJM, 2003, ANESTHESIOLOGY, V99, P896, DOI 10.1097/00000542-200310000-00023; de Klaver MJM, 2002, ANESTHESIOLOGY, V97, P24, DOI 10.1097/00000542-200207000-00005; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Flondor M, 2008, EUR SURG RES, V40, P1, DOI 10.1159/000107614; Fuentes JM, 2006, CLIN VACCINE IMMUNOL, V13, P281, DOI 10.1128/CVI.13.2.281-288.2006; Gelain DP, 2003, MOL CELL BIOCHEM, V245, P1, DOI 10.1023/A:1022857608849; Grenz A, 2007, J AM SOC NEPHROL, V18, P833, DOI 10.1681/ASN.2006101141; Hart ML, 2008, FASEB J, V22, P2784, DOI 10.1096/fj.07-103911; Hasko G, 2011, J IMMUNOL, V187, P4256, DOI 10.4049/jimmunol.1003379; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hayes JK, 2004, ANESTH ANALG, V98, P999, DOI 10.1213/01.ANE.0000104584.91385.1D; Higashi Y, 2012, HYPERTENS RES, V35, P1039, DOI 10.1038/hr.2012.138; Higashi Y, 2009, CIRC J, V73, P411, DOI 10.1253/circj.CJ-08-1102; Hofbauer R, 1999, CURR PHARM DESIGN, V5, P1015; Hofstetter C, 2005, INT IMMUNOPHARMACOL, V5, P1519, DOI 10.1016/j.intimp.2005.04.008; JAFFE EA, 1987, HUM PATHOL, V18, P234, DOI 10.1016/S0046-8177(87)80005-9; Kim M, 2010, AM J PHYSL RENAL PHY; Kim M, 2011, ANN SURG IN PRESS; Kim M, 2013, KIDNEY INT, V84, P90, DOI 10.1038/ki.2013.43; Kim M, 2010, AM J NEPHROL, V31, P353, DOI 10.1159/000298339; Kim M, 2007, AM J PHYSIOL-RENAL, V293, pF1827, DOI 10.1152/ajprenal.00290.2007; Kim M, 2009, KIDNEY INT, V75, P809, DOI 10.1038/ki.2008.699; Landoni G, 2009, MINERVA ANESTESIOL, V75, P269; Lee HT, 2007, AM J PHYSIOL-RENAL, V293, pF713, DOI 10.1152/ajprenal.00161.2007; Lee HT, 2007, SHOCK, V27, P373, DOI 10.1097/01.shk.0000248595.17130.24; Lee HT, 2006, AM J PHYSIOL-RENAL, V291, pF67, DOI 10.1152/ajprenal.00412.2005; Lemkuil BP, 2011, ANESTHESIOLOGY, V114, P49, DOI 10.1097/ALN.0b013e318201dcb3; Linden J, 2006, J CLIN INVEST, V116, P1835, DOI 10.1172/JCI29125; Luippold G, 1999, J CHROMATOGR B, V724, P231, DOI 10.1016/S0378-4347(98)00580-5; Mobert J, 1999, ANESTHESIOLOGY, V90, P1372, DOI 10.1097/00000542-199905000-00022; Park SW, 2012, J AM SOC NEPHROL, V23, P266, DOI 10.1681/ASN.2011050503; Plachinta RV, 2003, ANESTHESIOLOGY, V98, P89, DOI 10.1097/00000542-200301000-00017; Rautou PE, 2011, CIRC RES, V109, P593, DOI 10.1161/CIRCRESAHA.110.233163; Reutershan J, 2006, ANESTHESIOLOGY, V104, P511, DOI 10.1097/00000542-200603000-00019; Sapet C, 2006, BLOOD, V108, P1868, DOI 10.1182/blood-2006-04-014175; Seal JB, 2005, ANN VASC SURG, V19, P572, DOI 10.1007/s10016-005-4616-7; Strohmeier GR, 1997, J CLIN INVEST, V99, P2588, DOI 10.1172/JCI119447; Tas PWL, 2007, J CELL BIOCHEM, V102, P368, DOI 10.1002/jcb.21294; Tramontano AF, 2004, BIOCHEM BIOPH RES CO, V320, P34, DOI 10.1016/j.bbrc.2004.05.127; Van Hoozen BE, 1999, CRIT CARE MED, V27, P2836, DOI 10.1097/00003246-199912000-00044; Zhou Q, 2009, CURR PHARM DESIGN, V15, P3108, DOI 10.2174/138161209789057986	50	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99950	10.1371/journal.pone.0099950	http://dx.doi.org/10.1371/journal.pone.0099950			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945528	gold, Green Published, Green Submitted			2022-12-25	WOS:000340721500035
J	Konig, MAE; Lehtila, K; Wiklund, C; Ehrlen, J				Konig, Malin A. E.; Lehtila, Kari; Wiklund, Christer; Ehrlen, Johan			Among-Population Variation in Tolerance to Larval Herbivory by Anthocharis cardamines in the Polyploid Herb Cardamine pratensis	PLOS ONE			English	Article							PLANT PLOIDY LEVEL; FLOWERING PHENOLOGY; IMPOSE SELECTION; RESISTANCE; COSTS; STRATEGIES; EVOLUTION; RESPONSES; FITNESS; COMPENSATION	Plants have two principal defense mechanisms to decrease fitness losses to herbivory: tolerance, the ability to compensate fitness after damage, and resistance, the ability to avoid damage. Variation in intensity of herbivory among populations should result in variation in plant defense levels if tolerance and resistance are associated with costs. Yet little is known about how levels of tolerance are related to resistance and attack intensity in the field, and about the costs of tolerance. In this study, we used information about tolerance and resistance against larval herbivory by the butterfly Anthocharis cardamines under controlled conditions together with information about damage in the field for a large set of populations of the perennial plant Cardamine pratensis. Plant tolerance was estimated in a common garden experiment where plants were subjected to a combination of larval herbivory and clipping. We found no evidence of that the proportion of damage that was caused by larval feeding vs. clipping influenced plant responses. Damage treatments had a negative effect on the three measured fitness components and also resulted in an earlier flowering in the year after the attack. Tolerance was related to attack intensity in the population of origin, i.e. plants from populations with higher attack intensity were more likely to flower in the year following damage. However, we found no evidence of a relationship between tolerance and resistance. These results indicate that herbivory drives the evolution for increased tolerance, and that changes in tolerance are not linked to changes in resistance. We suggest that the simultaneous study of tolerance, attack intensity in the field and resistance constitutes a powerful tool to understand how plant strategies to avoid negative effects of herbivore damage evolve.	[Konig, Malin A. E.; Ehrlen, Johan] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Lehtila, Kari] Sodertorn Univ, Sch Nat Sci Technol & Environm Studies, Huddinge, Sweden; [Wiklund, Christer] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden	Stockholm University; Sodertorn University; Stockholm University	Konig, MAE (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden.	malin.konig@gmail.com		Ehrlen, Johan/0000-0001-8539-8967; Lehtila, Kari/0000-0002-0260-3978	Swedish research council [1043720]	Swedish research council(Swedish Research CouncilEuropean Commission)	This research was funded by a grant from the Swedish research council (1043720, http://www.vr.se/) to Johan Ehrlen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 1999, EVOLUTION, V53, P1093, DOI [10.2307/2640814, 10.1111/j.1558-5646.1999.tb04524.x]; Arvanitis L, 2008, OIKOS, V117, P1020, DOI 10.1111/j.0030-1299.2008.16347.x; Arvanitis L, 2007, OECOLOGIA, V152, P275, DOI 10.1007/s00442-007-0659-5; BALDWIN IT, 1990, TRENDS ECOL EVOL, V5, P91, DOI 10.1016/0169-5347(90)90237-8; BELSKY AJ, 1993, EVOL ECOL, V7, P109, DOI 10.1007/BF01237737; Boalt E, 2010, EVOL ECOL, V24, P1101, DOI 10.1007/s10682-010-9364-7; Bustos-Segura C, 2014, J EVOL BIOL IN PRESS; Carmona D, 2013, NEW PHYTOL, V197, P576, DOI 10.1111/nph.12023; COURTNEY SP, 1982, OECOLOGIA, V52, P258, DOI 10.1007/BF00363846; Dempster JP, 1997, OECOLOGIA, V111, P549, DOI 10.1007/s004420050270; DEMPSTER JP, 1992, ECOL ENTOMOL, V17, P83, DOI 10.1111/j.1365-2311.1992.tb01043.x; Espinosa EG, 2006, NEW PHYTOL, V170, P609, DOI 10.1111/j.1469-8137.2006.01681.x; FINEBLUM WL, 1995, NATURE, V377, P517, DOI 10.1038/377517a0; Fornoni J, 2004, EVOLUTION, V58, P1696, DOI 10.1111/j.0014-3820.2004.tb00455.x; FORNONI J, 2003, COMMENTS THEORETICAL, V8, P643, DOI DOI 10.1080/713713331; Fox J., 2014, R COMPANION APPL REG; Freeman RS, 2003, OECOLOGIA, V136, P394, DOI 10.1007/s00442-003-1276-6; Garrido E, 2012, NEW PHYTOL, V193, P445, DOI 10.1111/j.1469-8137.2011.03923.x; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Konig MAE, 2014, OECOLOGIA, V174, P1265, DOI 10.1007/s00442-013-2831-4; Koricheva J, 2002, ECOLOGY, V83, P176, DOI 10.2307/2680130; Lehtila K, 2004, ECOL STU AN, V173, P257; Leimu R, 2006, OIKOS, V112, P1, DOI 10.1111/j.0030-1299.2006.41023.x; Lennartsson T, 1997, AM NAT, V149, P1147, DOI 10.1086/286043; Loreti J, 2001, PLANT ECOL, V157, P195, DOI 10.1023/A:1013976316924; LOVKVIST B, 1956, THESIS U UPPSALA UPP; MARQUIS RJ, 1984, SCIENCE, V226, P537, DOI 10.1126/science.226.4674.537; MASCHINSKI J, 1989, AM NAT, V134, P1, DOI 10.1086/284962; Mauricio R, 1997, ECOLOGY, V78, P1301, DOI 10.1890/0012-9658(1997)078[1301:VITDSO]2.0.CO;2; McCall AC, 2006, ECOL LETT, V9, P1351, DOI 10.1111/j.1461-0248.2006.00975.x; Nunez-Farfan J, 2007, ANNU REV ECOL EVOL S, V38, P541, DOI 10.1146/annurev.ecolsys.38.091206.095822; Pilson D, 2000, OECOLOGIA, V122, P72, DOI 10.1007/PL00008838; Pilson D, 2000, EVOL ECOL, V14, P457, DOI 10.1023/A:1010953714344; Puustinen S, 2004, OECOLOGIA, V139, P76, DOI 10.1007/s00442-004-1488-4; R Core Team, 2021, R LANG ENV STAT COMP; Rosenheim JA, 1997, ENTOMOL EXP APPL, V85, P45, DOI 10.1023/A:1003026507687; Rotundo JL, 2008, PLANT ECOL, V194, P121, DOI 10.1007/s11258-007-9279-8; Sadras VO, 1996, OECOLOGIA, V106, P432, DOI 10.1007/BF00329698; Stinchcombe JR, 2002, EVOL ECOL, V16, P595, DOI 10.1023/A:1021617418037; Stinchcombe JR, 2002, EVOLUTION, V56, P1063; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; THOMAS C D, 1984, Entomologist's Gazette, V35, P145; Tiffin P, 1999, AM NAT, V154, P700, DOI 10.1086/303271; Tiffin P, 2000, EVOL ECOL, V14, P523, DOI 10.1023/A:1010881317261; van Kleunen M, 2003, ECOLOGY, V84, P2816, DOI 10.1890/02-0494; VANDERMEIJDEN E, 1988, OIKOS, V51, P355, DOI 10.2307/3565318; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; WIKLUND C, 1978, OIKOS, V31, P169, DOI 10.2307/3543560; WIKLUND C, 1984, OECOLOGIA, V63, P23, DOI 10.1007/BF00379780	50	13	13	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99333	10.1371/journal.pone.0099333	http://dx.doi.org/10.1371/journal.pone.0099333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945875	gold, Green Published, Green Submitted			2022-12-25	WOS:000340721500015
J	Liu, Z; Qian, JC; Liu, BM; Wang, Q; Ni, XY; Dong, YL; Zhong, K; Wu, YJ				Liu, Zan; Qian, Junchao; Liu, Binmei; Wang, Qi; Ni, Xiaoyu; Dong, Yaling; Zhong, Kai; Wu, Yuejin			Effects of the Magnetic Resonance Imaging Contrast Agent Gd-DTPA on Plant Growth and Root Imaging in Rice	PLOS ONE			English	Article							MRI; TRANSPORT	Although paramagnetic contrast agents have a wide range of applications in medical studies involving magnetic resonance imaging (MRI), these agents are seldom used to enhance MRI images of plant root systems. To extend the application of MRI contrast agents to plant research and to develop related techniques to study root systems, we examined the applicability of the MRI contrast agent Gd-DTPA to the imaging of rice roots. Specifically, we examined the biological effects of various concentrations of Gd-DTPA on rice growth and MRI images. Analysis of electrical conductivity and plant height demonstrated that 5 mmol Gd-DTPA had little impact on rice in the short-term. The results of signal intensity and spin-lattice relaxation time (T1) analysis suggested that 5 mmol Gd-DTPA was the appropriate concentration for enhancing MRI signals. In addition, examination of the long-term effects of Gd-DTPA on plant height showed that levels of this compound up to 5 mmol had little impact on rice growth and (to some extent) increased the biomass of rice.	[Liu, Zan; Liu, Binmei; Wang, Qi; Ni, Xiaoyu; Dong, Yaling; Wu, Yuejin] Chinese Acad Sci, Hefei Inst Phys Sci, Inst Tech Biol & Agr Engn, Key Lab Ion Beam Bioengn, Hefei, Peoples R China; [Qian, Junchao; Zhong, Kai] Chinese Acad Sci, Hefei Inst Phys Sci, High Field Magnet Lab, Hefei, Peoples R China	Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS	Zhong, K (corresponding author), Chinese Acad Sci, Hefei Inst Phys Sci, High Field Magnet Lab, Hefei, Peoples R China.	kzhong@hmfl.ac.cn; yjwu@ipp.ac.cn	Binmei, Liu/ABB-8384-2020		Strategic Priority Research Program of the Chinese Academy of Sciences [XDA08040107]; National Natural Science Foundation of China [31301297]; Knowledge Innovative Program of the Chinese Academy of Sciences [KJCX2-EW-N05, KJCX2-YW-N34]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovative Program of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences)	This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences, Grant No. XDA08040107(http://www.cas.cn/), the National Natural Science Foundation of China (No. 31301297) (http://www.nsfc.gov.cn/), the Knowledge Innovative Program of the Chinese Academy of Sciences (No. KJCX2-EW-N05; No. KJCX2-YW-N34) (http://www.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blossfeld Stephan, 2011, Commun Agric Appl Biol Sci, V76, P11; Borisjuk L, 2012, PLANT J, V70, P129, DOI 10.1111/j.1365-313X.2012.04927.x; BOTTOMLEY PA, 1986, P NATL ACAD SCI USA, V83, P87, DOI 10.1073/pnas.83.1.87; Cordova-Tellez L, 2002, CROP SCI, V42, P1989, DOI 10.2135/cropsci2002.1989; Eberhardt TL, 2009, HOLZFORSCHUNG, V63, P75, DOI 10.1515/HF.2009.024; Edzes HT, 1998, MAGN RESON IMAGING, V16, P185, DOI 10.1016/S0730-725X(97)00274-9; Hillnhutter C, 2012, J EXP BOT, V63, P319, DOI 10.1093/jxb/err273; Johnson MG, 2001, ENVIRON EXP BOT, V45, P263, DOI 10.1016/S0098-8472(01)00077-6; Kaestner A, 2006, GEODERMA, V136, P459, DOI 10.1016/j.geoderma.2006.04.009; Kaufmann I, 2009, NEW PHYTOL, V184, P245, DOI 10.1111/j.1469-8137.2009.02919.x; Melkus G, 2011, PLANT BIOTECHNOL J, V9, P1022, DOI 10.1111/j.1467-7652.2011.00618.x; Melkus G, 2009, PLANT PHYSIOL, V151, P1139, DOI 10.1104/pp.109.143974; Mooney SJ, 2012, PLANT SOIL, V352, P1, DOI 10.1007/s11104-011-1039-9; Ni JZ, 1995, USE RARE EARTH ELEME, P13; QUIQUAMPOIX H, 1990, J INORG BIOCHEM, V38, P265, DOI 10.1016/0162-0134(90)80002-F; Rathjen JR, 2009, J EXP BOT, V60, P1619, DOI 10.1093/jxb/erp037; Schneider H, 2003, NEW PHYTOL, V159, P487, DOI 10.1046/j.1469-8137.2003.00814.x; SNAAR JEM, 1992, BIOPHYS J, V63, P1654, DOI 10.1016/S0006-3495(92)81741-1; Sorensen AG, 1997, JMRI-J MAGN RESON IM, V7, P47, DOI 10.1002/jmri.1880070108; TOLLNER EW, 1991, COMMUN SOIL SCI PLAN, V22, P1941, DOI 10.1080/00103629109368548; Toth E, 2002, TOP CURR CHEM, V221, P61; Van der Weerd L, 2002, PLANT CELL ENVIRON, V25, P1539, DOI 10.1046/j.1365-3040.2002.00934.x; VANDUSSCHOTEN D, 1995, J MAGN RESON SER A, V116, P22, DOI 10.1006/jmra.1995.1185; Windt CW, 2006, PLANT CELL ENVIRON, V29, P1715, DOI 10.1111/j.1365-3040.2006.01544.x; Zhang HJ, 2009, BIOL TRACE ELEM RES, V127, P81, DOI 10.1007/s12011-008-8224-6; Zhong K, 2000, NMR BIOMED, V13, P392, DOI 10.1002/1099-1492(200011)13:7<392::AID-NBM659>3.0.CO;2-O	26	3	3	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100246	10.1371/journal.pone.0100246	http://dx.doi.org/10.1371/journal.pone.0100246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945975	Green Published, Green Submitted, gold			2022-12-25	WOS:000340721500052
J	Sun, Y; Kaneko, S; Li, XK; Li, X				Sun, Y.; Kaneko, S.; Li, X. K.; Li, X.			The PI3K/Akt signal hyperactivates Eya1 via the SUMOylation pathway	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CANCER CELL-LINES; EYES ABSENT PROTEINS; BREAST-CANCER; CONJUGATING ENZYME; TRANSCRIPTIONAL REPRESSION; TUMOR-CELLS; GENE; PHOSPHATASE; EXPRESSION	Eyes absent 1 (Eya1) is a conserved critical regulator of organ-specific stem cells. Ectopic Eya1 activities, however, promote transformation of mammary epithelial cells. Signals that instigate Eya1 oncogenic activities remain to be determined. Here, we show that Akt1 kinase physically interacts with Eya1 and phosphorylates a conserved consensus site of the Akt kinase. PI3K/Akt signaling enhances Eya1 transcription activity, which largely attributes to the phosphorylation-induced reduction of Eya1 SUMOylation. Indeed, SUMOylation inhibits Eya1 transcription activity; and pharmacologic and genetic activation of PI3K/Akt robustly reduces Eya1 SUMOylation. Wild-type but not Akt phosphorylation site mutant Eya1 variant rescues the cell migratory phenotype of EYA1-silenced breast cancer cells, highlighting the importance of Eya1 phosphorylation. Furthermore, knockdown EYA1 sensitizes breast cancer cells to the PI3K/Akt1 inhibitor and irradiation treatments. Thus, the PI3K/Akt signal pathway activates Eya1. These findings further suggest that regulation of SUMOylation by PI3K/Akt signaling is likely an important aspect of tumorigenesis.	[Sun, Y.; Kaneko, S.; Li, X.] Boston Childrens Hosp, Urol Dis Res Ctr, Boston, MA 02115 USA; [Sun, Y.; Kaneko, S.; Li, X.] Harvard Univ, Sch Med, Dept Surg, Boston, MA USA; [Sun, Y.; Kaneko, S.; Li, X.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA USA; [Li, X. K.] Wenzhou Med Coll, Sch Pharmaceut Sci, Wenzhou, Peoples R China	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Wenzhou Medical University	Li, XK (corresponding author), Boston Childrens Hosp, Urol Dis Res Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	sean.li@childrens.harvard.edu		Sun, Ye/0000-0002-7674-9056	NIH/NIDCR [1R01DE019823]; NIH/NIDDK [R01DK916451, P50DK65298]; AHA [13GRNT16950006]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK065298, R01DK091645] Funding Source: NIH RePORTER	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AHA(American Heart Association); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S Morley for suggestions and critical reading of the manuscript. We thank I Teng, CS Guo, XJ Shi, ZF Chai and K Pelton for technical supports. We are grateful to R Adam, G Gill, J Brugge, C Kuperwasser for providing reagents, cell lines and helpful discussion. This work was supported by grant from NIH/NIDCR (1R01DE019823, XL), NIH/NIDDK (R01DK916451 and P50DK65298, XL) and AHA (13GRNT16950006, XL).	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Alkuraya FS, 2006, SCIENCE, V313, P1751, DOI 10.1126/science.1128406; Bawa-Khalfe T, 2012, P NATL ACAD SCI USA, V109, P17466, DOI 10.1073/pnas.1209378109; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Coletta RD, 2004, P NATL ACAD SCI USA, V101, P6478, DOI 10.1073/pnas.0401139101; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Dunnebier T, 2010, BREAST CANCER RES TR, V121, P185, DOI 10.1007/s10549-009-0530-y; Dunnebier T, 2009, INT J CANCER, V125, P596, DOI 10.1002/ijc.24286; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Farabaugh SM, 2012, ONCOGENE, V31, P552, DOI 10.1038/onc.2011.259; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Ford HL, 1998, P NATL ACAD SCI USA, V95, P12608, DOI 10.1073/pnas.95.21.12608; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Guo CS, 2011, J CLIN INVEST, V121, P1585, DOI 10.1172/JCI44630; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Li R, 2013, CANCER RES, V73, P5742, DOI 10.1158/0008-5472.CAN-13-0538; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Machon O, 2000, MECH DEVELOP, V97, P3, DOI 10.1016/S0925-4773(00)00402-0; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McCoy EL, 2009, J CLIN INVEST, V119, P2663, DOI 10.1172/JCI37691; Micalizzi DS, 2009, J CLIN INVEST, V119, P2678, DOI 10.1172/JCI37815; Miller TW, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3039; Moschos SJ, 2010, HUM PATHOL, V41, P1286, DOI 10.1016/j.humpath.2010.02.007; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Pandey RN, 2010, ONCOGENE, V29, P3715, DOI 10.1038/onc.2010.122; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Reichenberger KJ, 2005, CANCER RES, V65, P2668, DOI 10.1158/0008-5472.CAN-04-4286; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Sajithlal G, 2005, DEV BIOL, V284, P323, DOI 10.1016/j.ydbio.2005.05.029; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; She QB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003065; Synowiec E, 2010, MUTAT RES-FUND MOL M, V694, P31, DOI 10.1016/j.mrfmmm.2010.09.002; Tadjuidje E, 2013, CELL MOL LIFE SCI, V70, P1897, DOI 10.1007/s00018-012-1144-9; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Torbett NE, 2008, BIOCHEM J, V415, P97, DOI 10.1042/BJ20080639; Wu KM, 2013, CANCER RES, V73, P4488, DOI 10.1158/0008-5472.CAN-12-4078; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Xu Q, 2002, MOL BIOL CELL, V13, P1940, DOI 10.1091/mbc.02-02-0016; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yang XJ, 2006, MOL CELL, V23, P779, DOI 10.1016/j.molcel.2006.08.009; Zhang H, 2002, J BIOL CHEM, V277, P39379, DOI 10.1074/jbc.M206399200	49	13	15	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 7	2015	34	19					2527	2537		10.1038/onc.2014.179	http://dx.doi.org/10.1038/onc.2014.179			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CH7BK	24954506	Green Accepted, Green Submitted			2022-12-25	WOS:000354190400011
J	Koo, BS; Lee, SH; Kim, JM; Huang, S; Kim, SH; Rho, YS; Bae, WJ; Kang, HJ; Kim, YS; Moon, JH; Lim, YC				Koo, B. S.; Lee, S. H.; Kim, J. M.; Huang, S.; Kim, S. H.; Rho, Y. S.; Bae, W. J.; Kang, H. J.; Kim, Y. S.; Moon, J. H.; Lim, Y. C.			Oct4 is a critical regulator of stemness in head and neck squamous carcinoma cells	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CANCER CELLS; RESISTANCE; IDENTIFICATION; PLURIPOTENCY; EXPRESSION; DISEASE; PROTEIN	Cancer stem cells (CSCs) have been suggested as responsible for the initiation and progression of cancers. Octamer-binding transcription factor 4 (Oct4) is an important regulator of embryonic stem cell fate. Here, we investigated whether Oct4 regulates stemness of head and neck squamous carcinoma (HNSC) CSCs. Our study showed that ectopic expression of Oct4 promotes tumor growth through cyclin E activation, increases chemoresistance through ABCC6 expression and enhances tumor invasion through slug expression. Also, Oct4 dedifferentiates differentiated HNSC cells to CSC-like cells. Furthermore, Oct4(high) HNSC CSCs have more stem cell-like traits compared with Oct4(low) cells, such as self-renewal, stem cell markers' expression, chemoresistance, invasion capacity and xenograft tumorigeneity in vitro and in vivo. In addition, knockdown of Oct4 led to markedly lower HNSC CSC stemness. Finally, there was a significant correlation between Oct4 expression and survival of 119 HNSC patients. Collectively, these data suggest that Oct4 may be a critical regulator of HNSC CSCs and its targeting may be potentially valuable in the treatment of HNSC CSCs.	[Koo, B. S.; Kim, S. H.] Canc Res Inst, Dept Otolaryngol Head & Neck Surg, Taejon, South Korea; [Lee, S. H.] Sungkyunkwan Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Kangbuk Samsung Hosp, Seoul, South Korea; [Kim, J. M.; Huang, S.] Chungnam Natl Univ, Coll Med, Res Inst Med Sci & Pathol, Taejon, South Korea; [Rho, Y. S.] Ewha Womans Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Bae, W. J.] Hallym Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea; [Kang, H. J.; Kim, Y. S.; Moon, J. H.; Lim, Y. C.] Konkuk Univ, Dept Otorhinolaryngol Head & Neck Surg, Res Inst Med Sci, Sch Med, Seoul 143729, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Chungnam National University; Ewha Womans University; Hallym University; Konkuk University; Konkuk University Medical Center	Lim, YC (corresponding author), Konkuk Univ, Dept Otorhinolaryngol Head & Neck Surg, Res Inst Med Sci, Sch Med, 120-1 Neungdong Ro Hwayang Dong, Seoul 143729, South Korea.	yclim69@hanmail.net		KIM, JIN MAN/0000-0003-0905-9730; Koo, Bon Seok/0000-0002-5928-0006	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A111700]; National Research Foundation of Korea (NRF) grant - Korea government (MEST) [2012R1A2A2A01046214, 2013R1A2A2A01015281]	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; National Research Foundation of Korea (NRF) grant - Korea government (MEST)	This work was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (Grant number A111700 to YCL) and by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (Grant number 2012R1A2A2A01046214 to YCL and 2013R1A2A2A01015281 to BSK).	Chang CC, 2008, CANCER RES, V68, P6281, DOI 10.1158/0008-5472.CAN-08-0094; Chen KG, 2012, CLIN CANCER RES, V18, P1863, DOI 10.1158/1078-0432.CCR-11-1590; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Ge N, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-94; Gerrard L, 2005, STEM CELLS, V23, P124, DOI 10.1634/stemcells.2004-0102; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Jung JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028068; Kumar SM, 2012, ONCOGENE, V31, P4898, DOI 10.1038/onc.2011.656; Lengner CJ, 2008, CELL CYCLE, V7, P725, DOI 10.4161/cc.7.6.5573; Lim YC, 2011, ORAL ONCOL, V47, P83, DOI 10.1016/j.oraloncology.2010.11.011; Looijenga LHJ, 2003, CANCER RES, V63, P2244; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Steg AD, 2012, CLIN CANCER RES, V18, P869, DOI 10.1158/1078-0432.CCR-11-2188; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsai LL, 2011, J ORAL PATHOL MED, V40, P621, DOI 10.1111/j.1600-0714.2011.01015.x; Wang XQ, 2010, HEPATOLOGY, V52, P528, DOI 10.1002/hep.23692; Wiegand S, 2005, CANCER-AM CANCER SOC, V104, P94, DOI 10.1002/cncr.21131; Xie LQ, 2010, ANN SURG ONCOL, V17, P1927, DOI 10.1245/s10434-010-0922-6; Yamano Y, 2010, INT J CANCER, V126, P437, DOI 10.1002/ijc.24704; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yu FG, 2013, LARYNGOSCOPE, V123, P1903, DOI 10.1002/lary.24003	27	81	85	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 30	2015	34	18					2317	2324		10.1038/onc.2014.174	http://dx.doi.org/10.1038/onc.2014.174			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CH2AH	24954502	Bronze			2022-12-25	WOS:000353824800005
J	Saab, S; Buteau, B; Leclere, L; Bron, AM; Creuzot-Garcher, CP; Bretillon, L; Acar, N				Saab, Sarah; Buteau, Benedicte; Leclere, Laurent; Bron, Alain M.; Creuzot-Garcher, Catherine P.; Bretillon, Lionel; Acar, Niyazi			Involvement of Plasmalogens in Post-Natal Retinal Vascular Development	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-2; BLOOD-VESSEL FORMATION; MACULAR DEGENERATION; TUMOR ANGIOGENESIS; FATTY-ACIDS; INTEGRIN; VASCULOGENESIS; ACTIVATION; EXPRESSION; STRESS	Objective: Proper development of retinal blood vessels is essential to ensure sufficient oxygen and nutrient supplies to the retina. It was shown that polyunsaturated fatty acids (PUFAs) could modulate factors involved in tissue vascularization. A congenital deficiency in ether-phospholipids, also termed "plasmalogens'', was shown to lead to abnormal ocular vascularization. Because plasmalogens are considered to be reservoirs of PUFAs, we wished to improve our understanding of the mechanisms by which plasmalogens regulate retinal vascular development and whether the release of PUFAs by calcium-independent phospholipase A2 (iPLA2) could be involved. Methods and Results: By characterizing the cellular and molecular steps of retinal vascular development in a mouse model of plasmalogen deficiency, we demonstrated that plasmalogens modulate angiogenic processes during the early phases of retinal vascularization. They influence glial activity and primary astrocyte template formation, endothelial cell proliferation and retinal vessel outgrowth, and impact the expression of the genes involved in angiogenesis in the retina. These early defects led to a disorganized and dysfunctional retinal vascular network at adult age. By comparing these data to those obtained on a mouse model of retinal iPLA2 inhibition, we suggest that these processes may be mediated by PUFAs released from plasmalogens and further signalling through the angiopoietin/tie pathways. Conclusions: These data suggest that plasmalogens play a crucial role in retinal vascularization processes.	[Saab, Sarah; Buteau, Benedicte; Leclere, Laurent; Bron, Alain M.; Creuzot-Garcher, Catherine P.; Bretillon, Lionel; Acar, Niyazi] CNRS, Ctr Sci Gout & Alimentat, UMR6265, Dijon, France; [Saab, Sarah; Buteau, Benedicte; Leclere, Laurent; Bron, Alain M.; Creuzot-Garcher, Catherine P.; Bretillon, Lionel; Acar, Niyazi] INRA, Ctr Sci Gout & Alimentat, UMR1324, F-21034 Dijon, France; [Saab, Sarah; Buteau, Benedicte; Leclere, Laurent; Bron, Alain M.; Creuzot-Garcher, Catherine P.; Bretillon, Lionel; Acar, Niyazi] Univ Bourgogne, UMR Ctr Sci Gout & Alimentat, Dijon, France; [Bron, Alain M.; Creuzot-Garcher, Catherine P.] Univ Hosp, Dept Ophthalmol, Dijon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; CHU Dijon Bourgogne	Acar, N (corresponding author), CNRS, Ctr Sci Gout & Alimentat, UMR6265, Dijon, France.	niyazi.acar@dijon.inra.fr	Bron, Alain/AAP-8010-2020	Bron, Alain/0000-0002-7265-931X; Bretillon, Lionel/0000-0002-6957-100X	French National Institute for Agricultural Research (INRA, France); Regional Council of Burgundy (France); French Government [ANR-11-LABEX-0021]; Abbott Laboratories (Dijon, France); FEDER (European Funding for Regional Economic Development)	French National Institute for Agricultural Research (INRA, France); Regional Council of Burgundy (France)(Region Bourgogne-Franche-Comte); French Government; Abbott Laboratories (Dijon, France); FEDER (European Funding for Regional Economic Development)	A PhD fellowship to Sarah Saab-Aoude was funded by a grant from the French National Institute for Agricultural Research (INRA, France) and the Regional Council of Burgundy (France). This work was supported by a French Government grant managed by the French National Research Agency (ANR) under the program "Investissements d'Avenir'' with reference ANR-11-LABEX-0021, and by grants from Abbott Laboratories (Dijon, France), the Regional Council of Burgundy (France), and the FEDER (European Funding for Regional Economic Development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar N, 2007, EXP EYE RES, V84, P143, DOI 10.1016/j.exer.2006.09.009; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Boudard DL, 2011, INVEST OPHTH VIS SCI, V52, P8686, DOI 10.1167/iovs.11-8162; Calviello G, 2004, CARCINOGENESIS, V25, P2303, DOI 10.1093/carcin/bgh265; Chen-Konak L, 2003, FASEB J, V17, P2121, DOI 10.1096/fj.02-1151fje; Chong EWT, 2009, ARCH OPHTHALMOL-CHIC, V127, P674, DOI 10.1001/archophthalmol.2009.60; Chong EWT, 2008, ARCH OPHTHALMOL-CHIC, V126, P826, DOI 10.1001/archopht.126.6.826; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; DIAZARAYA CM, 1995, J COMP NEUROL, V363, P53, DOI 10.1002/cne.903630106; Dorrell MI, 2002, INVEST OPHTH VIS SCI, V43, P3500; Ehlken C, 2011, ACTA OPHTHALMOL, V89, P82, DOI 10.1111/j.1755-3768.2009.01609.x; Fagiani E, 2013, CANCER LETT, V328, P18, DOI 10.1016/j.canlet.2012.08.018; Farooqui A. A., 2008, METABOLISM FUNCTIONS, P85; Farooqui AA, 2010, MOL NEUROBIOL, V41, P267, DOI 10.1007/s12035-009-8091-y; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Fujikawa K, 1999, J VASC RES, V36, P272, DOI 10.1159/000025655; GARIANO RF, 1994, INVEST OPHTH VIS SCI, V35, P3442; Hartnett ME, 2012, NEW ENGL J MED, V367, P2515, DOI 10.1056/NEJMra1208129; HAZEN SL, 1991, J BIOL CHEM, V266, P5629; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hennig T, 2011, J VASC RES, V48, P453, DOI 10.1159/000327009; Hoffmann J, 2005, FASEB J, V19, P2035, DOI 10.1096/fj.04-2109fje; Ito M, 1999, ANAT EMBRYOL, V200, P403, DOI 10.1007/s004290050289; JIANG B, 1994, J CELL SCI, V107, P2499; Kermorvant-Duchemin E, 2005, NAT MED, V11, P1339, DOI 10.1038/nm1336; Kishan AU, 2011, SURV OPHTHALMOL, V56, P195, DOI 10.1016/j.survophthal.2010.08.008; Kopatz K, 2000, J NEUROCYTOL, V29, P157, DOI 10.1023/A:1026594721760; Li LX, 2010, GLIA, V58, P1157, DOI 10.1002/glia.20995; Lorger M, 2009, P NATL ACAD SCI USA, V106, P10666, DOI 10.1073/pnas.0903035106; Luhmann UFO, 2005, GENESIS, V42, P253, DOI 10.1002/gene.20141; Luu CD, 2012, INVEST OPHTH VIS SCI, V53, P2218, DOI 10.1167/iovs.11-8490; Meitinger D, 2001, EXP EYE RES, V73, P681, DOI 10.1006/exer.2001.1079; Mitchell K, 2009, J CELL SCI, V122, P1778, DOI 10.1242/jcs.040956; Pickering JG, 1997, CIRC RES, V80, P627, DOI 10.1161/01.RES.80.5.627; RENNIE D, 1975, ARCH OPHTHALMOL-CHIC, V93, P395; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; Robinson SD, 2011, CURR OPIN CELL BIOL, V23, P630, DOI 10.1016/j.ceb.2011.03.014; Rodemer C, 2003, HUM MOL GENET, V12, P1881, DOI 10.1093/hmg/ddg191; Roy S, 1996, INVEST OPHTH VIS SCI, V37, P258; Ruegg C, 2010, RECENT RESULTS CANC, V180, P83, DOI 10.1007/978-3-540-78281-0_6; Saab-Aoude S, 2013, BIOCHIMIE, V95, P903, DOI 10.1016/j.biochi.2012.12.008; Sato T, 2011, AM J OPHTHALMOL, V151, P353, DOI 10.1016/j.ajo.2010.08.037; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; SCHUSCHEREBA ST, 1994, INVEST OPHTH VIS SCI, V35, P945; Seddon JM, 2006, ARCH OPHTHALMOL-CHIC, V124, P995, DOI 10.1001/archopht.124.7.995; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; Sinha D, 2012, TRANSGENIC RES, V21, P1033, DOI 10.1007/s11248-012-9608-0; Somanath PR, 2009, CELL BIOCHEM BIOPHYS, V53, P53, DOI 10.1007/s12013-008-9040-5; Szymczak M, 2008, BLOOD, V111, P3514, DOI 10.1182/blood-2007-08-109934; Tourtas T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031340; Uemura A, 2006, J CLIN INVEST, V116, P369, DOI 10.1172/JCI25964; Vardar-Sengul S, 2008, J PERIODONTOL, V79, P1934, DOI [10.1902/jop.2008.080001, 10.1902/jop.2008.080001 ]; Wilson SH, 2003, INVEST OPHTH VIS SCI, V44, P1704, DOI 10.1167/iovs.02-0773; Zhu MD, 2000, EXP EYE RES, V70, P767, DOI 10.1006/exer.2000.0844; Zhuang W, 2013, J CARDIOVASC TRANSL, V6, P287, DOI 10.1007/s12265-012-9409-0	57	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e101076	10.1371/journal.pone.0101076	http://dx.doi.org/10.1371/journal.pone.0101076			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963632	Green Published, gold, Green Submitted			2022-12-25	WOS:000338709500117
J	Dong, QS; Cai, N; Tao, T; Zhang, R; Yan, W; Li, R; Zhang, JX; Luo, H; Shi, Y; Luan, WK; Zhang, YX; You, YP; Wang, YY; Liu, N				Dong, Qingsheng; Cai, Ning; Tao, Tao; Zhang, Rui; Yan, Wei; Li, Rui; Zhang, Junxia; Luo, Hui; Shi, Yan; Luan, Wenkang; Zhang, Yaxuan; You, Yongping; Wang, Yingyi; Liu, Ning			An Axis Involving SNAI1, microRNA-128 and SP1 Modulates Glioma Progression	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; COLORECTAL-CANCER; MALIGNANT GLIOMAS; EPITHELIAL-CELLS; EXPRESSION; METASTASIS; INVOLVEMENT; BIOGENESIS; RESISTANCE; MECHANISM	Background: Glioblastoma is an extraordinarily aggressive disease that requires more effective therapeutic options. Snail zinc finger 1, dysregulated in many neoplasms, has been reported to be involved in gliomas. However, the biological mechanisms underlying SNAI1 function in gliomas need further investigation. Methods: Quantitative real-time PCR was used to measure microRNA-128 (miR-128) expression level and western blot was performed to detect protein expression in U87 and U251 cells and human brain tissues. Cell cycle, CCK-8, transwell and wound-healing assays were performed. Dual-luciferase reporter assay was used for identifying the mechanism of SNAI1 and miR-128b regulation. The mechanism of miR-128 targeting SP1 was also tested by luciferase reporter assay. Immunohistochemistry and in situ hybridisation staining were used for quantifying SNAI1, SP1 and miR-128 expression levels in human glioma samples. Results: The Chinese Glioma Genome Atlas (CGGA) data revealed that SNAI1 was up-regulated in glioma and we confirmed the findings in normal and glioma tissues. SNAI1 depletion by shRNA retarded the cell cycle and suppressed proliferation and invasion in glioma cell lines. The CGGA data showed that the Pearson correlation index between SNAI1 and miR-128 was negatively correlated. SNAI1 suppressed miR-128b expression by binding to the miR-128b specific promoter motif, and miR-128 targeted SP1 via binding to the 3'-untranslated region of SP1. Moreover, introduction of miR-128 anti-sense oligonucleotide alleviated the cell cycle retardation, proliferation and invasion inhibition induced by SNAI1 shRNA. Immunohistochemistry and in situ hybridisation analysis of SNAI1, SP1 and miR-128 unraveled their expression levels and correlations in glioma samples. Conclusions: We propose that the SNAI1/miR-128/SP1 axis, which plays a vital role in glioma progression, may come to be a clinically relevant therapeutic target.	[Dong, Qingsheng; Cai, Ning; Zhang, Rui; Yan, Wei; Li, Rui; Zhang, Junxia; Luo, Hui; Shi, Yan; Luan, Wenkang; Zhang, Yaxuan; You, Yongping; Wang, Yingyi; Liu, Ning] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Tao, Tao] Southeast Univ, Affiliated Zhongda Hosp, Dept Urol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Southeast University - China	Wang, YY (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China.	Lindsay_wang3431@126.com; Liuning0853@126.com		Liu, Ning/0000-0001-7895-1285	National High Technology Research and Development Program of China (863) [2012AA02A508]; International Cooperation Program [2012DFA30470]; National Natural Science Foundation of China [91229121, 81272792, 81172389, 81372709, 81302185, 81101901, 81302184]; Jiangsu Province's Key Provincial Talents Program [RC2011051]; Jiangsu Province's Key Discipline of Medicine [XK201117]; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Provincial Special Program of Medical Science [BL2012028]	National High Technology Research and Development Program of China (863)(National High Technology Research and Development Program of China); International Cooperation Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province's Key Provincial Talents Program; Jiangsu Province's Key Discipline of Medicine; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Provincial Special Program of Medical Science	This work was supported by grants from the National High Technology Research and Development Program of China (863) (2012AA02A508), International Cooperation Program (2012DFA30470), National Natural Science Foundation of China (91229121, 81272792, 81172389, 81372709, 81302185, 81101901, 81302184), Jiangsu Province's Key Provincial Talents Program (RC2011051), Jiangsu Province's Key Discipline of Medicine (XK201117), Jiangsu Provincial Special Program of Medical Science (BL2012028), and Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlakha YK, 2011, CELL MOL LIFE SCI, V68, P1415, DOI 10.1007/s00018-010-0528-y; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bruyere F, 2013, UROL ONCOL, V28, P591; Cieply B, 2013, CANC RES IN PRESS; Evangelisti C, 2009, FASEB J, V23, P4276, DOI 10.1096/fj.09-134965; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Grinstein E, 2002, ONCOGENE, V21, P1485, DOI 10.1038/sj.onc.1205211; Gupta K, 2012, J CANCER RES CLIN, V138, P1971, DOI 10.1007/s00432-012-1323-y; Haar CP, 2012, NEUROCHEM RES, V37, P1192, DOI 10.1007/s11064-011-0701-1; Han SP, 2011, CELL MOL NEUROBIOL, V31, P489, DOI 10.1007/s10571-010-9643-4; He J, 2011, ONCOL REP, V26, P1305, DOI 10.3892/or.2011.1393; Jackstadt R, 2013, J EXP MED, V210, P1331, DOI 10.1084/jem.20120812; Khan AP, 2010, MOL CELL PROTEOMICS, V9, P298, DOI 10.1074/mcp.M900159-MCP200; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Laneve P, 2010, NUCLEIC ACIDS RES, V38, P6895, DOI 10.1093/nar/gkq604; Lim SO, 2010, FEBS LETT, V584, P2231, DOI 10.1016/j.febslet.2010.04.006; Lin YH, 2013, ONCOGENE, V32, P4509, DOI 10.1038/onc.2013.309; Liu L, 2013, HEPATOLOGY IN PRESS; Lou Z, 2005, CANCER RES, V65, P1007; Mestdagh P, 2010, ONCOGENE, V29, P1394, DOI 10.1038/onc.2009.429; Murray SA, 2007, DEVELOPMENT, V134, P1789, DOI 10.1242/dev.02837; Nicoloso MS, 2008, BRAIN PATHOL, V18, P122, DOI 10.1111/j.1750-3639.2007.00119.x; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nuovo GJ, 2009, NAT PROTOC, V4, P107, DOI 10.1038/nprot.2008.215; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Olson RA, 2011, J NEURO-ONCOL, V105, P325, DOI 10.1007/s11060-011-0594-5; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Qian PX, 2012, CANCER RES, V72, P6036, DOI 10.1158/0008-5472.CAN-12-1507; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Shi ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032709; Singh A, 2013, J CLIN INVEST, V123, P2921, DOI 10.1172/JCI66353; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Tao T, 2013, EUR J CANCER, V49, P3055, DOI 10.1016/j.ejca.2013.05.010; Wang YZ, 2013, CANCER LETT, V331, P139, DOI 10.1016/j.canlet.2012.12.024; Wu YD, 2010, CELL ADHES MIGR, V4, P199, DOI 10.4161/cam.4.2.10943; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yeh Chi-Tai, 2013, CARCINOGENE IN PRESS; Zannetti A, 2005, BIOCHEM PHARMACOL, V70, P1277, DOI 10.1016/j.bcp.2005.07.024; Zhang CH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-184; Zhang Y, 2009, J MOL MED, V87, P43, DOI 10.1007/s00109-008-0403-6	42	45	45	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e98651	10.1371/journal.pone.0098651	http://dx.doi.org/10.1371/journal.pone.0098651			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959930	gold, Green Published, Green Submitted			2022-12-25	WOS:000338633900002
J	Pauwels, L; Swinnen, SP; Beets, IAM				Pauwels, Lisa; Swinnen, Stephan P.; Beets, Iseult A. M.			Contextual Interference in Complex Bimanual Skill Learning Leads to Better Skill Persistence	PLOS ONE			English	Article							MOTOR-SKILL; ACQUISITION; RETENTION; TASK; CONSOLIDATION; PERFORMANCE; PRINCIPLES; SCHEDULE	The contextual interference (CI) effect is a robust phenomenon in the (motor) skill learning literature. However, CI has yielded mixed results in complex task learning. The current study addressed whether the CI effect is generalizable to bimanual skill learning, with a focus on the temporal evolution of memory processes. In contrast to previous studies, an extensive training schedule, distributed across multiple days of practice, was provided. Participants practiced three frequency ratios across three practice days following either a blocked or random practice schedule. During the acquisition phase, better overall performance for the blocked practice group was observed, but this difference diminished as practice progressed. At immediate and delayed retention, the random practice group outperformed the blocked practice group, except for the most difficult frequency ratio. Our main finding is that the random practice group showed superior performance persistence over a one week time interval in all three frequency ratios compared to the blocked practice group. This study contributes to our understanding of learning, consolidation and memory of complex motor skills, which helps optimizing training protocols in future studies and rehabilitation settings.	[Pauwels, Lisa; Swinnen, Stephan P.; Beets, Iseult A. M.] Katholieke Univ Leuven, Dept Kinesiol, Movement Control & Neuroplast Res Grp, Grp Biomed Sci, Leuven, Belgium; [Swinnen, Stephan P.] Katholieke Univ Leuven, Leuven Res Inst Neurosci & Dis LIND, Leuven, Belgium	KU Leuven; KU Leuven	Pauwels, L (corresponding author), Katholieke Univ Leuven, Dept Kinesiol, Movement Control & Neuroplast Res Grp, Grp Biomed Sci, Leuven, Belgium.	Lisa.pauwels@faber.kuleuven.be		Pauwels, Lisa/0000-0002-2033-8274	Research Program of the Research Foundation; Flanders (Fonds Wetenschappelijk Onderzoek; FWO; Research Fund of KU Leuven, Belgium [G0483.10, G0721.12]; Interuniversity Attraction Poles program of the Belgian federal government [OT/11/071, Grant P7/11]; Research Foundation - Flanders (FWO)	Research Program of the Research Foundation; Flanders (Fonds Wetenschappelijk Onderzoek; FWO(FWO); Research Fund of KU Leuven, Belgium; Interuniversity Attraction Poles program of the Belgian federal government(Belgian Federal Science Policy Office); Research Foundation - Flanders (FWO)(FWO)	This work was supported by a grant from the Research Program of the Research Foundation - Flanders (Fonds Wetenschappelijk Onderzoek - FWO; http://www.fwo.be/) (G0483.10, G0721.12), from the Research Fund of KU Leuven, Belgium (OT/11/071), and Grant P7/11 from the Interuniversity Attraction Poles program of the Belgian federal government. LP is funded by an aspirant fellowship of the Research Foundation - Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JA, 1971, J MOTOR BEHAV, V3, P111; Albaret JM, 1998, ACTA PSYCHOL, V100, P9, DOI 10.1016/S0001-6918(98)00022-5; Barnett M L, 1973, Res Q, V44, P440; Battig W.F., 1979, LEVELS PROCESSING HU, P23; Boutin A, 2010, HUM MOVEMENT SCI, V29, P910, DOI 10.1016/j.humov.2010.07.011; Brady F, 1998, QUEST, V50, P266, DOI 10.1080/00336297.1998.10484285; Guadagnoli MA, 2004, J MOTOR BEHAV, V36, P212, DOI 10.3200/JMBR.36.2.212-224; Hebert EP, 1996, RES Q EXERCISE SPORT, V67, P52, DOI 10.1080/02701367.1996.10607925; Jarus T, 2001, Can J Occup Ther, V68, P280; Kantak SS, 2012, BEHAV BRAIN RES, V228, P219, DOI 10.1016/j.bbr.2011.11.028; Kantak SS, 2010, NAT NEUROSCI, V13, P923, DOI 10.1038/nn.2596; Kay H., 1970, MECH MOTOR SKILL DEV; Kovacs AJ, 2011, ACTA PSYCHOL, V136, P311, DOI 10.1016/j.actpsy.2010.12.004; Lee T.D., 2004, SKILL ACQUISITION SP, P29; Lee T.D., 1985, DIFFERING PERSPECTIV, P3, DOI DOI 10.1016/S0166-4115(08)62528-5; LEE TD, 1983, J EXP PSYCHOL LEARN, V9, P730, DOI 10.1037/0278-7393.9.4.730; Lin CH, 2008, J MOTOR BEHAV, V40, P578, DOI 10.3200/JMBR.40.6.578-586; Lin CH, 2010, J MOTOR BEHAV, V42, P223, DOI 10.1080/00222895.2010.492720; Magill R.A, 2020, MOTOR LEARNING CONTR, V12th; MAGILL RA, 1990, HUM MOVEMENT SCI, V9, P241, DOI 10.1016/0167-9457(90)90005-X; Marteniuk R.G., 1976, INFORM PROCESSING MO; Maslovat D, 2004, MOTOR CONTROL, V8, P213, DOI 10.1123/mcj.8.2.213; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Schmidt R.A., 2011, HUMAN KINETICS; SCHMIDT RA, 1992, PSYCHOL SCI, V3, P207, DOI 10.1111/j.1467-9280.1992.tb00029.x; SHEA CH, 1990, ACTA PSYCHOL, V73, P145, DOI 10.1016/0001-6918(90)90076-R; Shea J.B., 1983, MEMORY CONTROL ACTIO, P345, DOI DOI 10.1016/S0166-4115(08)61998-6; SHEA JB, 1979, J EXP PSYCHOL-HUM L, V5, P179, DOI 10.1037/0278-7393.5.2.179; Sisti HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023619; Smith PJK, 1995, J SPORT SCI, V13, P455, DOI 10.1080/02640419508732262; Swinnen SP, 2004, TRENDS COGN SCI, V8, P18, DOI 10.1016/j.tics.2003.10.017; Tanaka S, 2010, CEREB CORTEX, V20, P2114, DOI 10.1093/cercor/bhp276; Tsutsui S, 1998, J MOTOR BEHAV, V30, P151, DOI 10.1080/00222899809601332; WINSTEIN CJ, 1990, J EXP PSYCHOL LEARN, V16, P677, DOI 10.1037/0278-7393.16.4.677; WRISBERG CA, 1991, RES Q EXERCISE SPORT, V62, P406, DOI 10.1080/02701367.1991.10607541; Wulf G, 2002, PSYCHON B REV, V9, P185, DOI 10.3758/BF03196276; YOUNG DE, 1993, HUM MOVEMENT SCI, V12, P577, DOI 10.1016/0167-9457(93)90005-A	37	29	29	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100906	10.1371/journal.pone.0100906	http://dx.doi.org/10.1371/journal.pone.0100906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7UT	24960171	Green Published, Green Submitted, gold			2022-12-25	WOS:000338633900100
J	McDevitt, AD; Montgomery, WI; Tosh, DG; Lusby, J; Reid, N; White, TA; McDevitt, CD; O'Halloran, J; Searle, JB; Yearsley, JM				McDevitt, Allan D.; Montgomery, W. Ian; Tosh, David G.; Lusby, John; Reid, Neil; White, Thomas A.; McDevitt, C. Damien; O'Halloran, John; Searle, Jeremy B.; Yearsley, Jon M.			Invading and Expanding: Range Dynamics and Ecological Consequences of the Greater White-Toothed Shrew (Crocidura russula) Invasion in Ireland	PLOS ONE			English	Article							SOREX-MINUTUS; CLETHRIONOMYS-GLAREOLUS; DISPERSAL; EVOLUTION; COLONIZATION; COMPETITION; EXPANSION; RATES; IMPACTS; POPULATIONS	Establishing how invasive species impact upon pre-existing species is a fundamental question in ecology and conservation biology. The greater white-toothed shrew (Crocidura russula) is an invasive species in Ireland that was first recorded in 2007 and which, according to initial data, may be limiting the abundance/distribution of the pygmy shrew (Sorex minutus), previously Ireland's only shrew species. Because of these concerns, we undertook an intensive live-trapping survey (and used other data from live-trapping, sightings and bird of prey pellets/nest inspections collected between 2006 and 2013) to model the distribution and expansion of C. russula in Ireland and its impacts on Ireland's small mammal community. The main distribution range of C. russula was found to be approximately 7,600 km 2 in 2013, with established outlier populations suggesting that the species is dispersing with human assistance within the island. The species is expanding rapidly for a small mammal, with a radial expansion rate of 5.5 km/yr overall (2008-2013), and independent estimates from live-trapping in 2012-2013 showing rates of 2.4-14.1 km/yr, 0.5-7.1 km/yr and 0-5.6 km/yr depending on the landscape features present. S. minutus is negatively associated with C. russula. S. minutus is completely absent at sites where C. russula is established and is only present at sites at the edge of and beyond the invasion range of C. russula. The speed of this invasion and the homogenous nature of the Irish landscape may mean that S. minutus has not had sufficient time to adapt to the sudden appearance of C. russula. This may mean the continued decline/disappearance of S. minutus as C. russula spreads throughout the island.	[McDevitt, Allan D.; Yearsley, Jon M.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland; [Montgomery, W. Ian; Tosh, David G.; Reid, Neil] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Lusby, John] Birdwatch Ireland, Kilcoole, Wicklow, Ireland; [White, Thomas A.; Searle, Jeremy B.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [White, Thomas A.] Univ Oulu, Dept Biol, Oulu, Finland; [McDevitt, C. Damien] Deele Coll, Raphoe, Donegal, Ireland; [O'Halloran, John] Natl Univ Ireland Univ Coll Cork, Sch Biol Earth & Environm Sci, Cork, Ireland	University College Dublin; Queens University Belfast; Cornell University; University of Oulu; University College Cork	McDevitt, AD (corresponding author), Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland.	amcdev@gmail.com	Reid, Neil/D-1896-2010; Reid, Neil/M-8517-2019; Yearsley, Jon/H-5301-2011; McDevitt, Allan/A-9316-2011	Reid, Neil/0000-0001-8951-8292; Reid, Neil/0000-0001-8951-8292; Yearsley, Jon/0000-0003-1838-0454; Searle, Jeremy/0000-0001-7710-5204; McDevitt, Allan/0000-0002-2677-7833	Government of Ireland Postdoctoral Fellowship by the Irish Research Council (IRC); Heritage Council (HC), a Heredity Fieldwork Grant from the Genetics Society; Vincent Wildlife Trust; HC; Embark Scholarship from the IRC; National Parks and Wildlife Services of the Department of Arts, Heritage and the Gaelthacht; Department of Agriculture, Fisheries and the Marine; Kerry Co. Council; Cork Co. Council; Galway Co. Council; Northern Ireland Environment Agency; Quercus, Queen's University Belfast	Government of Ireland Postdoctoral Fellowship by the Irish Research Council (IRC); Heritage Council (HC), a Heredity Fieldwork Grant from the Genetics Society; Vincent Wildlife Trust; HC; Embark Scholarship from the IRC; National Parks and Wildlife Services of the Department of Arts, Heritage and the Gaelthacht; Department of Agriculture, Fisheries and the Marine; Kerry Co. Council; Cork Co. Council; Galway Co. Council; Northern Ireland Environment Agency; Quercus, Queen's University Belfast	ADM was funded by a Government of Ireland Postdoctoral Fellowship awarded by the Irish Research Council (IRC), and was provided with additional funding by the Heritage Council (HC), a Heredity Fieldwork Grant from the Genetics Society, and the Vincent Wildlife Trust. DGT was supported by the HC. JL was funded by an Embark Scholarship from the IRC; BirdWatch Ireland received funding through The National Parks and Wildlife Services of the Department of Arts, Heritage and the Gaelthacht; The Department of Agriculture, Fisheries and the Marine; the HC; Kerry Co. Council; Cork Co. Council and Galway Co. Council. NR was supported by the Natural Heritage Research Partnership between the Northern Ireland Environment Agency and Quercus, Queen's University Belfast. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Askew NP, 2006, THESIS U YORK; Barton KA, 2012, P ROY SOC B-BIOL SCI, V279, P1194, DOI 10.1098/rspb.2011.1254; Bouteiller C, 2000, P ROY SOC B-BIOL SCI, V267, P701, DOI 10.1098/rspb.2000.1059; Burton OJ, 2010, ECOL LETT, V13, P1210, DOI 10.1111/j.1461-0248.2010.01505.x; Butet A, 2006, AGR ECOSYST ENVIRON, V113, P364, DOI 10.1016/j.agee.2005.10.008; CANTONI D, 1989, ANIM BEHAV, V38, P205, DOI 10.1016/S0003-3472(89)80083-1; Churchfield S, 2006, J ZOOL, V269, P381, DOI 10.1111/j.1469-7998.2006.00115.x; Churchfield S, 1997, J ZOOL, V241, P55, DOI 10.1111/j.1469-7998.1997.tb05499.x; Churchfield S, 2008, MAMMALS BRIT ISLES H, P267; Churchfield S, 2008, MAMMALS BRIT ISLES H, P280; Cornette R, 2012, BIOL J LINN SOC, V107, P322, DOI 10.1111/j.1095-8312.2012.01934.x; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; DeCesare NJ, 2010, ANIM CONSERV, V13, P353, DOI 10.1111/j.1469-1795.2009.00328.x; DICKMAN CR, 1988, ECOLOGY, V69, P569, DOI 10.2307/1941006; Dussex N, 2008, THESIS U LAUSANNE; ELLENBROEK FJM, 1980, J ZOOL, V192, P119; Favre L, 1997, P ROY SOC B-BIOL SCI, V264, P127, DOI 10.1098/rspb.1997.0019; Flowerdew JR, 2004, MAMMAL REV, V34, P31, DOI 10.1046/j.0305-1838.2003.00025.x; Fontanillas P, 2004, EVOLUTION, V58, P886; Forsman A, 2011, P ROY SOC B-BIOL SCI, V278, P225, DOI 10.1098/rspb.2010.1325; GRAINGER JP, 1978, J ZOOL, V186, P109, DOI 10.1111/j.1469-7998.1978.tb03360.x; Guelat J, 2008, ECOLOGY, V89, P2033, DOI 10.1890/07-0905.1; HANSKI I, 1989, ANN ZOOL FENN, V26, P339; Jaquiery J, 2008, ECOLOGY, V89, P2777, DOI 10.1890/07-1833.1; Lindstrom T, 2013, P NATL ACAD SCI USA, V110, P13452, DOI 10.1073/pnas.1303157110; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Maestri R, 2014, ACTA THERIOL, V59, P427, DOI 10.1007/s13364-014-0177-x; MALMQUIST M, 1986, OECOLOGIA, V68, P344, DOI 10.1007/BF01036736; McDevitt AD, 2011, HEREDITY, V107, P548, DOI 10.1038/hdy.2011.41; McDevitt AD, 2008, THESIS U COLL DUBLIN; McDevitt AD, 2009, BIOL J LINN SOC, V97, P918, DOI 10.1111/j.1095-8312.2009.01218.x; Meehan JM, 2005, THESIS U COLL DUBLIN; MEHARG MJ, 1990, J ZOOL, V222, P1, DOI 10.1111/j.1469-7998.1990.tb04025.x; MICHIELSEN NORA CROIN, 1966, ARCH NEER ZOOL, V17, P73; MitchellJones A.J., 1999, ATLAS EUROPEAN MAMMA; Montgomery WI, 2012, BIOL INVASIONS, V14, P1111, DOI 10.1007/s10530-011-0142-4; O'Meara DB, 2014, ACTA THERIOL, V59, P111, DOI 10.1007/s13364-013-0155-8; PELTONEN A, 1991, ECOLOGY, V72, P1698, DOI 10.2307/1940969; Perkins TA, 2013, ECOL LETT, V16, P1079, DOI 10.1111/ele.12136; Petren K, 1998, P NATL ACAD SCI USA, V95, P11739, DOI 10.1073/pnas.95.20.11739; Petren K, 1996, ECOLOGY, V77, P118, DOI 10.2307/2265661; Phillips BL, 2010, J EVOLUTION BIOL, V23, P2595, DOI 10.1111/j.1420-9101.2010.02118.x; Phillips BL, 2009, BIOL LETTERS, V5, P802, DOI 10.1098/rsbl.2009.0367; Phillips BL, 2007, AUSTRAL ECOL, V32, P169, DOI 10.1111/j.1442-9993.2007.01664.x; Phillips BL, 2006, NATURE, V439, P803, DOI 10.1038/439803a; PREECE RC, 1986, J BIOGEOGR, V13, P487, DOI 10.2307/2844814; Reid N, 2011, BIOL INVASIONS, V13, P559, DOI 10.1007/s10530-010-9849-x; Service Forest, 2007, NAT FOR INV IR RES; Shawyer C. R., 1998, THE BARN OWL; Shine R, 2010, Q REV BIOL, V85, P253, DOI 10.1086/655116; Shine R, 2011, P NATL ACAD SCI USA, V108, P5708, DOI 10.1073/pnas.1018989108; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; SMAL CM, 1984, MAMMAL REV, V14, P71, DOI 10.1111/j.1365-2907.1984.tb00340.x; Solow A, 2008, J APPL ECOL, V45, P424, DOI 10.1111/j.1365-2664.2007.01446.x; Sutherland WJ, 2013, J ECOL, V101, P58, DOI 10.1111/1365-2745.12025; Terrink BJ, 1991, HAIR W EUROPEAN MAMM; Tosh DG, 2008, MAMMAL REV, V38, P321, DOI 10.1111/j.1365-2907.2008.00130.x; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Village A., 1990, THE KESTREL; Vogel P, 2002, ACTA THERIOL, V47, P15, DOI 10.1007/BF03193562; WATTS CHS, 1968, J ANIM ECOL, V37, P25, DOI 10.2307/2709; White TA, 2013, MOL ECOL, V22, P2971, DOI 10.1111/mec.12343; White TA, 2012, BIOL INVASIONS, V14, P2203, DOI 10.1007/s10530-012-0225-x; WOLFE JL, 1989, ANIM BEHAV, V37, P410, DOI 10.1016/0003-3472(89)90088-2; YALDEN D W, 1973, Mammalia, V37, P257, DOI 10.1515/mamm.1973.37.2.257; YALDEN DW, 1985, BIRD STUDY, V32, P50, DOI 10.1080/00063658509476855; Yalden DW, 2003, ANAL OWL PELLETS	71	20	20	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100403	10.1371/journal.pone.0100403	http://dx.doi.org/10.1371/journal.pone.0100403			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955824	Green Published, Green Submitted, gold			2022-12-25	WOS:000338917900048
J	Razak, FA; Jensen, HJ				Razak, Fatimah Abdul; Jensen, Henrik Jeldtoft			Quantifying 'Causality' in Complex Systems: Understanding Transfer Entropy	PLOS ONE			English	Article							TIME-SERIES	'Causal' direction is of great importance when dealing with complex systems. Often big volumes of data in the form of time series are available and it is important to develop methods that can inform about possible causal connections between the different observables. Here we investigate the ability of the Transfer Entropy measure to identify causal relations embedded in emergent coherent correlations. We do this by firstly applying Transfer Entropy to an amended Ising model. In addition we use a simple Random Transition model to test the reliability of Transfer Entropy as a measure of 'causal' direction in the presence of stochastic fluctuations. In particular we systematically study the effect of the finite size of data sets.	[Razak, Fatimah Abdul; Jensen, Henrik Jeldtoft] Univ London Imperial Coll Sci Technol & Med, Complex & Networks Grp, London, England; [Razak, Fatimah Abdul; Jensen, Henrik Jeldtoft] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England; [Razak, Fatimah Abdul] Univ Kebangsaan Malaysia, Sch Math Sci, Fac Sci & Technol, Bangi 43600, Selangor, Malaysia	Imperial College London; Imperial College London; Universiti Kebangsaan Malaysia	Razak, FA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Complex & Networks Grp, London, England.	fatima84@ukm.edu.my	Razak, Fatimah Abdul/AAT-8224-2021	Razak, Fatimah Abdul/0000-0002-3045-7963	Universiti Kebangsaan Malaysia [GGPM-2013-067, DLP-2013-007]	Universiti Kebangsaan Malaysia	The authors gratefully acknowledge the financial support received in the form of research grants from Universiti Kebangsaan Malaysia (GGPM-2013-067 and DLP-2013-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Razak F, 2013, THESIS IMPERIAL COLL; [Anonymous], 2008, POLITICAL I DICTATOR; Bak P., 1996, NATURE WORKS SCI SEL; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Christensen K., 2005, COMPLEXITY CRITICALI, V1, DOI DOI 10.1142/P365; CIPRA BA, 1987, AM MATH MON, V94, P937, DOI 10.2307/2322600; Cover TM., 1999, ELEMENTS INFORM THEO; Friston KJ, 2011, NEUROIMAGE, V58, P303, DOI 10.1016/j.neuroimage.2009.09.031; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hausman D. M., 1999, BRIT J PHILOS SCI, V50, P151, DOI [10.1093/bjps/50.1.151, DOI 10.1093/BJPS/50.1.151]; Hlavackova-Schindler K, 2007, PHYS REP, V441, P1, DOI 10.1016/j.physrep.2006.12.004; Jensen H.J., 1998, SELF ORG CRITICALITY; Jensen HJ, 2009, ENCY COMPLEXITY SYST, P7024; Kaiser A, 2002, PHYSICA D, V166, P43, DOI 10.1016/S0167-2789(02)00432-3; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Krauth W., 2006, STAT MECH ALGORITHMS; Li ZH, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021929; Lungarella M, 2007, INT J BIFURCAT CHAOS, V17, P903, DOI 10.1142/S0218127407017628; Marschinski R, 2002, EUR PHYS J B, V30, P275, DOI 10.1140/epjb/e2002-00379-2; Martini M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.011919; Nichols JM, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046217; Palus M, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.055201; Papana A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036207; Pompe B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051122; Pruessner G, 2012, SELF-ORGANISED CRITICALITY: THEORY, MODELS AND CHARACTERISATION, P1; Runge J, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.061121; Sauer N., 2010, T ROY SOC S AFR, V65, P65, DOI [DOI 10.1080/00359191003680091, 10.1080/00359191003680091]; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; THEILER J, 1986, PHYS REV A, V34, P2427, DOI 10.1103/PhysRevA.34.2427; Vejmelka M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026214; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Wibral M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055809; Wiener Norbert, 1956, I AM MATH LATER LIFE; Witthauer L., 2007, PHASE TRANSITION 2D	35	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99462	10.1371/journal.pone.0099462	http://dx.doi.org/10.1371/journal.pone.0099462			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955766	Green Submitted, gold, Green Published			2022-12-25	WOS:000338917900011
J	Xu, K; Xu, P				Xu, Ke; Xu, Ping			Betaine and Beet Molasses Enhance L-Lactic Acid Production by Bacillus coagulans	PLOS ONE			English	Article							GLYCINE BETAINE; OSMOTIC-STRESS; FERMENTATION; TOLERANCE; STRATEGY; GLUCOSE; BATCH; ACCUMULATION; SUBTILIS	Lactic acid is an important chemical with various industrial applications, and it can be efficiently produced by fermentation, in which Bacillus coagulans strains present excellent performance. Betaine can promote lactic acid fermentation as an effective osmoprotectant. Here, positive effect of betaine on fermentation by B. coagulans is revealed. Betaine could enhance lactic acid production by protecting L-LDH activity and cell growth from osmotic inhibition, especially under high glucose concentrations and with poor organic nitrogen nutrients. The fermentation with 0.05 g/L betaine could produce 17.9% more lactic acid compared to the fermentation without betaine. Beet molasses, which is rich in sucrose and betaine, was utilized in a co-feeding fermentation and raised the productivity by 22%. The efficient lactic acid fermentation by B. coagulans is thus developed by using betaine and beet molasses.	[Xu, Ke; Xu, Ping] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Xu, Ke; Xu, Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xu, P (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	pingxu@sjtu.edu.cn		Xu, Ping/0000-0002-4418-9680	National Basic Research Program of China from Ministry of Science and Technology of China [2013CB733901]; National Natural Science Foundation of China [31121064]; Chinese National Program for High Technology Research and Development [2011AA02A202]	National Basic Research Program of China from Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Program for High Technology Research and Development(National High Technology Research and Development Program of China)	The authors acknowledge the National Basic Research Program of China (2013CB733901) from Ministry of Science and Technology of China, and the grant from National Natural Science Foundation of China (31121064). This work was partially supported by the Chinese National Program for High Technology Research and Development (2011AA02A202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman MA, 2013, BIOTECHNOL ADV, V31, P877, DOI 10.1016/j.biotechadv.2013.04.002; Akerberg C, 1998, APPL MICROBIOL BIOT, V49, P682, DOI 10.1007/s002530051232; Boniolo FS, 2009, CURR MICROBIOL, V59, P593, DOI 10.1007/s00284-009-9479-7; Calik P, 2009, APPL MICROBIOL BIOT, V85, P65, DOI 10.1007/s00253-009-2060-2; Chojnacka A, 2011, BIORESOURCE TECHNOL, V102, P10057, DOI 10.1016/j.biortech.2011.08.063; Ding SF, 2006, PROCESS BIOCHEM, V41, P1451, DOI 10.1016/j.procbio.2006.01.014; Gao C, 2011, BIOTECHNOL ADV, V29, P930, DOI 10.1016/j.biotechadv.2011.07.022; Ge XY, 2011, APPL MICROBIOL BIOT, V89, P73, DOI 10.1007/s00253-010-2868-9; Goksungur Y, 1997, J CHEM TECHNOL BIOT, V69, P399, DOI [10.1002/(SICI)1097-4660(199708)69:4&lt;399::AID-JCTB728&gt;3.0.CO;2-Q, 10.1002/(SICI)1097-4660(199708)69:4<399::AID-JCTB728>3.0.CO;2-Q]; Hatano K, 2009, BIORESOURCE TECHNOL, V100, P4697, DOI 10.1016/j.biortech.2009.04.063; Hoffmann T, 2013, J BACTERIOL, V195, P510, DOI 10.1128/JB.01505-12; Lotfy WA, 2007, BIORESOURCE TECHNOL, V98, P3491, DOI 10.1016/j.biortech.2006.11.035; Maqueda M, 2011, J IND MICROBIOL BIOT, V38, P459, DOI 10.1007/s10295-010-0790-x; Obis D, 2001, FEMS MICROBIOL LETT, V202, P39, DOI [10.1111/j.1574-6968.2001.tb10777.x, 10.1016/S0378-1097(01)00293-2]; Ou MS, 2011, J IND MICROBIOL BIOT, V38, P599, DOI 10.1007/s10295-010-0796-4; Robert H, 2000, APPL ENVIRON MICROB, V66, P509, DOI 10.1128/AEM.66.2.509-517.2000; Romero-Garcia S, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-23; Ronsch H, 2003, J BIOTECHNOL, V104, P87, DOI 10.1016/S0168-1656(03)00166-4; Roukas T, 1999, APPL BIOCHEM BIOTECH, V80, P77, DOI 10.1385/ABAB:80:1:77; Sashihara T, 2001, APPL MICROBIOL BIOT, V56, P496, DOI 10.1007/s002530100669; Selmer-Olsen E, 1999, J APPL MICROBIOL, V87, P429, DOI 10.1046/j.1365-2672.1999.00839.x; SUTHERLAND L, 1986, J BACTERIOL, V168, P805, DOI 10.1128/jb.168.2.805-814.1986; THOMAS KC, 1994, APPL ENVIRON MICROB, V60, P1519, DOI 10.1128/AEM.60.5.1519-1524.1994; Wang XL, 2012, BIORESOURCE TECHNOL, V125, P165, DOI 10.1016/j.biortech.2012.08.125; Xi YL, 2013, BIORESOURCE TECHNOL, V136, P775, DOI 10.1016/j.biortech.2013.03.107; Xu K, 2013, GENOME ANNOUNC, V1; Xu K, 2014, BIORESOURCE TECHNOL, V153, P23, DOI 10.1016/j.biortech.2013.11.057; Yang LB, 2014, BIORESOURCE TECHNOL, V151, P120, DOI 10.1016/j.biortech.2013.10.031; Yu L, 2008, J BIOTECHNOL, V134, P154, DOI 10.1016/j.jbiotec.2008.01.008; Zheng ZJ, 2012, APPL ENVIRON MICROB, V78, P3480, DOI 10.1128/AEM.00058-12; Zhou S, 2006, BIOTECHNOL LETT, V28, P671, DOI 10.1007/s10529-006-0033-4; Zhou XD, 2013, APPL MICROBIOL BIOT, V97, P4309, DOI 10.1007/s00253-013-4710-7; Zou HB, 2013, BIORESOURCE TECHNOL, V148, P591, DOI 10.1016/j.biortech.2013.08.105	33	19	19	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100731	10.1371/journal.pone.0100731	http://dx.doi.org/10.1371/journal.pone.0100731			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956474	Green Published, Green Submitted, gold			2022-12-25	WOS:000338917900090
J	Li, N; Yu, J; Cao, X; Wu, QY; Li, WW; Li, TF; Zhang, C; Cui, YX; Li, XJ; Yin, ZM; Xia, XY				Li, Na; Yu, Jian; Cao, Xiang; Wu, Qiu-Yue; Li, Wei-Wei; Li, Tian-Fu; Zhang, Cui; Cui, Ying-Xia; Li, Xiao-Jun; Yin, Zhi-Min; Xia, Xin-Yi			A Novel p. Gly630Ser Mutation of COL2A1 in a Chinese Family with Presentations of Legg-Calve-Perthes Disease or Avascular Necrosis of the Femoral Head	PLOS ONE			English	Article							COLLAGEN GENE; CARTILAGE; PROPEPTIDE; SPECTRUM; BONE	Objective: Mutations in the type II collagen gene are associated with certain human disorders, collectively termed type II collagenopathies. They include Legg-Calve-Perthes disease (LCPD) and avascular necrosis of the femoral head (ANFH). These two diseases are skeletal dysplasias, inherited in an autosomal dominant fashion, characterized by groin pain, dislocation of the hip and diminished joint mobility. Coxa vara and elevation of the greater trochanter of the femur comprise the typical phenotype of LCPD, but do not occur in ANFH. Lack of synthesis of type II collagen and structural defects are responsible for the major clinical outcomes, because collagen is the essential matrix protein of all connective tissues. Type II collagen, encoded by the COL2A1 gene, contains N- and C-terminal regions that are cleaved after secretion into the extracellular matrix, and the core area is composed of a triple helical (Gly-X-Y) domain. If the Gly in this specific region is replaced by other amino acids, the structure of type II collagen will be destroyed. Method: Forty-five members of a four-generation family were recruited and investigated. Diagnosis was made by independent orthopedic surgeons and radiologists. A mutation of the COL2A1 gene was detected. Result: In our research, we identify a heterozygous mutation (c.1888 G>A, p. Gly630Ser) in exon 29 of COL2A1 in the Gly-X-Y domain, in a Chinese family affected by LCPD and ANFH. Our findings provide significant clues to the phenotype-genotype relationships in these syndromes and may be helpful in clinical diagnosis. Furthermore, these results should assist further studies of the mechanisms underlying collagen diseases. Conclusion: Our data add new variants to the repertoire of COL2A1 mutation resulting in related collagenopathies.	[Li, Na; Cao, Xiang; Wu, Qiu-Yue; Li, Wei-Wei; Li, Tian-Fu; Zhang, Cui; Cui, Ying-Xia; Li, Xiao-Jun; Yin, Zhi-Min; Xia, Xin-Yi] Nanjing Univ, Sch Med, Jinling Hosp, Inst Lab Med, Nanjing 210008, Jiangsu, Peoples R China; [Yu, Jian] Nanjing Univ, Sch Med, Jinling Hosp, Dept Orthopaed, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Xia, XY (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Inst Lab Med, Nanjing 210008, Jiangsu, Peoples R China.	xinyixia78@gmail.com			Natural Science Foundation of Jiangsu province [BK2011660]; Key Foundation of Jiangsu Science and Technology Bureau [BM2013058]	Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Key Foundation of Jiangsu Science and Technology Bureau	This work was financially supported by grants from the Natural Science Foundation of Jiangsu province (BK2011660) and Key Foundation of Jiangsu Science and Technology Bureau (BM2013058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON IJ, 1990, AM J HUM GENET, V46, P896; CHEAH KSE, 1991, DEVELOPMENT, V111, P945; Chung HJ, 2009, J MOL BIOL, V390, P306, DOI 10.1016/j.jmb.2009.05.004; Eyre D, 2002, ARTHRITIS RES, V4, P30, DOI 10.1186/ar380; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; GODFREY M, 1988, AM J HUM GENET, V43, P894; Jobling R, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-013-0394-3; Kannu P, 2011, AM J MED GENET A, V155A, P1759, DOI 10.1002/ajmg.a.34056; Kannu P, 2011, CLIN ORTHOP RELAT R, V469, P1785, DOI 10.1007/s11999-011-1850-x; Kerachian MA, 2006, ENDOTHELIUM-J ENDOTH, V13, P237, DOI 10.1080/10623320600904211; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; Lamande SR, 1999, SEMIN CELL DEV BIOL, V10, P455, DOI 10.1006/scdb.1999.0317; Liu YF, 2005, NEW ENGL J MED, V352, P2294, DOI 10.1056/NEJMoa042480; Meredith SP, 2007, BRIT J OPHTHALMOL, V91, P1148, DOI 10.1136/bjo.2006.112482; Miyamoto Y, 2007, HUM GENET, V121, P625, DOI 10.1007/s00439-007-0354-y; Mortier GR, 2000, J MED GENET, V37, P263, DOI 10.1136/jmg.37.4.263; Nishimura G, 2005, HUM MUTAT, V26, P36, DOI 10.1002/humu.20179; Pace JM, 2001, J MED GENET, V38, P443, DOI 10.1136/jmg.38.7.443; Seegmiller RE, 2008, J HISTOCHEM CYTOCHEM, V56, P1003, DOI 10.1369/jhc.2008.951673; Su PQ, 2008, ARTHRITIS RHEUM-US, V58, P1701, DOI 10.1002/art.23491; TAKAHASHI E, 1990, HUM GENET, V86, P14; Terhal PA, 2012, AM J MED GENET C, V160C, P205, DOI 10.1002/ajmg.c.31332; TILLER GE, 1995, AM J HUM GENET, V56, P388; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Yang RC, 2013, J FORMOS MED ASSOC, pS0929	25	41	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100505	10.1371/journal.pone.0100505	http://dx.doi.org/10.1371/journal.pone.0100505			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949742	Green Submitted, Green Published, gold			2022-12-25	WOS:000338276300081
J	Pohlkamp, T; Steller, L; May, P; Gunther, T; Schule, R; Frotscher, M; Herz, J; Bock, HH				Pohlkamp, Theresa; Steller, Laura; May, Petra; Guenther, Thomas; Schuele, Roland; Frotscher, Michael; Herz, Joachim; Bock, Hans H.			Generation and Characterization of an Nse-CreER(T2) Transgenic Line Suitable for Inducible Gene Manipulation in Cerebellar Granule Cells	PLOS ONE			English	Article							CRE RECOMBINASE ACTIVITY; MOUSE CEREBELLUM; PURKINJE-CELLS; QUANTITATIVE-ANALYSIS; NEURONAL MARKER; DIFFERENTIATION; EXPRESSION; MIGRATION; CORTEX; PROLIFERATION	We created an Nse-CreER(T2) mouse line expressing the tamoxifen-inducible CreER(T2) recombinase under the control of the neuron-specific enolase (Nse) promoter. By using Cre reporter lines we could show that this Nse-CreER(T2) line has recombination activity in the granule cells of all cerebellar lobules as well as in postmitotic granule cell precursors in the external granular layer of the developing cerebellum. A few hippocampal dentate gyrus granule cells showed Cre-mediated recombination as well. Cre activity could be induced in both the developing and adult mouse brain. The established mouse line constitutes a valuable tool to study the function of genes expressed by cerebellar granule cells in the developing and adult brain. In combination with reporter lines it is a useful model to analyze the development and maintenance of the cerebellar architecture including granule cell distribution, migration, and the extension of granule cell fibers in vivo.	[Pohlkamp, Theresa; Steller, Laura; May, Petra; Herz, Joachim; Bock, Hans H.] Univ Freiburg, Ctr Neurosci, Dept Neuroanat, D-79106 Freiburg, Germany; [Pohlkamp, Theresa; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [May, Petra; Bock, Hans H.] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infectiol, Dusseldorf, Germany; [Guenther, Thomas; Schuele, Roland] Univ Hosp Freiburg, Dept Urol, Freiburg, Germany; [Frotscher, Michael] Univ Hamburg, Ctr Mol Neurobiol, Inst Struct Neurobiol, Hamburg, Germany	University of Freiburg; University of Texas System; University of Texas Southwestern Medical Center Dallas; Heinrich Heine University Dusseldorf; University of Freiburg; University of Hamburg	Pohlkamp, T (corresponding author), Univ Freiburg, Ctr Neurosci, Dept Neuroanat, Hugstetter Str 55, D-79106 Freiburg, Germany.	theresa@herzlab.org; joachim.herz@utsouthwestern.edu; hans.bock@med.uni-duesseldorf.de	Bock, Hans/AAF-2635-2021; Pohlkamp, Theresa/H-2705-2019	Pohlkamp, Theresa/0000-0003-3923-1917; Gunther, Thomas/0000-0003-3903-9490	Deutsche Forschungsgemeinschaft (DFG) [SFB 780/TP5, MA2410/1-3, -4, FR 620/12-1]; National Institutes of Health (NIH) [R37 HL63762]; Bundesministerium fur Bildung und Forschung (BMBF, e:bio ReelinSys); Humboldt Foundation; American Health Assistance Foundation; Consortium for Frontotemporal Dementia Research; Bright Focus Foundation; Lupe Murchison Foundation; Ted Nash Long Life Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063762, R37HL063762] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bundesministerium fur Bildung und Forschung (BMBF, e:bio ReelinSys); Humboldt Foundation(Alexander von Humboldt Foundation); American Health Assistance Foundation(BrightFocus Foundation); Consortium for Frontotemporal Dementia Research; Bright Focus Foundation(BrightFocus Foundation); Lupe Murchison Foundation; Ted Nash Long Life Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) (grant numbers SFB 780/TP5 to J.H., H.B. and M.F.), MA2410/1-3 and -4 (P.M.), FR 620/12-1, National Institutes of Health (NIH) grant R37 HL63762 (to J.H.), and Bundesministerium fur Bildung und Forschung (BMBF, e:bio ReelinSys, to H.B.). J.H. was the recipient of a Wolfgang Paul award of the Humboldt Foundation and is further supported by the American Health Assistance Foundation, the Consortium for Frontotemporal Dementia Research, the Bright Focus Foundation, the Lupe Murchison Foundation, and The Ted Nash Long Life Foundation. M.F. is Senior Professor for Neuroscience of the Hertie Foundation. The authors wish to thank Jonathan Goldner, Aileen Koch, Tamara Terrones and Sandy Turner for technical support with genotyping. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN ND, 1988, NATURE, V333, P852, DOI 10.1038/333852a0; BAPTISTA CA, 1994, NEURON, V12, P243, DOI 10.1016/0896-6273(94)90268-2; BAYER SA, 1980, J COMP NEUROL, V190, P87, DOI 10.1002/cne.901900107; Chizhikov V, 2003, MOL GENET METAB, V80, P54, DOI 10.1016/j.ymgme.2003.08.019; Chow LML, 2006, DEV DYNAM, V235, P2991, DOI 10.1002/dvdy.20948; Cinato E, 2001, GENESIS, V31, P118, DOI 10.1002/gene.10014; ECCLES JC, 1966, EXP BRAIN RES, V1, P1; EDWARDS MA, 1986, J COMP NEUROL, V248, P410, DOI 10.1002/cne.902480309; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; FUJITA S, 1966, J COMP NEUROL, V128, P191, DOI 10.1002/cne.901280206; FUJITA S, 1967, J CELL BIOL, V32, P277, DOI 10.1083/jcb.32.2.277; HAMORI J, 1983, J COMP NEUROL, V220, P365, DOI 10.1002/cne.902200402; HANAWAY J, 1967, J COMP NEUROL, V131, P1, DOI 10.1002/cne.901310102; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Herrup K, 1997, ANNU REV NEUROSCI, V20, P61, DOI 10.1146/annurev.neuro.20.1.61; Hirai H, 2000, J NEUROSCI, V20, P5217, DOI 10.1523/JNEUROSCI.20-14-05217.2000; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Kaneko M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020108; Kioussis D, 1997, CURR OPIN GENET DEV, V7, P614, DOI 10.1016/S0959-437X(97)80008-1; KOMURO H, 1995, J NEUROSCI, V15, P1110; KOSAKA T, 1993, EXP BRAIN RES, V93, P483; Kwon CH, 2006, GENESIS, V44, P130, DOI 10.1002/gene.20197; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Massey PV, 2007, TRENDS NEUROSCI, V30, P176, DOI 10.1016/j.tins.2007.02.005; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; Morrison ME, 1998, J NEUROSCI, V18, P3563; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; Ram?n, 1995, HISTOLOGY NERVOUS SY; Reinert RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033529; SADLER M, 1984, PROC R SOC SER B-BIO, V221, P349, DOI 10.1098/rspb.1984.0037; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Sgaier SK, 2005, NEURON, V45, P27, DOI 10.1016/S0896-6273(04)00802-5; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Szentagothai J, 1963, MAGY TUD AKAD BIOL, V6, P217; Tsujita M, 1999, J NEUROSCI, V19, P10318; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Weyer A, 2003, J NEUROSCI RES, V73, P400, DOI 10.1002/jnr.10655; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; ZILLA P, 1985, ACTA ANAT, V124, P181	43	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100384	10.1371/journal.pone.0100384	http://dx.doi.org/10.1371/journal.pone.0100384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950299	Green Published, Green Submitted, gold			2022-12-25	WOS:000338276300071
J	Krupna-Gaylord, MA; Liveris, D; Love, AC; Wormser, GP; Schwartz, I; Petzke, MM				Krupna-Gaylord, Michelle A.; Liveris, Dionysios; Love, Andrea C.; Wormser, Gary P.; Schwartz, Ira; Petzke, Mary M.			Induction of Type I and Type III Interferons by Borrelia burgdorferi Correlates with Pathogenesis and Requires Linear Plasmid 36	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; FIBRONECTIN-BINDING PROTEIN; INNATE IMMUNE ACTIVATION; DENDRITIC CELLS; SENSU-STRICTO; INDOLEAMINE 2,3-DIOXYGENASE; HEMATOGENOUS DISSEMINATION; EXTRACHROMOSOMAL DNAS; PERIPHERAL-BLOOD; EXPRESSION	The capacity for Borrelia burgdorferi to cause disseminated infection in humans or mice is associated with the genotype of the infecting strain. The cytokine profiles elicited by B. burgdorferi clinical isolates of different genotype (ribosomal spacer type) groups were assessed in a human PBMC co-incubation model. RST1 isolates, which are more frequently associated with disseminated Lyme disease in humans and mice, induced significantly higher levels of IFN-alpha and IFN-lambda/IL29 relative to RST3 isolates, which are less frequently associated with disseminated infection. No differences in the protein concentrations of IFN-gamma, IL-1 beta, IL-6, IL-8, IL-10 or TNF-alpha were observed between isolates of differing genotype. The ability of B. burgdorferi to induce type I and type III IFNs was completely dependent on the presence of linear plasmid (lp) 36. An lp36-deficient B. burgdorferi mutant adhered to, and was internalized by, PBMCs and specific dendritic cell (DC) subsets less efficiently than its isogenic B31 parent strain. The association defect with mDC1s and pDCs could be restored by complementation of the mutant with the complete lp36. The RST1 clinical isolates studied were found to contain a 2.5-kB region, located in the distal one-third of lp36, which was not present in any of the RST3 isolates tested. This divergent region of lp36 may encode one or more factors required for optimal spirochetal recognition and the production of type I and type III IFNs by human DCs, thus suggesting a potential role for DCs in the pathogenesis of B. burgdorferi infection.	[Krupna-Gaylord, Michelle A.; Liveris, Dionysios; Love, Andrea C.; Schwartz, Ira; Petzke, Mary M.] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Wormser, Gary P.; Schwartz, Ira] New York Med Coll, Dept Med, Div Infect Dis, Valhalla, NY 10595 USA	New York Medical College; New York Medical College	Petzke, MM (corresponding author), New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.	mary_petzke@nymc.edu			Center for Disease Control [U01-CI000160]; Center for Prevention [U01-CI000160]; William and Sylvia Silberstein Foundation; National Institutes of Health [3R01-AR41511]; American Heart Association; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000160] Funding Source: NIH RePORTER	Center for Disease Control; Center for Prevention; William and Sylvia Silberstein Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by a cooperative agreement (U01-CI000160) from the Centers for Disease Control and Prevention (to IS), The William and Sylvia Silberstein Foundation (to IS), ARRA supplement (3R01-AR41511) from the National Institutes of Health (to IS), and a predoctoral fellowship to MAK-G from the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Anguita J, 2000, INFECT IMMUN, V68, P1222, DOI 10.1128/IAI.68.3.1222-1230.2000; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Baban B, 2009, J IMMUNOL, V183, P2475, DOI 10.4049/jimmunol.0900986; Babolin C, 2011, J IMMUNOL, V187, P1377, DOI 10.4049/jimmunol.1100615; BARTHOLD SW, 1988, J INFECT DIS, V157, P842, DOI 10.1093/infdis/157.4.842; Bierne H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039080; Bogdan C, 2004, IMMUNOL REV, V202, P33, DOI 10.1111/j.0105-2896.2004.00207.x; Bouchonnet F, 2002, INFECT IMMUN, V70, P3020, DOI 10.1128/IAI.70.6.3020-3025.2002; Bourreau E, 2009, INFECT IMMUN, V77, P1465, DOI 10.1128/IAI.01398-08; BUKHOLM G, 1984, INFECT IMMUN, V45, P62, DOI 10.1128/IAI.45.1.62-66.1984; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Carrero JA, 2007, IMMUNOL RES, V38, P333, DOI 10.1007/s12026-007-0017-z; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Casjens SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033280; Cervantes JL, 2013, J LEUKOCYTE BIOL, V94, P1231, DOI 10.1189/jlb.0413206; Cervantes JL, 2011, P NATL ACAD SCI USA, V108, P3683, DOI 10.1073/pnas.1013776108; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; Coleman AS, 2011, CLIN VACCINE IMMUNOL, V18, P406, DOI 10.1128/CVI.00461-10; Coleman AS, 2009, CLIN VACCINE IMMUNOL, V16, P1569, DOI 10.1128/CVI.00301-09; Crandall H, 2006, J IMMUNOL, V177, P7930, DOI 10.4049/jimmunol.177.11.7930; Cruz AR, 2008, INFECT IMMUN, V76, P56, DOI 10.1128/IAI.01039-07; DELAMAZA LM, 1985, INFECT IMMUN, V47, P719, DOI 10.1128/IAI.47.3.719-722.1985; Eggers CH, 2002, MOL MICROBIOL, V43, P281, DOI 10.1046/j.1365-2958.2002.02758.x; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Filgueira L, 1996, J IMMUNOL, V157, P2998; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gregorio J, 2010, J EXP MED, V207, P2921, DOI 10.1084/jem.20101102; Grimm D, 2005, J MED ENTOMOL, V42, P676, DOI 10.1603/0022-2585(2005)042[0676:DPRBBB]2.0.CO;2; Hawley KL, 2012, P NATL ACAD SCI USA, V109, P1228, DOI 10.1073/pnas.1112078109; He M, 2007, J BACTERIOL, V189, P8377, DOI 10.1128/JB.01199-07; HESS CB, 1987, J IMMUNOL, V138, P3949; HESS CB, 1989, MICROB PATHOGENESIS, V7, P111, DOI 10.1016/0882-4010(89)90030-2; Hovius JWR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040031; Iyer R, 2003, INFECT IMMUN, V71, P3699, DOI 10.1128/IAI.71.7.3699-3706.2003; Jewell NA, 2010, J VIROL, V84, P11515, DOI 10.1128/JVI.01703-09; Jewett MW, 2007, MOL MICROBIOL, V64, P1358, DOI 10.1111/j.1365-2958.2007.05746.x; KAZAR J, 1971, INFECT IMMUN, V3, P825, DOI 10.1128/IAI.3.6.825-832.1971; Kenedy MR, 2009, INFECT IMMUN, V77, P2773, DOI 10.1128/IAI.00318-09; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Krupna M, 2011, J IMMUNOL, V186; La QH, 2010, EUR J CANCER, V46, P180, DOI 10.1016/j.ejca.2009.10.002; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P446, DOI 10.1128/IAI.69.1.446-455.2001; Labandeira-Rey M, 2003, INFECT IMMUN, V71, P4608, DOI 10.1128/IAI.71.8.4608-4613.2003; Le Buanec H, 2011, P NATL ACAD SCI USA, V108, P18995, DOI 10.1073/pnas.1113301108; Lebreton A, 2011, SCIENCE, V331, P1319, DOI 10.1126/science.1200120; Li W, 2008, CELL PROLIFERAT, V41, P960, DOI 10.1111/j.1365-2184.2008.00558.x; Li W, 2011, INFECT IMMUN, V79, P3338, DOI 10.1128/IAI.05021-11; Li X, 2006, INFECT IMMUN, V74, P3305, DOI 10.1128/IAI.02035-05; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LIVERIS D, 1995, J CLIN MICROBIOL, V33, P589, DOI 10.1128/JCM.33.3.589-595.1995; Liveris D, 1996, J CLIN MICROBIOL, V34, P1306, DOI 10.1128/JCM.34.5.1306-1309.1996; Loughman JA, 2012, J INFECT DIS; Love AC, 2014, INFECT IMMUN, V82, P2405, DOI 10.1128/IAI.01617-14; Makala LHC, 2011, J INFECT DIS, V203, P715, DOI 10.1093/infdis/jiq095; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Mancuso G, 2007, J IMMUNOL, V178, P3126, DOI 10.4049/jimmunol.178.5.3126; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Mellor A, 2005, BIOCHEM BIOPH RES CO, V338, P20, DOI 10.1016/j.bbrc.2005.08.232; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Miller JC, 2008, J IMMUNOL, V181, P8492, DOI 10.4049/jimmunol.181.12.8492; Moore MW, 2007, INFECT IMMUN, V75, P2046, DOI 10.1128/IAI.01666-06; NIESEL DW, 1986, INFECT IMMUN, V52, P828, DOI 10.1128/IAI.52.3.828-833.1986; Numasaki M, 2007, J IMMUNOL, V178, P5086, DOI 10.4049/jimmunol.178.8.5086; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Pal U, 2008, J EXP MED, V205, P133, DOI 10.1084/jem.20070962; Palmer N, 2000, J BACTERIOL, V182, P2476, DOI 10.1128/JB.182.9.2476-2480.2000; Petzke MM, 2009, J IMMUNOL, V183, P5279, DOI 10.4049/jimmunol.0901390; Pietila TE, 2010, J LEUKOCYTE BIOL, V88, P665, DOI 10.1189/jlb.1009651; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Qiu WG, 2004, P NATL ACAD SCI USA, V101, P14150, DOI 10.1073/pnas.0402745101; Rothfuchs AG, 2001, J IMMUNOL, V167, P6453, DOI 10.4049/jimmunol.167.11.6453; SADZIENE A, 1993, INFECT IMMUN, V61, P2192, DOI 10.1128/IAI.61.5.2192-2195.1993; Salazar JC, 2003, J IMMUNOL, V171, P2660, DOI 10.4049/jimmunol.171.5.2660; Salazar JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000444; Samuels D S, 1995, Methods Mol Biol, V47, P253; Scheler M, 2007, AM J PATHOL, V171, P1936, DOI 10.2353/ajpath.2007.070281; Schutzer SE, 2011, J BACTERIOL, V193, P1018, DOI 10.1128/JB.01158-10; SCHWAN TG, 1988, INFECT IMMUN, V56, P1831, DOI 10.1128/IAI.56.8.1831-1836.1988; SCHWARTZ I, 1992, J CLIN MICROBIOL, V30, P3082, DOI 10.1128/JCM.30.12.3082-3088.1992; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Sjowall J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018220; STEERE AC, 1986, ZBL BAKT-INT J MED M, V263, P201; STEERE AC, 1989, NEW ENGL J MED, V321, P586, DOI 10.1056/NEJM198908313210906; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Strle K, 2011, AM J PATHOL, V178, P2726, DOI 10.1016/j.ajpath.2011.02.018; TEETSON W, 1983, AM J CLIN PATHOL, V79, P500, DOI 10.1093/ajcp/79.4.500; Terekhova D, 2006, J BACTERIOL, V188, P6124, DOI 10.1128/JB.00459-06; von Bubnoff D, 2011, J AM ACAD DERMATOL, V65, P819, DOI 10.1016/j.jaad.2010.07.050; Wang G, 2001, INFECT IMMUN, V69, P4303, DOI 10.1128/IAI.69.7.4303-4312.2001; Wang GQ, 2004, INFECT IMMUN, V72, P6702, DOI 10.1128/IAI.72.11.6702-6706.2004; Wang GQ, 2002, J INFECT DIS, V186, P782, DOI 10.1086/343043; Wolk K, 2008, J LEUKOCYTE BIOL, V83, P1181, DOI 10.1189/jlb.0807525; Wooten RM, 2002, VECTOR-BORNE ZOONOT, V2, P275, DOI 10.1089/153036602321653860; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279; Wormser GP, 1999, J INFECT DIS, V180, P720, DOI 10.1086/314922; Xu YN, 1996, INFECT IMMUN, V64, P3870, DOI 10.1128/IAI.64.9.3870-3876.1996; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	101	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100174	10.1371/journal.pone.0100174	http://dx.doi.org/10.1371/journal.pone.0100174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945497	gold, Green Submitted, Green Published			2022-12-25	WOS:000340721500047
J	Hu, QX; Dong, JH; Du, HB; Zhang, DL; Ren, HZ; Ma, ML; Cai, Y; Zhao, TC; Yin, XL; Yu, X; Xue, T; Xu, ZG; Sun, JP				Hu, Qiao-Xia; Dong, Jun-Hong; Du, Hai-Bo; Zhang, Dao-Lai; Ren, Hong-Ze; Ma, Ming-Liang; Cai, Yuan; Zhao, Tong-Chao; Yin, Xiao-Lei; Yu, Xiao; Xue, Tian; Xu, Zhi-Gang; Sun, Jin-Peng			Constitutive G alpha(i) Coupling Activity of Very Large G Protein-coupled Receptor 1 (VLGR1) and Its Regulation by PDZD7 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesion; Cell Signaling; G Protein; G Protein-coupled Receptor (GPCR); Hearing; VLGR1; PDZD7; GPCR; Adhesion; Usher Syndrome	COCHLEAR HAIR-CELLS; ANKLE-LINK COMPLEX; BETA(2)-ADRENERGIC RECEPTOR; SENSORINEURAL DEAFNESS; GENE; PATHOGENESIS; COMPONENT; NETWORK; TYPE-2; DOMAIN	Background: The signaling and regulatory mechanism of the orphan receptor VLGR1 remains elusive. Results: The cleaved VLGR1 -subunit constitutively coupled to G(i) and was regulated by the VLGR1 -subunit, a disease-associated mutation, and PDZD7. Conclusion: The VLGR1 -subunit signals independently and is regulated at multiple levels. Significance: The identified new signaling mechanism may aid in the design of a VLGR1-targeted therapy. The very large G protein-coupled receptor 1 (VLGR1) is a core component in inner ear hair cell development. Mutations in the vlgr1 gene cause Usher syndrome, the symptoms of which include congenital hearing loss and progressive retinitis pigmentosa. However, the mechanism of VLGR1-regulated intracellular signaling and its role in Usher syndrome remain elusive. Here, we show that VLGR1 is processed into two fragments after autocleavage at the G protein-coupled receptor proteolytic site. The cleaved VLGR1 -subunit constitutively inhibited adenylate cyclase (AC) activity through G(i) coupling. Co-expression of the G(iq) chimera with the VLGR1 -subunit changed its activity to the phospholipase C/nuclear factor of activated T cells signaling pathway, which demonstrates the G(i) protein coupling specificity of this subunit. An R6002A mutation in intracellular loop 2 of VLGR1 abolished G(i) coupling, but the pathogenic VLGR1 Y6236fsx1 mutant showed increased AC inhibition. Furthermore, overexpression of another Usher syndrome protein, PDZD7, decreased the AC inhibition of the VLGR1 -subunit but showed no effect on the VLGR1 Y6236fsx1 mutant. Taken together, we identified an independent G(i) signaling pathway of the VLGR1 -subunit and its regulatory mechanisms that may have a role in the development of Usher syndrome.	[Hu, Qiao-Xia; Zhang, Dao-Lai; Ma, Ming-Liang; Zhao, Tong-Chao; Sun, Jin-Peng] Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan 250100, Shandong, Peoples R China; [Hu, Qiao-Xia; Zhang, Dao-Lai; Ma, Ming-Liang; Zhao, Tong-Chao; Sun, Jin-Peng] Shandong Univ, Sch Med, Dept Biochem & Mol Biol, Jinan 250100, Shandong, Peoples R China; [Dong, Jun-Hong; Yu, Xiao] Shandong Univ, Sch Med, Dept Physiol, Jinan 250100, Shandong, Peoples R China; [Dong, Jun-Hong] Weifang Med Univ, Weifang 261053, Shandong, Peoples R China; [Du, Hai-Bo; Ren, Hong-Ze; Yin, Xiao-Lei; Xu, Zhi-Gang] Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan 250100, Shandong, Peoples R China; [Zhang, Dao-Lai] Binzhou Med Univ, Yantai 264003, Shandong, Peoples R China; [Cai, Yuan; Xue, Tian] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Shandong University; Shandong University; Shandong University; Weifang Medical University; Shandong University; Binzhou Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Xu, ZG (corresponding author), Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan 250100, Shandong, Peoples R China.	xuzg@sdu.edu.cn; sunjinpeng@sdu.edu.cn	Zhang, Daolai/AAA-4914-2021; Xue, Tian/G-9009-2018; sun, Jinpeng/AAR-9196-2020	Yu, Xiao/0000-0003-1119-8334	National Key Basic Research Program of China Grants [2013CB967700, 2011CB504505, 2012CB910402]; National Natural Science Foundation of China Grants [31371355, 31271505]; Interdiscipline Fund of Shandong University Grants [2012JC021, 2014JC029]; Independence Innovation Foundation of Shandong University Grant [2012TS114]; Program for Changjiang Scholars and Innovative Research Team in University Grant [IRT13028]	National Key Basic Research Program of China Grants(National Basic Research Program of China); National Natural Science Foundation of China Grants(National Natural Science Foundation of China (NSFC)); Interdiscipline Fund of Shandong University Grants; Independence Innovation Foundation of Shandong University Grant; Program for Changjiang Scholars and Innovative Research Team in University Grant(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by grants from the National Key Basic Research Program of China Grants 2013CB967700 (to X. Y., T. X., and Z.-G. X.), 2011CB504505 (to Z.-G. X.), and 2012CB910402 (to J.-P. S.); National Natural Science Foundation of China Grants 31371355 (to Z.-G. X.) and 31271505 (to J.-P. S.); Interdiscipline Fund of Shandong University Grants 2012JC021 (to Z.-G. X.) and 2014JC029 (to X. Y.); Independence Innovation Foundation of Shandong University Grant 2012TS114 (to J.-P. S.); and Program for Changjiang Scholars and Innovative Research Team in University Grant IRT13028.	Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; BERTIN B, 1994, P NATL ACAD SCI USA, V91, P8827, DOI 10.1073/pnas.91.19.8827; Bohnekamp J, 2011, J BIOL CHEM, V286, P41912, DOI 10.1074/jbc.C111.265934; Bonnet C, 2012, CURR OPIN NEUROL, V25, P42, DOI 10.1097/WCO.0b013e32834ef8b2; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; de Melo J., 2011, J VIS EXP, V52, pe2847; Ebermann I, 2010, J CLIN INVEST, V120, P1812, DOI 10.1172/JCI39715; Hase M, 2008, J BIOL CHEM, V283, P12747, DOI 10.1074/jbc.M709487200; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Holliday Nicholas D, 2011, Front Endocrinol (Lausanne), V2, P112, DOI 10.3389/fendo.2011.00112; Lin HH, 2004, J BIOL CHEM, V279, P31823, DOI 10.1074/jbc.M402974200; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Maerker T, 2008, HUM MOL GENET, V17, P71, DOI 10.1093/hmg/ddm285; McGee J, 2006, J NEUROSCI, V26, P6543, DOI 10.1523/JNEUROSCI.0693-06.2006; McMillan DR, 2002, J BIOL CHEM, V277, P785, DOI 10.1074/jbc.M108929200; Michalski N, 2007, J NEUROSCI, V27, P6478, DOI 10.1523/JNEUROSCI.0342-07.2007; Nakayama J, 2002, ANN NEUROL, V52, P654, DOI 10.1002/ana.10347; Nikkila H, 2000, MOL ENDOCRINOL, V14, P1351, DOI 10.1210/me.14.9.1351; Paavola KJ, 2012, MOL PHARMACOL, V82, P777, DOI 10.1124/mol.112.080309; Paavola KJ, 2011, J BIOL CHEM, V286, P28914, DOI 10.1074/jbc.M111.247973; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Reiners J, 2005, HUM MOL GENET, V14, P3933, DOI 10.1093/hmg/ddi417; Shin D, 2013, P NATL ACAD SCI USA, V110, P19101, DOI 10.1073/pnas.1318501110; Skradski SL, 2001, NEURON, V31, P537, DOI 10.1016/S0896-6273(01)00397-X; Stephenson JR, 2013, J BIOL CHEM, V288, P22248, DOI 10.1074/jbc.M113.489757; Sun JP, 2013, J MOL NEUROSCI, V50, P204, DOI 10.1007/s12031-012-9911-5; van Wijk E, 2006, HUM MOL GENET, V15, P751, DOI 10.1093/hmg/ddi490; Ward Y, 2011, CANCER RES, V71, P7301, DOI 10.1158/0008-5472.CAN-11-2381; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; White PC, 2011, ADV EXP MED BIOL, V707, P7, DOI 10.1007/978-1-4419-8002-1_2; Xiao RP, 2003, CIRCULATION, V108, P1633, DOI 10.1161/01.CIR.0000087595.17277.73; Xu ZG, 2008, J NEUROSCI, V28, P11269, DOI 10.1523/JNEUROSCI.3833-08.2008; Yang J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000955; Zallocchi M, 2012, J NEUROSCI, V32, P13841, DOI 10.1523/JNEUROSCI.1242-12.2012; Zallocchi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030573; Zou JH, 2014, HUM MOL GENET, V23, P2374, DOI 10.1093/hmg/ddt629	37	48	50	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24215	24225		10.1074/jbc.M114.549816	http://dx.doi.org/10.1074/jbc.M114.549816			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	24962568	Green Published, hybrid			2022-12-25	WOS:000341505600019
J	Shan, CL; Kang, HB; Elf, S; Xie, JX; Gu, TL; Aguiar, M; Lonning, S; Hitosugi, T; Chung, TW; Arellano, M; Khoury, HJ; Shin, DM; Khuri, FR; Boggon, TJ; Fan, J				Shan, Changliang; Kang, Hee-Bum; Elf, Shannon; Xie, Jianxin; Gu, Ting-Lei; Aguiar, Mike; Lonning, Scott; Hitosugi, Taro; Chung, Tae-Wook; Arellano, Martha; Khoury, Hanna J.; Shin, Dong M.; Khuri, Fadlo R.; Boggon, Titus J.; Fan, Jun			Tyr-94 Phosphorylation Inhibits Pyruvate Dehydrogenase Phosphatase 1 and Promotes Tumor Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; CANCER-CELLS; METABOLISM; HYPOXIA; COMPLEX; KINASE; ADAPTATION; EXPRESSION; PROTEIN	Many cancer cells rely more on aerobic glycolysis (the Warburg effect) than mitochondrial oxidative phosphorylation and catabolize glucose at a high rate. Such a metabolic switch is suggested to be due in part to functional attenuation of mitochondria in cancer cells. However, how oncogenic signals attenuate mitochondrial function and promote the switch to glycolysis remains unclear. We previously reported that tyrosine phosphorylation activates and inhibits mitochondrial pyruvate dehydrogenase kinase (PDK) and phosphatase (PDP), respectively, leading to enhanced inhibitory serine phosphorylation of pyruvate dehydrogenase (PDH) and consequently inhibition of pyruvate dehydrogenase complex (PDC) in cancer cells. In particular, Tyr-381 phosphorylation of PDP1 dissociates deacetylase SIRT3 and recruits acetyltransferase ACAT1 to PDC, resulting in increased inhibitory lysine acetylation of PDHA1 and PDP1. Here we report that phosphorylation at another tyrosine residue, Tyr-94, inhibits PDP1 by reducing the binding ability of PDP1 to lipoic acid, which is covalently attached to the L2 domain of dihydrolipoyl acetyltransferase (E2) to recruit PDP1 to PDC. We found that multiple oncogenic tyrosine kinases directly phosphorylated PDP1 at Tyr-94, and Tyr-94 phosphorylation of PDP1 was common in diverse human cancer cells and primary leukemia cells from patients. Moreover, expression of a phosphorylation-deficient PDP1 Y94F mutant in cancer cells resulted in increased oxidative phosphorylation, decreased cell proliferation under hypoxia, and reduced tumor growth in mice. Together, our findings suggest that phosphorylation at different tyrosine residues inhibits PDP1 through independent mechanisms, which act in concert to regulate PDC activity and promote the Warburg effect.	[Shan, Changliang; Kang, Hee-Bum; Elf, Shannon; Hitosugi, Taro; Chung, Tae-Wook; Arellano, Martha; Khoury, Hanna J.; Shin, Dong M.; Khuri, Fadlo R.; Fan, Jun] Emory Univ, Sch Med, Winship Canc Inst Emory, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Xie, Jianxin; Gu, Ting-Lei; Aguiar, Mike; Lonning, Scott] Cell Signaling Technol Inc, Danvers, MA 01923 USA; [Boggon, Titus J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Emory University; Yale University	Fan, J (corresponding author), Emory Univ, Sch Med, Winship Canc Inst, 1365-C Clifton Rd NE, Atlanta, GA 30322 USA.	jfan3@emory.edu	Khuri, Fadlo R./AAU-4942-2020; Shin, Dong Moon/G-9649-2013; Shan, changliang/L-9029-2016	Khuri, Fadlo R./0000-0002-8638-7618; Shin, Dong Moon/0000-0002-8245-4174; Chung, Tae-Wook/0000-0001-5243-5020; Shan, Changliang/0000-0002-4906-1686; Kang, Hee-Bum/0000-0002-3781-6893; Aguiar, Mike/0000-0001-8175-010X	National Institutes of Health; National Institutes of Health SPORE in Head and Neck Cancer [P50CA128613]; Pharmacological Sciences Training Grant [T32 GM008602]; Hematology Tissue Bank of the Emory University School of Medicine and the Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE [P50CA128613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health SPORE in Head and Neck Cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmacological Sciences Training Grant; Hematology Tissue Bank of the Emory University School of Medicine and the Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health grants including the Career Development Fellow Award (to J. F.) from National Institutes of Health SPORE in Head and Neck Cancer P50CA128613 (to D. M. S.), the Pharmacological Sciences Training Grant T32 GM008602 (to S. E.), and the Hematology Tissue Bank of the Emory University School of Medicine and the Georgia Cancer Coalition (to H. J. K.).	Boerner JL, 2004, MOL CELL BIOL, V24, P7059, DOI 10.1128/MCB.24.16.7059-7071.2004; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Fan J, 2014, MOL CELL, V53, P534, DOI 10.1016/j.molcel.2013.12.026; Fan J, 2011, MOL CELL BIOL, V31, P4938, DOI 10.1128/MCB.06120-11; Gottschalk S, 2004, CLIN CANCER RES, V10, P6661, DOI 10.1158/1078-0432.CCR-04-0039; Hiromasa Y, 2004, J BIOL CHEM, V279, P6921, DOI 10.1074/jbc.M308172200; Hitosugi T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2759; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; MORRISON RS, 1994, CANCER RES, V54, P2794; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pezzato E, 2009, AMINO ACIDS, V36, P449, DOI 10.1007/s00726-008-0099-5; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Roche TE, 2001, PROG NUCLEIC ACID RE, V70, P33, DOI 10.1016/S0079-6603(01)70013-X; Vassylyev DG, 2007, J MOL BIOL, V370, P417, DOI 10.1016/j.jmb.2007.05.002	19	36	40	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21413	21422		10.1074/jbc.M114.581124	http://dx.doi.org/10.1074/jbc.M114.581124			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24962578	Green Published, hybrid			2022-12-25	WOS:000340558300020
J	Ancel, A; Cristofari, R; Fretwell, PT; Trathan, PN; Wienecke, B; Boureau, M; Morinay, J; Blanc, S; Le Maho, Y; Le Bohec, C				Ancel, Andre; Cristofari, Robin; Fretwell, Peter T.; Trathan, Phil N.; Wienecke, Barbara; Boureau, Matthieu; Morinay, Jennifer; Blanc, Stephane; Le Maho, Yvon; Le Bohec, Celine			Emperors in Hiding: When Ice-Breakers and Satellites Complement Each Other in Antarctic Exploration	PLOS ONE			English	Article							PENGUIN COLONIES; BEHAVIOR; SEA	Evaluating the demographic trends of marine top predators is critical to understanding the processes involved in the ongoing rapid changes in Antarctic ecosystems. However, the remoteness and logistical complexity of operating in Antarctica, especially during winter, make such an assessment difficult. Satellite imaging is increasingly recognised as a valuable method for remote animal population monitoring, yet its accuracy and reliability are still to be fully evaluated. We report here the first ground visit of an emperor penguin colony first discovered by satellite, but also the discovery of a second one not indicated by satellite survey at that time. Several successive remote surveys in this coastal region of East Antarctica, both before and after sudden local changes, had indeed only identified one colony. These two colonies (with a total of ca. 7,400 breeding pairs) are located near the Mertz Glacier in an area that underwent tremendous habitat change after the glacier tongue broke off in February 2010. Our findings therefore suggest that a satellite survey, although offering a major advance since it allows a global imaging of emperor penguin colonies, may miss certain colony locations when challenged by certain features of polar ecosystems, such as snow cover, evolving ice topology, and rapidly changing habitat. Moreover our survey shows that this large seabird has considerable potential for rapid adaptation to sudden habitat loss, as the colony detected in 2009 may have moved and settled on new breeding grounds. Overall, the ability of emperor penguin colonies to relocate following habitat modification underlines the continued need for a mix of remote sensing and field surveys (aerial photography and ground counts), especially in the less-frequented parts of Antarctica, to gain reliable knowledge about the population demography and dynamics of this flagship species of the Antarctic ecosystem.	[Ancel, Andre; Cristofari, Robin; Boureau, Matthieu; Morinay, Jennifer; Blanc, Stephane; Le Maho, Yvon; Le Bohec, Celine] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [Ancel, Andre; Cristofari, Robin; Boureau, Matthieu; Morinay, Jennifer; Blanc, Stephane; Le Maho, Yvon; Le Bohec, Celine] CNRS, UMR 7178, Strasbourg, France; [Cristofari, Robin; Le Maho, Yvon; Le Bohec, Celine] Ctr Sci Monaco, LEA BioSensib 647, Monaco, Monaco; [Fretwell, Peter T.; Trathan, Phil N.] British Antarctic Survey, Cambridge CB3 0ET, England; [Wienecke, Barbara] Australian Antarctic Div, Kingston, Tas, Australia	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Australian Antarctic Division	Ancel, A (corresponding author), Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France.	andre.ancel@iphc.cnrs.fr	LE BOHEC, CELINE/AAD-3589-2022; Cristofari, Robin/AAO-8097-2021; Morinay, Jennifer/R-4535-2019	Morinay, Jennifer/0000-0002-7905-9691; LE BOHEC, Celine/0000-0003-0149-6477	Institut Polaire Francais Paul-Emile Victor (IPEV Programme) [137]; Centre National de la Recherche Scientifique (CNRS); NERC [bas0100025, bas010011] Funding Source: UKRI; Natural Environment Research Council [bas0100025, bas010011] Funding Source: researchfish	Institut Polaire Francais Paul-Emile Victor (IPEV Programme); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by the Institut Polaire Francais Paul-Emile Victor (IPEV Programme 137) and the Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancel A, 1999, RAPPORT ACTIVITE IFR, P40; Ancel A, 2013, CR BIOL, V336, P1, DOI 10.1016/j.crvi.2013.02.002; Ancel A, 2009, P ROY SOC B-BIOL SCI, V276, P2163, DOI 10.1098/rspb.2009.0140; Barber-Meyer SM, 2007, POLAR BIOL, V30, P1565, DOI 10.1007/s00300-007-0317-8; BUDD G. M., 1961, EMU, V61, P171; Budd GM, 1962, P ZOOL SOC LOND, V139, P365; Coria Nestor R., 2000, Marine Ornithology, V28, P119; Fretwell PT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085285, 10.1371/journal.pone.0088655]; Fretwell PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033751; Fretwell PT, 2009, GLOBAL ECOL BIOGEOGR, V18, P543, DOI 10.1111/j.1466-8238.2009.00467.x; Gilbert C, 2008, POLAR BIOL, V31, P163, DOI 10.1007/s00300-007-0343-6; Isenmann P, 1970, Oiseau, V40, P136; Isenmann P, 1971, OISEAU RFO, V40, P136; JOUVENTIN P, 1972, Alauda, V40, P56; JOUVENTIN P, 1972, Behaviour, V43, P176; JOUVENTIN P, 1971, Terre et la Vie, V25, P510; Jouventin P., 1971, Revue Comport Anim, V5, P189; Jouventin P., 1975, P435; KOOYMAN GL, 1993, ANTARCT SCI, V5, P143, DOI 10.1017/S0954102093000203; Lea Mary-Anne, 2005, Marine Ornithology, V33, P59; LEMAHO Y, 1977, AM SCI, V65, P680; Lynch HJ, 2012, ECOLOGY, V93, P1367; Massom RA, 2009, MAR ECOL PROG SER, V374, P243, DOI 10.3354/meps07734; Melick D., 1995, POLAR REC, V31, P426; Peter H.-U., 2008, FED ENV AGENCY TEXTE, V20, P508; Prevost J, 1961, ECOLOGIE MANCHOT EMP; STONEHOUSE B, 1952, NATURE, V169, P760, DOI 10.1038/169760a0; Todd Frank S., 2004, Marine Ornithology, V32, P193; Wienecke B, 2012, POLAR BIOL, V35, P1289, DOI 10.1007/s00300-012-1172-9; Wienecke B, 2010, POLAR REC, V46, P271, DOI 10.1017/S0032247409990283; Wienecke B, 2009, POLAR REC, V45, P304, DOI 10.1017/S0032247409008341; Wilson GJ, 1983, BIOMASS SCI SER, V4, P1; Wilson PR, 2001, MAR ECOL PROG SER, V213, P301, DOI 10.3354/meps213301; Woehler E. J., 1997, Marine Ornithology, V25, P43; Woehler EJ, 1993, DISTRIBUTION ABUNDAN	35	14	15	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100404	10.1371/journal.pone.0100404	http://dx.doi.org/10.1371/journal.pone.0100404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963661	Green Accepted, Green Published, gold			2022-12-25	WOS:000338709500046
J	Simeonov, KP; Uppal, H				Simeonov, Kamen P.; Uppal, Hirdesh			Direct Reprogramming of Human Fibroblasts to Hepatocyte-Like Cells by Synthetic Modified mRNAs	PLOS ONE			English	Article							DIRECT CONVERSION; STEM-CELLS; LIVER; TRANSPLANTATION; FOXA	Direct reprogramming by overexpression of defined transcription factors is a promising new method of deriving useful but rare cell types from readily available ones. While the method presents numerous advantages over induced pluripotent stem (iPS) cell approaches, a focus on murine conversions and a reliance on retroviral vectors limit potential human applications. Here we address these concerns by demonstrating direct conversion of human fibroblasts to hepatocyte-like cells via repeated transfection with synthetic modified mRNAs. Hepatic induction was achieved with as little as three transcription factor mRNAs encoding HNF1A plus any two of the factors, FOXA1, FOXA3, or HNF4A in the presence of an optimized hepatic growth medium. We show that the absolute necessity of exogenous HNF1A mRNA delivery is explained both by the factor's inability to be activated by any other factors screened and its simultaneous ability to strongly induce expression of other master hepatic transcription factors. Further analysis of factor interaction showed that a series of robust cross-activations exist between factors that induce a hepatocyte-like state. Transcriptome and small RNA sequencing during conversion toward hepatocyte-like cells revealed global preferential activation of liver genes and miRNAs over those associated with other endodermal tissues, as well as downregulation of fibroblast-associated genes. Induced hepatocytelike cells also exhibited hepatic morphology and protein expression. Our data provide insight into the process by which direct hepatic reprogramming occurs in human cells. More importantly, by demonstrating that it is possible to achieve direct reprogramming without the use of retroviral gene delivery, our results supply a crucial step toward realizing the potential of direct reprogramming in regenerative medicine.	[Simeonov, Kamen P.; Uppal, Hirdesh] Genentech Inc, Dept Invest Toxicol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Simeonov, KP (corresponding author), Genentech Inc, Dept Invest Toxicol, San Francisco, CA 94080 USA.	kamen.simeonov@gmail.com	Simeonov, Kamen/B-9230-2013	Simeonov, Kamen/0000-0003-2194-3668	Genentech	Genentech(Roche HoldingGenentech)	The work was funded by Genentech, performed internally at Genentech, and all authors are employed by Genentech. Two patent applications are filed related to this work: 1. Simeonov KP, Uppal H. Methods and Compositions for Producing Induced Hepatocytes. US20140087416 A1, March 27, 2014 (https://www.google.com/patents/US20140087416); 2. Simeonov KP, Uppal H. Methods and Compositions for Producing Induced Hepatocytes. WO2014039768 A1, March 13, 2014. (http://www.google.com/patents/WO2014039768A1?cl=en). The authors are the inventors listed on the patent applications but have no financial stake in either application. Both patent applications are wholly owned by the funder. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Chambers SM, 2011, CELL, V145, P827, DOI 10.1016/j.cell.2011.05.036; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Dhawan A, 2010, NAT REV GASTRO HEPAT, V7, P288, DOI 10.1038/nrgastro.2010.44; Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Huang PY, 2014, CELL STEM CELL, V14, P370, DOI 10.1016/j.stem.2014.01.003; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jang YY, 2004, NAT CELL BIOL, V6, P532, DOI 10.1038/ncb1132; Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; Le PP, 2005, PLOS GENET, V1, P159, DOI 10.1371/journal.pgen.0010016; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lee J, 2012, CELL, V151, P547, DOI 10.1016/j.cell.2012.09.034; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Odom DT, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100059; Ohtake Y, 2008, CELL BIOCHEM FUNCT, V26, P359, DOI 10.1002/cbf.1451; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Stainier DYR, 2002, GENE DEV, V16, P893, DOI 10.1101/gad.974902; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Thuluvath PJ, 2010, AM J TRANSPLANT, V10, P1003, DOI 10.1111/j.1600-6143.2010.03037.x; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wasmuth HE, 2009, GASTROENTEROLOGY, V137, P309, DOI 10.1053/j.gastro.2009.03.053; Yu B, 2013, CELL STEM CELL, V13, P328, DOI 10.1016/j.stem.2013.06.017	30	61	65	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100134	10.1371/journal.pone.0100134	http://dx.doi.org/10.1371/journal.pone.0100134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963715	Green Published, Green Submitted, gold			2022-12-25	WOS:000338709500029
J	Wei, LJ; Liu, CP; Kang, L; Liu, YF; Shi, SL; Wu, Q; Li, Y				Wei, Lijun; Liu, Chuanpeng; Kang, Li; Liu, Yufeng; Shi, Shuliang; Wu, Qiong; Li, Yu			Experimental Study on Effect of Simulated Microgravity on Structural Chromosome Instability of Human Peripheral Blood Lymphocytes	PLOS ONE			English	Article							COMMON FRAGILE SITES; CANCER; TISSUES; STRESS	Experimental study was made by keeping human peripheral blood lymphocytes under simulated microgravity in a Rotary Cell Culture System bioreactor to investigate the changes that occur in the number of chromosomes, the expression rate of chromosome fragile site, and the expressions of DNA replication- and repair-related genes. Experimental results indicate simulated microgravity has no effect on the numerical chromosome instability of human peripheral blood lymphocytes, but it enhances the structural chromosome instability of human peripheral blood lymphocytes through the inhibition of DNA replication and the reduction of DNA repair. So, the mechanism of chromosome fragile site induced by simulated microgravity can be explained using the changes that occur in the chromosome structure of human peripheral blood lymphocytes, the DNA replication and repair under the effect of simulated microgravity.	[Wei, Lijun; Liu, Chuanpeng; Kang, Li; Liu, Yufeng; Shi, Shuliang; Wu, Qiong; Li, Yu] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Peoples R China; [Wei, Lijun; Li, Yu] Chinese Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China	Harbin Institute of Technology	Li, Y (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Peoples R China.	liyugene@hit.edu.cn	黎, 伟/GXM-4040-2022; wei, li/GSD-3630-2022; wu, qiong/GRY-4672-2022		National Science Foundation of China [30970686, 31271507]; Opening Foundation of the State Key Laboratory for Space Medicine Fundamentals and Application [SMFA14K01]; Natural Science Foundation of Heilongjiang Province [D200879]; Natural Scientific Research Innovation Foundation of Harbin Institute of Technology [HIT.NSRIF.2008.14]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Opening Foundation of the State Key Laboratory for Space Medicine Fundamentals and Application; Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Natural Scientific Research Innovation Foundation of Harbin Institute of Technology(Harbin Institute of Technology)	This work is funded by National Science Foundation of China (30970686 and 31271507), Opening Foundation of the State Key Laboratory for Space Medicine Fundamentals and Application (SMFA14K01), Natural Science Foundation of Heilongjiang Province (D200879), and Natural Scientific Research Innovation Foundation of Harbin Institute of Technology (HIT.NSRIF.2008.14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Ducray C, 1998, ADV SPACE RES, V22, P597, DOI 10.1016/S0273-1177(98)00082-9; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Glover TW, 2006, CANCER LETT, V232, P4, DOI 10.1016/j.canlet.2005.08.032; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; Gollin SM, 2005, SEMIN CANCER BIOL, V15, P33, DOI 10.1016/j.semcancer.2004.09.004; GOODWIN TJ, 1993, J CELL BIOCHEM, V51, P301, DOI 10.1002/jcb.240510309; Gutala RV, 2004, J NEUROSCI METH, V132, P101, DOI 10.1016/j.jneumeth.2003.09.005; HECHT F, 1984, CANCER GENET CYTOGEN, V13, P185, DOI 10.1016/0165-4608(84)90060-8; Ingram M, 1997, IN VITRO CELL DEV-AN, V33, P459; Liu QZ, 1999, GENETIC COUNSELING K, P13; MONDELLO C, 1995, CANCER GENET CYTOGEN, V79, P41, DOI 10.1016/0165-4608(94)00085-P; O'Keefe LV, 2006, CANCER LETT, V232, P37, DOI 10.1016/j.canlet.2005.07.041; Ricke RM, 2008, TRENDS GENET, V24, P457, DOI 10.1016/j.tig.2008.07.002; Schwarz R P, 1992, J Tissue Cult Methods, V14, P51, DOI 10.1007/BF01404744; Unsworth BR, 1998, NAT MED, V4, P901, DOI 10.1038/nm0898-901; Wei L, 2013, PLOS ONE, V8, P1; Wei LJ, 2012, MICROGRAVITY SCI TEC, V24, P335, DOI 10.1007/s12217-012-9324-7	21	2	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100595	10.1371/journal.pone.0100595	http://dx.doi.org/10.1371/journal.pone.0100595			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963972	Green Published, Green Submitted, gold			2022-12-25	WOS:000338709500068
J	Yanez-Arenas, C; Peterson, AT; Mokondoko, P; Rojas-Soto, O; Martinez-Meyer, E				Yanez-Arenas, Carlos; Peterson, A. Townsend; Mokondoko, Pierre; Rojas-Soto, Octavio; Martinez-Meyer, Enrique			The Use of Ecological Niche Modeling to Infer Potential Risk Areas of Snakebite in the Mexican State of Veracruz	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; SUB-SAHARAN AFRICA; SAMPLE-SIZE; ABSENCE DATA; BITE; DISEASE; DISTRIBUTIONS; PERFORMANCE; POPULATION; EPIDEMIOLOGY	Background: Many authors have claimed that snakebite risk is associated with human population density, human activities, and snake behavior. Here we analyzed whether environmental suitability of vipers can be used as an indicator of snakebite risk. We tested several hypotheses to explain snakebite incidence, through the construction of models incorporating both environmental suitability and socioeconomic variables in Veracruz, Mexico. Methodology/Principal Findings: Ecological niche modeling (ENM) was used to estimate potential geographic and ecological distributions of nine viper species' in Veracruz. We calculated the distance to the species' niche centroid (DNC); this distance may be associated with a prediction of abundance. We found significant inverse relationships between snakebites and DNCs of common vipers (Crotalus simus and Bothrops asper), explaining respectively 15% and almost 35% of variation in snakebite incidence. Additionally, DNCs for these two vipers, in combination with marginalization of human populations, accounted for 76% of variation in incidence. Conclusions/Significance: Our results suggest that niche modeling and niche-centroid distance approaches can be used to mapping distributions of environmental suitability for venomous snakes; combining this ecological information with socioeconomic factors may help with inferring potential risk areas for snakebites, since hospital data are often biased (especially when incidences are low).	[Yanez-Arenas, Carlos; Peterson, A. Townsend] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Mokondoko, Pierre] Inst Ecol AC, Div Posgrado, Xalapa, Veracruz, Mexico; [Rojas-Soto, Octavio] Inst Ecol AC, Red Biol Evolut, Xalapa, Veracruz, Mexico; [Martinez-Meyer, Enrique] Univ Nacl Autonoma Mexico, Inst Biol, Mexico City 04510, DF, Mexico	University of Kansas; Instituto de Ecologia - Mexico; Instituto de Ecologia - Mexico; Universidad Nacional Autonoma de Mexico	Yanez-Arenas, C (corresponding author), Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA.	lichoso@gmail.com	Yañez-Arenas, Carlos/X-6091-2018; Rojas-Soto, Octavio/Q-6252-2018; Peterson, A. Townsend/I-5697-2013	Yañez-Arenas, Carlos/0000-0002-6299-275X; Rojas-Soto, Octavio/0000-0002-0201-1454; Martinez-Meyer, Enrique/0000-0003-1184-9264; Peterson, A. Townsend/0000-0003-0243-2379	CONACYT	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	CONACYT support the postdoctoral stay of Carlos Yanez-Arenas at the University of Kansas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alirol E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000603; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Balde MC, 2002, B SOC PATHOL EXOT, V95, P157; Barve N, 2008, TOOL PARTIAL ROC; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Campbell J. A., 2004, VENOMOUS REPTILES W; Chiappy-Jhones C.J., 2002, U CIENCIA, V18, P87; Chippaux JP, 2012, TOXICON, V59, P86, DOI 10.1016/j.toxicon.2011.10.008; Chippaux JP, 2011, TOXICON, V57, P586, DOI 10.1016/j.toxicon.2010.12.022; Chippaux JP, 2002, PERSPECTIVES IN MOLECULAR TOXINOLOGY, P457; CHIPPAUX JP, 1981, B SOC PATHOL EXOT, V74, P458; Chippaux JP, 2002, B SOC PATHOL EXOT, V95, P151; Coombs MD, 1997, T ROY SOC TROP MED H, V91, P319, DOI 10.1016/S0035-9203(97)90091-2; ESRI, 2011, ARCMAP 10; Faizma HM., 1995, J BANGLADESH COLL PH, V13, P3; Fayomi B, 2002, B SOC PATHOL EXOT, V95, P178; Lopez-Arevalo HF, 2011, BIOL CONSERV, V144, P1451, DOI 10.1016/j.biocon.2011.01.014; Flores-Villela O., 1994, BIODIVERSIDAD CONSER, V2nd, P439; Gormley AM, 2011, J APPL ECOL, V48, P25, DOI 10.1111/j.1365-2664.2010.01911.x; Guzman GS, 1990, 1 REUN HERP VILL TAB; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hansson E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000896; Harrison RA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000569; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Lee J.C., 1996, AMPHIBIANS REPTILES; Leynaud GC, 2009, REV PANAM SALUD PUBL, V26, P64, DOI 10.1590/S1020-49892009000700010; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Luna-Bauza E. M., 2004, REV FACULTAD MED UNA, V47, P149; Mak S, 2010, J MED ENTOMOL, V47, P99, DOI 10.1603/033.047.0114; Gutierrez JM, 2010, TOXICON, V56, P1223, DOI 10.1016/j.toxicon.2009.11.020; Martinez-Meyer E, 2006, ORYX, V40, P411, DOI 10.1017/S0030605306001360; Martinez-Meyer E, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0637; Miller RH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001678; Morrone J.J., 2001, BIOGEOGRAFIA AM LATI; Newman WJ, 1997, ANN TROP MED PARASIT, V91, P967, DOI 10.1080/00034989760392; PEREZ-HIGAREdA G., 1991, OFIDIOFAUNA VERACRUZ; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2006, EMERG INFECT DIS, V12, P1822; Peterson AT, 2005, T ROY SOC TROP MED H, V99, P647, DOI 10.1016/j.trstmh.2005.02.004; Peterson AT, 2002, EMERG INFECT DIS, V8, P662, DOI 10.3201/eid0807.010454; Peterson AT, 2011, ECOLOGICAL NICHES GE; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; PUGH RNH, 1980, LANCET, V2, P1181; R Development Core Team, 2012, R LANG ENV STAT COMP; Rahman R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000860; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; Sasa M, 2003, TOXICON, V41, P19, DOI 10.1016/S0041-0101(02)00172-1; SNOW RW, 1994, ANN TROP MED PARASIT, V88, P665, DOI 10.1080/00034983.1994.11812919; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Soto M., 1989, ATLAS CLIMATICO ESTA; Stock RP, 2007, NAT BIOTECHNOL, V25, P173, DOI 10.1038/nbt0207-173; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; Tay-Zavala J., 2002, REV FACULTAD MED UNA, V145, P212; Torres NM, 2012, DIVERS DISTRIB, V18, P615, DOI 10.1111/j.1472-4642.2012.00892.x; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2; White J, 2000, THER DRUG MONIT, V22, P65, DOI 10.1097/00007691-200002000-00014; WHO, 2009, NEGL TROP DIS SNAK; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2010, MGCV MIXED GAM COMPU; Yanez-Arenas C, 2012, OIKOS, V121, P2081, DOI 10.1111/j.1600-0706.2012.20350.x	67	35	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100957	10.1371/journal.pone.0100957	http://dx.doi.org/10.1371/journal.pone.0100957			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963989	Green Published, gold, Green Submitted			2022-12-25	WOS:000338709500104
J	Cespedes, N; Habel, C; Lopez-Perez, M; Castellanos, A; Kajava, AV; Servis, C; Felger, I; Moret, R; Arevalo-Herrera, M; Corradin, G; Herrera, S				Cespedes, Nora; Habel, Catherine; Lopez-Perez, Mary; Castellanos, Angelica; Kajava, Andrey V.; Servis, Catherine; Felger, Ingrid; Moret, Remy; Arevalo-Herrera, Myriam; Corradin, Giampietro; Herrera, Socrates			Plasmodium vivax Antigen Discovery Based on Alpha-Helical Coiled Coil Protein Motif	PLOS ONE			English	Article							RECEPTOR-BINDING DOMAIN; PAPUA-NEW-GUINEA; MALARIA VACCINE; CIRCUMSPOROZOITE PROTEIN; AOTUS MONKEYS; FALCIPARUM; IMMUNOGENICITY; SEQUENCE; PREDICTION; ANTIBODIES	Protein alpha-helical coiled coil structures that elicit antibody responses, which block critical functions of medically important microorganisms, represent a means for vaccine development. By using bioinformatics algorithms, a total of 50 antigens with alpha-helical coiled coil motifs orthologous to Plasmodium falciparum were identified in the P. vivax genome. The peptides identified in silico were chemically synthesized; circular dichroism studies indicated partial or high alpha-helical content. Antigenicity was evaluated using human sera samples from malaria-endemic areas of Colombia and Papua New Guinea. Eight of these fragments were selected and used to assess immunogenicity in BALB/c mice. ELISA assays indicated strong reactivity of serum samples from individuals residing in malaria-endemic regions and sera of immunized mice, with the alpha-helical coiled coil structures. In addition, ex vivo production of IFN-gamma by murine mononuclear cells confirmed the immunogenicity of these structures and the presence of T-cell epitopes in the peptide sequences. Moreover, sera of mice immunized with four of the eight antigens recognized native proteins on blood-stage P. vivax parasites, and antigenic cross-reactivity with three of the peptides was observed when reacted with both the P. falciparum orthologous fragments and whole parasites. Results here point to the alpha-helical coiled coil peptides as possible P. vivax malaria vaccine candidates as were observed for P. falciparum. Fragments selected here warrant further study in humans and non-human primate models to assess their protective efficacy as single components or assembled as hybrid linear epitopes.	[Cespedes, Nora; Castellanos, Angelica; Arevalo-Herrera, Myriam; Herrera, Socrates] Malaria Vaccine & Drug Dev Ctr MVDC, Cali, Colombia; [Cespedes, Nora; Arevalo-Herrera, Myriam] Univ Valle, Sch Hlth, Cali, Colombia; [Habel, Catherine; Servis, Catherine; Corradin, Giampietro] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Lopez-Perez, Mary; Herrera, Socrates] Caucaseco Sci Res Ctr, Cali, Colombia; [Castellanos, Angelica] Fdn Ctr Primates, Cali, Colombia; [Kajava, Andrey V.] Univ Montpellier, Ctr Rech Biochim Macromol, F-34059 Montpellier, France; [Kajava, Andrey V.] Univ Montpellier, Inst Biol Computat, CNRS, F-34059 Montpellier, France; [Kajava, Andrey V.] Univ ITMO, St Petersburg, Russia; [Felger, Ingrid] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Moret, Remy] Hop St Camille, Ouagadougou, Burkina Faso	Universidad del Valle; University of Lausanne; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; ITMO University; University of Basel; Swiss Tropical & Public Health Institute	Herrera, S (corresponding author), Malaria Vaccine & Drug Dev Ctr MVDC, Cali, Colombia.	sherrera@inmuno.org	Kajava, Andrey V/E-1107-2014; Lopez-Perez, Mary/E-5059-2016	Kajava, Andrey V/0000-0002-2342-6886; Lopez-Perez, Mary/0000-0002-9876-0248; Felger, Ingrid/0000-0003-1255-2606; Arevalo, Myriam/0000-0002-3434-9425; Castellanos Sanchez, Angelica Maria/0000-0002-6602-9696	Colciencias [278-2008, 360-2011, 458-2012, 719-2013]; NIH [5U19AI089702]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089702] Funding Source: NIH RePORTER	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by Colciencias (Contract 278-2008, Contract 360-2011, Contract 458-2012 and Contract 719-2013) and NIH (Grant number 5U19AI089702. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERS MP, 1992, PAPUA NEW GUINEA MED, V35, P285; Arevalo-Herrera M, 2005, AM J TROP MED HYG, V73, P25; Arevalo-Herrera M, 1998, ANN TROP MED PARASIT, V92, P539, DOI 10.1080/00034989859230; Arevalo-Herrera M, 2012, ACTA TROP, V121, P303, DOI 10.1016/j.actatropica.2011.06.008; Bell BA, 2009, VACCINE, V27, P1448, DOI 10.1016/j.vaccine.2008.12.027; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Cespedes N, 2013, VACCINE, V31, P4923, DOI 10.1016/j.vaccine.2013.05.082; Corradin Giarnpietro, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P259, DOI 10.2174/187153007782794371; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Greenwood BM, 2011, CLIN MICROBIOL INFEC, V17, P1600, DOI 10.1111/j.1469-0691.2011.03612.x; Guda C, 2005, BIOINFORMATICS, V21, P3963, DOI 10.1093/bioinformatics/bti650; Herrera S, 2005, AM J TROP MED HYG, V73, P3, DOI 10.4269/ajtmh.2005.73.3; Herrera S, 2011, AM J TROP MED HYG, V84, P12, DOI 10.4269/ajtmh.2011.09-0516; Valencia SH, 2011, MEM I OSWALDO CRUZ, V106, P179, DOI 10.1590/S0074-02762011000900023; Hill AVS, 2011, PHILOS T R SOC B, V366, P2806, DOI 10.1098/rstb.2011.0091; Jafarshad A, 2007, J IMMUNOL, V178, P3099, DOI 10.4049/jimmunol.178.5.3099; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; Koepfli C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001424; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kulangara C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046112; Kulangara C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005419; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Moreno A, 2008, VACCINE, V26, P4338, DOI 10.1016/j.vaccine.2008.06.010; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Olugbile S, 2009, INFECT IMMUN, V77, P5701, DOI 10.1128/IAI.00652-09; Olugbile S, 2011, VACCINE, V29, P7090, DOI 10.1016/j.vaccine.2011.06.122; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Salvador A, 2012, EXPERT REV VACCINES, V11, P1071, DOI [10.1586/ERV.12.87, 10.1586/erv.12.87]; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; Sidney John, 2008, Immunome Res, V4, P2, DOI 10.1186/1745-7580-4-2; Singh S, 2005, INFECT IMMUN, V73, P1235, DOI 10.1128/IAI.73.2.1235-1238.2005; Teixeira LH, 2014, INFECT IMMUN, V82, P793, DOI 10.1128/IAI.01410-13; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tripet B, 2006, J STRUCT BIOL, V155, P176, DOI 10.1016/j.jsb.2006.03.019; Vicentin EC, 2014, INFECT IMMUN, V82, P1296, DOI 10.1128/IAI.01169-13; Villard V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000645; Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wu Yu-Huan, 2008, P3	46	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100440	10.1371/journal.pone.0100440	http://dx.doi.org/10.1371/journal.pone.0100440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959747	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000338633900047
J	Perucho, L; Artero-Castro, A; Guerrero, S; Cajal, SRY; LLeonart, ME; Wang, ZQ				Perucho, Laura; Artero-Castro, Ana; Guerrero, Sergi; Ramon y Cajal, Santiago; LLeonart, Matilde E.; Wang, Zhao-Qi			RPLP1, a Crucial Ribosomal Protein for Embryonic Development of the Nervous System	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; SACCHAROMYCES-CEREVISIAE; P53-DEPENDENT CHECKPOINT; ACIDIC PHOSPHOPROTEINS; ESCHERICHIA-COLI; STEM-CELLS; RAT-LIVER; ACTIVATION; MINUTE; STRESS	Ribosomal proteins are pivotal to development and tissue homeostasis. RP Large P1 (Rplp1) overexpression is associated with tumorigenesis. However, the physiological function of Rplp1 in mammalian development remains unknown. In this study, we disrupted Rplp1 in the mouse germline and central nervous system (Rplp1(CNS Delta)). Rplp1 heterozygosity caused body size reductions, male infertility, systemic abnormalities in various tissues and a high frequency of early postnatal death. Rplp1(CNS Delta) newborn mice exhibited perinatal lethality and brain atrophy with size reductions of the neocortex, midbrain and ganglionic eminence. The Rplp1 knockout neocortex exhibited progenitor cell proliferation arrest and apoptosis due to the dysregulation of key cell cycle and apoptosis regulators (cyclin A, cyclin E, p21(CIP1), p27(KIP1), p53). Similarly, Rplp1 deletion in pMEFs led to proliferation arrest and premature senescence. Importantly, Rplp1 deletion in primary mouse embryonic fibroblasts did not alter global protein synthesis, but did change the expression patterns of specific protein subsets involved in protein folding and the unfolded protein response, cell death, protein transport and signal transduction, among others. Altogether, we demonstrated that the translation "fine- tuning'' exerted by Rplp1 is essential for embryonic and brain development and for proper cell proliferation.	[Perucho, Laura; Wang, Zhao-Qi] Leibniz Inst Age Res, Fritz Lipmann Inst, Jena, Germany; [Artero-Castro, Ana; Guerrero, Sergi; Ramon y Cajal, Santiago; LLeonart, Matilde E.] Hosp Valle De Hebron, Inst Recerca, Oncol & Pathol Grp, Barcelona, Spain; [Wang, Zhao-Qi] Univ Jena, Fac Biol & Pharm, Jena, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Friedrich Schiller University of Jena	LLeonart, ME (corresponding author), Hosp Valle De Hebron, Inst Recerca, Oncol & Pathol Grp, Barcelona, Spain.	melleona@ir.vhebron.net	Artero, Ana/AAD-2247-2022; LLeonart, Matilde E./Q-2662-2019; Ramon y Cajal, Santiago/H-4955-2016	LLeonart, Matilde E./0000-0002-6196-7405; Ramon y Cajal, Santiago/0000-0002-3867-1390; Perucho Aznar, Laura/0000-0002-0915-0633	Marato project [TV3/052130]; FIS project [PI12/01104]; MELL is a FIS investigator (Miguel Servet) [CP03/00101]; La Caixa and the Deutscher Akademischer Austauschdienst	Marato project; FIS project; MELL is a FIS investigator (Miguel Servet); La Caixa and the Deutscher Akademischer Austauschdienst	This work was supported by the Marato project TV3/052130 and the FIS project PI12/01104. MELL is a FIS investigator (Miguel Servet stabilized contract CP03/00101). Laura Perucho was supported by a fellowship from La Caixa and the Deutscher Akademischer Austauschdienst. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SJ, 2007, IMMUNITY, V26, P759, DOI 10.1016/j.immuni.2007.04.012; Artero-Castro A, 2009, EXP CELL RES, V315, P1372, DOI 10.1016/j.yexcr.2009.02.007; Artero-Castro A, 2011, HUM PATHOL, V42, P194, DOI 10.1016/j.humpath.2010.04.020; Bargis-Surgey P, 1999, EUR J BIOCHEM, V262, P606, DOI 10.1046/j.1432-1327.1999.00434.x; Chakraborty A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004152; Challagundla KB, 2011, MOL CELL BIOL, V31, P4007, DOI 10.1128/MCB.05810-11; Chen A, 2002, CANCER RES, V62, P1036; Chen QM, 1998, BIOCHEM J, V332, P43, DOI 10.1042/bj3320043; Colome N, 2010, J PROTEOME RES, V9, P2600, DOI 10.1021/pr100044d; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; de las Heras-Rubio A, 2014, CANCER METAST REV, V33, P115, DOI 10.1007/s10555-013-9460-6; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; EGEBJERG J, 1990, J MOL BIOL, V213, P275, DOI 10.1016/S0022-2836(05)80190-1; Eymin B, 1999, ONCOGENE, V18, P1411, DOI 10.1038/sj.onc.1202437; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Frippiat C, 2000, EXP GERONTOL, V35, P733, DOI 10.1016/S0531-5565(00)00167-4; FURUKAWA T, 1992, ARCH BIOCHEM BIOPHYS, V298, P182, DOI 10.1016/0003-9861(92)90110-I; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Huang CH, 2010, J MOL BIOL, V399, P145, DOI 10.1016/j.jmb.2010.04.009; Hustert E, 1996, MAMM GENOME, V7, P881, DOI 10.1007/s003359900261; Iadevaia V, 2010, ONCOGENE, V29, P5490, DOI 10.1038/onc.2010.279; Ishii K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-37; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kirn-Safran CB, 2007, DEV DYNAM, V236, P447, DOI 10.1002/dvdy.21046; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; KONGSUWAN K, 1985, NATURE, V317, P555, DOI 10.1038/317555a0; Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X; Lindstrom MS, 2010, PLOS ONE, V5, pA116, DOI 10.1371/journal.pone.0009578; Loging WT, 1999, CANCER EPIDEM BIOMAR, V8, P1011; Lopez-Contreras AJ, 2013, CELL REP, V3, P1105, DOI 10.1016/j.celrep.2013.03.009; Mansergh FC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-5; Marone M, 2002, LEUKEMIA LYMPHOMA, V43, P51, DOI 10.1080/10428190210195; Martinez-Azorin F, 2008, FEBS LETT, V582, P3029, DOI 10.1016/j.febslet.2008.07.039; Martinez-Azorin F, 2008, BIOCHEM J, V413, P527, DOI 10.1042/BJ20080049; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; Matsson H, 2004, MOL CELL BIOL, V24, P4032, DOI 10.1128/MCB.24.9.4032-4037.2004; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; MITSUI K, 1988, J BIOCHEM-TOKYO, V104, P908, DOI 10.1093/oxfordjournals.jbchem.a122581; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; Morgado-Palacin L, 2012, CELL CYCLE, V11, P503, DOI 10.4161/cc.11.3.19002; MORGAN WC, 1950, J HERED, V41, P208, DOI 10.1093/oxfordjournals.jhered.a106131; Nakayashiki T, 2013, J BACTERIOL, V195, P1226, DOI 10.1128/JB.02145-12; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Nusspaumer G, 2000, EMBO J, V19, P6075, DOI 10.1093/emboj/19.22.6075; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Panic L, 2006, MOL CELL BIOL, V26, P8880, DOI 10.1128/MCB.00751-06; REMACHA M, 1995, MOL CELL BIOL, V15, P4754; Ribeiro-Neto F, 2002, P NATL ACAD SCI USA, V99, P5418, DOI 10.1073/pnas.082122499; Robledo S, 2008, RNA, V14, P1918, DOI 10.1261/rna.1132008; SAENZROBLES MT, 1990, BIOCHIM BIOPHYS ACTA, V1050, P51, DOI 10.1016/0167-4781(90)90140-W; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; SANTOS C, 1995, J BIOL CHEM, V270, P20608, DOI 10.1074/jbc.270.35.20608; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Sulic S, 2005, GENE DEV, V19, P3070, DOI 10.1101/gad.359305; Sun L, 2008, J AM SOC NEPHROL, V19, P2293, DOI 10.1681/ASN.2008030336; Suzuki A, 1999, MOL CELL BIOL, V19, P3842; TSURUGI K, 1985, J BIOCHEM-TOKYO, V98, P1427, DOI 10.1093/oxfordjournals.jbchem.a135410; UCHIUMI T, 1990, J BIOL CHEM, V265, P89; Uchiumi T, 2002, J BIOL CHEM, V277, P3857, DOI 10.1074/jbc.M107730200; VANAGTHOVEN A, 1978, EUR J BIOCHEM, V91, P553; YOSHIDA Y, 1992, MOL CELL BIOL, V12, P3407, DOI 10.1128/MCB.12.8.3407; Yoshihama M, 2002, GENOME RES, V12, P379, DOI 10.1101/gr.214202; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268; ZINKER S, 1976, J BIOL CHEM, V251, P1799	65	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99956	10.1371/journal.pone.0099956	http://dx.doi.org/10.1371/journal.pone.0099956			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959908	Green Published, gold, Green Submitted			2022-12-25	WOS:000338633900018
J	Thompson, P; Urayama, K; Zheng, J; Yang, P; Ford, M; Buffler, P; Chokkalingam, A; Lightfoot, T; Taylor, M				Thompson, Pamela; Urayama, Kevin; Zheng, Jie; Yang, Peng; Ford, Matt; Buffler, Patricia; Chokkalingam, Anand; Lightfoot, Tracy; Taylor, Malcolm			Differences in Meiotic Recombination Rates in Childhood Acute Lymphoblastic Leukemia at an MHC Class II Hotspot Close to Disease Associated Haplotypes	PLOS ONE			English	Article							B-CELL PRECURSOR; HUMAN GENOME; SEQUENCE POLYMORPHISMS; RISK; SUSCEPTIBILITY; GENE; VARIANTS; CHILDREN; CANCER; LEUKEMOGENESIS	Childhood Acute Lymphoblastic Leukemia (ALL) is a malignant lymphoid disease of which B-cell precursor- (BCP) and T-cell-(T) ALL are subtypes. The role of alleles encoded by major histocompatibility loci (MHC) have been examined in a number of previous studies and results indicating weak, multi-allele associations between the HLA-DPB1 locus and BCP-ALL suggested a role for immunosusceptibility and possibly infection. Two independent SNP association studies of ALL identified loci approximately 37 kb from one another and flanking a strong meiotic recombination hotspot (DNA3), adjacent to HLA-DOA and centromeric of HLA-DPB1. To determine the relationship between this observation and HLA-DPB1 associations, we constructed high density SNP haplotypes of the 316 kb region from HLA-DMB to COL11A2 in childhood ALL and controls using a UK GWAS data subset and the software PHASE. Of four haplotype blocks identified, predicted haplotypes in Block 1 (centromeric of DNA3) differed significantly between BCP-ALL and controls (P = 0.002) and in Block 4 (including HLA-DPB1) between T-ALL and controls (P = 0.049). Of specific common (>5%) haplotypes in Block 1, two were less frequent in BCP-ALL, and in Block 4 a single haplotype was more frequent in T-ALL, compared to controls. Unexpectedly, we also observed apparent differences in ancestral meiotic recombination rates at DNA3, with BCP-ALL showing increased and T-ALL decreased levels compared to controls. In silico analysis using LDsplit sotware indicated that recombination rates at DNA3 are influenced by flanking loci, including SNPs identified in childhood ALL association studies. The observed differences in rates of meiotic recombination at this hotspot, and potentially others, may be a characteristic of childhood leukemia and contribute to disease susceptibility, alternatively they may reflect interactions between ALL-associated haplotypes in this region.	[Thompson, Pamela] Univ Manchester, St Marys Hosp, Inst Canc Sci, Paediat & Familial Canc Res Grp, Manchester M13 0JH, Lancs, England; [Urayama, Kevin; Buffler, Patricia; Chokkalingam, Anand] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Urayama, Kevin] Tokyo Med & Dent Univ, Dept Human Genet & Dis Div, Tokyo, Japan; [Zheng, Jie] Nanyang Technol Univ, Sch Comp Engn, Singapore 639798, Singapore; [Zheng, Jie] Biopolis, A STAR Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Yang, Peng] ASTAR, Inst Infocomm Res, Data Analyt Dept, Singapore, Singapore; [Ford, Matt] Univ Manchester, Fac Med & Human Sci, Res Comp Serv, Manchester, Lancs, England; [Lightfoot, Tracy] Univ York, York YO10 5DD, N Yorkshire, England	University of Manchester; University of California System; University of California Berkeley; Tokyo Medical & Dental University (TMDU); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R); University of Manchester; University of York - UK	Thompson, P (corresponding author), Univ Manchester, St Marys Hosp, Inst Canc Sci, Paediat & Familial Canc Res Grp, Manchester M13 0JH, Lancs, England.	pamela.thompson@manchester.ac.uk	Zheng, Jie/C-1356-2011; Zheng, Jie/AAX-1454-2021	Zheng, Jie/0000-0001-6774-9786; Thompson, Pamela/0000-0002-2660-6348	Children With Cancer, UK	Children With Cancer, UK	PT is supported by funds from Children With Cancer, UK (http://www.childrenwithcancer.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka T, 2007, BLOOD, V109, P3451, DOI 10.1182/blood-2006-08-041012; Berg IL, 2011, P NATL ACAD SCI USA, V108, P12378, DOI 10.1073/pnas.1109531108; Boulton A, 2000, BRIT J CANCER, V82, P1073; Coebergh JWW, 2006, EUR J CANCER, V42, P2019, DOI 10.1016/j.ejca.2006.06.005; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dorak MT, 2002, LEUKEMIA RES, V26, P651, DOI 10.1016/S0145-2126(01)00189-8; Eden T, 2010, CANCER TREAT REV, V36, P286, DOI 10.1016/j.ctrv.2010.02.004; Georgopoulos K, 1997, ANNU REV IMMUNOL, V15, P155, DOI 10.1146/annurev.immunol.15.1.155; Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816; Guce AI, 2013, NAT STRUCT MOL BIOL, V20, P90, DOI 10.1038/nsmb.2460; GURNEY JG, 1995, CANCER, V75, P2186, DOI 10.1002/1097-0142(19950415)75:8<2186::AID-CNCR2820750825>3.0.CO;2-F; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Hosking FJ, 2011, BLOOD, V117, P1633, DOI 10.1182/blood-2010-08-301598; Hussin J, 2013, GENOME RES, V23, P419, DOI 10.1101/gr.144188.112; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; KARLSSON L, 1991, NATURE, V351, P485, DOI 10.1038/351485a0; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Khor CC, 2012, TRENDS GENET, V28, P233, DOI 10.1016/j.tig.2012.02.001; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Lahoud MH, 2001, GENOME RES, V11, P1327, DOI 10.1101/gr.168801; Li N, 2003, GENETICS, V165, P2213; LILLY F, 1964, LANCET, V2, P1207; Migliorini G, 2013, BLOOD, V122, P3298, DOI 10.1182/blood-2013-03-491316; Mullighan CG, 2009, LEUKEMIA, V23, P1209, DOI 10.1038/leu.2009.18; Ng SK, 2010, PLOS ONE, V5, pA18, DOI 10.1371/journal.pone.0009547; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Shang EY, 2011, J CELL BIOCHEM, V112, P2784, DOI 10.1002/jcb.23192; Sherborne AL, 2010, NAT GENET, V42, P492, DOI 10.1038/ng.585; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tan IKL, 2010, GENOME RES, V20, P1629, DOI 10.1101/gr.101881.109; Taylor GM, 2008, BRIT J CANCER, V98, P1125, DOI 10.1038/sj.bjc.6604257; Taylor GM, 2009, LEUKEMIA, V23, P863, DOI 10.1038/leu.2008.374; Taylor GM, 2002, HUM MOL GENET, V11, P1585; Taylor M, 2011, HUM IMMUNOL, V72, P897, DOI 10.1016/j.humimm.2011.05.011; Taylor M, 2009, BLOOD CELL MOL DIS, V42, P129, DOI 10.1016/j.bcmd.2008.10.009; Trevino LR, 2009, NAT GENET, V41, P1001, DOI 10.1038/ng.432; Urayama KY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072557; Urayama KY, 2012, BLOOD, V120, P3039, DOI 10.1182/blood-2012-01-404723; Yang P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-48; Zheng J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r103	43	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100480	10.1371/journal.pone.0100480	http://dx.doi.org/10.1371/journal.pone.0100480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959916	Green Published, gold			2022-12-25	WOS:000338633900050
J	Xu, J; Wu, F; Tian, DY; Wang, JJ; Zheng, ZZ; Xia, NS				Xu, Jian; Wu, Fan; Tian, Deying; Wang, Jingjing; Zheng, Zizheng; Xia, Ningshao			Open Reading Frame 3 of Genotype 1 Hepatitis E Virus Inhibits Nuclear Factor-kappa appa B Signaling Induced by Tumor Necrosis Factor-alpha in Human A549 Lung Epithelial Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; HEV INFECTION; ACTIVATION; A20; UBIQUITINATION; INFLAMMATION; TRANSMISSION; PATHOGENESIS; SUPERFAMILY	Hepatitis E virus (HEV) is one of the primary causative agents of acute hepatitis, and represents a major cause of severe public health problems in developing countries. The pathogenesis of HEV is not well characterized, however, primarily due to the lack of well-defined cell and animal models. Here, we investigated the effects of genotype 1 HEV open reading frame 3 (ORF3) on TNF-alpha-induced nucleus factor-kappa appa B (NF-kappa B) signaling. Human lung epithelial cells (A549) were transiently transfected with ORF3 containing plasmids. These cells were then stimulated with TNF-alpha and the nucleus translocation of the p65 NF-kappa B subunit was assessed using western blot and laser confocal microscopy. DNA-binding activity of p65 was also examined using electrophoretic mobility shift assay (EMSA), and the suppression of NF-kappa B target genes were detected using real-time RT-PCR and ELISA. These results enabled us to identify the decreased phosphorylation levels of IKB alpha. We focused on the gene of negative regulation of NF-kappa B, represented by TNF-alpha-induced protein 3 (TNFAIP3, also known as A20). Reducing the levels of A20 with siRNAs significantly enhances luciferase activation of NF-kappa B. Furthermore, HEV ORF3 regulated A20 primarily via activating transcription factor 6 (ATF6), involved in unfolded protein response (UPR), resulting in the degradation or inactivation of the receptor interacting protein 1 (RIP1), a major upstream activator of IKB kinase compounds (IKKs). Consequently, the phosphorylation of IKBa and the nucleus translocation of p65 are blocked, which contributes to diminished NF-kappa B DNA-binding activation and NF-kappa B-dependent gene expression. The findings suggest that genotype 1 HEV, through ORF3, may transiently activate NF-kappa B through UPR in early stage, and subsequently inhibit TNF-alpha-induced NF-kappa B signaling in late phase so as to create a favorable virus replication environment.	[Xu, Jian; Wu, Fan; Tian, Deying] Huazhong Univ Sci & Technol, Dept Infect Dis, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Wang, Jingjing] Huazhong Univ Sci & Technol, Dept Anesthesiol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Zheng, Zizheng; Xia, Ningshao] Xiamen Univ, Sch Publ Hlth, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Xiamen University	Tian, DY (corresponding author), Huazhong Univ Sci & Technol, Dept Infect Dis, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	dytian@tjh.tjmu.edu.cn	Tian, Deying/AAB-3667-2019; WANG, JINGYI/GSJ-1241-2022; wang, jing/GRS-7509-2022					Abmayr Susan M, 2006, Curr Protoc Pharmacol, VChapter 12, DOI [10.1002/0471142727.mb1201s75, 10.1002/0471141755.ph1203s35]; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aggarwal R, 2011, HEPATOLOGY, V54, P2218, DOI 10.1002/hep.24674; Carrara M, 2013, INT J MOL SCI, V14, P6454, DOI 10.3390/ijms14036454; Chandra V, 2008, J BIOSCIENCES, V33, P451, DOI 10.1007/s12038-008-0064-1; Chandra V, 2008, J VIROL, V82, P7100, DOI 10.1128/JVI.00403-08; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; Devhare PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063793; DiPerna G, 2004, J BIOL CHEM, V279, P36570, DOI 10.1074/jbc.M400567200; Dong C, 2012, HEPATOLOGY, V55, P1324, DOI 10.1002/hep.25530; Elsharkawy AM, 2007, HEPATOLOGY, V46, P590, DOI 10.1002/hep.21802; Emerson SU, 2001, P NATL ACAD SCI USA, V98, P15270, DOI 10.1073/pnas.251555098; Fauquet CM, 2005, VIRUS TAXONOMY 8 REP; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Tallon AIG, 2011, GASTROENT HEPAT-BARC, V34, P398, DOI 10.1016/j.gastrohep.2011.02.011; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Holla RP, 2013, SEMIN LIVER DIS, V33, P3, DOI 10.1055/s-0033-1338110; Hosoi T, 2007, BRAIN RES, V1152, P27, DOI 10.1016/j.brainres.2007.03.052; Kaneko M, 2003, BIOL PHARM BULL, V26, P931, DOI 10.1248/bpb.26.931; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Khuroo MS, 2009, J VIRAL HEPATITIS, V16, P519, DOI 10.1111/j.1365-2893.2009.01101.x; Kumar A, 2004, INT J GYNECOL OBSTET, V85, P240, DOI 10.1016/j.ijgo.2003.11.018; Li QT, 2000, GENE DEV, V14, P1729; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; Mitsui T, 2004, J MED VIROL, V74, P563, DOI 10.1002/jmv.20215; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Motte A, 2012, J CLIN VIROL, V53, P162, DOI 10.1016/j.jcv.2011.11.012; Nagasaki F, 2005, HEPATOL RES, V32, P134, DOI 10.1016/j.hepres.2005.03.017; Nakajima S, 2010, BIOCHEM BIOPH RES CO, V397, P176, DOI 10.1016/j.bbrc.2010.05.069; Okada T, 2003, J BIOL CHEM, V278, P31024, DOI 10.1074/jbc.M300923200; Parmar VM, 2012, ADV EXP MED BIOL, V738, P153, DOI 10.1007/978-1-4614-1680-7_10; Pelzer C, 2013, NAT IMMUNOL, V14, P337, DOI 10.1038/ni.2540; Rehman S, 2008, VIROLOGY, V370, P77, DOI 10.1016/j.virol.2007.07.036; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; ROULSTON A, 1995, MICROBIOL REV, V59, P481, DOI 10.1128/MMBR.59.3.481-505.1995; Roy AK, 2004, J BIOL CHEM, V279, P28345, DOI 10.1074/jbc.M400457200; Schlosser B, 2012, J HEPATOL, V56, P500, DOI 10.1016/j.jhep.2011.06.021; Scobie L, 2013, J VIRAL HEPATITIS, V20, P1, DOI 10.1111/jvh.12024; Shembade N, 2012, CELL MOL IMMUNOL, V9, P123, DOI 10.1038/cmi.2011.59; Tai DI, 2000, HEPATOLOGY, V31, P656, DOI 10.1002/hep.510310316; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tanaka T, 2007, J GEN VIROL, V88, P903, DOI 10.1099/vir.0.82535-0; Perez-Gracia MT, 2014, INFECT GENET EVOL, V22, P40, DOI 10.1016/j.meegid.2014.01.002; Teshale EH, 2010, CLIN INFECT DIS, V51, P328, DOI 10.1086/653943; Teshale EH, 2010, CLIN INFECT DIS, V50, P1006, DOI 10.1086/651077; Verhelst K, 2012, EMBO J, V31, P3845, DOI 10.1038/emboj.2012.240; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yugo DM, 2013, INT J ENV RES PUB HE, V10, P4507, DOI 10.3390/ijerph10104507; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6	53	31	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100787	10.1371/journal.pone.0100787	http://dx.doi.org/10.1371/journal.pone.0100787			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959724	Green Published, gold, Green Submitted			2022-12-25	WOS:000338633900086
J	Zampighi, GA; Serrano, R; Vergara, JL				Zampighi, Guido A.; Serrano, Raul; Vergara, Julio L.			A Novel Synaptic Vesicle Fusion Path in the Rat Cerebral Cortex: The "Saddle'' Point Hypothesis	PLOS ONE			English	Article							CONICAL ELECTRON TOMOGRAPHY; ACTIVE ZONE; PRESYNAPTIC MEMBRANES; CHEMICAL SYNAPSE; FINE-STRUCTURE; MICROSCOPY; PROTEINS; SNARE; ORGANIZATION; EXOCYTOSIS	We improved freeze-fracture electron microscopy to study synapses in the neuropil of the rat cerebral cortex at similar to 2 nm resolution and in three-dimensions. In the pre-synaptic axon, we found that "rods'' assembled from short filaments protruding from the vesicle and the plasma membrane connects synaptic vesicles to the membrane of the active zone. We equated these "connector rods'' to protein complexes involved in "docking'' and "priming'' vesicles to the active zone. Depending on their orientation, the "rods'' define two synaptic vesicle-fusion paths: When parallel to the plasma membrane, the vesicles hemi-fuse anywhere ("randomly'') in the active zone following the conventional path anticipated by the SNARE hypothesis. When perpendicular to the plasma membrane, the vesicles hemi-fuse at the base of sharp crooks, called "indentations,'' that are spaced 75-85 nm center-to-center, arranged in files and contained within gutters. They result from primary and secondary membrane curvatures that intersect at stationary inflection ("saddle'') points. Computer simulations indicate that this novel vesicle-fusion path evokes neurotransmitter concentration domains on the postsynaptic spine that are wider, shallower, and that reach higher average concentrations than the more conventional vesicle fusion path. In the post-synaptic spine, large (similar to 9x similar to 15 nm) rectangular particles at densities of 72 +/- 10/mu m(2) (170-240/spine) match the envelopes of the homotetrameric GluR2 AMPA-sensitive receptor. While these putative receptors join clusters, called the "post-synaptic domains,'' the overwhelming majority of the rectangular particles formed bands in the "non-synaptic'' plasma membrane of the spine. In conclusion, in the neuropil of the rat cerebral cortex, curvatures of the plasma membrane define a novel vesicle-fusion path that preconditions specific regions of the active zone for neurotransmitter release. We hypothesize that a change in the hybridization of the R-SNARE synaptobrevin from parallel to antiparallel swings the synapse into this novel vesicle-fusion path.	[Zampighi, Guido A.] Univ Calif Los Angeles, UCLA Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Serrano, Raul; Vergara, Julio L.] Univ Calif Los Angeles, UCLA Sch Med, Dept Physiol, Los Angeles, CA USA; [Zampighi, Guido A.] Univ Calif Los Angeles, UCLA Sch Med, Jules Stein Eye Res Inst, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zampighi, GA (corresponding author), Univ Calif Los Angeles, UCLA Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.	gzampighi@mednet.ucla.edu			National Institutes of Health (NIH) [EY-04110]; NIH/NIAMS [AR047664, AR54816, AR041802]; Muscular Dystrophy Association; NATIONAL EYE INSTITUTE [R01EY004110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041802, R56AR047664, R01AR047664] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health (NIH) EY-04110 (GAZ) and NIH/NIAMS AR047664, AR54816, and AR041802 and a Grant in Aid from the Muscular Dystrophy Association (JLV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akert K., 1972, P67; BLOOM FE, 1966, SCIENCE, V154, P1575, DOI 10.1126/science.154.3756.1575; Boyken J, 2013, NEURON, V78, P285, DOI 10.1016/j.neuron.2013.02.027; BRANTON D, 1971, PHILOS T ROY SOC B, V261, P133, DOI 10.1098/rstb.1971.0043; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; COUTEAUX R, 1970, Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences Serie D Sciences Naturelles, V271, P2346; Degtyar V, 2013, J NEUROSCI, V33, P5507, DOI 10.1523/JNEUROSCI.2337-12.2013; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Eskandari S, 1998, P NATL ACAD SCI USA, V95, P11235, DOI 10.1073/pnas.95.19.11235; Fernandez-Busnadiego R, 2010, J CELL BIOL, V188, P145, DOI 10.1083/jcb.200908082; GRAY EG, 1963, J ANAT, V97, P101; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Harris KM, 2003, PHILOS T R SOC B, V358, P745, DOI 10.1098/rstb.2002.1254; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; KATZ B, 1971, SCIENCE, V173, P123, DOI 10.1126/science.173.3992.123; Lanzavecchia S, 2005, J STRUCT BIOL, V149, P87, DOI 10.1016/j.jsb.2004.09.004; MANDEL LJ, 1993, NATURE, V361, P552, DOI 10.1038/361552a0; O'Brien J, 2006, P NATL ACAD SCI USA, V103, P1575, DOI 10.1073/pnas.0507884103; PALAY SL, 1955, J BIOPHYS BIOCHEM CY, V1, P69, DOI 10.1083/jcb.1.1.69; PALAY SL, 1975, COLD SPRING HARB SYM, V40, P1; PFENNINGER K, 1971, PHILOS T R SOC B, V261, P387, DOI 10.1098/rstb.1971.0071; PFENNINGER K, 1972, J NEUROCYTOL, V1, P129, DOI 10.1007/BF01099180; Pinto da Silva P, 1972, CHEM PHYS LIPIDS, V8, P265; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Weninger K, 2003, P NATL ACAD SCI USA, V100, P14800, DOI 10.1073/pnas.2036428100; Zampighi GA, 2006, BIOPHYS J, V91, P2910, DOI 10.1529/biophysj.106.084814; Zampighi GA, 1999, J GEN PHYSIOL, V113, P507, DOI 10.1085/jgp.113.4.507; ZAMPIGHI GA, 1989, J CELL BIOL, V108, P2255, DOI 10.1083/jcb.108.6.2255; Zampighi GA, 2003, J MOL BIOL, V325, P201, DOI 10.1016/S0022-2836(02)01200-7; Zampighi GA, 1997, J STRUCT BIOL, V119, P347, DOI 10.1006/jsbi.1997.3882; Zampighi GA, 2008, J NEUROSCI, V28, P4151, DOI 10.1523/JNEUROSCI.4639-07.2008; Zampighi GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016944; Zampighi LM, 2004, J STRUCT BIOL, V146, P368, DOI 10.1016/j.jsb.2004.01.008	40	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100710	10.1371/journal.pone.0100710	http://dx.doi.org/10.1371/journal.pone.0100710			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959848	Green Published, gold			2022-12-25	WOS:000338633900073
J	Hatzirodos, N; Irving-Rodgers, HF; Hummitzsch, K; Rodgers, RJ				Hatzirodos, Nicholas; Irving-Rodgers, Helen F.; Hummitzsch, Katja; Rodgers, Raymond J.			Transcriptome Profiling of the Theca Interna from Bovine Ovarian Follicles during Atresia	PLOS ONE			English	Article							GRANULOSA-CELLS; ANTRAL FOLLICLES; DOMINANT FOLLICLE; BINDING-PROTEINS; GENE ONTOLOGY; BASAL LAMINA; EXPRESSION; GROWTH; CATTLE; DIFFERENTIATION	The theca interna is a specialized stromal layer that envelops each growing ovarian follicle. It contains capillaries, fibroblasts, immune cells and the steroidogenic cells that synthesize androgens for conversion to estradiol by the neighboring granulosa cells. During reproductive life only a small number of follicles will grow to a sufficient size to ovulate, whereas the majority of follicles will undergo regression/atresia and phagocytosis by macrophages. To identify genes which are differentially regulated in the theca interna during follicular atresia, we undertook transcriptome profiling of the theca interna from healthy (n = 10) and antral atretic (n = 5) bovine follicles at early antral stages (<5 mm). Principal Component Analyses and hierarchical classification of the signal intensity plots for the arrays showed primary clustering into two groups, healthy and atretic. A total of 543 probe sets were differentially expressed between the atretic and healthy theca interna. Further analyses of these genes by Ingenuity Pathway Analysis and Gene Ontology Enrichment Analysis Toolkit software found most of the genes being expressed were related to cytokines, hormones and receptors as well as the cell cycle and DNA replication. Cell cycle genes which encode components of the replicating chromosome complex and mitotic spindle were down-regulated in atretic theca interna, whereas stress response and inflammation-related genes such as TP53, IKBKB and TGFB1 were up-regulated. In addition to cell cycle regulators, upstream regulators that were predicted to be inhibited included Retinoblastoma 1, E2 transcription factor 1, and hepatocyte growth factor. Our study suggests that during antral atresia of small follicles in the theca interna, arrest of cell cycle and DNA replication occurs rather than up-regulation of apoptosis-associated genes as occurs in granulosa cells.	[Hatzirodos, Nicholas; Irving-Rodgers, Helen F.; Hummitzsch, Katja; Rodgers, Raymond J.] Univ Adelaide, Res Ctr Reprod Hlth, Discipline Obstet & Gynaecol, Sch Paediat & Reprod Hlth,Robinson Res Inst, Adelaide, SA, Australia	Robinson Research Institute; University of Adelaide	Rodgers, RJ (corresponding author), Univ Adelaide, Res Ctr Reprod Hlth, Discipline Obstet & Gynaecol, Sch Paediat & Reprod Hlth,Robinson Res Inst, Adelaide, SA, Australia.	ray.rodgers@adelaide.edu.au	Rodgers, Raymond J/C-3476-2009; Irving-Rodgers, Helen/E-3660-2010; Hummitzsch, Katja/K-6940-2013	Hummitzsch, Katja/0000-0001-5023-2668	National Health and Medical Research Council of Australia; Australian Research Council; University of Adelaide	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); University of Adelaide	This work was supported by the National Health and Medical Research Council of Australia, the Australian Research Council and the University of Adelaide. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu-Vieyra C, 2008, MOL ENDOCRINOL, V22, P2141, DOI 10.1210/me.2008-0033; [Anonymous], 2005, IPA NETW GEN ALG; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carvajal LA, 2013, EMBO REP, V14, P414, DOI 10.1038/embor.2013.25; Christenson LK, 2013, MOL ENDOCRINOL, V27, P1153, DOI 10.1210/me.2013-1093; Chu T, 2012, THERIOGENOLOGY, V77, P1928, DOI 10.1016/j.theriogenology.2012.01.015; Clark LJ, 2004, BIOL REPROD, V71, P1071, DOI 10.1095/biolreprod.104.029652; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; EISENHART C, 1947, BIOMETRICS, V3, P1, DOI 10.2307/3001534; Evans ACO, 2004, BIOL REPROD, V70, P1475, DOI 10.1095/biolreprod.103.025114; FALCK B, 1959, NATURE, V184, P1082, DOI 10.1038/1841082a0; Hatzirodos N, 2014, PLOS ONE UNPUB; Hatzirodos N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-40; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irving-Rodgers HF, 2009, HUM REPROD, V24, P936, DOI 10.1093/humrep/den447; Irving-Rodgers HF, 2003, BIOL REPROD, V69, P2022, DOI 10.1095/biolreprod.103.017442; Irving-Rodgers HF, 2003, REPROD FERT DEVELOP, V15, P241, DOI 10.1071/RD03008; Irving-Rodgers HF, 2002, REPRODUCTION, V123, P97, DOI 10.1530/rep.0.1230097; Irving-Rodgers HF, 2001, REPRODUCTION, V122, P761, DOI 10.1530/rep.0.1220761; Irving-Rodgers HF, 2000, J REPROD FERTIL, V118, P221, DOI 10.1530/reprod/118.2.221; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Li B, 2010, FASEB J, V24, P4767, DOI 10.1096/fj.10-154757; Matsuda F, 2012, J REPROD DEVELOP, V58, P44, DOI 10.1262/jrd.2011-012; Mattera L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000983; Mihm M, 2008, REPRODUCTION, V135, P253, DOI 10.1530/REP-06-0193; Mourot M, 2006, MOL REPROD DEV, V73, P1367, DOI 10.1002/mrd.20585; Patel SS, 2010, REPROD SCI, V17, P978, DOI 10.1177/1933719110379055; Portela VM, 2010, BIOL REPROD, V83, P339, DOI 10.1095/biolreprod.110.084277; Prodoehl MJ, 2009, MOL CELL ENDOCRINOL, V307, P133, DOI 10.1016/j.mce.2009.03.002; Rodgers RJ, 2010, REPRODUCTION, V139, P309, DOI 10.1530/REP-09-0177; Rodgers RJ, 2010, BIOL REPROD, V82, P1021, DOI 10.1095/biolreprod.109.082941; Sharma SC, 2000, J BIOL CHEM, V275, P33718, DOI 10.1074/jbc.M003555200; Sivko GS, 2004, J CELL BIOCHEM, V93, P830, DOI 10.1002/jcb.20223; Skinner MK, 2008, MOL REPROD DEV, V75, P1457, DOI 10.1002/mrd.20883; Turner EC, 2011, REPRODUCTION, V141, P821, DOI 10.1530/REP-10-0327; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Wu RJ, 2004, HUM REPROD UPDATE, V10, P119, DOI 10.1093/humupd/dmh011; YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	43	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99706	10.1371/journal.pone.0099706	http://dx.doi.org/10.1371/journal.pone.0099706			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956388	Green Submitted, Green Published, gold			2022-12-25	WOS:000338917900017
J	O'Donnell, DR; Parigi, A; Fish, JA; Dworkin, I; Wagner, AP				O'Donnell, Daniel R.; Parigi, Abhijna; Fish, Jordan A.; Dworkin, Ian; Wagner, Aaron P.			The Roles of Standing Genetic Variation and Evolutionary History in Determining the Evolvability of Anti-Predator Strategies	PLOS ONE			English	Article							HETEROGENEOUS ENVIRONMENT; ADAPTATION; POPULATION; RESPONSES; SELECTION; GENOMICS; SIZE	Standing genetic variation and the historical environment in which that variation arises (evolutionary history) are both potentially significant determinants of a population's capacity for evolutionary response to a changing environment. Using the open-ended digital evolution software Avida, we evaluated the relative importance of these two factors in influencing evolutionary trajectories in the face of sudden environmental change. We examined how historical exposure to predation pressures, different levels of genetic variation, and combinations of the two, affected the evolvability of anti-predator strategies and competitive abilities in the presence or absence of threats from new, invasive predator populations. We show that while standing genetic variation plays some role in determining evolutionary responses, evolutionary history has the greater influence on a population's capacity to evolve anti-predator traits, i.e. traits effective against novel predators. This adaptability likely reflects the relative ease of repurposing existing, relevant genes and traits, and the broader potential value of the generation and maintenance of adaptively flexible traits in evolving populations.	[O'Donnell, Daniel R.; Parigi, Abhijna; Dworkin, Ian] Michigan State Univ, Program Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA; [O'Donnell, Daniel R.; Parigi, Abhijna; Fish, Jordan A.; Dworkin, Ian] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Fish, Jordan A.] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA; [Dworkin, Ian; Wagner, Aaron P.] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University	O'Donnell, DR (corresponding author), Michigan State Univ, Program Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA.	odonn146@msu.edu	ODonnell, Daniel/GXG-8072-2022	Dworkin, Ian/0000-0002-2874-287X; O'Donnell, Daniel/0000-0003-0452-2888	BEACON Center for the Study of Evolution in Action (NSF) [DBI-0939454]; Michigan State University Institute for Cyber Enabled Research	BEACON Center for the Study of Evolution in Action (NSF); Michigan State University Institute for Cyber Enabled Research	Funding was provided by BEACON Center for the Study of Evolution in Action (NSF Cooperative Agreement DBI-0939454), beacon-center.org; and Michigan State University Institute for Cyber Enabled Research, icer.msu.edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CJ, 2013, ARTIF LIFE, V13, P3; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Barton K, 2013, R PACKAGE MUMIN MULT; Bell G, 2008, EVOL APPL, V1, P3, DOI 10.1111/j.1752-4571.2007.00011.x; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; BONNELL ML, 1974, SCIENCE, V184, P908, DOI 10.1126/science.184.4139.908; Bryson DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083242; Colegrave N, 2008, HEREDITY, V100, P464, DOI 10.1038/sj.hdy.6801095; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Dettman JR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-35; Dionne M, 2009, PHILOS T R SOC B, V364, P1555, DOI 10.1098/rstb.2009.0011; DODSON S, 1989, BIOSCIENCE, V39, P447, DOI 10.2307/1311136; Drake JW, 1998, GENETICS, V148, P1667; Elmer KR, 2011, TRENDS ECOL EVOL, V26, P298, DOI 10.1016/j.tree.2011.02.008; Fortuna MA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002928; Fox J, 2013, R PACKAGE EFFECTS EF; Frankham R, 1999, ANIM CONSERV, V2, P255, DOI 10.1111/j.1469-1795.1999.tb00071.x; Fry JD, 2001, J EVOLUTION BIOL, V14, P296, DOI 10.1046/j.1420-9101.2001.00271.x; Futuyma DJ, 1979, EVOLUTIONARY BIOL; Gillings MR, 2012, TRENDS ECOL EVOL, V27, P346, DOI 10.1016/j.tree.2012.02.006; Hayden EJ, 2011, NATURE, V474, P92, DOI 10.1038/nature10083; HEDRICK PW, 1976, GENETICS, V84, P145; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Innan H, 2004, P NATL ACAD SCI USA, V101, P10667, DOI 10.1073/pnas.0401720101; Jerome JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016399; Kawecki TJ, 2012, TRENDS ECOL EVOL, V27, P547, DOI 10.1016/j.tree.2012.06.001; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Lehmann K, 2013, PLOS ONE, V9; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; LEVINS R, 1963, AM NAT, V97, P75, DOI 10.1086/282258; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Litchman E, 2012, MAR ECOL PROG SER, V470, P235, DOI 10.3354/meps09912; Lohbeck KT, 2012, NAT GEOSCI, V5, P346, DOI [10.1038/NGEO1441, 10.1038/ngeo1441]; McCollum SA, 1996, EVOLUTION, V50, P583, DOI 10.1111/j.1558-5646.1996.tb03870.x; McGuigan K, 2009, TRENDS ECOL EVOL, V24, P305, DOI 10.1016/j.tree.2009.02.001; Messer PW, 2013, TRENDS ECOL EVOL, V28, P659, DOI 10.1016/j.tree.2013.08.003; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Ofria C, 2009, ARTIFICIAL LIFE MODE; Oksanen J., 2013, VEGAN COMMUNITY ECOL; Orr HA, 2001, GENETICS, V157, P875; Pennings PS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002527; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; Potts R, 1996, SCIENCE, V273, P922, DOI 10.1126/science.273.5277.922; Przeworski M, 2005, EVOLUTION, V59, P2312, DOI 10.1554/05-273.1; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schmitz OJ, 2008, SCIENCE, V319, P952, DOI 10.1126/science.1152355; Sih A., 1987, P203; Wagner AP, 2013, ARXIV13101369V2; Wilke CO, 2002, TRENDS ECOL EVOL, V17, P528, DOI 10.1016/S0169-5347(02)02612-5; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767	52	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100163	10.1371/journal.pone.0100163	http://dx.doi.org/10.1371/journal.pone.0100163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955847	Green Published, gold, Green Submitted			2022-12-25	WOS:000338917900030
J	Soebiyanto, RP; Clara, W; Jara, J; Castillo, L; Sorto, OR; Marinero, S; de Antinori, MEB; McCracken, JP; Widdowson, MA; Azziz-Baumgartner, E; Kiang, RK				Soebiyanto, Radina P.; Clara, Wilfrido; Jara, Jorge; Castillo, Leticia; Rene Sorto, Oscar; Marinero, Sidia; Barnett de Antinori, Maria E.; McCracken, John P.; Widdowson, Marc-Alain; Azziz-Baumgartner, Eduardo; Kiang, Richard K.			The Role of Temperature and Humidity on Seasonal Influenza in Tropical Areas: Guatemala, El Salvador and Panama, 2008-2013	PLOS ONE			English	Article							RELATIVE-HUMIDITY; TRANSMISSION; SURVEILLANCE; SURVIVAL; VIRUS; PATTERNS; DRIVERS; MODEL	Background: The role of meteorological factors on influenza transmission in the tropics is less defined than in the temperate regions. We assessed the association between influenza activity and temperature, specific humidity and rainfall in 6 study areas that included 11 departments or provinces within 3 tropical Central American countries: Guatemala, El Salvador and Panama. Method/Findings: Logistic regression was used to model the weekly proportion of laboratory-confirmed influenza positive samples during 2008 to 2013 (excluding pandemic year 2009). Meteorological data was obtained from the Tropical Rainfall Measuring Mission satellite and the Global Land Data Assimilation System. We found that specific humidity was positively associated with influenza activity in El Salvador (Odds Ratio (OR) and 95% Confidence Interval of 1.18 (1.07-1.31) and 1.32 (1.08-1.63)) and Panama (OR = 1.44 (1.08-1.93) and 1.97 (1.34-2.93)), but negatively associated with influenza activity in Guatemala (OR = 0.72 (0.6-0.86) and 0.79 (0.69-0.91)). Temperature was negatively associated with influenza in El Salvador's west-central departments (OR = 0.80 (0.7-0.91)) whilst rainfall was positively associated with influenza in Guatemala's central departments (OR = 1.05 (1.01-1.09)) and Panama province (OR = 1.10 (1.05-1.14)). In 4 out of the 6 locations, specific humidity had the highest contribution to the model as compared to temperature and rainfall. The model performed best in estimating 2013 influenza activity in Panama and west-central El Salvador departments (correlation coefficients: 0.5-0.9). Conclusions/Significance: The findings highlighted the association between influenza activity and specific humidity in these 3 tropical countries. Positive association with humidity was found in El Salvador and Panama. Negative association was found in the more subtropical Guatemala, similar to temperate regions. Of all the study locations, Guatemala had annual mean temperature and specific humidity that were lower than the others.	[Soebiyanto, Radina P.] Univ Space Res Assoc, Goddard Earth Sci Technol & Res GESTAR, Columbia, MD USA; [Soebiyanto, Radina P.; Kiang, Richard K.] NASA, Global Change Data Ctr, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Clara, Wilfrido] Ctr Dis Control & Prevent CDC, Reg Off Cent Amer Reg, Influenza Program, Guatemala City, Guatemala; [Jara, Jorge; McCracken, John P.] Univ Valle Guatemala, Influenza Unit, Ctr Hlth Studies, Guatemala City, Guatemala; [Castillo, Leticia] Minist Hlth Guatemala, Natl Influenza Ctr, Guatemala City, Guatemala; [Rene Sorto, Oscar] Minist Hlth El Salvador, Hlth Surveillance Div, San Salvador, El Salvador; [Marinero, Sidia] Minist Environm & Nat Resources El Salvador, Div Meteorol, Natl Environm Observ, San Salvador, El Salvador; [Barnett de Antinori, Maria E.] Gorgas Mem Inst Hlth Studies, Natl Influenza Ctr, Panama City, Panama; [Widdowson, Marc-Alain; Azziz-Baumgartner, Eduardo] Ctr Dis Control & Prevent CDC, Influenza Div, Atlanta, GA USA	Universities Space Research Association (USRA); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Universidad del Valle de Guatemala; Instituto Conmemorativo Gorgas de Estudios de la Salud; Centers for Disease Control & Prevention - USA	Kiang, RK (corresponding author), NASA, Global Change Data Ctr, Goddard Space Flight Ctr, Code 610-2, Greenbelt, MD 20771 USA.	richard.kiang@nasa.gov			NASA Applied Science - Public Health program; CDC Influenza Division	NASA Applied Science - Public Health program; CDC Influenza Division(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by NASA Applied Science - Public Health program and CDC Influenza Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker J.G., 2007, EOS T AGU, V88, P14, DOI [DOI 10.1029/2007EO020003, 10.1029/2007EO020003]; Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Baumgartner EA, 2012, J INFECT DIS, V206, P838, DOI 10.1093/infdis/jis467; *CDC CAP INFL PROG, 2010, NAT INV COR CAP PAND; *CDC CAP INFL PROG, 2009, INST DES UN CENT INF; *CDC CAP INFL PROG, 2010, ANN REPORT; *CDC CAR INFL PROG, 2011, INFL SURV CENTR AM R; Chadha MS, 2012, INFLUENZA OTHER RESP, V6, P196, DOI 10.1111/j.1750-2659.2011.00293.x; Charland KML, 2009, EPIDEMIOL INFECT, V137, P1377, DOI 10.1017/S0950268809002283; Chew FT, 1998, EPIDEMIOL INFECT, V121, P121, DOI 10.1017/S0950268898008905; Crawley MJ., 2007, R BOOK; Dosseh A, 2000, AM J TROP MED HYG, V62, P639, DOI 10.4269/ajtmh.2000.62.639; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Ek MB, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003296; Hampson AW, 1999, VACCINE, V17, pS19, DOI 10.1016/S0264-410X(99)00100-0; HARPER GJ, 1961, J HYG-CAMBRIDGE, V59, P479, DOI 10.1017/S0022172400039176; Haynes AK, 2013, J INFECT DIS, V208, pS246, DOI 10.1093/infdis/jit515; HEMMES JH, 1962, ANTON VAN LEE J M S, V28, P221, DOI 10.1007/BF02538737; Kasasa S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-63; Kazembe Lawrence N, 2006, Int J Health Geogr, V5, P41, DOI 10.1186/1476-072X-5-41; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Liao CM, 2009, INT J INFECT DIS, V13, P589, DOI 10.1016/j.ijid.2008.09.019; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Mahamat A, 2013, J INFECTION, V67, P141, DOI 10.1016/j.jinf.2013.03.018; Moura FEA, 2009, AM J TROP MED HYG, V81, P180, DOI 10.4269/ajtmh.2009.81.180; *PAHO, 2006, PAHO CDC GEN PROT IN; *PAHO CDC, 2009, PROT GEN VIG INFL; Polozov IV, 2008, NAT CHEM BIOL, V4, P248, DOI 10.1038/nchembio.77; R Core Team, 2012, R LANG ENV STAT COMP; Rodell M, 2004, B AM METEOROL SOC, V85, P381, DOI 10.1175/BAMS-85-3-381; SAHA S, WHO B IN PRESS; SCHAFFER FL, 1976, ARCH VIROL, V51, P263, DOI 10.1007/BF01317930; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Soebiyanto RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009450; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; Tamerius JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003194; Tang JW, 2010, J MED VIROL, V82, P1958, DOI 10.1002/jmv.21892; te Beest DE, 2013, AM J EPIDEMIOL, V178, P1469, DOI 10.1093/aje/kwt132; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Urashima M, 2003, JPN J INFECT DIS, V56, P43; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; WHO, 2008, INFLUENZA; WHO, 2007, REC LAB PROC DET AV; Yang L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001399; Yu HJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001552; Zaman RU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008452	51	55	57	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100659	10.1371/journal.pone.0100659	http://dx.doi.org/10.1371/journal.pone.0100659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956184	Green Submitted, gold, Green Published			2022-12-25	WOS:000338917900078
J	Kim, H; Shibayama, K; Rimbara, E; Mori, S				Kim, Hyun; Shibayama, Keigo; Rimbara, Emiko; Mori, Shigetarou			Biochemical Characterization of Quinolinic Acid Phosphoribosyltransferase from Mycobacterium tuberculosis H37Rv and Inhibition of Its Activity by Pyrazinamide	PLOS ONE			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; CRYSTAL-STRUCTURE; SALMONELLA-TYPHIMURIUM; NAD KINASE; RESISTANCE; ENZYME; BIOSYNTHESIS; METABOLISM; MECHANISMS; ROLES	Quinolinic acid phosphoribosyltransferase (QAPRTase EC 2.4.2.19) a key enzyme in the de novo pathway of nicotinamide adenine dinucleotide (NAD) biosynthesis and a target for h development of new anti-tuberculosis drugs. QAPRTase catalyzes the synthesis of nicotinic acid nlononucleotide from quinolinic acid (QA) and 5-phosphoribosyl-1-pyrophosphate (PRPP) through a phosphoribosyl transfer reaction followed by decarboycylation. The crystal structure of QAPRTase from Mycobacterium tuberculosis H37Rv (AAtQAPRTase) has been determined; however, a detailed functional analysis of MtQAPRTase has not been published. Here, we analyzed the enzymatic activities of MtQAPRTase and determined the effect. on catalysis of the anti-tuberculosis drug pyrazinamide (PZA). The optimum temperature and pH for MtQAPRTase activity were 60 degrees C and pH 9.2. MtQAPRTase required bivalent metal ions and its activity was highest in the presence of Mg2+. Kinetic analyses revealed that the K-m values for QA and PRPP were 0.08 and 0.39 mM, respectively, and the k(cat), values for A and PRPP were 0.12 and 0.14 [s(-1)], respectively. When the amino acid residues of MtQAPRTase, which may interact with QA, were substittuted with alanine residues, catalytic activity was undetectable. Further, PZA, which is an anti-tuberculosis drug and a structural analog of QA, markedly inhibited the catalytic activity of MtQAPRTase. The structure of PZA may provide the basis or the design of new inhibitors of MtQAPRTase. These findings provide new insights into the catalytic properties of MtQAPRTase.	[Kim, Hyun; Shibayama, Keigo; Rimbara, Emiko; Mori, Shigetarou] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan	National Institute of Infectious Diseases (NIID)	Mori, S (corresponding author), Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan.	mshige@niid.go.jp	Rimbara, Emiko/F-4113-2017	Rimbara, Emiko/0000-0001-8847-1840	Ministry of Health, Labor, and Welfare of Japan [H24-Shinkou-Ippan-010]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [25860329]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported, in part, by a grant from the Ministry of Health, Labor, and Welfare of Japan (H24-Shinkou-Ippan-010) and by a Grant-in-Aid for Young Scientists (No. 25860329) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Bellinzoni M, 2002, PROTEIN EXPRES PURIF, V25, P547, DOI 10.1016/S1046-5928(02)00041-4; Bello Z, 2010, BIOCHEMISTRY-US, V49, P1377, DOI 10.1021/bi9018219; Bello Z, 2010, BIOCHEMISTRY-US, V49, P1388, DOI 10.1021/bi9018225; Boshoff HI, 2002, J BACTERIOL, V184, P2167, DOI 10.1128/JB.184.8.2167-2172.2002; Cao H, 2002, BIOCHEMISTRY-US, V41, P3520, DOI 10.1021/bi012148g; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; Champagne KS, 2006, BIOCHEMISTRY-US, V45, P14933, DOI 10.1021/bi061802v; Chappie JS, 2005, STRUCTURE, V13, P1385, DOI 10.1016/j.str.2005.05.016; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de Figueiredo LF, 2011, BIOCHEM J, V439, P341, DOI 10.1042/BJ20110320; Di Luccio E, 2008, BIOCHEMISTRY-US, V47, P4039, DOI 10.1021/bi7020475; Eads JC, 1997, STRUCTURE, V5, P47, DOI 10.1016/S0969-2126(97)00165-2; FOSTER JW, 1980, MICROBIOL REV, V44, P83, DOI 10.1128/MMBR.44.1.83-105.1980; FOSTER JW, 1990, J BACTERIOL, V172, P4187, DOI 10.1128/jb.172.8.4187-4196.1990; Garavaglia S, 2004, J BIOL CHEM, V279, P40980, DOI 10.1074/jbc.M406586200; IWAI K, 1979, AGR BIOL CHEM TOKYO, V43, P345, DOI 10.1080/00021369.1979.10863445; KALIKIN L, 1988, BIOCHEM BIOPH RES CO, V152, P559, DOI 10.1016/S0006-291X(88)80074-3; Kim C, 2002, FEBS LETT, V523, P239, DOI 10.1016/S0014-5793(02)02905-8; Kim H, 2011, ANTIMICROB AGENTS CH, V55, P3661, DOI 10.1128/AAC.00042-11; Kim MK, 2006, PROTEINS, V63, P252, DOI 10.1002/prot.20834; Leslie NR, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-20; Liu H, 2007, J MOL BIOL, V373, P755, DOI 10.1016/j.jmb.2007.08.043; Mori S, 2010, PROTEIN EXPRES PURIF, V69, P99, DOI 10.1016/j.pep.2009.09.010; MUSICK WDL, 1981, CRC CR REV BIOCH MOL, V11, P1, DOI 10.3109/10409238109108698; Ngo SC, 2007, ANTIMICROB AGENTS CH, V51, P2430, DOI 10.1128/AAC.01458-06; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Penfound T, 1995, ESCHERICHIA COLI SAL, P721; Raffaelli N, 2004, BIOCHEMISTRY-US, V43, P7610, DOI 10.1021/bi049650w; Raynaud C, 1999, MICROBIOL-SGM, V145, P1359, DOI 10.1099/13500872-145-6-1359; Schramm VL, 2004, PROG NUCLEIC ACID RE, V78, P261, DOI 10.1016/S0079-6603(04)78007-1; Sharma V, 1998, STRUCTURE, V6, P1587, DOI 10.1016/S0969-2126(98)00156-7; Shi WL, 2011, SCIENCE, V333, P1630, DOI 10.1126/science.1208813; Shin DH, 2005, J BIOL CHEM, V280, P18326, DOI 10.1074/jbc.M501622200; Sinha SC, 2001, CURR OPIN STRUC BIOL, V11, P733, DOI 10.1016/S0959-440X(01)00274-3; Somoskovi A, 2001, RESP RES, V2, P164, DOI 10.1186/rr54; Tritz GJ, 1987, ESCHERICHIA COLI SAL, P557; Wang T, 2006, NAT STRUCT MOL BIOL, V13, P661, DOI 10.1038/nsmb1114; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2008, WHOHTMTB2008402; Zhang Y, 1999, J BACTERIOL, V181, P2044, DOI 10.1128/JB.181.7.2044-2049.1999; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877; Zimhony O, 2000, NAT MED, V6, P1043, DOI 10.1038/79558	43	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100062	10.1371/journal.pone.0100062	http://dx.doi.org/10.1371/journal.pone.0100062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949952	Green Submitted, Green Published, gold			2022-12-25	WOS:000338276300035
J	Marr, N; Hirschfeld, AF; Lam, A; Wang, S; Lavoie, PM; Turvey, SE				Marr, Nico; Hirschfeld, Aaron F.; Lam, Angie; Wang, Shirley; Lavoie, Pascal M.; Turvey, Stuart E.			Assessment of Genetic Associations between Common Single Nucleotide Polymorphisms in RIG-I-Like Receptor and IL-4 Signaling Genes and Severe Respiratory Syncytial Virus Infection in Children: A Candidate Gene Case-Control Study	PLOS ONE			English	Article							ILE50VAL VARIANT; RISK-FACTORS; SUSCEPTIBILITY; BRONCHIOLITIS; DISEASE; HOST; INTERLEUKIN-4; EPIDEMIOLOGY; REINFECTION; IL-4R-ALPHA	The majority of cases of severe pediatric respiratory syncytial virus (RSV) infection occur in otherwise healthy infants who have no identifiable risk factors, suggesting that additional subclinical factors, such as population genetic variation, influence the course of RSV infection. The objective of this study was to test if common single nucleotide polymorphisms (SNPs) in genes encoding for immune signalling components of the RIG-I-like receptor (RLR) and IL-4-signalling pathways affect the outcome of RSV infection in early life. We genotyped 8 SNPs using allele-specific probes combined with real-time PCR. Each of the SNPs tested had previously been established to have a functional impact on immune responsiveness and two of the SNPs in the IL4 and IL4R genes had previously been associated with severe RSV bronchiolitis. Association with susceptibility to severe RSV infection was tested by statistically comparing genotype and allele frequencies in infants and young children hospitalized with severe RSV bronchiolitis (n = 140) with two control groups-children who tested positive for RSV but did not require hospitalization (n = 100), and a general population control group (n = 285). Our study was designed with sufficient power (>80%) to detect clinically-relevant associations with effect sizes >= 1.5. However, we detected no statistically significant differences in allele and genotype frequencies of the investigated SNPs between the inpatient and control groups. To conclude, we could not replicate the previously reported association with SNPs in the IL4 and IL4R genes in our independent cohort, nor did we find that common SNPs in genes encoding for RLRs and the downstream adapter MAVS were associated with susceptibility to severe RSV infections. Despite the existing evidence demonstrating a functional immunological impact of these SNPs, our data suggest that the biological effect of each individual SNP is unlikely to affect clinical outcomes of RSV infection.	[Marr, Nico; Hirschfeld, Aaron F.; Lam, Angie; Wang, Shirley; Lavoie, Pascal M.; Turvey, Stuart E.] Univ British Columbia, Dept Pediat, Child & Family Res Inst, Vancouver, BC V6T 1W5, Canada	Child & Family Research Institute; University of British Columbia	Marr, N (corresponding author), Univ British Columbia, Dept Pediat, Child & Family Res Inst, Vancouver, BC V6T 1W5, Canada.	nmarr@cfri.ca; sturvey@cw.bc.ca	Marr, Nico/T-7741-2019; Turvey, Stuart/HGV-1191-2022	Marr, Nico/0000-0002-1927-7072; Turvey, Stuart/0000-0003-1599-1065; Lavoie, Pascal/0000-0002-2205-0362	British Columbia Lung Association; Canadian Institutes of Health Research; AllerGen N.C.E., Canada; Child and Family Research Institute; Michael Smith Foundation for Health Research	British Columbia Lung Association; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); AllerGen N.C.E., Canada; Child and Family Research Institute; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This study was funded by the British Columbia Lung Association (to N.M.), and the Canadian Institutes of Health Research (to S. E. T.). A.L. and S.W. were recipients of undergraduate summer studentships from AllerGen N.C.E., Canada and the Child and Family Research Institute. P.M.L. and S.E.T. acknowledge support from the Michael Smith Foundation for Health Research. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2013, J IMMUNOL, V190, P3949, DOI 10.4049/jimmunol.1201015; Amanatidou V, 2009, PEDIATR INFECT DIS J, V28, P135, DOI 10.1097/INF.0b013e31818c8d17; Awomoyi AA, 2007, J IMMUNOL, V179, P3171, DOI 10.4049/jimmunol.179.5.3171; Bendelja K, 2000, CLIN EXP IMMUNOL, V121, P332, DOI 10.1046/j.1365-2249.2000.01297.x; Bhoj VG, 2008, P NATL ACAD SCI USA, V105, P14046, DOI 10.1073/pnas.0804717105; Boyce TG, 2000, J PEDIATR-US, V137, P865, DOI 10.1067/mpd.2000.110531; Choi EH, 2002, J INFECT DIS, V186, P1207, DOI 10.1086/344310; Clarke GM, 2011, NAT PROTOC, V6, P121, DOI 10.1038/nprot.2010.182; Clausen LN, 2014, J VIRAL HEPATITIS, V21, P578, DOI 10.1111/jvh.12188; Culley FJ, 2002, J EXP MED, V196, P1381, DOI 10.1084/jem.20020943; Demoor T, 2012, J IMMUNOL, V189, P5942, DOI 10.4049/jimmunol.1201763; Garcia CG, 2010, PEDIATRICS, V126, pE1453, DOI 10.1542/peds.2010-0507; Goetghebuer T, 2004, PEDIATR PULM, V38, P321, DOI 10.1002/ppul.20069; Hakonarson H, 2009, SEMIN IMMUNOL, V21, P355, DOI 10.1016/j.smim.2009.06.001; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hashimoto Shu, 2008, Allergol Int, V57, P21, DOI 10.2332/allergolint.R-07-156; Hoebee B, 2003, J INFECT DIS, V187, P2, DOI 10.1086/345859; Hu JZ, 2010, J IMMUNOL, V185, P424, DOI 10.4049/jimmunol.0903291; Kwiatkowski D, 2000, BMJ-BRIT MED J, V321, P1061, DOI 10.1136/bmj.321.7268.1061; Lahti M, 2002, PEDIATR RES, V51, P696, DOI [10.1203/00006450-200206000-00006, 10.1023/01.PDR.0000015911.65104.93]; Liu XW, 2011, MOL BIOL REP, V38, P4583, DOI 10.1007/s11033-010-0590-4; Lofgren J, 2010, PEDIATR PULM, V45, P687, DOI 10.1002/ppul.21248; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marr N, 2014, J IMMUNOL, V192, P948, DOI 10.4049/jimmunol.1302007; Marr N, 2013, TRENDS MICROBIOL, V21, P568, DOI 10.1016/j.tim.2013.08.006; Mitsuyasu H, 1998, NAT GENET, V19, P119, DOI 10.1038/472; Mitsuyasu H, 1999, J IMMUNOL, V162, P1227; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Ovsyannikova IG, 2010, J INFECT DIS, V201, P207, DOI 10.1086/649588; Paes BA, 2011, CAN RESPIR J, V18, pE10, DOI 10.1155/2011/493056; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Paulus SC, 2007, CLIN IMMUNOL, V123, P252, DOI 10.1016/j.clim.2007.03.003; Petersen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010603; Pickerling LK., 2012, RED BOOK 2012 REPORT, V29th ed, P609; Pothlichet J, 2011, EMBO MOL MED, V3, P142, DOI 10.1002/emmm.201000120; Pothlichet J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007582; Puthothu B, 2006, J INFECT DIS, V193, P438, DOI 10.1086/499316; Ramet M, 2011, PEDIATR PULM, V46, P101, DOI 10.1002/ppul.21348; Ripple MJ, 2010, J IMMUNOL, V185, P4804, DOI 10.4049/jimmunol.1000484; Selvarajah S, 2010, CURR OPIN HEMATOL, V17, P550, DOI 10.1097/MOH.0b013e32833e7544; Siezen CLE, 2009, PEDIATR INFECT DIS J, V28, P333, DOI 10.1097/INF.0b013e31818e2aa9; Simoes EAF, 2003, PEDIATR INFECT DIS J, V22, pS13, DOI 10.1097/00006454-200302001-00003; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Soucy-Faulkner A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000930; Tal G, 2004, J INFECT DIS, V189, P2057, DOI 10.1086/420830; Thomsen SF, 2008, PEDIATRICS, V121, P493, DOI 10.1542/peds.2007-1889; Welliver RC, 2003, J PEDIATR-US, V143, pS112, DOI 10.1067/S0022-3476(03)00508-0; Yang H, 2012, AUTOIMMUNITY, V45, P226, DOI 10.3109/08916934.2011.633134; Yoboua F, 2010, J VIROL, V84, P7267, DOI 10.1128/JVI.00142-10; You DH, 2013, J LEUKOCYTE BIOL, V93, P933, DOI 10.1189/jlb.1012498	54	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100269	10.1371/journal.pone.0100269	http://dx.doi.org/10.1371/journal.pone.0100269			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949794	Green Published, gold			2022-12-25	WOS:000338276300057
J	Shafique, S; Siddiqi, S; Schraders, M; Oostrik, J; Ayub, H; Bilal, A; Ajmal, M; Seco, CZ; Strom, TM; Mansoor, A; Mazhar, K; Shah, STA; Hussain, A; Azam, M; Kremer, H; Qamar, R				Shafique, Sobia; Siddiqi, Saima; Schraders, Margit; Oostrik, Jaap; Ayub, Humaira; Bilal, Ammad; Ajmal, Muhammad; Seco, Celia Zazo; Strom, Tim M.; Mansoor, Atika; Mazhar, Kehkashan; Shah, Syed Tahir A.; Hussain, Alamdar; Azam, Maleeha; Kremer, Hannie; Qamar, Raheel			Genetic Spectrum of Autosomal Recessive Non-Syndromic Hearing Loss in Pakistani Families	PLOS ONE			English	Article							GJB2 MUTATIONS; HIGH-FREQUENCY; DEAFNESS; BARTTIN; TMPRSS3; MECHANISMS; EXPRESSION; SUBUNIT; DISEASE; DFNB1	The frequency of inherited bilateral autosomal recessive non-syndromic hearing loss (ARNSHL) in Pakistan is 1.6/1000 individuals. More than 50% of the families carry mutations in GJB2 while mutations in MYO15A account for about 5% of recessive deafness. In the present study a cohort of 30 ARNSHL families was initially screened for mutations in GJB2 and MYO15A. Homozygosity mapping was performed by employing whole genome single nucleotide polymorphism (SNP) genotyping in the families that did not carry mutations in GJB2 or MYO15A. Mutation analysis was performed for the known ARNSHL genes present in the homozygous regions to determine the causative mutations. This allowed the identification of a causative mutation in all the 30 families including 9 novel mutations, which were identified in 9 different families (GJB2 (c.598G>A, p.Gly200Arg); MYO15A (c.9948G>A, p.Gln3316GIn; c.3866+1G>A; c.8767C>T, p.Arg2923* and c.8222T>C, p.Phe2741Ser), TMC1 (c.362+18A>G), BSND (c.97G>C, p.Val33Leu), TMPRSS3 (c.726C>G, p.Cys242Trp) and MSRB3 (c.20T>G, p.Leu7Arg)). Furthermore, 12 recurrent mutations were detected in 21 other families. The 21 identified mutations included 10 (48%) missense changes, 4 (19%) nonsense mutations, 3 (14%) intronic mutations, 2 (9%) splice site mutations and 2 (9%) frameshift mutations. GJB2 accounted for 53% of the families, while mutations in MYO15A were the second most frequent (13%) cause of ARNSHL in these 30 families. The identification of novel as well as recurrent mutations in the present study increases the spectrum of mutations in known deafness genes which could lead to the identification of novel founder mutations and population specific mutated deafness genes causative of ARNSHL. These results provide detailed genetic information that has potential diagnostic implication in the establishment of cost-efficient allele-specific analysis of frequently occurring variants in combination with other reported mutations in Pakistani populations.	[Shafique, Sobia; Ayub, Humaira; Ajmal, Muhammad; Shah, Syed Tahir A.; Hussain, Alamdar; Azam, Maleeha; Qamar, Raheel] COMSATS Inst Informat Technol, Islamabad, Pakistan; [Siddiqi, Saima; Mansoor, Atika; Mazhar, Kehkashan] IBGE, Islamabad, Pakistan; [Schraders, Margit; Oostrik, Jaap; Seco, Celia Zazo; Kremer, Hannie] Radboud Univ Nijmegen, Dept Otorhinolaryngol Hearing & Genes, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Schraders, Margit; Oostrik, Jaap; Seco, Celia Zazo; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Schraders, Margit; Oostrik, Jaap; Seco, Celia Zazo; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Bilal, Ammad] Simon Fraser Univ, Vancouver, BC, Canada; [Strom, Tim M.] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Human Genet, Neuherberg, Germany; [Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Qamar, Raheel] Isra Univ, Al Nafees Med Coll & Hosp, Islamabad, Pakistan	COMSATS University Islamabad (CUI); Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Simon Fraser University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Radboud University Nijmegen	Kremer, H (corresponding author), Radboud Univ Nijmegen, Dept Otorhinolaryngol Hearing & Genes, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	Hannie.Kremer@radboudumc.nl; raheelqamar@hotmail.com	Azam, Maleeha/AAD-9924-2022; Oostrik, Jaap/A-1703-2016; Schraders, Margit/A-1607-2016; Siddiqi, Saima/AAJ-6584-2021; Shah, Syed Tahir Abbas/K-4637-2015; Seco, Celia Zazo/AAB-7636-2020; Kremer, Hannie/F-5126-2010; Ajmal, Muhammad/G-8163-2012; Azam, Maleeha/L-1721-2017	Shah, Syed Tahir Abbas/0000-0001-9151-9374; Seco, Celia Zazo/0000-0003-3506-7611; Kremer, Hannie/0000-0002-0841-8693; Ajmal, Muhammad/0000-0001-5207-2469; Azam, Maleeha/0000-0003-0170-3325	Higher Education Commission (HEC) under the National Research Program for Universities [2155]; Oticon Foundation [09-3742]; ZorgOnderzoek Nederland/Medische Wetenschappen [40-00812-98-09047]	Higher Education Commission (HEC) under the National Research Program for Universities; Oticon Foundation; ZorgOnderzoek Nederland/Medische Wetenschappen	This work was supported by Higher Education Commission (HEC) grant no 2155 to RQ under the National Research Program for Universities, by The Oticon Foundation (grant 09-3742 to HK), and by ZorgOnderzoek Nederland/Medische Wetenschappen (grant 40-00812-98-09047 to HK). The authors also acknowledge the Higher Education Commission of Pakistan for providing funds to S. Shafique and S. Siddiqi to work in The Netherlands. The funders had no role in study design, data collection and anlaysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmed ZM, 2011, AM J HUM GENET, V88, P19, DOI 10.1016/j.ajhg.2010.11.010; Anderson DW, 2000, HUM MOL GENET, V9, P1729, DOI 10.1093/hmg/9.12.1729; Bashir R, 2012, EUR J MED GENET, V55, P99, DOI 10.1016/j.ejmg.2011.12.003; Batissoco AC, 2009, BRAZ J MED BIOL RES, V42, P168, DOI 10.1590/S0100-879X2009000200004; Bayazit YA, 2006, ORL-J OTO-RHIN-LARYN, V68, P57, DOI 10.1159/000091090; Belyantseva IA, 2003, P NATL ACAD SCI USA, V100, P13958, DOI 10.1073/pnas.2334417100; Ben Said M, 2010, GENET TEST MOL BIOMA, V14, P307, DOI 10.1089/gtmb.2009.0174; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Bukhari I, 2013, BIOCHEM GENET, V51, P524, DOI 10.1007/s10528-013-9583-z; de Heer AMR, 2011, AUDIOL NEURO-OTOL, V16, P93, DOI 10.1159/000313282; Elahi MM, 1998, J OTOLARYNGOL, V27, P348; Elbracht M, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.049122; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Fasquelle L, 2011, J BIOL CHEM, V286, P17383, DOI 10.1074/jbc.M110.190652; Hayama A, 2003, HISTOCHEM CELL BIOL, V119, P485, DOI 10.1007/s00418-003-0535-2; Hilgert N, 2008, CLIN GENET, V74, P223, DOI 10.1111/j.1399-0004.2008.01053.x; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Janssen AGH, 2009, J AM SOC NEPHROL, V20, P145, DOI 10.1681/ASN.2008010102; Gamundi MJ, 2008, HUM MUTAT, V29, P869, DOI 10.1002/humu.20747; Kelley PM, 1998, AM J HUM GENET, V62, P792, DOI 10.1086/301807; Kitajiri SI, 2007, CLIN GENET, V72, P546, DOI 10.1111/j.1399-0004.2007.00895.x; Kramer BK, 2008, NAT CLIN PRACT NEPHR, V4, P38, DOI 10.1038/ncpneph0689; Mani RS, 2009, EUR J HUM GENET, V17, P502, DOI 10.1038/ejhg.2008.179; Matos TD, 2010, GENET TEST MOL BIOMA, V14, P141, DOI 10.1089/gtmb.2009.0103; Minarik G, 2003, GEN PHYSIOL BIOPHYS, V22, P549; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Mustapha M, 2001, J Med Genet, V38, pE36, DOI 10.1136/jmg.38.10.e36; Naz S, 2002, AM J HUM GENET, V71, P632, DOI 10.1086/342193; Padma G, 2009, J GENET, V88, P267, DOI 10.1007/s12041-009-0039-5; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Reardon W, 2000, QJM-INT J MED, V93, P99, DOI 10.1093/qjmed/93.2.99; Rickheit G, 2008, EMBO J, V27, P2907, DOI 10.1038/emboj.2008.203; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrook J., 2006, CONDENSED PROTOCOLS; Santos Regie Lyn P, 2005, Hum Mutat, V26, P396, DOI 10.1002/humu.9374; Santos RLP, 2005, CLIN GENET, V67, P61, DOI 10.1111/j.1399-0004.2005.00379.x; Schraders M, 2010, AM J HUM GENET, V86, P138, DOI 10.1016/j.ajhg.2009.12.017; Schultz JM, 2009, AM J HUM GENET, V85, P25, DOI 10.1016/j.ajhg.2009.06.003; Searle C, 2012, GENET TEST MOL BIOMA, V16, P453, DOI 10.1089/gtmb.2011.0254; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Sirmaci A, 2009, INT J PEDIATR OTORHI, V73, P699, DOI 10.1016/j.ijporl.2009.01.005; Snoeckx RL, 2005, AM J HUM GENET, V77, P945, DOI 10.1086/497996; VanCamp G, 1997, GENOMICS, V41, P70, DOI 10.1006/geno.1997.4624; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Waldegger S, 2002, PFLUG ARCH EUR J PHY, V444, P411, DOI 10.1007/s00424-002-0819-8; Weegerink NJD, 2011, JARO-J ASSOC RES OTO, V12, P753, DOI 10.1007/s10162-011-0282-3; WENG ZG, 1995, MOL CELL BIOL, V15, P5627; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605	53	48	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100146	10.1371/journal.pone.0100146	http://dx.doi.org/10.1371/journal.pone.0100146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949729	Green Published, Green Submitted, gold			2022-12-25	WOS:000338276300041
J	Silvani, A; Berteotti, C; Bastianini, S; Cohen, G; Lo Martire, V; Mazza, R; Pagotto, U; Quarta, C; Zoccoli, G				Silvani, Alessandro; Berteotti, Chiara; Bastianini, Stefano; Cohen, Gary; Lo Martire, Viviana; Mazza, Roberta; Pagotto, Uberto; Quarta, Carmelo; Zoccoli, Giovanna			Cardiorespiratory Anomalies in Mice Lacking CB1 Cannabinoid Receptors	PLOS ONE			English	Article							AUTONOMIC NERVOUS-SYSTEM; DIET-INDUCED OBESITY; BLOOD-PRESSURE; CARDIOVASCULAR FUNCTION; ENDOCANNABINOID SYSTEM; BAROREFLEX SENSITIVITY; ANGIOTENSIN-II; SLEEP; HEART; ACTIVATION	Cannabinoid type 1 (CB1) receptors are expressed in the nervous and cardiovascular systems. In mice, CB1 receptor deficiency protects from metabolic consequences of a high-fat diet (HFD), increases sympathetic activity to brown fat, and entails sleep anomalies. We investigated whether sleep-wake and diet-dependent cardiorespiratory control is altered in mice lacking CB1 receptors. CB1 receptor knock-out (KO) and intact wild-type (WT) mice were fed standard diet or a HFD for 3 months, and implanted with a telemetric arterial pressure transducer and electrodes for sleep scoring. Sleep state was assessed together with arterial pressure and heart rate (home cage), or breathing (whole-body plethysmograph). Increases in arterial pressure and heart rate on passing from the light (rest) to the dark (activity) period in the KO were significantly enhanced compared with the WT. These increases were unaffected by cardiac (beta(1)) or vascular (alpha(1)) adrenergic blockade. The breathing rhythm of the KO during sleep was also more irregular than that of the WT. A HFD increased heart rate, impaired cardiac vagal modulation, and blunted the central autonomic cardiac control during sleep. A HFD also decreased cardiac baroreflex sensitivity in the KO but not in the WT. In conclusion, we performed the first systematic study of cardiovascular function in CB1 receptor deficient mice during spontaneous wake-sleep behavior, and demonstrated that CB1 receptor KO alters cardiorespiratory control particularly in the presence of a HFD. The CB1 receptor signaling may thus play a role in physiological cardiorespiratory regulation and protect from some adverse cardiovascular consequences of a HFD.	[Silvani, Alessandro; Berteotti, Chiara; Bastianini, Stefano; Lo Martire, Viviana; Zoccoli, Giovanna] Alma Mater Studiorum Univ Bologna, PRISM Lab, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Cohen, Gary] Karolinska Inst, Dept Women & Child Hlth, Stockholm, Sweden; [Mazza, Roberta; Pagotto, Uberto; Quarta, Carmelo] Alma Mater Studiorum Univ Bologna, Endocrinol Unit, Bologna, Italy; [Mazza, Roberta; Pagotto, Uberto; Quarta, Carmelo] Alma Mater Studiorum Univ Bologna, Ctr Appl Biomed Res, Dept Med & Surg Sci, S Orsola Univ Hosp, Bologna, Italy	University of Bologna; Karolinska Institutet; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Zoccoli, G (corresponding author), Alma Mater Studiorum Univ Bologna, PRISM Lab, Dept Biomed & Neuromotor Sci, Bologna, Italy.	giovanna.zoccoli@unibo.it	Silvani, Alessandro/A-1027-2015; berteotti, chiara/AAK-9065-2020; Bastianini, Stefano/AAO-7982-2020; Zoccoli, Giovanna/CAH-3382-2022; Quarta, Carmelo/AAC-1629-2020	Silvani, Alessandro/0000-0003-3992-3892; Bastianini, Stefano/0000-0003-2468-1704; Zoccoli, Giovanna/0000-0002-9670-9959; Cohen, Gary/0000-0001-9677-2870; Quarta, Carmelo/0000-0002-1352-4239; Lo Martire, Viviana/0000-0001-8696-0835; BERTEOTTI, CHIARA/0000-0002-4143-9445	Bologna University	Bologna University	This work was funded by Bologna University (RFO 2010 and 2011 http://www.unibo.it/Portale/Ricerca/Servizi+Docenti+Ricercatori/finanziamentinaz/RFO+-+Finanziamento+alla+ricerca+di+base.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONNE LJ, 1995, AM J PHYSIOL-REG I, V269, pR222, DOI 10.1152/ajpregu.1995.269.1.R222; Bastianini S, 2012, CHRONOBIOL INT, V29, P82, DOI 10.3109/07420528.2011.635231; Batkai S, 2004, CIRCULATION, V110, P1996, DOI 10.1161/01.CIR.0000143230.23252.D2; Bellocchio L, 2013, P NATL ACAD SCI USA, V110, P4786, DOI 10.1073/pnas.1218573110; Billman GE, 2006, PHARMACOL THERAPEUT, V111, P808, DOI 10.1016/j.pharmthera.2006.01.002; Brennan M, 2001, IEEE T BIO-MED ENG, V48, P1342, DOI 10.1109/10.959330; Calik MW, 2014, RESP PHYSIOL NEUROBI, V190, P20, DOI 10.1016/j.resp.2013.10.001; Carley DW, 2002, SLEEP, V25, P391; Cohen G, 2002, J PHYSIOL-LONDON, V540, P691, DOI 10.1113/jphysiol.2001.014464; Cohen G, 2002, P NATL ACAD SCI USA, V99, P13272, DOI 10.1073/pnas.192463599; Gross V, 2005, AM J PHYSIOL-REG I, V288, pR1134, DOI 10.1152/ajpregu.00246.2004; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; JACKY JP, 1978, J APPL PHYSIOL, V45, P644, DOI 10.1152/jappl.1978.45.4.644; Johansson M, 2007, J HYPERTENS, V25, P163, DOI 10.1097/01.hjh.0000254377.18983.eb; Kario K, 2010, HYPERTENSION, V56, P765, DOI 10.1161/HYPERTENSIONAHA.110.157149; LUCE JM, 1980, CHEST, V78, P626, DOI 10.1378/chest.78.4.626; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Massa F, 2010, J NEUROSCI, V30, P6273, DOI 10.1523/JNEUROSCI.2648-09.2010; McCully BH, 2012, AM J PHYSIOL-HEART C, V302, pH2083, DOI 10.1152/ajpheart.01200.2011; Montecucco F, 2012, TRENDS PHARMACOL SCI, V33, P331, DOI 10.1016/j.tips.2012.03.002; Morrison SF, 1999, AM J PHYSIOL-REG I, V276, pR962, DOI 10.1152/ajpregu.1999.276.4.R962; MULLER JE, 1989, CIRCULATION, V79, P733, DOI 10.1161/01.CIR.79.4.733; Nanduri J, 2012, P NATL ACAD SCI USA, V109, P2515, DOI 10.1073/pnas.1120600109; O'Donnell CP, 1999, AM J RESP CRIT CARE, V159, P1477, DOI 10.1164/ajrccm.159.5.9809025; Prasad Bharati, 2013, Front Psychiatry, V4, P1, DOI 10.3389/fpsyt.2013.00001; Quarta C, 2010, CELL METAB, V11, P273, DOI 10.1016/j.cmet.2010.02.015; Seagard JL, 2005, NEUROSCI LETT, V381, P334, DOI 10.1016/j.neulet.2005.02.044; Silvani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089432; Silvani A, 2013, AM J PHYSIOL-HEART C, V305, pH1683, DOI 10.1152/ajpheart.00554.2013; Silvani A, 2011, AUTON NEUROSCI-BASIC, V162, P66, DOI 10.1016/j.autneu.2011.04.003; Silvani A, 2010, SLEEP, V33, P355, DOI 10.1093/sleep/33.3.355; Silvani A, 2009, HYPERTENSION, V53, P251, DOI 10.1161/HYPERTENSIONAHA.108.125542; Silvestri C, 2013, CELL METAB, V17, P475, DOI 10.1016/j.cmet.2013.03.001; Skrapari I, 2007, OBESITY, V15, P1685, DOI 10.1038/oby.2007.201; Szekeres M, 2012, J BIOL CHEM, V287, P31540, DOI 10.1074/jbc.M112.346296; Tissot AC, 2008, LANCET, V371, P821, DOI 10.1016/S0140-6736(08)60381-5; Wagner JA, 1997, NATURE, V390, P518, DOI 10.1038/37371; Williams TD, 2003, CLIN EXP PHARMACOL P, V30, P769, DOI 10.1046/j.1440-1681.2003.t01-1-03808.x	38	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100536	10.1371/journal.pone.0100536	http://dx.doi.org/10.1371/journal.pone.0100536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950219	gold, Green Published, Green Submitted			2022-12-25	WOS:000338276300086
J	Tan, TE; Peh, GSL; George, BL; Cajucom-Uy, HY; Dong, D; Finkelstein, EA; Mehta, JS				Tan, Tien-En; Peh, Gary S. L.; George, Benjamin L.; Cajucom-Uy, Howard Y.; Dong, Di; Finkelstein, Eric A.; Mehta, Jodhbir S.			A Cost-Minimization Analysis of Tissue-Engineered Constructs for Corneal Endothelial Transplantation	PLOS ONE			English	Article							STEM-CELL THERAPY; DONOR-TISSUE; DESCEMET MEMBRANE; EYE BANK; KERATOPLASTY; CARRIER; STRATEGIES; RECIPIENTS; PRIMATE; FUTURE	Corneal endothelial transplantation or endothelial keratoplasty has become the preferred choice of transplantation for patients with corneal blindness due to endothelial dysfunction. Currently, there is a worldwide shortage of transplantable tissue, and demand is expected to increase further with aging populations. Tissue-engineered alternatives are being developed, and are likely to be available soon. However, the cost of these constructs may impair their widespread use. A cost-minimization analysis comparing tissue-engineered constructs to donor tissue procured from eye banks for endothelial keratoplasty was performed. Both initial investment costs and recurring costs were considered in the analysis to arrive at a final tissue cost per transplant. The clinical outcomes of endothelial keratoplasty with tissue-engineered constructs and with donor tissue procured from eye banks were assumed to be equivalent. One-way and probabilistic sensitivity analyses were performed to simulate various possible scenarios, and to determine the robustness of the results. A tissue engineering strategy was cheaper in both investment cost and recurring cost. Tissue-engineered constructs for endothelial keratoplasty could be produced at a cost of US$880 per transplant. In contrast, utilizing donor tissue procured from eye banks for endothelial keratoplasty required US$3,710 per transplant. Sensitivity analyses performed further support the results of this cost-minimization analysis across a wide range of possible scenarios. The use of tissue-engineered constructs for endothelial keratoplasty could potentially increase the supply of transplantable tissue and bring the costs of corneal endothelial transplantation down, making this intervention accessible to a larger group of patients. Tissue-engineering strategies for corneal epithelial constructs or other tissue types, such as pancreatic islet cells, should also be subject to similar pharmacoeconomic analyses.	[Tan, Tien-En] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Tan, Tien-En; Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore; [Peh, Gary S. L.; George, Benjamin L.; Mehta, Jodhbir S.] Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore; [Cajucom-Uy, Howard Y.] Singapore Eye Bank, Singapore, Singapore; [Dong, Di; Finkelstein, Eric A.] Duke NUS Grad Med Sch, Singapore, Singapore; [Finkelstein, Eric A.] Lien Ctr Palliat Care, Singapore, Singapore; [Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore	Tan, TE (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore.	jodmehta@gmail.com	Peh, Gary/A-8327-2010	Peh, Gary/0000-0002-5387-4209				Aguayo-Mazzucato C, 2010, NAT REV ENDOCRINOL, V6, P139, DOI 10.1038/nrendo.2009.274; Anshu A, 2012, SURV OPHTHALMOL, V57, P236, DOI 10.1016/j.survophthal.2011.10.005; Badenoch PR, 2009, MED J AUSTRALIA, V191, P408, DOI 10.5694/j.1326-5377.2009.tb02853.x; Bayyoud T, 2012, CURR EYE RES, V37, P179, DOI 10.3109/02713683.2011.644382; Bohringer D, 2009, DEV OPHTHALMOL, V43, P120, DOI 10.1159/000223845; Bose S, 2012, OPHTHALMOLOGY; Cheong YK, 2013, INVEST OPHTH VIS SCI, V54, P4538, DOI 10.1167/iovs.13-11754; Chng ZZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067546; COLE G, 1994, CORNEA, V13, P87, DOI 10.1097/00003226-199401000-00016; Dominguez-Bendala J, 2011, CURR OPIN ORGAN TRAN, V16, P76, DOI 10.1097/MOT.0b013e32834252b5; Ezhkova E, 2010, NATURE, V466, P567, DOI 10.1038/466567a; Heindl LM, 2013, OPHTHALMOLOGY, V120, P899, DOI 10.1016/j.ophtha.2012.11.012; Heindl LM, 2011, AM J OPHTHALMOL, V152, P523, DOI 10.1016/j.ajo.2011.03.021; Heindl LM, 2011, OPHTHALMOLOGY, V118, P294, DOI 10.1016/j.ophtha.2010.05.025; Hirata-Tominaga K, 2013, STEM CELLS, V31, P1396, DOI 10.1002/stem.1390; JOLICOEUR LM, 1992, AM J HOSP PHARM, V49, P1741, DOI 10.1093/ajhp/49.7.1741; JUMBLATT MM, 1978, INVEST OPHTH VIS SCI, V17, P1135; Keenan TDL, 2011, BRIT J OPHTHALMOL, V95, P468, DOI 10.1136/bjo.2010.182329; Khor WB, 2011, AM J OPHTHALMOL, V151, P223, DOI 10.1016/j.ajo.2010.08.027; Kitzmann AS, 2008, CORNEA, V27, P634, DOI 10.1097/QAI.0b013e31815e4011; Koizumi N, 2008, CORNEA, V27, pS48, DOI 10.1097/ICO.0b013e31817f2298; Koizumi N, 2007, INVEST OPHTH VIS SCI, V48, P4519, DOI 10.1167/iovs.07-0567; Koo TS, 2011, AM J OPHTHALMOL, V152, P40, DOI 10.1016/j.ajo.2011.01.017; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Leung PS, 2013, CURR MOL MED, V13, P109; Levis HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050993; Li Jennifer Y, 2010, Int Ophthalmol Clin, V50, P101, DOI 10.1097/IIO.0b013e3181e20ebb; Liang Y, 2011, J MATER SCI-MATER M, V22, P175, DOI 10.1007/s10856-010-4190-6; Mannis MJ, 2006, CORNEA, V25, P164; Melles GRJ, 2006, CORNEA, V25, P987, DOI 10.1097/01.ico.0000248385.16896.34; Melles GRJ, 2004, CORNEA, V23, P286, DOI 10.1097/00003226-200404000-00011; Mohamed-Noriega K, 2011, TRANSPLANTATION, V92, pE31, DOI 10.1097/TP.0b013e31822d882d; Okumura N, 2012, AM J PATHOL, V181, P268, DOI 10.1016/j.ajpath.2012.03.033; Peh Gary S L, 2013, BMC Res Notes, V6, P176, DOI 10.1186/1756-0500-6-176; Peh GSL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028310; Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01; Peh GS, 2013, CELL TRANSPLANT; Price FW, 2005, J REFRACT SURG, V21, P339; Price MO, 2013, OPHTHALMOLOGY, V120, P246, DOI 10.1016/j.ophtha.2012.08.007; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Sabater AL, 2013, REGEN MED, V8, P183, DOI [10.2217/rme.13.11, 10.2217/RME.13.11]; Schlotzer-Schrehardt U, 2013, OPHTHALMOLOGY, V120, P1769, DOI 10.1016/j.ophtha.2013.06.038; Shapiro AMJ, 2011, CURR DIABETES REP, V11, P345, DOI 10.1007/s11892-011-0217-8; Sharma N, 2011, CORNEA, V30, P1140, DOI 10.1097/ICO.0b013e318209d23c; Shima N, 2011, INVEST OPHTH VIS SCI, V52, P8711, DOI 10.1167/iovs.11-7592; Tan DTH, 2012, LANCET, V379, P1749, DOI 10.1016/S0140-6736(12)60437-1; Tan DTH, 2009, ANN ACAD MED SINGAP, V38, P332; Vajpayee RB, 2007, ARCH OPHTHALMOL-CHIC, V125, P552, DOI 10.1001/archopht.125.4.552; Viswanathan C, 2013, CURR DIABETES REV, V9, P429, DOI 10.2174/15733998113096660082; Wang TJ, 2012, MOL VIS, V18, P255; Watanabe R, 2011, TISSUE ENG PT A, V17, P2213, DOI [10.1089/ten.tea.2010.0568, 10.1089/ten.TEA.2010.0568]; Wen YJ, 2011, EXPERT OPIN BIOL TH, V11, P41, DOI 10.1517/14712598.2011.540235; Woodward MA, 2013, CORNEA, V32, P737, DOI 10.1097/ICO.0b013e3182685cb2; Woodward MA, 2012, JOVE-J VIS EXP, DOI 10.3791/3847; Zhang WJ, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt352; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814; Zhu YT, 2012, J CELL SCI, V125, P3636, DOI 10.1242/jcs.103267; Zinger A, 2013, DIABETES METAB RES R	58	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100563	10.1371/journal.pone.0100563	http://dx.doi.org/10.1371/journal.pone.0100563			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949869	Green Submitted, Green Published, gold			2022-12-25	WOS:000338276300090
J	Wessels, B; Ciapaite, J; van den Broek, NMA; Nicolay, K; Prompers, JJ				Wessels, Bart; Ciapaite, Jolita; van den Broek, Nicole M. A.; Nicolay, Klaas; Prompers, Jeanine J.			Metformin Impairs Mitochondrial Function in Skeletal Muscle of Both Lean and Diabetic Rats in a Dose-Dependent Manner	PLOS ONE			English	Article							OXIDATIVE CAPACITY; LIVER-MITOCHONDRIA; INSULIN ACTION; GLUCOSE; EXERCISE; MECHANISM; PHARMACOKINETICS; PHOSPHORYLATION; INCREASES	Metformin is a widely prescribed drug for the treatment of type 2 diabetes. Previous studies have demonstrated in vitro that metformin specifically inhibits Complex I of the mitochondrial respiratory chain. This seems contraindicative since muscle mitochondrial dysfunction has been linked to the pathogenesis of type 2 diabetes. However, its significance for in vivo skeletal muscle mitochondrial function has yet to be elucidated. The aim of this study was to assess the effects of metformin on in vivo and ex vivo skeletal muscle mitochondrial function in a rat model of diabetes. Healthy (fa/+) and diabetic (fa/fa) Zucker diabetic fatty rats were treated by oral gavage with metformin dissolved in water (30, 100 or 300 mg/kg bodyweight/day) or water as a control for 2 weeks. After 2 weeks of treatment, muscle oxidative capacity was assessed in vivo using P-31 magnetic resonance spectroscopy and ex vivo by measuring oxygen consumption in isolated mitochondria using high-resolution respirometry. Two weeks of treatment with metformin impaired in vivo muscle oxidative capacity in a dose-dependent manner, both in healthy and diabetic rats. Whereas a dosage of 30 mg/kg/day had no significant effect, in vivo oxidative capacity was 21% and 48% lower after metformin treatment at 100 and 300 mg/kg/day, respectively, independent of genotype. High-resolution respirometry measurements demonstrated a similar dose-dependent effect of metformin on ex vivo mitochondrial function. In conclusion, metformin compromises in vivo and ex vivo muscle oxidative capacity in Zucker diabetic fatty rats in a dose-dependent manner.	[Wessels, Bart; van den Broek, Nicole M. A.; Nicolay, Klaas; Prompers, Jeanine J.] Eindhoven Univ Technol, Dept Biomed Engn, Biomed NMR, NL-5600 MB Eindhoven, Netherlands; [Ciapaite, Jolita] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Pediat, NL-9700 AB Groningen, Netherlands	Eindhoven University of Technology; University of Groningen	Prompers, JJ (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Biomed NMR, POB 513, NL-5600 MB Eindhoven, Netherlands.	j.j.prompers@tue.nl		Ciapaite, Jolita/0000-0001-8761-9233; Prompers, Jeanine/0000-0002-4756-4474; Nicolay, Klaas/0000-0002-4179-616X	VIDI grant from the Netherlands Organisation for Scientific Research (NWO) [700.58.421]; NWO	VIDI grant from the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO(Netherlands Organization for Scientific Research (NWO))	B.W. and J.J.P. are supported by a VIDI grant (project number 700.58.421) from the Netherlands Organisation for Scientific Research (NWO). J.C. is supported by the NWO-funded Groningen Systems Biology Center for Energy Metabolism and Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; ARGAUD D, 1993, EUR J BIOCHEM, V213, P1341, DOI 10.1111/j.1432-1033.1993.tb17886.x; BAILEY CJ, 1986, DIABETES METAB, V12, P212; Braun B, 2008, APPL PHYSIOL NUTR ME, V33, P61, DOI 10.1139/H07-144; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Carvalho C, 2008, MOL CELL BIOCHEM, V308, P75, DOI 10.1007/s11010-007-9614-3; Choi YH, 2006, J PHARM SCI-US, V95, P2543, DOI 10.1002/jps.20744; Ciapaite J, 2007, BBA-MOL BASIS DIS, V1772, P307, DOI 10.1016/j.bbadis.2006.10.018; De Feyter HM, 2008, FASEB J, V22, P3947, DOI 10.1096/fj.08-112318; Detaille D, 2002, BIOCHEM PHARMACOL, V63, P1259, DOI 10.1016/S0006-2952(02)00858-4; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; Graham GG, 2011, CLIN PHARMACOKINET, V50, P81, DOI 10.2165/11534750-000000000-00000; Guigas B, 2004, BIOCHEM J, V382, P877, DOI 10.1042/BJ20040885; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Inzucchi SE, 1998, NEW ENGL J MED, V338, P867, DOI 10.1056/NEJM199803263381303; Kane DA, 2010, FREE RADICAL BIO MED, V49, P1082, DOI 10.1016/j.freeradbiomed.2010.06.022; KLIP A, 1990, DIABETES CARE, V13, P696, DOI 10.2337/diacare.13.6.696; Kristensen JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053533; Larsen RG, 2009, J APPL PHYSIOL, V107, P873, DOI 10.1152/japplphysiol.00260.2009; Larsen S, 2012, DIABETOLOGIA, V55, P443, DOI 10.1007/s00125-011-2340-0; Leverve XM, 2003, DIABETES METAB, V29, pS88; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Palenickova E, 2011, PHYSIOL RES, V60, P835, DOI 10.33549/physiolres.932193; PENICAUD L, 1989, BIOCHEM J, V262, P881, DOI 10.1042/bj2620881; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; Praet SFE, 2007, J APPL PHYSIOL, V103, P1113, DOI 10.1152/japplphysiol.00566.2007; ROSSETTI L, 1990, METABOLISM, V39, P425, DOI 10.1016/0026-0495(90)90259-F; ROURU J, 1995, BRIT J PHARMACOL, V115, P1182, DOI 10.1111/j.1476-5381.1995.tb15022.x; SCHAFER G, 1974, EUR J BIOCHEM, V46, P613, DOI 10.1111/j.1432-1033.1974.tb03657.x; Sharoff CG, 2010, AM J PHYSIOL-ENDOC M, V298, pE815, DOI 10.1152/ajpendo.00517.2009; Smith AC, 2007, AM J PHYSIOL-ENDOC M, V293, pE172, DOI 10.1152/ajpendo.00677.2006; Suwa M, 2006, J APPL PHYSIOL, V101, P1685, DOI 10.1152/japplphysiol.00255.2006; Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138; Taylor D J, 1983, Mol Biol Med, V1, P77; van den Broek NMA, 2010, FASEB J, V24, P1354, DOI 10.1096/fj.09-143842; van den Broek NMA, 2007, AM J PHYSIOL-CELL PH, V293, pC228, DOI 10.1152/ajpcell.00023.2007; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Vytla VS, 2013, J BIOL CHEM, V288, P20369, DOI 10.1074/jbc.M113.482646; WILCOCK C, 1990, BIOCHEM PHARMACOL, V39, P1831, DOI 10.1016/0006-2952(90)90136-9	41	75	77	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100525	10.1371/journal.pone.0100525	http://dx.doi.org/10.1371/journal.pone.0100525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950069	Green Published, Green Submitted, gold			2022-12-25	WOS:000338276300084
J	Amarsaikhan, N; O'Dea, EM; Tsoggerel, A; Owegi, H; Gillenwater, J; Templeton, SP				Amarsaikhan, Nansalmaa; O'Dea, Evan M.; Tsoggerel, Angar; Owegi, Henry; Gillenwater, Jordan; Templeton, Steven P.			Isolate-Dependent Growth, Virulence, and Cell Wall Composition in the Human Pathogen Aspergillus fumigatus	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; MURINE MODEL; BETA-GLUCAN; CHITIN; LUNG; DECTIN-1; DEFENSE; PROTEIN; ENVIRONMENTS; RECOGNITION	The ubiquitous fungal pathogen Aspergillus fumigatus is a mediator of allergic sensitization and invasive disease in susceptible individuals. The significant genetic and phenotypic variability between and among clinical and environmental isolates are important considerations in host-pathogen studies of A. fumigatus-mediated disease. We observed decreased radial growth, rate of germination, and ability to establish colony growth in a single environmental isolate of A. fumigatus, Af5517, when compared to other clinical and environmental isolates. Af5517 also exhibited increased hyphal diameter and cell wall beta-glucan and chitin content, with chitin most significantly increased. Morbidity, mortality, lung fungal burden, and tissue pathology were decreased in neutropenic Af5517-infected mice when compared to the clinical isolate Af293. Our results support previous findings that suggest a correlation between in vitro growth rates and in vivo virulence, and we propose that changes in cell wall composition may contribute to this phenotype.	[Amarsaikhan, Nansalmaa; O'Dea, Evan M.; Tsoggerel, Angar; Owegi, Henry; Gillenwater, Jordan; Templeton, Steven P.] Indiana Univ Sch Med Terre Haute, Dept Microbiol & Immunol, Terre Haute, IN 47809 USA	Indiana University System	Templeton, SP (corresponding author), Indiana Univ Sch Med Terre Haute, Dept Microbiol & Immunol, Terre Haute, IN 47809 USA.	sptemple@iupui.edu	Templeton, Steven/I-6635-2013	Templeton, Steven/0000-0003-3430-7011	IUSM-TH start-up funds	IUSM-TH start-up funds	This research was supported by IUSM-TH start-up funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Araujo R, 2010, MED MYCOL, V48, P832, DOI 10.3109/13693780903575360; Askew DS, 2008, CURR OPIN MICROBIOL, V11, P331, DOI 10.1016/j.mib.2008.05.009; Aufauvre-Brown A, 1998, EUR J CLIN MICROBIOL, V17, P778, DOI 10.1007/s100960050184; Balajee SA, 2008, J MICROBIOL METH, V73, P252, DOI 10.1016/j.mimet.2008.02.011; Bhabhra R, 2005, MED MYCOL, V43, pS87, DOI 10.1080/13693780400029486; BORGIA PT, 1992, J BACTERIOL, V174, P377, DOI 10.1128/jb.174.2.377-383.1992; Bowman JC, 2001, ANTIMICROB AGENTS CH, V45, P3474, DOI 10.1128/AAC.45.12.3474-3481.2001; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Chai LYA, 2011, MICROBES INFECT, V13, P151, DOI 10.1016/j.micinf.2010.10.005; Chazalet V, 1998, J CLIN MICROBIOL, V36, P1494, DOI 10.1128/JCM.36.6.1494-1500.1998; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; Cramer RA, 2008, EUKARYOT CELL, V7, P1085, DOI 10.1128/EC.00086-08; Dague E, 2008, BIOPHYS J, V94, P656, DOI 10.1529/biophysj.107.116491; de Valk HA, 2008, MYCOSES, V51, P463, DOI 10.1111/j.1439-0507.2008.01538.x; de Valk HA, 2009, J CYST FIBROS, V8, P110, DOI 10.1016/j.jcf.2008.10.003; Faro-Trindade I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035675; Fontaine T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002372; Gessner MA, 2012, INFECT IMMUN, V80, P410, DOI 10.1128/IAI.05939-11; GIRARDIN H, 1994, J CLIN MICROBIOL, V32, P684, DOI 10.1128/JCM.32.3.684-690.1994; Grahl N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002145; Greenberger PA, 2004, ALLERGY ASTHMA PROC, V25, P219; Hohl TM, 2007, EUKARYOT CELL, V6, P1953, DOI 10.1128/EC.00274-07; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Latge JP, 2005, MED MYCOL, V43, pS15, DOI 10.1080/13693780400029155; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Leal SM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000976; Leenders ACAP, 1999, J CLIN MICROBIOL, V37, P1752, DOI 10.1128/JCM.37.6.1752-1757.1999; Lenardon MD, 2010, CURR OPIN MICROBIOL, V13, P416, DOI 10.1016/j.mib.2010.05.002; Levdansky E, 2010, EUKARYOT CELL, V9, P1403, DOI 10.1128/EC.00126-10; Li HY, 2011, EUKARYOT CELL, V10, P174, DOI 10.1128/EC.00288-10; Li K, 2011, MICROBIOL-SGM, V157, P1968, DOI 10.1099/mic.0.047712-0; Maduzia LL, 2011, J BIOL CHEM, V286, P4371, DOI 10.1074/jbc.M110.188581; Maubon D, 2006, FUNGAL GENET BIOL, V43, P366, DOI 10.1016/j.fgb.2006.01.006; Mellado E, 1996, MOL MICROBIOL, V20, P667, DOI 10.1046/j.1365-2958.1996.5571084.x; Mondon P, 1996, J MED MICROBIOL, V45, P186, DOI 10.1099/00222615-45-3-186; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Paisley D, 2005, MED MYCOL, V43, P397, DOI 10.1080/13693780400005866; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Rizzetto L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056651; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Sato M, 2003, J IMMUNOL, V171, P417, DOI 10.4049/jimmunol.171.1.417; Scharf DH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003859; Shepardson KM, 2013, MICROBES INFECT, V15, P259, DOI 10.1016/j.micinf.2012.11.010; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Templeton SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018777; Templeton SP, 2010, MED MYCOL, V48, P217, DOI 10.3109/13693780903420658; THAU N, 1994, INFECT IMMUN, V62, P4380, DOI 10.1128/IAI.62.10.4380-4388.1994; Tomee JFC, 2000, CLIN EXP ALLERGY, V30, P476, DOI 10.1046/j.1365-2222.2000.00796.x; Van Dyken SJ, 2014, IMMUNITY, V40, P414, DOI 10.1016/j.immuni.2014.02.003; Van Dyken SJ, 2011, J IMMUNOL, V187, P2261, DOI 10.4049/jimmunol.1100972; Vanhee LME, 2009, CLIN MICROBIOL INFEC, V15, P643, DOI 10.1111/j.1469-0691.2009.02844.x; Verwer PEB, 2012, ANTIMICROB AGENTS CH, V56, P1595, DOI 10.1128/AAC.05323-11; Wagener J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004050; Warn PA, 2010, INT J ANTIMICROB AG, V35, P146, DOI 10.1016/j.ijantimicag.2009.09.029; WATANABE T, 1994, J BACTERIOL, V176, P4465, DOI 10.1128/JB.176.15.4465-4472.1994; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250	58	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100430	10.1371/journal.pone.0100430	http://dx.doi.org/10.1371/journal.pone.0100430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945802	Green Published, Green Submitted, gold			2022-12-25	WOS:000340721500074
J	Wenzel, UA; Magnusson, MK; Rydstrom, A; Jonstrand, C; Hengst, J; Johansson, MEV; Velcich, A; Ohman, L; Strid, H; Sjovall, H; Hansson, GC; Wick, MJ				Wenzel, Ulf A.; Magnusson, Maria K.; Rydstrom, Anna; Jonstrand, Caroline; Hengst, Julia; Johansson, Malin E. V.; Velcich, Anna; Ohman, Lena; Strid, Hans; Sjovall, Henrik; Hansson, Gunnar C.; Wick, Mary Jo			Spontaneous Colitis in Muc2-Deficient Mice Reflects Clinical and Cellular Features of Active Ulcerative Colitis	PLOS ONE			English	Article							DENDRITIC CELLS; MUCUS LAYERS; GOBLET CELL; MACROPHAGES; DISEASE; MUCIN; PATHOGENESIS; PROMOTES; GUT; DEFICIENT	Background: The colonic mucus layer plays a critical role in intestinal homeostasis by limiting contact between luminal bacteria and the mucosal immune system. A defective mucus barrier in animal models allows bacterial contact with the intestinal epithelium and results in spontaneous colitis. A defective mucus barrier is also a key feature of active ulcerative colitis (UC). Alterations in the immune compartment due to intestinal bacterial breach in mice lacking the colon mucus barrier have not been characterized and correlated to active UC. Aims: To characterize alterations in the immune compartment due to intestinal bacterial breach in Muc2(-/-) mice, which lack the colon mucus barrier, and correlate the findings to active UC. Methods: Bacterial contact with colon epithelium and penetration into colon tissue was examined in Muc2(-/-) mice and colon biopsies from patients with active UC using fluorescence microscopy and qPCR. Neutrophils, lymphocytes, CD103(+) dendritic cell subsets and macrophages in colon from Muc2(-/-) mice and biopsies from UC patients were quantitated by flow cytometry. Results: Inflamed UC patients and Muc2(-/-) mice had bacteria in contact with the colon epithelium. Bacterial rRNA was present in colonic mucosa in humans and Muc2(-/-) mice and in the draining lymph nodes of mice. Inflamed Muc2(-/-) mice and UC patients had elevated colon neutrophils, T cells and macrophages while a reduced frequency of CD103(+) DCs was present in the inflamed colon of both mice and humans. Conclusions: The parallel features of the colon immune cell compartment in Muc2(-/-) mice and UC patients supports the usefulness of this model to understand the early phase of spontaneous colitis and will provide insight into novel strategies to treat UC.	[Wenzel, Ulf A.; Magnusson, Maria K.; Rydstrom, Anna; Jonstrand, Caroline; Hengst, Julia; Ohman, Lena; Wick, Mary Jo] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden; [Wenzel, Ulf A.; Magnusson, Maria K.; Rydstrom, Anna; Jonstrand, Caroline; Hengst, Julia; Ohman, Lena; Wick, Mary Jo] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Mucosal Immunobiol & Vaccine Ctr MIVAC, Gothenburg, Sweden; [Magnusson, Maria K.; Ohman, Lena; Strid, Hans; Sjovall, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Internal Med & Clin Nutr, Gothenburg, Sweden; [Magnusson, Maria K.; Johansson, Malin E. V.; Ohman, Lena; Strid, Hans; Sjovall, Henrik; Hansson, Gunnar C.] Univ Gothenburg, MIVAC, Gothenburg, Sweden; [Johansson, Malin E. V.; Hansson, Gunnar C.] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem, Gothenburg, Sweden; [Velcich, Anna] Montefiore Med Ctr, Albert Einstein Canc Ctr, Dept Oncol, New York, NY USA	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg; Montefiore Medical Center; Yeshiva University	Wick, MJ (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden.	mary-jo.wick@immuno.gu.se	Hansson, Gunnar C./AAF-7324-2019; Hansson, Gunnar C/A-1236-2009; Johansson, Malin E. V./HCH-7451-2022	Hansson, Gunnar C./0000-0002-1900-1869; Hansson, Gunnar C/0000-0002-1900-1869; Magnusson, Maria/0000-0002-8888-4968; Ohman, Lena/0000-0001-8142-2106; Johansson, Malin E. V./0000-0002-4237-6677; Wick, Mary Jo/0000-0003-3195-2904	Swedish Research Council; Swedish Cancer Foundation; Sahlgren's University Hospital (LUA-ALF); AFA Insurance; Knut and Alice Wallenberg Foundation; National Institute of Allergy and Infectious Diseases [U01AI095473]; Swedish Foundation for Strategic Research, Assar Gabrielssons Fond; Ruth and Richard Julin Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095473] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Sahlgren's University Hospital (LUA-ALF); AFA Insurance; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Swedish Foundation for Strategic Research, Assar Gabrielssons Fond; Ruth and Richard Julin Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Swedish Research Council, The Swedish Cancer Foundation, Sahlgren's University Hospital (LUA-ALF), AFA Insurance, The Knut and Alice Wallenberg Foundation, National Institute of Allergy and Infectious Diseases (U01AI095473, the content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH), the Swedish Foundation for Strategic Research, Assar Gabrielssons Fond and The Ruth and Richard Julin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Bain CC, 2012, MUCOSAL IMMUNOL, V6, P498; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Beitnes ACR, 2011, SCAND J IMMUNOL, V74, P186, DOI 10.1111/j.1365-3083.2011.02549.x; Bibiloni R, 2006, J MED MICROBIOL, V55, P1141, DOI 10.1099/jmm.0.46498-0; Burger-van Paassen N, 2011, AM J PHYSIOL-GASTR L, V301, pG667, DOI 10.1152/ajpgi.00199.2010; Cerovic V, 2013, MUCOSAL IMMUNOL, V6, P104, DOI 10.1038/mi.2012.53; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Dianda L, 1997, AM J PATHOL, V150, P91; Eri RD, 2011, MUCOSAL IMMUNOL, V4, P354, DOI 10.1038/mi.2010.74; Fortin G, 2009, J EXP MED, V206, P1995, DOI 10.1084/jem.20082805; Franze E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069839; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Gisbert JP, 2009, INFLAMM BOWEL DIS, V15, P1190, DOI 10.1002/ibd.20933; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Hasnain SZ, 2013, GASTROENTEROLOGY, V144, P357, DOI 10.1053/j.gastro.2012.10.043; He WM, 2003, GASTROENTEROLOGY, V125, P1388, DOI 10.1016/j.gastro.2003.07.009; Iliev ID, 2009, GUT, V58, P1481, DOI 10.1136/gut.2008.175166; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Johansson MEV, 2014, GUT, V63, P281, DOI 10.1136/gutjnl-2012-303207; Johansson MEV, 2013, GUT, V62, P188, DOI 10.1136/gutjnl-2012-302582; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kojima R, 2004, J PHARMACOL SCI, V96, P307, DOI 10.1254/jphs.FP0040214; Matteoli G, 2010, GUT, V59, P595, DOI 10.1136/gut.2009.185108; Ordas I, 2012, LANCET, V380, P1606, DOI 10.1016/S0140-6736(12)60150-0; Pfaffl MW., 2006, REAL TIME PCR, P63; Platt AM, 2010, J IMMUNOL, V184, P6843, DOI 10.4049/jimmunol.0903987; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Rupp J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006020; Rydstrom A, 2007, J IMMUNOL, V178, P5789, DOI 10.4049/jimmunol.178.9.5789; Scott CL, 2011, TRENDS IMMUNOL, V32, P412, DOI 10.1016/j.it.2011.06.003; Siddiqui KRR, 2010, IMMUNITY, V32, P557, DOI 10.1016/j.immuni.2010.03.017; Strauch UG, 2010, WORLD J GASTROENTERO, V16, P21, DOI 10.3748/wjg.v16.i1.21; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Varol C, 2010, NAT REV IMMUNOL, V10, P415, DOI 10.1038/nri2778; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Weber B, 2011, EUR J IMMUNOL, V41, P773, DOI 10.1002/eji.201040965; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	43	64	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100217	10.1371/journal.pone.0100217	http://dx.doi.org/10.1371/journal.pone.0100217			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945909	gold, Green Submitted, Green Published			2022-12-25	WOS:000340721500051
J	Cao, Q; Zhao, KX; Zhong, XZ; Zou, YJ; Yu, HC; Huang, P; Xu, TL; Dong, XP				Cao, Qi; Zhao, Kexin; Zhong, Xi Zoe; Zou, Yuanjie; Yu, Haichuan; Huang, Peng; Xu, Tian-Le; Dong, Xian-Ping			SLC17A9 Protein Functions as a Lysosomal ATP Transporter and Regulates Cell Viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR NUCLEOTIDE TRANSPORTER; RELEASE; EXOCYTOSIS; STORAGE; MECHANISM; CHANNELS	Lysosomes contain abundant ATP, which is released through lysosomal exocytosis following exposure to various stimuli. However, the molecular mechanisms underlying lysosomal ATP accumulation remain unknown. The vesicular nucleotide transporter, also known as solute carrier family 17 member 9 (SLC17A9), has been shown to function in ATP transport across secretory vesicles/granules membrane in adrenal chromaffin cells, T cells, and pancreatic cells. Here, using mammalian cell lines, we report that SLC17A9 is highly enriched in lysosomes and functions as an ATP transporter in those organelles. SLC17A9 deficiency reduced lysosome ATP accumulation and compromised lysosome function, resulting in cell death. Our data suggest that SLC17A9 activity mediates lysosomal ATP accumulation and plays an important role in lysosomal physiology and cell viability.	[Cao, Qi; Zhao, Kexin; Zhong, Xi Zoe; Zou, Yuanjie; Yu, Haichuan; Huang, Peng; Dong, Xian-Ping] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS B3H 4R2, Canada; [Xu, Tian-Le] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Key Lab Tumor Microenvironm & Inflammat, Shanghai 200025, Peoples R China	Dalhousie University; Shanghai Jiao Tong University	Dong, XP (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, Sir Charles Tupper Med Bldg,5850 Coll St, Halifax, NS B3H 4R2, Canada.	xpdong@dal.ca		Dong, Xianping/0000-0002-4496-7104	Department of Physiology and Biophysics, Dalhousie University; Dalhousie Medical Research Foundation (DMRF); DMRF; Canadian Institutes of Health Research (CIHR) [MOP-119349]; CIHR [201109MSH-261462-208625]; Nova Scotia Health Research Foundation [MED-PRO-2011-7485]; Canada Foundation for Innovation Leaders Opportunity Fund [29291]	Department of Physiology and Biophysics, Dalhousie University; Dalhousie Medical Research Foundation (DMRF); DMRF; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Nova Scotia Health Research Foundation; Canada Foundation for Innovation Leaders Opportunity Fund(Canada Foundation for Innovation)	This work was supported by start-up funds from the Department of Physiology and Biophysics, Dalhousie University (to X. D.), by a Dalhousie Medical Research Foundation (DMRF) equipment grant, by a DMRF new investigator award, by Canadian Institutes of Health Research (CIHR) Grant MOP-119349, by CIHR New Investigator Award 201109MSH-261462-208625, by Nova Scotia Health Research Foundation Establishment Grant MED-PRO-2011-7485, and by Canada Foundation for Innovation Leaders Opportunity Fund Funding for Research Infrastructure Grant 29291.	Aits S, 2013, J CELL SCI, V126, P1905, DOI 10.1242/jcs.091181; Cheng XP, 2010, FEBS LETT, V584, P2013, DOI 10.1016/j.febslet.2009.12.056; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Dahl Gerhard, 2009, P287, DOI 10.1007/978-1-59745-489-6_12; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Dou Y, 2012, CELL RES, V22, P1022, DOI 10.1038/cr.2012.10; El Mestikawy S, 2011, NAT REV NEUROSCI, V12, P204, DOI 10.1038/nrn2969; Fredriksson R, 2008, FEBS LETT, V582, P3811, DOI 10.1016/j.febslet.2008.10.016; Geisler JC, 2013, ENDOCRINOLOGY, V154, P675, DOI 10.1210/en.2012-1818; Haanes KA, 2010, BIOCHEM J, V429, P303, DOI 10.1042/BJ20091337; Hediger MA, 2013, MOL ASPECTS MED, V34, P95, DOI 10.1016/j.mam.2012.12.009; Huang P, 2014, J BIOL CHEM, V289, P17658, DOI 10.1074/jbc.M114.552158; Imura Y, 2013, GLIA, V61, P1320, DOI 10.1002/glia.22517; IRVIN JL, 1954, J BIOL CHEM, V210, P45; Koike M, 2000, J NEUROSCI, V20, P6898, DOI 10.1523/JNEUROSCI.20-18-06898.2000; Koivusalo M, 2011, TRAFFIC, V12, P972, DOI 10.1111/j.1600-0854.2011.01215.x; LEE C, 1971, BIOCHEMISTRY-US, V10, P4375, DOI 10.1021/bi00800a004; Liu T, 2011, J NEUROSCI, V31, P10593, DOI 10.1523/JNEUROSCI.6401-10.2011; Miyaji T, 2011, J BIOL CHEM, V286, P42881, DOI 10.1074/jbc.M111.277269; Omote H, 2013, PHYSIOLOGY, V28, P39, DOI 10.1152/physiol.00033.2012; Omote H, 2011, BIOCHEMISTRY-US, V50, P5558, DOI 10.1021/bi200567k; Oya M, 2013, BIOCHEM BIOPH RES CO, V438, P145, DOI 10.1016/j.bbrc.2013.07.043; PILLAI S, 1985, J BIOL CHEM, V260, P8384; Sathe MN, 2011, J BIOL CHEM, V286, P25363, DOI 10.1074/jbc.M111.232868; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Tokunaga A, 2010, J BIOL CHEM, V285, P17406, DOI 10.1074/jbc.M110.112417; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; WHITE PN, 1995, HEARING RES, V90, P97, DOI 10.1016/0378-5955(95)00151-1; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620	31	46	46	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23189	23199		10.1074/jbc.M114.567107	http://dx.doi.org/10.1074/jbc.M114.567107			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24962569	Green Published, hybrid			2022-12-25	WOS:000341017200055
J	Garcia-Sanz, P; Quintanilla, A; Lafita, MC; Moreno-Bueno, G; Garcia-Gutierrez, L; Tabor, V; Varela, I; Shiio, Y; Larsson, LG; Portillo, F; Leon, J				Garcia-Sanz, Pablo; Quintanilla, Andrea; Carmen Lafita, M.; Moreno-Bueno, Gema; Garcia-Gutierrez, Lucia; Tabor, Vedrana; Varela, Ignacio; Shiio, Yuzuru; Larsson, Lars-Gunnar; Portillo, Francisco; Leon, Javier			Sin3b Interacts with Myc and Decreases Myc Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NETWORK; C-MYC; HISTONE DEACETYLASE; GENE-EXPRESSION; CHROMATIN MODIFICATIONS; DIFFERENTIAL REGULATION; PROXIMITY LIGATION; REPRESSION DOMAIN; GENOMIC TARGETS; BREAST-CANCER	Myc expression is deregulated in many human cancers. A yeast two-hybrid screen has revealed that the transcriptional repressor Sin3b interacts with Myc protein. Endogenous Myc and Sin3b colocalize and interact in the nuclei of human and rat cells, as assessed by co-immunoprecipitation, immunofluorescence, and proximity ligation assay. The interaction is Max-independent. A conserved Myc region (amino acids 186 - 203) is required for the interaction with Sin3 proteins. Histone deacetylase 1 is recruited to Myc-Sin3b complexes, and its deacetylase activity is required for the effects of Sin3b on Myc. Myc and Sin3a/b co-occupied many sites on the chromatin of human leukemia cells, although the presence of Sin3 was not associated with gene down-regulation. In leukemia cells and fibroblasts, Sin3b silencing led to Myc up-regulation, whereas Sin3b overexpression induced Myc deacetylation and degradation. An analysis of Sin3b expression in breast tumors revealed an association between low Sin3b expression and disease progression. The data suggest that Sin3b decreases Myc protein levels upon Myc deacetylation. As Sin3b is also required for transcriptional repression by Mxd-Max complexes, our results suggest that, at least in some cell types, Sin3b limits Myc activity through two complementary activities: Mxd-dependent gene repression and reduction of Myc levels.	[Varela, Ignacio; Leon, Javier] Univ Cantabria, CSIC, Inst Biomed & Biotecnol Cantabria IBBTEC, Sociedad El Desarrollo Cantabria, Santander 39011, Spain; [Varela, Ignacio; Leon, Javier] Univ Cantabria, CSIC, Dept Biol Mol, Santander 39011, Spain; [Garcia-Sanz, Pablo; Moreno-Bueno, Gema; Portillo, Francisco] Univ Autonoma Madrid, Fac Med, CSIC, Inst Invest Biomed Alberto Sols,Inst Invest Hosp, Madrid 28046, Spain; [Garcia-Sanz, Pablo; Moreno-Bueno, Gema] Fdn MD Anderson Int, Madrid, Spain; [Tabor, Vedrana; Larsson, Lars-Gunnar] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden; [Shiio, Yuzuru] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); University of Texas System; UTMD Anderson Cancer Center; Karolinska Institutet; University of Texas System; University of Texas Health San Antonio	Portillo, F (corresponding author), Univ Autonoma Madrid, Fac Med, CSIC, Inst Invest Biomed Alberto Sols,Inst Invest Hosp, Madrid 28046, Spain.	fportillo@iib.uam.es; leonj@unican.es	Leon, Javier/K-4615-2014; Gutierrez, Lucia Garcia/ABH-3682-2020; Varela, Ignacio/G-1699-2016; Varela, Ignacio/AAA-7680-2021; Moreno-Bueno, Gema/K-9354-2016	Gutierrez, Lucia Garcia/0000-0003-4396-4814; Varela, Ignacio/0000-0002-0969-506X; Varela, Ignacio/0000-0002-0969-506X; Moreno-Bueno, Gema/0000-0002-5030-6687; Tabor, Vedrana/0000-0001-9224-208X; Lafita Navarro, Maria del Carmen/0000-0002-7266-651X; Portillo Perez, Francisco/0000-0003-4922-346X; Leon, Javier/0000-0001-5803-0112	Ministerio de Economia y Competitividad (MINECO) [SAF11-23796]; Instituto Carlos III [RETIC/RD012/0036/0033]; MINECO [SAF2010-20175, BFU2008-04285]; Asociacion Espanola Contra el Cancer (AECC) [AECC-2011]; Comunidad de Madrid [ReCaRe S2010/BMD-2303]; European Union Fondo de Desarrollo Regional de la Union Europea (FEDER) program; Formacion de Profesorado Universitario (FPU) program, Spanish Ministry of Education; Cancerfonden; Karolinska Institutet	Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Instituto Carlos III(Instituto de Salud Carlos III); MINECO(Spanish Government); Asociacion Espanola Contra el Cancer (AECC); Comunidad de Madrid(Comunidad de Madrid); European Union Fondo de Desarrollo Regional de la Union Europea (FEDER) program; Formacion de Profesorado Universitario (FPU) program, Spanish Ministry of Education(German Research Foundation (DFG)); Cancerfonden(Swedish Cancer Society); Karolinska Institutet(Karolinska Institutet)	This work was supported by Grants SAF11-23796 from the Ministerio de Economia y Competitividad (MINECO) and RETIC/RD012/0036/0033 from the Instituto Carlos III (to J. L.); SAF2010-20175 from MINECO, AECC-2011 from the Asociacion Espanola Contra el Cancer (AECC), and ReCaRe S2010/BMD-2303 from Comunidad de Madrid (to G. M.-B.); and BFU2008-04285 from MINECO (to F. P.). All Spanish funding, except from the AECC, was co-sponsored by the European Union Fondo de Desarrollo Regional de la Union Europea (FEDER) program.; Recipient of a fellowship from the Formacion de Profesorado Universitario (FPU) program, Spanish Ministry of Education.; Supported by grants from the Cancerfonden and the Karolinska Institutet.	Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Ayer DE, 1996, MOL CELL BIOL, V16, P5772; AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Conacci-Sorrell M, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014357; Cunliffe VT, 2008, CURR OPIN GENET DEV, V18, P404, DOI 10.1016/j.gde.2008.10.001; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; David G, 2008, P NATL ACAD SCI USA, V105, P4168, DOI 10.1073/pnas.0710285105; Delgado M Dolores, 2010, Genes Cancer, V1, P605, DOI 10.1177/1947601910377495; DELGADO MD, 1995, ONCOGENE, V10, P1659; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Faiola F, 2005, MOL CELL BIOL, V25, P10220, DOI 10.1128/MCB.25.23.10220-10234.2005; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gibbons RJ, 2005, HUM MOL GENET, V14, pR85, DOI 10.1093/hmg/ddi106; Gomez-Casares MT, 2013, ONCOGENE, V32, P2239, DOI 10.1038/onc.2012.246; Grandinetti KB, 2008, CELL CYCLE, V7, P1550, DOI 10.4161/cc.7.11.6052; Grandinetti KB, 2009, CANCER RES, V69, P6430, DOI 10.1158/0008-5472.CAN-09-0537; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Herbst A, 2005, EMBO REP, V6, P177, DOI 10.1038/sj.embor.7400333; HOANG AT, 1995, MOL CELL BIOL, V15, P4031; HOPEWELL R, 1995, MOL CELL BIOL, V15, P3470; Hurlin PJ, 2006, SEMIN CANCER BIOL, V16, P265, DOI 10.1016/j.semcancer.2006.07.009; Kiessling A, 2006, CHEM BIOL, V13, P745, DOI 10.1016/j.chembiol.2006.05.011; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurland JF, 2008, CANCER RES, V68, P3624, DOI 10.1158/0008-5472.CAN-07-6552; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Le Guezennec X, 2006, NUCLEIC ACIDS RES, V34, P3929, DOI 10.1093/nar/gkl537; Leon J, 2009, CELL CYCLE, V8, P1148, DOI 10.4161/cc.8.8.8126; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Martinato F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003650; Mauleon I, 2004, MOL CARCINOGEN, V39, P85, DOI 10.1002/mc.20000; Menssen A, 2012, P NATL ACAD SCI USA, V109, pE187, DOI 10.1073/pnas.1105304109; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Nascimento EM, 2011, NAT CELL BIOL, V13, P1395, DOI 10.1038/ncb2385; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Perreard L, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1399; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rao G, 1996, ONCOGENE, V12, P1165; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Rottmann S, 2006, CURR TOP MICROBIOL, V302, P63; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Swanson KA, 2004, NAT STRUCT MOL BIOL, V11, P738, DOI 10.1038/nsmb798; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vaque JP, 2008, MOL CANCER RES, V6, P325, DOI 10.1158/1541-7786.MCR-07-0180; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; Xu Y, 2006, J BIOL CHEM, V281, P9260, DOI 10.1074/jbc.M511724200; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	60	20	20	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22221	22236		10.1074/jbc.M113.538744	http://dx.doi.org/10.1074/jbc.M113.538744			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24951594	Green Published, hybrid			2022-12-25	WOS:000340593500036
J	Tala, A; Delle Side, D; Buccolieri, G; Tredici, SM; Velardi, L; Paladini, F; De Stefano, M; Nassisi, V; Alifano, P				Tala, Adelfia; Delle Side, Domenico; Buccolieri, Giovanni; Tredici, Salvatore Maurizio; Velardi, Luciano; Paladini, Fabio; De Stefano, Mario; Nassisi, Vincenzo; Alifano, Pietro			Exposure to Static Magnetic Field Stimulates Quorum Sensing Circuit in Luminescent Vibrio Strains of the Harveyi Clade	PLOS ONE			English	Article							S-RIBOSYLHOMOCYSTEINASE LUXS; GENE-EXPRESSION; III SECRETION; LUMINOUS BACTERIA; SENSOR KINASE; REAL-TIME; BIOLUMINESCENCE; VIRULENCE; SYSTEMS; SIGNAL	In this study, the evidence of electron-dense magnetic inclusions with polyhedral shape in the cytoplasm of Harveyi clade Vibrio strain PS1, a bioluminescent bacterium living in symbiosis with marine organisms, led us to investigate the behavior of this bacterium under exposure to static magnetic fields ranging between 20 and 2000 Gauss. When compared to sham-exposed, the light emission of magnetic field-exposed bacteria growing on solid medium at 18 degrees C +/- 0.1 degrees C was increased up to two-fold as a function of dose and growth phase. Stimulation of bioluminescence by magnetic field was more pronounced during the post-exponential growth and stationary phase, and was lost when bacteria were grown in the presence of the iron chelator deferoxamine, which caused disassembly of the magnetic inclusions suggesting their involvement in magnetic response. As in luminescent Vibrio spp. bioluminescence is regulated by quorum sensing, possible effects of magnetic field exposure on quorum sensing were investigated. Measurement of mRNA levels by reverse transcriptase real time-PCR demonstrated that luxR regulatory gene and luxCDABE operon coding for luciferase and fatty acid reductase complex were significantly up-regulated in magnetic field-exposed bacteria. In contrast, genes coding for a type III secretion system, whose expression was negatively affected by LuxR, were down-regulated. Up-regulation of luxR paralleled with down-regulation of small RNAs that mediate destabilization of luxR mRNA in quorum sensing signaling pathways. The results of experiments with the well-studied Vibrio campbellii strain BB120 (originally classified as Vibrio harveyi) and derivative mutants unable to synthesize autoinducers suggest that the effects of magnetic fields on quorum sensing may be mediated by AI-2, the interspecies quorum sensing signal molecule.	[Tala, Adelfia; Tredici, Salvatore Maurizio; Alifano, Pietro] Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali, Lecce, Italy; [Delle Side, Domenico; Buccolieri, Giovanni; Velardi, Luciano; Paladini, Fabio; Nassisi, Vincenzo] Univ Salento INFN Lecce, Dipartimento Matemat & Fis Ennio De Giorgi, Lecce, Italy; [De Stefano, Mario] Univ Naples 2, Dipartimento Sci Ambientali, Caserta, Italy	University of Salento; University of Salento; Universita della Campania Vanvitelli	Alifano, P (corresponding author), Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali, Lecce, Italy.	pietro.alifano@unisalento.it	Velardi, Luciano/D-4699-2016; Delle Side, Domenico/E-9245-2014	Velardi, Luciano/0000-0003-4518-9217; Delle Side, Domenico/0000-0003-3417-8803; BUCCOLIERI, Giovanni/0000-0001-8672-9238; Alifano, Pietro/0000-0003-3768-7275	Italian Ministero dell'Istruzione, dell' Universita e della Ricerca (MIUR)	Italian Ministero dell'Istruzione, dell' Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This study was supported by grants from Italian Ministero dell'Istruzione, dell' Universita e della Ricerca (MIUR) to Vincenzo Nassisi and Pietro Alifano (PRIN projects). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin B, 2006, LETT APPL MICROBIOL, V43, P119, DOI 10.1111/j.1472-765X.2006.01989.x; Barros MP, 1998, FREE RADICAL BIO MED, V24, P767, DOI 10.1016/S0891-5849(97)00335-3; BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Bazylinski DA, 1996, CHEM GEOL, V132, P191, DOI 10.1016/S0009-2541(96)00055-1; Bazylinski DA, 2000, CHEM GEOL, V169, P319, DOI 10.1016/S0009-2541(00)00211-4; Carrano CJ, 2009, MAR BIOTECHNOL, V11, P431, DOI 10.1007/s10126-009-9191-4; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; DEARAUJO FFT, 1986, BIOPHYS J, V50, P375, DOI 10.1016/S0006-3495(86)83471-3; DEBARROS HGPL, 1990, SCI PROG, V74, P347; Defoirdt T, 2008, ISME J, V2, P19, DOI 10.1038/ismej.2007.92; Defoirdt T, 2012, ISME J, V6, P2314, DOI 10.1038/ismej.2012.58; Freeman JA, 1999, MOL MICROBIOL, V31, P665, DOI 10.1046/j.1365-2958.1999.01208.x; Freeman JA, 2000, MOL MICROBIOL, V35, P139, DOI 10.1046/j.1365-2958.2000.01684.x; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Gao WM, 2005, BIOELECTROMAGNETICS, V26, P558, DOI 10.1002/bem.20133; Glasauer S, 2002, SCIENCE, V295, P117, DOI 10.1126/science.1066577; Gopishetty B, 2009, J AM CHEM SOC, V131, P1243, DOI 10.1021/ja808206w; Gravili C, 2012, J MAR BIOL ASSOC UK, V92, P1317, DOI 10.1017/S0025315411001408; GRISSOM CB, 1995, CHEM REV, V95, P3, DOI 10.1021/cr00033a001; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; Hellinger J, 2012, J COMP PHYSIOL A, V198, P593, DOI 10.1007/s00359-012-0732-3; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Henke JM, 2004, J BACTERIOL, V186, P3794, DOI 10.1128/JB.186.12.3794-3805.2004; Higgins DA, 2007, NATURE, V450, P883, DOI 10.1038/nature06284; HONG FT, 1995, BIOSYSTEMS, V36, P187, DOI 10.1016/0303-2647(95)01555-Y; Iwasaka M, 1998, J APPL PHYS, V83, P6456, DOI 10.1063/1.367736; Ji WJ, 2009, MICRON, V40, P894, DOI 10.1016/j.micron.2009.05.010; Kalirai SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053368; Klumpp S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033562; Kohno, 2000, Pathophysiology, V7, P143, DOI 10.1016/S0928-4680(00)00042-0; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Lilley BN, 2000, MOL MICROBIOL, V36, P940, DOI 10.1046/j.1365-2958.2000.01913.x; Lin BC, 2010, ENV MICROBIOL REP, V2, P81, DOI 10.1111/j.1758-2229.2009.00100.x; Liu D, 2013, ENVIRON SCI POLLUT R, V20, P60, DOI 10.1007/s11356-012-1052-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manefield M, 2000, APPL ENVIRON MICROB, V66, P2079, DOI 10.1128/AEM.66.5.2079-2084.2000; McKenzie KM, 2005, CHEM COMMUN, P4863, DOI 10.1039/b509396a; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Mok KC, 2003, EMBO J, V22, P870, DOI 10.1093/emboj/cdg085; Moore A, 2009, J FISH BIOL, V74, P1629, DOI 10.1111/j.1095-8649.2009.02197.x; Morrow AC, 2007, BIOELECTROMAGNETICS, V28, P439, DOI 10.1002/bem.20332; Mouchka ME, 2010, INTEGR COMP BIOL, V50, P662, DOI 10.1093/icb/icq061; Muscatine L., 1990, P75; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Neiditch MB, 2005, MOL CELL, V18, P507, DOI 10.1016/j.molcel.2005.04.020; Nodwell LM, 2001, LIMNOL OCEANOGR, V46, P765, DOI 10.4319/lo.2001.46.4.0765; Perez-Gonzalez T, 2010, GEOCHIM COSMOCHIM AC, V74, P967, DOI 10.1016/j.gca.2009.10.035; PETUSHKOV VN, 1985, BIOFIZIKA+, V30, P349; Potenza L, 2004, MUTAT RES-GEN TOX EN, V561, P53, DOI 10.1016/j.mrgentox.2004.03.009; Rees JF, 1998, J EXP BIOL, V201, P1211; Rodgers CT, 2009, PURE APPL CHEM, V81, P19, DOI 10.1351/PAC-CON-08-10-18; Rosen AD, 2003, CELL BIOCHEM BIOPHYS, V39, P163, DOI 10.1385/CBB:39:2:163; Rosen AD, 2003, BIOELECTROMAGNETICS, V24, P517, DOI 10.1002/bem.10124; Ruwandeepika HAD, 2012, REV AQUACULT, V4, P59, DOI 10.1111/j.1753-5131.2012.01061.x; SAKURAI I, 1980, P NATL ACAD SCI-BIOL, V77, P7232, DOI 10.1073/pnas.77.12.7232; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; SCHOLZ F, 1984, BIOPHYS J, V45, P589, DOI 10.1016/S0006-3495(84)84196-X; Stabili L, 2008, MICROB ECOL, V56, P625, DOI 10.1007/s00248-008-9382-y; Stabili L, 2006, MICROB ECOL, V52, P603, DOI 10.1007/s00248-006-9010-7; Stabili L, 2011, J EXP MAR BIOL ECOL, V396, P77, DOI 10.1016/j.jembe.2010.10.004; Stabili L, 2010, MICROB ECOL, V59, P555, DOI 10.1007/s00248-009-9605-x; STEINER UE, 1989, CHEM REV, V89, P51, DOI 10.1021/cr00091a003; STUBBE J, 1988, BIOCHEMISTRY-US, V27, P3893, DOI 10.1021/bi00411a001; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Triampo W, 2004, J BIOSCI BIOENG, V98, P182; VILCHESTROYA J, 1984, J COMP NEUROL, V226, P489, DOI 10.1002/cne.902260404; WALKER MM, 1984, SCIENCE, V224, P751, DOI 10.1126/science.224.4650.751; WALKER MM, 1988, J EXP BIOL, V140, P51; Weil E, 2006, DIS AQUAT ORGAN, V69, P1, DOI 10.3354/dao069001; Wooldridge SA, 2010, BIOESSAYS, V32, P615, DOI 10.1002/bies.200900182; Woutersen M, 2011, ANAL BIOANAL CHEM, V400, P915, DOI 10.1007/s00216-010-4372-6; Zhu JG, 2003, BIOCHEMISTRY-US, V42, P4717, DOI 10.1021/bi034289j	78	20	20	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100825	10.1371/journal.pone.0100825	http://dx.doi.org/10.1371/journal.pone.0100825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960170	gold, Green Submitted, Green Published			2022-12-25	WOS:000338633900092
J	Dietrich, J; Andreasen, LV; Andersen, P; Agger, EM				Dietrich, Jes; Andreasen, Lars Vibe; Andersen, Peter; Agger, Else Marie			Inducing Dose Sparing with Inactivated Polio Virus Formulated in Adjuvant CAF01	PLOS ONE			English	Article							CD4(+) T-CELLS; MATERNALLY DERIVED ANTIBODIES; MUCOSAL IMMUNE-RESPONSES; INTRADERMAL DELIVERY; CATIONIC LIPOSOMES; HEPATITIS-A; FEVER VIRUS; LIVE VIRUS; VACCINE; MICE	The development of new low cost inactivated polio virus based vaccines (IPV) is a high priority, and will be required to eradicate polio. In addition, such a vaccine constitutes the only realistic polio vaccine in the post-eradication era. One way to reduce the cost of a vaccine is to increase immunogenicity by use of adjuvants. The CAF01 adjuvant has previously been shown to be a safe and potent adjuvant with several antigens, and here we show that in mice IPV formulated with CAF01 induced increased systemic protective immunity measured by binding and neutralization antibody titers in serum. CAF01 also influenced the kinetics of both the cellular and humoral response against IPV to produce a faster, as well as a stronger, response, dominated by IgG2a, IgG2b, and IgG2c isotypes as well as IPV specific T cells secreting IFN-gamma/IL-2. Finally, as intestinal immunity is also a priority of polio vaccines, we present a vaccine strategy based on simultaneous priming at an intradermal and an intramuscular site that generate intestinal immune responses against polio virus. Taken together, the IPV-CAF01 formulation constitutes a new promising vaccine against polio with the ability to generate strong humoral and cellular immunity against the polio virus.	[Dietrich, Jes; Andersen, Peter; Agger, Else Marie] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark; [Andreasen, Lars Vibe] Statens Serum Inst, Dept Vaccine Dev, DK-2300 Copenhagen, Denmark	Statens Serum Institut; Statens Serum Institut	Dietrich, J (corresponding author), Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark.	jdi@ssi.dk		Andersen, Peter/0000-0002-5869-2551	Bill and Melinda Gates Foundation [OPP1041024, OPP1070613]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was supported by the Bill and Melinda Gates Foundation, Grant Number OPP1041024 and the Bill and Melinda Gates Foundation, Grant Number OPP1070613. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003116; Baldwin SL, 2011, VACCINE, V29, P644, DOI 10.1016/j.vaccine.2010.11.043; Baras B, 2008, INFLUENZA OTHER RESP, V2, P251, DOI 10.1111/j.1750-2659.2008.00054.x; Billeskov R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039909; Brady RC, 2009, VACCINE, V27, P5091, DOI 10.1016/j.vaccine.2009.06.057; Buisman AM, 2008, J INFECT DIS, V197, P698, DOI 10.1086/527487; Chen J, 2010, J VIROL, V84, P1289, DOI 10.1128/JVI.01281-09; Dagan R, 2000, PEDIATR INFECT DIS J, V19, P1045, DOI 10.1097/00006454-200011000-00004; Davidsen J, 2005, BBA-BIOMEMBRANES, V1718, P22, DOI 10.1016/j.bbamem.2005.10.011; Enioutina EY, 2000, VACCINE, V18, P2753, DOI 10.1016/S0264-410X(00)00059-1; Estivariz CF, 2013, CURR OPIN VIROL, V3, P309, DOI 10.1016/j.coviro.2013.05.007; Estivariz CF, 2012, LANCET INFECT DIS, V12, P128, DOI 10.1016/S1473-3099(11)70190-6; Fiore AE, 2003, PEDIATR INFECT DIS J, V22, P354; Fomsgaard A, 2011, VACCINE, V29, P7067, DOI 10.1016/j.vaccine.2011.07.025; Galindo M, 2007, NEW ENGL J MED, V356, P1536, DOI 10.1056/NEJMoa054960; Hawken J, 2012, VACCINE, V30, P6971, DOI 10.1016/j.vaccine.2012.09.059; HENRY JL, 1966, J HYG-CAMB, V64, P105, DOI 10.1017/S0022172400040389; Herremans TMPT, 1999, J IMMUNOL, V162, P5011; Hickling JK, 2011, B WORLD HEALTH ORGAN, V89, P221, DOI 10.2471/BLT.10.079426; Hird TR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002599; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Holmgren J, 2012, CURR OPIN IMMUNOL, V24, P343, DOI 10.1016/j.coi.2012.03.014; Ivanov AP, 2006, J INFECT DIS, V193, P598, DOI 10.1086/499970; Ivanov AP, 2005, EXPERT REV VACCINES, V4, P167, DOI 10.1586/14760584.4.2.167; Jenkins HE, 2010, NEW ENGL J MED, V362, P2360, DOI 10.1056/NEJMoa0910074; Karlsson I, 2013, CLIN IMMUNOL, V146, P120, DOI 10.1016/j.clim.2012.12.005; KATRAK K, 1991, J GEN VIROL, V72, P1093, DOI 10.1099/0022-1317-72-5-1093; Keitel W, 2010, VACCINE, V28, P840, DOI 10.1016/j.vaccine.2009.10.019; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Klinkenberg D, 2002, VACCINE, V20, P3005, DOI 10.1016/S0042-207X(02)00283-X; KRISHNAN R, 1983, B WORLD HEALTH ORGAN, V61, P689; Leroux-Roels I, 2010, VACCINE, V28, P849, DOI 10.1016/j.vaccine.2009.10.017; Liu T, 2001, J VIROL, V75, P2107, DOI 10.1128/JVI.75.5.2107-2118.2001; Loeffen WLA, 2003, VET IMMUNOL IMMUNOP, V92, P23, DOI 10.1016/S0165-2427(03)00019-9; MAHON BP, 1995, J EXP MED, V181, P1285, DOI 10.1084/jem.181.4.1285; MARINE WM, 1962, AM J HYG, V76, P173, DOI 10.1093/oxfordjournals.aje.a120272; Martel CJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022891; Mateen FJ, 2013, VACCINE, V31, P2517, DOI 10.1016/j.vaccine.2012.06.020; MILICH DR, 1987, NATURE, V329, P547, DOI 10.1038/329547a0; Modlin JF, 2012, LANCET INFECT DIS, V12, P93, DOI 10.1016/S1473-3099(11)70312-7; Mohammed AJ, 2010, NEW ENGL J MED, V362, P2351, DOI 10.1056/NEJMoa0909383; MORINIERE BJ, 1993, LANCET, V341, P1545, DOI 10.1016/0140-6736(93)90693-B; Nahm MH, 2003, VACCINE, V21, P3393, DOI 10.1016/S0264-410X(03)00340-2; Okayasu H, 2011, VACCINE, V29, P8205, DOI 10.1016/j.vaccine.2011.08.059; Olsen AW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010768; Ranasinghe C, 2014, IMMUNOL LETT, V161, P204, DOI 10.1016/j.imlet.2014.01.006; Resik S, 2010, J INFECT DIS, V201, P1344, DOI 10.1086/651611; Roman VRG, 2013, AIDS RES HUM RETROV, V29, P1504, DOI 10.1089/AID.2013.0076; Rosenkrands I, 2011, VACCINE, V29, P6283, DOI 10.1016/j.vaccine.2011.06.040; SCHERLE PA, 1986, J EXP MED, V164, P1114, DOI 10.1084/jem.164.4.1114; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; Siegrist CA, 1998, EUR J IMMUNOL, V28, P4138, DOI 10.1002/(SICI)1521-4141(199812)28:12<4138::AID-IMMU4138>3.0.CO;2-L; SIMHON A, 1990, INT J EPIDEMIOL, V19, P164, DOI 10.1093/ije/19.1.164; Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152; Thomsen AR, 1997, INT IMMUNOL, V9, P1757, DOI 10.1093/intimm/9.11.1757; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Weeratna RD, 2001, FEMS IMMUNOL MED MIC, V30, P241, DOI 10.1016/S0928-8244(01)00231-0; Westdijk J, 2013, VACCINE, V31, P1298, DOI 10.1016/j.vaccine.2012.12.076; Yang CT, 2009, VACCINE, V27, P6558, DOI 10.1016/j.vaccine.2009.08.047; Yin LS, 2013, J IMMUNOL, V190, P6023, DOI 10.4049/jimmunol.1202523; Yoshino N, 2010, SCAND J IMMUNOL, V72, P98, DOI 10.1111/j.1365-3083.2010.02416.x; Zehrung D, 2013, VACCINE, V31, P3392, DOI 10.1016/j.vaccine.2012.11.021	62	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100879	10.1371/journal.pone.0100879	http://dx.doi.org/10.1371/journal.pone.0100879			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956110	Green Published, gold, Green Submitted			2022-12-25	WOS:000338917900104
J	Grandchamp, N; Altemir, D; Philippe, S; Ursulet, S; Pilet, H; Serre, MC; Lenain, A; Serguera, C; Mallet, J; Sarkis, C				Grandchamp, Nicolas; Altemir, Dorothee; Philippe, Stephanie; Ursulet, Suzanna; Pilet, Heloise; Serre, Marie-Claude; Lenain, Aude; Serguera, Che; Mallet, Jacques; Sarkis, Chamsy			Hybrid Lentivirus-phiC31-int-NLS Vector Allows Site-Specific Recombination in Murine and Human Cells but Induces DNA Damage	PLOS ONE			English	Article							PHAGE PHI-C31 INTEGRASE; ZINC-FINGER NUCLEASES; XENOPUS-LAEVIS EMBRYOS; MEDIATED GENE-THERAPY; LENTIVIRAL VECTORS; PHIC31 INTEGRASE; MAMMALIAN-CELLS; GENOMIC INTEGRATION; CRE RECOMBINASE; IN-VIVO	Gene transfer allows transient or permanent genetic modifications of cells for experimental or therapeutic purposes. Gene delivery by HIV-derived lentiviral vector (LV) is highly effective but the risk of insertional mutagenesis is important and the random/uncontrollable integration of the DNA vector can deregulate the cell transcriptional activity. Non Integrative Lentiviral Vectors (NILVs) solve this issue in non-dividing cells, but they do not allow long term expression in dividing cells. In this context, obtaining stable expression while avoiding the problems inherent to unpredictable DNA vector integration requires the ability to control the integration site. One possibility is to use the integrase of phage phiC31 (phiC31-int) which catalyzes efficient site-specific recombination between the attP site in the phage genome and the chromosomal attB site of its Streptomyces host. Previous studies showed that phiC31-int is active in many eukaryotic cells, such as murine or human cells, and directs the integration of a DNA substrate into pseudo attP sites (pattP) which are homologous to the native attP site. In this study, we combined the efficiency of NILV for gene delivery and the specificity of phiC31-int for DNA substrate integration to engineer a hybrid tool for gene transfer with the aim of allowing long term expression in dividing and nondividing cells preventing genotoxicity. We demonstrated the feasibility to target NILV integration in human and murine pattP sites with a dual NILV vectors system: one which delivers phiC31-int, the other which constitute the substrate containing an attB site in its DNA sequence. These promising results are however alleviated by the occurrence of significant DNA damages. Further improvements are thus required to prevent chromosomal rearrangements for a therapeutic use of the system. However, its use as a tool for experimental applications such as transgenesis is already applicable.	[Grandchamp, Nicolas; Altemir, Dorothee; Philippe, Stephanie; Ursulet, Suzanna; Pilet, Heloise; Mallet, Jacques; Sarkis, Chamsy] Univ Paris 06, Inst Cerveau & Moelle Epiniere, INSERM, Ctr Rech,Unit Biotechnol & Biotherapy, Paris, France; [Grandchamp, Nicolas; Altemir, Dorothee; Philippe, Stephanie; Ursulet, Suzanna; Pilet, Heloise; Sarkis, Chamsy] NewVectys, Villebon Sur Yvette, France; [Grandchamp, Nicolas; Philippe, Stephanie; Ursulet, Suzanna; Pilet, Heloise] Biosource, Paris, France; [Serre, Marie-Claude] Lab Virol Mol & Struct, Gif Sur Yvette, France; [Lenain, Aude] CEA, Lab Radiobiol & Oncol, Fontenay Aux Roses, France; [Serguera, Che] Mol Imaging Res Ctr Modelisat Biotherapies, Fontenay Aux Roses, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Universite Paris Saclay	Sarkis, C (corresponding author), Univ Paris 06, Inst Cerveau & Moelle Epiniere, INSERM, Ctr Rech,Unit Biotechnol & Biotherapy, Paris, France.	chamsy.sarkis@newvectys.com		Serguera, Che/0000-0002-9210-0636; SERRE, Marie-Claude/0000-0002-7899-9833	European FP6 (INTEGRA NEST-Adventure contract) [29025]; AFM (Association Francaise contre les Myopathies); Retina France	European FP6 (INTEGRA NEST-Adventure contract); AFM (Association Francaise contre les Myopathies)(Association Francaise contre les Myopathies); Retina France	This work was supported by grants from European FP6 (INTEGRA NEST-Adventure contract #29025), AFM (Association Francaise contre les Myopathies), and Retina France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-authors NG, DA, SP, SU and HP are employed by NewVectys SAS. NewVectys SAS provided support in the form of salaries for authors NG, DA, SP, SU and HP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allen BG, 2005, NAT METHODS, V2, P975, DOI 10.1038/NMETH814; Allen BG, 2006, NAT PROTOC, V1, P1248, DOI 10.1038/nprot.2006.183; Andreas S, 2002, NUCLEIC ACIDS RES, V30, P2299, DOI 10.1093/nar/30.11.2299; ANTON M, 1995, J VIROL, V69, P4600, DOI 10.1128/JVI.69.8.4600-4606.1995; Bauer JW, 2004, EXPERT OPIN BIOL TH, V4, P1435, DOI 10.1517/14712598.4.9.1435; Belteki G, 2003, NAT BIOTECHNOL, V21, P321, DOI 10.1038/nbt787; Bertoni C, 2006, P NATL ACAD SCI USA, V103, P419, DOI 10.1073/pnas.0504505102; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bolusani S, 2006, NUCLEIC ACIDS RES, V34, P5259, DOI 10.1093/nar/gkl548; Bozas A, 2009, GENETICS, V182, P641, DOI 10.1534/genetics.109.101329; BYRNES AP, 1995, NEUROSCIENCE, V66, P1015, DOI 10.1016/0306-4522(95)00068-T; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Chalberg TW, 2005, INVEST OPHTH VIS SCI, V46, P2140, DOI 10.1167/iovs.04-1252; Chalberg TW, 2006, J MOL BIOL, V357, P28, DOI 10.1016/j.jmb.2005.11.098; Chavez CL, 2012, HUM GENE THER, V23, P390, DOI 10.1089/hum.2011.110; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cornu TI, 2007, MOL THER, V15, P2107, DOI 10.1038/sj.mt.6300345; Cornu TI, 2010, METHODS MOL BIOL, V649, P237, DOI 10.1007/978-1-60761-753-2_14; Cronin J, 2005, CURR GENE THER, V5, P387, DOI 10.2174/1566523054546224; Druskovic M, 2006, CROAT MED J, V47, P832; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Ehrhardt A, 2007, MOL THER, V15, P146, DOI 10.1038/sj.mt.6300011; Ehrhardt A, 2006, HUM GENE THER, V17, P1077, DOI 10.1089/hum.2006.17.1077; Fish MP, 2007, NAT PROTOC, V2, P2325, DOI 10.1038/nprot.2007.328; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Grandchamp Nicolas, 2011, Genet Vaccines Ther, V9, P1, DOI 10.1186/1479-0556-9-1; Gregory MA, 2003, J BACTERIOL, V185, P5320, DOI 10.1128/JB.185.17.5320-5323.2003; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Held PK, 2005, MOL THER, V11, P399, DOI 10.1016/j.ymthe.2004.11.001; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Holkers M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1446; Hollis Roger P, 2003, Reprod Biol Endocrinol, V1, P79, DOI 10.1186/1477-7827-1-79; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Ishikawa Y, 2006, J GENE MED, V8, P646, DOI 10.1002/jgm.891; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kafri T, 1997, NAT GENET, V17, P314, DOI 10.1038/ng1197-314; Keravala A, 2011, GENE THER, V18, P842, DOI 10.1038/gt.2011.31; Keravala A, 2006, J GENE MED, V8, P1008, DOI 10.1002/jgm.928; Kolot M, 2003, BIOTECHNOL BIOENG, V84, P56, DOI 10.1002/bit.10747; Kondo S, 2009, J MOL BIOL, V390, P221, DOI 10.1016/j.jmb.2009.04.057; Lister JA, 2011, METHOD CELL BIOL, V104, P195, DOI 10.1016/B978-0-12-374814-0.00011-2; Liu J, 2006, GENE THER, V13, P1188, DOI 10.1038/sj.gt.3302789; Liu J, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-31; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Ma QW, 2006, BIOCHEM BIOPH RES CO, V345, P984, DOI 10.1016/j.bbrc.2006.04.145; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; Meredith JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059264; Miller OJ, 2006, NAT METHODS, V3, P561, DOI 10.1038/NMETH897; Moldt B, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-60; Morton J, 2006, P NATL ACAD SCI USA, V103, P16370, DOI 10.1073/pnas.0605633103; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nakano M, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e40; Nakayama G, 2006, MOL GENET GENOMICS, V275, P1, DOI 10.1007/s00438-005-0026-3; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; Olivares EC, 2001, GENE, V278, P167, DOI 10.1016/S0378-1119(01)00711-9; Olivares EC, 2002, NAT BIOTECHNOL, V20, P1124, DOI 10.1038/nbt753; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Ortiz-Urda S, 2003, HUM GENE THER, V14, P923, DOI 10.1089/104303403765701204; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Philippe S, 2006, P NATL ACAD SCI USA, V103, P17684, DOI 10.1073/pnas.0606197103; Portlock JL, 2006, HUM GENE THER, V17, P871, DOI 10.1089/hum.2006.17.871; Pruett-Miller SM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000376; Ramalingam S, 2011, J MOL BIOL, V405, P630, DOI 10.1016/j.jmb.2010.10.043; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Robert MA, 2012, HUM GENE THER METHOD, V23, P393, DOI 10.1089/hgtb.2012.122; Rohlmann A, 1996, NAT BIOTECHNOL, V14, P1562, DOI 10.1038/nbt1196-1562; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Santoro SW, 2002, P NATL ACAD SCI USA, V99, P4185, DOI 10.1073/pnas.022039799; Sarkis C, 2008, CURR GENE THER, V8, P430, DOI 10.2174/156652308786848012; Schnell MA, 2001, MOL THER, V3, P708, DOI 10.1006/mthe.2001.0330; Sclimenti CR, 2001, NUCLEIC ACIDS RES, V29, P5044, DOI 10.1093/nar/29.24.5044; SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Smith MCM, 2010, BIOCHEM SOC T, V38, P388, DOI 10.1042/BST0380388; Staunstrup NH, 2009, MOL THER, V17, P1205, DOI 10.1038/mt.2009.10; Tay Y, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1089; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; Thyagarajan B, 2008, STEM CELLS, V26, P119, DOI 10.1634/stemcells.2007-0283; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Vink CA, 2009, MOL THER, V17, P1197, DOI 10.1038/mt.2009.94; Wah DA, 1998, P NATL ACAD SCI USA, V95, P10564, DOI 10.1073/pnas.95.18.10564; Wilson JH, 2003, NAT BIOTECHNOL, V21, P759, DOI 10.1038/nbt0703-759; Yanez-Munoz RJ, 2006, NAT MED, V12, P348, DOI 10.1038/nm1365; Zayed H, 2004, MOL THER, V9, P292, DOI 10.1016/j.ymthe.2003.11.024	97	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99649	10.1371/journal.pone.0099649	http://dx.doi.org/10.1371/journal.pone.0099649			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956106	Green Published, gold, Green Submitted			2022-12-25	WOS:000338917900014
J	Lage, GM; Miranda, DM; Romano-Silva, MA; Campos, SB; Albuquerque, MR; Correa, H; Malloy-Diniz, LF				Lage, Guilherme M.; Miranda, Debora M.; Romano-Silva, Marco A.; Campos, Simone B.; Albuquerque, Maicon R.; Correa, Humberto; Malloy-Diniz, Leandro F.			Association between the Catechol-O-Methyltransferase (COMT) Val(158)Met Polymorphism and Manual Aiming Control in Healthy Subjects	PLOS ONE			English	Article							WORKING-MEMORY; NUCLEUS-ACCUMBENS; DECISION-MAKING; MET GENOTYPE; DOPAMINE; VAL158MET; GENE	Background: Prefrontal dopamine is catabolized by the catechol-O-methyltransferase (COMT) enzyme. Current evidence suggests that the val/met single nucleotide polymorphism in the COMT gene can predict the efficiency of executive cognition in humans. Individuals carrying the val allele perform more poorly because less synaptic dopamine is available. Methodology/Principal Findings: We investigated the influence of the COMT polymorphism on motor performance in a task that requires different executive functions. We administered a manual aiming motor task that was performed under four different conditions of execution by 111 healthy participants. Participants were grouped according to genotype (met/met, met/val, val/val), and the motor performance among groups was compared. Overall, the results indicate that met/met carriers presented lower levels of peak velocity during the movement trajectory than the val carriers, but met/met carriers displayed higher accuracy than the val carriers. Conclusions/Significance: This study found a significant association between the COMT polymorphism and manual aiming control. Few studies have investigated the genetics of motor control, and these findings indicate that individual differences in motor control require further investigation using genetic studies.	[Lage, Guilherme M.] Univ Fed Minas Gerais, Escola Educ Fis Fisioterapia & Terapia Ocupac, Dept Educ Fis, Grp Estudo Desenvolvimento Motor & Aprendizagem M, Belo Horizonte, MG, Brazil; [Lage, Guilherme M.; Miranda, Debora M.; Romano-Silva, Marco A.; Albuquerque, Maicon R.; Correa, Humberto; Malloy-Diniz, Leandro F.] Univ Fed Minas Gerais, Fac Med, LINC, Belo Horizonte, MG, Brazil; [Lage, Guilherme M.; Miranda, Debora M.; Romano-Silva, Marco A.; Campos, Simone B.; Albuquerque, Maicon R.; Correa, Humberto; Malloy-Diniz, Leandro F.] Univ Fed Minas Gerais, Fac Med, INCT Med Mol, Belo Horizonte, MG, Brazil; [Romano-Silva, Marco A.; Correa, Humberto] Univ Fed Minas Gerais, Fac Med, Dept Saude Mental, Belo Horizonte, MG, Brazil; [Miranda, Debora M.; Malloy-Diniz, Leandro F.] Univ Fed Minas Gerais, Fac Med, Dept Pediat, Belo Horizonte, MG, Brazil; [Albuquerque, Maicon R.] Univ Fed Vicosa, Dept Educ Fis, Vicosa, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Vicosa	Lage, GM (corresponding author), Univ Fed Minas Gerais, Escola Educ Fis Fisioterapia & Terapia Ocupac, Dept Educ Fis, Grp Estudo Desenvolvimento Motor & Aprendizagem M, Belo Horizonte, MG, Brazil.	menezeslage@gmail.com	Lage, Guilherme/F-4355-2011; Malloy-Diniz, Leandro/D-7829-2013; Miranda, Debora/AAQ-1952-2020; Correa, Humberto/B-6497-2009; Romano-Silva, Marco Aurelio/T-8321-2019; Romano-Silva, Marco Aurelio/A-1790-2008; Malloy-Diniz, Leandro Fernandes/AAR-4025-2021; Albuquerque, Maicon Rodrigues/I-6227-2013	Lage, Guilherme/0000-0001-8296-3676; Malloy-Diniz, Leandro/0000-0002-6606-1354; Miranda, Debora/0000-0002-7081-8401; Correa, Humberto/0000-0003-4327-6413; Romano-Silva, Marco Aurelio/0000-0002-6558-4639; Malloy-Diniz, Leandro Fernandes/0000-0002-6606-1354; Albuquerque, Maicon Rodrigues/0000-0001-6021-8480	INCT-MM [FAPEMIG: CBB-APQ-00075- 584 09/CNPq 573646/2008-2]; FAPEMIG	INCT-MM; FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	Funding was provided by grant INCT-MM (FAPEMIG: CBB-APQ-00075- 584 09/CNPq 573646/2008-2); FAPEMIG - incentive program for publication in indexed journals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera M, 2008, AM J MED GENET B, V147B, P898, DOI 10.1002/ajmg.b.30705; Amorim P., 2000, REV BRAS PSIQUIATR, V22, P106, DOI DOI 10.1590/S1516-44462000000300003; Bardgett ME, 2009, BEHAV NEUROSCI, V123, P242, DOI 10.1037/a0014625; Bender S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037814; Bilder RM, 2002, BIOL PSYCHIAT, V52, P701, DOI 10.1016/S0006-3223(02)01416-6; Blasi G, 2005, J NEUROSCI, V25, P5038, DOI 10.1523/JNEUROSCI.0476-05.2005; BOUDIKOVA B, 1990, CLIN PHARMACOL THER, V48, P381, DOI 10.1038/clpt.1990.166; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Congdon E, 2008, J PERS, V76, P1447, DOI 10.1111/j.1467-6494.2008.00528.x; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Diamond A, 2000, CHILD DEV, V71, P44, DOI 10.1111/1467-8624.00117; Dickinson D, 2009, NEUROSCIENCE, V164, P72, DOI 10.1016/j.neuroscience.2009.05.014; DUM RP, 1991, J NEUROSCI, V11, P667; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Goldberg TE, 2003, ARCH GEN PSYCHIAT, V60, P889, DOI 10.1001/archpsyc.60.9.889; Karlsgodt KH, 2011, BEHAV BRAIN RES, V225, P610, DOI 10.1016/j.bbr.2011.08.016; KAROUM F, 1994, J NEUROCHEM, V63, P972, DOI 10.1046/j.1471-4159.1994.63030972.x; Kennedy Q, 2011, BEHAV GENET, V41, P700, DOI 10.1007/s10519-010-9436-z; Lage GM, 2012, PSYCHIAT RES, V30, P140; Lage GM, 2012, HUM MOVEMENT SCI, V31, P811, DOI 10.1016/j.humov.2011.08.008; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Malhotra AK, 2002, AM J PSYCHIAT, V159, P652, DOI 10.1176/appi.ajp.159.4.652; Malloy-Diniz LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073509; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Muller T, 2008, CLIN NEUROPHARMACOL, V31, P134, DOI 10.1097/WNF.0b013e31811510ed; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Nolan KA, 2004, AM J PSYCHIAT, V161, P359, DOI 10.1176/appi.ajp.161.2.359; Noudoost B, 2011, TRENDS COGN SCI, V15, P585, DOI 10.1016/j.tics.2011.10.006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pattij T, 2007, PSYCHOPHARMACOLOGY, V191, P587, DOI 10.1007/s00213-006-0533-x; Rosa EC, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-53; Serrien DJ, 2007, PROG NEUROBIOL, V82, P95, DOI 10.1016/j.pneurobio.2007.02.003; Sheldrick AJ, 2008, EUR PSYCHIAT, V23, P385, DOI 10.1016/j.eurpsy.2008.05.002; TANJI J, 1994, NEUROSCI RES, V19, P251, DOI 10.1016/0168-0102(94)90038-8; van den Bos R, 2009, NEUROPHARMACOLOGY, V56, P493, DOI 10.1016/j.neuropharm.2008.10.002; Wahlstrom D, 2007, BIOL PSYCHIAT, V61, P626, DOI 10.1016/j.biopsych.2006.05.045; Winterer G, 2006, NEUROIMAGE, V32, P1722, DOI 10.1016/j.neuroimage.2006.05.058; Woodworth RS, 1899, PSYCHOL REV-MONOGR S, V3, P1	40	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99698	10.1371/journal.pone.0099698	http://dx.doi.org/10.1371/journal.pone.0099698			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL1WV	24956262	Green Submitted, Green Published, gold			2022-12-25	WOS:000338917900016
J	Valdivia, N; Diaz, MJ; Holtheuer, J; Garrido, I; Huovinen, P; Gomez, I				Valdivia, Nelson; Diaz, Maria J.; Holtheuer, Jorge; Garrido, Ignacio; Huovinen, Pirjo; Gomez, Ivan			Up, Down, and All Around: Scale-Dependent Spatial Variation in Rocky-Shore Communities of Fildes Peninsula, King George Island, Antarctica	PLOS ONE			English	Article							ENVIRONMENTAL-STRESS; INTERTIDAL HABITATS; POTTER COVE; ICE SCOUR; PATTERNS; DISTURBANCE; MACROALGAE; ASSEMBLAGES; ZONATION; BIODIVERSITY	Understanding the variation of biodiversity along environmental gradients and multiple spatial scales is relevant for theoretical and management purposes. Hereby, we analysed the spatial variability in diversity and structure of intertidal and subtidal macrobenthic Antarctic communities along vertical environmental stress gradients and across multiple horizontal spatial scales. Since biotic interactions and local topographic features are likely major factors for coastal assemblages, we tested the hypothesis that fine-scale processes influence the effects of the vertical environmental stress gradients on the macrobenthic diversity and structure. We used nested sampling designs in the intertidal and subtidal habitats, including horizontal spatial scales ranging from few centimetres to 1000s of metres along the rocky shore of Fildes Peninsula, King George Island. In both intertidal and subtidal habitats, univariate and multivariate analyses showed a marked vertical zonation in taxon richness and community structure. These patterns depended on the horizontal spatial scale of observation, as all analyses showed a significant interaction between height (or depth) and the finer spatial scale analysed. Variance and pseudo-variance components supported our prediction for taxon richness, community structure, and the abundance of dominant species such as the filamentous green alga Urospora penicilliformis (intertidal), the herbivore Nacella concinna (intertidal), the large kelp-like Himantothallus grandifolius (subtidal), and the red crustose red alga Lithothamnion spp. (subtidal). We suggest that in coastal ecosystems strongly governed by physical factors, fine-scale processes (e. g. biotic interactions and refugia availability) are still relevant for the structuring and maintenance of the local communities. The spatial patterns found in this study serve as a necessary benchmark to understand the dynamics and adaptation of natural assemblages in response to observed and predicted environmental changes in Antarctica.	[Valdivia, Nelson; Diaz, Maria J.; Holtheuer, Jorge; Garrido, Ignacio; Huovinen, Pirjo; Gomez, Ivan] Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile; [Holtheuer, Jorge] Univ Austral Chile, Fac Ciencias, Programa Doctorado Biol Marina, Valdivia, Chile	Universidad Austral de Chile; Universidad Austral de Chile	Valdivia, N (corresponding author), Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile.	nelson.valdivia@uach.cl	Valdivia, Nelson A/C-3613-2009	Valdivia, Nelson A/0000-0002-5394-2072; Gomez, Ivan/0000-0001-8381-3792; Huovinen, Pirjo/0000-0002-7754-4933	PIA-CONICYT Anillo grant [ART1101]; Programa de Mejoramiento de la Calidad y la Equidad de la Educacioen Superior (MECESUP) through grant Fortalecimiento de las Ciencias Ecoloegicas y Evolutivas en la UACH [AUS0805]	PIA-CONICYT Anillo grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS); Programa de Mejoramiento de la Calidad y la Equidad de la Educacioen Superior (MECESUP) through grant Fortalecimiento de las Ciencias Ecoloegicas y Evolutivas en la UACH	Financial support was provided by the PIA-CONICYT Anillo grant # ART1101 to I.G., P.H., and N.V.; and by the Programa de Mejoramiento de la Calidad y la Equidad de la Educacioen Superior (MECESUP) through grant # AUS0805 Fortalecimiento de las Ciencias Ecoloegicas y Evolutivas en la UACH to N.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2001, OECOLOGIA, V128, P465, DOI 10.1007/s004420100737; Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; ARNTZ WE, 1994, OCEANOGR MAR BIOL, V32, P241; Barnes DKA, 2011, CURR BIOL, V21, pR451, DOI 10.1016/j.cub.2011.04.012; Benedetti-Cecchi L, 1999, MAR ECOL PROG SER, V181, P13, DOI 10.3354/meps181013; Benedetti-Cecchi L, 2000, NATURE, V407, P370, DOI 10.1038/35030089; BenedettiCecchi L, 1997, J EXP MAR BIOL ECOL, V209, P171, DOI 10.1016/S0022-0981(96)02686-X; Bick A, 2013, POLAR BIOL, V36, P673, DOI 10.1007/s00300-013-1293-9; Botsford LW, 2003, ECOL APPL, V13, pS25; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Coleman RA, 2006, OECOLOGIA, V147, P556, DOI 10.1007/s00442-005-0296-9; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; Denny MW, 2011, J EXP MAR BIOL ECOL, V400, P175, DOI 10.1016/j.jembe.2011.02.006; Diaz ER, 2011, J ECOL, V99, P416, DOI 10.1111/j.1365-2745.2010.01779.x; Fraschetti S, 2005, MAR ECOL PROG SER, V296, P13, DOI 10.3354/meps296013; Gomez I, 1997, MAR ECOL PROG SER, V148, P281, DOI 10.3354/meps148281; Gomez I, 2011, MAR ECOL PROG SER, V422, P77, DOI 10.3354/meps08937; Harley CDG, 2003, LIMNOL OCEANOGR, V48, P1498, DOI 10.4319/lo.2003.48.4.1498; Harley CDG, 2011, SCIENCE, V334, P1124, DOI 10.1126/science.1210199; Huovinen P, 2013, POLAR BIOL, V36, P1319, DOI 10.1007/s00300-013-1351-3; Johnston EL, 2007, POLAR BIOL, V30, P781, DOI 10.1007/s00300-006-0237-z; Khim BK, 2007, ESTUAR COAST SHELF S, V73, P111, DOI 10.1016/j.ecss.2006.12.015; Kiirikki M, 1996, EUR J PHYCOL, V31, P61, DOI 10.1080/09670269600651201; Kim D., 2001, SEASONALITY MARINE A; KLOSER H, 1994, POLAR BIOL, V14, P11; Kloser H, 1996, HYDROBIOLOGIA, V333, P1, DOI 10.1007/BF00020959; Konar B, 2009, MAR ECOL-EVOL PERSP, V30, P63, DOI 10.1111/j.1439-0485.2008.00259.x; Campana GL, 2009, BOT MAR, V52, P655, DOI 10.1515/BOT.2009.076; Martins GM, 2008, MAR ECOL PROG SER, V356, P15, DOI 10.3354/meps07247; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Menge BA, 2013, ECOL MONOGR, V83, P283, DOI 10.1890/12-1706.1; Molina-Montenegro MA, 2005, MAR ECOL PROG SER, V292, P173, DOI 10.3354/meps292173; Nybakken J., 2005, MARINE BIOL ECOLOGIC; PAINE RT, 1981, ECOL MONOGR, V51, P145, DOI 10.2307/2937261; Poore AGB, 2012, ECOL LETT, V15, P912, DOI 10.1111/j.1461-0248.2012.01804.x; Pugh PJA, 1997, J EXP MAR BIOL ECOL, V210, P1, DOI 10.1016/S0022-0981(96)02711-6; Richards ZT, 2013, DIVERS DISTRIB, V19, P884, DOI 10.1111/ddi.12032; Sarr DA, 2005, Q REV BIOL, V80, P187, DOI 10.1086/433058; Scrosati RA, 2011, ECOGRAPHY, V34, P151, DOI 10.1111/j.1600-0587.2010.06119.x; Smale DA, 2008, SCIENCE, V321, P371, DOI 10.1126/science.1158647; Smale DA, 2007, AUSTRAL ECOL, V32, P878, DOI 10.1111/j.1442-9993.2007.01776.x; Smale DA, 2010, DIVERS DISTRIB, V16, P985, DOI 10.1111/j.1472-4642.2010.00709.x; Smith SDA, 2002, ANTARCT SCI, V14, P374, DOI 10.1017/S0954102002000160; SOUSA WP, 1979, ECOLOGY, V60, P1225, DOI 10.2307/1936969; STEPHENSON TA, 1949, J ECOL, V37, P289, DOI 10.2307/2256610; Team RC, 2014, R LANG ENV STAT COMP; Terlizzi A, 2005, MAR BIOL, V148, P293, DOI 10.1007/s00227-005-0080-8; Terlizzi A, 2007, MAR ECOL PROG SER, V332, P25, DOI 10.3354/meps332025; Thompson RM, 2007, ECOLOGY, V88, P612, DOI 10.1890/05-1454; Underwood AJ, 2000, J EXP MAR BIOL ECOL, V250, P97, DOI 10.1016/S0022-0981(00)00181-7; Underwood AJ, 1996, OECOLOGIA, V107, P212, DOI 10.1007/BF00327905; Underwood AJ, 2000, J EXP MAR BIOL ECOL, V250, P51, DOI 10.1016/S0022-0981(00)00179-9; Valdivia N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024062; Waller CL, 2006, AUSTRAL ECOL, V31, P656, DOI 10.1111/j.1442-9993.2006.01618.x; Waller CL, 2013, ANTARCT SCI, V25, P62, DOI 10.1017/S0954102012000867; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Zacher K, 2007, POLAR BIOL, V30, P1203, DOI 10.1007/s00300-007-0278-y; Zacher K, 2007, GLOBAL CHANGE BIOL, V13, P1201, DOI 10.1111/j.1365-2486.2007.01349.x; Zacher K, 2009, BOT MAR, V52, P483, DOI 10.1515/BOT.2009.082	61	25	28	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100714	10.1371/journal.pone.0100714	http://dx.doi.org/10.1371/journal.pone.0100714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956114	Green Published, Green Submitted, gold			2022-12-25	WOS:000338917900086
J	Wang, YY; Luo, Y; Bing, T; Chen, Z; Lu, MH; Zhang, N; Shangguan, DH; Gao, X				Wang, Yuanyuan; Luo, Yun; Bing, Tao; Chen, Zheng; Lu, Minhua; Zhang, Nan; Shangguan, Dihua; Gao, Xin			DNA Aptamer Evolved by Cell-SELEX for Recognition of Prostate Cancer	PLOS ONE			English	Article							NUCLEIC-ACID APTAMERS; BREAST-CANCER; LIVE CELLS; IN-VIVO; ANTIGEN; INTERNALIZATION; THERAPEUTICS; DIAGNOSTICS; MOLECULES; MORTALITY	Morbidity and mortality of prostate cancer (PCa) have increased in recent years worldwide. Currently existing methods for diagnosis and treatment do not make the situation improve, especially for hormone refractory prostate cancer (HRPC). The lack of molecular probes for PCa hindered the early diagnosis of metastasis and accurate staging for PCa. In this work, we have developed a new aptamer probe Wy-5a against PCa cell line PC-3 by cell-SELEX technique. Wy-5a shows high specificity to the target cells with dissociation constants in the nanomolar range, and does not recognize other tested PCa cell lines and other tested tumor cell lines. The staining of clinical tissue sections with fluorescent dye labeled Wy-5a shows that sections from high risk group with metastasis exhibited stronger fluorescence and sections from Benign Prostatic Hyperplasia (BPH) did not exhibit notable fluorescence, which suggests that aptamer Wy-5a may bind to protein related to the progression of PCa. The high affinity and specificity of Wy-5a makes this aptamer hold potential for application in diagnosis and target therapy of PCa.	[Wang, Yuanyuan; Luo, Yun; Chen, Zheng; Lu, Minhua; Gao, Xin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Bing, Tao; Zhang, Nan; Shangguan, Dihua] Chinese Acad Sci, Inst Chem, Key Lab Analyt Chem Living Biosyst, Beijing Natl Lab Mol Sci, Beijing 100080, Peoples R China	Sun Yat Sen University; Chinese Academy of Sciences; Institute of Chemistry, CAS	Shangguan, DH (corresponding author), Chinese Acad Sci, Inst Chem, Key Lab Analyt Chem Living Biosyst, Beijing Natl Lab Mol Sci, Beijing 100080, Peoples R China.	sgdh@iccas.ac.cn; xin.gao.zsu@gmail.com	Bing, Tao/AAM-6162-2020; Bing, Tao/F-3476-2017; Shangguan, Dihua/G-4530-2011; Lv, Yuanjie/AER-0767-2022	Bing, Tao/0000-0002-5121-053X; Bing, Tao/0000-0002-5121-053X; Shangguan, Dihua/0000-0002-5746-803X; 	National Natural Science Foundation of China [81172430, 81372728, 21205124, 81201694]; Grant 973 Program [2011CB935800]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20120171120059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Grant 973 Program; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	The authors acknowledge the financial support from National Natural Science Foundation of China (81172430, 81372728, 21205124 and 81201694) and Grant 973 Program (2011CB935800) and Specialized Research Fund for the Doctoral Program of Higher Education of China (20120171120059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti C, 2013, EUR REV MED PHARMACO, V17, P1658; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Bing T, 2010, BIOORGAN MED CHEM, V18, P1798, DOI 10.1016/j.bmc.2010.01.054; Breaker RR, 2004, NATURE, V432, P838, DOI 10.1038/nature03195; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Chen HW, 2008, CHEMMEDCHEM, V3, P991, DOI 10.1002/cmdc.200800030; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; Gown AM, 2008, MODERN PATHOL, V21, pS8, DOI 10.1038/modpathol.2008.34; GUESS HA, 1993, PROSTATE, V22, P31, DOI 10.1002/pros.2990220105; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Jiang YX, 2003, ANAL CHEM, V75, P2112, DOI 10.1021/ac026182s; Kanwar JR, 2011, CRIT REV BIOCHEM MOL, V46, P459, DOI 10.3109/10409238.2011.614592; Kanwar JR, 2010, NANOMEDICINE-UK, V5, P1435, DOI 10.2217/NNM.10.115; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kovar JL, 2006, AM J PATHOL, V169, P1415, DOI 10.2353/ajpath.2006.060324; Lin GW, 2009, ASIAN J ANDROL, V11, P443, DOI 10.1038/aja.2008.36; Min K, 2011, BIOMATERIALS, V32, P2124, DOI 10.1016/j.biomaterials.2010.11.035; Montironi R, 2005, BJU INT, V95, P1146, DOI 10.1111/j.1464-410X.2005.05540.x; Navani NK, 2006, CURR OPIN CHEM BIOL, V10, P272, DOI 10.1016/j.cbpa.2006.04.003; Osborne SE, 1997, CURR OPIN CHEM BIOL, V1, P5, DOI 10.1016/S1367-5931(97)80102-0; Patil SD, 2005, AAPS J, V7, pE61, DOI 10.1208/aapsj070109; Pulukuri SM, 2005, J BIOL CHEM, V280, P36529, DOI 10.1074/jbc.M503111200; Rimmele M, 2003, CHEMBIOCHEM, V4, P963, DOI 10.1002/cbic.200300648; Robertson D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-13; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Sefah K, 2010, NAT PROTOC, V5, P1169, DOI 10.1038/nprot.2010.66; Shangguan DH, 2008, ANAL CHEM, V80, P721, DOI 10.1021/ac701962v; Shangguan D, 2007, CHEMBIOCHEM, V8, P603, DOI 10.1002/cbic.200600532; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sim HG, 2005, EUR J CANCER, V41, P834, DOI 10.1016/j.ejca.2004.12.033; Tchetgen MB, 1996, UROLOGY, V47, P511, DOI 10.1016/S0090-4295(99)80486-5; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wessels JT, 2007, CYTOM PART A, V71A, P542, DOI 10.1002/cyto.a.20419; World Health Organization, 2008, WORLD CANC REPORT, P450; Xia SJ, 2012, ASIAN J ANDROL, V14, P458, DOI 10.1038/aja.2010.137; Xiao ZY, 2008, CHEM-EUR J, V14, P1769, DOI 10.1002/chem.200701330; Yang XJ, 2011, ANALYST, V136, P577, DOI 10.1039/c0an00550a; Zhang KJ, 2012, CHEMMEDCHEM, V7, P79, DOI 10.1002/cmdc.201100457; Zhao ZL, 2009, ANALYST, V134, P1808, DOI 10.1039/b904476k; Zhou JH, 2011, OLIGONUCLEOTIDES, V21, P1, DOI 10.1089/oli.2010.0264; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	45	25	25	5	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100243	10.1371/journal.pone.0100243	http://dx.doi.org/10.1371/journal.pone.0100243			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956390	Green Published, gold, Green Submitted			2022-12-25	WOS:000338917900035
J	Breyer, MK; Spruit, MA; Hanson, CK; Franssen, FME; Vanfleteren, LEGW; Groenen, MTJ; Bruijnzeel, PLB; Wouters, EFM; Rutten, EPA				Breyer, Marie-Kathrin; Spruit, Martijn A.; Hanson, Corrine K.; Franssen, Frits M. E.; Vanfleteren, Lowie E. G. W.; Groenen, Miriam T. J.; Bruijnzeel, Piet L. B.; Wouters, Emiel F. M.; Rutten, Erica P. A.			Prevalence of Metabolic Syndrome in COPD Patients and Its Consequences	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; BONE-MINERAL DENSITY; CARDIOVASCULAR-DISEASE; EXERCISE CAPACITY; OBESE INDIVIDUALS; BODY-COMPOSITION; MORTALITY; COMORBIDITIES; ASSOCIATION	Background: The prevalence of metabolic syndrome in COPD patients and its impact on patient related outcomes has been little studied. We evaluated the prevalence of metabolic syndrome and clinical and functional characteristics in patients with COPD and healthy subjects. Methods: 228 COPD patients and 156 healthy subjects were included. Metabolic syndrome was defined using criteria of the IDF. In all patients spirometry, body composition, functional exercise performance, and mood and health status were assessed. Groups were stratified for BMI and gender. Results: Metabolic syndrome was present in 57% of the COPD patients and 40% of the healthy subjects. After stratification for BMI, presence of metabolic syndrome in patients with a BMI >= 25 kg/m(2) was higher than in healthy peers. Patients with metabolic syndrome and a BMI <25 kg/m(2) had higher BMI, fat free mass index and bone mineral density, and a lower 6MWD than the BMI matched patients without metabolic syndrome. Spirometry, maximal ergometry, mood and health status, and blood gases were not different between those groups. In COPD patients with metabolic syndrome self-reported co-morbidities and medication use were higher than in those without. Conclusion: Metabolic syndrome is more prevalent in overweight or obese COPD patients than in BMI matched healthy subjects. Metabolic syndrome did not additionally impact patients' functional outcomes, but did impact the prevalence of co-morbidities.	[Breyer, Marie-Kathrin; Wouters, Emiel F. M.] MUMC, Dept Resp Med, Maastricht, Netherlands; [Breyer, Marie-Kathrin; Spruit, Martijn A.; Franssen, Frits M. E.; Vanfleteren, Lowie E. G. W.; Groenen, Miriam T. J.; Wouters, Emiel F. M.; Rutten, Erica P. A.] Ctr Expertise Chron Organ Failure, Program Dev Ctr CIRO, Horn, Netherlands; [Breyer, Marie-Kathrin] Otto Wagner Hosp, Dept Resp & Crit Care Med, Vienna, Austria; [Breyer, Marie-Kathrin] Otto Wagner Hosp, Ludwig Boltzmann Inst COPD & Pulm Epidemiol, Vienna, Austria; [Hanson, Corrine K.] Univ Nebraska Med Ctr, Sch Allied Hlth Profess, Div Med Nutr Educ, Ohmaha, NE USA; [Bruijnzeel, Piet L. B.] AstraZeneca, Inflammat Neurosci & Resp, Molndal, Sweden	Maastricht University; University of Nebraska System; University of Nebraska Medical Center; AstraZeneca	Breyer, MK (corresponding author), MUMC, Dept Resp Med, Maastricht, Netherlands.	marie.breyer@gmx.at	Wouters, Emiel/ABD-6200-2021; Franssen, Frits M.E./L-3334-2019; Franssen, Frits M.E./B-6988-2018	Franssen, Frits M.E./0000-0002-1633-6356; Franssen, Frits M.E./0000-0002-1633-6356; Hanson, Corrine/0000-0002-5118-591X	Ludwig Boltzmann Institute for COPD and Respiratory Epidemiology, Vienna, Austria; AstraZeneca	Ludwig Boltzmann Institute for COPD and Respiratory Epidemiology, Vienna, Austria; AstraZeneca(AstraZeneca)	MKB was funded by the Ludwig Boltzmann Institute for COPD and Respiratory Epidemiology, Vienna, Austria. AstraZeneca provided support in the form of a salary for author PLBB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the author contributions section.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Curkendall SM, 2006, ANN EPIDEMIOL, V16, P63, DOI 10.1016/j.annepidem.2005.04.008; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Ferrer M, 1997, ANN INTERN MED, V127, P1072, DOI 10.7326/0003-4819-127-12-199712150-00003; Ford Earl S, 2006, Expert Rev Cardiovasc Ther, V4, P897, DOI 10.1586/14779072.4.6.897; Hajiro T, 1998, AM J RESP CRIT CARE, V157, P785, DOI 10.1164/ajrccm.157.3.9703055; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Ketelaars CAJ, 1996, THORAX, V51, P39, DOI 10.1136/thx.51.1.39; Kinjo M, 2007, J CLIN ENDOCR METAB, V92, P4161, DOI 10.1210/jc.2007-0757; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Leone N, 2009, AM J RESP CRIT CARE, V179, P509, DOI 10.1164/rccm.200807-1195OC; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; Marquis K, 2005, J CARDIOPULM REHABIL, V25, P233; Marquis Karine, 2005, J Cardiopulm Rehabil, V25, P226, DOI 10.1097/00008483-200507000-00010; Minas M, 2011, COPD, V8, P414, DOI 10.3109/15412555.2011.619600; Pobeha P, 2011, BONE, V48, P1008, DOI 10.1016/j.bone.2011.02.017; Reid IR, 2010, ARCH BIOCHEM BIOPHYS, V503, P20, DOI 10.1016/j.abb.2010.06.027; Reid IR, 2006, ANN ENDOCRINOL-PARIS, V67, P125, DOI 10.1016/S0003-4266(06)72567-7; Ribisl PM, 2007, DIABETES CARE, V30, P2679, DOI 10.2337/dc06-2487; Roriz-Cruz M, 2007, J AM GERIATR SOC, V55, P374, DOI 10.1111/j.1532-5415.2007.01068.x; SCHOLS AMWJ, 1991, THORAX, V46, P695, DOI 10.1136/thx.46.10.695; Shoup R, 1997, EUR RESPIR J, V10, P1576, DOI 10.1183/09031936.97.10071576; Tsai AG, 2008, OBESITY, V16, P59, DOI 10.1038/oby.2007.8; van den Borst B, 2012, AM J CLIN NUTR, V96, P516, DOI 10.3945/ajcn.112.040774; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Watz H, 2009, CHEST, V136, P1039, DOI 10.1378/chest.09-0393; Wells G, 2013, EUROPEAN RESP MONOGR; Wong CY, 2005, AM J CARDIOL, V96, P1686, DOI 10.1016/j.amjcard.2005.07.091; Yamaguchi T, 2009, BONE, V45, P174, DOI 10.1016/j.bone.2009.05.003; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	34	52	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e98013	10.1371/journal.pone.0098013	http://dx.doi.org/10.1371/journal.pone.0098013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950070	Green Published, Green Submitted, gold			2022-12-25	WOS:000338276300004
J	Dodd, KA; Bird, BH; Jones, MEB; Nichol, ST; Spiropoulou, CF				Dodd, Kimberly A.; Bird, Brian H.; Jones, Megan E. B.; Nichol, Stuart T.; Spiropoulou, Christina F.			Kyasanur Forest Disease Virus Infection in Mice Is Associated with Higher Morbidity and Mortality than Infection with the Closely Related Alkhurma Hemorrhagic Fever Virus	PLOS ONE			English	Article							SAUDI-ARABIA; ENCEPHALITIS; TICKS; NAJRAN; MODELS; MOUSE; INDIA	Background: Kyasanur Forest disease virus (KFDV) and Alkhurma hemorrhagic fever virus (AHFV) are closely related members of the Flavivirus genus and are important causes of human disease in India and the Arabian Peninsula, respectively. Despite high genetic similarity, the viruses have distinctly different host ranges and ecologies. Human cases of KFDV or AHFV develop a spectrum of disease syndromes ranging from liver pathology to neurologic disease. Case reports suggest KFDV is more commonly associated with hepatic and gastrointestinal manifestations whereas AHFV is more commonly associated with neurologic disease. Methodology/Principal Findings: Inoculation of three immunocompetent laboratory mouse strains revealed that KFDV was consistently more lethal than AHFV. In subsequent studies utilizing C57BL/6J mice, we demonstrated that KFDV infection was associated with higher viral loads and significantly higher mortality. KFDV-infected mice rapidly developed more severe disease than AHFV-infected mice, as evidenced by significant abnormalities on clinical chemistry panels and more severe pathology in the brain and gastrointestinal tract. Conclusions/Significance: Infections of C57BL/6J mice with KFDV or AHFV resulted in clinical disease syndromes that closely approximate the diseases seen in human cases. Despite high genetic similarity, there were clear differences in survival, viral kinetics, clinical chemistry data and histology. These results suggest that distinct mouse models for AHFV and KFDV are necessary in order to gain a better understanding of the unique pathogenesis of each virus, as well as to provide platforms for testing promising vaccines and therapeutics.	[Dodd, Kimberly A.; Bird, Brian H.; Jones, Megan E. B.; Nichol, Stuart T.; Spiropoulou, Christina F.] Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA; [Dodd, Kimberly A.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Jones, Megan E. B.] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA	Centers for Disease Control & Prevention - USA; University of California System; University of California Davis; University System of Georgia; University of Georgia	Spiropoulou, CF (corresponding author), Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA.	ccs8@cdc.gov						Adhikari Prabha M R, 1993, Indian J Med Sci, V47, P124; Alzahrani AG, 2010, EMERG INFECT DIS, V16, P1882, DOI 10.3201/eid1612.100417; Carletti F, 2010, EMERG INFECT DIS, V16, P1979, DOI 10.3201/eid1612.101092; Charrel RN, 2007, EMERG INFECT DIS, V13, P153, DOI 10.3201/eid1301.061094; Dodd KA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001352; Holbrook MR, 2005, J INFECT DIS, V191, P100, DOI 10.1086/426397; Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599; Kasabi GS, 2013, EMERG INFECT DIS, V19, P278, DOI 10.3201/eid1902.120544; Kimura T, 2010, VET PATHOL, V47, P806, DOI 10.1177/0300985810372507; Madani TA, 2005, J INFECTION, V51, P91, DOI 10.1016/j.jinf.2004.11.012; Madani TA, 2011, J INFECTION, V62, P67, DOI 10.1016/j.jinf.2010.09.032; Mahdi M, 2011, EMERG INFECT DIS, V17, P945, DOI 10.3201/eid1705.101824; Memish ZA, 2005, BRIT J BIOMED SCI, V62, P37, DOI 10.1080/09674845.2005.11978070; Memish ZA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001604; Memish ZA, 2010, INT J ANTIMICROB AG, V36, pS53, DOI 10.1016/j.ijantimicag.2010.06.022; Munoz-Jordan JL, 2010, VIRUSES-BASEL, V2, P676, DOI 10.3390/v2020676; Pattnaik P, 2006, REV MED VIROL, V16, P151, DOI 10.1002/rmv.495; PAVRI K, 1989, REV INFECT DIS, V11, pS854; Tigabu B, 2010, VIROLOGY, V408, P57, DOI 10.1016/j.virol.2010.08.021; Zaki AM, 1997, T ROY SOC TROP MED H, V91, P179, DOI 10.1016/S0035-9203(97)90215-7; Zivcec M, 2013, PATHOGENS, V2, P402, DOI 10.3390/pathogens2020402	21	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100301	10.1371/journal.pone.0100301	http://dx.doi.org/10.1371/journal.pone.0100301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950196	gold, Green Published, Green Submitted			2022-12-25	WOS:000338276300061
J	May, SL; Zhou, Q; Lewellen, M; Carter, CM; Coffey, D; Highfill, SL; Bucher, CM; Matise, I; Morse, HC; O'Sullivan, MG; Schutten, M; Johnson, C; Bellgrau, D; Blazar, BR; Modiano, JF				May, Sarah L.; Zhou, Qing; Lewellen, Mitzi; Carter, Cristan M.; Coffey, David; Highfill, Steven L.; Bucher, Christoph M.; Matise, Ilze; Morse, Herbert C., III; O'Sullivan, M. Gerard; Schutten, Melissa; Johnson, Charles; Bellgrau, Donald; Blazar, Bruce R.; Modiano, Jaime F.			Nfatc2 and Tob1 Have Non-Overlapping Function in T Cell Negative Regulation and Tumorigenesis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; NUCLEAR FACTOR; CYCLOSPORINE-A; MICE; ACTIVATION; FOXP3; TOLERANCE; NEOPLASMS; PARTNERS; CANCER	Nfatc2 and Tob1 are intrinsic negative regulators of T cell activation. Nfatc2-deficient and Tob1-deficient T cells show reduced thresholds of activation; however, whether these factors have independent or overlapping roles in negative regulation of T cell responses has not been previously examined. Here, we show that Nfatc2 knockout (KO) but not Tob1 KO mice have age-associated accumulation of persistently activated T cells in vivo and expansion of the CD44(+) memory cell compartment and age-associated lymphocytic infiltrates in visceral organs, without significant changes in numbers of CD4(+)CD25(+)Foxp3(+) regulatory T cells (Treg). In vitro, CD4(+)CD25(-) "conventional'' T cells (Tconvs) from both KO strains showed greater proliferation than wild type (WT) Tconvs. However, while Tregs from Nfatc2 KO mice retained normal suppressive function, Tregs from Tob1 KOs had enhanced suppressive activity. Nfatc2 KO Tconvs expanded somewhat more rapidly than WT Tconvs under conditions of homeostatic proliferation, but their accelerated growth capacity was negated, at least acutely, in a lymphoreplete environment. Finally, Nfatc2 KO mice developed a previously uncharacterized increase in B-cell malignancies, which was not accelerated by the absence of Tob1. The data thus support the prevailing hypothesis that Nfatc2 and Tob1 are non-redundant regulators of lymphocyte homeostasis.	[May, Sarah L.; Zhou, Qing; Lewellen, Mitzi; Highfill, Steven L.; Bucher, Christoph M.; Matise, Ilze; O'Sullivan, M. Gerard; Schutten, Melissa; Johnson, Charles; Blazar, Bruce R.; Modiano, Jaime F.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [May, Sarah L.; Lewellen, Mitzi; Modiano, Jaime F.] Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA; [Zhou, Qing; Highfill, Steven L.; Bucher, Christoph M.; Blazar, Bruce R.] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; [Carter, Cristan M.; Coffey, David; Bellgrau, Donald; Modiano, Jaime F.] Univ Colorado, Sch Med, Integrated Dept Immunol, Denver, CO USA; [Carter, Cristan M.; Coffey, David; Bellgrau, Donald; Modiano, Jaime F.] Univ Colorado, Ctr Canc, Aurora, CO USA; [Matise, Ilze; O'Sullivan, M. Gerard; Schutten, Melissa; Johnson, Charles] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Morse, Herbert C., III] NIAID, NIH, Rockville, MD USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Modiano, JF (corresponding author), Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA.	modiano@umn.edu	bucher, christoph/A-2520-2008; MODIANO, JAIME/K-3583-2019; Bucher, Christoph/AAQ-5650-2021	MODIANO, JAIME/0000-0001-6398-7648; Bucher, Christoph/0000-0003-0902-2874; Morse, Herbert/0000-0002-9331-3705; Coffey, David G./0000-0003-3544-8836	National Institute of Diabetes and Digestive and Kidney Diseases [R21DK63410]; National Institutes of Health National Heart Lung and Blood Institute [R01HL56067]; National Institutes of Health National Cancer Institute [R01CA72669, P01CA065493, P30CA077598]; National Institutes of Health National Institute of Allergy and Infectious Diseases [R01AI081918]; National Institutes of Health (Cancer Center Support Grant, Masonic Cancer Center, University of Minnesota, Douglas Yee) Intramural Research Program of the National Institutes of Health; National Institute of Allergy and Infectious Diseases University of Minnesota Animal Cancer Care and Research Program Alvin S. and June Perlman Chair in Animal Oncology at the University of Minnesota; NATIONAL CANCER INSTITUTE [P30CA077598, R01CA072669, P01CA142106, P01CA065493] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118979, R01HL056067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK063410] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (Cancer Center Support Grant, Masonic Cancer Center, University of Minnesota, Douglas Yee) Intramural Research Program of the National Institutes of Health; National Institute of Allergy and Infectious Diseases University of Minnesota Animal Cancer Care and Research Program Alvin S. and June Perlman Chair in Animal Oncology at the University of Minnesota; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	R21DK63410 National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (JFM DB) R01HL56067 National Heart Lung and Blood Institute, National Institutes of Health (BRB) R01CA72669 National Cancer Institute, National Institutes of Health (BRB) R01AI081918 National Institute of Allergy and Infectious Diseases, National Institutes of Health (BRB) P01CA065493 National Cancer Institute, National Institutes of Health (BRB) P30CA077598 National Cancer Institute, National Institutes of Health (Cancer Center Support Grant, Masonic Cancer Center, University of Minnesota, Douglas Yee) Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases (HRM) University of Minnesota Animal Cancer Care and Research Program (JFM) Alvin S. and June Perlman Chair in Animal Oncology at the University of Minnesota (JFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe BT, 2012, CANCER RES, V72, P4642, DOI 10.1158/0008-5472.CAN-11-3775; Baine I, 2009, IMMUNOL REV, V231, P225, DOI 10.1111/j.1600-065X.2009.00817.x; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Bocian K, 2010, NEPHROL DIAL TRANSPL, V25, P710, DOI 10.1093/ndt/gfp586; Bopp T, 2005, J EXP MED, V201, P181, DOI 10.1084/jem.20041538; Davidson WF, 1998, J EXP MED, V187, P1825, DOI 10.1084/jem.187.11.1825; Fehr T, 2010, BLOOD, V115, P1280, DOI 10.1182/blood-2009-07-230680; Fisher SG, 2006, CURR OPIN ONCOL, V18, P417, DOI 10.1097/01.cco.0000239878.31463.0b; Frazer-Abel AA, 2004, J PHARMACOL EXP THER, V311, P758, DOI 10.1124/jpet.104.070060; Gerlach K, 2012, CANCER RES, V72, P4340, DOI 10.1158/0008-5472.CAN-11-4155; Ghosh S, 2010, P NATL ACAD SCI USA, V107, P15169, DOI 10.1073/pnas.1009193107; Hu H, 2007, TRENDS IMMUNOL, V28, P329, DOI 10.1016/j.it.2007.06.006; Jia SJ, 2007, DEV DYNAM, V236, P913, DOI 10.1002/dvdy.21092; Jubala C, 2009, CANCER IMMUNOL IMMUN, V58, P171, DOI 10.1007/s00262-008-0535-0; Karwot R, 2008, J ALLERGY CLIN IMMUN, V121, P992, DOI 10.1016/j.jaci.2007.12.1172; Karwot R, 2012, IMMUNOBIOLOGY, V217, P905, DOI 10.1016/j.imbio.2012.01.004; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Kondo E, 2003, EUR J IMMUNOL, V33, P1, DOI 10.1002/immu.200390000; Lim DG, 2010, TRANSPLANTATION, V89, P928, DOI 10.1097/TP.0b013e3181d3c9d4; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Meloni F, 2006, INT IMMUNOPHARMACOL, V6, P2002, DOI 10.1016/j.intimp.2006.07.019; Miroux C, 2009, TRANSPL P, V41, P3371, DOI 10.1016/j.transproceed.2009.08.043; Miroux C, 2012, TRANSPLANTATION, V94, P123, DOI 10.1097/TP.0b013e3182590d8f; Modiano JF, 2008, IMMUNOL RES, V41, P137, DOI 10.1007/s12026-008-8017-1; Morse HC, 2002, BLOOD, V100, P246, DOI 10.1182/blood.V100.1.246; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Qi CF, 2007, CANCER RES, V67, P2439, DOI 10.1158/0008-5472.CAN-06-1561; Ranger AM, 2000, J EXP MED, V191, P9, DOI 10.1084/jem.191.1.9; Robbs BK, 2008, MOL CELL BIOL, V28, P7168, DOI 10.1128/MCB.00256-08; Schulze-Topphoff U, 2013, J EXP MED, V210, P1301, DOI 10.1084/jem.20121611; Sundrud MS, 2007, CURR OPIN IMMUNOL, V19, P287, DOI 10.1016/j.coi.2007.04.014; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; Vaeth M, 2012, P NATL ACAD SCI USA, V109, P16258, DOI 10.1073/pnas.1203870109; Weigmann B, 2008, J EXP MED, V205, P2099, DOI 10.1084/jem.20072484; Werneck MBF, 2011, CANCER IMMUNOL IMMUN, V60, P537, DOI 10.1007/s00262-010-0964-4; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Xiao X, 2008, J IMMUNOL, V181, P3193, DOI 10.4049/jimmunol.181.5.3193; Yamashiro H, 2002, BIOCHEM BIOPH RES CO, V299, P148, DOI 10.1016/S0006-291X(02)02586-X; Yang J, 2007, P NATL ACAD SCI USA, V104, P19954, DOI 10.1073/pnas.0704397104; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7; Zeiser R, 2006, BLOOD, V108, P390, DOI 10.1182/blood-2006-01-0329; Zhang JQ, 2004, J EXP MED, V200, P1467, DOI 10.1084/jem.20041575	44	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100629	10.1371/journal.pone.0100629	http://dx.doi.org/10.1371/journal.pone.0100629			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945807	Green Published, gold, Green Submitted			2022-12-25	WOS:000340721500099
J	Stawikowski, MJ; Aukszi, B; Stawikowska, R; Cudic, M; Fields, GB				Stawikowski, Maciej J.; Aukszi, Beatrix; Stawikowska, Roma; Cudic, Mare; Fields, Gregg B.			Glycosylation Modulates Melanoma Cell alpha 2 beta 1 and alpha 3 beta 1 Integrin Interactions with Type IV Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE COLLAGEN; AMINO-ACID-SEQUENCE; REPEATING TRIPEPTIDE PATTERN; LYSYL HYDROXYLASE 3; CRYSTAL-STRUCTURE; LIGAND-BINDING; ALPHA(3)BETA(1) INTEGRIN; LYSYL-HYDROXYLASE-3 LH3; ALPHA-1-BETA-1 INTEGRIN; MOLECULAR ARCHITECTURE	Although type IV collagen is heavily glycosylated, the influence of this post-translational modification on integrin binding has not been investigated. In the present study, galactosylated and nongalactosylated triple-helical peptides have been constructed containing the alpha 1(IV)382-393 and alpha 1(IV)531-543 sequences, which are binding sites for the alpha 2 beta 1 and alpha 3 beta 1 integrins, respectively. All peptides had triple-helical stabilities of 37 degrees C or greater. The galactosylation of Hyl(393) in alpha 1(IV)382-393 and Hyl(540) and Hyl(543) in alpha 1(IV) 531-543 had a dose-dependent influence on melanoma cell adhesion that was much more pronounced in the case of alpha 3 beta 1 integrin binding. Molecular modeling indicated that galactosylation occurred on the periphery of alpha 2 beta 1 integrin interaction with alpha 1(IV)382-393 but right in the middle of alpha 3 beta 1 integrin interaction with alpha 1(IV)531-543. The possibility of extracellular deglycosylation of type IV collagen was investigated, but no beta-galactosidase-like activity capable of collagen modification was found. Thus, glycosylation of collagen can modulate integrin binding, and levels of glycosylation could be altered by reduction in expression of glycosylation enzymes but most likely not by extracellular deglycosylation activity.	[Stawikowski, Maciej J.; Stawikowska, Roma; Cudic, Mare; Fields, Gregg B.] Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA; [Aukszi, Beatrix] Nova SE Univ, Ft Lauderdale, FL 33314 USA	Torrey Pines Institute for Molecular Studies, Florida; Nova Southeastern University	Fields, GB (corresponding author), Torrey Pines Inst Mol Studies, 11350 SW Village Pkwy, Port St Lucie, FL 34987 USA.	gfields@tpims.org	Stawikowski, Maciej J./AAH-5790-2021	Stawikowski, Maciej J./0000-0002-6394-459X	National Institutes of Health [CA77402]; NATIONAL CANCER INSTITUTE [R01CA077402] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA77402 (to G. B. F.).	Allen BL, 2002, MICROB PATHOGENESIS, V32, P191, DOI 10.1006/mpat.2002.0496; ANBAZHAGAN R, 1995, J PATHOL, V176, P227, DOI 10.1002/path.1711760304; Andersson IE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017881; BABEL W, 1984, EUR J BIOCHEM, V143, P545, DOI 10.1111/j.1432-1033.1984.tb08404.x; BABIARZ B, 1992, EXP CELL RES, V203, P276, DOI 10.1016/0014-4827(92)90065-G; Bao XF, 2009, P NATL ACAD SCI USA, V106, P12109, DOI 10.1073/pnas.0904515106; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Baronas-Lowell D, 2004, J BIOL CHEM, V279, P43503, DOI 10.1074/jbc.M405979200; Barth L, 2009, ADV EXP MED BIOL, V611, P295, DOI 10.1007/978-0-387-73657-0_132; Cairns RA, 2003, CURR MOL MED, V3, P659, DOI 10.2174/1566524033479447; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DENNIS J, 1982, NATURE, V300, P274, DOI 10.1038/300274a0; Dent WH, 2002, ORG LETT, V4, P1249, DOI 10.1021/ol017241b; Des Parkin J, 2011, HUM MUTAT, V32, P127, DOI 10.1002/humu.21401; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; EBLE JA, 1993, EMBO J, V12, P4795, DOI 10.1002/j.1460-2075.1993.tb06168.x; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; FIDLER IJ, 1990, CANCER RES, V50, P6130; Fields GB, 1998, BIOPOLYMERS, V47, P143, DOI 10.1002/(SICI)1097-0282(1998)47:2<143::AID-BIP3>3.0.CO;2-U; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Golbik R, 2000, J MOL BIOL, V297, P501, DOI 10.1006/jmbi.2000.3575; Gullberg DE, 2002, PROG HISTOCHEM CYTO, V37, P9; Haass NK, 2005, PIGM CELL RES, V18, P150, DOI 10.1111/j.1600-0749.2005.00235.x; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Heikkinen J, 2000, J BIOL CHEM, V275, P36158, DOI 10.1074/jbc.M006203200; Hoekstra HJ, 2008, INT J HYPERTHER, V24, P227, DOI 10.1080/02656730701816402; Holm B, 2000, TETRAHEDRON, V56, P1579, DOI 10.1016/S0040-4020(00)00061-2; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Humphries MJ, 2001, SCIENCE, V294, P316, DOI 10.1126/science.1066240; Hwang ES, 2010, PROTEIN SCI, V19, P1053, DOI 10.1002/pro.383; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; KERN A, 1993, EUR J BIOCHEM, V215, P151, DOI 10.1111/j.1432-1033.1993.tb18017.x; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Kuhn K, 1994, Trends Cell Biol, V4, P256, DOI 10.1016/0962-8924(94)90124-4; LAFERTE S, 1988, CANCER RES, V48, P4743; Lauer JL, 1998, BIOCHEMISTRY-US, V37, P5279, DOI 10.1021/bi972958l; Lauer-Fields JL, 2003, J BIOL CHEM, V278, P14321, DOI 10.1074/jbc.M212246200; Lee MM, 2014, J BIOL CHEM, V289, P8742, DOI 10.1074/jbc.C113.546713; Li YJ, 2007, J BIOL CHEM, V282, P22699, DOI 10.1074/jbc.M702910200; Liddington RC, 2002, J CELL BIOL, V158, P833, DOI 10.1083/jcb.200206011; Lin ECK, 1997, J BIOL CHEM, V272, P14236, DOI 10.1074/jbc.272.22.14236; Lin ECK, 1997, J BIOL CHEM, V272, P23912, DOI 10.1074/jbc.272.38.23912; LONG CG, 1995, BIOPOLYMERS, V35, P621, DOI 10.1002/bip.360350608; Madsen DH, 2011, J BIOL CHEM, V286, P26996, DOI 10.1074/jbc.M110.208033; MARSHALL JF, 1991, INT J CANCER, V49, P924, DOI 10.1002/ijc.2910490621; MELCHIORI A, 1995, EXP CELL RES, V219, P233, DOI 10.1006/excr.1995.1223; MILES AJ, 1994, J BIOL CHEM, V269, P30939; MILES AJ, 1995, J BIOL CHEM, V270, P29047, DOI 10.1074/jbc.270.49.29047; Mohs A, 2006, J BIOL CHEM, V281, P17197, DOI 10.1074/jbc.M601763200; Myllyla R, 2007, J CELL PHYSIOL, V212, P323, DOI 10.1002/jcp.21036; Nagae M, 2012, J CELL BIOL, V197, P131, DOI 10.1083/jcb.201111077; NAYAK BR, 1991, J BIOL CHEM, V266, P13978; PATTI JM, 1993, BIOCHEMISTRY-US, V32, P11428, DOI 10.1021/bi00093a021; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Privitera S, 1998, J BIOL CHEM, V273, P6319, DOI 10.1074/jbc.273.11.6319; PuzonMcLaughlin W, 1996, J BIOL CHEM, V271, P20438, DOI 10.1074/jbc.271.34.20438; Rautavuoma K, 2002, J BIOL CHEM, V277, P23084, DOI 10.1074/jbc.M112077200; Renner C, 2004, BIOPOLYMERS, V76, P34, DOI 10.1002/bip.10569; Ruoslahti E., 1991, CELL BIOL EXTRACELLU, P343; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Sacca B, 2002, CHEMBIOCHEM, V3, P904, DOI 10.1002/1439-7633(20020902)3:9<904::AID-CBIC904>3.0.CO;2-I; Salo AM, 2006, J CELL PHYSIOL, V207, P644, DOI 10.1002/jcp.20596; Schegg B, 2009, MOL CELL BIOL, V29, P943, DOI 10.1128/MCB.02085-07; Schwartz MA, 2001, TRENDS CELL BIOL, V11, P466, DOI 10.1016/S0962-8924(01)02152-3; SEYER JM, 1989, EUR J BIOCHEM, V181, P159, DOI 10.1111/j.1432-1033.1989.tb14707.x; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; SPIRO MJ, 1971, J BIOL CHEM, V246, P4910; SPIRO RG, 1967, J BIOL CHEM, V242, P4813; SPIRO RG, 1969, J BIOL CHEM, V244, P602; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; Sricholpech M, 2012, J BIOL CHEM, V287, P22998, DOI 10.1074/jbc.M112.343954; Sricholpech M, 2011, J BIOL CHEM, V286, P8846, DOI 10.1074/jbc.M110.178509; STERNBERG M, 1979, J BIOL CHEM, V254, P329; Syed BM, 2004, TETRAHEDRON, V60, P5571, DOI 10.1016/j.tet.2004.04.081; Taga Y, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010397; TAKADA Y, 1988, J CELL BIOCHEM, V37, P385, DOI 10.1002/jcb.240370406; TENCHINI ML, 1993, CELL ADHES COMMUN, V1, P55, DOI 10.3109/15419069309095681; Thiagranjan G, 2008, J MOL BIOL, V376, P736, DOI 10.1016/j.jmb.2007.11.075; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; URUSHIZAKI Y, 1985, P NATL ACAD SCI USA, V82, P3091, DOI 10.1073/pnas.82.10.3091; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; VANDENBERG P, 1991, J CELL BIOL, V113, P1475, DOI 10.1083/jcb.113.6.1475; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Wang CG, 2002, MATRIX BIOL, V21, P559, DOI 10.1016/S0945-053X(02)00071-9; Wang CG, 2009, J CELL MOL MED, V13, P508, DOI 10.1111/j.1582-4934.2008.00286.x; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yegorova S, 2013, ANAL BIOCHEM, V439, P123, DOI 10.1016/j.ab.2013.04.028; Yongye AB, 2012, BIOCHEMISTRY-US, V51, P7278, DOI 10.1021/bi300761s; YOSHINAGA IG, 1993, MELANOMA RES, V3, P435, DOI 10.1097/00008390-199311000-00006; Yu YC, 1998, J AM CHEM SOC, V120, P9979, DOI 10.1021/ja981654z; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678; Zimina EP, 2007, J BIOL CHEM, V282, P22737, DOI 10.1074/jbc.M701937200; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	102	24	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21591	21604		10.1074/jbc.M114.572073	http://dx.doi.org/10.1074/jbc.M114.572073			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24958723	hybrid, Green Published			2022-12-25	WOS:000340558300034
J	Wang, S; Linde, MH; Munde, M; Carvalho, VD; Wilson, WD; Poon, GMK				Wang, Shuo; Linde, Miles H.; Munde, Manoj; Carvalho, Victor D.; Wilson, W. David; Poon, Gregory M. K.			Mechanistic Heterogeneity in Site Recognition by the Structurally Homologous DNA-binding Domains of the ETS Family Transcription Factors Ets-1 and PU.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; OSMOTIC-STRESS; MURINE ETS-1; IN-VIVO; SEQUENCE DISCRIMINATION; SELF-ASSOCIATION; PROTEIN; MACROPHAGES; COMPLEX; AUTOINHIBITION	ETS family transcription factors regulate diverse genes through binding at cognate DNA sites that overlap substantially in sequence. The DNA-binding domains of ETS proteins (ETS domains) are highly conserved structurally yet share limited amino acid homology. To define the mechanistic implications of sequence diversity within the ETS family, we characterized the thermodynamics and kinetics of DNA site recognition by the ETS domains of Ets-1 and PU.1, which represent the extremes in amino acid divergence among ETS proteins. Even though the two ETS domains bind their optimal sites with similar affinities under physiologic conditions, their nature of site recognition differs strikingly in terms of the role of hydration and counter ion release. The data suggest two distinct mechanisms where in Ets-1 follows a "dry" mechanism that rapidly parses sites through electrostatic interactions and direct protein-DNA contacts, whereas PU. 1 utilizes hydration to interrogate sequence-specific sites and form a long-lived complex relative to the Ets-1 counterpart. The kinetic persistence of the high affinity PU.1.DNA complex may be relevant to an emerging role of PU.1, but not Ets-1, as a pioneer transcription factor in vivo. In addition, PU.1 activity is critical to the development and function of macrophages and lymphocytes, which present osmotically variable environments, and hydration-dependent specificity may represent an important regulatory mechanism in vivo, a hypothesis that finds support in gene expression profiles of primary murine macrophages.	[Wang, Shuo; Munde, Manoj; Wilson, W. David] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Linde, Miles H.; Carvalho, Victor D.; Poon, Gregory M. K.] Washington State Univ, Dept Pharmaceut Sci, Spokane, WA 99210 USA	University System of Georgia; Georgia State University; Washington State University	Wilson, WD (corresponding author), Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA.	wdw@gsu.edu; gpoon@wsu.edu		Linde, Miles/0000-0003-2553-2890; Wilson, W David/0000-0001-5225-5089	National Institutes of Health [AI064200]; National Science Foundation [MCB 1411502]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI064200 (to W. D. W.). This work was also supported by National Science Foundation Grant MCB 1411502 (to G. M. K. P.).	Anderson KL, 1998, BLOOD, V91, P3702, DOI 10.1182/blood.V91.10.3702; Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598; Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; Buxade M, 2012, J EXP MED, V209, P379, DOI 10.1084/jem.20111569; Cheung Chris Yk, 2013, J Mol Signal, V8, P5, DOI 10.1186/1750-2187-8-5; Clark JP, 2009, NAT REV UROL, V6, P429, DOI 10.1038/nrurol.2009.127; Courtenay ES, 2000, BIOCHEMISTRY-US, V39, P4455, DOI 10.1021/bi992887l; Dahl SC, 2001, AM J PHYSIOL-CELL PH, V280, pC248, DOI 10.1152/ajpcell.2001.280.2.C248; De S., 2013, J MOL BIOL, V426, P1390; DEGNAN BM, 1993, NUCLEIC ACIDS RES, V21, P3479, DOI 10.1093/nar/21.15.3479; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Donaldson LW, 1996, EMBO J, V15, P125, DOI 10.1002/j.1460-2075.1996.tb00340.x; EISENBEIS CF, 1993, MOL CELL BIOL, V13, P6452, DOI 10.1128/MCB.13.10.6452; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P16800, DOI 10.1073/pnas.222659799; Ferraris JD, 2007, METHOD ENZYMOL, V428, P279, DOI 10.1016/S0076-6879(07)28016-4; Forties RA, 2011, NUCLEIC ACIDS RES, V39, P8306, DOI 10.1093/nar/gkr422; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Gold ES, 2012, J EXP MED, V209, P807, DOI 10.1084/jem.20111202; Graves BJ, 1998, COLD SPRING HARB SYM, V63, P621, DOI 10.1101/sqb.1998.63.621; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Green SM, 2010, J BIOL CHEM, V285, P18496, DOI 10.1074/jbc.M109.096958; HA JH, 1992, J MOL BIOL, V228, P252, DOI 10.1016/0022-2836(92)90504-D; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Holbrook JA, 2001, J MOL BIOL, V310, P379, DOI 10.1006/jmbi.2001.4768; Irarrazabal CE, 2004, P NATL ACAD SCI USA, V101, P8809, DOI 10.1073/pnas.0403062101; Jia X, 1999, J MOL BIOL, V292, P1083, DOI 10.1006/jmbi.1999.3123; Jonsen MD, 1996, MOL CELL BIOL, V16, P2065; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; Kopp JL, 2004, J BIOL CHEM, V279, P19407, DOI 10.1074/jbc.M314115200; Lacaze P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-372; Lee GM, 2005, J BIOL CHEM, V280, P7088, DOI 10.1074/jbc.M410722200; Lee SD, 2002, BIOCHEM BIOPH RES CO, V294, P968, DOI 10.1016/S0006-291X(02)00572-7; Maallem S, 2008, J NEUROCHEM, V105, P1198, DOI 10.1111/j.1471-4159.2008.05222.x; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Mo Y, 1998, MOL CELL, V2, P201, DOI 10.1016/S1097-2765(00)80130-6; Mo Y, 2000, NAT STRUCT BIOL, V7, P292; Mosca R, 2008, NUCLEIC ACIDS RES, V36, pW42, DOI 10.1093/nar/gkn197; Munde M, 2014, NUCLEIC ACIDS RES, V42, P1379, DOI 10.1093/nar/gkt955; Munde M, 2013, J MOL BIOL, V425, P1655, DOI 10.1016/j.jmb.2013.02.010; North JA, 2012, NUCLEIC ACIDS RES, V40, P10215, DOI 10.1093/nar/gks747; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; O'Neill WC, 1999, AM J PHYSIOL-CELL PH, V276, pC995, DOI 10.1152/ajpcell.1999.276.5.C995; Parsegian VA, 1995, METHOD ENZYMOL, V259, P43; PETERSEN JM, 1995, SCIENCE, V269, P1866, DOI 10.1126/science.7569926; Poon GMK, 2004, J MOL BIOL, V335, P113, DOI 10.1016/j.jmb.2003.09.046; Poon GMK, 2003, J MOL BIOL, V328, P805, DOI 10.1016/S0022-2836(03)00362-0; Poon GMK, 2002, BIOCHEMISTRY-US, V41, P2361, DOI 10.1021/bi015572q; Poon GMK, 2011, THERMODYNAMICS - INTERACTION STUDIES - SOLIDS, LIQUIDS AND GASES, P871; Poon GMK, 2012, J BIOL CHEM, V287, P18297, DOI 10.1074/jbc.M112.342345; Poon GMK, 2012, BIOCHEMISTRY-US, V51, P4096, DOI 10.1021/bi300331v; Poon GMK, 2010, ANAL BIOCHEM, V400, P229, DOI 10.1016/j.ab.2010.01.025; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Ross IL, 1998, J BIOL CHEM, V273, P6662, DOI 10.1074/jbc.273.12.6662; Sharp KA, 1997, J PHYS CHEM B, V101, P4343, DOI 10.1021/jp9702457; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Skalicky JJ, 1996, PROTEIN SCI, V5, P296; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Szymczyna BR, 2000, J BIOL CHEM, V275, P28363, DOI 10.1074/jbc.M004294200; Tataurov AV, 2008, BIOPHYS CHEM, V133, P66, DOI 10.1016/j.bpc.2007.12.004; Pham TH, 2013, NUCLEIC ACIDS RES, V41, P6391, DOI 10.1093/nar/gkt355; Pham TH, 2012, BLOOD, V119, pE161, DOI 10.1182/blood-2012-01-402453; Timasheff SN, 2002, P NATL ACAD SCI USA, V99, P9721, DOI 10.1073/pnas.122225399; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Weigelt K, 2009, BIOCHEM BIOPH RES CO, V380, P308, DOI 10.1016/j.bbrc.2009.01.067; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	68	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21605	21616		10.1074/jbc.M114.575340	http://dx.doi.org/10.1074/jbc.M114.575340			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24952944	Green Published, hybrid			2022-12-25	WOS:000340558300035
J	Damiano, M; Gautier, CA; Bulteau, AL; Ferrando-Miguel, R; Gouarne, C; Paoli, MG; Pruss, R; Auchere, F; L'Hermitte-Stead, C; Bouillaud, F; Brice, A; Corti, O; Lombes, A				Damiano, Maria; Gautier, Clement A.; Bulteau, Anne-Laure; Ferrando-Miguel, Rosa; Gouarne, Caroline; Paoli, Marc Giraudon; Pruss, Rebecca; Auchere, Francoise; L'Hermitte-Stead, Caroline; Bouillaud, Frederic; Brice, Alexis; Corti, Olga; Lombes, Anne			Tissue- and Cell-Specific Mitochondrial Defect in Parkin-Deficient Mice	PLOS ONE			English	Article							COMPLEX I DEFICIENCY; OXIDATIVE STRESS; ENERGY-METABOLISM; SYNAPTIC FUNCTION; YEAST MODEL; MOUSE MODEL; DISEASE; PINK1; DYSFUNCTION; MUTATIONS	Loss of Parkin, encoded by PARK2 gene, is a major cause of autosomal recessive Parkinson's disease. In Drosophila and mammalian cell models Parkin has been shown in to play a role in various processes essential to maintenance of mitochondrial quality, including mitochondrial dynamics, biogenesis and degradation. However, the relevance of altered mitochondrial quality control mechanisms to neuronal survival in vivo is still under debate. We addressed this issue in the brain of PARK2(-/-) mice using an integrated mitochondrial evaluation, including analysis of respiration by polarography or by fluorescence, respiratory complexes activity by spectrophotometric assays, mitochondrial membrane potential by rhodamine 123 fluorescence, mitochondrial DNA content by real time PCR, and oxidative stress by total glutathione measurement, proteasome activity, SOD2 expression and proteins oxidative damage. Respiration rates were lowered in PARK2(-/-) brain with high resolution but not standard respirometry. This defect was specific to the striatum, where it was prominent in neurons but less severe in astrocytes. It was present in primary embryonic cells and did not worsen in vivo from 9 to 24 months of age. It was not associated with any respiratory complex defect, including complex I. Mitochondrial inner membrane potential in PARK2(-/-) mice was similar to that of wild-type mice but showed increased sensitivity to uncoupling with ageing in striatum. The presence of oxidative stress was suggested in the striatum by increased mitochondrial glutathione content and oxidative adducts but normal proteasome activity showed efficient compensation. SOD2 expression was increased only in the striatum of PARK2(-/-) mice at 24 months of age. Altogether our results show a tissue-specific mitochondrial defect, present early in life of PARK2(-/-) mice, mildly affecting respiration, without prominent impact on mitochondrial membrane potential, whose underlying mechanisms remain to be elucidated, as complex I defect and prominent oxidative damage were ruled out.	[Damiano, Maria; Gautier, Clement A.; Ferrando-Miguel, Rosa; Brice, Alexis; Corti, Olga] Hop La Pitie Salpetriere, CRICM, INSERM, U975, Paris, France; [Damiano, Maria; Gautier, Clement A.; Ferrando-Miguel, Rosa; Brice, Alexis; Corti, Olga] Univ Paris 06, UMR S975, Paris, France; [Damiano, Maria; Gautier, Clement A.; Ferrando-Miguel, Rosa; Brice, Alexis; Corti, Olga] CNRS, UMR 7225, Paris, France; [Bulteau, Anne-Laure; L'Hermitte-Stead, Caroline; Bouillaud, Frederic; Lombes, Anne] Inst Cochin, Inserm U1016, Paris, France; [Bulteau, Anne-Laure; L'Hermitte-Stead, Caroline; Bouillaud, Frederic; Lombes, Anne] CNRS, UMR 8104, Paris, France; [Bulteau, Anne-Laure; L'Hermitte-Stead, Caroline; Bouillaud, Frederic; Lombes, Anne] Univ Paris 05, UMR S1016, Paris, France; [Gouarne, Caroline; Paoli, Marc Giraudon; Pruss, Rebecca] Trophos SA, Marseille, France; [Auchere, Francoise] Univ Paris Diderot CNRS, Inst Jacques Monod, Dept Pathol Mol & Cellulaire, Lab Mitochondries Met & Stress Oxydatif, Paris, France; [Brice, Alexis] Hop La Pitie Salpetriere, AP HP, Dept Genet & Cytogenet, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Lombes, A (corresponding author), Inst Cochin, Inserm U1016, Paris, France.	anne.lombes@inserm.fr	Bouillaud, Frédéric R/L-3238-2017; Corti, Olga/AAC-3160-2019; Lombes, Anne/G-4684-2014; Brice, Alexis/A-2170-2009; Corti, Olga/I-4981-2016; bulteau, anne-laure/AAN-4004-2020; brice, alexis/AAE-8275-2019	Bouillaud, Frédéric R/0000-0002-7518-9237; Lombes, Anne/0000-0002-9064-0399; Corti, Olga/0000-0003-2093-7389; brice, alexis/0000-0002-0941-3990	Institut national de la sante et de la recherche medicale; Association France Parkinson; Fondation de France; Agence Nationale de la Recherche; MEFOPA - EU 7th Framework Programme [HEALTH-2009-241791]; Fondation ICM, "Investissements d'avenir'' [ANR-10-IAIHU-06]; Fondation pour la Recherche Medicale	Institut national de la sante et de la recherche medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association France Parkinson; Fondation de France(Fondation de France); Agence Nationale de la Recherche(French National Research Agency (ANR)); MEFOPA - EU 7th Framework Programme; Fondation ICM, "Investissements d'avenir''(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by Institut national de la sante et de la recherche medicale, Association France Parkinson, Fondation de France, Agence Nationale de la Recherche, MEFOPA (funded by the EU 7th Framework Programme, Grant Agreement HEALTH-2009-241791), Fondation ICM, "Investissements d'avenir'' ANR-10-IAIHU-06. CG was supported by a fellowship from the Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auchere F, 2008, HUM MOL GENET, V17, P2790, DOI 10.1093/hmg/ddn178; Bulteau AL, 2007, FREE RADICAL BIO MED, V42, P1561, DOI 10.1016/j.freeradbiomed.2007.02.014; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Cardoso SM, 2011, CURR PHARM DESIGN, V17, P3390; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chinopoulos C, 2011, METHODS MOL BIOL, V793, P311, DOI 10.1007/978-1-61779-328-8_20; Corti O, 2013, CURR OPIN NEUROBIOL, V23, P100, DOI 10.1016/j.conb.2012.11.002; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Couplan E, 2002, J BIOL CHEM, V277, P43079, DOI 10.1074/jbc.M206726200; Dagda RK, 2011, CELL DEATH DIFFER, V18, P1914, DOI 10.1038/cdd.2011.74; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108; Fournier M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006629; FRIEDMAN WJ, 1993, EXP NEUROL, V119, P72, DOI 10.1006/exnr.1993.1007; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Geisler S, 2010, AUTOPHAGY, V6, P871, DOI 10.4161/auto.6.7.13286; Gimenez-Cassina A, 2012, NEURON, V74, P719, DOI 10.1016/j.neuron.2012.03.032; Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Grunewald A, 2009, EXP NEUROL, V219, P266, DOI 10.1016/j.expneurol.2009.05.027; Grunewald A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012962; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; Hauser DN, 2013, NEUROBIOL DIS, V51, P35, DOI 10.1016/j.nbd.2012.10.011; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Kubli Dieter A, 2013, Commun Integr Biol, V6, pe24511, DOI 10.4161/cib.24511; Kubli DA, 2013, J BIOL CHEM, V288, P915, DOI 10.1074/jbc.M112.411363; Larsen NJ, 2011, NEUROSCIENCE, V196, P251, DOI 10.1016/j.neuroscience.2011.08.016; Liu S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002537; MacMillan-Crow LA, 2001, FREE RADICAL RES, V34, P325, DOI 10.1080/10715760100300281; Magistretti PJ, 1996, ANN NY ACAD SCI, V777, P380, DOI 10.1111/j.1749-6632.1996.tb34449.x; Mann VM, 1992, BRAIN, V115; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001; Moisoi N, 2014, NEUROPHARMACOLOGY, V77, P350, DOI 10.1016/j.neuropharm.2013.10.009; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; MORGANTI MC, 1990, EXP NEUROL, V109, P98, DOI 10.1016/S0014-4886(05)80012-3; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; Muftuoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695; Narendra D, 2012, COLD SPRING HARB PER, V4; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Pacelli C, 2011, BBA-MOL BASIS DIS, V1812, P1041, DOI 10.1016/j.bbadis.2010.12.022; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102; Periquet M, 2005, J NEUROCHEM, V95, P1259, DOI 10.1111/j.1471-4159.2005.03442.x; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Schagger H, 2001, J BIOL CHEM, V276, P37861; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108; Stichel CC, 2007, HUM MOL GENET, V16, P2377, DOI 10.1093/hmg/ddm083; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Van Laar VS, 2011, HUM MOL GENET, V20, P927, DOI 10.1093/hmg/ddq531; Viengchareun S, 2007, ANTIVIR THER, V12, P919; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; von Coelln R, 2004, P NATL ACAD SCI USA, V101, P10744, DOI 10.1073/pnas.0401297101; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zhang C, 2011, P NATL ACAD SCI USA, V108, P16259, DOI 10.1073/pnas.1113884108	64	32	33	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99898	10.1371/journal.pone.0099898	http://dx.doi.org/10.1371/journal.pone.0099898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959870	Green Submitted, Green Published, gold			2022-12-25	WOS:000338633900017
J	Garcia-Arevalo, M; Alonso-Magdalena, P; Dos Santos, JR; Quesada, I; Carneiro, EM; Nadal, A				Garcia-Arevalo, Marta; Alonso-Magdalena, Paloma; Rebelo Dos Santos, Junia; Quesada, Ivan; Carneiro, Everardo M.; Nadal, Angel			Exposure to Bisphenol-A during Pregnancy Partially Mimics the Effects of a High-Fat Diet Altering Glucose Homeostasis and Gene Expression in Adult Male Mice	PLOS ONE			English	Article							PERINATAL EXPOSURE; ENDOCRINE DISRUPTORS; BODY-WEIGHT; MOLECULAR-MECHANISMS; INSULIN-RESISTANCE; METABOLIC SYNDROME; HEPATIC STEATOSIS; RECEPTOR-ALPHA; FOOD-INTAKE; OBESITY	Bisphenol-A (BPA) is one of the most widespread EDCs used as a base compound in the manufacture of polycarbonate plastics. The aim of our research has been to study how the exposure to BPA during pregnancy affects weight, glucose homeostasis, pancreatic beta-cell function and gene expression in the major peripheral organs that control energy flux: white adipose tissue (WAT), the liver and skeletal muscle, in male offspring 17 and 28 weeks old. Pregnant mice were treated with a subcutaneous injection of 10 mu g/kg/day of BPA or a vehicle from day 9 to 16 of pregnancy. One month old offspring were divided into four different groups: vehicle treated mice that ate a normal chow diet (Control group); BPA treated mice that also ate a normal chow diet (BPA); vehicle treated animals that had a high fat diet (HFD) and BPA treated animals that were fed HFD (HFD-BPA). The BPA group started to gain weight at 18 weeks old and caught up to the HFD group before week 28. The BPA group as well as the HFD and HFD-BPA ones presented fasting hyperglycemia, glucose intolerance and high levels of non-esterified fatty acids (NEFA) in plasma compared with the Control one. Glucose stimulated insulin release was disrupted, particularly in the HFD-BPA group. In WAT, the mRNA expression of the genes involved in fatty acid metabolism, Srebpc1, Ppar alpha and Cpt1 beta was decreased by BPA to the same extent as with the HFD treatment. BPA treatment upregulated Pparc and Prkaa1 genes in the liver; yet it diminished the expression of Cd36. Hepatic triglyceride levels were increased in all groups compared to control. In conclusion, male offspring from BPA-treated mothers presented symptoms of diabesity. This term refers to a form of diabetes which typically develops in later life and is associated with obesity.	[Garcia-Arevalo, Marta; Rebelo Dos Santos, Junia; Quesada, Ivan; Nadal, Angel] Univ Miguel Hernandez Elche, Inst Bioingn, Elche, Spain; [Alonso-Magdalena, Paloma; Quesada, Ivan] Univ Miguel Hernandez Elche, Dept Biol Aplicada, Elche, Spain; [Garcia-Arevalo, Marta; Alonso-Magdalena, Paloma; Quesada, Ivan; Nadal, Angel] Univ Miguel Hernandez Elche, CIBERDEM, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Elche, Spain; [Rebelo Dos Santos, Junia; Carneiro, Everardo M.] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Biol Estruct & Func, Campinas, SP, Brazil	Universidad Miguel Hernandez de Elche; Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universidad Miguel Hernandez de Elche; Universidade de Sao Paulo; Universidade Estadual de Campinas	Nadal, A (corresponding author), Univ Miguel Hernandez Elche, Inst Bioingn, Elche, Spain.	nadal@umh.es	García-Arévalo, Marta/C-9440-2014; Ivan, Quesada/P-6541-2014; Carneiro, Everardo/D-4758-2012; Alonso-Magdalena, Paloma/AAH-2076-2021; Silva, Junia C Santos/E-5052-2015; Nadal, Angel/G-6721-2014	Ivan, Quesada/0000-0002-9808-514X; Silva, Junia C Santos/0000-0002-8667-8140; Nadal, Angel/0000-0003-4178-2152; ALONSO MAGDALENA, PALOMA/0000-0003-1065-5388; Garcia-Arevalo Provencio, Marta/0000-0001-7238-9498	Ministerio de Economia y Competitividad [BFU2011-28358, BFU2010-21773]; Generalitat Valenciana [Prometeo/2011/080, ACOMP/2010/113]	Ministerio de Economia y Competitividad(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This research was supported by grants from Ministerio de Economia y Competitividad grants, BFU2011-28358 and BFU2010-21773, and Generalitat Valenciana grants Prometeo/2011/080 and ACOMP/2010/113. The "Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas'' is an initiative of the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Alonso-Magdalena P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002069; Alonso-Magdalena P, 2012, MOL CELL ENDOCRINOL, V355, P201, DOI 10.1016/j.mce.2011.12.012; Alonso-Magdalena P, 2011, NAT REV ENDOCRINOL, V7, P346, DOI 10.1038/nrendo.2011.56; Alonso-Magdalena P, 2010, ENVIRON HEALTH PERSP, V118, P1243, DOI 10.1289/ehp.1001993; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Angle BM, 2013, REPROD TOXICOL, V42, P256, DOI 10.1016/j.reprotox.2013.07.017; Batista TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033814; Boslem E, 2013, J BIOL CHEM, V288, P26569, DOI 10.1074/jbc.M113.489310; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bryzgalova G, 2008, AM J PHYSIOL-ENDOC M, V295, pE904, DOI 10.1152/ajpendo.90248.2008; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Casals-Casas C, 2011, ANNU REV PHYSIOL, V73, P135, DOI 10.1146/annurev-physiol-012110-142200; Chamorro-Garcia R, 2013, ENVIRON HEALTH PERSP, V121, P359, DOI 10.1289/ehp.1205701; Collins SC, 2010, DIABETES, V59, P1192, DOI 10.2337/db09-0791; Fradin D, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/647514; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Goudriaan JR, 2003, J LIPID RES, V44, P2270, DOI 10.1194/jlr.M300143-JLR200; Grasselli E, 2013, CHEMOSPHERE, V91, P1123, DOI 10.1016/j.chemosphere.2013.01.016; Guerre-Millo M, 2001, DIABETES, V50, P2809, DOI 10.2337/diabetes.50.12.2809; Hajszan T, 2010, FRONT NEUROENDOCRIN, V31, P519, DOI 10.1016/j.yfrne.2010.06.004; Hectors TLM, 2011, DIABETOLOGIA, V54, P1273, DOI 10.1007/s00125-011-2109-5; Howdeshell KL, 1999, NATURE, V401, P763, DOI 10.1038/44517; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Lakind JS, 2008, J EXPO SCI ENV EPID, V18, P608, DOI 10.1038/jes.2008.20; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Li X, 2012, ENVIRON HEALTH PERSP, V120, P1720, DOI 10.1289/ehp.1205383; Lin Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.206; Liu JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064143; MacKay H, 2013, ENDOCRINOLOGY, V154, P1465, DOI 10.1210/en.2012-2044; Maffini MV, 2006, MOL CELL ENDOCRINOL, V254, P179, DOI 10.1016/j.mce.2006.04.033; Marchetti P, 2013, ADV EXP MED BIOL, V771, P288; Marmugi A, 2012, HEPATOLOGY, V55, P395, DOI 10.1002/hep.24685; Marroqui L, 2011, DIABETOLOGIA, V54, P843, DOI 10.1007/s00125-010-2024-1; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Nadal A, 2000, P NATL ACAD SCI USA, V97, P11603, DOI 10.1073/pnas.97.21.11603; Nadal A, 2013, NAT REV ENDOCRINOL, V9, P9, DOI 10.1038/nrendo.2012.205; Nadal A, 2009, MOL CELL ENDOCRINOL, V304, P63, DOI 10.1016/j.mce.2009.02.016; Neel BA, 2011, DIABETES, V60, P1838, DOI 10.2337/db11-0153; Newbold Retha R, 2008, Fertil Steril, V89, pe55, DOI 10.1016/j.fertnstert.2008.01.062; Newbold RR, 2009, MOL CELL ENDOCRINOL, V304, P84, DOI 10.1016/j.mce.2009.02.024; Quesada I, 2002, FASEB J, V16, P1671, DOI 10.1096/fj.02-0313fje; Rubin BS, 2009, MOL CELL ENDOCRINOL, V304, P55, DOI 10.1016/j.mce.2009.02.023; Rubin BS, 2001, ENVIRON HEALTH PERSP, V109, P675, DOI 10.2307/3454783; Ryan KK, 2010, ENDOCRINOLOGY, V151, P2603, DOI 10.1210/en.2009-1218; Saal FSV, 2012, MOL CELL ENDOCRINOL, V354, P74, DOI 10.1016/j.mce.2012.01.001; Sachdeva MM, 2009, MOL ENDOCRINOL, V23, P747, DOI 10.1210/me.2008-0400; Shankar A, 2011, J CLIN ENDOCR METAB, V96, P3822, DOI 10.1210/jc.2011-1682; Sharpe RM, 2013, OBESITY, V21, P1081, DOI 10.1002/oby.20373; Silva E, 2011, TOXICOL SCI, V122, P383, DOI 10.1093/toxsci/kfr103; Somm E, 2009, ENVIRON HEALTH PERSP, V117, P1549, DOI 10.1289/ehp.11342; Soriano S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031109; Supale S, 2012, TRENDS ENDOCRIN MET, V23, P477, DOI 10.1016/j.tem.2012.06.002; Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281; Taylor JA, 2011, ENVIRON HEALTH PERSP, V119, P422, DOI 10.1289/ehp.1002514; Taylor M, 2013, J TOXICOL ENV HEAL A, V76, P1333, DOI 10.1080/15287394.2013.854715; Toth JI, 2004, MOL CELL BIOL, V24, P8288, DOI 10.1128/MCB.24.18.8288-8300.2004; Trasande L, 2012, JAMA-J AM MED ASSOC, V308, P1113, DOI 10.1001/2012.jama.11461; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; vom Saal FS, 2007, REPROD TOXICOL, V24, P131, DOI 10.1016/j.reprotox.2007.07.005; Wang TG, 2012, J CLIN ENDOCR METAB, V97, pE223, DOI 10.1210/jc.2011-1989; Wei J, 2011, ENDOCRINOLOGY, V152, P3049, DOI 10.1210/en.2011-0045; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010	72	114	116	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100214	10.1371/journal.pone.0100214	http://dx.doi.org/10.1371/journal.pone.0100214			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959901	Green Published, gold, Green Submitted			2022-12-25	WOS:000338633900026
J	Gotz, R; Sendtner, M				Goetz, Rudolf; Sendtner, Michael			Cooperation of Tyrosine Kinase Receptor TrkB and Epidermal Growth Factor Receptor Signaling Enhances Migration and Dispersal of Lung Tumor Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NEUROTROPHIC FACTOR; ANOIKIS RESISTANCE; BETA-CATENIN; E-CADHERIN; CANCER CELLS; IN-VITRO; METASTASIS; EXPRESSION; BDNF	TrkB mediates the effects of brain-derived neurotrophic factor (BDNF) in neuronal and nonnneuronal cells. Based on recent reports that TrkB can also be transactivated through epidermal growth-factor receptor (EGFR) signaling and thus regulates migration of early neurons, we investigated the role of TrkB in migration of lung tumor cells. Early metastasis remains a major challenge in the clinical management of non-small cell lung cancer (NSCLC). TrkB receptor signaling is associated with metastasis and poor patient prognosis in NSCLC. Expression of this receptor in A549 cells and in another adenocarcinoma cell line, NCI-H441, promoted enhanced migratory capacity in wound healing assays in the presence of the TrkB ligand BDNF. Furthermore, TrkB expression in A549 cells potentiated the stimulatory effect of EGF in wound healing and in Boyden chamber migration experiments. Consistent with a potential loss of cell polarity upon TrkB expression, cell dispersal and de-clustering was induced in A549 cells independently of exogeneous BDNF. Morphological transformation involved extensive cytoskeletal changes, reduced E-cadherin expression and suppression of E-cadherin expression on the cell surface in TrkB expressing tumor cells. This function depended on MEK and Akt kinase activity but was independent of Src. These data indicate that TrkB expression in lung adenoma cells is an early step in tumor cell dissemination, and thus could represent a target for therapy development.	[Goetz, Rudolf; Sendtner, Michael] Univ Hosp Wurzburg, Inst Clin Neurobiol, Wurzburg, Germany	University of Wurzburg	Gotz, R (corresponding author), Univ Hosp Wurzburg, Inst Clin Neurobiol, Wurzburg, Germany.	Goetz_R1@ukw.de	Sendtner, Michael/J-1542-2012; Sendtner, Michael/M-8137-2014	Sendtner, Michael/0000-0002-4737-2974; Sendtner, Michael/0000-0002-4737-2974	Wilhelm Sander-Stiftung [2011.059.1]	Wilhelm Sander-Stiftung	This work was supported by Wilhelm Sander-Stiftung (grant number 2011.059.1). Url of the funder: http://www.sanst.de/cms/front_content.php?idcat = 1&lang = 1 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Bartkowska K, 2007, DEVELOPMENT, V134, P4369, DOI 10.1242/dev.008227; Beckles MA, 2003, CHEST, V123, p97S, DOI 10.1378/chest.123.1_suppl.97S; Brodeur GM, 2009, CLIN CANCER RES, V15, P3244, DOI 10.1158/1078-0432.CCR-08-1815; BROWER M, 1986, CANCER RES, V46, P798; Buckley ST, 2010, CELL TISSUE RES, V342, P39, DOI 10.1007/s00441-010-1029-x; Camarero G, 2006, MOL CELL BIOL, V26, P7103, DOI 10.1128/MCB.00424-06; Ceteci F, 2007, CANCER CELL, V12, P145, DOI 10.1016/j.ccr.2007.06.014; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Eide FF, 1996, J NEUROSCI, V16, P3123; Geiger TR, 2007, CANCER RES, V67, P6221, DOI 10.1158/0008-5472.CAN-07-0121; Geiger TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016871; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Harada T, 2011, CLIN CANCER RES, V17, P2638, DOI 10.1158/1078-0432.CCR-10-3034; Harel L, 2009, NEURON, V63, P585, DOI 10.1016/j.neuron.2009.08.020; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Kim H, 2004, J BIOL CHEM, V279, P33538, DOI 10.1074/jbc.M404115200; Kim Y, 2009, J CELL BIOL, V184, P309, DOI 10.1083/jcb.200806067; Larsen JE, 2011, CLIN CHEST MED, V32, P703, DOI 10.1016/j.ccm.2011.08.003; Liebmann C, 2011, MOL CELL ENDOCRINOL, V331, P222, DOI 10.1016/j.mce.2010.04.008; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Marchetti A, 2008, HUM MUTAT, V29, P609, DOI 10.1002/humu.20707; Marques FR, 2004, GYNECOL ONCOL, V94, P16, DOI 10.1016/j.ygyno.2004.03.037; MATSUMOTO K, 1995, CANCER RES, V55, P1798; Medina DL, 2004, EMBO J, V23, P3803, DOI 10.1038/sj.emboj.7600399; Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336; Okamura K, 2012, LUNG CANCER, V78, P100, DOI 10.1016/j.lungcan.2012.07.011; Pearse RN, 2005, BLOOD, V105, P4429, DOI 10.1182/blood-2004-08-3096; Puehringer D, 2013, NAT NEUROSCI, V16, P407, DOI 10.1038/nn.3333; Ramos C, 2010, AM J PHYSIOL-LUNG C, V299, pL222, DOI 10.1152/ajplung.00070.2010; Ricci A, 2001, AM J RESP CELL MOL, V25, P439, DOI 10.1165/ajrcmb.25.4.4470; Rinker-Schaeffer CW, 2006, CLIN CANCER RES, V12, P3882, DOI 10.1158/1078-0432.CCR-06-1014; Sclabas GM, 2005, CLIN CANCER RES, V11, P440; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smit MA, 2011, ONCOGENE, V30, P3735, DOI 10.1038/onc.2011.96; Smit MA, 2009, MOL CELL BIOL, V29, P3722, DOI 10.1128/MCB.01164-08; Swartz MA, 2012, CANCER RES, V72, P2473, DOI 10.1158/0008-5472.CAN-12-0122; Thiele CJ, 2009, CLIN CANCER RES, V15, P5962, DOI 10.1158/1078-0432.CCR-08-0651; Travis WD, 2013, J CLIN ONCOL, V31, P992, DOI 10.1200/JCO.2012.46.9270; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wells A, 2013, CANCER RES, V73, P3811, DOI 10.1158/0008-5472.CAN-13-0356; YAMAMOTO H, 1990, J NEUROSCI, V10, P3469; Yu YJ, 2010, APMIS, V118, P188, DOI 10.1111/j.1600-0463.2009.02577.x; Zhang SY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-43; Zhang Y, 2008, ONCOLOGY-BASEL, V75, P17, DOI 10.1159/000151615	51	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100944	10.1371/journal.pone.0100944	http://dx.doi.org/10.1371/journal.pone.0100944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959744	gold, Green Published, Green Submitted			2022-12-25	WOS:000338633900103
J	Jin, L; Lim, SW; Doh, KC; Piao, SG; Jin, J; Heo, SB; Chung, BH; Yang, CW				Jin, Long; Lim, Sun Woo; Doh, Kyoung Chan; Piao, Shang Guo; Jin, Jian; Heo, Seong Beom; Chung, Byung Ha; Yang, Chul Woo			Dipeptidyl Peptidase IV Inhibitor MK-0626 Attenuates Pancreatic Islet Injury in Tacrolimus-Induced Diabetic Rats	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; EXENDIN-4 ANALOG; BETA-CELLS; CYCLOSPORINE; SITAGLIPTIN; KIDNEY; MODEL; FK506; NEPHROTOXICITY; NEPHROPATHY	Background: Tacrolimus (TAC)-induced pancreatic islet injury is one of the important causes of new-onset diabetes in transplant recipients. This study was performed to evaluate whether a dipeptidyl peptidase IV (DPP IV) inhibitor is effective in improving TAC-induced diabetes mellitus by reducing pancreatic islet injury. Methods: Rats were treated with TAC (1.5 mg/kg, subcutaneously) and the DPP IV inhibitor MK-0626 (10 or 20 mg/kg, oral gavage) for 4 weeks. The effect of MK-0626 on TAC-induced diabetes was evaluated by assessing pancreatic islet function, histopathology. TAC-induced incretin dysfunction was also examined based on active glucagon-like peptide-1 (GLP-1) levels in the serum after glucose loading. The protective effect of MK-0626 was evaluated by measuring markers of oxidative stress, oxidative resistance, and apoptosis. To determine whether enhanced GLP-1 signaling is associated with these protective effects, we measured the expression of the GLP-1 receptor (GLP-1R) and the effect of the GLP-1 analog exendin-4 on cell viability and oxidative stress in isolated islets. Results: MK-0626 treatment attenuated TAC-induced pancreatic islet dysfunction and islet morphology. TAC treatment led to a defect in active GLP-1 secretion; however, MK-0626 reversed these effects. TAC treatment increased the level of 8-hydroxy-2'-deoxyguanosine (8-OHdG), the number of apoptotic death, and the level of active caspase-3, and decreased the level of manganese superoxide dismutase and heme oxygenase-1; MK-0626 treatment reversed these changes. MK-0626 treatment restored the expression of GLP-1R, and direct administration of exendin-4 to isolated islets reduced TAC-induced cell death and 8-OHdG expression. Conclusions: The DPP IV inhibitor MK-0626wasan effective antidiabetic agent that exerted antioxidative and antiapoptotic effects via enhanced GLP-1 signaling in TAC-induced diabetics.	[Jin, Long; Lim, Sun Woo; Doh, Kyoung Chan; Piao, Shang Guo; Jin, Jian; Heo, Seong Beom; Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Seoul St Marys Hosp, Convergent Res Consortium Immunol Dis, Seoul, South Korea; [Jin, Long; Lim, Sun Woo; Doh, Kyoung Chan; Piao, Shang Guo; Jin, Jian; Heo, Seong Beom; Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Transplant Res Ctr, Seoul, South Korea; [Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Div Nephrol, Dept Internal Med, Seoul St Marys Hosp, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Yang, CW (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Convergent Res Consortium Immunol Dis, Seoul, South Korea.	yangch@catholic.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2012R1A1A30-01890]; Korean Health Technology R & D Project, Ministry for Health & Welfare, Republic of Korea [HI09C1555]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Korean Health Technology R & D Project, Ministry for Health & Welfare, Republic of Korea	This work was supported by a Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2012R1A1A30-01890) and the Korean Health Technology R & D Project, Ministry for Health & Welfare, Republic of Korea (HI09C1555). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANK HL, 1987, DIABETOLOGIA, V30, P812; BANK HL, 1988, IN VITRO CELL DEV B, V24, P266; Chang GL, 2013, EUR J PHARMACOL, V718, P105, DOI 10.1016/j.ejphar.2013.09.007; Edmondson SD, 2006, J MED CHEM, V49, P3614, DOI 10.1021/jm060015t; GHIANI BU, 1995, COMP BIOCHEM PHYS A, V111, P439; Glorie LLF, 2012, AM J PHYSIOL-RENAL, V303, pF681, DOI 10.1152/ajprenal.00075.2012; Haidinger M, 2013, AM J TRANSPLANT; Hirata K, 2009, BIOCHEM BIOPH RES CO, V380, P44, DOI 10.1016/j.bbrc.2009.01.003; Hwang H, 2012, IMMUNOPHARM IMMUNOT, V34, P434, DOI 10.3109/08923973.2011.618135; ISHIZUKA J, 1993, TRANSPLANTATION, V56, P1486, DOI 10.1097/00007890-199312000-00039; Iwasaki K, 2007, DRUG METAB PHARMACOK, V22, P328, DOI 10.2133/dmpk.22.328; Joo KW, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-98; Kan M, 2012, J NEUROPATH EXP NEUR, V71, P494, DOI 10.1097/NEN.0b013e3182580673; Katagiri D, 2013, J AM SOC NEPHROL, V24, P2034, DOI 10.1681/ASN.2013020134; Kim D, 2005, J MED CHEM, V48, P141, DOI 10.1021/jm0493156; Krishna R, 2007, J CLIN PHARMACOL, V47, P165, DOI 10.1177/0091270006296523; Lane JT, 2011, TRANSPLANTATION, V92, pE56, DOI 10.1097/TP.0b013e3182347ea4; Lee BW, 2011, TOXICOL APPL PHARM, V252, P47, DOI 10.1016/j.taap.2011.01.018; Lee E, 2011, BIOCHEM BIOPH RES CO, V414, P397, DOI 10.1016/j.bbrc.2011.09.087; Lee YE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050412; Lim S, 2013, PLOS ONE, V8; Lim SW, 2012, TRANSPLANTATION, V94, P218, DOI 10.1097/TP.0b013e31825ace5c; Liu WJ, 2012, J PHARMACOL EXP THER, V340, P248, DOI 10.1124/jpet.111.186866; Mu J, 2009, EUR J PHARMACOL, V623, P148, DOI 10.1016/j.ejphar.2009.09.027; Park CW, 2007, J AM SOC NEPHROL, V18, P1227, DOI 10.1681/ASN.2006070778; Piao SG, 2012, TRANSPLANTATION, V93, P383, DOI 10.1097/TP.0b013e3182421604; Sharif A, 2012, TRANSPLANTATION, V94, pE23, DOI 10.1097/TP.0b013e318260b1e9; Shih CM, 2013, CURR MED CHEM; Shihab FS, 1997, TRANSPLANTATION, V64, P1829, DOI 10.1097/00007890-199712270-00034; Song HK, 2009, AM J TRANSPLANT, V9, P2024, DOI 10.1111/j.1600-6143.2009.02751.x; Song YM, 2013, ENDOCRINOLOGY, V154, P2626, DOI 10.1210/en.2013-1031; Stillman IE, 1995, LAB INVEST, V73, P794; Strom Halden TA, 2014, NEPHROL DIAL TRANSPL; Valderhaug TG, 2011, DIABETOLOGIA, V54, P1341, DOI 10.1007/s00125-011-2105-9; Yoon HE, 2012, NEPHRON EXP NEPHROL, V120, pE123, DOI 10.1159/000342117; Yuan L, 2010, J ENDOCRINOL INVEST, V33, P13, DOI 10.1007/BF03346544; Yuan L, 2013, ACTA DIABETOL, V50, P479, DOI 10.1007/s00592-010-0210-8; Zhang Y, 2011, INVEST OPHTH VIS SCI, V52, P278, DOI 10.1167/iovs.09-4727; Zhang Y, 2009, GRAEF ARCH CLIN EXP, V247, P699, DOI 10.1007/s00417-008-1004-3	39	17	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100798	10.1371/journal.pone.0100798	http://dx.doi.org/10.1371/journal.pone.0100798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959755	Green Published, Green Submitted, gold			2022-12-25	WOS:000338633900087
J	Krohn, A; Ahrens, T; Yalcin, A; Plones, T; Wehrle, J; Taromi, S; Wollner, S; Follo, M; Brabletz, T; Mani, SA; Claus, R; Hackanson, B; Burger, M				Krohn, Alexander; Ahrens, Theresa; Yalcin, Arzu; Ploenes, Till; Wehrle, Julius; Taromi, Sanaz; Wollner, Stefan; Follo, Marie; Brabletz, Thomas; Mani, Sendurai A.; Claus, Rainer; Hackanson, Bjoern; Burger, Meike			Tumor Cell Heterogeneity in Small Cell Lung Cancer (SCLC): Phenotypical and Functional Differences Associated with Epithelial-Mesenchymal Transition (EMT) and DNA Methylation Changes	PLOS ONE			English	Article							CLINICAL-SIGNIFICANCE; ABERRANT EXPRESSION; STEM-CELLS; CARCINOMAS; ADHESION; DIFFERENTIATION; CHEMORESISTANCE; IDENTIFICATION; CHEMOTHERAPY; METASTASIS	Small Cell Lung Cancer (SCLC) is a specific subtype of lung cancer presenting as highly metastatic disease with extremely poor prognosis. Despite responding initially well to chemo- or radiotherapy, SCLC almost invariably relapses and develops resistance to chemotherapy. This is suspected to be related to tumor cell subpopulations with different characteristics resembling stem cells. Epithelial-Mesenchymal Transition (EMT) is known to play a key role in metastatic processes and in developing drug resistance. This is also true for NSCLC, but there is very little information on EMT processes in SCLC so far. SCLC, in contrast to NSCLC cell lines, grow mainly in floating cell clusters and a minor part as adherent cells. We compared these morphologically different subpopulations of SCLC cell lines for EMT and epigenetic features, detecting significant differences in the adherent subpopulations with high levels of mesenchymal markers such as Vimentin and Fibronectin and very low levels of epithelial markers like E-cadherin and Zona Occludens 1. In addition, expression of EMT-related transcription factors such as Snail/Snai1, Slug/Snai2, and Zeb1, DNA methylation patterns of the EMT hallmark genes, functional responses like migration, invasion, matrix metalloproteases secretion, and resistance to chemotherapeutic drug treatment all differed significantly between the sublines. This phenotypic variability might reflect tumor cell heterogeneity and EMT during metastasis in vivo, accompanied by the development of refractory disease in relapse. We propose that epigenetic regulation plays a key role during phenotypical and functional changes in tumor cells and might therefore provide new treatment options for SCLC patients.	[Krohn, Alexander; Yalcin, Arzu; Wehrle, Julius; Taromi, Sanaz; Wollner, Stefan; Follo, Marie; Claus, Rainer; Hackanson, Bjoern; Burger, Meike] Univ Med Ctr, Dept Hematol Oncol & Stem Cell Transplantat, Freiburg, Germany; [Ahrens, Theresa] Univ Med Ctr, Dept Pathol, Freiburg, Germany; [Ahrens, Theresa] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Ploenes, Till] Univ Med Ctr Witten Herdecke, Dept Thorac Surg, Cologne, Germany; [Brabletz, Thomas] Univ Med Ctr, Dept Visceral Surg, Freiburg, Germany; [Mani, Sendurai A.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Burger, Meike] Univ Furtwangen, Fac Med & Life Sci, Villingen Schwenningen, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Texas System; UTMD Anderson Cancer Center	Burger, M (corresponding author), Univ Med Ctr, Dept Hematol Oncol & Stem Cell Transplantat, Freiburg, Germany.	meike.burger@uniklinik-freiburg.de	Claus, Rainer/AAZ-5606-2020; Plönes, Till/AAK-8208-2021; Mani, Sendurai A./A-7244-2009	Claus, Rainer/0000-0003-2617-8766; Plönes, Till/0000-0003-4839-2130; Mani, Sendurai A./0000-0002-5918-4276; Follo, Marie/0000-0002-3090-7442; Ahrens, Theresa/0000-0003-0667-9248	Deutsche Forschungsgemeinschaft (DFG) [CRC 850, C3]; Deutsche Krebshilfe [110213]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG), project C3, CRC 850 (to MB), and the Deutsche Krebshilfe (110213 to BH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; BRAMBILLA E, 1991, J CLIN ONCOL, V9, P50, DOI 10.1200/JCO.1991.9.1.50; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; CARNEY DN, 1985, CANCER RES, V45, P2913; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Grady WM, 2000, NAT GENET, V26, P16, DOI 10.1038/79120; GRAFF JR, 1995, CANCER RES, V55, P5195; Gunasinghe NP, 2012, CANC METASTASIS REV; Haberland J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-52; Haddadin S, 2011, CLIN LUNG CANCER, V12, P87, DOI 10.1016/j.cllc.2011.03.002; Hara J, 2014, ONCOL REP, V31, P589, DOI 10.3892/or.2013.2876; Hartmann TN, 2005, ONCOGENE, V24, P4462, DOI 10.1038/sj.onc.1208621; Iniesta P, 2007, ONCOL REP, V17, P217; Islam S, 2000, J CELL BIOCHEM, V78, P141, DOI 10.1002/(SICI)1097-4644(20000701)78:1<141::AID-JCB13>3.0.CO;2-R; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Jing J, 2004, EUR J CANCER, V40, P2143, DOI 10.1016/j.ejca.2004.05.018; Justilien V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035040; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; KHAN MZ, 1991, ANTICANCER RES, V11, P1687; Kobayashi S, 1999, TOHOKU J EXP MED, V189, P37, DOI 10.1620/tjem.189.37; Kraus AC, 2002, ONCOGENE, V21, P8683, DOI 10.1038/sj.onc.1205939; Liu LK, 2010, MODERN PATHOL, V23, P213, DOI 10.1038/modpathol.2009.160; Lovly CM, 2011, NAT REV CLIN ONCOL, V8, P68, DOI 10.1038/nrclinonc.2010.224; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MIRSKI SEL, 1987, CANCER RES, V47, P2594; Pirozzi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021548; Ploenes Till, 2012, Asian Cardiovasc Thorac Ann, V20, P694, DOI 10.1177/0218492312453348; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Radisky DC, 2008, CELL STEM CELL, V2, P511, DOI 10.1016/j.stem.2008.05.007; Rekhtman N, 2010, ARCH PATHOL LAB MED, V134, P1628, DOI 10.1043/2009-0583-RAR.1; Riaz SP, 2011, LUNG CANC; Sanchez-Tillo E, 2012, CELL MOL LIFE SCI, V69, P3429, DOI 10.1007/s00018-012-1122-2; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Scheel C., 2012, SEMINARS CANC BIOL; SEHESTED M, 1986, CANCER, V57, P804, DOI 10.1002/1097-0142(19860215)57:4<804::AID-CNCR2820570420>3.0.CO;2-E; Shibue T, 2011, SEMIN CANCER BIOL, V21, P99, DOI 10.1016/j.semcancer.2010.12.003; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tiwari N, 2012, SEMIN CANCER BIOL, V22, P194, DOI 10.1016/j.semcancer.2012.02.013; Travis WD., 2004, TRAVIS WB WHO CLASSI; van Meerbeeck JP, 2011, LANCET, V378, P1741, DOI 10.1016/S0140-6736(11)60165-7	47	38	39	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100249	10.1371/journal.pone.0100249	http://dx.doi.org/10.1371/journal.pone.0100249			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959847	Green Published, gold, Green Submitted			2022-12-25	WOS:000338633900031
J	Meireles, DD; Alegria, TGP; Alves, SV; Arantes, CRR; Netto, LES				Meireles, Diogo de Abreu; Pires Alegria, Thiago Geronimo; Alves, Simone Vidigal; Rocha Arantes, Carla Rani; Soares Netto, Luis Eduardo			A 14.7 kDa Protein from Francisella tularensis subsp novicida (Named FTN_1133), Involved in the Response to Oxidative Stress Induced by Organic Peroxides, Is Not Endowed with Thiol-Dependent Peroxidase Activity	PLOS ONE			English	Article							HYDROPEROXIDE RESISTANCE PROTEIN; SUCCINATE-DEHYDROGENASE; SECONDARY STRUCTURE; ESCHERICHIA-COLI; REACTIVE OXYGEN; PEROXYNITRITE; GENE; EXPRESSION; VIRULENCE; REDUCTION	Francisella genus comprises Gram-negative facultative intracellular bacteria that are among the most infectious human pathogens. A protein of 14.7 KDa named as FTN_1133 was previously described as a novel hydroperoxide resistance protein in F. tularensis subsp. novicida, implicated in organic peroxide detoxification and virulence. Here, we describe a structural and biochemical characterization of FTN_1133. Contrary to previous assumptions, multiple amino acid sequence alignment analyses revealed that FTN_1133 does not share significant similarity with proteins of the Ohr/OsmC family or any other Cys-based, thiol dependent peroxidase, including conserved motifs around reactive cysteine residues. Circular dichroism analyses were consistent with the in silico prediction of an all-a-helix secondary structure. The pK(a) of its single cysteine residue, determined by a monobromobimane alkylation method, was shown to be 8.0=0.1, value that is elevated when compared with other Cys-based peroxidases, such as peroxiredoxins and Ohr/OsmC proteins. Attempts to determine a thiol peroxidase activity for FTN_1133 failed, using both dithiols (DTT, thioredoxin and lipoamide) and monothiols (glutathione or 2-mercaptoethanol) as reducing agents. Heterologous expression of FTN_1133 gene in ahpC and oxyR mutants of E. coli showed no complementation. Furthermore, analysis of FTN_1133 protein by non-reducing SDS-PAGE showed that an intermolecular disulfide bond (not detected in Ohr proteins) can be generated under hydroperoxide treatment, but the observed rates were not comparable to those observed for other thiol-dependent peroxidases. All the biochemical and structural data taken together indicated that FTN_1133 displayed distinct characteristics from other thiol dependent peroxidases and, therefore, suggested that FTN_1133 is not directly involved in hydroperoxide detoxification.	[Meireles, Diogo de Abreu; Pires Alegria, Thiago Geronimo; Alves, Simone Vidigal; Rocha Arantes, Carla Rani; Soares Netto, Luis Eduardo] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, Brazil	Universidade de Sao Paulo	Netto, LES (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, Brazil.	nettoles@ib.usp.br	de Abreu Meireles, Diogo/AAP-7591-2020; Meireles, Diogo/C-4427-2014; Netto, Luis/A-3783-2008	de Abreu Meireles, Diogo/0000-0002-8451-2083; Meireles, Diogo/0000-0002-8451-2083; Netto, Luis/0000-0002-4250-9177; Alegria, Thiago Geronimo Pires/0000-0002-3086-4059	Fundacao de Amparo a Pesquisado Estado de Sao Paulo (FAPESP) [2007/58147-6, 2013/07937-8]; FAPESP [2012/21722-1]	Fundacao de Amparo a Pesquisado Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants 2007/58147-6 and 2013/07937-8 from the Fundacao de Amparo a Pesquisado Estado de Sao Paulo (FAPESP) and by a post-doctoral fellowship from FAPESP, process number 2012/21722-1, to Diogo de Abreu Meireles. The funder (FAPESP) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk M, 2006, MICROBIOL-SGM, V152, P1621, DOI 10.1099/mic.0.28495-0; Allen RG, 2012, INFECT IMMUN, V80, P3429, DOI 10.1128/IAI.00714-12; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atichartpongkul S, 2001, MICROBIOL-SGM, V147, P1775, DOI 10.1099/00221287-147-7-1775; Bakshi CS, 2006, J BACTERIOL, V188, P6443, DOI 10.1128/JB.00266-06; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; Caina JA, 2014, J PROTEOMICS, V97, P265, DOI 10.1016/j.jprot.2013.08.012; Chauhan R, 2002, BIOCHEM J, V367, P255, DOI 10.1042/BJ20020545; Clarke TE, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-27; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Cussiol JRR, 2010, J BIOL CHEM, V285, P21943, DOI 10.1074/jbc.M110.117283; Discola KF, 2009, J MOL BIOL, V385, P889, DOI 10.1016/j.jmb.2008.10.055; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Ferrer-Sueta G, 2011, CHEM RES TOXICOL, V24, P434, DOI 10.1021/tx100413v; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Hansen RE, 2009, ANAL BIOCHEM, V394, P147, DOI 10.1016/j.ab.2009.07.051; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; HOLLIS DG, 1989, J CLIN MICROBIOL, V27, P1601, DOI 10.1128/JCM.27.7.1601-1608.1989; Horta BB, 2010, J BIOL CHEM, V285, P16051, DOI 10.1074/jbc.M109.094839; Hugo M, 2009, BIOCHEMISTRY-US, V48, P9416, DOI 10.1021/bi901221s; IYER KS, 1973, J BIOL CHEM, V248, P707; JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N; Kadzhaev K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005463; Lassmann T, 2006, NUCLEIC ACIDS RES, V34, pW596, DOI 10.1093/nar/gkl191; Lesniak J, 2003, PROTEIN SCI, V12, P2838, DOI 10.1110/ps.03375603; Llewellyn AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024201; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Mailman Timothy L, 2005, Can J Infect Dis Med Microbiol, V16, P245; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; Manta B, 2009, ARCH BIOCHEM BIOPHYS, V484, P146, DOI 10.1016/j.abb.2008.11.017; McCaffrey RL, 2010, J LEUKOCYTE BIOL, V88, P791, DOI 10.1189/jlb.1209811; McLean S, 2010, J BIOL CHEM, V285, P20724, DOI 10.1074/jbc.M109.085506; Mcneil MB, 2012, J BIOL CHEM, V287, P18418, DOI 10.1074/jbc.M111.293803; Melillo AA, 2010, J BIOL CHEM, V285, P27553, DOI 10.1074/jbc.M110.144394; Melillo AA, 2009, J BACTERIOL, V191, P6447, DOI 10.1128/JB.00534-09; Nelson KJ, 2011, PROTEINS, V79, P947, DOI 10.1002/prot.22936; Nelson KJ, 2008, BIOCHEMISTRY-US, V47, P12860, DOI 10.1021/bi801718d; Ogusucu R, 2007, FREE RADICAL BIO MED, V42, P326, DOI 10.1016/j.freeradbiomed.2006.10.042; Oliveira MA, 2006, J MOL BIOL, V359, P433, DOI 10.1016/j.jmb.2006.03.054; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Porollo AA, 2004, BIOINFORMATICS, V20, P2460, DOI 10.1093/bioinformatics/bth248; Renato J, 2003, J BIOL CHEM, V278, P11570, DOI 10.1074/jbc.M300252200; Sardi F, 2013, ANAL BIOCHEM, V435, P74, DOI 10.1016/j.ab.2012.12.017; Shin DH, 2004, ACTA CRYSTALLOGR D, V60, P903, DOI 10.1107/S0907444904005013; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sugano Y, 2007, J BIOL CHEM, V282, P36652, DOI 10.1074/jbc.M706996200; Tairum CA, 2012, J MOL BIOL, V424, P28, DOI 10.1016/j.jmb.2012.09.008; Trujillo M, 2007, ARCH BIOCHEM BIOPHYS, V467, P95, DOI 10.1016/j.abb.2007.08.008; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x	54	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99492	10.1371/journal.pone.0099492	http://dx.doi.org/10.1371/journal.pone.0099492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959833	Green Published, gold, Green Submitted			2022-12-25	WOS:000338633900007
J	Qi, LS; Li, BL; Dong, Y; Xu, H; Chen, LB; Wang, HW; Li, PF; Zhao, WY; Gu, YY; Wang, CG; Guo, Z				Qi, Lishuang; Li, Bailiang; Dong, Yu; Xu, Hui; Chen, Libin; Wang, Hongwei; Li, Pengfei; Zhao, Wenyuan; Gu, Yunyan; Wang, Chenguang; Guo, Zheng			Deconvolution of the Gene Expression Profiles of Valuable Banked Blood Specimens for Studying the Prognostic Values of Altered Peripheral Immune Cell Proportions in Cancer Patients	PLOS ONE			English	Article							LUNG-CANCER; COLORECTAL-CANCER; DENDRITIC CELLS; ADJUVANT CHEMOTHERAPY; MONONUCLEAR-CELLS; LYMPHOCYTE RATIO; FLOW-CYTOMETRY; OVARIAN-CANCER; BREAST-CANCER; SURVIVAL	Background: The altered composition of immune cells in peripheral blood has been reported to be associated with cancer patient survival. However, analysis of the composition of peripheral immune cells are often limited in retrospective survival studies employing banked blood specimens with long-term follow-up because the application of flow cytometry to such specimens is problematic. The aim of this study was to demonstrate the feasibility of deconvolving blood-based gene expression profiles (GEPs) to estimate the proportions of immune cells and determine their prognostic values for cancer patients. Methods and Results: Here, using GEPs from peripheral blood mononuclear cells (PBMC) of 108 non-small cell lung cancer (NSCLC) patients, we deconvolved the immune cell proportions and analyzed their association with patient survival. Univariate Kaplan-Meier analysis showed that a low proportion of T cells was significantly associated with poor patient survival, as was the proportion of T helper cells; however, only the proportion of T cells was independently prognostic for patients by a multivariate Cox regression analysis (hazard ratio = 2.23; 95% CI, 1.01-4.92; p = .048). Considering that altered peripheral blood compositions can reflect altered immune responses within the tumor microenvironment, based on a tissue-based GEPs of NSCLC patients, we demonstrated a significant association between poor patient survival and the low level of antigen presentation, which play a critical role in T cell proliferation. Conclusions: These results demonstrate that it is feasible to deconvolve GEPs from banked blood specimens for retrospective survival analysis of alterations of immune cell composition, and suggest the proportion of T cells in PBMC which might reflect the antigen presentation level within the tumor microenvironment can be a prognostic marker for NSCLC patients.	[Qi, Lishuang; Dong, Yu; Xu, Hui; Chen, Libin; Wang, Hongwei; Li, Pengfei; Zhao, Wenyuan; Gu, Yunyan; Guo, Zheng] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Li, Bailiang; Wang, Chenguang] Harbin Med Univ, Coll Pharm, Harbin, Peoples R China; [Guo, Zheng] Fujian Med Univ, Sch Basic Med Sci, Dept Bioinformat, Fuzhou, Peoples R China	Harbin Medical University; Harbin Medical University; Fujian Medical University	Wang, CG (corresponding author), Harbin Med Univ, Coll Pharm, Harbin, Peoples R China.	cgwang1231@hotmail.com; guoz@ems.hrbmu.edu.cn	Wang, Hongwei/E-5448-2016; Li, Bailiang/AAL-5871-2020	Li, Bailiang/0000-0001-6729-219X; Gu, Yunyan/0000-0001-5693-4126; Wang, Hongwei/0000-0003-3581-8892	National Natural Science Foundation of China [91029717, 81071646, 81372213, 81201822]; Research Fund for the Doctoral Program of Higher Education of China [20112307110011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (Grant Nos. 91029717, 81071646, 81372213 and 81201822), and Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20112307110011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098; Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; BONADONNA G, 1981, NEW ENGL J MED, V304, P10, DOI 10.1056/NEJM198101013040103; Burczynski ME, 2005, CLIN CANCER RES, V11, P1181; Cedres S, 2012, CLIN TRANSL ONCOL, V14, P864, DOI 10.1007/s12094-012-0872-5; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Croci DO, 2007, CANCER IMMUNOL IMMUN, V56, P1687, DOI 10.1007/s00262-007-0343-y; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; DEVAUX BC, 1993, J NEUROSURG, V78, P767, DOI 10.3171/jns.1993.78.5.0767; Dieu-Nosjean MC, 2008, J CLIN ONCOL, V26, P4410, DOI 10.1200/JCO.2007.15.0284; Eisenthal A, 2001, HUM PATHOL, V32, P803, DOI 10.1053/hupa.2001.26455; Fan HT, 2005, CURR MOL MED, V5, P3, DOI 10.2174/1566524053152861; Fox J., 2002, R S PLUS COMPANION A; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gaujoux R, 2013, BIOINFORMATICS, V29, P2211, DOI 10.1093/bioinformatics/btt351; Gaujoux R, 2012, INFECT GENET EVOL, V12, P913, DOI 10.1016/j.meegid.2011.08.014; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; Hirashima M, 1998, J CANCER RES CLIN, V124, P329, DOI 10.1007/s004320050178; Hirschowitz EA, 2004, J CLIN ONCOL, V22, P2808, DOI 10.1200/JCO.2004.01.074; Jaye DL, 2012, J IMMUNOL, V188, P4715, DOI 10.4049/jimmunol.1290017; Johnson SK, 2000, LUNG CANCER-J IASLC, V27, P27, DOI 10.1016/S0169-5002(99)00095-1; Kikuchi E, 2007, CANCER SCI, V98, P1424, DOI 10.1111/j.1349-7006.2007.00558.x; Kossenkov AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034392; Leffers N, 2009, CANCER IMMUNOL IMMUN, V58, P449, DOI 10.1007/s00262-008-0583-5; Li YX, 2012, J CANC THERAPY, V03, P412; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mohr S, 2007, TRENDS MOL MED, V13, P422, DOI 10.1016/j.molmed.2007.08.003; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pautu Jeremy L, 2003, Natl Med J India, V16, P150; Pinzon-Charry A, 2005, IMMUNOL CELL BIOL, V83, P451, DOI 10.1111/j.1440-1711.2005.01371.x; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Ruffini E, 2009, ANN THORAC SURG, V87, P365, DOI 10.1016/j.athoracsur.2008.10.067; Sandel MH, 2005, CLIN CANCER RES, V11, P2576, DOI 10.1158/1078-0432.CCR-04-1448; Sarraf KM, 2009, J THORAC CARDIOV SUR, V137, P425, DOI 10.1016/j.jtcvs.2008.05.046; SATOMI A, 1995, ACTA ONCOL, V34, P69, DOI 10.3109/02841869509093641; Showe MK, 2012, ONCOIMMUNOLOGY, V1, P1414, DOI 10.4161/onci.21096; Showe MK, 2009, CANCER RES, V69, P9202, DOI 10.1158/0008-5472.CAN-09-1378; Solsona E, 2001, J UROLOGY, V165, P1506, DOI 10.1016/S0022-5347(05)66337-9; Suzuki K, 2011, CLIN CANCER RES, V17, P5247, DOI 10.1158/1078-0432.CCR-10-2805; Takeuchi T, 2006, J CLIN ONCOL, V24, P1679, DOI 10.1200/JCO.2005.03.8224; TOLLERUD DJ, 1991, J CLIN LAB ANAL, V5, P255; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; Wei SH, 2006, CLIN CANCER RES, V12, P2788, DOI 10.1158/1078-0432.CCR-05-1551; WRONSKI M, 1995, J NEUROSURG, V83, P605, DOI 10.3171/jns.1995.83.4.0605	51	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100934	10.1371/journal.pone.0100934	http://dx.doi.org/10.1371/journal.pone.0100934			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959668	Green Submitted, Green Published, gold			2022-12-25	WOS:000338633900101
J	Sohn, MJ; Yoo, SJ; Oh, DB; Kwon, O; Lee, SY; Sibirny, AA; Kang, HA				Sohn, Min Jeong; Yoo, Su Jin; Oh, Doo-Byoung; Kwon, Ohsuk; Lee, Sang Yup; Sibirny, Andriy A.; Kang, Hyun Ah			Novel Cysteine-Centered Sulfur Metabolic Pathway in the Thermotolerant Methylotrophic Yeast Hansenula polymorpha	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; GENE ENCODES; N-GLYCAN; GLUTATHIONE; PROTEIN; TRANSCRIPTION; BIOSYNTHESIS; ASSIMILATION; AUXOTROPHY	In yeast and filamentous fungi, sulfide can be condensed either with O-acetylhomoserine to generate homocysteine, the precursor of methionine, or with O-acetylserine to directly generate cysteine. The resulting homocysteine and cysteine can be interconverted through transsulfuration pathway. Here, we systematically analyzed the sulfur metabolic pathway of the thermotolerant methylotrophic yeast Hansenula polymorpha, which has attracted much attention as an industrial yeast strain for various biotechnological applications. Quite interestingly, the detailed sulfur metabolic pathway of H. polymorpha, which was reconstructed based on combined analyses of the genome sequences and validation by systematic gene deletion experiments, revealed the absence of de novo synthesis of homocysteine from inorganic sulfur in this yeast. Thus, the direct biosynthesis of cysteine from sulfide is the only pathway of synthesizing sulfur amino acids from inorganic sulfur in H. polymorpha, despite the presence of both directions of transsulfuration pathway Moreover, only cysteine, but no other sulfur amino acid, was able to repress the expression of a subset of sulfur genes, suggesting its central and exclusive role in the control of H. polymorpha sulfur metabolism. S-35-Cys was more efficiently incorporated into intracellular sulfur compounds such as glutathione than S-35-Met in H. polymorpha, further supporting the cysteine-centered sulfur pathway. This is the first report on the novel features of H. polymorpha sulfur metabolic pathway, which are noticeably distinct from those of other yeast and filamentous fungal species.	[Sohn, Min Jeong; Yoo, Su Jin; Kang, Hyun Ah] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea; [Sohn, Min Jeong; Lee, Sang Yup] Korea Adv Inst Sci & Technol, Dept Biomol & Chem Engn, Program BK21, Taejon 305701, South Korea; [Oh, Doo-Byoung; Kwon, Ohsuk] Korea Res Inst Biosci & Biotechnol, Biochem & Synthet Biol Res Ctr, Taejon, South Korea; [Sibirny, Andriy A.] Natl Acad Sci Ukraine, Inst Cell Biol, Lvov, Ukraine	Chung Ang University; Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); National Academy of Sciences Ukraine; Institute of Cell Biology of NASU	Kang, HA (corresponding author), Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea.	hyunkang@cau.ac.kr	Lee, Sang Yup/C-1526-2011	Lee, Sang Yup/0000-0003-0599-3091; Sibirny, Andriy/0000-0001-8579-1566; Yoo, Su Jin/0000-0001-5023-5164; Oh, Doo-Byoung/0000-0002-4432-0941	National Research Foundation of Korea (NRF) [NRF-2012-0001150, NRF-2013M3A6A8073554]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	Funding provided by the National Research Foundation of Korea (NRF) grant No. NRF-2012-0001150, http://www.nrf.re.kr/nrf_eng_cms/ and the National Research Foundation of Korea (NRF) grant No. NRF-2013M3A6A8073554, http://www.nrf.re.kr/nrf_eng_cms/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blazhenko Oleksandra V, 2006, Biometals, V19, P593, DOI 10.1007/s10534-006-0005-0; Brzywczy J, 2002, YEAST, V19, P29, DOI 10.1002/yea.798; Cheon SA, 2012, J MICROBIOL, V50, P341, DOI 10.1007/s12275-012-2097-2; Cheon SA, 2009, YEAST, V26, P507, DOI 10.1002/yea.1701; CHEREST H, 1992, GENETICS, V130, P51; Fujita Y, 2004, BIOSCI BIOTECH BIOCH, V68, P306, DOI 10.1271/bbb.68.306; Gellissen G, 2002, HANSENULA POLYMORPHA; Gidijala L, 2007, FEMS YEAST RES, V7, P1160, DOI 10.1111/j.1567-1364.2007.00228.x; Grynberg M, 2000, MICROBIOL-UK, V146, P2695, DOI 10.1099/00221287-146-10-2695; Hebert A, 2011, APPL MICROBIOL BIOT, V91, P1409, DOI 10.1007/s00253-011-3481-2; Hebert A, 2011, FEMS YEAST RES, V11, P366, DOI 10.1111/j.1567-1364.2011.00725.x; Isnard AD, 1996, J MOL BIOL, V262, P473, DOI 10.1006/jmbi.1996.0529; Kaur J, 2007, GENETICS, V176, P877, DOI 10.1534/genetics.107.070342; KUMARI K, 1994, ANAL BIOCHEM, V220, P374, DOI 10.1006/abio.1994.1352; Lafaye A, 2005, J BIOL CHEM, V280, P24723, DOI 10.1074/JBC.M502285200; Lee B, 2002, MICROBIOL-SGM, V148, P2697, DOI 10.1099/00221287-148-9-2697; Marzluf GA, 1997, ANNU REV MICROBIOL, V51, P73, DOI 10.1146/annurev.micro.51.1.73; Menant A, 2006, J BIOL CHEM, V281, P11744, DOI 10.1074/jbc.M600037200; Mendoza-Cozatl D, 2005, FEMS MICROBIOL REV, V29, P653, DOI 10.1016/j.femsre.2004.09.004; Natorff R, 2003, MOL MICROBIOL, V49, P1081, DOI 10.1046/j.1365-2958.2003.03617.x; Oh Doo-Byoung, 2008, Biotechnology Journal, V3, P659, DOI 10.1002/biot.200700252; Penninckx MJ, 2002, FEMS YEAST RES, V2, P295, DOI 10.1111/j.1567-1364.2002.tb00098.x; Saito K, 2004, PLANT PHYSIOL, V136, P2443, DOI 10.1104/pp.104.046755; Spector D, 2001, J BIOL CHEM, V276, P7011, DOI 10.1074/jbc.M009814200; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; THOMAS D, 1992, MOL CELL BIOL, V12, P1719, DOI 10.1128/MCB.12.4.1719; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ubiyvovk VM, 2006, CELL BIOL INT, V30, P665, DOI 10.1016/j.cellbi.2006.04.006; Ubiyvovk VM, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-8; van der Klei IJ, 2002, HANSENULA POLYMORPHA: BIOLOGY AND APPLICATIONS, P76; Vido K, 2001, J BIOL CHEM, V276, P8469, DOI 10.1074/jbc.M008708200; Yurimoto H, 2011, INT J MICROBIOL, V2011, DOI DOI 10.1155/2011/101298	32	18	19	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100725	10.1371/journal.pone.0100725	http://dx.doi.org/10.1371/journal.pone.0100725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959887	Green Submitted, Green Published, gold			2022-12-25	WOS:000338633900075
J	Xu, Y; Lin, ZW; Zhao, N; Zhou, LP; Liu, F; Cichacz, Z; Zhang, L; Zhan, QM; Zhao, XH				Xu, Yang; Lin, Zhengwei; Zhao, Nan; Zhou, Lanping; Liu, Fang; Cichacz, Zbigniew; Zhang, Lin; Zhan, Qimin; Zhao, Xiaohang			Receptor Interactive Protein Kinase 3 Promotes Cisplatin-Triggered Necrosis in Apoptosis-Resistant Esophageal Squamous Cell Carcinoma Cells	PLOS ONE			English	Article							MIXED LINEAGE KINASE; DOMAIN-LIKE; C-FOS; MOLECULAR-MECHANISMS; INDUCED CYTOTOXICITY; PROGRAMMED NECROSIS; INDUCED NECROPTOSIS; RIP KINASES; L929 CELLS; DEATH	Cisplatin-based chemotherapy is currently the standard treatment for locally advanced esophageal cancer. Cisplatin has been shown to induce both apoptosis and necrosis in cancer cells, but the mechanism by which programmed necrosis is induced remains unknown. In this study, we provide evidence that cisplatin induces necrotic cell death in apoptosis-resistant esophageal cancer cells. This cell death is dependent on RIPK3 and on necrosome formation via autocrine production of TNF alpha. More importantly, we demonstrate that RIPK3 is necessary for cisplatin-induced killing of esophageal cancer cells because inhibition of RIPK1 activity by necrostatin or knockdown of RIPK3 significantly attenuates necrosis and leads to cisplatin resistance. Moreover, microarray analysis confirmed an anti-apoptotic molecular expression pattern in esophageal cancer cells in response to cisplatin. Taken together, our data indicate that RIPK3 and autocrine production of TNFa contribute to cisplatin sensitivity by initiating necrosis when the apoptotic pathway is suppressed or absent in esophageal cancer cells. These data provide new insight into the molecular mechanisms underlying cisplatin-induced necrosis and suggest that RIPK3 is a potential marker for predicting cisplatin sensitivity in apoptosis-resistant and advanced esophageal cancer.	[Xu, Yang; Lin, Zhengwei; Zhao, Nan; Zhou, Lanping; Liu, Fang; Zhan, Qimin; Zhao, Xiaohang] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Zhang, Lin] Univ Pittsburgh, Inst Canc, Dept Pharmacol, Pittsburgh, PA USA; [Zhang, Lin] Univ Pittsburgh, Inst Canc, Dept Biol Chem, Pittsburgh, PA USA; [Cichacz, Zbigniew] Arizona State Univ, Biodesign Inst, Tempe, AZ USA; [Zhao, Xiaohang] Navy Gen Hosp, Ctr Basic Med Sci, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Arizona State University; Arizona State University-Tempe; Sixth Medical Center of Chinese PLA General Hospital	Zhao, XH (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China.	zhaoxh@cicams.ac.cn	Zhang, Lin/A-7389-2009	Zhang, Lin/0000-0003-0018-3903	NSFC [81071811, 91029725, 81321091, 81372591, 81372385]; National High-tech R D Program [2012AA020206, 2012AA02A503]; State Key Projects for Basic Research of China [2011CB910703]	NSFC(National Natural Science Foundation of China (NSFC)); National High-tech R D Program(National High Technology Research and Development Program of China); State Key Projects for Basic Research of China	This work was supported by grants from the NSFC (No. 81071811, 91029725, 81321091, 81372591, 81372385), the National High-tech R & D Program (No. 2012AA020206, 2012AA02A503), and the State Key Projects for Basic Research (No. 2011CB910703) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajpai J, 2011, PEDIATR RADIOL, V41, P441, DOI 10.1007/s00247-010-1876-3; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Chen WZ, 2013, J BIOL CHEM, V288, P16247, DOI 10.1074/jbc.M112.435545; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cui Q, 2011, PATHOL ONCOL RES, V17, P587, DOI 10.1007/s12253-010-9354-7; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Eilber FC, 2001, J CLIN ONCOL, V19, P3203, DOI 10.1200/JCO.2001.19.13.3203; Eschenburg G, 2012, CANCER RES, V72, P2645, DOI 10.1158/0008-5472.CAN-11-4072; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Fortes GB, 2012, BLOOD, V119, P2368, DOI 10.1182/blood-2011-08-375303; Fuertes MA, 2003, CURR MED CHEM, V10, P257, DOI 10.2174/0929867033368484; Galluzzi L, 2009, J MOL CELL BIOL, V1, P8, DOI 10.1093/jmcb/mjp007; Gonzalez VM, 2001, MOL PHARMACOL, V59, P657, DOI 10.1124/mol.59.4.657; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes MA, 2013, METHODS, V61, P98, DOI 10.1016/j.ymeth.2013.02.006; Ilson David H, 2008, Gastrointest Cancer Res, V2, P85; Irizarry RA, 2003, STAT APPL GENET MOL, V2, DOI DOI 10.2202/1544-6115.1002; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kravchenko-Balasha N, 2009, J BIOL CHEM, V284, P11717, DOI 10.1074/jbc.M900217200; Lash LH, 2003, J PHARMACOL EXP THER, V305, P1163, DOI 10.1124/jpet.102.046185; Li DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045058; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Lin J, 2013, CELL REP, V3, P200, DOI 10.1016/j.celrep.2012.12.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loder S, 2012, LEUKEMIA, V26, P1020, DOI 10.1038/leu.2011.353; Miller CR, 2006, J CLIN ONCOL, V24, P5419, DOI 10.1200/JCO.2006.08.1497; Muscella A, 2009, BRIT J PHARMACOL, V156, P751, DOI 10.1111/j.1476-5381.2008.00049.x; Ogawa Y, 1997, CLIN CANCER RES, V3, P2301; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Ramesh G, 2003, AM J PHYSIOL-RENAL, V285, pF610, DOI 10.1152/ajprenal.00101.2003; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Roychowdhury S, 2013, HEPATOLOGY, V57, P1773, DOI 10.1002/hep.26200; Sancho-Martinez SM, 2011, TOXICOL SCI, V122, P73, DOI 10.1093/toxsci/kfr098; Sharma A, 2009, DNA CELL BIOL, V28, P311, DOI 10.1089/dna.2009.0851; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vanlangenakker N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.111; Wainford RD, 2009, TOXICOL IN VITRO, V23, P780, DOI 10.1016/j.tiv.2009.04.004; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Wu YT, 2011, CELL DEATH DIFFER, V18, P26, DOI 10.1038/cdd.2010.72; Xia Y, 2013, J BIOL CHEM; Xu Y, 2011, CLIN CANCER RES, V17, P5412, DOI 10.1158/1078-0432.CCR-11-0426; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang LJ, 2008, ANTI-CANCER DRUG, V19, P159, DOI 10.1097/CAD.0b013e3282f30d05; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	53	32	35	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100127	10.1371/journal.pone.0100127	http://dx.doi.org/10.1371/journal.pone.0100127			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959694	Green Published, gold, Green Accepted			2022-12-25	WOS:000338633900021
J	Di Marco, F; Di Paolo, M; Romeo, S; Colecchi, L; Fiorani, L; Spana, S; Stone, J; Bisti, S				Di Marco, Fabiana; Di Paolo, Mattia; Romeo, Stefania; Colecchi, Linda; Fiorani, Lavinia; Spana, Sharon; Stone, Jonathan; Bisti, Silvia			Combining Neuroprotectants in a Model of Retinal Degeneration: No Additive Benefit	PLOS ONE			English	Article							SAFFRON SUPPLEMENTATION; LIGHT; PHOTOBIOMODULATION; DEATH; MECHANISMS; SURVIVAL; OXYGEN	The central nervous system undergoing degeneration can be stabilized, and in some models can be restored to function, by neuroprotective treatments. Photobiomodulation (PBM) and dietary saffron are distinctive as neuroprotectants in that they upregulate protective mechanisms, without causing measurable tissue damage. This study reports a first attempt to combine the actions of PBM and saffron. Our working hypothesis was that the actions of PBM and saffron in protecting retinal photoreceptors, in a rat light damage model, would be additive. Results confirmed the neuroprotective potential of each used separately, but gave no evidence that their effects are additive. Detailed analysis suggests that there is actually a negative interaction between PBM and saffron when given simultaneously, with a consequent reduction of the neuroprotection. Specific testing will be required to understand the mechanisms involved and to establish whether there is clinical potential in combining neuroprotectants, to improve the quality of life of people affected by retinal pathology, such as age-related macular degeneration, the major cause of blindness and visual impairment in older adults.	[Di Marco, Fabiana; Di Paolo, Mattia; Romeo, Stefania; Colecchi, Linda; Fiorani, Lavinia; Bisti, Silvia] Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy; [Spana, Sharon; Stone, Jonathan] Univ Sydney, Discipline Physiol, Sydney, NSW 2006, Australia; [Spana, Sharon; Stone, Jonathan] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Stone, Jonathan; Bisti, Silvia] Australian Natl Univ, ARC Ctr Excellence Vis Sci, Canberra, ACT, Australia	University of L'Aquila; University of Sydney; University of Sydney; Australian National University	Di Marco, F (corresponding author), Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy.	dm.fabiana@hotmail.it			Australian Research Council Centre of Excellence in Vision Science; Sir Zelman Cowen Universities Fund; Lord Mayor's Charitable Foundation; Australian Travel Awards for L'Aquila Researchers (ARIA); Ministero dell'Istruzione, dell'Universita e della Ricerca dedicato ai PRIN, Progetti di Ricerca di Interesse Nazionale (MIUR-PRIN)	Australian Research Council Centre of Excellence in Vision Science(Australian Research Council); Sir Zelman Cowen Universities Fund; Lord Mayor's Charitable Foundation; Australian Travel Awards for L'Aquila Researchers (ARIA); Ministero dell'Istruzione, dell'Universita e della Ricerca dedicato ai PRIN, Progetti di Ricerca di Interesse Nazionale (MIUR-PRIN)	This work was supported by the Australian Research Council Centre of Excellence in Vision Science, by the Sir Zelman Cowen Universities Fund and the Lord Mayor's Charitable Foundation, by Australian Travel Awards for L'Aquila Researchers (ARIA) to FDM and SR and by a Ministero dell'Istruzione, dell'Universita e della Ricerca dedicato ai PRIN, Progetti di Ricerca di Interesse Nazionale (MIUR-PRIN) (2010-2011) research grant to SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarracin R, 2011, INVEST OPHTH VIS SCI, V52, P3582, DOI 10.1167/iovs.10-6664; Begum R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057828; Bisti S, 2014, VISUAL NEUROSCI, V12, P1; Bowers F, 2001, INVEST OPHTH VIS SCI, V42, P804; Di Marco F, 2013, AM J NEURODEGENER DI, V2, P208; Eells JT, 2008, LECT NOTES ELECTR EN, V12, P39; Falsini B, 2010, INVEST OPHTH VIS SCI, V51, P6118, DOI 10.1167/iovs.09-4995; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Giaccio M, 2004, CRIT REV FOOD SCI, V44, P155, DOI 10.1080/10408690490441433; Maccarone R, 2008, INVEST OPHTH VIS SCI, V49, P1254, DOI 10.1167/iovs.07-0438; Marangoni D, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-228; Maslim J, 1997, INVEST OPHTH VIS SCI, V38, P1667; Natoli R, 2010, MOL VIS, V16, P1801; Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004; Purushothuman S, 2013, BRAIN RES, V1535, P61, DOI 10.1016/j.brainres.2013.08.047; Rutar M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-257; Stone J, 1999, PROG RETIN EYE RES, V18, P689, DOI 10.1016/S1350-9462(98)00032-9	17	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100389	10.1371/journal.pone.0100389	http://dx.doi.org/10.1371/journal.pone.0100389			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955576	Green Submitted, Green Published, gold			2022-12-25	WOS:000338917900046
J	Meng, HZ; Li, XC; Qiao, PH				Meng, Hongzhe; Li, Xiaochen; Qiao, Penghai			Population Structure, Historical Biogeography and Demographic History of the Alpine Toad Scutiger ningshanensis in the Tsinling Mountains of Central China	PLOS ONE			English	Article							HIGH GENETIC DIVERSITY; LAST GLACIAL MAXIMUM; SPECIES GROUP; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENETICS; LANDSCAPE GENETICS; AMPHIBIAN DECLINES; MITOCHONDRIAL-DNA; AREA CLADOGRAM; SALAMANDER	Population genetic structure, historical biogeography and historical demography of the alpine toad Scutiger ningshanensis were studied using the combined data mtDNA cytochrome b (cyt b) and the mtDNA cytochrome c oxidase subunit I (COI) as the molecular markers. This species has high genetic variation. There was a significant genetic differentiation among most populations. Three lineages were detected. The phylogenetic relationship analyses and the SAMOVA (spatial analysis of molecular variance) results showed significant phylogeographic structure. 82.15% genetic variation occurred among populations whereas differentiation within populations only contributed 17.85% to the total. Mantel test results showed a significant correlation between the pairwise calculated genetic distance and pairwise calculated geographical distance of the populations (regression coefficient = 0.001286, correlation coefficient = 0.77051, p (r(rand)>= r(obs)) = 0.0185<0.05), indicating the existence of isolation-by-distance pattern of genetic divergence for cyt b + COI sequence, which suggests that the distribution of genetic variation is due to geographical separation rather than natural selection. The population expansion or contraction and genetic differentiation between populations or lineages could be explained by topography and the repetitive uplifts of the Tsinling Mountains and the climatic cycles during the late Pliocene and Pleistocene. S. ningshanensis experienced a rapid population expansion about 40,000 years before present. The current decline in population size was probably caused by anthropogenic disturbance. Current populations of S. ningshanensis are from different refugia though the location of these refugia could not be determined in our study. Topography, climatic changes and repetitive population expansion/contraction together led to the high level of genetic variation in S. ningshanensis. A total of three management units (MUs) was determined, which must be considered when conservation policy is made in the future.	[Meng, Hongzhe; Li, Xiaochen; Qiao, Penghai] Shaanxi Normal Univ, Coll Life Sci, Coinnovat Ctr Qinba Reg Sustainable Dev, Xian, Peoples R China	Shaanxi Normal University	Li, XC (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Coinnovat Ctr Qinba Reg Sustainable Dev, Xian, Peoples R China.	xiaochen@snnu.edu.cn			National Natural Science Foundation of China [31071888]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by the National Natural Science Foundation of China (No. 31071888). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Avise JC, 2000, PHYLOGEOGRAPHY; Axelrod D, 1998, HIST MODERN FLORA CH; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bidlack AL, 2001, ANIM CONSERV, V4, P283, DOI 10.1017/S1367943001008885; BLAUSTEIN AR, 1994, CONSERV BIOL, V8, P60, DOI 10.1046/j.1523-1739.1994.08010060.x; Bryson RW, 2011, J BIOGEOGR, V38, P2299, DOI 10.1111/j.1365-2699.2011.02565.x; Bryson RW, 2011, J BIOGEOGR, V38, P697, DOI 10.1111/j.1365-2699.2010.02431.x; Carey C, 2003, AMPHIBIAN DECLINE: AN INTEGRATED ANALYSIS OF MULTIPLE STRESSOR EFFECTS, P153; Carstens BC, 2004, MOL ECOL, V13, P2557, DOI 10.1111/j.1365-294X.2004.02250.x; Carstens BC, 2005, EVOLUTION, V59, P1639, DOI 10.1554/04-661.1; Chen Xiao-Hong, 2009, Acta Zootaxonomica Sinica, V34, P647; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Collins JP, 2003, DIVERS DISTRIB, V9, P89, DOI 10.1046/j.1472-4642.2003.00012.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DeChaine EG, 2004, EVOLUTION, V58, P113, DOI 10.1111/j.0014-3820.2004.tb01578.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fang Rengsheng, 1985, Acta Herpetologica Sinica, V4, P305; Fei L., 2009, FAUNA SIN; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Fu YX, 1997, GENETICS, V147, P915; Guillot G, 2013, METHODS ECOL EVOL, V4, P336, DOI 10.1111/2041-210x.12018; Guo XR, 2000, J NW FORESTRY U, V15, P71; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hayes John P., 1992, Systematic Biology, V41, P331, DOI 10.2307/2992570; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Hillis David M., 1996, P321; Huang YZ, 1985, ACTA BIOL PLATEAU SI, V4, P77; Jijun L., 2001, QUAT SCI, V21, P381, DOI DOI 10.3321/J.ISSN:1001-7410.2001.05.001; Ju LX, 2007, PALAEOGEOGR PALAEOCL, V248, P376, DOI 10.1016/j.palaeo.2006.12.012; Knowles LL, 2009, ANNU REV ECOL EVOL S, V40, P593, DOI 10.1146/annurev.ecolsys.38.091206.095702; Knowles LL, 2002, MOL ECOL, V11, P2623, DOI 10.1046/j.1365-294X.2002.01637.x; Kraaijeveld-Smit FJL, 2005, MOL ECOL, V14, P3307, DOI 10.1111/j.1365-294X.2005.02614.x; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Kumbar SM, 2001, J BIOSCIENCE, V26, P265, DOI 10.1007/BF02703650; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; Liang G, 1989, J SHAANXI NORMAL U N, V17, P92; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; [刘康 Liu Kang], 2004, [生态学杂志, Chinese Journal of Ecology], V23, P157; Liu YH, 1974, J SHAANXI NORM U NAT, P74; Liu YM, 1985, B TIANJIN I GEOL MIN, V14, P1; Lu Yu-Yan, 2007, Acta Zoologica Sinica, V53, P383; Ma CC, 2007, J SUZHOU U, V22, p[23, 109]; Ma Q., 1988, J GLACIOL GEOCRYOL, V10, P66; Macey JR, 2001, MOL PHYLOGENET EVOL, V19, P131, DOI 10.1006/mpev.2000.0908; Macey JR, 1999, MOL PHYLOGENET EVOL, V12, P320, DOI 10.1006/mpev.1999.0641; Macey JR, 1998, MOL PHYLOGENET EVOL, V9, P80, DOI 10.1006/mpev.1997.0440; Macey JR, 1998, MOL PHYLOGENET EVOL, V10, P118, DOI 10.1006/mpev.1997.0478; Maddison WP, 2011, MESQUITE MODULAR SYS; Martel C, 2004, J EXP MAR BIOL ECOL, V305, P155, DOI 10.1016/j.jembe.2003.11.011; Masel J, 2011, CURR BIOL, V21, pR837, DOI 10.1016/j.cub.2011.08.007; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.es.18.110187.001413; Murphy MA, 2010, MOL ECOL, V19, P3634, DOI 10.1111/j.1365-294X.2010.04723.x; NEI M, 2003, MOL EVOLUTION PHYLOG; [潘保田 Pan Baotian], 2004, [第四纪研究, Quaternary Sciences], V24, P50; Pinot S, 1999, CLIM DYNAM, V15, P857, DOI 10.1007/s003820050318; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rost KT, 1994, J XIAN COLL GEOL, V16, P39; Rowe G, 2000, OIKOS, V88, P641, DOI 10.1034/j.1600-0706.2000.880321.x; Schneider S, 1999, GENETICS, V152, P1079; Shepard DB, 2009, MOL ECOL, V18, P2243, DOI 10.1111/j.1365-294X.2009.04164.x; Shepard DB, 2008, MOL ECOL, V17, P5315, DOI 10.1111/j.1365-294X.2008.03998.x; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Smith CI, 2005, MOL ECOL, V14, P3049, DOI 10.1111/j.1365-294X.2005.02647.x; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Spear SF, 2005, MOL ECOL, V14, P2553, DOI 10.1111/j.1365-294X.2005.02573.x; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAJIMA F, 1993, MECHANISMS OF MOLECULAR EVOLUTION, P37; Tajima F, 1996, GENETICS, V143, P1457; TAJIMA F, 1989, GENETICS, V123, P585; Takahashi K, 2000, MOL BIOL EVOL, V17, P1251, DOI 10.1093/oxfordjournals.molbev.a026408; Tallmon DA, 2000, COPEIA, P27, DOI 10.1643/0045-8511(2000)2000[0027:GDALTS]2.0.CO;2; Teng ZH, 1996, GEOL SHAANXI, V14, P33; Tian ZS, 1990, GEOGR RES, V9, P15; Torres-Diaz C, 2007, ANN BOT-LONDON, V100, P75, DOI 10.1093/aob/mcm073; Walker George F., 2008, Bulletin Southern California Academy of Sciences, V107, P158, DOI 10.3160/0038-3872-107.3.158; Wang B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041579; Wang GZ., 1984, GEOLOGY SHAANXI, V2, P47; Wang HW, 2006, MOL ECOL, V15, P4109, DOI 10.1111/j.1365-294X.2006.03086.x; Weisrock DW, 2001, MOL PHYLOGENET EVOL, V18, P434, DOI 10.1006/mpev.2000.0905; Xia ZK, 1990, J GLACIOL GEOCRYOL, V12, P155; Xue DW, 2004, ACTA BOT SIN, V46, P1163; [薛祥煦 Xue Xiangxu], 2004, [第四纪研究, Quaternary Sciences], V24, P82; [薛祥煦 Xue Xiangxu], 2002, [西北大学学报. 自然科学版, Journal of Northwest University], V32, P451; Xue XX, 1996, GEOL REV, V42, P30; Yuan SL, 2006, MOL ECOL, V15, P2119, DOI 10.1111/j.1365-294X.2006.02875.x; Zhang JL, 1997, CHINESE BIODIVERSITY, V5, P155; ZHANG Y, 1978, ACTA ZOOL SINICA, V24, P196; Zhao ZZ, 1997, J GEOMECH, V3, P18	104	7	11	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100729	10.1371/journal.pone.0100729	http://dx.doi.org/10.1371/journal.pone.0100729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956389	gold, Green Published, Green Submitted			2022-12-25	WOS:000338917900089
J	Chaiyasap, P; Kulawonganunchai, S; Srichomthong, C; Tongsima, S; Suphapeetiporn, K; Shotelersuk, V				Chaiyasap, Pongsathorn; Kulawonganunchai, Supasak; Srichomthong, Chalurmpon; Tongsima, Sissades; Suphapeetiporn, Kanya; Shotelersuk, Vorasuk			Whole Genome and Exome Sequencing of Monozygotic Twins with Trisomy 21, Discordant for a Congenital Heart Defect and Epilepsy	PLOS ONE			English	Article							DOWN-SYNDROME; CHROMOSOME-21; DISEASE	Congenital heart defects (CHD) occur in 40% of patients with trisomy 21, while the other 60% have a structurally normal heart. This suggests that the increased dosage of genes on chromosome 21 is a risk factor for abnormal heart development. Interaction of genes on chromosome 21 or their gene products with certain alleles of genes on other chromosomes could contribute to CHD. Here, we identified a pair of monozygotic twins with trisomy 21 but discordant for a ventricular septal defect and epilepsy. Twin-zygosity was confirmed by microsatellite genotyping. We hypothesized that some genetic differences from post-twinning mutations caused the discordant phenotypes. Thus, next generation sequencing (NGS) technologies were applied to sequence both whole genome and exome of their leukocytes. The post-analyses of the sequencing data revealed 21 putative discordant exonic variants between the twins from either genome or exome data. However, of the 15 variants chosen for validation with conventional Sanger sequencing, these candidate variants showed no differences in both twins. The fact that no discordant DNA variants were found suggests that sequence differences of DNA from leukocytes of monozygotic twins might be extremely rare. It also emphasizes the limitation of the current NGS technology in identifying causative genes for discordant phenotypes in monozygotic twins.	[Chaiyasap, Pongsathorn; Kulawonganunchai, Supasak] Chulalongkorn Univ, Fac Grad Sch, Interdept Biomed Sci, Bangkok, Thailand; [Kulawonganunchai, Supasak; Tongsima, Sissades] Natl Ctr Genet Engn & Biotechnol, Genome Inst, Khlong Luang, Pathum Thani, Thailand; [Srichomthong, Chalurmpon; Suphapeetiporn, Kanya; Shotelersuk, Vorasuk] Chulalongkorn Univ, Fac Med, Dept Pediat, Ctr Excellence Med Genet, Bangkok 10330, Thailand; [Srichomthong, Chalurmpon; Suphapeetiporn, Kanya; Shotelersuk, Vorasuk] King Chulalongkorn Mem Hosp, Excellence Ctr Med Genet, Bangkok, Thailand	Chulalongkorn University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chulalongkorn University; Chulalongkorn University	Suphapeetiporn, K (corresponding author), Chulalongkorn Univ, Fac Med, Dept Pediat, Ctr Excellence Med Genet, Bangkok 10330, Thailand.	Kanya.Su@chula.ac.th	; Tongsima, Sissades/F-4891-2011	Shotelersuk, Vorasuk/0000-0002-1856-0589; Tongsima, Sissades/0000-0002-1491-1839	Ratchadapiseksomphot Endowment Fund of Chulalongkorn University [RES560530177-HR]; Thailand Research Fund [RTA5680003, RSA5480022, RSA5480026]; Royal Golden Jubilee Ph.D. Program [PHD/0071/2552]; Research Chair Grants by the National Science and Technology Development Agency (NSTDA)	Ratchadapiseksomphot Endowment Fund of Chulalongkorn University; Thailand Research Fund(Thailand Research Fund (TRF)); Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); Research Chair Grants by the National Science and Technology Development Agency (NSTDA)	This study was funded through Ratchadapiseksomphot Endowment Fund of Chulalongkorn University (RES560530177-HR) awarded to CS, VS and KS and through the Thailand Research Fund (RTA5680003, RSA5480022). PC is a recipient of Royal Golden Jubilee Ph.D. Program (Grant No. PHD/0071/2552). ST and SK were supported in part by the 2011 Research Chair Grants issued by the National Science and Technology Development Agency (NSTDA) and the Thailand Research Fund (RSA5480026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Antonarakis SE, 1998, GENOMICS, V51, P1, DOI 10.1006/geno.1998.5335; Aparicio SAJR, 2010, J PATHOL, V220, P307, DOI 10.1002/path.2636; Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; Brickell KL, 2007, J NEUROL NEUROSUR PS, V78, P1050, DOI 10.1136/jnnp.2006.113803; Chahrour MH, 2012, PLOS GENET, V8, P236, DOI 10.1371/journal.pgen.1002635; Erlich Y, 2011, TWIN RES HUM GENET, V14, P137, DOI 10.1375/twin.14.2.137; Imelfort Michael, 2009, V513, P345, DOI 10.1007/978-1-59745-427-8_18; Ketelaar ME, 2012, CLIN GENET, V81, P325, DOI 10.1111/j.1399-0004.2011.01795.x; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kuhlenbaumer G, 2011, HUM MUTAT, V32, P144, DOI 10.1002/humu.21400; Langdon J, 1966, HEREDITY, V21, P695; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Maiti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017125; Makrythanasis P, 2013, CLIN GENET, V84, P422, DOI 10.1111/cge.12272; Nachman MW, 2000, GENETICS, V156, P297; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Reumers J, 2012, NAT BIOTECHNOL, V30, P61, DOI 10.1038/nbt.2053; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; Solomon BD, 2013, MOL SYNDROMOL, V4, P27, DOI 10.1159/000345406	23	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100191	10.1371/journal.pone.0100191	http://dx.doi.org/10.1371/journal.pone.0100191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950249	Green Published, Green Submitted, gold			2022-12-25	WOS:000338276300047
J	Li, HY; Zhang, Y; Yi, ZHZ; Huang, DH; Wei, SH				Li, Hongyang; Zhang, Yan; Yi, Zuohuizi; Huang, Dehui; Wei, Shihui			Frequency of Autoantibodies and Connective Tissue Diseases in Chinese Patients with Optic Neuritis	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PRIMARY SJOGRENS-SYNDROME; MULTIPLE-SCLEROSIS; NEUROMYELITIS-OPTICA; CLASSIFICATION CRITERIA; OLIGODENDROCYTE GLYCOPROTEIN; DIAGNOSTIC-CRITERIA; ANTIBODIES; AUTOIMMUNITY; DISTINCTION	Background: Optic neuritis (ON) is often associated with other clinical or serological markers of connective tissue diseases (CTDs). To date, the effects of autoantibodies on ON are not clear. Purpose: To assess the prevalence, clinical patterns, and short outcomes of autoantibodies and Sjogren's syndrome (SS) involvement in Chinese ON patients and evaluate the relationship between ON, including their subtypes, and autoantibodies. Methods: A total of 190 ON patients were divided into recurrent ON (RON), bilateral ON (BON), and isolated monocular ON (ION). Demographic, clinical, and serum autoantibodies data were compared between them with and without SS involvement. Serum was drawn for antinuclear antibody (ANA), extractable nuclear antigen antibodies (SSA/SSB), rheumatoid factor (RF), anticardiolipin antibodies (ACA), and anti-double-stranded DNA antibody (A-ds DNA), anticardiolipin antibody (ACLs), anti-beta 2-glycoprotein I (beta 2-GPI) and Aquaporin-4 antibodies (AQP4-Ab). Spectral-domain optical coherence tomography (SD-OCT) was used to evaluate the atrophy of the optic nerve. Results: 68 patients (35.79%) had abnormal autoantibodies, 26(13.68%) patients met diagnostic criteria for CTDs, including 15(7.89%) patients meeting the criteria for SS. Antibodies including SSA/SSB 23 (30.26%) (p1 and p 2<0.001) and AQP4-Ab10 (13.16%) (p1 = 0.044, p2 = 0.01) were significantly different in patients in the RON group when compared with those in the BON (P1 = RON VS ION) and ION (p2 = RON VS ION) groups. SS was more common in RON patients (p1 = 0.04, p2 = 0.028). There was no significant difference between SSA/SSB positive and negative patients in disease characteristics or severity. Similar results were obtained when SS was diagnosed in SSA/SSB positive patients. Conclusion: RON and BON were more likely associated with abnormal autoantibodies; furthermore, AQP4 antibody, SSA/SSB and SS were more common in the RON patients. AQP4 antibodydetermination is crucial in RON patients who will develop NMO. However, when compared with other autoantibodies, SSA/SSB detected in patients was not significantly associated with disease characteristics or severity.	[Li, Hongyang; Wei, Shihui] Chinese Peoples Liberat Army Gen Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Zhang, Yan] Gen Hosp Beijing Mil Reg, Dept Ophthalmol, Beijing, Peoples R China; [Yi, Zuohuizi] Wuhan Univ, Peoples Hosp, Dept Ophthalmol, Wuhan 430072, Peoples R China; [Huang, Dehui] Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Seventh Medical Center of Chinese PLA General Hospital; Wuhan University; Chinese People's Liberation Army General Hospital	Wei, SH (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Ophthalmol, Beijing, Peoples R China.	weishihui1958@163.com			National the 12th Five-Year Plan Science and Technology support project "clinical epidemiological studies of optic neuritis [2012BAI08B06]; China Postdoctoral Science Foundation [2013M532109]	National the 12th Five-Year Plan Science and Technology support project "clinical epidemiological studies of optic neuritis; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work is supported by National the 12th Five-Year Plan Science and Technology support project "clinical epidemiological studies of optic neuritis (Number: 2012BAI08B06) and China Postdoctoral Science Foundation (NO:2013M532109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; [Anonymous], 1991, ARCH OPHTHALMOL, V109, P1673; BECK RW, 1992, NEW ENGL J MED, V326, P581, DOI 10.1056/NEJM199202273260901; Bejot Y, 2008, REV NEUROL-FRANCE, V164, P1044, DOI 10.1016/j.neurol.2008.04.017; Benoilid A, 2013, MULT SCLER; Bichuetti DB, 2009, MULT SCLER, V15, P613, DOI 10.1177/1352458508101935; Burgoyne PS, 2002, CYTOGENET GENOME RES, V99, P252, DOI 10.1159/000071601; Capel B, 1999, MECH DEVELOP, V84, P127, DOI 10.1016/S0925-4773(99)00047-7; Castro J, 2008, AUTOIMMUN REV, V7, P345, DOI 10.1016/j.autrev.2008.01.001; Cojocaru Inimioara Mihaela, 2011, Rom J Intern Med, V49, P301; de Seze J, 2001, NEUROLOGY, V57, P1359, DOI 10.1212/WNL.57.8.1359; DEROSBO NK, 1993, J CLIN INVEST, V92, P2602, DOI 10.1172/JCI116875; Eckstein C, 2012, J NEUROL, V259, P801, DOI 10.1007/s00415-011-6240-5; Etemadifar M, 2012, INT J PREVENTIVE MED, V3, P612; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Gan FY, 2014, CLIN RHEUMATOL, V33, P355, DOI 10.1007/s10067-013-2444-7; Garcia-Martin E, 2014, OPHTHALMOLOGY, V121, P573, DOI 10.1016/j.ophtha.2013.09.035; Gono T, 2011, CLIN RHEUMATOL, V30, P485, DOI 10.1007/s10067-010-1458-7; Heinzlef O, 2002, J NEUROL NEUROSUR PS, V72, P647, DOI 10.1136/jnnp.72.5.647; Hinson SR, 2010, NEUROSCIENCE, V168, P1009, DOI 10.1016/j.neuroscience.2009.08.032; HOFFMAN GS, 1992, ANN INTERN MED, V116, P488, DOI 10.7326/0003-4819-116-6-488; Hummers LK, 2004, NEUROLOGY, V62, P147, DOI 10.1212/01.WNL.0000101715.32569.1A; International Study Group for Behcet's Disease, 1990, LANCET, V335, P1078; Jarius S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-14; Jarius S, 2010, J NEUROL SCI, V298, P158, DOI 10.1016/j.jns.2010.07.011; Javed A, 2008, MULT SCLER, V14, P809, DOI 10.1177/1352458508088941; Kurne A, 2008, J NEUROL, V255, P1625, DOI 10.1007/s00415-008-0882-y; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Mader S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010455; Massara A, 2010, RHEUMATOLOGY, V49, P1540, DOI 10.1093/rheumatology/keq111; Matiello M, 2008, NEUROLOGY, V70, P2197, DOI 10.1212/01.wnl.0000303817.82134.da; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Mochizuki A, 2000, NEUROLOGY, V54, P1391, DOI 10.1212/WNL.54.6.1391; Nielsen NM, 2011, HUM REPROD, V26, P1555, DOI 10.1093/humrep/der105; Petzold A, 2010, J NEUROL NEUROSUR PS, V81, P109, DOI 10.1136/jnnp.2008.146894; Pittock SJ, 2008, ARCH NEUROL-CHICAGO, V65, P78, DOI 10.1001/archneurol.2007.17; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ramirez M, 2009, MED CLIN-BARCELONA, V133, P349, DOI 10.1016/j.medcli.2008.12.027; Ramos-Casals M, 2007, J RHEUMATOL, V34, P754; Rostasy K, 2012, ARCH NEUROL-CHICAGO, V69, P752, DOI 10.1001/archneurol.2011.2956; SANDBERGWOLLHEIM M, 1992, NEUROLOGY, V42, P845, DOI 10.1212/WNL.42.4.845; Sato DK, 2014, NEUROLOGY, V82, P474, DOI 10.1212/WNL.0000000000000101; Silva FR, 2013, ARQ BRAS OFTALMOL, V76, P170, DOI 10.1590/S0004-27492013000300008; Solomon A, 2013, NY TIMES BK REV, P8; Spadaro M, 1999, MULT SCLER, V5, P121, DOI 10.1191/135245899678847211; Szmyrka-Kaczmarek M, 2012, LUPUS, V21, P412, DOI 10.1177/0961203311427550; Tan Petrina, 2012, J Med Case Rep, V6, P401, DOI 10.1186/1752-1947-6-401; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Waschbisch A, 2013, J NEUROL SCI, V331, P72, DOI 10.1016/j.jns.2013.05.012; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2012, MULT SCLER J, V18, P5, DOI 10.1177/1352458511431077; Yang Y, 2013, J CLIN NEUROSCI, V20, P94, DOI 10.1016/j.jocn.2012.06.006	53	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99323	10.1371/journal.pone.0099323	http://dx.doi.org/10.1371/journal.pone.0099323			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950188	Green Published, gold, Green Submitted			2022-12-25	WOS:000338276300013
J	Wong, YYE; Hyde, Z; McCaul, KA; Yeap, BB; Golledge, J; Hankey, GJ; Flicker, L				Wong, Yuen Y. E.; Hyde, Zoe; McCaul, Kieran A.; Yeap, Bu B.; Golledge, Jonathan; Hankey, Graeme J.; Flicker, Leon			In Older Men, Lower Plasma 25-Hydroxyvitamin D Is Associated with Reduced Incidence of Prostate, but Not Colorectal or Lung Cancer	PLOS ONE			English	Article							VITAMIN-D SUPPLEMENTATION; D METABOLITE LEVELS; 1,25-DIHYDROXYVITAMIN D-3; SUBSEQUENT DEVELOPMENT; RISK; HEALTH; COHORT; POLYMORPHISMS; POPULATION; PREVALENCE	Context and objective: Prostate, colorectal and lung cancers are common in men. In this study, we aimed to determine whether vitamin D status is associated with the incidence of these cancers in older men. Design: Prospective cohort study. Setting and participants: 4208 older men aged 70-88 years in Perth, Western Australia Main outcome measures: Plasma 25-hydroxyvitamin D [25(OH)D] concentration was measured by immunoassay. New diagnoses of prostate, colorectal and lung cancers were determined via electronic record linkage. Results: During a mean follow-up of 6.7 +/- 1.8 years, there were 315, 117 and 101 new diagnoses of prostate, colorectal and lung cancer. In multivariate competing risks proportional hazards models, every 10 nmol/l decrease in 25(OH)D concentration was associated with a 4% reduction in prostate cancer incidence (sub-hazard ratio [SHR] 0.96, 95% confidence interval [CI] 0.92-1.00). Every halving of 25(OH)D concentration was associated with a 21% reduction in incident prostate cancer in multivariate analysis (SHR 0.79, 95% CI 0.63-0.99). Following exclusion of prostate cancer cases diagnosed within 3 years of blood sampling, low 25(OH)D <50 nmol/l was associated with lower incident prostate cancer, and higher 25(OH)D >75 nmol/l was associated with higher incidence, when compared to the reference range 50-75 nmol/l, respectively (p = 0.027). Significant associations were also observed when 25(OH)D was modeled as a quantitative variable. No associations were observed between plasma 25(OH)D concentration with incidence of colorectal or lung cancer. Conclusion: Lower levels of vitamin D may reduce prostate cancer risk in older men. By contrast, levels of vitamin D did not predict incidence of colorectal or lung cancers. Further studies are needed to determine whether a causal relationship exists between vitamin D and prostate cancer in ageing men.	[Wong, Yuen Y. E.; Hyde, Zoe; Flicker, Leon] Western Australian Inst Med Res, Med Res Ctr, Western Australian Ctr Hlth & Ageing, Perth, WA, Australia; [Wong, Yuen Y. E.; Hyde, Zoe; McCaul, Kieran A.; Yeap, Bu B.; Hankey, Graeme J.; Flicker, Leon] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Yeap, Bu B.] Fremantle Hosp, Dept Endocrinol & Diabet, Perth, WA, Australia; [Golledge, Jonathan] James Cook Univ, Sch Med & Dent, Queensland Res Ctr Peripheral Vasc Dis, Vasc Biol Unit, Townsville, Qld 4811, Australia; [Golledge, Jonathan] Townsville Hosp, Dept Vasc & Endovasc Surg, Townsville, Qld, Australia; [Hankey, Graeme J.] Sir Charles Gairdner Hosp, Dept Neurol, Perth, WA, Australia	University of Western Australia; University of Western Australia; James Cook University; University of Western Australia	Wong, YYE (corresponding author), Western Australian Inst Med Res, Med Res Ctr, Western Australian Ctr Hlth & Ageing, Perth, WA, Australia.	elizabeth.wong@uwa.edu.au; leon.flicker@uwa.edu.au	golledge, jonathan/I-2371-2013; Hankey, Graeme J/H-4968-2014; Hyde, Zoë/B-6411-2009; Flicker, Leon/AAE-1530-2022; McCaul, Kieran A/B-8751-2008	Hankey, Graeme J/0000-0002-6044-7328; Hyde, Zoë/0000-0002-5985-1729; Flicker, Leon/0000-0002-3650-0475; golledge, jonathan/0000-0002-5779-8848	National Health and Medical Research Council (NHMRC) of Australia [279408, 379600, 404963, 634492]; Australian Postgraduate Awards Scholarship through University of Western Australia	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Awards Scholarship through University of Western Australia	This work was supported by funding from the National Health and Medical Research Council (NHMRC) of Australia (Grant numbers 279408, 379600, 404963 and 634492). YYE Wong was recipient of the Australian Postgraduate Awards Scholarship through the University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal S, 2013, CLIN CHEM, V59, P771, DOI 10.1373/clinchem.2012.201939; Ahn J, 2008, JNCI-J NATL CANCER I, V100, P796, DOI 10.1093/jnci/djn152; Ahonen MH, 2000, CANCER CAUSE CONTROL, V11, P847, DOI 10.1023/A:1008923802001; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Baeke F, 2008, MOL ASPECTS MED, V29, P376, DOI 10.1016/j.mam.2008.05.004; Barreto AM, 2000, CANCER EPIDEM BIOMAR, V9, P265; Beer TM, 2004, CANCER EPIDEM BIOMAR, V13, P2225; BRAUN MM, 1995, AM J EPIDEMIOL, V142, P608, DOI 10.1093/oxfordjournals.aje.a117682; Cancer Research UK, 2011, CANCERSTATS CANC WOR; Chapuy MC, 1997, OSTEOPOROSIS INT, V7, P439, DOI 10.1007/s001980050030; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chiang KC, 2013, ANTI-CANCER AGENT ME, V13, P126, DOI 10.2174/187152013804487443; CORDER EH, 1993, CANCER EPIDEM BIOMAR, V2, P467; Dawson-Hughes B, 2010, OSTEOPOROSIS INT, V21, P1151, DOI 10.1007/s00198-010-1285-3; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gann PH, 1996, CANCER EPIDEM BIOMAR, V5, P121; Holick MF, 2006, MAYO CLIN PROC, V81, P353, DOI 10.4065/81.3.353; Hollis BW, 2013, J STEROID BIOCHEM, V136, P233, DOI 10.1016/j.jsbmb.2012.11.012; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Jenab M, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5500; Kilkkinen A, 2008, CANCER EPIDEM BIOMAR, V17, P3274, DOI 10.1158/1055-9965.EPI-08-0199; Lazzeroni M, 2013, ANTI-CANCER AGENT ME, V13, P118, DOI 10.2174/187152013804487281; Li HJ, 2007, PLOS MED, V4, P562, DOI 10.1371/journal.pmed.0040103; Ma YL, 2011, J CLIN ONCOL, V29, P3775, DOI 10.1200/JCO.2011.35.7566; Mikhak B, 2007, PROSTATE, V67, P911, DOI 10.1002/pros.20570; Nakagawa K, 2005, CARCINOGENESIS, V26, P1044, DOI 10.1093/carcin/bgi049; Nomura AMY, 1998, CANCER CAUSE CONTROL, V9, P425, DOI 10.1023/A:1008875819232; Norman PE, 2009, INT J EPIDEMIOL, V38, P48, DOI 10.1093/ije/dyn041; Norton K., 2000, ANTHROPOMETRICA, V2, P27; Ordonez-Mena JM, 2013, CANCER EPIDEM BIOMAR, V22, P905, DOI 10.1158/1055-9965.EPI-12-1332; Otani T, 2007, BRIT J CANCER, V97, P446, DOI 10.1038/sj.bjc.6603892; Pilz S, 2013, ANTI-CANCER AGENT ME, V13, P107, DOI 10.2174/187152013804487407; Ranasinghe W, 2013, BJU INT; Schwartz GG, 1998, CANCER EPIDEM BIOMAR, V7, P391; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Tuohimaa P, 2004, INT J CANCER, V108, P104, DOI 10.1002/ijc.11375; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; Weinstein SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020796; Whidatch LW, 2002, MOL BIOL, V81, P135; Wong YYE, 2013, EUR J VASC ENDOVASC, V45, P657, DOI 10.1016/j.ejvs.2013.03.015; Wong YY, 2013, J CLIN ENDOCRINOL ME; Woolcott CG, 2010, CANCER EPIDEM BIOMAR, V19, P130, DOI 10.1158/1055-9965.EPI-09-0475; Wu K, 2007, J NATL CANCER I, V99, P1120, DOI 10.1093/jnci/djm038	44	27	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99954	10.1371/journal.pone.0099954	http://dx.doi.org/10.1371/journal.pone.0099954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949795	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000338276300025
J	Alonso, BD; Tobon, SH; Suarez, PD; Flores, JG; Carrillo, BD; Perez, EB				de Celis Alonso, Benito; Hidalgo Tobon, Silvia; Dies Suarez, Pilar; Flores, Julio Garcia; de Celis Carrillo, Benito; Barragan Perez, Eduardo			A Multi-Methodological MR Resting State Network Analysis to Assess the Changes in Brain Physiology of Children with ADHD	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; LOW-FREQUENCY FLUCTUATION; FUNCTIONAL CONNECTIVITY; REGIONAL HOMOGENEITY; CINGULATE CORTEX; TEMPORAL CORTEX; DEFAULT-MODE; FMRI; ACTIVATION	The purpose of this work was to highlight the neurological differences between the MR resting state networks of a group of children with ADHD (pre-treatment) and an age-matched healthy group. Results were obtained using different image analysis techniques. A sample of n = 46 children with ages between 6 and 12 years were included in this study (23 per cohort). Resting state image analysis was performed using ReHo, ALFF and ICA techniques. ReHo and ICA represent connectivity analyses calculated with different mathematical approaches. ALFF represents an indirect measurement of brain activity. The ReHo and ICA analyses suggested differences between the two groups, while the ALFF analysis did not. The ReHo and ALFF analyses presented differences with respect to the results previously reported in the literature. ICA analysis showed that the same resting state networks that appear in healthy volunteers of adult age were obtained for both groups. In contrast, these networks were not identical when comparing the healthy and ADHD groups. These differences affected areas for all the networks except the Right Memory Function network. All techniques employed in this study were used to monitor different cerebral regions which participate in the phenomenological characterization of ADHD patients when compared to healthy controls. Results from our three analyses indicated that the cerebellum and mid-frontal lobe bilaterally for ReHo, the executive function regions in ICA, and the precuneus, cuneus and the clacarine fissure for ALFF, were the "hubs" in which the main inter-group differences were found. These results do not just help to explain the physiology underlying the disorder but open the door to future uses of these methodologies to monitor and evaluate patients with ADHD.	[de Celis Alonso, Benito] Benemerita Univ Autonoma Puebla, Fac Math & Phys, Puebla, Mexico; [Hidalgo Tobon, Silvia; Dies Suarez, Pilar] Hosp Infantil Mexico Dr Federico Gomez, Dept Imaging, Mexico City, DF, Mexico; [Flores, Julio Garcia] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [de Celis Carrillo, Benito] Univ Leon, Sch Ind Engn, E-24071 Leon, Castilla & Leon, Spain; [Barragan Perez, Eduardo] Hosp Infantil Mexico Dr Federico Gomez, Dept Neurol, Mexico City, DF, Mexico	Benemerita Universidad Autonoma de Puebla; Hospital Infantil de Mexico Federico Gomez; Northwestern University; Feinberg School of Medicine; Universidad de Leon; Hospital Infantil de Mexico Federico Gomez	Alonso, BD (corresponding author), Benemerita Univ Autonoma Puebla, Fac Math & Phys, Puebla, Mexico.	benileon@yahoo.com	, db/GRS-6835-2022; , de Celis Alonso Benito/AAP-4512-2021	, de Celis Alonso Benito/0000-0003-2124-1084; , Eduardo Javier/0000-0003-1019-8017				Anderson A., 2013, NEUROIMAGE; [Anonymous], BIOL PSYCHIAT; Arnsten AFT, 2005, BIOL PSYCHIAT, V57, P1377, DOI 10.1016/j.biopsych.2004.08.019; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Berquin PC, 1998, NEUROLOGY, V50, P1087, DOI 10.1212/WNL.50.4.1087; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Born P, 1998, PEDIATR RES, V44, P578, DOI 10.1203/00006450-199810000-00018; Calhoun VD, 2004, MAGN RESON IMAGING, V22, P1181, DOI 10.1016/j.mri.2004.09.004; Cao Qing-jiu, 2007, Beijing Da Xue Xue Bao Yi Xue Ban, V39, P261; Cao QJ, 2006, NEUROREPORT, V17, P1033, DOI 10.1097/01.wnr.0000224769.92454.5d; Castellanos FX, 2012, TRENDS COGN SCI, V16, P17, DOI 10.1016/j.tics.2011.11.007; Castellanos FX, 2009, CAN J PSYCHIAT, V54, P665, DOI 10.1177/070674370905401003; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Cubillo A, 2014, CEREB CORTEX, V24, P174, DOI 10.1093/cercor/bhs296; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Alonso BD, 2008, CEREB CORTEX, V18, P1314, DOI 10.1093/cercor/bhm163; Dey S, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00075; Ferreira LK, 2013, NEUROSCI BIOBEHAV R, V37, P384, DOI 10.1016/j.neubiorev.2013.01.017; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Hampson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044067; He HJ, 2012, NEUROIMAGE, V59, P2339, DOI 10.1016/j.neuroimage.2011.09.018; Kobel M, 2010, PSYCHIAT RES-NEUROIM, V183, P230, DOI 10.1016/j.pscychresns.2010.03.010; Konrad K, 2010, HUM BRAIN MAPP, V31, P904, DOI 10.1002/hbm.21058; Lenz D, 2010, NEUROPSYCHOLOGIA, V48, P1985, DOI 10.1016/j.neuropsychologia.2010.03.019; Li L, 2013, NEUROPSYCHOLOGIA, V51, P1571, DOI 10.1016/j.neuropsychologia.2013.05.011; Li Q, 2013, CHINESE MED J-PEKING, V126, P734, DOI 10.3760/cma.j.issn.0366-6999.20120960; Li YY, 2013, CEREB CORTEX, V23, P1988, DOI 10.1093/cercor/bhs185; LOU H, 1990, BRAIN DEV-JPN, V12, P301, DOI 10.1016/S0387-7604(12)80310-X; Lv YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064115; Mueller Andreas, 2010, Nonlinear Biomed Phys, V4 Suppl 1, pS1, DOI 10.1186/1753-4631-4-S1-S1; Pievani M, 2011, LANCET NEUROL, V10, P829, DOI 10.1016/S1474-4422(11)70158-2; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Power JD, 2013, NEUROIMAGE, V76, P439, DOI 10.1016/j.neuroimage.2012.03.017; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Robinson SD, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00724; Rubia K, 2011, NEUROPSYCHOPHARMACOL, V36, P1575, DOI 10.1038/npp.2011.30; SATTERFIELD JH, 1984, BIOL PSYCHIAT, V19, P973; Skidmore FM, 2013, NEUROIMAGE, V81, P484, DOI 10.1016/j.neuroimage.2011.07.012; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Spinelli S, 2011, J CHILD PSYCHOL PSYC, V52, P808, DOI 10.1111/j.1469-7610.2010.02356.x; Sripada C, 2014, HUM BRAIN MAPP; Takeuchi H., 2012, CORTEX; Tang JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071061; Teicher MH, 2000, NAT MED, V6, P470, DOI 10.1038/74737; Tian LX, 2008, BRAIN DEV-JPN, V30, P342, DOI 10.1016/j.braindev.2007.10.005; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Turner JA, 2012, PSYCHIAT RES-NEUROIM, V201, P253, DOI 10.1016/j.pscychresns.2011.09.012; Uddin LQ, 2008, J NEUROSCI METH, V169, P249, DOI 10.1016/j.jneumeth.2007.11.031; Wolf RC, 2009, HUM BRAIN MAPP, V30, P2252, DOI 10.1002/hbm.20665; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Yu DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054516; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zeng HW, 2013, EPILEPSIA, V54, P658, DOI 10.1111/epi.12066; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	57	20	20	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99119	10.1371/journal.pone.0099119	http://dx.doi.org/10.1371/journal.pone.0099119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945408	gold, Green Published			2022-12-25	WOS:000340721500010
J	Mao, FF; Yang, XF; Fu, L; Lv, XD; Zhang, Z; Wu, WQ; Yang, SQ; Zhou, ZC; Zhang, L; Zhao, Y				Mao, Feifei; Yang, Xiaofeng; Fu, Lin; Lv, Xiangdong; Zhang, Zhao; Wu, Wenqing; Yang, Siqi; Zhou, Zhaocai; Zhang, Lei; Zhao, Yun			The Kto-Skd Complex Can Regulate ptc Expression by Interacting with Cubitus interruptus (Ci) in the Hedgehog Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN MEDIATOR COMPLEX; TRANSCRIPTIONAL ACTIVATION; TARGET GENES; COMPARTMENT BOUNDARIES; DROSOPHILA; PROTEIN; SUBUNITS; REPRESSOR; YEAST; BINDING	The hedgehog (Hh) signaling pathway plays a very important role in metazoan development by controlling pattern formation. Drosophila imaginal discs are subdivided into anterior and posterior compartments that derive from adjacent cell populations. The anterior/posterior (A/P) boundaries, which are critical to maintaining the position of organizers, are established by a complex mechanism involving Hh signaling. Here, we uncover the regulation of ptc in the Hh signaling pathway by two subunits of mediator complex, Kto and Skd, which can also regulate boundary location. Collectively, we provide further evidence that Kto-Skd affects the A/P-axial development of the whole wing disc. Kto can interact with Cubitus interruptus (Ci), bind to the Ci-binding region on ptc promoter, which are both regulated by Hh signals to down-regulate ptc expression.	[Mao, Feifei; Yang, Xiaofeng; Fu, Lin; Lv, Xiangdong; Zhang, Zhao; Wu, Wenqing; Yang, Siqi; Zhou, Zhaocai; Zhang, Lei; Zhao, Yun] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Cell Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhao, Y (corresponding author), 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	yunzhao@sibcb.ac.cn	Zhang, Zhao/S-2072-2016; Lv, Xiangdong/S-9034-2019	Zhang, Zhao/0000-0001-9345-3663; Lv, Xiangdong/0000-0001-5310-5816	National Basic Research Program of China (973 Program) [2010CB912101, 2011CB943902, 2012CB945001]; Chinese Academy of Sciences [XDA01010405]; National Natural Science Foundation of China [31171414, 31371492]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China (973 Program: 2010CB912101, 2011CB943902, 2012CB945001), the "Strategic Priority Research Program" of the Chinese Academy of Sciences (XDA01010405), and also from the National Natural Science Foundation of China (31171414, 31371492).	Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Belakavadi M, 2010, MOL CELL BIOL, V30, P2437, DOI 10.1128/MCB.01541-09; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Borggrefe T, 2002, J BIOL CHEM, V277, P44202, DOI 10.1074/jbc.M207195200; Carlson M, 1997, ANNU REV CELL DEV BI, V13, P1, DOI 10.1146/annurev.cellbio.13.1.1; Carrera I, 2008, P NATL ACAD SCI USA, V105, P6644, DOI 10.1073/pnas.0709749105; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Dahmann C, 1999, TRENDS GENET, V15, P320, DOI 10.1016/S0168-9525(99)01774-6; Dahmann C, 2000, CELL, V100, P411, DOI 10.1016/S0092-8674(00)80677-7; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Galbraith MD, 2010, TRANSCR-AUSTIN, V1, P4, DOI 10.4161/trns.1.1.12373; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; Harada J, 2003, J BIOL CHEM, V278, P38998, DOI 10.1074/jbc.M307112200; Hong SK, 2005, P NATL ACAD SCI USA, V102, P18473, DOI 10.1073/pnas.0509457102; Huang CY, 2010, CELL RES, V20, P154, DOI 10.1038/cr.2010.5; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Janody F, 2003, DEVELOPMENT, V130, P3691, DOI 10.1242/dev.00607; Janody F, 2011, DEV DYNAM, V240, P2051, DOI 10.1002/dvdy.22705; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; Jiang J, 2002, GENE DEV, V16, P2315, DOI 10.1101/gad.1027902; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kalderon D, 2000, CELL, V103, P371, DOI 10.1016/S0092-8674(00)00129-X; Kang JS, 2001, J BIOL CHEM, V276, P42003, DOI 10.1074/jbc.M105961200; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Larschan E, 2005, MOL CELL BIOL, V25, P114, DOI 10.1128/MCB.25.1.114-123.2005; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; Lim J, 2007, DEV BIOL, V308, P322, DOI 10.1016/j.ydbio.2007.05.029; Loncle N, 2007, EMBO J, V26, P1045, DOI 10.1038/sj.emboj.7601566; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Malik S, 2000, MOL CELL, V5, P753, DOI 10.1016/S1097-2765(00)80254-3; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Meyer KD, 2008, EMBO J, V27, P1447, DOI 10.1038/emboj.2008.78; Muller B, 2000, DEVELOPMENT, V127, P2999; Mullor JL, 1997, DEVELOPMENT, V124, P1227; Nestoras K, 1997, GENETICS, V147, P1203; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Samuelsen CO, 2003, P NATL ACAD SCI USA, V100, P6422, DOI 10.1073/pnas.1030497100; Smelkinson MG, 2007, DEV CELL, V13, P481, DOI 10.1016/j.devcel.2007.09.006; Song WJ, 1998, EMBO J, V17, P5757, DOI 10.1093/emboj/17.19.5757; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Treisman JE, 2001, DEVELOPMENT, V128, P603; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; Wang X, 2006, P NATL ACAD SCI USA, V103, P17284, DOI 10.1073/pnas.0605414103; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; ZECCA M, 1995, DEVELOPMENT, V121, P2265; Zhang YY, 2011, CELL RES, V21, P1436, DOI 10.1038/cr.2011.136; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225; Zhou HY, 2006, MOL CELL BIOL, V26, P8667, DOI 10.1128/MCB.00443-06	56	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22333	22341		10.1074/jbc.M114.560995	http://dx.doi.org/10.1074/jbc.M114.560995			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24962581	Green Published, hybrid			2022-12-25	WOS:000340593500044
J	Yao, JW; Abdelrahman, YM; Robertson, RM; Cox, JV; Belland, RJ; White, SW; Rock, CO				Yao, Jiangwei; Abdelrahman, Yasser M.; Robertson, Rosanna M.; Cox, John V.; Belland, Robert J.; White, Stephen W.; Rock, Charles O.			Type II Fatty Acid Synthesis Is Essential for the Replication of Chlamydia trachomatis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; ENOYL-ACP REDUCTASE; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; LIPID-A; INHIBITOR AFN-1252; FABI INHIBITOR; HOST-CELL; LIPOPOLYSACCHARIDE; BIOSYNTHESIS	The major phospholipid classes of the obligate intracellular bacterial parasite Chlamydia trachomatis are the same as its eukaryotic host except that they also contain chlamydiamade branched-chain fatty acids in the 2-position. Genomic analysis predicts that C. trachomatis is capable of type II fatty acid synthesis (FASII). AFN-1252 was deployed as a chemical tool to specifically inhibit the enoyl-acyl carrier protein reductase (FabI) of C. trachomatis to determine whether chlamydial FASII is essential for replication within the host. The C. trachomatis FabI (CtFabI) is a homotetramer and exhibited typical FabI kinetics, and its expression complemented an Escherichia coli fabI(Ts) strain. AFN-1252 inhibited CtFabI by binding to the FabI.NADH complex with an IC50 of 0.9 mu M at saturating substrate concentration. The x-ray crystal structure of the CtFabI.NADH.AFN-1252 ternary complex revealed the specific interactions between the drug, protein, and cofactor within the substrate binding site. AFN-1252 treatment of C. trachomatis-infected HeLa cells at any point in the infectious cycle caused a decrease in infectious titers that correlated with a decrease in branched-chain fatty acid biosynthesis. AFN-1252 treatment at the time of infection prevented the first cell division of C. trachomatis, although the cell morphology suggested differentiation into a metabolically active reticulate body. These results demonstrate that FASII activity is essential for C. trachomatis proliferation within its eukaryotic host and validate CtFabI as a therapeutic target against C. trachomatis.	[Yao, Jiangwei; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Robertson, Rosanna M.; White, Stephen W.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Abdelrahman, Yasser M.; Cox, John V.; Belland, Robert J.] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Abdelrahman, Yasser M.] Cairo Univ, Dept Microbiol & Immunol, Fac Pharm, Cairo 11562, Egypt	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Egyptian Knowledge Bank (EKB); Cairo University	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	charles.rock@stjude.org	White, Stephen W/N-8164-2018	Yao, Jiangwei/0000-0001-7088-3468	National Institutes of Health [GM034496, AI070693]; Cancer Center Support Grant [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034496, R01GM034496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM034496 (to C. O. R.), AI070693 (to R. J. B), and Cancer Center Support Grant CA21765. This work was also supported by the American Lebanese Syrian Associated Charities.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Banevicius MA, 2013, J CHEMOTHERAPY, V25, P26, DOI 10.1179/1973947812Y.0000000061; BECKER Y, 1978, MICROBIOL REV, V42, P274, DOI 10.1128/MMBR.42.2.274-306.1978; Belland R, 2004, NAT REV MICROBIOL, V2, P530, DOI 10.1038/nrmicro931; BERGLER H, 1992, J GEN MICROBIOL, V138, P2093, DOI 10.1099/00221287-138-10-2093; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Braberg H, 2012, BIOINFORMATICS, V28, P2072, DOI 10.1093/bioinformatics/bts302; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Girard G, 2006, J BACTERIOL, V188, P8283, DOI 10.1128/JB.00893-06; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hatch GM, 1998, INFECT IMMUN, V66, P3727, DOI 10.1128/IAI.66.8.3727-3735.1998; Heath RJ, 1996, J BIOL CHEM, V271, P1833, DOI 10.1074/jbc.271.4.1833; HEATH RJ, 1995, J BIOL CHEM, V270, P26538, DOI 10.1074/jbc.270.44.26538; Heine H, 2003, EUR J BIOCHEM, V270, P440, DOI 10.1046/j.1432-1033.2003.03392.x; Heine H, 2007, J ENDOTOXIN RES, V13, P126, DOI 10.1177/0968051907079122; Hutson SM, 2005, J NUTR, V135, p1557S, DOI 10.1093/jn/135.6.1557S; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; Kaplan N, 2013, EUR J PHARM SCI, V50, P440, DOI 10.1016/j.ejps.2013.08.019; Kaplan N, 2012, ANTIMICROB AGENTS CH, V56, P5865, DOI 10.1128/AAC.01411-12; Kosma P, 1999, BBA-MOL BASIS DIS, V1455, P387, DOI 10.1016/S0925-4439(99)00061-7; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Moldoveanu T, 2013, NAT STRUCT MOL BIOL, V20, P589, DOI 10.1038/nsmb.2563; Nguyen BD, 2011, P NATL ACAD SCI USA, V108, P10284, DOI 10.1073/pnas.1107478108; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paoletti L, 2007, J BACTERIOL, V189, P5816, DOI 10.1128/JB.00602-07; Parsons JB, 2013, ANTIMICROB AGENTS CH, V57, P2182, DOI 10.1128/AAC.02307-12; Pemble CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014165; Priyadarshi A, 2010, PROTEINS, V78, P480, DOI 10.1002/prot.22581; Qiu XY, 1999, PROTEIN SCI, V8, P2529, DOI 10.1110/ps.8.11.2529; Qureshi N, 1997, J BIOL CHEM, V272, P10594; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Rafi S, 2006, J BIOL CHEM, V281, P39285, DOI 10.1074/jbc.M608758200; Rock CO, 2002, BIOCHEM BIOPH RES CO, V292, P1155, DOI 10.1006/bbrc.2001.2022; Rozwarski DA, 1999, J BIOL CHEM, V274, P15582, DOI 10.1074/jbc.274.22.15582; Rund S, 1999, J BIOL CHEM, V274, P16819, DOI 10.1074/jbc.274.24.16819; Saka HA, 2010, CURR OPIN MICROBIOL, V13, P4, DOI 10.1016/j.mib.2009.11.002; Schiebel J, 2012, STRUCTURE, V20, P802, DOI 10.1016/j.str.2012.03.013; Scidmore Marci A, 2005, Curr Protoc Microbiol, VChapter 11, DOI 10.1002/9780471729259.mc11a01s00; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Su H, 2004, J BIOL CHEM, V279, P9409, DOI 10.1074/jbc.M312008200; Suh MC, 1999, PLANT J, V17, P679, DOI 10.1046/j.1365-313X.1999.00418.x; Sweet CR, 2001, J BIOL CHEM, V276, P19565, DOI 10.1074/jbc.M101868200; Vignola MJ, 2010, J BIOL CHEM, V285, P21625, DOI 10.1074/jbc.M110.103010; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wylie JL, 1997, J BACTERIOL, V179, P7233, DOI 10.1128/jb.179.23.7233-7242.1997; Xu H, 2008, BIOCHEMISTRY-US, V47, P4228, DOI 10.1021/bi800023a; Yao JW, 2013, J BIOL CHEM, V288, P36261, DOI 10.1074/jbc.M113.512905	48	34	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22365	22376		10.1074/jbc.M114.584185	http://dx.doi.org/10.1074/jbc.M114.584185			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24958721	Green Published, hybrid			2022-12-25	WOS:000340593500047
J	Lemaire, PA; Huang, LY; Zhuo, Y; Lu, J; Bahnck, C; Stachel, SJ; Carroll, SS; Duong, LT				Lemaire, Peter A.; Huang, Lingyi; Zhuo, Ya; Lu, Jun; Bahnck, Carolyn; Stachel, Shawn J.; Carroll, Steve S.; Duong, Le T.			Chondroitin Sulfate Promotes Activation of Cathepsin K	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOCLASTIC BONE-RESORPTION; DEFICIENT-MICE; COLLAGENOLYTIC ACTIVITY; EXTRACELLULAR-MATRIX; CYSTEINE PROTEASES; PROCATHEPSIN-B; IN-VITRO; GLYCOSAMINOGLYCANS; PYCNODYSOSTOSIS; EXPRESSION	Cathepsin K (CatK), a major lysosomal collagenase produced by osteoclasts, plays an important role in bone resorption. Evidence exists that the collagenase activity of CatK is promoted by chondroitin sulfate (CS), a sulfated glycosaminoglycan. This study examines the role of CS in facilitating CatK activation. We have demonstrated that chondroitin 4-sulfate (C4-S) promotes autoprocessing of the pro-domain of CatK at pH <= 5, leading to a fully matured enzyme with collagenase and peptidase activities. We present evidence to demonstrate this autoactivation process is a trans-activation event that is efficiently inhibited by both the covalent cysteine protease inhibitor E-64 and the reversible selective CatK inhibitor L-006,235. During bone resorption, CatK and C4-S are co-localized at the ruffled border between osteoclast bone interface, supporting the proposal that CatK activation is accomplished through the combined action of the acidic environment together with the presence of a high concentration of C4-S. Formation of a multimeric complex between C4-S and pro-CatK has been speculated to accelerate CatK autoactivation and promote efficient collagen degradation. Together, these results demonstrate that CS plays an important role in contributing to the enhanced efficiency of CatK collagenase activity in vivo.	Merck Res Labs, Dept In Vitro Pharmacol, West Point, PA 19486 USA; [Huang, Lingyi; Zhuo, Ya; Duong, Le T.] Merck Res Labs, Dept Bone Biol, West Point, PA 19486 USA; [Lu, Jun] Merck Res Labs, Dept Struct Chem, West Point, PA 19486 USA; [Stachel, Shawn J.] Merck Res Labs, Dept Med Chem, West Point, PA 19486 USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company	Duong, LT (corresponding author), Merck Res Labs, Dept Bone Biol, West Point, PA 19486 USA.	le_duong@merck.com			Merck Co.	Merck Co.(Merck & Company)	This work was supported by Merck & Co. All authors are employees of Merck, the studies' sponsor, and may own stock/stock options in this company.	BARON R, 1989, ANAT RECORD, V224, P317, DOI 10.1002/ar.1092240220; Billington CJ, 2000, BIOCHEM BIOPH RES CO, V276, P924, DOI 10.1006/bbrc.2000.3553; Borel O, 2012, CALCIFIED TISSUE INT, V91, P32, DOI 10.1007/s00223-012-9604-7; Bossard MJ, 1996, J BIOL CHEM, V271, P12517, DOI 10.1074/jbc.271.21.12517; Bromme D, 2004, METHODS, V32, P199, DOI 10.1016/S1046-2023(03)00212-3; Bromme D, 1996, J BIOL CHEM, V271, P2126, DOI 10.1074/jbc.271.4.2126; Caglic D, 2007, J BIOL CHEM, V282, P33076, DOI 10.1074/jbc.M705761200; Cherney MM, 2011, J BIOL CHEM, V286, P8988, DOI 10.1074/jbc.M110.126706; COSCARELLI PG, 1991, MEM I OSWALDO CRUZ, V86, P99, DOI 10.1590/S0074-02761991000700014; Costa AG, 2011, NAT REV RHEUMATOL, V7, P447, DOI 10.1038/nrrheum.2011.77; Drake FH, 1996, J BIOL CHEM, V271, P12511, DOI 10.1074/jbc.271.21.12511; DRENTH J, 1976, BIOCHEMISTRY-US, V15, P3731, DOI 10.1021/bi00662a014; Everts V, 2003, CALCIFIED TISSUE INT, V73, P380, DOI 10.1007/s00223-002-2092-4; Everts V, 2006, J BONE MINER RES, V21, P1399, DOI 10.1359/JBMR.060614; Falgueyret JP, 2005, J MED CHEM, V48, P7535, DOI 10.1021/jm0504961; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; Haylock-Jacobs S, 2011, AUTOIMMUN REV, V10, P766, DOI 10.1016/j.autrev.2011.05.019; Horkay F, 2012, MACROMOLECULES, V45, P2882, DOI 10.1021/ma202693s; Hou WS, 1999, J CLIN INVEST, V103, P731, DOI 10.1172/JCI653; HUNTER GK, 1987, ANAL BIOCHEM, V165, P435, DOI 10.1016/0003-2697(87)90293-4; INAOKA T, 1995, BIOCHEM BIOPH RES CO, V206, P89, DOI 10.1006/bbrc.1995.1013; Kiviranta R, 2005, BONE, V36, P159, DOI 10.1016/j.bone.2004.09.020; LaLonde JM, 1999, BIOCHEMISTRY-US, V38, P862, DOI 10.1021/bi9822271; Lecaille F, 2008, BIOCHIMIE, V90, P208, DOI 10.1016/j.biochi.2007.08.011; Leung P, 2011, BONE, V49, P623, DOI 10.1016/j.bone.2011.06.014; Li ZQ, 2008, J MOL BIOL, V383, P78, DOI 10.1016/j.jmb.2008.07.038; Li ZQ, 2004, J BIOL CHEM, V279, P5470, DOI 10.1074/jbc.M310349200; Li ZQ, 2002, J BIOL CHEM, V277, P28669, DOI 10.1074/jbc.M204004200; Li ZQ, 2000, BIOCHEMISTRY-US, V39, P529, DOI 10.1021/bi992251u; McQueney MS, 1997, J BIOL CHEM, V272, P13955, DOI 10.1074/jbc.272.21.13955; Menard R, 1998, J BIOL CHEM, V273, P4478, DOI 10.1074/jbc.273.8.4478; Morko J, 2009, BONE, V44, P717, DOI 10.1016/j.bone.2008.11.019; MOURAO PAS, 1988, ARTHRITIS RHEUM, V31, P1028, DOI 10.1002/art.1780310814; Novinec M, 2010, BIOCHEM J, V429, P379, DOI 10.1042/BJ20100337; Palmer JT, 2005, J MED CHEM, V48, P7520, DOI 10.1021/jm058198r; Panwar P, 2013, J BIOL CHEM, V288, P5940, DOI 10.1074/jbc.M112.419689; Pungercar JR, 2009, FEBS J, V276, P660, DOI 10.1111/j.1742-4658.2008.06815.x; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Saftig P, 2000, ADV EXP MED BIOL, V477, P293; Salbach J, 2012, J MOL MED, V90, P625, DOI 10.1007/s00109-011-0843-2; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; TOOLE BP, 1977, CLIN ORTHOP RELAT R, P258; Vasiljeva O, 2005, FEBS LETT, V579, P1285, DOI 10.1016/j.febslet.2004.12.093; VERNET T, 1990, J BIOL CHEM, V265, P16661; Zhao HB, 2012, TRAFFIC, V13, P1307, DOI 10.1111/j.1600-0854.2012.01395.x	47	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21562	21572		10.1074/jbc.M114.559898	http://dx.doi.org/10.1074/jbc.M114.559898			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24958728	Green Published, hybrid			2022-12-25	WOS:000340558300031
J	Neundlinger, I; Puntheeranurak, T; Wildling, L; Rankl, C; Wang, LX; Gruber, HJ; Kinne, RKH; Hinterdorfer, P				Neundlinger, Isabel; Puntheeranurak, Theeraporn; Wildling, Linda; Rankl, Christian; Wang, Lai-Xi; Gruber, Hermann J.; Kinne, Rolf K. H.; Hinterdorfer, Peter			Forces and Dynamics of Glucose and Inhibitor Binding to Sodium Glucose Co-transporter SGLT1 Studied by Single Molecule Force Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHLORHIZIN-BINDING; SUGAR-TRANSPORT; TEMPERATURE-DEPENDENCE; CONFORMATIONAL-CHANGES; RECOGNITION EVENTS; MECHANISM; ADHESION; PROTEIN; HSGLT1; SITE	Single molecule force spectroscopy was employed to investigate the dynamics of the sodium glucose co-transporter (SGLT1) upon substrate and inhibitor binding on the single molecule level. CHO cells stably expressing rbSGLT1 were probed by using atomic force microscopy tips carrying either thioglucose, 2'aminoethyl beta-D-glucopyranoside, or aminophlorizin. Poly(ethylene glycol) (PEG) chains of different length and varying end groups were used as tether. Experiments were performed at 10, 25 and 37 degrees C to address different conformational states of SGLT1. Unbinding forces between ligands and SGLT1 were recorded at different loading rates by changing the retraction velocity, yielding binding probability, width of energy barrier of the binding pocket, and the kinetic off rate constant of the binding reaction. With increasing temperature, width of energy barrier and average life time increased for the interaction of SGLT1 with thioglucose (coupled via acrylamide to a long PEG) but decreased for aminophlorizin binding. The former indicates that in the membrane-bound SGLT1 the pathway to sugar translocation involves several steps with different temperature sensitivity. The latter suggests that also the aglucon binding sites for transport inhibitors have specific, temperature-sensitive conformations.	[Neundlinger, Isabel; Puntheeranurak, Theeraporn; Wildling, Linda; Gruber, Hermann J.; Hinterdorfer, Peter] Johannes Kepler Univ Linz, Inst Biophys, A-4020 Linz, Austria; [Puntheeranurak, Theeraporn] Mahidol Univ, Fac Sci, Dept Biol, Bangkok 10400, Thailand; [Puntheeranurak, Theeraporn] Nanotec MU Ctr Excellence Intelligent Mat & Syst, Bangkok 10400, Thailand; [Rankl, Christian] Agilent Technol, A-4020 Linz, Austria; [Wang, Lai-Xi] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Wang, Lai-Xi] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Kinne, Rolf K. H.] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany	Johannes Kepler University Linz; Mahidol University; Agilent Technologies; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Max Planck Society	Hinterdorfer, P (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Gruberstr 40, A-4020 Linz, Austria.	peter.hinterdorfer@jku.at	Gruber, Hermann J./C-4234-2013; Wang, Lai-Xi/E-8755-2019; Hinterdorfer, Peter/C-4235-2013; wang, xiao/HGB-7081-2022; wang, xl/Y-8251-2019; Wang, Xin/AAN-8435-2021; Wang, Lai-Xi/E-8790-2019	wang, xiao/0000-0002-4088-3341; Wang, Xin/0000-0002-4457-7376; Wang, Lai-Xi/0000-0003-4293-5819; Rankl, Christian/0000-0002-7354-7651; Hinterdorfer, Peter/0000-0003-2583-1305	State of Upper Austria; Austrian Science Fund [SFB35]; Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Ministry of Science and Technology, Thailand through program of Center of Excellence Network; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080374] Funding Source: NIH RePORTER	State of Upper Austria; Austrian Science Fund(Austrian Science Fund (FWF)); Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Ministry of Science and Technology, Thailand through program of Center of Excellence Network; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the State of Upper Austria and the Austrian Science Fund (Project SFB35) and supported in part by the Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Ministry of Science and Technology, Thailand, through its program of Center of Excellence Network.	ARONSON PS, 1978, J MEMBRANE BIOL, V42, P81, DOI 10.1007/BF01870395; Baumgartner W, 2000, ULTRAMICROSCOPY, V82, P85, DOI 10.1016/S0304-3991(99)00154-0; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Castaneda F, 2005, MOL CELL BIOCHEM, V280, P91, DOI 10.1007/s11010-005-8235-y; Castaneda Francisco, 2007, Int J Med Sci, V4, P131; CRANE RK, 1977, REV PHYSIOL BIOCH P, V78, P99, DOI 10.1007/BFb0027722; DACRUZ MEM, 1983, BIOCHIM BIOPHYS ACTA, V732, P691, DOI 10.1016/0005-2736(83)90248-1; DESMEDT H, 1981, BIOCHIM BIOPHYS ACTA, V648, P247, DOI 10.1016/0005-2736(81)90040-7; DIEDRICH DF, 1966, ARCH BIOCHEM BIOPHYS, V117, P248, DOI 10.1016/0003-9861(66)90409-7; Ebner A, 2007, ULTRAMICROSCOPY, V107, P922, DOI 10.1016/j.ultramic.2007.02.035; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 1999, BIOPHYS J, V76, P2439, DOI 10.1016/S0006-3495(99)77399-6; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Hinterdorfer P, 1996, P NATL ACAD SCI USA, V93, P3477, DOI 10.1073/pnas.93.8.3477; Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871; Hirayama BA, 2001, BRIT J PHARMACOL, V134, P484, DOI 10.1038/sj.bjp.0704274; Hirayama BA, 2007, BIOCHEMISTRY-US, V46, P13391, DOI 10.1021/bi701562k; Hummel CS, 2011, AM J PHYSIOL-CELL PH, V300, pC14, DOI 10.1152/ajpcell.00388.2010; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Kamruzzahan ASM, 2006, BIOCONJUGATE CHEM, V17, P1473, DOI 10.1021/bc060252a; Kienberger F., 2000, Single Molecules, V1, P123, DOI 10.1002/1438-5171(200006)1:2<123::AID-SIMO123>3.0.CO;2-3; Kinne RKH, 2011, HANDB EXP PHARMACOL, V203, P105, DOI 10.1007/978-3-642-17214-4_5; Kipp H, 1996, Biochim Biophys Acta, V1282, P125; Kumar A, 2007, BIOPHYS CHEM, V127, P69, DOI 10.1016/j.bpc.2006.12.006; LEE GU, 1994, SCIENCE, V266, P771, DOI 10.1126/science.7973628; Lin JT, 1998, BBA-BIOMEMBRANES, V1373, P309, DOI 10.1016/S0005-2736(98)00116-3; Lin JT, 1999, J MEMBRANE BIOL, V170, P243, DOI 10.1007/s002329900553; LIN JT, 1982, BIOCHIM BIOPHYS ACTA, V693, P379, DOI 10.1016/0005-2736(82)90445-X; Loo DDF, 2005, J GEN PHYSIOL, V125, P13, DOI 10.1085/jgp.200409150; Maitra A, 2011, PHYS CHEM CHEM PHYS, V13, P1836, DOI 10.1039/c0cp01528h; Nestorovich EM, 2012, P NATL ACAD SCI USA, V109, P18453, DOI 10.1073/pnas.1208771109; Ni JH, 2003, BIOCONJUGATE CHEM, V14, P232, DOI 10.1021/bc025617f; Novakova R, 2001, J MEMBRANE BIOL, V184, P55, DOI 10.1007/s00232-001-0073-6; Oulianova N, 2001, J MEMBRANE BIOL, V179, P223, DOI 10.1007/s002320010049; Panayotova-Heiermann M, 1999, FEBS LETT, V459, P386, DOI 10.1016/S0014-5793(99)01292-2; PANAYOTOVAHEIERMANN M, 1994, J BIOL CHEM, V269, P21016; PanayotovaHeiermann M, 1997, J BIOL CHEM, V272, P20324, DOI 10.1074/jbc.272.33.20324; PanayotovaHeiermann M, 1996, J BIOL CHEM, V271, P10029, DOI 10.1074/jbc.271.17.10029; Puntheeranurak T, 2008, J KOREAN PHYS SOC, V52, P1336, DOI 10.3938/jkps.52.1336; Puntheeranurak T, 2007, J BIOL CHEM, V282, P25222, DOI 10.1074/jbc.M704190200; Puntheeranurak T, 2007, BIOCHEMISTRY-US, V46, P2797, DOI 10.1021/bi061917z; Puntheeranurak T, 2006, J CELL SCI, V119, P2960, DOI 10.1242/jcs.03035; Raja MM, 2005, BIOCHEMISTRY-US, V44, P9123, DOI 10.1021/bi050323d; Raja MM, 2004, BIOCHEMISTRY-US, V43, P10944, DOI 10.1021/bi049106n; Raja MM, 2003, J BIOL CHEM, V278, P49154, DOI 10.1074/jbc.M306881200; RESTREPO D, 1986, J MEMBRANE BIOL, V89, P269, DOI 10.1007/BF01870669; Rico F, 2007, J MOL RECOGNIT, V20, P495, DOI 10.1002/jmr.841; Riener CK, 2003, ANAL CHIM ACTA, V479, P59, DOI 10.1016/S0003-2670(02)01373-9; Sala-Rabanal M, 2012, AM J PHYSIOL-CELL PH, V302, pC1293, DOI 10.1152/ajpcell.00397.2011; Strunz T, 1999, P NATL ACAD SCI USA, V96, P11277, DOI 10.1073/pnas.96.20.11277; Tyagi NK, 2007, BIOCHEMISTRY-US, V46, P13616, DOI 10.1021/bi701193x; Tyagi NK, 2011, BBA-BIOMEMBRANES, V1808, P1, DOI 10.1016/j.bbamem.2010.07.028; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Wielert-Badt S, 2000, J MED CHEM, V43, P1692, DOI 10.1021/jm9905460; Wielert-Badt S, 2002, BIOPHYS J, V82, P2767, DOI 10.1016/S0006-3495(02)75617-8; Wildling L., 2008, THESIS J KEPLER U LI; Wildling L., 2005, THESIS J KEPLER U LI; Wildling L, 2012, J BIOL CHEM, V287, P105, DOI 10.1074/jbc.M111.304873; Wimmer B, 2009, J BIOL CHEM, V284, P983, DOI 10.1074/jbc.M805082200; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Wright EM, 1998, AM J PHYSIOL-GASTR L, V275, pG879, DOI 10.1152/ajpgi.1998.275.5.G879; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Wruss J, 2009, J AM CHEM SOC, V131, P5478, DOI 10.1021/ja807917t; Zaccai G, 2000, SCIENCE, V288, P1604, DOI 10.1126/science.288.5471.1604	65	16	16	3	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21673	21683		10.1074/jbc.M113.529875	http://dx.doi.org/10.1074/jbc.M113.529875			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24962566	Green Published, hybrid			2022-12-25	WOS:000340558300041
J	Di Loreto, C; La Marra, F; Mazzon, G; Belgrano, E; Trombetta, C; Cauci, S				Di Loreto, Carla; La Marra, Francesco; Mazzon, Giorgio; Belgrano, Emanuele; Trombetta, Carlo; Cauci, Sabina			Immunohistochemical Evaluation of Androgen Receptor and Nerve Structure Density in Human Prepuce from Patients with Persistent Sexual Side Effects after Finasteride Use for Androgenetic Alopecia	PLOS ONE			English	Article							MALE-PATTERN BALDNESS; PROSTATE-CANCER; HAIR LOSS; 5-ALPHA-REDUCTASE INHIBITOR; STEROID-HORMONES; TESTOSTERONE; EXPRESSION; HYPERPLASIA; DUTASTERIDE; EXPERIENCE	Finasteride is an inhibitor of 5-alpha-reductase used against male androgenetic alopecia (AGA). Reported side effects of finasteride comprise sexual dysfunction including erectile dysfunction, male infertility, and loss of libido. Recently these effects were described as persistent in some subjects. Molecular events inducing persistent adverse sexual symptoms are unexplored. This study was designed as a retrospective case-control study to assess if androgen receptor (AR) and nerve density in foreskin prepuce specimens were associated with persistent sexual side effects including loss of sensitivity in the genital area due to former finasteride use against AGA. Cases were 8 males (aged 29-43 years) reporting sexual side effects including loss of penis sensitivity over 6 months after discontinuation of finasteride who were interviewed and clinically visited. After informed consent they were invited to undergo a small excision of skin from prepuce. Controls were 11 otherwise healthy matched men (aged 23-49 years) who undergone circumcision for phimosis, and who never took finasteride or analogues. Differences in AR expression and nerve density in different portions of dermal prepuce were evaluated in the 2 groups. Density of nuclear AR in stromal and epithelial cells was higher in cases (mean 40.0%, and 80.6% of positive cells, respectively) than controls (mean 23.4%, and 65.0% of positive cells, respectively), P = 0.023 and P = 0.043, respectively. Conversely, percentage of vessel smooth muscle cells positive for AR and density of nerves were similar in the 2 groups. The ratio of AR positive stromal cells % to serum testosterone concentrations was 2-fold higher in cases than in controls (P = 0.001). Our findings revealed that modulation of local AR levels might be implicated in long-term side effects of finasteride use. This provides the first evidence of a molecular objective difference between patients with long-term adverse sexual effects after finasteride use versus drug untreated healthy controls in certain tissues.	[Di Loreto, Carla; La Marra, Francesco; Cauci, Sabina] Univ Udine, Sch Med, Dept Med & Biol Sci, I-33100 Udine, Italy; [Mazzon, Giorgio; Belgrano, Emanuele; Trombetta, Carlo] Univ Trieste, Dept Med Surg & Hlth Sci, Urol Hosp Dept, Trieste, Italy	University of Udine; University of Trieste	Cauci, S (corresponding author), Univ Udine, Sch Med, Dept Med & Biol Sci, I-33100 Udine, Italy.	sabina.cauci@uniud.it	Mazzon, Giorgio/AHE-5020-2022	Cauci, Sabina/0000-0001-7443-1899; carlo, trombetta/0000-0003-0237-544X; Mazzon, Giorgio/0000-0002-7890-2018	University of Udine funds	University of Udine funds	Support was provided by University of Udine funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anitha B, 2009, J Cutan Aesthet Surg, V2, P12, DOI 10.4103/0974-2077.53093; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Banerjee PP, 2001, ENDOCRINOLOGY, V142, P4066, DOI 10.1210/en.142.9.4066; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Brand LJ, 2013, CURR DRUG TARGETS, V14, P441; Budd D, 2000, EUR J DERMATOL, V10, P122; Cecchin E, 2014, INT J BIOL MARKERS; Chang CS, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109132; Chhipa RR, 2013, PROSTATE, V73, P1483, DOI 10.1002/pros.22696; Cobb JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005081; Duskova M, 2010, Endocr Regul, V44, P3; Finasteride, 2014, DRUG INFORM LEXI COM; Friedman AE, 2012, PROSTATE, V72, P703, DOI 10.1002/pros.21480; GELLER J, 1990, J CLIN ENDOCR METAB, V71, P1552, DOI 10.1210/jcem-71-6-1552; GRINO PB, 1990, ENDOCRINOLOGY, V126, P1165, DOI 10.1210/endo-126-2-1165; Hsieh JT, 2011, PROSTATE, V71, P1115, DOI 10.1002/pros.21325; Huang PX, 2010, ANNU REV PHYSIOL, V72, P247, DOI 10.1146/annurev-physiol-021909-135917; Iacono F, 2012, BMC SURG, V12, DOI [10.1186/1471-2482-12-S1-S24, 10.1186/1471-2482-12-S1-S21]; Ing NH, 2005, BIOL REPROD, V72, P1290, DOI 10.1095/biolreprod.105.040014; Irwig MS, 2012, J SEX MED, V9, P2927, DOI 10.1111/j.1743-6109.2012.02846.x; Irwig MS, 2011, J SEX MED, V8, P1747, DOI 10.1111/j.1743-6109.2011.02255.x; Isidori AM, 2013, EUR UROL, V2838, P876; Kato S, 2011, TRENDS BIOCHEM SCI, V36, P272, DOI 10.1016/j.tibs.2011.01.001; Kaufman KD, 2002, MOL CELL ENDOCRINOL, V198, P89, DOI 10.1016/S0303-7207(02)00372-6; Kaufman KD, 2002, EUR J DERMATOL, V12, P38; La Marra F, 2012, AM J PATHOL, V181, pS8; Leader JE, 2006, BIOCHEM PHARMACOL, V72, P1589, DOI 10.1016/j.bcp.2006.05.024; Lee HJ, 2003, CELL MOL LIFE SCI, V60, P1613, DOI 10.1007/s00018-003-2309-3; Li J, 2009, MATURITAS, V63, P142, DOI 10.1016/j.maturitas.2009.03.008; Lim AC, 2013, CURR DRUG TARGETS, V14, P408; LIN MC, 1993, J STEROID BIOCHEM, V45, P333; Marron TU, 2005, J NEUROCHEM, V92, P10, DOI 10.1111/j.1471-4159.2004.02836.x; McDonough PH, 2011, CUTIS, V88, P165; McGahuey CA, 2000, J SEX MARITAL THER, V26, P25, DOI 10.1080/009262300278623; Melcangi RC, 2013, J SEX MED, V10, P2598, DOI 10.1111/jsm.12269; Nickel JC, 1996, CAN MED ASSOC J, V155, P1251; NORWOOD OT, 1975, SOUTHERN MED J, V68, P1359, DOI 10.1097/00007611-197511000-00009; Nyquist MD, 2013, HORM CANCER-US, V4, P61, DOI 10.1007/s12672-013-0131-4; Otberg N, 2007, ENDOCRIN METAB CLIN, V36, P379, DOI 10.1016/j.ecl.2007.03.004; Patrao MTCC, 2009, ARQ BRAS ENDOCRINOL, V53, P934, DOI 10.1590/S0004-27302009000800006; Perobelli JE, 2013, REPROD TOXICOL, V38, P65, DOI 10.1016/j.reprotox.2013.03.004; Pinsky MR, 2011, J SEX MED, V8, P3066, DOI 10.1111/j.1743-6109.2011.02425.x; Pozzi P, 2003, J NEUROENDOCRINOL, V15, P882, DOI 10.1046/j.1365-2826.2003.01074.x; Randhawa HK, 2013, JAMA DERMATOL, V149, P732, DOI 10.1001/jamadermatol.2013.2874; Rathnayake D, 2010, EXPERT OPIN PHARMACO, V11, P1295, DOI 10.1517/14656561003752730; Rhodes T, 1998, DERMATOL SURG, V24, P1330, DOI 10.1111/j.1524-4725.1998.tb00009.x; RITTMASTER RS, 1994, NEW ENGL J MED, V330, P120; Ryu HK, 2006, BRIT J DERMATOL, V154, P730, DOI 10.1111/j.1365-2133.2005.07072.x; Schmidt LJ, 2013, CURR DRUG TARGETS, V14, P401; Traish AM, 2012, ENDOCR PRACT, V18, P965, DOI 10.4158/12108.RA; Traish AM, 2011, J SEX MED, V8, P872, DOI 10.1111/j.1743-6109.2010.02157.x; Traish AM, 2009, J ANDROL, V30, P363, DOI 10.2164/jandrol.108.006007; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Vierhapper H, 2001, J CLIN ENDOCR METAB, V86, P5762, DOI 10.1210/jc.86.12.5762; Waltering KK, 2009, CANCER RES, V69, P8141, DOI 10.1158/0008-5472.CAN-09-0919; Winiarska A, 2006, SKIN PHARMACOL PHYS, V19, P311, DOI 10.1159/000095251; Yip L, 2011, AUSTRALAS J DERMATOL, V52, P81, DOI 10.1111/j.1440-0960.2011.00745.x; Zhang MG, 2013, UROLOGY, V82, DOI 10.1016/j.urology.2013.02.045; Zhang MG, 2012, J SEX MED, V9, P1328, DOI 10.1111/j.1743-6109.2012.02661.x	59	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100237	10.1371/journal.pone.0100237	http://dx.doi.org/10.1371/journal.pone.0100237			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959691	Green Submitted, Green Published, gold			2022-12-25	WOS:000338633900029
J	Gomez-Segui, I; Sanchez-Izquierdo, D; Barragan, E; Such, E; Luna, I; Lopez-Pavia, M; Ibanez, M; Villamon, E; Alonso, C; Martin, I; Llop, M; Dolz, S; Fuster, O; Montesinos, P; Canigral, C; Boluda, B; Salazar, C; Cervera, J; Sanz, MA				Gomez-Segui, Ines; Sanchez-Izquierdo, Dolors; Barragan, Eva; Such, Esperanza; Luna, Irene; Lopez-Pavia, Maria; Ibanez, Mariam; Villamon, Eva; Alonso, Carmen; Martin, Ivan; Llop, Marta; Dolz, Sandra; Fuster, Oscar; Montesinos, Pau; Canigral, Carolina; Boluda, Blanca; Salazar, Claudia; Cervera, Jose; Sanz, Miguel A.			Single-Nucleotide Polymorphism Array-Based Karyotyping of Acute Promyelocytic Leukemia	PLOS ONE			English	Article							TRANS-RETINOIC ACID; RISK-ADAPTED TREATMENT; ANTHRACYCLINE MONOCHEMOTHERAPY; COPY; GENE; ADULT; ISOCHROMOSOME; MALIGNANCIES; PETHEMA; PATIENT	Acute promyelocytic leukemia (APL) is characterized by the t(15; 17)(q22; q21), but additional chromosomal abnormalities (ACA) and other rearrangements can contribute in the development of the whole leukemic phenotype. We hypothesized that some ACA not detected by conventional techniques may be informative of the onset of APL. We performed the high-resolution SNP array (SNP-A) 6.0 (Affymetrix) in 48 patients diagnosed with APL on matched diagnosis and remission sample. Forty-six abnormalities were found as an acquired event in 23 patients (48%): 22 duplications, 23 deletions and 1 Copy-Neutral Loss of Heterozygocity (CN-LOH), being a duplication of 8(q24) (23%) and a deletion of 7(q33-qter) (6%) the most frequent copy-number abnormalities (CNA). Four patients (8%) showed CNAs adjacent to the breakpoints of the translocation. We compared our results with other APL series and found that, except for dup(8q24) and del(7q33-qter), ACA were infrequent (<= 3%) but most of them recurrent (70%). Interestingly, having CNA or FLT3 mutation were mutually exclusive events. Neither the number of CNA, nor any specific CNA was associated significantly with prognosis. This study has delineated recurrent abnormalities in addition to t(15; 17) that may act as secondary events and could explain leukemogenesis in up to 40% of APL cases with no ACA by conventional cytogenetics.	[Gomez-Segui, Ines; Such, Esperanza; Luna, Irene; Lopez-Pavia, Maria; Ibanez, Mariam; Villamon, Eva; Alonso, Carmen; Martin, Ivan; Montesinos, Pau; Canigral, Carolina; Boluda, Blanca; Salazar, Claudia; Cervera, Jose; Sanz, Miguel A.] Hosp Univ & Politecn La Fe, Dept Hematol, Valencia, Spain; [Sanchez-Izquierdo, Dolors] Inst Invest Sanitaria Fdn La Fe, Arrays Unit, Valencia, Spain; [Barragan, Eva; Llop, Marta; Dolz, Sandra; Fuster, Oscar] Univ Hosp La Fe, Dept Clin Chem, Mol Biol Lab, Valencia, Spain; [Cervera, Jose] Hosp Univ & Politecn La Fe, Genet Unit, Valencia, Spain; [Sanz, Miguel A.] Univ Valencia, Dept Med, Valencia, Spain	Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; University of Valencia	Cervera, J (corresponding author), Hosp Univ & Politecn La Fe, Dept Hematol, Valencia, Spain.	gomez_ine@gva.es; sanz_mig@gva.es	Martin, Ivan/K-9286-2016; Luna del Valle, Irene/GZL-0421-2022; Martín, Iván/AAL-7783-2021; Sanz, Miguel A./F-7485-2018; Seguí, Inés Gómez/ABH-5290-2020; IBAÑEZ COMPANY, MARIAM/AAW-9082-2021; Villamon, Eva/A-6574-2016; Cervera, Jose/ABF-2143-2020	Sanz, Miguel A./0000-0003-1489-1177; IBAÑEZ COMPANY, MARIAM/0000-0002-7486-4659; Cervera, Jose/0000-0001-8252-1106; Fuster, Oscar/0000-0001-9011-2062; Such, Esperanza/0000-0001-6892-403X; Llop, Marta/0000-0002-0106-7296; Lopez Pavia, Maria/0000-0002-8529-4372; Montesinos, Pau/0000-0002-3275-5593; Villamon, Eva/0000-0003-0636-3358	Rio Hortega [CM10/00321, CM11/00343]; Health Research Program [PI12/01047]; program "Red Tematica de Investigacion Cooperativa en Cancer'' [RD12/0036/0014]; "Red Cooperativa de Biobancos Hospitalarios'' from "Instituto de Salud Carlos III'', Ministry of Science and Innovation, Spain [RD09/0076/00021]; "Instituto Investigacion Sanitaria Hospital La Fe'' [2013/0327]; Generalitat Valenciana [PROMETEO/2011/025]	Rio Hortega; Health Research Program; program "Red Tematica de Investigacion Cooperativa en Cancer''; "Red Cooperativa de Biobancos Hospitalarios'' from "Instituto de Salud Carlos III'', Ministry of Science and Innovation, Spain; "Instituto Investigacion Sanitaria Hospital La Fe''; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work was supported by the Grant "Rio Hortega'' (CM10/00321, CM11/00343), the Health Research Program (PI12/01047), the program "Red Tematica de Investigacion Cooperativa en Cancer'' (RD12/0036/0014) and the "Red Cooperativa de Biobancos Hospitalarios'' (RD09/0076/00021) from "Instituto de Salud Carlos III'', Ministry of Science and Innovation, Spain, (www.isciii.es); the research grant 2013/0327 from the "Instituto Investigacion Sanitaria Hospital La Fe'', (www.iislafe.es); and the Excellence Research Project (PROMETEO/2011/025) granted by Generalitat Valenciana, (www.cece.gva.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2009, BLOOD, V113, P1741, DOI 10.1182/blood-2007-12-130260; Barbouti A, 2004, AM J HUM GENET, V74, P1, DOI 10.1086/380648; Barragan E, 2011, HAEMATOL-HEMATOL J, V96, P1470, DOI 10.3324/haematol.2011.044933; Cervera J, 2010, HAEMATOL-HEMATOL J, V95, P424, DOI 10.3324/haematol.2009.013243; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Delgado MD, 2013, CLIN TRANSL ONCOL, V15, P87, DOI 10.1007/s12094-012-0926-8; Garcia-Casado Z, 2006, CANCER GENET CYTOGEN, V168, P73, DOI 10.1016/j.cancergencyto.2005.12.014; Goldschmidt N, 2010, HEMATOLOGY, V15, P332, DOI 10.1179/102453310X12647083621083; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Haraguchi K, 2009, LEUKEMIA RES, V33, P1552, DOI 10.1016/j.leukres.2009.04.033; Heinrichs S, 2010, BLOOD, V115, P4157, DOI 10.1182/blood-2009-11-203182; Hernandez JM, 2001, HAEMATOLOGICA, V86, P807; Huh J, 2011, ANN HEMATOL, V90, P1255, DOI 10.1007/s00277-011-1195-2; Koshy J, 2012, CANCER GENET-NY, V205, P537, DOI 10.1016/j.cancergen.2012.07.017; Kuhn MWM, 2012, BLOOD, V119, pE67, DOI 10.1182/blood-2011-09-380444; Manola KN, 2010, ACTA HAEMATOL-BASEL, V123, P162, DOI 10.1159/000294959; Nowak D, 2012, GENE CHROMOSOME CANC, V51, P756, DOI 10.1002/gcc.21961; O'Keefe C, 2010, BLOOD, V115, P2731, DOI 10.1182/blood-2009-10-201848; Parkin B, 2010, BLOOD, V116, P4958, DOI 10.1182/blood-2010-01-266999; Sanz MA, 2004, BLOOD, V103, P1237, DOI 10.1182/blood-2003-07-2462; Sanz MA, 2010, BLOOD, V115, P5137, DOI 10.1182/blood-2010-01-266007; Schweighofer CD, 2013, J MOL DIAGN, V15, P196, DOI 10.1016/j.jmoldx.2012.09.006; Slack GW, 2011, ADV ANAT PATHOL, V18, P219, DOI 10.1097/PAP.0b013e3182169948; Such E, 2011, HAEMATOL-HEMATOL J, V96, P375, DOI 10.3324/haematol.2010.030957; Tiu RV, 2009, J CLIN ONCOL, V27, P5219, DOI 10.1200/JCO.2009.21.9840; Walter MJ, 2009, P NATL ACAD SCI USA, V106, P12950, DOI 10.1073/pnas.0903091106	26	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100245	10.1371/journal.pone.0100245	http://dx.doi.org/10.1371/journal.pone.0100245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959826	Green Published, gold, Green Submitted			2022-12-25	WOS:000338633900030
J	Kim, JM; Lee, ST; Chu, K; Jung, KH; Kim, JH; Yu, JS; Kim, S; Kim, SH; Park, DK; Moon, J; Ban, J; Kim, M; Lee, SK; Roh, JK				Kim, Jeong-Min; Lee, Soon-Tae; Chu, Kon; Jung, Keun-Hwa; Kim, Jin Hee; Yu, Jung-Suk; Kim, Soyun; Kim, So Hee; Park, Dong-Kyu; Moon, Jangsup; Ban, Jaejun; Kim, Manho; Lee, Sang Kun; Roh, Jae-Kyu			Inhibition of Let7c MicroRNA Is Neuroprotective in a Rat Intracerebral Hemorrhage Model	PLOS ONE			English	Article							GROWTH-FACTOR-I; INTRANASAL DELIVERY; INSULIN; STROKE	Intracerebral hemorrhage (ICH) is a devastating neurological disease with a grave prognosis. We evaluated microRNA (miRNA) expression after ICH and evaluated Let7c as a therapeutic target. We harvested hemorrhagic brain 24 hours after collagenase induced ICH in the rat. Microarray analysis was performed to compare the miRNAs expression pattern between hemorrhagic hemisphere and contralateral hemisphere. An in vitro thrombin toxicity model and blood injection ICH model were also used to evaluate miRNA expression. We selected miRNA for the therapeutic target study after reviewing target gene databases and their expression. The antagonistic sequence of the selected miRNA (antagomir) was used to evaluate its therapeutic potential in the in vitro thrombin toxicity and in vivo ICH models. Among 1,088 miRNAs analyzed, let7c was induced in the thrombin and ICH models. Let7c antagomir treatment increased cell survival in the in vitro thrombin injury model and improved neurological function at 4 weeks after ICH. Let7c antagomir decreased perihematoma edema, apoptotic cell death and inflammation around hematoma. Let7c antagomir also induced insulin like growth factor receptor 1 (IGF1R) protein and phosphorylated serine threonine kinase after ICH. This study shows a distinct miRNA expression pattern after ICH. The let7c antagomir reduced cell death and edema and enhanced neurological recovery at least in part by activating the IGF1R pro-survival pathway. This suggests blocking let7c might be a potential therapeutic target in ICH.	[Kim, Jeong-Min; Lee, Soon-Tae; Chu, Kon; Jung, Keun-Hwa; Kim, Jin Hee; Yu, Jung-Suk; Kim, Soyun; Kim, So Hee; Park, Dong-Kyu; Moon, Jangsup; Ban, Jaejun; Kim, Manho; Lee, Sang Kun; Roh, Jae-Kyu] Seoul Natl Univ Hosp, Biomed Res Inst, Lab Neurotherapeut, Seoul 110744, South Korea; [Kim, Jeong-Min] Chung Ang Univ, Med Ctr, Dept Neurol, Seoul 156756, South Korea; [Lee, Soon-Tae; Chu, Kon; Jung, Keun-Hwa; Moon, Jangsup; Kim, Manho; Lee, Sang Kun; Roh, Jae-Kyu] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Seoul National University Hospital	Chu, K (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Lab Neurotherapeut, Seoul 110744, South Korea.	stemcell.snu@gmail.com; rohjk777@gmail.com		Chu, Kon/0000-0001-5863-0302; Kim, Jeong-Min/0000-0001-7213-5527; Kim, Jin Hee/0000-0003-4980-6331; Moon, Jangsup/0000-0003-1282-4528; Lee, Soon-Tae/0000-0003-4767-7564; Jung, Keun-Hwa/0000-0003-1433-8005	Korea Health Technology R & D Project, Ministry of Health & Welfare, Republic of Korea [HI11C1347]; Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2009-0080355]	Korea Health Technology R & D Project, Ministry of Health & Welfare, Republic of Korea; Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This study was supported by a grant from the Korea Health Technology R & D Project, Ministry of Health & Welfare, Republic of Korea (HI11C1347). Dr. Roh was supported by the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2009-0080355). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Fletcher L, 2009, J NEUROSURG, V111, P164, DOI 10.3171/2009.2.JNS081199; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Jung KH, 2004, STROKE, V35, P1744, DOI 10.1161/01.STR.0000131270.45822.85; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Lee ST, 2012, ANN NEUROL, V72, P269, DOI 10.1002/ana.23588; Lee ST, 2011, J NEURO-ONCOL, V102, P19, DOI 10.1007/s11060-010-0286-6; Lee ST, 2010, STROKE, V41, P1646, DOI 10.1161/STROKEAHA.110.579649; Lee ST, 2006, J NEUROCHEM, V96, P1728, DOI 10.1111/j.1471-4159.2006.03697.x; Lehmann SM, 2012, NAT NEUROSCI, V15, P827, DOI 10.1038/nn.3113; Levi M, 2010, NEW ENGL J MED, V363, P1791, DOI 10.1056/NEJMoa1006221; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Lu AG, 2006, J CEREBR BLOOD F MET, V26, P230, DOI 10.1038/sj.jcbfm.9600183; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Rosell A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016750; Selvamani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032662; Shingaki T, 2010, MOL PHARMACEUT, V7, P1561, DOI 10.1021/mp900275s; Smith TJ, 2010, PHARMACOL REV, V62, P199, DOI 10.1124/pr.109.002469; Sukhanov S, 2007, ARTERIOSCL THROM VAS, V27, P2684, DOI 10.1161/ATVBAHA.107.156257; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Wolf DA, 2012, MOL GENET METAB, V106, P131, DOI 10.1016/j.ymgme.2012.02.006; Zheng HW, 2012, CNS NEUROSCI THER, V18, P1003, DOI 10.1111/cns.12019	25	14	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e97946	10.1371/journal.pone.0097946	http://dx.doi.org/10.1371/journal.pone.0097946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959881	Green Published, Green Submitted, gold			2022-12-25	WOS:000338633900001
J	Logan, D; Kiemel, T; Jeka, JJ				Logan, David; Kiemel, Tim; Jeka, John J.			Asymmetric Sensory Reweighting in Human Upright Stance	PLOS ONE			English	Article							POSTURAL CONTROL; SENSORIMOTOR INTEGRATION; SUPPORT; IDENTIFICATION; BOOTSTRAP; IDENTIFY	To investigate sensory reweighting as a fundamental property of sensor fusion during standing, we probed postural control with simultaneous rotations of the visual scene and surface of support. Nineteen subjects were presented with pseudo-random pitch rotations of visual scene and platform at the ankle to test for amplitude dependencies in the following conditions: low amplitude vision: high amplitude platform, low amplitude vision: low amplitude platform, and high amplitude vision: low amplitude platform. Gain and phase of frequency response functions (FRFs) to each stimulus were computed for two body sway angles and a single weighted EMG signal recorded from seven muscles. When platform stimulus amplitude was increased while visual stimulus amplitude remained constant, gain to vision increased, providing strong evidence for inter-modal reweighting between vision and somatosensation during standing. Intra-modal reweighting of vision was also observed as gains to vision decreased as visual stimulus amplitude increased. Such intra-modal and inter-modal amplitude dependent changes in gain were also observed in muscular activity. Gains of leg segment angle and muscular activity relative to the platform, on the other hand, showed only intra-modal reweighting. That is, changing platform motion amplitude altered the responses to both visual and support surface motion whereas changing visual scene motion amplitude did not significantly affect responses to support surface motion, indicating that the sensory integration scheme between somatosensation (at the support surface) and vision is asymmetric.	[Logan, David; Kiemel, Tim; Jeka, John J.] Univ Maryland, Dept Kinesiol, College Pk, MD 20742 USA; [Logan, David; Jeka, John J.] Univ Maryland, Neurosci & Cognit Sci Program, College Pk, MD 20742 USA; [Jeka, John J.] Univ Maryland, Biomed Engn Grad Program, College Pk, MD 20742 USA; [Jeka, John J.] Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Jeka, JJ (corresponding author), Univ Maryland, Dept Kinesiol, College Pk, MD 20742 USA.	jjeka@temple.edu		Jeka, John/0000-0001-5942-3209	National Institute of Neurological Disorders and Stroke [R01 NS-35070]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035070] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this research was provided by National Institute of Neurological Disorders and Stroke grant R01 NS-35070 (PI: J. Jeka). NIH Reporter: http://projectreporter.nih.gov/project_info_description.cfm?aid=6911493&icde=15217597&ddparam=&ddvalue=&ddsub=&cr=3&csb=default&cs=ASC. Funding ders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendat J.S., 2000, RANDOM DATA ANAL MEA; Cenciarini M, 2006, J NEUROPHYSIOL, V95, P2733, DOI 10.1152/jn.00856.2004; DIETZ V, 1992, PHYSIOL REV, V72, P33, DOI 10.1152/physrev.1992.72.1.33; DIJKSTRA TMH, 1994, BIOL CYBERN, V71, P489, DOI 10.1007/BF00198467; Fitzpatrick R, 1996, J NEUROPHYSIOL, V76, P3994, DOI 10.1152/jn.1996.76.6.3994; HALL P, 1988, ANN STAT, V16, P927, DOI 10.1214/aos/1176350933; Horak F, 1996, HDB PHYSIOL 12, V12, P255; Hwang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088132; Kiemel T, 2011, J NEUROSCI, V31, P15144, DOI 10.1523/JNEUROSCI.1013-11.2011; Kiemel T, 2011, J MOTOR BEHAV, V43, P237, DOI 10.1080/00222895.2011.568991; Kiemel T, 2008, J NEUROPHYSIOL, V100, P3394, DOI 10.1152/jn.01272.2007; Loram ID, 2007, J PHYSIOL-LONDON, V584, P661, DOI 10.1113/jphysiol.2007.140046; Mahboobin A, 2005, EXP BRAIN RES, V167, P260, DOI 10.1007/s00221-005-0053-7; MAKI BE, 1986, IEEE T BIO-MED ENG, V33, P775, DOI 10.1109/TBME.1986.325901; Maurer C, 2006, EXP BRAIN RES, V171, P231, DOI 10.1007/s00221-005-0256-y; McIlroy WE, 1997, CLIN BIOMECH, V12, P66, DOI 10.1016/S0268-0033(96)00040-X; Mergner T, 2005, EXP BRAIN RES, V167, P535, DOI 10.1007/s00221-005-0065-3; NASHNER LM, 1982, J NEUROSCI, V2, P536; Nashner LM, 1982, HDB BEHAV NEUROBIOLO, P527; Oie KS, 2002, COGNITIVE BRAIN RES, V14, P164, DOI 10.1016/S0926-6410(02)00071-X; Peterka RJ, 2004, J NEUROPHYSIOL, V91, P410, DOI 10.1152/jn.00516.2003; PETERKA RJ, 1995, EXP BRAIN RES, V105, P101; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Shumway-Cook A, 2000, J GERONTOL A-BIOL, V55, pM10; TEASDALE N, 1991, J GERONTOL, V46, pB238, DOI 10.1093/geronj/46.6.B238; van der Kooij H, 2005, J NEUROSCI METH, V145, P175, DOI 10.1016/j.jneumeth.2005.01.003; van der Kooij H, 2011, J COMPUT NEUROSCI, V30, P759, DOI 10.1007/s10827-010-0291-y; WOOLLACOTT MH, 1986, INT J AGING HUM DEV, V23, P97, DOI 10.2190/VXN3-N3RT-54JB-X16X; Zoubir AM, 1998, IEEE SIGNAL PROC MAG, V15, P56, DOI 10.1109/79.647043	29	20	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100418	10.1371/journal.pone.0100418	http://dx.doi.org/10.1371/journal.pone.0100418			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959665	Green Published, gold			2022-12-25	WOS:000338633900045
J	Allen, CPG; Dunkley, BT; Muthukumaraswamy, SD; Edden, R; Evans, CJ; Sumner, P; Singh, KD; Chambers, CD				Allen, Christopher P. G.; Dunkley, Benjamin T.; Muthukumaraswamy, Suresh D.; Edden, Richard; Evans, C. John; Sumner, Petroc; Singh, Krish D.; Chambers, Christopher D.			Enhanced Awareness Followed Reversible Inhibition of Human Visual Cortex: A Combined TMS, MRS and MEG Study	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; THETA-BURST STIMULATION; ALPHA-BAND; PHOSPHENE THRESHOLDS; CONFIDENCE-INTERVALS; OSCILLATORY ACTIVITY; BETA OSCILLATIONS; NEURONAL-ACTIVITY; MOTOR; SYNCHRONIZATION	This series of experiments investigated the neural basis of conscious vision in humans using a form of transcranial magnetic stimulation (TMS) known as continuous theta burst stimulation (cTBS). Previous studies have shown that occipital TMS, when time-locked to the onset of visual stimuli, can induce a phenomenon analogous to blindsight in which conscious detection is impaired while the ability to discriminate 'unseen' stimuli is preserved above chance. Here we sought to reproduce this phenomenon using offline occipital cTBS, which has been shown to induce an inhibitory cortical aftereffect lasting 45-60 minutes. Contrary to expectations, our first experiment revealed the opposite effect: cTBS enhanced conscious vision relative to a sham control. We then sought to replicate this cTBS-induced potentiation of consciousness in conjunction with magnetoencephalography (MEG) and undertook additional experiments to assess its relationship to visual cortical excitability and levels of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA; via magnetic resonance spectroscopy, MRS). Occipital cTBS decreased cortical excitability and increased regional GABA concentration. No significant effects of cTBS on MEG measures were observed, although the results provided weak evidence for potentiation of event related desynchronisation in the beta band. Collectively these experiments suggest that, through the suppression of noise, cTBS can increase the signal-to-noise ratio of neural activity underlying conscious vision. We speculate that gating-byinhibition in the visual cortex may provide a key foundation of consciousness.	[Allen, Christopher P. G.; Dunkley, Benjamin T.; Muthukumaraswamy, Suresh D.; Edden, Richard; Evans, C. John; Sumner, Petroc; Singh, Krish D.; Chambers, Christopher D.] Cardiff Univ, Sch Psychol, Brain Res Imaging Ctr, Cardiff CF10 3AX, S Glam, Wales; [Dunkley, Benjamin T.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Edden, Richard] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Cardiff University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Johns Hopkins University	Allen, CPG (corresponding author), Cardiff Univ, Sch Psychol, Brain Res Imaging Ctr, Cardiff CF10 3AX, S Glam, Wales.	allencp@cf.ac.uk	Chambers, Chris/E-7827-2010; Singh, Krish/D-1066-2009; Evans, C. John/A-8054-2010	Evans, C. John/0000-0002-6619-4245; Edden, Richard/0000-0002-0671-7374; Dunkley, Benjamin Thomas/0000-0001-6173-1171; Muthukumaraswamy, Suresh/0000-0001-7042-3920; Singh, Krishna/0000-0002-3094-2475; Chambers, Chris/0000-0001-6058-4114; Allen, Chris/0000-0001-9809-1630	BBSRC [B/K008277/1]; Welcome Trust [086453/z/08/z]; National Institutes of Health [R01EB016089, P41EB15909]; Biotechnology and Biological Sciences Research Council [BB/C515271/1, BB/C515271/2] Funding Source: researchfish; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB016089, P41EB015909] Funding Source: NIH RePORTER	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Welcome Trust(Wellcome Trust); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was completed with assistance from the Welsh Institute of Cognitive Neuroscience (CPGA, CDC ref: WCI018), a BBSRC David Phillips Fellowship (CDC) and grant (CPGA and CDC B/K008277/1), the Welcome Trust (PS, CPGA ref: 086453/z/08/z), the National Institutes of Health (RE, CJE ref: R01EB016089 and RE ref: P41EB15909). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamyan A, 2011, J NEUROSCI, V31, P3290, DOI 10.1523/JNEUROSCI.6256-10.2011; Allen Sumner P, J COGNITIVE IN PRESS; Babiloni C, 2006, CEREB CORTEX, V16, P37, DOI 10.1093/cercor/bhi082; Babiloni C, 2006, CEREB CORTEX, V16, P1690, DOI 10.1093/cercor/bhj104; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; BLOCK N, 1995, BEHAV BRAIN SCI, V18, P227, DOI 10.1017/S0140525X00038188; Boyer JL, 2005, P NATL ACAD SCI USA, V102, P16875, DOI 10.1073/pnas.0505332102; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; BRADSHAW J, 1967, NATURE, V216, P515, DOI 10.1038/216515a0; BRESSLER SL, 1990, TRENDS NEUROSCI, V13, P161, DOI 10.1016/0166-2236(90)90039-D; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; CAMPION J, 1983, BEHAV BRAIN SCI, V6, P423, DOI 10.1017/S0140525X00016861; Cazzoli D, 2012, BRAIN, V135, P3426, DOI 10.1093/brain/aws182; Cazzoli D, 2009, EUR J NEUROSCI, V29, P1271, DOI 10.1111/j.1460-9568.2009.06665.x; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Corwin J, 1994, NEUROPSYCHOLOGY, V8, P110, DOI 10.1037/0894-4105.8.1.110; Crick F, 1990, SEMINARS NEUROSCIENC, V2, P12; Deblieck C, 2008, HUM BRAIN MAPP, V29, P662, DOI 10.1002/hbm.20427; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Del Cul A, 2007, PLOS BIOL, V5, P2408, DOI 10.1371/journal.pbio.0050260; Dienes Z., 2008, UNDERSTANDING PSYCHO; Dienes Z, USING BAYES IN PRESS; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; EASON RG, 1969, PHYSIOL BEHAV, V4, P283, DOI 10.1016/0031-9384(69)90176-0; EBERT U, 1995, EXP BRAIN RES, V104, P310; Edden RAE, 2013, J MAGNETIC RESONANCE; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Ericsson KA, 2003, J CONSCIOUSNESS STUD, V10, P1; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; Franca M, 2006, CLIN NEUROPHYSIOL, V117, P1808, DOI 10.1016/j.clinph.2006.03.019; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Funke K, 2011, J PHYSIOL-LONDON, V589, P4423, DOI 10.1113/jphysiol.2011.206573; Galarreta M, 2001, NAT REV NEUROSCI, V2, P425, DOI 10.1038/35077566; Green D. M., 1966, SIGNAL DETECTION THE, DOI DOI 10.1086/405615; Hamidi M, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.014.2009; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; HOLM S, 1979, SCAND J STAT, V6, P65; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Jeffreys ET., 1961, THEORY PROBABILITY, V3; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Jolij J, 2005, P NATL ACAD SCI USA, V102, P10747, DOI 10.1073/pnas.0500834102; Kaernbach C, 1999, NEUROREPORT, V10, P713, DOI 10.1097/00001756-199903170-00010; Katzner S, 2011, J NEUROSCI, V31, P5931, DOI 10.1523/JNEUROSCI.5753-10.2011; Kerr N L, 1998, Pers Soc Psychol Rev, V2, P196, DOI 10.1207/s15327957pspr0203_4; Kindler J, 2012, STROKE, V43, P2175, DOI 10.1161/STROKEAHA.111.647503; Koch G, 2008, BRAIN, V131, P3147, DOI 10.1093/brain/awn273; Koelewijn L, 2013, NEUROIMAGE, V79, P295, DOI 10.1016/j.neuroimage.2013.04.108; Koivisto M, 2003, PSYCHOPHYSIOLOGY, V40, P423, DOI 10.1111/1469-8986.00044; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kujala J, 2007, CEREB CORTEX, V17, P1476, DOI 10.1093/cercor/bhl059; Lamme VAF, 2001, ACTA PSYCHOL, V107, P209, DOI 10.1016/S0001-6918(01)00020-8; Lamy D, 2009, J COGNITIVE NEUROSCI, V21, P1435, DOI 10.1162/jocn.2009.21064; Lau HC, 2006, P NATL ACAD SCI USA, V103, P18763, DOI 10.1073/pnas.0607716103; Liddell BJ, 2004, J COGNITIVE NEUROSCI, V16, P479, DOI 10.1162/089892904322926809; Llinas R, 2005, TRENDS NEUROSCI, V28, P325, DOI 10.1016/j.tins.2005.04.006; Lloyd DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082828; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Lutz A, 2004, P NATL ACAD SCI USA, V101, P16369, DOI 10.1073/pnas.0407401101; Lutz A, 2002, P NATL ACAD SCI USA, V99, P1586, DOI 10.1073/pnas.032658199; Macmillan NA, 1990, DETECTION THEORY USE; Maizey L, 2013, CLIN NEUROPHYSIOL, V124, P8; Marzi CA, 1998, EXP BRAIN RES, V118, P435, DOI 10.1007/s002210050299; Marzi CA, 2000, J COGNITIVE NEUROSCI, V12, P869, DOI 10.1162/089892900562471; Masson MEJ, 2003, CAN J EXP PSYCHOL, V57, P203, DOI 10.1037/h0087426; McAllister CJ, 2013, J NEUROSCI, V33, P7919, DOI 10.1523/JNEUROSCI.5624-12.2013; McAllister SM, 2011, EUR J NEUROSCI, V33, P1916, DOI 10.1111/j.1460-9568.2011.07673.x; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Niehaus L, 2001, J NEUROL SCI, V182, P123, DOI 10.1016/S0022-510X(00)00462-7; NOGAWA T, 1976, ELECTROEN CLIN NEURO, V40, P78, DOI 10.1016/0013-4694(76)90181-4; Noh NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035080; Panagiotaropoulos TI, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00603; Panagiotaropoulos TI, 2012, NEURON, V74, P924, DOI 10.1016/j.neuron.2012.04.013; PFURTSCHELLER G, 1992, ELECTROEN CLIN NEURO, V83, P62, DOI 10.1016/0013-4694(92)90133-3; Pfurtscheller G, 1996, INT J PSYCHOPHYSIOL, V24, P39, DOI 10.1016/S0167-8760(96)00066-9; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; PFURTSCHELLER G, 1979, ELECTROEN CLIN NEURO, V46, P138, DOI 10.1016/0013-4694(79)90063-4; PFURTSCHELLER G, 1983, ELECTROEN CLIN NEURO, V56, P114, DOI 10.1016/0013-4694(83)90014-7; Pfurtscheller Gert, 1994, Brain Topography, V6, P269, DOI 10.1007/BF01211172; Piantoni G, 2010, J VISION, V10, DOI 10.1167/10.13.18; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Puts NAJ, 2012, PROG NUCL MAG RES SP, V60, P29, DOI 10.1016/j.pnmrs.2011.06.001; Rahnev D, 2013, J NEUROPHYSIOL, V110, P10; REUTERLORENZ PA, 1990, BRAIN COGNITION, V12, P240, DOI 10.1016/0278-2626(90)90018-J; Ro T, 2004, P NATL ACAD SCI USA, V101, P9933, DOI 10.1073/pnas.0403061101; Romei V, 2010, J NEUROSCI, V30, P8692, DOI 10.1523/JNEUROSCI.0160-10.2010; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Sanchez-Meca J, 2003, PSYCHOL METHODS, V8, P448, DOI 10.1037/1082-989X.8.4.448; Schwarzkopf DS, 2011, J NEUROSCI, V31, P3143, DOI 10.1523/JNEUROSCI.4863-10.2011; Sergent C, 2005, NAT NEUROSCI, V8, P1391, DOI 10.1038/nn1549; Shafi MM, 2014, BRAIN TOPOGR, V27, P172, DOI 10.1007/s10548-013-0277-y; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Simon M, 2011, CLIN NEUROPHYSIOL, V122, P1168, DOI 10.1016/j.clinph.2010.10.044; Stagg CJ, 2009, J NEUROPHYSIOL, V101, P2872, DOI 10.1152/jn.91060.2008; Stewart LM, 2001, NEUROPSYCHOLOGIA, V39, P415, DOI 10.1016/S0028-3932(00)00130-5; Stokes MG, 2013, J NEUROPHYSIOL, V109, P437, DOI 10.1152/jn.00510.2012; Taylor JR, 1997, INTRO ERROR ANAL STU, VSecond; Tegenthoff M, 2005, PLOS BIOL, V3, P2031, DOI 10.1371/journal.pbio.0030362; Thielscher A, 2010, CEREB CORTEX, V20, P328, DOI 10.1093/cercor/bhp102; Thompson B, 2008, CURR BIOL, V18, P1067, DOI 10.1016/j.cub.2008.06.052; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; VARELA FJ, 1981, NEUROPSYCHOLOGIA, V19, P675; Varnava A, 2011, J NEUROSCI METH, V201, P327, DOI 10.1016/j.jneumeth.2011.08.016; Verbruggen F, 2010, P NATL ACAD SCI USA, V107, P13966, DOI 10.1073/pnas.1001957107; Vernet M, 2013, EUR J NEUROSCI, V37, P598, DOI 10.1111/ejn.12069; VONDERMALSBURG C, 1986, BIOL CYBERN, V54, P29, DOI 10.1007/BF00337113; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; Vuilleumier P, 2001, P NATL ACAD SCI USA, V98, P3495, DOI 10.1073/pnas.051436898; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Waterston ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010354; Weiskrantz L., 1986, BLINDSIGHT CASE STUD; Weiskrantz L, 2009, EXP BRAIN RES, V192, P413, DOI 10.1007/s00221-008-1388-7; Wilke M, 2006, P NATL ACAD SCI USA, V103, P17507, DOI 10.1073/pnas.0604673103; Yamanaka K, 2010, CEREB CORTEX, V20, P1037, DOI 10.1093/cercor/bhp163; Zeki S, 1998, BRAIN, V121, P25, DOI 10.1093/brain/121.1.25; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	123	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100350	10.1371/journal.pone.0100350	http://dx.doi.org/10.1371/journal.pone.0100350			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956195	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000338917900042
J	Hoellein, T; Rojas, M; Pink, A; Gasior, J; Kelly, J				Hoellein, Timothy; Rojas, Miguel; Pink, Adam; Gasior, Joseph; Kelly, John			Anthropogenic Litter in Urban Freshwater Ecosystems: Distribution and Microbial Interactions	PLOS ONE			English	Article							MARINE DEBRIS; PLASTIC DEBRIS; NUTRIENT LIMITATION; TEMPORAL VARIATIONS; ENVIRONMENT; INGESTION; BIOFILMS; POLLUTION; BEACHES; SEA	Accumulation of anthropogenic litter (i.e. garbage; AL) and its ecosystem effects in marine environments are well documented. Rivers receive AL from terrestrial habitats and represent a major source of AL to marine environments, but AL is rarely studied within freshwater ecosystems. Our objectives were to 1) quantify AL density in urban freshwaters, 2) compare AL abundance among freshwater, terrestrial, and marine ecosystems, and 3) characterize the activity and composition of AL biofilms in freshwater habitats. We quantified AL from the Chicago River and Chicago's Lake Michigan shoreline, and found that AL abundance in Chicago freshwater ecosystems was comparable to previously reported data for marine and terrestrial ecosystems, although AL density and composition differed among habitats. To assess microbial interactions with AL, we incubated AL and natural substrates in 3 freshwater ecosystems, quantified biofilm metabolism as gross primary production (GPP) and community respiration (CR), and characterized biofilm bacterial community composition via high-throughput sequencing of 16S rRNA genes. The main driver of biofilm community composition was incubation location (e.g., river vs pond), but there were some significant differences in biofilm composition and metabolism among substrates. For example, biofilms on organic substrates (cardboard and leaves) had lower GPP than hard substrates (glass, plastic, aluminum and tiles). In addition, bacterial communities on organic substrates were distinct in composition from those on hard substrates, with higher relative abundances of bacteria associated with cellulose decomposition. Finally, we used our results to develop a conceptual diagram designed to unite the study of AL in terrestrial and freshwater environments with the well-established field of marine debris research. We suggest this broad perspective will be useful for future studies which synthesize AL sources, ecosystem effects, and fate across multiple ecosystem types, and will benefit management and reduction of global AL accumulations.	[Hoellein, Timothy; Rojas, Miguel; Pink, Adam; Gasior, Joseph; Kelly, John] Loyola Univ, Dept Biol, Chicago, IL 60626 USA	Loyola University Chicago	Hoellein, T (corresponding author), Loyola Univ, Dept Biol, Chicago, IL 60626 USA.	thoellein@luc.edu	Raju, Nethaji/J-9085-2018	Hoellein, Timothy/0000-0002-9201-3225; Kelly, John/0000-0002-0894-137X	Loyola University Chicago through Center for Urban Environment Research and Policy (CUERP); Loyola University Chicago through Department of Biology; NSF [NSF-DGE-1257295]	Loyola University Chicago through Center for Urban Environment Research and Policy (CUERP); Loyola University Chicago through Department of Biology; NSF(National Science Foundation (NSF))	Loyola University Chicago supported undergraduate researchers Adam Pink and Joseph Gasior through summer research fellowships from the Center for Urban Environment Research and Policy (CUERP) and the Department of Biology, respectively. Miguel Rojas's work on this project was supported by an NSF Graduate Research Fellowship (NSF-DGE-1257295). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hilal A, 2009, J ENVIRON MANAGE, V90, P1043, DOI 10.1016/j.jenvman.2008.03.014; Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030; [Anonymous], 2001, BERGEYS MANUAL SYSTE; [Anonymous], 2005, BERGEYS MANUAL SYSTE; Araujo M. C. B., 2006, PAN AM J AQUATIC SCI, V1, P28; Armitage N, 2000, WATER SA, V26, P181; Barnes DKA, 2005, MAR BIOL, V146, P815, DOI 10.1007/s00227-004-1474-8; Battin TJ, 2003, NATURE, V426, P439, DOI 10.1038/nature02152; Besemer K, 2007, APPL ENVIRON MICROB, V73, P4966, DOI 10.1128/AEM.00588-07; Bott Thomas L., 1996, P533; Bowman D, 1998, J COASTAL RES, V14, P418; Browne MA, 2011, ENVIRON SCI TECHNOL, V45, P9175, DOI 10.1021/es201811s; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chassard C, 2012, INT J SYST EVOL MICR, V62, P138, DOI 10.1099/ijs.0.027375-0; Choy CA, 2013, MAR ECOL PROG SER, V485, P155, DOI 10.3354/meps10342; Chung EJ, 2012, INT J SYST EVOL MICR, V62, P3030, DOI 10.1099/ijs.0.036442-0; Claereboudt MR, 2004, MAR POLLUT BULL, V49, P770, DOI 10.1016/j.marpolbul.2004.06.004; CLARKE KR, 1988, MAR ECOL PROG SER, V46, P213, DOI 10.3354/meps046213; Cole M, 2011, MAR POLLUT BULL, V62, P2588, DOI 10.1016/j.marpolbul.2011.09.025; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Derraik JGB, 2002, MAR POLLUT BULL, V44, P842, DOI 10.1016/S0025-326X(02)00220-5; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fitzpatrick FA, 2005, AM FISH S S, V47, P87; Gregory MR, 2009, PHILOS T R SOC B, V364, P2013, DOI 10.1098/rstb.2008.0265; Hall RO, 1998, ECOLOGY, V79, P1995, DOI 10.1890/0012-9658(1998)079[1995:TTSOBI]2.0.CO;2; Hammer J, 2012, REV ENVIRON CONTAM T, V220, P1, DOI 10.1007/978-1-4614-3414-6_1; Hoellein TJ, 2010, HYDROBIOLOGIA, V649, P331, DOI 10.1007/s10750-010-0276-x; Hoellein TJ, 2009, J N AM BENTHOL SOC, V28, P305, DOI 10.1899/08-073.1; Hoppe PD, 2012, FRESHW SCI, V31, P379, DOI 10.1899/11-089; Isanapong J, 2012, J BACTERIOL, V194, P2744, DOI 10.1128/JB.00264-12; do Sul JAI, 2007, MAR POLLUT BULL, V54, P1087, DOI 10.1016/j.marpolbul.2007.05.004; do Sul JAI, 2011, ESTUAR COAST, V34, P814, DOI 10.1007/s12237-011-9392-8; Johnson LT, 2009, CAN J FISH AQUAT SCI, V66, P1081, DOI 10.1139/F09-065; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Law KL, 2010, SCIENCE, V329, P1185, DOI 10.1126/science.1192321; Lee DI, 2006, ESTUAR COAST SHELF S, V70, P187, DOI 10.1016/j.ecss.2006.06.003; Madzena A, 1997, MAR POLLUT BULL, V34, P900, DOI 10.1016/S0025-326X(97)00052-0; McNamara CJ, 2004, J N AM BENTHOL SOC, V23, P677, DOI 10.1899/0887-3593(2004)023<0677:BCCIBO>2.0.CO;2; Mhedbi-Hajri N, 2011, ADV EXP MED BIOL, V715, P71, DOI 10.1007/978-94-007-0940-9_5; Moore CJ, 2008, ENVIRON RES, V108, P131, DOI 10.1016/j.envres.2008.07.025; NOLLKAEMPER A, 1994, MAR POLLUT BULL, V28, P649, DOI 10.1016/0025-326X(94)90299-2; Ofek M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040117; Phillips RA, 2010, BIOL CONSERV, V143, P501, DOI 10.1016/j.biocon.2009.11.020; Puls J, 2011, J POLYM ENVIRON, V19, P152, DOI 10.1007/s10924-010-0258-0; Ribic CA, 1998, MAR POLLUT BULL, V36, P887, DOI 10.1016/S0025-326X(98)00064-2; Rickard AH, 2003, FEMS MICROBIOL LETT, V220, P133, DOI 10.1016/S0378-1097(03)00094-6; Ryan PG, 2009, PHILOS T R SOC B, V364, P1999, DOI 10.1098/rstb.2008.0207; Santos IR, 2009, ENVIRON MONIT ASSESS, V148, P455, DOI 10.1007/s10661-008-0175-z; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schuyler Q, 2014, CONSERV BIOL, V28, P129, DOI 10.1111/cobi.12126; Pon JPS, 2012, WASTE MANAGE, V32, P343, DOI 10.1016/j.wasman.2011.10.012; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sheavly SB, 2007, J POLYM ENVIRON, V15, P301, DOI 10.1007/s10924-007-0074-3; van Sebille E, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044040; Vos P., 2009, BERGEYS MANUAL SYSTE; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI [10.1899/04-020.1, 10.1899/04-028.1]; Williams AT, 1999, WATER AIR SOIL POLL, V112, P197, DOI 10.1023/A:1005000724803; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418; Zbyszewski M, 2011, WATER AIR SOIL POLL, V220, P365, DOI 10.1007/s11270-011-0760-6; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	60	162	166	4	189	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e98485	10.1371/journal.pone.0098485	http://dx.doi.org/10.1371/journal.pone.0098485			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955768	gold, Green Published			2022-12-25	WOS:000338917900002
J	Morrison, PK; Bing, C; Harris, PA; Maltin, CA; Grove-White, D; Argo, CM				Morrison, Philippa K.; Bing, Chen; Harris, Patricia A.; Maltin, Charlotte A.; Grove-White, Dai; Argo, Caroline McG			Post-Mortem Stability of RNA in Skeletal Muscle and Adipose Tissue and the Tissue-Specific Expression of Myostatin, Perilipin and Associated Factors in the Horse	PLOS ONE			English	Article							REAL-TIME PCR; GENE-EXPRESSION; MESSENGER-RNA; ACTIVIN-A; ADIPOCYTE LIPOLYSIS; BOVINE PREADIPOCYTE; FOLLISTATIN; MICE; DIFFERENTIATION; OBESITY	Obesity, a major concern for equine welfare, is highly prevalent in the leisure horse population. Skeletal-muscle and adipose tissues are important determinants of maintenance energy requirements. The myostatin and perilipin pathways play key roles in the regulation of muscle mass and lipolysis respectively and have both been associated with obesity predisposition in other mammalian species. High quality samples, suitable for molecular biology, are an essential prerequisite for detailed investigations of gene and protein expression. Hence, this study has evaluated a) the post-mortem stability of RNA extracted from skeletal-muscle and adipose-tissues collected under commercial conditions and b) the tissue-specific presence of myostatin, the moystatin receptor (activin receptor IIB, ActRIIB), follistatin and perilipin, genes and proteins across a range of equine tissues. Objectives were addressed using tissues from 7 Thoroughbred horses presented for slaughter at a commercial abattoir; a) samples were collected at 7 time-points from Masseter muscle and perirenal adipose from 5 minutes to 6 hours post-mortem. Extracted RN was appraised by Optical Density analysis and agarose-gel electrophoresis. b) Quantitative real time PCR and Western Blotting were used to evaluate gene and protein expression in anatomically-defined samples collected from 17 tissues (6 organs, 4 skeletal muscles and 7 discrete adipose depots). The results indicate that, under the present collection conditions, intact, good quality RNA could be extracted from skeletal-muscle for up to 2 hours post-mortem. However, RNA from adipose tissue may be more susceptible to degradation/contamination and samples should be collected no later than 30 minutes post-mortem. The data also show that myostatin and ActRIIB genes and proteins were almost exclusively expressed in skeletal muscle. The follistatin gene showed a more diverse gene expression profile, with expression evident in several organs, adipose tissue depots and skeletal muscles. Perilipin gene and protein were almost exclusively expressed by adipose tissue.	[Morrison, Philippa K.; Bing, Chen; Maltin, Charlotte A.; Grove-White, Dai; Argo, Caroline McG] Univ Liverpool, Dept Obes & Endocrinol, Fac Hlth & Life Sci, Wirral L64 7TE, Merseyside, England; [Harris, Patricia A.] WALTHAM Ctr Pet Nutr, Equine Studies Grp, Melton Mowbray, Leics, England	University of Liverpool; Mars; WALTHAM Petcare Science Institute	Argo, CM (corresponding author), Univ Liverpool, Dept Obes & Endocrinol, Fac Hlth & Life Sci, Leahurst Campus, Wirral L64 7TE, Merseyside, England.	argo@liv.ac.uk		Morrison, Philippa/0000-0003-4187-0371; Argo, Caroline/0000-0002-8279-6350	WALTHAM	WALTHAM	This research was funded by a PhD Scholarship from WALTHAM. The funders (with the exception of Patricia A. Harris, co-author and collaborator), had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2011, GENES GENOM, V33, P245, DOI 10.1007/s13258-010-0114-6; Allen DL, 2008, AM J PHYSIOL-ENDOC M, V294, pE918, DOI 10.1152/ajpendo.00798.2007; Amthor H, 2004, DEV BIOL, V270, P19, DOI 10.1016/j.ydbio.2004.01.046; Argo CM, 2012, VET J; Arvidsson E, 2004, J INTERN MED, V255, P595, DOI 10.1111/j.1365-2796.2004.01314.x; Bahar B, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-108; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Bogaert L, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-24; Brandt C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037236; Carlson CJ, 1999, AM J PHYSIOL-REG I, V277, pR601, DOI 10.1152/ajpregu.1999.277.2.R601; Cash JN, 2012, MOL ENDOCRINOL, V26, P1167, DOI 10.1210/me.2012-1061; Flanagan JN, 2009, J CLIN ENDOCR METAB, V94, P3003, DOI 10.1210/jc.2008-2005; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Fontanesi L, 2008, MEAT SCI, V80, P1345, DOI 10.1016/j.meatsci.2008.06.014; Gill JL, 2009, ANIM GENET, V40, P97, DOI 10.1111/j.1365-2052.2008.01790.x; Gjelstad IMF, 2012, ARCH PHYSIOL BIOCHEM, V118, P22, DOI 10.3109/13813455.2011.630009; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Gu YR, 2011, J ANIM BREED GENET, V128, P319, DOI 10.1111/j.1439-0388.2011.00920.x; Guo W, 2008, J BIOL CHEM, V283, P9136, DOI 10.1074/jbc.M708968200; Harker I.J., 2011, J EQUINE VET SCI, V31, P253, DOI [10.1016/j.jevs.2011.03.058, DOI 10.1016/J.JEVS.2011.03.058]; HARRIS RBS, 1986, J NUTR, V116, P2536, DOI 10.1093/jn/116.12.2536; Hemmrich K, 2010, LABMEDICINE, V41, P104, DOI 10.1309/LMFSBPUOA19MH5BV; Hennebry A, 2009, AM J PHYSIOL-CELL PH, V296, pC525, DOI 10.1152/ajpcell.00259.2007; Hickford JGH, 2010, ANIM GENET, V41, P64, DOI 10.1111/j.1365-2052.2009.01965.x; Hill EW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-552; Hirai S, 2007, DOMEST ANIM ENDOCRIN, V33, P269, DOI 10.1016/j.domaniend.2006.06.001; Hirai S, 2007, DOMEST ANIM ENDOCRIN, V32, P1, DOI 10.1016/j.domaniend.2005.12.001; Hittel DS, 2009, DIABETES, V58, P30, DOI 10.2337/db08-0943; Hosoyama T, 2002, J REPROD DEVELOP, V48, P335, DOI 10.1262/jrd.48.335; Ju MJ, 2009, AM J CLIN PATHOL, V131, P498, DOI 10.1309/AJCP86PPBNGOHNNL; Kern PA, 2004, J CLIN ENDOCR METAB, V89, P1352, DOI 10.1210/jc.2003-031388; Kessler Y, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-106; Keutmann HT, 2004, MOL ENDOCRINOL, V18, P228, DOI 10.1210/me.2003-0112; Kijas JW, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-80; Koch L, 2008, J CLIN INVEST, V118, P2132, DOI 10.1172/JCI31073; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mosher DS, 2007, PLOS GENET, V3; Mottagui-Tabar S, 2003, DIABETOLOGIA, V46, P789, DOI 10.1007/s00125-003-1112-x; Pedersen B.K., 2012, NAT REV ENDOCRINOL; Peters IR, 2007, VET IMMUNOL IMMUNOP, V117, P55, DOI 10.1016/j.vetimm.2007.01.011; Pratt S, 2013, ISOLATION TOTAL RNA, P181; Qi L, 2004, CLIN GENET, V66, P299, DOI 10.1111/j.1399-0004.2004.00309.x; Rebouissou S, 2008, J HEPATOL, V49, P61, DOI 10.1016/j.jhep.2008.03.013; Ruiz JR, 2011, BRIT J NUTR, V106, P486, DOI 10.1017/S0007114511000432; Shen WJ, 2009, J LIPID RES, V50, P2306, DOI 10.1194/jlr.M900176-JLR200; Sidis Y, 2006, ENDOCRINOLOGY, V147, P3586, DOI 10.1210/en.2006-0089; Tansey JT, 2004, IUBMB LIFE, V56, P379, DOI 10.1080/15216540400009968; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Tortoriello DV, 2001, ENDOCRINOLOGY, V142, P3426, DOI 10.1210/en.142.8.3426; Trayhurn Paul, 2011, Archives of Physiology and Biochemistry, V117, P47, DOI 10.3109/13813455.2010.535835; Tu PA, 2012, ANIM BIOTECHNOL, V23, P291, DOI 10.1080/10495398.2012.709205; UENO N, 1987, P NATL ACAD SCI USA, V84, P8282, DOI 10.1073/pnas.84.23.8282; Wang YX, 2003, OBES RES, V11, P930, DOI 10.1038/oby.2003.128; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Zaragosi LE, 2010, DIABETES, V59, P2513, DOI 10.2337/db10-0013; Zhang C, 2012, DIABETOLOGIA, V55, P183, DOI 10.1007/s00125-011-2304-4; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	57	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100810	10.1371/journal.pone.0100810	http://dx.doi.org/10.1371/journal.pone.0100810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956155	Green Submitted, Green Published, gold			2022-12-25	WOS:000338917900096
J	Su, ZX; Zhu, HG; Zhang, MH; Wang, LL; He, HC; Jiang, SL; Hou, FF; Li, AQ				Su, Zhengxiu; Zhu, Hongguo; Zhang, Menghuan; Wang, Liangliang; He, Hanchang; Jiang, Shaoling; Hou, Fan Fan; Li, Aiqing			Salt-Induced Changes in Cardiac Phosphoproteome in a Rat Model of Chronic Renal Failure	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; LEFT-VENTRICULAR HYPERTROPHY; GLOMERULAR-FILTRATION-RATE; CARDIOVASCULAR COMPLICATIONS; OXIDATIVE STRESS; RISK-FACTORS; HEART; HYPERTENSION; PHOSPHORYLATION; PROTEINS	Heart damage is widely present in patients with chronic kidney disease. Salt diet is the most important environmental factor affecting development of chronic renal failure and cardiovascular diseases. The proteins involved in chronic kidney disease induced heart damage, especially their posttranslational modifications, remain largely unknown to date. Sprague-Dawley rats underwent 5/6 nephrectomy (chronic renal failure model) or sham operation were treated for 2 weeks with a normal(0.4% NaCl), or high-salt (4% NaCl) diet. We employed TiO2 enrichment, iTRAQ labeling and liquid-chromatography tandem mass spectrometry strategy for phosphoproteomic profiling of left ventricular free walls in these animals. A total of 1724 unique phosphopeptides representing 2551 non-redundant phosphorylation sites corresponding to 763 phosphoproteins were identified. During normal salt feeding, 89 (54%) phosphopeptides upregulated and 76 (46%) phosphopeptides downregulated in chronic renal failure rats relative to sham rats. In chronic renal failure rats, high salt intake induced upregulation of 84 (49%) phosphopeptides and downregulation of 88 (51%) phosphopeptides. Database searches revealed that most of the identified phospholproteins were important signaling molecules such as protein kinases, receptors and phosphatases. These phospholproteins were involved in energy metabolism, cell communication, cell differentiation, cell death and other biological processes. The Search Tool for the Retrieval of Interacting Genes analysis revealed functional links among 15 significantly regulated phosphoproteins in chronic renal failure rats compared to sham group, and 23 altered phosphoproteins induced by high salt intake. The altered phosphorylation levels of two proteins involved in heart damage, lamin A and phospholamban were validated. Expression of the downstream genes of these two proteins, desmin and SERCA2a, were also analyzed.	[Su, Zhengxiu; Zhu, Hongguo; Zhang, Menghuan; Wang, Liangliang; He, Hanchang; Jiang, Shaoling; Hou, Fan Fan; Li, Aiqing] Southern Med Univ, Nanfang Hosp, State Key Lab Organ Failure Res, Div Nephrol,Natl Clin Res Ctr Kidney Dis, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Hou, FF (corresponding author), Southern Med Univ, Nanfang Hosp, State Key Lab Organ Failure Res, Div Nephrol,Natl Clin Res Ctr Kidney Dis, Guangzhou, Guangdong, Peoples R China.	ffhouguangzhou@163.com; liaiqing@smu.edu.cn			Major State Basic Research Development Program of China (National 973 program) [2012CB517703, 2011CB504005]; National Nature and Science [81270825, 31201751]	Major State Basic Research Development Program of China (National 973 program); National Nature and Science	This study is supported by the Major State Basic Research Development Program of China (National 973 program) (Nos. 2012CB517703 & 2011CB504005) to Dr. Fan Fan Hou and National Nature and Science Grants (Nos. 81270825 & 31201751) to Dr. Ai Qing Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggeli IKS, 2008, CELL SIGNAL, V20, P1292, DOI 10.1016/j.cellsig.2008.02.019; Aviv A, 2001, ARCH INTERN MED, V161, P507, DOI 10.1001/archinte.161.4.507; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bugger H, 2010, CARDIOVASC RES, V85, P376, DOI 10.1093/cvr/cvp344; Cacciapuoti F, 2011, J AM SOC HYPERTENS, V5, P449, DOI 10.1016/j.jash.2011.08.006; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Delom F, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-15; du Cailar G, 2004, J HYPERTENS, V22, P697, DOI 10.1097/00004872-200404000-00011; DUCAILAR G, 1992, AM J PHYSIOL, V263, pH177, DOI 10.1152/ajpheart.1992.263.1.H177; DUCAILAR G, 1995, ARCH MAL COEUR VAISS, V88, P15; El-Armouche A, 2007, J MOL CELL CARDIOL, V43, P223, DOI 10.1016/j.yjmcc.2007.05.003; Engholm-Keller K, 2013, PROTEOMICS, V13, P910, DOI 10.1002/pmic.201200484; Frisoli TM, 2012, AM J MED, V125, P433, DOI 10.1016/j.amjmed.2011.10.023; Frock RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042918; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; Garbino A, 2010, ACTA PHARMACOL SIN, V31, P1019, DOI 10.1038/aps.2010.116; Grussenmeyer T, 2011, J PROTEOMICS, V74, P672, DOI 10.1016/j.jprot.2011.02.015; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; Gustavsson M, 2013, P NATL ACAD SCI USA, V110, P17338, DOI 10.1073/pnas.1303006110; Jin X, 2006, PROTEOMICS, V6, P1948, DOI 10.1002/pmic.200500337; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kotlo K, 2012, J PROTEOMICS, V77, P1, DOI 10.1016/j.jprot.2012.05.041; Landstrom AP, 2007, J MOL CELL CARDIOL, V42, P1026, DOI 10.1016/j.yjmcc.2007.04.006; Levey AS, 1998, PRIMER KIDNEY DIS, P20; Li AQ, 2010, BRAIN PATHOL, V20, P1077, DOI 10.1111/j.1750-3639.2010.00414.x; Li AQ, 2009, PROTEOMICS, V9, P2788, DOI 10.1002/pmic.200800850; Li AQ, 2009, BBA-PROTEINS PROTEOM, V1794, P663, DOI 10.1016/j.bbapap.2008.11.025; LOTT JA, 1983, CLIN CHEM, V29, P1946; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Mataradzija A, 2010, BOSNIAN J BASIC MED, V10, pS44; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Meng C, 2009, J PROTEOME RES, V8, P2463, DOI 10.1021/pr801059u; Mensah GA, 2003, CURR PROB CARDIOLOGY, V28, P156, DOI 10.1016/S0146-2806(03)00017-3; Mensah George A., 2002, Cardiology Clinics, V20, P225, DOI 10.1016/S0733-8651(02)00004-8; Minamisawa S, 2004, BIOCHEM BIOPH RES CO, V325, P852, DOI 10.1016/j.bbrc.2004.10.107; Morimoto A, 1997, LANCET, V350, P1734, DOI 10.1016/S0140-6736(97)05189-1; Muntner P, 2005, J AM SOC NEPHROL, V16, P529, DOI 10.1681/ASN.2004080656; Rizzi E, 2013, EXP MOL PATHOL, V94, P1, DOI 10.1016/j.yexmp.2012.10.010; Ross L, 2013, INT J CLIN PRACT, V67, P4, DOI 10.1111/ijcp.12069; Shiba N, 2011, J CARDIOL, V57, P8, DOI 10.1016/j.jjcc.2010.09.004; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Sun ZY, 2012, J MOL CELL CARDIOL, V53, P354, DOI 10.1016/j.yjmcc.2012.06.001; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Van Biesen W, 2007, EUR HEART J, V28, P478, DOI 10.1093/eurheartj/ehl455; Weir MR, 2005, AM J KIDNEY DIS, V45, P176, DOI 10.1053/j.ajkd.2004.08.041; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Zamorano-Leon JJ, 2010, CELL PHYSIOL BIOCHEM, V25, P347, DOI 10.1159/000276567; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	51	12	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100331	10.1371/journal.pone.0100331	http://dx.doi.org/10.1371/journal.pone.0100331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945867	Green Published, Green Submitted, gold			2022-12-25	WOS:000340721500064
J	Yang, PW; Hsieh, MS; Huang, YC; Hsieh, CY; Chiang, TH; Lee, JM				Yang, Pei-Wen; Hsieh, Min-Shu; Huang, Ya-Chuan; Hsieh, Ching-Yueh; Chiang, Tzu-Hsuan; Lee, Jang-Ming			Genetic Variants of EGF and VEGF Predict Prognosis of Patients with Advanced Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; R497K POLYMORPHISM; COLORECTAL-CANCER; FACTOR PRECURSOR; IN-VITRO; SURVIVAL; PATHWAY; RISK; EXPRESSION; RECEPTORS	Purpose: To investigate the association between genetic polymorphisms of growth factor-related genes and prognosis in patients with advanced esophageal squamous cell carcinoma (ESCC). Patients and Methods: A total of 334 ESCC patients with advanced tumor stages (stages IIB, III and IV) were enrolled in the study. The genotypes of 14 candidate single nucleotide polymorphisms (SNPs) involved in growth factor-related functions were analyzed using iPLEX Gold technology from the genomic DNA of peripheral leukocytes, and were correlated with the clinical outcome of patients. Serum levels of growth factors were examined by enzyme-linked immunosorbent assay (ELISA). Results: The genetic polymorphisms of EGF:rs4444903, EGF:rs2237051 and VEGF:rs2010963 showed significant associations with overall survival (OS) of advanced ESCC patients (A/A+ A/G vs. GG, [HR = 0.77, 95% CI = 0.60-0.99, P = 0.039 for rs4444903; A/G+ G/G vs. A/A, [HR = 0.74, 95% CI = 0.58-0.95, P = 0.019 for rs2237051; G/G+ G/C vs. C/C, [HR] inves = 0.69, 95% CI = 0.50-0.95, P = 0.023 for rs2010963). EGFR:rs2227983 and 3 SNPs of PIK3CA also showed borderline significant correlation with OS of advanced ESCC patients (P = 0.058 for rs2227983; P = 0.069, 0.091 and 0.067 for rs6443624, rs7651265 and rs7621329 of PIK3CA respectively). According to cumulative effect analysis of multiple SNPs, patients carrying 4 unfavorable genotypes exhibited more than a 3-fold increased risk of mortality. Finally, both EGF and VEGF expression levels significantly associated with patient mortality. Conclusion: The genetic variants and expression levels of EGF and VEGF can serve as prognostic predictors in patients with advanced ESCC, and thus provide more information for optimizing personalized therapies for patients with ESCC.	[Yang, Pei-Wen; Huang, Ya-Chuan; Hsieh, Ching-Yueh; Chiang, Tzu-Hsuan; Lee, Jang-Ming] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Yang, Pei-Wen; Hsieh, Min-Shu; Huang, Ya-Chuan; Hsieh, Ching-Yueh; Chiang, Tzu-Hsuan; Lee, Jang-Ming] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Hsieh, Min-Shu] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Lee, JM (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan.	jmlee@ntu.edu.tw		Hsieh, Min-Shu/0000-0002-0594-3732; LEE, JANG-MING/0000-0001-9727-227X	Ministry of Science and Technology [NSC100-2314-B-002-016, NSC 101-2314-B-002-020-MY3]; National Health Research Institutes [NHRI-EX102-10032BI]; Ministry of Health and Welfare [DOH101-TD-PB-111-NSC003]; National Taiwan University Hospital [NTUH.102-S2140]; National Taiwan University College of Medicine; National Taiwan University Hospital of the Republic of China	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Health Research Institutes(National Health Research Institutes, Japan); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); National Taiwan University Hospital(National Taiwan University); National Taiwan University College of Medicine(National Taiwan University); National Taiwan University Hospital of the Republic of China(National Taiwan University)	This study was supported by the Ministry of Science and Technology (NSC100-2314-B-002-016, NSC 101-2314-B-002-020-MY3), National Health Research Institutes (NHRI-EX102-10032BI), Ministry of Health and Welfare (DOH101-TD-PB-111-NSC003), National Taiwan University Hospital (NTUH.102-S2140), and Excellent Translational Medicine Research Projects of National Taiwan University College of Medicine and National Taiwan University Hospital of the Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedenne L, 2007, J CLIN ONCOL, V25, P1160, DOI 10.1200/JCO.2005.04.7118; BELL GI, 1986, NUCLEIC ACIDS RES, V14, P8427, DOI 10.1093/nar/14.21.8427; Boyd D Barry, 2003, Integr Cancer Ther, V2, P315, DOI 10.1177/1534735403259152; Bradbury PA, 2009, CLIN CANCER RES, V15, P4680, DOI 10.1158/1078-0432.CCR-09-0192; Buerger H, 2000, CANCER RES, V60, P854; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; Dong J, 2010, CARCINOGENESIS, V31, P1080, DOI 10.1093/carcin/bgq079; Edge S, 2009, AJCC CANC STAGING MA, P143; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Ferrara N, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053/sonc.2002.37264; Goncalves A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-169; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Hildebrandt MAT, 2009, J CLIN ONCOL, V27, P857, DOI 10.1200/JCO.2008.17.6297; Hirai T, 1998, Dis Esophagus, V11, P221; Ho GYF, 2003, BRIT J CANCER, V88, P263, DOI 10.1038/sj.bjc.6600747; Hosgood HD, 2008, CARCINOGENESIS, V29, P1938, DOI 10.1093/carcin/bgn178; Inada S, 1999, SURG TODAY, V29, P493, DOI 10.1007/BF02482343; Islami F, 2010, INT J CANC; ITAKURA Y, 1994, CANCER, V74, P795, DOI 10.1002/1097-0142(19940801)74:3<795::AID-CNCR2820740303>3.0.CO;2-I; Jain M, 2007, CANCER BIOL THER, V6, P1553, DOI 10.4161/cbt.6.10.4709; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kelsen DP, 1998, NEW ENGL J MED, V339, P1979, DOI 10.1056/NEJM199812313392704; Kitadai Y, 1998, CLIN CANCER RES, V4, P2195; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lanuti M, 2008, CLIN CANCER RES, V14, P3216, DOI 10.1158/1078-0432.CCR-07-4932; Lee JM, 2011, ANN SURG ONCOL, V18, P2066, DOI 10.1245/s10434-011-1559-9; Melis M, 2011, ANN SURG ONCOL, V18, P824, DOI 10.1245/s10434-010-1336-1; MORIAI T, 1994, P NATL ACAD SCI USA, V91, P10217, DOI 10.1073/pnas.91.21.10217; MROCZKOWSKI B, 1988, P NATL ACAD SCI USA, V85, P126, DOI 10.1073/pnas.85.1.126; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Normanno N, 2003, ENDOCR-RELAT CANCER, V10, P1, DOI 10.1677/erc.0.0100001; PARRIES G, 1995, J BIOL CHEM, V270, P27954, DOI 10.1074/jbc.270.46.27954; Pawson T, 2002, FEBS LETT, V513, P2, DOI 10.1016/S0014-5793(01)03292-6; Pechlivanis S, 2007, ENDOCR-RELAT CANCER, V14, P733, DOI 10.1677/ERC-07-0107; Perez CA, 2010, J UROLOGY, V183, P2062, DOI 10.1016/j.juro.2009.12.098; Reid TD, 2012, CLIN ONCOL R COLL RA; Sasaki H, 2009, J CANCER RES CLIN, V135, P313, DOI 10.1007/s00432-008-0464-5; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Shahbazi M, 2002, LANCET, V359, P397, DOI 10.1016/S0140-6736(02)07600-6; Shih CH, 2000, CLIN CANCER RES, V6, P1161; Tzeng CWD, 2007, ANN SURG ONCOL, V14, P2150, DOI 10.1245/s10434-007-9409-5; Upadhyay R, 2008, ONCOL RES, V17, P167, DOI 10.3727/096504008785114147; Wang LE, 2012, J CANCER RES CLIN, V138, P377, DOI 10.1007/s00432-011-1103-0; Wang WS, 2007, CLIN CANCER RES, V13, P3597, DOI 10.1158/1078-0432.CCR-06-2601; Watson CJ, 2000, CYTOKINE, V12, P1232, DOI 10.1006/cyto.2000.0692; Winder T, 2010, CLIN CANCER RES, V16, P5591, DOI 10.1158/1078-0432.CCR-10-2092; Wu MT, 2001, BRIT J CANCER, V85, P658, DOI 10.1054/bjoc.2001.1927; Zhang JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059254	48	28	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100326	10.1371/journal.pone.0100326	http://dx.doi.org/10.1371/journal.pone.0100326			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945674	Green Published, Green Submitted, gold			2022-12-25	WOS:000340721500061
J	Yang, H; Salz, T; Zajac-Kaye, M; Liao, DQ; Huang, SM; Qiu, Y				Yang, Hui; Salz, Tal; Zajac-Kaye, Maria; Liao, Daiqing; Huang, Suming; Qiu, Yi			Overexpression of histone deacetylases in cancer cells is controlled by interplay of transcription factors and epigenetic modulators	FASEB JOURNAL			English	Article						Sp1; Sp3; SET1; p300	HUMAN COLON-CANCER; HUMAN COLORECTAL-CANCER; G1/S TRANSITION; CYCLE ARREST; DNA-BINDING; EXPRESSION; ACETYLATION; INHIBITOR; SP1; APOPTOSIS	Histone deacetylases (HDACs) that deacetylate histone and nonhistone proteins play crucial roles in a variety of cellular processes. The overexpression of HDACs is reported in many cancer types and is directly linked to accelerated cell proliferation and survival. However, little is known about how HDAC expression is regulated in cancer cells. In this study, we found that HDAC1 and HDAC2 promoters are regulated through collaborative binding of transcription factors Sp1/Sp3 and epigenetic modulators, including histone H3K4 methyltransferase SET1 and histone acetyltransferase p300, whose levels are also elevated in colon cancer cell lines and patient samples. Interestingly, Sp1 and Sp3 differentially regulate HDAC1 and HDAC2 promoter activity. In addition, Sp1/Sp3 recruits SET1 and p300 to the promoters. SET1 knockdown (KD) results in a loss of the H3K4 trimethylation mark at the promoters, as well as destabilizes p300 at the promoters. Conversely, p300 also influences SET1 recruitment and H3K4me3 level, indicating a crosstalk between p300 and SET1. Further, SET1 KD reduces Sp1 binding to the HDAC1 promoter through the increase of Sp1 acetylation. These results indicate that interactions among transcription factors and epigenetic modulators orchestrate the activation of HDAC1 and HDAC2 promoter activity in colon cancer cells.	[Yang, Hui; Zajac-Kaye, Maria; Liao, Daiqing; Qiu, Yi] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL USA; [Salz, Tal; Huang, Suming] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Qiu, Y (corresponding author), 2033 Mowry Rd,Room 356, Gainesville, FL 32610 USA.	sumingh@ufl.edu; qiuy@ufl.edu		, Yi/0000-0002-3282-6072	U.S. National Institutes of Health [R01-HL-095674, R01-HL-091929, R01-HL-090589]; Florida Bankhead Coley Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090589, R01HL095674, R01HL091929] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Bankhead Coley Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Bowen Yan for excellent technical assistance. This work was supported by U.S. National Institutes of Health grants R01-HL-095674 (to Y.Q.), R01-HL-091929 (to S.H.), and R01-HL-090589 (to S.H.) and a Florida Bankhead Coley Research Foundation grant (to Y.Q.). The authors declare no conflicts of interest.	Abaza MSI, 2012, TUMOR BIOL, V33, P1951, DOI 10.1007/s13277-012-0456-6; Ait-Si-Ali S, 2000, ONCOGENE, V19, P2430, DOI 10.1038/sj.onc.1203562; Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Azizkhan Jane C., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P229; Billon N, 1999, ONCOGENE, V18, P2872, DOI 10.1038/sj.onc.1202712; Bracker TU, 2009, INT J ONCOL, V35, P909, DOI 10.3892/ijo_00000406; Brunmeir R, 2009, INT J DEV BIOL, V53, P275, DOI 10.1387/ijdb.082649rb; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Choi JH, 2001, JPN J CANCER RES, V92, P1300, DOI 10.1111/j.1349-7006.2001.tb02153.x; CHU E, 1993, MOL PHARMACOL, V43, P527; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Enroth S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-450; Flatmark K, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-25; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Haberland M, 2009, P NATL ACAD SCI USA, V106, P7751, DOI 10.1073/pnas.0903139106; Halkidou K, 2004, PROSTATE, V59, P177, DOI 10.1002/pros.20022; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Higashijima J, 2011, ONCOL REP, V26, P343, DOI 10.3892/or.2011.1312; Huang BH, 2005, CELL DEATH DIFFER, V12, P395, DOI 10.1038/sj.cdd.4401567; Hung JJ, 2006, MOL CELL BIOL, V26, P1770, DOI 10.1128/MCB.26.5.1770-1785.2006; Iyer NG, 2007, ONCOGENE, V26, P21, DOI 10.1038/sj.onc.1209771; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Liu L, 2010, BIOCHEM BIOPH RES CO, V392, P190, DOI 10.1016/j.bbrc.2010.01.011; Loboda A, 2010, MOL CELLS, V29, P435, DOI 10.1007/s10059-010-0067-2; Ma WL, 2008, BIOL REPROD, V79, P289, DOI 10.1095/biolreprod.107.067082; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Martin DGE, 2006, MOL CELL BIOL, V26, P7871, DOI 10.1128/MCB.00573-06; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Meng J, 2012, ONCOL REP, V28, P384, DOI 10.3892/or.2012.1793; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Salz T, 2014, CANCER RES, V74, P775, DOI 10.1158/0008-5472.CAN-13-1400; Schuettengruber B, 2003, MOL CELL BIOL, V23, P6993, DOI 10.1128/MCB.23.19.6993-7004.2003; Senese S, 2007, MOL CELL BIOL, V27, P4784, DOI 10.1128/MCB.00494-07; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Tang ZY, 2013, CELL, V154, P297, DOI 10.1016/j.cell.2013.06.027; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; Valin A, 2013, MOL CELL BIOL, V33, P1582, DOI 10.1128/MCB.00323-12; Waby JS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-275; Wada T, 2009, J BIOL CHEM, V284, P30673, DOI 10.1074/jbc.M109.042242; Weichert W, 2008, CLIN CANCER RES, V14, P1669, DOI 10.1158/1078-0432.CCR-07-0990; WILLSON JKV, 1987, CANCER RES, V47, P2704; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Wilson AJ, 2010, CANCER RES, V70, P609, DOI 10.1158/0008-5472.CAN-09-2327; Xiao HY, 2000, J BIOL CHEM, V275, P1371, DOI 10.1074/jbc.275.2.1371; Yang T, 2012, J BIOL CHEM, V287, P40279, DOI 10.1074/jbc.M112.349704; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yang YH, 2008, CANCER RES, V68, P4833, DOI 10.1158/0008-5472.CAN-08-0644; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zeng YY, 1998, J BIOL CHEM, V273, P28921, DOI 10.1074/jbc.273.44.28921; Zhu P, 2004, CELL CYCLE, V3, P1240, DOI 10.4161/cc.3.10.1195	57	42	43	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4265	4279		10.1096/fj.14-250654	http://dx.doi.org/10.1096/fj.14-250654			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	24948597	Green Published			2022-12-25	WOS:000342222700007
J	Seifert, M; Abou-El-Ardat, K; Friedrich, B; Klink, B; Deutsch, A				Seifert, Michael; Abou-El-Ardat, Khalil; Friedrich, Betty; Klink, Barbara; Deutsch, Andreas			Autoregressive Higher-Order Hidden Markov Models: Exploiting Local Chromosomal Dependencies in the Analysis of Tumor Expression Profiles	PLOS ONE			English	Article							COPY-NUMBER ALTERATION; ARRAY CGH; ANALYSIS REVEALS; PATTERNS; SUBTYPES; CANCER	Changes in gene expression programs play a central role in cancer. Chromosomal aberrations such as deletions, duplications and translocations of DNA segments can lead to highly significant positive correlations of gene expression levels of neighboring genes. This should be utilized to improve the analysis of tumor expression profiles. Here, we develop a novel model class of autoregressive higher-order Hidden Markov Models (HMMs) that carefully exploit local data-dependent chromosomal dependencies to improve the identification of differentially expressed genes in tumor. Autoregressive higher-order HMMs overcome generally existing limitations of standard first-order HMMs in the modeling of dependencies between genes in close chromosomal proximity by the simultaneous usage of higher-order state-transitions and autoregressive emissions as novel model features. We apply autoregressive higher-order HMMs to the analysis of breast cancer and glioma gene expression data and perform in-depth model evaluation studies. We find that autoregressive higher-order HMMs clearly improve the identification of overexpressed genes with underlying gene copy number duplications in breast cancer in comparison to mixture models, standard first-and higher-order HMMs, and other related methods. The performance benefit is attributed to the simultaneous usage of higher-order state-transitions in combination with autoregressive emissions. This benefit could not be reached by using each of these two features independently. We also find that autoregressive higher-order HMMs are better able to identify differentially expressed genes in tumors independent of the underlying gene copy number status in comparison to the majority of related methods. This is further supported by the identification of well-known and of previously unreported hotspots of differential expression in glioblastomas demonstrating the efficacy of autoregressive higher-order HMMs for the analysis of individual tumor expression profiles. Moreover, we reveal interesting novel details of systematic alterations of gene expression levels in known cancer signaling pathways distinguishing oligodendrogliomas, astrocytomas and glioblastomas. An implementation is available under www.jstacs.de/index.php/ARHMM.	[Seifert, Michael; Friedrich, Betty; Deutsch, Andreas] Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, Dresden, Germany; [Abou-El-Ardat, Khalil; Klink, Barbara] Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Clin Genet, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Seifert, M (corresponding author), Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, Dresden, Germany.	michael.seifert@zih.tu-dresden.de		Klink, Barbara/0000-0002-8753-8238	European Social Fund; Free State of Saxony; German Research Foundation; Open Access Publication Funds of the TU Dresden	European Social Fund(European Social Fund (ESF)); Free State of Saxony; German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the TU Dresden	This work was done in the frame of the GlioMath-Dresden project funded by the European Social Fund and the Free State of Saxony. We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the TU Dresden.	Aycard O., 2004, International Journal of Advanced Robotic Systems, V1, P231; Baum LE, 1972, INEQUALITIES, V3, P1; Benyoussef L, 2008, DIGIT SIGNAL PROCESS, V18, P849, DOI 10.1016/j.dsp.2007.10.010; Berchtold A, 2002, STAT SCI, V17, P328; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; BILMES JA, 1998, 97021 ICSITR; Callegaro A, 2006, BIOINFORMATICS, V22, P2658, DOI 10.1093/bioinformatics/btl455; Cassidy MJ, 2002, J NEUROSCI METH, V116, P35, DOI 10.1016/S0165-0270(02)00026-2; Cavalli G, 2013, NAT STRUCT MOL BIOL, V20, P290, DOI 10.1038/nsmb.2474; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cooper LAD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012548; Crawley JJ, 2002, GENOME BIOL, V3; de Tayrac M, 2009, GENE CHROMOSOME CANC, V48, P55, DOI 10.1002/gcc.20618; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Derrode S, 2004, 2004 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH, AND SIGNAL PROCESSING, VOL V, PROCEEDINGS, P769; Diaz-Uriarte R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000737; Durbin R., 1998, BIOL SEQUENCE ANAL P; Eng C, 2009, J COMPUT BIOL, V16, P1211, DOI 10.1089/cmb.2008.0122; Ephraim Y, 1988, APR P INT C AC SPEEC, P533; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Fridlyand J, 2004, J MULTIVARIATE ANAL, V90, P132, DOI 10.1016/j.jmva.2004.02.008; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Grau J, 2012, J MACH LEARN RES, V13, P1967; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heidenblad M, 2005, ONCOGENE, V24, P1794, DOI 10.1038/sj.onc.1208383; Hicklin J., 2012, JAMA JAVA MATRIX PAC; Holland JD, 2013, CURR OPIN CELL BIOL, V25, P254, DOI 10.1016/j.ceb.2013.01.004; Hsu L, 2005, BIOSTATISTICS, V6, P211, DOI 10.1093/biostatistics/kxi004; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Hyman E, 2002, CANCER RES, V62, P6240; Jelinek F., 1998, STAT METHODS SPEECH; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Kalliovirta L, 2012, 35217950562 HECER; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Khan MS, 2011, THESIS U EDINBURGH; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lai WR, 2005, BIOINFORMATICS, V21, P3763, DOI 10.1093/bioinformatics/bti611; Lee LM, 2006, STUDY HIGH ORDER HID; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Marioni JC, 2006, BIOINFORMATICS, V22, P1144, DOI 10.1093/bioinformatics/btl089; Martinez-Beneito MA, 2008, STAT MED, V27, P4455, DOI 10.1002/sim.3320; Myers CL, 2004, BIOINFORMATICS, V20, P3533, DOI 10.1093/bioinformatics/bth440; Nel EM, 2005, IEEE T PATTERN ANAL, V27, P1733, DOI 10.1109/TPAMI.2005.221; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Olteanu M, 2009, LECT NOTES COMPUT SC, V5517, P886, DOI 10.1007/978-3-642-02478-8_111; Picard F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-27; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Seifert M., 2010, THESIS M LUTHER U HA; Seifert M, 2012, BIOINFORMATICS, V28, P2930, DOI 10.1093/bioinformatics/bts562; Seifert M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002286; Seifert M, 2011, BIOINFORMATICS, V27, P1645, DOI 10.1093/bioinformatics/btr199; Shai R, 2003, ONCOGENE, V22, P4918, DOI 10.1038/sj.onc.1206753; Shannon M, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 1-2, P829; Shi SM, 1997, PROCEEDINGS OF THE IEEE/IAFE 1997 COMPUTATIONAL INTELLIGENCE FOR FINANCIAL ENGINEERING (CIFER), P244, DOI 10.1109/CIFER.1997.618944; Stockhausen MT, 2010, NEURO-ONCOLOGY, V12, P199, DOI 10.1093/neuonc/nop022; Tak-Kuen Siu, 2005, Computational Economics, V26, P251, DOI 10.1007/s10614-005-9010-6; Toedling J, 2005, BIOINFORMATICS, V21, P2112, DOI 10.1093/bioinformatics/bti183; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xuan T, 2004, THESIS U SASKATCHEWA; Zucchini W, 2009, MONOGR STAT APPL PRO, V110, P3	64	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100295	10.1371/journal.pone.0100295	http://dx.doi.org/10.1371/journal.pone.0100295			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955771	gold, Green Published, Green Submitted			2022-12-25	WOS:000338917900038
J	Allman, D; Ditmore, MH; Kaplan, K				Allman, Dan; Ditmore, Melissa Hope; Kaplan, Karyn			Improving Ethical and Participatory Practice for Marginalized Populations in Biomedical HIV Prevention Trials: Lessons from Thailand	PLOS ONE			English	Article							RESEARCH-AND-DEVELOPMENT; CIVIL-SOCIETY PERSPECTIVES; FEMALE SEX WORKERS; COMMUNITY ENGAGEMENT; PREEXPOSURE PROPHYLAXIS; VULNERABLE POPULATIONS; COMBINATION PREVENTION; RESEARCH CONTEXTS; VACCINE TRIALS; PUBLIC-HEALTH	Background: This paper presents findings from a qualitative investigation of ethical and participatory issues related to the conduct of biomedical HIV prevention trials among marginalized populations in Thailand. This research was deemed important to conduct, as several large-scale biomedical HIV prevention trials among marginalized populations had closed prematurely in other countries, and a better understanding of how to prevent similar trial closures from occurring in the future was desired. Methods: In-depth key informant interviews were held in Bangkok and Chiang Mai, Thailand. Interviews were audio recorded, transcribed, translated and thematically analyzed. The Good Participatory Practice Guidelines for Biomedical HIV Prevention Trials (GPP) guided this work. Results: Fourteen interviews were conducted: 10 with policymakers, academic and community-based researchers and trial staff and four with representatives of non-governmental organizations (NGOs). Suggested ways to improve ethical and participatory practice centered on standards of HIV prevention, informed consent, communication and human rights. In particular, the need to overcome language and literacy differences was identified. Key informants felt communication was the basis of ethical understanding and trust within biomedical HIV prevention trial contexts, and thus fundamental to trial participants' ability to exercise free will. Discussion: Biomedical HIV prevention trials present opportunities for inclusive and productive ethical and participatory practice. Key informants suggested that efforts to improve practice could result in better relationships between research stakeholders and research investigative teams and by extension, better, more ethical participatory trials. This research took place in Thailand and its findings apply primarily to Thailand. However, given the universality of many ethical considerations, the results of this study can inform the improvement of ethical and participatory practice in other parts of the world where biomedical HIV prevention trials occur, and where clinical trials in marginalized populations continue.	[Allman, Dan] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Allman, Dan] Univ Toronto, Dalla Lana Sch Publ Hlth, CIHR Social Res Ctr HIV Prevent SRC, Toronto, ON, Canada; [Ditmore, Melissa Hope] Urban Justice Ctr, Sex Workers Project, New York, NY USA; [Kaplan, Karyn] Thai AIDS Treatment Act Grp TTAG, Bangkok, Thailand	University of Toronto; University of Toronto	Allman, D (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	dan.allman@utoronto.ca	Allman, Dan/B-5086-2012	Allman, Dan/0000-0001-5198-751X	AVAC: Global Advocacy for HIV Prevention	AVAC: Global Advocacy for HIV Prevention	The funding for this research was provided by AVAC: Global Advocacy for HIV Prevention. The funder had a role in study design through participation in the development of the questions asked of key informants. The funder had no role in the data collection, data analysis, decision to publish, or preparation of the manuscript.	Ahmed SM, 2010, AM J PUBLIC HEALTH, V100, P1380, DOI 10.2105/AJPH.2009.178137; Andanda Pamela, 2011, Afr J AIDS Res, V10, P451, DOI 10.2989/16085906.2011.646660; [Anonymous], 2011, GOOD PART PRACT GUID; Barsdorf N, 2010, DEV WORLD BIOETH, V10, P78, DOI 10.1111/j.1471-8847.2009.00265.x; Bekker LG, 2014, JAIDS-J ACQ IMM DEF, V65, pS24, DOI 10.1097/QAI.0000000000000036; Benatar SR, 2010, J MED ETHICS, V36, P194, DOI 10.1136/jme.2009.032672; Bhan A, 2007, PLOS MED, V4, P1456, DOI 10.1371/journal.pmed.0040272; Borek N, 2010, JAIDS-J ACQ IMM DEF, V54, pS43, DOI 10.1097/QAI.0b013e3181e3627d; Boulanger RF, 2013, LANCET INFECT DIS, V13, P540, DOI 10.1016/S1473-3099(13)70042-2; Buchbinder SP, 2011, AIDS BEHAV, V15, pS72, DOI 10.1007/s10461-011-9894-1; Bull S, 2013, J EMPIR RES HUM RES, V8, P1, DOI 10.1525/jer.2013.8.4.1; Bull S, 2012, J EMPIR RES HUM RES, V7, P37, DOI 10.1525/jer.2012.7.1.37; Chakrapani V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051080; Chilengi Roma, 2009, Acta Trop, V112 Suppl 1, pS53, DOI 10.1016/j.actatropica.2009.08.004; Chua A, 2005, PLOS MED, V2, P1044, DOI 10.1371/journal.pmed.0020346; Cole CA, 2013, PROG COMM HLTH PARTN, V7, P323, DOI 10.1353/cpr.2013.0034; de Wit JBF, 2011, HEALTH EDUC RES, V26, P381, DOI 10.1093/her/cyr021; Delany-Moretlwe S, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-S1-S8; Ditmore MH, 2011, HEALTH EDUC RES, V26, P466, DOI 10.1093/her/cyq087; Ellen JM, 2010, JAIDS-J ACQ IMM DEF, V54, pS7, DOI 10.1097/QAI.0b013e3181e25779; Essack Z, 2012, AIDS CARE, V24, P1249, DOI 10.1080/09540121.2012.656566; Essack Z, 2010, DEV WORLD BIOETH, V10, P11, DOI 10.1111/j.1471-8847.2009.00254.x; Essack Z, 2010, SAMJ S AFR MED J, V100, P45; Fast PE, 2010, AIDS, V24, pS50, DOI 10.1097/01.aids.0000390707.58512.5e; Folayan MO, 2015, DEV WORLD BIOETH, V15, P1, DOI 10.1111/dewb.12020; Folayan MO, 2014, DEV WORLD BIOETH, V14, P1, DOI 10.1111/j.1471-8847.2012.00340.x; Folayan MO, 2011, J CULT ECON-UK, V4, P97, DOI 10.1080/17530350.2011.535376; Frew PM, 2011, VACCINE, V29, P6136, DOI 10.1016/j.vaccine.2011.06.082; Frew PM, 2010, PREV SCI, V11, P207, DOI 10.1007/s11121-009-0162-9; Fuchs JD, 2013, JAIDS-J ACQ IMM DEF, V63, P259, DOI 10.1097/QAI.0b013e318296df94; Fuchs JD, 2010, JAIDS-J ACQ IMM DEF, V55, pS128, DOI 10.1097/QAI.0b013e3181fbca02; Gafos M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014577; Gahagan J, 2008, INT J INFECT DIS, V12, P569, DOI 10.1016/j.ijid.2008.07.002; Golub Sarit A, 2010, Curr HIV/AIDS Rep, V7, P201, DOI 10.1007/s11904-010-0057-1; Gomez G B, 2013, Adv Prev Med, V2013, P190190, DOI 10.1155/2013/190190; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Haire B, 2013, DEV WORLD BIOETH, V13, P87, DOI 10.1111/dewb.12032; Haire B, 2012, AM J BIOETHICS, V12, P21, DOI 10.1080/15265161.2012.671887; Haire BG, 2011, DEV WORLD BIOETH, V11, P63, DOI 10.1111/j.1471-8847.2010.00292.x; Hankins CA, 2010, AIDS, V24, pS70, DOI 10.1097/01.aids.0000390709.04255.fd; Kaewkungwal J, 2013, AIDS RES HUM RETROV, V29, P1524, DOI [10.1089/aid.2012.0265, 10.1089/AID.2012.0265]; Kiawi E, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-8; Koen J, 2013, DEV WORLD BIOETH, V13, P138, DOI 10.1111/j.1471-8847.2012.00338.x; Koff WC, 2013, VACCINE, V31, pB204, DOI 10.1016/j.vaccine.2012.10.115; Kokolo MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022497; Lang TA, 2012, INT HEALTH, V4, P47, DOI 10.1016/j.inhe.2011.10.003; Lau CY, 2011, VACCINE, V29, P7794, DOI 10.1016/j.vaccine.2011.07.108; Lienhardt C, 2012, TUBERCULOSIS, V92, pS33, DOI 10.1016/S1472-9792(12)70011-2; Loff B, 2005, LANCET, V365, P1618, DOI 10.1016/S0140-6736(05)66502-6; Mack N, 2013, OPEN ACCESS J CLIN T, V5, P127, DOI 10.2147/OAJCT.S45717; Mack N, 2010, J EMPIR RES HUM RES, V5, P3, DOI 10.1525/jer.2010.5.2.3; Macklin R, 2011, INT J FEM APPROACHES, V4, P124; Macklin R, 2012, AM J BIOETHICS, V12, P31, DOI 10.1080/15265161.2012.671889; Macklin R, 2010, PUBLIC HEALTH ETH-UK, V3, P199, DOI 10.1093/phe/phq019; Macklin Ruth, 2009, HIV Therapy, V3, P229, DOI 10.2217/HIV.09.7; MacQueen Kathleen M, 2011, J Int AIDS Soc, V14 Suppl 2, pS3, DOI 10.1186/1758-2652-14-S2-S3; Mamotte N, 2010, BMC MED ETHICS, V11, DOI 10.1186/1472-6939-11-3; McCormick JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004659; Meyer DZ, 2009, FIELD METHOD, V21, P91, DOI 10.1177/1525822X08323985; Michael M, 2012, THEOR CULT SOC, V29, P93, DOI 10.1177/0263276412443567; Miller L, 2010, INT J CLIN PRACT, V64, P1179, DOI 10.1111/j.1742-1241.2010.02421.x; Mills EJ, 2005, BRIT MED J, V331, P1403, DOI 10.1136/bmj.331.7529.1403; Ngongo BP, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-S2-O25; Ngongo PB, 2012, AIDS CARE, V24, P1277, DOI 10.1080/09540121.2012.656572; Okpokoro E., 2013, Journal of AIDS and Clinical Research, V4, P260; Ozdemir V, 2009, AM J BIOETHICS, V9, P65, DOI 10.1080/15265160903197671; Philpott S, 2011, J MED ETHICS, V37, P244, DOI 10.1136/jme.2010.037176; Pitisuttithum P, 2010, VACCINE, V28, pB45, DOI 10.1016/j.vaccine.2009.08.061; Poynten IM, 2010, HIV MED, V11, P282, DOI 10.1111/j.1468-1293.2009.00777.x; Presidential Commission for the Study of Bioethical Issues, 2011, MOR SCI PROT PART HU; Raju M S, 2008, Indian J Lepr, V80, P267; Reed E, 2014, J EMPIR RES HUM RES, V9, P19, DOI 10.1525/jer.2014.9.1.19; Rennie S, 2010, J MED ETHICS, V36, P810, DOI 10.1136/jme.2010.035444; Rerks-Ngarm S, 2010, CURR OPIN HIV AIDS, V5, P435, DOI 10.1097/COH.0b013e32833c95c1; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Rosengarten M, 2009, SCI CULT-UK, V18, P183, DOI 10.1080/09505430902885565; Rosengarten M, 2009, SOC SCI MED, V69, P1049, DOI 10.1016/j.socscimed.2009.07.039; Sahay Seema, 2011, East J Med, V16, P168; Shagi C, 2008, AIDS CARE, V20, P1039, DOI 10.1080/09540120701842803; Simon C, 2010, AM J BIOETHICS, V10, P3, DOI 10.1080/15265160903585578; Singh JA, 2005, PLOS MED, V2, P824, DOI 10.1371/journal.pmed.0020234; Stobie M, 2010, DEV WORLD BIOETH, V10, P150, DOI 10.1111/j.1471-8847.2009.00272.x; Swallow V, 2003, J CLIN NURS, V12, P610, DOI 10.1046/j.1365-2702.2003.00728.x; Tarimo EAM, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-283; UNAIDS AVAC, 2007, GOOD PART PRACT GUID; Urada LA, 2014, J EMPIR RES HUM RES, V9, P29, DOI 10.1525/jer.2014.9.1.29; Vallely A, 2012, AM J BIOETHICS, V12, P46, DOI 10.1080/15265161.2012.719268; Watermeyer Jennifer, 2011, J Pharm Pract, V24, P498, DOI 10.1177/0897190011415685; Weijer C, 2006, J LAW MED ETHICS, V34, P793, DOI 10.1111/j.1748-720X.2006.00099.x; White R, 2011, CLIN TRIALS, V8, P103, DOI 10.1177/1740774510387170	90	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100058	10.1371/journal.pone.0100058	http://dx.doi.org/10.1371/journal.pone.0100058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2UZ	24949864	Green Published, Green Submitted, gold			2022-12-25	WOS:000338276300034
J	Ge, S; Wang, RM; Yu, DC				Ge, Sheng; Wang, Ruimin; Yu, Dongchuan			Classification of Four-Class Motor Imagery Employing Single-Channel Electroencephalography	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACES; BCI COMPETITION 2003; EEG; MU; PATTERNS; FILTERS	With advances in brain-computer interface (BCI) research, a portable few-or single-channel BCI system has become necessary. Most recent BCI studies have demonstrated that the common spatial pattern (CSP) algorithm is a powerful tool in extracting features for multiple-class motor imagery. However, since the CSP algorithm requires multi-channel information, it is not suitable for a few-or single-channel system. In this study, we applied a short-time Fourier transform to decompose a single-channel electroencephalography signal into the time-frequency domain and construct multi-channel information. Using the reconstructed data, the CSP was combined with a support vector machine to obtain high classification accuracies from channels of both the sensorimotor and forehead areas. These results suggest that motor imagery can be detected with a single channel not only from the traditional sensorimotor area but also from the forehead area.	[Ge, Sheng; Yu, Dongchuan] Southeast Univ, Res Ctr Learning Sci, Minist Educ, Key Lab Child Dev & Learning Sci, Nanjing, Jiangsu, Peoples R China; [Wang, Ruimin] Nanjing Univ Sci & Technol, Sch Elect Engn & Optoelect Technol, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Nanjing University of Science & Technology	Ge, S (corresponding author), Southeast Univ, Res Ctr Learning Sci, Minist Educ, Key Lab Child Dev & Learning Sci, Nanjing, Jiangsu, Peoples R China.	shengge@seu.edu.cn			National Natural Science Foundation of China [51007040, 61273224]; Program for New Century Excellent Talents in University of Ministry of Education, China [61074126]; Fundamental Research Funds for the Central Universities, China [3250183202, 10602026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of Ministry of Education, China(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (No. 51007040, 61273224), the Program for New Century Excellent Talents in University of Ministry of Education, China (No. 61074126), and the Fundamental Research Funds for the Central Universities, China (No. 3250183202, 10602026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belousov AI, 2002, CHEMOMETR INTELL LAB, V64, P15, DOI 10.1016/S0169-7439(02)00046-1; Birbaumer N, 2006, PSYCHOPHYSIOLOGY, V43, P517, DOI 10.1111/j.1469-8986.2006.00456.x; Blankertz B, 2003, IEEE T NEUR SYS REH, V11, P127, DOI 10.1109/TNSRE.2003.814456; Blankertz B, 2004, IEEE T BIO-MED ENG, V51, P1044, DOI 10.1109/TBME.2004.826692; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P153, DOI 10.1109/TNSRE.2006.875642; Cabrera AF, 2008, J NEUROSCI METH, V174, P135, DOI 10.1016/j.jneumeth.2008.06.026; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; COLLURA T F, 1990, Brain Topography, V3, P65, DOI 10.1007/BF01128863; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Coyle D, 2008, IEEE IJCNN, P3696, DOI 10.1109/IJCNN.2008.4634328; Dornhege G, 2006, IEEE T BIO-MED ENG, V53, P2274, DOI 10.1109/TBME.2006.883649; Ebrahimpour Reza, 2012, 2012 16th CSI International Symposium on Artificial Intelligence and Signal Processing (AISP), P458, DOI 10.1109/AISP.2012.6313791; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Fried SJ, 2012, CLIN EEG NEUROSCI, V43, P121, DOI 10.1177/1550059411433613; Fukunaga K, 1990, INTRO STAT PATTERN R; Graimann B, 2003, IEEE T NEUR SYS REH, V11, P276, DOI 10.1109/TNSRE.2003.816863; Guger C, 2000, IEEE T REHABIL ENG, V8, P447, DOI 10.1109/86.895947; Hsu C.W., 2003, PRACTICAL GUIDE SUPP; Ince NF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014384; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Jha AK, 2013, INT J ENG RES TECHNO, V2, P269; KOLES Z J, 1990, Brain Topography, V2, P275, DOI 10.1007/BF01129656; Lal TN, 2004, IEEE T BIO-MED ENG, V51, P1003, DOI 10.1109/TBME.2004.827827; Lemm S, 2004, IEEE T BIO-MED ENG, V51, P1077, DOI 10.1109/TBME.2004.827076; Li KD, 2009, EIGHTH IEEE INTERNATIONAL CONFERENCE ON DEPENDABLE, AUTONOMIC AND SECURE COMPUTING, PROCEEDINGS, P430, DOI 10.1109/DASC.2009.66; Lu Wang, 2008, 2008 2nd International Conference on Bioinformatics and Biomedical Engineering (ICBBE '08), P2153; Luck SJ., 2011, OXFORD HDB EVENT REL, DOI DOI 10.1093/OXFORDHB/9780195374148.013.0089; McFarland DJ, 2000, BRAIN TOPOGR, V12, P177, DOI 10.1023/A:1023437823106; Mingai Li, 2011, Proceedings of the 2011 IEEE International Conference on Mechatronics and Automation (ICMA 2011), P1184, DOI 10.1109/ICMA.2011.5985829; Mu ZD, 2009, INT J DIGITAL CONTEN, V3, P116; Muller-Putz GR, 2010, MED BIOL ENG COMPUT, V48, P229, DOI 10.1007/s11517-009-0572-7; Neuper C, 2009, CLIN NEUROPHYSIOL, V120, P239, DOI 10.1016/j.clinph.2008.11.015; Nunez PL, 2000, BEHAV BRAIN SCI, V23, P371, DOI 10.1017/S0140525X00003253; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 2009, CLIN NEUROPHYSIOL, V120, P24, DOI 10.1016/j.clinph.2008.09.027; Rato RT, 2008, MECH SYST SIGNAL PR, V22, P1374, DOI 10.1016/j.ymssp.2007.11.028; Schlogl A, 2005, J NEURAL ENG, V2, pL14, DOI 10.1088/1741-2560/2/4/L02; Shi LC, 2011, LECT NOTES COMPUT SC, V7062, P725, DOI 10.1007/978-3-642-24955-6_86; Shih JJ, 2012, MAYO CLIN PROC, V87, P268, DOI 10.1016/j.mayocp.2011.12.008; Solis-Escalante T, 2010, BIOMED SIGNAL PROCES, V5, P15, DOI 10.1016/j.bspc.2009.09.002; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; van den Broek SP, 1998, ELECTROEN CLIN NEURO, V106, P522, DOI 10.1016/S0013-4694(97)00147-8; Vapnik V. N., 2000, NATURE STAT LEARNING, DOI DOI 10.1007/978-1-4757-3264-1_1	44	42	49	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e98019	10.1371/journal.pone.0098019	http://dx.doi.org/10.1371/journal.pone.0098019			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950192	Green Submitted, gold, Green Published			2022-12-25	WOS:000338276300005
J	Kraus, D; Horowitz-Kraus, T				Kraus, Dror; Horowitz-Kraus, Tzipi			The Effect of Learning on Feedback-Related Potentials in Adolescents with Dyslexia: An EEG-ERP Study	PLOS ONE			English	Article							CARD SORTING TEST; ERROR-DETECTION MECHANISM; EVENT-RELATED POTENTIALS; PERFORMANCE FEEDBACK; SKILLED READERS; WORKING-MEMORY; CHILDREN; TASK; NEGATIVITY; DEFICITS	Introduction: Individuals with dyslexia exhibit associated learning deficits and impaired executive functions. The Wisconsin Card Sorting Test (WCST) is a learning-based task that relies heavily on executive functioning, in particular, attention shift and working memory. Performance during early and late phases of a series within the task represents learning and implementation of a newly learned rule. Here, we aimed to examine two event-related potentials associated with learning, feedback-related negativity (FRN)-P300 complex, in individuals with dyslexia performing the WCST. Methods: Adolescents with dyslexia and age-matched typical readers performed the Madrid card sorting test (MCST), a computerized version of the WCST. Task performance, reading measures, and cognitive measures were collected. FRN and the P300 complex were acquired using the event-related potentials methodology and were compared in early vs late errors within a series. Results: While performing the MCST, both groups showed a significant reduction in average reaction times and a trend toward decreased error rates. Typical readers performed consistently better than individuals with dyslexia. FRN amplitudes in early phases were significantly smaller in dyslexic readers, but were essentially equivalent to typical readers in the late phase. P300 amplitudes were initially smaller among readers with dyslexia and tended to decrease further in late phases. Differences in FRN amplitudes for early vs late phases were positively correlated with those of P300 amplitudes in the entire sample. Conclusion: Individuals with dyslexia demonstrate a behavioral and electrophysiological change within single series of the MCST. However, learning patterns seem to differ between individuals with dyslexia and typical readers. We attribute these differences to the lower baseline performance of individuals with dyslexia. We suggest that these changes represent a fast compensatory mechanism, demonstrating the importance of learning strategies on reading among individuals with dyslexia.	[Kraus, Dror] Cincinnati Childrens Hosp Med Ctr, Dept Pediat Neurol, Cincinnati, OH 45229 USA; [Horowitz-Kraus, Tzipi] Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, Cincinnati, OH 45229 USA; [Horowitz-Kraus, Tzipi] Univ Haifa, Fac Educ, Edmond J Safra Brain Res Ctr Study Learning Disab, IL-31999 Haifa, Israel	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University of Haifa	Horowitz-Kraus, T (corresponding author), Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, Cincinnati, OH 45229 USA.	Tzipi.Horowitz-Kraus@cchmc.org			Edmond J Safra foundation	Edmond J Safra foundation	This study was supported by the Edmond J Safra foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcelo F, 2002, NEUROPSYCHOLOGIA, V40, P349, DOI 10.1016/S0028-3932(01)00110-5; Barcelo F, 2003, BRAIN RES PROTOC, V11, P27, DOI 10.1016/S1385-299X(03)00013-8; Barcelo F, 2002, NEUROREPORT, V13, P1887, DOI 10.1097/00001756-200210280-00011; Bellebaum C, 2008, EUR J NEUROSCI, V27, P1823, DOI 10.1111/j.1460-9568.2008.06138.x; Breznitz Z, 2003, BRAIN LANG, V85, P486, DOI 10.1016/S0093-934X(03)00071-3; Breznitz Z., 2006, FLUENCY READING SYNC; Brown L, 1997, TONI 3 FORM PICTURE; Bujoreanu IS, 2008, DEV NEUROPSYCHOL, V33, P584, DOI 10.1080/87565640802254364; COURCHESNE E, 1975, ELECTROEN CLIN NEURO, V39, P131, DOI 10.1016/0013-4694(75)90003-6; Crutch SJ, 2006, NEUROCASE, V12, P91, DOI 10.1080/13554790500507172; DENCKLA MB, 1976, NEUROPSYCHOLOGIA, V14, P471, DOI 10.1016/0028-3932(76)90075-0; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Groen Y, 2007, BIOL PSYCHOL, V76, P174, DOI 10.1016/j.biopsycho.2007.07.006; Helland T, 2000, CHILD NEUROPSYCHOL, V6, P37, DOI 10.1076/0929-7049(200003)6:1;1-B;FT037; Henson R, 2005, Q J EXP PSYCHOL-A, V58, P193, DOI 10.1080/02724980443000502; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Horowitz-Kraus T., 2012, J LEARNING DISABILIT, V10; Horowitz-Kraus T, 2012, INT DYSL ASS C BALT; Horowitz-Kraus T, 2008, CLIN NEUROPHYSIOL, V119, P2238, DOI 10.1016/j.clinph.2008.06.009; Horowitz-Kraus T, 2011, DEV NEUROPSYCHOL, V36, P914, DOI 10.1080/87565641.2011.606415; Horowitz-Kraus T, 2011, INT J DISABIL DEV ED, V58, P33, DOI 10.1080/1034912X.2011.548466; Horowitz-Kraus T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007141; Igarashi K, 2002, BRAIN DEV-JPN, V24, P174, DOI 10.1016/S0387-7604(02)00024-4; International Dyslexia Association, 2011, DEF DYSL; Jacobson LA, 2011, CHILD NEUROPSYCHOL, V17, P209, DOI 10.1080/09297049.2010.532204; Kado Y, 2012, BRAIN DEV-JPN, V34, P354, DOI 10.1016/j.braindev.2011.08.008; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kopp B, 2006, J COGNITIVE NEUROSCI, V18, P949, DOI 10.1162/jocn.2006.18.6.949; Menghini D, 2006, NEUROIMAGE, V33, P1218, DOI 10.1016/j.neuroimage.2006.08.024; Milner B., 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI DOI 10.1001/ARCHNEUR.1963.00460070100010; Nicolson RI, 1999, LANCET, V353, P1662, DOI 10.1016/S0140-6736(98)09165-X; Nieuwenhuis S, 2004, CEREB CORTEX, V14, P741, DOI 10.1093/cercor/bhh034; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Reitan RM, 1985, HALSTEAD REITAN NEUR; Ritter F.E., 2001, INT ENCY SOCIAL BEHA, P8602, DOI DOI 10.1016/B0-08-043076-7/01480-7; Romine CB, 2004, ARCH CLIN NEUROPSYCH, V19, P1027, DOI 10.1016/j.acn.2003.12.009; RUDEL RG, 1978, BRAIN LANG, V6, P52, DOI 10.1016/0093-934X(78)90043-3; Sailer U, 2010, BRAIN RES, V1342, P85, DOI 10.1016/j.brainres.2010.04.051; Segalowitz SJ, 2004, BRAIN COGNITION, V55, P116, DOI 10.1016/s0278-2626(03)00283-5; Shany M., 2006, TEL AVIV; Shatil E., 2008, ELULL LEARNING DISAB; Stoet G, 2007, NEUROSCI LETT, V427, P61, DOI 10.1016/j.neulet.2007.09.014; van Noordt SJR, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00197; Vicari S, 2005, J NEUROL NEUROSUR PS, V76, P1392, DOI 10.1136/jnnp.2004.061093; Wechsler D., 1997, WECHSLER ADULT INTEL; WITELSON SF, 1976, SCIENCE, V193, P425, DOI 10.1126/science.935879; WOLF M, 1986, CHILD DEV, V57, P988, DOI 10.2307/1130373	50	16	17	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100486	10.1371/journal.pone.0100486	http://dx.doi.org/10.1371/journal.pone.0100486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950233	Green Published, gold, Green Submitted			2022-12-25	WOS:000338276300079
J	Zhang, PJ; Li, CH; Zhang, P; Jin, CH; Pan, DD; Bao, YB				Zhang, Pengjuan; Li, Chenghua; Zhang, Peng; Jin, Chunhua; Pan, Daodong; Bao, Yongbo			iTRAQ-Based Proteomics Reveals Novel Members Involved in Pathogen Challenge in Sea Cucumber Apostichopus japonicus	PLOS ONE			English	Article							SKIN ULCERATION SYNDROME; CAENORHABDITIS-ELEGANS; IDENTIFICATION; APOPTOSIS; VINCULIN; VITRONECTIN; MICRORNAS; RESPONSES	Skin ulceration syndrome (SUS) is considered to be a major constraint for the stable development of Apostichopus japonicus culture industries. In this study, we investigated protein changes in the coelomocytes of A. japonicus challenged by Vibrio splendidus using isobaric tags for relative and absolute quantification (iTRAQ) over a 96 h time course. Consequently, 228 differentially expressed proteins were identified in two iTRAQs. A comparison of the protein expression profiles among different time points detected 125 proteins primarily involved in response to endogenous stimuli at 24 h. At 48 h, the number of differentially expressed proteins decreased to 67, with their primary function being oxidation reduction. At the end of pathogen infection, proteins responsive to amino acid stimuli and some metabolic processes were classified as the predominant group. Fifteen proteins were differentially expressed at all time points, among which eight proteins related to pathologies in higher animals were shown to be down-regulated after V. splendidus infection: paxillin, fascin-2, aggrecan, ololfactomedin-1, nesprin-3, a disintegrin-like and metallopeptidase with thrombospondin type 1 motif (Adamts7), C-type lectin domain family 4 (Clec4g) and n-myc downstream regulated gene 1 (Ndrg1). To gain more insight into two SUS-related miRNA (miR-31 and miR-2008) targets at the protein level, all 129 down-regulated proteins were further analyzed in combination with RNA-seq. Twelve and eight proteins were identified as putative targets for miR-31 and miR-2008, respectively, in which six proteins (5 for miR-31 and 1 for miR-2008) displayed higher possibilities to be regulated at the level of translation. Overall, the present work enhances our understanding of the process of V. splendidus-challenged sea cucumber and provides a new method for screening miRNAs targets at the translation level.	[Zhang, Pengjuan; Li, Chenghua; Zhang, Peng; Jin, Chunhua; Pan, Daodong] Ningbo Univ, Dept Aquaculture, Ningbo 315211, Zhejiang, Peoples R China; [Bao, Yongbo] Zhejiang Wanli Univ, Dept Aquat Germplasm Resources, Ningbo, Zhejiang, Peoples R China	Ningbo University; Zhejiang Wanli University	Li, CH (corresponding author), Ningbo Univ, Dept Aquaculture, Ningbo 315211, Zhejiang, Peoples R China.	lichenghua@nbu.edu.cn	Li, Chenghua/L-9825-2019	Li, Chenghua/0000-0003-2978-8762	NSFC [31101919, 4127610]; Zhejiang Provincial Natural Science Foundation of China; young academic leaders in colleges and universities in Zhejiang province [pd2013099]; Natural Science foundation of Ningbo [2013C10013]; K.C. Wong Magna Fund at Ningbo University	NSFC(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); young academic leaders in colleges and universities in Zhejiang province; Natural Science foundation of Ningbo; K.C. Wong Magna Fund at Ningbo University	This work was financially supported by NSFC (31101919, 4127610), Zhejiang Provincial Natural Science Foundation of China, the young academic leaders in colleges and universities in Zhejiang province (pd2013099), the Natural Science foundation of Ningbo (2013C10013), and the K.C. Wong Magna Fund at Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae HB, 2012, AM J RESP CELL MOL, V46, P790, DOI 10.1165/rcmb.2011-0187OC; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen CZ, 2013, IMMUNOL REV, V253, P112, DOI 10.1111/imr.12060; Chen M, 2013, PLOS ONE, V15; Di Pietro G, 2010, EXPERT OPIN DRUG MET, V6, P153, DOI 10.1517/17425250903427980; Evans C, 2012, ANAL BIOANAL CHEM, V404, P1011, DOI 10.1007/s00216-012-5918-6; Haasnoot J, 2011, METHODS MOL BIOL, V721, P23, DOI 10.1007/978-1-61779-037-9_2; HE L, 2004, NAT REV GENET, V5, P522; Herbrich SM, 2013, J PROTEOME RES, V12, P594, DOI 10.1021/pr300624g; Li CH, 2012, FISH SHELLFISH IMMUN, V33, P436, DOI 10.1016/j.fsi.2012.04.013; Li CY, 2012, EXPERT REV PROTEOMIC, V9, P549, DOI [10.1586/EPR.12.49, 10.1586/epr.12.49]; Li ZJ, 2007, MOL CELL PROTEOMICS, V6, P1609, DOI 10.1074/mcp.M600327-MCP200; Lietzen N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001340; Lopez J, 2012, CELL DEATH DIFFER, V19, P1459, DOI 10.1038/cdd.2012.21; Lu AJ, 2014, FISH SHELLFISH IMMUN, V36, P229, DOI 10.1016/j.fsi.2013.11.007; Ma Yue-xin, 2006, Dalian Shuichan Xueyuan Xuebao, V21, P13; Magro AM, 2007, NEOPLASMA, V54, P517; Morita S, 2013, PEERJ, V1, DOI 10.7717/peerj.162; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Ou ML, 2014, EUR J HUM GENET, V22, P625, DOI 10.1038/ejhg.2013.221; Peng XA, 2011, INT REV CEL MOL BIO, V287, P191, DOI 10.1016/B978-0-12-386043-9.00005-0; Rabilloud T, 2010, J PROTEOMICS, V73, P2064, DOI 10.1016/j.jprot.2010.05.016; Ren Yushan, 2014, Virologica Sinica, V29, P25, DOI 10.1007/s12250-014-3421-2; Revathy KS, 2012, COMP BIOCHEM PHYS B, V162, P10, DOI 10.1016/j.cbpb.2012.02.004; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Shao YN, 2013, J AGR FOOD CHEM, V61, P10766, DOI 10.1021/jf4038776; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Subauste MC, 2004, J CELL BIOL, V165, P371, DOI 10.1083/jcb.200308011; Thakur SS, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003699; Tsuruta Y, 2007, J IMMUNOL, V179, P7079, DOI 10.4049/jimmunol.179.10.7079; Uhlmann S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.100; Wang Pin-hong, 2005, Journal of Fishery Sciences of China, V12, P766; [王印庚 Wang Yingeng], 2005, [海洋科学, Marine Sciences], V29, P1; Zhang Chun-yun, 2006, Journal of Fisheries of China, V30, P118; [张春云 Zhang Chunyun], 2004, [海洋水产研究, Marine Fisheries Research], V25, P89; Zhang PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073506; Zhou ZC, 2014, MOL ECOL RESOUR, V14, P127, DOI 10.1111/1755-0998.12147; Zhu L, 2013, GENET MOL RES, V12, P3028, DOI 10.4238/2013.August.20.4	39	54	56	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100492	10.1371/journal.pone.0100492	http://dx.doi.org/10.1371/journal.pone.0100492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949634	gold, Green Submitted, Green Published			2022-12-25	WOS:000338276300080
J	Cheng, VCC; Tai, JWM; Chau, PH; Chen, JHK; Yan, MK; So, SYC; To, KKW; Chan, JFW; Wong, SCY; Ho, PL; Yuen, KY				Cheng, Vincent Chi-Chung; Tai, Josepha Wai-Ming; Chau, Pui-Hing; Chen, Jonathan Hon-Kwan; Yan, Mei-Kum; So, Simon Yung-Chun; To, Kelvin Kai-Wang; Chan, Jasper Fuk-Woo; Wong, Sally Cheuk-Ying; Ho, Pak-Leung; Yuen, Kwok-Yung			Minimal Intervention for Controlling Nosocomial Transmission of Methicillin-Resistant Staphylococcus aureus in Resource Limited Setting with High Endemicity	PLOS ONE			English	Article							HEALTH-CARE SETTINGS; HONG-KONG; HAND HYGIENE; INFECTION; SURVEILLANCE; PRECAUTIONS; BACTEREMIA; MRSA; ENTEROBACTERIACEAE; DECOLONIZATION	Objective: To control nosocomial transmission of methicillin-resistant Staphylococcus aureus (MRSA) in resource-limited healthcare setting with high endemicity. Methods: Three phases of infection control interventions were implemented in a University-affiliated hospital between 1-January-2004 and 31-December-2012. The first phase of baseline period, defined as the first 48-months of the study period, when all MRSA patients were managed with standard precautions, followed by a second phase of 24-months, when a hospital-wide hand hygiene campaign was launched. In the third phase of 36-months, contact precautions in open cubicle, use of dedicated medical items, and 2% chlorhexidine gluconate daily bathing for MRSA-positive patients were implemented while hand hygiene campaign was continued. The changes in the incidence rates of hospital-acquired MRSA-per-1000-patient admissions, per-1000-patient-days, and per-1000-MRSA-positive-days were analyzed using segmented Poisson regression (an interrupted time series model). Usage density of broad-spectrum antibiotics was monitored. Results: During the study period, 4256 MRSA-positive patients were newly diagnosed, of which 1589 (37.3%) were hospital-acquired. The reduction of hospital-acquired MRSA per 1000-patient admissions, per 1000-patient-days, and per 1000-MRSA-positive-days from phase 1 to 2 was 36.3% (p < 0.001), 30.4% (p < 0.001), and 19.6% (p = 0.040), while the reduction of hospital-acquired MRSA per 1000-patient admissions, per 1000-patient-days, and per 1000-MRSA-positive-days from phase 2 to 3 was 27.4% (p < 0.001), 24.1% (p < 0.001), and 21.9% (p = 0.041) respectively. This reduction is sustained despite that the usage density of broad-spectrum antibiotics has increased from 132.02 (phase 1) to 168.99 per 1000 patient-days (phase 3). Conclusions: Nosocomial transmission of MRSA can be reduced with hand hygiene campaign, contact precautions in open cubicle, and 2% chlorhexidine gluconate daily bathing for MRSA-positive despite an increasing consumption of broad-spectrum antibiotics.	[Cheng, Vincent Chi-Chung; Chen, Jonathan Hon-Kwan; Yan, Mei-Kum; So, Simon Yung-Chun; To, Kelvin Kai-Wang; Chan, Jasper Fuk-Woo; Wong, Sally Cheuk-Ying; Ho, Pak-Leung; Yuen, Kwok-Yung] Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Cheng, Vincent Chi-Chung; Tai, Josepha Wai-Ming] Queen Mary Hosp, Infect Control Team, Hong Kong, Hong Kong, Peoples R China; [Chau, Pui-Hing] Univ Hong Kong, Sch Nursing, Hong Kong, Hong Kong, Peoples R China; [To, Kelvin Kai-Wang; Chan, Jasper Fuk-Woo; Ho, Pak-Leung; Yuen, Kwok-Yung] Univ Hong Kong, Carol Yu Ctr Infect, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Yuen, KY (corresponding author), Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	kyyuen@hkucc.hku.hk	何栢良, Pak-Leung HO/C-4310-2009; To, Kelvin/AAV-7007-2020; Chan, Jasper F. W./D-8007-2013	何栢良, Pak-Leung HO/0000-0002-8811-1308; To, Kelvin/0000-0002-1921-5824; Chan, Jasper F. W./0000-0001-6336-6657; Yuen, Kwok-yung/0000-0002-2083-1552; CHENG, Vincent Chi-Chung/0000-0003-1765-7706				Bosso JA, 2006, ANTIMICROB AGENTS CH, V50, P2106, DOI 10.1128/AAC.01359-05; Cepeda JA, 2005, LANCET, V365, P295, DOI 10.1016/S0140-6736(05)17783-6; Cheng VCC, 2008, J HOSP INFECT, V70, P27, DOI 10.1016/j.jhin.2008.05.019; Cheng VCC, 2011, J HOSP INFECT, V79, P206, DOI 10.1016/j.jhin.2011.03.024; Cheng VCC, 2009, EUR J CLIN MICROBIOL, V28, P1447, DOI 10.1007/s10096-009-0803-8; Cheng VCC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-205; Cheng VCC, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-151; Cheng VCC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-263; Cheng VCC, 2013, CHINESE MED J-PEKING, V126, P4504, DOI 10.3760/cma.j.issn.0366-6999.20130741; Cheng VCC, 2012, CHINESE MED J-PEKING, V125, P3450, DOI 10.3760/cma.j.issn.0366-6999.2012.19.017; Climo MW, 2013, NEW ENGL J MED, V368, P533, DOI 10.1056/NEJMoa1113849; Cooper BS, 2004, BMJ-BRIT MED J, V329, P533, DOI 10.1136/bmj.329.7465.533; Deeny SR, 2013, J HOSP INFECT, V85, P33, DOI 10.1016/j.jhin.2013.03.011; Ellingson K, 2011, INFECT CONT HOSP EP, V32, P1, DOI 10.1086/657665; Fisher D, 2013, J HOSP INFECT, V85, P141, DOI 10.1016/j.jhin.2013.07.005; Halcomb EJ, 2008, INT J EVID-BASED HEA, V6, P206, DOI 10.1111/j.1479-6988.2008.00089.x; Ho PL, 2012, J ANTIMICROB CHEMOTH, V67, P1553, DOI 10.1093/jac/dks095; Ho PL, 2012, J ANTIMICROB CHEMOTH, V67, P778, DOI 10.1093/jac/dkr502; Ho PL, 2010, INT J ANTIMICROB AG, V36, P469, DOI 10.1016/j.ijantimicag.2010.07.004; Huang SS, 2006, CLIN INFECT DIS, V43, P971, DOI 10.1086/507636; Huang SS, 2013, NEW ENGL J MED, V368, P2255, DOI 10.1056/NEJMoa1207290; Jain R, 2011, NEW ENGL J MED, V364, P1419, DOI 10.1056/NEJMoa1007474; Johnson AP, 2012, J ANTIMICROB CHEMOTH, V67, P802, DOI 10.1093/jac/dkr561; Kassakian SZ, 2011, INFECT CONT HOSP EP, V32, P238, DOI 10.1086/658334; Masse V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057057; Morgan DJ, 2013, INFECT CONT HOSP EP, V34, P69, DOI 10.1086/668775; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS165, DOI 10.1016/j.ajic.2007.10.006; Tai JW, IMPACT IMPLEME UNPUB	31	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100493	10.1371/journal.pone.0100493	http://dx.doi.org/10.1371/journal.pone.0100493			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945412	Green Published, gold, Green Submitted			2022-12-25	WOS:000340721500081
J	Huang, CY; Lee, CL				Huang, Chung-Yuan; Lee, Chun-Liang			Influences of Agents with a Self-Reputation Awareness Component in an Evolutionary Spatial IPD Game	PLOS ONE			English	Article							COOPERATION; TRUST; INFORMATION; DILEMMAS; NETWORKS	Iterated prisoner's dilemma (IPD) researchers have shown that strong positive reputations plus an efficient reputation evaluation system encourages both sides to pursue long-term collaboration and to avoid falling into mutual defection cycles. In agent-based environments with reliable reputation rating systems, agents interested in maximizing their private interests must show concern for other agents as well as their own self-reputations-an important capability that standard IPD game agents lack. Here we present a novel learning agent model possessing self-reputation awareness. Agents in our proposed model are capable of evaluating self-behaviors based on a mix of public and private interest considerations, and of testing various solutions aimed at meeting social standards. Simulation results indicate multiple outcomes from the addition of a small percentage of self-reputation awareness agents: faster cooperation, faster movement toward stability in an agent society, a higher level of public interest in the agent society, the resolution of common conflicts between public and private interests, and a lower potential for rational individual behavior to transform into irrational group behavior.	[Huang, Chung-Yuan; Lee, Chun-Liang] Chang Gung Univ, Coll Engn, Sch Elect & Comp Engn, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan	Chang Gung University	Lee, CL (corresponding author), Chang Gung Univ, Coll Engn, Sch Elect & Comp Engn, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan.	cllee@mail.cgu.edu.tw	Huang, Chung-Yuan/AAH-2330-2019	Huang, Chung-Yuan/0000-0002-8680-6755	High Speed Intelligent Communication (HSIC) research center, Chang Gung University, Taiwan, R.O.C.; Republic of China National Science Council [NSC-102-2221-E-182-052, NSC-102-2221-E-182-034]	High Speed Intelligent Communication (HSIC) research center, Chang Gung University, Taiwan, R.O.C.; Republic of China National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported in part by the High Speed Intelligent Communication (HSIC) research center, Chang Gung University, Taiwan, R.O.C. and by grants from the Republic of China National Science Council (NSC-102-2221-E-182-052 and NSC-102-2221-E-182-034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER E, 1992, INT ORGAN, V46, P101, DOI 10.1017/S0020818300001466; [Anonymous], 1999, P 4 NORD WORKSH SEC, P496; Aronson E., 2010, SOC PSYCHOL-GERMANY, V7; Axelrod R., 1997, COMPLEXITY COOPERATI, DOI [10.1515/9781400822300, DOI 10.1515/9781400822300]; Axelrod R, 1987, REV AUSTRIAN EC, V211, P227; Baumeister R. F., 1999, SELF SOCIAL PSYCHOL; Bromley Dennis-Basil, 1993, REPUTATION IMAGE IMP; Carter J, 2002, COMPUT INTELL-US, V18, P515, DOI 10.1111/1467-8640.t01-1-00201; Carver C.S., 2012, ATTENTION SELF REGUL; Chen SH, 2001, J ECON DYN CONTROL, V25, P363, DOI 10.1016/S0165-1889(00)00030-0; Dobbyn C, 2003, MIND MACH, V13, P187, DOI 10.1023/A:1022997315561; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016104; Garfinkel S, 2002, WEB SECURITY PRIVACY; Gutowska A, 2010, LECT NOTES BUS INF P, V45, P212; Hendler J, 2009, COMPUTER, V42, P111, DOI 10.1109/MC.2009.30; Huang CY, 2004, LECT NOTES COMPUT SC, V3103, P774; Kawamura K, 2003, PROCEEDINGS OF THE 11TH INTERNATIONAL CONFERENCE ON ADVANCED ROBOTICS 2003, VOL 1-3, P568; KREPS DM, 1982, J ECON THEORY, V27, P253, DOI 10.1016/0022-0531(82)90030-8; Leimar O, 2001, P ROY SOC B-BIOL SCI, V268, P745, DOI 10.1098/rspb.2000.1573; Liu YK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030689; Maes P, 1999, COMMUN ACM, V42, P81, DOI 10.1145/295685.295716; MARKUS H, 1977, J PERS SOC PSYCHOL, V35, P63, DOI 10.1037/0022-3514.35.2.63; Maskin E, 2009, SPRINGER SER GAME TH, P79, DOI 10.1007/978-3-540-85436-4_4; McGillivray F, 2000, INT ORGAN, V54, P809, DOI 10.1162/002081800551370; McKnight D. H., 2002, INT J ELECTRON COMM, V62, P35, DOI DOI 10.1080/10864415.2001.11044235; Mintz Anne P, 2002, WEB DECEPTION MISINF; Mitchell M., 1998, INTRO GENETIC ALGORI; Mitchell T.M, 2003, MACH LEARN; Morris RD, 2011, TECHTRENDS, V55, P42, DOI 10.1007/s11528-011-0469-9; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 1993, INT J BIFURCAT CHAOS, V3, P35, DOI 10.1142/S0218127493000040; Peacocke Christopher, 2009, MENTAL ACTIONS; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Phillips AG, 2005, PERS SOC PSYCHOL B, V31, P703, DOI 10.1177/0146167204271559; Ramchurn SD, 2004, KNOWL ENG REV, V19, P1, DOI 10.1017/S0269888904000116; Resnick P, 2002, ADV APP M-E, V11, P127; Russell S, 2009, ARTIFICIAL INTELLIGE; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Slater P., 2006, WEB SERVICE SECURITY; Sutton R. S., 1998, INTRO REINFORCEMENT; Tasner M., 2010, MARKETING MOMENT PRA; Wang L, 2009, INT J DISTRIB SENS N, V5, P39, DOI 10.1080/15501320802533467; Wang W, 2006, LECT NOTES ARTIF INT, V4088, P211; Wang Y, 2008, IEEE INTERNET COMPUT, V12, P55, DOI 10.1109/MIC.2008.84; Wang Z, 2014, J THEOR BIOL, V349, P50, DOI 10.1016/j.jtbi.2014.01.037; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep02470; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01183; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Wang Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00369; Wang Z, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.037101; Wang Z, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/48001; Wellman M. P., 2007, AUTONOMOUS BIDDING A	54	0	0	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99841	10.1371/journal.pone.0099841	http://dx.doi.org/10.1371/journal.pone.0099841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945966	Green Submitted, Green Published, gold			2022-12-25	WOS:000340721500028
J	Lightfoot, YL; Yang, T; Sahay, B; Zadeh, M; Cheng, SX; Wang, GP; Owen, JL; Mohamadzadeh, M				Lightfoot, Yaima L.; Yang, Tao; Sahay, Bikash; Zadeh, Mojgan; Cheng, Sam X.; Wang, Gary P.; Owen, Jennifer L.; Mohamadzadeh, Mansour			Colonic Immune Suppression, Barrier Dysfunction, and Dysbiosis by Gastrointestinal Bacillus anthracis Infection	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; REGULATORY T-CELLS; LETHAL TOXIN; INHALATION ANTHRAX; B7-H1 EXPRESSION; EDEMA TOXIN; PATHOGENESIS; MURINE; SUSCEPTIBILITY; INACTIVATION	Gastrointestinal (GI) anthrax results from the ingestion of Bacillus anthracis. Herein, we investigated the pathogenesis of GI anthrax in animals orally infected with toxigenic non-encapsulated B. anthracis Sterne strain (pXO1(+) pXO2(-)) spores that resulted in rapid animal death. B. anthracis Sterne induced significant breakdown of intestinal barrier function and led to gut dysbiosis, resulting in systemic dissemination of not only B. anthracis, but also of commensals. Disease progression significantly correlated with the deterioration of innate and T cell functions. Our studies provide critical immunologic and physiologic insights into the pathogenesis of GI anthrax infection, whereupon cleavage of mitogen-activated protein kinases (MAPKs) in immune cells may play a central role in promoting dysfunctional immune responses against this deadly pathogen.	[Lightfoot, Yaima L.; Yang, Tao; Sahay, Bikash; Zadeh, Mojgan; Mohamadzadeh, Mansour] Univ Florida, Dept Infect Dis & Pathol, Gainesville, FL 32611 USA; [Lightfoot, Yaima L.; Yang, Tao; Sahay, Bikash; Zadeh, Mojgan; Mohamadzadeh, Mansour] Univ Florida, Dept Med, Div Gastroenterol Hepatol & Nutr, Gainesville, FL USA; [Cheng, Sam X.] Univ Florida, Dept Pediat, Div Gastroenterol, Gainesville, FL USA; [Wang, Gary P.] Univ Florida, Dept Med, Div Infect Dis & Global Med, Gainesville, FL USA; [Owen, Jennifer L.] Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Mohamadzadeh, M (corresponding author), Univ Florida, Dept Infect Dis & Pathol, Gainesville, FL 32611 USA.	m.zadeh@ufl.edu	yang, tao/J-2418-2015	yang, tao/0000-0002-4182-9793; Sahay, Bikash/0000-0003-0905-733X	National Institute of Allergy and Infectious Diseases [RO1 AI093370]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases RO1 AI093370 to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2003, NATURE, V424, P329, DOI 10.1038/nature01794; [Anonymous], 2013, DIVERSITY-BASEL, DOI DOI 10.3390/d5030627; Antharam VC, 2013, J CLIN MICROBIOL, V51, P2884, DOI 10.1128/JCM.00845-13; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bachmann M, 2007, MOL CANCER THER, V6, P723, DOI 10.1158/1535-7163.MCT-06-0505; Baldari CT, 2006, TRENDS IMMUNOL, V27, P434, DOI 10.1016/j.it.2006.07.002; Balhara J, 2012, MUCOSAL IMMUNOL, V5, P605, DOI 10.1038/mi.2012.74; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Beatty ME, 2003, ARCH INTERN MED, V163, P2527, DOI 10.1001/archinte.163.20.2527; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Chandra RK, 1996, P NATL ACAD SCI USA, V93, P14304, DOI 10.1073/pnas.93.25.14304; Cheng SX, 2012, AM J PHYSIOL-GASTR L, V303, pG60, DOI 10.1152/ajpgi.00425.2011; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; Chou PJ, 2008, DNA CELL BIOL, V27, P637, DOI 10.1089/dna.2008.0760; Coggeshall KM, 2013, J CELL MOL MED, V17, P914, DOI 10.1111/jcmm.12075; Datta SK, 2010, P NATL ACAD SCI USA, V107, P10638, DOI 10.1073/pnas.1002348107; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; During RL, 2005, J INFECT DIS, V192, P837, DOI 10.1086/432516; Ebrahimi CM, 2011, INFECT IMMUN, V79, P2510, DOI 10.1128/IAI.00006-11; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Gianchecchi E, 2013, AUTOIMMUNITY REV; Glomski IJ, 2007, PLOS PATHOG, V3, P699, DOI 10.1371/journal.ppat.0030076; Goossens PL, 2009, MOL ASPECTS MED, V30, P467, DOI 10.1016/j.mam.2009.07.005; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Hill JE, 2010, APPL ENVIRON MICROB, V76, P4550, DOI 10.1128/AEM.01510-09; Hu HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007946; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Karakhanova S, 2010, EUR J IMMUNOL, V40, P254, DOI 10.1002/eji.200939289; Kern J, 2010, MOL MICROBIOL, V75, P324, DOI 10.1111/j.1365-2958.2009.06958.x; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Lau SKP, 2006, J CLIN PATHOL, V59, P748, DOI 10.1136/jcp.2005.031773; Loving CL, 2007, INFECT IMMUN, V75, P2689, DOI 10.1128/IAI.01875-06; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Makino S, 2002, J INFECT DIS, V186, P227, DOI 10.1086/341299; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; MIKESELL P, 1983, INFECT IMMUN, V39, P371, DOI 10.1128/IAI.39.1.371-376.1983; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Mohamadzadeh M, 2009, P NATL ACAD SCI USA, V106, P4331, DOI 10.1073/pnas.0900029106; Mohamadzadeh M, 2007, NAT REV IMMUNOL, V7, P556, DOI 10.1038/nri2098; Paccani SR, 2011, J ALLERGY CLIN IMMUN, V127, P1635, DOI 10.1016/j.jaci.2010.12.1104; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Qian YG, 2008, CANCER INVEST, V26, P816, DOI 10.1080/07357900801941852; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Scorpio A, 2007, ANTIMICROB AGENTS CH, V51, P215, DOI 10.1128/AAC.00706-06; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sun C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033583; Swartz MN, 2001, NEW ENGL J MED, V345, P1621, DOI 10.1056/NEJMra012892; Thibault R, 2010, INFLAMM BOWEL DIS, V16, P684, DOI 10.1002/ibd.21108; Tonello F, 2012, TOXINS, V4, P536, DOI 10.3390/toxins4070536; Tonry JH, 2013, MICROBES INFECT, V15, P37, DOI 10.1016/j.micinf.2012.10.004; Tournier JN, 2009, EXPERT REV ANTI-INFE, V7, P219, DOI 10.1586/14787210.7.2.219; Tsuji NM, 2008, TRENDS IMMUNOL, V29, P532, DOI 10.1016/j.it.2008.09.002; TURNBULL PCB, 1991, VACCINE, V9, P533, DOI 10.1016/0264-410X(91)90237-Z; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; WELKOS SL, 1986, INFECT IMMUN, V51, P795, DOI 10.1128/IAI.51.3.795-800.1986; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Xie T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066943; Xie T, 2011, TOXINS, V3, P591, DOI 10.3390/toxins3060591; Xu LX, 2007, INT J BIOCHEM CELL B, V39, P20, DOI 10.1016/j.biocel.2006.08.010	60	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100532	10.1371/journal.pone.0100532	http://dx.doi.org/10.1371/journal.pone.0100532			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945934	Green Published, gold, Green Submitted			2022-12-25	WOS:000340721500087
J	Mayle, S; Boyle, JP; Sekine, E; Zurek, B; Kufer, TA; Monie, TP				Mayle, Sophie; Boyle, Joseph P.; Sekine, Eiki; Zurek, Birte; Kufer, Thomas A.; Monie, Tom P.			Engagement of Nucleotide-binding Oligomerization Domain-containing Protein 1 (NOD1) by Receptor-interacting Protein 2 (RIP2) Is Insufficient for Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; CRYSTAL-STRUCTURE; ACTIVATION; RECRUITMENT; RECOGNITION; MECHANISM; RESPONSES; FILAMENT; MEMBRANE; ERBIN	Following activation, the cytoplasmic pattern recognition receptor nucleotide-binding oligomerization domain-containing protein 1 (NOD1) interacts with its adaptor protein receptor-interacting protein 2 (RIP2) to propagate immune signaling and initiate a proinflammatory immune response. This interaction is mediated by the caspase recruitment domain (CARD) of both proteins. Polymorphisms in immune proteins can affect receptor function and predispose individuals to specific autoinflammatory disorders. In this report, we show that mutations in helix 2 of the CARD of NOD1 disrupted receptor function but did not interfere with RIP2 interaction. In particular, N43S, a rare polymorphism, resulted in receptor dysfunction despite retaining normal cellular localization, protein folding, and an ability to interact with RIP2. Mutation of Asn-43 resulted in an increased tendency to form dimers, which we propose is the source of this dysfunction. We also demonstrate that mutation of Lys-443 and Tyr-474 in RIP2 disrupted the interaction with NOD1. Mapping the key residues involved in the interaction between NOD1 and RIP2 to the known structures of CARD complexes revealed the likely involvement of both type I and type III interfaces in the NOD1.RIP2 complex. Overall we demonstrate that the NOD1-RIP2 signaling axis is more complex than previously assumed, that simple engagement of RIP2 is insufficient to mediate signaling, and that the interaction between NOD1 and RIP2 constitutes multiple CARD-CARD interfaces.	[Mayle, Sophie; Boyle, Joseph P.; Sekine, Eiki; Monie, Tom P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Zurek, Birte; Kufer, Thomas A.] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50935 Cologne, Germany; [Monie, Tom P.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England	University of Cambridge; University of Cologne; University of Cambridge	Monie, TP (corresponding author), Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 0ES, England.	tpm22@cam.ac.uk	Monie, Tom/H-4662-2019; Kufer, Thomas A/I-5146-2015	Monie, Tom/0000-0003-4097-1680; Kufer, Thomas A/0000-0003-4563-0412; Sekine, Eiki/0000-0001-6555-7879; Zurek, PhD, Birte/0000-0002-8200-7542	Wellcome Trust [WT085090MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by Wellcome Trust Career Development Fellowship WT085090MA (to T.P.M.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Berke IC, 2012, P NATL ACAD SCI USA, V109, P18437, DOI 10.1073/pnas.1212186109; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Boyle JP, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00317; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Coussens NP, 2007, BIOCHEM BIOPH RES CO, V353, P1, DOI 10.1016/j.bbrc.2006.11.122; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Fridh V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034375; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Heul AMV, 2013, J BIOL CHEM, V288, P6890, DOI 10.1074/jbc.M112.413781; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Kersse K, 2011, J BIOL CHEM, V286, P35874, DOI 10.1074/jbc.M111.242321; Krieg A, 2009, P NATL ACAD SCI USA, V106, P14524, DOI 10.1073/pnas.0907131106; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kufer TA, 2006, INFECT IMMUN, V74, P3115, DOI 10.1128/IAI.00035-06; Kufer TA, 2008, CELL MICROBIOL, V10, P477, DOI 10.1111/j.1462-5822.2007.01062.x; Lecine P, 2007, J BIOL CHEM, V282, P15197, DOI 10.1074/jbc.M606242200; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Maekawa T, 2011, CELL HOST MICROBE, V9, P187, DOI 10.1016/j.chom.2011.02.008; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; McDonald C, 2005, J BIOL CHEM, V280, P40301, DOI 10.1074/jbc.M508538200; Monie TP, 2009, TRENDS BIOCHEM SCI, V34, P553, DOI 10.1016/j.tibs.2009.06.011; Nallamsetty S, 2005, PROTEIN SCI, V14, P2964, DOI 10.1110/ps.051718605; Pan QL, 2006, INFECT IMMUN, V74, P2121, DOI 10.1128/IAI.74.4.2121-2127.2006; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Peisley A, 2014, NATURE, V509, P110, DOI 10.1038/nature13140; Peisley A, 2011, P NATL ACAD SCI USA, V108, P21010, DOI 10.1073/pnas.1113651108; Philpott DJ, 2010, CURR OPIN IMMUNOL, V22, P428, DOI 10.1016/j.coi.2010.04.010; Proell M, 2013, BIOCHEM J, V449, P613, DOI 10.1042/BJ20121198; Qiao Q, 2013, MOL CELL, V51, P766, DOI 10.1016/j.molcel.2013.08.032; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Srimathi T, 2008, BIOCHEMISTRY-US, V47, P1319, DOI 10.1021/bi7016602; Tigno-Aranjuez JT, 2010, GENE DEV, V24, P2666, DOI 10.1101/gad.1964410; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Xu H, 2014, ELIFE, V3, DOI 10.7554/eLife.01489; Zurek B, 2012, INNATE IMMUN-LONDON, V18, P100, DOI 10.1177/1753425910394002	50	22	22	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22900	22914		10.1074/jbc.M114.557900	http://dx.doi.org/10.1074/jbc.M114.557900			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24958724	Green Published, hybrid			2022-12-25	WOS:000341017200031
J	Perry, DM; Newcomb, B; Adada, M; Wu, BX; Roddy, P; Kitatani, K; Siskind, L; Obeid, LM; Hannun, YA				Perry, David M.; Newcomb, Benjamin; Adada, Mohamad; Wu, Bill X.; Roddy, Patrick; Kitatani, Kazuyuki; Siskind, Leah; Obeid, Lina M.; Hannun, Yusuf A.			Defining a Role for Acid Sphingomyelinase in the p38/Interleukin-6 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; ACTIVATED PROTEIN-KINASE; DELTA-MEDIATED PHOSPHORYLATION; BETA-GLUCOSIDASE 1; SALVAGE PATHWAY; BREAST-CANCER; KAPPA-B; LYSOSOMAL SPHINGOMYELINASE; INFLAMMATORY CYTOKINES; INTERLEUKIN-6 GENE	Acid sphingomyelinase (ASM) is one of the key enzymes involved in regulating the metabolism of the bioactive sphingolipid ceramide in the sphingolipid salvage pathway, yet defining signaling pathways by which ASM exerts its effects has proven difficult. Previous literature has implicated sphingolipids in the regulation of cytokines such as interleukin-6 (IL-6), but the specific sphingolipid pathways and mechanisms involved in inflammatory signaling need to be further elucidated. In this work, we sought to define the role of ASM in IL-6 production because our previous work showed that a parallel pathway of ceramide metabolism, acid beta-glucosidase 1, negatively regulates IL-6. First, silencing ASM with siRNA abrogated IL-6 production in response to the tumor promoter, 4 beta-phorbol 12-myristate 13-acetate (PMA), in MCF-7 cells, in distinction to acid beta-glucosidase 1 and acid ceramidase, suggesting specialization of the pathways. Moreover, treating cells with siRNA to ASM or with the indirect pharmacologic inhibitor desipramine resulted in significant inhibition of TNF alpha- and PMA-induced IL-6 production in MDA-MB-231 and HeLa cells. Knockdown of ASM was found to significantly inhibit PMA-dependent IL-6 induction at the mRNA level, probably ruling out mechanisms of translation or secretion of IL-6. Further, ASM knockdown or desipramine blunted p38 MAPK activation in response to TNF alpha, revealing a key role for ASM in activating p38, a signaling pathway known to regulate IL-6 induction. Last, knockdown of ASM dramatically blunted invasion of HeLa and MDA-MB-231 cells through Matrigel. Taken together, these results demonstrate that ASM plays a critical role in p38 signaling and IL-6 synthesis with implications for tumor pathobiology.	[Perry, David M.; Wu, Bill X.; Roddy, Patrick] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Kitatani, Kazuyuki] Tohoku Univ, Grad Sch Med, Tohoku Med Megabank Org, Sendai, Miyagi 9808575, Japan; [Kitatani, Kazuyuki] Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi 9808575, Japan; [Siskind, Leah] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40202 USA; [Newcomb, Benjamin; Adada, Mohamad; Hannun, Yusuf A.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Obeid, Lina M.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Obeid, Lina M.] Northport Vet Affairs Hosp, Northport, NY 11768 USA	Medical University of South Carolina; Tohoku University; Tohoku University; University of Louisville; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Hannun, YA (corresponding author), SUNY Stony Brook, Stony Brook Canc Ctr, Hlth Sci Ctr, L-4,182, Stony Brook, NY 11794 USA.	yusuf.hannun@sbumed.org	Kitatani, Kazuyuki/H-7100-2019	Kitatani, Kazuyuki/0000-0002-8516-6135; obeid, lina/0000-0002-0734-0847; Adada, Mohamad/0000-0002-2988-2081	National Institutes of Health [CA 097132, GM097741]; Veterans Affairs merit award; NATIONAL CANCER INSTITUTE [R01CA087584, P01CA097132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097741, T32GM008444] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs merit award(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants CA 097132 (to Y. A. H. and L. M. O.) and GM097741 (to L. M. O.). This work was also supported by a Veterans Affairs merit award (to L. M. O.).	Adada MM, 2013, J BIOL CHEM, V288, P27667, DOI 10.1074/jbc.M113.489443; Aureli M, 2009, FEBS LETT, V583, P2469, DOI 10.1016/j.febslet.2009.06.048; Bauer J, 2009, FEBS LETT, V583, P915, DOI 10.1016/j.febslet.2009.02.008; Becker KP, 2005, J BIOL CHEM, V280, P2606, DOI 10.1074/jbc.M409066200; Carter AB, 1999, AM J RESP CELL MOL, V20, P751, DOI 10.1165/ajrcmb.20.4.3420; Charruyer A, 2007, BIOCHEM J, V405, P77, DOI 10.1042/BJ20061528; Faggioli L, 1996, EUR J BIOCHEM, V239, P624, DOI 10.1111/j.1432-1033.1996.0624u.x; Falcone S, 2004, J IMMUNOL, V173, P4452, DOI 10.4049/jimmunol.173.7.4452; Feng YD, 2009, ARCH PATHOL LAB MED, V133, P1850, DOI 10.1043/1543-2165-133.11.1850; Gallucci RM, 2004, J INVEST DERMATOL, V122, P764, DOI 10.1111/j.0022-202X.2004.22323.x; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; HURWITZ R, 1994, BIOL CHEM H-S, V375, P447, DOI 10.1515/bchm3.1994.375.7.447; Ion G, 2006, CELL SIGNAL, V18, P1887, DOI 10.1016/j.cellsig.2006.02.007; Jenkins RW, 2011, J BIOL CHEM, V286, P13292, DOI 10.1074/jbc.M110.163378; Jenkins RW, 2010, J BIOL CHEM, V285, P35706, DOI 10.1074/jbc.M110.125609; Jin J., 2013, AM J PHYSIOL-ENDOC M, V305, pE853; Kato Y, 2007, FEBS J, V274, P3171, DOI 10.1111/j.1742-4658.2007.05848.x; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kitatani K, 2009, J BIOL CHEM, V284, P12979, DOI 10.1074/jbc.M809500200; Kitatani K, 2009, J BIOL CHEM, V284, P12972, DOI 10.1074/jbc.M802790200; Kondo A, 2001, J INTERF CYTOK RES, V21, P943, DOI 10.1089/107999001753289550; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Kumagai T, 2012, ARCH BIOCHEM BIOPHYS, V519, P8, DOI 10.1016/j.abb.2011.12.015; LAULEDERKIND SJF, 1995, J EXP MED, V182, P599, DOI 10.1084/jem.182.2.599; Liangpunsakul S, 2012, AM J PHYSIOL-GASTR L, V302, pG515, DOI 10.1152/ajpgi.00455.2011; Manthey CL, 1998, CYTOKINE, V10, P654, DOI 10.1006/cyto.1998.0344; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Modur V, 1996, J BIOL CHEM, V271, P13094, DOI 10.1074/jbc.271.22.13094; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Oh K, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3034; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Pena LA, 2000, CANCER RES, V60, P321; Rousseau S, 2002, EMBO J, V21, P6505, DOI 10.1093/emboj/cdf639; Rozenova KA, 2010, J BIOL CHEM, V285, P21103, DOI 10.1074/jbc.M109.080671; Sakata A, 2007, IMMUNOLOGY, V122, P54, DOI 10.1111/j.1365-2567.2007.02612.x; Schissel SL, 1998, J BIOL CHEM, V273, P18250, DOI 10.1074/jbc.273.29.18250; Studebaker AW, 2008, CANCER RES, V68, P9087, DOI 10.1158/0008-5472.CAN-08-0400; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Tawara Ken, 2011, Cancer Manag Res, V3, P177, DOI 10.2147/CMR.S18101; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Zeidan YH, 2008, FASEB J, V22, P183, DOI 10.1096/fj.07-8967com; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200; Zeisel A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.62; Zhang Y, 2008, J IMMUNOL, V181, P4247, DOI 10.4049/jimmunol.181.6.4247	46	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22401	22412		10.1074/jbc.M114.589648	http://dx.doi.org/10.1074/jbc.M114.589648			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24951586	Green Published, hybrid			2022-12-25	WOS:000340593500050
J	Khademi, A; Braithwaite, RS; Saure, D; Schaefer, AJ; Nucifora, K; Roberts, MS				Khademi, Amin; Braithwaite, R. Scott; Saure, Denis; Schaefer, Andrew J.; Nucifora, Kimberly; Roberts, Mark S.			Should Expectations about the Rate of New Antiretroviral Drug Development Impact the Timing of HIV Treatment Initiation and Expectations about Treatment Benefits?	PLOS ONE			English	Article							THERAPY; INFECTION; MODEL	Background: Many analyses of HIV treatment decisions assume a fixed formulary of HIV drugs. However, new drugs are approved nearly twice a year, and the rate of availability of new drugs may affect treatment decisions, particularly when to initiate antiretroviral therapy (ART). Objectives: To determine the impact of considering the availability of new drugs on the optimal initiation criteria for ART and outcomes in patients with HIV/AIDS. Methods: We enhanced a previously described simulation model of the optimal time to initiate ART to incorporate the rate of availability of new antiviral drugs. We assumed that the future rate of availability of new drugs would be similar to the past rate of availability of new drugs, and we estimated the past rate by fitting a statistical model to actual HIV drug approval data from 1982-2010. We then tested whether or not the future availability of new drugs affected the model-predicted optimal time to initiate ART based on clinical outcomes, considering treatment initiation thresholds of 200, 350, and 500 cells/mm(3). We also quantified the impact of the future availability of new drugs on life expectancy (LE) and quality-adjusted life expectancy (QALE). Results: In base case analysis, considering the availability of new drugs raised the optimal starting CD4 threshold for most patients to 500 cells/mm(3). The predicted gains in outcomes due to availability of pipeline drugs were generally small (less than 1%), but for young patients with a high viral load could add as much as a 4.9% (1.73 years) increase in LE and a 8% (2.43 QALY) increase in QALE, because these patients were particularly likely to exhaust currently available ART regimens before they died. In sensitivity analysis, increasing the rate of availability of new drugs did not substantially alter the results. Lowering the toxicity of future ART drugs had greater potential to increase benefit for many patient groups, increasing QALE by as much as 10%. Conclusions: The future availability of new ART drugs without lower toxicity raises optimal treatment initiation for most patients, and improves clinical outcomes, especially for younger patients with higher viral loads. Reductions in toxicity of future ART drugs could impact optimal treatment initiation and improve clinical outcomes for all HIV patients.	[Khademi, Amin] Clemson Univ, Dept Ind Engn, Clemson, SC USA; [Braithwaite, R. Scott] NYU, Dept Med, New York, NY 10016 USA; [Braithwaite, R. Scott; Nucifora, Kimberly] NYU, Sch Med, Dept Populat Hlth, Div Comparat Effectiveness & Decis Sci, New York, NY USA; [Saure, Denis] Univ Chile, Dept Ind Engn, Santiago, RM, Chile; [Schaefer, Andrew J.; Roberts, Mark S.] Univ Pittsburgh, Dept Ind Engn, Pittsburgh, PA 15261 USA; [Roberts, Mark S.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA USA; [Roberts, Mark S.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA	Clemson University; New York University; New York University; Universidad de Chile; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Roberts, MS (corresponding author), Univ Pittsburgh, Dept Ind Engn, Pittsburgh, PA 15261 USA.	mroberts@Pitt.edu	Sauré, Denis/F-5598-2016	Sauré, Denis/0000-0002-8123-5009; Braithwaite, Ronald Scott/0000-0001-7067-3655	A computer simulation of the Sub-Saharan HIV pandemic that can estimate benefit and value from alcohol interventions [R01AA017385-01]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017385, U24AA022007] Funding Source: NIH RePORTER	A computer simulation of the Sub-Saharan HIV pandemic that can estimate benefit and value from alcohol interventions; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was partially supported by: R01AA017385-01 "A computer simulation of the Sub-Saharan HIV pandemic that can estimate benefit and value from alcohol interventions" - PI: Braithwaite (http://www.niaaa.nih.gov/), and U24AA022007-01 "The Operations Research Collaboration for Alcohol Abuse and Aids - ORCAAA" - PI: Braithwaite (http://www.niaaa.nih.gov/) and NS grant (NS F CMMI-0546960). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braithwaite RS, 2006, J ANTIMICROB CHEMOTH, V58, P1036, DOI 10.1093/jac/dkl386; Braithwaite RS, 2008, ANN INTERN MED, V148, P178, DOI 10.7326/0003-4819-148-3-200802050-00004; Braithwaite RS, 2007, VALUE HEALTH, V10, P204, DOI 10.1111/j.1524-4733.2007.00170.x; Braithwaite RS, 2005, AM J MED, V118, P890, DOI 10.1016/j.amjmed.2004.12.034; Food and Drug Administration, 2013, ANT DRUGS US TREATM; Harrington M, 2000, LANCET, V355, P2147, DOI 10.1016/S0140-6736(00)02388-6; Holmberg SD, 2004, CLIN INFECT DIS, V39, P1699, DOI 10.1086/425743; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Lane HC, 2003, ANN INTERN MED, V138, P680, DOI 10.7326/0003-4819-138-8-200304150-00018; Maida A, 2009, APPRAISAL REPORT FEA; MONTGOMERY DC, 2003, ENG STAT; Negoescu DM, 2012, CLIN INFECT DIS, V55, P1392, DOI 10.1093/cid/cis731; Nelson R., 1995, PROBABILITY STOCHAST; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Phillips AN, 2007, BRIT MED J, V334, P76, DOI 10.1136/bmj.39064.406389.94; Shechter SM, 2008, OPER RES, V56, P20, DOI 10.1287/opre.1070.0480; Sloan CE, 2012, AIDS, V26, P45, DOI 10.1097/QAD.0b013e32834dce6e; WHO, 2013, WHO ISS NEW HIV REC; World Health Organisation, 2021, CONSOLIDATED GUIDELI	19	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e98354	10.1371/journal.pone.0098354	http://dx.doi.org/10.1371/journal.pone.0098354			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963883	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000338709500004
J	Nickerson, A; Huang, T; Lin, LJ; Nan, XL				Nickerson, Andrew; Huang, Tao; Lin, Li-Jung; Nan, Xiaolin			Photoactivated Localization Microscopy with Bimolecular Fluorescence Complementation (BiFC-PALM) for Nanoscale Imaging of Protein-Protein Interactions in Cells	PLOS ONE			English	Article							RAS; VISUALIZATION; MECHANISM; MCHERRY; GFP	Bimolecular fluorescence complementation (BiFC) has been widely used to visualize protein-protein interactions (PPIs) in cells. Until now, however, the resolution of BiFC has been limited by the diffraction of light to similar to 250 nm, much larger than the nanometer scale at which PPIs occur or are regulated. Cellular imaging at the nanometer scale has recently been realized with single molecule superresolution imaging techniques such as photoactivated localization microscopy (PALM). Here we have combined BiFC with PALM to visualize PPIs inside cells with nanometer spatial resolution and single molecule sensitivity. We demonstrated that PAmCherry1, a photoactivatable fluorescent protein commonly used for PALM, can be used as a BiFC probe when split between residues 159 and 160 into two fragments. PAmCherry1 BiFC exhibits high specificity and high efficiency even at 37 degrees C in detecting PPIs with virtually no background from spontaneous reconstitution. Moreover, the reconstituted protein maintains the fast photoconversion, high contrast ratio, and single molecule brightness of the parent PAmCherry1, which enables selective PALM localization of PPIs with similar to 18 nm spatial precision. With BiFC-PALM, we studied the interactions between the small GTPase Ras and its downstream effector Raf, and clearly observed nanoscale clustering and diffusion of individual KRas G12D/CRaf RBD (Ras-binding domain) complexes on the cell membrane. These observations provided novel insights into the regulation of Ras/Raf interaction at the molecular scale, which would be difficult with other techniques such as conventional BiFC, fluorescence co-localization or FRET.	[Nan, Xiaolin] Oregon Hlth & Sci Univ, Dept Biomed Engn, Knight Canc Inst, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, OHSU Ctr Spatial Syst Biomed, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Nan, XL (corresponding author), Oregon Hlth & Sci Univ, Dept Biomed Engn, Knight Canc Inst, Portland, OR 97201 USA.	nan@ohsu.edu		Nan, Xiaolin/0000-0002-0597-0255	OHSU; NIH [5U54CA143836-05]; Damon Runyon Cancer Research Foundation; M. J. Murdock Charitable Trust; FEI company; NATIONAL CANCER INSTITUTE [U54CA143836] Funding Source: NIH RePORTER	OHSU; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; M. J. Murdock Charitable Trust; FEI company; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by startup funds to X.N. from OHSU. Research in the Nan laboratory is also supported by NIH 5U54CA143836-05 (PI: J. Liphardt), the Damon Runyon Cancer Research Foundation, the M. J. Murdock Charitable Trust, and the FEI company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2008, MOL BIOL CELL, Vxxxiii, P1601; Allen JR, 2013, J OPTICS-UK, V15, DOI 10.1088/2040-8978/15/9/094001; Annibale P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022678; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bonetta L, 2010, NATURE, V468, P851, DOI [10.1038/468851a, 10.1038/468854a, 10.1038/468852a]; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; Edelstein A., 2010, COMPUTER CONTROL MIC; FABIAN JR, 1994, P NATL ACAD SCI USA, V91, P5982, DOI 10.1073/pnas.91.13.5982; Fan JY, 2008, BIOCHEM BIOPH RES CO, V367, P47, DOI 10.1016/j.bbrc.2007.12.101; Habuchi S, 2005, P NATL ACAD SCI USA, V102, P9511, DOI 10.1073/pnas.0500489102; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kerppola Tom K, 2013, Cold Spring Harb Protoc, V2013, P727, DOI 10.1101/pdb.prot076497; Kodama Y, 2012, BIOTECHNIQUES, V53, P285, DOI [10.2144/0000113943, 10.2144/000113943]; Lee YR, 2010, MOL IMAGING BIOL, V12, P468, DOI 10.1007/s11307-010-0312-2; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Nan XL, 2013, P NATL ACAD SCI USA, V110, P18519, DOI 10.1073/pnas.1318188110; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Persson F, 2013, NAT METHODS, V10, P265, DOI [10.1038/NMETH.2367, 10.1038/nmeth.2367]; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Subach FV, 2009, P NATL ACAD SCI USA, V106, P21097, DOI 10.1073/pnas.0909204106; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Zhang MS, 2012, NAT METHODS, V9, P727, DOI [10.1038/NMETH.2021, 10.1038/nmeth.2021]	33	52	56	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100589	10.1371/journal.pone.0100589	http://dx.doi.org/10.1371/journal.pone.0100589			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963703	Green Published, Green Submitted, gold			2022-12-25	WOS:000338709500065
J	Wang, C; Cai, YY; Zhang, Y; Xiong, ZY; Li, GZ; Cui, L				Wang, Chen; Cai, Yuanyuan; Zhang, Yun; Xiong, Zhuyou; Li, Guangzao; Cui, Lei			Local Injection of Deferoxamine Improves Neovascularization in Ischemic Diabetic Random Flap by Increasing HIF-1 alpha and VEGF Expression	PLOS ONE			English	Article							MARROW-DERIVED CELLS; SKIN FLAP; MOLECULAR-BASIS; STEM-CELLS; HYPOXIA; ANGIOGENESIS; GROWTH; RECRUITMENT; DYSFUNCTION; SURVIVAL	Background: Although the systemic administration of deferoxamine (DFO) is protective in experimental models of normal ischemic flap and diabetic wound, its effect on diabetic flap ischemia using a local injection remains unknown. Objective: To explore the feasibility of local injection of DFO to improve the survival of ischemic random skin flaps in streptozotocin (STZ)-induced diabetic mice. Methods: Ischemic random skin flaps were made in 125 mice. Animals were divided into the DFO-treated (n = 20), PBS-treated (n = 16) and untreated (n = 16) groups. Surviving area, vessel density, and expression of vascular endothelial growth factor (VEGF) and hypoxia-inducible factor-1 alpha (HIF-1 alpha) were evaluated on the seventh day after local injection. Results: The viability of DFO-treated flap was significantly enhanced, with increased regional blood perfusion and capillary density compared with those in the two control groups. Fluorescence-activated cell sorting (FACS)analysis demonstrated a marked increase in systemic Flk-1(+)/CD11b(-) endothelial progenitor cells (EPCs) in DFO-treated mice. Furthermore, the expression of VEGF and HIF-1 alpha was increased not only in diabetic flap tissue, but also in dermal fibroblasts cultured under hyperglycemic and hypoxic conditions. Conclusions: Local injection of DFO could exert preventive effects against skin flap necrosis in STZ-induced diabetic mice by elevating the expression of HIF-1 alpha and VEGF, increased EPC mobilization, which all contributed to promote ischemic diabetic flap survival.	[Wang, Chen; Zhang, Yun; Cui, Lei] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Plast & Reconstruct Surg, Shanghai 200030, Peoples R China; [Cai, Yuanyuan] Changzhou 2 Peoples Hosp, Dept Plast & Aesthet Surg, Changzhou, Peoples R China; [Xiong, Zhuyou; Li, Guangzao] Bengbu Med Coll, Affiliated Hosp 1, Dept Plast Surg, Bengbu, Anhui, Peoples R China	Shanghai Jiao Tong University; Bengbu Medical College	Li, GZ (corresponding author), Bengbu Med Coll, Affiliated Hosp 1, Dept Plast Surg, Bengbu, Anhui, Peoples R China.	liguangzhaoby_jy@163.com; cuileijy@163.com		Cui, Lei/0000-0002-4339-6629	Natural Science Foundation of China [81201204]; Natural Science Foundation of Shanghai [11ZR1420300]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This work was supported by the Natural Science Foundation of China (Grant No: 81201204) and the Natural Science Foundation of Shanghai (Grant No: 11ZR1420300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL MF, 1986, BRIT J PLAST SURG, V39, P469, DOI 10.1016/0007-1226(86)90115-3; Botusan IR, 2008, P NATL ACAD SCI USA, V105, P19426, DOI 10.1073/pnas.0805230105; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Catrina SB, 2004, DIABETES, V53, P3226, DOI 10.2337/diabetes.53.12.3226; Ceradini DJ, 2008, J BIOL CHEM, V283, P10930, DOI 10.1074/jbc.M707451200; Chang EI, 2007, CIRCULATION, V116, P2818, DOI 10.1161/CIRCULATIONAHA.107.715847; Chekanov VS, 2002, CIRCULATION, V105, pE35; Dobryansky M, 2004, ANN PLAS SURG, V52, P512, DOI 10.1097/01.sap.0000123022.98361.c5; Emerit J, 2001, BIOMED PHARMACOTHER, V55, P333, DOI 10.1016/S0753-3322(01)00068-3; Epstein SE, 2001, CIRCULATION, V104, P115, DOI 10.1161/01.CIR.104.1.115; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Gao WC, 2011, J CELL MOL MED, V15, P2575, DOI 10.1111/j.1582-4934.2011.01313.x; Green R, 1985, Bibl Haematol, P25; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Gurunluoglu R, 2005, MICROSURG, V25, P433, DOI 10.1002/micr.20142; Haimovici R, 2002, OPHTHALMOLOGY, V109, P164, DOI 10.1016/S0161-6420(01)00947-2; Haws MJ, 2001, J RECONSTR MICROSURG, V17, P39, DOI 10.1055/s-2001-12687; Kang LN, 2009, CLIN EXP PHARMACOL P, V36, pe47, DOI 10.1111/j.1440-1681.2009.05219.x; Lerman OZ, 2003, AM J PATHOL, V162, P303, DOI 10.1016/S0002-9440(10)63821-7; Lu F, 2008, PLAST RECONSTR SURG, V121, P50, DOI 10.1097/01.prs.0000293876.10700.b8; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Okauchi M, 2010, STROKE, V41, P375, DOI 10.1161/STROKEAHA.109.569830; Potier E, 2008, J TISSUE ENG REGEN M, V2, P272, DOI 10.1002/term.92; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; STREMMEL W, 1988, ANN NY ACAD SCI, V526, P209; Tanaka R, 2008, PLAST RECONSTR SURG, V121, P1929, DOI 10.1097/PRS.0b013e3181715218; Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051; Thangarajah H, 2009, P NATL ACAD SCI USA, V106, P13505, DOI 10.1073/pnas.0906670106; Vija L, 2009, DIABETES METAB, V35, P85, DOI 10.1016/j.diabet.2008.10.003; WEINSTEIN GS, 1989, OTOLARYNG HEAD NECK, V101, P559, DOI 10.1177/019459988910100508; Weng R, 2010, J PLAST RECONSTR AES, V63, P2152, DOI 10.1016/j.bjps.2010.02.001; Westermann D, 2006, DIABETOLOGIA, V49, P2507, DOI 10.1007/s00125-006-0385-2; Westerweel PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060357; Zhang T, 2007, UNDERSEA HYPERBAR M, V34, P335	36	32	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100818	10.1371/journal.pone.0100818	http://dx.doi.org/10.1371/journal.pone.0100818			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963878	Green Published, gold, Green Submitted			2022-12-25	WOS:000338709500085
J	Barashkov, NA; Teryutin, FM; Pshennikova, VG; Solovyev, AV; Klarov, LA; Solovyeva, NA; Kozhevnikov, AA; Vasilyeva, LM; Fedotova, EE; Pak, MV; Lekhanova, SN; Zakharova, EV; Savvinova, KE; Gotovtsev, NN; Rafailo, AM; Luginov, NV; Alexeev, AN; Posukh, OL; Dzhemileva, LU; Khusnutdinova, EK; Fedorova, SA				Barashkov, Nikolay A.; Teryutin, Fedor M.; Pshennikova, Vera G.; Solovyev, Aisen V.; Klarov, Leonid A.; Solovyeva, Natalya A.; Kozhevnikov, Andrei A.; Vasilyeva, Lena M.; Fedotova, Elvira E.; Pak, Maria V.; Lekhanova, Sargylana N.; Zakharova, Elena V.; Savvinova, Kyunney E.; Gotovtsev, Nyurgun N.; Rafailo, Adyum M.; Luginov, Nikolay V.; Alexeev, Anatoliy N.; Posukh, Olga L.; Dzhemileva, Lilya U.; Khusnutdinova, Elza K.; Fedorova, Sardana A.			Age-Related Hearing Impairment (ARHI) Associated with GJB2 Single Mutation IVS1+1G > A in the Yakut Population Isolate in Eastern Siberia	PLOS ONE			English	Article							STEM EVOKED-POTENTIALS; 26 GENE GJB2; OTOACOUSTIC EMISSIONS; CONNEXIN-26; CARRIERS; DEAFNESS; DFNB1; NOISE	Age-Related Hearing Impairment (ARHI) is one of the frequent sensory disorders registered in 50% of individuals over 80 years. ARHI is a multifactorial disorder due to environmental and poor-known genetic components. In this study, we present the data on age-related hearing impairment of 48 heterozygous carriers of mutation IVS1+ 1G. A (GJB2 gene) and 97 subjects with GJB2 genotype wt/wt in the Republic of Sakha/Yakutia (Eastern Siberia, Russia). This subarctic territory was found as the region with the most extensive accumulation of mutation IVS1+ 1G>A in the world as a result of founder effect in the unique Yakut population isolate. The GJB2 gene resequencing and detailed audiological analysis in the frequency range 0.25, 0.5, 1.0, 2.0, 4.0, 8.0 kHz were performed in all examined subjects that allowed to investigate genotypephenotype correlations between the presence of single mutation IVS1+ 1G>A and hearing of subjects from examined groups. We revealed the linear correlation between increase of average hearing thresholds at speech frequencies (PTA0.5,1.0,2.0,4.0 kHz) and age of individuals with GJB2 genotype IVS1+ 1G>A/wt (rs = 0.499, p = 0.006860 for males and rs = 0.427, p = 0.000277 for females). Moreover, the average hearing thresholds on high frequency (8.0 kHz) in individuals with genotype IVS1+ 1G>A/wt (both sexes) were significantly worse than in individuals with genotype wt/wt (p, 0.05). Age of hearing loss manifestation in individuals with genotype IVS1+ 1G>A/wt was estimated to be,40 years (rs = 0.504, p = 0.003). These findings demonstrate that the single IVS1+ 1G. A mutation (GJB2) is associated with age-related hearing impairment (ARHI) of the IVS1+ 1G>A carriers in the Yakuts.	[Barashkov, Nikolay A.; Teryutin, Fedor M.; Pshennikova, Vera G.; Solovyeva, Natalya A.; Fedorova, Sardana A.] Russian Acad Med Sci, Siberian Branch, Yakut Sci Ctr Complex Med Problems, Dept Mol Genet, Yakutsk, Russia; [Barashkov, Nikolay A.; Teryutin, Fedor M.; Solovyev, Aisen V.; Savvinova, Kyunney E.; Gotovtsev, Nyurgun N.; Fedorova, Sardana A.] MK Ammosov North Eastern Fed Univ, Inst Nat Sci, Mol Biol Lab, Yakutsk, Russia; [Klarov, Leonid A.; Luginov, Nikolay V.] Minist Publ Hlth Sakha Republ, Ctr Emergency Med, Republican Hosp 2, Dept Radiol, Yakutsk, Russia; [Kozhevnikov, Andrei A.] Minist Publ Hlth Sakha Republ, Ctr Emergency Med, Republican Hosp 2, Republican Ctr Profess Pathol, Yakutsk, Russia; [Vasilyeva, Lena M.; Fedotova, Elvira E.] Minist Publ Hlth Sakha Republ, Natl Med Ctr, Republican Hosp 1, Audiology Logopaed Ctr, Yakutsk, Russia; [Pak, Maria V.] MK Ammosov North Eastern Fed Univ, Inst Med, Dept Pediat, Yakutsk, Russia; [Lekhanova, Sargylana N.] MK Ammosov North Eastern Fed Univ, Inst Med, Dept Normal & Abnormal Anat, Yakutsk, Russia; [Zakharova, Elena V.] MK Ammosov North Eastern Fed Univ, Inst Foreign Philol & Reg Studies, Yakutsk, Russia; [Savvinova, Kyunney E.; Gotovtsev, Nyurgun N.; Rafailo, Adyum M.] MK Ammosov North Eastern Fed Univ, Inst Nat Sci, Yakutsk, Russia; [Alexeev, Anatoliy N.] Russian Acad Sci, Inst Humanitarian Res & Indigenous Peoples North, Siberian Branch, Yakutsk, Russia; [Posukh, Olga L.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia; [Posukh, Olga L.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Dzhemileva, Lilya U.; Khusnutdinova, Elza K.] Russian Acad Sci, Ufa Sci Ctr, Dept Genom, Inst Biochem & Genet, Ufa 450001, Russia; [Khusnutdinova, Elza K.] Bashkir State Univ, Dept Genet & Fundamental Med, Ufa 450074, Russia	Russian Academy of Medical Sciences; Yakut Science Centre of Complex Medical Problems; North-Eastern Federal University in Yakutsk; North-Eastern Federal University in Yakutsk; North-Eastern Federal University in Yakutsk; North-Eastern Federal University in Yakutsk; North-Eastern Federal University in Yakutsk; Institute for Humanities Research & Indigenous Studies of the North; Russian Academy of Sciences; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Novosibirsk State University; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Bashkir State University	Barashkov, NA (corresponding author), Russian Acad Med Sci, Siberian Branch, Yakut Sci Ctr Complex Med Problems, Dept Mol Genet, Yakutsk, Russia.	barashkov2004@mail.ru	Solovyeva, Natalya/L-4470-2017; Solovyev, Aisen/F-4012-2017; Posukh, Olga L/Q-6065-2016; Dzhemileva, Lilya U/K-8636-2013; Klarov, Leonid/L-4463-2017; Alekseev, Anatoliy Nickolaevich/O-1096-2015; Barashkov, Nikolay/F-1499-2017; Fedorova, Sardana/K-5445-2017; Khusnutdinova, Elza Kamilevna/A-4810-2013; Teryutin, Fedor/K-5104-2017; Lekhanova, Sargylana/AAZ-4597-2021; Dzhemilev, Usein M./O-5155-2015; Pshennikova, Vera/F-4031-2017; Готовцев, Ньургун/K-8020-2017; Solovyeva, Natalya/Q-9965-2018	Posukh, Olga L/0000-0003-1352-3591; Dzhemileva, Lilya U/0000-0003-3315-4746; Klarov, Leonid/0000-0003-1588-0971; Alekseev, Anatoliy Nickolaevich/0000-0002-9488-573X; Barashkov, Nikolay/0000-0002-6984-7934; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Teryutin, Fedor/0000-0002-8659-0886; Dzhemilev, Usein M./0000-0002-7992-6337; Pshennikova, Vera/0000-0001-6866-9462; Готовцев, Ньургун/0000-0002-4710-1592; Solovyeva, Natalya/0000-0002-3570-2585; Fedorova, Sardana/0000-0002-6952-3868	Russian Foundation for Basic Research [12-04-00342_a, 12-04-98520_r_vostok_a, 12-04-97004_r_povolzhye_a, 12-04-31230_mol_a, 14-04-01741_A]; Federal Program Scientific and educational staff for innovative Russia [16.740.11.0190, 16.740.11.0346]; Integration project of SB RAS [92]; Sakha Republic President [80]; Scientific and Educational Foundation for Young Scientists of Republic of Sakha (Yakutia) of Ministry of Education and Science of Russia [656]; RAS Program Fundamental Sciences for Medicine [30(2013-2015)]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Federal Program Scientific and educational staff for innovative Russia; Integration project of SB RAS; Sakha Republic President; Scientific and Educational Foundation for Young Scientists of Republic of Sakha (Yakutia) of Ministry of Education and Science of Russia; RAS Program Fundamental Sciences for Medicine	The authors thank all patients and blood sample donors who have contributed to this study. This study was supported by the Russian Foundation for Basic Research (12-04-00342_a, 12-04-98520_r_vostok_a, 12-04-97004_r_povolzhye_a, 12-04-31230_mol_a, 14-04-01741_A), Federal Program Scientific and educational staff for innovative Russia (#16.740.11.0190, #16.740.11.0346), Integration project of SB RAS #92 Ethnogeny of indigenous peoples in Siberia and North Asia: comparative, historical, ethno-social and genomic analysis, the Sakha Republic President Grant# 80 for Young Researchers for 2014 year, Scientific and Educational Foundation for Young Scientists of Republic of Sakha (Yakutia) for 2014 year, Project # 656 of Ministry of Education and Science of Russia, by grant # 30(2013-2015) of RAS Program Fundamental Sciences for Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLANA E, CONNEXINS DEAFNESS; Barashkov NA, 2011, J HUM GENET, V56, P631, DOI 10.1038/jhg.2011.72; Engel-Yeger B, 2003, HEARING RES, V175, P140, DOI 10.1016/S0378-5955(02)00719-0; Engel-Yeger B, 2002, HEARING RES, V163, P93, DOI 10.1016/S0378-5955(01)00386-0; Fedorova SA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-127; Fransen E, 2008, JARO-J ASSOC RES OTO, V9, P264, DOI 10.1007/s10162-008-0123-1; Franze A, 2005, EUR ARCH OTO-RHINO-L, V262, P921, DOI 10.1007/s00405-005-0918-1; Friedman RA, 2009, HUM MOL GENET, V18, P785, DOI 10.1093/hmg/ddn402; Groh D, 2013, PHYSIOL RES, V62, P323, DOI 10.33549/physiolres.932475; Hall A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001238; Huyghe JR, 2008, AM J HUM GENET, V83, P401, DOI 10.1016/j.ajhg.2008.08.002; Kelley PM, 1998, AM J HUM GENET, V62, P792, DOI 10.1086/301807; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kharkov VN, 2008, MOL BIOL+, V42, P198, DOI 10.1134/S0026893308020040; Lefebvre PP, 2000, BRAIN RES REV, V32, P159; Li Qi, 2011, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V46, P543; Morell RJ, 1998, NEW ENGL J MED, V339, P1500, DOI 10.1056/NEJM199811193392103; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Pakendorf B, 2006, HUM GENET, V120, P334, DOI 10.1007/s00439-006-0213-2; Sirmaci A, 2006, J GENET, V85, P213, DOI 10.1007/BF02935334; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; Van Eyken E, 2007, OTOL NEUROTOL, V28, P970; Van Laer L, 2008, HUM MOL GENET, V17, P159, DOI 10.1093/hmg/ddm292; Van Laer L, 2010, EUR J HUM GENET, V18, P685, DOI 10.1038/ejhg.2009.234; Yamasoba T, 2013, HEARING RES, V303, P30, DOI 10.1016/j.heares.2013.01.021; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605; Zerjal T, 1997, AM J HUM GENET, V60, P1174	27	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100848	10.1371/journal.pone.0100848	http://dx.doi.org/10.1371/journal.pone.0100848			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959830	Green Published, gold, Green Submitted			2022-12-25	WOS:000338633900095
J	Ding, Y; Ruan, DK; Luk, KDK; He, Q; Wang, CF				Ding, Yu; Ruan, Dike; Luk, Keith D. K.; He, Qing; Wang, Chaofeng			The Effect of Gamma Irradiation on the Biological Properties of Intervertebral Disc Allografts: In Vitro and In Vivo Studies in a Beagle Model	PLOS ONE			English	Article							ADJACENT-SEGMENT DEGENERATION; BONE; TRANSPLANTATION; STERILIZATION; ARTHROPLASTY; REGENERATION; RADIATION; FUSION; CELLS	Study Design: An animal experiment about intervertebral disc allograft. Objective: To explore the feasibility to decellularize disc allografts treated by Co-60 Gamma Irradiation, and simultaneously, to assess the possibility to make use of the decellularized natural disc scaffold for disc degeneration biotherapy. Summary of Background Data: Studies of both animal and human disc allograft transplantation indicated that the disc allograft may serve as a scaffold to undertake the physiological responsibility of the segment. Methods: Experiment in vitro: 48 discs of beagles were harvested and divided randomly into four groups including a control group and three irradiated groups. Immediate cell viability and biomechanical properties of the discs were checked and comparisons were made among these groups. Experiment in vivo: 24 beagles accepted single-level allografted disc treated with different doses of gamma irradiation. Plain X-rays and MRIs were taken before and after surgery. Then, the spinal columns were harvested en bloc from the sacrificed beagles and were examined morphologically. Results: There were significant differences of both the annulus fibrosus and nucleus pulposus immediate cell viabilities among the various groups. There were no obvious differences of the biomechanical properties among the four groups. The disc height and range of motion decreased significantly in all groups as time went on. The observed indexes in irradiated groups were much smaller than those in the control group, but the indexes in 18-kGy group were larger than those in 25-kGy and 50-kGy groups. Both MRI and macroscopic findings showed that the segmental degeneration in the control and 18-kGy group was less severe than that in 25-kGy and 50-kGy groups. Conclusion: Gamma Irradiation can decellularize disc allograft successfully to provide natural scaffold for the study of degenerative disc disease therapy, and also can be used as an effective method to produce adjustable animal models.	[Ding, Yu] Navy Gen Hosp, Dept Rehabil Med, Beijing, Peoples R China; [Ding, Yu] Navy Gen Hosp, Pain Management Ctr, Beijing, Peoples R China; [Ruan, Dike; He, Qing; Wang, Chaofeng] Navy Gen Hosp, Dept Orthopaed, Beijing, Peoples R China; [Luk, Keith D. K.] Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China	Sixth Medical Center of Chinese PLA General Hospital; Sixth Medical Center of Chinese PLA General Hospital; Sixth Medical Center of Chinese PLA General Hospital; University of Hong Kong	Ruan, DK (corresponding author), Navy Gen Hosp, Dept Orthopaed, Beijing, Peoples R China.	ruyi_2013@yeah.net			National Natural Science Foundation of China [30730095]; Beijing Municipal Science and Technology Commission [Z131107002213058]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission)	This work was supported by: 1. No. 30730095, the National Natural Science Foundation of China (www.nsfc.gov.cn); and 2. No. Z131107002213058, supported by the Beijing Municipal Science and Technology Commission (www.bjkw.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Akkus O, 2005, J ORTHOP RES, V23, P1054, DOI 10.1016/j.orthres.2005.03.003; Aslan H, 2009, REGEN MED, V4, P99, DOI 10.2217/17460751.4.1.99; Balsly CR, 2008, CELL TISSUE BANK, V9, P289, DOI 10.1007/s10561-008-9069-0; Bertagnoli R, 2006, J NEUROSURG-SPINE, V4, P91, DOI 10.3171/spi.2006.4.2.91; Gamero EC, 2009, CELL TISSUE BANK, V10, P167, DOI 10.1007/s10561-008-9093-0; Chiang CJ, 2011, SPINE, V36, P761, DOI 10.1097/BRS.0b013e3181e08f01; Cho H, 2011, EXP MOL MED, V43, P334, DOI 10.3858/emm.2011.43.6.036; Fassett DR, 2009, J SPINAL DISORD TECH, V22, P297, DOI 10.1097/BSD.0b013e31816d5f64; Ghiselli G, 2004, J BONE JOINT SURG AM, V86A, P1497, DOI 10.2106/00004623-200407000-00020; GIBBONS MJ, 1991, J ORTHOPAED RES, V9, P209, DOI 10.1002/jor.1100090209; Grieb TA, 2006, J ORTHOP RES, V24, P1011, DOI 10.1002/jor.20079; Hamer AJ, 1999, J BONE JOINT SURG BR, V81B, P342, DOI 10.1302/0301-620X.81B2.9083; Henriksson HB, 2009, SPINE, V34, P141, DOI 10.1097/BRS.0b013e31818f8c20; Hoogendoorn RJ, 2007, SPINE, V32, P1816, DOI 10.1097/BRS.0b013e31811ebac5; Kim KT, 2009, SPINE, V34, P2674, DOI 10.1097/BRS.0b013e3181b4aaac; Kroeber MW, 2002, SPINE, V27, P2684, DOI 10.1097/00007632-200212010-00007; Kunnev D, 2010, ONCOGENE, V29, P3630, DOI 10.1038/onc.2010.125; Luk KDK, 1997, CLIN ORTHOP RELAT R, P13; Matsuzaki H, 1996, SPINE, V21, P178, DOI 10.1097/00007632-199601150-00004; Murrell W, 2009, SPINE J, V9, P585, DOI 10.1016/j.spinee.2009.02.011; Nguyen Huynh, 2007, Cell and Tissue Banking, V8, P81, DOI 10.1007/s10561-006-9019-7; Qi A. Q., 2000, CHIN J CELL BIOL, V22, P50, DOI [10.3969/j.issn.1674-7666.2000.01.013, DOI 10.3969/J.ISSN.1674-7666.2000.01.013]; Rohl K, 2009, SPINAL CORD, V47, P705, DOI 10.1038/sc.2009.31; Ruan DK, 2010, TISSUE ENG PT A, V16, P2381, DOI [10.1089/ten.tea.2009.0770, 10.1089/ten.TEA.2009.0770]; Ruan DK, 2007, LANCET, V369, P993, DOI 10.1016/S0140-6736(07)60496-6; Sakai D, 2008, EUR SPINE J, V17, pS452, DOI 10.1007/s00586-008-0743-5; Singh VA, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-48; Taher F, 2012, ADV ORTHOP, V2012, DOI 10.1155/2012/970752; Xia XP, 2013, SPINE, V38, P597, DOI 10.1097/BRS.0b013e318273a2ea; Yang YC, 2009, INT ORTHOP, V33, P1037, DOI 10.1007/s00264-008-0571-6; Zeiter S, 2005, EUR SPINE J, V14, P874, DOI 10.1007/s00586-005-0957-8	32	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100304	10.1371/journal.pone.0100304	http://dx.doi.org/10.1371/journal.pone.0100304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959720	gold, Green Submitted, Green Published			2022-12-25	WOS:000338633900038
J	Tang, LD; Wang, XM; Jin, FL; Qiu, BL; Wu, JH; Ren, SX				Tang, Liang-De; Wang, Xing-Min; Jin, Feng-Liang; Qiu, Bao-Li; Wu, Jian-Hui; Ren, Shun-Xiang			De Novo Sequencing-Based Transcriptome and Digital Gene Expression Analysis Reveals Insecticide ResistanceRelevant Genes in Propylaea japonica (Thunberg) (Coleoptea: Coccinellidae)	PLOS ONE			English	Article							APHIS-GOSSYPII; BEETLE; REPRODUCTION; HEMIPTERA; APHIDIDAE; GENOME	The ladybird Propylaea japonica (Thunberg) is one of most important natural enemies of aphids in China. This species is threatened by the extensive use of insecticides but genomics-based information on the molecular mechanisms underlying insecticide resistance is limited. Hence, we analyzed the transcriptome and expression profile data of P. japonica in order to gain a deeper understanding of insecticide resistance in ladybirds. We performed de novo assembly of a transcriptome using Illumina's Solexa sequencing technology and short reads. A total of 27,243,552 reads were generated. These were assembled into 81,458 contigs and 33,647 unigenes (6,862 clusters and 26,785 singletons). Of the unigenes, 23,965 (71.22%) have putative homologues in the non-redundant (nr) protein database from NCBI, using BLASTX, with a cut-off E-value of 10(-5). We examined COG , GO and KEGG annotations to better understand the functions of these unigenes. Digital gene expression (DGE) libraries showed differences in gene expression profiles between two insecticide resistant strains. When compared with an insecticide susceptible profile, a total of 4,692 genes were significantly up-or down-regulated in a moderately resistant strain. Among these genes, 125 putative insecticide resistance genes were identified. To confirm the DGE results, 16 selected genes were validated using quantitative real time PCR (qRT-PCR). This study is the first to report genetic information on P. japonica and has greatly enriched the sequence data for ladybirds. The large number of gene sequences produced from the transcriptome and DGE sequencing will greatly improve our understanding of this important insect, at the molecular level, and could contribute to the in-depth research into insecticide resistance mechanisms.	[Tang, Liang-De; Wang, Xing-Min; Jin, Feng-Liang; Qiu, Bao-Li; Wu, Jian-Hui; Ren, Shun-Xiang] South China Agr Univ, Coll Nat Resource & Environm, Minist Educ, Engn Res Ctr Biol Control, Guangzhou, Guangdong, Peoples R China; [Tang, Liang-De] Chinese Acad Trop Agr, Environm & Plant Protect Inst, Haikou, Peoples R China	South China Agricultural University	Ren, SX (corresponding author), South China Agr Univ, Coll Nat Resource & Environm, Minist Educ, Engn Res Ctr Biol Control, Guangzhou, Guangdong, Peoples R China.	rensxcn@aliyun.com		Wang, Xingmin/0000-0001-9327-9159	National Basic Research Program of China (973 program) [2013CB127600]	National Basic Research Program of China (973 program)(National Basic Research Program of China)	This work was supported by National Basic Research Program of China (973 program, Grant No. 2013CB127600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alias Z, 2010, PESTIC BIOCHEM PHYS, V98, P94, DOI 10.1016/j.pestbp.2010.05.005; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bozsik A, 2006, PEST MANAG SCI, V62, P651, DOI 10.1002/ps.1221; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Galvan TL, 2005, BIOL CONTROL, V34, P108, DOI 10.1016/j.biocontrol.2005.04.005; Gao F, 2010, ENTOMOL EXP APPL, V136, P72, DOI 10.1111/j.1570-7458.2010.01005.x; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hanriot L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-418; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; KAWAUCHI S-E, 1985, Kontyu, V53, P536; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MULLINS JW, 1993, ACS SYM SER, V524, P183; Nauen R, 2003, B ENTOMOL RES, V93, P47, DOI 10.1079/BER2002215; Papachristos DP, 2008, BIOL CONTROL, V47, P77, DOI 10.1016/j.biocontrol.2008.06.009; Rahmani S, 2013, CROP PROT, V54, P168, DOI 10.1016/j.cropro.2013.08.002; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Rodrigues ARS, 2013, ECOTOX ENVIRON SAFE, V96, P53, DOI 10.1016/j.ecoenv.2013.06.014; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shun Ei K., 1992, Shokubutsu Boeki, V46, P495; Singh SR, 2004, BIOL CONTROL, V30, P127, DOI 10.1016/j.biocontrol.2004.01.003; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; Weichel L, 2003, PEST MANAG SCI, V59, P991, DOI 10.1002/ps.711; Yamamoto K, 2009, PESTIC BIOCHEM PHYS, V94, P30, DOI 10.1016/j.pestbp.2009.02.008; Youn YN, 2003, BIOL CONTROL, V28, P164, DOI 10.1016/S1049-9644(03)00098-7; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang SZ, 2012, BIOL CONTROL, V62, DOI 10.1016/j.biocontrol.2012.05.002; [张世泽 Zhang Shize], 2004, [干旱地区农业研究, Agricultural Research in the Arid Areas], V22, P206; Zhang SY, 2006, J APPL ENTOMOL, V130, P206, DOI 10.1111/j.1439-0418.2006.01049.x; Zhang YH, 2012, GENOMICS, V100, P35, DOI 10.1016/j.ygeno.2012.05.002	33	25	27	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100946	10.1371/journal.pone.0100946	http://dx.doi.org/10.1371/journal.pone.0100946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959827	Green Submitted, Green Published, gold			2022-12-25	WOS:000338633900104
J	Winter, C; Garcia, JAL; Weinbauer, MG; DuBow, MS; Herndl, GJ				Winter, Christian; Garcia, Juan A. L.; Weinbauer, Markus G.; DuBow, Michael S.; Herndl, Gerhard J.			Comparison of Deep-Water Viromes from the Atlantic Ocean and the Mediterranean Sea	PLOS ONE			English	Article							REFERENCE SEQUENCES REFSEQ; MARINE VIRUSES; BACTERIAL; COMMUNITIES; DIVERSITY	The aim of this study was to compare the composition of two deep-sea viral communities obtained from the Romanche Fracture Zone in the Atlantic Ocean (collected at 5200 m depth) and the southwest Mediterranean Sea (from 2400 m depth) using a pyro-sequencing approach. The results are based on 18.7% and 6.9% of the sequences obtained from the Atlantic Ocean and the Mediterranean Sea, respectively, with hits to genomes in the non-redundant viral RefSeq database. The identifiable richness and relative abundance in both viromes were dominated by archaeal and bacterial viruses accounting for 92.3% of the relative abundance in the Atlantic Ocean and for 83.6% in the Mediterranean Sea. Despite characteristic differences in hydrographic features between the sampling sites in the Atlantic Ocean and the Mediterranean Sea, 440 virus genomes were found in both viromes. An additional 431 virus genomes were identified in the Atlantic Ocean and 75 virus genomes were only found in the Mediterranean Sea. The results indicate that the rather contrasting deep-sea environments of the Atlantic Ocean and the Mediterranean Sea share a common core set of virus types constituting the majority of both virus communities in terms of relative abundance (Atlantic Ocean: 81.4%; Mediterranean Sea: 88.7%).	[Winter, Christian; Garcia, Juan A. L.] Univ Vienna, Dept Limnol & Oceanog, Vienna, Austria; [Weinbauer, Markus G.] Univ Sorbonne, Observ Oceanol, Villefranche Sur Mer, France; [Weinbauer, Markus G.] CNRS, UMR 7093, Observ Oceanol, Villefranche Sur Mer, France; [DuBow, Michael S.] Univ Paris 11, Inst Genet & Microbiol, F-91405 Orsay, France; [Herndl, Gerhard J.] Royal Netherlands Inst Sea Res, Dept Biol Oceanog, Den Burg, Netherlands	University of Vienna; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Winter, C (corresponding author), Univ Vienna, Dept Limnol & Oceanog, Vienna, Austria.	christian.winter@univie.ac.at	Herndl, Gerhard J./B-1513-2013; Herndl, Gerhard J./S-3011-2019; Weinbauer, Markus/ABC-7017-2020; Garcia, Juan Antonio/J-9242-2012	Herndl, Gerhard J./0000-0002-2223-2852; Herndl, Gerhard J./0000-0002-2223-2852; Weinbauer, Markus/0000-0002-7697-5571; Garcia, Juan Antonio/0000-0003-4564-7281; Winter, Christian/0000-0001-6327-0209	Gordon and Betty Moore Foundation [GBMF1799]; European Research Council Advanced Grant (MEDEA) [268595]; Austrian Science Fund (FWF) [P24413-B21]; Austrian Science Fund (FWF) [P 24413] Funding Source: researchfish	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); European Research Council Advanced Grant (MEDEA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was funded in part by the Gordon and Betty Moore Foundation through grant GBMF1799 to the Broad Institute. Samples G2361 and G2362 were sequenced at the Broad Institute. Additional financial support was provided by an European Research Council Advanced Grant (MEDEA, grant number 268595) to GJH and the Austrian Science Fund (FWF): (P24413-B21) to CW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agogue H, 2011, MOL ECOL, V20, P258, DOI 10.1111/j.1365-294X.2010.04932.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Angly FE, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000593; Aristegui J, 2009, LIMNOL OCEANOGR, V54, P1501, DOI 10.4319/lo.2009.54.5.1501; BETHOUX JP, 1990, NATURE, V347, P660, DOI 10.1038/347660a0; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Fouts DE, 2006, NUCLEIC ACIDS RES, V34, P5839, DOI 10.1093/nar/gkl732; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Guo L, 2007, ENV COLLOIDS PARTICL, V10, P159, DOI DOI 10.1002/9780470024539.CH4; Herndl GJ, 2013, NAT GEOSCI, V6, P718, DOI [10.1038/ngeo1921, 10.1038/NGEO1921]; Lerat E, 2005, PLOS BIOL, V3, P807, DOI 10.1371/journal.pbio.0030130; Marie D, 1999, CURRENT PROTOCOLS CY; Monier A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r106; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rodriguez-Brito B, 2010, ISME J, V4, P739, DOI 10.1038/ismej.2010.1; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Romero P, 2004, VIROLOGY, V322, P239, DOI 10.1016/j.virol.2004.01.029; Roux S, 2011, BIOINFORMATICS, V27, P3074, DOI 10.1093/bioinformatics/btr519; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Tanaka T, 2002, DEEP-SEA RES PT II, V49, P2093, DOI 10.1016/S0967-0645(02)00029-2; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; Winter C, 2010, APPL ENVIRON MICROB, V76, P6724, DOI 10.1128/AEM.00531-10; Winter C, 2010, MICROBIOL MOL BIOL R, V74, P42, DOI 10.1128/MMBR.00034-09; Winter C, 2009, DEEP-SEA RES PT I, V56, P1972, DOI 10.1016/j.dsr.2009.07.003; Winter C, 2009, LIMNOL OCEANOGR, V54, P160, DOI 10.4319/lo.2009.54.1.0160; Yin YB, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-63	36	25	27	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100600	10.1371/journal.pone.0100600	http://dx.doi.org/10.1371/journal.pone.0100600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959907	Green Published, Green Submitted, gold			2022-12-25	WOS:000338633900060
J	Yang, L; Wang, J; Huang, YH; Hui, DF; Wen, ML				Yang, Long; Wang, Jun; Huang, Yuhui; Hui, Dafeng; Wen, Meili			Effects of the Interception of Litterfall by the Understory on Carbon Cycling in Eucalyptus Plantations of South China	PLOS ONE			English	Article							SOIL CO2 EFFLUX; RESPIRATION; FOREST; BIOMASS; VEGETATION; DECOMPOSITION; ROOT; ECOSYSTEMS; EXCLUSION; DRIVER	For the purposes of forest restoration, carbon (C) fixation, and economic improvement, eucalyptus (Eucalyptus urophylla) has been widely planted in South China. The understory of eucalyptus plantations is often occupied by a dense community of the fern Dicranopteris dichotoma, which intercepts tree canopy leaf litter before it reaches the ground. To understand the effects of this interception of litterfall on C cycling in eucalyptus plantations, we quantified the mass of intercepted litter and the influences of litterfall interception on litter decomposition and soil respiration. The total mass of E. urophylla litterfall collected on the understory was similar to that collected by the traditional litter trap method. All of the eucalyptus litterfall is intercepted by the D. dichotoma canopy. Of the litterfall that was intercepted by D. dichotoma, 20-40% and 60-80% was intercepted by the top (50-100 cm) and bottom (0-50 cm) of the understory canopy, respectively. Intercepted litterfall decomposed faster at the bottom of understory canopy (at the base of the plants) than at the top, and decomposition was slower on the soil surface in the absence of understory than on any location in the understory canopy. Soil respiration was highest when both the understory and litter were present and was lowest when both the understory and litter were absent. These results indicate that litterfall interception changed carbon flow between aboveground and belowground through litter decomposition and soil respiration, which changed carbon cycling in eucalyptus plantations. The effects of the understory on litter decomposition and soil respiration should be considered in ecosystem carbon models.	[Yang, Long; Wen, Meili] Guangzhou Inst Geog, Ctr Resource & Environm, Guangzhou, Guangdong, Peoples R China; [Yang, Long; Wang, Jun] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Huang, Yuhui] Guangdong Acad Forestry, Guangzhou, Guangdong, Peoples R China; [Hui, Dafeng] Tennessee State Univ, Dept Biol Sci, Nashville, TN 37203 USA	Guangdong Academy of Sciences; Guangzhou Institute of Geography, Guangdong Academy of Sciences; Chinese Academy of Sciences; South China Botanical Garden, CAS; Tennessee State University	Yang, L (corresponding author), Guangzhou Inst Geog, Ctr Resource & Environm, Guangzhou, Guangdong, Peoples R China.	yanglong@scib.ac.cn		Wang, Jun/0000-0003-4492-4953; Hui, Dafeng/0000-0002-5284-2897	National Natural Science Foundation of China [31000212]; Special Foundation for Young Scientists of Guangdong Academy of Sciences [2009-46]; Key Laboratory of Vegetation Restoration and Management of Degraded Ecosystems, Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Foundation for Young Scientists of Guangdong Academy of Sciences; Key Laboratory of Vegetation Restoration and Management of Degraded Ecosystems, Chinese Academy of Sciences	This research was funded by the National Natural Science Foundation of China (No. 31000212), the Special Foundation for Young Scientists of Guangdong Academy of Sciences (2009-46), and the Key Laboratory of Vegetation Restoration and Management of Degraded Ecosystems, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Sanchez J, 1999, BIOTROPICA, V31, P89; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Cadisch G, 1996, DRIVEN NATURE PLANT; Chen DM, 2009, FOREST ECOL MANAG, V257, P2088, DOI 10.1016/j.foreco.2009.02.018; *CHIN STAT FOR BUR, 2005, 6 NAT FOR INV 1999 2; Dearden FM, 2008, OIKOS, V117, P83, DOI 10.1111/j.2007.0030-1299.16136.x; [邓琦 DENG Qi], 2007, [地球科学进展, Advance in Earth Sciences], V22, P976; Dirks I, 2010, GLOBAL CHANGE BIOL, V16, P2799, DOI 10.1111/j.1365-2486.2010.02172.x; Ehrenfeld JG, 2001, ECOL APPL, V11, P1287, DOI 10.2307/3060920; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Fang JY, 2001, ACTA BOT SIN, V43, P967; Flora of China Editorial Committee, 1999, FLORA CHINA; George LO, 1999, ECOLOGY, V80, P833, DOI 10.1890/0012-9658(1999)080[0833:TFUAAE]2.0.CO;2; Gough CM, 2004, FOREST ECOL MANAG, V191, P353, DOI 10.1016/j.foreco.2004.01.011; He XB, 2013, PLANT SOIL, V372, P207, DOI 10.1007/s11104-013-1734-9; Huang YH, 2011, ENVIRON MANAGE, V48, P1189, DOI 10.1007/s00267-011-9758-5; Hui DF, 2009, PLANT SOIL, V314, P263, DOI 10.1007/s11104-008-9726-x; Kauffman JB, 2009, ECOL APPL, V19, P1211, DOI 10.1890/08-1696.1; Li YQ, 2004, SOIL BIOL BIOCHEM, V36, P2111, DOI 10.1016/j.soilbio.2004.06.003; Lin X.X., 2004, FUJIAN SOIL WATER CO, V16, P60; Liu Wen-fei, 2009, Shengtaixue Zazhi, V28, P1928; Liu Ying-chun, 2008, Shengtaixue Zazhi, V27, P705; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Nilsson MC, 2005, FRONT ECOL ENVIRON, V3, P421, DOI 10.2307/3868658; OCONNELL AM, 1986, PLANT SOIL, V92, P235, DOI 10.1007/BF02372637; Peng SL, 2009, RESTOR ECOL, V17, P487, DOI 10.1111/j.1526-100X.2008.00399.x; Piao SL, 2005, J GEOPHYS RES-BIOGEO, V110, DOI 10.1029/2005JG000014; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Schimel JP, 1999, SOIL BIOL BIOCHEM, V31, P831, DOI 10.1016/S0038-0717(98)00182-5; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Tang XL, 2006, GLOBAL CHANGE BIOL, V12, P546, DOI 10.1111/j.1365-2486.2006.01109.x; Wang Guang-Jun, 2009, Chinese Journal of Plant Ecology, V33, P739, DOI 10.3773/j.issn.1005-264x.2009.04.012; Wang J, 2009, FOREST ECOL MANAG, V258, P1293, DOI 10.1016/j.foreco.2009.06.022; Wang XL, 2011, FOREST ECOL MANAG, V261, P1053, DOI 10.1016/j.foreco.2010.12.027; Wang YD, 2009, ASIA-PAC J ATMOS SCI, V45, P137; Wu ChuanSheng, 2012, Journal of Northeast Forestry University, V40, P37; Wu JP, 2011, SOIL BIOL BIOCHEM, V43, P2355, DOI 10.1016/j.soilbio.2011.07.011; Wu JP, 2011, FUNCT ECOL, V25, P921, DOI 10.1111/j.1365-2435.2011.01845.x; Xu M, 2001, GLOBAL CHANGE BIOL, V7, P667, DOI 10.1046/j.1354-1013.2001.00435.x; Xue Li, 2005, Acta Phytoecologica Sinica, V29, P415; YARIE J, 1980, ECOLOGY, V61, P1498, DOI 10.2307/1939057; Yashiro Y, 2012, ECOL RES, V27, P577, DOI 10.1007/s11284-012-0925-9; YE JX, 1987, ACTA PHYTOECLOGICA G, V11, P203; [袁宜如 YUAN Yiru], 2007, [安徽农业科学, Journal of Anhui Agricultural Sciences], V35, P5047; [张继光 ZHANG Ji-guang], 2009, [热带亚热带植物学报, Journal of Tropical and Subtropical Botany], V17, P395; Zhu HG, 2010, J ANHUI AGR SCI, V38; Zimmermann M, 2009, SOIL BIOL BIOCHEM, V41, P1338, DOI 10.1016/j.soilbio.2009.02.023	48	14	17	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100464	10.1371/journal.pone.0100464	http://dx.doi.org/10.1371/journal.pone.0100464			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959853	gold, Green Submitted, Green Published			2022-12-25	WOS:000338633900048
J	Mehemed, TM; Fushimi, Y; Okada, T; Yamamoto, A; Kanagaki, M; Kido, A; Fujimoto, K; Sakashita, N; Togashi, K				Mehemed, Taha M.; Fushimi, Yasutaka; Okada, Tomohisa; Yamamoto, Akira; Kanagaki, Mitsunori; Kido, Aki; Fujimoto, Koji; Sakashita, Naotaka; Togashi, Kaori			Dynamic Oxygen-Enhanced MRI of Cerebrospinal Fluid	PLOS ONE			English	Article							ATTENUATED INVERSION-RECOVERY; SUPPLEMENTAL OXYGEN; SIGNAL INTENSITY; GENERAL-ANESTHESIA; RELAXATION-TIMES; PARTIAL-PRESSURE; IMAGES; CONTRAST; INHALATION; BRAIN	Oxygen causes an increase in the longitudinal relaxation rate of tissues through its T1-shortening effect owing to its paramagnetic properties. Due to such effects, MRI has been used to study oxygen-related signal intensity changes in various body parts including cerebrospinal fluid (CSF) space. Oxygen enhancement of CSF has been mainly studied using MRI sequences with relatively longer time resolution such as FLAIR, and T1 value calculation. In this study, fifteen healthy volunteers were scanned using fast advanced spin echo MRI sequence with and without inversion recovery pulse in order to dynamically track oxygen enhancement of CSF. We also focused on the differences of oxygen enhancement at sulcal and ventricular CSF. Our results revealed that CSF signal after administration of oxygen shows rapid signal increase in both sulcal CSF and ventricular CSF on both sequences, with statistically significant predominant increase in sulcal CSF compared with ventricular CSF. CSF is traditionally thought to mainly form from the choroid plexus in the ventricles and is absorbed at the arachnoid villi, however, it is also believed that cerebral arterioles contribute to the production and absorption of CSF, and controversy remains in terms of the precise mechanism. Our results demonstrated rapid oxygen enhancement in sulcal CSF, which may suggest inhaled oxygen may diffuse into sulcal CSF space rapidly probably due to the abundance of pial arterioles on the brain sulci.	[Mehemed, Taha M.; Fushimi, Yasutaka; Okada, Tomohisa; Yamamoto, Akira; Kanagaki, Mitsunori; Kido, Aki; Fujimoto, Koji; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan; [Sakashita, Naotaka] Toshiba Med Syst Corp, MRI Syst Dev Dept, Otawara, Tochigi, Japan	Kyoto University; Toshiba Corporation	Fushimi, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan.	yfushimi@kuhp.kyoto-u.ac.jp	Fushimi, Yasutaka/L-8922-2017; Okada, Tomohisa/C-5939-2008	Fushimi, Yasutaka/0000-0002-1982-3168; Kanagaki, Mitsunori/0000-0002-9447-018X; Okada, Tomohisa/0000-0003-2312-5677; Mehemed, Taha/0000-0003-2670-9993	JSPS KAKENHI Grant [25461815]; Toshiba Medical Systems Corporation, Japan [150100700014]; Grants-in-Aid for Scientific Research [25461815] Funding Source: KAKEN	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Toshiba Medical Systems Corporation, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 25461815 and a sponsored research program, "Researches for improvement of MR visualization (No. 150100700014)'' provided to one of the authors, Professor Kaori Togashi, by Toshiba Medical Systems Corporation, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKSNE JF, 1972, ARCH NEUROL-CHICAGO, V27, P371, DOI 10.1001/archneur.1972.00490170003002; Anzai Y, 2004, AM J NEURORADIOL, V25, P274; Bargallo N, 2005, AM J NEURORADIOL, V26, P2514; BHADELIA RA, 1995, RADIOLOGY, V196, P195, DOI 10.1148/radiology.196.1.7784567; Braga F, 2004, AM J NEURORADIOL, V25, P295; Braga FT, 2003, AM J NEURORADIOL, V24, P1863; Bulat M, 2011, BRAIN RES REV, V65, P99, DOI 10.1016/j.brainresrev.2010.08.002; Cohen Benjamin, 2009, Cerebrospinal Fluid Res, V6, P12, DOI 10.1186/1743-8454-6-12; Daners MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037502; Deliganis AV, 2001, RADIOLOGY, V218, P152, DOI 10.1148/radiology.218.1.r01ja43152; Filippi CG, 2001, AM J NEURORADIOL, V22, P394; Frigon C, 2004, RADIOLOGY, V233, P51, DOI 10.1148/radiol.2331031375; Fushimi Y, 2003, RADIOLOGY, V229, P360, DOI 10.1148/radiol.2292021507; Greitz D, 2004, NEUROSURG REV, V27, P145, DOI 10.1007/s10143-004-0326-9; Igarashi H, 2014, NEUROREPORT, V25, P39, DOI 10.1097/WNR.0000000000000042; Jones RA, 2002, MAGN RESON MED, V47, P728, DOI 10.1002/mrm.10127; Losert C, 2002, MAGN RESON MED, V48, P271, DOI 10.1002/mrm.10215; Moody DM, 2006, SEMIN CARDIOTHORAC V, V10, P128, DOI 10.1177/1089253206288992; O'Connor JPB, 2007, MAGN RESON MED, V58, P490, DOI 10.1002/mrm.21357; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Okada T, 2005, ACAD RADIOL, V12, P142, DOI 10.1016/j.acra.2004.11.012; Oreskovic D, 2010, BRAIN RES REV, V64, P241, DOI 10.1016/j.brainresrev.2010.04.006; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Stock KW, 1999, JMRI-J MAGN RESON IM, V9, P838, DOI 10.1002/(SICI)1522-2586(199906)9:6<838::AID-JMRI11>3.0.CO;2-H; Tadamura E, 1997, J MAGN RESON IMAGING, V7, P220, DOI 10.1002/jmri.1880070134; Taoka T, 2001, AM J ROENTGENOL, V176, P519, DOI 10.2214/ajr.176.2.1760519; Yamada S, 2008, RADIOLOGY, V249, P644, DOI 10.1148/radiol.2492071985; Yang DW, 1999, MAGN RESON IMAGING, V17, P171, DOI 10.1016/S0730-725X(98)00165-9; Yoshino N, 2003, RADIOLOGY, V228, P539, DOI 10.1148/radiol.2282020439; Zaharchuk G, 2005, MAGNET RESON MED, V54, P113, DOI 10.1002/mrm.20546; Zaharchuk G, 2006, ACAD RADIOL, V13, P1016, DOI 10.1016/j.acra.2006.04.016	31	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100723	10.1371/journal.pone.0100723	http://dx.doi.org/10.1371/journal.pone.0100723			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956198	Green Published, Green Submitted, gold			2022-12-25	WOS:000338917900087
J	Zhang, L; Lei, Y; Liu, X; Wang, X; Liu, Z; Li, D; Zheng, P; Zhang, LJ; Chen, SG; Xie, P				Zhang, Liang; Lei, Yang; Liu, Xia; Wang, Xiao; Liu, Zhao; Li, Dan; Zheng, Peng; Zhang, Lujun; Chen, Shigang; Xie, Peng			Glutamate and Lipid Metabolic Perturbation in the Hippocampi of Asymptomatic Borna Disease Virus-Infected Horses	PLOS ONE			English	Article							PSYCHIATRIC-PATIENTS; MOOD DISORDERS; RAT MODEL; ANTIBODIES; ANIMALS; NEUROPATHOLOGY; EPIDEMIOLOGY; CELLS; SERUM; RNA	Borna disease virus (BDV) is a neurotropic, enveloped, non-segmented, negative-stranded RNA virus that infects a wide variety of vertebrate species from birds to humans across a broad global geographic distribution. Animal symptomatology range from asymptomatic infection to behavioral abnormalities to acute meningoencephalitis. Asymptomatic BDV infection has been shown to be more frequent than conventionally estimated. However, the molecular mechanism(s) underyling asymptomatic BDV infection remain largely unknown. Here, based on real-time quantitative PCR and Western blotting, a total of 18 horse hippocampi were divided into BDV-infected (n = 8) and non-infected control (n = 10) groups. A gas chromatography coupled with mass spectrometry (GC-MS) metabolomic approach, in conjunction with multivariate statistical analysis, was used to characterize the hippocampal metabolic changes associated with asymptomatic BDV infection. Multivariate statistical analysis showed a significant discrimination between the BDV-infected and control groups. BDV-infected hippocampi were characterized by lower levels of D-myo-inositol-1-phosphate, glutamate, phosphoethanolamine, heptadecanoic acid, and linoleic acid in combination with a higher level of ammonia. These differential metabolites are primarily involved in glutamate and lipid metabolism. These finding provide an improved understanding of hippocampal changes associated with asymptomatic BDV infection.	[Zhang, Liang; Liu, Xia; Zheng, Peng; Xie, Peng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Zhang, Liang; Lei, Yang; Liu, Xia; Wang, Xiao; Liu, Zhao; Li, Dan; Zheng, Peng; Zhang, Lujun; Chen, Shigang; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China; [Zhang, Liang; Lei, Yang; Liu, Xia; Wang, Xiao; Liu, Zhao; Li, Dan; Zheng, Peng; Zhang, Lujun; Chen, Shigang; Xie, Peng] Chongqing Med Univ, Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Li, Dan] Chongqing Med Univ, Dept Pathol, Fac Basic Med, Chongqing, Peoples R China; [Lei, Yang] Chongqing Med Univ, Dept Neurol, Univ Town Hosp, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Xie, P (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China.	xiepeng@cqmu.edu.cn			National Basic Research Program of China (973 Program) [2009CB918300]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (973 Program) (Grant No. 2009CB918300) (http://www.973.gov.cn/Default_3.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahmani MK, 1996, VIRUS RES, V45, P1, DOI 10.1016/0168-1702(96)01355-X; Beaver BV, 2001, J AM VET MED ASSOC, V218, P669, DOI 10.2460/javma.2001.218.669; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Bilzer T, 1993, Arch Virol Suppl, V7, P153; Bode L, 2003, CLIN MICROBIOL REV, V16, P534, DOI 10.1128/CMR.16.3.534-545.2003; BODE L, 1995, NAT MED, V1, P232, DOI 10.1038/nm0395-232; Bode L, 1996, MOL PSYCHIATR, V1, P200; Bode L, 2001, MOL PSYCHIATR, V6, P481, DOI 10.1038/sj.mp.4000909; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; de la Torre JC, 2000, VIRUS TAXONOMY, V10, P531; Eisenman LM, 1999, J NEUROVIROL, V5, P181, DOI 10.3109/13550289909022000; GOSZTONYI G, 1995, CURR TOP MICROBIOL, V190, P39; GOSZTONYI G, 1984, ACTA NEUROPATHOL, V64, P213, DOI 10.1007/BF00688111; Gosztonyi G, 2001, CURR TOP MICROBIOL, V253, P121; Gosztonyi G, 2008, APMIS, V116, P53, DOI 10.1111/j.1600-0463.2008.000m8.x; Hagiwara K, 2001, VET MICROBIOL, V80, P383, DOI 10.1016/S0378-1135(01)00324-8; HERZOG S, 1994, WIEN TIERARZTL MONAT, V81, P374; Hornig M, 1999, P NATL ACAD SCI USA, V96, P12102, DOI 10.1073/pnas.96.21.12102; Huang RZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044665; Joest E, 1911, J NEUROL, V42, P293; KANOSUEOKA T, 1979, P NATL ACAD SCI USA, V76, P5741, DOI 10.1073/pnas.76.11.5741; Kinnunen PM, 2007, J CLIN VIROL, V38, P64, DOI 10.1016/j.jcv.2006.10.003; Kinnunen PM, 2013, J GEN VIROL, V94, P247, DOI 10.1099/vir.0.046961-0; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lei Y, 2014, METABOLOMICS, V10, P484, DOI 10.1007/s11306-013-0593-y; LUDWIG H, 1977, MED MICROBIOL IMMUN, V163, P215, DOI 10.1007/BF02125505; Ludwig H, 1985, Tierarztl Prax, V13, P421; Ludwig H, 2000, REV SCI TECH OIE, V19, P259, DOI 10.20506/rst.19.1.1217; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Munger J, 2006, PLOS PATHOG, V2, P1165, DOI 10.1371/journal.ppat.0020132; NAKAMURA Y, 1995, VACCINE, V13, P1076, DOI 10.1016/0264-410X(95)00050-B; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; PLANZ O, 1995, J VIROL, V69, P896, DOI 10.1128/JVI.69.2.896-903.1995; Priestnall SL, 2011, VET REC, V168, P380, DOI 10.1136/vr.c6405; Resources IoLA, 1996, GUIDE CARE USE LAB A; Richt JA, 2001, VET J, V161, P24, DOI 10.1053/tvjl.2000.0533; ROTT R, 1985, SCIENCE, V228, P755, DOI 10.1126/science.3922055; ROTT R, 1995, CURR TOP MICROBIOL, V190, P17; Sauder C, 1996, J VIROL, V70, P7713, DOI 10.1128/JVI.70.11.7713-7724.1996; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schindler AR, 2007, MOL CELL PROBE, V21, P47, DOI 10.1016/j.mcp.2006.08.001; Shao WH, 2013, METABOLOMICS, V9, P433, DOI 10.1007/s11306-012-0460-2; Siger M, 2009, ALZ DIS ASSOC DIS, V23, P57, DOI 10.1097/WAD.0b013e3181875434; Sitole LJ, 2013, MOL BIOSYST, V9, P18, DOI 10.1039/c2mb25318f; Sripadi P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012590; Thakur R, 2009, INDIAN J MED MICROBI, V27, P191, DOI 10.4103/0255-0857.53200; Zhang L, 2014, ARCH VIROL, V159, P1941, DOI 10.1007/s00705-013-1971-5; Zhou B, 2012, MOL BIOSYST, V8, P470, DOI 10.1039/c1mb05350g	49	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99752	10.1371/journal.pone.0099752	http://dx.doi.org/10.1371/journal.pone.0099752			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956478	gold, Green Submitted, Green Published			2022-12-25	WOS:000338917900018
J	Carazzolle, MF; de Carvalho, LM; Slepicka, HH; Vidal, RO; Pereira, GAG; Kobarg, J; Meirelles, GV				Carazzolle, Marcelo Falsarella; de Carvalho, Lucas Miguel; Slepicka, Hugo Henrique; Vidal, Ramon Oliveira; Guimaraes Pereira, Goncalo Amarante; Kobarg, Joerg; Meirelles, Gabriela Vaz			IIS - Integrated Interactome System: A Web-Based Platform for the Annotation, Analysis and Visualization of Protein-Metabolite-Gene-Drug Interactions by Integrating a Variety of Data Sources and Tools	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; KAPPA-B; NETWORK; IDENTIFICATION; KNOWLEDGEBASE; CYTOSCAPE; ONTOLOGY; ASSOCIATION; RESISTANCE	Background: High-throughput screening of physical, genetic and chemical-genetic interactions brings important perspectives in the Systems Biology field, as the analysis of these interactions provides new insights into protein/gene function, cellular metabolic variations and the validation of therapeutic targets and drug design. However, such analysis depends on a pipeline connecting different tools that can automatically integrate data from diverse sources and result in a more comprehensive dataset that can be properly interpreted. Results: We describe here the Integrated Interactome System (IIS), an integrative platform with a web-based interface for the annotation, analysis and visualization of the interaction profiles of proteins/genes, metabolites and drugs of interest. IIS works in four connected modules: (i) Submission module, which receives raw data derived from Sanger sequencing (e. g. two-hybrid system); (ii) Search module, which enables the user to search for the processed reads to be assembled into contigs/singlets, or for lists of proteins/genes, metabolites and drugs of interest, and add them to the project; (iii) Annotation module, which assigns annotations from several databases for the contigs/singlets or lists of proteins/genes, generating tables with automatic annotation that can be manually curated; and (iv) Interactome module, which maps the contigs/singlets or the uploaded lists to entries in our integrated database, building networks that gather novel identified interactions, protein and metabolite expression/concentration levels, subcellular localization and computed topological metrics, GO biological processes and KEGG pathways enrichment. This module generates a XGMML file that can be imported into Cytoscape or be visualized directly on the web. Conclusions: We have developed IIS by the integration of diverse databases following the need of appropriate tools for a systematic analysis of physical, genetic and chemical-genetic interactions. IIS was validated with yeast two-hybrid, proteomics and metabolomics datasets, but it is also extendable to other datasets. IIS is freely available online at: http://www.lge.ibi.unicamp.br/lnbio/IIS/.	[Carazzolle, Marcelo Falsarella; de Carvalho, Lucas Miguel; Kobarg, Joerg; Meirelles, Gabriela Vaz] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Sao Paulo, Brazil; [Carazzolle, Marcelo Falsarella; Vidal, Ramon Oliveira; Guimaraes Pereira, Goncalo Amarante] Univ Estadual Campinas, Inst Biol, Dept Genet & Evolucao, Lab Genom & Expressao, Sao Paulo, Brazil; [Slepicka, Hugo Henrique] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Luz Sincrotron, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Laboratorio Nacional de Luz Sincrotron (LNLS)	Meirelles, GV (corresponding author), Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Sao Paulo, Brazil.	gabriela.meirelles@lnbio.cnpem.br	de Carvalho, Lucas/GRY-7167-2022; Pereira, Gonçalo A. G./B-7944-2012; Carazzolle, Marcelo Falsarella/C-6503-2012; Kobarg, Jörg/T-4736-2019; UNICAMP, CCES -/J-7787-2015; Slepicka, Hugo/F-7844-2012; Meirelles, Gabriela Vaz/H-4151-2013	Carazzolle, Marcelo Falsarella/0000-0002-5474-2830; Kobarg, Jörg/0000-0002-9419-0145; Slepicka, Hugo/0000-0002-8378-3017; Meirelles, Gabriela Vaz/0000-0003-4371-0419	Fundacao de Amparo a Pesquisa do Estado Sao Paulo (FAPESP); Conselho Nacional de Pesquisa e Desenvolvimento (CNPq); Brazilian Biosciences National Laboratory (LNBio); Center for Computational Engineering and Sciences at UNICAMP/Brazil (FAPESP/CEPID project) [2013/08293-7]	Fundacao de Amparo a Pesquisa do Estado Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Biosciences National Laboratory (LNBio); Center for Computational Engineering and Sciences at UNICAMP/Brazil (FAPESP/CEPID project)	This work was supported by Fundacao de Amparo a Pesquisa do Estado Sao Paulo (FAPESP), Conselho Nacional de Pesquisa e Desenvolvimento (CNPq), Brazilian Biosciences National Laboratory (LNBio) and Center for Computational Engineering and Sciences at UNICAMP/Brazil (FAPESP/CEPID project #2013/08293-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barsky A, 2007, BIOINFORMATICS, V23, P1040, DOI 10.1093/bioinformatics/btm057; Baudet C, 2006, GENET MOL RES, V5, P169; Berger SI, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-372; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brandao MM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-454; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Chen Jin, 2006, Genome Inform, V17, P284; Chen J, 2006, BIOINFORMATICS, V22, P1998, DOI 10.1093/bioinformatics/btl335; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; De Bodt S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-288; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fong MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019963; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Gerstein M, 2002, SCIENCE, V295, P284, DOI 10.1126/science.1068664; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Guo AC, 2013, NUCLEIC ACIDS RES, V41, pD625, DOI 10.1093/nar/gks992; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Jewison T, 2012, NUCLEIC ACIDS RES, V40, pD815, DOI 10.1093/nar/gkr916; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kang HG, 2008, PLANT SIGNAL BEHAV, V3, P689, DOI 10.4161/psb.3.9.5822; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kormish JD, 2010, DEV DYNAM, V239, P56, DOI 10.1002/dvdy.22046; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lin MZ, 2009, PLANT PHYSIOL, V151, P34, DOI 10.1104/pp.109.141317; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Liu GM, 2009, BIOINFORMATICS, V25, P1891, DOI 10.1093/bioinformatics/btp311; Liu H, 2005, CYTOKINE, V31, P251, DOI 10.1016/j.cyto.2004.12.008; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Lupetti A, 2002, TRENDS MOL MED, V8, P76, DOI 10.1016/S1471-4914(02)02280-3; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Meirelles Gabriela Vaz, 2014, World J Biol Chem, V5, P141, DOI 10.4331/wjbc.v5.i2.141; Meirelles GV, 2010, J PROTEOME RES, V9, P6298, DOI 10.1021/pr100562w; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Pellet Johann, 2009, BMC Res Notes, V2, P220, DOI 10.1186/1756-0500-2-220; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Talebnia F, 2006, J BIOTECHNOL, V125, P377, DOI 10.1016/j.jbiotec.2006.03.013; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Westman JO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049335; Westman JO, 2012, INT J MOL SCI, V13, P11881, DOI 10.3390/ijms130911881; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797	61	35	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100385	10.1371/journal.pone.0100385	http://dx.doi.org/10.1371/journal.pone.0100385			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949626	gold, Green Published, Green Submitted			2022-12-25	WOS:000338276300072
J	Feilotter, HE; Michel, C; Uy, P; Bathurst, L; Davey, S				Feilotter, Harriet E.; Michel, Claire; Uy, Paolo; Bathurst, Lauren; Davey, Scott			BRCA1 Haploinsufficiency Leads to Altered Expression of Genes Involved in Cellular Proliferation and Development	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; INACTIVE X-CHROMOSOME; INDUCED DNA-DAMAGE; BREAST-CANCER SUSCEPTIBILITY; POLYMERASE-II HOLOENZYME; IONIZING-RADIATION; UBIQUITIN LIGASE; TRANSCRIPTIONAL ACTIVATION; MUTATION CARRIERS; OVARIAN-TUMORS	The assessment of BRCA1 and BRCA2 coding sequences to identify pathogenic mutations associated with inherited breast/ovarian cancer syndrome has provided a method to identify high-risk individuals, allowing them to seek preventative treatments and strategies. However, the current test is expensive, and cannot differentiate between pathogenic variants and those that may be benign. Focusing only on one of the two BRCA partners, we have developed a biological assay for haploinsufficiency of BRCA1. Using a series of EBV-transformed cell lines, we explored gene expression patterns in cells that were BRCA1 wildtype compared to those that carried (heterozygous) BRCA1 pathogenic mutations. We identified a subset of 43 genes whose combined expression pattern is a sensitive predictor of BRCA1 status. The gene set was disproportionately made up of genes involved in cellular differentiation, lending credence to the hypothesis that single copy loss of BRCA1 function may impact differentiation, rendering cells more susceptible to undergoing malignant processes.	[Feilotter, Harriet E.; Michel, Claire; Uy, Paolo; Bathurst, Lauren; Davey, Scott] Queens Univ, Dept Pathol, Kingston, ON K7L 3N6, Canada; [Feilotter, Harriet E.; Michel, Claire; Uy, Paolo; Bathurst, Lauren; Davey, Scott] Queens Univ, Dept Mol Med, Kingston, ON, Canada; [Davey, Scott] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Davey, Scott] Queens Univ, Dept Oncol, Kingston, ON, Canada; [Feilotter, Harriet E.] Queens Univ, Canc Res Inst, Kingston, ON, Canada; [Michel, Claire; Uy, Paolo; Bathurst, Lauren; Davey, Scott] Queens Univ, Div Canc Biol & Genet, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada; Queens University - Canada; Queens University - Canada; Queens University - Canada	Davey, S (corresponding author), Queens Univ, Dept Pathol, Kingston, ON K7L 3N6, Canada.	sd13@queensu.ca			Canadian Breast Cancer Foundation (Ontario Chapter); Kingston General Hospital Department of Pathology Clinical Trust Fund	Canadian Breast Cancer Foundation (Ontario Chapter); Kingston General Hospital Department of Pathology Clinical Trust Fund	This work was supported by operating funds from the Canadian Breast Cancer Foundation (Ontario Chapter) and the Kingston General Hospital Department of Pathology Clinical Trust Fund to SD and HF, and by infrastructure support through the Canada Foundation for Innovation Leaders Opportunity Fund, and the Ontario Research Fund (SD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; Andrulis IL, 2002, HUM MUTAT, V20, P65, DOI 10.1002/humu.10097; Bellacosa A, 2010, CANCER PREV RES, V3, P48, DOI 10.1158/1940-6207.CAPR-09-0078; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Brody LC, 1998, MEDICINE, V77, P208, DOI 10.1097/00005792-199805000-00006; Burga LN, 2009, CANCER RES, V69, P1273, DOI 10.1158/0008-5472.CAN-08-2954; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chang SW, 2009, J CLIN INVEST, V119, P3160, DOI 10.1172/JCI39836; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Chen A, 2002, J BIOL CHEM, V277, P22085, DOI 10.1074/jbc.M201252200; CORNELIS RS, 1995, GENE CHROMOSOME CANC, V13, P203, DOI 10.1002/gcc.2870130310; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Fabbro M, 2004, J BIOL CHEM, V279, P31251, DOI 10.1074/jbc.M405372200; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; Furuta S, 2005, P NATL ACAD SCI USA, V102, P9176, DOI 10.1073/pnas.0503793102; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Ganesan S, 2002, CELL, V111, P393, DOI 10.1016/S0092-8674(02)01052-8; Ganesan S, 2004, PHILOS T R SOC B, V359, P123, DOI 10.1098/rstb.2003.1371; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Jen KY, 2003, GENOME RES, V13, P2092, DOI 10.1101/gr.1240103; King TA, 2007, ANN SURG ONCOL, V14, P2510, DOI 10.1245/s10434-007-9372-1; Kote-Jarai Z, 2004, CLIN CANCER RES, V10, P958, DOI 10.1158/1078-0432.CCR-1067-3; Kote-Jarai Z, 2006, CLIN CANCER RES, V12, P3896, DOI 10.1158/1078-0432.CCR-05-2805; Kubista M, 2002, ONCOGENE, V21, P4747, DOI 10.1038/sj.onc.1205580; Lee MS, 2010, CANCER RES, V70, P4880, DOI 10.1158/0008-5472.CAN-09-4563; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Mak TW, 2000, NAT IMMUNOL, V1, P77, DOI 10.1038/76950; MERAJVER SD, 1995, NAT GENET, V9, P439, DOI 10.1038/ng0495-439; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Morris JR, 2006, HUM MOL GENET, V15, P599, DOI 10.1093/hmg/ddi476; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Moynahan ME, 2001, CANCER RES, V61, P4842; NEUHAUSEN SL, 1994, CANCER RES, V54, P6069; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Rieger KE, 2004, NUCLEIC ACIDS RES, V32, P4786, DOI 10.1093/nar/gkh783; Salmon AY, 2013, CANCER PREV RES, V6, P82, DOI 10.1158/1940-6207.CAPR-12-0105; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Silver DP, 2007, CELL, V128, P991, DOI 10.1016/j.cell.2007.02.025; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; Sorlie T, 1998, BREAST CANCER RES TR, V48, P259, DOI 10.1023/A:1005953519972; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Turner JMA, 2004, CURR BIOL, V14, P2135, DOI 10.1016/j.cub.2004.11.032; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vallon-Christersson J, 2001, HUM MOL GENET, V10, P353, DOI 10.1093/hmg/10.4.353; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Xu B, 2002, CANCER RES, V62, P4588; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371	59	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100068	10.1371/journal.pone.0100068	http://dx.doi.org/10.1371/journal.pone.0100068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950059	Green Published, Green Submitted, gold			2022-12-25	WOS:000338276300036
J	Munir, A; Shahzad, A; Khan, M				Munir, Asif; Shahzad, Azeem; Khan, Masood			Forced Convective Heat Transfer in Boundary Layer Flow of Sisko Fluid over a Nonlinear Stretching Sheet	PLOS ONE			English	Article							POWER-LAW FLUID; SURFACE	The major focus of this article is to analyze the forced convective heat transfer in a steady boundary layer flow of Sisko fluid over a nonlinear stretching sheet. Two cases are studied, namely (i) the sheet with variable temperature (PST case) and (ii) the sheet with variable heat flux (PHF case). The heat transfer aspects are investigated for both integer and non-integer values of the power-law index. The governing partial differential equations are reduced to a system of nonlinear ordinary differential equations using appropriate similarity variables and solved numerically. The numerical results are obtained by the shooting method using adaptive Runge Kutta method with Broyden's method in the domain 0,infinity). The numerical results for the temperature field are found to be strongly dependent upon the power-law index, stretching parameter, wall temperature parameter, material parameter of the Sisko fluid and Prandtl number. In addition, the local Nusselt number versus wall temperature parameter is also graphed and tabulated for different values of pertaining parameters. Further, numerical results are validated by comparison with exact solutions as well as previously published results in the literature.	[Munir, Asif; Khan, Masood] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Shahzad, Azeem] UET, Dept Basic Sci, Taxila, Pakistan	Quaid I Azam University	Munir, A (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad, Pakistan.	asifmunir1000@yahoo.com	KHAN, Masood/AAA-7384-2020; khan, Masood/F-7143-2015; Shahzad, Azeem/P-9740-2019	KHAN, Masood/0000-0003-4404-1456; 	Higher education Commission of Pakistan	Higher education Commission of Pakistan(Higher Education Commission of Pakistan)	Sincere thanks are due to Higher education Commission of Pakistan for granting scholarship in Indigenous Ph.D. Fellowship Program to carry out Ph.D. studies. Moreover, the authors would like to thank the reviewer for his careful assessment and fruitful suggestions.	Abel MS, 2009, INT J HEAT MASS TRAN, V52, P2902, DOI 10.1016/j.ijheatmasstransfer.2008.08.042; Alinejad J, 2012, J APPL MATH, DOI 10.1155/2012/587834; Barnes H.A., 1989, INTRO RHEOLOGY; Berk Z, 2008, FOOD PROCESSING ENG; Chen CH, 2008, INT J THERM SCI, V47, P954, DOI 10.1016/j.ijthermalsci.2007.06.003; Chhabra R. P., 2006, BUBBLES DROPS PARTIC; Chhabra RP, 2008, NON-NEWTONIAN FLOW AND APPLIED RHEOLOGY: ENGINEERING APPLICATIONS, 2ND EDITION, P1; Cortell R, 2007, APPL MATH COMPUT, V184, P864, DOI 10.1016/j.amc.2006.06.077; Cortell RB, 2008, J MATER PROCESS TECH, V203, P176; Dandapat BS, 2004, ARCH MECH, V56, P87; Deshpande AP, 2010, RHEOLOGY OF COMPLEX FLUIDS, P87, DOI 10.1007/978-1-4419-6494-6_4; Hassanien IA, 1998, MATH COMPUT MODEL, V28, P105, DOI 10.1016/S0895-7177(98)00148-4; Howell TG, 1997, INT J HEAT MASS TRAN, V40, P1853, DOI 10.1016/S0017-9310(96)00247-5; JADHAV BP, 1990, WARME STOFFUBERTRAG, V25, P377, DOI 10.1007/BF01811562; Khan M, 2010, INT J HEAT MASS TRAN, V53, P1290, DOI 10.1016/j.ijheatmasstransfer.2009.12.037; Khan M, 2013, QUAEST MATH, V36, P137, DOI 10.2989/16073606.2013.779971; Khan M, 2012, INT J NONLIN MECH, V47, P999, DOI 10.1016/j.ijnonlinmec.2012.06.003; Magyari E, 1999, J PHYS D APPL PHYS, V32, P577, DOI 10.1088/0022-3727/32/5/012; SAKIADIS BC, 1961, AICHE J, V7, P26, DOI 10.1002/aic.690070108; SCHOWALTER WR, 1960, AICHE J, V6, P24, DOI 10.1002/aic.690060105; Shahzad A, 2012, CHINESE PHYS LETT, V29, DOI 10.1088/0256-307X/29/8/084705; SISKO AW, 1958, IND ENG CHEM, V50, P1789, DOI 10.1021/ie50588a042; Tadmor Z, 2006, PRINCIPLES POLYM PRO, P184; Xu, 2005, THESIS OHIO STATE U; Young I C, 2011, ADV HEAT TRANSFER, V43	25	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100056	10.1371/journal.pone.0100056	http://dx.doi.org/10.1371/journal.pone.0100056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949738	Green Submitted, Green Published, gold			2022-12-25	WOS:000338276300033
J	Zhang, J; Hsieh, JH; Zhu, H				Zhang, Jun; Hsieh, Jui-Hua; Zhu, Hao			Profiling Animal Toxicants by Automatically Mining Public Bioassay Data: A Big Data Approach for Computational Toxicology	PLOS ONE			English	Article							PUBCHEM; MANAGEMENT; CHEMICALS; TOXICITY; ASSAYS	In vitro bioassays have been developed and are currently being evaluated as potential alternatives to traditional animal toxicity models. Already, the progress of high throughput screening techniques has resulted in an enormous amount of publicly available bioassay data having been generated for a large collection of compounds. When a compound is tested using a collection of various bioassays, all the testing results can be considered as providing a unique bio-profile for this compound, which records the responses induced when the compound interacts with different cellular systems or biological targets. Profiling compounds of environmental or pharmaceutical interest using useful toxicity bioassay data is a promising method to study complex animal toxicity. In this study, we developed an automatic virtual profiling tool to evaluate potential animal toxicants. First, we automatically acquired all PubChem bioassay data for a set of 4,841 compounds with publicly available rat acute toxicity results. Next, we developed a scoring system to evaluate the relevance between these extracted bioassays and animal acute toxicity. Finally, the top ranked bioassays were selected to profile the compounds of interest. The resulting response profiles proved to be useful to prioritize untested compounds for their animal toxicity potentials and form a potential in vitro toxicity testing panel. The protocol developed in this study could be combined with structure-activity approaches and used to explore additional publicly available bioassay datasets for modeling a broader range of animal toxicities.	[Zhang, Jun; Zhu, Hao] Rutgers State Univ, Dept Chem, Camden, NJ 08102 USA; [Zhang, Jun; Zhu, Hao] Rutgers Ctr Computat & Integrat Biol, Camden, NJ USA; [Hsieh, Jui-Hua] Natl Inst Environm Hlth Sci, Div Natl Toxicol Program, Biomol Screening Branch, Res Triangle Pk, NC USA	Rutgers State University Camden; Rutgers State University New Brunswick; Rutgers State University Camden; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Zhu, H (corresponding author), Rutgers State Univ, Dept Chem, Camden, NJ 08102 USA.	hao.zhu99@rutgers.edu	zh, H/HIK-0903-2022	Zhu, Hao/0000-0002-3559-6129	National Institute of Environmental Health Sciences of the National Institutes of Health [R15ES023148]; Colgate-Palmolive Grant for Alternative Research; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R15ES023148] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Colgate-Palmolive Grant for Alternative Research; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in part, by the National Institute of Environmental Health Sciences of the National Institutes of Health under Award Number [R15ES023148] and the Colgate-Palmolive Grant for Alternative Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. https://www.niehs.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betts KS, 2013, ENVIRON HEALTH PERSP, V121, pA228, DOI 10.1289/ehp.121-a228; Butkiewicz M, 2013, MOLECULES, V18, P735, DOI 10.3390/molecules18010735; Chen B, 2010, J MOL GRAPH MODEL, V28, P420, DOI 10.1016/j.jmgm.2009.10.001; Clothier R, 2008, ATLA-ALTERN LAB ANIM, V36, P503, DOI 10.1177/026119290803600509; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Greenwood PE, 1996, GUIDE CHI SQUARE TES, V280; Han LY, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-401; Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392; Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939; Kinsner-Ovaskainen A, 2009, TOXICOL IN VITRO, V23, P476, DOI 10.1016/j.tiv.2008.12.019; Liao Q, 2009, J CHEM INF MODEL, V49, P2718, DOI 10.1021/ci900337f; Martin MT, 2009, TOXICOL SCI, V110, P181, DOI 10.1093/toxsci/kfp080; Rohrer SG, 2009, J CHEM INF MODEL, V49, P169, DOI 10.1021/ci8002649; Schadt EE, 2011, NAT REV GENET, V12, DOI 10.1038/nrg2857-c2; Schadt EE, 2010, NAT REV GENET, V11, P647, DOI 10.1038/nrg2857; Schierz AC, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-21; Sedykh A, 2011, ENVIRON HEALTH PERSP, V119, P364, DOI 10.1289/ehp.1002476; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Sipes NS, 2013, CHEM RES TOXICOL, V26, P878, DOI 10.1021/tx400021f; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Walum E, 1998, ENVIRON HEALTH PERSP, V106, P497, DOI 10.2307/3433801; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Wang YP, 2012, NUCLEIC ACIDS RES, V40, DOI [10.1093/nar/gkr1293, 10.1093/nar/gkr1132]; Weis DC, 2008, J MOL GRAPH MODEL, V27, P466, DOI 10.1016/j.jmgm.2008.08.004; WOOSLEY RL, 1993, JAMA-J AM MED ASSOC, V269, P1532, DOI 10.1001/jama.269.12.1532; Xia M, 2008, ENVIRON HEALTH PERSP, V116, P284, DOI 10.1289/ehp.10727; Xie XQS, 2010, EXPERT OPIN DRUG DIS, V5, P1205, DOI 10.1517/17460441.2010.524924; Zhu H, 2009, ENVIRON HEALTH PERSP, V117, P1257, DOI 10.1289/ehp.0800471	28	28	28	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99863	10.1371/journal.pone.0099863	http://dx.doi.org/10.1371/journal.pone.0099863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950175	Green Published, gold, Green Submitted			2022-12-25	WOS:000338276300021
J	Thiagarajah, JR; Yildiz, H; Carlson, T; Thomas, AR; Steiger, C; Pieretti, A; Zukerberg, LR; Carrier, RL; Goldstein, AM				Thiagarajah, Jay R.; Yildiz, Hasan; Carlson, Taylor; Thomas, Alyssa R.; Steiger, Casey; Pieretti, Alberto; Zukerberg, Lawrence R.; Carrier, Rebecca L.; Goldstein, Allan M.			Altered Goblet Cell Differentiation and Surface Mucus Properties in Hirschsprung Disease	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; PATHO-PHYSIOLOGY; MOUSE; ENTEROCOLITIS; SECRETION; TRANSPORT; MATH1; ACETYLCHOLINE; AGANGLIONOSIS; INTESTINE	Hirschsprung disease-associated enterocolitis (HAEC) leads to significant mortality and morbidity, but its pathogenesis remains unknown. Changes in the colonic epithelium related to goblet cells and the luminal mucus layer have been postulated to play a key role. Here we show that the colonic epithelium of both aganglionic and ganglionic segments are altered in patients and in mice with Hirschsprung disease (HSCR). Structurally, goblet cells were altered with increased goblet cell number and reduced intracellular mucins in the distal colon of biopsies from patients with HSCR. Endothelin receptor B (Ednrb) mutant mice showed increased goblet cell number and size and increased cell proliferation compared to wild-type mice in aganglionic segments, and reduced goblet cell size and number in ganglionic segments. Functionally, compared to littermates, Ednrb(-/-) mice showed increased transepithelial resistance, reduced stool water content and similar chloride secretion in the distal colon. Transcript levels of goblet cell differentiation factors SPDEF and Math1 were increased in the distal colon of Ednrb(-/-) mice. Both distal colon from Ednrb mice and biopsies from HSCR patients showed reduced Muc4 expression as compared to controls, but similar expression of Muc2. Particle tracking studies showed that mucus from Ednrb(-/-) mice provided a more significant barrier to diffusion of 200 nm nanoparticles as compared to wildtype mice. These results suggest that aganglionosis is associated with increased goblet cell proliferation and differentiation and subsequent altered surface mucus properties, prior to the development of inflammation in the distal colon epithelium. Restoration of normal goblet cell function and mucus layer properties in the colonic epithelium may represent a therapeutic strategy for prevention of HAEC.	[Thiagarajah, Jay R.] Boston Childrens Hosp, Dept Gastroenterol & Nutr, Boston, MA USA; [Yildiz, Hasan; Carlson, Taylor; Carrier, Rebecca L.] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA; [Thomas, Alyssa R.; Steiger, Casey; Pieretti, Alberto; Goldstein, Allan M.] Massachusetts Gen Hosp, Dept Pediat Surg, Boston, MA 02114 USA; [Zukerberg, Lawrence R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Northeastern University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Goldstein, AM (corresponding author), Massachusetts Gen Hosp, Dept Pediat Surg, Boston, MA 02114 USA.	agoldstein@partners.org	yıldız, hasan/GSN-9276-2022; Carrier, Rebecca/AAK-2315-2020	Pieretti, Alberto/0000-0003-4268-4597	NIH [5R21EB015750]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB015750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grant NIH 5R21EB015750 (RC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam A, 1997, J PEDIATR SURG, V32, P1206, DOI 10.1016/S0022-3468(97)90683-7; Aslam A, 1998, J PEDIATR SURG, V33, P103, DOI 10.1016/S0022-3468(98)90372-4; Aslam A, 1999, J PEDIATR SURG, V34, P330, DOI 10.1016/S0022-3468(99)90202-6; Aslam A., 1997, Biochemical Society Transactions, V25, p8S; Austin KM, 2012, SEMIN PEDIATR SURG, V21, P319, DOI 10.1053/j.sempedsurg.2012.07.006; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; Cheng Z, 2010, J PEDIATR SURG, V45, P475, DOI 10.1016/j.jpedsurg.2009.06.009; FUJIMOTO T, 1988, J PEDIATR SURG, V23, P237, DOI 10.1016/S0022-3468(88)80730-9; Gersemann M, 2009, DIFFERENTIATION, V77, P84, DOI 10.1016/j.diff.2008.09.008; Gregorieff A, 2009, GASTROENTEROLOGY, V137, P1333, DOI 10.1053/j.gastro.2009.06.044; HARDY SP, 1993, GUT, V34, P1405, DOI 10.1136/gut.34.10.1405; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; HEATH AL, 1985, J PEDIATR SURG, V20, P34, DOI 10.1016/S0022-3468(85)80388-2; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; JODAL M, 1993, GASTROENTEROLOGY, V105, P1286, DOI 10.1016/0016-5085(93)90130-5; Johansson MEV, 2013, DIGEST DIS, V31, P305, DOI 10.1159/000354683; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Johansson ME, 2013, GUT; Kenny SE, 2010, SEMIN PEDIATR SURG, V19, P194, DOI 10.1053/j.sempedsurg.2010.03.004; Koch S, 2011, GASTROENTEROLOGY, V141, P259, DOI 10.1053/j.gastro.2011.03.043; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Lundgren O, 2000, SCIENCE, V287, P491, DOI 10.1126/science.287.5452.491; Mattar AF, 2003, J PEDIATR SURG, V38, P417, DOI 10.1053/jpsu.2003.50071; McConnell BB, 2011, GASTROENTEROLOGY, V140, P540, DOI 10.1053/j.gastro.2010.10.061; Moore SW, 2008, J PEDIATR SURG, V43, P1439, DOI 10.1016/j.jpedsurg.2007.12.057; Moore SW, 2012, SEMIN PEDIATR SURG, V21, P302, DOI 10.1053/j.sempedsurg.2012.07.004; Neumann H, 2012, INFLAMM BOWEL DIS, V18, P2261, DOI 10.1002/ibd.22907; Noah TK, 2010, EXP CELL RES, V316, P452, DOI 10.1016/j.yexcr.2009.09.020; Oue T, 2000, PEDIATR SURG INT, V16, P267, DOI 10.1007/s003830050742; Park KS, 2007, J CLIN INVEST, V117, P978, DOI 10.1172/JCI29176; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Schmitz-Moormann P, 1985, Pathol Annu, V20 Pt 1, P281; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Soret R, 2013, NEUROGASTROENT MOTIL, V25, pE755, DOI 10.1111/nmo.12200; Suh JH, 2004, BIOTECHNOL PROGR, V20, P598, DOI 10.1021/bp034251y; TEITELBAUM DH, 1989, J PEDIATR SURG, V24, P1271, DOI 10.1016/S0022-3468(89)80566-4; Thiagarajah JR, 2007, GUT, V56, P1529, DOI 10.1136/gut.2006.104620; Ward NL, 2012, NEUROGASTROENT MOTIL, V24, P874, DOI 10.1111/j.1365-2982.2012.01937.x; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zhang YQ, 2012, LAB INVEST, V92, P437, DOI 10.1038/labinvest.2011.192	42	37	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99944	10.1371/journal.pone.0099944	http://dx.doi.org/10.1371/journal.pone.0099944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945437	Green Published, Green Submitted, gold			2022-12-25	WOS:000340721500034
J	Yan, J; Ginsberg, SD; Powers, B; Alldred, MJ; Saltzman, A; Strupp, BJ; Caudill, MA				Yan, Jian; Ginsberg, Stephen D.; Powers, Brian; Alldred, Melissa J.; Saltzman, Arthur; Strupp, Barbara J.; Caudill, Marie A.			Maternal choline supplementation programs greater activity of the phosphatidylethanolamine N-methyltransferase (PEMT) pathway in adult Ts65Dn trisomic mice	FASEB JOURNAL			English	Article						Alzheimer's disease; docosahexaenoic acid; Down syndrome; fetal programming; phosphatidylcholine	DOWN-SYNDROME; MOUSE MODEL; ALZHEIMERS-DISEASE; BASAL FOREBRAIN; DOCOSAHEXAENOIC ACID; SPATIAL MEMORY; ABNORMALITIES; DEMENTIA; ALTERS; METABOLISM	Maternal choline supplementation (MCS) induces lifelong cognitive benefits in the Ts65Dn mouse, a trisomic mouse model of Down syndrome and Alzheimer's disease. To gain insight into the mechanisms underlying these beneficial effects, we conducted a study to test the hypothesis that MCS alters choline metabolism in adult Ts65Dn offspring. Deuterium-labeled methyl-d9-choline was administered to adult Ts65Dn and disomic (2N) female littermates born to choline-unsupplemented or choline-supplemented Ts65Dn dams. Enrichment of d9-choline metabolites (derived from intact choline) and d3 + d6-choline metabolites [produced when cholinederived methyl groups are used by phosphatidylethanolamine N-methyltransferase (PEMT)] was measured in harvested tissues. Adult offspring (both Ts65Dn and 2N) of choline-supplemented (vs. choline-unsupplemented) dams exhibited 60% greater (P <= 0.007) activity of hepatic PEMT, which functions in de novo choline synthesis and produces phosphatidylcholine (PC) enriched in docosahexaenoic acid. Higher (P<0.001) enrichment of PEMT-derived d3 and d6 metabolites was detected in liver, plasma, and brain in both genotypes but to a greater extent in the Ts65Dn adult offspring. MCS also yielded higher (P<0.05) d9 metabolite enrichments in liver, plasma, and brain. These data demonstrate that MCS exerts lasting effects on offspring choline metabolism, including up-regulation of the hepatic PEMT pathway and enhanced provision of choline and PEMT-PC to the brain.	[Yan, Jian; Powers, Brian; Strupp, Barbara J.; Caudill, Marie A.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Ginsberg, Stephen D.; Alldred, Melissa J.; Saltzman, Arthur] Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY USA; [Ginsberg, Stephen D.; Alldred, Melissa J.] NYU, Langone Med Ctr, Dept Psychiat, New York, NY USA; [Ginsberg, Stephen D.; Alldred, Melissa J.] NYU, Langone Med Ctr, Dept Physiol & Neurosci, New York, NY USA	Cornell University; Nathan Kline Institute for Psychiatric Research; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Caudill, MA (corresponding author), Cornell Univ, Div Nutr Sci, 228 Savage Hall, Ithaca, NY 14853 USA.	mac379@cornell.edu	, SDG/AAB-3329-2022	Ginsberg, Stephen/0000-0002-1797-4288	U.S. National Institutes of Health [HD057564, AG043375, AG017617, AG014449]; Alzheimer's Association [IIRG-12-237253]; NATIONAL INSTITUTE ON AGING [R01AG043375, P01AG017617, P01AG014449] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the U.S. National Institutes of Health (HD057564, AG043375, AG017617, and AG014449) and the Alzheimer's Association (IIRG-12-237253). The funding sources had no role in the study design, interpretation of the data, and/or publication of the results. The authors thank Olga Malysheva for expert technical assistance.	Alldred MJ, 2012, NEUROBIOL DIS, V45, P751, DOI 10.1016/j.nbd.2011.10.022; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Belichenko NP, 2009, J NEUROSCI, V29, P5938, DOI 10.1523/JNEUROSCI.1547-09.2009; Blusztajn JK, 2013, CLIN CHEM LAB MED, V51, P591, DOI 10.1515/cclm-2012-0635; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Chew TW, 2011, J NUTR, V141, P1475, DOI 10.3945/jn.111.138859; CHUNG SY, 1995, J NUTR, V125, P1484; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Duchon A, 2011, MAMM GENOME, V22, P674, DOI 10.1007/s00335-011-9356-0; Eilander A, 2007, PROSTAG LEUKOTR ESS, V76, P189, DOI 10.1016/j.plefa.2007.01.003; ESCORIHUELA RM, 1995, NEUROSCI LETT, V199, P143, DOI 10.1016/0304-3940(95)12052-6; Ferrier D. R., 2013, LIPPINCOTTS ILLUSTRA, P322; GINSBERG SD, 1995, J NEUROCHEM, V65, P2800; Ginsberg SD, 2011, BRAIN STRUCT FUNCT, V216, P347, DOI 10.1007/s00429-011-0315-z; Granholm AC, 2003, HIPPOCAMPUS, V13, P905, DOI 10.1002/hipo.10130; Granholm ACE, 2000, EXP NEUROL, V161, P647, DOI 10.1006/exnr.1999.7289; HELLERSTEIN MK, 1992, AM J PHYSIOL, V263, pE988; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Hyde LA, 2001, BEHAV NEUROSCI, V115, P1239, DOI 10.1037//0735-7044.115.6.1239; Insausti AM, 1998, NEUROSCI LETT, V253, P175, DOI 10.1016/S0304-3940(98)00641-7; Jacobs PA, 1995, ADV GENET, V33, P101, DOI 10.1016/S0065-2660(08)60332-6; Kelley CM, 2014, J COMP NEUROL, V522, P1390, DOI 10.1002/cne.23492; Kelley CM, 2014, BRAIN PATHOL, V24, P33, DOI 10.1111/bpa.12073; Koc H, 2002, ANAL CHEM, V74, P4734, DOI 10.1021/ac025624x; Kurt MA, 2000, BRAIN RES, V858, P191, DOI 10.1016/S0006-8993(00)01984-3; Leverenz JB, 1998, EXP NEUROL, V150, P296, DOI 10.1006/exnr.1997.6777; Li ZY, 2007, J BIOL CHEM, V282, P10283, DOI 10.1074/jbc.M611726200; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Lorenzi H, 2010, BIOTECHNIQUES, V48, P35, DOI 10.2144/000113342; MANN DMA, 1986, NEUROPATH APPL NEURO, V12, P447, DOI 10.1111/j.1365-2990.1986.tb00053.x; Meck WH, 2008, FRONT INTEGR NEUROSC, V1, DOI 10.3389/neuro.07.007.2007; MECK WH, 1988, DEV PSYCHOBIOL, V21, P339, DOI 10.1002/dev.420210405; MECK WH, 1989, BEHAV NEUROSCI, V103, P1234, DOI 10.1037/0735-7044.103.6.1234; Meck WH, 1999, DEV BRAIN RES, V118, P51, DOI 10.1016/S0165-3806(99)00105-4; Meck WH, 2003, NEUROSCI BIOBEHAV R, V27, P385, DOI 10.1016/S0149-7634(03)00069-1; Moon J, 2010, BEHAV NEUROSCI, V124, P346, DOI 10.1037/a0019590; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Pynn CJ, 2011, J LIPID RES, V52, P399, DOI 10.1194/jlr.d011916; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; ROSSOR MN, 1984, BRIT MED J, V288, P961, DOI 10.1136/bmj.288.6422.961; Scheltens P, 2012, J ALZHEIMERS DIS, V31, P225, DOI 10.3233/JAD-2012-121189; Sheehan R, 2014, CURR OPIN PSYCHIATR, V27, P143, DOI 10.1097/YCO.0000000000000032; Thomas JD, 2010, BIRTH DEFECTS RES A, V88, P827, DOI 10.1002/bdra.20713; Velazquez R, 2013, NEUROBIOL DIS, V58, P92, DOI 10.1016/j.nbd.2013.04.016; Visootsak Jeannie, 2007, Curr Psychiatry Rep, V9, P135; Watkins SM, 2003, J NUTR, V133, P3386, DOI 10.1093/jn/133.11.3386; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; Wong-Goodrich SJE, 2011, HIPPOCAMPUS, V21, P584, DOI 10.1002/hipo.20783; Wurtman RJ, 2008, METABOLISM, V57, pS6, DOI 10.1016/j.metabol.2008.07.007; Wurtman RJ, 2009, ANNU REV NUTR, V29, P59, DOI 10.1146/annurev-nutr-080508-141059; Yan J, 2013, AM J CLIN NUTR, V98, P1459, DOI 10.3945/ajcn.113.066092; Yan JA, 2011, AM J CLIN NUTR, V93, P348, DOI 10.3945/ajcn.110.005975; Yang YL, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0006.2000	54	11	11	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4312	4323		10.1096/fj.14-251736	http://dx.doi.org/10.1096/fj.14-251736			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	24963152	Green Published			2022-12-25	WOS:000342222700011
J	Sachelaru, I; Petriman, NA; Kudva, R; Koch, HG				Sachelaru, Ilie; Petriman, Narcis-Adrian; Kudva, Renuka; Koch, Hans-Georg			Dynamic Interaction of the Sec Translocon with the Chaperone PpiD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-RECOGNITION PARTICLE; MEMBRANE-PROTEIN INSERTION; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; INNER MEMBRANE; PREPROTEIN TRANSLOCASE; CYTOPLASMIC MEMBRANE; TRANSPORT PATHWAYS; RIBOSOME BINDING; SRP RECEPTOR	The Sec translocon constitutes a ubiquitous protein transport channel that consists in bacteria of the three core components: SecY, SecE, and SecG. Additional proteins interact with SecYEG during different stages of protein transport. During targeting, SecYEG interacts with SecA, the SRP receptor, or the ribosome. Protein transport into or across the membrane is then facilitated by the interaction of SecYEG with YidC and the SecDFYajC complex. During protein transport, SecYEG is likely to interact also with the protein quality control machinery, but details about this interaction are missing. By in vivo and in vitro site-directed cross-linking, we show here that the periplasmic chaperone PpiD is located in front of the lateral gate of SecY, through which transmembrane domains exit the SecY channel. The strongest contacts were found to helix 2b of SecY. Blue native PAGE analyses verify the presence of a SecYEG-PpiD complex in native Escherichia coli membranes. The PpiD-SecY interaction was not influenced by the addition of SecA and only weakly influenced by binding of nontranslating ribosomes to SecYEG. In contrast, PpiD lost contact to the lateral gate of SecY during membrane protein insertion. These data identify PpiD as an additional and transient subunit of the bacterial SecYEG translocon. The data furthermore demonstrate the highly modular and versatile composition of the Sec translocon, which is probably essential for its ability to transport a wide range of substrates across membranes in bacteria and eukaryotes.	[Sachelaru, Ilie; Petriman, Narcis-Adrian; Kudva, Renuka; Koch, Hans-Georg] Univ Freiburg, Inst Biochem & Mol Biol, Fac Med, ZBMZ, D-79104 Freiburg, Germany; [Sachelaru, Ilie; Petriman, Narcis-Adrian; Kudva, Renuka] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Kudva, Renuka; Koch, Hans-Georg] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Koch, HG (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, Stefan Meier Str 17, D-79104 Freiburg, Germany.	Hans-Georg.Koch@biochemie.uni-freiburg.de		Petriman, Narcis Adrian/0000-0002-3189-7530; Kudva, Renuka/0000-0003-0426-3716	Deutsche Forschungsgemeinschaft [GRK1478, DFG-FOR967, DFG-FOR929]; Excellence Initiative of the German Federal and State Governments Spemann Graduate School of Biology and Medicine [GSC-4]; Deutscher Akademischer Austauschdienst	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments Spemann Graduate School of Biology and Medicine; Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by Deutsche Forschungsgemeinschaft Grants GRK1478, DFG-FOR967, and DFG-FOR929 (to H.-G. K.), funds from the Excellence Initiative of the German Federal and State Governments GSC-4 Spemann Graduate School of Biology and Medicine (to H.-G. K.), and a Ph.D. fellowship from the Deutscher Akademischer Austauschdienst (to N.-A. P.).	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Akopian D, 2013, J CELL BIOL, V200, P397, DOI 10.1083/jcb.201208045; Angelini S, 2005, EMBO REP, V6, P476, DOI 10.1038/sj.embor.7400385; Angelini S, 2006, J CELL BIOL, V174, P715, DOI 10.1083/jcb.200606093; Antonoaea R, 2008, BIOCHEMISTRY-US, V47, P5649, DOI 10.1021/bi800233w; BABA T, 1990, J BACTERIOL, V172, P7005, DOI 10.1128/jb.172.12.7005-7010.1990; Bange G, 2013, NAT STRUCT MOL BIOL, V20, P776, DOI 10.1038/nsmb.2605; Beck K, 2001, EMBO REP, V2, P709, DOI 10.1093/embo-reports/kve154; Becker T, 2012, TRENDS BIOCHEM SCI, V37, P85, DOI 10.1016/j.tibs.2011.11.004; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Boy D, 2009, MOL BIOL CELL, V20, P1804, DOI 10.1091/mbc.E08-08-0886; Braig D, 2011, MOL BIOL CELL, V22, P2309, DOI 10.1091/mbc.E11-02-0152; Braig D, 2009, J MOL BIOL, V390, P401, DOI 10.1016/j.jmb.2009.04.061; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; Dartigalongue C, 1998, EMBO J, V17, P3968, DOI 10.1093/emboj/17.14.3968; Deitermann S, 2005, J BIOL CHEM, V280, P39077, DOI 10.1074/jbc.M509647200; Denks K, 2014, MOL MEMBR BIOL, V31, P58, DOI 10.3109/09687688.2014.907455; Deuerling E, 2003, MOL MICROBIOL, V47, P1317, DOI 10.1046/j.1365-2958.2003.03370.x; Di Cola A, 2005, BIOCHEM SOC T, V33, P1024, DOI 10.1042/BST20051024; Drew D, 2003, BBA-BIOMEMBRANES, V1610, P3, DOI 10.1016/S0005-2736(02)00707-1; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; Duong F, 1997, EMBO J, V16, P2756, DOI 10.1093/emboj/16.10.2756; Echizen Y, 2011, ACTA CRYSTALLOGR F, V67, P1367, DOI 10.1107/S1744309111031885; Erdmann F, 2011, EMBO J, V30, P17, DOI 10.1038/emboj.2010.284; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; Gogala M, 2014, NATURE, V506, P107, DOI 10.1038/nature12950; Gotzke H, 2014, J BIOL CHEM, V289, P19089, DOI 10.1074/jbc.M113.541672; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harms N, 2001, J BIOL CHEM, V276, P18804, DOI 10.1074/jbc.M011194200; Hizlan D, 2012, CELL REPORTS, V1, P21, DOI 10.1016/j.celrep.2011.11.003; Houben ENG, 2002, J BIOL CHEM, V277, P35880, DOI 10.1074/jbc.M205556200; Kedrov A, 2011, EMBO J, V30, P4387, DOI 10.1038/emboj.2011.314; Knyazev DG, 2013, J BIOL CHEM, V288, P17941, DOI 10.1074/jbc.M113.477893; Koch HG, 2002, J BIOL CHEM, V277, P5715, DOI 10.1074/jbc.C100683200; Koch HG, 1999, MOL BIOL CELL, V10, P2163, DOI 10.1091/mbc.10.7.2163; Kudva R, 2013, RES MICROBIOL, V164, P505, DOI 10.1016/j.resmic.2013.03.016; Kuhn P, 2011, TRAFFIC, V12, P563, DOI 10.1111/j.1600-0854.2011.01167.x; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; Maddalo G, 2011, J PROTEOME RES, V10, P1848, DOI 10.1021/pr101105c; Manting EH, 1997, J BACTERIOL, V179, P5699, DOI 10.1128/jb.179.18.5699-5704.1997; Matern Y, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-251; Merdanovic M, 2011, ANNU REV MICROBIOL, V65, P149, DOI 10.1146/annurev-micro-090110-102925; Moran U, 2010, CELL, V141, P1262, DOI 10.1016/j.cell.2010.06.019; Neumann-Haefelin C, 2000, EMBO J, V19, P6419, DOI 10.1093/emboj/19.23.6419; Park E, 2014, NATURE, V506, P102, DOI 10.1038/nature12720; Park E, 2012, J CELL BIOL, V198, P881, DOI 10.1083/jcb.201205140; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Prinz A, 2000, EMBO J, V19, P1900, DOI 10.1093/emboj/19.8.1900; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Sachelaru I, 2013, J BIOL CHEM, V288, P16295, DOI 10.1074/jbc.M112.446583; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Schauble N, 2012, EMBO J, V31, P3282, DOI 10.1038/emboj.2012.189; Schafer U, 1999, J BIOL CHEM, V274, P24567, DOI 10.1074/jbc.274.35.24567; Schaletzky J, 2006, MOL BIOL CELL, V17, P3860, DOI 10.1091/mbc.e06-05-0439; Schulze RJ, 2014, P NATL ACAD SCI USA, V111, P4844, DOI 10.1073/pnas.1315901111; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Weininger U, 2010, PROTEIN SCI, V19, P6, DOI 10.1002/pro.277; Welte T, 2012, MOL BIOL CELL, V23, P464, DOI 10.1091/mbc.E11-07-0590; Weski J, 2012, J BACTERIOL, V194, P3225, DOI 10.1128/JB.00221-12; Wickstrom D, 2011, J MOL BIOL, V409, P124, DOI 10.1016/j.jmb.2011.03.068; Wu ZC, 2012, J BIOL CHEM, V287, P7885, DOI 10.1074/jbc.M111.297911; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	67	21	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21706	21715		10.1074/jbc.M114.577916	http://dx.doi.org/10.1074/jbc.M114.577916			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24951590	hybrid, Green Published			2022-12-25	WOS:000340558300044
J	Anton, L; Brown, AG; Bartolomei, MS; Elovitz, MA				Anton, Lauren; Brown, Amy G.; Bartolomei, Marisa S.; Elovitz, Michal A.			Differential Methylation of Genes Associated with Cell Adhesion in Preeclamptic Placentas	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GLOBAL DNA METHYLATION; EARLY-ONSET PREECLAMPSIA; ESTROGEN-RECEPTOR GENE; GROWTH-FACTOR-BETA; CPG ISLAND; EPIGENETIC ALTERATIONS; TROPHOBLAST INVASION; REGULATED EXPRESSION; PROMOTER METHYLATION	Preeclampsia (PE), a hypertensive disorder of pregnancy, is hypothesized to be associated with, if not mechanistically related to abnormal placental function. However, the exact mechanisms regulating the pathogenesis of PE remain unclear. While many studies have investigated changes in gene expression in the PE placenta, the role of epigenetics in PE associated placental dysfunction remains unclear. Using the genome-wide Illumina Infinium Methylation 450 BeadChip array, we analyzed gene-specific alterations in DNA methylation in placental biopsies collected from normal pregnant women delivering at term (n = 14), with term PE (>= 37 weeks; n = 19) or with preterm PE (<37 weeks, n = 12). Of the 485,582 gene loci on the array, compared to controls, 229 loci were differentially methylated in PE placentas and 3411 loci were differentially methylated in preterm PE (step up p-value <0.05 and >5% methylation difference). Functional annotation of the differentially methylated genes in preterm PE placentas revealed a 32 gene cluster in the cadherin and cell adhesion functional groups (Benjamini p < 0.00001). Hypermethylation of CDH11 (p = 0.0143), COL5A1 (p = 0.0127) and TNF (p = 0.0098) and hypomethylation of NCAM1 (p = 0.0158) was associated with altered mRNA expression in preterm PE placentas. Demethylation of first trimester extravillous trophoblast cells resulted in altered CDH11 (p = 0.0087), COL5A1 (p = 0.0043), NCAM1 (p = 0.0260) and TNF (p = 0.0022) mRNA expression. These studies demonstrate aberrant methylation, correlating with disease severity, in PE placentas. Furthermore, we provide evidence that disruption of gene-specific methylation in preterm PE placentas and first trimester trophoblasts is significantly associated with altered gene expression demonstrating that epigenetic modifications early in pregnancy can have effects on trophoblast function contributing to PE.	[Anton, Lauren; Brown, Amy G.; Elovitz, Michal A.] Univ Penn, Dept Obstet & Gynecol, Perelman Sch Med, Maternal & Child Hlth Res Program, Philadelphia, PA 19104 USA; [Bartolomei, Marisa S.] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Anton, L (corresponding author), Univ Penn, Dept Obstet & Gynecol, Perelman Sch Med, Maternal & Child Hlth Res Program, Philadelphia, PA 19104 USA.	lanton@mail.med.upenn.edu		Elovitz, Michal/0000-0001-7554-7180; Bartolomei, Marisa/0000-0001-9410-5222	Vision Grant from the Preeclampsia Foundation; Maternal and Child Health Research Fund at the University of Pennsylvania (MAE)	Vision Grant from the Preeclampsia Foundation; Maternal and Child Health Research Fund at the University of Pennsylvania (MAE)	This work was supported by a 2010 Vision Grant from the Preeclampsia Foundation (www.preeclampsia.org) (LA) and the Maternal and Child Health Research Fund at the University of Pennsylvania (MAE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, 913029 US DEP HLTH H; Anton L, 2013, AM J PATHOL, V183, P1437, DOI 10.1016/j.ajpath.2013.07.021; Anton L, 2012, HUM REPROD, V27, P61, DOI 10.1093/humrep/der362; Bauer S, 2004, J CLIN ENDOCR METAB, V89, P812, DOI 10.1210/jc.2003-031351; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Blair JD, 2013, MOL HUM REPROD, V19, P697, DOI 10.1093/molehr/gat044; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Chang Jeani, 2003, MMWR Surveill Summ, V52, P1; Chavan-Gautam P, 2011, MOL REPROD DEV, V78, P150, DOI 10.1002/mrd.21296; Chelbi ST, 2008, MOL CELL ENDOCRINOL, V282, P120, DOI 10.1016/j.mce.2007.11.022; Chelbi ST, 2007, HYPERTENSION, V49, P76, DOI 10.1161/01.HYP.0000250831.52876.cb; Chelbi ST, 2012, HUM MOL GENET, V21, P1968, DOI 10.1093/hmg/dds006; Clarke MA, 2012, CANC EPIDEMIOLOGY BI; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Enquobahrie DA, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.020; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; FALETTE NS, 1990, CANCER RES, V50, P3974; Founds SA, 2009, PLACENTA, V30, P15, DOI 10.1016/j.placenta.2008.09.015; Gao WL, 2011, HYPERTENS RES, V34, P655, DOI 10.1038/hr.2011.9; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Getsios S, 2003, DEV BIOL, V257, P41, DOI 10.1016/S0012-1606(03)00041-1; Getsios S, 1998, J REPROD FERTIL, V114, P357; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gomez LM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.10.872; Gonzalgo ML, 1998, CANCER RES, V58, P1245; GRAHAM CH, 1992, BIOL REPROD, V46, P561, DOI 10.1095/biolreprod46.4.561; Hamai Y, 1997, AM J REPROD IMMUNOL, V38, P89; Hiltunen M, 2002, VASC MED, V7, P5, DOI 10.1191/1358863x02vm418oa; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huber AV, 2006, PLACENTA, V27, P127, DOI 10.1016/j.placenta.2005.02.012; Issa JPJ, 1996, P NATL ACAD SCI USA, V93, P11757, DOI 10.1073/pnas.93.21.11757; Iwahashi M, 1997, MOL HUM REPROD, V3, P725, DOI 10.1093/molehr/3.8.725; Jia RZ, 2012, INT J MOL MED, V30, P133, DOI 10.3892/ijmm.2012.983; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Koi H, 2002, BIOL REPROD, V67, P1572, DOI 10.1095/biolreprod.102.004325; Koonin L M, 1988, MMWR CDC Surveill Summ, V37, P19; Kulkarni A, 2011, DNA CELL BIOL, V30, P79, DOI 10.1089/dna.2010.1084; LARSEN F, 1993, HUM MOL GENET, V2, P775, DOI 10.1093/hmg/2.6.775; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Lim KH, 1997, AM J PATHOL, V151, P1809; Lockwood CJ, 2008, BIOL REPROD, V78, P1064, DOI 10.1095/biolreprod.107.063743; Louwen F, 2012, LESSON CANC RES PLAC; MacCalman CD, 1996, DEV DYNAM, V206, P201; MEEKINS JW, 1994, CLIN EXP IMMUNOL, V98, P110; Meissner A, 1999, MOL HUM REPROD, V5, P252, DOI 10.1093/molehr/5.3.252; Nelissen ECM, 2011, HUM REPROD UPDATE, V17, P397, DOI 10.1093/humupd/dmq052; Neudeck H, 1997, HISTOCHEM J, V29, P419, DOI 10.1023/A:1026499203743; Novakovic B, 2009, J BIOL CHEM; Novakovic B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-529; Ozkan S, 2008, J MATERN-FETAL NEO M, V21, P831, DOI 10.1080/14767050802251024; Petrykowska HM, 2008, GENOME RES, V18, P1238, DOI 10.1101/gr.073817.107; Pilsner JR, 2010, MOL ECOL, V19, P307, DOI 10.1111/j.1365-294X.2009.04452.x; Post WS, 1999, CARDIOVASC RES, V43, P985, DOI 10.1016/S0008-6363(99)00153-4; Proll J, 1996, Early Pregnancy, V2, P271; Renaud SJ, 2005, BIOL REPROD, V73, P237, DOI 10.1095/biolreprod.104.038000; Ruebner M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056145; Sharma P, 2008, DNA CELL BIOL, V27, P357, DOI 10.1089/dna.2007.0694; Sitras V, 2009, PLACENTA, V30, P424, DOI 10.1016/j.placenta.2009.01.012; Sriram K, 2007, J NEUROIMMUNE PHARM, V2, P140, DOI 10.1007/s11481-007-9070-6; TAKAGI H, 1995, EUR J BIOCHEM, V231, P282, DOI 10.1111/j.1432-1033.1995.tb20698.x; van Dijk M, 2010, EPIGENETICS-US, V5, P736, DOI 10.4161/epi.5.8.13084; Wang ZQ, 2010, GYNECOL ENDOCRINOL, V26, P96, DOI 10.3109/09513590903184100; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Xue WC, 2003, INT J GYNECOL CANCER, V13, P879, DOI 10.1136/ijgc-00009577-200311000-00022; Yuen RKC, 2010, EUR J HUM GENET, V18, P1006, DOI 10.1038/ejhg.2010.63; Zhou Y, 1997, J CLIN INVEST, V99, P2139, DOI 10.1172/JCI119387; ZHOU Y, 1993, J CLIN INVEST, V91, P950, DOI 10.1172/JCI116316; ZION M, 1994, P NATL ACAD SCI USA, V91, P10722, DOI 10.1073/pnas.91.22.10722	70	64	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100148	10.1371/journal.pone.0100148	http://dx.doi.org/10.1371/journal.pone.0100148			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963923	Green Published, gold, Green Submitted			2022-12-25	WOS:000338709500031
J	Avey, MT; Bloomfield, LL; Elie, JE; Freeberg, TM; Guillette, LM; Hoeschele, M; Lee, H; Moscicki, MK; Owens, JL; Sturdy, CB				Avey, Marc T.; Bloomfield, Laurie L.; Elie, Julie E.; Freeberg, Todd M.; Guillette, Lauren M.; Hoeschele, Marisa; Lee, Homan; Moscicki, Michele K.; Owens, Jessica L.; Sturdy, Christopher B.			ZENK Activation in the Nidopallium of Black-Capped Chickadees in Response to Both Conspecific and Heterospecific Calls	PLOS ONE			English	Article							A-DEE CALLS; FEMALE ZEBRA FINCH; POECILE-ATRICAPILLUS; GENE-EXPRESSION; AUDITORY FOREBRAIN; SONGBIRD FOREBRAIN; CAUDOMEDIAL NEOSTRIATUM; ALLOPATRIC CHICKADEES; PARID VOCALIZATIONS; CAROLINA CHICKADEES	Neuronal populations in the songbird nidopallium increase in activity the most to conspecific vocalizations relative to heterospecific songbird vocalizations or artificial stimuli such as tones. Here, we tested whether the difference in neural activity between conspecific and heterospecific vocalizations is due to acoustic differences or to the degree of phylogenetic relatedness of the species producing the vocalizations. To compare differences in neural responses of black-capped chickadees, Poecile atricapillus, to playback conditions we used a known marker for neural activity, ZENK, in the caudal medial nidopallium and caudomedial mesopallium. We used the acoustically complex 'dee' notes from chick-a-dee calls, and vocalizations from other heterospecific species similar in duration and spectral features. We tested the vocalizations from three heterospecific species (chestnut-backed chickadees, tufted titmice, and zebra finches), the vocalizations from conspecific individuals (black-capped chickadees), and reversed versions of the latter. There were no significant differences in the amount of expression between any of the groups except in the control condition, which resulted in significantly less neuronal activation. Our results suggest that, in certain cases, neuronal activity is not higher in response to conspecific than in response to heterospecific vocalizations for songbirds, but rather is sensitive to the acoustic features of the signal. Both acoustic features of the calls and the phylogenetic relationship between of the signaler and the receiver interact in the response of the nidopallium.	[Avey, Marc T.; Guillette, Lauren M.; Hoeschele, Marisa; Lee, Homan; Moscicki, Michele K.; Sturdy, Christopher B.] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [Bloomfield, Laurie L.] Algoma Univ, Dept Psychol, Sault Ste Marie, ON, Canada; [Elie, Julie E.] Univ Calif Berkeley, Dept Psychol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Freeberg, Todd M.; Owens, Jessica L.] Univ Tennessee, Dept Psychol, Knoxville, TN 37996 USA; [Freeberg, Todd M.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA	University of Alberta; Algoma University; University of California System; University of California Berkeley; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Sturdy, CB (corresponding author), Univ Alberta, Dept Psychol, Edmonton, AB, Canada.	csturdy@ualberta.ca	Guillette, Lauren/K-8154-2013; Hoeschele, Marisa/R-2176-2019; Sturdy, Christopher B/A-4407-2009; Hoeschele, Marisa/R-6198-2018	Guillette, Lauren/0000-0002-8777-6543; Hoeschele, Marisa/0000-0002-2102-0882; Hoeschele, Marisa/0000-0002-2102-0882; Sturdy, Christopher/0000-0003-2721-3770; Elie, Julie/0000-0002-7993-0264; Avey, Marc/0000-0002-8696-3232; Freeberg, Todd/0000-0003-3807-4147	Natural Sciences and Engineering Research Council of Canada; Alberta Ingenuity Fund New Faculty Grant; Canada Foundation for Innovation New Opportunities Fund Award; Infrastructure Operating Grants (IOF); University of Alberta; Alberta Ingenuity Fund; Newton Fellowship from The Royal Society and British Academy; European Research Council [230604 "SOMACCA"]; Fondation Fyssen; University of Tennessee	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Ingenuity Fund New Faculty Grant; Canada Foundation for Innovation New Opportunities Fund Award; Infrastructure Operating Grants (IOF); University of Alberta(University of Alberta); Alberta Ingenuity Fund; Newton Fellowship from The Royal Society and British Academy; European Research Council(European Research Council (ERC)European Commission); Fondation Fyssen; University of Tennessee	C.B.S. was supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant and a Discovery Accelerator Supplement, an Alberta Ingenuity Fund New Faculty Grant, Canada Foundation for Innovation New Opportunities Fund Award and Infrastructure Operating Grants (IOF), as well as start-up and partner funding from the University of Alberta. M.T.A., M.H., M.K.M., and L.L.B. were supported by the Natural Sciences and Engineering Research Council of Canada and Alberta Ingenuity Fund. L.M.G. and M.H. were supported by Izaak Walton Killiam Memorial Scholarships. L.M.G. was supported by a Newton Fellowship from The Royal Society and British Academy. M.H. is currently funded by a European Research Council advanced grant [No. 230604 "SOMACCA"] awarded to W. Tecumseh Fitch at the University of Vienna. J.E.E. was supported by a post-doctoral study grant from the Fondation Fyssen. T.M.F. and J.L.O. acknowledge the funding from the University of Tennessee for portions of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avey MT, 2008, BEHAV BRAIN RES, V188, P201, DOI 10.1016/j.bbr.2007.10.034; Avey MT, 2008, BEHAV PROCESS, V77, P149, DOI 10.1016/j.beproc.2007.12.004; Avey MT, 2011, BEHAV PROCESS, V88, P177, DOI 10.1016/j.beproc.2011.09.005; Avey MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023844; Avey MT, 2005, BEHAV BRAIN RES, V165, P247, DOI 10.1016/j.bbr.2005.07.002; Bailey DJ, 2006, NEUROSCI LETT, V401, P86, DOI 10.1016/j.neulet.2006.02.076; Bailey DJ, 2005, BEHAV BRAIN RES, V162, P108, DOI 10.1016/j.bbr.2005.03.016; Bailey DJ, 2002, J NEUROBIOL, V52, P43, DOI 10.1002/neu.10070; Bailey DJ, 2003, MOL BRAIN RES, V116, P147, DOI 10.1016/S0169-328X(03)00288-2; Bentley GE, 2000, HORM BEHAV, V37, P179, DOI 10.1006/hbeh.2000.1573; Bloomfield LL, 2008, BEHAV PROCESS, V77, P87, DOI 10.1016/j.beproc.2007.06.008; Bloomfield LL, 2008, BEHAV PROCESS, V77, P166, DOI 10.1016/j.beproc.2007.08.003; Bloomfield LL, 2008, BEHAV PROCESS, V77, P73, DOI 10.1016/j.beproc.2007.06.011; BRENOWITZ EA, 1991, SCIENCE, V251, P303, DOI 10.1126/science.1987645; Charrier I, 2005, BEHAV PROCESS, V70, P271, DOI 10.1016/j.beproc.2005.07.007; Charrier I, 2004, CAN J ZOOL, V82, P769, DOI 10.1139/Z04-045; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Chew SJ, 1996, P NATL ACAD SCI USA, V93, P1950, DOI 10.1073/pnas.93.5.1950; Courter JR, 2010, BEHAV ECOL, V21, P936, DOI 10.1093/beheco/arq086; CYNX J, 1992, P NATL ACAD SCI USA, V89, P1372, DOI 10.1073/pnas.89.4.1372; De Groof G, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00196; Gee JM, 2009, BRAIN BEHAV EVOLUT, V74, P258, DOI 10.1159/000264661; Gentner TQ, 2001, J NEUROBIOL, V46, P48, DOI 10.1002/1097-4695(200101)46:1<48::AID-NEU5>3.0.CO;2-3; George I, 2004, BEHAV NEUROSCI, V118, P597, DOI 10.1037/0735-7044.118.3.597; Gill FB, 2005, AUK, V122, P121, DOI 10.1642/0004-8038(2005)122[0121:POTPIS]2.0.CO;2; Guillette LM, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00229; Hailman Jack P., 1996, P136; HAILMAN JP, 1989, WILSON BULL, V101, P305; Hernandez AM, 2004, J NEUROBIOL, V59, P247, DOI 10.1002/neu.10312; Hoeschele M, 2009, J ACOUST SOC AM, V126, P2088, DOI 10.1121/1.3203736; Huchzermeyer C, 2006, BEHAV BRAIN RES, V171, P154, DOI 10.1016/j.bbr.2006.03.034; Johnson FR, 2003, AUST J ZOOL, V51, P577, DOI 10.1071/ZO03031; Krams I, 2012, PHILOS T R SOC B, V367, P1879, DOI 10.1098/rstb.2011.0222; Long KD, 2002, J COMP PHYSIOL A, V188, P25, DOI 10.1007/s00359-001-0276-4; Lynch KS, 2008, BRAIN BEHAV EVOLUT, V72, P207, DOI 10.1159/000157357; MacDougall-Shackleton SA, 1998, NEUROREPORT, V9, P3047, DOI 10.1097/00001756-199809140-00024; Mahurin EJ, 2009, BEHAV ECOL, V20, P111, DOI 10.1093/beheco/arn121; McLean MJ, 2013, EVOL BIOL, V40, P141, DOI 10.1007/s11692-012-9197-0; Mello CV, 2002, J COMP PHYSIOL A, V188, P943, DOI 10.1007/s00359-002-0347-1; MELLO CV, 1994, J NEUROSCI, V14, P6652; Mello CV, 2004, ANN NY ACAD SCI, V1016, P263, DOI 10.1196/annals.1298.021; MELLO CV, 1995, J NEUROBIOL, V26, P145, DOI 10.1002/neu.480260112; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Mooney R, 2001, P NATL ACAD SCI USA, V98, P12778, DOI 10.1073/pnas.221453298; Nolen MT, 2009, ANIM BEHAV, V77, P1137, DOI 10.1016/j.anbehav.2009.01.023; Ord TJ, 2002, BIOL J LINN SOC, V77, P127, DOI 10.1046/j.1095-8312.2002.00100.x; Ord TJ, 2001, P ROY SOC B-BIOL SCI, V268, P737, DOI 10.1098/rspb.2000.1417; Owens JL, 2007, J ACOUST SOC AM, V122, P1216, DOI 10.1121/1.2749459; Park KHJ, 2002, BEHAV BRAIN RES, V136, P185, DOI 10.1016/S0166-4328(02)00129-8; Phelps SM, 2000, P ROY SOC B-BIOL SCI, V267, P1633, DOI 10.1098/rspb.2000.1189; Phillmore LS, 2011, BEHAV BRAIN RES, V225, P464, DOI 10.1016/j.bbr.2011.08.004; Phillmore LS, 2003, BEHAV BRAIN RES, V147, P125, DOI 10.1016/S0166-4328(03)00155-4; Pinaud R, 2008, J BIOSCIENCES, V33, P145, DOI 10.1007/s12038-008-0030-y; Poirier C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020131; Poirier C, 2009, J NEUROSCI, V29, P2252, DOI 10.1523/JNEUROSCI.4650-08.2009; Ramsier MA, 2012, PHILOS T R SOC B, V367, P1860, DOI 10.1098/rstb.2011.0219; Robillard T, 2011, BEHAVIOUR, V148, P627, DOI 10.1163/000579511X572044; Rosen MJ, 2000, J NEUROSCI, V20, P5437, DOI 10.1523/JNEUROSCI.20-14-05437.2000; Ryan MJ, 1999, ANIM BEHAV, V57, P945, DOI 10.1006/anbe.1998.1057; Scharff C, 1998, J NEUROBIOL, V36, P81, DOI 10.1002/(SICI)1097-4695(199807)36:1<81::AID-NEU7>3.3.CO;2-8; Soard CM, 2009, ANIM BEHAV, V78, P1447, DOI 10.1016/j.anbehav.2009.09.026; Stripling R, 1997, J NEUROSCI, V17, P3883; Stripling R, 2001, J NEUROBIOL, V48, P163, DOI 10.1002/neu.1049; Templeton CN, 2005, SCIENCE, V308, P1934, DOI 10.1126/science.1108841; Terpstra NJ, 2005, J COMP NEUROL, V488, P342, DOI 10.1002/cne.20592; Theunissen FE, 2004, ANN NY ACAD SCI, V1016, P222, DOI 10.1196/annals.1298.023; Tobias ML, 2011, BEHAVIOUR, V148, P519, DOI 10.1163/000579511X569435; Tucker MA, 2012, P ROY SOC B-BIOL SCI, V279, P1583, DOI 10.1098/rspb.2011.1968; Velho TAF, 2005, EUR J NEUROSCI, V22, P1667, DOI 10.1111/j.1460-9568.2005.04369.x; WILLIAMS H, 1985, SCIENCE, V229, P279, DOI 10.1126/science.4012321; Wilson DR, 2011, BEHAV ECOL, V22, P784, DOI 10.1093/beheco/arr051; Yoder KM, 2012, NEUROREPORT, V23, P922, DOI 10.1097/WNR.0b013e3283588b61; Zann RA., 1996, ZEBRA FINCH SYNTHESI	73	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100927	10.1371/journal.pone.0100927	http://dx.doi.org/10.1371/journal.pone.0100927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963707	gold, Green Published			2022-12-25	WOS:000338709500101
J	Ban, L; West, J; Gibson, JE; Fiaschi, L; Sokal, R; Doyle, P; Hubbard, R; Smeeth, L; Tata, LJ				Ban, Lu; West, Joe; Gibson, Jack E.; Fiaschi, Linda; Sokal, Rachel; Doyle, Pat; Hubbard, Richard; Smeeth, Liam; Tata, Laila J.			First Trimester Exposure to Anxiolytic and Hypnotic Drugs and the Risks of Major Congenital Anomalies: A United Kingdom Population-Based Cohort Study	PLOS ONE			English	Article							PRACTICE RESEARCH DATABASE; BENZODIAZEPINE-RECEPTOR AGONISTS; ORAL CLEFTS; PRENATAL EXPOSURE; MEDICAL-RECORDS; HEART-DEFECTS; PREGNANCY; MALFORMATIONS; DIAZEPAM; VALIDATION	Background: Despite their widespread use the effects of taking benzodiazepines and non-benzodiazepine hypnotics during pregnancy on the risk of major congenital anomaly (MCA) are uncertain. The objectives were to estimate absolute and relative risks of MCAs in children exposed to specific anxiolytic and hypnotic drugs taken in the first trimester of pregnancy, compared with children of mothers with depression and/or anxiety but not treated with medication and children of mothers without diagnosed mental illness during pregnancy. Methods: We identified singleton children born to women aged 15-45 years between 1990 and 2010 from a large United Kingdom primary care database. We calculated absolute risks of MCAs for children with first trimester exposures of different anxiolytic and hypnotic drugs and used logistic regression with a generalised estimating equation to compare risks adjusted for year of childbirth, maternal age, smoking, body mass index, and socioeconomic status. Results: Overall MCA prevalence was 2.7% in 1,159 children of mothers prescribed diazepam, 2.9% in 379 children with temazepam, 2.5% in 406 children with zopiclone, and 2.7% in 19,193 children whose mothers had diagnosed depression and/or anxiety but no first trimester drug exposures. When compared with 2.7% in 351,785 children with no diagnosed depression/anxiety nor medication use, the adjusted odds ratios were 1.02 (99% confidence interval 0.63-1.64) for diazepam, 1.07 (0.49-2.37) for temazepam, 0.96 (0.42-2.20) for zopiclone and 1.27 (0.43-3.75) for other anxiolytic/hypnotic drugs and 1.01 (0.90-1.14) for un-medicated depression/anxiety. Risks of system-specific MCAs were generally similar in children exposed and not exposed to such medications. Conclusions: We found no evidence for an increase in MCAs in children exposed to benzodiazepines and non-benzodiazepine hypnotics in the first trimester of pregnancy. These findings suggest that prescription of these drugs during early pregnancy may be safe in terms of MCA risk, but findings from other studies are required before safety can be confirmed.	[Ban, Lu; West, Joe; Gibson, Jack E.; Fiaschi, Linda; Sokal, Rachel; Hubbard, Richard; Tata, Laila J.] Univ Nottingham, City Hosp Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Doyle, Pat; Smeeth, Liam] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; University of London; London School of Hygiene & Tropical Medicine	Ban, L (corresponding author), Univ Nottingham, City Hosp Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England.	lu.ban@nottingham.ac.uk; laila.tata@nottingham.ac.uk	West, Joe/M-3867-2019; Fiaschi, Linda/AAB-4905-2022; West, Joe/I-6637-2012; Gibson, Jack E/A-5746-2009; Smeeth, Liam/X-5862-2018; Tata, Laila/J-5227-2012	West, Joe/0000-0002-1135-9356; Fiaschi, Linda/0000-0002-3780-5895; West, Joe/0000-0002-1135-9356; Gibson, Jack E/0000-0003-1717-0252; Ban, Lu/0000-0001-9388-9141; Smeeth, Liam/0000-0002-9168-6022; Tata, Laila/0000-0002-6404-8658	Wellcome Trust; Medical Research Council [MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study is funded by a grant from Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban L, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X656801; Ban L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043462; Bellantuono C, 2013, GEN HOSP PSYCHIAT, V35, P3, DOI 10.1016/j.genhosppsych.2012.09.003; Boden R, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7085; Boden R, 2012, ARCH GEN PSYCHIAT, V69, P715, DOI 10.1001/archgenpsychiatry.2011.1870; Borthen I, 2012, CURR OPIN OBSTET GYN, V24, P78, DOI 10.1097/GCO.0b013e32834feb6a; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2459, DOI 10.1001/jama.2011.1823; Cates C, 1999, BRIT MED J, V319, P918; Charlton RA, 2008, DRUG SAFETY, V31, P39, DOI 10.2165/00002018-200831010-00004; Charlton RA, 2011, DRUG SAFETY, V34, P157, DOI 10.2165/11584970-000000000-00000; Charlton RA, 2010, DRUG SAFETY, V33, P741, DOI 10.2165/11536820-000000000-00000; Confidential Enquiry into Maternal and Child Health (CEMACH), PER MORT 2007 UK; CORREAVILLASENOR A, 1994, TERATOLOGY, V50, P137, DOI 10.1002/tera.1420500208; Czeizel A, 1987, Reprod Toxicol, V1, P183; Czeizel AE, 2004, NEUROTOXICOL TERATOL, V26, P593, DOI 10.1016/j.ntt.2004.03.009; Czeizel AE, 2003, CLIN DRUG INVEST, V23, P451, DOI 10.2165/00044011-200323070-00004; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; Devine S, 2008, PHARMACOEPIDEM DR S, V17, P434, DOI 10.1002/pds.1573; Dhalwani NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072218; Dolk H, 2005, ARCH DIS CHILD-FETAL, V90, pF355, DOI 10.1136/adc.2004.062810; Enato E, 2011, J OBSTET GYNAECOL CA, V33, P46, DOI 10.1016/S1701-2163(16)34772-7; Joint Formulary Committee, 2012, BRIT NAT FORM BNF 63, V63; Jueckstock JK, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-46; Kjaer D, 2007, PHARMACOEPIDEM DR S, V16, P181, DOI 10.1002/pds.1288; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; MARCHETTI F, 1993, EUR J CLIN PHARMACOL, V45, P495, DOI 10.1007/BF00315304; Murray C. J. L., 2013, LANCET; National Institute for Health and Clinical Excellence, 2007, ANT POSTN MENT HLTH; Oberlander TF, 2008, BIRTH DEFECTS RES B, V83, P68, DOI 10.1002/bdrb.20144; Oyebode F, 2012, PHARMACOL THERAPEUT, V135, P71, DOI 10.1016/j.pharmthera.2012.03.008; Prajapati B, 2010, OPTOM TODAY; ROSENBERG L, 1983, NEW ENGL J MED, V309, P1282, DOI 10.1056/NEJM198311243092103; SAFRA MJ, 1975, LANCET, V2, P478; SAXEN I, 1975, INT J EPIDEMIOL, V4, P37, DOI 10.1093/ije/4.1.37; Say Lale, 2006, Reprod Health, V3, P1, DOI 10.1186/1742-4755-3-1; Sokal R, 2013, BIRTH DEFECTS RES A, V97, P546, DOI 10.1002/bdra.23150; StataCorp, GEN EST EQ XTG; Szatkowski L, 2012, J EPIDEMIOL COMMUN H, V66, P791, DOI 10.1136/jech.2010.120154; TIKKANEN J, 1992, TERATOLOGY, V46, P447, DOI 10.1002/tera.1420460509; Townsend PP., 1988, HLTH DEPRIVATION INE; Wikner BN, 2007, PHARMACOEPIDEM DR S, V16, P1203, DOI 10.1002/pds.1457; Wikner BN, 2011, J CLIN PSYCHOPHARM, V31, P356, DOI 10.1097/JCP.0b013e3182197055; World Health Organization(WHO), BMI CLASS; World Health Organization  (WHO), 2001, GEND DISP MENT HLTH; Wurst KE, 2007, PHARMACOEPIDEM DR S, V16, P867, DOI 10.1002/pds.1431; Wurst KE, 2007, BIRTH DEFECTS RES A, V79, P309, DOI 10.1002/bdra.20356	46	40	41	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100996	10.1371/journal.pone.0100996	http://dx.doi.org/10.1371/journal.pone.0100996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963627	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000338709500108
J	Fu, SH; Sun, YQ; Luo, LM; Ye, P				Fu, Shihui; Sun, Yuqing; Luo, Leiming; Ye, Ping			Relationship of Arterial Compliance and Blood Pressure with Microalbuminuria and Mildly Decreased Glomerular Filtration Rate: A Chinese Community-Based Analysis	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; RENAL-FUNCTION; ENDOTHELIAL FUNCTION; AORTIC STIFFNESS; HYPERTENSION; INDEX	Objective: This analysis is designed to determine the prevalence of microalbuminuria (MAU) and mildly decreased glomerular filtration rate (GFR); to investigate the association of augmentation index (AIx), central blood pressure (cBP) and peripheral blood pressure (pBP) with MAU and mildly decreased GFR; and to compare the association strength of cBP and pBP with MAU and mildly decreased GFR. Methods: This community-based analysis included 2071 Chinese residents. Urine albumin-to-creatinine ratio (UACR), GFR, and pulse wave measurements were performed. UACR of 30-299 mg/g and GFR of 60-89 ml/min/1.73 m(2) were identified as MAU and mildly decreased GFR. Results: The prevalence of MAU and mildly decreased GFR was 21.3% and 33.2%. The AIx, cBP and pBP were significantly higher in participants with MAU compared with those without MAU, and in participants with mildly decreased GFR compared with those without mildly decreased GFR (all P<0.001). After participants were categorized into four subgroups based on the presence or absence of MAU and mildly decreased GFR, Aix, cBP and pBP progressively increased from the subgroup without both of MAU and mildly decreased GFR to the subgroups with either one of them, and arrived at top in the subgroup with both of them (all P<0.001). Compared with the reference category without MAU and mildly decreased GFR, the odd ratio values significantly increased from the category with either one of MAU and mildly decreased GFR to the category with both of them (all P<0.001). The AIx, cBP and pBP were all independently associated with MAU and mildly decreased GFR after full adjustment (all P<0.05), and the association strength of MAU and mildly decreased GFR with cBP was similar to those with pBP. Conclusions: In Chinese community-dwelling population, there was a high prevalence of MAU and mildly decreased GFR. The AIx, cBP and pBP were all independently associated with MAU and mildly decreased GFR; meanwhile, cBP did not exhibit stronger association with MAU and mildly decreased GFR compared with pBP.	[Fu, Shihui] Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing, Peoples R China; [Fu, Shihui] Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Beijing, Peoples R China; [Sun, Yuqing; Luo, Leiming; Ye, Ping] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Luo, LM (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China.	lleim@sina.com	Luo, Leiming/AAD-5533-2019	Fu, Shihui/0000-0001-6707-9049	National Key Basic Research Project [2012CB517503, 2013CB530804]; Health Special Scientific Research Subject of Chinese People's Liberation Army [12BLZ34]; Clinical Scientific Research Project of Chinese People's Liberation Army General Hospital [2012FC-TSYS1021]	National Key Basic Research Project(National Basic Research Program of China); Health Special Scientific Research Subject of Chinese People's Liberation Army; Clinical Scientific Research Project of Chinese People's Liberation Army General Hospital	This study was supported by grants from the National Key Basic Research Project (2012CB517503 and 2013CB530804), the Health Special Scientific Research Subject of Chinese People's Liberation Army (12BLZ34), and the Clinical Scientific Research Project of Chinese People's Liberation Army General Hospital (2012FC-TSYS1021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN K, 1995, AM J HYPERTENS, V8, P409, DOI 10.1016/0895-7061(94)00248-A; Benetos A, 2002, CIRCULATION, V105, P1202, DOI 10.1161/hc1002.105135; Cherney DZI, 2010, DIABETES CARE, V33, P1344, DOI 10.2337/dc09-2340; Chue CD, 2011, NEPHROL DIAL TRANSPL, V26, P2576, DOI 10.1093/ndt/gfq787; Cottone S, 2009, NEPHROL DIAL TRANSPL, V24, P497, DOI 10.1093/ndt/gfn489; Eddington H, 2009, NEPHRON CLIN PRACT, V112, pC190, DOI 10.1159/000218108; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Hashimoto J, 2011, HYPERTENSION, V58, P839, DOI 10.1161/HYPERTENSIONAHA.111.177469; Hermans MMH, 2007, J AM SOC NEPHROL, V18, P1942, DOI 10.1681/ASN.2006111217; HOEGHOLM A, 1994, HYPERTENSION, V24, P101, DOI 10.1161/01.HYP.24.1.101; Kanaoka T, 2012, CLIN EXP HYPERTENS, V34, P264, DOI 10.3109/10641963.2012.681082; Khoshdel Ali Reza, 2008, Urol J, V5, P3; LONDON G, 1992, HYPERTENSION, V20, P10, DOI 10.1161/01.HYP.20.1.10; London GM, 1998, J HYPERTENS, V16, P1931, DOI 10.1097/00004872-199816121-00012; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Matsui Y, 2011, ATHEROSCLEROSIS, V219, P637, DOI 10.1016/j.atherosclerosis.2011.09.027; McEniery CM, 2006, HYPERTENSION, V48, P602, DOI 10.1161/01.HYP.0000239206.64270.5f; Mule G, 2010, INT J CARDIOL, V145, P372, DOI 10.1016/j.ijcard.2010.02.047; Neisius U, 2012, J HYPERTENS, V30, P67, DOI 10.1097/HJH.0b013e32834e12d8; Oliveras A, 2013, J HYPERTENS, V31, P103, DOI 10.1097/HJH.0b013e32835ac7b5; Olsen BS, 1999, DIABETIC MED, V16, P79, DOI 10.1046/j.1464-5491.1999.00024.x; Prince CT, 2010, DIABETES VASC DIS RE, V7, P216, DOI 10.1177/1479164110375297; Safar ME, 2004, HYPERTENSION, V43, P163, DOI 10.1161/01.HYP.0000114571.75762.b0; Safar ME, 2000, CARDIOVASC RES, V46, P269, DOI 10.1016/S0008-6363(99)00426-5; Tryfonopoulos D, 2005, J ENDOCRINOL INVEST, V28, P616, DOI 10.1007/BF03347260; Tsioufis C, 2003, NEPHRON CLIN PRACT, V93, pC106, DOI 10.1159/000069546; Upadhyay A, 2009, J AM SOC NEPHROL, V20, P2044, DOI 10.1681/ASN.2009010074; Wang KL, 2009, J HYPERTENS, V27, P461, DOI 10.1097/HJH.0b013e3283220ea4; Weir MR, 2011, CLIN J AM SOC NEPHRO, V6, P2403, DOI 10.2215/CJN.01670211	29	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e101013	10.1371/journal.pone.0101013	http://dx.doi.org/10.1371/journal.pone.0101013			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963717	Green Published, gold, Green Submitted			2022-12-25	WOS:000338709500110
J	Niu, YD; McAllister, TA; Nash, JHE; Kropinski, AM; Stanford, K				Niu, Yan D.; McAllister, Tim A.; Nash, John H. E.; Kropinski, Andrew M.; Stanford, Kim			Four Escherichia coli O157:H7 Phages: A New Bacteriophage Genus and Taxonomic Classification of T1-Like Phages	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; TRANSFER-RNA GENES; LYTIC BACTERIOPHAGES; GENERATION; SALMONELLA; THERAPY; POPULATIONS; INFECTION; PROTEOME; VIRULENT	The T1-like bacteriophages vB_EcoS_AHP24, AHS24, AHP42 and AKS96 of the family Siphoviridae were shown to lyse common phage types of Shiga toxin-producing Escherichia coli O157:H7 (STEC O157: H7), but not non-O157 E. coli. All contained circularly permuted genomes of 45.7-46.8 kb (43.8-44 mol% G+C) encoding 74-81 open reading frames and 1 arginyl-tRNA. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed that the structural proteins were identical among the four phages. Further proteomic analysis identified seven structural proteins responsible for tail fiber, tail tape measure protein, major capsid, portal protein as well as major and minor tail proteins. Bioinformatic analyses on the proteins revealed that genomes of AHP24, AHS24, AHP42 and AKS96 did not encode for bacterial virulence factors, integration-related proteins or antibiotic resistance determinants. All four phages were highly lytic to STEC O157:H7 with considerable potential as biocontrol agents. Comparative genomic, proteomic and phylogenetic analysis suggested that the four phages along with 17 T1-like phage genomes from database of National Center for Biotechnology Information (NCBI) can be assigned into a proposed subfamily "Tunavirinae" with further classification into five genera, namely "Tlslikevirus" (TLS, FSL SP-126), "Kp36likevirus" (KP36, F20), Tunalikevirus (T1, ADB-2 and Shf1), "Rtplikevirus" (RTP, vB_EcoS_ACG-M12) and "Jk06likevirus" (JK06, vB_EcoS_Rogue1, AHP24, AHS24, AHP42, AKS96, phiJLA23, phiKP26, phiEB49). The fact that the viruses related to JK06 have been isolated independently in Israel (JK06) (GenBank Assession #, NC_007291), Canada (vB_EcoS_Rogue1, AHP24, AHS24, AHP42, AKS96) and Mexico (phiKP26, phiJLA23) (between 2005 and 2011) indicates that these similar phages are widely distributed, and that horizontal gene transfer does not always prevent the characterization of bacteriophage evolution. With this new scheme, any new discovered phages with same type can be more properly identified. Genomic- and proteomic-based taxonomic classification of phages would facilitate better understanding phages diversity and genetic traits involved in phage evolution.	[Niu, Yan D.; Stanford, Kim] Alberta Agr & Rural Dev, Ctr Agr, Lethbridge, AB, Canada; [McAllister, Tim A.] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada; [Nash, John H. E.; Kropinski, Andrew M.] Publ Hlth Agcy Canada, Lab Foodborne Zoonoses, Guelph, ON, Canada; [Nash, John H. E.] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Kropinski, Andrew M.] Univ Guelph, Dept Cellular & Mol Biol, Guelph, ON N1G 2W1, Canada	Agriculture & Agri Food Canada; Public Health Agency of Canada; University of Guelph; University of Guelph	Niu, YD (corresponding author), Alberta Agr & Rural Dev, Ctr Agr, Lethbridge, AB, Canada.	dongyan.niu@gov.ab.ca; kim.stanford@gov.ab.ca	Kropinski, Andrew M/H-7130-2016; Nash, John HE/P-2384-2017; McAllister, Tim A./R-9201-2017	Kropinski, Andrew M/0000-0002-6871-6799; Nash, John HE/0000-0003-2925-8710; McAllister, Tim A./0000-0002-8266-6513	Alberta Livestock and Meat Agency, Agriculture and Agri-Food Canada	Alberta Livestock and Meat Agency, Agriculture and Agri-Food Canada	This work was supported by the Alberta Livestock and Meat Agency, Agriculture and Agri-Food Canada Peer-Reviewed Project Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann Hans-W., 2009, V501, P127, DOI 10.1007/978-1-60327-164-6_13; Alonso C, 2013, PREV VET MED, V112, P109, DOI 10.1016/j.prevetmed.2013.06.001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amarillas L, 2013, GENOME ANNOUNC, V1; Amarillas L, 2013, ARCH VIROL, V158, P2395, DOI 10.1007/s00705-013-1725-4; Atterbury RJ, 2009, MICROB BIOTECHNOL, V2, P601, DOI 10.1111/j.1751-7915.2009.00089.x; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Balogh B, 2010, CURR PHARM BIOTECHNO, V11, P48, DOI 10.2174/138920110790725302; Battaglioli EJ, 2011, APPL ENVIRON MICROB, V77, P6630, DOI 10.1128/AEM.05307-11; Bhensdadia DV, 2013, GENOME ANNOUNC, V1; Callaway TR, 2011, FOODBORNE PATHOG DIS, V8, P261, DOI 10.1089/fpd.2010.0671; Carvalho CM, 2012, BACTERIOPHAGES; Chibeu A, 2012, VIRUSES-BASEL, V4, P471, DOI 10.3390/v4040471; Comeau AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040102; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; German GJ., 2006, R, P211; Havlis J, 2003, ANAL CHEM, V75, P1300, DOI 10.1021/ac026136s; Johnson R. P., 2008, Animal Health Research Reviews, V9, P201, DOI 10.1017/S1466252308001576; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jun JW, 2013, RES MICROBIOL, V164, P979, DOI 10.1016/j.resmic.2013.08.007; Juretic D, 2002, J CHEM INF COMP SCI, V42, P620, DOI 10.1021/ci010263s; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kesik-Szeloch A, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-100; King A.M., 2012, VIRUS TAXONOMY, V9; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Kropinski AM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-207; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lavigne R, 2008, RES MICROBIOL, V159, P406, DOI 10.1016/j.resmic.2008.03.005; Lee YD, 2012, ARCH VIROL, V157, P199, DOI 10.1007/s00705-011-1147-0; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; Liu H, 2013, JOINT CAN SOC AN SCI; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mahadevan P, 2010, ADV EXP MED BIOL, V680, P379, DOI 10.1007/978-1-4419-5913-3_43; Mahadevan Padmanabhan, 2009, International Journal of Computational Biology and Drug Design, V2, P100; Mahadevan Padmanabhan, 2009, BMC Res Notes, V2, P168, DOI 10.1186/1756-0500-2-168; MARTIN DTM, 1976, J GEN VIROL, V33, P309, DOI 10.1099/0022-1317-33-2-309; Maura D, 2011, APPL MICROBIOL BIOT, V90, P851, DOI 10.1007/s00253-011-3227-1; Mishra CK, 2012, J GEN VIROL, V93, P2310, DOI 10.1099/vir.0.043562-0; Mitra A, 2011, NUCLEIC ACIDS RES, V39, pD129, DOI 10.1093/nar/gkq971; Mollov D, 2013, ARCH VIROL, V158, P1917, DOI 10.1007/s00705-013-1686-7; Niu YD, 2009, J APPL MICROBIOL, V107, P646, DOI 10.1111/j.1365-2672.2009.04231.x; Niu YD, 2009, APPL ENVIRON MICROB, V75, P1271, DOI 10.1128/AEM.02100-08; Niu YD, 2012, CAN J MICROBIOL, V58, P923, DOI [10.1139/w2012-063, 10.1139/W2012-063]; Nyachuba DG, 2010, NUTR REV, V68, P257, DOI 10.1111/j.1753-4887.2010.00286.x; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Olson Sue A, 2002, Brief Bioinform, V3, P87, DOI 10.1093/bib/3.1.87; Public Health Agency of Canada, 2011, NAT ENT SURV PROGR N; RAMSAY N, 1984, VIROLOGY, V132, P239, DOI 10.1016/0042-6822(84)90031-X; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Reyes A, 2012, NAT REV MICROBIOL, V10, P607, DOI 10.1038/nrmicro2853; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roberts MD, 2004, VIROLOGY, V318, P245, DOI 10.1016/j.virol.2003.09.020; Rozema EA, 2009, J FOOD PROTECT, V72, P241, DOI 10.4315/0362-028X-72.2.241; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J, 2001, MOL CLONING LAB MANU; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stanford K, 2010, J FOOD PROTECT, V73, P1304, DOI 10.4315/0362-028X-73.7.1304; Switt AIM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-481; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Westover KM, 2013, MOL PHYLOGENET EVOL, V69, P1, DOI 10.1016/j.ympev.2013.05.010; Wietzorrek A, 2006, J BACTERIOL, V188, P1419, DOI 10.1128/JB.188.4.1419-1436.2006	66	40	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100426	10.1371/journal.pone.0100426	http://dx.doi.org/10.1371/journal.pone.0100426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963920	Green Submitted, Green Published, gold			2022-12-25	WOS:000338709500049
J	Real, A; Comino, I; Moreno, MD; Lopez-Casado, MA; Lorite, P; Torres, MI; Cebolla, A; Sousa, C				Real, Ana; Comino, Isabel; de Lourdes Moreno, Ma; Angel Lopez-Casado, Miguel; Lorite, Pedro; Isabel Torres, Ma; Cebolla, Angel; Sousa, Carolina			Identification and In Vitro Reactivity of Celiac Immunoactive Peptides in an Apparent Gluten-Free Beer	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; DISEASE; INTOLERANCE; TOXICITY; GUT	Gluten content from barley, rye, wheat and in certain oat varieties, must be avoid in individuals with celiac disease. In most of the Western countries, the level of gluten content in food to be considered as gluten-free products is below 20 parts per million measured by ELISA based on specific anti-gluten peptide antibody. However, in beverages or food suffering complex hydrolytic processes as beers, the relative proportion of reactive peptides for celiac patients and the analytical techniques may differ, because of the diversity of the resulting peptide populations after fermentations. A beer below 20 parts per million of gluten but yet detectable levels of gluten peptides by anti-gliadin 33-mer antibodies (G12 and A1) was analyzed. We identified and characterized the relevant peptides for either antibody recognition or immunoactivity in celiac patients. The beer was fractionated by HPLC. The relative reactivity of the different HPLC fractions to the G12/A1 antibodies correlated to the reactivity of peripheral blood mononuclear cells isolated from 14 celiac individuals. Peptides from representative fractions classified according to the relative reactivity to G12/A1 antibodies were identified by mass spectrometry. The beer peptides containing sequences with similarity to those of previously described G12 and A1 epitopes were synthesized and confirmed significant reactivity for the antibodies. The most reactive peptides for G12/A1 also confirmed the highest immunogenicity by peripheral blood mononuclear cell activation and interferon c production from celiac patients. We concluded that preparative HPLC combined with anti-gliadin 33-mer G12/A1 antibodies were very sensitive and specific methods to analyze the relevant immunogenic peptides in hydrolyzed gluten.	[Real, Ana; Comino, Isabel; de Lourdes Moreno, Ma; Sousa, Carolina] Univ Seville, Fac Farm, Dept Microbiol & Parasitol, Seville, Spain; [Angel Lopez-Casado, Miguel] Hosp Virgen de las Nieves, Dept Gastroenterol Pediat, Granada, Spain; [Lorite, Pedro; Isabel Torres, Ma] Campus Univ Las Lagunillas, Dept Biol Expt, Jaen, Spain; [Cebolla, Angel] Biomedal SL, Seville, Spain	University of Sevilla; Hospital Universitario Virgen de las Nieves	Sousa, C (corresponding author), Univ Seville, Fac Farm, Dept Microbiol & Parasitol, Seville, Spain.	csoumar@us.es	de Lourdes Moreno Amador, María/H-5836-2012; Torres, Maria/GVU-3391-2022; Martínez, Pedro Lorite/K-6806-2012; MI, Torres/G-8789-2015	de Lourdes Moreno Amador, María/0000-0002-7490-2037; Martínez, Pedro Lorite/0000-0002-9692-5870; MI, Torres/0000-0002-9309-3837; Sousa Martin, Carolina/0000-0002-9235-9496	Ministerio de Ciencia e Innovacion [IPT-010-2010-26]; Corporacion Tecnologica de Andalucia [12/610]; Agencia IDEA [860203]; Junta de Andalucia (Proyectos de Investigacion de Excelencia) [AGR-4783];  [AGR2009-4966M]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Corporacion Tecnologica de Andalucia; Agencia IDEA; Junta de Andalucia (Proyectos de Investigacion de Excelencia)(Junta de Andalucia); 	This study was supported by a grant (no IPT-010-2010-26, subprograma INNPACTO) from de Ministerio de Ciencia e Innovacion (Fondos Tecnologicos 2007-2013, FEDER). Biomedal thanks Corporacion Tecnologica de Andalucia (Ref. 12/610) and Agencia IDEA (Ref. 860203) for co-funding this study. Ana Real was supported by a fellowship from Junta de Andalucia (Proyectos de Investigacion de Excelencia, AGR-4783). This work was also supported by AGR2009-4966M to M a Isabel Torres (Proyectos de Excelencia, Junta de Andalucia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton SH, 2008, GASTROENTEROL CLIN N, V37, P411, DOI 10.1016/j.gtc.2008.02.001; Bernardo D, 2012, EUR J INTERN MED, V23, P6, DOI 10.1016/j.ejim.2011.09.016; Chen TS, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-16; Comino I, 2013, J SCI FOOD AGR, V93, P933, DOI 10.1002/jsfa.5830; Comino I, 2012, MOL NUTR FOOD RES, V56, P1697, DOI 10.1002/mnfr.201200358; Comino I, 2011, GUT, V60, P915, DOI 10.1136/gut.2010.225268; Ehren J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006313; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Hadjivassiliou M, 2010, LANCET NEUROL, V9, P318, DOI 10.1016/S1474-4422(09)70290-X; Koning F, 2003, SCIENCE, V299, P513, DOI 10.1126/science.299.5606.513; MARSH MN, 1995, BAILLIERE CLIN GASTR, V9, P273, DOI 10.1016/0950-3528(95)90032-2; McFarland B, 2009, WORLDS BEST BEERS 10; Moron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002294; Moron B, 2008, AM J CLIN NUTR, V87, P405, DOI 10.1093/ajcn/87.2.405; Piastowska-Ciesielska AW, 2013, ARCH MED SCI, V9, P739, DOI 10.5114/aoms.2012.30955; Picariello G, 2011, FOOD CHEM, V124, P1718, DOI 10.1016/j.foodchem.2010.07.111; Real A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048365; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Sheehan MC, 1997, J I BREWING, V103, P297, DOI 10.1002/j.2050-0416.1997.tb00960.x; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Shoghi KI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074188; Silano M, 2014, EUR J NUTR, V53, P1177, DOI 10.1007/s00394-013-0617-4; Tye-Din JA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001012; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606	25	30	31	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100917	10.1371/journal.pone.0100917	http://dx.doi.org/10.1371/journal.pone.0100917			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963630	Green Published, gold, Green Submitted			2022-12-25	WOS:000338709500099
J	Aterido, A; Palacio, C; Marsal, S; Avila, G; Julia, A				Aterido, Adria; Palacio, Carlos; Marsal, Sara; Avila, Gabriela; Julia, Antonio			Novel Insights into the Regulatory Architecture of CD4+T Cells in Rheumatoid Arthritis	PLOS ONE			English	Article							NF-KAPPA-B; QUANTITATIVE TRAIT LOCI; T-CELL; DISEASE-ACTIVITY; GENE-EXPRESSION; NONCODING RNAS; SURVIVIN; INFLAMMATION; ASSOCIATION; HYPOMETHYLATION	Rheumatoid arthritis (RA) is the most frequent autoimmune chronic inflammatory disease of the joints and it is characterized by the inflammation of the synovial membrane and the subsequent destruction of the joints. In RA, CD4+ T cells are the main drivers of disease initiation and the perpetuation of the damaging inflammatory process. To date, however, the genetic regulatory mechanisms of CD4+ T cells associated with RA etiology are poorly understood. The genome-wide analysis of expression quantitative trait loci (eQTL) in disease-relevant cell types is a recent genomic integration approach that is providing significant insights into the genetic regulatory mechanisms of many human pathologies. The objective of the present study was to analyze, for the first time, the genome-wide genetic regulatory mechanisms associated with the gene expression of CD4+ T cells in RA. Whole genome gene expression profiling of CD4+ T cells and the genome-wide genotyping (598,258 SNPs) of 29 RA patients with an active disease were performed. In order to avoid the excessive burden of multiple testing associated with genome-wide trans-eQTL analysis, we developed and implemented a novel systems genetics approach. Finally, we compared the genomic regulation pattern of CD4+ T cells in RA with the genomic regulation observed in reference lymphoblastoid cell lines (LCLs). We identified a genome-wide significant cis-eQTL associated with the expression of FAM66C gene (P = 6.51e-9). Using our new systems genetics approach we identified six statistically significant trans-eQTLs associated with the expression of KIAA0101 (P<7.4e-8) and BIRC5 (P = 5.35e-8) genes. Finally, comparing the genomic regulation profiles between RA CD4+ T cells and control LCLs we found 20 genes showing differential regulatory patterns between both cell types. The present genome-wide eQTL analysis has identified new genetic regulatory elements that are key to the activity of CD4+ T cells in RA.	[Aterido, Adria; Marsal, Sara; Avila, Gabriela; Julia, Antonio] Vall dHebron Hosp Res Inst, Rheumatol Res Grp, Barcelona, Spain; [Palacio, Carlos] Hosp Univ Vall dHebron, Dept Hematol, Barcelona, Spain	Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron	Marsal, S (corresponding author), Vall dHebron Hosp Res Inst, Rheumatol Res Grp, Barcelona, Spain.	sara.marsal@vhir.org; toni.julia@vhir.org		marsal, sara/0000-0001-5515-3854; Avila-Pedretti, Gabriela/0000-0002-6526-6278; Julia Cano, Antonio/0000-0001-6064-3620; Palacio-Garcia, Carles/0000-0002-9085-3327	Spanish Ministry of Economy and Competitiveness [PSE-010000-2006-6, IPT-010000-2010-36]; Fondo de Investigacion Sanitaria [PI040720]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III)	This work was supported by the Spanish Ministry of Economy and Competitiveness grants [PSE-010000-2006-6 and IPT-010000-2010-36] and the Fondo de Investigacion Sanitaria grant [PI040720]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003514; Ahn JK, 2010, INFLAMMATION, V33, P381, DOI 10.1007/s10753-010-9196-1; Andersson SEM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047668; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bokarewa M, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4474; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Burkovics P, 2009, NUCLEIC ACIDS RES, V37, P4247, DOI 10.1093/nar/gkp357; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Civelek M, 2013, NAT REV GENET, V3; Contassot E, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13590; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Deshpande P, 2013, J IMMUNOL, V190, P1416, DOI 10.4049/jimmunol.1201620; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisenstein EM, 2009, PEDIATR RES, V65, p26R, DOI 10.1203/PDR.0b013e31819e76c7; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Feldmann M, 2002, ANN RHEUM DIS, V61, P13; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fu LH, 2011, ACTA PHARMACOL SIN, V32, P1373, DOI 10.1038/aps.2011.98; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Grundberg E, 2009, GENOME RES, V19, P1942, DOI 10.1101/gr.095224.109; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Julia A, 2013, CURR TOP MED CHEM, V13, P720, DOI 10.2174/1568026611313060005; Kais Z, 2011, MOL CANCER RES, V9, P1091, DOI 10.1158/1541-7786.MCR-10-0503; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karouzakis E, 2009, ARTHRITIS RHEUM-US, V60, P3613, DOI 10.1002/art.25018; Kolev M, 2013, SEMIN IMMUNOL, V25, P12, DOI 10.1016/j.smim.2013.04.012; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Liu HT, 2003, CURR OPIN PHARMACOL, V3, P317, DOI 10.1016/S1471-4892(03)00037-7; Majewski J, 2011, TRENDS GENET, V27, P72, DOI 10.1016/j.tig.2010.10.006; Makarov SS, 2001, ARTHRITIS RES, V3, P200, DOI 10.1186/ar300; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Maxwell L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007277.pub2; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Montgomery SB, 2011, NAT REV GENET, V12, P277, DOI 10.1038/nrg2969; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nica AC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0362; Noack M, 2014, AUTOIMMUN REV, V11, P00008; Oh H, 2013, IMMUNOL REV, V252, P41, DOI 10.1111/imr.12033; Page CE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2960; Pieper J, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-34; Pope RM, 2013, NAT REV RHEUMATOL, V9, P252, DOI 10.1038/nrrheum.2012.170; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Salmon M, 1997, J CLIN INVEST, V99, P439, DOI 10.1172/JCI119178; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Simmonds RE, 2008, RHEUMATOLOGY, V47, P584, DOI 10.1093/rheumatology/kem298; Skapenko A, 2005, ARTHRITIS RES THER, V7, pS4, DOI 10.1186/ar1703; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Smolen JS, 2012, NAT REV RHEUMATOL, V8, P235, DOI 10.1038/nrrheum.2012.23; Song JX, 2007, NAT IMMUNOL, V8, P64, DOI 10.1038/ni1413; Song JX, 2005, IMMUNITY, V22, P621, DOI 10.1016/j.immuni.2005.03.012; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Strainic MG, 2013, NAT IMMUNOL, V14, P162, DOI 10.1038/ni.2499; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Svensson B, 2010, ANN MED, V42, P45, DOI 10.3109/07853890903376280; Vallabhajosyula RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005344; van Nas A, 2010, GENETICS, V185, P1059, DOI 10.1534/genetics.110.116087; Vasanthi P, ROLE TUMOR NECROSIS; Wang WH, 2012, RHEUMATOL INT, V32, P887, DOI 10.1007/s00296-010-1710-0; Zhu M, 2009, J DRUG TARGET, V17, P524, DOI 10.1080/10611860903046610	78	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100690	10.1371/journal.pone.0100690	http://dx.doi.org/10.1371/journal.pone.0100690			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959711	gold, Green Published, Green Submitted			2022-12-25	WOS:000338633900070
J	Vilaplana, C; Prats, C; Marzo, E; Barril, C; Vegue, M; Diaz, J; Valls, J; Lopez, D; Cardona, PJ				Vilaplana, Cristina; Prats, Clara; Marzo, Elena; Barril, Carles; Vegue, Marina; Diaz, Jorge; Valls, Joaquim; Lopez, Daniel; Cardona, Pere-Joan			To Achieve an Earlier IFN-gamma Response Is Not Sufficient to Control Mycobacterium tuberculosis Infection in Mice	PLOS ONE			English	Article							INITIATION; HISTOLOGY	The temporo-spatial relationship between the three organs (lung, spleen and lymph node) involved during the initial stages of Mycobacterium tuberculosis infection has been poorly studied. As such, we performed an experimental study to evaluate the bacillary load in each organ after aerosol or intravenous infection and developed a mathematical approach using the data obtained in order to extract conclusions. The results showed that higher bacillary doses result in an earlier IFN-gamma response, that a certain bacillary load (BL) needs to be reached to trigger the IFN-gamma response, and that control of the BL is not immediate after onset of the IFN-gamma response, which might be a consequence of the spatial dimension. This study may have an important impact when it comes to designing new vaccine candidates as it suggests that triggering an earlier IFN-gamma response might not guarantee good infection control, and therefore that additional properties should be considered for these candidates.	[Vilaplana, Cristina; Marzo, Elena; Diaz, Jorge; Cardona, Pere-Joan] Univ Autonoma Barcelona, CIBERES, Unitat TB Expt, Fundacio Inst Invest Ciencies Salut German Trias, Badalona, Catalonia, Spain; [Prats, Clara; Barril, Carles; Vegue, Marina; Valls, Joaquim; Lopez, Daniel] Univ Politecn Cataluna, Escola Super Agr Barcelona, Dept Fis & Engn Nucl, Castelldefels, Catalonia, Spain	Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Universitat Politecnica de Catalunya	Cardona, PJ (corresponding author), Univ Autonoma Barcelona, CIBERES, Unitat TB Expt, Fundacio Inst Invest Ciencies Salut German Trias, Badalona, Catalonia, Spain.	pjcardona@igtp.cat	Marzo, Elena/AAG-7662-2020; Valls, Joaquim/L-7135-2014; Codina, Daniel Lopez/Q-5959-2019; Barril, Carles/AGH-0271-2022; Prats, Clara/L-4797-2014; Codina, Daniel Lopez/L-5309-2014; Cardona, Pere-Joan/A-5258-2011; Vilaplana, Cristina/K-7216-2012	Valls, Joaquim/0000-0002-2346-5041; Codina, Daniel Lopez/0000-0002-0408-4526; Prats, Clara/0000-0002-1398-7559; Codina, Daniel Lopez/0000-0002-0408-4526; Cardona, Pere-Joan/0000-0001-5623-7873; Vilaplana, Cristina/0000-0002-2808-7270; Barril, Carles/0000-0002-4612-5533	Spanish Government through the Ministerio de Ciencia e Innovacion [CGL2010-20160]; FIS [11/01702];  [CP13/00174]	Spanish Government through the Ministerio de Ciencia e Innovacion; FIS(Instituto de Salud Carlos III); 	This study was financially supported by the Spanish Government through the Plan Nacional I+D+i of the Ministerio de Ciencia e Innovacion CGL2010-20160, the FIS 11/01702 and Dr Vilaplana's Miguel Servet Contract CP13/00174. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baena A, 2009, TISSUE ANTIGENS, V74, P189, DOI 10.1111/j.1399-0039.2009.01301.x; Briken V, 2013, ADV EXP MED BIOL, V783, P93, DOI 10.1007/978-1-4614-6111-1_5; Bru A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012985; Cardona PJ, 2009, INFECTION, V37, P80, DOI 10.1007/s15010-008-8087-y; Cardona PJ, 2011, ENFERM INFEC MICR CL, V29, P14, DOI 10.1016/S0213-005X(11)70013-1; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002; Gill WP, 2009, NAT MED, V15, P211, DOI 10.1038/nm.1915; Hernandez-Pando R, 2000, LANCET, V356, P2133, DOI 10.1016/S0140-6736(00)03493-0; Jung YJ, 2005, J EXP MED, V201, P1915, DOI 10.1084/jem.20050265; Khader SA, 2009, J IMMUNOL, V183, P8004, DOI 10.4049/jimmunol.0901937; Marzo E, 2014, TUBERCULOSIS, V94, P55, DOI 10.1016/j.tube.2013.09.004; McCullagh P, 1989, NAT MED; Mehra A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003734; Ramachandra L, 2005, INFECT IMMUN, V73, P1097, DOI 10.1128/IAI.73.2.1097-1105.2005; Ramachandra L, 2001, J EXP MED, V194, P1421, DOI 10.1084/jem.194.10.1421; Rubin EJ, 2009, NEW ENGL J MED, V360, P2471, DOI 10.1056/NEJMcibr0902539; Treuting PM, 2012, COMP ANATOMY HISTOLO, pxii; Vilaplana C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00055; Wang CY, 1916, LANCET, V2, P417; Willard-Mack CL, 2006, TOXICOL PATHOL, V34, P409, DOI 10.1080/01926230600867727; Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367	22	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100830	10.1371/journal.pone.0100830	http://dx.doi.org/10.1371/journal.pone.0100830			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959669	Green Published, gold, Green Submitted			2022-12-25	WOS:000338633900093
J	Wu, G; Jia, HB; Huang, YW; Gan, L; Fu, CH; Zhang, LB; Yu, LJ; Li, MT				Wu, Geng; Jia, Haibo; Huang, Yongwei; Gan, Lu; Fu, Chunhua; Zhang, Libin; Yu, Longjiang; Li, Maoteng			Characterization and Molecular Interpretation of the Photosynthetic Traits of Lonicera confusa in Karst Environment	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; SEEDLING GROWTH; CALCIUM; PROTEIN; SALT; RESPONSES; DROUGHT; LEAVES; PLANT; CHLOROPLASTS	Lonicera confusa was a medical plant which could adapt to the Ca-rich environment in the karst area of China. The photosynthesis, relative chlorophyll content, differentially expressed genes (DEGs) and differentially expressed proteins (DEPs) of L. confusa that cultivated in calcareous and sandstone soils were investigated. The results showed that the relative chlorophyll content and net photosynthesis rate of L. confusa in calcareous soil are much higher than that planted in sandstone soil, the higher content of calcium might play a role in keeping the chloroplast from harm and showed higher photosynthesis rate. The transpiration and stomata conductance were decreased in calcareous soil, which might result from the closure of stomata. The GeneFishing and proteomic results showed that the expression of DEGs and DEPs were critical for photosynthesis and stomata closure, such as RuBisCO, photosynthetic electron transfer c and malate dehydrogenase varied in the leaves of L. confusa that cultivated in different soils. These DEGs or DEPs were further found to be directly or indirectly regulated by calcium sensor proteins. This study enriched our knowledge of the molecular mechanism of high net photosynthesis rate and lower transpiration of L. confusa that cultivated in the calcareous soil in some degree.	[Wu, Geng; Jia, Haibo; Huang, Yongwei; Gan, Lu; Fu, Chunhua; Zhang, Libin; Yu, Longjiang; Li, Maoteng] Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Wu, Geng] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; China University of Geosciences	Li, MT (corresponding author), Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	limaoteng426@mail.hust.edu.cn	Wu, Geng/G-9740-2018; WU, Geng/F-8840-2010	WU, Geng/0000-0002-7259-1044	National Science Foundation of China [31270373]; Natural Science Funds for Distinguished Young Scholars of Hubei Province of China [2010CDA097]; Ministry of Education of China [NCET110172]; Hubei Key Laboratory of Economic Forest Germplasm Improvement and Resources Comprehensive Utilization [2011BLKF247]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Funds for Distinguished Young Scholars of Hubei Province of China; Ministry of Education of China(Ministry of Education, China); Hubei Key Laboratory of Economic Forest Germplasm Improvement and Resources Comprehensive Utilization	The research was supported by the National Science Foundation of China (31270373), Natural Science Funds for Distinguished Young Scholars of Hubei Province of China (2010CDA097), New Century Talents Support Program by the Ministry of Education of China (NCET110172) and Hubei Key Laboratory of Economic Forest Germplasm Improvement and Resources Comprehensive Utilization (2011BLKF247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, PLANT PHYSL 5 EDITIO; Bertsch U, 1995, PLANT MOL BIOL, V29, P1039, DOI 10.1007/BF00014976; BRAND JJ, 1984, J BIOENERG BIOMEMBR, V16, P239, DOI 10.1007/BF00744278; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; [曹建华 Cao Jian hua], 2003, [地球科学进展, Advance in Earth Sciences], V18, P37; Chaerle L, 2006, PLANT CELL PHYSIOL, V47, P1323, DOI 10.1093/pcp/pcj102; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Coria NA, 1998, J AGR FOOD CHEM, V46, P4524, DOI 10.1021/jf980151+; Crafts-Brandner SJ, 2002, PLANT PHYSIOL, V129, P1773, DOI 10.1104/pp.002170; DAMERVAL C, 1988, PLANT PHYSIOL, V86, P1304, DOI 10.1104/pp.86.4.1304; Davis PA, 2011, PLANT CELL ENVIRON, V34, P2047, DOI 10.1111/j.1365-3040.2011.02402.x; Deng YM, 2012, PLANT PHYSIOL BIOCH, V55, P93, DOI 10.1016/j.plaphy.2012.03.006; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Gabara B, 2003, PLANT SCI, V164, P507, DOI 10.1016/S0168-9452(02)00447-8; Garty J, 2001, J ENVIRON QUAL, V30, P884, DOI 10.2134/jeq2001.303884x; He ChengXin, 2007, Guangxi Zhiwu / Guihaia, V27, P53; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; [黄玉清 HUANG Yuqing], 2006, [广西植物, Guihaia], V26, P171; Hughes NM, 2007, NEW PHYTOL, V175, P675, DOI 10.1111/j.1469-8137.2007.02133.x; Kasahara M, 2002, NATURE, V420, P829, DOI 10.1038/nature01213; Khayyat M, 2009, FRUITS, V64, P53, DOI 10.1051/fruits/2008050; Kiegle E, 2000, PLANT J, V23, P267, DOI 10.1046/j.1365-313x.2000.00786.x; Kobe RK, 2002, CAN J FOREST RES, V32, P954, DOI [10.1139/x02-018, 10.1139/X02-018]; KRETSINGER RH, 1976, INT REV CYTOL, V46, P323, DOI 10.1016/S0074-7696(08)60994-8; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Lasserre Jean Paul, 2012, Methods Mol Biol, V869, P317, DOI 10.1007/978-1-61779-821-4_27; [李强 LI Qiang], 2006, [水科学进展, Advances in Water Science], V17, P733; Li XH, 2006, J PROTEOME RES, V5, P2809, DOI 10.1021/pr0603093; Liu HT, 2003, PLANT PHYSIOL, V132, P1186, DOI 10.1104/pp.102.018564; Liu TW, 2011, TREE PHYSIOL, V31, P402, DOI 10.1093/treephys/tpr019; Liu ZH, 2004, GROUND WATER, V42, P491, DOI 10.1111/j.1745-6584.2004.tb02617.x; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; Ludlow M. M., 1989, Current Topics in Plant Biochemistry and Physiology, V8, P81; Mall TK, 2011, PLANT MOL BIOL, V75, P467, DOI 10.1007/s11103-011-9741-9; Miller A, 2000, PHOTOSYNTH RES, V63, P1, DOI 10.1023/A:1006367719639; Ng CKY, 2001, NATURE, V410, P596, DOI 10.1038/35069092; Nunes-Nesi A, 2005, PLANT PHYSIOL, V137, P611, DOI 10.1104/pp.104.055566; Ouyang B, 2007, J EXP BOT, V58, P507, DOI 10.1093/jxb/erl258; [彭涛 PENG Tao], 2006, [植物生理学通讯, Plant Physiology Communications], V42, P83; Petroutsos D, 2011, PLANT CELL, V23, P2950, DOI 10.1105/tpc.111.087973; Qiu QS, 2007, PLANT PHYSIOL, V144, P468, DOI 10.1104/pp.106.095182; Rocha AG, 2012, PROTOPLASMA, V249, P957, DOI 10.1007/s00709-011-0373-3; Roxas VP, 1997, NAT BIOTECHNOL, V15, P988, DOI 10.1038/nbt1097-988; Roy A, 2013, PLANT CELL ENVIRON, V36, P2120, DOI 10.1111/pce.12099; Selth LA, 2005, PLANT CELL, V17, P311, DOI 10.1105/tpc.104.027235; Sun Xian-zhi, 2008, Yingyong Shengtai Xuebao, V19, P1983; Tan W, 2011, J PLANT PHYSIOL, V168, P2063, DOI 10.1016/j.jplph.2011.06.009; TANAKA A, 1980, PLANT PHYSIOL, V65, P1211, DOI 10.1104/pp.65.6.1211; Terashima M, 2012, P NATL ACAD SCI USA, V109, P17717, DOI 10.1073/pnas.1207118109; Tian HQ, 1997, PLANTA, V202, P93, DOI 10.1007/s004250050107; Wang WH, 2012, J EXP BOT, V63, P177, DOI 10.1093/jxb/err259; [吴耿 Wu Geng], 2011, [植物学报, Chinese Bulletin of Botany], V46, P658; Wu G, 2011, PLANT SOIL, V338, P343, DOI 10.1007/s11104-010-0549-1; Xu D.Q., 1997, PLANT PHYSL COMMUN, V33, P241, DOI [10.13592/j.cnki.ppj.1997.04.001, DOI 10.13592/J.CNKI.PPJ.1997.04.001]; Yang Y, 2012, PLANT CELL PHYSIOL, V53, P1083, DOI 10.1093/pcp/pcs055; Yao X, 2006, BIOMED CHROMATOGR, V20, P1192, DOI 10.1002/bmc.684; [由继红 You Jihong], 2002, [作物学报, Acta Agronomica Sinica], V28, P693; Yuan DX, 2001, ACTA GEOL SIN-ENGL, V75, P336; Yue YM, 2010, ENVIRON MONIT ASSESS, V160, P157, DOI 10.1007/s10661-008-0665-z; Zhu S, 2013, PLANT MOL BIOL REP, V31, P1193, DOI 10.1007/s11105-013-0631-y	62	1	1	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100703	10.1371/journal.pone.0100703	http://dx.doi.org/10.1371/journal.pone.0100703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959829	gold, Green Published, Green Submitted			2022-12-25	WOS:000338633900072
J	Park, JM; Tougeron, D; Huang, SB; Okamoto, K; Sinicrope, FA				Park, Jae Myung; Tougeron, David; Huang, Shengbing; Okamoto, Koichi; Sinicrope, Frank A.			Beclin 1 and UVRAG Confer Protection from Radiation-Induced DNA Damage and Maintain Centrosome Stability in Colorectal Cancer Cells	PLOS ONE			English	Article							INDUCED APOPTOSIS; AUTOPHAGY; REPAIR; INHIBITION; RECOMBINATION; CYCLE; GENE; LC3; ATM	Beclin 1 interacts with UV-irradiation-resistance-associated gene (UVRAG) to form core complexes that induce autophagy. While cells with defective autophagy are prone to genomic instability that contributes to tumorigenesis, it is unknown whether Beclin1 or UVRAG can regulate the DNA damage/repair response to cancer treatment in established tumor cells. We found that siRNA knockdown of Beclin 1 or UVRAG can increase radiation-induced DNA double strand breaks (DSBs), shown by pATM and gamma H2Ax, and promote colorectal cancer cell death. Furthermore, knockdown of Beclin 1, UVRAG or ATG5 increased the percentage of irradiated cells with nuclear foci expressing 53BP1, a marker of nonhomologous end joining but not RAD51 (homologous recombination), compared to control siRNA. Beclin 1 siRNA was shown to attenuate UVRAG expression. Cells with a UVRAG deletion mutant defective in Beclin 1 binding showed increased radiation-induced DSBs and cell death compared to cells with ectopic wild-type UVRAG. Knockdown of Beclin 1 or UVRAG, but not ATG5, resulted in a significant increase in centrosome number (gamma-tubulin staining) in irradiated cells compared to control siRNA. Taken together, these data indicate that Beclin 1 and UVRAG confer protection against radiation-induced DNA DSBs and may maintain centrosome stability in established tumor cells.	[Sinicrope, Frank A.] Mayo Clin, Rochester, MN 55902 USA; Mayo Clin, Ctr Canc, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Sinicrope, FA (corresponding author), Mayo Clin, Rochester, MN 55902 USA.	sinicrope.frank@mayo.edu	tougeron, david/ABF-3217-2020	tougeron, david/0000-0002-8065-9635	National Cancer Institute [5 K05 CA142885, CA113681]; Multi-Organizational Thematic Institute for Cancer; French National Cancer Institute; NATIONAL CANCER INSTITUTE [K05CA142885, R01CA113681] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Multi-Organizational Thematic Institute for Cancer; French National Cancer Institute(Institut National du Cancer (INCA) France); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute (5 K05 CA142885 and CA113681, both to FAS). DT is a recipient of financial support from the Multi-Organizational Thematic Institute for Cancer and the French National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Acu ID, 2010, CANCER RES, V70, P3320, DOI 10.1158/0008-5472.CAN-09-3800; Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Bourke E, 2007, EMBO REP, V8, P603, DOI 10.1038/sj.embor.7400962; D'Assoro AB, 2002, ONCOGENE, V21, P6146, DOI 10.1038/sj.onc.1205772; Flatten K, 2005, J BIOL CHEM, V280, P14349, DOI 10.1074/jbc.M411890200; Fremont S, 2013, EMBO REP, V14, P364, DOI 10.1038/embor.2013.23; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Huang SB, 2013, J BIOL CHEM, V288, P33654, DOI 10.1074/jbc.M113.518134; Huang SB, 2011, J BIOL CHEM, V286, P40002, DOI 10.1074/jbc.M111.297432; Huang SB, 2010, AUTOPHAGY, V6, P256, DOI 10.4161/auto.6.2.11124; Ionov Y, 2004, ONCOGENE, V23, P639, DOI 10.1038/sj.onc.1207178; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kuwahara Y, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.56; Li XH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1648; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 2001, CANCER RES, V61, P3443; Liu J, 2010, CELL, V147, P223; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Park JM, 2013, CANCER BIOL THER, V14, P100, DOI 10.4161/cbt.22954; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Sato N, 2000, ONCOGENE, V19, P5281, DOI 10.1038/sj.onc.1203902; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Suwaki N, 2011, SEMIN CELL DEV BIOL, V22, P898, DOI 10.1016/j.semcdb.2011.07.019; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zhao Z, 2012, AUTOPHAGY, V8, P1392, DOI 10.4161/auto.21035; Zhao Z, 2012, DEV CELL, V22, P1001, DOI 10.1016/j.devcel.2011.12.027	39	50	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100819	10.1371/journal.pone.0100819	http://dx.doi.org/10.1371/journal.pone.0100819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956373	Green Published, gold, Green Submitted			2022-12-25	WOS:000338917900098
J	Huang, SY; Ko, CE; Chen, GS; Chung, IF; Yang, FY				Huang, Sheng-Yao; Ko, Chia-En; Chen, Gin-Shin; Chung, I-Fang; Yang, Feng-Yi			Focused Ultrasound Simultaneous Irradiation/MRI Imaging, and Two-Stage General Kinetic Model	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CONTRAST-ENHANCED MRI; ARTERIAL INPUT FUNCTION; QUANTITATIVE-EVALUATION; IN-VIVO; DCE-MRI; PERMEABILITY; DISRUPTION; DELIVERY; TRACER	Many studies have investigated how to use focused ultrasound (FUS) to temporarily disrupt the blood-brain barrier (BBB) in order to facilitate the delivery of medication into lesion sites in the brain. In this study, through the setup of a real-time system, FUS irradiation and injections of ultrasound contrast agent (UCA) and Gadodiamide (Gd, an MRI contrast agent) can be conducted simultaneously during MRI scanning. By using this real-time system, we were able to investigate in detail how the general kinetic model (GKM) is used to estimate Gd penetration in the FUS irradiated area in a rat's brain resulting from UCA concentration changes after single FUS irradiation. Two-stage GKM was proposed to estimate the Gd penetration in the FUS irradiated area in a rat's brain under experimental conditions with repeated FUS irradiation combined with different UCA concentrations. The results showed that the focal increase in the transfer rate constant of K-trans caused by BBB disruption was dependent on the doses of UCA. Moreover, the amount of in vivo penetration of Evans blue in the FUS irradiated area in a rat's brain under various FUS irradiation experimental conditions was assessed to show the positive correlation with the transfer rate constants. Compared to the GKM method, the Two-stage GKM is more suitable for estimating the transfer rate constants of the brain treated with repeated FUS irradiations. This study demonstrated that the entire process of BBB disrupted by FUS could be quantitatively monitored by real-time dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI).	[Huang, Sheng-Yao; Chung, I-Fang] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Chung, I-Fang] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Taipei 112, Taiwan; [Yang, Feng-Yi] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Yang, Feng-Yi] Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei 112, Taiwan; [Chen, Gin-Shin] Natl Hlth Res Inst, Div Med Engn Res, Zhunan, Miaoli County, Taiwan; [Ko, Chia-En] Mackay Mem Hosp Tan Shui, Dept Diagnost Radiol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; Mackay Memorial Hospital	Chung, IF (corresponding author), Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan.	ifchung@ym.edu.tw; fyyang@ym.edu.tw	Chen, Gin-Shin/E-3988-2010	Huang, Sheng-Yao/0000-0002-3241-430X; Chen, Gin-Shin/0000-0003-3368-7470	National Science Council of Taiwan [NSC 101-2320-B-010-036-MY3, NSC 102-2221-E-010-005-MY3, NSC 102-2221-E-010-014]; Cheng Hsin General Hospital Foundation [102F218C11, 103F003C17]; Biophotonics & Molecular Imaging Research Center; Ministry of Education, Aim for the Top University Plan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Cheng Hsin General Hospital Foundation; Biophotonics & Molecular Imaging Research Center; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This study was supported by grants from the National Science Council of Taiwan (no. NSC 101-2320-B-010-036-MY3, NSC 102-2221-E-010-005-MY3, and NSC 102-2221-E-010-014), Cheng Hsin General Hospital Foundation (no. 102F218C11 and 103F003C17), Biophotonics & Molecular Imaging Research Center, and the Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Beaumont M, 2009, J CEREBR BLOOD F MET, V29, P1714, DOI 10.1038/jcbfm.2009.86; Bilgen M, 2001, MAGN RESON MED, V46, P1099, DOI 10.1002/mrm.1305; Chan AH, 2002, MED PHYS, V29, P2611, DOI 10.1118/1.1513990; Choi JJ, 2010, IEEE T BIO-MED ENG, V57, P145, DOI 10.1109/TBME.2009.2034533; Duiardin M, 2009, EUR J RADIOL, V69, P542, DOI 10.1016/j.ejrad.2007.11.033; Ferrier MC, 2007, NEOPLASIA, V9, P546, DOI 10.1593/neo.07289; Holford NHG, 2005, STAT MED, V24, P2745, DOI DOI 10.1002/SIM.2181; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Kinoshita M, 2006, P NATL ACAD SCI USA, V103, P11719, DOI 10.1073/pnas.0604318103; Liu HL, 2010, P NATL ACAD SCI USA, V107, P15205, DOI 10.1073/pnas.1003388107; McDannold N, 2006, PHYS MED BIOL, V51, P793, DOI 10.1088/0031-9155/51/4/003; McGrath DM, 2009, MAGN RESON MED, V61, P1173, DOI 10.1002/mrm.21959; MILLER DL, 1987, ULTRASOUND MED BIOL, V13, P443, DOI 10.1016/0301-5629(87)90110-4; Muldoon LL, 2011, NEURO-ONCOLOGY, V13, P51, DOI 10.1093/neuonc/noq150; Nyborg WL, 2001, ULTRASOUND MED BIOL, V27, P301, DOI 10.1016/S0301-5629(00)00333-1; Park J, 2012, J CONTROL RELEASE, V162, P134, DOI 10.1016/j.jconrel.2012.06.012; Peruzzo D, 2011, COMPUT METH PROG BIO, V104, pE148, DOI 10.1016/j.cmpb.2011.02.012; Ponce AM, 2007, J NATL CANCER I, V99, P53, DOI 10.1093/jnci/djk005; Raymond SB, 2007, J CEREBR BLOOD F MET, V27, P393, DOI 10.1038/sj.jcbfm.9600336; Sheikov N, 2006, ULTRASOUND MED BIOL, V32, P1399, DOI 10.1016/j.ultrasmedbio.2006.05.015; Simpson NE, 1999, MAGN RESON MED, V42, P42, DOI 10.1002/(SICI)1522-2594(199907)42:1<42::AID-MRM8>3.0.CO;2-Z; Thomas DL, 2006, MAGN RESON MED, V55, P943, DOI 10.1002/mrm.20823; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Vlachos F, 2010, PHYS MED BIOL, V55, P5451, DOI 10.1088/0031-9155/55/18/012; Vlachos F, 2011, MAGN RESON MED, V66, P821, DOI 10.1002/mrm.22848; Yang FY, 2008, ULTRASON SONOCHEM, V15, P636, DOI 10.1016/j.ultsonch.2007.08.003; Yang FY, 2007, ULTRASOUND MED BIOL, V33, P1421, DOI 10.1016/j.ultrasmedbio.2007.04.006; Yang FY, 2011, IEEE T ULTRASON FERR, V58, P964, DOI 10.1109/TUFFC.2011.1897; Yang FY, 2011, J CONTROL RELEASE, V150, P111, DOI 10.1016/j.jconrel.2010.10.038; Yang FY, 2009, J ACOUST SOC AM, V126, P3344, DOI 10.1121/1.3242376; Yankeelov TE, 2005, MAGN RESON IMAGING, V23, P519, DOI 10.1016/j.mri.2005.02.013	33	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100280	10.1371/journal.pone.0100280	http://dx.doi.org/10.1371/journal.pone.0100280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949997	Green Submitted, Green Published, gold			2022-12-25	WOS:000338276300059
J	Varela, M; Diaz-Rosales, P; Pereiro, P; Forn-Cuni, G; Costa, MM; Dios, S; Romero, A; Figueras, A; Novoa, B				Varela, Monica; Diaz-Rosales, Patricia; Pereiro, Patricia; Forn-Cuni, Gabriel; Costa, Maria M.; Dios, Sonia; Romero, Alejandro; Figueras, Antonio; Novoa, Beatriz			Interferon-Induced Genes of the Expanded IFIT Family Show Conserved Antiviral Activities in Non-Mammalian Species	PLOS ONE			English	Article							INDUCIBLE PROTEIN; STIMULATED GENES; RNA-BINDING; INDUCTION; EXPRESSION; EVOLUTION; P56; INFECTION; SELECTION; INNATE	Interferon-induced proteins with tetratricopeptide repeats (IFITs) are involved in the protective response to viral infection, although the precise mechanism of IFITs for reducing viral proliferation is currently unknown. The interaction with the translation initiation factor eIF-3 or viral proteins and the sequestering of viral RNA have been proposed as potential antiviral functions for these proteins. In humans, four members of this family have been characterized. Nevertheless, information about these proteins in fish is almost non-existent. Exploiting the conservation of synteny between human and zebrafish genomes, we have identified ten members of the IFIT family located on four different chromosomes. The induction of these genes was examined both in vitro and in vivo after interferon (IFN) administration and rhabdovirus challenge. Whereas an induction of IFIT genes was observed after interferon treatments (IFN Phi 1, IFN Phi 2 and IFN Phi 3), the viral infection did not affect these IFN-induced genes in vitro, and even reduced the IFN-induced expression of these genes. The response was largely different in vivo, with a broad up-regulation of IFIT genes after viral challenge. In addition, three selected IFITs were cloned in an expression vector and microinjected into zebrafish larvae to examine the protective effect of IFITs upon viral infection. Reduction in the mortality rate was observed confirming a conserved antiviral function in non-mammalian species.	[Varela, Monica; Diaz-Rosales, Patricia; Pereiro, Patricia; Forn-Cuni, Gabriel; Costa, Maria M.; Dios, Sonia; Romero, Alejandro; Figueras, Antonio; Novoa, Beatriz] CSIC, IIM, Vigo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Novoa, B (corresponding author), CSIC, IIM, Vigo, Spain.	virus@iim.csic.es	Forn-Cuní, Gabriel/M-8498-2016; Romero, Alejandro/R-4565-2019; Dios, Sonia/M-4201-2018; Novoa, Beatriz/K-3785-2014; Pereiro, Patricia/AAS-9514-2020; Figueras, Antonio/B-5133-2015; Diaz-Rosales, Patricia/H-9679-2013; Costa, María M/M-2485-2017; Figueras, Antonio/AAB-8921-2019	Forn-Cuní, Gabriel/0000-0001-5976-4759; Romero, Alejandro/0000-0002-9343-3352; Dios, Sonia/0000-0002-2126-991X; Pereiro, Patricia/0000-0002-8734-3334; Figueras, Antonio/0000-0002-0617-0030; Diaz-Rosales, Patricia/0000-0001-6965-3702; Costa, María M/0000-0002-5497-3102; Figueras, Antonio/0000-0002-0617-0030; Novoa, Beatriz/0000-0003-4888-8419	Spanish Ministerio de Ciencia e Innovacion [CSD2007-00002, AGL2011-28921]; "FISHFORPHARMA" (EU) [ITN 289209]; Agencia Estatal Consejo Superior de Investigaciones Cientificas (CSIC) [201230E057]; CSIC, Spain; Ministerio de Educacion [AP2010-2408]; JAE Program	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); "FISHFORPHARMA" (EU); Agencia Estatal Consejo Superior de Investigaciones Cientificas (CSIC); CSIC, Spain; Ministerio de Educacion; JAE Program	This study was funded through the project CSD2007-00002 "Aquagenomics" and AGL2011-28921 from the Spanish Ministerio de Ciencia e Innovacion. The authors' laboratory is also funded by ITN 289209 "FISHFORPHARMA" (EU) and project 201230E057 from the Agencia Estatal Consejo Superior de Investigaciones Cientificas (CSIC). P. Diaz-Rosales received a JAE-Doc contract from the CSIC, Spain, and P. Pereiro and M. Varela received predoctoral grants from the Ministerio de Educacion (F.P.U. fellowship AP2010-2408) and the JAE Program (funded though the CSIC and European Social Funds), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas YM, 2013, NATURE, V494, P60, DOI 10.1038/nature11783; Aggad D, 2009, J IMMUNOL, V183, P3924, DOI 10.4049/jimmunol.0901495; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Belanger SE, 2010, AQUAT TOXICOL, V97, P88, DOI 10.1016/j.aquatox.2009.11.020; Berchtold S, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-75; Boudinot P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022022; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Chiou PP, 2000, J VIROL, V74, P7619, DOI 10.1128/JVI.74.16.7619-7627.2000; Daffis S, 2007, PLOS PATHOG, V3, P1005, DOI 10.1371/journal.ppat.0030106; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Diaz-Rosales P, 2012, MAR BIOTECHNOL, V14, P515, DOI 10.1007/s10126-012-9465-0; DRIEVER W, 1993, IN VITRO CELL DEV-AN, V29, P749; Du Pasquier L, 2009, FRONT BIOSCI-LANDMRK, V14, P177, DOI 10.2741/3239; Faul EJ, 2009, VIRUSES-BASEL, V1, P832, DOI 10.3390/v1030832; Fensterl V, 2008, J VIROL, V82, P11045, DOI 10.1128/JVI.01593-08; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Fernandes JMO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009501; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo JJ, 2000, VIROLOGY, V267, P209, DOI 10.1006/viro.1999.0135; Guo JJ, 2000, EMBO J, V19, P6891, DOI 10.1093/emboj/19.24.6891; Haller O, 2007, BIOCHIMIE, V89, P812, DOI 10.1016/j.biochi.2007.04.015; Hui DJ, 2003, J BIOL CHEM, V278, P39477, DOI 10.1074/jbc.M305038200; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Katibah GE, 2013, MOL CELL, V49, P743, DOI 10.1016/j.molcel.2012.12.015; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0; Kylaniemi MK, 2009, MICROB PATHOGENESIS, V46, P235, DOI 10.1016/j.micpath.2009.01.006; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066859; Lopez-Munoz A, 2009, J IMMUNOL, V182, P3440, DOI 10.4049/jimmunol.0802528; Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Ovstebo R, 2008, INFECT IMMUN, V76, P2685, DOI 10.1128/IAI.01625-07; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rathi AV, 2010, VIROLOGY, V406, P202, DOI 10.1016/j.virol.2010.07.018; Ravi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003177; Raychoudhuri A, 2011, J VIROL, V85, P12881, DOI 10.1128/JVI.05633-11; Reed L.J., 1938, SIMPLE METHOD ESTIMA, V27, P493, DOI [10.1093/oxfordjournals.aje.a118408, DOI 10.1093/OXFORDJOURNALS.AJE.A118408]; Rieder M, 2009, J INTERF CYTOK RES, V29, P499, DOI 10.1089/jir.2009.0068; Robertsen B, 2006, FISH SHELLFISH IMMUN, V20, P172, DOI 10.1016/j.fsi.2005.01.010; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rozen S, 2000, Methods Mol Biol, V132, P365; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saha S, 2003, J GEN VIROL, V84, P1729, DOI 10.1099/vir.0.18826-0; Samuel MA, 2006, J VIROL, V80, P9349, DOI 10.1128/JVI.01122-06; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Soukup S. W, 1974, TERATOLOGY, V9, P250, DOI DOI 10.1002/TERA.1420090224; Stein C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r251; Sunyer JO, 1998, IMMUNOL REV, V166, P39, DOI 10.1111/j.1600-065X.1998.tb01251.x; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Terenzi F, 2007, J VIROL, V81, P8656, DOI 10.1128/JVI.00322-07; Terenzi F, 2008, EMBO J, V27, P3311, DOI 10.1038/emboj.2008.241; Verrier ER, 2011, DEV COMP IMMUNOL, V35, P1204, DOI 10.1016/j.dci.2011.03.012; Viertlboeck BC, 2005, J IMMUNOL, V175, P385, DOI 10.4049/jimmunol.175.1.385; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; Wacher C, 2007, J VIROL, V81, P860, DOI 10.1128/JVI.01167-06; Wang CF, 2003, J VIROL, V77, P3898, DOI 10.1128/JVI.77.7.3898-3912.2003; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZL, 2012, CELL RES, V22, P1328, DOI 10.1038/cr.2012.111; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu XJ, 2006, GENOMICS, V88, P745, DOI 10.1016/j.ygeno.2006.05.008; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708; Zhou X, 2013, INT J BIOL SCI, V9, P200, DOI 10.7150/ijbs.5613; Zhu H, 1997, P NATL ACAD SCI USA, V94, P13985, DOI 10.1073/pnas.94.25.13985; Zou J, 2007, J IMMUNOL, V179, P3859, DOI 10.4049/jimmunol.179.6.3859; Zou J, 2011, DEV COMP IMMUNOL, V35, P1376, DOI 10.1016/j.dci.2011.07.001	79	30	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100015	10.1371/journal.pone.0100015	http://dx.doi.org/10.1371/journal.pone.0100015			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950240	Green Published, gold			2022-12-25	WOS:000338276300030
J	Qaddoumi, MG; Ananthalakshmi, KVV; Phillips, OA; Edafiogho, IO; Kombian, SB				Qaddoumi, Mohamed G.; Ananthalakshmi, Kethireddy V. V.; Phillips, Oludotun A.; Edafiogho, Ivan O.; Kombian, Samuel B.			Evaluation of Anticonvulsant Actions of Dibromophenyl Enaminones Using In Vitro and In Vivo Seizure Models	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; SUPPRESSES EPILEPTIFORM ACTIVITY; ELECTROSHOCK-INDUCED SEIZURES; RAT HIPPOCAMPAL SLICE; ANTIEPILEPTIC DRUGS; RECEPTOR ANTAGONISTS; NEUROPEPTIDE-Y; BRAIN-SLICES; PHARMACOLOGY; PROFILE	Epilepsy and other seizure disorders are not adequately managed with currently available drugs. We recently synthesized a series of dibromophenyl enaminones and demonstrated that AK6 and E249 were equipotent to previous analogs but more efficacious in suppressing neuronal excitation. Here we examined the actions of these lead compounds on in vitro and in vivo seizure models. In vitro seizures were induced in the hippocampal slice chemically (zero Mg2+ buffer and picrotoxin) and electrically using patterned high frequency stimulation (HFS) of afferents. In vivo seizures were induced in rats using the 6 Hz and the maximal electroshock models. AK6 (10 mu M) and E249 (10 mu M) depressed the amplitude of population spikes recorded in area CA1 of the hippocampus by -50.5 +/- 4.3% and -40.1 +/- 3.1% respectively, with partial recovery after washout. In the zero Mg2+ model, AK6 (10 mu M) depressed multiple population spiking (mPS) by -59.3 +/- 6.9% and spontaneous bursts (SBs) by -65.9 +/- 7.2% and in the picrotoxin-model by -43.3 +/- 7.2% and -50.0 +/- 8.3%, respectively. Likewise, E249 (10 mu M) depressed the zero-Mg2+-induced mPS by -48.8 +/- 9.5% and SBs by -55.8 +/- 15.5%, and in the picrotoxin model by -37.1 +/- 5.5% and -56.5 +/- 11.4%, respectively. They both suppressed post-HFS induced afterdischarges and SBs. AK6 and E249 dose-dependently protected rats in maximal electroshock and 6 Hz models of in vivo seizures after 30 min pretreatment. Their level of protection in both models was similar to that obtained with phenytoin Finally, while AK6 had no effect on locomotion in rats, phenytoin significantly decreased locomotion. AK6 and E249, suppressed in vitro and in vivo seizures to a similar extent. Their in vivo activities are comparable with but not superior to phenytoin. The most efficacious, AK6 produced no locomotor suppression while phenytoin did. Thus, AK6 and E249 may be excellent candidates for further investigation as potential agents for the treatment of epilepsy syndromes with possibly less CNS side effects.	[Qaddoumi, Mohamed G.; Ananthalakshmi, Kethireddy V. V.; Kombian, Samuel B.] Kuwait Univ, Fac Pharm, Dept Pharmacol & Therapeut, Safat, Kuwait; [Phillips, Oludotun A.] Kuwait Univ, Fac Pharm, Dept Pharmaceut Chem, Safat, Kuwait; [Edafiogho, Ivan O.] Univ St Joseph, Sch Pharm, Dept Pharmaceut Sci, Hartford, CT USA	Kuwait University; Kuwait University	Kombian, SB (corresponding author), Kuwait Univ, Fac Pharm, Dept Pharmacol & Therapeut, Safat, Kuwait.	kombian@hsc.edu.kw	Qaddoumi, Mohammad/AAT-2452-2020		Kuwait University Research grant [PR01/08]	Kuwait University Research grant	This work was funded by Kuwait University Research grant award #PR01/08. Kuwait University had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthalakshmi KVV, 2006, NEUROSCIENCE, V141, P345, DOI 10.1016/j.neuroscience.2006.03.021; Ananthalakshmi KVV, 2007, EPILEPSY RES, V76, P85, DOI 10.1016/j.eplepsyres.2007.07.001; Avoli Massimo, 2006, Epilepsy Curr, V6, P203, DOI 10.1111/j.1535-7511.2006.00146.x; Avoli M, 2013, NEUROPHARMACOLOGY, V69, P37, DOI 10.1016/j.neuropharm.2012.06.044; Barton ME, 2001, EPILEPSY RES, V47, P217, DOI 10.1016/S0920-1211(01)00302-3; Bethmann K, 2008, NEUROBIOL DIS, V31, P169, DOI 10.1016/j.nbd.2008.01.005; Borgland SL, 2004, J NEUROSCI, V24, P7482, DOI 10.1523/JNEUROSCI.1312-04.2004; Brodie MJ, 2013, EPILEPSIA, V54, P11, DOI 10.1111/j.1528-1167.2012.03671.x; BROWNING RA, 1985, LIFE SCI, V37, P2205, DOI 10.1016/0024-3205(85)90573-9; BUCKMASTER PS, 1994, HIPPOCAMPUS, V4, P393, DOI 10.1002/hipo.450040402; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; de Curtis M, 2012, NETWORK; Deeb TZ, 2012, EPILEPSIA, V53, P79, DOI 10.1111/epi.12037; Delgado-Escueta A V, 1999, Adv Neurol, V79, P3; EDAFIOGHO IO, 1992, J MED CHEM, V35, P2798, DOI 10.1021/jm00093a012; Edafiogho IO, 2007, J PHARM SCI-US, V96, P2509, DOI 10.1002/jps.20967; Edafiogho IO, 2014, EUR J MED CHEM, V76, P20, DOI 10.1016/j.ejmech.2014.02.002; El Bahh B, 2005, EUR J NEUROSCI, V22, P1417, DOI 10.1111/j.1460-9568.2005.04338.x; Faught E, 2007, LANCET NEUROL, V6, P476, DOI 10.1016/S1474-4422(07)70115-1; Feng ZY, 2003, J NEUROPHYSIOL, V90, P2253, DOI 10.1152/jn.00241.2003; Gaitatzis A, 2013, CNS DRUGS, V27, P435, DOI 10.1007/s40263-013-0063-0; GEAN PW, 1988, NEUROPHARMACOLOGY, V27, P557, DOI 10.1016/0028-3908(88)90175-X; Gulyas-Kovacs A, 2002, BRAIN RES, V945, P174, DOI 10.1016/S0006-8993(02)02751-8; Huberfeld G, 2011, NAT NEUROSCI, V14, P627, DOI 10.1038/nn.2790; KALIVAS PW, 1993, J NEUROSCI, V13, P266; Kerr MP, 2012, ACTA NEUROL SCAND, V126, P1, DOI 10.1111/ane.12014; Klapstein GJ, 1997, J NEUROPHYSIOL, V78, P1651, DOI 10.1152/jn.1997.78.3.1651; Kobow K, 2012, EPILEPSIA, V53, P1868, DOI 10.1111/j.1528-1167.2012.03716.x; Kombian SB, 2005, BRIT J PHARMACOL, V145, P945, DOI 10.1038/sj.bjp.0706250; Kwan P, 2011, NEW ENGL J MED, V365, P919, DOI 10.1056/NEJMra1004418; Lenkowski PW, 2007, NEUROPHARMACOLOGY, V52, P1044, DOI 10.1016/j.neuropharm.2006.11.001; Loscher W, 1998, PROG NEUROBIOL, V54, P721, DOI 10.1016/S0301-0082(97)00092-0; Loscher W, 2002, EPILEPSY RES, V50, P105, DOI 10.1016/S0920-1211(02)00073-6; Loscher W, 2002, EPILEPSY RES, V50, P3, DOI 10.1016/S0920-1211(02)00063-3; Mares P, 2006, MODELS OF SEIZURES AND EPILEPSY, P153, DOI 10.1016/B978-012088554-1/50014-1; Mattson RH, 1998, NEUROLOGY, V51, pS15, DOI 10.1212/WNL.51.5_Suppl_4.S15; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; MCNAMARA JO, 1994, EPILEPSIA, V35, pS51, DOI 10.1111/j.1528-1157.1994.tb05929.x; McNamara JO, 2006, SCI STKE, P12; Motamedia GK, 2006, EPILEPSY RES, V70, P200, DOI 10.1016/j.eplepsyres.2006.05.001; MULZAC D, 1993, EPILEPSIA, V34, P1141, DOI 10.1111/j.1528-1157.1993.tb02147.x; Pahuja M, 2012, EPILEPSY BEHAV, V25, P368, DOI 10.1016/j.yebeh.2012.08.014; Pollard JR, 2006, LANCET NEUROL; Rogawski Michael A, 2006, Epilepsy Curr, V6, P197, DOI 10.1111/j.1535-7511.2006.00144.x; Rowley NM, 2010, EPILEPSY RES, V92, P163, DOI 10.1016/j.eplepsyres.2010.09.002; Rubio Carmen, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P298; Santhouse J, 2007, EPILEPSIA; SCHARFMAN HE, 1990, NEUROSCIENCE, V35, P491, DOI 10.1016/0306-4522(90)90324-W; Schmidt D, 2012, EPILEPTIC DISORD, V14, P105, DOI 10.1684/epd.2012.0512; Sorensen AT, 2013, EPILEPSIA, V54, P1, DOI 10.1111/epi.12000; Staley Kevin J, 2006, Epilepsy Curr, V6, P199, DOI 10.1111/j.1535-7511.2006.00145.x; Staley KJ, 2011, NEUROSCI LETT, V497, P247, DOI 10.1016/j.neulet.2011.03.070; STASHEFF SF, 1985, BRAIN RES, V344, P296, DOI 10.1016/0006-8993(85)90807-8; Stohr T, 2007, EPILEPSY RES, V74, P147, DOI 10.1016/j.eplepsyres.2007.03.004; SUZDAK PD, 1995, EPILEPSIA, V36, P612, DOI 10.1111/j.1528-1157.1995.tb02576.x; SWANSON TH, 1995, J CLIN NEUROPHYSIOL, V12, P2; SWARTZWELDER HS, 1987, BRAIN RES, V410, P362; TRAYNELIS SF, 1988, J NEUROPHYSIOL, V59, P259, DOI 10.1152/jn.1988.59.1.259; Trinka E, 2012, ACTA NEUROL SCAND, V126, P10, DOI 10.1111/ane.12015; URUNO K, 1994, HIPPOCAMPUS, V4, P583, DOI 10.1002/hipo.450040508; Vincent P, 2009, NEUROSCIENCE, V158, P309, DOI 10.1016/j.neuroscience.2008.02.066; Wang ZJ, 2011, J PHARMACOL EXP THER, V336, P916, DOI 10.1124/jpet.110.173740; White HS, 2002, J PHARMACOL EXP THER, V302, P636, DOI 10.1124/jpet.102.034819; WONG BY, 1990, EPILEPSY RES, V7, P29, DOI 10.1016/0920-1211(90)90051-V	65	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99770	10.1371/journal.pone.0099770	http://dx.doi.org/10.1371/journal.pone.0099770			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945912	gold, Green Published, Green Submitted			2022-12-25	WOS:000340721500027
J	Edelstein, M; Wallensten, A; Zetterqvist, I; Hulth, A				Edelstein, Michael; Wallensten, Anders; Zetterqvist, Inga; Hulth, Anette			Detecting the Norovirus Season in Sweden Using Search Engine Data - Meeting the Needs of Hospital Infection Control Teams	PLOS ONE			English	Article							ECONOMIC VALUE; GASTROENTERITIS; EPIDEMIOLOGY; ENGLAND; COMMUNITY; OUTBREAKS; WEATHER; DISEASE	Norovirus outbreaks severely disrupt healthcare systems. We evaluated whether Websok, an internet-based surveillance system using search engine data, improved norovirus surveillance and response in Sweden. We compared Websok users' characteristics with the general population, cross-correlated weekly Websok searches with laboratory notifications between 2006 and 2013, compared the time Websok and laboratory data crossed the epidemic threshold and surveyed infection control teams about their perception and use of Websok. Users of Websok were not representative of the general population. Websok correlated with laboratory data (b = 0.88-0.89) and gave an earlier signal to the onset of the norovirus season compared with laboratory-based surveillance. 17/21 (81%) infection control teams answered the survey, of which 11 (65%) believed Websok could help with infection control plans. Websok is a low-resource, easily replicable system that detects the norovirus season as reliably as laboratory data, but earlier. Using Websok in routine surveillance can help infection control teams prepare for the yearly norovirus season.	[Edelstein, Michael; Wallensten, Anders; Zetterqvist, Inga; Hulth, Anette] Publ Hlth Agcy Sweden, Dept Epidemiol & Evaluat, Solna, Sweden; [Edelstein, Michael] European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden	Public Health Agency of Sweden; European Centre for Disease Prevention & Control	Edelstein, M (corresponding author), Publ Hlth Agcy Sweden, Dept Epidemiol & Evaluat, Solna, Sweden.	Michael.edelstein@folkhalsomyndigheten.se	Edelstein, Michael/GQY-7219-2022; Hulth, Anette/E-2162-2017	Edelstein, Michael/0000-0002-7323-0806; Hulth, Anette/0000-0002-3132-808X				Bartsch SM, 2012, VACCINE, V30, P7097, DOI 10.1016/j.vaccine.2012.09.040; Butler D, 2013, NATURE, V494, P155, DOI 10.1038/494155a; Crepey P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075226; Desai R, 2012, CLIN INFECT DIS, V55, pE75, DOI 10.1093/cid/cis579; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Hall AJ, 2011, EMERG INFECT DIS, V17, P1381, DOI 10.3201/eid1708.101533; Hedlund KO, 2000, J INFECT DIS, V181, pS275, DOI 10.1086/315585; Hulth A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-252; Hulth A, 2010, EMERG INFECT DIS, V16, P1319, DOI 10.3201/eid1608.100093; Hulth A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004378; Koopmans M, 2009, J HOSP INFECT, V73, P331, DOI 10.1016/j.jhin.2009.06.028; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Lee BY, 2011, CLIN MICROBIOL INFEC, V17, P640, DOI 10.1111/j.1469-0691.2010.03345.x; Lee BY, 2011, INFECT CONT HOSP EP, V32, P191, DOI 10.1086/657910; Lopman BA, 2004, EMERG INFECT DIS, V10, P1827, DOI 10.3201/eid1010.030941; Lopman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006671; Loveridge P, 2010, J HOSP INFECT, V74, P385, DOI 10.1016/j.jhin.2009.10.007; MONTO AS, 1983, J INFECT DIS, V148, P284, DOI 10.1093/infdis/148.2.284; Mounts AW, 2000, J INFECT DIS, V181, pS284, DOI 10.1086/315586; Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Pelat C, 2009, EMERG INFECT DIS, V15, P1327, DOI 10.3201/eid1508.090299; Pelat C, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-29; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046	28	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100309	10.1371/journal.pone.0100309	http://dx.doi.org/10.1371/journal.pone.0100309			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24944844	Green Published, Green Submitted, gold			2022-12-25	WOS:000338917900039
J	Fernandez, J; Wilson, RA				Fernandez, Jessie; Wilson, Richard A.			Characterizing Roles for the Glutathione Reductase, Thioredoxin Reductase and Thioredoxin Peroxidase-Encoding Genes of Magnaporthe oryzae during Rice Blast Disease	PLOS ONE			English	Article							PLANT INFECTION; SACCHAROMYCES-CEREVISIAE; TRIGGERED IMMUNITY; ESCHERICHIA-COLI; OXIDATIVE STRESS; NADPH OXIDASES; CELL-DEATH; FUNGUS; METABOLISM; INVASION	Understanding how pathogenic fungi adapt to host plant cells is of major concern to securing global food production. The hemibiotrophic rice blast fungus Magnaporthe oryzae, cause of the most serious disease of cultivated rice, colonizes leaf cells asymptomatically as a biotroph for 4-5 days in susceptible rice cultivars before entering its destructive necrotrophic phase. During the biotrophic growth stage, M. oryzae remains undetected in the plant while acquiring nutrients and growing cell-to-cell. Which fungal processes facilitate in planta growth and development are still being elucidated. Here, we used gene functional analysis to show how components of the NADPH-requiring glutathione and thioredoxin antioxidation systems of M. oryzae contribute to disease. Loss of glutathione reductase, thioredoxin reductase and thioredoxin peroxidase-encoding genes resulted in strains severely attenuated in their ability to grow in rice cells and that failed to produce spreading necrotic lesions on the leaf surface. Glutathione reductase, but not thioredoxin reductase or thioredoxin peroxidase, was shown to be required for neutralizing plant generated reactive oxygen species (ROS). The thioredoxin proteins, but not glutathione reductase, were shown to contribute to cell-wall integrity. Furthermore, glutathione and thioredoxin gene expression, under axenic growth conditions, was dependent on both the presence of glucose and the M. oryzae sugar/NADPH sensor Tps1, thereby suggesting how glucose availability, NADPH production and antioxidation might be connected. Taken together, this work identifies components of the fungal glutathione and thioredoxin antioxidation systems as determinants of rice blast disease that act to facilitate biotrophic colonization of host cells by M. oryzae.	[Fernandez, Jessie; Wilson, Richard A.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln	Wilson, RA (corresponding author), Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA.	rwilson10@unl.edu	Fernandez, Jessie/AAR-3477-2021	Fernandez, Jessie/0000-0002-0897-2707	National Science Foundation [IOS-1145347]	National Science Foundation(National Science Foundation (NSF))	This work was funded by the National Science Foundation (IOS-1145347). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery AM, 2001, J BIOL CHEM, V276, P33730, DOI 10.1074/jbc.M105672200; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Chi MH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000401; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Dagdas YF, 2012, SCIENCE, V336, P1590, DOI 10.1126/science.1222934; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Donofrio NM, 2014, NEW PHYTOL, V201, P367, DOI 10.1111/nph.12623; Egan MJ, 2007, P NATL ACAD SCI USA, V104, P11772, DOI 10.1073/pnas.0700574104; Fernandez J, 2012, MOL PLANT MICROBE IN, V25, P1286, DOI 10.1094/MPMI-12-11-0326; Fernandez J., 2011, Mycology - An International Journal on Fungal Biology, V2, P46, DOI 10.1080/21501203.2011.563431; Fernandez J, 2014, PROTOPLASMA, V251, P37, DOI 10.1007/s00709-013-0541-8; Fernandez J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02398; Fernandez J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002673; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Foster AJ, 2003, EMBO J, V22, P225, DOI 10.1093/emboj/cdg018; Gassmann W, 2012, MOL PLANT MICROBE IN, V25, P862, DOI 10.1094/MPMI-01-12-0024-IA; Giraldo MC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2996; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Huang K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001335; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Koeck M, 2011, CELL MICROBIOL, V13, P1849, DOI 10.1111/j.1462-5822.2011.01665.x; KOSOWER NS, 1969, BIOCHEM BIOPH RES CO, V37, P593, DOI 10.1016/0006-291X(69)90850-X; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; Kupferschmidt K, 2012, SCIENCE, V337, P636, DOI 10.1126/science.337.6095.636; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Meng L, 2010, P NATL ACAD SCI USA, V107, P3900, DOI 10.1073/pnas.0913759107; Mentlak TA, 2012, PLANT CELL, V24, P322, DOI 10.1105/tpc.111.092957; Muller EGD, 1996, MOL BIOL CELL, V7, P1805, DOI 10.1091/mbc.7.11.1805; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Park CH, 2012, PLANT CELL, V24, P4748, DOI 10.1105/tpc.112.105429; Pennisi E, 2010, SCIENCE, V327, P804, DOI 10.1126/science.327.5967.804; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; Ross SJ, 2000, MOL BIOL CELL, V11, P2631, DOI 10.1091/mbc.11.8.2631; Ryder LS, 2013, P NATL ACAD SCI USA, V110, P3179, DOI 10.1073/pnas.1217470110; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Skamnioti P, 2007, MOL PLANT MICROBE IN, V20, P568, DOI 10.1094/MPMI-20-5-0568; Tanabe S, 2011, MOL PLANT MICROBE IN, V24, P163, DOI 10.1094/MPMI-07-10-0175; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Valent B, 2010, CURR OPIN PLANT BIOL, V13, P434, DOI 10.1016/j.pbi.2010.04.012; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; Wilson RA, 2007, EMBO J, V26, P3673, DOI 10.1038/sj.emboj.7601795; Wilson RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047392; Wilson RA, 2010, P NATL ACAD SCI USA, V107, P21902, DOI 10.1073/pnas.1006839107; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Yi M, 2013, ANNU REV PHYTOPATHOL, V51, P587, DOI 10.1146/annurev-phyto-081211-172916; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Zhou XY, 2011, METHODS MOL BIOL, V722, P199, DOI 10.1007/978-1-61779-040-9_15	51	43	43	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87300	10.1371/journal.pone.0087300	http://dx.doi.org/10.1371/journal.pone.0087300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24955977	Green Published, gold			2022-12-25	WOS:000330339800093
J	Heming, N; Urien, S; Fulda, V; Meziani, F; Gacouin, A; Clavel, M; Planquette, B; Faisy, C				Heming, Nicholas; Urien, Saik; Fulda, Virginie; Meziani, Ferhat; Gacouin, Arnaud; Clavel, Marc; Planquette, Benjamin; Faisy, Christophe			Population Pharmacodynamic Modeling and Simulation of the Respiratory Effect of Acetazolamide in Decompensated COPD Patients	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; INTENSIVE-CARE-UNIT; MECHANICAL VENTILATION; METABOLIC ALKALOSIS; CRITICALLY-ILL; ACUTE EXACERBATION; SURVIVAL; FAILURE; PHARMACOKINETICS; DETERMINANTS	Background: Chronic obstructive pulmonary disease (COPD) patients may develop metabolic alkalosis during weaning from mechanical ventilation. Acetazolamide is one of the treatments used to reverse metabolic alkalosis. Methods: 619 time-respiratory (minute ventilation, tidal volume and respiratory rate) and 207 time-PaCO2 observations were obtained from 68 invasively ventilated COPD patients. We modeled respiratory responses to acetazolamide in mechanically ventilated COPD patients and then simulated the effect of increased amounts of the drug. Results: The effect of acetazolamide on minute ventilation and PaCO2 levels was analyzed using a nonlinear mixed effect model. The effect of different ventilatory modes was assessed on the model. Only slightly increased minute ventilation without decreased PaCO2 levels were observed in response to 250 to 500 mg of acetazolamide administered twice daily. Simulations indicated that higher acetazolamide dosage (>1000 mg daily) was required to significantly increase minute ventilation (P<.001 vs pre-acetazolamide administration). Based on our model, 1000 mg per day of acetazolamide would increase minute ventilation by >0.75 L min(-1) in 60% of the population. The model also predicts that 45% of patients would have a decrease of PaCO2>5 mmHg with doses of 1000 mg per day. Conclusions: Simulations suggest that COPD patients might benefit from the respiratory stimulant effect after the administration of higher doses of acetazolamide.	[Heming, Nicholas; Faisy, Christophe] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Sorbonne Paris Cite,Serv Reanimat Med, Paris, France; [Urien, Saik] Univ Paris 05, Hop Tarnier, AP HP,Unite Rech Clin, Sorbonne Paris Cite,CIC Cochin Necker INSERM 0110, Paris, France; [Fulda, Virginie] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Sorbonne Paris Cite,Ctr Reg Pharmacovigilance, Paris, France; [Meziani, Ferhat] Hop Civil, Serv Reanimat Med, Strasbourg, France; [Gacouin, Arnaud] Hop Pontchaillou, Serv Reanimat Med & Infect, Rennes, France; [Clavel, Marc] CHU Limoges, Serv Reanimat Polyvalente, Limoges, France; [Planquette, Benjamin] Hop Andre Mignot, Serv Reanimat Med Chirurg, Le Chesnay, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Strasbourg; CHU Rennes; CHU Limoges; Centre Hospitalier de Versailles	Heming, N (corresponding author), Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Sorbonne Paris Cite,Serv Reanimat Med, Paris, France.	nicholas.heming@orange.fr	Urien, Saïk/G-3240-2013; PLANQUETTE, Benjamin/AAL-7166-2021	Urien, Saïk/0000-0002-1065-0600; 				Arozullah AM, 2000, ANN SURG, V232, P242, DOI 10.1097/00000658-200008000-00015; BERTHELSEN P, 1985, INTENS CARE MED, V11, P26; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; BRIMIOULLE S, 1989, CRIT CARE MED, V17, P232, DOI 10.1097/00003246-198903000-00006; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; Faisy C, 2010, INTENS CARE MED, V36, P859, DOI 10.1007/s00134-010-1795-7; Gosselink R, 1996, AM J RESP CRIT CARE, V153, P976, DOI 10.1164/ajrccm.153.3.8630582; Groenewegen KH, 2003, CHEST, V124, P459, DOI 10.1378/chest.124.2.459; Gunen H, 2005, EUR RESPIR J, V26, P234, DOI 10.1183/09031936.05.00024804; Gursel G, 2005, RESPIRATION, V72, P61, DOI 10.1159/000083402; Heming N, 2012, CRIT CARE, V16, DOI 10.1186/cc11323; Heming N, 2011, CRIT CARE, V15, DOI 10.1186/cc10448; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Khanna A, 2001, Respir Care, V46, P354; Kiwull-Schone HF, 2001, AM J RESP CRIT CARE, V163, P478, DOI 10.1164/ajrccm.163.2.9911075; Laghi F, 2012, MINERVA ANESTESIOL, V78, P201; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; Mazur JE, 1999, CRIT CARE MED, V27, P1257, DOI 10.1097/00003246-199907000-00004; MENZIES R, 1989, CHEST, V95, P398, DOI 10.1378/chest.95.2.398; Moran JL, 1998, CRIT CARE MED, V26, P71, DOI 10.1097/00003246-199801000-00019; Nevins ML, 2001, CHEST, V119, P1840, DOI 10.1378/chest.119.6.1840; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Ritschel WA, 1998, J CLIN PHARMACOL, V38, P533, DOI 10.1002/j.1552-4604.1998.tb05791.x; SENEFF MG, 1995, JAMA-J AM MED ASSOC, V274, P1852, DOI 10.1001/jama.274.23.1852; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Swenson ER, 1998, EUR RESPIR J, V12, P1242, DOI 10.1183/09031936.98.12061242; Teppema LJ, 1999, AM J RESP CRIT CARE, V160, P1592, DOI 10.1164/ajrccm.160.5.9903088; VOS PJE, 1994, EUR RESPIR J, V7, P850; Webster NR, 1999, CRIT REV CL LAB SCI, V36, P497, DOI 10.1080/10408369991239286; WONG DH, 1995, ANESTH ANALG, V80, P276, DOI 10.1097/00000539-199502000-00013; YANG KL, 1991, NEW ENGL J MED, V324, P1445, DOI 10.1056/NEJM199105233242101; Yano I, 1998, EUR J CLIN PHARMACOL, V54, P63, DOI 10.1007/s002280050422	32	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e86313	10.1371/journal.pone.0086313	http://dx.doi.org/10.1371/journal.pone.0086313			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24956152	Green Submitted, gold, Green Published			2022-12-25	WOS:000330237000090
